{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_cross_year",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 1000,
    "successful_questions_in_experiment": 1000,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 1000,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/nemotron-nano-30b-reasoning/e5_page_window_relevance_asc/qualitative_2hop_cross_year.json",
    "timestamp": "2026-02-04T15:31:49.551905"
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "\nThe gross benefit obligation for LMT’s non‑qualified defined‑benefit pension plans fell from about **$1.0 billion at the end of 2023 to $905 million at the end of 2024**.  At the same time, the pretax actuarial losses that remained in accumulated other comprehensive loss dropped from **$347 million in 2023 to $303 million in 2024**, a decline of roughly **$44 million** over the year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the gross benefit obligation decreased from $1.0 billion in 2023 to $905 million in 2024, and actuarial losses declined from $347 million to $303 million. The implied $44 million reduction in actuarial losses is correctly calculated. Minor formatting differences (e.g., 'about $1.0 billion' vs. exact $1.0 billion) are acceptable and do not affect factual accuracy. (2) The answer is complete, addressing both the gross benefit obligation and actuarial losses for both years, as required by the question. (3) Entities are correctly identified: LMT (Lockheed Martin), nonqualified defined benefit pension plans, and the correct fiscal years (2023 to 2024). (4) The reasoning is sound, showing a clear understanding of the trend (decline in both liability and losses) and synthesizing data across two time points. The answer conveys the same semantic meaning as the original, with slightly enhanced detail (e.g., mentioning 'pretax actuarial losses' and 'accumulated other comprehensive loss'), which is consistent with typical 10-K disclosures. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 342,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "\nBetween 2022 and 2024 the long‑term return assumption for GM’s U.S. pension assets rose from about **5.4 % (2022)** to **6.3 % (2023)** and **6.5 % (2024)** — a clear upward shift that the company tied to its December‑2024 investment‑policy study [GM 10‑K 2024, p. 86].  To support the higher expected return, GM increased the target equity and “other” (private‑equity, real‑estate, hedge‑fund) allocations (e.g., equity up to 11 % and other up to 29 % of assets in 2024 vs. 9 % and 23 % in 2022) while modestly reducing the debt share [GM 10‑K 2024, p. 88].  This re‑balancing signals a strategic move toward a more growth‑oriented asset mix to improve funded status and reduce volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in General Motors' long-term rate of return assumptions on U.S. pension plan assets from 2022 to 2024 and links it to strategic asset mix changes, which aligns with the ground truth. However, there is a discrepancy in the starting point: the LLM states the 2022 assumption was 5.4%, which refers to the rate at December 31, 2021 (as reported in the 2022 filing), but the ground truth clarifies this was a decrease from 5.6% in 2020 to 5.4% in 2021. The LLM omits the 2020 baseline and misrepresents the 5.4% figure as the '2022 assumption' rather than the end-of-2021 assumption reported in 2022. The 2023 (6.3%) and 2024 (6.5%) figures are accurate per the ground truth. (2) The quantitative accuracy is mostly correct but slightly off due to the misattribution of timing: the 5.4% rate was effective at the end of 2021, not representative of a 2022 assumption per se. The increase to 6.5% by end of 2024 is correctly reported. The LLM adds specific allocation percentages (e.g., equity up to 11%, 'other' to 29% in 2024 vs. 9% and 23% in 2022), which are plausible and consistent with a growth-oriented shift but are not present in the ground truth, introducing unverified detail. (3) The multi-hop reasoning is sound: the LLM correctly infers that higher return assumptions reflect strategic asset mix adjustments and connects this to improved funded status and reduced volatility. It synthesizes information across time and investment strategy, demonstrating strong qualitative reasoning. (4) The answer is contextually excellent, directly addressing both parts of the question—evolution of return assumptions and strategic implications—with relevant detail. The correctness score is 8 due to accurate core facts and reasoning but minor inaccuracies in temporal attribution and inclusion of unsupported granular allocation data. Quantitative accuracy is 7 due to the mislabeling of the 5.4% figure as '2022' without clarifying it was set in 2021. Qualitative and contextual scores are high due to strong logic and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 563,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "\nBetween 2023 and 2024 the ties with PDC Energy moved from a recent acquisition to full‑scale integration, with Chevron now reporting “legacy PDC assets” as a core part of its U.S. upstream segment.  The integration delivered a $3.5 billion rise in U.S. upstream earnings—driven by $2.2 billion of higher sales volumes from those assets and a 19 % (≈250 k boe/d) increase in net oil‑equivalent production, largely from the Permian Basin—while also eliminating $1.9 billion of decommissioning charges that had weighed on results in prior periods.  The upside was partially offset by lower commodity realizations, but overall the change translated into markedly stronger upstream earnings and production growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the acquisition and integration of PDC Energy by Chevron between 2023 and 2024, and notes the shift to reporting 'legacy PDC assets' contributing to upstream performance, which aligns with the ground truth. However, there are significant quantitative inaccuracies. The ground truth states a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, but the LLM claims a $3.5 billion rise in U.S. upstream earnings, with $2.2 billion attributed to higher sales volumes—this misrepresents the source and total impact. Additionally, the LLM introduces a $1.9 billion elimination of decommissioning charges and a production increase of approximately 250k boe/d, which are not present in the original answer and appear fabricated. The 19% increase in net oil-equivalent production matches the ground truth, but the LLM incorrectly equates this to ~250k boe/d without supporting data. (2) The $2.2 billion figure is correctly used but miscontextualized as part of a larger $3.5 billion increase not mentioned in the original. The 19% production growth is accurate, but the conversion to absolute volume is unsupported. The decommissioning charge elimination and lower commodity realizations are extraneous and unverified. (3) The multi-hop reasoning is partially sound—the model connects the acquisition in 2023 to operational impacts in 2024 and attributes financial and production impacts to PDC integration. However, it overreaches by introducing unverified financial components and misattributing earnings drivers. (4) The contextual relevance is high as it directly addresses the evolution and impacts; qualitative accuracy is moderate due to correct narrative flow but flawed entity-specific synthesis. Quantitative accuracy is low due to incorrect dollar amounts and unsupported conversions. Correctness score reflects partial factual alignment with major numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 525,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "\nSouthern Company continues to carry its energy‑related derivatives that are designated as regulatory hedges at fair value, recording any unrealized gain or loss as a regulatory asset or liability that is later amortized into fuel expense.  In the 2022 filing (reflected in the 2021 annual‑report tables) the net regulatory balances were relatively modest—e.g., Alabama Power showed a net regulatory asset of $50 million and a liability of $6 million, while Georgia Power’s net liability was only a few million dollars.  By the 2024 filing the same line items have expanded sharply: Georgia Power’s net liability grew to $27 million, Mississippi Power’s to $17 million and Southern Power’s to $51 million, indicating larger unrealized losses, but the presentation format (current and non‑current regulatory assets/liabilities, netted against offsetting positions) has remained the same.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several specific dollar amounts and company-level details (e.g., Alabama Power, Georgia Power, Mississippi Power, Southern Power) and claims changes in net regulatory liabilities between 2022 and 2024. However, these figures are not present in the original ground truth, which does not provide specific dollar amounts for individual subsidiaries or quantify the changes in unrealized gains/losses. The ground truth emphasizes a shift in disclosure focus—from reporting pre-tax effects of unrealized gains/losses on regulatory hedging instruments (as of 2020 and 2021) in the 2022 filing, to presenting fair values of energy-related, interest rate, and foreign currency derivatives as assets or liabilities in the balance sheet under 'Other' or 'Risk Management Activities' by 2024. The LLM incorrectly implies that the presentation format remained the same (i.e., netted in regulatory assets/liabilities), which contradicts the ground truth indicating a change in both valuation approach and presentation. While the LLM correctly identifies that derivatives are carried at fair value and that regulatory assets/liabilities are involved, it misrepresents the nature and direction of the change in financial statement presentation. The detailed numerical claims (e.g., $50M asset, $27M liability growth) lack support in the provided ground truth and introduce fabricated data, severely impacting quantitative accuracy. The reasoning is partially sound in recognizing regulatory treatment but fails on the multi-hop synthesis of how disclosure practices evolved across years. The answer is contextually relevant and addresses the question's intent but is factually misleading in key aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 464,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "\nChevron’s recorded stake in Tengizchevroil was roughly $27.4 billion at the end of 2022, edged down to about $26.95 billion in 2023 and stayed essentially flat near $27.3 billion by the end of 2024.  At the same time, the equity earnings it recognized from the affiliate fell from $4.39 billion in 2022 to $3.38 billion in 2023 and to $3.03 billion in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly regarding the investment carrying value in 2022. The ground truth states that Chevron's investment and advances reached $27,368 million in 2024 (up from $26,954 million in 2023), but the LLM incorrectly claims the value was $27.4 billion in 2022 — this is chronologically reversed and factually wrong. The correct 2022 carrying value is not explicitly stated in the original answer, only that it was about $100 higher than its equity in net assets and tied to a $4.5 billion loan. The LLM fabricates a precise $27.4 billion figure for 2022 that is unsupported by the ground truth. Additionally, the equity earnings for 2023 are stated as $3.38 billion in the LLM answer, but this number is not present in the original answer, which only provides 2022 ($4,386 million) and 2024 ($3,033 million) figures. (2) The only correct quantitative values are the $3.03 billion equity earnings in 2024 and the approximate $26.95 billion investment in 2023. The $27.3 billion in 2024 is close to the correct $27,368 million (~$27.37 billion), so minor rounding is acceptable. However, the erroneous 2022 investment value and the made-up 2023 earnings significantly undermine quantitative accuracy. (3) The qualitative reasoning shows understanding of the trend — declining equity earnings and relatively stable but slightly increasing investment — which aligns with the ground truth. However, the failure to accurately represent the 2022–2023–2024 investment trajectory (which actually increased from 2023 to 2024) and the introduction of unsupported numbers breaks the multi-hop synthesis. The mention of the $4.5 billion loan and the FGP/WPMP development, which is a key explanatory factor in the original answer, is entirely omitted. (4) Despite these issues, the answer remains contextually relevant, addressing both investment carrying value and equity earnings over the specified period, and correctly identifying the downward trend in profitability. However, due to significant numerical inaccuracies and missing explanatory context, the correctness score is reduced to 6, reflecting partial accuracy with major flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 591,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s ownership of Alert Innovation remained at 100 % – the company had acquired the entity in fiscal 2023 and held it as a wholly‑owned subsidiary throughout fiscal 2024. The relationship changed when Walmart completed a $0.4 billion purchase of Alert Innovation in fiscal 2023, converting the target from a variable‑interest entity to a fully consolidated, 100 % owned subsidiary.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding Walmart's ownership stake in fiscal 2024. While it correctly states that Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023 and previously consolidated it as a variable interest entity, it falsely claims that Walmart retained 100% ownership throughout fiscal 2024. The ground truth confirms that Walmart sold and deconsolidated Alert Innovation in fiscal 2024, resulting in 0% ownership—making the core claim of continued ownership completely wrong. (2) Quantitatively, the $0.4 billion acquisition amount is accurate and correctly attributed to fiscal 2023, so numerical data is correct. However, the answer fails to mention the sale transaction in fiscal 2024, which is a critical omission. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes across two fiscal years and two transactions (acquisition and divestiture), but the LLM only accounts for the first hop (acquisition) and misses the second (sale). This breaks the logical chain and leads to an incorrect conclusion. (4) Despite correct use of terminology (e.g., variable interest entity, wholly-owned subsidiary) and accurate numbers, the answer contradicts the ground truth on the key point of ownership evolution. Hence, correctness and qualitative accuracy are low. Contextual relevance is moderate because the answer addresses the right entities and timeframe but omits a pivotal event.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 403,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the fair‑value of Starbucks’ foreign‑currency‑other derivative **assets** fell from roughly **$73 million** (reported on page 68 for Oct 2 2022) to about **$55 million** (page 72 for Oct 1 2023).  At the same time the corresponding **liability** rose from roughly **$0.3 million** to **$4.8 million**.  The decline in asset hedges and the increase in liability hedges show that the company is re‑balancing its foreign‑currency exposure—shifting from a larger net‑asset position to a more neutral net‑liability stance—to better match its hedges against anticipated cash‑flow fluctuations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers compared to the ground truth. In fiscal 2022, the correct foreign currency - other derivative asset in AOCI was $55.3 million, not $73 million as stated. The LLM incorrectly cites a total asset value of $73 million in 2022, which does not match the ground truth breakdown of $55.3 million in AOCI with $32.5 million expected to be reclassified. For 2023, the LLM reports total assets of $55 million, but the correct figures are $1.9 million (current) and $1.7 million (long-term), summing to $3.6 million—not $55 million. The liability increase to $4.8 million is close to the correct total of $8.8 million ($4.7M current + $4.1M long-term), but still underreports by over 40%. (2) Calculations and comparisons are flawed: the claimed drop from $73M to $55M in assets is incorrect both in magnitude and direction—ground truth shows a much steeper decline to just $3.6M. The liability rise from $0.3M to $4.8M misrepresents the actual shift, as the 2022 liability was not $0.3M (ground truth does not specify a liability for 2022, implying minimal or zero, but the 2023 total is significantly higher than $4.8M). (3) Multi-hop reasoning is partially sound—the LLM correctly infers a strategic rebalancing toward a more neutral exposure stance based on changing asset/liability positions. However, due to incorrect inputs, the reasoning is based on flawed data. The conclusion about shifting to match anticipated cash flows is plausible but not fully supported by the actual data provided in the ground truth. (4) Scores reflect major quantitative errors (3/10), partially correct qualitative interpretation (5/10), high contextual relevance (8/10) as it addresses the right concepts and time frame, and an overall correctness score of 4 due to severe number inaccuracies undermining the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 511,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "\nMedtronic eliminated its A Preferred Shares between fiscal 2022 and 2024: the company fully redeemed the remaining 1,872 A Preferred Shares in the third quarter of fiscal 2022 (for a total of $0.075 million), and as a result no A Preferred Shares were outstanding at the end of either fiscal 2023 or fiscal 2024. No further issuance, redemption or other treatment of these shares is noted in the subsequent years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers and dates are correct: the redemption of 1,872 A Preferred Shares for $0.075 million in the third quarter of fiscal 2022 is accurately reported. The dollar amount and share count match the original answer exactly, and format is acceptable. (2) The statement that no A Preferred Shares were outstanding by the end of fiscal 2023 and 2024 aligns with the ground truth that no shares remained outstanding after April 29, 2022, and were not reissued through 2024. (3) The multi-hop reasoning is sound: the model correctly infers that because the shares were fully redeemed in 2022 and none were outstanding in 2023 and 2024, there was no reissuance, indicating discontinuation. (4) The only minor difference is that the original answer explicitly states the shares were gone 'by April 29, 2022' (a specific date), while the LLM says 'at the end of fiscal 2023 or 2024'—slightly less precise on timing but still factually consistent. The LLM also uses 'eliminated' and 'fully redeemed', which are semantically equivalent to 'redeemed' and 'discontinued'. No incorrect entities or metrics are introduced. The answer fully addresses both parts of the question: evolution between 2022–2024 and the specific 2022 action. Thus, the answer is excellent with only negligible loss in temporal precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 390,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "\nComcast’s equity income from Atairos flipped from a **$537 million loss in 2022 to a $789 million gain in 2023**.  This swing was driven by fair‑value adjustments on Atairos’s underlying investments, which produced **$1.1 billion of income in 2023 versus a $434 million loss in 2022**, propelling total investment income from a $861 million net loss to a $1.25 billion net gain.  (Pages 39‑40, CMCSA 10‑K 2023; see the “Equity in net income (losses) of investees, net” table.)",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies despite capturing the general trend and context correctly. (1) The reported $537 million loss for 2022 is incorrect; the ground truth states a $434 million loss, which the LLM partially acknowledges later when mentioning 'a $434 million loss in 2022'—but contradicts itself by stating a $537 million loss earlier. This inconsistency undermines factual reliability. (2) The 2023 income is stated as $789 million, but the correct figure from the original answer is $1.1 billion, which the LLM does mention in the context of fair value adjustments but fails to align with the overall equity income number. (3) The derived total investment income swing ($861 million loss to $1.25 billion gain) is not supported by the ground truth and introduces unverified calculations not present in the original answer. (4) While the LLM correctly identifies that fair value adjustments drove the change and references Atairos as the key investee, it confuses Comcast's total investment income with Atairos-specific results. The multi-hop reasoning is partially sound—linking fair value changes to equity income shifts—but the synthesis is flawed due to incorrect aggregation and conflicting numbers. (5) Contextually, the answer is relevant and addresses the evolution of Comcast's financial relationship with Atairos, citing the correct document source. However, the numerical inconsistencies—especially the conflicting figures for the same metric—result in a partially correct but misleading response. The qualitative understanding is adequate, but quantitative precision is poor, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 450,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "\nProved natural gas reserves in the Asia Pacific/Middle East region declined modestly from about 305 billion cubic feet (developed) in 2023 to 289 billion cubic feet in 2024 (≈5 % drop), with undeveloped reserves essentially unchanged at roughly 7 BCF. The dip reflects downward price‑related and operating‑cost revisions in equity affiliates, but ConocoPhillips is still pursuing growth there through equity‑affiliate acquisitions and discoveries, underscoring a strategic emphasis on the region despite the modest reserve decline.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, COP's natural gas reserves in the Asia Pacific/Middle East region were 312 BCF in 2023 and 296 BCF in 2024, representing a decline of 16 BCF (≈5.1%). The LLM incorrectly reports 305 BCF in 2023 and 289 BCF in 2024, which are both factually wrong. Additionally, the LLM introduces 'developed' and 'undeveloped' reserve categories (e.g., 7 BCF undeveloped) that are not present in the original answer and cannot be verified against the ground truth. (2) The calculation of a '≈5% drop' is directionally reasonable but based on incorrect base numbers, making the percentage slightly misleading. The actual drop from 312 to 296 is exactly 5.13%, so the approximation is acceptable if based on correct inputs. (3) The qualitative reasoning about strategic positioning partially aligns with the original answer's implication of limited growth or reallocation, but the LLM overreaches by asserting 'pursuing growth through equity-affiliate acquisitions and discoveries' and citing 'price-related and operating-cost revisions'—details not present in the ground truth and thus unsupported. This suggests the model added external knowledge or inference beyond the provided data. (4) Despite these issues, the LLM correctly identifies the geographic region, company (COP/ConocoPhillips), time frame (2023–2024), and general trend (modest decline), and addresses both parts of the question: reserve evolution and strategic implication. However, the factual inaccuracies in core numbers and unsupported explanatory details significantly reduce correctness. Hence, the scores reflect partial credit for structure and direction, but major deductions for factual and quantitative fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 484,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "\nENBREL’s Canadian sales fell sharply—$73 million in 2022, $47 million in 2023 (‑36 %), and $28 million in 2024 (‑40 %). This consecutive decline signals eroding market demand in Canada, driven by price compression and competitive pressures, indicating a downward trajectory for the product in that market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward revenue trend and provides accurate figures for 2023 ($47 million) and 2024 ($28 million), which match the ground truth. However, it incorrectly states 2022 revenue as $73 million instead of the correct $113 million, a significant error affecting quantitative accuracy. (2) The percentage declines are based on the incorrect 2022 baseline: -36% from $73M to $47M is accurate math but uses the wrong starting value; the actual drop from $113M to $47M is about -58.4%, and from $47M to $28M is ~-40.4%, so the second percentage is approximately correct. (3) The reasoning and synthesis are sound—correctly identifying a consistent decline and inferring a negative market trajectory, which aligns with the ground truth’s conclusion. The addition of 'price compression and competitive pressures' is contextual elaboration not contradicted by the original. (4) Despite the incorrect 2022 figure, the core trend and direction are correctly conveyed, warranting a 7 for overall correctness. Quantitative accuracy is penalized due to the major error in the initial revenue number. Qualitative and contextual scores are high because the logic, entity identification (ENBREL, Canada, correct years), and interpretation are valid and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 363,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "\nQualcomm moved from a generic reference in fiscal 2023 that human‑capital achievements would influence executive bonuses to a concrete, quantified mechanism in fiscal 2024, wherein such progress serves as a non‑financial performance modifier that can adjust the bonus payout by a multiple of **0.9 to 1.1** (i.e., up to roughly ±10 % of the target bonus). This explicit range reflects the company’s evolved approach to linking human‑capital advancements directly to executive compensation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately captures the evolution from fiscal 2023 to fiscal 2024: in 2023, human capital advancements were a general consideration for executive bonuses, while in 2024, they became a formal non-financial performance modifier. (2) The specific performance modifier range of 0.9 to 1.1 is correctly stated, with the interpretation of ±10% being a semantically valid explanation. (3) The multi-hop reasoning—linking changes across two fiscal years and identifying the shift from qualitative to quantitative treatment—is sound and well-articulated. (4) All entities (Qualcomm, fiscal years 2023 and 2024, executive compensation, bonus modifier) are correctly identified and synthesized. The answer is factually precise, complete, and contextually appropriate, with no omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 255,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s approved use expanded from a single hematologic indication to a broader B‑cell‑malignancy portfolio.  The 2022 filing (BMY 10‑K 2022, p. 19‑21) listed only a planned 3‑line‑plus chronic lymphocytic leukemia (CLL) indication.  By 2024 the product had received FDA accelerated approvals for three additional relapsed/refractory diseases—CLL/SLL (May 2024), follicular lymphoma after ≥ 2 prior therapies (May 2024) and mantle‑cell lymphoma after ≥ 2 prior lines (May 2024)—and a Japan approval for relapsed/refractory follicular lymphoma (August 2024) (BMY 10‑K 2024, pp. 44‑45).  Thus, Breyanzi’s therapeutic scope grew from a solitary CLL indication in 2022 to multiple, distinct hematologic approvals by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Breyanzi received two FDA accelerated approvals by 2024: one for relapsed/refractory CLL/SLL (March 2024, not May 2024) and another for relapsed/refractory Follicular Lymphoma (FL) after at least two prior therapies (May 2024). However, the LLM incorrectly states that *three additional* indications were approved in May 2024, including mantle-cell lymphoma (MCL), which is not supported by the original answer or known public data as of 2024. There is no mention of MCL in the ground truth, making this a major factual error. Additionally, the Japan approval in August 2024 is not mentioned in the original answer, introducing unverified information. (2) Date inaccuracies: the CLL/SLL approval was in March 2024 (per ground truth), but LLM states May 2024 for both CLL/SLL and FL, conflating the two. This misalignment affects quantitative accuracy. The claim of 'three additional' approvals is false—only two total approvals occurred, both in 2024, and neither were in 2022. (3) Multi-hop reasoning is partially sound—the model attempts to track evolution over time and cites specific trials and approvals—but it fails in synthesis by adding non-existent indications (MCL) and misattributing approval timelines. The original answer emphasizes a shift from late-stage trials in 2022 (TRANSCEND-CLL-004 and TRANSCEND-FL) to concrete approvals in 2024, which the LLM oversimplifies by stating only a 'planned 3-line-plus CLL indication' in 2022, omitting FL trial activity. (4) Correctness score is low due to major factual and numerical errors, especially the invention of an MCL indication and incorrect approval counts. Quantitative accuracy is poor due to wrong dates and fabricated approvals. Qualitative accuracy is moderate because the general direction of expansion is correct, but entity and reasoning flaws reduce reliability. Contextual relevance is high as the response stays on topic and addresses therapeutic scope evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 549,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "\nResorts and Vacations revenue grew from **$7.95 billion in 2023 to $8.38 billion in 2024**, a **5 % increase** (page 47).  That rise helped lift the overall **Parks & Experiences segment revenue from $32.55 billion to $34.15 billion**, also a **5 % rise** (page 47), indicating the segment’s performance was essentially in step with the broader segment’s growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for Resorts and Vacations ($7.95B in 2023 and $8.38B in 2024), which are accurate rounded versions of the ground truth values ($7,949M and $8,375M). The 5% growth rate is correctly calculated and matches the ground truth. Similarly, the overall Parks & Experiences revenue increase from $32.55B to $34.15B (from $32,549M to $34,151M) is accurately rounded and reflects the correct 5% growth. (2) All calculations are correct: (8,375 - 7,949)/7,949 ≈ 5.36%, which rounds to 5%; same for the overall segment. The LLM correctly states both grew by 5%, which aligns with the ground truth's characterization of 'slightly below' being negligible—here, effectively equal due to rounding. (3) The multi-hop reasoning is sound: the model synthesizes data from the same segment and year, compares sub-segment to total segment growth, and draws a valid conclusion. (4) The only minor deviation from the original answer is that the ground truth notes Resorts and Vacations growth was 'slightly below' overall Parks & Experiences growth, while the LLM says 'essentially in step', implying parity. However, due to rounding both to 5%, this interpretation is reasonable and not factually incorrect. Thus, the answer is semantically equivalent with negligible difference in interpretation. Quantitative accuracy is perfect; qualitative and overall correctness are marked down slightly due to the subtle misrepresentation of the comparative growth nuance, though it remains within acceptable rounding tolerance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 429,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s ASR‑related forward contracts continued to be recorded as equity (initially in capital‑surplus) and then re‑classified to treasury stock once the remaining shares were delivered. In 2023 the firm executed a $2.0 billion fixed‑dollar ASR with Citibank, posting a $0.4 billion forward‑contract amount (representing the 20 % of the notional not yet settled) and later re‑classifying that equity position to treasury stock in February 2023. In 2024 it entered a larger $3.0 billion fixed‑dollar ASR with Morgan Stanley, again recording a $0.4 billion forward‑contract (≈15 % of the notional) as equity in capital‑surplus and moving it to treasury stock in March 2024 when the final shares were received. Thus, while the absolute dollar size of the forward contract grew with the bigger 2024 program, its proportion of the total ASR notional fell, and the accounting treatment—equity recorded in capital‑surplus and subsequent transfer to treasury stock—remained the same.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in CVS's ASR forward contracts between 2023 and 2024. It correctly identifies the $2.0 billion 2023 ASR with Citibank and the $3.0 billion 2024 ASR with Morgan Stanley, and accurately states the forward contract value was $0.4 billion in both years. It correctly notes the forward contracts were recorded as equity in capital surplus and later reclassified to treasury stock upon final share delivery in February 2023 and March 2024, respectively. The answer also correctly observes that the proportion of the ASR allocated to the forward contract decreased (from 20% to ~15%), reflecting a shift in structure despite constant dollar value. However, there is a minor inaccuracy in stating that the 'absolute dollar size of the forward contract grew'—in fact, it remained constant at $0.4 billion in both years, as confirmed in the ground truth. This misstatement affects quantitative precision, though the core facts and reasoning are sound. All entities (CVS, Citibank, Morgan Stanley), years, and accounting treatments are correct. The multi-hop synthesis across years and contracts is well executed, and the answer directly addresses the question about structural and value evolution. Wording differences are acceptable under semantic equivalence, but the erroneous claim about forward contract dollar growth prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 385,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "\nThe 2023 filing described the valuation methods and listed total fair‑value amounts with only aggregate Level 1, Level 2 and Level 3 figures, and it treated the “Not Categorized” column as a catch‑all without explicit labeling. In the 2024 filing Duke Energy added a clearly labeled “Not Categorized (b)” column, expanded the reconciliation of Level 3 balances, and explicitly stated that investments measured using the NAV practical‑expedient are excluded from the hierarchy, thereby providing a much clearer and more transparent breakdown of how each asset class is categorized.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of increased transparency in Duke Energy's 2024 disclosure regarding fair value categorization, which aligns with the ground truth. It correctly identifies that investments using the NAV practical expedient are excluded from the fair value hierarchy and that labeling improved in 2024 (e.g., 'Not Categorized (b)'). However, it introduces details not present in the original answer: specifically, the mention of 'aggregate Level 1, Level 2 and Level 3 figures' in 2023 and a 'clearly labeled Not Categorized (b)' column are not mentioned in the ground truth and may reflect over-interpretation or inference beyond the provided data. The original answer emphasizes the *new reconciliation of beginning and ending balances for Level 3 assets* as the key 2024 enhancement, which the LLM mentions only indirectly via 'expanded the reconciliation of Level 3 balances'—this is partially correct but lacks precision about the focus on *qualified pension and other post-retirement assets*. Additionally, while the LLM correctly notes the continued use of the NAV expedient, it does not mention the unchanged allocation percentages among subsidiaries, a key point in the original answer. Thus, while the qualitative trend is right, the specific multi-hop synthesis (linking unchanged allocations + new Level 3 reconciliation = increased transparency) is incomplete. Quantitative accuracy is moderate—no explicit numbers are wrong, but no specific percentages or dollar amounts are cited from either year, and the answer fabricates structural details (like column labels) not in the source. Contextual relevance is high, as the response stays focused on pension asset valuation and fair value transparency. Overall, the answer is partially correct with plausible elaboration but contains unsupported specifics and omits key elements of the actual evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 509,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer moved from recognizing large U.S.‑government sales of Paxlovid under EUA contracts to a situation where most of that revenue was reversed and re‑characterized as a credit.  In Q4 2023 the company recorded a **$3.5 bn non‑cash revenue reversal** tied to the expected return of about 6.5 million treatment courses of EUA‑labeled inventory, and in Q1 2024 it booked a **$771 m favorable adjustment** reflecting 5.1 million courses actually returned, converting those courses into a volume‑based credit for a U.S. government patient‑assistance program.  At the same time, Pfizer **created a U.S. Strategic National Stockpile of 1.0 million courses** (provided at no cost) and now recognizes revenue only as the remaining contracted courses are delivered, with Paxlovid‑related deferred revenue falling to **$3.4 bn** (split between current and non‑current liabilities) and expected to be recognized through 2028.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: the $3.5 billion non-cash revenue reversal in 2023 (Q4), the $771 million favorable adjustment in 2024 (Q1), and the 5.1 million treatment courses actually returned (vs. 6.5 million initially expected). The mention of the 1.0 million Paxlovid treatment courses for the U.S. Strategic National Stockpile (SNS) is accurate. (2) Quantitative accuracy is perfect: values match the original answer exactly, including magnitude and timing. The $771 million adjustment correctly reflects the difference between expected and actual returns. (3) The reasoning is sound and captures the multi-hop transition from revenue reversal in 2023 to adjustment and new stockpile activity in 2024. However, the LLM states the SNS courses were 'provided at no cost,' while the original answer says Pfizer recognized $442 million in revenue related to the SNS. This is a material discrepancy: the LLM contradicts the ground truth by implying no revenue was recognized, when in fact $442 million was recognized. This affects qualitative accuracy but does not undermine the entire response. (4) Contextual relevance is excellent—the answer directly addresses the question about changes in financial obligations and revenue recognition, synthesizing events across 2023 and 2024. The only error is the mischaracterization of SNS revenue treatment. Otherwise, the answer is complete, well-structured, and semantically aligned with the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 417,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "\nERLEADA’s worldwide sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023**, a **~27 % increase** (as reported in the oncology segment breakdown).  This strong growth—driven by continued share gains and expanding market demand for the next‑generation androgen‑receptor inhibitor—helped offset declines in other oncology products such as ZYTIGA and IMBRUVICA, underscoring ERLEADA’s importance as a **key growth engine and strategic pillar within J&J’s oncology portfolio**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports ERLEADA's sales as $1.88 billion in 2022 and $2.39 billion in 2023, which aligns with the ground truth values of $1,881 million and $2,387 million (rounded appropriately). The calculated growth rate of ~27% matches the actual 26.9% increase (2,387 - 1,881) / 1,881 ≈ 26.9%, so quantitative accuracy is perfect. 2) The answer addresses both parts of the question: the financial performance evolution (sales growth) and ERLEADA's role in J&J's oncology portfolio. It correctly identifies that ERLEADA offset declines in ZYTIGA and IMBRUVICA, which is consistent with the ground truth. 3) All entities (ERLEADA, ZYTIGA, IMBRUVICA, J&J oncology portfolio) and time periods (2022–2023) are accurate. 4) The reasoning is sound: the LLM synthesizes sales data, growth trends, and competitive dynamics across multiple products to conclude ERLEADA is a key growth driver—this reflects valid multi-hop logic from product performance to portfolio impact. The only minor shortcoming is that it does not explicitly mention the overall oncology segment growth of 10.5%, which provides context for how ERLEADA outperformed the segment average. While this detail is omitted, the core conclusion about ERLEADA’s strategic importance remains well-supported. Thus, the answer is factually excellent and contextually relevant, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 387,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "\nERLEADA’s global sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023**, a **~27 % increase** (26.9 % total change, 27.5 % operational growth). This growth outpaced the overall Oncology segment’s 10.5 % rise and was driven by continued share gains and market expansion for apalutamide in metastatic castration‑resistant prostate cancer. The strong upward trend signals a robust and accelerating market trajectory for ERLEADA.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, ERLEADA's global sales in 2022 were $1,291 million, not $1.88 billion as stated in the LLM answer. The 2023 sales figure of $2.39 billion is close to the correct value of $2,387 million and can be considered acceptable due to rounding. However, the 2022 figure is off by nearly $600 million, which severely impacts calculation accuracy. (2) The reported growth rate of 26.9% from 2022 to 2023 is correct and matches the ground truth calculation: ($2,387M - $1,291M) / $1,291M ≈ 84.9%, not the implied growth from $1.88B to $2.39B (~27%), which would only be possible if the starting value were accurate. The LLM incorrectly implies that the 26.9% growth is from $1.88B, which invalidates the reasoning behind the percentage. Additionally, the mention of '27.5% operational growth' and comparison to the Oncology segment’s 10.5% rise introduces data not present in the original answer and may reflect hallucination or unsupported inference. (3) The multi-hop reasoning is partially sound—recognizing growth and interpreting it as a positive market trajectory aligns with the original conclusion. However, because the base year sales figure is wrong, the synthesis fails at a foundational level. The conclusion about 'accelerating market trajectory' contradicts the ground truth, which notes a slowdown from 70.0% growth in 2022 (vs 2021) to 26.9% in 2023 (vs 2022), indicating a maturing, not accelerating, phase. (4) Scores reflect: correctness penalized heavily for major factual error in 2022 sales; quantitative accuracy low due to incorrect dollar figures and misleading growth context; qualitative accuracy moderate due to correct identification of trend direction and some supporting logic; contextual relevance high as the response addresses the question’s intent and structure appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 515,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "\nIn FY 2023 the 0.584% Notes Due 2024 were still on the books with a net carrying amount of about $1.25 billion (see the 2023 10‑K table). The company retired the entire issue in FY 2024, so that by the FY 2024 filing the notes showed a $0 balance, indicating a deliberate shift away from that near‑term, low‑interest tranche to simplify the overall debt profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.25 billion carrying amount of the 0.584% Notes Due 2024 in FY 2023, matching the ground truth of $1,250 million. It also correctly states that the notes were retired and show a $0 balance in the FY 2024 filing. However, it inaccurately claims the retirement occurred in FY 2024, while the ground truth specifies repayment occurred in FY 2025 (with the balance reported as zero as of January 26, 2025). This misrepresents the timing of the repayment, a key factual detail. (2) Quantitatively, the dollar amounts and percentages are accurate, with acceptable format variation ($1.25 billion = $1,250 million). The interest rate (0.66%) is omitted in the LLM answer but not required for full correctness since the question focuses on balance and strategy evolution. (3) The reasoning is partially sound: the conclusion about simplifying the debt profile is plausible, but the incorrect timing of repayment (FY 2024 vs FY 2025) undermines the multi-hop synthesis across fiscal years. The model fails to correctly align the event (repayment) with the correct fiscal year (2025), which is critical for accurate debt strategy analysis. (4) Despite the timing error, the answer captures the core evolution—retirement of the notes rather than rollover—and remains contextually relevant and logically coherent. Hence, correctness is reduced to 7 due to significant but not fundamental factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 399,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s pension‑plan holdings of mortgage‑backed/asset‑backed securities fell sharply.  In 2022 the U.S. plans held **$1.119 bn** of such securities and the non‑U.S. plans held **$31 m** (total ≈ $1.15 bn); by the end of 2023 those amounts had dropped to **$676 m** in the U.S. and **$10 m** in non‑U.S. (total ≈ $686 m).  This represents a decline of roughly **$464 m, or about 40 %**, in the overall mortgage/asset‑backed securities investment.  (Values are taken from the Level‑2 tables on page 109 for 2022 U.S. plans and page 112 for 2023 U.S. and non‑U.S. plans.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Honeywell reported $982 million in Mortgage/Asset-backed securities under U.S. Plans, but the LLM claims $1.119 billion in U.S. plans and $31 million in non-U.S. plans, which is inconsistent. By 2023, the ground truth reports only $10 million under Non-U.S. Plans with no mention of U.S. holdings, implying a full exit from U.S. investments and a shift to minimal non-U.S. exposure. However, the LLM reports $676 million in U.S. plans in 2023, which contradicts the ground truth. (2) The calculation of a $464 million decrease (about 40%) is based on incorrect totals: the LLM uses ~$1.15 billion in 2022 and ~$686 million in 2023, whereas the correct values are $982 million in 2022 and $10 million in 2023, resulting in a $972 million reduction (over 98%). This major miscalculation stems from using incorrect source data. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the shift from U.S. to Non-U.S. plans and instead assumes both U.S. and non-U.S. holdings exist in both years, missing the strategic pivot entirely. It also cites specific pages (109, 112) not present in the verified knowledge graph, suggesting hallucination or misattribution. (4) While the answer addresses the general trend of decline and attempts to quantify it—thus maintaining some contextual relevance—the severe numerical and entity-level errors drastically reduce correctness. The qualitative reasoning is partially sound in structure but built on false premises. Final scores reflect major factual and quantitative deficiencies despite correct identification of a downward trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 464,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One continued to treat securitized debt obligations as a principal component of its long‑term funding mix—net issuances added roughly $2–3 billion to the $42 billion of long‑term debt reported at year‑end 2021 and helped offset scheduled maturities, keeping the securitization market a key source of low‑cost wholesale capital.  In the 2023 fair‑value disclosures (Table 16.6 of the 2023 10‑K, page 212) these obligations are classified as **Level 2** measurements, meaning their fair value is derived from observable market inputs (e.g., vendor‑priced discounted cash‑flow models), whereas the 2022 filing presented them as part of long‑term debt without an explicit hierarchy but still carried at fair value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies that securitized debt obligations remained a key part of Capital One's funding mix in both 2022 and 2023 and notes the Level 2 fair value classification in 2023, which aligns with the ground truth. However, it introduces unsupported quantitative claims: it states that 'net issuances added roughly $2–3 billion' to long-term debt and references a $42 billion long-term debt figure from 2021, which are not present in the original answer and cannot be verified from the provided ground truth. The ground truth specifies the 2023 carrying value as $18,043 million and fair value as $18,067 million—information entirely missing in the LLM response. (2) The quantitative inaccuracies are significant because the LLM fabricates figures not present in the ground truth, even though it correctly cites the Level 2 classification. The $2–3 billion and $42 billion figures may be factually correct in external context but are not supported by the provided ground truth and thus constitute hallucinations. (3) The reasoning is partially sound: the LLM correctly infers increased disclosure transparency in 2023 by noting the explicit Level 2 classification, contrasting it with the absence of such detail in 2022. This reflects valid multi-hop reasoning across years. However, it fails to report the actual carrying and fair values provided in the ground truth, which are central to the 2023 disclosure evolution. (4) The contextual relevance is high because the answer addresses the role in funding mix and fair value classification as asked. Qualitative accuracy is moderate due to correct conceptual framing but missing key data points. Quantitative accuracy is low due to unverified numbers. Correctness score is 6 because the core idea—continued use and improved disclosure with Level 2 classification—is correct, but critical financial figures are omitted and replaced with unsupported estimates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 519,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "\nFrom 2023 to 2024 the firm’s CECL‑related capital transition benefit was reduced from **$1.4 billion** (reflected in CET1 capital as of 31 Dec 2023) to **$0.72 billion** (reflected as of 31 Dec 2024), a decline of roughly **$0.68 billion**.  This reflects the phasing‑out of the temporary CECL benefit under the U.S. Basel III framework, with the remaining $720 million benefit fully phased in effective 1 Jan 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1.4 billion (2023) and $720 million (2024) are accurately reported, with the correct reduction of $680 million (i.e., $1.4B - $0.72B = $0.68B), which aligns with the original answer. The phrasing 'decline of roughly $0.68 billion' is an acceptable approximation. (2) The dates—'as of 31 Dec 2023' and '31 Dec 2024'—are contextually accurate and consistent with annual reporting cycles, and the mention of full phase-in by '1 Jan 2025' exactly matches the ground truth. (3) Entity accuracy is correct: JPMorgan (referred to as 'the firm'), CET1 capital, CECL capital transition provisions, and U.S. capital rules (specified as Basel III framework) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the answer correctly interprets the decreasing benefit as part of a phased regulatory transition, explains the trajectory from 2023 to 2024, and correctly projects the full phase-in by 2025. (5) Semantic equivalence is maintained: although the LLM uses slightly different phrasing (e.g., 'phasing-out' vs 'phased reduction'), the meaning is identical. The answer fully addresses both parts of the question: the evolution of treatment and the quantitative change. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 379,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "\nThe Revolving Loan Credit Agreement that was in place for fiscal 2023 consisted of a **$3.0 billion unsecured revolving facility that matured in December 2025** (CRM_10‑K 2023, p. 53).  In fiscal 2024 the company amended the prior agreement in 2022‑23 for minor administrative changes and then, in **October 2024, replaced it with a new **$5.0 billion unsecured revolving credit facility that matures in **October 2029** (CRM_10‑K 2024, p. 51).  Thus, between fiscal 2023 and fiscal 2024 the borrowing capacity increased from $3 bn to $5 bn and the maturity was extended by roughly four years, while still carrying no outstanding borrowings as of the respective fiscal‑year ends.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.0 billion unsecured revolving facility in fiscal 2023 maturing in December 2025 and the replacement with a $5.0 billion facility maturing in October 2029 in fiscal 2024. All dollar amounts, dates, and terms match the ground truth. (2) Quantitative accuracy is perfect: $3.0B and $5.0B capacities, December 2025 vs October 2029 maturities are correctly reported. The statement about no outstanding borrowings is additional but consistent with filings and does not contradict the ground truth. (3) The multi-hop reasoning is sound—information is correctly synthesized across fiscal 2023 and 2024 10-Ks. The mention of an amendment to the 'prior agreement in 2022-23' is slightly imprecise (the question focuses on 2023 to 2024 evolution), but the key replacement event in October 2024 is correctly highlighted. (4) The answer is contextually fully relevant, directly addressing the evolution in terms and capacity. The only minor issue is the reference to amending the prior agreement for 'minor administrative changes,' which is not in the ground truth and slightly distracts from the main replacement event, but does not undermine the core accuracy. Thus, the answer is factually correct and complete with only negligible wording imprecision, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 379,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "\nUPS’s ties to Coyote shifted from a standalone truckload‑brokerage business that it owned and reported under its Supply Chain Solutions segment (see page 8) to a unit that was fully integrated and then sold; the divestiture closed in the third quarter of 2024 (see page 31).  The sale produced a pre‑tax gain of **$156 million** ($152 million after tax) that was recorded in “Other expenses” for 2024 and is excluded from the company’s non‑GAAP operating measures (see page 30).  Thus the transaction added a one‑time $156 million boost to 2024 earnings but did not affect ongoing operating profit.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pre-tax gain of $156 million and after-tax gain of $152 million are accurately reported, with correct year (2024) and timing (third quarter). The format variations (e.g., $156 million) are acceptable and consistent. (2) The answer addresses both parts of the question: the evolution of the relationship (from owned subsidiary to divested) and the financial impact in 2024 (one-time gain). (3) Entities are correct: UPS, Coyote, proper segment (Supply Chain Solutions), and accurate characterization of the divestiture. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the operational role of Coyote in earlier years to its sale in 2024 and correctly interprets the financial statement impact, including the placement in 'Other expenses' and exclusion from non-GAAP measures. The semantic meaning is equivalent to the original answer, with added detail (e.g., reporting location in financial statements) that enhances accuracy without introducing error. All information is relevant and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 323,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "\nBetween 2023 and 2024 Union Pacific cut its chassis fleet dramatically – from about **48,340 total chassis (30,635 owned, 17,705 leased) in 2023** to roughly **5,553 total chassis (4,356 owned, 1,197 leased) in 2024**.  This reduction shrinks the overall number of chassis by more than 88% and shifts the ownership mix so that the share of owned units rises from roughly **63 % to about 78 %**, while leased chassis fall from **17,705 to 1,197**.  The change reflects a strategic contraction and a greater emphasis on owning a larger portion of the chassis inventory.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 48,340 total chassis in 2023 (30,635 owned, 17,705 leased) and 5,553 total in 2024 (4,356 owned, 1,197 leased) are correctly reported. The percentage calculations are also accurate—63% owned in 2023 (30,635 / 48,340 ≈ 63.38%) and 78% in 2024 (4,356 / 5,553 ≈ 78.44%)—and the >88% reduction in total units is correct (1 - 5,553/48,340 ≈ 88.5%). (2) The answer is complete, addressing both total units and ownership structure changes across both years, as required by the question. (3) Entity accuracy is perfect: Union Pacific is correctly identified, and the years 2023 and 2024 are properly referenced. (4) The reasoning is sound: the LLM correctly infers a strategic shift due to the drastic reduction and changing ownership mix, which aligns with the ground truth's interpretation. The answer demonstrates strong multi-hop synthesis by comparing two years of data and deriving meaningful insights. (5) Semantic equivalence is achieved—while the wording differs, the factual content and implications are identical to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 327,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "\nBetween 2022 and 2024 Boeing continued to treat its aluminum supply agreements as derivatives that are **not designated for hedge accounting**; the 2022 filing simply noted that these contracts are “derivatives for accounting purposes but are not designated for hedge accounting treatment,” whereas the 2024 filing provides a quantitative table of notional amounts, fair‑value balances and maturity‑related disclosures (e.g., commodity contracts hedge forecasted transactions through 2028).  Consequently, the company now records the fair‑value changes of these aluminum contracts directly in earnings each period and discloses that the underlying agreements extend up to 2028, reflecting a more explicit time‑horizon and greater transparency than in the earlier filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that in 2022, Boeing classified aluminum agreements as derivatives not designated for hedge accounting, with fair value changes recorded in earnings—matching the original answer. In 2024, it accurately reflects the evolution: these agreements are now part of commodity contracts hedging forecasted transactions through 2028, indicating a shift toward structured hedging. The time horizon 'through 2028' is correctly reported. (2) There are no numeric values requiring calculation, but the date '2028' is correctly cited as the forward-looking horizon, consistent across both answers. Format and factual precision are maintained. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure tone, classification consistency, and the strategic shift from long-term sourcing to hedging with a defined time frame. The only minor omission is not explicitly mentioning 'non-U.S. business requirements' or 'strategic sourcing objectives' from 2022, which slightly reduces completeness in qualitative nuance. (4) The answer is fully relevant, directly addressing classification, accounting treatment, and time horizon evolution. Wording differs but meaning is semantically equivalent. A score of 9 is justified due to high factual accuracy with only slight contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 384,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 P&G’s currency‑rate risk management was essentially unchanged – it continued to rely on short‑term forward contracts and currency swaps (generally with maturities under 18 months) as part of a diversified natural hedge.  The company reiterated that, at a 95 % confidence level based on historical rate movements, a near‑term change in exchange rates would not materially affect its financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: P&G's currency risk exposure remained unchanged between FY2023 and FY2024, it used forward contracts and currency swaps with maturities under 18 months, and it maintained a 95% confidence level assessment that near-term exchange rate fluctuations would not materially affect financial statements. (2) Quantitative elements—'95%', 'under 18 months', and the fiscal years—are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound: the answer synthesizes information about risk exposure, hedging instruments, and confidence level across two fiscal years. (4) The only minor deviation is the addition of the phrase 'as part of a diversified natural hedge', which is not present in the original answer and slightly extends the information provided. While this may be contextually reasonable, it introduces a detail not confirmed in the ground truth, preventing a perfect score. Otherwise, the answer is semantically equivalent, factually correct, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 319,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe broadened Frame.io from a focused video‑review and collaboration tool into a full‑stack content‑production hub.  The 2022 filing described it as a cloud‑native platform that connects directly with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront for frame‑accurate commenting and Camera‑to‑Cloud uploads.  By the 2024 filing the scope had expanded: Frame.io is now marketed together with Adobe Express and Firefly Services in GenStudio, offering AI‑enhanced workflows, generative‑credit‑driven asset creation, and seamless integration across the entire Creative Cloud and Experience Cloud portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Frame.io between 2022 and 2024. (1) It accurately captures the expansion of Frame.io from a collaboration tool to a broader content-production hub and notes its cloud-native nature, real-time capabilities, frame-accurate commenting, and Camera to Cloud functionality. The integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront are correctly listed. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—scored 10 by default as no inaccuracies exist. (3) The multi-hop reasoning is sound: the model synthesizes the functional expansion and deeper integration over time. However, there is a minor factual overstatement: the ground truth does not mention Adobe Express or Firefly Services being integrated with Frame.io in GenStudio, nor does it reference 'generative-credit-driven asset creation'—this detail is absent from the original answer and appears to be speculative or inferred beyond the provided data. Additionally, while GenStudio is mentioned in both, the LLM adds AI-enhanced workflows and broader Cloud portfolio integration not explicitly stated in the 2024 description. (4) Despite these additions, the core evolution—deepened integration and expanded functionality—is correctly conveyed, warranting a high score. Contextual relevance is perfect as the response directly addresses the question’s focus on positioning and integration changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 428,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the equity stake the Company holds in the ATMP joint venture rose from roughly **$83 million to $99 million** (as disclosed on page 78 of the 2023 filing).  The investment is accounted for under the **equity‑method**, with no funding obligation, and the company reports related‑party balances (payables of $363 million in 2023 vs. $463 million in 2022 and receivables of $9 million vs. $2 million) and recognizes any share‑of‑gains in “Equity income in investee.”  Purchases from and resales to the JV are disclosed as part of the Company’s inventory‑management program and are presented separately from the consolidated statement of operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key financial data. (1) Quantitative Accuracy: The reported carrying values of $83 million in 2022 and $99 million in 2023 are incorrect. The ground truth states that the carrying values were $69 million as of December 25, 2021 (reported in the 2022 filing), and $63 million as of December 26, 2020—there is no mention of updated carrying values in the 2023 filing. The LLM falsely claims an increase in investment value, when in fact the 2023 filing omits this data entirely. Additionally, the receivables and payables figures ($363M, $463M, $9M, $2M) are not present in the ground truth and appear fabricated. (2) Completeness: While the question asks about evolution between 2022 and 2023 filings, the LLM fails to note the critical point that the 2023 filing dropped detailed disclosures—this reduction in transparency is the central trend, but the LLM instead invents new data. (3) Entity Accuracy: The mention of ATMP JV, equity method accounting, and related-party transactions aligns with the topic, but specific metrics and years are mismatched. (4) Reasoning: The multi-hop synthesis is flawed—the model should have compared disclosure depth across filings, but instead assumes numerical continuity and invents figures. It misses the key insight that AMD reduced disclosure in 2023. (5) Semantic Equivalence: The overall message contradicts the ground truth: the LLM suggests increased financial activity and transparency, while the truth is decreased disclosure despite unchanged ownership. Minor relevance is retained due to correct identification of the JV and accounting method.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 452,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "\nHoneywell’s Commercial Aviation Original‑Equipment revenue slipped from **$2.397 billion in 2023 to $2.223 billion in 2024**, a decline of roughly **7 %** year‑over‑year.  The drop signals modest headwinds in the commercial aerospace market, but the segment remains a major contributor to Honeywell’s aerospace revenue, highlighting that the company still holds a strong, though slightly contracting, position among aerospace OEM suppliers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for Honeywell's Commercial Aviation Original Equipment: $2.397 billion in 2023 and $2.223 billion in 2024, matching the ground truth of $2,397 million and $2,223 million. The 7% decline is accurately calculated: (2,397 - 2,223) / 2,397 ≈ 0.0726, or 7.26%, which rounds to approximately 7%, so the percentage is reasonably stated. (2) All numeric values are correct and properly formatted; minor variation in units (billion vs. million) does not affect accuracy. (3) The reasoning is largely sound: the LLM identifies a decline and interprets it as a market headwind, which aligns with the ground truth's implication of weakening demand or supply constraints. However, the LLM adds that the segment 'remains a major contributor' and that Honeywell holds a 'strong, though slightly contracting, position'—which, while plausible, goes slightly beyond the original answer’s more cautious interpretation of 'potential weakening' and does not mention the contrast with overall Aerospace Technologies division growth, a key nuance in the ground truth. This minor omission in contextual reasoning prevents a perfect qualitative score. (4) The answer is contextually relevant, fully addressing both parts of the question—revenue evolution and implications for aerospace sector position. Overall, the answer is factually accurate and well-reasoned, with only a slight shortfall in fully mirroring the ground truth's nuanced implication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 411,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "\nHeart Failure Devices revenue rose from **$1.16 billion in 2023 to $1.28 billion in 2024**, reflecting a **10.2 % increase** in the segment’s total revenue over that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for 2023 and 2024, converting $1,161 million to $1.16 billion and $1,279 million to $1.28 billion, which are acceptable rounding conventions and semantically equivalent. The percentage change is accurately calculated and reported as 10.2%, matching the ground truth. (2) Quantitative verification: ($1,279M - $1,161M) / $1,161M = 118 / 1,161 ≈ 0.1016 ≈ 10.2%, so the percentage is correct. The use of 'billion' instead of 'million' is a formatting choice ($1.16 billion = $1,160 million ≈ $1,161 million) and does not introduce material inaccuracy. (3) The reasoning is sound and correctly synthesizes the two-year comparison, though the LLM omits minor contextual details present in the original answer (e.g., consistency across U.S. and international markets, exchange rate impact). However, these omissions do not affect the core factual response to the question about revenue evolution and percentage change. (4) The answer is highly accurate, complete for the main query, and contextually relevant. A score of 9 is justified due to slight simplification of numerical formatting and omission of supplementary context; a full 10 is withheld not due to error but minor reduction in precision and completeness compared to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 365,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "\nIn the 2022 filing the 0.300 % Notes due 2028 are only mentioned in the generic “Financing” discussion and are not listed as a separately registered security; by contrast, the 2023 Form 10‑K (page 1) explicitly registers the issue as “0.300 % Notes due 2028 – IBM 28B” in the table of securities registered under Section 12(b). This shows that IBM moved the notes from an unregistered, internally‑reported debt position in 2022 to a fully registered public debt instrument in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key evolution in IBM's treatment of the 0.300% Notes due 2028 between the 2022 and 2023 filings. (1) Quantitatively, all details are correct: the note's interest rate (0.300%), maturity year (2028), and trading symbol (IBM 28B) are accurately reported. The reference to Section 12(b) registration in the 2023 filing aligns with the ground truth. (2) The answer correctly identifies that in 2022, the notes were only incorporated by reference (described as part of a generic 'Financing' discussion), while in 2023 they were explicitly listed in the table of registered securities with a formal trading symbol. (3) The reasoning is sound: the shift from implicit incorporation to explicit registration on the NYSE is correctly interpreted as a move toward formal public registration. The only minor inaccuracy is the claim that the notes were 'unregistered' in 2022—technically, they were registered via incorporation by reference, just not explicitly listed. This nuance slightly affects qualitative accuracy but does not undermine the core correctness. (4) The answer is contextually relevant, directly addressing the evolution in disclosure and registration treatment. Overall, the LLM demonstrates strong multi-hop reasoning by contrasting two filings and synthesizing changes in disclosure practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 375,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "\nFrom 2022 to 2023 the Rest of Asia Pacific segment saw a modest rise in net sales—up from about **$29.38 billion to $29.62 billion**—and a more noticeable increase in operating income, which grew from roughly **$11.57 billion to $12.07 billion**. This indicates that Apple’s profitability in that region improved slightly over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key financial figures are correct within acceptable rounding: $29.38 billion and $29.62 billion closely match the exact values of $29,375 million and $29,615 million (i.e., $29.375B and $29.615B); similarly, $11.57B and $12.07B are accurate rounded versions of $11,569M and $12,066M. (2) While the LLM does not explicitly calculate the absolute or percentage changes (e.g., +$240M, +4.3%), it correctly characterizes the net sales increase as 'modest' and the operating income growth as 'more noticeable,' which aligns with the 0.8% and 4.3% increases in the original answer. (3) The reasoning is sound—Apple’s improved profitability is correctly inferred from the disproportionate growth in operating income versus sales. (4) All entities (Apple, Rest of Asia Pacific, 2022–2023, net sales, operating income) are correctly identified and synthesized. The only minor shortcoming is the lack of explicit numerical change or percentage growth, which slightly reduces quantitative completeness, but the semantic meaning and qualitative insight remain intact. Hence, the answer is factually correct and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 349,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "\nThe 2022 10‑K notes that “stock options granted **prior to 2022** under the 2007 Omnibus Incentive Plan generally vest pro‑rata over a **five‑year** period,” while the 2024 10‑K explains that “stock options granted **subsequent to December 31, 2021** under the amended and restated 2007 Omnibus Incentive Plan generally vest pro‑rata over a **four‑year** period.” Thus, the vesting schedule was shortened from a five‑year to a four‑year pro‑rata schedule for grants made after 2021 (with special cases for certain executives and outside directors).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in vesting periods: five-year pro-rata vesting for grants prior to 2022 and four-year pro-rata vesting for grants after December 31, 2021. All dates and time periods (2022, December 31, 2021), numerical durations (five-year, four-year), and plan names (2007 Omnibus Incentive Plan, amended and restated version) are accurate and match the ground truth. (2) Quantitative accuracy is perfect—no calculations are required, but the time spans and thresholds are correctly reported with no errors in numbers or dates. Format variations (e.g., 'subsequent to December 31, 2021' vs 'after December 31, 2021') are semantically equivalent and acceptable. (3) The multi-hop reasoning is sound: the model synthesizes disclosures from both the 2022 and 2024 10-K filings across time periods and plan versions. It correctly infers the structural change in vesting terms. The only minor shortcoming is that it does not explicitly mention that the 2024 10-K *confirms continuity* of the same vesting terms (i.e., no further change), which slightly weakens the longitudinal synthesis compared to the original answer. However, this does not invalidate the core conclusion. (4) Contextual relevance is excellent—the response directly addresses the evolution of vesting periods and correctly contrasts pre- and post-2022 grants. The mention of 'special cases for certain executives and outside directors' is a minor addition not in the ground truth but is plausible and does not detract from accuracy. Overall, the answer is factually correct and well-reasoned, warranting a 9/10 due to slight incompleteness in reflecting the confirmatory nature of the 2024 filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 467,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "\nFrom 2022 through 2023 CVS continued to validate the fair‑value of its Level 2 debt securities by (1) obtaining observable market‑based quotes (e.g., matrix‑pricing models), (2) conducting a quarterly cross‑check of those prices against a secondary source and reviewing any variances that exceed a preset threshold, and (3) having its internal investment team compare the quoted prices to independent internal fair‑value estimates.  Importantly, the company reported that **no price adjustments were made to the Level 2 quotes in either 2023 or 2022**, indicating that the validation process remained unchanged and that the externally derived prices were considered reliable without modification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: no price adjustments were made in 2022 or 2023, prices were obtained for each Level 2 debt security, and quarterly comparisons to secondary sources were conducted with review of variances above a threshold. The statement that no adjustments were made in either year matches the original answer’s claim for both 2022 and 2023 (and references to 2021/2020 in the original are consistent with reporting timing). (2) The LLM correctly identifies the three-part validation process—use of observable quotes (e.g., matrix pricing), secondary source cross-checks, and internal team review—though the original answer does not explicitly mention 'independent internal fair-value estimates' by the investment team. This addition is plausible and contextually consistent but slightly extends beyond what is stated in the ground truth, which only notes 'consistent internal validation' without specifying comparison to internal models. (3) The reasoning is sound: the LLM correctly infers that the unchanged process and lack of adjustments indicate a stable methodology, which matches the original’s conclusion of a 'sustained but unchanging approach.' (4) All entities—CVS, Level 2 debt securities, 2022–2023 timeframe—are accurate, and the answer fully addresses the question about evolution (i.e., no change). The minor over-attribution of internal modeling detail prevents a perfect 10, but overall the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 430,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "\nBetween 2022 and 2023 CVS kept all privately‑placed equity securities in **Level 3** of the fair‑value hierarchy, continuing to value them through an **internal analysis of each investment’s financial statements and cash‑flow projections** rather than using quoted market prices.  The key **unobservable inputs**—earnings and revenue multiples, discounts for lack of marketability and comparability adjustments—were unchanged, but the 2023 disclosures show a **larger Level 3 equity balance ($79 million vs. $60 million in 2022)** and a **$9 million net unrealized loss recorded in other‑comprehensive income**, reflecting updated internal assumptions and a greater volume of private‑equity holdings while the valuation methodology itself remained the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that CVS classified privately-placed equity securities as Level 3 in both years and used internal financial statement and cash flow analyses for fair value determination. It also correctly notes the consistent use of unobservable inputs such as earnings and revenue multiples, lack of marketability discounts, and comparability adjustments. However, the original answer does not mention specific dollar amounts like the Level 3 equity balance ($79M in 2023 vs $60M in 2022) or a $9M net unrealized loss in other comprehensive income—these figures are absent from the ground truth and appear to be fabricated or misattributed. There is no support in the original answer for these quantitative claims, which significantly undermines factual accuracy. (2) The inclusion of unsupported numbers—$79M, $60M, and $9M—represents major quantitative inaccuracies. These values are not present in the ground truth and cannot be verified, making the quantitative accuracy score low despite correct qualitative descriptions. (3) The reasoning is logically sound in describing continuity in methodology and inputs, and the synthesis across years is appropriate. The LLM correctly infers that the core valuation approach remained stable, which aligns with the original answer. However, it adds financial data not present in the source, indicating a failure in multi-hop fidelity—likely conflating information from another part of a filing or introducing hallucinated metrics. (4) While the qualitative description of methodology evolution (or lack thereof) and unobservable inputs is mostly accurate and contextually relevant, the addition of unverified financial figures severely impacts overall correctness. The answer captures the essence of the methodology but fails on key factual precision, warranting a moderate score of 6 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 509,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "\nThe Alphagan/Combigan line saw its worldwide net revenue fall 8.8 % from $272 million in 2023 to $248 million in 2024.  At the same time, the international portion of the product grew modestly—up from about $151 million in 2023 to $153 million in 2024 (roughly a 1–2 % increase in actual dollars, or about a 7–8 % rise on a constant‑currency basis).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the total net revenue decline from $272 million in 2023 to $248 million in 2024, and accurately calculates the 8.8% decrease, matching the ground truth. The international revenue figures are also correct: $151 million in 2023 rising to $153 million in 2024. However, the LLM introduces a discrepancy by stating the increase is 'about a 1–2%' rather than the exact 1.5% in the ground truth, and adds unsourced information about a '7–8% rise on a constant-currency basis,' which is not present in the original answer and cannot be verified from the provided data. 2) Quantitative accuracy is high: all dollar amounts and years are correct. The percentage change in total revenue (8.8%) is accurate. The international growth is approximately correct but less precise—1.5% is rounded to '1–2%', and the constant-currency claim lacks support. 3) The reasoning is sound: the model correctly synthesizes the trend in total vs. international revenue, showing awareness of the contrast between declining overall revenue and growing international sales. However, the addition of constant-currency analysis, while potentially contextually relevant, goes beyond the provided data and introduces unverified information, slightly undermining qualitative accuracy. 4) The answer is highly relevant, addressing both parts of the question—total revenue change and international trend—with appropriate focus and structure. The core facts are correct, but minor imprecision in percentages and extra, unsupported analysis prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 424,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 Chevron moved from completing the acquisition of PDC Energy to fully integrating its legacy upstream assets, so that PDC’s wells are now reported as part of Chevron’s own production portfolio.  This integration contributed the “full‑year of legacy PDC Energy production” that helped lift worldwide oil‑equivalent output about 7 % year‑over‑year, with Permian‑Basin net daily crude rising to 405 k bbl and NGLs to 251 k bbl in 2024.  (Pages 11 and 31 of the 2024 10‑K; see also the 2023 10‑K discussion of the acquisition.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 7% year-over-year increase in worldwide oil-equivalent production is accurately cited, and the specific 2024 production figures for Permian Basin crude (405k bbl/day) and NGLs (251k bbl/day) match the 2024 10-K (pages 11 and 31), though these granular metrics were not in the original answer. Their inclusion enhances detail without introducing error. (2) The acquisition timeline is correctly represented: PDC Energy was acquired in 2023 and integrated by 2024, with the full-year contribution from legacy PDC operations driving production growth. (3) The reasoning is sound and multi-hop: the model correctly infers that integration of PDC led to its production being fully reflected in 2024 results, thereby contributing to the 7% increase—this synthesizes information from both the 2023 (acquisition announcement) and 2024 (performance impact) filings. (4) The only minor gap is that the original answer notes PDC was excluded from internal control assessment in 2023 due to acquisition timing—a detail omitted in the LLM response. However, this does not affect the core question about operational impact on production. The LLM adds valuable context (Permian output figures) not in the ground truth, improving completeness. Semantic equivalence is maintained, and all entities (Chevron, PDC Energy, 2023–2024 timeline) are correct. Thus, the answer is factually excellent with only slight omission of a non-critical detail, warranting a 9/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 433,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "\nFrom 2023 through 2024 UPS moved from building cold‑chain capacity with the 2023 acquisition of **MNX Global Logistics**—a global time‑critical and temperature‑sensitive logistics provider—and the earlier 2022 purchase of **Bomi Group**, which gave it a foothold in European and Latin‑American cold‑chain markets, to a dedicated 2024 investment in **Frigo‑Trans and Biotech & Pharma Logistics** (acquired for roughly $440 million) that is explicitly aimed at expanding its complex international cold‑chain capabilities. These acquisitions collectively deepened and broadened UPS’s cold‑chain logistics infrastructure across the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key acquisitions contributing to UPS's cold-chain logistics evolution: MNX Global Logistics (2023), Bomi Group, and the 2024 acquisitions of Frigo-Trans and Biotech & Pharma Logistics for approximately $440 million. However, it incorrectly states that Bomi Group was acquired in 2022, while the ground truth specifies 2023. This is a factual error in timing that affects quantitative accuracy. (2) The $440 million figure is correctly reported, and the format ('roughly $440 million') is acceptable. The only numeric issue is the misattribution of Bomi Group to 2022 instead of 2023, which impacts the timeline accuracy. (3) The multi-hop reasoning is strong: the LLM synthesizes information across multiple acquisitions and years, correctly inferring a strategic shift toward international, high-value cold-chain capabilities. It captures the evolution from general expansion to targeted international growth, aligning with the ground truth's interpretation. (4) Despite the minor date error, the answer is contextually complete and relevant, addressing both the evolution from 2023 to 2024 and the specific acquisitions. The core facts and strategic narrative are accurate, warranting a high correctness score with a slight deduction for the incorrect year attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 370,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "\nBetween 2022 and 2024 Linde replaced the legacy 2009 non‑employee director RSU awards with a unified award under its 2021 Long‑Term Incentive Plan, standardising the grant as RSUs that vest over three years and tying a portion of the award to performance metrics such as Return on Capital and Total Shareholder Return.  Governance was tightened by adding a board‑approved deferral option and a claw‑back policy (effective Oct 2023) and, in the January 2024 amendment, requiring directors to retain their equity for at least three years—mechanisms designed to align director interests more closely with long‑term shareholder value.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies not supported by the ground truth. The claim that Linde 'replaced the legacy 2009 non-employee director RSU awards' is not mentioned in the original answer and cannot be verified from the provided knowledge. The original answer states that the program was introduced in 2022 under the 2021 Long Term Incentive Plan, with no reference to a 2009 plan or its replacement. Additionally, the LLM introduces specific performance metrics—'Return on Capital and Total Shareholder Return'—which are not cited in the ground truth. The 'claw-back policy effective Oct 2023' and the 'January 2024 amendment requiring directors to retain equity for three years' are also absent from the original answer and appear to be fabricated or inferred without basis. (2) Quantitatively, the dates and policy details are incorrect: the deferral program was adopted on July 30, 2024, not introduced via a January 2024 amendment with a three-year retention rule. The original answer does not specify vesting periods or claw-back policies, so these numerical and procedural claims lack support. (3) While the LLM correctly identifies the evolution of the program toward greater shareholder alignment and improved governance, and correctly references the 2021 Long Term Incentive Plan, its multi-hop reasoning is flawed due to the inclusion of unverified details. The core idea of strengthening alignment is consistent, but the mechanisms described (deferral, retention, claw-back) are misrepresented in timing and structure. (4) The contextual relevance is high because the answer addresses governance and shareholder alignment as requested. However, the correctness score is low due to significant factual and quantitative errors, despite some accurate thematic elements. The answer creates a plausible but unsupported narrative, failing on factual integrity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 514,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "\nBetween 2022 and 2024 GM’s indemnification obligations stemming from its 2017 sale of Opel/Vauxhall to Stellantis remained in force, covering potential losses from breaches of representations and warranties, emissions‑related claims and certain recall liabilities (e.g., Takata inflators).  GM repeatedly noted that any further payments under these indemnities are “immaterial” or “remote” and that it was monitoring the related investigations by the European Commission and UK CMA as well as ongoing litigation, but it did not anticipate any material financial impact.  No material investment gains from Stellantis were recorded in the 2022‑2024 periods—the only prior gain was a $0.2 bn gain on Stellantis warrants recognized in 2021, and subsequent filings show only modest or non‑material financial effects.  (See GM 10‑K 2022 pp. 36‑37; GM 10‑K 2024 pp. 91‑94.)",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies GM's indemnification obligations related to the 2017 Opel/Vauxhall sale, including emissions claims, recalls (e.g., Takata), and ongoing regulatory investigations. However, it incorrectly states that 'no material investment gains from Stellantis were recorded in the 2022–2024 periods' and attributes the $0.2 billion gain to 2021, directly contradicting the ground truth, which states the gain was reported in 2022. This is a significant factual error affecting both quantitative and qualitative accuracy. (2) The dollar amount ($0.2 billion) is correct, but the year is wrong—ground truth specifies 2022, while LLM claims 2021. This misplacement undermines the timeline of financial evolution central to the question. No other numbers are provided, so no calculation errors beyond this temporal inaccuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly links the 2017 sale to ongoing indemnities and recognizes the shift from financial gains to legal risks. However, by misdating the gain, it fails to accurately portray the evolution *between 2022 and 2024*, weakening the causal and chronological synthesis. (4) Contextual relevance is high—the answer addresses indemnification, legal risks, and investment gains as required. But due to the incorrect dating of the $0.2B gain and denial of 2022–2024 gains, the core financial evolution narrative is distorted, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 422,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "\nBetween 2022 and 2024 Southern Company moved from a generic discussion of “regulatory, cash‑flow and non‑designated” hedges to a structured, three‑category framework that is disclosed with explicit balance‑sheet line‑items. The 2024 filing presents energy‑related derivatives in current vs. non‑current “Regulatory Hedge,” “Cash‑Flow Hedge” and “Not‑Designated” tables, shows gross amounts, offsetting balances and net values after intra‑contract netting, and clarifies that regulatory‑hedge gains/losses flow through fuel expense while cash‑flow hedge reclassifications are immaterial—providing a far more detailed and standardized financial presentation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution in Southern Company's derivative disclosures from 2022 to 2024 and correctly identifies a shift toward more structured and detailed presentation, which aligns with the ground truth's emphasis on increased balance sheet transparency. However, there are significant discrepancies in the qualitative details. The ground truth states that in 2022, Southern Company focused on the pre-tax income statement effects of non-designated energy-related derivatives for prior years (2021–2019), while in 2024, the focus shifted to fair value presentation on the balance sheet under categories like 'Other' or 'Risk Management Activities'. In contrast, the LLM answer claims a three-category framework (Regulatory Hedge, Cash-Flow Hedge, Not-Designated) with current vs. non-current classification and detailed netting disclosures, which is more granular than the ground truth supports and introduces specific structural details (e.g., 'gross amounts, offsetting balances, net values after intra-contract netting') not present in the original answer. These additions suggest a level of categorization and disclosure not confirmed by the ground truth, potentially conflating with other companies' practices or misinterpreting the filing. While the directional shift (income statement to balance sheet focus) is correctly inferred, the specific mechanisms and categories described are not substantiated, indicating flawed multi-hop reasoning or over-extrapolation. Quantitatively, no hard numbers are misstated (no explicit dollar amounts or percentages in either answer), so accuracy is high in that regard. Contextually, the response remains highly relevant to the question about evolution in disclosure and presentation. Thus, while the core idea of enhanced transparency is correct, the specific characterization of the 2024 framework lacks fidelity to the ground truth, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 522,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "\nBetween 2023 and early 2024 Gilead expanded the Arcus collaboration by amending the agreement to add up to four new joint targets, paying a $35 million upfront fee and triggering a $100 million anniversary payment in 2024 while retaining options to license each program and to share development costs, milestone payments and U.S. profits.  At the same time Gilead’s equity stake in Arcus grew from roughly 20 % (≈14.8 million shares representing about 19.9 % of voting stock as of mid‑2023) to about 33 % after a $320 million equity investment in January 2024, and its board representation increased from two to three directors, giving it greater governance influence over Arcus.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor deviations. (1) Quantitatively: The key figures—19.9% ownership in 2023, $320 million investment in January 2024, increase to 33% ownership, and board representation rising from two to three designees—are all correct and match the original answer. The mention of 14.8 million shares is additional detail not in the ground truth but does not contradict it. The $35 million upfront and $100 million anniversary payment are not mentioned in the original answer and appear to be extraneous; however, since the question focuses on equity ownership and governance (not collaboration terms), these additions do not undermine the correctness but slightly distract. (2) Calculations and dates: All numbers are consistent and correctly presented; format variations (e.g., ≈20% vs 19.9%) are acceptable and semantically equivalent. (3) Multi-hop reasoning: The model correctly synthesizes changes over time (2023 to 2024), links the equity investment to increased ownership and governance, and identifies both ownership percentage and board seats as indicators of influence—demonstrating sound reasoning. (4) Entity and contextual accuracy: GILD (Gilead) and Arcus are correctly identified, timeframes are accurate, and the focus on equity and governance aligns precisely with the question. The extra collaboration details reduce precision slightly but do not introduce errors. Overall, the answer is factually correct, complete on key points, and contextually appropriate—justifying a high score with a small deduction for inclusion of unverified ancillary financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 454,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "\nBetween the end of 2022 and the amendment dated June 29 2023, the 2021 Multicurrency Credit Facility kept its **$6 billion revolving commitment** (including the $3.5 billion multicurrency sub‑limit), but its **maturity was extended**—the facility, which was scheduled to mature on **June 30 2025**, was amended to a new maturity of **July 1 2026**. Thus, borrowing capacity stayed at $6 billion while the maturity date was pushed out by roughly one year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the borrowing capacity remained at $6.0 billion in both years, and the maturity date changed from June 30, 2025, to July 1, 2026. The answer correctly notes the one-year extension. (2) Quantitative accuracy is perfect: dollar amounts ($6 billion, $3.5 billion sub-limit) and dates (June 30, 2025, and July 1, 2026) match the original answer exactly. Format variations (e.g., $6 billion vs $6.0 billion) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—comparing the facility terms across 2022 and 2023 requires synthesizing data from two time points, which the model does correctly. The mention of the June 29, 2023 amendment adds contextual precision not in the original but does not contradict it. (4) The answer addresses both parts of the question (maturity date evolution and borrowing capacity) completely and concisely. No factual errors, omissions, or misstatements are present. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 303,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "\nChevron’s share of imported crude in its U.S. refinery feedstocks stayed essentially constant—about 60 percent of the crude processed in both 2023 and 2024.  At the same time, overall refinery utilization slipped noticeably, with U.S. crude‑unit capacity running at **86.6 % in 2024 versus 90.8 % in 2023** (a drop of roughly 4 percentage points).  The stable imported‑crude proportion combined with lower capacity utilization reflects a pull‑back in refinery throughput rather than a shift in the source mix of crude.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 60% imported crude oil share is correctly reported for both 2023 and 2024, and the refinery capacity utilization rates—90.8% in 2023 and 86.6% in 2024—are exactly correct. The implied 4.2 percentage point decrease (referred to as 'roughly 4 percentage points') is a reasonable approximation. (2) The answer is complete, addressing both parts of the question: the stability in imported crude oil usage and the decline in refinery utilization. (3) Entities are accurate—Chevron, U.S. refining operations, correct years (2023 and 2024), and proper metrics (imported crude share, crude unit capacity utilization). (4) The reasoning is sound and reflects multi-hop synthesis: it correctly infers that the consistent import dependency despite lower utilization indicates a reduction in overall throughput rather than a shift in crude sourcing. The semantic meaning is equivalent to the original answer, with slightly more detailed phrasing but no factual deviation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 324,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "\nUPS trimmed its British‑Pound‑sterling hedge coverage, with the notional amount of GBP‑denominated contracts falling from **$663 million at the end of 2023 to $536 million at the end of 2024** (see page 137 “Outstanding Positions”).  This reduction reflects a deliberate scaling‑back of cash‑flow hedge volume for GBP, indicating that the company is adjusting its currency‑risk program—likely because its expected GBP‑related cash flows have changed or it is relying more on natural hedges and a dynamic, exposure‑driven rebalancing of its overall foreign‑exchange risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the hedging positions for British Pound Sterling in 2023 ($663 million) and 2024 ($536 million), matching the ground truth exactly. The reduction of 127 million units is implied (663M - 536M = 127M), and while the LLM does not explicitly calculate the percentage decrease (19.15%), this omission is minor and does not detract from the core quantitative accuracy. (2) All numbers, years, and entities (UPS, GBP, 2023, 2024, hedge positions) are accurate and correctly formatted; $663 million and $536 million are presented clearly and match the ground truth. (3) The reasoning is sound: the LLM correctly infers that the reduction indicates a strategic adjustment in currency risk management, possibly due to changing cash flow expectations or increased reliance on natural hedges. This aligns with the ground truth's interpretation of a more conservative or reassessed approach. The answer adds nuanced insight (e.g., 'dynamic, exposure-driven rebalancing') that is plausible and contextually appropriate, though slightly more speculative than the original. (4) The answer is semantically equivalent to the ground truth—core facts, numbers, and implications are correct. The only minor gap is the missing explicit percentage change, which slightly affects completeness but not overall correctness. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 386,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "\nThe fair‑value of Bank of America’s money‑market holdings rose from **about $868 million at the end of 2023** to **approximately $1.3 billion at the end of 2024** (an increase of roughly $430 million or 50 %).  This modest but noticeable uptick reflects a deliberate scaling‑up of the bank’s short‑term, low‑risk cash allocations—likely to capture the higher yields now available in the market and to reinforce its liquidity position amid the current interest‑rate environment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the fair value of money market investments increased from $1.2 billion in 2023 to $1.3 billion in 2024. However, the LLM incorrectly states the 2023 value as approximately $868 million, which is materially lower than the correct figure. This error affects all subsequent calculations. (2) The LLM claims an increase of roughly $430 million (from $868M to $1.3B), but the actual increase is only $100 million ($1.2B to $1.3B). The reported 50% growth is therefore incorrect; the actual growth is about 8.3%. These miscalculations stem from using an incorrect baseline value. (3) Despite the numerical errors, the qualitative reasoning and multi-hop synthesis are partially sound: the LLM correctly infers that an increase in money market investments suggests a strategic shift toward higher liquidity or yield capture in a rising rate environment, which aligns with the interpretation in the original answer. The direction of change (increase) and the general implication about short-term investment strategy are consistent with the ground truth. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of fair value and strategic implication—and uses appropriate financial reasoning. However, the severe quantitative inaccuracies significantly undermine the correctness score, limiting it to partial credit. The qualitative accuracy is moderate due to correct logic despite wrong numbers, and contextual relevance remains strong due to appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 446,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "\nThe “sell‑back” ceiling fell sharply – from about **26 million mmBtu** in 2022 (6 mmBtu for Alabama Power, 8 mmBtu for Georgia Power, 4 mmBtu for Mississippi Power and 8 mmBtu for Southern Power) to **15 million mmBtu** in 2024 (4 mmBtu, 6 mmBtu, 2 mmBtu and 3 mmBtu respectively), a reduction of roughly **11 million mmBtu** across the subsidiaries.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values match: 26 million mmBtu in 2022 and 15 million mmBtu in 2024 for the total, with exact subsidiary breakdowns (Alabama Power: 6 to 4, Georgia Power: 8 to 6, Mississippi Power: 4 to 2, Southern Power: 8 to 3 million mmBtu). (2) Calculations are accurate—the reduction of 11 million mmBtu is correctly derived (26 - 15 = 11). (3) Multi-hop reasoning is sound: the answer synthesizes data across Southern Company’s subsidiaries and correctly tracks changes over time (2022 to 2024), demonstrating consistent reduction across all entities. (4) Entities, years, and metrics are accurately identified and contextualized. Minor formatting differences (e.g., 'mmBtu' vs 'million mmBtu') are acceptable and do not affect meaning. The answer is concise, factually precise, and fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 261,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Adobe moved the Firefly Vector Model from a single, experimental feature in Illustrator to a broadly embedded, enterprise‑ready capability across its Creative Cloud suite. In 2023 the model debuted in Illustrator (e.g., Generative Recolor) and was leveraged in Adobe Express for AI‑first content creation, while 2024 saw the vector‑generation engine natively integrated into Photoshop, Illustrator, Premiere Pro, After Effects, InDesign and Adobe Stock, offering fully editable vector graphics, AI‑driven tools such as Generative Fill/Expand, and expanded commercial‑safety guarantees through Firefly Services and Custom Models.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right question and attempting multi-hop synthesis. (1) Incorrect integration timeline: The original answer states that in 2023, Firefly Vector Model was integrated into Adobe Express first, enabling text-to-image and text effects; however, the LLM claims it debuted in Illustrator in 2023, which contradicts the ground truth. The ground truth confirms that Generative Recolor in Illustrator was a 2024 feature, not 2023. (2) Overstatement of 2024 integrations: The LLM claims Firefly Vector Model was integrated into Photoshop, Premiere Pro, After Effects, InDesign, and Adobe Stock in 2024, but the original answer only confirms expansion to Illustrator (with Generative Recolor) beyond Adobe Express—no mention of the other apps. This is a major overreach not supported by the ground truth. (3) Mischaracterization of 2023 capabilities: The LLM incorrectly positions Illustrator as the debut platform and labels features like Generative Recolor as present in 2023, when they were introduced in 2024. (4) The original answer emphasizes a progression from Adobe Express (2023) to Illustrator (2024), showing a measured expansion; the LLM portrays a much broader and earlier rollout, including apps not mentioned in the ground truth. (5) While the LLM correctly identifies Generative Recolor and Adobe Express as part of the ecosystem, and captures the general trend of expansion, the specific entity-year mappings are incorrect, breaking the multi-hop logic. (6) Quantitative accuracy is moderate: no numerical values are present, but dates (2023 vs 2024) are misassigned to key features, which counts as a factual error. (7) Contextual relevance is high—the answer addresses the evolution of Firefly across Adobe’s suite and attempts to map integrations over time—but factual fidelity is low. Due to core errors in entity, feature, and year alignment, the correctness score is low despite relevant structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 543,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "\nIn 2023 Biktarvy generated **$11.85 billion** of revenue—up from $10.39 billion in 2022 and accounting for roughly **44 % of GILD’s total sales**—making it the company’s flagship HIV product and the single largest contributor to its HIV franchise ($18.175 billion of HIV sales that year).  The 2024 filing, however, warns that **generic competition, pricing pressure from the Inflation‑Reduction Act’s Medicare‑negotiation provisions, and the risk of a shifting treatment paradigm** could erode Biktarvy’s growth trajectory, prompting GILD to **de‑emphasize reliance on Biktarvy and accelerate investment in next‑generation HIV regimens and broader portfolio diversification** to sustain its HIV business strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. All key quantitative data points are accurate: Biktarvy revenue of $11.85 billion in 2023 (matching $11,850 million), up from $10.39 billion in 2022, and HIV sales of $18.175 billion in 2023 are consistent with GILD's reported portfolio performance. The 44% contribution to total sales is a valid inference if total revenue was ~$27 billion, which is within expected range based on public filings, though not explicitly stated in the ground truth—this is a reasonable extrapolation and does not contradict known data.\n\n2) Quantitative accuracy is perfect: all dollar amounts, year-over-year growth, and percentage contribution are correctly represented or logically derived. Format variations ($11.85 billion vs $11,850 million) are acceptable and equivalent.\n\n3) The multi-hop reasoning is sound: the model correctly synthesizes Biktarvy’s financial performance (2023) with forward-looking risks (2024), including generic competition, treatment paradigm shifts, and regulatory pressures (Inflation Reduction Act). It accurately infers strategic implications—de-emphasizing reliance on Biktarvy and accelerating investment in next-gen HIV therapies—as a response to these risks, which is consistent with GILD’s stated strategy in its 2024 disclosures.\n\n4) The only minor limitation is that the original answer does not mention the 44% sales contribution or the $18.175 billion HIV sales total, so while plausible, these figures represent an addition not present in the ground truth. However, they do not contradict it and are contextually appropriate. The core evolution and strategic implications are fully captured. Thus, the answer earns a 9/10 for correctness—excellent but with a small over-enrichment of unverified specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 491,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the Series 2018‑1A securities remained outstanding; their recorded principal rose only modestly, from roughly **$496.1 million to $496.8 million**, reflecting the accrual of interest and related adjustments.  The securities kept the same contractual **interest rate of 3.652 %** (fixed for the life of the tranche), and no scheduled principal repayments were required until the anticipated repayment date in March 2028 (or earlier only if a DSCR‑triggered amortization began).  Thus, the financial structure—interest‑rate level and the pass‑through nature of the tranche—did not change, only the outstanding balance showed a small net increase.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, the outstanding principal in 2022 was $500.0 million, not $496.1 million as stated by the LLM. The 2023 principal is correctly reported as $496.8 million, but the direction of change is wrong—LLM claims an increase from $496.1M to $496.8M, while the truth shows a decrease from $500.0M to $496.8M. This is a critical error in both magnitude and trend. The interest rate of 3.652% is correctly reported. (2) The LLM incorrectly frames the principal change as an 'increase' due to interest accrual, which contradicts the actual amortization or repayment pattern implied by a $3.2 million reduction. Moreover, the claim that 'no scheduled principal repayments were required' conflicts with the observed principal reduction, suggesting flawed reasoning. (3) While the LLM correctly identifies the security series and maintains the right interest rate, it fails to accurately synthesize the multi-hop financial data across years. The reasoning about interest accrual increasing principal is inconsistent with typical bond amortization and the provided ground truth. (4) Despite incorrect numbers and logic, the answer is contextually relevant—addressing the right security, time frame, and financial attributes—and attempts to explain structural behavior, hence moderate qualitative and relevance scores. However, the quantitative inaccuracy severely undermines the correctness, warranting a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 420,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 UPS moved from testing and impairing Coyote’s goodwill and trade‑name (recording a $111 million impairment charge on the trade name and $56 million/$61 million of goodwill impairments in 2023) to completing a strategic divestiture of the business in September 2024. The sale generated a $156 million gain, eliminated the unit’s operating losses and cut Forwarding operating expenses by roughly $1 billion, allowing UPS to exit a low‑margin brokerage operation and re‑allocate capital toward higher‑growth areas such as its healthcare‑focused logistics and other Supply Chain Solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details not present in the ground truth. While it correctly identifies the $111 million trade name impairment in 2023, it adds unsupported figures: $56 million/$61 million goodwill impairments and a $156 million gain from the sale, which are not in the original answer and cannot be verified from the provided truth. The claim of 'cutting Forwarding operating expenses by roughly $1 billion' and 'eliminating operating losses' is also absent from the ground truth and introduces new, unverified financial impacts. (2) The date of divestiture (September 2024) is correctly stated and aligns with the original answer. However, the financial figures around the gain and expense reductions are fabrications or hallucinations not supported by the ground truth. The original answer only states that Coyote's exit contributed to a revenue decrease in Supply Chain Solutions, not cost savings or gains. (3) The multi-hop reasoning is partially sound—connecting 2023 impairment to 2024 divestiture is correct and reflects strategic evolution. However, the LLM overreaches by inferring financial outcomes of the divestiture (gain, cost cuts) that are not in the source data, undermining the reasoning integrity. (4) Contextual relevance is high—the answer addresses both financial impact and strategic direction as asked. However, correctness score is low due to major quantitative inaccuracies and unsupported claims, despite capturing the high-level narrative of impairment leading to divestiture. The answer goes beyond the known facts with speculative financials, which violates factual grounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 462,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "\nThe 2022 10‑K shows that PSU grants initiated in 2019 were awarded under the 2021 Long‑Term Incentive Plan using either a Return‑on‑Capital performance metric or a Total‑Shareholder‑Return metric (Exhibits 10.03c‑d). The 2024 10‑K reveals that the First Amendment to the 2021 Plan (Exhibit 10.03e) revised the award structure—adding new performance criteria and refining the ROC/TSR targets—demonstrating how Linde’s PSU metric framework evolved between 2022 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that PSU grants from 2019 were awarded under the '2021 Long-Term Incentive Plan', while the ground truth confirms they were issued under the 'Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan'. This misidentification of the plan is a critical error. Additionally, the LLM claims that the 2024 10-K shows a structural change via the 'First Amendment to the 2021 Plan' (Exhibit 10.03e), introducing new performance criteria and refining targets. However, the ground truth states that the same dual structure (ROC and TSR) remained in place through 2024 with no changes to metrics for the 2019 grants, directly contradicting the LLM's assertion of evolution. (2) Quantitatively, the years (2019, 2022, 2024) are correct, but the exhibit numbers cited (10.03c-d, 10.03e) do not match the ground truth (10.11k-l in 2022, 10.10l-m in 2024), indicating incorrect sourcing. There are no numerical calculations in this question, but the timeline and exhibit references are factually wrong. (3) The multi-hop reasoning fails: the model incorrectly infers evolution in structure when the truth is stability. It synthesizes non-existent changes between 2022 and 2024, failing to recognize that the same award forms carried forward. The logic is flawed because it assumes amendments to the plan (2021 Plan) affected 2019 grants, which is not supported. (4) Contextual relevance is moderate—the answer addresses PSU structure and performance metrics over time, which is relevant—but the conclusions are factually incorrect, severely undermining usefulness. The answer suggests evolution where there was continuity, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 475,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "\nBetween 2023 and 2024 Trodelvy shifted from its earlier accelerated approvals in metastatic triple‑negative breast cancer and second‑line urothelial cancer to gaining a **second FDA Breakthrough‑Therapy designation** for extensive‑stage small‑cell lung cancer (after progression on platinum chemotherapy) and an **EC approval for monotherapy in HR⁺/HER2‑ breast cancer**.  These actions show that the drug’s regulatory path is expanding into new tumor types and that the FDA is increasingly viewing it as a promising, expedited‑development candidate, indicating a trajectory toward broader oncology indications and further commercial growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory developments for Trodelvy between 2023 and 2024, including the Breakthrough Therapy designation for extensive-stage small cell lung cancer in 2024, which aligns with the ground truth. It also accurately notes the expansion into HR+/HER2-negative breast cancer, consistent with the original answer. However, the LLM incorrectly states that Trodelvy received a 'second FDA Breakthrough-Therapy designation,' which is not confirmed in the ground truth; while plausible, the original answer does not mention prior Breakthrough Therapy designations, so this is an unsupported inference. Additionally, the mention of 'EC approval for monotherapy in HR+/HER2- breast cancer' is accurate but not included in the ground truth, suggesting the LLM may have introduced external knowledge not present in the provided data. (2) There are no numerical values requiring calculation, so quantitative accuracy is high by default—no errors in dates or financials. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes changes in indications and infers a broader development trajectory. However, the claim about a 'second' Breakthrough Therapy designation reflects an overinterpretation not supported by the source. (4) Despite minor overreach in details not in the ground truth, the core facts about new indications and strategic expansion are correct, warranting a high correctness score. Contextual relevance is perfect as the answer directly addresses the evolution and implications of regulatory status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 434,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "\nFrom 2023 to 2024 Vertex AI moved from a newly‑launched, unified hub for training, tuning and serving Gemini and other generative models into a mature, end‑to‑end platform that tightly integrates the newest Gemini 2.0 multimodal model and adds pre‑packaged AI agents (e.g., for code, security, search) and deeper connections to Imagen, Veo and other Google Cloud services. This evolution gives developers a complete pipeline—from model selection and grounding/distillation tools to production‑grade deployment and scaling—making Vertex AI the central engine for building and operating generative‑AI applications on Google Cloud.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Vertex AI from 2023 to 2024 with respect to enhanced generative AI integration, improved capabilities, and broader service connectivity, aligning well with the ground truth in intent and context. It accurately reflects the platform's expanded role in supporting Gemini and other models, as well as offering tools for training, tuning, and deployment. However, the LLM introduces specific details not present in the original answer, such as 'Gemini 2.0', 'pre-packaged AI agents', and mentions of 'Imagen' and 'Veo' by name, which were not part of the ground truth. While these may be factually plausible within Google's ecosystem, they represent unverified additions that go beyond the provided knowledge. The original answer emphasizes new services like vector search, grounding, and distillation—points partially reflected in the LLM’s mention of 'grounding/distillation tools' but not fully detailed (e.g., vector search is omitted). The timeline (2023 to 2024) is correctly used, and no numeric inaccuracies are present (quantitative accuracy is perfect). The reasoning is logically sound and relevant, showing a proper multi-hop synthesis of platform evolution, though with some over-enrichment. Thus, while the core facts and direction of evolution are correct, the answer includes speculative enhancements and omits specific new services mentioned in the ground truth, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 409,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company continues to treat weather‑related derivatives as immaterial – both the 2022 MD&A (pages 122 & 124) and the 2024 combined notes (pages 283‑287) explicitly state that the premium and intrinsic value of weather derivatives are excluded from derivative fair‑value measurements and from the balance‑sheet and AOCI tables. Consequently, the amounts considered immaterial have not changed; they remain effectively zero and are consistently omitted from derivative valuations across the two reporting periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Southern Company (SO) consistently treated weather derivatives as immaterial in both 2022 and 2024, and that the premium and intrinsic value were excluded from derivative valuations in both years. This aligns with the ground truth and shows accurate entity and metric identification (SO, weather derivatives, premium/intrinsic value, immateriality). However, the LLM answer fails to mention a key development in the 2024 disclosures: the specific disclosure of cash collateral held in broker margin accounts ($17 million at end of 2024 and $62 million at end of 2023), which indicates a more detailed disclosure framework over time. While the core point about immateriality and exclusion remains valid, the omission of this new quantitative context significantly weakens the answer's completeness and evolution analysis. The LLM implies no change in disclosure practices beyond consistent exclusion, which contradicts the ground truth showing increased specificity in 2024. Quantitative accuracy is high because no incorrect numbers are stated—the LLM avoids asserting false figures—but it misses the opportunity to report the new collateral amounts. Reasoning is sound within the scope of exclusion logic but lacks multi-hop synthesis between immateriality and evolving disclosure depth. Contextual relevance is strong as the response directly addresses the question’s focus on treatment and valuation changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 399,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Gilead’s filings show that Biktarvy remained a cornerstone of its HIV portfolio, but its regulatory scope widened markedly in 2024.  The FDA granted an expanded indication allowing treatment of patients with suppressed viral loads who have M184V/I resistance—a common resistance mutation—and issued an updated label that includes new safety‑and‑efficacy data for use in pregnant women living with HIV‑1.  These approvals reinforce Biktarvy’s differentiated position as a high‑barrier, once‑daily regimen that can address treatment‑resistant and special‑population patients, while its U.S. patent protection (expiring 2033) secures its market exclusivity for the near term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Biktarvy's U.S. patent expiration in 2033 (mentioned in the LLM response as securing market exclusivity), the 2024 expanded FDA indication for patients with M184V/I resistance, and the updated label for use in pregnant people with HIV-1 are all accurately reported. (2) Quantitative accuracy is perfect: the year 2033 for patent expiration and the 2024 timing of regulatory updates are correctly stated; no calculations were required. (3) Multi-hop reasoning is sound—the model synthesizes information across time (2023 vs 2024) and across types of developments (patent protection vs regulatory expansions), correctly identifying the shift in positioning. (4) The only minor shortcoming is that the LLM does not explicitly frame the evolution as a 'shift from patent protection in 2023 to expanded therapeutic application in 2024' as in the original answer, but it does convey the same information implicitly by describing both aspects in context. Wording differences are acceptable under semantic equivalence. The answer is fully relevant and addresses the evolution in both regulatory and market positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 340,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "\nIn 2023 AMT borrowed roughly $3 billion under its 2021 Multicurrency Credit Facility and repaid about $6.1 billion, producing a net repayment of roughly $3 billion, and in June 2023 it amended the facility to extend the maturity to July 1 2026 and replace LIBOR with SOFR; by contrast, in 2022 the company’s draws on the facility were modest and the facility was not amended.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.0 billion borrowed and $6.1 billion repaid in 2023, the net repayment of approximately $3.1 billion (stated as 'roughly $3 billion'), the July 1, 2026 maturity extension, and the replacement of LIBOR with SOFR. It also correctly notes no amendments in 2022. However, it inaccurately describes 2022 draws as 'modest'—the ground truth specifies $850.0 million in additional net borrowings, which is substantial, not modest. This is a meaningful qualitative omission. (2) All provided numbers are accurate: $3 billion borrowed, $6.1 billion repaid, net repayment ~$3.1 billion (rounding to $3 billion is acceptable), EUR 842.6 million equivalent to $919.1 million is not mentioned but not critical to the core summary. The 2023 amendment date (June 2023) aligns with the July 1, 2026 maturity extension. (3) The multi-hop reasoning is sound—comparing 2022 and 2023 usage and amendments—but the characterization of 2022 activity undermines full accuracy. The model synthesizes borrowing, repayment, and amendment data across years correctly, except for downplaying 2022 draw activity. (4) Correctness is high due to accurate numbers and structural changes, but the mischaracterization of 2022 borrowing as 'modest' prevents a 9–10 score. Quantitative accuracy is strong (9) due to correct figures and acceptable rounding. Qualitative accuracy is slightly reduced (8) due to the misleading 'modest' descriptor. Contextual relevance is perfect (10) as all key aspects of the question are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 426,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "\nBetween 2023 and 2024 Alphabet moved from a simple “gross‑when‑principal” treatment of Google Ad Manager inventory to a more granular revenue‑recognition model.  In the 2024 filing the company explicitly notes that Ad Manager contracts can contain multiple performance obligations and that revenue is allocated to each obligation on the basis of relative standalone selling prices, while variable consideration (e.g., customer incentives and credits) is estimated and deducted from gross amounts.  This refinement integrates Ad Manager transactions more closely with Alphabet’s overall revenue‑reporting framework, expanding the scope of gross reporting and adding allocation and variable‑consideration adjustments that were not emphasized in the 2023 disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually plausible and uses appropriate accounting terminology, but diverges significantly from the ground truth in terms of the core evolution described. (1) The original answer emphasizes a shift in *justification* for gross revenue recognition—from transactional reporting to a control-based principal assessment (control of inventory, primary responsibility, pricing discretion)—centered on Google Ad Manager's role in revenue operations. The LLM instead claims a shift toward allocating revenue across multiple performance obligations and applying variable consideration adjustments, which is not supported by the ground truth. (2) There are no numeric values in either response, so quantitative accuracy is not applicable; however, the LLM introduces concepts like 'relative standalone selling prices' and 'variable consideration' that do not appear in the original and represent a different accounting evolution. (3) The multi-hop reasoning is internally logical but incorrect: it fabricates a change in revenue allocation methodology rather than identifying the actual shift in control-based rationale for gross reporting. (4) While the LLM addresses the time frame (2023–2024) and correctly identifies Google Ad Manager and Alphabet, and the response is contextually relevant to revenue recognition strategy, it misrepresents the nature of the evolution. Thus, the answer is partially correct in framing a more complex model but fundamentally inaccurate in substance, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 420,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "\nUPS recorded a $56 million goodwill impairment on Roadie in 2023, but no impairment charge was taken in 2024; nevertheless, Roadie remains one of three reporting units with only limited excess of fair value—accounting for roughly $1.1 billion of the company’s $4.3 billion goodwill balance—and is therefore flagged as a higher‑risk unit that is continuously monitored for potential future write‑downs.  Strategically, Roadie is housed within the Supply Chain Solutions segment, where UPS continues to pursue synergies and growth, but the thin fair‑value cushion means that any deterioration in performance or an increase in the cost of capital could trigger additional impairments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $56 million goodwill impairment in 2023 is accurately reported, and the absence of a 2024 impairment is correctly stated. The additional detail about Roadie accounting for roughly $1.1 billion of the $4.3 billion goodwill balance, while not in the original answer, is plausible and contextually enriching without contradicting the ground truth. (2) The entity identification is correct—UPS, Roadie, the 2023–2024 timeframe, and the Supply Chain Solutions segment are all accurately referenced. (3) The reasoning is sound: the answer captures the multi-hop evolution from active impairment in 2023 to ongoing risk monitoring in 2024 due to limited excess fair value, which reflects the correct synthesis across years and financial assessments. (4) Semantically, the LLM conveys the same core message as the original—financial exposure decreased in terms of immediate charge but remains high due to risk sensitivity—and adds strategic context (segment placement, synergy pursuit) that enhances completeness without introducing error. The only minor gap is that the original emphasizes the shift in stance (from impairment to monitoring) more explicitly, while the LLM implies it. However, this does not detract from factual correctness. No calculation errors; number formats are consistent and acceptable. All in all, this is a robust, factually correct, and contextually enriched response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 415,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "\nFrom 2022 through 2024 Linde’s helium‑related business shifted from a modest growth contributor to a small drag on overall sales – in 2024 the “Other” segment (which includes global helium wholesale) posted a **$32 million (≈2 %) decline in sales** versus 2023, driven by lower helium volumes.  Despite that sales dip, operating profit in the same segment **rose $19 million (≈44 %)**, reflecting an insurance recovery that more than offset the higher helium‑related costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that helium had a negative impact on sales in 2024 due to lower volumes in the 'Other' segment, it fabricates specific dollar amounts ($32M sales decline, $19M operating profit increase) and percentages (2%, 44%) not present in the ground truth. The original answer does not provide any exact dollar figures or percentage changes for operating profit, only stating that costs increased but were partially offset by an insurance recovery. The LLM incorrectly claims operating profit rose 44%, which contradicts the ground truth implication of cost pressure reducing profitability. (2) Quantitative accuracy is low because the model invents precise financial figures and growth rates unsupported by the source. There is no mention in the original answer of a $32M sales drop or $19M profit increase; the 2% sales decline is mentioned but attributed to underlying sales, not absolute dollar terms. The 44% operating profit growth is entirely fabricated. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the shift in helium’s role and links it to the 'Other' segment and LAMT. It also correctly infers that insurance recovery played a role. However, it misrepresents the financial outcome by asserting profit growth when the ground truth indicates cost pressures, undermining the reasoning chain. (4) Contextual relevance is high because the answer addresses the evolution of Linde's relationship with helium and attempts to quantify the impact on sales and profit. However, the invented metrics severely compromise factual correctness, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 464,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "\nThe amount of loans covered by the Corporation’s long‑term credit‑protection agreements with FNMA and FHLMC fell from **$8.7 billion at the end of 2023 to $8.0 billion at the end of 2024** (a decline of about $0.7 billion, or roughly 8 %).  \nBecause these guarantees provide full credit protection only on the covered residential‑mortgage loans, the reduction shows that a smaller share of the Corporation’s residential‑mortgage portfolio is now insulated from loss—i.e., the firm’s direct credit‑risk exposure on its remaining residential mortgages has increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the loan values: $8.7 billion in 2023 and $8.0 billion in 2024, matching the ground truth exactly. The calculated decrease of $0.7 billion (approximately 8%) is accurate: (8.7 - 8.0) / 8.7 ≈ 8.05%, which rounds to about 8%, so the percentage is reasonably stated. 2) All entities are correct: FNMA and FHLMC are properly identified, the time periods (end of 2023 to end of 2024) are accurate, and the financial metric (loans covered under credit protection agreements) is correctly used. 3) The reasoning is largely sound: the LLM correctly infers that a decline in covered loans means less insulation from loss and thus increased direct credit risk exposure. However, it omits a key nuance from the original answer — that these agreements cover loans that become severely delinquent and that the Corporation does not record an allowance for credit losses on them. This context explains why the reduction might indicate a decrease in high-risk loans rather than just increased exposure. While the LLM’s conclusion isn’t wrong, it presents a slightly different interpretation (increased risk exposure) without acknowledging the alternative explanation (reduction in high-risk loan volume). 4) Despite this nuance, the answer is factually correct, complete in addressing both parts of the question (evolution of value and implication), and contextually relevant. The minor omission in reasoning depth prevents a perfect 10, but the core facts, calculations, and logic are solid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 414,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Adobe moved Firefly from a niche, standalone generative‑AI web app into a core, native capability woven throughout Photoshop, Illustrator, Adobe Express and the broader Experience Cloud, and it began marketing the service as “commercially safe” with multi‑language prompts, vector‑output models and enterprise‑level IP indemnification—key points of differentiation from other AI providers.  At the same time, the 2024 filing flags heightened regulatory risk, noting that emerging AI‑specific rules (e.g., the EU AI Act) and the need for extensive compliance, governance and indemnity frameworks could increase costs, expose Adobe to liability for AI‑generated content and constrain the rollout of new Firefly‑powered features.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Adobe's strategic evolution of Firefly from 2023 to 2024: starting as a standalone tool and becoming a natively integrated, commercially safe AI across core Adobe products—highlighting competitive differentiation through IP indemnification, vector outputs, and multi-language support. It also correctly identifies the emergence of regulatory risks in 2024, specifically referencing the EU AI Act and its potential impact on compliance costs, liability, and feature rollouts. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification; the years 2023 and 2024 are used appropriately and consistently. (3) The multi-hop reasoning is sound: the answer synthesizes Firefly’s product evolution (competitive positioning) with external regulatory developments (risk landscape), correctly attributing shifts in tone and focus between the two years. (4) The only minor shortcoming is that the LLM slightly expands on details not explicitly confirmed in the ground truth (e.g., 'vector-output models', 'multi-language prompts', 'enterprise-level IP indemnification')—while plausible and consistent with Adobe’s public messaging, these specifics are not present in the original answer. However, they do not contradict it and fall within reasonable inference. Overall, the answer is factually correct, comprehensive, and contextually precise, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 415,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "\nIn 2023 Trodelvy’s sales surged — up 56 % to $1.1 billion (page 41) — driven by strong demand in breast‑cancer and new markets, and the FDA approved it as a monotherapy for HR⁺/HER2‑ metastatic breast cancer while also granting a second Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer (pages 39, 7). Building on that momentum, in 2024 the company again received a Breakthrough‑Therapy designation for the SCLC indication (page 8), reinforcing an accelerating regulatory trajectory that expands Trodelvy’s approved uses and positions it for faster development and commercial growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 56% sales increase and approximates the 2023 sales figure as $1.1 billion, which is a reasonable rounding of the exact $1,063 million reported in the ground truth. However, it does not explicitly state the exact figure, slightly reducing quantitative precision. The 2024 regulatory milestone — the second Breakthrough Therapy designation for extensive-stage small cell lung cancer (SCLC) — is accurately reported, including correct context and indication. (2) The numeric values are mostly accurate: 56% growth is correct; $1.1 billion is an acceptable rounded version of $1,063 million. No calculation errors are present, though the lack of exact dollar amount slightly affects precision. The FDA action in 2024 is correctly attributed to the SCLC indication. (3) Multi-hop reasoning is sound: the model synthesizes financial performance (2023 sales growth) with regulatory developments (2024 Breakthrough Therapy designation), linking both years appropriately. It correctly identifies the drug, company (implied), indication, and regulatory agency. However, the claim that the FDA approved Trodelvy as a monotherapy for HR+/HER2- metastatic breast cancer in 2023 is not supported by the ground truth and introduces extraneous, unverified information, which affects qualitative accuracy. (4) The answer is highly contextually relevant, addressing both financial performance and regulatory trajectory across 2023 and 2024. Despite minor inaccuracies and an unsupported approval claim, the core of the answer aligns with the ground truth, warranting a high correctness score with room for improvement in factual precision and restraint in inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 463,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "\nChevron’s 36.4 % stake in Angola LNG Limited stayed unchanged, but the investment’s carrying value slipped from about **$1.76 bn (2023)** to **$1.66 bn (2024)** after having peaked at **$1.86 bn in 2022** (Notes 15 & 16, 2024 10‑K).  Correspondingly, equity‑method earnings fell sharply from **$1.86 bn in 2022** to **$0.51 bn in 2023** and remained modest in 2024, indicating a reduced financial contribution from the project.  The partnership continues to provide a strategic LNG outlet and generates tax cash‑flows (Chevron’s share of the 2024 affiliate tax expense was **$1.29 bn**), but the lower investment balance and earnings reflect a deliberate scaling back of Angola LNG’s role in Chevron’s overall cash‑flow strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Chevron's income from equity affiliates in 2022 was $5,657 million overall, with Angola LNG contributing to upstream-related earnings, but it does not specify that Chevron earned $1.86 billion from Angola LNG alone in 2022. The LLM incorrectly attributes the entire $1.86 billion (which appears to be the carrying value, not earnings) to Angola LNG earnings, conflating investment carrying value with income. There is no support in the original answer for equity-method earnings of $1.86B in 2022, $0.51B in 2023, or 'modest' earnings in 2024. Additionally, the original answer does not mention any carrying value of the investment (e.g., $1.76B, $1.66B, $1.86B) or tax expenses ($1.29B in affiliate tax), so these figures are unsupported. (2) The only correct quantitative element is the 36.4% ownership stake in Angola LNG Limited in 2024, which matches the ground truth. All other numbers are either fabricated or misattributed. (3) The multi-hop reasoning is flawed: the LLM infers a 'deliberate scaling back' of Angola LNG’s role based on unsupported declines in carrying value and earnings, contradicting the original answer’s conclusion of 'continued strategic emphasis' and 'more defined and stable long-term positioning.' The original answer shows an evolution toward greater clarity and strategic importance, not reduction. (4) While the LLM attempts to address Chevron’s financial involvement and strategic positioning over time, it does so with fabricated data and incorrect interpretation, leading to a misleading conclusion. The contextual relevance is moderate because it addresses the right topic and timeframe, but factual accuracy is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 482,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "\nBy year‑end 2024 Meta’s fixed‑rate senior unsecured notes had a face value of roughly **$29 billion**, compared with **$18.5 billion** at the end of 2023.  The jump reflects a **$10.5 billion issuance in August 2024** (on top of the $8.5 billion May 2023 tranche), expanding the total outstanding notes and driving interest expense up from $420 million in 2023 to $683 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively: The key figures are correct—$18.5 billion (end of 2023), $29 billion (end of 2024), $10.5 billion issued in August 2024, and approximately $8.5 billion in May 2023 (ground truth specifies $8.46 billion, so rounding to $8.5 billion is acceptable). The increase from $18.5B to $29B is correctly implied as a $10.5B rise. (2) Minor discrepancy: The original answer specifies 'net proceeds' of $8.46 billion in May 2023, while the LLM rounds to $8.5 billion—this is a negligible rounding difference and does not affect correctness. (3) The LLM adds contextual detail not in the original—interest expense rising from $420M to $683M—which is factually consistent with increased debt issuance and enhances the answer without contradicting the ground truth. (4) Multi-hop reasoning is sound: the model correctly synthesizes issuance events in 2023 and 2024 and links them to the growth in total outstanding notes. (5) Entity accuracy is perfect: correct company (Meta), correct instrument (fixed-rate senior unsecured notes), correct years and issuance dates. (6) The answer fully addresses the evolution of value and issuance activity across 2023–2024. Only a 9 due to the slight rounding of $8.46B to $8.5B without qualification, though this is within acceptable variation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 381,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "\nIn the 2023 10‑K (page 62) helium was listed only as part of “Rawmaterials and supplies” with a $614 million balance and was treated simply as a routine supply, without any risk‑or‑dependency language. The 2024 filing (also page 62) shows the raw‑materials inventory falling to $529 million and the accompanying footnote now explicitly identifies helium as a “critical raw material” and notes heightened sourcing constraints and rising cost volatility, signalling that the company now views helium as a dependency rather than a mere supply.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. The ground truth states that helium costs were 4.2% of total raw material expenses in 2023 and rose to 6.8% in 2024, but the LLM instead reports total raw materials inventory balances ($614M in 2023, $529M in 2024), which are not equivalent to helium-specific cost percentages. These dollar figures may be accurate line items, but they do not represent the proportion of helium costs as a share of raw material expenses, which is the core metric in the question. (2) There is no verification of the key percentage increase from 4.2% to 6.8%, and the LLM fails to mention these percentages entirely, instead focusing on aggregate inventory values that are not directly comparable to the ground truth metric. This represents a failure in quantitative accuracy. (3) Qualitatively, the LLM correctly identifies the shift in categorization from a routine 'supply' in 2023 to a 'critical raw material' with dependency language in 2024, including sourcing constraints and cost volatility. This reflects sound multi-hop reasoning in interpreting the change in disclosure tone and strategic classification. (4) Contextually, the answer is relevant and addresses the evolution in LIN's exposure to helium, citing correct document locations (page 62 of both 10-Ks) and appropriate qualitative shifts. However, the absence of the specific cost percentages — the primary quantitative evidence of increased exposure — severely undermines the correctness. While the direction of change (increased importance) is right, the evidentiary support is misaligned with the required metric. Hence, the correctness score is low due to missing core numerical data, despite accurate reasoning and contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 485,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "\nBetween 2022 and 2023 the amount of European customer balances that PayPal’s management could designate for funding credit activities fell sharply—from **$3.8 billion approved in 2022 to $3.0 billion approved in 2023**.  This represents a **year‑over‑year decline of roughly 21 %** in the approved amount for such credit‑related uses.  (Source: PYPL_10k_2023.pdf p. 49; PYPL_10k_2022.pdf p. 75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the approved amounts for credit activities in both years: $3.8 billion in 2022 and $3.0 billion in 2023, matching the ground truth. The percentage change is accurately calculated as approximately 21% (exact calculation: (3.8 - 3.0)/3.8 ≈ 21.05%), which is correctly characterized as a decline. (2) All numeric values are accurate and properly cited to the relevant 10-K filings. The dollar amounts and years are correct, and the calculation of the percentage decrease is sound. (3) The LLM captures the evolution in absolute terms but omits the contextual nuance about the percentage of European customer balances increasing slightly from 37% to 39%, which indicates a more conservative utilization despite the lower absolute amount. This missing detail slightly weakens the qualitative reasoning and synthesis, though the core multi-hop comparison across years is correctly executed. (4) The answer is highly relevant, factually precise, and directly addresses the question’s focus on the change in approved amounts. The omission of the balance percentage context prevents a perfect score, but the key facts and calculation are correct, warranting a 9/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 340,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "\nBetween fiscal 2023 (Oct 1 2023) and fiscal 2024 (Sep 29 2024) the fair‑value of Starbucks’ “foreign‑currency – other” derivatives fell sharply on the asset side (from $32 million of derivative assets to $1.9 million) while the liability side grew (from $2.0 million accrued plus virtually no long‑term liability to $4.7 million accrued and $4.1 million long‑term).  As a result, the pre‑tax gain that remains in AOCI and is expected to be re‑classified to earnings over the next 12 months dropped from $28.2 million to $9.5 million, indicating that the anticipated earnings impact of these foreign‑currency hedges has been cut by roughly two‑thirds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers compared to the ground truth. The fair value of foreign currency - other instruments is reported as $1,164 million in 2023 and $920 million in 2024 in the original answer, but the LLM incorrectly breaks this down into small asset/liability components ($32M, $1.9M, etc.), which contradicts the aggregate fair value figures. These values are off by orders of magnitude and do not align with the ground truth. Additionally, the net gain in AOCI is misreported: the LLM states a pre-tax gain reclassification expectation dropping from $28.2M to $9.5M, while the original answer specifies the expected reclassification impact declined from $55.3M to $9.5M. The $28.2M figure does not appear in the ground truth and is therefore incorrect. (2) The only correct number is the 2024 expected reclassification amount ($9.5M), which matches the original answer. However, the 2023 figure is wrong, and the core fair values are entirely misrepresented. Calculations or comparisons based on these numbers (e.g., 'cut by roughly two-thirds') are therefore also flawed. (3) The reasoning structure is partially sound—recognizing a decline in fair value and reduced earnings impact—and attempts multi-hop synthesis by linking fair value changes to AOCI and future earnings. However, due to incorrect underlying data, the conclusions are not supported. The model appears to confuse derivative classifications or misreads the instrument type (possibly conflating with another category). (4) Despite incorrect numbers, the answer addresses the right question contextually—evolution of foreign currency instruments, fair value trends, and earnings impact—so relevance is high. However, due to major quantitative errors and partial qualitative misrepresentation, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 503,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "\nAlabama Power’s energy‑related derivative assets fell from about $55 million in 2022 to $15 million in 2023, while its liabilities rose from $11 million to $61 million; Georgia Power’s assets declined from roughly $75 million to $13 million and its liabilities increased from $8 million to $124 million. In each case the drop in derivative assets was matched by a rise in derivative liabilities, shifting both subsidiaries from a net derivative‑asset to a net derivative‑liability position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the directional changes and overall trend — both Alabama Power and Georgia Power experienced significant declines in derivative assets and increases in liabilities, shifting from net asset to net liability positions. However, there is a critical error in Alabama Power’s 2023 liabilities: the LLM states $61 million, while the ground truth reports $110 million. This is a substantial numerical inaccuracy affecting quantitative correctness. All other numbers — Alabama 2022 assets ($55M), 2023 assets ($15M), Georgia 2022 assets ($75M), 2023 assets ($13M), 2022 liabilities ($8M), and 2023 liabilities ($124M) — are correctly reported (with acceptable rounding noted by 'about' or 'roughly'). (2) The calculation of directional change and net position shift is logically sound, but the incorrect liability figure for Alabama Power in 2023 undermines the precision of the financial representation. The claim that 'drop in assets was matched by a rise in liabilities' is a simplification but captures the essence of increased liability exposure. (3) Multi-hop reasoning is well-executed: the model synthesizes data across two companies and two years, compares asset versus liability positions, and infers the shift in net exposure. Entity identification (Alabama Power, Georgia Power), years (2022, 2023), and financial metrics (fair value of energy-related derivatives, assets vs liabilities) are accurate. (4) The contextual relevance is perfect — the answer directly addresses both parts of the question: evolution of fair value and directional change in asset/liability positions. Due to the significant error in Alabama Power’s 2023 liabilities, the quantitative accuracy is reduced to 6, pulling the overall correctness score to 7 despite strong qualitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 499,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "\nThe U.S. Retiree Health Care Plan’s asset mix moved markedly toward fixed‑income securities between 2022 and 2023. In 2022 the plan held about $182 million of fixed‑income/cash equivalents (≈ 65 % of its $280 million total) and roughly $98 million of equity (≈ 35 %). By the end of 2023 the allocation had shifted to roughly $210 million of fixed‑income (≈ 80 % of its $264 million total) and only $54 million of equity (≈ 20 %). Thus, the strategy evolved from a roughly 65/35 split to an approximate 80/20 split in favor of fixed‑income securities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages (65%/35% in 2022 and 80%/20% in 2023) are accurately reported. The dollar amounts ($182M fixed income and $98M equity in 2022; $210M fixed income and $54M equity in 2023) align with the stated percentages and total plan values ($280M in 2022, $264M in 2023), and all calculations are accurate. Minor variations in total assets across years are acceptable and do not contradict the percentage allocations. (2) The answer is complete, addressing both years and both asset classes, and explicitly notes the shift from 65/35 to 80/20. (3) Entities are correct: 'U.S. Retiree Health Care Plan', years 2022 and 2023, and asset classes (fixed income securities, equity securities) are properly identified. (4) The reasoning is sound: the LLM correctly infers a shift toward a more conservative strategy based on the increased allocation to fixed income, which is a valid conclusion from the data. The multi-hop synthesis—comparing allocations across two years and computing proportions—is accurately executed. (5) The semantic meaning is equivalent to the original answer, with added detail (dollar amounts) that enhance clarity without introducing error. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 361,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s regulatory standing moved from *accelerated‑approval only* for two prior indications—metastatic triple‑negative breast cancer and advanced urothelial cancer after platinum‑based chemotherapy plus a PD‑1/PD‑L1 inhibitor—to a **full FDA approval (with European Commission conditional authorization)** for a **new indication in 2023**: monotherapy treatment of adult patients with unresectable or metastatic HR‑positive/HER2‑negative breast cancer who have received endocrine therapy and at least two prior systemic therapies. The earlier accelerated approvals for TNBC and urothelial cancer remained in place, but the 2023 approval added the HR⁺/HER2⁻ breast‑cancer label.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Trodelvy's 2022 indications for metastatic triple-negative breast cancer (TNBC) and urothelial cancer are accurately described, and the 2023 approval for HR+/HER2- breast cancer is correctly identified with the appropriate patient criteria (endocrine-based therapy and at least two prior systemic therapies). (2) Quantitative accuracy is perfect: years (2022, 2023), number of prior therapies (two or more), and sequence of treatments are all factually correct. The mention of FDA and EC approvals aligns with the ground truth’s 'FDA approval' and 'EC approval'—though the LLM specifies 'conditional authorization' for EC, which is a minor elaboration not contradicted by the original. (3) Multi-hop reasoning is sound: the model correctly synthesizes the evolution of approval status over time and identifies the new indication as an expansion. The distinction between accelerated and full approval adds value, though the original answer does not specify this detail—this is a minor over-clarification but not factually incorrect. (4) The only reason for not scoring 10 is that the original answer emphasizes the 'significant expansion of the drug’s therapeutic applications,' a qualitative synthesis slightly underemphasized in the LLM response. However, the core facts, entities, dates, and indications are all correct and semantically equivalent. Contextual relevance is excellent as all parts of the question are addressed directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 426,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "\nIn the 2023 10‑K Meta warned that adverse media coverage, privacy‑related controversies and content‑moderation decisions (including those of the independent Oversight Board) could prompt marketers to cut ad spend and users to disengage, directly threatening revenue. By the 2024 filing the language was broadened: it flags heightened public scrutiny over data‑transfer rulings, the rollout of a paid‑ad‑free “subscription‑for‑no‑ads” option, and more general trust concerns, stressing that any erosion in user perception of the platform’s safety and integrity could materially reduce user growth, engagement and advertiser demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually plausible and includes relevant details about Meta's risk disclosures in 2023 and 2024, with accurate entity and year references. There are no numeric values to verify, so quantitative accuracy is scored as 10 by default. However, the LLM misrepresents the evolution of Meta's risk disclosure: while the 2023 description aligns with the ground truth (privacy, content moderation, and user disengagement risks affecting revenue), the 2024 characterization does not reflect the actual shift described in the original answer. The ground truth states that Meta *reduced* emphasis on user perception as a direct risk factor in 2024 and shifted focus to operational and financial risks like acquisition integration and tax liabilities. In contrast, the LLM claims the 2024 filing 'broadened' language and continued to stress user perception risks (e.g., trust, safety, subscription option), which contradicts the documented strategic shift. This is a significant qualitative error in reasoning and synthesis across years. While the LLM addresses the question's core theme (evolution of user perception as a risk), it fails to accurately capture the *nature* of the shift—specifically, the de-emphasis on user perception in favor of broader financial and operational risks. Thus, despite good contextual relevance and no factual inaccuracies in the details it provides, the answer misses a key analytical point, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 404,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "\nThe notional amount of Lockheed Martin’s outstanding variable‑interest‑rate swaps rose from roughly **$0.5 billion in 2021** to **$1.3 billion by the end of 2023**, and remained at that $1.3 billion level through 2024. This expansion shows the company has deliberately increased its use of fair‑value hedges to convert fixed‑rate debt into variable‑rate exposure, a proactive move to manage interest‑rate risk in a period of rising rates and to stabilize earnings and cash‑flow volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct. It accurately reports the notional amount of $0.5 billion in 2021 (equivalent to $500 million in the ground truth) and correctly states the 2024 amount as $1.3 billion. The only minor discrepancy is that the LLM specifies the increase occurred 'by the end of 2023' and remained at $1.3 billion through 2024, whereas the ground truth directly states the 2024 amount without specifying the exact timing of the increase. However, this does not contradict the ground truth and is likely based on finer-grained data. 2) Quantitatively, all numbers are accurate with acceptable format variations ($0.5 billion = $500 million). The $1.3 billion figure matches exactly. There are no calculation errors. 3) The reasoning is sound: the LLM correctly infers that the increase in variable-rate swaps indicates a strategy to convert fixed-rate debt to variable-rate, aligning with interest rate risk management, particularly in a rising rate environment. This matches the multi-hop synthesis required—linking swap notional changes to strategic risk management. 4) The answer is contextually fully relevant, addressing both the evolution of the notional amount and its implication for risk strategy. The addition of 'fair-value hedges' and 'stabilize earnings and cash-flow volatility' provides slightly more detail than the original but is consistent with plausible financial reasoning and does not introduce inaccuracies. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth, warranting a high score with only minor deductibility for the slight ambiguity in timing (2023 vs 2024).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 450,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal’s Seller‑Protection reserve was trimmed only modestly – the allowance for transaction losses fell from **$66 million (as of 31 Dec 2022) to $64 million (as of 31 Dec 2023)** [page 113].  The company recorded a slightly higher provision expense in 2023 ($1.192 billion vs. $1.170 billion in 2022) but realized a larger reduction in actual losses ($1.313 billion of write‑offs versus $1.417 billion the prior year), resulting in a net decline in the reserve.  This reflects a more refined estimation of exposure—incorporating updated macro‑economic trends and loss experience—so that the financial provision for seller‑protection‑related transaction losses was modestly decreased while still being monitored closely.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the allowance for transaction losses decreased from $66 million in 2022 to $64 million in 2023, matching the original answer. The additional details—provision expense increasing from $1.170 billion to $1.192 billion and write-offs decreasing from $1.417 billion to $1.313 billion—are consistent with a more granular but accurate financial narrative. These figures support the net decline in reserve, which is correctly interpreted. (2) The entity accuracy is correct: PayPal is the subject, and the years 2022 and 2023 are properly referenced with fiscal year-end dates (Dec 31). The metric 'allowance for transaction losses' is used appropriately. (3) Reasoning is sound: the LLM correctly infers that a lower reserve despite higher provision expense results from reduced write-offs, indicating improved loss experience and refined risk modeling. This supports the conclusion of a more structured, data-driven approach in 2023 versus the more qualitative 2022 assessment mentioned in the ground truth. (4) The answer is semantically equivalent and contextually complete, capturing both the numerical evolution and the implied shift in risk management strategy. The only minor limitation is that it does not explicitly mention the 2022 reference to historical loss rates (0.09%–0.15% of TPV) or macroeconomic concerns like the pandemic’s impact, which were part of PayPal’s 2022 qualitative risk disclosure. While the LLM references 'updated macro-economic trends,' the specific context from 2022 is slightly underdeveloped. However, this omission does not undermine the core correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 498,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "\nFrom fiscal 2023 (balance as of Oct 1 2023) to fiscal 2024 (balance as of Sep 29 2024) the foreign‑currency‑other derivative **asset** fell from **$54.9 million** to **$3.6 million** – a **$51.3 million** decrease – while the foreign‑currency‑other derivative **liability** rose from **$2.0 million** to **$8.8 million** – an **$6.8 million** increase.  Consequently, the balance‑sheet shows a **$51.3 million reduction in derivative assets** and a **$6.8 million increase in derivative liabilities** for this category, producing a net swing of roughly **$44–$58 million** in the overall foreign‑currency‑other derivative position.  (Values are taken from the “Derivative Assets” and “Derivative Liabilities” rows for “Foreign currency – other” in the fair‑value tables on pages 72/73 of the 2023 and 2024 Form 10‑K filings.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy. According to the ground truth, Starbucks' derivative asset for 'Foreign currency - other' decreased from $1,164 million in fiscal year 2023 to $1.9 million in 2024, a reduction of approximately $1,162.1 million. However, the LLM reports the asset decreasing from $54.9 million to $3.6 million, which is off by over $1.1 billion. Similarly, the derivative liability increased from $2.0 million to $4.7 million in reality, but the LLM claims it rose to $8.8 million—an overstatement by $4.1 million. These errors invalidate the core of the answer. The calculations based on the incorrect numbers (e.g., $51.3 million decrease in assets, $6.8 million increase in liabilities) are internally consistent but fundamentally wrong due to incorrect input data. The mention of specific 10-K page numbers (72/73) and fiscal dates (Oct 1, 2023; Sep 29, 2024) suggests an attempt at precision, but the values do not align with the ground truth. While the LLM correctly identifies the direction of change (asset down, liability up) and attempts multi-hop synthesis across fiscal years, the magnitude errors are so severe that the answer misrepresents the financial reality. The net swing estimate of $44–$58 million is also incorrect given the true scale of change (~$1.16 billion reduction in assets alone). Thus, despite correct qualitative direction and some contextual framing, the answer fails on factual accuracy, which is critical in financial reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 415,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "\nIn 2022 the energy‑related derivatives produced a $59 million net positive contribution to earnings from natural‑gas cost and revenue hedges, but by 2023 that contribution had reversed to a $76 million net loss. This swing reflects a shift in the revenue hedge from a $134 million gain (2021) to an $11 million loss (2023), while the cost‑hedge gain remained modest ($59 million in 2023), causing the overall hedging impact to move from a positive to a negative result.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on cost, totaling a $144 million negative impact. However, the LLM claims a $59 million 'net positive contribution' in 2022, which is factually incorrect and misrepresents both direction and magnitude. In 2023, the ground truth states a $59 million gain on cost and $0 on revenue (net positive $59M), but the LLM incorrectly reports a $76 million net loss, again reversing the actual financial outcome. The LLM also references a $134 million gain in 2021, which is not mentioned in the original answer and introduces unsupported data. (2) Number verification: Ground truth values are $117M loss (revenue, 2022), $27M loss (cost, 2022), $59M gain (cost, 2023), $0 (revenue, 2023). LLM reports $59M net gain (2022), $76M net loss (2023), $11M loss (revenue hedge, 2023), and references 2021 data not in the original—none of these align. Calculations and figures are fundamentally wrong. (3) Multi-hop reasoning is flawed: The question asks for evolution from 2022 to 2023, requiring accurate synthesis of revenue and cost impacts across both years. The LLM fails this by inventing data (2021), misstating signs (positive vs negative), and miscalculating net impacts. It does not reflect the actual shift from negative to positive cost impact and neutral revenue in 2023. (4) Correctness and quantitative accuracy are low due to pervasive number errors and direction reversals. Qualitative accuracy is slightly higher because the model attempts to discuss cost and revenue hedging evolution, showing some understanding of the conceptual framework. Contextual relevance is moderate as it addresses hedging impacts over time, but with incorrect data undermining utility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 510,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "\nIn the 2023 Form 10‑K the Deferred Compensation Matching Plan was only listed among the exhibit indexes and was not presented as a separately filed, restated agreement, so its effective date was not highlighted. The 2024 filing, however, includes the plan as Exhibit 10.1 and explicitly states that it was “amended and restated effective November 8, 2023,” formally documenting the update and providing a clear effective date. Thus, the treatment evolved from an informal, undated reference to a fully documented, restated plan with a specified November 8, 2023 effective date.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly claims that in the 2023 10-K, the Deferred Compensation Matching Plan was 'only listed among the exhibit indexes' and 'not presented as a separately filed, restated agreement' — this contradicts the ground truth, which states the plan was explicitly introduced in the 2023 filing as 'amended and restated effective November 8, 2023.' The effective date *was* highlighted in 2023, contrary to the LLM's claim. (2) The LLM reverses the evolution: it portrays the 2024 filing as the first to document the plan with an effective date, but the ground truth confirms the plan was already introduced with that date in 2023. The actual evolution was from 'newly introduced' in 2023 to 'incorporated by reference' in 2024, indicating normalization, not initial documentation. (3) The effective date (November 8, 2023) is correctly stated, earning partial quantitative credit, but the reasoning about documentation status is inverted. (4) The multi-hop synthesis is flawed — the model fails to track the correct progression of the plan’s treatment across filings, misrepresenting the nature of disclosure changes. While the answer addresses the question’s scope (documentation status and effective date), the core factual narrative is incorrect, leading to a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but accuracy is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 412,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "\nBetween 2023 and 2024 the company continued to disclose LTIP Units as “potentially dilutive securities” in its earnings‑per‑share/unit tables, but in both years it concluded that they did **not** have a material dilutive effect and therefore made no adjustments to net income or to the weighted‑average share (or unit) counts.  The accrual policy for any distributions related to those units was unchanged – distributions are accrued only when they are declared.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that LTIP Units were disclosed as potentially dilutive in both 2023 and 2024, with no material dilutive effect in either year, leading to no adjustments to net income or weighted-average shares outstanding—this matches the original answer exactly. (2) There are no numerical values requiring calculation (e.g., percentages, dollar amounts), but the temporal scope (2023, 2022, 2021 in 2023 reporting; 2024, 2023, 2022 in 2024 reporting) is correctly implied through context, and no inaccuracies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes the continuity of disclosure and policy across two reporting years, identifying both the dilutive treatment and accrual policy as stable. (4) The accrual policy—'distributions are accrued when declared'—is correctly reported as unchanged. The LLM answer is concise but complete, addressing both parts of the question (dilutive effect and accrual policy) across the two years with precise, factually aligned reasoning. All entities (LTIP Units, dilutive effect, accrual of distributions) are correctly identified and treated. No factual, quantitative, or qualitative errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 353,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "\nBetween 2023 and 2024 Meta shifted from a defensive stance—appealing the Irish DPC’s €1.2 bn fine and corrective order that required it to suspend EU‑US transfers under the invalidated SCCs (with an interim stay in place)—to an active compliance posture built around the newly‑adopted EU‑U.S. Data Privacy Framework.  After the European Commission’s July 2023 adequacy decision, the company began revising its legal bases for processing in the EU (moving from “legitimate interests” to consent), introduced a “subscription‑for‑no‑ads” option, and invested in privacy‑by‑design controls and governance to meet the DPF’s safeguards.  It also engaged directly with EU regulators on DMA and DSA matters, reflecting a move from reactive appeals to proactive alignment with the DPF and related EU data‑protection requirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Meta's compliance approach between 2023 and 2024 with respect to the EU-U.S. DPF, regulatory actions, and broader EU data laws. Quantitatively, all key figures (e.g., €1.2 billion fine, July 2023 adequacy decision) are accurate, and no incorrect numbers or dates are present—minor note: the original answer mentions July 2024 as the date for the European Commission’s preliminary findings on DMA non-compliance, which the LLM omits, though it correctly references engagement with regulators under the DMA/DSA. The LLM correctly identifies the shift from reliance on SCCs to the EU-U.S. DPF, the move from 'legitimate interests' to consent, and the introduction of the 'subscription-for-no-ads' model in late 2023. However, it does not explicitly mention that the European Commission opened formal proceedings into this model or issued preliminary findings of non-compliance in July 2024—a key development in 2024 regulatory scrutiny. This omission affects completeness and slightly weakens the multi-hop synthesis between Meta’s compliance actions and the resulting regulatory response. The reasoning is sound and reflects a logical progression from reactive to proactive compliance, but the failure to fully close the loop on the 2024 DMA proceedings reduces qualitative accuracy slightly. Contextual relevance is excellent, as the response directly addresses the evolution of Meta’s compliance posture in response to regulatory actions. Overall, the answer is factually strong with minor gaps in completeness regarding 2024 regulatory outcomes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 440,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Linde moved from describing green hydrogen only as “hydrogen produced by electrolysis using renewable energy” — a side‑note among gray and blue pathways — to explicitly positioning renewable‑electrolysis hydrogen as a distinct, non‑fossil feedstock and a core element of its clean‑energy strategy.  The 2024 document emphasizes that this “renewable (green) hydrogen” is produced via electrolysis powered by renewable electricity and water, and it highlights Linde’s engineering, digital‑service and distribution capabilities as the platform for scaling those electrolytic projects, underscoring a stronger, dedicated focus on renewable‑energy‑driven production methods.  (Pages 5‑6 of the 2024 10‑K; comparable discussion appears on pages 4‑5 of the 2023 10‑K.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly captures the evolution in Linde's framing of green hydrogen between 2023 and 2024: from a less emphasized clean energy option to a more clearly defined and strategically prioritized 'renewable (green) hydrogen' produced via electrolysis using renewable energy and water. The answer accurately reflects the shift in terminology and emphasis, including the distinction from blue hydrogen and the focus on renewable feedstocks. It also correctly identifies the increased strategic importance of green hydrogen in 2024, supported by Linde’s engineering and distribution capabilities. The citation of specific pages in the 10-K filings adds contextual support. One minor omission is that the original answer notes Linde’s 2023 inclusion of green hydrogen from steam methane reforming of biomethane as a method, which the LLM answer does not mention—this slightly reduces completeness in the multi-hop synthesis. However, the core facts, reasoning, and qualitative shift are correctly conveyed. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is fully relevant to the question. The reasoning is sound and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 363,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "\nBetween 2022 and 2023 Southern Company completely exited its ownership of Sequent— the wholesale‑gas services business that had been reported as a distinct segment in 2021‑2022—by selling its controlling interest in July 2021 and then removing the segment from its 2022 and 2023 filings.  The 2021 transaction produced a $121 million pre‑tax gain (≈ $92 million after tax), but the subsequent re‑allocation of state‑apportionment rates created an additional $85 million tax expense, and after the sale Sequent no longer contributed any revenue or earnings, leaving the company without that source of income in the 2023 segment results.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several key inaccuracies. Most critically, it incorrectly states that the sale occurred in July 2021, while the ground truth confirms the sale took place in 2022. This misalignment in timing undermines the core of the multi-hop analysis between 2022 and 2023. Additionally, the LLM claims Sequent was removed from filings in 2022 and 2023 due to a 2021 sale, which contradicts the original answer stating the divestiture was completed in 2022 and fully reflected by 2023. (2) Quantitatively, the $121 million pre-tax gain and $85 million tax expense are correctly reported, which supports partial credit. However, the after-tax gain of $92 million is not mentioned in the ground truth and appears to be an unsupported inference. The sale price of $159 million is entirely omitted, a significant financial detail. (3) The reasoning is flawed in its timeline: the evolution from ownership to divestiture between 2022 and 2023 is misrepresented because the sale is backdated to 2021. This breaks the logical synthesis required for the multi-hop question, as the transformation is framed as occurring before the period in question. (4) Despite these issues, the answer is contextually relevant—addressing the relationship change and financial implications—and correctly identifies the financial impact of the divestiture (gain and tax expense), even if misattributed in time. Thus, moderate scores are given for quantitative and qualitative accuracy, with a low correctness score due to the critical error in timing and missing sale value.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 432,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart continued to list **Allswell** in the same “private‑brand” section of its 10‑K filings, but it no longer highlighted the brand with separate performance or growth language – the reference was identical in both years.  This consistency shows that Walmart is treating Allswell as a stable, value‑oriented home‑goods label that fits within its broader private‑brand portfolio, using it to reinforce the everyday‑low‑price proposition while expanding its home‑category offerings without creating a distinct strategic shift.  In short, the relationship has remained steady, indicating that Allswell is viewed as a core component of Walmart’s private‑brand strategy rather than a brand undergoing transformation.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its reasoning that undermines the overall correctness. (1) The LLM claims that Walmart 'continued to list Allswell in the same private-brand section' and that the reference was 'identical' in both years, with no longer highlighting it with performance language. However, the ground truth states that Allswell was *introduced* in 2023, meaning it did not exist in prior years, and by 2024 it was grouped with mature brands like 'bettergoods' and 'Equate', indicating progression from new to established status. The LLM incorrectly frames the brand as static, missing the key evolution from introduction to integration among mature brands. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is flawed: the model fails to recognize that the shift from being a newly introduced brand in 2023 to being listed alongside established brands in 2024 represents a strategic elevation, not stability. This misinterpretation leads to an incorrect conclusion about the brand’s trajectory. (4) Despite this, the answer is contextually relevant and correctly identifies Allswell as part of Walmart’s private brand portfolio and infers it is viewed as a core component, which aligns with the ground truth’s conclusion. However, the reasoning path to that conclusion is incorrect, warranting a moderate score of 6 for correctness—some key facts are right, but the central analysis is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 432,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "\nEmbedded Processing’s strategic weight grew noticeably from 2022 to 2023: its revenue rose 3 % year‑over‑year (to $3.37 bn) while Analog revenue fell 15 %, pushing Embedded Processing’s share of total sales upward and offsetting the decline in the Analog segment.  Management continues to allocate disproportionate resources—higher capital‑expenditure levels, expanded R&D and the CHIPS‑Act‑driven capacity build‑out—to Embedded Processing, even though its operating margin slipped (from 38.4 % to 29.9 %).  This reflects a clear shift toward positioning Embedded Processing as a longer‑term growth engine for cash‑flow generation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific revenue figures for Embedded Processing were disclosed in 2022, and the $17.52 billion refers to total company revenue in 2023—not broken down by segment. However, the LLM claims Embedded Processing revenue was $3.37 billion in 2023 with a 3% YoY increase, which is not supported by the original answer. It also states Analog revenue fell 15%, which is not mentioned in the ground truth. Additionally, operating margin decline from 38.4% to 29.9% and capital expenditure allocations are not present in the original answer. (2) All numeric values (e.g., $3.37B, 3%, 15%, 38.4% to 29.9%) are fabricated or incorrectly inferred; no calculations can be verified as accurate because the source data does not exist in the ground truth. (3) The multi-hop reasoning is flawed: while the original answer notes Embedded Processing partially offset Analog's decline, it does not provide segment-level revenue or margins, so the LLM overreaches by introducing unsupported quantitative comparisons and strategic shifts. (4) Despite incorrect numbers, the LLM captures the general qualitative direction—Embedded Processing maintained strategic importance and helped offset Analog's weakness—so some contextual relevance and basic reasoning are preserved, but quantitative inaccuracy severely undermines correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 392,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "\nChevron’s equity stake in Angola LNG Limited has stayed roughly steady at about 36 % from 2022 through 2024, but the carrying value of the investment slipped only modestly (from ≈ $1.76 bn in 2023 to ≈ $1.66 bn in 2024) and equity‑method earnings fell from $513 m to $405 m over the same period.  At the same time the company has continued to fund the project – a $4.5 bn loan for the Wellhead‑Pressure‑Management and Future‑Growth projects – and Angola LNG still contributes roughly 70‑80 k bbl eq / day of oil‑equivalent production to Chevron’s upstream output.  This persistence shows that Angola LNG remains a core pillar of Chevron’s global LNG strategy, providing diversified, long‑term gas supplies and reinforcing its push to expand its overseas LNG footprint.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies not supported by the ground truth. The original answer states that Chevron's stake was not explicitly quantified in 2022 but became clearly defined as 36.4% in 2024, indicating an evolution in disclosure and strategic clarity. However, the LLM claims Chevron's stake was 'roughly steady at about 36%' from 2022 through 2024, which contradicts the ground truth and misrepresents the nature of the evolution. Additionally, the LLM introduces specific financial figures—carrying value ($1.76B to $1.66B), equity-method earnings ($513M to $405M), a $4.5B loan, and production contribution (70–80k bbl eq/day)—that are not present in the original answer and cannot be verified against the provided ground truth. These numbers may be plausible but are not part of the known facts from the knowledge graph, making them hallucinated or unsupported. (2) Quantitative accuracy is low because none of the specific dollar amounts, percentages over time, or production metrics can be confirmed; in fact, the only correct number is the 2024 stake of ~36.4%, which the LLM approximates as 'about 36%', but it incorrectly applies this figure retroactively to 2022. (3) The multi-hop reasoning is partially sound in that the LLM attempts to infer strategic positioning from investment persistence and financial support, but it fails to accurately reflect the actual evolution described in the ground truth—i.e., from operational involvement to formalized equity ownership. The reasoning is based on fabricated data rather than correct synthesis. (4) Contextual relevance is high because the answer addresses Chevron’s role in Angola LNG and draws conclusions about its LNG strategy, aligning with the question’s intent. However, correctness and qualitative accuracy are penalized due to unsupported numbers and misrepresentation of the timeline and stake evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 518,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "\nBetween 2021 and 2024 the CH‑53K heavy‑lift helicopter moved from a modest backlog to a major sales driver for Lockheed Martin’s Rotary and Mission Systems (RMS) segment.  In 2021 RMS net sales rose $794 million, with $540 million of that increase coming from Sikorsky helicopter programs—including a $140 million boost to operating profit from higher production volume and risk‑retirements on the CH‑53K (page 48).  By 2024 the program was cited as a key contributor to the “higher production volume on CH‑53K” that lifted RMS product sales by roughly $1 billion and added several hundred million dollars of operating profit, while offsetting declines in other lines such as the VH‑92A (pages 32, 34).  This trend shows that the CH‑53K has become a central, high‑margin revenue source for RMS, underpinning the division’s growth strategy and its focus on future vertical‑lift capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the CH-53K program between 2021 and 2024. (1) Quantitatively, it correctly states the $540 million contribution to RMS net sales in 2021 and the $1.1 billion figure is accurately rounded to 'roughly $1 billion'—an acceptable approximation. The $140 million increase in operating profit in 2021 is correctly cited. The mention of 'several hundred million dollars of operating profit' in 2024 aligns with the knowledge graph's implication of growing profitability, though the exact figure is not specified in the ground truth, so this is a reasonable inference. (2) The timeline (2021 to 2024) is correctly framed, and the shift from risk retirement and volume increases to production ramp-up is accurately described. (3) Entity accuracy is strong: Lockheed Martin, RMS, CH-53K, and related programs (VH-92A, Black Hawk) are correctly identified. The reference to Sikorsky is contextually appropriate as the manufacturer. (4) Multi-hop reasoning is sound: the LLM synthesizes financial impact, production status, and strategic role across years, correctly concluding that CH-53K evolved into a key growth driver. The only minor shortcoming is the slightly imprecise characterization of the 2021 $540M increase as part of a $794M RMS sales rise, which, while possibly true, introduces data not in the ground truth and slightly distracts from the focus on CH-53K’s specific contribution. However, this does not distort the overall accuracy. The conclusion about CH-53K being a 'central, high-margin revenue source' is a valid interpretation of its transition to a key RMS growth driver. Thus, the answer is factually correct, well-reasoned, and contextually complete—deserving a 9 due to minor peripheral elaboration but no material errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 487,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal shifted from a short‑term, two‑year macro‑driven forecast for its revolving‑credit loss curves to a longer, more detailed horizon—approximately five years (with a 7‑month to 3.5‑year range for related segments)—and refreshed the loss models in the second quarter of 2023.  The updated models still rely on a single external macro scenario but now incorporate additional economic indicators such as household disposable‑income trends and retail‑e‑commerce sales alongside unemployment and charge‑off rates.  This evolution reflects a deeper integration of macroeconomic assumptions into the loss‑curve methodology, although the quantitative effect on the provision was immaterial.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies that PayPal updated its models in 2023 and added household disposable income and retail e-commerce sales as macroeconomic factors, it incorrectly states that unemployment rates were retained in the updated model. The original answer explicitly states that unemployment rates were *replaced* after Q1 2023, whereas the LLM claims they were still used alongside the new indicators. This is a significant factual error. Additionally, the LLM introduces specific time horizons—'five years' and '7-month to 3.5-year range'—that are not present in the original answer and lack support from the ground truth. There is also no mention in the original answer of a shift from a two-year to a longer forecast horizon, nor of the model refresh occurring in Q2 2023. (2) Quantitatively, the introduced timeframes (e.g., five-year forecast, 7-month to 3.5-year range) are unsupported and likely incorrect. The original answer does not specify forecast horizons, so these additions reduce quantitative accuracy. Dates such as 'second quarter of 2023' are not confirmed in the ground truth, which only notes a change 'after the first quarter of 2023'—a more general timeframe. (3) The reasoning partially captures the evolution in model inputs but fails on key synthesis: it misrepresents the replacement of unemployment with new variables as an addition rather than a substitution. This undermines the multi-hop logic required to understand how the set of macroeconomic factors changed. The claim about immaterial quantitative impact on provision is not in the original answer and introduces unverified information. (4) Despite these issues, the answer is contextually relevant and addresses the core question about evolution in macroeconomic factor usage. It correctly identifies the new variables added and acknowledges model updates in 2023. The qualitative accuracy is moderate because the direction of change (enhanced macroeconomic integration) is plausibly conveyed, even if specifics are flawed. Correctness is scored at 5 due to a mix of correct elements (new factors added) and major errors (retention of unemployment, unsupported timeframes).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 603,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 the foreign‑currency‑debt gains recorded in AOCI fell from **$140.2 million** to **$135.2 million** (a $5 million decline) – see the “Foreign currency debt” line under Net Investment Hedges in the table of “Net Gains/(Losses) Included in AOCI” on **page 70**.  This reduction shows that the company’s foreign‑currency hedging produced smaller net gains, indicating either less favorable currency movements or more effective hedging that limited its exposure to foreign‑currency fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, Starbucks had a foreign currency debt-related **loss of $6.3 million in 2023** and a **gain of $135.2 million in 2024**, representing a shift from loss to gain. However, the LLM incorrectly states that gains were $140.2 million in 2023 and $135.2 million in 2024 — implying a small decline in gains, which is the opposite of the truth. This misrepresents both the direction and magnitude of change. (2) The numbers are significantly off: the LLM invents a $140.2 million figure for 2023 that does not appear in the ground truth, and ignores the $6.3 million loss entirely. The $5 million decline mentioned is therefore based on false premises. The only correct number is the $135.2 million gain in 2024. (3) The multi-hop reasoning fails because the model does not recognize that the change involves a reversal from loss to gain — a critical qualitative shift — and instead frames it as a minor reduction in gains. This undermines the conclusion about exposure to currency fluctuations. (4) The contextual relevance is moderate because the answer addresses the right topic (AOCI, foreign currency debt, hedging, exposure) and cites a plausible location (page 70, Net Investment Hedges), but the factual inaccuracies severely compromise the qualitative and quantitative accuracy. The conclusion about 'smaller net gains' and 'more effective hedging' is unsupported and likely incorrect given the actual swing from loss to large gain, which suggests favorable currency movements rather than reduced exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 444,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "\nAlabama Power’s liability for energy‑related derivatives rose from roughly **$32 million in 2022 to $110 million in 2023**, and Georgia Power’s liability increased from about **$30 million to $124 million** over the same period.  Together, their combined derivative liabilities grew from approximately **$62 million to $234 million**, reflecting a clear upward trend.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM incorrectly states Alabama Power's 2022 liability as $32 million, while the ground truth reports a net liability of $144 million (from 'net liability of $144 million' in 2022). For 2023, Alabama Power had a net liability of $95 million (assets of $15M, liabilities of $110M), not $110M in liabilities alone as presented. The LLM treats liabilities in isolation, ignoring asset offsets, which distorts the trend. Similarly, Georgia Power had no reported value in 2022 in the ground truth, but the LLM invents a $30M figure. In 2023, Georgia Power’s net liability was $111M ($124M liabilities - $13M assets), which the LLM partially gets right by citing $124M liabilities but omits the asset offset. The combined 2022 net liability was $255M (Alabama $144M + Georgia unknown but implied zero or included), not $62M as claimed. The 2023 combined net liability is $206M, not $234M. The LLM’s calculation of combined liabilities ($110M + $124M = $234M) ignores asset offsets and misrepresents net positions. (2) Completeness: The answer fails to report Alabama Power’s 2022 net liability correctly and fabricates Georgia Power’s 2022 data. It also omits the concept of net liability, instead reporting gross liabilities, which misleads the trend. (3) Entity Accuracy: Company names and years are correct, and the focus on energy-related derivatives is appropriate. (4) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers an upward trend by comparing incomplete and inaccurate figures, while the ground truth shows a decrease from $255M to $206M. The model fails to compute net positions by subtracting assets from liabilities, a critical step in derivative valuation. (5) Semantic Equivalence: The overall message is opposite—LLM claims increasing liabilities, while truth shows a reduction. Despite addressing the right entities and general topic, the factual inaccuracies and incorrect trend conclusion severely undermine the answer. Minor relevance is retained for mentioning correct companies and derivatives context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 574,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "\nIn fiscal 2023 Walmart spent roughly $0.4 billion to acquire the remaining non‑controlling interests and bring its stake in Alert Innovation to 100 % ownership (the same transaction that completed the buy‑out of Massmart’s minority shareholders). The company then held Alert Innovation as a consolidated subsidiary throughout fiscal 2024, but did not make any further acquisition or disposal moves; the eventual sale and de‑consolidation of Alert Innovation was executed in fiscal 2025, ending the relationship.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timing of the disposition. While it correctly states that Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023 and reached 100% ownership, it incorrectly claims the sale and deconsolidation occurred in fiscal 2025, whereas the ground truth confirms it happened in fiscal 2024. This misplacement of a key event by a full fiscal year undermines the core of the multi-hop timeline being assessed. (2) Quantitatively, the $0.4 billion acquisition amount and 100% ownership stake are accurate, earning partial credit. However, the fiscal year mismatch for the divestiture is a major quantitative inaccuracy in terms of temporal data. (3) The reasoning is partially sound in recognizing the acquisition and eventual divestiture as a two-step evolution, but fails in synthesizing the correct timeline across fiscal years. The mention of Massmart’s minority shareholders introduces irrelevant information not present in the ground truth, suggesting potential confusion or hallucination. (4) Contextual relevance is high because the answer addresses the financial relationship evolution and uses appropriate terms like 'deconsolidation' and 'non-controlling interests.' However, due to the incorrect fiscal year for the sale, the overall correctness score is low, as the central claim about the one-year acquisition-to-divestiture cycle is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 396,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy moved from its earlier approvals (metastatic triple‑negative breast cancer and urothelial cancer) to new label expansions: the FDA and the European Commission granted approval for Trodelvy as a monotherapy for adult patients with unresectable or metastatic HR⁺/HER2‑ breast cancer who have already received endocrine therapy and at least two systemic treatments. This adds a high‑value solid‑tumor indication to its portfolio.  \n\nThe approvals illustrate Gilead’s oncology strategy of broadening the commercial reach of its antibody‑drug‑conjugate platform, diversifying into additional cancer types, and using Trodelvy to drive sustained growth across multiple oncology markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2023, Trodelvy received FDA and European Commission (EC) approval for HR+/HER2- breast cancer in patients who had prior endocrine therapy and at least two systemic treatments—matching the original answer's key regulatory milestones. While the original answer notes no specific regulatory updates in 2022, the LLM correctly implies continuity by referencing prior approvals without attributing new 2022 actions, which is consistent. (2) There are no numerical values requiring calculation, but all dates (2022–2023) and regulatory bodies (FDA, EC) are correctly named. (3) The multi-hop reasoning is sound: the model connects Trodelvy’s label expansion to Gilead’s broader oncology strategy, correctly inferring a strategic intent to expand the antibody-drug conjugate platform across solid tumors—this synthesis is supported by the original answer’s conclusion about strengthening Gilead’s oncology position. (4) The LLM adds contextual detail not in the original (mentioning prior indications: triple-negative breast cancer and urothelial cancer), which is factually correct and enriches the response without introducing error. The only minor gap is that the original emphasizes Trodelvy’s contribution to 2022 oncology growth, which the LLM omits, but this does not detract from the core regulatory and strategic analysis. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 419,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Simon Property Group systematically unwound its equity relationship with ABG.  In 2023 it sold portions of its stake, recognized a $157.1 million pretax gain and recorded non‑cash gains from dilution‑related disposals, and in early 2024 it sold the remaining ABG interest for $1.2 billion, generating a $414.8 million pretax gain that it used to pay down debt and reinvest in its core retail development pipeline.  This series of capital transactions reflects a strategic shift away from ABG toward its core property and development focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) did not sell its remaining ABG interest in early 2024 for $1.2 billion or record a $414.8 million pretax gain. Instead, SPG recognized non-cash gains of $36.4 million in Q2 2023 and $145.8 million in Q3 2023 due to dilution from SPARC Group issuing equity. The LLM incorrectly states that SPG sold portions of its stake and recorded a $157.1 million gain in 2023—this total is close but not exact ($36.4M + $145.8M = $182.2M, not $157.1M), and the nature of the gains (non-cash, from dilution, not direct sales) is misrepresented. Furthermore, the $1.2 billion sale and $414.8 million gain in early 2024 are entirely fabricated and not supported by the original answer. (2) Quantitative accuracy is poor: the numbers cited ($157.1M, $1.2B, $414.8M) do not match the ground truth ($36.4M, $145.8M), and the calculation of the 2023 gains is incorrect. The original answer notes no active capital transactions in 2024, directly contradicting the LLM’s claim of a major sale. (3) The multi-hop reasoning is flawed. The LLM infers a strategic shift toward core retail development, which is plausible, but bases it on false financial events. The original answer indicates a shift from active engagement in 2023 to passive, historical referencing in 2024—not a full divestiture. The LLM fails to mention the strategic licensing ventures (Forever 21, Brooks Brothers, Eddie Bauer) or the 2021 and 2022 transactions referenced in 2024 filings, missing key elements of the strategic positioning. (4) Contextual relevance is moderate—the answer addresses capital transactions and strategic positioning as asked, but the factual foundation is incorrect, undermining the analysis. While the general direction of 'reducing involvement' aligns loosely with the truth, the specific claims are unsupported. Correctness is severely compromised by fabrication of major transactions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 537,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "\nChevron’s equity investment in Chevron Phillips Chemical Company LLC rose from $7.765 billion (reported in the 2022 10‑K, page 33) to $8.571 billion at year‑end 2024 (2024 10‑K, page 84), and the equity‑method earnings from the venture increased from $608 million in 2023 to $867 million in 2024 (2024 10‑K, page 84). This growth is reflected in the downstream segment’s “Income from equity affiliates” and is underpinned by a $669 million loan to fund the Golden Triangle Polymers project disclosed in Note 15 of the 2024 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the timeline and nature of Chevron's relationship with Chevron Phillips Chemical Company LLC. The original answer states that in 2022, the entity was a consolidated subsidiary (per Note 8, page 70 of the 2022 10-K), but the LLM incorrectly claims that in 2022, Chevron already had an equity investment of $7.765 billion, which contradicts the ground truth. The shift from consolidation to equity method occurred between 2022 and 2024, but the LLM implies the equity method was already in place in 2022. The investment value of $8,571 million as of December 31, 2024, is correct (matches ground truth), and the 2023 value of $7,765 million is also correctly cited, though misattributed to the 2022 10-K. (2) The LLM cites the $7.765 billion figure as being from the 2022 10-K, but according to the ground truth, this value is from 2023, not 2022. This is a critical error in both quantitative accuracy and reasoning. The equity earnings ($608M in 2023, $867M in 2024) and the $669M loan for the Golden Triangle Polymers project are not mentioned in the original answer and cannot be verified against the ground truth, suggesting potential hallucination or use of external data. (3) The multi-hop reasoning is flawed: the key evolution — the change from consolidation to equity method — is entirely omitted. Instead, the LLM assumes an equity method relationship existed in 2022, missing the structural shift that defines the relationship's evolution. This undermines the qualitative accuracy. (4) Despite these issues, the answer is contextually relevant, discussing the right company and financial trends, and includes some correct figures (2023 and 2024 investment values, though mislabeled), earning moderate scores in quantitative and qualitative accuracy. However, the failure to identify the critical accounting change results in a correctness score of 6, indicating partial accuracy with significant errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 540,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "\nBy the end of 2023 the 2022 facilities‑consolidation program was essentially finished—most lease‑exit and sub‑lease actions had been completed, the related accrual had been reduced to a modest balance, and the plan had generated about $2.255 billion of pre‑tax restructuring charges through 2023. In 2024 the company continued to advance the strategy, recording an additional $389 million of pre‑tax facilities‑consolidation charges (all tied to lease terminations and sub‑lease activities) and expecting roughly $721 million of deferred revenue to be recognized within the next year, showing that the consolidation effort had shifted from a multi‑year, large‑scale initiative to a smaller, ongoing set of lease‑exit costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported quantitative details not present in the ground truth. (1) The original answer states that Meta had 'substantially completed' the facilities consolidation by end of 2023 and 'completed the 2022 restructuring initiatives' by end of 2024, indicating full completion. The LLM incorrectly frames the 2024 period as one of continued active advancement with $389 million in new charges, whereas the ground truth emphasizes retrospective summary, not ongoing accruals. (2) The specific figures cited—$2.255 billion through 2023 and an additional $389 million in 2024—are not present in the original answer; while the ground truth mentions a financial summary across 2022–2024, it does not break down charges by year or confirm these exact numbers. The $721 million deferred revenue expectation is entirely fabricated and not mentioned in the original. (3) The multi-hop reasoning is flawed: the LLM misinterprets 'completion' in 2024 as ongoing activity rather than finalization, and invents granular financial data without source support. (4) Contextually, the answer addresses the evolution of the strategy but fails on factual correctness, particularly in numbers and the nature of 2024 developments, severely undermining reliability. Minor relevance is retained by discussing facilities consolidation and restructuring charges in the correct timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 394,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "\nFrom 2022 to 2024 Lockheed Martin moved its hypersonics effort from a broad, early‑stage Advanced Development Program focus toward concrete, program‑level development and demonstration for the U.S. Army and Navy, emphasizing rapid‑prototype flight testing and a clear path to production.  The company also broadened the strategic emphasis, tying hypersonic strike weapons to multi‑domain “21st Century Security” initiatives (e.g., CJADC2, next‑gen air dominance) and integrating them across Aeronautics, Missiles & Fire Control and Space, positioning the capability as an imminent fielded system rather than a purely exploratory project.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Lockheed Martin's hypersonics involvement from 2022 to 2024. It accurately reflects a shift from early-stage development to more concrete, program-level efforts with a path to production, aligning with the ground truth's emphasis on progression from funding-dependent development to active production. The mention of U.S. Army and Navy programs is consistent with the original answer’s reference to U.S. Air Force and Army programs—while the services differ slightly (Navy vs. Air Force), both indicate a multi-service, operational focus. The strategic reframing of hypersonics as part of broader 21st-century security and multi-domain operations (e.g., CJADC2) adds valuable context not in the original but does not contradict it. However, the original answer specifically highlights a dependency on government funding and authorization in 2022, which the LLM answer omits, and the transition to 'active production' by 2024 is slightly understated in the LLM version, which emphasizes 'path to production' rather than confirmed production. These nuances represent minor gaps in completeness and precision. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and the reasoning is sound, showing appropriate multi-hop synthesis across time, strategy, and program status. The answer is highly relevant and well-contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 398,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "\nFrom 2022 to 2023 Southern Company kept its energy‑related contracts in the “regulatory‑hedging” category, but the size of the associated gains/losses changed dramatically.  In 2022 the regulatory‑hedge adjustment showed a modest $9 million gain that was recorded in OCI and the balance‑sheet, whereas by the end of 2023 the same adjustment had turned into a $257 million unrealized loss (Southern Company), reflecting larger foreign‑currency and commodity positions and a shift in the composition of the hedge program.  At the same time, derivatives that were no longer designated as hedges began to affect earnings directly—producing a $59 million gain in natural‑gas revenues and a $59 million increase in cost of natural gas in 2023—so the company’s hedge disclosures expanded both in scope and in financial impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($9 million gain in 2022, $257 million loss in 2023, $59 million gains/losses) that are not present in the original answer (ground truth), and there is no verification that these figures are accurate. The ground truth does not mention OCI, balance sheet entries, foreign currency positions, or natural gas revenue impacts, making these additions factually unsupported. (2) Quantitative accuracy is low because the LLM fabricates precise financial figures and attributes them to specific line items (e.g., natural gas revenues, cost of natural gas) without corroboration in the ground truth. The original answer only states that Southern Company expanded its disclosures to include non-designated derivatives across 2023, 2022, and 2021, with no mention of actual gains or losses beyond the general concept of unrealized derivative effects. (3) Qualitatively, the LLM captures a partial evolution in disclosure—mentioning a shift in designation and broader impact—but misrepresents the nature of the change by focusing on magnitude and composition shifts (e.g., 'larger foreign-currency and commodity positions') not mentioned in the ground truth. It incorrectly implies that changes in gains/losses drove disclosure changes, whereas the original answer emphasizes an expansion in reporting scope. (4) Contextual relevance is high because the response addresses the evolution of derivative treatment and disclosure between 2022 and 2023, correctly identifying a broadening in the scope of reported derivatives. However, the inclusion of unverified financial data and misattribution of reasoning significantly undermines factual correctness. The core idea of expanded disclosure is present, but the supporting details are largely invented, leading to a partially correct but misleading answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 502,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "\nBetween 2022 and 2023 Gilead’s 10‑K filings moved from describing Truvada’s core composition‑of‑matter patents as “expiring in the EU” with only pending U.S. manufacturing‑process applications (and noting the 2020 U.S. loss of exclusivity and generic‑competition settlements) to explicitly stating that those composition‑of‑matter patents are now fully expired in both the U.S. and EU, with no new patent claims covering Truvada itself—leaving only a few pending process‑patent applications and reliance on regulatory exclusivity (e.g., pediatric extensions) and trade‑secret know‑how for protection. This shift reflects a strategic pivot away from seeking new composition‑of‑matter exclusivity for Truvada and toward protecting future products through pending process patents and extensions rather than new Truvada‑specific patent filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the 2020 U.S. loss of exclusivity for Truvada, which is a key factual anchor in the original answer, and accurately characterizes Gilead's shift in disclosure strategy between 2022 and 2023. The LLM adds granular detail not explicitly in the ground truth—such as the distinction between composition-of-matter patents (expired in both U.S. and EU) and pending process patents—but this is consistent with typical 10-K disclosures and represents a plausible, deeper interpretation of the evolution in patent strategy. There are no incorrect dates, numbers, or entities. The reasoning is sound: it captures the multi-hop progression from acknowledging past exclusivity loss (2022) to providing structured, forward-looking IP timelines (2023), and infers a strategic pivot supported by the evidence. The only reason for not scoring a 10 is that the LLM slightly exceeds the scope of the original answer by introducing specific patent categories (e.g., 'manufacturing-process applications', 'pediatric extensions') without explicit confirmation from the ground truth, which stays at a higher level. However, these details are contextually appropriate and do not contradict known facts. Quantitative accuracy is high—no numerical errors. Qualitative accuracy and contextual relevance are excellent, as the response directly addresses the evolution in patent disclosures and intellectual property strategy for Truvada across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 418,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "\nBetween 2022 and 2024 SPG’s use of the Supplemental Facility shifted from active borrowing to a planned wind‑down.  In the 2022 filing the company disclosed that, as of December 2021, it had drawn **$1.05 billion** under the Supplemental Facility (the balance was still reflected in 2022‑year‑end debt tables) and had used those funds to retire a group of mortgages and support other cash‑needs.  By late 2023 SPG tapped the public bond market, issuing **€750 million** of senior unsecured bonds and using the proceeds on **November 17, 2023** to **repay the entire €750 million outstanding under the Supplemental Facility**, effectively eliminating the balance.  Consequently, in the 2024 disclosures the Supplemental Facility carried **no outstanding borrowings**, with the company relying instead on its broader Credit Facility and commercial‑paper program for any remaining short‑term financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of SPG using the Supplemental Facility for short-term borrowing and repaying it, but contains significant factual inaccuracies that affect correctness. (1) Quantitative Accuracy: The $1.05 billion borrowing in January 2022 is correct, but the LLM incorrectly implies this balance was still outstanding as of December 2021 and carried into 2022 — the ground truth states it was borrowed in January 2022 and repaid shortly after, not carried from prior year. Additionally, the €750 million borrowing is correctly dated to November 2023 and repaid on November 17, 2023, but the LLM mischaracterizes it as proceeds from 'senior unsecured bonds' being used to repay the facility, whereas the ground truth specifies the borrowing under the Supplemental Facility itself was in euros and directly repaid — not funded by bond issuance. The bond issuance mentioned in the ground truth was for redeeming other notes, not repaying the Supplemental Facility. (2) Completeness: The LLM omits the key detail that the 2022 borrowing was used specifically to extinguish nine mortgages with a $1.16 billion principal balance, a central purpose. It also fails to mention that the 2024 context includes a shift in financing strategy involving new senior unsecured notes — instead conflating that event with the repayment of the Supplemental Facility. (3) Entity Accuracy: SPG and the Supplemental Facility are correctly identified; years and amounts are mostly accurate in magnitude but misaligned in timing and source. (4) Reasoning: The multi-hop synthesis is partially sound — the LLM correctly infers reduced reliance on the facility by 2024 — but the causal logic is flawed due to incorrect linkage between bond proceeds and repayment. (5) Semantic Equivalence: While the overall narrative of wind-down is plausible, the factual misstatements about timing, funding sources, and use of proceeds reduce accuracy. The conclusion that the facility had no outstanding borrowings in 2024 aligns with the truth, but the path to that point is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 555,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "\nFrom 2022 to 2024 MetLife moved from a general emphasis on statutory surplus and RBC compliance toward treating a sizeable cash buffer as a core element of its capital‑management framework.  The 2024 disclosures explicitly link the buffer to “cash‑buffer needs” that constrain dividend payments and share‑repurchase programs, forcing the company to prioritize liquidity preservation and conservative financing over more aggressive capital‑allocation moves.  Consequently, liquidity levels now directly shape capital‑allocation decisions, limiting payouts and guiding the firm’s risk‑adjusted investment and financing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures a shift in tone and strategic emphasis from 2022 to 2024 regarding cash buffers and capital allocation, which aligns with the ground truth. It correctly identifies that by 2024, cash-buffer needs were constraining capital allocation decisions such as dividends and share repurchases. However, it fails to include any of the specific quantitative data present in the original answer—namely, the $12.4 billion short-term liquidity position and $223.0 billion total liquid asset base in 2022. These omissions significantly impact quantitative accuracy. There is no mention of liquidity levels in 2024 either, nor any reference to the actual figures, which were central to the original answer’s completeness. (2) No numbers are provided in the LLM response, so there is no way to verify quantitative accuracy; thus, this aspect is rated low. The original answer relies on precise dollar amounts to substantiate claims about liquidity, which the LLM omits entirely. (3) The multi-hop reasoning is partially sound: the model infers a strategic evolution from liquidity assurance to trade-offs with capital deployment, which is supported by the ground truth. However, it introduces the concept of 'statutory surplus and RBC compliance' in 2022, which is not mentioned in the original answer and may reflect an overinterpretation or external knowledge. While the conclusion about constrained payouts and conservative financing is consistent with the cautious tone in 2024, the absence of supporting data weakens the reasoning chain. (4) Contextual relevance is high because the answer directly addresses the evolution of cash buffer needs and their impact on capital allocation. The qualitative accuracy is moderate due to correct directional insights but lacks grounding in actual reported figures. Correctness score is 6 due to accurate conceptual framing but major omission of key financial data required for full factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 530,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "\nIn the 2022 10‑K (page 68) the “foreign‑currency‑other” derivatives appeared as $39.9 million of derivative assets in prepaid expenses (current) and $33.5 million in other long‑term assets, with only $0.3 million of derivative liabilities recorded in accrued liabilities (current). By the 2023 10‑K (page 70) those assets had fallen to $32.0 million (current) and $22.9 million (long‑term), while derivative liabilities increased to $2.0 million in accrued liabilities (current). Thus the exposure moved from a large net‑asset position in 2022 to a smaller net‑asset position in 2023, with assets declining and liabilities modestly rising, though the classification between current and long‑term remained the same.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks reported only a $0.3 million liability with no asset for 'Foreign currency - other' derivatives. However, the LLM claims there were derivative assets of $39.9 million (current) and $33.5 million (long-term), which is completely incorrect. In 2023, the ground truth states there was a $1.9 million asset and $4.7 million liability, but the LLM reports $32.0 million and $22.9 million in assets and $2.0 million in liabilities—again, these numbers are wrong. (2) All key numeric values are incorrect: the LLM invents large asset positions that do not exist in the ground truth, misrepresents the magnitude of liabilities, and falsely asserts long-term asset classifications. The only correct number is the $0.3 million liability in 2022. Calculations based on these false numbers (e.g., net asset positions) are therefore invalid. (3) The reasoning is flawed because it assumes a large net asset position in 2022 and tracks its reduction, when in reality, Starbucks had nearly no asset exposure in 2022 and only developed a modest asset in 2023. The multi-hop synthesis fails because the model did not correctly extract or align data across the two years. (4) The contextual relevance is moderate—it addresses the right topic (evolution of derivative exposure) and uses appropriate classifications (accrued liabilities, prepaid expenses), but the factual foundation is unsound. Due to major quantitative errors and incorrect entity-state assignments, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 440,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "\nFrom 2023 to 2024 the relationship moved beyond a standard bottler contract to a deeper strategic partnership: Coca‑Cola now holds a 28 % equity‑method investment in Coca‑Cola FEMSA (Note 6 of the 2024 10‑K, pages 85‑87), giving the Company a direct financial stake in FEMSA’s earnings, and FEMSA has been designated an “expanding participating bottler” with 10‑year renewable CBAs and exclusive territory rights (Bottler’s Agreements section, pages 5‑6). This increased equity ownership and the expanded long‑term bottler framework reflect a more aligned, collaborative strategy between the two companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 28% ownership stake is accurately reported, and the time frame (2023 to 2024) is properly referenced. There are no calculation errors. (2) The answer adds specific document-level detail (Note 6, pages 85–87 of the 2024 10-K; Bottler’s Agreements, pages 5–6) not in the original answer but consistent with plausible sourcing, enhancing credibility. (3) The multi-hop reasoning is sound: it correctly synthesizes the shift from a traditional bottling relationship to an equity-method investee with deeper strategic alignment, capturing both financial and strategic dimensions of the evolution. (4) The LLM includes additional accurate context—such as 'expanding participating bottler,' '10-year renewable CBAs,' and 'exclusive territory rights'—that enriches the original answer without contradicting it. The only minor shortcoming is that it does not explicitly mention Coca-Cola FEMSA’s geographic operations (e.g., Mexico, Brazil, Argentina) or the 42% volume contribution from the top five bottlers in 2023, which were part of the original answer. However, these omissions do not detract from the core of the question, which focuses on the evolution of the relationship and financial stake. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 393,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "\nBetween 2022 and 2024 Intel moved FPGAs out of a stand‑alone, legacy line‑card role and embedded them as a core element of its **adjacent‑product strategy**—positioning the devices alongside modems, Ethernet, silicon‑photonic and other non‑platform offerings in the CCG, DCG and IOTG segments to create “comprehensive platform solutions” for customers.  At the same time, the company refocused its **production footprint** on a Smart‑Capital model that relies on capacity investments, government incentives and external foundries, using that infrastructure to scale FPGA manufacturing while tying the technology to broader platform and services initiatives (e.g., AI, networking, edge computing).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but misrepresents the core evolution of Intel's FPGA strategic positioning. The ground truth states that in 2022, FPGAs were part of 'adjacent products' within CCG, DCG, and IOTG, and by 2024 they were elevated to direct product definitions—indicating a shift from supplementary to core. However, the LLM incorrectly frames this as embedding FPGAs *into* an 'adjacent-product strategy' by 2024, which contradicts the actual shift *away* from being just an adjacent product. This is a critical factual and logical error in directionality. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly identifies the organizational segments (CCG, DCG, IOTG) and mentions platform integration. However, it fails the key synthesis: the strategic repositioning of FPGAs from 'adjacent' (supporting) in 2022 to 'core' (central) in 2024. Instead, it suggests FPGAs became part of the adjacent-product strategy during this period, which is the opposite of the truth. (4) Contextual relevance is high—the response addresses the question’s focus on strategic positioning, adjacent products, and production focus. It introduces the 'Smart-Capital model' and external foundries, which add context not in the ground truth but are plausible elaborations. However, the central claim about FPGA role evolution is factually inverted, warranting a moderate correctness score of 5 due to significant qualitative inaccuracy despite relevant framing and no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 463,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "\nFrom 2022 to 2023 ConocoPhillips significantly expanded its Lower 48 position—capital spending rose to $6.5 billion (up from $5.6 billion in 2022) and purchases/extensions added several hundred MMBOE of reserves (notably the Concho acquisition and subsequent unconventional‑play development).  This larger, newly‑acquired asset base drove a jump in depreciation, depletion and amortization from $4.85 billion in 2022 to $5.73 billion in 2023, reflecting the higher DD&A expense associated with the expanded reserve base and the ongoing conversion of PUDs to developed status.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Concho acquisition as a key driver of asset growth in the Lower 48 in 2022, consistent with the original answer. It accurately reports the depreciation, depletion, and amortization (DD&A) expenses for 2022 ($4.85 billion) and 2023 ($5.73 billion), which align with the ground truth values of $4,854 million and $5,729 million—minor rounding differences are acceptable. The increase of $875 million is implied and correctly contextualized as a 'jump' in expense due to the expanded asset base. (2) Quantitatively, the figures are accurate within reasonable rounding: $4.85B ≈ $4,854M and $5.73B ≈ $5,729M. However, the LLM introduces additional details not present in the ground truth—capital spending of $5.6B in 2022 and $6.5B in 2023, and reserve additions in MMBOE—which, while plausible, are not part of the verified knowledge graph and thus cannot be confirmed. These additions slightly reduce quantitative accuracy due to unverifiable claims. (3) The multi-hop reasoning is sound: the model correctly links the Concho acquisition to increased asset base, which in turn drives higher DD&A expenses in 2023. The explanation that PUDs (proved undeveloped reserves) conversion contributes to rising DD&A is logically consistent with industry practices and supports the conclusion of continued investment. (4) The answer is highly relevant, addressing both asset acquisition and DD&A evolution. The core facts are correct, and the reasoning is strong, warranting a high correctness score. The only deduction is for the inclusion of unverified financial figures (capex) not in the ground truth, which slightly affects precision but not the central accuracy of the main metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 472,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s stake in AspenTech moved from a **55 % equity position** (established after the May 2022 contribution of its software businesses and $6 bn cash, which gave Emerson a non‑controlling interest of $5.9 bn for the remaining 45 %) to a **planned full acquisition**—on Nov 5 2024 Emerson announced a cash offer to buy the ~45 % of AspenTech it did not already own, implying a $15 bn enterprise value.  This shift meant the relationship evolved from a minority, equity‑method investment to a near‑total ownership that would bring AspenTech fully under Emerson’s control.  \n\nFinancially, the deeper integration helped lift Emerson’s **consolidated gross margin** to **50.8 % in 2024**, an increase of 1.8 percentage points from 2023.  The improvement was driven by the Test & Measurement acquisition and higher pricing, but was partially offset by **$231 m of acquisition‑related inventory step‑up amortization**, which shaved roughly **1.3 pts** off the margin; the earlier Heritage AspenTech purchase had contributed a modest **~0.6‑pt** margin benefit.  (Pages 55‑59, 24‑28).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the ownership timeline and acquisition sequence, which undermines the core correctness. (1) It incorrectly states that Emerson held a 55% stake in AspenTech starting in May 2022, whereas the ground truth confirms that the full acquisition occurred in 2022, and by 2024 Emerson owned 55% on a fully diluted basis—implying the 55% ownership was post-acquisition, not pre. The claim that Emerson announced a cash offer on November 5, 2024, to acquire the remaining 45% contradicts the ground truth that the acquisition was already completed in 2022. This reverses the actual timeline and misrepresents the nature of the relationship evolution. (2) The $6 billion cash contribution is correctly cited, but the valuation of the 'remaining 45%' at $5.9 billion is inconsistent with the ground truth per-share price of $87.69 and total cash of $6.0 billion. The $15 billion enterprise value implied in 2024 is unsupported by the original answer. (3) The gross margin increase to 50.8% in 2024 and the 1.8 percentage point increase are correctly reported. The $231 million inventory step-up amortization reducing margins by 1.3 points and the prior 0.6-point benefit from the acquisition are also accurate. However, attributing margin improvement partly to the 'Test & Measurement acquisition' introduces an unsupported factor not mentioned in the ground truth. (4) The multi-hop reasoning fails because the model misrepresents the ownership evolution: it frames the relationship as moving toward full acquisition by 2024, when in fact the acquisition was completed in 2022. This fundamental error invalidates the strategic narrative. While some financial figures are correct, the synthesis of ownership and timeline is flawed. Semantic equivalence is partially achieved on financial impacts but not on ownership structure. The answer is contextually relevant and addresses the right metrics, but with key factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 532,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "\nBetween 2022 and 2024 the 2015 Director Stock Plan saw a net **increase in recovered shares** (cumulative shares recovered rose from roughly 31.5 million at the end of 2021 to about 37.6 million by the end of 2024), but an even larger **increase in shares used for new awards and imputed dividend equivalents** (allocated shares grew from ~32.9 million through 2021 to ~42.3 million through 2024). Consequently, the **net pool of shares remaining available for future issuance fell** from about 34.1 million (reported for 2021) to roughly 30.7 million as of 31 December 2024. The mechanics involve re‑authorizing recovered shares (triggered by forfeiture, cash settlement, expiration, etc.) and then reducing that pool by the number of shares actually granted or credited as dividends on Deferred Shares, so recoveries are offset by subsequent award allocations and dividend imputations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of the 2015 Director Stock Plan between 2022 and 2024, focusing on share recovery and issuance mechanics. (2) Quantitatively, the LLM reports ~37.6 million shares recovered by 2024 and ~42.3 million shares used for awards and dividends, matching the original answer's 37,608,213 recovered and 42,343,146 issued/used. The available shares are stated as ~30.7 million, consistent with the ground truth's 30,660,961. The LLM references 2021 baselines (e.g., 31.5M recovered, 32.9M allocated), which are not in the original answer but are plausibly inferred for trend context and do not contradict the truth. (3) The reasoning is sound: it correctly explains that recovered shares (from forfeiture, expiration, cash settlement) are reused, but new awards and dividend equivalents exceed recoveries, leading to a net decline in availability. This reflects proper multi-hop synthesis of authorization, recovery, and usage mechanics. (4) The answer is fully relevant, directly addressing the question’s focus on treatment and availability changes. The only minor limitation is the use of approximations (e.g., 'about', 'roughly') and reliance on inferred 2021 data for comparison, but these do not undermine factual correctness. Overall, the answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 388,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "\nFrom FY 2022 through FY 2023 the alliance moved from being a “revenue‑boost” that added roughly $250 million (≈ 16 %) to the Channel Development segment in 2022—driving segment growth but also pressuring operating margin as joint‑venture income slipped—to a more strategic, long‑term partnership that Starbucks continues to feature in its 2023 business overview as a key channel for Nestlé‑produced Starbucks‑branded products.  While the 2023 filing does not give a separate revenue figure, the partnership is now positioned as an integrated growth platform rather than a one‑off contributor, underscoring a shift in strategic emphasis toward sustained, expanded sales and royalty streams from the Global Coffee Alliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states the $250 million revenue contribution in FY2022, which matches the original answer. It also accurately notes that FY2023 does not provide a specific revenue figure, which is consistent with the source. However, the addition of '≈16%' and 'pressuring operating margin as joint-venture income slipped' introduces details not present in the ground truth; while not necessarily incorrect, these are unsupported inferences that slightly reduce quantitative precision. (2) The entity identification is correct: Starbucks, the Global Coffee Alliance, Nestlé, and the Channel Development segment are all accurately referenced with correct fiscal years (FY2022 and FY2023). (3) The reasoning is sound and captures the multi-hop evolution: from a revenue driver in 2022 to a strategic, integrated platform in 2023. The shift in strategic emphasis—from short-term revenue boost to long-term distribution and brand extension via licensing—is correctly synthesized and semantically equivalent to the original. (4) Contextual relevance is excellent; the answer directly addresses both strategic emphasis and revenue contribution over the two fiscal years. The only minor deviation is the inclusion of margin pressure and percentage estimates not in the original, which prevents a perfect score, but core facts, synthesis, and interpretation remain highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 402,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "\nBetween 2022 and 2023 NEE’s exposure to the Mountain Valley Pipeline shifted from an equity‑method investment that was fully impaired in 2022 to a complete exit in 2023.  In 2022 the company recorded an impairment that wrote‑off its stake in the pipeline, and in 2023 it closed the sale of the related natural‑gas assets (including the MVP project), recognizing roughly $450 million of discontinued‑operations revenue and a $375 million gain on disposal.  This divestiture reflects NEE’s strategy of pruning lower‑margin pipeline assets and reallocating capital toward its core regulated utility and renewable‑energy growth initiatives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) According to the original answer, NEE maintained its equity method investment in the Mountain Valley Pipeline (MVP) in both 2022 and 2023, with ownership stakes ranging from 32%–55% in 2022 and 32.8%–52.6% in 2023—indicating continued involvement, not exit or impairment. The LLM falsely claims NEE fully impaired the stake in 2022 and exited in 2023, recognizing $450 million in revenue and a $375 million gain, none of which appears in the ground truth. (2) No numbers in the LLM answer (e.g., $450M, $375M) are supported by the original answer; the only figures in the truth are total equity method investments ($6,159M in 2022, $6,156M in 2023) and ownership percentage ranges. The LLM invents financials and events (impairment, sale, gain) with no basis in the provided data. (3) The multi-hop reasoning is fundamentally flawed: instead of noting continuity in investment with slight ownership adjustments and a new mention in fair value measurements, the LLM fabricates a divestiture narrative. (4) The conclusion about NEE’s strategy shifting away from pipelines is unsupported by the truth, which suggests strategic refinement, not exit. The answer is contextually related (discusses MVP and strategy) but factually baseless. Hence, very low scores across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 376,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic expanded the InterStim portfolio with newer platforms—including the InterStim X, InterStim II and the rechargeable InterStim Micro devices—and in April 2024 received FDA approval for the closed‑loop Inceptiv SCS. These devices now support a broader set of therapeutic indications, moving beyond the original chronic‑pain and diabetic peripheral neuropathy indications to include overactive bladder, urinary retention, bowel (fecal) incontinence and other pelvic‑health conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents key aspects of Medtronic's InterStim product evolution between 2022 and 2024. (1) It incorrectly states that InterStim Micro is rechargeable, while the ground truth indicates that by 2024, InterStim II and InterStim X were specifically labeled as 'recharge-free'—implying Micro may not be the focus or may be rechargeable, but the LLM mischaracterizes the portfolio's recharge feature. (2) The mention of 'closed-loop Inceptiv SCS' receiving FDA approval in April 2024 is factually incorrect in this context—Inceptiv is a sacral neuromodulation system, not a spinal cord stimulator (SCS) for chronic pain, and more importantly, it is not part of the InterStim therapy line as described in the ground truth. (3) The answer incorrectly frames the expansion as moving 'beyond chronic-pain and diabetic peripheral neuropathy'—but InterStim therapy was never indicated for these conditions; it has historically targeted bladder and bowel dysfunction, not general chronic pain. (4) While the LLM correctly identifies the expansion to include bowel (fecal) incontinence, it misattributes the timeline and context, failing to note that fecal incontinence was already part of the 2022 indications (ground truth shows continuity, not new addition in 2024). (5) The portfolio evolution is misrepresented: the ground truth shows a refinement (retaining II and X, with updated labeling), while the LLM suggests an expansion with newer platforms, which is not supported. (6) Dates: April 2024 FDA approval is fabricated or misapplied. Multi-hop reasoning fails because the model conflates different product lines (InterStim vs. Inceptiv SCS) and misidentifies indications. Despite this, the answer is contextually relevant—it addresses product evolution and indications—but is fundamentally flawed in facts and logic. Quantitative accuracy is low due to incorrect dates and implied approvals. Qualitative accuracy suffers from incorrect entity relationships and reasoning. Correctness score is low due to major factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 560,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "\nBetween 2022 and 2024 Simon steadily pared down its ownership in Authentic Brands Group, moving from roughly a 10‑12 % non‑controlling stake (after the 2021 licensing‑venture contributions) to essentially zero.  In 2022 it sold a portion of that interest to ABG, and a series of dilutive capital transactions in 2023 reduced the stake further—resulting in recognized gains of $157 million, $10 million, $12 million, $36 million and $146 million as the partnership’s share fell to about 9‑10 %.  In February 2024 Simon sold the remaining interest for $1.2 billion, generating a $415 million pretax gain and completing its exit from the strategic relationship with ABG.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both factual content and direction of events. The ground truth states that Simon Property Group started with a 1.37% stake in ABG in 2022, sold a portion for an $18.8 million pre-tax gain, and then *acquired additional interests* for $100 million in 2024—indicating continued strategic engagement. In contrast, the LLM claims Simon reduced its stake from 10–12% to zero, culminating in a $1.2 billion sale in February 2024 with a $415 million gain, which directly contradicts the original. (2) Quantitative inaccuracies are severe: the initial stake is wrong (1.37% vs. 10–12%), the gains reported ($157M, $10M, etc.) do not appear in the ground truth, the final sale amount ($1.2B) and gain ($415M) are fabricated, and the $100 million *acquisition* by Simon in 2024 is misrepresented as a sale *by* Simon. (3) The multi-hop reasoning is fundamentally flawed: instead of recognizing a complex but ongoing relationship with increasing involvement in 2024, the model incorrectly infers a complete exit. It also invents dilutive capital transactions in 2023 not present in the source. (4) Scores are low because the answer fails on core facts, numbers, direction of financial flows, and strategic interpretation. Contextual relevance is slightly above zero because it addresses the right companies and time frame, but the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 390,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "\nConocoPhillips has markedly expanded its Lower 48 investment between 2021 and 2023—capital spending in that region rose from $3.1 bn (2021) to $5.6 bn (2022) and $6.5 bn (2023) – and the resulting depreciation, depletion and amortization (DD&A) expense followed the same upward trend, climbing from $4.07 bn in 2021 to $4.85 bn in 2022 and $5.73 bn in 2023 (as shown in the segment DD&A tables for 2021‑2023).  This increase reflects the impact of major acquisitions (e.g., Concho and Shell Permian) and additional drilling/infrastructure, which added to the depletion base and drove higher DD&A charges each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend and provides accurate DD&A figures for 2021 ($4.07 billion vs. ground truth $4,067 million) and 2023 ($5.73 billion vs. ground truth $5,729 million), with only a negligible rounding difference (e.g., $4.07B = $4,070M, very close to $4,067M). The 2022 figure of $4.85 billion is not in the ground truth but is plausible and consistent with a smooth progression; however, since the original answer does not include 2022, this addition is not penalized as it does not contradict. (2) All key numbers are quantitatively accurate within acceptable rounding—$4.07B ≈ $4,067M, $5.73B = $5,730M ≈ $5,729M. The LLM also correctly references capital spending increases, which, while not part of the original answer, provide useful context and align with the conclusion about rising investment. (3) The reasoning is sound: the LLM correctly infers that higher DD&A reflects increased asset utilization or investment, and it appropriately cites acquisitions (Concho, Shell Permian) as drivers—information consistent with ConocoPhillips’ 10-K filings and supportive of the multi-hop logic. (4) The answer is semantically equivalent to the ground truth: it confirms the significant rise in DD&A, ties it to investment activity, and correctly identifies the Lower 48 as a focus area. The only minor deviation is the inclusion of 2022 data and capex figures not in the original, but these enhance rather than distort the answer. Thus, the response is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 427,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "\nVerizon continues to value its international bond holdings by matrix pricing using independent third‑party inputs and classifies them as Level 2 assets in both the 2023 and 2024 disclosures.  The only change is the size and composition of the holdings—international bonds dropped from $341 million (2023) to $113 million in the pension portfolio and from $12 million to $15 million in other post‑retirement assets—while the underlying valuation methodology remains the same.  (Pages 92‑95 2023 10‑K; pages 93‑94 2024 10‑K)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that in 2023, Verizon used matrix pricing with third-party inputs for international bonds as part of a broader fixed income category, but in 2024, they specifically itemized international bonds with a total value of $12 million, split into $10 million Level 1 and $2 million Level 2. The LLM instead claims the valuation methodology remained unchanged (still Level 2 only), which contradicts the ground truth showing a shift to more granular disclosure including Level 1 inputs. (2) The dollar amounts cited in the LLM answer ($341M in 2023, $113M in 2024, etc.) are entirely inconsistent with the ground truth ($12M total in 2024, no mention of 2023 value but clearly not $341M). These numbers appear to be fabricated or misattributed, possibly from different line items (e.g., pension portfolios), which the LLM incorrectly associates with international bonds. (3) The multi-hop reasoning fails: the question asks about evolution in treatment and valuation approach, but the LLM misses the key shift from general description to specific segmentation and mischaracterizes the methodology as unchanged. It also conflates different financial categories (pension portfolio vs. general bond holdings), indicating poor synthesis across disclosures. (4) The contextual relevance is moderate because it addresses Verizon’s bond valuation and cites 10-K pages, but the core facts, numbers, and analytical conclusion are wrong, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 432,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Emerson’s ownership of AspenTech grew from roughly **55 % of the fully‑diluted share count** (after the Heritage AspenTech acquisition described on page 26) to about **57 %** (noted in the 2024 announcement on pages 24‑25), and in November 2024 Emerson unveiled a cash proposal to acquire the remaining shares, effectively taking AspenTech private.  The 2022 transaction also marked the start of operational integration—AspenTech’s businesses were run under Emerson’s structure and reported within Emerson’s segments—while the 2024 proposal signals a move toward full consolidation of the company.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the answer incorrectly states that Emerson's ownership increased from 55% to 57% between 2022 and 2024, and that Emerson made a cash proposal in November 2024 to acquire the remaining shares. This contradicts the ground truth: in 2022, Emerson held a financial stake valued at $8,326 million, and by 2024, it had restructured its relationship by contributing AspenTech’s Industrial Software Business and $6.0 billion in cash to form 'New AspenTech', retaining a 55% stake. There is no mention of a 57% ownership or a November 2024 acquisition proposal in the ground truth. (2) The financial figures are entirely misrepresented—no $6.0 billion cash contribution is mentioned in the LLM response, nor is the formation of 'New AspenTech' accurately described. Instead, the LLM fabricates a narrative about a privatization attempt not present in the original data. (3) Qualitatively, the reasoning is flawed: the LLM incorrectly frames the evolution as a gradual increase in ownership leading to a buyout, whereas the actual transformation was a strategic restructuring involving operational integration and a new entity formation. The LLM also misrepresents the nature of the 2022 transaction as establishing a 55% ownership, while the ground truth indicates a financial stake on the balance sheet, not necessarily majority ownership at that stage. (4) Contextually, the answer addresses the right companies and time frame and attempts to discuss both financial stake and operational integration, so it maintains some relevance. However, due to major errors in numbers, entities, and logic, the overall correctness is low. Minor credit is given for recognizing some level of integration and ownership change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 489,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the company’s interest‑rate swaps remained classified as **designated fair‑value hedging instruments** of its long‑term debt.  In 2022 a $34 million derivative liability for these swaps was recorded in **other long‑term liabilities**, and by the end of 2023 that liability had risen to **$41.4 million** (still in other long‑term liabilities), reflecting a larger notional position and higher fair‑value losses as market rates moved.  The liability is offset by the corresponding fair‑value adjustment on the hedged long‑term‑debt balance, which was $1.06 billion at the end of 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Starbucks' interest rate swap liability decreased from $34.0 million in 2022 to $19.6 million in 2023 ($0.4M current + $19.2M long-term), but the LLM claims it increased to $41.4 million, which is factually incorrect. Additionally, the LLM states the entire liability remained in 'other long-term liabilities' in 2023, while the ground truth shows a split classification into both current (accrued liabilities) and long-term components, indicating a change in presentation. (2) Quantitative accuracy is severely compromised: the 2023 liability is reported as $41.4M by the LLM vs. $19.6M in the original answer; no mention of the $0.4M current portion. The claim of a rising liability contradicts the actual net decrease of $14.4M. (3) The reasoning is flawed: the LLM suggests an increase due to larger notional and fair-value losses, but fails to recognize the reclassification and reduction in exposure. It also introduces unrelated information about a $1.06 billion fair-value adjustment on debt, which, while contextually plausible, distracts from the specific question about classification and liability amounts. (4) Despite incorrect facts, the answer is contextually relevant—addressing the evolution of swap classification and liabilities—and correctly identifies the hedging context. However, core numbers and synthesis are wrong, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 408,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "\nIn 2022 NextEra Energy Resources recorded a $0.8 bn impairment charge and fully wrote down its equity‑method stake in the Mountain Valley Pipeline, even recognizing a $0.2 bn liability for future ARO costs, effectively removing the investment from its balance sheet. By 2023 the company’s exposure had been reduced to a modest, planned equity contribution for 2024 under a 20‑year gas‑transport agreement, preserving only a 32.8 % equity interest and no further capital commitment beyond that contribution.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly states the $0.8 billion impairment charge in 2022 and the 32.8% equity interest in 2023, it introduces a $0.2 billion liability for future ARO (Asset Retirement Obligation) costs not mentioned in the original answer, which lacks support in the provided ground truth. Additionally, the claim that there is 'no further capital commitment beyond that [planned equity] contribution' for 2024 contradicts the original answer, which specifies a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million—this is a significant ongoing financial commitment that the LLM downplays or omits. (2) The $0.8 billion impairment is correctly reported, and 32.8% ownership is accurate. However, the $0.2 billion ARO liability is unsupported, and the nature of the $70 million annual obligation is misrepresented by framing future commitments as minimal. The LLM implies reduced exposure without citing the $70M/year obligation, which is a material financial liability. (3) The multi-hop reasoning is partially sound—linking 2022 write-down to 2023 continued involvement—but fails in synthesizing the full scope of financial obligations in 2023. The model incorrectly suggests de-risking and minimal exposure, missing the contractual commitment that constitutes a major ongoing financial involvement. (4) The contextual relevance is high as the answer addresses the evolution of involvement across years and maintains focus on financial commitment. However, due to the omission of the $70M annual obligation and introduction of unsupported liabilities, the quantitative and qualitative accuracy scores are reduced. The correctness score is 6 because core facts (impairment, ownership %) are correct, but key financial commitments are misrepresented, leading to an incomplete and somewhat misleading picture of NEE's 2023 involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 530,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "\nThe captive insurance company that reinsures the group‑annuity policies holds a portfolio of marketable equity and debt securities that funds its solvency‑capital requirement.  At the end of 2023 the portfolio was valued at **$1.643 billion** in total equity and debt, and by the end of 2024 it had risen to **$1.883 billion**—an increase of roughly **$240 million (about 15 %)**.  This growth reflects a larger investment in both equity and debt securities to support the captive’s annuity‑reinsurance activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values for 2023 ($1.643 billion = $1,643 million) and 2024 ($1.883 billion = $1,883 million) are accurate, and the calculated increase of $240 million is correct (1,883 - 1,643 = 240). The percentage increase is approximately 14.6%, which rounds to the stated 'about 15%', so this is acceptable. (2) The answer is complete, addressing the evolution of Coca-Cola's investment in equity and debt securities through its captive insurance company over the two years, including both absolute values and the trend. (3) Entities are correctly identified: The Coca-Cola Company, its captive insurance company, group annuity insurance contracts, and the relevant time periods (2023 and 2024) are all accurately referenced. (4) The reasoning is sound: the LLM correctly synthesizes the purpose of the securities (to fund solvency-capital requirements) and interprets the increase as a growth in investment to support reinsurance activities, which aligns with the implied financial behavior. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced detail (e.g., percentage change) that adds value without introducing error. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 361,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved the Intel 4 EUV node from early‑stage sampling to full‑scale production: the Core Ultra processor became the first high‑volume client chip on Intel 4 in 2023, and by 2024 the node had shifted to high‑volume manufacturing in the Ireland fab, with Intel 4 expected to represent an increasing share of the company’s processor output in 2025.  Strategically, Intel 4 anchors Intel’s AI‑PC and data‑center roadmap—supporting products such as the Xeon 6 Scalable family and serving as the foundation for future nodes (Intel 3 and the upcoming Intel 18A)—and it is a core element of the IDM 2.0 strategy that delivers both internal leadership products and external foundry opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Intel 4 from early-stage production in 2022 to high-volume manufacturing by 2024, noting the ramp-up in Ireland and its use in the high-volume Intel Core Ultra processor. The mention of 2023 for Core Ultra's introduction is a slight deviation from the original answer, which emphasizes 2024 for high-volume manufacturing, but this is not necessarily incorrect—product ramp-up can begin in one year and reach high volume in the next. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is based on dates and timelines. The LLM correctly sequences 2022 (early sampling/ramp-up), 2023 (first high-volume client chip), and 2024 (HVM in Ireland), which is consistent with the progression in the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes production status, strategic positioning, product integration (Core Ultra, Xeon 6), and roadmap significance (foundation for Intel 3 and 18A), all of which reflect correct entity identification and logical connections. (4) The answer adds slightly more strategic context (e.g., IDM 2.0, AI-PC, foundry opportunities) than the original, but this is enriching rather than contradicting. The core facts—transition from ramp-up to HVM, Ireland fab, Core Ultra as key product—are correct. One minor point: the original emphasizes 2024 as the year of transition to HVM, while LLM cites 2023 for high-volume production; this slight discrepancy prevents a perfect 10. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 459,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s relationship with AspenTech shifted from a partial equity investment to full‑scale integration.  In 2022 Emerson acquired Heritage AspenTech and, after the transaction, owned roughly 55 % of AspenTech’s fully‑diluted shares, embedding the company’s asset‑optimization software into Emerson’s Automation Solutions segment and generating a 48 % jump in Software & Control sales.  By late 2024 Emerson announced a cash proposal to purchase the remaining ≈ 45 % of AspenTech shares (implying a $15.3 bn fully‑diluted market cap), which would give Emerson 100 % ownership and complete the financial and operational integration of AspenTech’s software portfolio into Emerson’s own earnings base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Emerson did not own any stake in AspenTech and was merely a strategic partner. However, the LLM claims Emerson 'acquired Heritage AspenTech' and owned 55% in 2022, which is incorrect. The 55% ownership stake was established in 2024 after a merger to form 'New AspenTech', not in 2022. Additionally, the LLM incorrectly states that Emerson planned to acquire the remaining ~45% by late 2024 via a cash proposal implying a $15.3B valuation — this event is not supported by the original answer and introduces new, unverified details. (2) Quantitative inaccuracies include the timing of the 55% ownership (placed in 2022 instead of 2024), the claim of a '48% jump in Software & Control sales' (not mentioned in ground truth), and the $15.3B market cap figure (absent from original). The only correct number is 55%, though it is misattributed to the wrong year and context. (3) The multi-hop reasoning is flawed: the model fails to correctly trace the evolution from partnership (2022) to partial ownership (2024), instead inventing an early acquisition and a future buyout. It also incorrectly frames the relationship as moving toward 100% ownership, while the ground truth confirms only 55% ownership with no mention of plans for full acquisition. (4) Despite these errors, the answer is contextually relevant — it addresses ownership structure and financial integration as asked, and correctly identifies the deepening relationship and integration into Emerson's financials. However, core facts and timeline are wrong, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 461,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved the Intel 4 node from early‑stage development to full‑scale production: the company began shipping its first high‑volume client product—Core Ultra—on Intel 4 in 2023 and, by 2024, shifted that node to high‑volume manufacturing in its Ireland fab, where it is now slated to become an increasingly dominant part of Intel’s processor output in 2025.  Intel 4 delivers roughly 20 % better performance‑per‑watt and markedly higher transistor density than the preceding Intel 7 node, and the company has continued to refine the process (e.g., adding EUV lithography, optimizing yield) to boost readiness and prepare it for broader adoption in upcoming client and data‑center products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel 4 transitioned from development to high-volume manufacturing by 2024, with production ramped in Ireland; the first high-volume product was the Core Ultra processor, shipped in 2023; and it delivers a 20% performance-per-watt improvement over Intel 7. The mention of EUV lithography as a key enabler is consistent with the original answer. (2) Quantitative accuracy is excellent: the 20% performance-per-watt figure is correctly cited, and all dates (2022 introduction, 2023 shipments, 2024 high-volume manufacturing) match the ground truth. (3) The reasoning is sound and reflects proper multi-hop synthesis across time and technical milestones—linking naming changes in 2022 to production ramp in 2024, and connecting technical improvements (EUV, density, yield) to manufacturing readiness. (4) The only minor shortcoming is that the original answer explicitly notes Intel 4 as Intel’s 'first EUV lithography node,' which the LLM mentions but does not emphasize as a milestone. Otherwise, the answer is complete, factually correct, and contextually appropriate, capturing the evolution in both manufacturing readiness and performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 348,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "\nBetween 2022 and 2024, InterStim Micro moved from being listed simply as one of several Pelvic‑Health neurostimulators (InterStim X, InterStim II, InterStim Micro) in Medtronic’s 2022 portfolio to being explicitly highlighted as the **rechargeable** option within the InterStim therapy suite.  The 2024 disclosures emphasize continued market acceptance and growth of “InterStim Micro rechargeable neurostimulator” for overactive bladder, non‑obstructive urinary retention and chronic fecal incontinence, underscoring its expanded positioning as a key, rechargeable solution that drives the overall Pelvic‑Health business forward.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: InterStim Micro was part of a broader portfolio in 2022 alongside InterStim X and II, and by 2024 it was explicitly positioned as the rechargeable option, differentiated from the recharge-free models. The indications (overactive bladder, urinary retention, fecal incontinence) are correctly stated. (2) There are no numeric values requiring calculation, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly synthesizing changes in product positioning across years and companies (MDT/Medtronic). The only minor shortcoming is that the answer does not explicitly name InterStim X and II as recharge-free in 2024 (though it implies it by contrast), which slightly reduces qualitative accuracy. (4) The response is highly relevant, directly addressing the evolution of InterStim Micro’s role and strategic positioning. Wording differs slightly but maintains semantic equivalence. No factual errors—only a small omission in specifying the recharge-free nature of the other models.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 314,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s footnote on diluted earnings per share/unit consistently identifies LTIP Units as potentially dilutive but explicitly states that, for each of those reporting periods, no security—including the LTIP Units—produced a material dilutive effect. Consequently, the filings do not adjust net income attributable to common stockholders (or unitholders) or the weighted‑average share (or unit) counts for any of the years 2022, 2023, or 2024. This language shows that the dilutive impact of LTIP Units has been considered immaterial across the three periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that LTIP Units were considered but had no material dilutive effect in 2022, 2023, and 2024, which aligns with the ground truth. It accurately states that no adjustment was made to net income or weighted-average shares due to immateriality, and correctly captures the consistent conclusion across periods—this supports a high contextual relevance and acceptable quantitative accuracy (dates and conclusions are correct). However, the LLM fails to capture the key evolution in disclosure detail: in 2022, the filing explicitly mentioned that LTIP units were exchangeable for common stock, while by 2024 this detail was omitted. The LLM does not note this reduction in disclosure specificity, instead implying consistent treatment and language over time. This omission represents a significant qualitative inaccuracy in the multi-hop reasoning required to assess *how the disclosure evolved*. The answer suggests consistency in disclosure language when in fact the level of detail decreased, which is the central point of the original answer. Thus, while the factual core about lack of material dilution is correct, the failure to identify the change in disclosure richness undermines the overall correctness, warranting a score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 353,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "\nIn the 2022 filing MetLife disclosed a $3.0 billion common‑stock repurchase authorization with roughly $1.5 billion still available as of Dec 31 2021, and it warned that a larger cash‑buffer—needed to meet liquidity, claims‑paying and regulatory requirements—could curb further purchases. The 2024 filing keeps the same $3.0 billion ceiling but explicitly ties any increase in the required cash buffer to a reduced pool of capital for repurchases, indicating that the effective remaining authorization has become more constrained by liquidity and regulatory considerations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $3.0 billion total authorization and $1.5 billion remaining as of December 31, 2021, are accurately reported. The LLM correctly references the 2022 and 2024 filings, matching the time frame in the question. (2) The answer captures the evolution in MetLife’s approach—highlighting that while the formal authorization remains unchanged, increased cash buffer needs due to liquidity, regulatory, and claims-paying requirements constrain repurchase capacity in 2024. This reflects the shift from active repurchases in 2022 to a more conservative stance in 2024. (3) The multi-hop reasoning is sound: it synthesizes information across two years, connects liquidity considerations to capital allocation trade-offs, and correctly infers that the effective repurchase capacity is more constrained even if the headline authorization is unchanged. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly state that the $1.5 billion remaining was as of the end of 2021 (though implied), and the emphasis on 'same $3.0 billion ceiling' could be misinterpreted as a 2024 renewal rather than continuation. However, the core message about increased caution and liquidity trade-offs is correctly conveyed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 401,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the foreign‑currency‑other derivative asset fell from $73.4 million ( $39.9 million recorded in current “prepaid expenses and other current assets” and $33.5 million in long‑term “other assets”) to $54.9 million ( $32.0 million in current assets and $22.9 million in long‑term assets), showing a reduction in both classifications.  The related liability shifted from being recorded entirely in long‑term liabilities in FY 2022 to a split of $2.0 million in accrued liabilities (current) and $0.5 million in other long‑term liabilities in FY 2023, reflecting a partial reclassification of the liability to current‑liability accounts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that in FY 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. However, the LLM claims the total derivative asset was $73.4 million, broken into $39.9 million in current assets and $33.5 million in long-term assets — none of which appear in the ground truth. In FY 2023, the ground truth reports only $1.9 million in prepaid expenses (current) and $1.7 million in long-term assets for derivative assets, and liabilities of $4.7 million (accrued) and $4.1 million (long-term). The LLM instead reports $54.9 million in total assets and liabilities of $2.0 million and $0.5 million — all significantly off. (2) Quantitative accuracy is very low: every dollar amount provided by the LLM is factually wrong and does not match the ground truth. There is no indication in the original answer that the FY2022 derivative assets were split between current and long-term accounts; rather, the $103.9 million was an OCI amount before reclassification. The LLM fabricates balance sheet splits not present in the source. (3) The reasoning is flawed: the LLM fails to capture the multi-hop nature of the question — it should have contrasted the OCI-based reporting in FY2022 with the explicit balance sheet line items in FY2023. Instead, it invents comparable balance sheet classifications for both years that do not align with the source. It also misses the key point of a 'significant reduction' due to the drop from over $100 million in OCI to under $2 million on the balance sheet. (4) Contextual relevance is moderate because the answer addresses derivative assets/liabilities and balance sheet classification shifts, but the incorrect numbers and fabricated details severely undermine correctness. The qualitative reasoning is partially sound in structure (comparing years, discussing classification changes), but based on false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 554,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 P&G’s cash‑management shifted from preserving liquidity and using modest $250‑$500 million of annual restructuring spend to recycling cash through working‑capital efficiencies, extended supplier payment terms and its $8 billion credit facilities in order to fund a much larger $659 million restructuring program (including about $216 million of non‑cash translation losses).  This enabled operating cash flow to rise to $19.8 billion and adjusted free cash flow to grow 21 % to $16.9 billion, but the higher restructuring outlays and a $1.4 billion impairment pushed corporate‑level earnings into a loss in 2024, even as credit ratings and overall cash positions remained strong.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly around financial figures not present in the ground truth. While it correctly identifies the $659 million restructuring cost in fiscal 2024 and the $1.4 billion Gillette impairment, it introduces new figures—such as operating cash flow of $19.8 billion, adjusted free cash flow of $16.9 billion, and a claim of 21% growth in free cash flow—that are not supported by the original answer or knowledge graph. These numbers cannot be verified and appear to be hallucinated. Additionally, the mention of an $8 billion credit facility and extended supplier payment terms is absent from the ground truth and not corroborated. (2) The restructuring accrual of $147 million in 2022 and the $216 million non-cash foreign currency loss are correctly referenced. However, the claim that corporate net earnings turned into a loss in 2024 is misleading—the original answer states a $1.0 billion decrease in corporate net earnings, not necessarily a net loss, and does not support the magnitude implied. The calculation of a 21% free cash flow increase cannot be validated and is extraneous. (3) The multi-hop reasoning is partially sound: the model correctly infers that increased restructuring costs and impairment charges negatively impacted earnings, and that cash management strategies remained focused on liquidity despite pressures. It connects restructuring activities to financial performance, but overreaches by introducing unsupported mechanisms like working-capital efficiencies and credit facilities. (4) The contextual relevance is high—the answer addresses the evolution of cash management strategy in relation to restructuring and financial performance across the specified fiscal years. The qualitative reasoning about strategic shifts is plausible and aligns with the direction of the ground truth, but the inclusion of unverified quantitative data significantly undermines factual correctness. Thus, while the narrative flow and synthesis are reasonable, the quantitative inaccuracies reduce the correctness score to a 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 565,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "\nBetween 2022 and 2023 NVIDIA moved Omniverse from a primarily developer‑oriented, real‑time 3D collaboration tool to an enterprise‑grade simulation and digital‑twin platform, introducing a paid subscription model and tighter integration with its AI‑ and data‑center stack.  It is now used by industrial customers to create digital twins, real‑time product configurators and to test autonomous‑vehicle stacks through DRIVE Sim (built on Omniverse), while Omniverse Avatar and AI Enterprise extend the platform with generative‑AI services, positioning Omniverse as a core simulation engine within NVIDIA’s broader enterprise solution portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of NVIDIA's Omniverse between 2022 and 2023. (1) It correctly identifies the shift from a developer-focused 3D collaboration tool to an enterprise-grade simulation and digital twin platform, aligning with the ground truth's emphasis on expanded enterprise integration and industrial use cases like digital twins and real-time configurators. The mention of DRIVE Sim as built on Omniverse for autonomous vehicle testing matches the original answer. It also correctly notes tighter integration with NVIDIA’s AI and data center stack, reflecting the deeper alignment with accelerated computing infrastructure. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information about Omniverse’s changing positioning, enterprise adoption, simulation use cases, and integration with other NVIDIA platforms (DRIVE Sim, AI Enterprise, Omniverse Avatar). The only minor omission is that the original answer specifies Omniverse was free for individuals in 2022, which the LLM answer does not mention, and the 2022 use cases (e.g., surgical training, architectural walkthroughs) are not explicitly referenced. However, these are contextual details that do not undermine the core factual accuracy. (4) The LLM answer is semantically equivalent in substance and highly relevant to the question, with only slight compression of detail. The introduction of generative AI via Omniverse Avatar and AI Enterprise adds a valid dimension of platform expansion in 2023. Overall, the answer is factually correct, well-reasoned, and contextually appropriate—just missing a few illustrative details from 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 486,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 AMT trimmed its planned outlay on communications‑site development modestly but kept the focus on building new towers and data‑center assets: it spent about **$1.83 billion in 2023** (including the construction of roughly **3,200 sites** and **≈ $395 million for data‑center spend**) and, for 2024, projects **$1.55‑$1.66 billion** in total capital expenditures—​**$790‑$820 million on discretionary projects, $70‑$90 million on ground‑lease purchases, $165‑$175 million on improvements, $455‑$485 million on redevelopment and $65‑$85 million on start‑up capital**, still targeting **2,500‑3,500 new sites** and **≈ $450 million for data‑center expansion**.  \n\nAt the same time, the company’s future obligations have shifted toward larger debt‑service and lease commitments: **$3.7 billion of senior notes and term‑loan principal matures in 2025**, with **$986 million of operating‑lease payments due in 2025** and a cumulative **≈ $7.1 billion of lease obligations** over the long run, while covenant‑driven cash‑trap tests could restrict excess cash that might otherwise be used for these capital projects or distributions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of AMT's financial commitments related to communications sites from 2023 to 2024 as described in the ground truth. (1) The original answer states that in 2023, AMT anticipated spending approximately $450 million on data center assets as part of construction plans for 2,500 to 3,500 communications sites. However, the LLM claims AMT spent $1.83 billion in 2023 overall, with $395 million on data centers and construction of 3,200 sites—none of which is supported by the ground truth. The $1.83B figure and its breakdown appear fabricated or misattributed. (2) For 2024, the ground truth highlights a $4.5 billion undiscounted future cash outlay for asset retirement obligations (AROs) tied to leased sites, indicating a major increase in long-term liability. The LLM instead reports projected capital expenditures of $1.55–1.66 billion and $450 million for data centers, which conflates capital spending with long-term obligations and completely misses the ARO increase. The LLM also introduces unrelated details like debt maturities ($3.7B in 2025), $986M lease payments due in 2025, and $7.1B in cumulative lease obligations—none of which are mentioned in the original answer and which shift focus away from the specific evolution of commitments tied to communications sites. (3) The multi-hop reasoning is flawed: the question asks about the evolution from anticipated spending (2023) to future obligations (2024), particularly the shift from near-term capital planning to long-term liabilities. The LLM fails to identify this conceptual shift and instead presents a detailed but incorrect capital expenditure forecast without referencing the key $4.5B ARO figure. (4) While the LLM attempts to address spending trends and future obligations, it does so with incorrect numbers, wrong financial categories (mixing capex with debt and lease payments), and introduces irrelevant data. The only partial match is the mention of $450 million for data center expansion in 2024, which aligns with the 2023 anticipated spend in the ground truth—but even this is misrepresented as recurring rather than a forward-looking plan. Overall, the answer is largely incorrect in both quantitative and qualitative terms, though it remains contextually relevant in topic focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 627,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "\nIn the 2023 filing ExxonMobil described asset‑sale proceeds as the result of a “long‑standing and regular disciplined review process” that ensures assets align with strategic objectives, noting that such proceeds are useful for investors evaluating cash for investment and shareholder distributions (page 37). By the 2024 filing the language was reframed to present those proceeds as an explicit component of the company’s capital‑allocation strategy—emphasizing portfolio simplification and the redeployment of capital to higher‑return projects—thereby linking divestiture proceeds more directly to strategic objectives (page 39).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2023 and 2024) and correctly identifies ExxonMobil as the entity, satisfying entity accuracy and contextual relevance. There are no numeric values to verify, so quantitative accuracy is scored as 10 by default. However, the qualitative analysis diverges from the ground truth in key aspects. The original answer emphasizes a linguistic evolution from a detailed categorization of proceeds (e.g., 'sales of subsidiaries, property, plant and equipment') in 2023 to a more consolidated 'proceeds from asset sales and returns of investments' in 2024, highlighting a shift toward streamlined, generalized framing. In contrast, the LLM answer introduces new strategic concepts—such as 'portfolio simplification' and 'redeployment of capital to higher-return projects'—and claims a reframing around 'capital-allocation strategy' that are not present in the ground truth. While it correctly notes the continued emphasis on strategic alignment, the LLM infers a deeper strategic shift and intent not supported by the original knowledge graph, which only reports a change in descriptive language, not strategic rationale. This misrepresents the nature of the evolution, focusing on inferred strategic intent rather than the actual linguistic consolidation documented. Thus, while the answer is relevant and plausible, it fails to accurately reflect the specific evolution in language as described in the ground truth, resulting in a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 412,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "\nFrom 2022 to 2023 the amounts of Universal Beijing Resort that appear on Comcast’s consolidated balance sheet fell – assets dropped from roughly **$8.5 billion to $7.8 billion** and liabilities slipped from about **$7.9 billion to $7.2 billion**.  This decline in both the asset base and the debt level reduces Comcast’s maximum potential loss to its 30 % equity stake, meaning its financial exposure to the resort is lower in 2023 than it was in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the direction of change (decrease in both assets and liabilities from 2022 to 2023) and the correct 2023 figures ($7.8 billion in assets and $7.2 billion in liabilities). However, it reports incorrect 2022 figures: it states assets were 'roughly $8.5 billion' and liabilities 'about $7.9 billion', whereas the ground truth specifies $9.7 billion in assets and $8.1 billion in liabilities. These discrepancies are significant (off by $1.2B in assets and $0.2B in liabilities), undermining quantitative accuracy. 2) The numbers are not accurate: the LLM underestimates 2022 assets by over 12% and misrepresents the scale of the reduction. The actual decrease in assets is $1.9 billion (from $9.7B to $7.8B), but the LLM implies only a $0.7B drop. Similarly, the liability decrease is $0.9B (from $8.1B to $7.2B), not $0.7B as implied. 3) The reasoning is sound in interpreting the decline as reduced financial exposure and linking it to Comcast's equity stake, which shows good qualitative understanding of financial implications. The multi-hop synthesis—connecting balance sheet changes to exposure risk—is logically valid and relevant. 4) Despite incorrect input numbers, the conclusion (reduced exposure in 2023) aligns with the ground truth. The answer is contextually relevant and well-structured, but the factual errors in key financial data limit correctness. Minor phrasing like 'roughly' or 'about' does not excuse the magnitude of error. Thus, partial credit is given for correct trend and 2023 values, but significant deduction for inaccurate 2022 figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 437,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, Caterpillar’s description of customer‑demand volatility moved from a broad, cyclical macro‑economic risk—driven mainly by commodity‑price swings and pandemic‑related uncertainty—to a more acute, multi‑factor uncertainty amplified by inflation, higher interest rates, tighter credit conditions and persistent supply‑chain bottlenecks.  This heightened volatility now directly threatens revenue swings and forces tighter inventory and production scheduling, making demand instability a more immediate risk to both financial performance and the stability of Caterpillar’s supply chain.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment and contextually relevant, but diverges slightly from the ground truth in emphasis and detail. (1) The original answer specifies that in 2023, Customer Demand Volatility was driven by economic uncertainties including the lingering effects of the global pandemic, inflationary pressures, supply chain disruptions, and labor inefficiencies. The LLM correctly identifies macroeconomic and pandemic-related factors but overemphasizes 'commodity-price swings' as a 2023 driver, which the original answer places more prominently in 2024. (2) There are no numeric values to verify, so quantitative accuracy is 10 by default. (3) The multi-hop reasoning is sound—comparing risk factor evolution across years—but the synthesis slightly misattributes the timing of commodity price concerns. The original answer states that in 2024, the risk broadened to include commodity price changes, material cost increases, and supply-side disruptions, whereas the LLM presents these as concurrent with demand volatility without clearly distinguishing the shift in emphasis. (4) The LLM captures the increased severity and operational impact of the risk (e.g., inventory and production scheduling), which aligns with the original's conclusion about broader systemic challenges. However, it misses the precise evolution: from pandemic-driven demand-side volatility (2023) to a combined demand-and-supply risk profile (2024). Wording is semantically close but not fully equivalent. Thus, correctness is reduced to 7 due to partial misattribution of causal factors across years, despite strong overall alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 449,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "\nFrom the 2022 10‑K the net derivative position was only $5 million (largely Level 2, with a small Level 3 component), and it was measured using vendor‑based discounted‑cash‑flow models that rely on market‑observable inputs and credit‑risk adjustments. By year‑end 2023 the balance had jumped to $69 million, driven by a larger share of Level 3 derivatives (e.g., SOFR‑indexed swaps) and wider pricing variations among vendors, while the underlying valuation approach—discounted cash‑flow with observable inputs where available and internal pricing cross‑checks—remained the same. The 2024 roll‑forward shows the same $69 million balance, indicating stability in fair‑value magnitude but continued classification as Level 3 and the same methodology of applying credit‑risk adjustments and internal‑external pricing validation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and dates. The ground truth states the fair value was $19 million as of December 31, 2021 (reported in 2022 10-K), while the LLM claims $5 million for 2022, which is both numerically incorrect and misaligned with the reporting period. The 2024 value (as of December 31, 2023) is stated as $58 million in the original answer, but the LLM reports $69 million—this discrepancy is material. Additionally, the LLM incorrectly states the 2024 roll-forward shows $69 million, implying stability, when the ground truth shows a significant increase from $19M to $58M. (2) The valuation methodology shift described in the original answer—from realized/unrealized gains/losses in net income to discounted cash flows with observable inputs like swap rates (3–5%, weighted average 4%)—is misrepresented. The LLM claims the methodology remained 'the same,' using discounted cash flows with observable inputs and credit-risk adjustments, which contradicts the ground truth that identifies a methodological evolution. The mention of SOFR-indexed swaps and Level 3 classification is not supported in the original answer and introduces unverified details. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the change in both value and methodology over time. It incorrectly assumes continuity in valuation approach while fabricating elements like vendor pricing variations and internal-external validation not present in the ground truth. (4) Despite these issues, the answer is contextually relevant—it addresses fair value changes and methodology over time, uses appropriate financial terminology, and attempts to compare across years. However, due to major quantitative errors and incorrect qualitative conclusions about methodology, the correctness score is low. Quantitative accuracy is severely compromised; qualitative accuracy is partially met due to correct framing but incorrect details; contextual relevance is acceptable as the structure aligns with the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 558,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "\nFrom 2022 to 2023 NVIDIA moved GeForce NOW from a stand‑alone cloud‑gaming service into a core part of its accelerated‑computing and AI cloud platform.  The 2023 disclosures highlight that the service now runs on the same RTX‑based data‑center GPUs that power AI workloads, leveraging AI‑enhanced features such as DLSS and ray‑tracing to deliver higher‑fidelity, lower‑latency streaming.  Consequently, GeForce NOW is positioned as a showcase and consumer‑facing extension of NVIDIA’s full‑stack GPU‑AI ecosystem, tying cloud gaming performance directly to the company’s broader GPU‑cloud and AI‑software strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of GeForce NOW from a standalone cloud gaming service in 2022 to a more integrated component of NVIDIA’s broader accelerated computing and AI cloud platform in 2023. The emphasis on RTX-based data-center GPUs, AI-enhanced features like DLSS and ray-tracing, and positioning as a consumer-facing extension of the full-stack GPU-AI ecosystem are consistent with the original answer’s narrative about strategic alignment with cloud infrastructure and software offerings. (2) There are no numeric values, dates, or financial figures in either answer that require verification—both correctly reference 2022 and 2023 as the time frame, and no calculations are needed. Format and temporal references are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes the shift in strategic positioning across years and connects GeForce NOW to other elements of NVIDIA’s ecosystem (AI, data-center GPUs, software features), mirroring the original answer’s logic. The only minor gap is that the LLM does not explicitly mention vGPU or NVIDIA DGX Cloud as comparative platforms (as in the original), which slightly reduces completeness in entity coverage, though the core synthesis remains correct. (4) The answer is contextually excellent—directly addressing the question about positioning within the broader GPU and cloud platform ecosystem, using semantically equivalent and technically precise language. The slight deduction from 10 to 9 in correctness and qualitative accuracy reflects the omission of explicit mention of vGPU and DGX Cloud as part of the ecosystem context, but the overall meaning and strategic interpretation remain intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 475,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "\nInlyta’s worldwide sales rose modestly from about **$1.00 billion in 2022 to $1.04 billion in 2023** (≈3‑4 % growth), with U.S. revenue up **4 %** (from $618 M to $642 M) and international sales up **3 %** (from $385 M to $394 M).  The increase was driven mainly by greater use of Inlyta in combination regimens for first‑line advanced renal‑cell carcinoma and continued expansion in emerging markets, although this was partially offset by lower volumes and price reductions in certain European markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It reports Inlyta's global revenue increasing from $1.00 billion in 2022 to $1.04 billion in 2023, which aligns closely with the ground truth values of $1,003 million and $1,036 million (a 3.3% increase). The LLM rounds these to $1.00B and $1.04B, which is acceptable formatting variation and still reflects ≈3% growth. The U.S. and international breakdowns ($618M to $642M and $385M to $394M) sum correctly to the total (e.g., $618M + $385M = $1,003M in 2022; $642M + $394M = $1,036M in 2023), confirming internal consistency and accurate multi-hop synthesis. (2) Percentage growth calculations are accurate: U.S. growth is correctly ≈4% ((642-618)/618 ≈ 3.87%), international ≈2.6% ((394-385)/385 ≈ 2.6%), and total ≈3.3%, which the LLM reasonably rounds to '3-4%'. The ground truth cites 3%, so the approximation is justified. (3) The reasoning and synthesis are sound: the LLM correctly identifies the primary drivers—increased use in combination therapies for first-line advanced RCC and growth in emerging markets—and notes the offsetting pressure from lower volumes and prices in Europe, matching the original answer exactly in substance. (4) All entities (Inlyta, advanced renal cell carcinoma, immune checkpoint inhibitors, U.S., Europe, emerging markets) are correctly identified and contextually used. The answer fully addresses both parts of the question: revenue evolution and influencing factors. Only minor deduction in quantitative accuracy due to rounding of total revenue to $1.04B instead of $1.036B, but this does not affect overall correctness. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 464,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "\nFrom 2023 to 2024 the Company changed how it accounts for network‑location intangibles: the assets were previously amortized over the shorter of the underlying ground‑lease term (generally up to 20 years) and were tested for impairment on a tower‑by‑tower basis when cash‑flow indicators suggested a loss; beginning January 1 2024 the Company extended the estimated useful life of towers (and therefore of the related intangibles) to 30 years and began amortizing them over that period, which reduces annual amortization expense (the change was accounted for as a prospective ASC 250 accounting‑estimate adjustment and is expected to cut depreciation/amortization by about $730 million in 2024). The impairment review now uses the longer‑life cash‑flow model—projecting undiscounted future cash flows and comparing them to the revised carrying amount—to determine whether an impairment charge is required, but the underlying trigger criteria (e.g., loss of tenant leases or negative cash flows) remain the same.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the LLM claims a change in amortization period from up to 20 years to 30 years effective January 1, 2024, with a $730 million reduction in D&A — none of which appears in the original answer. The ground truth states a weighted average amortization period of 15 years in 2023 and no change in amortization method or period by 2024. The $470 million liability increase in 2024 (due to revised asset retirement obligations) is misrepresented in the LLM answer as a $730 million D&A reduction, which is incorrect in both amount and context. (2) The LLM invents an accounting change under ASC 250 and a prospective estimate adjustment, which are not mentioned in the original. (3) While the original notes that impairment reviews in 2024 are done on an individual tower basis with triggers like lack of leases or expenses exceeding revenues, the LLM incorrectly frames this as a change tied to a new 30-year cash flow model, which is unsupported. (4) The original emphasizes expanded disclosures and indirect impacts from asset retirement obligation changes, but the LLM fabricates a major accounting policy shift. Although the LLM correctly identifies impairment triggers (e.g., loss of leases) and the tower-level review, it misplaces them within a false narrative of changed amortization assumptions. The reasoning is internally logical but based on incorrect premises, failing the multi-hop synthesis. Contextually, the answer addresses amortization and impairment, so relevance is moderate, but factual correctness is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 444,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil moved from the early‑stage development and name‑plate ramp‑up of three Stabroek Block FPSOs (Prosperity, Liza Destiny, Liza Unity) to a deliberate expansion strategy that treats Guyana as a core “advantaged” upstream asset.  The 2024 filing still lists Guyana alongside the Permian and LNG as a key growth pillar and targets six FPSOs on the block by 2027, including regulatory work on a sixth Whiptail project, underscoring a shift toward consolidating and scaling Guyana’s production capacity within the broader upstream growth portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core strategic evolution of ExxonMobil's emphasis on Guyana from 2023 to 2024, correctly identifying Guyana's elevation to an 'advantaged' asset alongside Permian and LNG, and its role in upstream growth. It appropriately notes the continued development of FPSOs and the target of six by 2027, including Whiptail, which aligns with the forward-looking strategy. However, there are key quantitative and factual inaccuracies: (1) The LLM incorrectly states that three FPSOs (Prosperity, Liza Destiny, Liza Unity) were in ramp-up in 2023–2024; the ground truth specifies that Prosperity started up in 2023, but does not confirm all three were in name-plate ramp-up during this period. (2) The original answer highlights four additional discoveries in 2023 and production reaching nearly 440 kbd in Q4 2023—specific data points missing in the LLM response. (3) The term 'name-plate ramp-up' and 'three FPSOs' is speculative and not supported in the ground truth, which only confirms Prosperity's startup. While the qualitative shift to 'advantaged asset' in 2024 is correctly identified, the LLM omits the explicit reclassification within 'updated earnings drivers' and the significance of Guyana transitioning from exploration to a financially impactful asset. The reasoning is logically sound and contextually relevant, but the inclusion of unverified details and omission of key facts from the ground truth reduces quantitative accuracy. Semantic equivalence is partially achieved, but not fully due to missing specifics and minor factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 430,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast moved the X1 platform from a separate Flex streaming dongle to a fully integrated X1 experience that natively aggregates third‑party DTC services (e.g., Disney+, Netflix, Peacock) and adds a new ad‑supported “NOW” streaming tier that can be accessed without a set‑top box; the platform also now earns commission revenue from DTC subscriptions.  This evolution reflects Comcast’s strategy of keeping broadband/video subscribers inside its own ecosystem—by embedding popular OTT services directly in X1 and offering premium, commission‑generating streaming options—thereby curbing cord‑cutting and driving higher average revenue per user.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic direction of Comcast's X1 platform evolution and correctly identifies key elements such as integration of third-party services (Disney+, Netflix, Peacock), commission revenue generation, and the goal of reducing cord-cutting and increasing ARPU. However, there are significant factual inaccuracies in the details of the platform's evolution. The claim that Comcast moved from a 'Flex streaming dongle' to X1 integration is not supported in the ground truth, which does not mention Flex or a transition from a dongle-based system. Additionally, the introduction of an ad-supported 'NOW' streaming tier accessible without a set-top box is incorrect; the ground truth specifies that NOW TV service included Xumo Play, NBC, and Sky, not a new 'NOW' tier. The LLM also fails to mention the specific 2023 addition of Xumo Play, NBC, and Sky as part of NOW TV, which is a key factual update. While the strategic interpretation about ecosystem retention and ARPU growth is semantically aligned with the ground truth, the incorrect platform transition narrative and misrepresentation of the new offerings reduce factual accuracy. Quantitatively, there are no numerical errors (dates 2022–2023 are correct), so quantitative accuracy is high. Qualitative accuracy is moderate due to correct identification of major services and strategic intent but flawed execution details. Contextual relevance is strong as the answer addresses both parts of the question: platform evolution and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 420,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "\nBetween 2023 and 2024 Caterpillar trimmed the FG Wilson distributor count from **110 to 108**, while expanding the geographic footprint from **109 to 158 countries** — a shift that tightens the partner base but broadens coverage of its electric‑power‑generation systems. This evolution is noted in the “Nature of operations” sections of the 2023 and 2024 10‑K filings (pages 65 and 66).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: distributor count decreased from 110 in 2023 to 108 in 2024, and geographic coverage expanded from 109 to 158 countries. These values exactly match the original answer. (2) The answer is complete, addressing both the change in distributor count and geographic reach, which are the core components of the question. (3) Entity accuracy is correct—Caterpillar, FG Wilson, and the relevant time frame (2023–2024) are properly identified. (4) The reasoning is sound: the LLM correctly infers a strategic shift toward a more efficient distributor network with broader market access, aligning with the original conclusion. It also cites the correct source (10-K 'Nature of operations' sections), demonstrating proper multi-hop synthesis across filings. (5) Semantic equivalence is maintained—though phrased more concisely, the LLM conveys the same factual content and implication as the original answer. Minor formatting differences (e.g., em dashes, spacing) do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 311,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "\nBetween the 2022 filing (which reported consolidated VIE liabilities of about **$15.2 billion** — $13.0 billion for credit‑card securitizations plus $2.2 billion for auto securitizations) and the 2024 filing, the **carrying amount of Capital One’s securitized‑debt obligations fell to $14.3 billion** as of December 31 2024.  The **estimated fair value moved in step with the carrying amount**, declining from roughly **$15.3 billion** to **$14.3 billion** over the same period, reflecting a modest reduction in the company’s exposure to securitized debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2024, the carrying value of Capital One's securitized debt obligations was $18,043 million ($18.043 billion), not $14.3 billion as stated in the LLM answer. Similarly, the fair value was $18,067 million ($18.067 billion), not $14.3 billion. The LLM incorrectly reports a decline from ~$15.3 billion to $14.3 billion, which contradicts the ground truth showing an increase from 2022 to 2024. The 2022 figures cited in the LLM answer ($15.2 billion total) are plausible but not explicitly confirmed in the original answer, which only describes the composition of VIE liabilities without giving a total dollar figure. (2) The quantitative values are entirely incorrect: the LLM reports $14.3 billion for both carrying and fair value in 2024, while the correct values are $18,043 million and $18,067 million respectively. There is no indication in the ground truth of a reduction in exposure; rather, the stable and slightly higher fair value suggests continued or increased involvement. (3) The multi-hop reasoning is flawed: the LLM infers a downward trend in exposure, which is unsupported by the data. It fails to recognize that the 2024 values represent an increase from 2022, and mischaracterizes the nature of the exposure. The original answer emphasizes stable valuation and continued involvement, while the LLM concludes a 'modest reduction'—a directly contradictory interpretation. (4) Scores are justified as follows: correctness is low (2/10) due to major factual and directional errors; quantitative accuracy is poor (2/10) because all key numbers are wrong; qualitative accuracy is slightly higher (3/10) because the LLM identifies the right metric category (securitized debt obligations) and mentions fair value hierarchy implicitly; contextual relevance is moderate (6/10) because the response addresses the right topic and time frame, but with incorrect data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 537,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s replaced its prior $15 billion revolving‑credit facility (authorized in December 2022, with about $7.4 billion still unused at the end of 2023) with a new identical $15 billion facility that became effective on January 1 2025, while still maintaining a $4 billion committed line‑of‑credit availability. This restructuring preserves the same borrowing capacity and flexibility to meet short‑term funding needs—such as share‑repurchases, dividend payments and debt‑service obligations—without altering the company’s overall cash‑flow strategy, which continues to rely primarily on strong operating cash generation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the actual evolution of McDonald's use of line of credit agreements between 2023 and 2024 as reflected in the ground truth. (1) The answer fabricates a new $15 billion credit facility effective January 1, 2025, which is outside the 2023–2024 timeframe and not mentioned in the original answer. The original answer does not mention any replacement or restructuring of credit facilities during this period. (2) The quantitative details such as the $15 billion revolving-credit facility and $7.4 billion unused balance at end-2023 are not present in the ground truth and cannot be verified; the original answer only discusses cash flows and liquidity without specifying credit facility sizes. (3) The original answer focuses on changes in financing activities: cash used for financing increased from $4.4B in 2023 to $7.5B in 2024, with a drop in cash and equivalents from $4.6B to $1.1B, driven by reduced bond issuances and reliance on credit facilities to manage outflows. The LLM answer completely omits these key financial figures and trends. (4) The reasoning is flawed: instead of analyzing the shift from surplus liquidity in 2023 to a cash-constrained environment in 2024 and increased reliance on credit lines, the LLM claims no change in strategy, contradicting the ground truth. (5) The mention of a $4 billion committed line-of-credit is unsupported in the provided data. While the LLM correctly notes reliance on credit facilities for short-term needs, this is generic and does not reflect the specific evolution in usage patterns. Overall, the answer invents details not in the source and misses the core multi-hop insight: changing cash flow dynamics led to greater dependence on credit in 2024 despite lower bond issuance. Thus, factual accuracy is very low, with only partial contextual relevance to the topic of credit usage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 510,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "\nBetween 2022 and 2024 the Company’s internal‑control disclosures shifted from a generic statement that the **Worldwide Business Conduct Manual “reinforces” a culture of integrity** to an explicit reference that the Manual underpins **specific control activities around complex financial estimates**—particularly the valuation and impairment of the Gillette indefinite‑lived intangible asset.  The 2024 report details testing of controls over forecasts, royalty rates and discount‑rate assumptions used in fair‑value measurements, showing that the Manual is now treated as an operational framework that drives documented, risk‑based procedures and independent validation of key judgments.  This evolution indicates that Procter & Gamble is embedding the Manual more tightly into its governance structure, using it to strengthen oversight, ensure consistent risk‑assessment practices, and demonstrate a proactive, transparent approach to financial reporting controls.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth, despite addressing the right question and showing plausible reasoning. (1) The original answer states that in 2022, the Manual reinforced integrity, internal controls via policies, segregation of duties, and employee development, and in 2024 was more closely tied to governance bodies like the Global Leadership Council and Disclosure Committee. The LLM answer instead claims that in 2024 the Manual was linked to 'complex financial estimates' and specifically the 'valuation and impairment of the Gillette indefinite-lived intangible asset,' including testing of forecasts, royalty rates, and discount rates. These specific financial control details and asset references are not present in the ground truth and appear fabricated or hallucinated. (2) There are no numeric values (dates aside) in either answer, so quantitative accuracy is not heavily penalized, but the mention of '2022' and '2024' is correct, earning partial credit. (3) The multi-hop reasoning is structurally sound—comparing evolution over time and inferring governance implications—but it synthesizes incorrect details. The LLM invents a shift toward financial estimation controls rather than the actual shift toward structured governance oversight. (4) While the conclusion about tighter integration into governance aligns thematically with the original, the factual basis for that conclusion is incorrect. The LLM misrepresents the nature of the evolution, undermining qualitative accuracy. Contextual relevance is fair because the response stays on topic and attempts the correct analysis, but factual correctness is too low for a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 463,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "\nExxon’s Guyana exposure grew sharply in the 2023‑2024 reporting period – long‑lived assets in the country rose from roughly **$6.8 bn to $9.7 bn**, underscoring a larger capital commitment – and the company now classifies Guyana as an **“advantaged asset”** within its earnings‑driver framework (Advantaged Volume Growth), tying its future earnings to Guyana’s high‑value, lower‑emission oil production. This evolution reflects a strategic shift from early‑stage development to positioning Guyana as a core, high‑return growth pillar of Exxon’s upstream portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error: it states that long-lived assets in Guyana increased from $6.8 billion in 2023 to $9.7 billion, whereas the ground truth reports $9,689 million (i.e., $9.689 billion) in 2023—meaning there was no increase from $6.8B to $9.7B as implied, and the $6.8B figure is entirely incorrect. The 2024 asset value is not provided in the original answer, so the claim of growth is unsupported. (2) The qualitative aspects are mostly accurate: the LLM correctly identifies that Guyana was classified as an 'advantaged asset' under the 'Advantaged Volume Growth' earnings driver in 2024, reflecting a strategic elevation. It also correctly interprets the strategic shift toward positioning Guyana as a core growth pillar. (3) The multi-hop reasoning is sound—linking asset disclosures to strategic framing in earnings drivers—but is undermined by the incorrect financial data. (4) Despite the wrong starting asset value, the overall narrative of strategic evolution is aligned with the ground truth, and the terminology ('advantaged asset', 'high-return growth pillar') reflects accurate synthesis. However, the major factual error in the quantitative baseline severely impacts correctness. Hence, correctness and quantitative accuracy are penalized, while qualitative reasoning and relevance remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 379,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "\nFrom the 2022 10‑K (pages 111‑115) Capital One was still building its securitization portfolio – it issued **$6.3 billion** of securitized‑debt obligations in 2021, which helped lift total long‑term debt to **$42.3 billion** (up $2.4 billion from the prior year).  \nIn contrast, the 2024 10‑K (pages 217‑221) shows the **carrying value of securitized‑debt obligations falling to $14.3 billion** (down from $18.0 billion in 2023) and no new issuance disclosed, indicating that the firm has markedly **reduced its reliance on securitized debt** over the 2022‑2024 period and is now funding growth primarily through senior/subordinated notes and deposit sources.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM claims Capital One issued $6.3 billion in securitized debt in 2021 and had total long-term debt of $42.3 billion in 2022, but the ground truth does not disclose any specific dollar amounts for securitized debt in 2022—only that it was part of the funding mix. Furthermore, the LLM states that the carrying value of securitized debt fell to $14.3 billion in 2024 from $18.0 billion in 2023, but the ground truth reports a 2024 carrying value of $14,264 million ($14.264 billion), with no mention of a 2023 figure or a decline from $18.0 billion. Thus, the key numbers and trends are fabricated or incorrect. (2) Completeness: While the question asks about the evolution from 2022 to 2024, the LLM incorrectly introduces 2021 and 2023 data not present in the ground truth and fails to note the increased transparency in disclosure in 2024, which is a key point. (3) Entity Accuracy: The company (Capital One) and metric (securitized debt obligations) are correctly identified, and the years referenced are relevant, though unsupported values are attributed. (4) Reasoning: The LLM draws an incorrect conclusion—reduced reliance on securitized debt—based on made-up figures, whereas the ground truth indicates continued use and increased disclosure (from no specific value in 2022 to a precise $14,264 million in 2024), suggesting stable or possibly growing strategic importance. The reasoning is therefore flawed. (5) Semantic Equivalence: The overall message of the LLM answer contradicts the ground truth: it suggests a decline in reliance, while the original answer indicates sustained use with improved transparency. Despite addressing the general topic and timeframe, the answer is factually incorrect in its core claims, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 507,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA reframed Omniverse from a real‑time 3D collaboration and simulation tool (offered as an enterprise subscription with a free individual tier) into a core “industrial‑metaverse” platform for building digital‑twin and AI‑driven virtual‑world applications.  This repositioning was accompanied by a sharp rise in enterprise adoption—industrial customers began deploying Omniverse at scale for factory digital twins, real‑time product configurators and autonomous‑vehicle simulation, and the platform was integrated with NVIDIA’s AI, cloud (vGPU/GeForce NOW) and DRIVE Sim services, driving a noticeable increase in enterprise‑level revenue and partner engagements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of NVIDIA's Omniverse platform between fiscal years 2022 and 2023. (1) It correctly identifies the shift from a 3D collaboration tool to an enterprise 'industrial-metaverse' platform focused on digital twins and simulation, aligning with the ground truth's description of Omniverse evolving into a development platform and operating system for virtual world applications. The mention of enterprise subscription with a free tier for individuals matches the original answer. (2) There are no numeric values, dates, or financial figures in dispute—both answers reference the same fiscal years and no incorrect numbers are introduced, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM synthesizes positioning changes and adoption trends across fiscal years, correctly linking Omniverse to industrial use cases (factory digital twins, product configurators, AV simulation) and integration with NVIDIA’s AI, vGPU, and DRIVE Sim services—details consistent with the strategic expansion described in the ground truth. (4) The only minor gap is that the LLM emphasizes 'revenue and partner engagements' increase, which, while plausible, is not explicitly stated in the ground truth; this adds inference beyond the provided data, slightly reducing qualitative accuracy. However, the core facts, entity identification (NVIDIA, Omniverse, fiscal years), and semantic meaning remain fully aligned. Contextual relevance is excellent as it directly addresses both positioning and enterprise adoption evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 435,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 Pfizer’s net payable to Viatris fell sharply — from **$94 million** (as reported on page 75 of the 2023 Form 10‑K) to **$33 million**, a reduction of about **$61 million** as the transitional MSAs, TSAs and other separation agreements were settled.  At the same time the receivable that Viatris owed Pfizer dropped from **$53 million** in 2021 to essentially zero by 2022, reflecting the collection or write‑off of the $401 million balance that had been recorded in 2020.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key net payable amounts from Pfizer to Viatris—$94 million as of December 31, 2022, and $33 million as of December 31, 2023—which matches the ground truth. The calculated reduction of $61 million is accurate. However, the LLM introduces additional information not present in the original answer or question: specifically, Viatris’s receivable from Pfizer dropping from $53 million in 2021 to zero by 2022 and a reference to a $401 million balance from 2020. This data, while potentially factual, is not part of the ground truth and distracts from the core question, which focuses on the evolution of net amounts due between 2022 and 2023. (2) Quantitative accuracy is high for the relevant figures: $94M and $33M are correct, and the $61M difference is properly computed. The out-of-scope receivables data reduces precision in focus but not in calculation. (3) The multi-hop reasoning is partially sound—correctly tracking the change in net payables over two years—but extends beyond the required scope by incorporating unrelated historical receivables. The core synthesis of Pfizer’s decreasing obligation is valid, but the added context risks misalignment with the question’s intent. (4) The answer is contextually relevant and well-structured, but the inclusion of unrequested, extraneous financial details lowers qualitative accuracy. The main facts are correct, so the correctness score is 7—minor overreach but core accuracy maintained.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 411,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "\nExxonMobil’s focus on Guyana has shifted from early‑stage exploration toward treating the offshore discoveries as a core, high‑return growth pillar.  In the 2024 filing the company explicitly places Guyana within the “Advantaged Volume Growth” and “Advantaged Projects” earnings‑driver categories, and the 2024 disclosures show a larger share of development‑type wells (12.6 net development wells completed in 2023) being counted as development activity and earmarked for dedicated capital investment—highlighting the Payara, Yellowtail and Uaru projects as strategic, advantaged assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in ExxonMobil's strategic emphasis on Guyana between 2023 and 2024. (1) Quantitatively, the number of net development wells (12.6) is correctly cited and attributed to 2023, matching the ground truth. The mention of Payara, Yellowtail, and Uaru projects aligns exactly with the original answer. (2) The strategic reclassification in 2024—placing Guyana under 'Advantaged Volume Growth' and 'Advantaged Projects' (or 'Advantaged Assets' in the original)—is correctly identified, though the phrasing 'Advantaged Projects' is slightly less precise than the original 'Advantaged Assets', but semantically close and contextually acceptable. (3) The reasoning correctly synthesizes multi-hop information: it infers a strategic elevation from operational activity (well completions) to formal classification as a core growth pillar, which reflects sound logic and proper cross-year analysis. (4) The answer addresses both parts of the question: the evolution in strategic emphasis and the specific changes (project classification and capital allocation). The only minor shortcoming is the slightly imprecise labeling of the strategic category—'Advantaged Projects' vs. the exact term 'Advantaged Assets' used in the original—warranting a deduction of 1 point in qualitative accuracy. Overall, the answer is factually correct, complete, and contextually excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 392,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "\nThe weighted‑average interest rate on senior notes with maturities > 10 years was unchanged at **3.8 %** in both 2022 and 2023.  Their face‑value amount rose slightly, from **$52.8 billion** at the end of 2022 to **$53.4 billion** at the end of 2023.  (Pages 82 and 82 of the 2023 10‑K and the comparable 2022 table.)",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in key numeric values. According to the ground truth, the 2022 weighted-average interest rate was 3.67%, not 3.8% as stated in the LLM answer. While the 2023 rate is correctly reported as 3.8%, the claim that it was 'unchanged' is incorrect because it implies the 2022 rate was also 3.8%, when in fact it increased from 3.67% to 3.8%. Additionally, the face value for 2022 is incorrect: the LLM reports $52.8 billion, whereas the ground truth is $54.536 billion. The 2023 face value ($53.4 billion) is correct. The direction of change in face value is also wrong: the LLM claims it 'rose slightly', but in reality it decreased from $54.536B to $53.4B. (2) Quantitative accuracy is low due to incorrect numbers for both the 2022 interest rate and 2022 face value, as well as the erroneous comparison of change in face value. The 2023 values are accurate. (3) The reasoning is partially sound in that it attempts to compare year-over-year changes, but the multi-hop synthesis fails because it uses incorrect source data. The conclusion about stability in interest rates is misleading due to the incorrect 2022 rate. (4) Contextual relevance is high—the answer addresses the right metric, time frame, and debt category, and cites appropriate document locations. However, factual inaccuracies severely undermine correctness. Minor formatting variations (e.g., $53.4 billion vs $53.4B) are acceptable, but core numbers must match. Overall, the answer is partially correct but contains critical quantitative errors that change the interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 434,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "\nThe 2023 fair‑value tables show Alabama Power’s domestic equity split between $396 million classified as Level 2 and $169 million as Level 3, while Georgia Power’s domestic equity was $255 million Level 2 with only $1 million Level 3. In 2024 the private‑market equity in Alabama Power’s nuclear decommissioning trust increased to $190 million (up from $178 million) and is now valued via the NAV practical expedient, which the company classifies as a Level 2 input, so the holdings are reported primarily as Level 2 (with only minimal Level 1 components), whereas Georgia Power’s domestic equity remains classified as Level 2 with a stable allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both numbers and classifications. It incorrectly states that Alabama Power's 2023 domestic equity investments were $396 million in Level 2 and $169 million in Level 3, when the ground truth reports $396 million in Level 1 and $169 million in Level 2 (no Level 3 mentioned). Similarly, it misclassifies Georgia Power’s 2023 holdings as Level 2 and Level 3, while the truth is Level 1 and Level 2. In 2024, the LLM claims Alabama Power’s private-market equity increased and is now valued via NAV as Level 2, but the truth shows a rise in Level 1 to $443 million and Level 2 to $208 million — indicating increased transparency, not a shift to Level 2 via NAV. The LLM also introduces 'private-market equity' and 'NAV practical expedient' not mentioned in the original answer, which distorts the actual trend toward more Level 1 (not Level 2) investments. (2) All key numbers are wrong: Alabama Power’s 2023 Level 1 is reported as Level 2, Level 2 as Level 3; 2024 figures are entirely fabricated (e.g., $190 million private equity). Georgia Power’s Level 1 increase to $321 million in 2024 is completely omitted. (3) The multi-hop reasoning fails: instead of synthesizing the shift toward higher domestic equity allocations via more liquid (Level 1) instruments, the LLM incorrectly infers a move toward Level 2 via NAV, which contradicts the ground truth. It fails to compare both companies across both years correctly. (4) The contextual relevance is moderate because it addresses nuclear decommissioning trusts and valuation levels, but the qualitative and quantitative inaccuracies severely undermine correctness. The answer misrepresents the direction of the shift (toward Level 2 instead of Level 1), making the conclusion invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 489,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "\nFrom 2022 to 2023 NVIDIA moved CUDA from a core accelerator inside its GPU‑centric platform to the central, unifying layer of a full‑stack computing architecture that now spans silicon (GPU, DPU and the 2024 Grace CPU), system software, enterprise AI suites (e.g., NVIDIA AI Enterprise), and cloud services such as DGX Cloud.  This evolution ties CUDA to a common programmable foundation that delivers end‑to‑end solutions across the data‑center, gaming, professional‑visualization and automotive end markets, leveraging a shared developer ecosystem and software stacks to integrate those markets around a single CUDA‑based platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of CUDA's strategic positioning from 2022 to 2023. It accurately conveys that CUDA evolved from a core accelerator in a GPU-centric platform to the central, unifying layer of a full-stack computing architecture, which aligns with the ground truth's description of CUDA becoming the foundational programming model across a broader software stack. The mention of integration across data center, gaming, professional visualization, and automotive markets matches the original answer. It also correctly emphasizes the unification of hardware (GPU, DPU, Grace CPU), software (NVIDIA AI Enterprise), and cloud services (DGX Cloud) under a CUDA-based platform, reflecting vertical integration. However, the LLM answer introduces the '2024 Grace CPU'—a detail not present in the ground truth and potentially anachronistic for a 2022–2023 analysis—which slightly undermines entity accuracy. Additionally, while the ground truth explicitly highlights CUDA’s expansion into domain-specific verticals like healthcare, telecom, and manufacturing and its role supporting hundreds of domain-specific libraries and SDKs, the LLM answer implies this through 'enterprise AI suites' and 'full-stack' but does not explicitly mention the proliferation of software layers or specific new verticals. This results in a minor omission in completeness. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound, showing multi-hop synthesis across time, platform layers, and markets. The answer is highly contextually relevant. Thus, the correctness score is 8 due to strong factual alignment with minor gaps in specificity and one minor forward-looking detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 471,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "\nFrom 2022 to 2023 Pfizer’s post‑spin‑off transitional service and manufacturing agreements with Viatris were largely wound down.  Net amounts payable to Viatris under those agreements fell from **$94 million as of December 31 2022** to **$33 million as of December 31 2023**, reflecting the completion of the interim TSAs and supply arrangements by the end of 2023.  (See Notes to Consolidated Financial Statements on pages 72 and 74 of the 2023 Form 10‑K.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the net amounts owed to Viatris decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023, which matches the original answer exactly. (2) The quantitative accuracy is perfect—both dollar amounts and dates are correct, and the implied reduction of $61 million is consistent with the data. (3) The qualitative reasoning is sound: the answer correctly identifies that transitional service agreements (TSAs) and related arrangements were largely completed by the end of 2022 and fully completed by the end of 2023, aligning with the multi-hop synthesis required across years and contractual terms. (4) The context is fully preserved—Pfizer’s evolving financial obligations post-spin-off are clearly explained, with accurate reference to the nature of the agreements (TSAs, manufacturing, supply) and their winding down. The citation to the 2023 Form 10-K (pages 72 and 74) adds appropriate sourcing. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 313,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "\nFrom 2022 to 2023 the filing shows that retail‑deregulation risk remained a “significant adverse impact” on earnings, but the discussion of environmental compliance costs grew more explicit about how those costs are tied to rate‑recovery mechanisms. In 2022 the 10‑K warned that deregulation could create stranded‑cost exposure while also noting that CCR‑related expenditures would be pursued for full recovery through regulated rates; by 2023 the company stresses that new EPA interpretations of the CCR rule and tighter state climate mandates are raising compliance outlays, and that any delay or denial of cost recovery—whether because of deregulation‑driven market changes or regulatory setbacks—could magnify the financial strain of those environmental obligations. Thus, the link between deregulation pressures and environmental‑regulation costs has tightened: the prospect of reduced rate‑recovery opportunities now directly amplifies the fiscal impact of Duke Energy’s environmental compliance spending.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the persistence of retail deregulation as a risk, its impact on cost recovery, and the increasing environmental compliance costs due to EPA and state-level regulations are all consistent with the original answer. The mention of CCR (Coal Combustion Residuals) rule developments and state climate mandates in 2023 adds specificity that is factually sound and contextually appropriate. (2) There are no numeric values in the question or answers that require verification—both responses are qualitative and descriptive, so quantitative accuracy is not compromised. Format and terminology (e.g., 'stranded-cost exposure', 'rate-recovery mechanisms') are used appropriately. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes how deregulation limits cost recovery and how rising environmental obligations (from federal and state regulations) compound financial risk when recovery is uncertain. It accurately traces the evolution from 2022 (concern about unrecovered costs) to 2023 (increased compliance costs and tighter regulatory scrutiny). (4) The only minor gap is that the LLM answer does not explicitly mention PURPA or qualifying facilities (QFs), which are part of the original 2022 risk explanation. While the concept of 'stranded costs' and 'above-market purchased power' is implied, the absence of PURPA slightly reduces completeness in entity coverage. However, the core reasoning and synthesis remain intact. Overall, the answer is semantically equivalent and contextually excellent, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 451,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "\nThe retail share of Skoal fell from **9.5 % in 2023 to 7.6 % in 2024** (a drop of roughly 1.9 percentage points). This decline happened even though Altria/USSTC raised Skoal’s list price several times during 2023—​including $0.09‑$0.10 per‑can increases in January, April, July and August — so the brand’s share eroded despite a higher pricing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the 2024 retail share (7.6%) and the general trend of decline, but reports the 2023 retail share as 9.5% instead of the correct 9.3%, which is a factual inaccuracy. The drop is stated as roughly 1.9 percentage points, which would be consistent with a decline from 9.5% to 7.6%, but the actual drop from 9.3% to 7.6% is 1.7 points, so the calculation based on incorrect input is misleading. Regarding pricing, the LLM claims price increases occurred in January, April, July, and August of 2023 in the range of $0.09–$0.10 per can, but the ground truth specifies a $0.11 increase effective January 23, 2024 (announced in 2023), and notes prior increases in 2022 (not 2023). Thus, the LLM incorrectly attributes multiple 2023 price increases that are not supported by the source, and misrepresents the timing and amounts. 2) Quantitative accuracy is low due to the incorrect 2023 share value and fabricated price increase dates/amounts in 2023. The $0.11 increase was announced in 2023 but effective in 2024, which the LLM conflates. 3) The qualitative reasoning is partially sound—linking price increases to declining retail share is consistent with the original answer’s implication—but the multi-hop synthesis is flawed because the pricing data comes from incorrect time periods and lacks mention of the cumulative effect from earlier (2022) increases. 4) Contextual relevance is high as the answer addresses both parts of the question: change in retail share and contrast with pricing strategy. However, due to significant numerical and factual errors in key data points, the overall correctness is reduced to a 6, indicating partial correctness with major flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 461,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "\nBetween 2023 and 2024 the amortized cost of Amgen’s “Other short‑term interest‑bearing securities” slipped only slightly—from **$138 million** (2023) to **$135 million** (2024)—while the securities continued to be carried at essentially their fair value (no unrealized gains or losses).  The modest decline occurs even as the overall pool of available‑for‑sale investments grew, driven largely by higher money‑market fund holdings, indicating that Amgen is reallocating a small portion of its ultra‑short‑term cash from these securities into highly liquid money‑market funds.  This reflects the company’s stated investment objective of preserving principal and maintaining prudent liquidity, favoring the safest, most liquid instruments and keeping its short‑term portfolio modest and low‑risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The original answer states that Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. However, the LLM claims it decreased from $138 million to $135 million, which contradicts the ground truth. This error undermines the entire response. (2) The numbers are not accurate: $135 million in 2024 is incorrect; it should be $138 million. Even though the format ($138 million) is acceptable, the value itself is wrong. There is no indication of a decline in the ground truth, so the reported 'slip' is false. (3) The reasoning is partially sound in that it attempts multi-hop synthesis—linking changes in investment categories to broader strategy, mentioning money-market funds and liquidity objectives. However, because the foundational data is incorrect, the conclusion about reallocation is unsupported. The model infers a strategic shift that isn't reflected in the actual data. (4) While the LLM addresses both parts of the question (evolution and strategic implication), and uses relevant context (liquidity, risk), the factual inaccuracy in the key metric severely limits correctness. The contextual relevance is moderate because the type of explanation is appropriate, but the conclusion is based on false premises. Thus, correctness and quantitative accuracy are low; qualitative reasoning is partially valid but built on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 413,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "\nFrom 2022 to 2024 the Abrams‑upgrade effort moved from a single $350 million Army contract that covered “engineering and logistics support services, and system and sustainment technical support” (GD 10‑K 2022, p. 44) to a broader, multi‑year package that now also funds the System‑Enhancement‑Package v3 (SEPv3) production for Romania and includes options that can lift the contract’s maximum potential value to roughly $1 billion (GD 10‑K 2024, p. 44).  Thus, while the base award amount stayed about $350 million, the scope expanded to include additional production and sustainment work and a larger potential value, reflecting a deeper, longer‑term involvement in the tank‑upgrade program.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 2022 contract was $350 million and covered 'engineering and logistics support services'—but the ground truth specifies a $360 million contract in 2022 for upgrades, mission control units, and technical support. The $350 million figure actually belongs to the 2024 upgrade contract, not 2022. Additionally, the LLM claims the 2022 contract is cited from 'GD 10-K 2022, p. 44', but this misattributes the content. (2) The LLM correctly identifies the $350 million 2024 contract for Abrams upgrades and support services, and mentions the $285 million Romania SEPv3 production contract, but fails to explicitly state the latter as a separate award, instead implying it's part of a 'multi-year package' with options pushing value to $1 billion—this synthesis is speculative and not supported in the ground truth. The total combined value of the two 2024 contracts is $635 million, not 'up to $1 billion' as stated, and no source confirms that figure. (3) The reasoning partially captures the evolution in scope—from upgrades to include production—but misrepresents the timeline and contractual structure. It misses the shift from a single 2022 upgrade contract to multiple 2024 contracts covering both upgrades and foreign production. The multi-hop synthesis is flawed due to incorrect year-to-value mapping and unsupported extrapolation of contract options. (4) Despite these issues, the answer is contextually relevant and captures the general trend of expanding scope and deeper involvement. The qualitative reasoning is somewhat sound but based on incorrect inputs. Quantitative accuracy is low due to wrong numbers and unsupported total value claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 478,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "\nFrom 2023 through mid‑2024 AIG’s stake in Corebridge was steadily reduced until the June 9 2024 de‑consolidation, after which it held only about 22 % of Corebridge’s common stock and its borrowing link was limited to contingent guarantees and collateral obligations on Corebridge’s roughly $9.4 bn of debt.  Thereafter AIG accounts for the remaining interest as an equity‑method investment, so income from Corebridge is recognized only as dividends and fair‑value‑related gains (including the $282 m gain on the December 2024 share sale) in net investment income, rather than in consolidated segment earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's financial relationship with Corebridge from 2023 to 2024, noting the shift from a consolidated borrowing arrangement to an equity-method investment post-June 9, 2024. It accurately identifies the deconsolidation date (June 9, 2024), which aligns with the ground truth's emphasis on income recognition starting from that date. However, the ground truth does not mention AIG reducing its stake gradually before deconsolidation or the $282M gain from a December 2024 share sale—details not present in the original answer and potentially speculative or extraneous. The 22% ownership and $9.4B debt figure are plausible but not confirmed in the ground truth, introducing unverified quantitative claims. (2) Quantitative accuracy is partially compromised: while June 9, 2024, is correctly cited, the $282M gain, 22%, and $9.4B debt figures are not in the original answer and cannot be verified against the provided truth. These may be factually correct in external context but are not supported by the ground truth, lowering confidence in strict factual alignment. (3) The multi-hop reasoning is strong—the model infers a shift in accounting treatment (from borrowing-based to equity-method income) and correctly links deconsolidation to changes in income recognition (dividends and fair value gains). This reflects sound synthesis across time and financial concepts. (4) Contextual relevance is excellent—the answer directly addresses borrowing arrangements and income recognition as required. Despite adding details beyond the original, the core transformation in the financial relationship is accurately portrayed, warranting a high correctness score with minor deductions for unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 481,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla moved the Solar Roof from a pilot‑scale, installation‑focused offering—sold directly and through channel partners and still being refined with real‑estate developers—to a core element of its vertically‑integrated energy strategy that now depends on large‑scale battery‑cell production and new factory capacity; by 2024 the company explicitly links Solar Roof volume to the development of its own lithium‑ion cells and to the reliable supply of raw materials such as lithium, nickel and cobalt, making the product’s rollout vulnerable to the same supply‑chain and raw‑material constraints that affect its vehicle and energy‑storage lines. This shift reflects a strategic dependency on in‑house cell manufacturing and global factory expansion, while production challenges have grown to include securing consistent component supplies and managing the complexities of ramping new manufacturing sites.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable in a traditional sense; however, since no numbers are misstated, it receives a 10. The answer addresses the evolution of Tesla's Solar Roof strategy and correctly identifies increased production challenges and strategic dependencies by 2024, maintaining contextual relevance. However, it introduces claims not supported by the ground truth: specifically, that the Solar Roof's rollout depends on 'lithium-ion cell production' and raw materials like 'lithium, nickel, and cobalt'—this is a significant factual overreach. The original answer states that Tesla's 2024 10-K highlights general production ramp challenges (bottlenecks, supplier risks, cost control), not a direct dependency on battery cell manufacturing or raw materials. This misrepresents the nature of the strategic dependency. Additionally, the claim that Solar Roof became a 'core element of its vertically-integrated energy strategy' by 2024 is speculative and not stated in the ground truth. The original answer reflects a shift in emphasis from sales and installation efficiency to production challenges, not an expansion into battery supply chain dependencies. Thus, while the answer captures a general trend of increasing production concerns, it fabricates specific multi-hop linkages (e.g., between Solar Roof and battery materials) that are not present in the source. This undermines the qualitative accuracy despite correct entity and year identification. The reasoning is partially sound but includes unsupported extrapolations, leading to a correctness score of 5 due to significant factual inaccuracies in synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 458,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "\nBetween 2023 and 2024 Skoal’s retail share fell from **9.3 % to 7.6 %** – a decline of roughly 1.7 percentage points (about an 18 % relative drop).  This loss of share, while the overall oral‑tobacco category grew, shows that Skoal is ceding ground to competitors such as Copenhagen and the on! nicotine‑pouch brand, indicating a weakening competitive position in the U.S. oral‑tobacco market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports Skoal's retail share in 2023 (9.3%) and 2024 (7.6%), matching the ground truth exactly. The calculated decline of 1.7 percentage points is accurate, and the relative drop of approximately 18% (1.7 / 9.3 ≈ 18.3%) is a reasonable interpretation. 2) All numeric values and calculations are correct. The percentage point difference and implied relative decline are mathematically sound. Format variations (e.g., spacing in '9.3 %') do not affect accuracy. 3) The LLM correctly identifies the key trend—Skoal losing market share—and infers a weakening competitive position, aligning with the ground truth. It appropriately contextualizes the decline by referencing competitor growth (Copenhagen and on!), even though specific on! figures (6.8% to 8.3%) are not repeated. Mentioning on! and Copenhagen as gaining at Skoal’s expense is consistent with the knowledge graph. 4) The answer is semantically equivalent to the original: it captures the core facts, corrects the trend, and draws the same conclusion about competitive positioning. The only minor omission is the exact comparative data for on!, but the qualitative point about competitors gaining is still valid and relevant. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 due to slight lack of full comparative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 375,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "\nThe 2024 filing sharpens the warning that premium‑tier device share is increasingly concentrated in a handful of OEMs—Apple, major Chinese manufacturers and a few other large customers—while also noting concrete developments that deepen the risk: Apple’s move to its own modem chips, the revocation of Huawei’s export licence in May 2024, and Chinese government‑driven “Made‑in‑China 2025” efforts that push OEMs to develop their own integrated circuits.  These trends give the few dominant customers greater purchasing power, forcing Qualcomm to face downward pricing pressure and making its revenue far more vulnerable to the purchase volumes and technology choices of those limited, high‑tier partners.  As a result, Qualcomm’s pricing power and revenue stability have weakened noticeably from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the persistence and intensification of the risk related to device share concentration among premium-tier OEMs from 2023 to 2024. The answer accurately reflects that this concentration impacts Qualcomm's pricing power and revenue stability due to the growing leverage of a few large customers. It adds specific, relevant developments not explicitly detailed in the original answer—such as Apple’s shift to in-house modem chips, the May 2024 Huawei export license revocation, and the 'Made-in-China 2025' initiative—which are contextually plausible and enhance the explanation without contradicting the source. These additions are consistent with known industry trends and do not introduce factual errors; they strengthen the qualitative reasoning. There are no numerical figures in the question or answers, so quantitative accuracy is scored as 10 by default. The only reason for not scoring a perfect 10 in correctness and qualitative accuracy is that the original answer does not mention the Huawei license revocation date or Apple’s modem timeline with such specificity—these details, while reasonable, go slightly beyond the provided ground truth and could be seen as speculative if not directly cited. However, since they support the same conclusion and are industry-known trends, the deviation is minor. The answer fully addresses the evolution of risk, its impact on pricing power, and revenue stability—meeting all aspects of the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 424,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "\nAmgen’s short‑term liquidity was anchored in money‑market mutual funds that grew from **≈ $2.66 billion (amortized cost) in 2023** to **≈ $10.35 billion (amortized cost) in 2024**—a more than four‑fold increase that now makes up the bulk of its cash and cash‑equivalents. This shift reflects a deliberate move to hold a larger share of low‑risk, highly liquid assets to preserve liquidity while maintaining a conservative investment stance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims Amgen's allocation to money market mutual funds increased from approximately $2.66 billion in 2023 to $10.35 billion in 2024, which directly contradicts the ground truth stating the amount was unchanged at $10,266 million (i.e., $10.266 billion) in both years. This represents a severe factual error, including both the base value in 2023 and the alleged growth. (2) The calculation of a 'more than four-fold increase' is therefore also incorrect, as there was no increase at all. (3) Qualitatively, the reasoning fails: the model invents a strategic shift that did not occur, asserting a 'deliberate move' to increase low-risk holdings, while the ground truth indicates stability in this allocation. The entity identification (Amgen, money market mutual funds, years 2023–2024) and context of short-term liquidity management are correct, which supports a moderate contextual relevance score. However, the core factual claim about the evolution of the allocation is entirely wrong, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 321,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "\nGeneral Dynamics’ pledged U.S. government accounts receivable under the Capital Construction Fund rose from **$295 million at the end of 2022** to **$315 million in 2023** and further to **$333 million by the end of 2024**.  This reflects a modest but consistent increase of roughly $18‑$38 million over the two‑year period, underscoring growing participation in the program.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in date labeling that affects quantitative precision. The original answer states that the $295 million was pledged as of December 31, 2021 (reported in the 2022 filing), not 'at the end of 2022' as the LLM claims. The LLM incorrectly associates the $295M figure with year-end 2022, when it actually reflects year-end 2021 data disclosed in the 2022 report. However, the $315M (as of Dec 31, 2023) and $333M (as of Dec 31, 2024) figures are correctly stated and timed. The trend description — a steady increase in participation — is accurate and well-reasoned. The calculation of increases (~$18–$38M) is roughly correct: $315M - $295M = $20M increase from 2021 to 2023, and $333M - $315M = $18M from 2023 to 2024. The multi-hop reasoning across years is sound, and the conclusion about growing utilization aligns with the ground truth. Entity identification (General Dynamics, Capital Construction Fund, U.S. government accounts receivable) is accurate. The answer is contextually relevant and conveys the core trend correctly, but the misattribution of the first data point's timing prevents a top score on quantitative and correctness metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 338,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s ownership of Corebridge fell from just over 80 % (post‑IPO) to 48.4 % on June 9 2024, triggering the de‑consolidation of Corebridge for U.S. federal tax purposes; thereafter AIG’s stake was further reduced to about 22.7 % by the end of 2024 after secondary sales.  The de‑consolidation moved Corebridge’s tax attributes—such as its net‑operating‑loss and credit‑carryforwards—into Corebridge’s own tax filing group, so AIG no longer includes those attributes in its consolidated tax return and must assess the realizability of any remaining deferred‑tax assets separately.  As a result, AIG’s financial income from Corebridge shifted from consolidated net‑investment income to equity‑method income (dividends plus changes in the market‑value‑based equity interest), and the 2024 de‑consolidation produced a $4.8 bn pre‑tax loss (primarily from an AOCI reclassification) that was recorded in discontinued operations, with an after‑tax loss of $4.754 bn after tax expense and the related tax adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of AIG's financial relationship with Corebridge and correctly identifies key qualitative aspects: tax deconsolidation due to ownership falling below 80%, shift to equity method accounting, movement of tax attributes (NOLs and credits) to Corebridge, and change in income recognition. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the original answer states that ownership dropped below 80% after the September 19, 2022 IPO, not in 2023—this misaligns the timeline. The LLM claims ownership fell to 48.4% on June 9, 2024, and then to 22.7% by end of 2024, but these specific percentages and dates are not supported in the ground truth, which only notes deconsolidation occurred and that equity income was recognized from June 10, 2024. The $4.8 billion pre-tax loss and $4.754 billion after-tax loss from deconsolidation are not mentioned in the original answer and appear to be fabricated or misattributed. Additionally, the original answer states AIG recognized $X (placeholder) in equity method income from June 10 to December 31, 2024, but the LLM invents specific loss figures and attributes them to AOCI reclassification and discontinued operations—details absent in the ground truth. While the reasoning framework is sound—understanding deconsolidation triggers, tax consequences, and accounting shifts—the inclusion of unsupported numbers and events (especially the large losses) constitutes major factual errors. The contextual relevance is high as all aspects of the question (tax implications, investment income, IPO, deconsolidation) are addressed, and the qualitative logic of the transition is well-articulated. However, the quantitative inaccuracies, particularly the invented dollar amounts and precise ownership percentages, reduce the correctness score to 6—partially correct but with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 517,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "\nFrom 2022 to 2024 Tesla shifted Solar Roof from a pilot‑scale, installation‑focused model—training new installers, partnering with developers to shorten install time and relying on external battery‑cell suppliers—to a more vertically integrated and supply‑chain‑resilient strategy.  It now stresses building its own cell production, diversifying and securing battery‑cell and raw‑material sources, expanding internal training and apprenticeship programs, and tightening inventory controls, while still contending with global component constraints, raw‑material price volatility and the risk of production delays.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in direction and captures the high-level evolution in Tesla's Solar Roof strategy from 2022 to 2024, with accurate emphasis on shifting focus from installation scalability to broader supply chain and production resilience. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages, headcount) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. Contextual relevance is high (9) because the response directly addresses the question’s focus on operational strategy and supply chain evolution. However, the qualitative accuracy is 7 due to some overreach in the LLM answer: while the original answer mentions Tesla’s 2022 focus on installer training, real estate partnerships, and battery cell supply, it does not state that Tesla was relying on external battery-cell suppliers or that it planned to build its own cell production—this vertical integration claim is an inference not supported in the ground truth. Similarly, the LLM mentions 'diversifying and securing raw-material sources' and 'tightening inventory controls,' which are plausible but not explicitly stated in the original. The core shift—from localized installation challenges to systemic supply chain risks—is correctly identified, supporting a correctness score of 7. The answer adds details beyond the source, slightly distorting the factual basis, but maintains the essential reasoning trajectory across years and strategic domains.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 411,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "\nDuke Energy’s cost estimate for permanently closing all of its North Carolina and South Carolina coal‑ash basins fell from **about $8 billion–$9 billion** in the 2022 filing (≈ $3.1 billion already spent through 2021) to **roughly $7 billion–$8 billion** in the 2023 filing, with **≈ $4 billion spent through 2023**【page_73】【page_68】.  The downward revision and the increase in expenditures indicate that the company is advancing its Coal Ash Act obligations—substantial excavation and closure work has been completed, and the remaining spend is now lower and spread over the next 10‑20 years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 2022 cost estimate of $8 billion–$9 billion, the 2023 revised estimate of $7 billion–$8 billion, the $3.1 billion spent through 2021 (as reported in 2022), and the $4 billion spent through 2023 are all correctly reported. Minor formatting variations (e.g., ≈, about, roughly) are acceptable and do not affect factual accuracy. (2) The answer is complete, addressing both the evolution of cost estimates and what it indicates about progress under the Coal Ash Act. (3) Entities—Duke Energy, North Carolina and South Carolina coal ash basins, the Coal Ash Act—are correctly identified and contextualized. (4) The reasoning is sound: the downward cost revision combined with increased expenditures logically indicates progress in basin closures, with more work completed and remaining costs better defined. The multi-hop synthesis across years and financial figures is accurate and well-articulated. The inclusion of timeframes (next 10–20 years) adds context without contradicting the original. Overall, the answer is factually precise, semantically equivalent, and demonstrates strong multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 344,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "\nBetween 2023 and 2024 the retail share of **on!** grew from **6.8 % to 8.3 %** of the oral‑tobacco market – an increase of roughly 1.5 percentage points.  This rise occurred while the **overall oral‑tobacco segment’s share fell from 42.5 % to 37.5 %**, showing that on! is gaining ground in a contracting market and is becoming a more prominent growth driver within the segment, even though it still accounts for only a modest portion of total oral‑tobacco sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the retail share of 'on!' increased from 6.8% in 2023 to 8.3% in 2024, and the overall oral tobacco segment's retail share declined from 42.5% to 37.5%, as stated in the original answer. The implied 1.5 percentage point increase is correctly represented. (2) The answer is complete, addressing both the evolution of 'on!'s retail share and its market position relative to the broader segment. (3) Entities are correctly identified: the product 'on!', the time frame (2023–2024), and the relevant market segment (oral tobacco) are all accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly infers that 'on!' is gaining market share during a period of overall segment contraction, indicating relative strength and an improving market position. The conclusion that 'on!' is becoming a more prominent growth driver aligns semantically with the original answer’s interpretation. Minor wording differences (e.g., 'contracting market' vs. 'decline in retail share') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 337,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 Qualcomm’s exposure to Chinese OEMs stayed high but grew more precarious: the 2024 filing stresses that a “significant portion” of its revenue still comes from a handful of Chinese device makers, and recent U.S. export‑license revocations (e.g., the $560 million of product sales to Huawei that ended in May 2024) together with China’s “Made‑in‑China 2025” push have already forced at least one major OEM to source its own chips or switch to competitors.  This heightened concentration—and the broader U.S./China trade and security tensions that can restrict sales or payments—means that any slowdown or displacement of these Chinese customers could sharply cut Qualcomm’s cash flow and jeopardize its growth outlook, undermining overall business stability.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Qualcomm's reliance on Chinese OEMs remained significant from 2023 to 2024, aligning with the ground truth. However, it introduces specific details not present in the original answer or potentially unsupported by the source filings: the $560 million in sales to Huawei ending in May 2024 and the claim that a major OEM is switching to in-house chips or competitors due to 'Made-in-China 2025' are not mentioned in the ground truth and may represent overreach or inference beyond the provided data. (2) The $560 million figure and May 2024 date are specific quantitative claims absent from the original answer; there is no verification in the ground truth that these numbers are accurate, so they cannot be considered correct. This significantly impacts quantitative accuracy. (3) The multi-hop reasoning is partially sound—Qualcomm’s continued dependency and exposure to geopolitical risks are correctly synthesized from the two years’ filings. However, the LLM adds causal links (e.g., export-license revocations directly causing OEMs to switch) and specific events (Huawei sales cutoff) that go beyond the original answer’s more cautious, descriptive tone. The core implication about business stability being at risk due to U.S./China tensions is consistent and well-reasoned. (4) Correctness score is 5 due to partially correct facts but significant addition of unverified specifics; quantitative accuracy is low (3) due to unsupported dollar amounts and dates; qualitative accuracy is moderate (6) as the reasoning framework is logical but overreaches; contextual relevance is high (8) because the answer addresses the evolution and implications as asked, despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 473,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "\nBetween 2022 and 2023 Amgen shifted its available‑for‑sale portfolio away from Treasury‑bill holdings and toward cash‑equivalent money‑market funds.  In 2022 the AFS book was about $4.3 bn, comprised mainly of U.S. Treasury bills ($1.7 bn) and money‑market funds ($2.7 bn) with only a trivial amount of other short‑term securities.  By the end of 2023 Treasury holdings had fallen to near $0, money‑market funds rose sharply to roughly $10.3 bn, and a modest position in other short‑term interest‑bearing securities ($≈$0.1 bn) appeared, pushing total AFS investments up to about $10.4 bn.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the composition of Amgen's 2022 available-for-sale investments. According to the ground truth, in 2022, Amgen held $1,676 million in marketable securities and $2,659 million in cash and cash equivalents (totaling $4,335 million). However, the LLM incorrectly states that the 2022 portfolio consisted of $1.7 billion in U.S. Treasury bills and $2.7 billion in money market funds, which misrepresents both the security types and their values. In reality, money market funds were not a reported component in 2022, and U.S. Treasury bills were not separately disclosed as a category. (2) The 2023 figures are closer but still inaccurate: the LLM reports ~$10.3 billion in money market funds and ~$0.1 billion in other securities, while the ground truth specifies $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities (summing to $10,404 million). The LLM’s rounding is acceptable, but the attribution of 2022 holdings is fundamentally wrong. (3) The multi-hop reasoning is partially sound in identifying a shift toward more liquid instruments and the elimination of marketable securities/Treasury bills by 2023, which aligns with the strategic shift described in the original answer. However, because the baseline (2022) composition is incorrect, the comparative analysis is flawed. (4) The contextual relevance is high as the answer addresses the evolution of investment composition and identifies the key trend. However, due to major quantitative and qualitative errors in the 2022 breakdown—specifically misattributing security types and amounts—the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the direction of change is correctly interpreted, but entity and metric assignments are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 508,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "\nIn 2022 the only premium‑outlet listing for Shake Shack in the SPG filings appears at the Las Vegas Outlets (page 34 of the 2022 10‑K). By 2023 the brand is also listed as a tenant at Woodbury Common Premium Outlets (page 36 of the 2023 10‑K), indicating that SPG added Shake Shack to an additional premium‑outlet property, expanding its presence across the portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that in 2022, Shake Shack was at Las Vegas Outlets, when the ground truth confirms it was only at Woodbury Common Premium Outlets in New York. (2) It then claims that by 2023, Shake Shack was added to Woodbury Common, which contradicts the truth: Shake Shack was already there in 2022 and expanded to Las Vegas Outlets North Premium in 2023. (3) The LLM reverses the actual expansion path—Shake Shack was not at any Las Vegas outlet in 2022 according to SPG filings, but was present at Woodbury Common; in 2023, it expanded to Las Vegas, not the other way around. (4) The reasoning is therefore flawed in both direction and entity placement, failing the multi-hop synthesis of tenant presence across years and properties. While the general idea of 'expansion' is correct, the specific locations and timeline are inverted, making the answer factually wrong. (5) Quantitative accuracy is low because the years and locations are mismatched. (6) Contextual relevance is moderate since the answer addresses the right topic (Shake Shack's presence in SPG outlets over time) and references correct document sources (10-K pages), but draws incorrect conclusions from them. Overall, the answer fails on core factual accuracy despite plausible structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 374,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "\nBetween 2022 and 2024 the retirement‑annuity contracts remained classified as **Level 3** in the fair‑value hierarchy—i.e., they continued to be valued with significant unobservable inputs (internal discount‑rate and actuarial assumptions) rather than quoted market prices.  The disclosed fair‑value declined from about **$38 million (2022)** to **$22 million (2024)**, but the hierarchy level did not change, indicating that GD’s valuation methodology for these assets stays rooted in proprietary, internally‑derived models rather than market‑observable pricing.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that retirement annuity contracts remained in Level 3 from 2022 to 2024, which aligns with the ground truth. However, it introduces specific dollar amounts—$38 million in 2022 and $22 million in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. These figures are likely fabricated or misattributed, severely undermining quantitative accuracy. (2) There are no calculations in the original answer, so the LLM’s inclusion of a decline in value is an unsupported addition. The ground truth emphasizes a change in disclosure practices around NAV as a practical expedient, which the LLM completely omits. This is a significant omission affecting completeness and correctness. (3) The multi-hop reasoning is partially sound—the model correctly infers that remaining in Level 3 implies continued use of unobservable inputs and internal models. However, it fails to recognize the key evolution in disclosure transparency related to NAV, which is central to the original answer’s conclusion about improved reporting practices. This missing link breaks the full synthesis required. (4) Despite the factual error in numbers and omission of the NAV disclosure refinement, the LLM captures the core idea that the valuation methodology remained largely unchanged and reliant on internal assumptions. Wording and conceptual framing are relevant and mostly accurate, hence high contextual relevance. The qualitative accuracy is moderate because the reasoning is logical but based on incomplete evidence. The correctness score is reduced primarily due to hallucinated financial figures and failure to report the key disclosure change involving NAV.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 471,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s ownership in Corebridge fell dramatically—from roughly 52 % at the end of 2023 to about 22.7 % by the end of 2024—through a series of secondary offerings and sales (including the June 9 2024 de‑consolidation and the later $3.8 bn sale of 120 million shares to Nippon), which created potential equity dilution for AIG’s remaining stake.  As a result of the de‑consolidation AIG recorded a $4.8 bn loss (largely from re‑classifying accumulated other‑comprehensive loss) and then began accounting for its retained interest as an equity‑method investment, so that dividends received and the fair‑value changes of the Corebridge shares are now recognized in net investment income rather than consolidated earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right themes (equity dilution, income recognition, deconsolidation). (1) Quantitative inaccuracies: The claim that AIG owned 52% of Corebridge at the end of 2023 and 22.7% at the end of 2024 is not supported by the ground truth, which does not specify ownership percentages. The $3.8 billion sale of 120 million shares to Nippon is not mentioned in the original answer and appears fabricated. The $4.8 billion loss is also not in the ground truth and conflicts with the actual narrative. (2) The IPO date is incorrectly implied to have occurred after 2023; the ground truth states the IPO was on September 19, 2022, which terminated the exchange right with Blackstone—this key timeline is misrepresented. (3) The LLM incorrectly suggests that secondary offerings in 2023–2024 created potential equity dilution for AIG; in fact, the dilution mechanism (Blackstone’s exchange right) was terminated due to the 2022 IPO, so no such risk existed in 2023–2024. (4) While the LLM correctly identifies the shift to equity method accounting and income recognition via dividends and fair value changes starting June 9, 2024, it conflates fair value changes with equity method accounting—under equity method, income is based on share of earnings, not fair value changes. The original answer correctly states that income recognition is based on dividends and stock price changes, but this reflects a fair value approach, not equity method, indicating some conceptual confusion in both answers. However, the core idea of a shift from consolidation to a post-divestiture income model is directionally correct. (5) The mention of June 9, 2024, as the start date for new accounting aligns with the ground truth and is accurate. Overall, while the answer captures the high-level transition, it introduces false numbers, misrepresents the timeline, and misstates key mechanisms, leading to a low correctness score despite relevant context and partial qualitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 552,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "\nFrom the 2022 10‑K (page 71) Comcast reported roughly **$3.6 billion** of debt at Universal Beijing Resort, and by the 2024 filing (page 86) that figure had fallen to **about $3.4 billion**, reflecting modest repayments on the resort’s term‑loan.  The resort is treated as a variable‑interest entity that Comcast consolidates, so the debt now appears on Comcast’s balance sheet, but the exposure is non‑recourse—Comcast’s maximum loss is limited to its 30 % equity stake and a remaining unfunded capital commitment of roughly **$1.4 billion**.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but has significant factual inaccuracies. It correctly identifies that Universal Beijing Resort had $3.6 billion in debt as of 2021 (disclosed in 2022 filing) and $3.4 billion as of 2024 (disclosed in 2024 filing), which aligns with the ground truth. However, it omits the $3.5 billion debt figure for 2023 and incorrectly implies a steady decline from $3.6B to $3.4B, when the debt actually increased from $3.5B to $3.6B before decreasing. More critically, the LLM introduces a non-recourse exposure framework with a 'maximum loss' tied to a 30% equity stake and $1.4 billion unfunded commitment—this is not supported by the original answer and contradicts the consolidation treatment described. The original answer states that Comcast fully consolidates the VIE with $7.3B in assets and $7.0B in liabilities included in its balance sheet as of 2024, indicating full on-balance-sheet exposure, not limited liability. (2) Quantitative accuracy is compromised: while two debt figures are correct, the omission of the 2023 value and the incorrect characterization of financial exposure (e.g., $1.4B unfunded commitment not in ground truth) reduce precision. The consolidation amounts ($7.3B assets, $7.0B liabilities) are entirely missing. (3) Multi-hop reasoning is partially sound—the model connects disclosures across years and identifies VIE consolidation—but fails to synthesize the full scope of consolidation and misrepresents the nature of financial exposure. (4) Contextual relevance is high as the answer addresses debt trends and consolidation, but the incorrect qualitative framing of non-recourse exposure and missing consolidated balance sheet figures significantly reduce factual correctness. Hence, correctness is scored at 5 due to partial accuracy with major omissions and one key factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 508,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "\nThe trade‑in rights that accompany new‑aircraft orders continue to be offered only to a limited set of Gulfstream customers who have options in their purchase contracts; they can be structured either as an option to sell the aircraft at its then‑fair‑market value (determined within roughly 45 days of delivery and requiring the customer to exercise or let it expire) or as a guarantee of a pre‑established trade‑in price.  In the 2023 filing the company notes that the estimated deviation of the guaranteed price from fair market value was immaterial, indicating that the exposure to adverse market movements has been characterized as negligible, whereas earlier disclosures did not highlight such a quantitative assessment.  Consequently, customer eligibility has not changed materially, but the perceived risk associated with the guaranteed‑price commitments is now described as immaterial.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key qualitative aspects, particularly regarding customer eligibility and the evolution of risk framing between 2022 and 2023. (1) On correctness: The ground truth states that in 2022, trade-in options were available to 'some customers' broadly, while in 2023 they were narrowed to 'some Gulfstream customers'—indicating a restriction in eligibility. However, the LLM claims eligibility 'has not changed materially,' which contradicts the original answer’s assertion of a narrowing in scope. This is a major factual discrepancy. (2) Quantitative accuracy is relatively strong: the LLM correctly notes that the deviation from fair market value was 'immaterial' in 2023, aligning with the ground truth that the estimated change in fair market values was 'not material' in both years. The mention of immaterial exposure is consistent, though the LLM incorrectly implies this quantitative assessment was absent in earlier years ('earlier disclosures did not highlight such a quantitative assessment'), while the ground truth does not support this claim. (3) Multi-hop reasoning is partially sound—the model connects trade-in structures to risk exposure and attempts to compare across years—but fails to accurately represent the shift in customer eligibility, a core part of the question. It also introduces details not in the original (e.g., 45-day valuation window, two types of trade-in structures) that, while plausible, are not supported by the ground truth and may reflect hallucination. (4) Contextual relevance is high, as the response addresses both customer eligibility and risk exposure as asked, but the synthesis is flawed due to incorrect interpretation of changes over time. Overall, the answer gets credit for correct risk characterization in 2023 but is penalized for misrepresenting the change in customer eligibility and overstating differences in disclosure practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 531,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla moved the Semi from a announced commercial‑vehicle concept to a modest pilot‑production effort that remains confined to its Nevada factory; the 2024 filing shows the Semi still listed under “Pilot production” alongside the still‑in‑development Cybercab and Roadster, with no indication of volume‑scale manufacturing.  Strategically, the Semi is now positioned as one of several next‑generation commercial‑vehicle offerings (alongside Cybertruck and future models on the next‑generation platform) that support Tesla’s broader goal of expanding into fleet and commercial markets while the company continues to prioritize profitable growth, cost‑reduction, and the rollout of full‑self‑driving and battery‑cell technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that in 2022, the Tesla Semi was an announced concept, and by 2024 it had entered 'pilot production' at the Nevada facility—matching the original answer's key claim. (2) There are no numeric values requiring verification (e.g., dates like 2022 and 2024 are correct and consistent), and no calculations are involved, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes information about production status evolution and strategic positioning across time, correctly identifying that pilot production indicates progress toward commercialization without implying full-scale rollout. It adds contextual detail—positioning the Semi alongside Cybercab and Roadster in pilot production, and linking it to Tesla’s broader commercial fleet strategy—which is consistent with and expands upon the ground truth without introducing inaccuracies. (4) The answer is fully relevant, addressing both production status and strategic positioning as required. The only minor point preventing a perfect 10 is the slight expansion on strategic context (e.g., mentioning Cybertruck and next-gen platform) that, while plausible and coherent, goes slightly beyond the specific scope of the original answer’s more concise strategic interpretation. However, this does not constitute an error, so a score of 9 is justified for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 405,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "\nThe valuation allowance tied to Altria’s Cronos investment rose from about **$379 million at the end of 2022 to $397 million in 2023 and to roughly $402 million by the end of 2024**. This modest increase shows that Altria continues to view the deferred tax assets associated with its Cronos stake as uncertain of realization and therefore maintains a full valuation allowance against them.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the valuation allowance amounts for 2022 ($379 million) and 2024 (~$402 million), matching the ground truth. It also includes an intermediate 2023 figure ($397 million), which is plausible and consistent with the upward trend, though not present in the original answer. This addition does not contradict the ground truth and enhances completeness. The minor discrepancy is the use of 'about' and 'roughly' for 2024, but $402 million is exact in both answers.\n\n2) Quantitatively, all provided numbers align with the ground truth: $379M in 2022 and $402M in 2024 are exact matches. The inclusion of $397M in 2023 is not contradicted by the original answer and reflects a reasonable inference of progression. No calculation errors are present.\n\n3) The reasoning is sound: the LLM correctly infers that the increasing allowance reflects ongoing uncertainty about the realizability of deferred tax assets. It accurately states that Altria maintains a full valuation allowance, which aligns with the original answer’s interpretation of 'significant uncertainty' and lack of expectation for reversal in the foreseeable future.\n\n4) The answer is semantically equivalent and contextually complete. It addresses both parts of the question: the evolution of the allowance and its implication. The wording differs slightly (e.g., 'modest increase' vs. 'steady increase'), but the meaning is consistent. The LLM provides slightly more granular data (2023 value), which improves rather than detracts from accuracy. Only a minor deduction is made due to the use of approximating language ('about', 'roughly') for figures that are known precisely in the ground truth, though the values themselves are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 470,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "\nBetween 2023 and 2024 Amgen’s accounting for its BeiGene stake shifted from the equity‑method to fair‑value measurement, so that changes in the investment’s fair value moved from “Other income (expense), net” into earnings. In 2023 the fair‑value adjustment generated recognized gains that boosted other‑income and overall profit, while in 2024 the same fair‑value approach produced net unrealized losses on the BeiGene (and other strategic equity) holdings, turning that line item negative and reducing net income; the shift also altered the composition of earnings that drove the lower effective tax rate reported for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key accounting change in 2023: Amgen's shift from the equity method to fair-value measurement for its BeiGene investment, resulting in gains recognized in 2023. In 2024, it accurately notes the transition to net unrealized losses within 'Other income (expense), net,' reflecting a reversal in financial impact. (2) There are no explicit numerical values (e.g., dollar amounts or percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2023 and 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change in accounting method and its cascading effects on income recognition, earnings, and even correctly infers a secondary impact on the effective tax rate due to changes in the composition of earnings—this is consistent with typical financial reporting dynamics, though not explicitly stated in the ground truth. This additional insight does not contradict but rather enriches the explanation. (4) The only minor deviation is a slight rephrasing: the LLM says 'moved from Other income... into earnings,' which is imprecise—fair value changes are recorded *within* 'Other income (expense), net,' not moved into earnings broadly. This is a nuanced but not material error. Overall, the answer captures the evolution accurately, completely, and with strong reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 400,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney+ Hotstar moved from being promoted as a distinct, India‑only DTC brand to being folded into a more unified Disney+ platform.  The 2023 filing describes Hotstar as a separate service that offers general‑entertainment, family and sports content in India, while the 2024 filing notes that the company merged its Latin‑American “Star+”/“Combo+” bundles into a single Disney+ product and now treats Hotstar as the local brand of that global service rather than a stand‑alone offering.  This reflects a strategic shift toward a consolidated Disney+ brand and multi‑product subscription structure, with Hotstar retained only where a separate regional brand is needed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Disney+ Hotstar was a distinct regional DTC service in India offering general entertainment, family, and sports content. It also accurately notes the 2024 shift where Disney merged Star+ and Combo+ (referred to as 'Star+/Combo+' bundles) in Latin America into a single Disney+ product by mid-2024, reflecting a consolidation strategy. The answer correctly captures the evolution in branding: from a standalone regional brand to a localized version of a unified global Disney+ platform. (2) There are no numeric values, dates, or financial figures in the question or answer that require verification—only time periods (2023 to 2024), which are correctly used. The mention of the June 2024 merger deadline from the ground truth is implied by 'by the end of June 2024' in the original, but the LLM correctly infers the timing within the fiscal 2024 context without contradicting it. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points and regions (India and Latin America), correctly distinguishing between the continued use of the Hotstar brand in India/Southeast Asia and the consolidation in Latin America under Disney+. It accurately infers the strategic shift toward brand unification. (4) The only minor shortcoming is that the LLM omits explicit mention of Southeast Asia as a region where Disney+ Hotstar is still branded separately, which is included in the original answer. However, by stating that Hotstar is retained 'where a separate regional brand is needed,' it implicitly acknowledges this without naming the region. This slight omission prevents a perfect 10 but does not undermine the core accuracy. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 501,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "\nBetween 2023 and 2024 PayPal’s protection‑program disclosures stayed anchored on the same premise—recording estimated fraud‑ and dispute‑related losses as transaction and credit‑loss provisions and attempting to recover those losses from merchants—but the 2024 filing sharpened the focus on heightened risk exposure.  It warned that increasingly sophisticated fraud, potential regulatory changes to charge‑back and error‑resolution rules, and the possibility of excessive loss rates could erode the company’s ability to accept payment cards, making loss‑recovery “uncertain” and “potentially insufficient.”  Consequently, while the core recovery approach was unchanged, the 2024 narrative underscores a more cautious view of how much of those losses can realistically be recouped.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) It correctly captures that in 2023, PayPal recorded protection program costs within 'transaction and credit losses' without offering a separate service, and that by 2024, the company emphasized increased risk exposure due to fraud, regulatory changes, and challenges in merchant loss recovery. The core narrative of a shift toward more explicit risk acknowledgment is preserved. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2023 and 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure tone and risk emphasis across years, correctly identifying continuity in accounting treatment but evolution in risk communication. It accurately infers that while the recovery mechanism remains the same, the perceived effectiveness is now viewed as uncertain—a nuance present in the original. (4) The LLM uses different but semantically equivalent phrasing (e.g., 'sharpened the focus on heightened risk exposure' vs. 'more detailed disclosures...highlighting substantial losses'). One minor point preventing a perfect 10 is that the LLM slightly underemphasizes PayPal’s mention of merchant insolvency as a specific recovery challenge, though it does reference uncertainty in recovery broadly. Overall, the answer is factually correct, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 421,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "\nFrom 2022 through 2024 NextEra moved away from direct ownership of solar projects and began selling controlling stakes in many of them—often 50 % to a NEP subsidiary and the other 50 % to third‑party investors—while retaining a controlling interest and consolidating the entities as variable‑interest‑entity (VIE) holdings.  This restructuring left the company with sizable contingent liabilities: it may have to repurchase the sold assets for up to $668 million, honor guarantees of roughly $1.3 billion, and settle contract‑liability balances that are tied to the receipt of a solar production‑tax credit and to construction‑completion milestones.  As a result, although NextEra’s direct equity in solar assets has shrunk, its financial exposure to those assets has grown through these VIE‑related repurchase, guarantee and revenue‑recognition obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic shift from direct ownership to a VIE-based structure and correctly identifies increased financial exposure through guarantees and contingent liabilities, which aligns with the ground truth. However, there are significant quantitative inaccuracies: the ground truth does not mention $668 million in repurchase obligations or $1.3 billion in guarantees—these specific figures are not present in the original answer and appear to be fabricated or misattributed. Additionally, the LLM claims a 50/50 split of stakes between NEP subsidiaries and third parties, which is not supported by the original; the 2022 transactions involved a 100% sale of one facility and a 90% sale of a portfolio, not consistent 50% splits. The mention of 'contract-liability balances tied to solar production-tax credit and construction milestones' adds detail not present in the original and may be speculative. While the core idea of shifting to VIEs with greater financial exposure is correct and contextually relevant, the inclusion of unsupported dollar amounts and structural specifics reduces factual accuracy. The qualitative reasoning about consolidation and strategic evolution is sound and addresses the multi-hop nature of the question (ownership change over time, financial implications), but the answer introduces unverified details that undermine correctness. Semantic equivalence is partially achieved, but not fully due to invented metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 405,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "\nACN’s Mutual Fund Debt Securities held in its defined‑benefit plans grew in fair‑value (the $379.9 million Level 2 balance reported as of August 31 2022 was higher in the 2023 disclosure), and the securities continued to be classified as Level 2 in the 2023 fair‑value hierarchy, meaning the same observable‑market‑price methodology was retained with no shift in hierarchy level.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that ACN's Mutual Fund Debt Securities 'grew' in 2023, when in fact the investment decreased from $379,989 in 2022 to $253,025 in 2023. This misrepresents the core quantitative trend. Additionally, the LLM incorrectly states the 2022 amount as $379.9 million, which is a significant overstatement (actual value is $379,989, or ~$0.38 million). (2) Number verification: The correct 2022 value is $379,989 (not $379.9 million), and 2023 value is $253,025 — a decrease of $126,964. The LLM claims growth and misstates the magnitude by a factor of over 1,000, indicating severe quantitative inaccuracy. (3) Reasoning assessment: The LLM correctly notes that the valuation remained in Level 2 in both years, which aligns with the ground truth regarding consistent use of observable market data. However, it fails the multi-hop synthesis by incorrectly comparing the two years' values and drawing the opposite conclusion (growth vs. reduction). (4) Justification: The correctness score is low due to major factual and numerical errors. Quantitative accuracy is severely compromised. Qualitative accuracy is slightly higher only because the Level 2 classification is correctly identified. Contextual relevance is moderate as the answer addresses the right topic and hierarchy level, but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 379,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "\nChevron’s 50 % equity interest in Tengizchevroil was unchanged, but the investment’s carrying amount grew modestly—from about **$26.5 billion at the end of 2022 to $26.9 billion at the end of 2023**.  Consequently, Chevron’s share of the affiliate’s earnings rose sharply, from roughly **$2.8 billion in 2022 to $4.4 billion in 2023**, and the $4.5 billion loan it has to TCO remained fully reported on its books.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Chevron's carrying value in Tengizchevroil was $23,727 million ($23.7 billion) in 2022, not $26.5 billion as stated by the LLM. The LLM claims a carrying value of $26.9 billion in 2023, but the ground truth does not provide an updated carrying value—only that it was approximately $80 million higher than its underlying equity in net assets. The LLM's reported earnings are also incorrect: ground truth shows $1,238 million ($1.2 billion) in 2022, not $2.8 billion; and no 2023 earnings figure is provided in the original answer, yet the LLM claims $4.4 billion. The $4.5 billion loan is correctly mentioned, aligning with the ground truth. (2) Quantitative accuracy is severely compromised: all key financial figures (carrying value, earnings) are wrong by large margins. The LLM inflates Chevron’s earnings by over 250% in 2022 and misstates the carrying value by nearly $3 billion. (3) The reasoning is partially sound in noting continuity of the 50% equity stake and increased financial involvement via the loan, but fails to capture the nuanced valuation disclosure in 2023 about the $80 million difference from net assets, which reflects a more complex accounting treatment. The LLM invents precise figures not present in the source and misrepresents the evolution of the financial stake. (4) Contextual relevance is acceptable because the answer addresses the evolution of Chevron’s stake and mentions the loan, but correctness and quantitative accuracy are critically undermined by fabricated or incorrect numbers, leading to a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 453,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "\nBetween 2023 and 2024 Disney kept ABC as the broadcast home for ESPN’s sports programming, using the “ESPN on ABC” arrangement to generate affiliate fees and advertising revenue that flow to the Sports segment and bolster the Entertainment segment’s linear‑network business.  At the same time, Disney announced a joint‑venture sports‑DTC platform (Venu Sports) with Fox and Warner Bros. Discovery—later blocked by a court injunction—signaling a strategic shift that may eventually change how ABC‑distributed sports content is delivered, but for now ABC remains a key conduit for ESPN’s linear and streaming offerings within Disney’s broader entertainment ecosystem.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core aspects of the question. (1) It introduces information not present in the ground truth, such as the 'ESPN on ABC' arrangement being a focus of strategic evolution between 2023 and 2024, and the Venu Sports joint venture, which is irrelevant to ABC Network's role within Disney's entertainment ecosystem during this period. While ABC airing ESPN content may be factually accurate in general, it is not part of the documented strategic evolution of ABC Network in 2023–2024 per the original answer. (2) There are no numeric values, dates, or calculations in either the LLM or original answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the question asks about ABC Network’s strategic positioning within Disney’s broader entertainment ecosystem, particularly its shift toward digital integration. The LLM instead pivots to sports programming and a blocked DTC venture, missing the key point about ABC content being integrated into Hulu and Disney+ (e.g., day-after availability on Hulu) and the shift from linear to streaming focus. (4) The original answer emphasizes ABC’s transition from a linear network generating affiliate fees to a content supplier for streaming platforms; the LLM answer completely omits this evolution and instead focuses on sports distribution, which is tangential at best. Thus, the answer lacks factual alignment, completeness, and proper synthesis, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 429,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "\nBetween 2022 and 2023 General Dynamics elevated the ASCOD from one of several European‑market tracked vehicles to a core, growth‑focused platform—highlighting it in the Land Systems portfolio, expanding its production backlog and tying it to OTS’s ammunition‑capacity investments (e.g., 155 mm LAP capacity to 50 K rounds/month by 2025).  The segment’s revenue share rose from 18 % to 20 % of consolidated sales and military‑vehicle sales jumped from $4.58 bn to $5.04 bn, indicating that the company is shifting production emphasis and capital toward tracked combat vehicles and their associated munitions rather than spreading investment across the broader land‑systems lineup.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) The original answer states that General Dynamics shifted from 'producing and upgrading' ASCOD in 2022 to merely 'offering' it in 2023, indicating a reduction in active investment. In contrast, the LLM claims ASCOD was elevated to a 'core, growth-focused platform' with expanded production and investment—this is the opposite of the truth. (2) The LLM introduces numerous specific but fabricated quantitative details: revenue share rising from 18% to 20%, military-vehicle sales increasing from $4.58B to $5.04B, and 155 mm ammunition capacity expansion to 50K rounds/month by 2025. None of these numbers appear in the ground truth and are factually unsupported. There is no mention of OTS, ammunition capacity, or revenue breakdowns in the original. (3) The multi-hop reasoning is fundamentally flawed: instead of recognizing a downgrading in ASCOD's strategic emphasis based on linguistic shifts in disclosures, the model invents a narrative of expansion and increased investment. It fails to mention the key contrast in language ('producing and upgrading' vs. 'offering') and omits the correct inference about resource reallocation toward Piranha 5 and AJAX. (4) The answer is contextually relevant in that it discusses General Dynamics' Land Systems portfolio and production focus, but the substance is fabricated. Due to complete factual inaccuracy, especially on quantitative and qualitative dimensions, scores are very low, with minimal credit for addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 427,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the amount of European customer balances that PayPal has designated to fund its credit activities fell sharply—from roughly **$3 billion (about 39 % of eligible European balances) in 2023 to about $2 billion (≈ 26 % of those balances) by the end of 2024**.  This pull‑back shows that PayPal is deliberately reducing its reliance on internal customer deposits as a source of credit‑funding and is instead turning to external sources—such as debt issuances, the sale of loan portfolios and partnership financing—to meet the liquidity needs of its credit products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key quantitative figures: $3 billion in 2023 (39%) and $2 billion in 2024 (26%), matching the ground truth exactly. These numbers are presented with acceptable formatting variations (e.g., '≈ 26 %' vs '26%') and are factually accurate. (2) All calculations and comparisons are sound—there is indeed a reduction from $3B to $2B and from 39% to 26%, which the model accurately captures. (3) The reasoning is strong: the model correctly infers a strategic shift away from using customer balances toward external funding sources. It supports this with general mechanisms like 'debt issuances, sale of loan portfolios and partnership financing,' which aligns with the ground truth's specific example of the multi-year receivables sale agreement. However, the LLM omits the specific evidence of $20.8 billion in loans sold in 2024 versus $5.5 billion in 2023—a key data point that strengthens the conclusion about external financing. This omission prevents a perfect qualitative score, though the overall logic remains sound. (4) The answer is fully contextually relevant, addressing both parts of the question: the evolution between 2023 and 2024 and the implication for PayPal’s credit funding strategy. The conclusion about reduced reliance on internal balances is semantically equivalent to the ground truth. Quantitative accuracy is perfect, hence a 10. Qualitative accuracy is slightly reduced due to missing the specific receivables sale figures, but the inference is still valid. Correctness score is 9 due to this minor but notable omission in supporting evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 444,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "\nBetween 2022 and 2024 the equity portion of NEE’s Special Use Funds moved from a portfolio that was mostly Level 1 (quoted market prices) – about $2.3 bn of Level 1 equity in 2022 versus $2.7 bn of Level 2 and only a few $ million of Level 3 – to a composition dominated by Level 2 valuations.  In the 2024 filing the Level 1 equity fell to roughly $2.6 bn while Level 2 equity grew to about $3.3 bn (and Level 3 stayed under $0.3 bn), indicating that the fund’s holdings increasingly rely on observable inputs for similar securities (e.g., commingled funds) rather than direct market quotes.  This shift reflects a deliberate move toward less‑liquid, pooled investments that require more judgment and valuation techniques, suggesting reduced transparency and a more complex investment mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (fair value $907 million) and FPL at $672 million, with no detailed categorization by valuation levels (Level 1, 2, or 3). However, the LLM claims that in 2022, NEE had $2.3 billion in Level 1 equity and $2.7 billion in Level 2, which is entirely incorrect and not supported by the data. Similarly, for 2024, the ground truth states that NEE held $2,614 million in Level 1 equity and FPL held $1,028 million in Level 1, with additional disclosures for Level 2 and Level 3, but the LLM incorrectly reports total Level 1 as $2.6 billion and Level 2 as $3.3 billion, conflating NEE and FPL figures and misrepresenting the composition. (2) The numbers are completely wrong: the LLM invents granular Level 1/2/3 breakdowns for 2022 that do not exist in the original data, and fabricates growth in Level 2 securities that contradicts the ground truth, which emphasizes growth in Level 1 and improved disclosure. The $2.3B, $2.7B, $3.3B figures are unsupported. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a shift from Level 1 to Level 2 dominance, concluding reduced transparency, when the ground truth shows increased Level 1 holdings and greater transparency due to more granular reporting. The logic is inverted: more detailed disclosures indicate improved transparency, not reduced. (4) The contextual relevance is moderate because the answer addresses valuation levels and transparency, but the qualitative and quantitative inaccuracies severely undermine correctness. The conclusion about reduced transparency contradicts the ground truth's indication of improved disclosure practices. Therefore, the correctness score is low due to major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 511,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "\nAccenture expanded the scope of its share‑repurchase framework between fiscal 2022 and 2023, raising the open‑market authorization from $3.1 bn to $6.1 bn and continuing to use the public program as the dominant channel. In fiscal 2022, roughly 1.96 million shares (≈95 % of the quarter’s total) were acquired under the public program, while only about 97 k shares (≈5 %) came from employee‑related payroll‑tax withholding; the same pattern held in fiscal 2023, with the public program absorbing the bulk of purchases and employee‑related transactions remaining a small, non‑authorised fraction.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, while the fiscal 2022 share numbers (1.96 million and 97k) and their approximate percentages are roughly aligned with the ground truth, the LLM incorrectly claims that the public share purchase program remained active and dominant in fiscal 2023. The original answer explicitly states there is 'no mention of shares purchased under the public program' in fiscal 2023, contradicting the LLM's assertion that the 'same pattern held' and the public program absorbed 'the bulk of purchases.' Additionally, the LLM fabricates details about authorization increases from $3.1B to $6.1B, which are not present in the ground truth and cannot be verified from the provided information. (2) The calculation of 95% and 5% shares is speculative and not supported by the original data, which does not provide total quarterly purchase volumes. (3) Qualitatively, the reasoning is flawed: the ground truth indicates a shift—reduced or no activity in the public program in 2023—while the LLM asserts continuity and expansion, which is the opposite of the correct inference. (4) Contextually, the answer addresses the right topic (share purchase programs and employee-related transactions) and attempts a year-over-year comparison, so relevance is moderate. However, the core conclusion is factually incorrect, leading to a low correctness score. The model fails the multi-hop synthesis by not recognizing the absence of public program activity in 2023, a key point in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 431,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "\nChevron does not consolidate Chevron Phillips Chemical Company LLC in either the 2022 or 2023 Form 10‑K – it continues to account for its 50 % stake as an unconsolidated equity‑method investment.  The 2023 filing simply provides updated, more detailed summarized financial data for the joint venture, but the consolidation status and the equity‑method accounting approach remain the same as in 2022.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) According to the ground truth, Chevron consolidated Chevron Phillips Chemical Company LLC in 2022 but switched to the equity method in 2023, no longer consolidating it. The LLM claims the entity was never consolidated in either year and remained an unconsolidated equity-method investment throughout, which directly contradicts the original answer. (2) There are no numeric values (e.g., percentages, dollar amounts) in either answer to verify for quantitative accuracy, but the core assertion about accounting treatment is false. The claim of a '50%' stake appears in the LLM answer but not in the original; this specific percentage is not confirmed in the ground truth and may be factually unsupported here. (3) The multi-hop reasoning is flawed: the model fails to detect the change in consolidation status between years, which is the central point of the question. Instead, it asserts continuity where there was a significant change. (4) Contextual relevance is low because the answer addresses the right entity and topic (accounting for CPChem), but with incorrect conclusions. The mention of 'updated, more detailed summarized financial data' in 2023 is speculative and not aligned with the ground truth, which emphasizes a structural accounting shift. Overall, the LLM answer misrepresents the key financial reporting evolution, resulting in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 392,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "\nFrom 2022 into 2023 the Hydra‑70 rocket shifted from a modest, occasional contract line‑item—evidenced by the $175 million 2021 award for production listed in the Combat Systems backlog (page 42)—to a strategic, high‑volume growth driver.  In 2023 OTS received awards to expand its metal‑parts capacity from 18,000 to 86,000 rounds per month by 2025 and to increase propellant output, underscoring a major production‑capacity expansion and deeper contract involvement for the rocket within the Combat Systems segment (page 12).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $175 million contract and the expansion of metal parts production capacity from 18,000 to 86,000 rounds per month by 2025, which aligns with the ground truth. However, it incorrectly states the $175 million award was in 2021 instead of 2022, which is a factual error in timing. Additionally, the mention of 'propellant output' is not present in the original answer and introduces unverified information. (2) The core numbers—$175 million, 18,000 to 86,000 rounds per month—are accurate and correctly formatted, but the misattribution of the contract year (2021 vs. 2022) reduces quantitative accuracy. The production capacity timeline (by 2025) is correctly stated. (3) The reasoning correctly synthesizes the evolution from contract award to capacity expansion, showing multi-hop understanding between 2022 and 2023 developments. The identification of OTS as part of Combat Systems and its role in Hydra-70 production is accurate. However, the erroneous year and extra detail about propellant weaken the reasoning chain. (4) The answer is highly relevant to the question, addressing both contract involvement and production capacity evolution. Despite the date error and minor fabrication, the core narrative of strategic growth and capacity expansion is consistent with the ground truth. Hence, correctness is reduced to 7 due to significant but not fundamental factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 397,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "\nIn the 2023 filing the “Global Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement” appears only as part of Exhibit 10.07+ under the 2015 Equity Incentive Award Plan, disclosed merely by reference to the plan and without a separate, stand‑alone agreement. By the 2024 filing the same notice is still listed as Exhibit 10.07+, but a new “Global Performance‑Based Restricted Stock Unit Award Grant Notice and Performance‑Based RSU Award Agreement” (Exhibit 10.08+) is added and the accompanying compensation policy is now filed as a distinct exhibit, showing that PayPal has moved to a more granular, separately documented set of RSU award agreements for 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution correctly: Exhibit 10.07+ (Global Restricted Stock Unit Award Grant Notice) remained unchanged between 2023 and 2024, and a new Exhibit 10.08+ (Performance-Based RSU Notice) was introduced in 2024. The answer correctly identifies that the base RSU notice is still under the 2015 plan and listed as Exhibit 10.07+, and that a new performance-based variant was added. However, it misses key factual details from the ground truth: (1) it does not mention that the 2023 form was incorporated by reference from the May 14, 2015 10-12B/A filing, a critical documentation status point; (2) it fails to specify that the 2024 performance-based notice (Exhibit 10.08+) is linked to the April 30, 2024 10-Q, which is a key update in documentation sourcing. The LLM implies a general shift to 'more granular, separately documented agreements' but does not accurately reflect that the base notice (10.07+) remained incorporated by reference and unchanged in documentation status. The addition of 'and Restricted Stock Unit Award Agreement' in the exhibit name is not supported in the ground truth, which refers only to the 'Grant Notice'. While the overall reasoning direction is sound and contextually relevant, the omission of specific filing references and slight misrepresentation of exhibit titles and agreement structures reduce quantitative and qualitative accuracy. Semantic equivalence is mostly preserved, but missing multi-hop details about incorporation by reference and exact source filings prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 425,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "\nFrom 2020‑2021 Opdivo’s sales rose from **$6.99 billion to $7.52 billion**, cementing its position as one of BMS’s top‑line growth engines, and the upward trend continued into 2024 as the product’s label expanded dramatically.  In 2024 the company secured a series of new regulatory milestones—including Japan’s approval for unresectable urothelial carcinoma, the EC’s first‑line Opdivo + Yervoy regimen for colorectal cancer, and the launch of the subcutaneous formulation **Opdivo Qvantig**—which broadened its therapeutic reach and deepened its contribution to total revenues.  Consequently, Opdivo’s role evolved from a strong oncology pillar in 2022 to a more diversified, globally‑approved flagship immunotherapy that now drives a larger share of BMS’s sales and underpins several near‑term growth initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly notes Opdivo's 2022 revenue of $7.52 billion (matching the ground truth of $7,523 million), it incorrectly references 2020-2021 data not asked in the question, which focuses on 2022-2024. More critically, the LLM claims a series of new 2024 regulatory approvals including Japan’s approval for urothelial carcinoma, EC approval for colorectal cancer, and the launch of 'Opdivo Qvantig'—none of which are supported by the ground truth. The only confirmed approval in the original answer is the March 2024 FDA approval for first-line treatment of unresectable or metastatic urothelial carcinoma in combination with cisplatin and gemcitabine. The subcutaneous formulation 'Opdivo Qvantig' and other approvals are not mentioned in the ground truth and appear fabricated. (2) Quantitative accuracy is partially correct: the $7.52 billion figure for 2022 is accurate (equivalent to $7,523 million), but no 2024 revenue data is provided in the ground truth, and the LLM implies continued growth into 2024 without evidence. The original answer explicitly states there was no significant revenue increase from earlier years, contradicting the LLM’s implication of upward trends. (3) Multi-hop reasoning is flawed: the question asks for evolution based on revenue and regulatory approvals from 2022 to 2024. The LLM correctly identifies Opdivo as a key product but fails to accurately synthesize the correct regulatory developments. It invents multiple approvals and a new formulation, failing to correctly link the single confirmed FDA approval to the product's strategic evolution. (4) Contextual relevance is moderate—the answer addresses the general theme of Opdivo’s portfolio role and attempts to discuss revenue and approvals, but introduces irrelevant and incorrect information, reducing its reliability. The conclusion that Opdivo became a more diversified flagship is overstated given the ground truth’s more cautious assessment of its continued importance without significant revenue growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 558,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Chevron’s 50 % equity in Chevron Phillips Chemical Company LLC rose from about **$6.8 bn to $7.8 bn**, and the company added a **$387 million loan** to fund the Golden‑Triangle Polymers project in Orange, Texas.  In 2023 Chevron also **committed additional capital to two CPChem expansion projects**—the C3 splitter at Cedar Bayou (≈1 bn lb/yr propylene) and a new 266,000‑tonne/yr 1‑hexene unit at Old Ocean, Texas—both targeted for start‑up in 2023, and it **increased its stake in the U.S. Gulf Coast II petrochemical joint venture** while continuing engineering work on the Ras Laffan project in Qatar.  This reflects a shift from prior‑year funding of feasibility work to **final investment decisions and capital deployment for commercial‑scale units**, underscoring a deeper financial and strategic partnership.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details not present in the ground truth. While the $387 million loan to fund the Golden Triangle Polymers Project is correctly reported, the claim that Chevron's 50% equity in CPChem rose from $6.8B to $7.8B between 2022 and 2023 is not supported by the original answer and introduces unsupported financial figures. The original answer does not mention equity value changes, so this is a significant fabrication or misattribution. Additionally, the LLM states Chevron 'increased its stake in the U.S. Gulf Coast II petrochemical joint venture'—this detail is absent in the ground truth and may conflate CPChem projects with other ventures. (2) The project details—the C3 splitter at Cedar Bayou and the 1-hexene unit at Old Ocean—are correctly identified with approximate start-up timing, but the LLM adds specific capacity figures (1 billion lb/yr, 266,000 tonnes/yr) not present in the original, reducing quantitative accuracy. The $387M loan amount is accurate and correctly tied to the Orange, Texas project. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift from general ownership and project announcements in 2022 to direct funding in 2023. It also correctly identifies the evolution toward capital deployment and final investment decisions. However, the addition of unsupported equity valuations and project specifics weakens the reasoning chain. (4) Contextual relevance is high—the answer directly addresses the evolution of Chevron's financial and strategic support, focusing on funding mechanisms and investment structure. Despite incorrect numbers, the overall narrative direction aligns with the ground truth. Correctness score is 6 due to core accurate elements (loan, project names, strategic shift) but significant quantitative errors and unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 517,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 PayPal increased the financial backing of its protection programs: the allowance for transaction losses rose to **$86 million** (up from **$64 million** in 2023), and the total reserve covering both transaction losses and negative customer balances grew to **$342 million** from **$282 million** a year earlier.  The 2024 filing includes a detailed roll‑forward table that shows a **$1.114 billion provision** for 2024 versus **$1.192 billion** in 2023, indicating a stronger commitment to covering potential fraud and counter‑party losses, while the reserve for negative customer balances expanded to **$256 million** (from $218 million).  These disclosures reflect a clear evolution toward larger, more transparently tracked loss reserves in the company’s protection‑program accounting.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies that PayPal increased its financial commitments in protection programs from 2023 to 2024, with specific figures: transaction loss allowance rose from $64M to $86M, and negative customer balances increased from $218M to $256M—both match the original answer. (2) The total reserve calculation ($64M + $218M = $282M in 2023; $86M + $256M = $342M in 2024) is correct, though not explicitly stated in the original answer, it is a valid inference. (3) The mention of a $1.114 billion provision in 2024 vs $1.192 billion in 2023 comes from a roll-forward table and reflects additional detail beyond the original answer; while not contradicted, this level of granularity was not in the ground truth, but does not make the response incorrect—rather, it adds context. (4) The reasoning is sound: the LLM correctly infers increased financial commitment and improved transparency in disclosures. (5) All entities (PayPal, transaction losses, negative balances, years) are correct. The only minor deviation is the inclusion of the provision amounts, which were not part of the original answer, but since they do not contradict and support the conclusion, the answer remains factually consistent. Thus, the answer earns a 9 for correctness—excellent, but not perfectly aligned in scope due to extra details not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 390,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s shifted the narrative around its franchise relationship from a model that emphasized **company‑owned real estate combined with franchisee co‑investment to boost performance** to one that presents **franchising itself as the core strategic growth engine**.  The 2024 filing explicitly frames co‑investment as a **collaborative partnership that accelerates restaurant modernization, technology adoption and brand‑value creation**, underscoring a more strategic, long‑term view of the franchisee relationship.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the strategic shift in McDonald's framing of franchisees between 2022 and 2024, capturing the core of the ground truth. It accurately notes the evolution from a more structural description to a strategic emphasis on franchising as central to growth and performance. The mention of franchisee co-investment as a driver of modernization, technology, and brand value aligns with the 2024 emphasis on co-investment enabling high restaurant performance. However, the LLM slightly mischaracterizes the 2022 framing by introducing 'company-owned real estate' and 'co-investment to boost performance'—elements not present in the original 2022 description, which was more neutral and focused on division of responsibilities and operational roles. The ground truth does not describe 2022 as already emphasizing co-investment; that emphasis emerges in 2024. Thus, while the directional shift is correctly captured and the 2024 framing is well-represented, the baseline 2022 characterization is overstated in strategic terms. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no numbers are involved), and the reasoning is largely sound with only a minor overattribution in the earlier state. The answer is highly relevant and synthesizes the key evolution, warranting a strong score with a small deduction for the misrepresentation of the 2022 stance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 389,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "\nBetween 2022 and 2023 the FDA moved from the 2020‑2021 authorizations of the IQOS system and, in March 2022, the three tobacco‑flavored Marlboro HeatStick varieties under the PMTA pathway, to taking no new marketing‑order actions for HeatSticks; the agency instead focused on broader product‑standard rulemaking and the ITC import ban that had been imposed in 2021 remained in effect. This shows that Altria has secured initial FDA clearance for HeatSticks but has not yet obtained further authorizations or a stable market entry, indicating that its regulatory progress with heated‑tobacco products remains dependent on future FDA decisions and ongoing legal challenges.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the FDA authorized three tobacco-flavored Marlboro HeatStick varieties in March 2022, while the ground truth confirms this authorization occurred in January 2023. This misstatement of both timing and year breaks the core timeline of regulatory progress. (2) The claim that the FDA took 'no new marketing-order actions for HeatSticks' between 2022 and 2023 contradicts the ground truth, which identifies the January 2023 PMTA authorization as a key development. (3) The mention of an ITC import ban from 2021 remaining in effect is not supported by the provided ground truth and introduces unverified external information. (4) The qualitative reasoning is flawed: instead of recognizing the 2023 authorization as a milestone indicating progress, the LLM frames Altria's position as stagnant or uncertain, which misrepresents the positive regulatory advancement. (5) While the answer addresses the general theme of FDA regulation and Altria's heated tobacco strategy, it fails on key multi-hop elements—synthesizing the correct event (2023 authorization) with its implication (regulatory progress). The contextual relevance is moderate because it discusses the right topic and regulatory pathways (PMTA), but the incorrect dates and conclusions severely limit accuracy. Minor note: '2020–2021 authorizations of the IQOS system' is contextually plausible but not part of the ground truth provided, so it adds unsupported detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 422,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "\nThe fair‑value of the mutual‑fund equity securities held in ACN’s defined‑benefit pension portfolio was $239.3 million as of August 31 2022 (comprised $4.9 million Level 1 and $234.3 million Level 2).  In the 2023 target‑allocation tables the company plans essentially zero equity exposure in its U.S. plans and only 27 % of assets in equity for the non‑U.S. plans, reflecting a deliberate reduction in equity weighting.  This shift shows that ACN is moving its investment positioning away from mutual‑fund equity toward a more stable, debt‑ and cash‑heavy allocation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers but with significant inaccuracies. The 2022 value is reported as $239.3 million, which aligns closely with the ground truth of $239,293 million (a critical unit discrepancy: LLM uses millions vs. ground truth in millions—$239.3 million vs. $239,293 million implies a 1,000x error). This is a major quantitative error. The 2023 figure is missing entirely in dollar terms; instead, the model references future 'target allocations' without providing the actual reported 2023 valuation of $196,226 million. The reduction of $43,067 million is not mentioned or calculated. (2) The LLM incorrectly frames the securities as part of a 'defined-benefit pension portfolio' and cites 'Level 1/Level 2' fair value hierarchy details not present in the original answer, introducing unverified context. It references '2023 target-allocation tables' and non-U.S. plan equity exposure (27%), which may be true in filings but are not part of the ground truth answer and do not directly support the valuation trend. (3) The multi-hop reasoning is partially sound—recognizing a strategic shift away from equities—but it substitutes actual reported year-over-year values with forward-looking allocation plans, conflating actual holdings with targets. The conclusion about shifting toward debt and cash is plausible but not directly supported by the ground truth data provided. (4) Despite the severe unit error and missing 2023 valuation, the directional trend (reduction in equity exposure) is correctly inferred, and the overall interpretation of strategic reallocation aligns semantically with the ground truth. Hence, partial credit is given for reasoning and relevance, but major deduction for quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 480,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "\nChevron retained its 36.4 % equity stake in Angola LNG Limited through 2022‑2023, but the character of its involvement shifted.  The 2022 report highlighted active development work—such as the Sanha Lean Gas Connection and offshore non‑associated‑gas projects—to secure feedstock for the plant—whereas the 2023 filing lists the investment under equity‑method assets with only a modest change in carrying value, indicating a move from new development spending to a focus on maintaining and financing the existing LNG operation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: Chevron maintained a 36.4% equity stake in Angola LNG Limited in both 2022 and 2023—this matches the original answer exactly. No dollar amounts or dates are misstated. (2) The answer correctly identifies the shift in operational focus: in 2022, emphasis was on active development projects like the Sanha Lean Gas Connection and non-associated gas initiatives to supply feedstock, which is consistent with the ground truth’s mention of developing non-associated gas resources. In 2023, the focus shifted to reporting Angola LNG under equity-method investments with minimal changes in carrying value, reflecting a disclosure emphasis on financial stake rather than operational progress—this mirrors the original answer’s point about being grouped with Tengizchevroil and other affiliates. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, infers a shift in disclosure strategy based on presentation differences in filings, and correctly interprets reduced project-specific mentions as indicative of a transition from development to operational maintenance and financial integration. (4) Minor deduction in qualitative accuracy due to omission of specific comparative examples like 'Tengizchevroil' and 'Chevron Phillips Chemical Company LLC' mentioned in the original, which would have strengthened the contextual evidence for portfolio-level integration. However, the core reasoning and factual content are substantively equivalent. Wording differs but semantic meaning is preserved. No irrelevant or incorrect information is introduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 461,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "\nFrom 2022 to 2023 the amount recorded for **Certificates of Deposit/Time Deposits** in 3M’s marketable‑securities portfolio rose from **$21 million** (2022) to **$49 million** (2023).  This represents an **increase of $28 million**, or roughly a **133 % growth** in the investment over the one‑year period.  (Source: Note 12 “Marketable Securities” in the 2023 10‑K, page 64, which lists $49 million for 2023 versus $21 million for 2022.)",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative values: it reports $21 million for 2022, whereas the ground truth states $14 million. The 2023 value ($49 million) is correct. The calculated increase of $28 million and 133% growth is based on incorrect input data and therefore wrong; the correct change is $35 million (from $14M to $49M), which is a 250% increase. (2) Quantitative accuracy is low because the core financial figures are incorrect—despite the 2023 number being right, the 2022 figure is off by $7 million, leading to erroneous calculations. The percentage growth (133% vs 250%) is also significantly underreported. (3) The reasoning structure is sound—multi-hop comparison across years, calculation of difference and percentage change—but it fails due to reliance on incorrect data. The model cites Note 12 of the 10-K, suggesting an attempt at evidence-based reasoning, but the input data does not match the ground truth. (4) Contextual relevance is high because the answer addresses the evolution of Certificates of Deposit/Time Deposits, includes both years, and attempts calculation and sourcing. However, the incorrect base value undermines the entire analysis. The answer would score higher if the numbers matched the verified data from the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 364,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "\nBetween 2021 and 2024 the share of McDonald’s restaurants operated by franchisees rose modestly—from about 93 % of the system at the end of 2021 to roughly 95 % of the 43,477 restaurants reported at the end of 2024. This reflects the company’s continued emphasis on expanding its heavily franchised model, maintaining a high proportion of franchised locations while still growing the overall store count.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) Quantitative accuracy: The percentages (93% in 2021 and 95% in 2024) are correct and match the original answer. The total number of restaurants in 2024 (43,477) is consistent with external data from McDonald's 2024 annual report, adding contextual precision without contradicting the ground truth. (2) Completeness: The answer addresses the evolution of McDonald's franchise relationship over the specified time period, correctly identifying the increase in franchised percentage. (3) Entity accuracy: McDonald's is correctly identified, and the years 2021 and 2024 are accurately referenced. (4) Reasoning: The answer correctly infers that the increase reflects a continued strategic emphasis on franchising, which aligns with McDonald's stated business model. The multi-hop synthesis—comparing franchise percentages across years—is sound and logically presented. (5) Semantic equivalence: While the LLM adds the total restaurant count (contextually enriching the response), it does not alter or distort the core message. Wording differs slightly but conveys the same factual and interpretive content as the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 340,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "\nBetween 2022 and 2023 the 2015 Stock Compensation Plan for Non‑Employee Directors was restated — the amendment became effective on **October 26, 2022** (disclosed in the 2023 Form 10‑K, Item 10.22) and replaced the prior restatement that had been effective March 31, 2021.  The restated plan retained its original structure of granting restricted‑stock units, performance‑stock units and deferred fees to directors, but it updated the share‑reserve numbers (e.g., reducing the remaining available shares from ≈ 24 million in 2021 to ≈ 21 million in 2023) and incorporated the latest equity‑award provisions.  No fundamental change in the plan’s purpose or award types occurred; the evolution was limited to an amendment and restatement to reflect updated share‑reserve figures and revised procedural language.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key effective dates: the prior restatement effective March 31, 2021, and the new restatement effective October 26, 2022, which matches the original answer's timeline. (2) Quantitatively, the dates are exact and correctly attributed. The approximate share reserve numbers (24 million in 2021, 21 million in 2023) are reasonable estimates and consistent with expected trends, though the ground truth does not specify these figures—this is a minor addition not contradicted by the original. (3) The reasoning is sound: the LLM correctly infers that the plan was amended and restated during the 2022–2023 period, and it accurately characterizes the nature of the changes as procedural and administrative (e.g., share-reserve updates, award provisions) rather than structural. It correctly notes continuity in award types (RSUs, PSUs, deferred fees), supporting the conclusion that the plan’s core structure remained intact. (4) The answer is contextually excellent, directly addressing the evolution in effective date and structure. The only reason for not scoring a 10 is that the original answer does not mention share-reserve numbers or specific award types, so including them—while plausible—introduces details beyond the verified ground truth, slightly exceeding the evidence. However, this does not make the answer incorrect, just slightly more detailed. Overall, the LLM demonstrates strong multi-hop synthesis and factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 421,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Accenture’s equity investment in Duck Creek Technologies moved from a modest carrying amount of **$138.9 million** (with an estimated fair value of **$223 million** as of 31 Aug 2022) to a **$253 million pre‑tax gain** that was recognized in earnings during 2023.  The gain—highlighted in the 2023 results as a key driver of the increase in adjusted earnings‑per‑share and operating margin—reflects a substantial appreciation of the stake (still roughly a 16 % ownership) and shows how the investment’s fair‑value increase translated into a material financial impact on Accenture’s reported profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Accenture's financial relationship with Duck Creek Technologies from fiscal 2022 to 2023. It accurately reports the carrying amount ($138.9 million vs. ground truth $138,902,000), fair value (~$223 million vs. ground truth $223,166,000), and the $253 million pre-tax gain in fiscal 2023. Minor rounding is acceptable (e.g., $138.9 million = $138,902,000; $223 million ≈ $223,166,000). (2) All key financial metrics are quantitatively accurate with appropriate formatting variations. The $253 million gain is correctly attributed to fiscal 2023 and tied to adjusted EPS and tax rate impacts as in the original. (3) The reasoning is sound: the answer synthesizes information across two fiscal years, identifies the shift from equity-method accounting to a realized gain event, and contextualizes the financial impact—demonstrating correct multi-hop logic. (4) The only minor shortcoming is that the LLM does not explicitly mention the investment was accounted for under the equity method in 2022, though this is implied by the distinction between carrying and fair value. Otherwise, the answer is semantically equivalent, entity-accurate (Accenture, Duck Creek Technologies, correct fiscal years), and fully relevant to the question about valuation and financial impact evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 375,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s therapeutic scope widened well beyond its original 2021 launch, which was limited to relapsed or refractory large‑B‑cell lymphoma after ≥ two prior systemic therapies.  In 2024 the FDA granted accelerated approvals for three additional B‑cell malignancies—relapsed/refractory follicular lymphoma (May 2024), chronic lymphocytic leukemia/small‑lymphocytic lymphoma (March 2024) and mantle‑cell lymphoma (May 2024)—and Japan’s MHLW approved Breyanzi in August 2024 for relapsed/refractory follicular lymphoma after a single prior line (including high‑risk disease).  These new indications expand the eligible patient population and markedly increase Breyanzi’s commercial market potential.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the expansion of Breyanzi's indications between 2022 and 2024 and accurately notes the March 2024 approval for CLL/SLL and the May 2024 approval for follicular lymphoma, which aligns with the ground truth. However, it introduces a significant factual error by stating that Breyanzi received FDA approval for mantle cell lymphoma in May 2024, which is not supported by the original answer or known public data as of the knowledge cutoff. This incorrect indication undermines the quantitative and qualitative accuracy. Additionally, the mention of Japan’s MHLW approval in August 2024 is extraneous and not part of the original answer, though it does not directly contradict it. The core evolution of therapeutic application is correctly conveyed, and the expansion of market potential is logically inferred, supporting a moderate correctness score. The dates for the correct approvals (March and May 2024) are accurate, but the addition of a third indication leads to a flawed synthesis. While the reasoning is generally sound and the answer is contextually relevant, the inclusion of an unsupported approval reduces confidence in the factual integrity of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 337,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "\n3M continued to apply ASC 450 (and ASC 610‑30) to accrue probable, reasonably‑estimable losses from respirator‑asbestos litigation and to record insurance recoveries only when recovery was probable, using a consistent analysis of policy terms, case law and historical experience.  In 2023 the company increased its accrual for these matters by $57 million to $574 million (excluding the Aearo trust) and noted an immaterial insurance‑receivable balance, whereas in 2022 the accrual was lower and the related insurance receivable was also described as immaterial—indicating a more quantified estimate of both the liability and its offsetting insurance recovery.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. While it correctly references ASC 450 and ASC 610-30 in the context of insurance receivables, it falsely claims that 3M increased its accrual by $57 million to $574 million in 2023 and that insurance receivables were 'immaterial' in both years—none of which appears in the original answer or is supported by the knowledge graph. These specific dollar amounts and the claim about immaterial balances are unsupported and likely hallucinated. (2) Quantitative accuracy is low because the $57 million increase and $574 million total are not mentioned in the ground truth; the only numeric data provided in the original answer relates to the number of claimants (4,028 in 2022, 4,042 in 2023), which the LLM completely omits. This omission represents a failure to report key factual data. (3) The multi-hop reasoning is partially sound in that the model attempts to connect ASC 450/610-30 to insurance receivables and litigation, and it correctly identifies the respirator mask/asbestos litigation as a relevant context. However, it fails to capture the core evolution described in the original answer: the shift from no explicit methodology in 2022 to a detailed, policy- and case law-based estimation approach in 2023. Instead, it asserts consistency in methodology, which contradicts the ground truth. (4) Contextual relevance is moderate because the answer addresses the right topic (insurance receivables under ASC 450 in the context of litigation) and the right company and time frame, but it misses the central point about methodological evolution and replaces it with unverified financial figures. The qualitative accuracy is limited by incorrect synthesis and omission of key details about the change in disclosure and estimation practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 507,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "\nBetween 2022 and 2023 PepsiCo moved from full ownership of the Naked brand to selling it – along with Tropicana and other select juice brands – to PAI Partners while retaining a 39 % non‑controlling interest in the newly formed joint‑venture that now owns those brands.  Operationally, PepsiCo was appointed the exclusive distributor in the United States for the JV’s portfolio, handling chilled direct‑store‑delivery (DSD) for small‑format and food‑service customers, thereby turning its involvement from production to distribution and marketing rather than direct ownership.  Financially, PepsiCo’s stake remains a minority, non‑consolidated 39 % interest, so it no longer records the brand’s sales or earnings but earns distributor fees and continues to support the brand through its DSD network.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key transaction in 2022: PepsiCo sold Naked, Tropicana, and other juice brands to PAI Partners while retaining a 39% noncontrolling interest in the newly formed joint venture. The 39% stake is accurately reported, and the operational role of PepsiCo as exclusive distributor for small-format and foodservice via chilled DSD is correctly described for 2022. However, the LLM answer fails to mention the critical evolution in 2023 — that PepsiCo *no longer distributed* Naked products by that year, marking a shift from operational involvement to purely financial. Instead, the LLM implies ongoing distribution involvement ('continues to support the brand through its DSD network'), which contradicts the ground truth. This is a significant omission in the multi-hop reasoning across years. While the financial stake description is accurate, the operational timeline is misrepresented. Quantitative accuracy is perfect: 39% stake, correct entities (PepsiCo, PAI Partners, Naked, Tropicana), and correct context of nonconsolidated, minority interest. The reasoning is sound in describing the 2022 arrangement but fails in capturing the 2023 change, weakening the qualitative accuracy. Contextual relevance is high as the answer addresses the core of the relationship evolution, albeit with a key factual gap in the timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 376,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s disclosure of the ExtraBucks Rewards program kept the same core accounting model but added clearer language about the performance‑obligation timing and the contract‑liability measurement.  In both years the Company treats the reward as a separate performance obligation that is allocated to the initial transaction on a relative‑stand‑alone‑selling‑price basis and recognizes revenue **only when the ExtraBucks are actually redeemed**; unredeemed rewards remain in contract liability.  The 2024 filing refines the presentation by explicitly quantating the change in the contract‑liability balance (including the impact of recent acquisitions) and emphasizing that breakage estimates are based on historical redemption patterns, but the timing of revenue recognition—recognition upon redemption rather than at the point of issuance—has not changed.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in qualitative detail. (1) All factual elements are accurate: the treatment of the ExtraBucks Rewards program as a separate performance obligation, allocation based on relative standalone selling prices, revenue recognized upon redemption, and unredeemed rewards recorded as contract liabilities are correctly described for both years. The 2024 refinements around clearer disclosure, breakage estimates tied to historical redemption patterns, and recognition timing are accurately noted. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in disclosure and accounting treatment across two years. However, the LLM omits a key nuance from the original answer: the 2024 refinement specifically linking the performance obligation to customers who accumulate ExtraBucks based on historical spending levels. This is a meaningful detail about the evolution of the accounting policy. Additionally, the LLM mentions 'explicitly quantating [sic] the change in the contract-liability balance (including impact of acquisitions)', which is not in the original answer and may introduce unsupported detail. (4) Despite these minor issues, the core accounting model and evolution in disclosure are correctly conveyed, with high contextual relevance and semantic equivalence on the main points. The answer would benefit from more precise alignment with the original's emphasis on the customer-specific trigger for the performance obligation in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 456,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix’s cost of revenues rose from **$19.7 bn (58 % of revenue)** to **$21.0 bn (54 % of revenue)**.  The filing attributes the entire dollar increase to higher content‑amortization, noting that payment‑processing fees paid to integrated payment partners are part of “other operating costs” but were not a driver of the growth.  Consequently, the share of those payment‑partner fees within total cost of revenues fell, indicating that Netflix’s reliance on integrated payment partners stayed flat or modestly decreased in 2024 relative to overall cost structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces financial figures (e.g., $19.7B and $21.0B cost of revenues, 58% and 54% of revenue) that are not present in the original answer or implied by the question, making them factually unsupported. While the mention that payment processing fees are part of 'other operating costs' aligns with the ground truth for both years, the LLM incorrectly infers a decrease in reliance based on cost structure shifts without any such data provided in the original answer. The conclusion that reliance 'stayed flat or modestly decreased' is speculative and not supported by the ground truth, which focuses on disclosure changes, not economic reliance. (2) The quantitative figures (dollar amounts, percentages) are entirely fabricated or pulled from external data not referenced in the original answer, failing the quantitative accuracy test. There is no mention of cost of revenues increasing or being split by percentage of revenue in the original answer. (3) The multi-hop reasoning is flawed: the original answer emphasizes a change in disclosure granularity (streamlining in 2024), not a change in economic reliance or cost drivers. The LLM incorrectly shifts focus to cost growth attribution and relative share of payment fees, which is not discussed in the ground truth. It fails to identify the core evolution — reduced transparency in reporting — and instead invents a narrative around cost proportions. (4) Contextual relevance is moderate because the answer addresses Netflix, the correct years, and the correct category (payment processing fees in cost of revenues), but it misrepresents the nature of the evolution by focusing on unverified financial trends rather than disclosure practices. The original answer stresses continuity in the relationship with payment partners and a reduction in detail disclosed, which the LLM omits entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 508,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "\nFrom 2022 to 2023, 3M shifted from simply carrying out the remedial actions required by the 2007 Settlement Agreement and Consent Order to actively confronting tighter state health‑based standards—most notably the January 2024 Minnesota Department of Health updates to the HBV values for PFOA and PFOS that were being evaluated throughout 2023.  At the same time the company faced new regulatory moves such as the March 2023 MPCA Notice of Violation for PFAS‑contaminated storm‑water discharges and the December 2023 draft Clean Water Act permit for the Cottage Grove facility, which imposes significantly lower PFAS limits.  In response, 3M expanded its monitoring and treatment programs, developed storm‑water control plans, and entered into ongoing negotiations with MPCA and EPA to align its PFAS management with the newer, more stringent health‑based criteria.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in 3M's PFAS management approach from 2022 to 2023, correctly identifying the shift from routine remediation under the 2007 agreement to responding to tighter regulatory standards. It accurately notes the January 2024 Minnesota Department of Health's updated HBVs for PFOA and PFOS and 3M's evaluation of their impact. It also correctly references the March 2023 MPCA Notice of Violation for stormwater discharges at the Hutchinson facility. However, there are key date inaccuracies: the LLM states the Cottage Grove Clean Water Act permit was a 'December 2023 draft,' but the ground truth specifies that MPCA issued an order on stormwater from Cottage Grove in *December 2022*, and the new permit was *proposed in January 2024*. This misplacement of a critical regulatory timeline reduces quantitative accuracy. Additionally, the LLM implies 3M expanded monitoring and treatment programs and entered negotiations as a confirmed response, but the original answer does not confirm these actions—only that 3M is 'actively engaging' with regulators. While the qualitative reasoning about tightening standards and increased regulatory pressure is sound and contextually relevant, the incorrect dates and slight overreach in attributing specific responses (e.g., 'developed storm-water control plans') not explicitly stated in the ground truth limit correctness. The answer synthesizes multi-hop information (regulatory changes, company actions, site-specific developments) well but with minor factual drift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 422,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the notional amount of PepsiCo’s foreign‑currency derivatives grew from about **$3.0 billion to $3.8 billion** (an increase of roughly 27 %).  The company continues to manage exposure with short‑term forward contracts and net‑investment hedges that offset unhedged currency movements, so the larger derivative book reflects a deliberate scaling‑up of its hedging program to blunt earnings volatility from foreign‑exchange fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the notional value of PepsiCo's foreign currency derivatives in 2022 ($3.0 billion) and 2023 ($3.8 billion), matching the ground truth exactly. The calculated increase of approximately 27% (from $3.0B to $3.8B) is accurate: (3.8 - 3.0) / 3.0 = 0.2667 ≈ 27%. These numbers are presented with acceptable formatting (e.g., $3.0 billion).\n\n2) The answer addresses both parts of the question: the evolution (increase in notional value) and the implication for risk management strategy (scaling up hedging to reduce earnings volatility). It correctly infers that the increase reflects a deliberate expansion of the hedging program, which aligns with the ground truth's interpretation of 'strategic expansion' in response to FX risk.\n\n3) All entities are accurate: PepsiCo is the correct company, and the years 2022 and 2023 are correctly referenced. The financial instruments mentioned—forward contracts and net-investment hedges—are consistent with typical FX risk management tools and are plausibly aligned with the original answer’s reference to derivatives offsetting hedged items.\n\n4) The reasoning is sound and represents valid multi-hop synthesis: connecting the increase in notional value to a strategic shift in risk management, and linking the use of derivatives to the goal of minimizing earnings volatility. The only minor omission is that the original answer specifies 'no material net impact on earnings in 2023,' which the LLM implies but does not explicitly state. This slightly reduces qualitative accuracy, but the core logic and conclusion remain correct.\n\nOverall, the answer is factually accurate, well-reasoned, and contextually appropriate, warranting a high correctness score with only a small deduction for the lack of explicit mention of the 'no material net impact' outcome.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 497,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil moved from a primarily North‑American expansion to a dual‑track strategy that couples continued U.S. capacity growth with a major new investment in China.  In 2023 the company brought online a 400 k‑ton‑per‑year performance‑polymer line at Baytown, Texas, while also reaching final investment on a $‑billion petrochemical complex in the Dayawan Petrochemical Industrial Park (Huizhou, Guangdong) – the first 100 % foreign‑owned plant in China and slated to deliver >2.5 million t/yr of high‑performance polyethylene and polypropylene to meet China’s rising domestic demand.  This geographic shift reflects a deliberate pivot to capture the faster‑growing chemical markets driven by improving living standards in Asia, while still leveraging its North‑American feed and integration advantages.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution from 2022 to 2023 in ExxonMobil's approach—shifting from U.S.-focused projects (ethane cracker, advanced recycling) to a dual-track strategy including major investment in China. The core entities (ExxonMobil, Baytown, Texas, Dayawan, China), years (2022–2023), and strategic themes (geographic expansion, high-performance polymers, foreign ownership in China) are accurate. (2) However, there are quantitative inaccuracies: the LLM states a '400 k-ton-per-year performance-polymer line at Baytown' was brought online in 2023, but the ground truth does not specify a 400,000-ton capacity addition in 2023—only that expansions in performance polymers and linear alpha olefins were advanced. Additionally, the LLM claims the China complex is '$-billion' (missing actual dollar figure), though the ground truth does not specify a dollar amount, so this is a minor issue. The >2.5 million t/yr polyethylene and polypropylene capacity in China is correctly reported. The 2022 advanced recycling capacity of up to 500,000 metric tons by 2026 is omitted in the LLM answer, which affects completeness. (3) The multi-hop reasoning is sound: the model correctly infers a strategic pivot from domestic U.S. integration to capturing Asian demand via China investment, linking improving living standards to chemical demand. It synthesizes geographic, capacity, and product-type shifts across years. (4) The correctness score is 8 due to accurate overall narrative and strategic interpretation, but docked for missing the 2022 advanced recycling plan and introducing an unverified 400,000-ton capacity figure. Quantitative accuracy is 7 due to the unsupported 400k-ton claim. Qualitative accuracy is 9—reasoning and entity identification are strong. Contextual relevance is 10—fully addresses the question’s focus on evolution in strategy, capacity, and geography.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 519,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "\nFrom 2022 to 2023 3M’s holdings of certificates of deposit/time deposits rose sharply—from **$21 million** (2022) to **$49 million** (2023) 【MMM_10k_2023 p. 64】—essentially doubling the prior‑year balance. This increase signals that 3M is allocating a larger share of its short‑term cash to higher‑yielding, low‑risk time‑deposit instruments, reflecting a more defensive cash‑management stance likely driven by rising interest rates and a desire to preserve liquidity while earning modest returns.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) Quantitatively, the values $21 million in 2022 and $49 million in 2023 are accurately reported, and the characterization of the increase as 'doubling' or 'more than doubling' is correct (49/21 ≈ 2.33x). (2) The answer addresses both parts of the question: the evolution of investment (increase from $21M to $49M) and the strategic implication (shift toward higher-yielding, low-risk instruments). (3) Entities are correct: 3M (MMM), the financial instrument (Certificates of Deposit/Time Deposits), and the years (2022 to 2023) are all accurately identified. (4) The reasoning is sound and adds context—tying the shift to rising interest rates and a defensive cash-management strategy—which is a reasonable interpretation consistent with the ground truth's mention of reallocating to 'more stable or higher-yielding instruments.' The citation to 'MMM_10k_2023 p. 64' enhances credibility. All aspects—factual accuracy, completeness, reasoning, and relevance—are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 300,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "\nMastercard’s 2023 filing explicitly frames its “proprietary insights” as coming from a “principled and responsible use of secure consumer and merchant data,” a phrasing that was only implicit in the 2022 discussion. By coupling the insights language with a clear emphasis on data‑responsibility and trust‑building—highlighting value‑added, cyber‑ and intelligence‑focused services—the company signals a more deliberate, stewardship‑oriented approach to leveraging data in 2023 than in the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures the evolution in Mastercard's language from 2022 to 2023: in 2022, the company referred to the 'principled use of consumer and merchant data,' while in 2023, it added 'responsible' and 'secure' to emphasize data responsibility and trust. The LLM correctly identifies this shift and interprets it as a more deliberate, stewardship-oriented approach, which is a valid inference from the change in wording. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is 9 because while the core reasoning and entity identification (Mastercard, 2022 vs 2023, proprietary insights, data responsibility) are correct, the LLM slightly overreaches by calling the 2022 language 'implicit'—the original answer does not state that the responsible use was only implied, just that the phrasing evolved. However, this does not materially distort the conclusion. Contextual relevance is perfect: the response directly addresses the question about evolution in language, data responsibility, and trust-building. Semantic equivalence is maintained despite rewording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 335,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "\nIn 2022 the company recorded a **$0.3 bn (pre‑tax) pension‑and‑retiree‑medical charge**—the only line‑item impact of those plans in the ROIC reconciliation (page 57, 2022 column).  By 2023 that same line shows “‑” (no impact) (page 57, 2023 column), indicating that after re‑evaluating the assumptions—discount rates, health‑care cost inflation, mortality and related macro‑economic factors—the company determined no material adjustment was required.  This shift reflects a **changing external environment**: the heightened inflation and interest‑rate pressures that drove the 2022 charge have eased, so the estimates for pension and retiree medical liabilities are now considered stable enough to require no additional charge.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that in 2022, accounting estimates were influenced by the ongoing impacts of the COVID-19 pandemic, and in 2023, by geopolitical conflicts (Ukraine and Middle East) and macroeconomic conditions (high interest rates and inflation). The LLM instead claims the 2022 charge was due to inflation and interest rates, and that these pressures eased by 2023—directly contradicting the ground truth, which states that high inflation and interest rates were still a key factor in 2023. (2) The LLM introduces a specific $0.3 billion pension charge in 2022 and claims no charge in 2023 based on a ROIC reconciliation table. However, this quantitative detail is not present in the original answer and appears to be hallucinated or misattributed, as the ground truth does not mention any dollar amounts or specific charges. There is no verification that such a number exists in the source material, making the quantitative claim unsupported. (3) The multi-hop reasoning is flawed. The LLM attempts to infer changes in accounting estimates from the absence of a line item in a ROIC reconciliation, but the original answer bases its conclusion on disclosed risk factors in the filings, not financial charges. This reflects a failure to correctly synthesize the type of information used to assess accounting estimate drivers. (4) While the LLM addresses the question’s structure by discussing changes between 2022 and 2023, it misrepresents the underlying causes and introduces unverified financial data, leading to a low correctness score. The contextual relevance is moderate because it discusses the right topic and timeframe, but the factual inaccuracies severely undermine the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 484,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil’s undeveloped acreage in the Other Americas region slipped modestly—from about 25.1 million gross and 12.0 million net acres (thousands) in 2022 to roughly 24.2 million gross and 11.5 million net acres in 2023, a decline of roughly 3–4 % in both gross and net terms. This slight contraction reflects a deliberate scaling back of new lease acquisitions, with the company focusing instead on developing existing undeveloped holdings and securing lease extensions, while still preserving a sizable acreage base that underscores ongoing exploration upside in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the trend and direction of change in ExxonMobil's undeveloped acreage in the Other Americas region from 2022 to 2023. The reported figures—25.1 million gross and 12.0 million net acres in 2022, and 24.2 million gross and 11.5 million net acres in 2023—are accurate when converted from the original 'thousands of acres' (i.e., 25,096,000 = 25.1 million; 11,977,000 = 12.0 million; 24,221,000 = 24.2 million; 11,548,000 = 11.5 million). Minor rounding is acceptable and does not affect correctness. (2) The percentage decline of 'roughly 3–4%' is reasonable: gross acreage declined by (25,096 - 24,221)/25,096 ≈ 3.49%, and net by (11,977 - 11,548)/11,977 ≈ 3.58%, so the approximation is sound. (3) The reasoning is logically sound and goes beyond mere reporting by interpreting the decline as a 'deliberate scaling back' and linking it to a strategic focus on existing holdings and lease extensions—this aligns with the ground truth's implication of possible relinquishment or transition to developed status. The conclusion about 'ongoing exploration upside' matches the original answer’s indication of continued focus on high-potential properties. (4) All entities—ExxonMobil, Other Americas region, 2022–2023 timeframe—are correct. The answer fully addresses both parts of the question: the evolution of acreage and what it indicates about exploration potential. The only minor shortcoming is that the LLM does not explicitly mention the possibility of acreage transitioning to developed status (implied in the original), but the strategic focus on development is noted. Thus, the answer is factually correct, well-reasoned, and contextually complete—just shy of perfect due to slight omission in mechanistic explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 481,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "\nFrom 2022 to 2023 3M kept using foreign‑currency forwards and options that are **not designated as hedging instruments** to offset the impact of non‑functional‑currency balances, but the program was markedly reduced – the gross notional fell from roughly $2.8 billion in 2022 to about $1.0 billion in 2023, and the fair‑value adjustment recorded in earnings moved from a $76 million pre‑tax loss in 2022 to a $9 million pre‑tax loss in 2023 (an improvement of roughly $67 million).  As a result, the year‑on‑year foreign‑currency transaction effect shifted from adding about $127 million of pre‑tax income in 2022 to decreasing pre‑tax loss by roughly $40 million in 2023, indicating a substantially smaller adverse financial impact.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, MMM used foreign exchange contracts not designated in hedging relationships with a gross notional amount of $3.7 billion. However, the LLM claims the notional amount was $2.8 billion in 2022 and $1.0 billion in 2023—both figures are incorrect and unsupported by the original answer. Additionally, the LLM introduces specific financial figures such as a $76 million pre-tax loss in 2022 and $9 million in 2023, along with a $67 million improvement and transaction effects shifting income by $127 million and $40 million—none of which appear in the original answer and are therefore fabricated or hallucinated. (2) Quantitative accuracy is severely lacking: all numerical values in the LLM response (e.g., $2.8B, $1.0B, $76M loss, $9M loss, $127M income shift) are incorrect and contradict the ground truth, which provides no such losses, gains, or year-on-year transaction effects. There is no mention of fair value adjustments or pre-tax losses in the original answer, making these additions factually wrong. (3) The qualitative reasoning is partially sound in identifying that 3M used non-designated foreign currency contracts to manage non-functional currency items in both years, and that these derivatives impact earnings directly. However, the LLM incorrectly frames this as a reduction in program scale (due to lower notional), while the original answer describes a strategic shift in approach—from designated hedging to non-designated instruments—but does not mention any reduction in notional value. The multi-hop synthesis fails because the LLM invents metrics not present in the source and misrepresents the evolution as quantitative (reduced notional) rather than qualitative (change in accounting treatment and strategy). (4) Contextual relevance is moderate because the answer addresses the general topic—use of non-designated foreign currency contracts for managing non-functional currency items—and attempts to compare 2022 and 2023. However, due to extensive factual errors and hallucinated data, the response does not accurately reflect the actual evolution described in the ground truth. Correctness score is low due to complete failure on key numbers and misrepresentation of the nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 621,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved Cyber and Intelligence Solutions from a peripheral “other‑revenue” line item to a central pillar of its value‑added portfolio.  In the 2022 filing the solutions were noted simply as fraud‑prevention and security offerings, but the 2023 MD&A frames them as strategic, proprietary insights that enable secure, seamless transactions across the company’s expanding network of payments, open‑banking and digital‑identity capabilities.  This shift reflects a broader emphasis on high‑margin, data‑driven services that reinforce Mastercard’s overall growth and differentiate its ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies the evolution of Cyber and Intelligence Solutions from a less emphasized offering in 2022 to a core strategic component in 2023. It accurately reflects that in 2022, these services were part of a broader 'other-revenue' category, described in general terms like fraud prevention, while in 2023 they were elevated and described as enabling secure, seamless transactions. (3) The multi-hop reasoning is sound: the model synthesizes changes in narrative tone and strategic positioning across two years, correctly inferring a shift in emphasis within Mastercard’s value proposition. The LLM adds contextual insight—linking the change to data-driven, high-margin services and integration with open banking and digital identity—which is consistent with the direction of the 2023 filing and represents reasonable inference without contradicting the ground truth. (4) The only minor gap is that the original answer emphasizes the 2022 grouping with consulting, loyalty, and gateway services, which the LLM summarizes more narrowly as 'fraud-prevention and security offerings'—a slight loss of contextual detail but not a factual error. Overall, the answer captures the core evolution accurately and provides relevant, logically sound interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 403,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "\nThe 2022 Form 10‑K presented “Income Tax Expense and Accruals” as a stand‑alone critical‑accounting‑policy section (page 61) that explained the annual tax‑rate determination, the judgment required, and the establishment of reserves that are adjusted when tax positions are challenged. In the 2023 filing the same topic remains a critical policy, but its discussion has been moved to the “Income Tax Expense and Accruals” subsection (now on page 35) and includes expanded language on transfer‑pricing, pandemic‑related tax risks and the ongoing reassessment of reserves, while preserving the core emphasis on judgment and reserve adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that 'Income Tax Expense and Accruals' was a standalone critical accounting policy in 2022 and remained a critical policy in 2023 but was restructured into a subsection. The mention of page numbers (61 in 2022, 35 in 2023) adds specificity and matches typical 10-K formatting, though such details are not in the ground truth; however, they do not contradict it. (2) There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10 as no inaccuracies exist. (3) The LLM correctly captures the evolution: continued significance, structural change, and enhanced disclosure including new elements like transfer pricing and pandemic-related tax risks, which reflects deeper transparency as noted in the ground truth. The reference to 'expanded language' and ongoing reserve reassessment supports the notion of more detailed reporting. (4) The reasoning is sound and synthesizes the multi-hop requirement—comparing treatment across two years and interpreting the shift in presentation as reflecting improved organization and transparency. The only minor gap is that the LLM does not explicitly mention 'Note 5 - Income Taxes' as a vehicle for deeper disclosure, which is a specific detail in the ground truth. However, the essence of increased structure and transparency is conveyed. Thus, while slightly less comprehensive in referencing supporting notes, the LLM answer remains factually correct and contextually appropriate, warranting a high score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 443,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "\nIn 2023 Intel first demonstrated the Universal Chiplet Interconnect Express (UCIe) in silicon, positioning it as the key interconnect standard for its emerging “systems‑of‑chips” approach. By 2024 the company had folded UCIe into the broader Open System Foundry and IFS Accelerator ecosystem—leveraging its ARM and Synopsys partnerships, reference designs, and design‑win momentum—to make UCIe the default chiplet‑communication standard that underpins Intel’s systems‑level strategy for AI‑centric, chiplet‑based products.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of timeline and strategic evolution of Intel's UCIe standard. It accurately states that Intel demonstrated UCIe in silicon in 2023 and advanced its integration into broader ecosystems by 2024. The mention of Open System Foundry and IFS Accelerator ecosystem, while not explicitly in the original answer, is contextually plausible and consistent with Intel's foundry and partnership initiatives, adding detail without contradicting facts. However, the original answer emphasizes active production and integration into advanced semiconductor assembly and test offerings in 2024, which the LLM answer omits in favor of ecosystem partnerships (ARM, Synopsys) and design wins. These additions are reasonable but shift focus slightly from manufacturing integration to ecosystem expansion, missing a core element of the original's emphasis on production and packaging technologies. There are no numerical inaccuracies (dates 2023/2024 are correct), so quantitative accuracy is perfect. The reasoning is sound and reflects multi-hop understanding of Intel’s strategy evolution, though the synthesis leans more on inferred ecosystem strategy than the documented shift to production. Semantic equivalence is high, with only minor differences in emphasis, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 381,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "\nThe 2023 10‑K describes the $2.0 bn ASR with Citibank that was entered into on January 4 2023, settled in February 2023, and was accounted for by recording the initial 80 % of shares as treasury stock while the remaining forward component was recorded in capital‑surplus equity; the forward was later re‑classified to treasury stock when the final shares were received.  \nThe 2024 10‑K reports a larger $3.0 bn ASR with Morgan Stanley entered into on January 4 2024, under which 85 % of the notional was placed in treasury in January 2024, the forward was recorded as equity in capital‑surplus, and the remaining 15 % of shares were received in March 2024, at which point the forward was re‑classified to treasury stock, completing the transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $2.0 billion ASR with Citibank in 2023 and $3.0 billion with Morgan Stanley in 2024, entry date of January 4 for both, initial share percentages (80% and 85%), and final settlement in February 2023 and March 2024 respectively. The accounting treatment—initial recording of shares as treasury stock, forward portion in capital surplus, and reclassification to treasury stock upon completion—is correctly described. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and timelines match the ground truth. The 2023 ASR concluded in one month (January to February), the 2024 in two months (January to March), which aligns with the original answer. While the exact number of shares (17.4M + 5.4M and 31.4M + 8.3M) is omitted, the percentages and total notional amounts are correct, and the share counts are not required to answer the evolution of accounting and timeline. (3) Multi-hop reasoning is sound: the model correctly compares the two years, identifies consistency in accounting treatment, and notes changes in scale (larger notional, higher initial percentage) and timeline. (4) The only minor omission is the explicit mention of share counts, but since the question focuses on accounting treatment and timeline—not share volume—the answer remains semantically equivalent and fully responsive. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight incompleteness on granular detail, but full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 440,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "\nIn 2022 UPS disclosed a $5.1 billion pre‑tax gain from coordinating benefits with the Central States Pension Fund as part of its actuarial gain/loss, but it did not break out the effect of specific assumptions. By 2023 the company added a quantitative sensitivity analysis that shows a 25‑basis‑point change in the discount rate would alter the projected benefit obligation by roughly $1.55 billion and change expense by about $423 million, and it explicitly references note 5 for the potential coordinating‑benefit liability, indicating a more detailed and transparent reporting of its exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. The ground truth states that UPS disclosed a $2.3 billion pre-tax *actuarial loss* in 2022 related to potential coordinating benefits for the Central States Pension Fund. However, the LLM incorrectly reports a $5.1 billion pre-tax *gain*, which is both the wrong magnitude and the wrong direction (gain vs. loss). This is a critical error in financial reporting context. Additionally, the $1.55 billion and $423 million figures related to a 25-basis-point change in the *discount rate* are fabricated and not present in the original answer; the ground truth specifies that the sensitivity analysis in 2023 focused on a 25-basis-point change in *expected and actual returns on assets*, not the discount rate. (2) Number verification: $5.1B gain (incorrect), $1.55B PBO impact (not in source), $423M expense impact (not in source) — all quantitatively inaccurate. The only correct numeric element is the 25 basis point change, though it is misattributed to the wrong assumption. (3) Multi-hop reasoning is partially present — the model attempts to compare 2022 and 2023 reporting approaches and notes increased transparency with reference to Note 5, which aligns with the original answer. However, the reasoning is built on false premises due to incorrect numbers and misidentified assumptions. (4) Contextual relevance is moderate because the answer addresses the evolution of disclosure and mentions Note 5 correctly, but the core financial facts and actuarial concepts are wrong, undermining the overall correctness. The shift from specific quantification to sensitivity analysis is noted, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 458,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved from describing cyber‑and‑intelligence solutions simply as a “value‑added service” that fuels other‑revenue growth to positioning them as a strategic pillar of its “secure, simple, smart and accessible” payments ecosystem.  In the 2022 filing the company highlighted that growth in its Cyber & Intelligence and Data & Services solutions drove the bulk of other‑revenue gains, while the 2023 filing expands the narrative to stress that these solutions—augmented by open‑banking and digital‑identity capabilities—deliver trusted, data‑driven insights that differentiate Mastercard’s network and reinforce its value proposition to investors, partners and customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in Mastercard's messaging between 2022 and 2023: from positioning Cyber and Intelligence Solutions as a value-added service contributing to other revenue in 2022, to a strategic pillar of the broader payments ecosystem in 2023. The emphasis on secure, simple, smart, and accessible payments is consistent with Mastercard's public narrative. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes in tone and strategic emphasis across the two years, noting the expanded role of cyber solutions in conjunction with open banking and digital identity, which matches the ground truth's mention of new networks. The only minor shortcoming is that the LLM does not explicitly mention the 'principled use of data' emphasis from 2022, which is a small but relevant detail about stakeholder communication. (4) Despite this slight omission, the LLM conveys the core evolution in value proposition and strategic integration, making the answer semantically equivalent and contextually excellent. The response is directly relevant and addresses all key aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 367,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings, PepsiCo switched the way it cited the 4.450 % Senior Note due 2046. In the 2022 filing (page 126) the note is referenced as **Exhibit 4.13** and is tied to a **February 24, 2016** Form 8‑K filing. In the 2023 filing (page 125) the same instrument is cited as **Exhibit 4.11** and is linked to an **October 14, 2015** Form 8‑K, indicating a change in both the exhibit number and the source documentation date.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is completely incorrect in terms of quantitative accuracy. According to the ground truth, in the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12 and referenced the Form 8-K filed on October 14, 2015. In the 2023 filing, it was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. The LLM answer reverses both the exhibit numbers and the associated Form 8-K dates: it claims Exhibit 4.13 and February 24, 2016 in 2022 (wrong), and Exhibit 4.11 and October 14, 2015 in 2023 (also wrong). These are direct factual inversions of the ground truth. The multi-hop reasoning is therefore flawed, as the model failed to correctly identify or synthesize the exhibit numbering and documentation dates across the two filings. While the answer attempts to address the question's focus on exhibit referencing and documentation dates, the complete reversal of data renders it factually invalid. The contextual relevance is low but not zero because the structure of the response matches the question's intent—discussing changes in exhibit references and source dates—though the content is entirely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 327,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "\nIntel continued to interact with Positive Technologies solely under the OFAC‑issued license that permits limited security‑research and vulnerability‑coordination activities; the company confirmed that no revenues or profits are derived from these dealings and that it plans to keep the communications going in accordance with the license terms【69†page_69】【55†page_55】.  Thus, between 2023 and 2024 the relationship showed no substantive change—it remained a sanctioned‑compliant, non‑commercial engagement focused on coordinating disclosures, still authorized by the same OFAC license.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Intel's engagement with Positive Technologies remained under an OFAC license, non-commercial, and focused on vulnerability coordination, with no revenues or profits—this aligns with the ground truth. Quantitatively, there are no numerical inaccuracies, and the citations reference appropriate content, so quantitative accuracy is high. However, the key deficiency lies in qualitative accuracy: the LLM incorrectly asserts that there was 'no substantive change' between 2023 and 2024, directly contradicting the ground truth, which emphasizes an evolution in tone and intent—from disclosing past communication in 2023 to expressing a forward-looking intent to continue the relationship in 2024. This shift reflects a more sustained and proactive posture under the license, which the LLM answer fails to acknowledge. Thus, while the factual components are present, the reasoning and synthesis across years is flawed, missing the nuanced but important evolution in Intel's disclosure strategy and relationship framing. Contextual relevance is strong as the answer addresses the core topic of sanctioned engagement, but the failure to capture the progression undermines the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 347,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "\nThe $4.78 % senior notes maturing in March 2038 stayed at **$5 billion** in both the 2023 and 2024 borrowings tables, showing no increase or repayment of that tranche.  This indicates that CVS is maintaining a sizable, long‑dated fixed‑rate debt pillar while refinancing nearer‑term maturities through newer issuances and commercial‑paper funding, underscoring a stable long‑term debt structure anchored by large, far‑out obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies that the balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5 billion (equivalent to $5,000 million) in both 2023 and 2024, matching the ground truth exactly in value and year. The formatting difference ($5 billion vs $5,000 million) is acceptable and semantically equivalent. 2) All quantitative elements are accurate: the amount ($5 billion), the interest rate (4.78%), and the maturity date (March 2038) are correctly reported. There are no calculation errors. 3) The reasoning is sound: the LLM correctly infers that the stability of this debt tranche indicates CVS is maintaining a long-dated, fixed-rate debt component. It also correctly contrasts this with refinancing activity in other tranches (implied by mentioning newer issuances and commercial paper), though it does not explicitly name the 2.7% senior notes due August 2040 as in the ground truth. This is a minor omission in completeness but does not detract from the core multi-hop insight—stable long-term structure with selective refinancing. 4) The answer is contextually relevant, directly addressing both parts of the question: the evolution of the specific notes and what it indicates about long-term debt structure. The qualitative interpretation is strong and logically derived, earning a 9 due to the lack of explicit comparison to other notes mentioned in the ground truth, which would have strengthened completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 398,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "\nThe 0.835 % Notes due 2032 remained on Exxon Mobil’s registration list in both filings.  \n\n- In the 2022 Form 10‑K (page 1) the notes were listed as “0.835 % Notes due 2032 – XOM32 – New York Stock Exchange.”  \n- The 2024 Form 10‑K (page 1) shows the identical entry, confirming that the notes were still registered, outstanding and trading on the NYSE under the ticker XOM32, with no indication of redemption, default or amendment between the two filings.  \n\nThus, the security’s status did not change – it continued to be a registered, publicly‑traded debt issue of Exxon Mobil.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the 0.835% Notes due 2032 remained listed in both the 2022 and 2024 SEC filings with the trading symbol XOM32 and were still registered and trading on the NYSE. All quantitative details—interest rate (0.835%), maturity year (2032), ticker (XOM32), and exchange (NYSE)—are correct and match the ground truth. The answer correctly identifies the continuity of the 2032 notes’ status, which is the core of the question. However, it omits a key comparative insight present in the original answer: the disappearance of the 0.142% Notes due 2024 (XOM24B) from the 2024 filing, which provides context for changes in Exxon Mobil’s broader debt structure. While the LLM accurately reports the status of the 2032 notes, it fails to synthesize the multi-hop element—comparing the evolution of multiple debt instruments across filings to infer a shift in short-to-intermediate term debt composition. This limits the qualitative depth and completeness of the response. Despite this omission, the answer remains factually sound and directly relevant, earning high marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 326,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "\nBetween 2022 and 2024 American Express trimmed its U.S. Government treasury allocation from roughly $1.7 bn (about 68 % of its AFS debt portfolio) to about $0.29 bn (≈ 24 % of AFS debt), reflecting a deliberate reduction in treasury exposure.  The maturity profile shifted dramatically, moving from a laddered mix that included sizable 1‑5‑year and 5‑10‑year positions in 2021 to a near‑all‑short‑term stance by 2024, with more than 90 % of the remaining treasury holdings maturing within five years and virtually none beyond that.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 American Express held $477 million in short-term U.S. Treasury obligations with no long-term exposure. By 2024, it diversified into intermediate-term holdings ($98 million) while reducing short-term to $189 million. The LLM instead claims a reduction from $1.7 billion in 2022 to $0.29 billion in 2024, which contradicts the ground truth on both absolute values and trend direction. The percentages cited (68% and 24%) are unsupported by the provided data. (2) The quantitative inaccuracies are severe: the LLM reports a total portfolio value (~$1.7B and ~$0.29B) and percentage allocations not present in the original answer. It also misrepresents the maturity shift—claiming a move to 'near-all-short-term' by 2024, whereas the truth is a diversification *into* intermediate-term, away from *exclusive* short-term. The claim that in 2021 there was a 'laddered mix' including 5–10 year positions is irrelevant (question asks about 2022–2024) and unsupported. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the evolution from 2022 (only short-term) to 2024 (short + intermediate-term), instead asserting a continued short-term concentration. It introduces data from 2021 and mischaracterizes the strategic shift. (4) Contextual relevance is moderate—the answer addresses investment strategy, fair value, and maturity distribution, but with incorrect data and inverted conclusions. Due to major factual and directional errors, the correctness score is low at 2, with similarly low quantitative accuracy. Qualitative accuracy is slightly higher due to correct use of financial terminology and structure, but reasoning is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 480,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "\nAmazon first issued the 2.500% Note due 2050 in a June 3 2020 officers’ certificate, which is listed in the 2022 10‑K (Exhibit 4.5). The subsequent 2022 and 2024 filings show the tranche remained outstanding with no amendment, redemption, or new issuance disclosed—it continued to be reported as senior unsecured debt in the company’s long‑term‑debt schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitative accuracy: All dates (June 3, 2020), percentages (2.500%), and maturities (2050) are correct. The reference to Exhibit 4.5 in the 2022 10-K matches the original answer. (2) Completeness: The answer correctly identifies the introduction of the note in 2020 and its continued presence through 2024 without modification. While it does not explicitly mention Exhibit 4.6 in the 2024 filing, it correctly infers that the note remained outstanding with no amendments, redemptions, or new issuances, which is consistent with the ground truth's claim of replication. (3) Entity accuracy: Amazon, the 2.500% Note due 2050, and the correct time frame (2022–2024) are properly identified. (4) Reasoning: The multi-hop synthesis across years and filings is sound—correctly linking the 2020 issuance to 2022 and 2024 disclosures. (5) Semantic equivalence: Though the LLM does not explicitly state that Exhibit 4.6 in 2024 was an 'exact replication' of Exhibit 4.5, it effectively conveys the same conclusion—that the note was maintained without change. This minor omission prevents a perfect 10, but the core facts and reasoning are correct. Hence, a score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 350,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "\nBetween the 2022 filing and the 2023 filing, the Citibank, N.A. Co‑Branded Credit Card Agreement moved from the **Eighth Amendment** (recorded as 10.8.8, filed 3/10/2022) to **four additional amendments**—the Ninth, Tenth, Eleventh and Twelfth—filed in late 2022 and throughout 2023 (10.8.9 through 10.8.12). Consequently, the total number of amendments grew from eight in 2022 to at least twelve by the end of 2023, reflecting a series of incremental updates to the credit‑card agreement over that period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the Eighth Amendment as the most recent in 2022, filed on March 10, 2022, and correctly states that by 2023, the Twelfth Amendment was filed, indicating four additional amendments (Ninth through Twelfth). (2) The dates and amendment numbers match the ground truth; the LLM correctly infers that four amendments occurred between the Eighth and Twelfth, even though exact filing dates for the Ninth to Eleventh are not specified. The reference to 'late 2022 and throughout 2023' aligns with the October 11, 2023 filing of the Twelfth Amendment. (3) The multi-hop reasoning is sound: the model correctly synthesizes the progression of amendments across years and calculates the number of new amendments (12 - 8 = 4). (4) All entities—Citibank, N.A. Co-Branded Credit Card Agreement, amendment numbers, and time frame—are correctly identified and contextualized. The answer is complete, factually accurate, and directly addresses the evolution of the number of amendments from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 311,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA broadened CUDA from a GPU‑only parallel‑programming layer into a full‑stack, hardware‑agnostic foundation that spans GPUs, DPUs and CPUs and is embedded in end‑to‑end AI platforms such as AI Enterprise, Omniverse and the DRIVE Hyperion automotive stack.  This period saw the rollout of new silicon (Orin SoC, DPUs added in 2022 and CPUs in 2024) and the launch of Blackwell‑class GPUs, with CUDA now tightly coupled to software services like DGX Cloud, NIM, NeMo and AI Blueprints, enabling developers to deploy AI workloads across data‑center, automotive and graphics ecosystems while using the same CUDA‑based programming model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of CUDA from a GPU-centric programming model in 2022 to a full-stack, heterogeneous computing platform by 2024. The integration with CPUs (introduced in fiscal 2024), DPUs, and new architectures like Orin SoC is accurately noted, matching the original answer's emphasis on expanded data center platforms. The mention of CUDA’s role in AI Enterprise, Omniverse, and DRIVE Hyperion reflects correct synthesis across software ecosystems. The reference to Blackwell-class GPUs, DGX Cloud, NIM, NeMo, and AI Blueprints adds timely detail consistent with NVIDIA's 2024 direction. While the original answer does not explicitly name 'Blackwell' or 'Orin SoC', these are factually correct product launches within the timeframe and support the broader narrative of deeper integration. The only minor gap is that the original emphasizes CUDA-X libraries and domain-specific frameworks more centrally, which the LLM mentions implicitly through software services but could have named explicitly. No numeric inaccuracies exist—dates (2022, 2024), product rollouts, and architectural expansions are correctly used. The reasoning is sound, showing multi-hop understanding across hardware (GPUs, CPUs, DPUs), software (AI Enterprise, Omniverse), and strategic positioning. Semantic equivalence is strong, with slightly more product-specific detail in the LLM answer than the original, which is acceptable and enriching.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 414,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "\nPfizer’s Paxlovid revenue collapsed from $18.9 bn in 2022 to $1.28 bn in 2023, and in 2024 the company recorded about $5.7 bn of product revenue—including a $442 m SNS delivery and a $771 m favorable adjustment to the $3.5 bn fourth‑quarter 2023 revenue reversal.  At the same time, deferred revenue linked to Paxlovid fell from $5.1 bn (as of 31 Dec 2023) to $2.2 bn (as of 31 Dec 2024), reflecting the transition from government‑procured EUA sales to commercial market contracts, with roughly $1 bn of contracted revenue still expected to be recognized through 2028.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant quantitative inaccuracies. It correctly identifies the $1.28 billion Paxlovid revenue in 2023 (matching the ground truth $1.279 billion), the $3.5 billion non-cash revenue reversal in Q4 2023, the $771 million favorable adjustment in 2024 due to lower-than-expected returns, and the $442 million SNS-related revenue. However, it incorrectly states that Pfizer recorded 'about $5.7 billion of product revenue' in 2024, which is not supported by the ground truth—no such total product revenue figure is mentioned, and the $771M + $442M = $1.213B in additional revenue does not imply $5.7B total. This number appears fabricated or misattributed. Additionally, the LLM introduces deferred revenue figures of $5.1B (end-2023) and $2.2B (end-2024), which are not present in the original answer and contradict the ground truth focus on remaining performance obligations of $1B as of 2024. (2) While the $771M adjustment and $442M SNS revenue are accurate and correctly contextualized, the unsupported $5.7B revenue claim and incorrect deferred revenue numbers severely undermine quantitative accuracy. The calculation of the net impact in 2024 ($771M + $442M = $1.213B added back) is plausible but not explicitly confirmed in the ground truth, which only states these were separate favorable adjustments. (3) The qualitative reasoning is sound in interpreting the shift from government EUA-driven sales to contracted commercial supply, and the mention of $1B in future contracted revenue aligns with the ground truth's 'remaining performance obligations' through 2028. This shows correct multi-hop synthesis of evolving contractual obligations. However, the introduction of unverified deferred revenue balances weakens the reasoning. (4) Contextual relevance is high—the answer directly addresses revenue recognition changes and contractual evolution. Despite factual errors, it captures the narrative arc of declining government demand, adjustments due to returns, SNS formation, and transition to long-term contracts. The core story is aligned, but key numbers are incorrect, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 589,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "\nBetween 2022 and the end of 2024 the pool of shares reserved for future grants under ExxonMobil’s 2003 Incentive Program fell sharply—from about **65.8 million shares** available for award in 2022 (as disclosed in the 2022 proxy filing) to **≈47 million shares** remaining at year‑end 2024.  This reduction reflects the program’s continued use for new restricted‑stock, stock‑option and SAR grants, including the conversion of Pioneer RSUs acquired in the May 2024 merger, while the plan’s structural limits (a 220 million‑share ceiling, no expiration date and no counting of forfeited, expired or cash‑settled awards) remained unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the share pool 'fell sharply' from 65.8 million in 2022 to 47 million in 2024, implying a reduction in the total authorized shares. However, the ground truth states that the total maximum number of shares was *increased* to 220 million by 2024, with 47 million of those remaining available. The LLM incorrectly frames a structural expansion as a contraction. (2) Quantitative accuracy is partially correct on individual numbers: 65.8 million ≈ 65,754,069 (acceptable rounding), and 47 million matches. However, it omits the critical fact that the cap was raised to 220 million, and misrepresents the 47 million as a reduction rather than a residual after increased issuance. It also fails to mention the increase in restricted stock units granted from 9,392 thousand to 10,393 thousand. (3) Multi-hop reasoning is flawed: the model correctly identifies usage of the plan and references the Pioneer merger, but fails to synthesize the key structural change—the increase in total authorized shares. Instead, it assumes the total pool shrank, which contradicts the ground truth. The mention of structural limits (220 million ceiling, no expiration) is accurate but presented without context of the increase. (4) Contextual relevance is high—the answer addresses share availability, time frame, and program structure—but the core factual error about the direction of change (decrease vs. increase in total shares) severely undermines correctness. The qualitative score reflects accurate terminology and some correct details, but flawed synthesis. Quantitative score is low due to missing the 220 million figure and misrepresenting trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 468,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "\nBetween 2022 and 2024 AdSense moved from a stand‑alone publisher‑network product to a central pillar of Google’s AI‑enhanced advertising stack, feeding directly into the broader Google Ads/Google Network ecosystem.  The service now runs on Gemini‑powered bidding and creative tools (e.g., Performance Max, Demand Gen, Product Studio) that unify search, YouTube, display and brand‑video inventory, so AdSense’s inventory is no longer siloed but part of an end‑to‑end portfolio that spans performance‑ and brand‑advertising, cross‑device measurement and AI‑driven ad creation.  This integration has expanded its contribution to Google’s overall advertising revenue while tying it tightly to the company’s wider advertising‑technology portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the evolution of AdSense. The original answer states that AdSense was a key growth driver in 2022 with an $8.6B YoY increase in Google Network revenue (attributed collectively to AdSense, AdMob, and Google Ad Manager), but by 2024, AdSense was no longer called out as a specific growth lever. In contrast, the LLM claims AdSense evolved into a 'central pillar' powered by Gemini AI and integrated into Performance Max and Demand Gen, which contradicts the ground truth that newer AI products replaced AdSense as growth drivers. (2) There are no correct quantitative elements: the $8.6B figure is entirely omitted, and no accurate revenue data or year-over-year changes are mentioned. The LLM introduces unsupported claims about integration with AI tools without any numerical or strategic backing from the original. (3) The multi-hop reasoning is flawed: while the question requires synthesis of AdSense’s changing role across 2022–2024, the LLM incorrectly infers deeper integration and enhanced strategic importance, when the truth indicates a decline in emphasis—shifting from highlighted contributor to a mature, background offering. It fails to recognize the strategic demotion implied by the removal of AdSense from explicit growth narratives. (4) Despite these issues, the answer is contextually relevant—addressing the evolution of AdSense within Google's ad portfolio—and uses appropriate terminology (e.g., Google Network, Performance Max), earning moderate scores for qualitative accuracy and high relevance. However, the lack of factual alignment, especially on quantitative and strategic points, limits correctness to a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 474,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "\nBetween 2022 and 2023 the UPS Retirement Plan moved non‑union participants from a traditional defined‑benefit accrual to a defined‑contribution structure. Effective January 1 2023 the plan stopped accruing any additional defined‑benefit benefits for future service and compensation for these participants, and instead began providing a retirement contribution of **5 %–8 % of eligible compensation** (up from the prior **3 %–8 %** rate for employees hired after July 1 2016) into the UPS 401(k) Savings Plan, with the exact rate tied to years of vesting service. This amendment replaces the former benefit‑accrual mechanism with a fixed employer contribution that will fund retirees’ retirement income going forward.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding the introduction of a defined-contribution structure and specific contribution percentages, which are not supported by the ground truth. While the cessation of benefit accruals for non-union participants effective January 1, 2023 is correctly identified, the LLM incorrectly states that UPS shifted to a defined-contribution model with 5%–8% employer contributions to the 401(k) plan, increasing from a prior 3%–8% rate. The original answer does not mention any such contribution changes or the replacement of the defined-benefit plan with a defined-contribution structure. This is a critical error in both quantitative and qualitative terms. The dates (January 1, 2023) and the population affected (non-union participants) are accurate, and the answer correctly identifies the accrual freeze as a key change, satisfying part of the multi-hop requirement. However, the reasoning is flawed because it fabricates a new contribution structure not present in the source. The answer is contextually relevant and addresses the evolution of the plan and changes to future accruals, but the invented details about 401(k) contribution rates severely undermine factual correctness. No calculations are performed, but the inclusion of unsupported percentages (5%, 8%, 3%) fails the quantitative accuracy check. Overall, the answer captures the high-level change (accrual freeze) but misrepresents the strategic shift by adding unverified elements about replacement benefits.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 422,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon replaced its relatively small, secured $1 billion revolving line (which bore interest at LIBOR + 1.40 % and a 0.5 % commitment fee and had about $800 million drawn in 2021) with a much larger, unsecured $15 billion revolving credit facility (maturing 2028, interest = benchmark + 0.45 % with a 0.03 % fee) and a $5 billion 364‑day revolving facility (maturing 2025, interest = SOFR + 0.45 % and a 0.03 % fee).  Although the new facilities provide far greater credit capacity, Amazon has kept borrowings essentially at zero on these lines, relying instead on modest commercial‑paper programs and other short‑term facilities that had only about $150 million outstanding as of 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite capturing the general trend of increased credit capacity and low utilization. (1) Quantitative inaccuracies: The 2022 facility was $7.0 billion (not $1 billion), unsecured (not secured), with interest at benchmark + 0.50% (not LIBOR + 1.40%) and a 0.04% commitment fee (not 0.5%). No borrowings were outstanding in 2022, contradicting the claim of $800 million drawn in 2021 under that facility. The ground truth states no borrowings under the main credit agreements in 2023–2024, but the LLM incorrectly implies the $150 million in other short-term borrowings are from commercial paper, which is unsupported. (2) The $15 billion and $5 billion facilities in 2024 are correctly identified in amount, interest rate (benchmark/SOFR + 0.45%), and fee (0.03%), aligning with the ground truth. (3) Reasoning is partially sound in noting increased capacity and minimal drawdowns, but flawed in describing the structure and terms of the earlier facility and misrepresenting the source of short-term borrowings. (4) Contextually relevant and addresses credit capacity, interest terms, and utilization, but major numerical and factual errors reduce correctness. Semantic equivalence fails on key financial terms and figures, warranting a low quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 367,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "\nCostco’s disclosures for both 2022 (p. 31) and 2023 (p. 47) show that it continued to supplement fixed‑price energy contracts with index‑based variable‑priced contracts for electricity, natural‑gas and fuel, and that these variable contracts are accounted for under the “normal purchases and normal sales” exception with no mark‑to‑market adjustments. This consistency indicates that the company’s commodity‑price risk strategy relies on a blended approach—using fixed contracts to secure stability while retaining variable, index‑linked contracts to capture market movements without creating earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Costco used variable-priced, index-based contracts in both 2022 and 2023 for electricity, natural gas, and fuel, and that these qualify for the 'normal purchases and normal sales' exception with no mark-to-market adjustments—this matches the original answer exactly. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all references to years (2022, 2023) and page numbers (p. 31, p. 47) are consistent with expected disclosure locations and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the strategy remained consistent across years and infers a blended risk management approach—this is a reasonable interpretation supported by the data, even if the original answer emphasizes 'no significant shift' rather than explicitly calling it a 'blended approach.' The only minor difference is that the LLM answer includes electricity in the 2023 emphasis, while the original specifies natural gas and fuel as 'key components' in 2023, slightly overgeneralizing. However, this does not constitute a factual error, as electricity was still part of the broader category. (4) The answer is fully relevant, directly addressing both the evolution (consistency) and strategic implication (stable, blended risk management). Thus, the correctness score is 9 due to slight overinclusion of electricity in the 2023 focus, but all key facts, entities, and reasoning are accurate and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 449,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "\nBetween 2022 and 2024, NVIDIA AI Enterprise moved from a newly‑launched, add‑on software stack that complemented the data‑center GPU portfolio to a core, revenue‑generating pillar of the company’s data‑center offering.  In 2022 it was introduced as a paid, enterprise‑focused suite (NIM, Nemo, AI Blueprints) for simplifying production‑grade generative‑AI deployment, while by 2024 it was tightly integrated with the full‑stack accelerated‑computing platform—including the Blackwell architecture—and expanded with performance‑boosting features (2.5× token‑throughput, model‑curation tools, privacy‑preserving AI Blueprints), positioning AI Enterprise as the primary commercial vehicle for NVIDIA’s end‑to‑end AI workloads across cloud, on‑prem and edge environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of NVIDIA AI Enterprise from a foundational, enterprise-focused software suite in 2022 to a core, revenue-generating component of the data center offerings by 2024. The description of it being a 'comprehensive suite' and 'primary commercial vehicle' matches the original answer's emphasis on monetization and integration. (2) Quantitatively, the LLM introduces specific performance metrics such as '2.5× token-throughput' and references to NIM, Nemo, and AI Blueprints. While these details are not present in the ground truth, they are plausible enhancements consistent with NVIDIA's public roadmap and do not contradict known facts. Since the ground truth does not include quantitative metrics, the LLM's inclusion of them does not reduce accuracy but adds contextual detail. (3) The multi-hop reasoning is sound: the answer synthesizes the product’s strategic positioning over time, links it to broader platform developments (e.g., Blackwell architecture, full-stack platform), and correctly situates it within cloud, on-prem, and edge environments—reflecting NVIDIA’s expanded commercial reach. (4) Minor deduction in qualitative accuracy due to the introduction of specific features (e.g., privacy-preserving AI Blueprints, 2.5× throughput) not verifiable from the ground truth, though they are reasonable inferences. Overall, the answer captures the strategic shift accurately and enriches it with contextually appropriate details, earning high marks for correctness, relevance, and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 439,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer’s Paxlovid contracts moved from heavy reliance on government‑procured, advance‑payment agreements (which generated ≈ $5 bn of deferred revenue in 2023) to a commercial‑market model with far lower deferred balances (≈ $2.2 bn as of Dec 31 2024) and only about $1 bn of remaining performance‑obligation revenue expected to be recognized through 2028.  The shift reflects Pfizer’s expectation that future Paxlovid sales will be limited to modest, long‑term commercial supply arrangements rather than the blockbuster, government‑driven revenues of the prior year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key quantitative details. The ground truth states that Pfizer recorded a $3.5 billion non-cash revenue reversal in Q4 2023 due to expected returns of 6.5 million treatment courses under EUA from the U.S. government. However, the LLM incorrectly frames this as ≈$5 billion of deferred revenue in 2023, which is factually wrong in both amount and characterization (it was a reversal, not deferred revenue). Additionally, the LLM claims deferred balances were ≈$2.2 billion as of Dec 31, 2024, but the ground truth reports remaining performance obligations at approximately $1 billion as of that date. The $1 billion figure for future revenue recognition through 2028 aligns roughly with the ground truth, though the time horizon (through 2028) is not mentioned in the original and may be extraneous or unverified. (2) The core financial figures are thus partially incorrect: $5B deferred revenue and $2.2B deferred balance are not supported by the ground truth; only the $1B remaining obligation is approximately correct. The critical $3.5B reversal is entirely omitted. (3) The qualitative reasoning about a shift from government-driven to commercial demand is plausible and reflects a reasonable interpretation of the trend, showing sound multi-hop logic in inferring future revenue expectations. The LLM correctly identifies the move toward lower, more stable future revenues and interprets the decline in obligations as signaling reduced blockbuster potential. However, it fails to mention the key event of the 2023 revenue reversal due to product returns, which is central to understanding the uncertainty in 2023. (4) Despite missing the most critical financial event (the $3.5B reversal), the answer captures the directional shift in contractual obligations and offers a coherent explanation of future revenue expectations. Hence, correctness is partially accurate but undermined by significant numerical and factual errors, warranting a score of 6. Quantitative accuracy is low (5) due to incorrect figures, qualitative accuracy is moderate (7) due to sound reasoning on an incomplete factual basis, and contextual relevance is high (9) as the response directly addresses the evolution and implications of contractual obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 613,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s view of regulatory risk in overseas markets shifted from a focus on general cross‑border hurdles—such as foreign‑ownership limits, sanctions, export‑control restrictions, anti‑corruption rules and basic data‑privacy compliance—to a much broader set of technology‑driven and geopolitical concerns.  The 2022 filing highlighted currency exposure, investment‑valuation uncertainty and the need to navigate differing labor and tax regimes, whereas the 2024 filing adds explicit warnings about emerging AI‑related liabilities, stricter data‑privacy and security obligations, supply‑chain vulnerabilities tied to sanctions‑related components, and the potential for new foreign‑policy‑driven regulations (e.g., EU‑U.S. data‑transfer rules) that could impose fresh compliance costs and brand‑reputational risk.  In short, the scope of regulatory challenges expanded from traditional trade and anti‑corruption issues to include AI, data‑privacy, cyber‑security and geopolitical‑risk‑linked compliance requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low because the LLM misrepresents the actual content of Google's filings. The original answer states that in 2022, Google specifically cited 'data transfers between the EU and the UK' and 'new customer requirements' as regulatory concerns, and by 2024 expanded to include 'uncertainty regarding regulatory outcomes' and risks under 'local laws that may not offer due process.' In contrast, the LLM answer fabricates details not present in the ground truth, such as 'foreign-ownership limits,' 'sanctions,' 'export-control restrictions,' 'anti-corruption rules,' 'AI-related liabilities,' 'supply-chain vulnerabilities,' and 'brand-reputational risk.' These were not mentioned in the original knowledge graph. While the LLM correctly identifies a broadening of regulatory scope over time, it invents specific regulatory domains (e.g., AI, anti-corruption, labor regimes) that are unsupported by the source. The core evolution—from data-transfer issues to broader legal uncertainty—is partially aligned, but the LLM introduces significant hallucinated content, undermining factual correctness. Contextual relevance is moderate because the answer addresses regulatory evolution but with incorrect specifics. Multi-hop reasoning is flawed due to reliance on non-existent details rather than accurate synthesis from the provided years and filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 417,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "\nBetween 2022 and 2023 UPS reduced the amount of new cash it must put into the post‑retirement medical fund – from about **$177 million** of employer contributions in 2022 (see page 109) to roughly **$74 million** projected for 2024 (see pages 92‑93).  The source of the benefit payments themselves has not changed; they are still expected to be paid primarily from **plan trusts, with corporate assets providing the remainder** (as noted in the “Expected Benefit Payments” tables on pages 109 and 92‑93).  Thus, the evolution is a **significant cut in required employer contributions**, while funding continues to rely on the same trust‑and‑corporate‑asset mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that the source of postretirement medical benefit payments remains the same between 2022 and 2023—paid from plan trusts and corporate assets—which aligns with the ground truth. However, it introduces a significant quantitative inaccuracy by citing $177 million in employer contributions for 2022 and $74 million projected for 2024, neither of which are mentioned in the original answer or supported by the question context. The original answer states there was no change in funding sources but does not provide any figures on employer contributions or trends in cash inputs. The inclusion of specific dollar amounts and a projection for 2024 (not 2023) reflects a failure in quantitative accuracy and introduces data not present in the ground truth. While the qualitative reasoning about continuity in funding sources is sound and contextually relevant, the unsupported numbers undermine factual correctness. The model appears to have hallucinated specific financial figures and misaligned the time frame (using 2024 instead of 2023), which constitutes a major error in a financial multi-hop evaluation. Thus, while the core concept of unchanged funding mix is correct, the erroneous numerical claims reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 352,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "\nFrom its 2022 launch, NVIDIA AI Enterprise was positioned as a modest, enterprise‑grade software stack for AI workloads. By 2024 the offering had grown into a full‑stack, end‑to‑end AI platform that is tightly coupled with the Blackwell data‑center architecture, DPUs and networking, and delivered through services such as DGX Cloud and expanded AI‑Enterprise modules (NIM, NeMo, AI Blueprints), delivering broader workload coverage, higher performance and deeper integration across cloud, on‑prem and edge environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 2022 introduction of NVIDIA AI Enterprise as an enterprise software stack and its 2024 evolution into a full-stack, integrated AI platform. Key components mentioned—NIM, NeMo, and AI Blueprints—match the original answer. (2) There are no explicit numerical values (e.g., 2.5x token throughput) in the LLM answer, but it does not fabricate any numbers and avoids quantitative claims not in the source. The absence of the specific 2.5x improvement is a minor omission but does not detract significantly from correctness. (3) The reasoning is sound: it captures the multi-hop evolution from a foundational suite to a broader, integrated platform with expanded deployment options (cloud, on-prem, edge), and correctly links it to hardware (Blackwell, DPUs, networking) and services (DGX Cloud), demonstrating proper synthesis. (4) The answer is contextually relevant, directly addressing the evolution in role and scope from 2022 to 2024. The only reason for not scoring a 10 is the omission of the specific performance metric (2.5x token throughput), which was present in the ground truth and adds concrete evidence of enhancement. Otherwise, the semantic meaning and factual content are equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 361,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "\nBetween 2022 and 2024 ExxonMobil’s proved reserves that are reported through equity‑company affiliates grew sharply – from roughly **1.2 billion oil‑equivalent barrels (boe)** in 2022 to **about 2.0 billion boe** by the end of 2024.  The increase is driven almost entirely by large additions in **Africa (e.g., Angola, Mozambique, Chad) and Asia (e.g., Kazakhstan, Azerbaijan)**, while U.S. equity‑company reserves stayed essentially flat.  This pattern shows that ExxonMobil is deliberately concentrating its equity‑based reserve base in high‑potential overseas basins to secure future production growth and to diversify its geographic exposure away from domestic, mature fields.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative data. According to the ground truth, ExxonMobil's proved reserves from equity companies were 14 million barrels gross (1 million net) in 2022. The LLM claims 1.2 billion boe in 2022 and 2.0 billion boe in 2024—over 85 times larger than the actual gross figure for 2022. This is a massive overstatement. Additionally, the 2024 ground truth specifies 467 million barrels of crude oil, 120 million barrels of NGLs, and 5,367 billion cubic feet of natural gas—with the growth concentrated in Asia. The LLM incorrectly attributes major growth to Africa and Asia, including countries like Angola, Mozambique, Chad, Kazakhstan, and Azerbaijan, which are not mentioned in the ground truth. The U.S. equity reserves being 'flat' is also unsupported. (2) The numbers are entirely fabricated or misattributed. There is no indication in the original answer that reserves were measured in billions of boe, nor that Africa played a major role. The conversion from physical units to boe is not provided or justifiable here. (3) The multi-hop reasoning is flawed: the LLM invents regional contributions and strategic emphasis on Africa and specific countries not in the source. While it correctly infers a strategic shift toward international equity investments, the geographic emphasis on Asia in the ground truth is diluted and distorted by adding unsupported African growth. (4) The contextual relevance is moderate because the answer addresses the evolution of equity-company reserves and attempts to interpret strategic positioning. However, due to severe factual inaccuracies in numbers and regions, the qualitative and quantitative accuracy scores are very low. The correctness score is 2 because the only element aligning with the ground truth is the general idea of growth in equity-company reserves and a strategic shift—though the details that support this conclusion are entirely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 528,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "\nBetween 2022 and 2024 the cash outflows for Google’s Traffic‑Acquisition Costs—i.e., payments to Google Network Partners—rose steadily (from roughly $13 billion in 2022 to $15 billion in 2023 and about $17 billion in 2024), reflecting a larger, more‑active partner ecosystem that continues to monetize the bulk of the company’s advertising inventory. Because Google records those ads on a gross basis, the growing TAC spend is classified as cost of revenues, so the expanding partner network drives higher gross revenue but also lifts the cost side of the ledger, modestly compressing the net margin of the Google Services segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts for Traffic-Acquisition Costs (TAC) — $13B in 2022, $15B in 2023, and $17B in 2024 — which are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate but are not supported by the knowledge graph data given, making them potentially hallucinated. The original answer does not provide any numerical data on TAC or revenue trends, so the inclusion of these numbers undermines quantitative accuracy. (2) While the LLM correctly identifies that payments to Google Network Partners are recorded as cost of revenues and that Google reports ad revenue on a gross basis, it fails to capture the key evolution highlighted in the original answer: the shift in financial reporting emphasis from revenue generation (2022) to cost structure and cash flow usage (2024). Instead, the LLM focuses on margin compression and growing partner monetization, which is plausible but not aligned with the ground truth's focus on reporting framing and cash flow classification. (3) The multi-hop reasoning is partially sound — it connects Google Network Partners to TAC, cost of revenues, and gross reporting — but misses the core conceptual shift between 2022 and 2024 regarding how the relationship is framed in financial disclosures. The original answer emphasizes a change in narrative (from revenue role to cost/cash use), while the LLM emphasizes scale and margin impact. (4) Contextual relevance is high because the answer addresses the financial relationship, revenue, and cost aspects, but correctness is limited due to unsupported numbers and misaligned qualitative evolution. Without verification of the TAC figures, the answer cannot be considered factually accurate, warranting a low-to-mid score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 494,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s exposure to undesignated foreign‑currency forward contracts fell dramatically, cutting the earnings‑impact from a $69 million loss to only a $7 million loss (as shown in the “Income Statement Recognition of Non‑Designated Derivative Instruments” table).  This reduction reflects a more disciplined hedging program—shifting toward designated cash‑flow hedges and trimming the notional of outstanding forwards (e.g., a large drop in HKD‑linked contracts)—and therefore markedly lowered earnings volatility from foreign‑exchange risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims specific dollar amounts—$69 million loss in 2022 and $7 million loss in 2023—for undesignated derivative impacts, but the original answer (ground truth) contains no such figures. There is no mention of actual losses or a 'table' showing these numbers in the ground truth, making these values fabricated. (2) COMPLETENESS: The question asks about the evolution of UPS's risk management strategy and the financial impact of undesignated forward contracts on earnings volatility. The LLM incorrectly attributes the change to a reduction in notional exposure and a shift to designated hedges, which is not supported by the original answer. The ground truth emphasizes improved disclosure practices and structured presentation of fair value changes, not operational changes in hedging strategy. (3) ENTITY & REASONING: While the LLM correctly identifies UPS and the relevance of undesignated foreign currency forwards, it misrepresents the nature of the evolution—focusing on quantitative risk reduction rather than enhanced transparency and disclosure. The reasoning is flawed because it invents a narrative around hedging discipline and notional reductions (e.g., HKD-linked contracts) that are absent from the source. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys a different meaning—operational risk reduction—versus the actual evolution in disclosure and reporting structure. Despite addressing earnings volatility, the explanation is factually unsupported. Thus, while contextually relevant and attempting multi-hop reasoning, the answer fails on factual correctness, especially in numbers and strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 473,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "\nBetween 2022 and 2023 the membership format remained a cornerstone of Costco’s profitability strategy, with fee revenue climbing 9 % in 2022 to $4.2 bn and then 5 % in 2023 to $4.8 bn, both gains attributed to new member sign‑ups, higher Executive‑membership penetration and sustained high renewal rates that reinforce customer loyalty.  The company continues to treat the membership model as integral to its financial performance, leveraging loyalty‑driven fee income while noting that expansion of new warehouses in existing markets could temper paid‑membership growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims membership fee revenue increased 9% to $4.2 billion in 2022 and then 5% to $4.8 billion in 2023. However, according to the ground truth (and actual SEC filings), Costco's membership fees were $4.103 billion in 2022 (up from $3.80 billion in 2021, ~8% growth) and $4.45 billion in 2023 (up ~8.5% from 2022), not $4.8 billion. The $4.8 billion figure is incorrect and misrepresents the financial trajectory. (2) The LLM invents precise percentage growth (9%, 5%) and rounds to incorrect totals, undermining quantitative accuracy. These numbers do not align with the actual reported figures, and the 5% growth to $4.8 billion is mathematically inconsistent (a 5% increase from $4.2B would be ~$4.41B, not $4.8B). (3) Qualitatively, the LLM captures that membership remains central to profitability and mentions correct drivers—new sign-ups, Executive membership penetration, and renewal rates. It also notes expansion in existing markets possibly tempering growth, which is contextually relevant. However, it completely misses the key evolution highlighted in the ground truth: the shift in language from 'significant effect on profitability' in 2022 to 'integral part of our business and profitability' in 2023, which reflects a strategic consolidation. More critically, it fails to mention the new 2023 concern about lower renewal rates in newer markets affecting the worldwide renewal rate—a crucial point in the evolution of the strategy. (4) While the answer is relevant and addresses the general theme of membership and profitability, the incorrect numbers and omission of key strategic shifts—especially the emerging risk in newer markets—severely limit its correctness. The reasoning is partially sound but lacks the required multi-hop synthesis between years and strategic language changes in filings. Thus, the correctness score is low due to major quantitative errors and incomplete qualitative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 548,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA broadened CUDA from a GPU‑only programming model into the core of a full‑stack data‑center platform, pairing its GPUs with new CPUs (Grace), DPUs (Mellanox), and high‑speed networking and wrapping them in the AI‑Enterprise software suite (NIM, NeMo, AI Blueprints) and the managed DGX Cloud service. This tighter integration has expanded the CUDA ecosystem—now used by >5 million developers—and binds CUDA to NVIDIA’s broader software stack, including Omniverse, DRIVE, and enterprise AI workloads across data‑center, automotive and professional‑visualization markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of CUDA from a developer-focused tool to a full-stack data center platform, which aligns with the ground truth. It correctly identifies the strategic shift toward deeper integration within NVIDIA's broader computing ecosystem, including software suites like AI Enterprise and services like DGX Cloud. However, there are key quantitative inaccuracies: the original answer states ~3 million developers in 2022 and implies growth by 2024, but the LLM claims '>5 million developers' without support in the ground truth, making this an unsupported extrapolation. Additionally, the LLM introduces specific hardware (Grace CPUs, Mellanox DPUs), software (NIM, NeMo, Omniverse, DRIVE), and services (DGX Cloud) not mentioned in the original answer, which, while factually plausible, go beyond the scope of the provided ground truth and add unverified detail. The qualitative reasoning is strong—correctly inferring a shift from GPU-centric programming to full-stack infrastructure—and the contextual relevance is high as it directly addresses CUDA’s integration in the data center and software ecosystem. The answer synthesizes the multi-hop concept of platform evolution well, but adds unsupported specifics, slightly reducing factual accuracy. Semantic equivalence is mostly preserved but with overreach in detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 373,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "\nFrom 2023 to 2024 Pfizer shifted Paxlovid from a largely government‑procured, high‑volume revenue source to a commercial market, causing total Paxlovid revenue to climb to **$5.7 billion in 2024** (up from **$1.28 billion in 2023**) while deferred revenue fell sharply from **$5.1 billion** to **$2.2 billion**.  The company now expects to recognize roughly **$1 billion of remaining contracted Paxlovid revenue over the next four years (2025‑2028)**, with product deliveries scheduled to continue through 2028.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The reported 2023 Paxlovid revenue of $1.28 billion and 2024 revenue of $5.7 billion are incorrect; the ground truth does not provide total annual Paxlovid revenues for these years. More critically, the $3.5 billion non-cash revenue reversal in Q4 2023 due to expected returns of 6.5 million treatment courses from U.S. government inventory is entirely omitted. Instead, the LLM fabricates revenue growth, contradicting the actual trend of declining government procurement and revenue reversals. The deferred revenue figures ($5.1B to $2.2B) are also not supported by the ground truth. (2) COMPLETENESS: The answer fails to mention the key event of the $3.5B non-cash reversal in 2023, which is central to understanding Pfizer's financial commitment shift. While it correctly notes $1B in remaining performance obligations for delivery from 2025–2028, this is the only accurate quantitative point. (3) ENTITY & REASONING: The claim of a shift to commercial market driving revenue growth is speculative and not in the original answer; the ground truth emphasizes a shift from uncertain returns to firm contracts, not commercial sales growth. The reasoning incorrectly frames the evolution as revenue growth rather than risk mitigation and revenue recognition deferral. (4) SEMANTIC EQUIVALENCE: The overall narrative is misleading—portraying increasing commercial success rather than declining government demand and revenue reversals. Only the $1B forward-looking obligation is correct, but without proper context. Due to major factual and directional errors, the correctness score is low despite partial relevance to the topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 472,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "\nBetween 2022 and 2024 ExxonMobil moved Guyana from a newly‑discovered frontier with ≈1.3 billion oil‑equivalent barrels of proved undeveloped reserves — and a $8 bn upstream investment to advance its development — to a core “advantaged asset” that is now explicitly cited in the company’s earnings‑driver framework as a source of advantaged volume growth.  This shift reflects a strategic emphasis on accelerating Guyana’s production and treating it as a high‑return, near‑term contributor to earnings, rather than a long‑lead‑time undeveloped reserve.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Guyana contributed approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves, matching the original answer. The mention of an $8 billion upstream investment is plausible context but not present in the ground truth; however, it does not contradict it and may reflect additional disclosure, so it doesn't significantly detract from accuracy. (2) The key evolution — Guyana transitioning from a reserves growth region to a core 'advantaged asset' in the earnings-driver framework by 2024 — is accurately captured. The LLM correctly conveys the strategic shift in emphasis from long-term reserves to near-term, high-return production and earnings visibility. (3) Multi-hop reasoning is sound: the model synthesizes information across years (2022 to 2024), asset classification (reserves to advantaged asset), and strategic framing (reserves growth to earnings contribution). (4) Semantic equivalence is strong — while the LLM adds slight elaboration (e.g., 'frontier', 'near-term contributor'), the core facts, entities, and strategic narrative match the ground truth. The only minor deviation is the inclusion of the $8B investment figure, which is not in the original answer and cannot be verified from the provided truth; however, it is contextually reasonable and doesn't distort the main conclusion. Thus, the answer earns a 9/10 for correctness, with full marks in contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 420,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "\nFrom 2022 to 2024 the schedule for the ATR 72‑600F shifted from 11 aircraft slated for delivery in 2023, 6 in 2024 and 6 in 2025 (total 24) to a more modest pipeline of 7 aircraft arriving in 2025 and 3 in 2026 (total 10) as shown in the 2024 commitment tables.  This reduction reflects FedEx’s decision to use the ATR 72‑600F as a niche, fuel‑efficient regional freighter that supplements its larger jet fleet on high‑density, short‑ to medium‑range routes, underscoring its role in the company’s broader fleet‑modernization strategy to improve operating economics and support growth in regional and international package traffic.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. According to the ground truth, in 2022 the projection was for ATR 72-600F units to drop from 11 in 2023 to just 1 by 2026. By 2024, the projection shifted to 7 units in 2025 and 3 by 2026. However, the LLM incorrectly states that in the initial plan there were 11 aircraft slated for delivery in 2023, 6 in 2024, and 6 in 2025 (total 24), which contradicts the ground truth of a declining fleet from 11 to 1. The 2024 revised plan is partially correct with 7 in 2025 and 3 in 2026, but the LLM misrepresents this as a 'pipeline of aircraft arriving' rather than planned utilization or retention, implying deliveries rather than fleet size. (2) The quantitative inaccuracies are severe: the original answer does not mention any increase or total of 24 aircraft; instead, it describes a drawdown from 11 to 1. The LLM fabricates delivery numbers not present in the ground truth. The correct comparison is a less steep decline (from an initial forecast of 1 unit by 2026 to a revised 3 units), not a reduction from 24 to 10. (3) The multi-hop reasoning is partially sound—the LLM identifies a strategic shift and links it to fleet modernization and operational efficiency—but it is based on incorrect data, undermining the logic. The conclusion about niche use and fuel efficiency is plausible but not supported in the ground truth, which only states a 'more sustained, albeit reduced role.' (4) Correctness is scored low (4) due to major factual and numerical errors. Quantitative accuracy is poor (3) because of invented figures. Qualitative accuracy is moderate (5) as the reasoning framework is logical but built on false premises. Contextual relevance is high (8) because the answer addresses fleet strategy evolution and attempts to interpret strategic intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 503,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA shifted Omniverse from a pure 3‑D collaboration and simulation tool to a central hub of its AI‑driven simulation stack.  The platform now embeds directly with AI Enterprise software (e.g., NIM, NeMo, AI Blueprints) and Blackwell GPUs to generate synthetic data, power digital‑twin and autonomous‑vehicle testing, and support AI‑enhanced avatars and generative‑AI workflows, while still being offered as an enterprise subscription and a free individual tier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of NVIDIA's Omniverse between 2022 and 2024. It correctly identifies the shift from a 3D collaboration tool to a more integrated, AI-driven simulation platform, aligning with the ground truth. The mention of enterprise subscription and free individual tier matches the original answer. The integration with AI Enterprise software (NIM, NeMo, AI Blueprints) and Blackwell GPUs is consistent with NVIDIA's 2024 direction, even if not explicitly detailed in the ground truth—these are plausible and contextually accurate enhancements reflecting Omniverse’s deeper AI integration. The focus on digital twins, autonomous vehicle testing, and generative AI workflows correctly reflects the expanded industrial use cases. The only minor shortcoming is the omission of specific examples like virtual car showrooms or surgical training from 2022, and less emphasis on the 'operating system for virtual worlds' conceptual framing in 2024. However, the semantic content and multi-hop synthesis across time, platform evolution, and integration with AI/simulation infrastructure are sound. No numeric inaccuracies; dates and tiers are correct. The answer is fully relevant and conveys the essential transformation in NVIDIA's strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 358,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the share of Google Play in Alphabet’s non‑advertising revenue grew noticeably.  The 2023 filing notes that “non‑advertising revenues—including sales of apps and in‑app purchases from Google Play—are increasing and now represent a larger portion of total revenue,” helping drive the overall rise in Google Services revenue (which grew $19 billion, or 8 %).  Thus, Google Play’s contribution to the company’s non‑advertising earnings expanded materially over that period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Google Play's role in non-advertising revenue between 2022 and 2023, correctly identifying its growing importance and linkage to app sales and in-app purchases. It appropriately notes the strategic expansion and increased contribution to non-advertising revenue, aligning with the ground truth's emphasis on Google Play becoming a more defined monetization platform. However, the quantitative claim of an $19 billion increase (8%) in Google Services revenue is not present in the original answer and cannot be verified from the provided ground truth, introducing a potentially inaccurate specific figure. While the general trend of growth is consistent, this unsupported numeric detail reduces quantitative accuracy. The answer does not mention the re-categorization of Google Play under 'platforms' or the strategic shift in reporting and structure, which is a key qualitative point in the original. Despite this, the reasoning is largely sound, and the response remains contextually relevant and focused on the question. Semantic equivalence is partially achieved, but missing the structural evolution and introducing unverified numbers prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 338,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG kept the same basic rule‑of‑thumb but refined its application: for guaranteed‑cost workers‑comp business it still assigns significant weight to expected‑loss‑ratio estimates only in the most recent accident year, whereas for excess‑of‑deductible business it now extends that weighting to the five most recent accident years to accommodate slower claim emergence and the growing share of large‑deductible policies. The 2023 disclosures note that the expected‑loss‑ratio inputs are adjusted for inflation, rate changes and market conditions and that the portfolio is segmented by deductible size, state and third‑party administrator to capture the evolving development patterns.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements correctly but contains significant inaccuracies in the evolution of AIG's methodology between 2022 and 2023. (1) Correctly identifies that in 2022, expected loss ratio methods were given significant weight only in the most recent accident year for guaranteed cost business and in the most recent five accident years for excess of deductible business — this aligns with the ground truth. However, the LLM incorrectly implies a change in 2023 by stating 'it now extends that weighting to the five most recent accident years' for excess of deductible business, suggesting a shift from prior practice. In reality, the ground truth states this five-year approach was already in place in 2022, and the methodology remained 'broadly consistent' in 2023. Thus, the LLM misrepresents a stable practice as a change. (2) The LLM introduces new details not present in the original answer — such as adjustments for inflation, rate changes, market conditions, and segmentation by deductible size, state, and TPA — which, while plausible, are not supported by the ground truth and represent unverified additions. (3) The ground truth highlights a key reporting refinement in 2023: losses presented net of reinsurance and undiscounted, which the LLM omits entirely. This is a material omission in the evolution of reserving transparency. (4) The point about large deductible business slowing claims reporting is correctly noted as a continuing trend, supporting contextual relevance. Quantitative accuracy is high because no incorrect numbers are introduced (the years and structure are factually consistent where stated), but qualitative accuracy suffers due to incorrect inference of change and addition of unsupported details. The reasoning fails the multi-hop requirement to compare year-over-year evolution accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 498,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Cisco reshaped how it groups its products: in FY22 it reported six distinct categories (Secure & Agile Networks, Internet for the Future, **Collaboration**, End‑to‑End Security, Optimized Application Experiences, Other), but by FY24 the taxonomy was consolidated to four broader groups—Networking, Security, **Collaboration**, and Observability—with the former six‑category structure folded into these four.  During that span the **Collaboration** segment moved from a 5 % revenue decline in FY22 to a deeper 9 % drop in FY23, then rebounded with a modest 2 % increase in FY24, reflecting both the category‑re‑organization and a turnaround in its sales trend.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in Cisco's product category segmentation between fiscal 2022 and 2024, noting the shift from six categories to four and the retention of 'Collaboration' as a distinct category. It accurately names most of the original FY22 categories and correctly identifies the new FY24 structure (Networking, Security, Collaboration, Observability), demonstrating sound qualitative understanding and multi-hop reasoning. However, the answer introduces quantitative claims not present in the ground truth: specifically, the 5% decline in FY22, 9% drop in FY23, and 2% increase in FY24 for the Collaboration segment. These figures are factually unsupported by the provided ground truth, which contains no revenue performance data. This significantly undermines quantitative accuracy. While the structural and categorical changes are correctly synthesized and contextually relevant, the inclusion of unverified financial performance metrics constitutes a major factual overreach, reducing overall correctness. The core categorical evolution is well-explained, but the added numerical trends make the response partially incorrect despite strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 335,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "\nFrom the 2022 filing (10‑K pages 128‑132) the $1 billion 3.125% 2025 Notes were disclosed as having a notional amount of $1 bn and, because of interest‑rate swaps, an effective floating rate of **LIBOR + 1.8 %** (the swap conversion was shown in the “Effective interest rates on notes” table for 2021/2020).  \n\nIn the 2023 filing (10‑K pages 142‑146) the same $1 bn of 3.125% 2025 Notes appears in the “Effective interest rates on notes” table with an updated effective spread of **SOFR + 2.1 %**, reflecting the market transition from LIBOR to SOFR and a modest increase in the swap‑derived margin. The 2023 disclosure also explicitly notes that the swaps are designated cash‑flow hedges and places the notes alongside other SOFR‑linked swaps in the aggregate presentation.  \n\nThus, the financial presentation of the 3.125% 2025 Notes remained the same $1 bn notional, but the underlying interest‑rate framework shifted from a LIBOR‑plus‑1.8 % swap structure in 2022 to a SOFR‑plus‑2.1 % structure in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The Original Answer (ground truth) states that in 2022, Amgen did *not* disclose any specific interest rate framework for the 3.125% 2025 Notes—only the $1,000 million carrying value was reported. However, the LLM claims that in 2022, the notes had an effective floating rate of LIBOR + 1.8% due to interest rate swaps. This is incorrect and contradicts the ground truth, which explicitly says no interest rate framework was disclosed in 2022. (2) The LLM asserts that the 2022 filing showed a swap conversion based on data from 2021/2020, but this is speculative and not supported by the ground truth; the question is about 2022–2023 evolution, and introducing prior-year swap details as if they apply to 2022 misrepresents the disclosure timeline. (3) While the 2023 disclosure of SOFR + 2.1% aligns with the ground truth, the LLM incorrectly frames this as a 'shift' from LIBOR + 1.8% in 2022, implying continuity in swap disclosure that did not exist. The ground truth emphasizes that 2023 introduced the *first* explicit interest rate mechanism disclosure. (4) The LLM incorrectly refers to 'notional amount' and 'effective floating rate' due to swaps, but the ground truth makes no mention of swaps in 2022 and only notes a new interest rate framework (SOFR + 2.1%) in 2023 without attributing it to swaps in the same way. (5) Multi-hop reasoning fails because the model assumes swap disclosures from prior years carry forward into 2022, which is not justified. The core evolution described in the ground truth—from no rate framework to an explicit SOFR-based one—is misrepresented as a transition between two disclosed frameworks. Thus, despite correct identification of the $1 billion amount and the 2023 SOFR + 2.1% figure, the incorrect attribution of a 2022 interest rate framework severely undermines factual accuracy. Quantitative accuracy is low due to false precision around percentages (LIBOR + 1.8%) not present in ground truth. Qualitative accuracy suffers from flawed reasoning and entity/timing misattribution. Contextual relevance is moderate because the answer addresses the right document years and notes, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 598,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "\nCOP’s proved natural‑gas reserves in the Asia Pacific/Middle East fell from **≈ 326 billion cubic feet (BCF) at the end of 2022** to **≈ 312 BCF in 2023** and **≈ 296 BCF by the end of 2024** – a net decline of roughly **30 BCF (about 9 %)** over the two‑year span.  The decrease reflects normal production and price‑related revisions, but the company continues to invest in the region through equity‑affiliate participation, targeted acquisitions and development projects, underscoring a deliberate strategic focus on maintaining a presence in Asia Pacific/Middle East despite modest reserve growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 (326 BCF) and 2024 (296 BCF) reserve figures from the ground truth, which aligns with the original answer. However, it introduces an intermediate 2023 value of 312 BCF that is not present in the ground truth, and the knowledge graph contains no data to confirm this number. This unsupported addition reduces quantitative accuracy. The net decline of 30 BCF (9%) is mathematically correct based on 326 → 296, so the calculation is accurate. (2) The original answer does not mention 2023 data, so including it as a point in the trend constitutes a factual overreach, even if the final 2024 number is correct. The percentage decline is reasonably calculated and acceptable. (3) The multi-hop reasoning is partially sound—reserves decreased over the period, and the LLM attempts to interpret strategic implications. However, the qualitative conclusion contradicts the ground truth: while the original answer suggests a 'potential strategic shift or divestment,' the LLM claims 'deliberate strategic focus' and 'continues to invest,' which is not supported by the provided data and inverts the implied direction of strategy. This misrepresents the inference and reflects flawed reasoning. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of reserves and strategic implications) and focuses on the correct company (COP), region (Asia Pacific/Middle East), and metric (natural gas reserves). However, the incorrect interpretation of strategic intent and the inclusion of unverified 2023 data significantly reduce overall correctness. Final scores reflect partial factual accuracy but major issues in reasoning and unsupported data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 472,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "\nBetween 2022 and 2023 Alphabet repurchased **450 million Class C shares for $52.9 billion in 2023**, versus **469 million shares for $52.6 billion in 2022** – a small drop in the number of shares bought back but a modest rise in total dollars spent.  The company therefore kept its shareholder‑return program active, yet executed it more selectively (maintaining a $36 billion remaining repurchase authorization), reflecting a capital‑allocation strategy that prioritizes returning excess cash to investors while balancing other investments and market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Alphabet repurchased $59.3 billion in 2022 and $62.2 billion in 2023, but the LLM claims $52.6 billion in 2022 and $52.9 billion in 2023 — both figures are incorrect. Additionally, the LLM introduces specific share counts (450 million and 469 million) that are not present in the original answer and may be fabricated or misattributed. The remaining repurchase authorization is stated as $36.3 billion in the ground truth (as of Dec 31, 2023), which the LLM approximates as $36 billion — this part is acceptable. However, the LLM fails to mention the key fact that the board authorized an additional $70.0 billion in April 2023, a major signal of strategic intent. (2) Quantitative accuracy is low: the dollar amounts are off by several billion dollars in both years, and the share counts are unsupported by the ground truth. The comparison of a 'small drop in shares but modest rise in dollars' is based on incorrect data and thus misleading. (3) The multi-hop reasoning is partially sound — the LLM attempts to interpret the repurchase activity in the context of capital allocation strategy and correctly infers a continued focus on shareholder returns. However, it misses the expansionary signal from the new $70 billion authorization, which is central to the original conclusion of an 'expanding emphasis.' (4) The contextual relevance is moderate because the answer addresses the general theme of share repurchases and capital allocation, but due to major factual errors and omission of critical information (especially the new authorization), the overall correctness score is low. The answer conveys a different trend (slight decrease in activity) than the actual increase from $59.3B to $62.2B, leading to a misleading interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 500,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "\nBetween 2022 and 2023 AIG continued to rely on frequency‑severity techniques for its short‑tail property and program‑business lines (U.S. Property, program property and, where appropriate, liability classes), while deliberately **not** using them for high‑severity, long‑tail classes such as aviation.  In 2023 the company expanded the same approach to U.S. Workers’ Compensation and to excess‑casualty business, but it emphasized that the growing proportion of large‑deductible and high‑attachment policies—producing slower, more variable claim‑reporting patterns—required additional segmentation and a more cautious, blended use of frequency‑severity methods together with expected‑loss‑ratio and Bornhuetter‑Ferguson approaches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, AIG used frequency/severity methods for short-tail lines like U.S. Property and avoided them for aviation due to high severity and claim variability—this matches the original answer. It also accurately states that in 2023, AIG expanded the use of these methods to U.S. Workers’ Compensation, a long-tail line, which is correct. The reasoning about increased large-deductible and high-attachment policies affecting claim reporting is consistent with the ground truth’s emphasis on risk-sharing features and large deductible business. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answers, so quantitative accuracy is not compromised—score 10 is justified. (3) The multi-hop reasoning is sound: the model synthesizes changes over time (2022 vs 2023), identifies correct lines of business, and explains the rationale behind methodological shifts. One minor discrepancy: the LLM mentions 'excess-casualty business' as a new line where frequency/severity methods were expanded in 2023, which is not explicitly stated in the ground truth. While plausible and contextually consistent, this addition slightly exceeds the provided information, preventing a perfect 10 on qualitative accuracy. (4) The answer is fully relevant, addressing evolution in usage, specific lines of business, and reasoning—contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 407,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "\nFrom 2022 to 2023 Amgen’s net cost recoveries from BeiGene fell sharply—from **$199 million** in 2022 to **$109 million** in 2023—while product sales to BeiGene rose from **$64 million** to **$125 million**.  Accordingly, profit‑and‑loss sharing expenses dropped from **$53 million** to **$40 million**, and the receivable for cost‑recovery and P&L payments declined from **$99 million** to **$61 million**, reflecting a shift toward higher sales and lower shared‑cost reimbursements in the later year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: cost recovery decreased from $199 million in 2022 to $109 million in 2023, product sales increased from $64 million to $125 million, and profit and loss sharing expenses declined from $53 million to $40 million. These numbers are quantitatively accurate with correct formatting and units. (2) The additional detail about the receivable for cost-recovery and P&L payments declining from $99 million to $61 million is not present in the original answer and cannot be verified against the ground truth; however, it does not contradict the main narrative and may represent supplementary data from the filings. This introduces a minor completeness concern but does not affect core accuracy. (3) The reasoning is sound: the model correctly infers a shift in the financial relationship—lower cost recovery and P&L expenses alongside higher product sales—indicating maturation of the collaboration, which aligns with the original conclusion. (4) All entities (Amgen, BeiGene, years 2022–2023, financial metrics) are accurately identified and correctly contextualized. The answer is semantically equivalent to the ground truth, with slightly enhanced detail. The correctness score is 9 due to the unverified receivable figure, but quantitative accuracy remains perfect. Qualitative accuracy is high due to correct multi-hop synthesis and logical interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 401,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024, natural‑gas reserves in the Asia‑Pacific/Middle‑East region fell from 326 bcf to 240 bcf in 2023 before edging up to 279 bcf by the end of 2024. The 2023 decline reflected a modest upward revision of 6 bcf that was far outweighed by 25 bcf of production and zero purchases, while the 2024 rebound came from a slightly larger upward revision of 9 bcf, still no purchases, and continued production of 25 bcf, yielding a net gain of 39 bcf.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, COP's natural gas reserves decreased from 326 bcf in 2022 to 296 bcf in 2024. However, the LLM claims reserves dropped to 240 bcf in 2023 and then rose to 279 bcf in 2024—both figures are incorrect. The correct 2024 reserve level is 296 bcf, not 279 bcf. (2) The LLM correctly states that there was a 9 bcf upward revision in 2024 and that production was 25 bcf in 2024, which aligns with the ground truth. It also correctly notes no purchases in 2024. However, it incorrectly claims a 6 bcf revision in 2023, while the ground truth reports a 9 bcf revision. Additionally, the LLM implies a net gain of 39 bcf in 2024, which is mathematically and factually wrong—reserves actually declined. (3) The multi-hop reasoning is flawed: the model fails to accurately track the year-over-year evolution of reserves, invents an intermediate 2023 value (240 bcf) not present in the original answer, and misrepresents the direction of change in 2024. While it attempts to break down revisions, production, and purchases, the synthesis is based on incorrect underlying data. (4) Despite these errors, the answer is contextually relevant—it addresses the right region, company (COP), and types of changes (revisions, production, purchases). The qualitative reasoning structure is sound even if the facts are not, and it correctly identifies that no purchases occurred. Hence, low scores on correctness and quantitative accuracy due to major factual and numerical errors, moderate qualitative accuracy for logical framing, and high contextual relevance for addressing the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 458,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "\nFrom the 2022 filing FedEx had pledged to purchase **14 B767F aircraft in 2024 and a further 10 in 2025** (total 38 B767Fs over 2023‑2025). By the 2024 filing the commitment had been reshaped to **11 deliveries in 2025 and 3 in 2026**, reducing the near‑term cadence and spreading the intake over later years. This evolution shows that FedEx is now staggering the B767F rollout—using the type to modernize its cargo fleet while preserving cash flow and aligning the aircraft’s fuel‑efficient capacity with longer‑term strategic capacity needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. However, the LLM incorrectly states that FedEx 'pledged to purchase 14 B767F aircraft in 2024 and a further 10 in 2025', which misrepresents both the timing and nature of the plan (usage vs. purchase). Furthermore, the LLM claims a total of 38 B767Fs over 2023–2025, which is not supported by the original answer and appears fabricated. By 2024, the revised projection was for 11 aircraft in 2025 and only 3 by 2026 — this part is correctly reflected in the LLM answer regarding the 2025 and 2026 numbers. However, the characterization as 'deliveries' rather than 'planned usage' misrepresents the data. (2) Quantitative accuracy is poor: the original answer discusses projected usage (not purchases or deliveries), and there is no mention of a total of 38 aircraft or purchases in 2024. The LLM invents a timeline and total fleet intake not present in the ground truth. (3) The multi-hop reasoning is flawed: while the LLM identifies a shift in projections, it interprets the data as a 'staggering of rollout' and modernization effort, whereas the ground truth indicates an accelerated reduction, suggesting decreased reliance, not a strategic rollout. This reverses the strategic implication. (4) Contextual relevance is moderate — the answer addresses fleet planning and evolution over time, but due to factual errors and mischaracterization of the data, the conclusion is misleading. The reasoning and synthesis fail to align with the actual strategic shift toward faster phase-out.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 464,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG expanded the expected‑loss‑ratio (ELR) approach from a narrow set of specialty lines (mainly aviation and program‑business, used only for the most recent accident year) to a broader portfolio that now includes long‑tail classes such as U.S. Workers’ Compensation and Excess Casualty.  The 2023 disclosures explain that ELRs are applied when loss‑development patterns are inconsistent, emergence is slow, or historical data are thin, and the ratios are derived from premiums and adjusted for rate changes, inflation and current market conditions, with particular weight given to the latest five accident years.  This evolution reflects a shift toward using premium‑based ELR estimates as a more reliable reserve driver for lines where traditional development methods are less effective.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of AIG's use of Expected Loss Ratio (ELR) methods from 2022 to 2023: starting with narrow application in high-severity, short-term contexts like aviation (2022) and expanding to long-tail lines such as U.S. Workers’ Compensation and Excess Casualty in 2023. The core reasoning—ELR used when loss development is inconsistent, emergence slow, or data sparse—is consistent with the original answer. (2) There are no numeric values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not compromised; all dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes over time, identifies correct lines of business, and explains the rationale for methodological shift (from high-severity to structurally complex, long-tail lines). The mention of 'Excess Casualty' is not in the original answer but is contextually plausible and does not contradict the ground truth; it adds minor detail without inaccuracy. (4) Semantic equivalence is strong: the LLM captures the shift in application scope and reasoning (premium-based ELR as a more reliable driver where development methods fail). The only minor gap is that the original emphasizes 'risk-sharing features in policies' as a reason for use in Workers’ Compensation, which the LLM does not explicitly mention. However, this is a nuanced detail, and the overall reasoning about slow emergence and unreliable development patterns covers similar ground. Thus, the answer is excellent but not perfect—hence 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 456,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Cisco shifted from merely describing the enterprise‑data‑center “convergence of computing, networking, storage and software” to actively building an ecosystem of strategic alliances—e.g., with Equinix, Microsoft, Amazon Web Services, Google and Apple—to co‑develop, finance and market end‑to‑end data‑center solutions.  At the same time, the competitive set widened: traditional networking rivals (Arista, Juniper, HPE) and hyperscale cloud providers are expanding their own data‑center offerings, and some alliance partners can also become competitors, intensifying price‑focused and technology‑driven competition in this space.  Consequently, Cisco’s positioning now hinges on leveraging these partnerships and outcome‑based services to differentiate itself amid a more crowded and collaborative landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Cisco's positioning around Enterprise Data Center Transformation from 2022 to 2024. It accurately captures the shift from describing technological convergence to actively building strategic alliances (e.g., with Equinix, Microsoft, AWS, Google, Apple), which reflects Cisco’s expanded focus on ecosystem collaboration—consistent with the 2024 update in the original answer. The mention of competitive landscape expansion is also accurate, including traditional rivals (Arista, Juniper, HPE) and hyperscalers, and the nuanced point that some partners can also be competitors matches the ground truth’s note about alliances with competitors affecting Cisco’s business. However, the LLM answer does not explicitly name Nvidia Corporation as a new entrant in the competitive landscape, which is a specific and important detail highlighted in the original answer as signaling a shift in market dynamics. This omission prevents a perfect score on qualitative accuracy. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default—no errors in dates or fiscal years (2022–2024 correctly referenced). The reasoning is sound and reflects multi-hop synthesis across time, strategic alliances, and competitive shifts. The answer is highly contextually relevant, addressing all aspects of Cisco’s evolving positioning. The wording differs but maintains semantic equivalence on most key points, except for the missing Nvidia reference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 429,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "\nBetween 2022 and 2023 the 3.125% 2025 Notes kept the same notional exposure of **$1 billion**, and the effective interest rate tied to the swap remained **SOFR + 2.1%** in both years—i.e., it did not change materially.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect. (1) Quantitatively, it claims the notional amount remained constant at $1 billion in both 2022 and 2023, but the ground truth states that in 2022 the notional was part of a $5.2 billion principal amount, which decreased to $1.0 billion in 2023. This is a significant factual error. The effective interest rate of SOFR + 2.1% in 2023 is correctly mentioned, but the answer falsely implies it was the same in 2022, which is unsupported by the original text—no such rate is mentioned for 2022, only that new swaps were entered due to low rates. (2) The answer misses the evolution entirely: it fails to note the reduction from $5.2B to $1.0B and the shift in hedging strategy/environment. (3) Multi-hop reasoning is absent—the model did not synthesize the change over time or the implications of the reduced notional and changing rate environment. Instead, it incorrectly asserts stability. (4) While the mention of SOFR + 2.1% and $1B in 2023 aligns with the truth, the misrepresentation of 2022 data and lack of change undermines correctness. Contextual relevance is moderate as it discusses the right instrument and timeframe but with wrong facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 332,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Cisco folded AppDynamics into its broader **Observability** offering rather than keeping it as a stand‑alone APM product.  In the 2022 filing the company highlighted AppDynamics as part of a “full‑stack observability” push that spanned application performance monitoring to infrastructure visibility.  By fiscal 2024 the Observability category is presented as a distinct revenue line that includes network‑assurance tools (ThousandEyes), the Splunk‑based observability suite, and the AppDynamics technology, with growth driven primarily by ThousandEyes and Splunk.  Thus, AppDynamics has evolved from a discrete application‑performance solution into one component of an end‑to‑end observability platform that Cisco promotes as a strategic pillar for hybrid‑work, multicloud and security‑focused customer outcomes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of AppDynamics from a key component of Cisco's full-stack observability strategy in 2022 to being integrated into a formal 'Observability' revenue category by 2024. The entities—AppDynamics, ThousandEyes, Splunk, and Intersight (implied via context of observability stack)—are accurately referenced, though Intersight is not explicitly mentioned in the LLM answer, which is a minor omission. (2) There are no numeric values (e.g., revenue figures, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in strategic positioning and reporting structure over time, correctly inferring that the creation of a dedicated 'Observability' revenue line signifies a more integrated and elevated strategic role. It also correctly notes that growth in the Observability segment is now driven more by ThousandEyes and Splunk, adding contextual insight beyond the ground truth without contradicting it. (4) The answer is semantically equivalent to the original, with slightly expanded interpretation (e.g., linking observability to hybrid-work and multicloud outcomes), which adds relevant context without introducing inaccuracies. The only reason for not scoring a 10 is the slight omission of Intersight as a co-located component in the 2022 strategy, which was part of the original answer’s multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 431,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "\nThe 4.663% 2051 Notes kept the same outstanding notional amount of **$1.5 billion** from the end of 2022 through the end of 2023, and their **effective interest rate remained indexed to SOFR + 4.3%** (i.e., the spread did not change between the two years).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the notional amount of $1.5 billion and the effective interest rate of SOFR + 4.3% for 2023, which aligns with the ground truth. However, it incorrectly states that the notional amount and effective interest rate remained unchanged from 2022 to 2023, implying continuity in both the hedging terms and the notional amount for the 4.663% 2051 Notes specifically in 2022. The ground truth clarifies that in 2022, the 4.663% 2051 Notes were part of a broader $5.2 billion hedged note portfolio, with interest rate swaps terminated and replaced at then-current rates—indicating that the specific SOFR + 4.3% rate and $1.5 billion notional for the 2051 Notes were not yet disclosed or possibly not yet in effect. Thus, the LLM assumes stability across years without acknowledging the evolution in disclosure and structure. While the 2023 data is accurate, the characterization of 2022 is unsupported and contradicts the multi-hop implication that the hedging strategy was updated. This is a significant qualitative error in reasoning and synthesis, though numbers themselves (when present) are correctly formatted and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 328,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG broadened and refined its use of expected‑loss‑ratio techniques. In 2022 the method was applied chiefly to long‑tail, claims‑made lines—particularly U.S. Excess Casualty, U.S. Financial Lines (D&O) and U.S. Workers’ Compensation—with segmentation by “guaranteed‑cost” versus “excess‑of‑deductible” and by state/industry subsets. By 2023 the Company extended the approach to additional run‑off and short‑tail lines, used the expected‑loss‑ratio assumption across more recent accident years, and applied a finer segmentation (e.g., deductible size, third‑party administrator handling, and risk‑sharing features) when selecting loss‑cost trends and development factors for reserve estimates.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies compared to the ground truth, particularly regarding AIG's use of expected loss ratio methods in 2022. The original answer states that in 2022, AIG only referenced the method in a general sensitivity analysis without specifying lines of business or segmentation—however, the LLM incorrectly claims detailed application in 2022 to specific lines like U.S. Excess Casualty, D&O, and Workers’ Compensation with segmentation by guaranteed-cost and state/industry. This level of specificity and line-of-business breakdown is only accurate for 2023 per the ground truth. Additionally, the LLM asserts expansion into 'run-off and short-tail lines' in 2023, which is not mentioned in the original answer—instead, the truth specifies focused application to U.S. Workers’ Compensation (a long-tail line) with new segmentation criteria. The LLM correctly identifies some 2023 segmentation elements (deductible size, risk-sharing features, third-party administrators), aligning partially with the ground truth’s mention of deductible size, risk-sharing, state/industry, and claim handling entities. However, the misrepresentation of 2022 usage and incorrect expansion claims undermine the reasoning and factual correctness. While the answer is contextually relevant and attempts multi-hop synthesis, the core evolution narrative is flawed due to incorrect attribution of detailed methods to 2022. Quantitative accuracy is moderate—no numeric values are present, but temporal and categorical details are partially correct for 2023. Qualitative accuracy suffers from incorrect entity (lines of business) and year attributions, leading to a misleading evolution story.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 463,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "\nPepsiCo first issued the 2.850% Senior Notes due 2026 in February 2023 (8‑K filing). In 2024 the Board re‑authorized that tranche and, as part of a wider multi‑year debt program, added a suite of new senior and floating‑rate notes—including 4.650% 2027, 4.550% 2029 and 4.700% 2034 issues through its Singapore financing vehicle—showing a strategic shift toward diversifying funding sources and extending the maturity profile of its debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The original answer states that PepsiCo referenced the 2.850% Senior Notes due 2026 as part of its broader debt instruments in 2023, but does not confirm a February 2023 issuance via an 8-K filing—this specific timing and filing type are not supported by the ground truth and introduce unverified detail. More critically, the LLM claims new notes issued in 2024 included 4.650% 2027, 4.550% 2029, and 4.700% 2034 tranches, whereas the ground truth identifies the new instruments as higher-yielding 7.00% Senior Notes due 2029 and 5.50% due 2035. These percentages and maturities do not match, indicating significant quantitative errors. Additionally, the mention of a Singapore financing vehicle is absent from the original answer and introduces unsupported entity-specific detail. (2) The dates and percentages are incorrect or unverifiable: no confirmation of February 2023 issuance or 8-K filing exists in the ground truth; the new note rates (4.650%, 4.550%, 4.700%) conflict directly with the correct rates (7.00%, 5.50%). (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift toward diversification and extended maturities, aligning with the original answer’s conclusion about a broader, long-term debt strategy. However, this reasoning is based on incorrect data inputs, weakening the validity of the synthesis. (4) The contextual relevance is high because the answer addresses the evolution of the 2.850% notes and PepsiCo’s broader debt strategy. Qualitative accuracy is moderate due to correct directional logic but undermined by false specifics. Quantitative accuracy is low due to incorrect rates, dates, and unverified issuance mechanisms. Correctness score is 5 due to partially correct strategic interpretation but significant factual and numerical discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 509,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "\nCisco’s channel‑partner financing guarantee exposure was about $1.4 billion in outstanding guarantees and roughly $188 million in maximum potential future payments at the close of fiscal 2022; by fiscal 2024 the underlying financing receivables slipped to $6.7 billion and the guarantee levels remained essentially unchanged. This stability shows that Cisco manages the risk by keeping off‑balance‑sheet commitments modest, closely monitoring credit exposure, and preserving liquidity to absorb any potential guarantor obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal year 2022, Cisco had $1.4 billion in guarantees related to $27.9 billion in channel partner financing. However, the LLM incorrectly states that the outstanding guarantees were $1.4 billion and introduces a figure of $188 million in maximum potential future payments, which is not present in the original answer. Furthermore, the LLM claims that by fiscal 2024, the underlying financing receivables dropped to $6.7 billion, which directly contradicts the ground truth stating that Cisco no longer disclosed specific figures for fiscal 2024. There is no mention of $6.7 billion or any updated quantification in the original answer. (2) The quantitative inaccuracies are severe: the $6.7 billion receivables figure is fabricated, the $188 million future payment amount is unsupported, and the comparison between years relies on non-existent data. The only correct number is the $1.4 billion in guarantees for FY2022. (3) The reasoning is flawed because it assumes continuity of disclosure and quantifies a trend (stability) that cannot be established due to lack of data in FY2024. The original answer emphasizes that disclosures became less transparent, preventing definitive conclusions—this nuance is entirely missing. Instead, the LLM asserts a confident conclusion about risk management strategy based on false data. (4) While the answer attempts to address the question’s components (evolution over time and implications for risk management), it fails on factual correctness and synthesis. The contextual relevance is moderate because it discusses the right topic and risk management concepts, but the incorrect data undermines all conclusions. Correctness score is low due to major factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 496,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "\nThe $1 billion 2.45% 2030 Notes remained outstanding through 2022‑2023 and continued to be hedged by the same interest‑rate swap that converts the fixed 2.45% coupon into a floating SOFR + 1.3% rate; the swap’s notional amount and spread were unchanged during that period. Consequently, their effective interest‑rate structure and hedge designation were unchanged from 2022 to 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that the $1 billion 2.45% 2030 Notes remained outstanding from 2022 to 2023 and that an interest rate swap was in place. It also accurately states the floating rate as SOFR + 1.3% and notes the notional amount of $1 billion, which aligns with the ground truth. However, there is a critical factual error in the timeline of the benchmark transition: the original answer specifies that in 2022, the swap converted the fixed rate to a LIBOR-based floating rate, and only in 2023 did it transition to SOFR. The LLM incorrectly claims the swap was already SOFR-based in 2022, which contradicts the ground truth. This misrepresents the evolution of the interest rate structure—the core of the question. While the quantitative values (notional amount, percentages) are accurate, the reasoning about the evolution over time is flawed. The model fails to correctly synthesize the multi-hop detail that the benchmark changed from LIBOR to SOFR between years, instead asserting a static SOFR-based structure throughout. This undermines the qualitative accuracy despite otherwise relevant and well-structured information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 322,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "\nBetween the 2022 and 2023 filings the $970 million of FedEx Express Series 2020‑1AA pass‑through certificates continued to be “fully and unconditionally guaranteed by FedEx” – the guarantee itself did not change. The only evolution was a modest update to the collateral valuation (the pledged aircraft’s net book value fell from about $1.8 billion in 2022 to $1.7 billion in 2023) and corresponding wording adjustments; the financial guarantee and payment obligations remained the same.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. While it correctly states that in 2022, the $970 million Pass-Through Certificates, Series 2020-1AA were fully and unconditionally guaranteed by FedEx, it incorrectly asserts that this guarantee remained unchanged in 2023. The ground truth explicitly states that in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were *not* direct obligations of, nor guaranteed by, FedEx or FedEx Express—indicating a significant shift in financial obligation. The LLM instead claims the guarantee 'did not change,' which directly contradicts the ground truth. (2) Quantitatively, the numbers are mostly accurate: $970 million in certificates, $1.8 billion collateral value in 2022, and a drop to $1.7 billion in 2023 are plausible and align with typical depreciation; these values do not contradict the knowledge graph. However, the focus on a $0.1 billion decrease in collateral value distracts from the key qualitative shift in guarantee status. (3) The multi-hop reasoning is flawed. The model fails to synthesize the critical evolution from a guaranteed obligation in 2022 to a disavowal of guarantee in 203, which requires connecting disclosures across years and understanding the implications of 'leveraged operating leases' and 'not direct obligations.' Instead, it assumes continuity, missing the pivot in FedEx's financial exposure. (4) The contextual relevance is moderate because the answer discusses the correct certificates and collateral, but it misrepresents the central financial relationship evolution. The correctness score is low due to the major factual error in the key claim about guarantees, despite numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 475,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "\nFrom 2023 to 2024 Mastercard’s gross settlement exposure edged up from **$75.0 bn to $78.4 bn**, while the amount of risk‑mitigation arrangements applied grew from **$12.2 bn to $13.5 bn**.  Consequently, net settlement exposure rose only modestly, from **$62.9 bn to $64.9 bn**.  This pattern shows that the company is scaling its collateral‑ and credit‑enhancement framework in step with higher transaction volumes, continuously revising its risk‑management methodology to keep potential losses low and to preserve financial stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's risk mitigation arrangements from 2023 to 2024 with accurate figures, albeit rounded: $75,023 million gross exposure in 2023 is reported as $75.0 bn (correct within rounding); $78,385 million in 2024 is reported as $78.4 bn (also correct within rounding). Similarly, risk mitigation amounts are accurately rounded: $12,167 million → $12.2 bn, and $13,466 million → $13.5 bn. The derived net exposure values ($62.9 bn in 2023 and $64.9 bn in 2024) are correct calculations (75.0 - 12.2 = 62.8 ≈ 62.9; 78.4 - 13.5 = 64.9), with minor rounding in the first case explained by precise inputs. (2) All quantitative values align with the ground truth when accounting for standard financial rounding practices (to nearest $100 million). No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes gross exposure, mitigated amounts, and infers net exposure, then interprets the trend as evidence of a scaling, proactive risk management strategy—consistent with the ground truth’s conclusion about increasing robustness. (4) The answer is semantically equivalent and adds slight interpretive depth (e.g., linking to transaction volumes and financial stability), which is reasonable and contextually supported. The only reason for not scoring 10 is the use of rounded figures without explicit acknowledgment, though this is common and acceptable in financial reporting. All parts of the question are addressed: evolution over time and strategic implication. Thus, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 448,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "\nThe liability recorded for foreign‑exchange forwards and options that are designated as hedging instruments was roughly $48 million at the end of fiscal 2022 and stayed at about the same level at the end of fiscal 2024 (after having dropped sharply from $426 million in 2023).  This flat, low‑level liability indicates that Nike’s formal derivative hedge book is now minimal – the company has largely unwound or let mature its foreign‑currency hedges and is managing most currency risk through natural/operational offsets rather than through new hedge positions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and direction of change. According to the ground truth, Nike's total liabilities for foreign exchange forwards and options designated as hedging instruments increased from $48 million in 2022 to $115 million in 2024. The LLM claims the liability was 'roughly $48 million' in 2022 and 'stayed at about the same level' in 2024, which directly contradicts the data showing a significant increase. Additionally, the LLM introduces a $426 million figure for 2023 not present in the original answer, which may be a hallucination or misattribution. (2) Quantitative accuracy is severely lacking: the correct 2024 total is $115 million (comprising $110M in accrued liabilities and $5M in deferred taxes), but the LLM reports it as flat at $48 million. This misrepresents the financial reality and invalidates any downstream reasoning. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the two liability components across years. Instead of recognizing an increase in accrued liabilities and a small decrease in deferred tax liabilities, it assumes stability and infers a strategic unwinding of hedges, which is unsupported by the provided data. The conclusion about shifting to 'natural/operational offsets' is speculative and contradicted by the rising hedge-related liabilities. (4) Contextual relevance is moderate because the answer addresses the right topic (hedging instruments and foreign exchange risk) and attempts to interpret strategic implications, but the incorrect data renders the analysis invalid. The model shows understanding of financial concepts but applies them to false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 463,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "\nIn the 2022 filing (page 19) Bounty was explicitly highlighted— the narrative singled out “Bounty paper‑towel” and noted that it captured “over 40 % market share” in North America, underscoring its importance within the Baby, Feminine & Family Care segment. By contrast, the 2023 filing (page 20) merely lists Bounty among the segment’s major brands without any share‑related commentary or emphasis. This shift indicates that P&G is giving Bounty markedly less explicit focus, suggesting a decline in its brand visibility and strategic prominence.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) According to the ground truth, in the 2022 10-K, Bounty was *not* explicitly listed among key brands and there was no mention of market share; however, the LLM claims Bounty was 'explicitly highlighted' with 'over 40% market share'—a detail entirely fabricated and not present in the actual filings. (2) The quantitative claim of 'over 40% market share' has no basis in the ground truth and is a severe factual error, making the quantitative accuracy score extremely low. (3) The reasoning is flawed: the LLM asserts that brand visibility *declined* from 2022 to 2023 due to reduced emphasis, but the ground truth states the opposite—that Bounty went from *not* being explicitly named in 2022 to being explicitly listed in 2023, indicating *increased* visibility. This reverses the correct multi-hop synthesis across filings. (4) Contextual relevance is slightly preserved because the answer addresses the right segment and brand, and attempts to compare two years’ disclosures, but the core facts and conclusion are inverted. The answer misrepresents both the data and its implications, failing on all critical dimensions of accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 341,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "\nOracle still records hardware product sales—including its Engineered Systems—at the point in time when the hardware and its bundled software are delivered, and it recognizes hardware‑support fees ratably over the contract term; this accounting treatment is unchanged in the FY 2022 and FY 2023 filings (see 2022 Notes 104‑107 and 2023 page 44).  However, the strategic focus on the hardware segment has shifted: both years report that hardware represents only about 6 % of total revenue, operates at lower margins than the cloud‑and‑license business, and is described as a “difficult‑to‑predict” line that receives only modest R&D investment, indicating that Oracle is scaling back the priority of Engineered Systems in favor of its higher‑growth cloud and license offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but fundamentally contradicts the ground truth in key areas. It correctly notes that hardware revenue recognition occurs at the point of delivery and support fees are recognized ratably, which aligns with the consistent treatment mentioned in the original answer. The 6% of total revenue figure and lower-margin characterization are plausible contextual details, though not present in the provided ground truth. However, the LLM claims Oracle is 'scaling back' R&D investment in hardware and deemphasizing Engineered Systems, which directly contradicts the ground truth stating that in FY2023, Oracle emphasized *increased* R&D investments in hardware innovation—a critical strategic shift. (2) Quantitatively, the 6% figure and accounting policy references (e.g., FY2022 Notes 104–107, FY2023 page 44) appear accurate or at least plausible, earning high marks for numerical precision where stated. There are no calculation errors because no computations were performed. (3) The multi-hop reasoning is flawed: while the LLM synthesizes information across years, it draws the opposite conclusion from the evidence. Instead of identifying a growing strategic emphasis on hardware integration and R&D in FY2023, it asserts a de-prioritization, missing the core evolution described in the ground truth. This represents a failure in qualitative synthesis despite some correct factual fragments. (4) The contextual relevance is moderate—the answer addresses revenue recognition and strategic emphasis as asked, but the strategic interpretation is incorrect, undermining the overall correctness. Due to the major factual contradiction on Oracle’s strategic direction, the correctness score is low despite some accurate details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 484,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "\nERLEADA’s sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023**, a **~27 % year‑over‑year increase** (operations‑adjusted growth of ~27.5 %). This strong upside—driven by continued share gains and expanding use in metastatic castration‑resistant prostate cancer—signals a **robust and upward market trajectory**, indicating that the product is gaining traction and is on a positive growth path.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the sales evolution of ERLEADA from 2022 to 2023 and accurately reflects the strong market trajectory. The reported sales figures are $1.88 billion (2022) and $2.39 billion (2023), which align closely with the ground truth values of $1,881 million and $2,387 million (i.e., $1.881B and $2.387B). The percentage growth is stated as ~27%, which is a valid approximation of the exact 26.9% increase (calculated as (2,387 - 1,881) / 1,881 ≈ 0.269 or 26.9%). The mention of 'operations-adjusted growth of ~27.5%' is additional context not in the ground truth but does not contradict it and may reflect a more nuanced internal metric; it does not detract from factual accuracy. 2) Quantitative verification: $1.88B ≈ $1,881M (difference of $1M, <0.06% error), $2.39B ≈ $2,387M (difference of $3M, ~0.13% error), and 27% ≈ 26.9% — all within acceptable rounding tolerance. 3) The reasoning is sound and multi-hop: the model correctly identifies year-over-year sales, computes the growth rate accurately, and infers the market trajectory. It adds relevant clinical context (use in metastatic castration-resistant prostate cancer) and commercial drivers (share gains), which enrich the answer without introducing inaccuracies. 4) The answer is semantically equivalent to the ground truth, with slightly more detailed commentary on drivers, but the core facts, numbers, and conclusion about upward trajectory are fully aligned. Minor rounding is acceptable per scoring guidelines. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9 (not 10 due to slight rounding in final digits).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 448,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "\nFrom 2023 to 2024 the affiliate model that once gave CMCSA a relatively predictable pipeline of linear‑television carriage has become far more contested and costly.  The 2023 filing describes the need to secure “must‑carry” or retransmission‑consent agreements with independent local stations to reach a nationwide audience, while the 2024 filing stresses that these stations are increasingly demanding higher fees and more favorable terms as they vie for compensation amid audience fragmentation and the rise of OTT competitors.  Consequently, CMCSA’s competitive positioning now hinges not only on delivering popular network programming but also on navigating a landscape where local broadcast stations are both a critical distribution channel and a growing source of financial and carriage risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolving relationship between CMCSA and local broadcast television stations from 2023 to 2024. It accurately captures the shift from a competitive dynamic to one of increasing dependency, particularly through the lens of retransmission consent and carriage agreements. The answer correctly identifies that in 2023, CMCSA needed to secure retransmission-consent agreements, and by 2024, these stations were demanding higher fees and better terms, reflecting growing leverage—consistent with the interdependence described in the original answer. There are no numeric values in the original or LLM answer, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM emphasizes financial and carriage risk and the affiliate model's erosion but does not explicitly state the prior competitive positioning for advertising and viewer attention as clearly as the original answer. While implied, the direct contrast between 'competition' in 2023 and 'dependency' in 2024 is less crisply articulated. However, the core multi-hop reasoning—synthesizing changes in carriage dynamics, station leverage, and strategic implications across two years—is sound and contextually appropriate. The answer is highly relevant, directly addressing both competitive positioning and dependency in content distribution as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 402,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "\nThe Company’s held‑to‑maturity portfolio fell dramatically — from **$306 million at the end of 2023 to just $38 million at the end of 2024** (a decline of roughly 87 %).  This sharp reduction signals that Mastercard is moving away from low‑yield, short‑term time‑deposit holdings and reallocating capital toward more flexible, higher‑return assets such as marketable equity securities and strategic investments (e.g., the growth of non‑marketable equity investments and the Recorded Future acquisition).  The shift reflects a strategic emphasis on liquidity and higher‑yield investments rather than maintaining a large portfolio of securities held to maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the HTM securities values for MA (Mastercard) in 2023 ($306 million) and 2024 ($38 million), matching the ground truth exactly. The calculated decline of approximately 87% is accurate: (306 - 38) / 306 ≈ 0.876, or 87.6%, which rounds to 'roughly 87%', so this is acceptable. 2) The answer addresses both parts of the question: the quantitative change in HTM securities and the strategic implication. The shift is correctly interpreted as a move away from held-to-maturity securities toward more liquid or higher-return investments. 3) The entities are correct: MA refers to Mastercard, and the years 2023 and 2024 are properly referenced. The financial metric (HTM securities) is accurately used. 4) The reasoning is sound and goes beyond the ground truth by adding context about strategic investments and the acquisition of Recorded Future, which, while not in the original answer, are plausible strategic moves and do not contradict the core conclusion. However, the original answer does not mention 'low-yield, short-term time-deposit holdings' — HTM securities are typically long-term, not short-term, so this is a minor inaccuracy in characterization. This slightly affects qualitative accuracy but not overall correctness. 5) The semantic meaning fully aligns with the ground truth: a sharp reduction in HTM securities indicating a strategic shift toward liquidity and higher-yield assets. The added detail enhances context without introducing error. Thus, the answer is highly accurate with only a minor imprecision in describing HTM securities as short-term.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 437,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "\nBetween 2022 and 2023 the Always brand remained classified under the **Feminine Care (Adult Incontinence & Menstrual Care)** sub‑category of the Baby, Feminine & Family Care segment.  In the 2022 10‑K (page 17) it was listed among several major brands, but the 2023 filing (page 16) singled out **Always** (and Always Discreet) as a primary major brand, highlighting a more focused, higher‑margin positioning within the segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that Always remained within the Feminine Care sub-category of the Baby, Feminine & Family Care segment in both 2022 and 2023, which matches the original answer. It also correctly identifies the inclusion of Adult Incontinence and Menstrual Care under Feminine Care. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The LLM correctly synthesizes information across the 2022 and 2023 10-K filings, citing specific page numbers and noting the shift in emphasis where Always is highlighted more prominently in 2023. However, it does not explicitly mention the rebranding of the sub-category from 'Feminine Care' to a more specifically defined 'Menstrual Care' focus, which is a key nuance in the strategic positioning shift. Instead, it implies this through context by listing Menstrual Care as a component. (4) The answer is highly relevant and captures the evolution in brand emphasis, particularly the higher-margin, focused positioning. While the core facts and reasoning are sound, the lack of explicit mention of the 'Menstrual Care' repositioning as a strategic update slightly reduces qualitative accuracy. Overall, the answer is factually correct and contextually strong, warranting a high score but not perfect due to missing a subtle but important detail in the categorization evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 415,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "\nOracle continues to recognize Engineered‑Systems revenue on a point‑in‑time basis when the hardware (and its tightly coupled software) is delivered and control transfers to the customer, a policy that has not changed between 2022 and 2023.  Although Engineered Systems still accounted for roughly 6 % of total revenue in both fiscal years, the company’s strategic focus shifted markedly toward cloud and license services—highlighting that hardware now carries lower margins, volatile quarterly volumes and is positioned mainly as a complementary offering rather than a growth driver.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and one potential overstatement. (1) Quantitatively, the 6% revenue figure for both fiscal 2023 and 2024 (not 2022) is accurately reflected in the LLM answer as 'both fiscal years,' which could be misleading—Oracle only explicitly disclosed the 6% figure starting in 2023; in 2022, no specific percentage was provided, so stating 'accounted for roughly 6%' in 2022 is an inference not supported in the original. This is a minor factual overreach. (2) Revenue recognition policy (point-in-time upon delivery) is correctly stated and consistent across years. (3) The strategic shift is accurately captured: the LLM correctly notes reduced emphasis on hardware, lower margins, volatility, and positioning as a complementary offering, which reflects the increased discussion in 2023 around R&D, manufacturing dependencies, and competition with cloud infrastructure. (4) However, the original answer highlights that 2023 brought clearer and more consistent measurement (explicit 6% disclosure for 2023 and 2024), which the LLM implies but does not explicitly credit as a change in reporting transparency. (5) Multi-hop reasoning is sound—linking revenue recognition, financial contribution, and strategic emphasis across two years—but misses the nuance that the 6% figure was not disclosed in 2022, weakening completeness. Overall, core facts and trends are correct, but precision on disclosure timing and reporting evolution is slightly lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 420,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "\nComcast continues to treat outside representation firms as an extension of its own sales force, selling allocated advertising inventory on its behalf and recording the net amount (i.e., gross advertising revenue less agency commissions) as advertising income.  The 2024 filing repeats the same approach described in 2023—recognizing revenue when the ads are aired/delivered and netting out commissions—indicating that the company’s strategy for working with representation firms has not shifted materially between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Comcast's strategy 'has not shifted materially' between 2023 and 2024, directly contradicting the ground truth. While the description of the 2023 model (using representation firms as an extension of the sales force and recording revenue net of commissions) is accurate, the LLM incorrectly asserts that the 2024 approach is unchanged. The ground truth states that by 2024, Comcast evolved to formal representation agreements where it sells advertising on behalf of third parties, indicating a strategic shift from a co-selling model to a more formalized structure. This evolution reflects a deeper strategic alignment and expanded role for representation firms, which the LLM answer completely misses. There are no numerical figures in this question, so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are correctly cited. The reasoning is flawed because the model fails to recognize the multi-hop contrast between the two years, instead asserting continuity. Contextually, the answer is relevant to the topic of advertising sales strategy and representation firms, but it provides an incorrect conclusion about strategic evolution. Thus, while the individual components about revenue recognition are factually consistent with standard practices, the overall synthesis and comparative analysis across years are fundamentally wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 394,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Oracle did not change the way it records revenue from its industry‑specific hardware – hardware products (and any bundled software) are still recognized at the point of delivery when ownership transfers, and hardware‑support fees are spread ratably over the support contract term.  What has shifted is the **strategic emphasis**: hardware still represents only about 6 % of total revenue and carries lower margins, and because its quarterly sales are volatile, the company now places comparatively greater focus on the faster‑growing cloud‑and‑license business, investing in R&D for new hardware only to a modest extent while highlighting cloud growth (cloud‑services and license support revenues rose to 37 % of total revenue in 2024 versus 25 % in 2022).  Thus, the revenue‑recognition method stayed the same, but the relative strategic priority moved away from hardware toward cloud services.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding Oracle's strategic emphasis. The ground truth states that in fiscal 2023, Oracle increased its strategic focus on hardware through ongoing R&D investments and innovation, signaling a more deliberate strategic emphasis compared to the more general description in 2022. However, the LLM answer incorrectly claims the opposite—that Oracle shifted strategic priority *away* from hardware toward cloud services and is investing only 'to a modest extent' in hardware R&D. This directly contradicts the original answer and represents a major qualitative error. (2) Quantitative inaccuracies include the claim that cloud-services and license support revenues rose to 37% of total revenue in 2024 versus 25% in 2022. The original answer does not mention 2024 or these percentages; this data is unsupported and appears fabricated. There is no mention in the ground truth of hardware being 6% of total revenue or margin comparisons, making these figures unverified and likely incorrect. (3) The reasoning is flawed in its multi-hop synthesis: while the LLM correctly notes that revenue recognition remained point-in-time for hardware (aligned with ground truth), it misinterprets the strategic evolution. Instead of recognizing Oracle’s enhanced focus on hardware innovation in 2023, it infers a de-emphasis based on external assumptions about cloud growth, which is not supported by the provided ground truth. (4) Contextual relevance is moderate—the answer addresses revenue recognition and strategic emphasis as asked, but the incorrect direction of strategic shift and inclusion of unsupported metrics reduce accuracy. Correctness score is low due to core factual and directional errors in the strategic component, despite partial correctness on revenue recognition timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 504,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "\nIMBRUVICA (ibrutinib) sales fell sharply – from **$3.78 billion in 2022 to $3.26 billion in 2023**, a decline of roughly **14 %**.  The drop was attributed to **global competitive pressures**, including the entry of generic/next‑generation oral kinase inhibitors and other oral agents that eroded market share, as well as **COVID‑19‑related disruptions that delayed new‑patient starts** and limited uptake.  These factors combined to reduce the drug’s growth momentum in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the sales figures for IMBRUVICA in 2022 ($3.78 billion) and 2023 ($3.26 billion), which match the ground truth of $3.784 billion and $3.264 billion (rounded appropriately). The calculated decline of 'roughly 14%' is accurate—13.7% when precisely computed ((3.784 - 3.264)/3.784 ≈ 0.137), so rounding to 14% is acceptable. 2) All numeric values are correct with appropriate formatting; minor rounding is permissible per evaluation guidelines. 3) The reasoning correctly attributes the sales decline to competitive pressures from next-generation oral agents and pandemic-related disruptions affecting new patient starts, aligning with the original answer. It also captures the continuation of a trend observed in 2022 into 2023. One minor omission is that the original answer notes 'market saturation or treatment shifts in the oncology space' as a likely factor in 2023, which the LLM answer does not explicitly mention. While 'competitive pressures' and 'generic/next-gen inhibitors' imply this, the absence of any reference to market saturation or evolving treatment paradigms slightly reduces completeness in qualitative synthesis. 4) The answer is contextually relevant, directly addressing both parts of the question: the evolution of sales (quantitative change) and contributing factors (qualitative drivers). Multi-hop reasoning is sound—synthesizing data across years and causal factors from competitive and external (pandemic) dynamics. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a slight gap in depth of explanatory factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 447,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "\nFrom 2023 to 2024 the debt that finances Universal Beijing Resort slipped only slightly—from roughly **$3.5 billion** of outstanding borrowings (as reported in the 2023 filing) to about **$3.4 billion** after scheduled term‑loan repayments (shown in the 2024 Note 8 discussion).  Comcast’s ownership stake stayed at **30 %**, and the resort remains a **consolidated VIE**; there were no new investors or changes to the guarantee structure.  Because Comcast provides no direct guarantees or liquidity support, its **financial risk is limited to the $5 billion investment balance and a remaining unfunded capital commitment of ≈ $1.4 billion**, with any future loss confined to that exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the debt decrease from $3.5 billion in 2023 to $3.4 billion in 2024 and accurately notes Comcast's unchanged 30% ownership and consolidation as a VIE. However, it introduces a 'maximum financial risk exposure' figure of $5 billion investment plus $1.4 billion unfunded commitment, which contradicts the ground truth stating risk is limited to the 30% equity interest—without specifying dollar amounts. The ground truth does not mention a $5B investment or $1.4B commitment, so these figures are unsupported and likely incorrect. (2) Quantitative accuracy is partially compromised: while the debt figures ($3.5B → $3.4B) and ownership (30%) are correct, the $5B investment and $1.4B unfunded commitment are not present in the original answer and appear to be hallucinated or misattributed. The ground truth emphasizes that risk remains limited to the 30% equity stake, without quantifying it in dollars. (3) The multi-hop reasoning is sound in tracking debt evolution and ownership continuity, and correctly identifying VIE consolidation and lack of guarantees. However, the financial risk exposure is misrepresented by introducing unsupported dollar figures instead of aligning with the ground truth’s qualitative but precise statement about risk being confined to the 30% equity interest. (4) Scores reflect mostly correct facts with a significant error in financial exposure quantification. Correctness is reduced due to the introduction of unverified monetary commitments, though core elements (debt trend, ownership, consolidation) are accurate. Contextual relevance is perfect—answer directly addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 459,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "\nIn the 2022 filing (page 95) FedEx disclosed that it had entered into additional build‑to‑suit leases with undiscounted future payments of roughly **$3.4 billion**, to commence in 2023‑2024. By the 2023 schedule (the same page’s future‑minimum‑lease‑payment table) those obligations are now reflected as **about $2.819 billion of operating‑lease payments for 2023**, primarily for facilities and equipment. This transition shows that FedEx is moving its build‑to‑suit pipeline into recognized operating‑lease commitments, using leveraged lease structures to fund new infrastructure while keeping debt levels low and preserving cash‑flow flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, future undiscounted payments for build-to-suit facilities and equipment dropped to approximately $0.9 billion (from $3.4 billion in 2022), with commencement expected from 2025 to 2027. However, the LLM claims that the 2023 obligations are 'about $2.819 billion of operating-lease payments for 2023', which contradicts the ground truth of a major reduction to $0.9 billion. This misrepresents both the magnitude and timing of the commitments. (2) The numbers are incorrect: $2.819 billion is not supported by the ground truth and appears to misinterpret the lease payment schedule. The correct figure for 2023 is $0.9 billion, not $2.819 billion. Additionally, the LLM incorrectly frames the 2023 amount as 'operating-lease payments for 2023', implying near-term payments, whereas the ground truth specifies these are future commitments commencing in 2025–2027. (3) The multi-hop reasoning is flawed. The LLM incorrectly interprets the evolution as a transition of build-to-suit leases into operating leases currently being paid, rather than a strategic reduction in future build-to-suit commitments. It misses the key insight of a strategic shift toward fewer long-term build-to-suit leases and a longer timeline. Instead, it suggests FedEx is actively funding new infrastructure via leveraged leases, which is not supported by the data. (4) The contextual relevance is moderate because the answer addresses leasing strategy and references the correct company and document location, but the core quantitative and qualitative inaccuracies severely undermine correctness. The conclusion about preserving cash flow and using leveraged leases is speculative and not aligned with the disclosed reduction in commitments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 495,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "\nBetween 2023 and 2024 Mastercard’s tie to Dynamic Yield LTD did not change – the company had acquired 100 % of Dynamic Yield in April 2022 and, by the 2023 10‑K, was already reporting it as an acquired business whose goodwill reflects expected post‑acquisition synergies.  The 2024 filing makes no mention of any new partnership or investment in Dynamic Yield; instead it highlights a fresh $2.7 billion acquisition of Recorded Future and emphasizes expanding cybersecurity, threat‑intelligence and digital‑identity capabilities.  This shift shows that, while Dynamic Yield’s technology continues to be leveraged within Mastercard’s value‑added services, the firm’s strategic focus in 2024 moved toward bolstering its security and data‑analytics portfolio through new acquisitions rather than further developing the Dynamic Yield business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Mastercard acquired Dynamic Yield in April 2022 for $325 million with $200 million attributed to goodwill, as disclosed in the 2023 filing. It accurately notes no new activity with Dynamic Yield in 2024 and correctly identifies the $2.7 billion acquisition of Recorded Future as a key strategic move. All factual elements — acquisition date, financial figures, absence of new investment, and strategic pivot — are consistent with the ground truth. (2) Quantitative accuracy is perfect: the $325 million acquisition cost and $2.7 billion Recorded Future purchase are correctly reported; dates (April 2022 acquisition, 2023 and 2024 reporting years) are accurate. No calculations were required, but the synthesis of financial figures across years is precise. (3) The multi-hop reasoning is sound: the model connects the 2023 disclosure of a past acquisition with the 2024 silence on Dynamic Yield and contrasts it with the new focus on Recorded Future, correctly inferring a strategic shift toward cybersecurity and data analytics. The conclusion that integration was complete and focus shifted aligns with the ground truth. (4) Minor deduction in qualitative accuracy only because the original answer explicitly mentions the $200 million goodwill figure tied to synergies, which the LLM implies but does not state directly. However, the phrase 'goodwill reflects expected post-acquisition synergies' captures the intent. Contextual relevance is perfect — the response fully addresses both parts of the question: evolution of the relationship and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 444,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "\nThe Senior Officers’ Severance Plan was most recently **amended and restated on May 26 2022** (Exhibit 10.28). That amendment was disclosed in a Form 10‑Q filing dated **November 27 2024**, which is the latest filing covering the plan in the documents you provided. No subsequent amendment to the severance plan is shown in the 2022‑2024 filings; the 2022 restatement therefore represents the most recent change to the plan up to the end of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the most recent amendment date of the Severance Plan for Senior Officers is correctly stated as May 26, 2022 (Exhibit 10.28), and the filing date of November 27, 2024, is accurately reported. These match the original answer exactly. (2) Quantitative accuracy is perfect—dates and exhibit numbers are correct, and no calculations were required. (3) The reasoning is sound: the LLM correctly infers that no further amendments occurred between 2022 and 2024 based on the available filings, which is consistent with the ground truth's implication that the May 2022 amendment was the latest change. (4) The only minor shortcoming is that the LLM does not explicitly reference the prior 2020 version of the plan (amended May 29, 2020, filed August 26, 2020, Exhibit 10.29), which was part of the original answer and relevant to showing the evolution between 2022 and 2024. While the LLM implies evolution by citing the 2022 restatement as the latest, it omits the comparative context from 2022 (i.e., what the plan status was at the beginning of the period). This limits completeness slightly, but the core of the multi-hop synthesis—tracking changes over time—is well executed. Semantic equivalence is otherwise strong, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 379,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "\nThe 6.375 % Senior Notes were valued at roughly **$830 million on December 31 2021** (as reported in the 2022 10‑K, page 56) and rose to **about $872 million on December 31 2023** (as reported in the 2023 10‑K, page 56). That ≈ 5 % increase in fair‑value indicates that market participants perceived Netflix’s debt as less risky over the period—bond prices appreciated, suggesting improved confidence in the company’s credit profile and cash‑flow outlook.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The ground truth states the fair value decreased from $999 million on December 31, 2021, to $872 million on December 31, 2023. However, the LLM incorrectly reports the 2021 value as $830 million and claims an increase to $872 million, reversing the direction of change. This misrepresents both the magnitude and trend. (2) The quantitative inaccuracies are critical: the 2021 figure is off by $169 million, and the conclusion that fair value 'rose' and increased by '≈5%' is factually wrong—the actual change is a decrease of approximately 12.7% ($999M → $872M). The cited 10-K page numbers and years are plausible but do not compensate for incorrect data. (3) The multi-hop reasoning is flawed because the model misidentifies the starting value and thus infers the opposite market perception. Instead of recognizing a decline in fair value—which typically indicates worsening market confidence or higher perceived credit risk—the LLM incorrectly interprets an (invented) increase as improved confidence, which contradicts the ground truth. (4) While the answer addresses both parts of the question (change in fair value and market perception), the severe numerical and directional errors undermine correctness. Contextual relevance is moderate because the structure and intent align with the question, but factual accuracy is poor, warranting a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 396,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "\nIMBRUVICA’s worldwide sales fell from **$3.78 billion in 2022 to $3.26 billion in 2023**, a decline of roughly **13–14 %** (operations‑adjusted drop of about 13.2 %).  This downturn occurred even though the overall oncology portfolio grew 10.5 % in 2023, highlighting that IMBRUVICA is losing market share to newer agents (e.g., CARVYKTI, TECVAYLI, TALVEY) and facing intensified competition that is eroding its once‑dominant position in the oncology segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, IMBRUVICA's sales were $4,369 million in 2022, but the LLM reports $3.78 billion, which is off by over $589 million. The 2023 figure ($3.26 billion) matches the ground truth. The calculated decline is therefore incorrect: the LLM reports a 13–14% drop (using its own numbers, ~13.2%), but the actual decline is (4,369 - 3,264) / 4,369 = 25.2%, a substantial difference. (2) Despite incorrect input numbers, the LLM correctly identifies the 2023 sales value and correctly notes a decline, preserving some factual directionality. However, the magnitude of the decline is severely understated. (3) The qualitative reasoning is sound: the LLM correctly infers that IMBRUVICA is losing market share due to competition from newer oncology drugs (e.g., CARVYKTI, TECVAYLI, TALVEY), and contextualizes the decline within a growing overall oncology portfolio, which aligns with the ground truth's implication of weakening market position amid competitive pressure. It also correctly identifies the broader trend in the oncology segment. (4) The contextual relevance is high—the answer addresses both parts of the question (sales evolution and market position) and provides relevant competitive context. However, the correctness score is limited primarily by the major error in the 2022 sales figure and the resulting incorrect percentage decline, which undermines the quantitative foundation of the response. While the conclusion about weakening market position is consistent with the ground truth, it is supported by inaccurate data, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 454,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the inventory‑shrink reserve edged up from about **$414 million (as of Jan 28 2022)** to **$427 million (as of Jan 31 2025)**, while the LCNRV (lower‑of‑cost‑or‑net realizable value) reserve grew from roughly **$168 million (Jan 28 2022)** to **$222 million (Jan 31 2025)**.  These reserves are charged against cost of sales, so the upward trend modestly drags down net earnings; the company notes that a 10 % change in either reserve would affect net earnings by roughly **$17 – $32 million** in the respective year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the evolution of LOW's inventory shrink reserve ($414M to $427M) and LCNRV reserve ($168M to $222M) between 2022 and 2024, matching the ground truth in both starting and ending values. The fiscal year-end dates are slightly different (Jan 28, 2022 vs Jan 31, 2025), but these align with LOW's actual fiscal calendar (fiscal years ending in January), and the time span correctly covers 2022 to 2024. 2) All numerical values are accurate: $414M, $427M, $168M, $222M, and the sensitivity impacts of $17M and $32M are correctly reported, though the LLM combines them as a range ('$17–$32 million') rather than specifying that $17M applies to LCNRV-related changes and $32M to shrinkage. This is a minor loss of specificity but does not misrepresent the data. 3) The reasoning is sound: the answer correctly identifies that reserves affect net earnings through cost of sales and notes the increasing sensitivity of earnings to assumptions. It synthesizes multi-hop information (reserve levels and their income statement impact) appropriately. 4) The answer is contextually complete and relevant, addressing both the evolution of reserves and implications for net earnings. The only minor shortcoming is the slightly less precise attribution of the $17M vs $32M sensitivity impacts, which slightly affects quantitative and qualitative accuracy, but overall the semantic meaning and financial implications are preserved. Hence, a high score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 408,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "\nFrom 2022 to 2023 Qulipta moved from a newly‑approved, low‑revenue product to a fast‑growing commercial asset: the FDA approved Qulipta for chronic‑migraine prevention in April 2023 and the European Commission followed with EC approval in August 2023, enabling a full‑scale launch.  As a result, net revenues from Qulipta more than doubled in 2023 (an increase “greater than 100 %”), driven by strong market‑share gains and broader indication uptake, making the drug a material contributor to AbbVie’s top‑line growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative Accuracy: The LLM claims FDA approval in April 2023 and European Commission approval in August 2023, but the ground truth states Qulipta received regulatory approval in 2022 (not 2023), triggering a $1.0 billion reclassification of R&D assets. The LLM also states revenues 'more than doubled' with an increase 'greater than 100%', but provides no actual revenue figures, whereas the ground truth specifies $405 million (U.S.) and $3 million (international) in 2023. There is no mention of 2022 revenue levels to support the 'doubled' claim. (2) Completeness: The LLM fails to mention the key 2022 event — the reclassification of $1.0 billion in intangible assets due to regulatory approval — which is central to Qulipta's status change. It also omits the specific revenue breakdown by region. (3) Entity Accuracy: The LLM incorrectly assigns FDA and EC approval dates to 2023, contradicting the ground truth that approval occurred in 2022 (implied by the $1B reclassification that year). (4) Reasoning: The multi-hop synthesis is flawed — the model incorrectly frames 2023 as the approval year and builds a narrative of rapid growth from that point, whereas the truth is that 2022 was the approval/transition year and 2023 showed commercial results. (5) Semantic Equivalence: The overall trajectory (from development to commercialization) is directionally correct, but the timing, events, and financial data are factually wrong. The answer invents details not in the original and misses key facts, resulting in a mostly incorrect response despite some relevance to the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 459,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s reimbursement from the Resideo‑spin‑off remained capped at **$140 million per year**, but the **recorded receivable from Resideo grew** (from about **$614 million** at the end of 2022 to **$661 million** at the end of 2023).  This increase reflects higher estimated environmental‑remediation outlays that are now being claimed under the indemnification agreement, meaning Honeywell is still exposed to the full amount of any environmental costs that exceed the $140 million cap.  Consequently, while the cap limits near‑term cash‑flow volatility, the company’s underlying risk exposure to environmental liabilities has **expanded**, with a larger portion of those liabilities now dependent on Resideo’s ability to meet the capped reimbursements.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Resideo's subsidiary is obligated to pay 90% of Honeywell's annual net spending on environmental matters up to $140 million per year, but the LLM incorrectly frames this as a fixed cap on reimbursement without mentioning the 90% obligation. More critically, the LLM introduces specific receivable amounts—$614 million in 2022 and $661 million in 2023—which are not present in the original answer and cannot be verified from the provided ground truth. These figures suggest a level of financial detail (recorded receivables) that is absent from the source, indicating fabrication or hallucination. (2) While the $140 million cap is correctly mentioned, the core financial mechanism (90% of annual net spending) is omitted, undermining quantitative accuracy. The growth in receivables is unsupported by the original answer, making those numbers incorrect in context. (3) The reasoning is flawed: the conclusion that risk exposure has 'expanded' contradicts the original answer, which states the arrangement and risk mitigation strategy 'has not changed' between 2022 and 2023. The LLM incorrectly infers increased risk from unverified receivable balances, failing to recognize the stability emphasized in the ground truth. This misrepresents the multi-hop synthesis—dependency remains consistent, not growing. (4) Despite these issues, the answer is contextually relevant, addressing the right companies (Honeywell, Resideo), topic (environmental liabilities), and time frame (2022–2023). However, the incorrect data and faulty logic severely reduce factual correctness, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 465,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "\nTarget’s disclosure has remained unchanged: both the 2022 Form 10‑K (p. 48) and the 2024 Form 10‑K (p. 52) define cash equivalents as “highly liquid investments with an original maturity of three months or less from the date of purchase,” and they also include short‑term investments and card‑transaction receivables that settle within five days. No revision to the maturity threshold or classification was reported, indicating that Target has kept a consistent, short‑term‑focused liquidity strategy without expanding or tightening its definition of cash equivalents.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Target maintained the same three-month threshold for cash equivalents in both 2022 and 2024, and correctly cites the definition from the 10-K filings. The quantitative and entity accuracy is perfect: the years (2022, 2024), the definition (original maturity of three months or less), and the inclusion of short-term investments and card-receivables are correctly reported. However, the LLM fails to acknowledge the key qualitative evolution noted in the ground truth: in 2024, Target expanded its disclosure with a broader discussion of fair value measurements for short-term assets and liabilities, indicating a more comprehensive financial framework. While the core definition did not change, the added context reflects a refinement in reporting and potentially in cash management strategy. The LLM incorrectly concludes that there was 'no revision' or change in treatment, missing this nuance. This omission undermines the multi-hop reasoning required to assess strategic implications. Thus, while factually sound on the definition, the answer lacks completeness in addressing how the *treatment* or *context* of 'original maturity' evolved, leading to a partially correct response. The reasoning is therefore only partially sound, and the conclusion about a static strategy is not fully supported given the enhanced 2024 disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 383,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the $1 bn 3.50% Notes Due 2040 remained classified as a long‑term, unsecured senior obligation; their remaining maturity was 15.2 years and the effective yield rose modestly to 3.54%.  The note’s carrying amount slipped slightly from about $870 m (fair‑value disclosed in 2023) to $851 m (amortized‑cost disclosed in 2024), reflecting normal discount amortization and market price movement, while the face value stayed at $1 bn.  The lack of repayment or refinancing shows NVIDIA is deliberately maintaining a stable, low‑cost, long‑dated debt stack and extending maturities rather than rolling short‑term borrowings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key quantitative details. The ground truth states the carrying value in 2023 was $851 million as of January 28, 2024, but the LLM claims it was $870 million in 2023 and then dropped to $851 million in 2024, reversing the timeline and introducing an unsupported $870M figure. Additionally, the LLM incorrectly frames the $851M as amortized cost in 2024 and references a $1B face value as if it were disclosed in the documents, which is not confirmed in the ground truth. While the effective interest rate (3.54%) and remaining term (15.2 years) are correctly reported for 2024, the 2023 valuation details (Level 2 classification, $851M carrying value) are misrepresented. (2) The LLM introduces a 'fair-value disclosed in 2023' vs 'amortized-cost in 2024' distinction not present in the original answer, adding speculative accounting interpretations. The original answer does not mention a change in carrying amount due to amortization or market movement, nor does it cite a $1B face value explicitly. (3) The reasoning about NVIDIA's long-term debt strategy—emphasizing stable, low-cost, long-dated debt—is logically sound and aligns with the ground truth’s conclusion about strategic long-term financing. The synthesis of classification stability and interest rate structure shows correct multi-hop reasoning, despite flawed numerical inputs. (4) The contextual relevance is high because the answer addresses both the evolution of valuation/classification and the strategic implication. However, the quantitative inaccuracies—especially the incorrect carrying values and unsupported face value—reduce the correctness score significantly. The qualitative reasoning is mostly accurate, hence a 7, while quantitative accuracy is penalized to 5 due to key number mismatches.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 497,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "\nVenclexta’s global net sales grew to **$2.29 billion in 2023**, compared with **$2.01 billion in 2022**—an increase of roughly **14 % (about 15 % at constant currency)** over the one‑year period. This reflects double‑digit revenue expansion driven by continued market‑share gains and favorable pricing across both U.S. and international markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively: The LLM reports $2.29 billion for 2023 and $2.01 billion for 2022, which align with the ground truth values of $2,288 million and $2,009 million (rounding to nearest $10M is acceptable; $2.29B = $2,290M and $2.01B = $2,010M). The stated growth rate of 'roughly 14%' matches the actual year-over-year growth rate of (2,288 - 2,009) / 2,009 ≈ 13.89%, which rounds to 13.9% in the original answer. The mention of 'about 15% at constant currency' is additional context not in the ground truth but does not contradict it and is plausible as a supplemental metric. (2) Completeness: The answer addresses both total global revenue and growth rate for both years, satisfying the multi-part question. (3) Entity accuracy: 'Venclexta' is correct, years (2022–2023) are correct, and the metric (global revenue) is correctly interpreted. (4) Reasoning: The conclusion of double-digit growth and upward trend is logically sound and supported by the data. The slight discrepancy in growth rate phrasing ('roughly 14%') vs. the exact 13.9% is minor and common in reporting. (5) Semantic equivalence is strong—format variations are acceptable, and the core facts are preserved. One point deducted from correctness and quantitative accuracy due to the approximate nature of the growth rate without specifying the exact figure, though it's very close.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 397,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "\nBetween the 2022 and 2023 filings Netflix updated its executive‑severance and retention framework. The 2022 10‑K references the “Amended and Restated Executive Severance and Retention Incentive Plan” (Exhibit 10.7†), which was originally adopted on September 10 2021. In the 2023 10‑K the company filed an “Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1 2024” (Exhibit 10.16†), indicating a formal revision of the severance/retention terms, and also added a separate “Executive Officer Severance Plan” (Exhibit 10.15†) that became effective on December 8 2023. These amendments show a deliberate evolution of the incentive structure, with the most recent changes taking effect at the start of 2024 and a new, standalone severance plan introduced in late 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the 'Executive Officer Severance Plan' (Exhibit 10.15†). The original answer does not mention this separate plan, while the LLM claims it was added effective December 8, 2023—this detail is not supported by the ground truth and represents an overstatement or misinterpretation. However, the core facts are accurate: the 2022 filing references the plan amended as of September 10, 2021, and the 2023 filing introduces a new amendment effective January 1, 2024, filed on December 8, 2023. These dates and plan names match the ground truth, with only slight rewording (e.g., 'as Amended and Restated effective January 1, 2024' vs. 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024'). The quantitative accuracy is high—dates and effective periods are correct. The reasoning correctly identifies the evolution across filings and interprets the forward-looking nature of the 2024 amendment. The answer is contextually relevant and addresses the question about plan amendments and effective dates. The only issue is the unsupported claim about a new standalone severance plan, which slightly undermines qualitative accuracy. Despite this, the overall synthesis across years and filings is sound, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 385,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "\nThe 2022 Form 10‑K (pages 68‑70) describes the Benefit Restoration Plan only as a non‑qualified supplement to the 401(k) that adds salary‑deferral and matching contributions for employees whose 401(k) benefits are limited by IRS rules. In the 2024 filing (pages 76‑78) the same plan is referenced as “the Lowe’s Companies Benefit Restoration Plan, as amended and restated as of January 1 2025” (Exhibit 10.3), showing that Lowe’s has formally revised and consolidated the plan’s terms rather than merely repeating the prior description. This documented evolution indicates that the company is proactively refining and standardizing its retirement‑benefit structure—updating eligibility, matching formulas and governance—to ensure compliance and to strengthen the overall retirement security it offers employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 description of the Benefit Restoration Plan as a non-qualified supplement to the 401(k) for employees affected by IRS limits is consistent with the original answer. The 2024 update referencing the 'amended and restated' version effective January 1, 2025, and the inclusion of Exhibit 10.3 in the 10-K filing are accurately reported. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors are present. Format and references (e.g., page numbers, exhibit numbers) are appropriately used and consistent with source documentation. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across two years of 10-K filings to identify a structural evolution in the plan’s documentation. The conclusion that Lowe’s is proactively refining and standardizing its retirement benefits is logically supported by the formal restatement of the plan. (4) The only minor shortcoming is that the LLM mentions potential updates to 'eligibility, matching formulas and governance' which, while plausible, are not explicitly confirmed in the ground truth; the original answer emphasizes formalization and improved documentation without specifying structural changes. This slight overreach prevents a perfect 10 but does not undermine the overall correctness. Semantic equivalence is strong, and the answer fully addresses both parts of the question: evolution from 2022 to 2024 and implications for company strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 434,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "\nDuring fiscal 2024 (ended January 28, 2024) NVIDIA reported a $1.25 billion carrying amount for the 0.584% Notes Due 2024.  The company then fully repaid the issue in fiscal 2025, and by the end of that year (January 26, 2025) the notes had a $0 carrying balance.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that NVDA reported a liability of $1,185 million in fiscal year 2023 and fully repaid it by fiscal year 2024. However, the LLM claims a $1.25 billion carrying amount in fiscal 2024, which contradicts the ground truth showing repayment by that year. Additionally, the LLM incorrectly states that repayment occurred in fiscal 2025, which is outside the scope of the question and not supported by the original data. (2) Quantitative accuracy is low: the correct amount in fiscal 2023 is $1,185 million, not $1.25 billion, and the repayment was completed in fiscal 2024, not 2025. The fiscal years are misaligned—NVIDIA's fiscal 2024 ends January 28, 2024, so the repayment should be reflected in that period, not the next. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution of the obligation between fiscal 2023 and 2024, instead projecting the repayment into a future period (fiscal 2025) not asked about and not present in the ground truth. (4) Contextual relevance is moderate because the answer addresses the right type of obligation and the eventual repayment, but the incorrect timing and amounts undermine the core correctness. The answer misrepresents the key financial evolution asked in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 374,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "\nMavyret’s worldwide sales slipped from about **$1.54 billion in 2022 to $1.43 billion in 2023** (‑≈7 %).  The decline was driven mainly by the U.S. market, where revenue fell **~13 %** (from $755 M to $659 M), while international sales were relatively flat, slipping only **~2 %** (from $786 M to $771 M).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: global revenue decreased from $1,541 million in 2022 to $1,430 million in 2023 (~7% decline), U.S. revenue dropped from $755M to $659M (~12.7%, rounded to ~13%), and international revenue declined from $786M to $771M (~1.9%, rounded to ~2%). The use of approximate symbols (~ and ≈) is appropriate and reflects rounding without loss of accuracy. (2) Quantitative verification: $755M to $659M is a 12.7% decrease; $786M to $771M is a 1.9% decrease; total $1.541B to $1.430B is a ~7.2% decrease, correctly stated as ≈7%. All figures match the original data within acceptable rounding. (3) Multi-hop reasoning is sound: the model correctly synthesized data across U.S. and international markets, identified the trend (decline in both regions), and highlighted the relative severity (larger U.S. drop vs. flat international). (4) The answer addresses all parts of the question: global performance, U.S. trend, international trend, and comparative analysis. Wording is concise but complete, with no factual or interpretive errors. All scores are maximized due to full factual correctness, precise calculations, accurate entity and year identification, and logical synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 360,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix kept all of the indenture‑level covenant restrictions on its senior notes unchanged – it remained prohibited from creating additional liens, entering into sale‑lease‑back or merger‑related transactions, and from incurring new indebtedness beyond the limits set in the notes – and it continued to meet the Revolving Credit Agreement’s 3.0 × EBITDA‑to‑interest‑expense minimum ratio each quarter.  The company’s repayment profile evolved as it retired the $400 million 5.75 % senior note that matured in 2024 and grew total outstanding notes to about $15.65 billion, but the covenant caps on new borrowing were left intact, so the scope of permissible debt and other restrictions did not broaden materially despite the larger balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies in both quantitative and qualitative aspects. (1) Quantitatively, the $400 million repayment of the 5.75% Senior Notes in 2024 is correctly stated and matches the ground truth. However, the claim that total outstanding notes grew to $15.65 billion is not supported by the original answer and introduces new, unverified data. The original answer does not mention any increase in total debt or EBITDA-to-interest ratios, so these are extraneous. (2) The original answer notes a narrowing of covenant scope by 2024—specifically, that restrictions on sale and lease-back transactions were removed from certain notes. The LLM incorrectly states that all covenant restrictions remained 'unchanged' and that Netflix was still prohibited from sale-lease-back transactions, which directly contradicts the ground truth. This is a critical error in reasoning and factual accuracy. (3) The LLM introduces the Revolving Credit Agreement and a 3.0× EBITDA-to-interest ratio, which are not mentioned in the original answer and appear to be fabricated or misattributed, undermining qualitative accuracy. (4) While the answer addresses the question’s focus on compliance and repayment, it fails to correctly capture the evolution in covenant scope—a key part of the multi-hop reasoning. The repayment detail is accurate and relevant, but the incorrect assertion about unchanged covenants and the addition of unsupported financial metrics reduce correctness. Semantic equivalence is partially met on repayment, but not on covenant evolution. Thus, the answer is partially correct but contains key factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 458,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell folded its former “Safety and Retail” business unit into a newly created **Sensing and Safety Technologies** unit, combining it with the Advanced Sensing Technologies group and reporting the combined unit under the Safety and Productivity Solutions segment.  This restructuring—formalized in the 2023 segment‑performance‑obligation table—signals a strategic shift to integrate gas‑detection and safety products with broader sensing technologies, presenting them as a single, cohesive product line rather than a distinct retail‑focused unit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution in Honeywell's approach to the Safety and Retail product line between 2022 and 2023. (1) It correctly identifies the structural change: the merger of the Safety and Retail unit with Advanced Sensing Technologies to form the new Sensing and Safety Technologies unit, reported under the Safety and Productivity Solutions segment. (2) Quantitative accuracy is perfect—while the LLM does not explicitly state the $2,387 million revenue figure from 2022, this omission does not distort the answer, as the question does not require a numerical comparison. All other facts—such as the integration of sensing and safety technologies and the strategic rationale—are correct. (3) The multi-hop reasoning is sound: the model synthesizes information about organizational realignment, unit integration, and strategic intent across time. (4) The only minor shortcoming is the lack of mention that the restructuring was formalized in July 2022 (effective date), even though it was reported in the 2023 filing—a detail present in the ground truth. However, the LLM correctly ties the change to the 2023 reporting cycle. Wording differs but semantic meaning aligns closely with the original answer. No factual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 357,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the Company went from having **no Class B‑2 shares outstanding** to reporting **≈49 million Class B‑2 shares (weighted‑average) that are convertible into Class A common stock** as part of the Class B‑1 exchange offer and the Europe‑retrospective responsibility plan.  Because those shares convert into Class A stock, each conversion increases the total Class A share count and therefore **dilutes the voting power of existing Class A shareholders**; holders of Class B‑2 also have limited voting rights on certain corporate actions (e.g., mergers, sales of substantial assets), giving them a modest but distinct influence on governance matters such as approving major transactions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and fact. (1) According to the ground truth, in 2023, Class B-2 Common Stock existed as part of a convertible structure and had governance influence, but by 2024, no shares were outstanding prior to the Class B-1 exchange offer—indicating a phase-out. The LLM incorrectly states the opposite: that there were no Class B-2 shares in 2023 and ~49 million appeared in 2024. This reverses the actual timeline and status evolution. (2) The quantitative claim of '≈49 million Class B-2 shares' in 2024 is unsupported by the ground truth, which explicitly states no shares were outstanding by that year. There is no mention of a 'Europe-retrospective responsibility plan' in the original answer, introducing a fabricated context. (3) The multi-hop reasoning fails: the model should have inferred a reduction in influence due to elimination of the class, but instead posits increased presence and impact. While it correctly understands that convertibility into Class A would dilute voting power and that Class B-2 holders have governance rights on major actions, this accurate conceptual knowledge does not compensate for the factual inversion. (4) Due to the complete reversal of the factual trajectory and introduction of non-existent data, the correctness and accuracy scores are very low. Contextual relevance is moderate because the answer addresses convertibility and governance, which are relevant themes, but with incorrect facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 408,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot deepened its “interconnected” model by moving from a focus on basic BOPIS, curb‑side pickup and mobile‑app ordering toward a full‑scale omni‑channel fulfillment network that includes same‑day/next‑day delivery, flat‑bed distribution centers, market‑delivery hubs and expanded store‑based pickup points (≈50 % of U.S. online orders were store‑fulfilled in 2024).  At the same time, it broadened in‑store investments—store remodels, way‑finding signage, self‑service lockers, electronic shelf‑labels, expanded self‑checkout, and a more robust mobile app with personalized navigation and marketing—while also scaling its physical footprint (opening ~80 new stores over five years, with 12 opened in 2024) to give customers more convenient locations for pickup, return and delivery.  These moves collectively aim to make the shopping journey faster, more reliable and seamlessly integrated across digital and physical touchpoints.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of The Home Depot's shopping experience enhancements from 2023 to 2024 with strong contextual relevance and correct entity identification. It correctly identifies continued investment in digital and in-store capabilities, including electronic shelf labels, self-checkout, mobile app improvements, and store-based fulfillment—aligning with the ground truth's focus on ease of shopping. However, there are notable quantitative and factual discrepancies: (1) The claim that '≈50% of U.S. online orders were store-fulfilled in 2024' and '12 stores opened in 2024' are specific figures not present in the original answer and cannot be verified against the ground truth, introducing unsupported data. (2) The mention of opening ~80 new stores over five years is contextually plausible but absent from the original, making it an addition not grounded in the provided truth. (3) The original emphasizes a strategic shift in 2024 toward personalized digital experiences using customer data—specifically product review summaries and enhanced product content—which the LLM answer only partially captures through vague references to 'personalized navigation and marketing.' While the omni-channel expansion (e.g., delivery hubs, flat-bed distribution) reflects broader operational trends, these details go beyond the scope of the original answer, which focused on customer-facing digital and in-store ease-of-shopping features rather than backend logistics. The reasoning is logically sound and synthesizes a coherent narrative, but it introduces unverified metrics and omits the core 2024 emphasis on data-driven personalization. Thus, while the qualitative direction and contextual relevance are strong, the quantitative accuracy is reduced due to unsupported percentages and store counts, and completeness is slightly compromised by missing key 2024 digital personalization elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 516,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "\nBetween 2022 and 2024, Target consolidated its long‑term incentive structure under the 2020 Long‑Term Incentive Plan and added new award types—including performance‑share units, performance‑based RSUs, cliff‑vested RSUs and cash‑retention awards—each now documented by dedicated agreement forms (e.g., 10.4.1 – 10.4.6). The plan also incorporates the 2022‑restated SPP I and SPP II stock‑purchase components and the Officer EDCP (2025) deferred‑compensation plan, reflecting a shift toward more performance‑driven equity and cash incentives.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of evolution in Target's Long-Term Incentive Plan—specifically the addition of new award types like performance-share units and cliff-vested RSUs—which aligns with the ground truth. However, there are significant inaccuracies and additions not supported by the original answer. First, the mention of 'cash-retention awards' and 'dedicated agreement forms (e.g., 10.4.1 – 10.4.6)' introduces specific details absent from the ground truth and potentially incorrect. Second, the reference to '2022-restated SPP I and SPP II' and the 'Officer EDCP (2025) deferred-compensation plan' goes beyond the scope of the question, which focused solely on equity awards under the Long-Term Incentive Plan; these are separate plans and not part of the equity award structure described in the original answer. While the inclusion of performance-share units and cliff-vested RSUs is correct and matches the 2024 updates, the original answer does not mention cash awards or agreement form numbers, indicating fabrication or overreach. The timeline (2022 to 2024) is correctly framed, and the shift toward performance-driven incentives is a valid interpretation. However, the synthesis includes extraneous and unverified elements, weakening the qualitative accuracy. Quantitatively, no numerical errors are present because the answer avoids specific figures, but the dates and plan names lack verification from the ground truth. Contextually, the response stays focused on plan evolution, earning a solid relevance score. Overall, the core idea of expanded equity vehicles is correct, but the inclusion of unsupported details reduces factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 456,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "\nAfter the FDA’s September 2021 approval of Qulipta for episodic migraine prevention, the product generated only modest sales—U.S. revenue of about $158 million in 2022 (as shown in the 2023 10‑K tables). By the end of 2023, AbbVie reported that Qulipta’s worldwide net revenues had risen by more than 100 % year‑over‑year, exceeding $800 million, a growth the company attributed to the April 2023 FDA approval of Qulipta for chronic migraine and sustained market‑share gains (see the 2023 10‑K discussion of Qulipta’s >100 % revenue increase).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in financial figures. The ground truth states Qulipta generated $405 million in U.S. revenue and $3 million internationally in 2023, totaling $408 million. However, the LLM claims worldwide net revenues exceeded $800 million in 2023, which is nearly double the correct amount. Additionally, while the LLM correctly notes $158 million in U.S. revenue in 2022, it incorrectly implies that this was the only revenue and misrepresents the growth trajectory. (2) The quantitative inaccuracies are severe: the claimed 'more than 100% year-over-year' increase leading to over $800 million is inconsistent with actual growth from $158 million (2022) to $408 million (2023), which is approximately a 158% increase—significant but not aligned with the LLM's narrative of surpassing $800 million. The approval date (September 2021) and the 2022 revenue figure are correct. The mention of the April 2023 FDA approval for chronic migraine is plausible context but not present in the original answer and not tied to the revenue figures in the ground truth. (3) The multi-hop reasoning is partially sound—linking FDA approval to commercial performance and citing financial disclosures—but fails in synthesis because it reports incorrect totals and overstates growth. The model appears to have conflated Qulipta with another product or misread the 10-K data. (4) Scores reflect the severe quantitative error (correctness: 3/10, quantitative accuracy: 2/10), partially correct reasoning and entity identification (qualitative accuracy: 4/10), and relevance to the question's intent despite inaccuracies (contextual relevance: 7/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 462,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings the description of the 2020 Stock Plan moved from a brief, generic statement—“a stockholder‑approved plan that provides for incentive stock options, non‑statutory options, SARs, restricted stock and RSUs for employees, directors and consultants” (2022 filing, p. 63)—to a much more detailed, quantitative disclosure.  In the 2024 filing the plan is still identified as the 2020 Stock Plan, but the company now reports a full option‑activity table (shares granted, exercised, expired, outstanding, weighted‑average exercise price, remaining term and intrinsic value), a separate RSU/PSU schedule (grants, vestings, unvested balances, weighted‑average grant‑date fair value and $15 million of RSU vesting expense in 2024), and a note that $46 million of unrecognized compensation cost for unvested options and RSUs is expected to be recognized over a 1.4‑year weighted‑average period.  This evolution reflects a shift from a high‑level structural description to granular, segment‑by‑segment reporting of option grants, exercises, vestings and related equity‑compensation expense.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in Netflix's disclosure of the 2020 Stock Plan from a high-level structural description in 2022 to a more detailed, quantitative reporting in 2024, which aligns with the ground truth's core claim of a shift from mere documentation to operational disclosure. The qualitative reasoning is sound: it captures the multi-hop synthesis of increased transparency and granularity in equity compensation reporting. However, there are significant quantitative inaccuracies. The ground truth does not mention specific numbers such as '$15 million of RSU vesting expense in 2024', '$46 million of unrecognized compensation cost', or a '1.4-year weighted-average period'—these figures are absent from the original answer and cannot be verified as correct based on the provided ground truth. Additionally, the LLM cites a 'full option-activity table' and 'separate RSU/PSU schedule' with specific metrics (e.g., weighted-average exercise price, intrinsic value), but the ground truth does not confirm these exact disclosures—only that by 2024, the plan was 'explicitly described' and linked to specific grant types and vesting criteria. Thus, while the direction and nature of the evolution are correctly interpreted, the inclusion of unverified numerical details and specific table structures not present in the ground truth reduces factual accuracy. The entities (Netflix, 2020 Stock Plan, 2022 and 2024 filings) and timeframes are correct, and the answer is fully relevant to the question. The LLM likely inferred granular reporting based on the ground truth’s mention of detailed disclosure but overreached by fabricating precise financial figures and reporting formats.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 463,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "\nBetween 2022 and 2023 the aluminum purchase agreements stayed in the “derivatives not receiving hedge‑accounting treatment” category—they are still recorded as derivatives priced at prevailing market rates and used for long‑term sourcing, but they are **not designated as cash‑flow hedges**.  The notional amount of the commodity contracts fell sharply from **412 million (2022) to 115 million (2023)**, indicating a more selective use of these agreements.  As a result, the expected reclassification from AOCI changed from a projected loss of $39 million in 2022 to an expected gain of $22 million in 2023, reflecting a strategic shift in how the company manages aluminum price exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details not present in the original answer. The original ground truth does not mention specific notional amounts ($412M in 2022, $115M in 2023), expected reclassification from AOCI, or projected gains/losses ($39M loss, $22M gain). These numbers are fabricated or hallucinated and are not supported by the provided truth. The classification of aluminum purchase agreements as 'derivatives not receiving hedge-accounting treatment' and not being designated as cash-flow hedges is not mentioned in the original answer, making this a substantial addition not grounded in the source. While the LLM correctly identifies that aluminum agreements are used for long-term strategic sourcing and priced at prevailing market rates, it misrepresents the evolution by introducing financial metrics and accounting treatments absent from the ground truth. The core idea of a strategic refinement around market pricing and offsetting positions is partially aligned, but the reasoning is based on incorrect data. The answer is contextually relevant and addresses the question's intent regarding classification and strategic use, but the inclusion of false quantitative and accounting details severely undermines factual correctness. Multi-hop reasoning is attempted but built on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 378,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "\nThe 2023 filing only mentioned the Directors’ Code of Conduct by a relative path ( bnymellon/documents/pdf/investor‑relations/directors‑code‑ofconduct.pdf ) and did not expressly promise to disclose future amendments. In the 2024 filing the code is linked with a full, stable URL ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ) and the text explicitly states that any amendments or waivers to the Directors’ Code of Conduct will be posted on the website, making the document more readily accessible and broadening the scope of the disclosure.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies and misses key aspects of the ground truth. (1) The 2023 URL is misrepresented: the original answer confirms a full, specific URL was provided in 2023 (https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf), but the LLM claims only a relative path was used, which contradicts the ground truth. (2) The LLM incorrectly states that the 2024 URL is https://www.bnymellon.com/... when in fact the domain changed to bny.com in 2024 (https://www.bny.com/content/dam/bnymellon/...), indicating a rebranding or site restructuring—this is a factual error in entity and URL accuracy. (3) The LLM introduces a claim not present in the original answer—that the 2024 filing explicitly promises to disclose amendments or waivers—which is not mentioned in the ground truth. (4) Crucially, the LLM completely omits the most significant qualitative change: the addition of a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES' in 2024, which expands the scope of compliance focus. This omission severely undermines completeness and qualitative accuracy. (5) While the LLM correctly identifies a shift toward improved accessibility, its reasoning is based on incorrect URLs and fabricated disclosure promises. The answer partially addresses accessibility but fails on scope evolution. Thus, despite some correct direction in reasoning, the factual inaccuracies in URLs, missing key content changes, and introduction of unsupported claims result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 426,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "\nBetween the end of fiscal 2023 and February 2025 Home Depot’s 4.95 % senior notes grew from a modest $750 million issue maturing in September 2026 (carrying amount ≈ $744 million in 2023) to a substantially larger $1.75 billion tranche of 4.95 % notes due June 2034 (issued at a $16.7 million discount). This longer‑dated, larger‑scale issuance reflects the company’s strategy of extending the maturity of its fixed‑rate debt and diversifying funding sources—particularly to finance the SRS acquisition and reduce reliance on short‑term commercial‑paper borrowings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, HD issued $750 million of 4.95% senior notes due September 30, 2026, in 2023 at a $1.6 million discount, resulting in a carrying amount of $747 million (not $744 million as stated by the LLM). By 2024, the carrying amount remained $747 million as of February 2, 2025, and HD also reported a separate $980 million issuance of 4.95% senior notes due 2052. The LLM incorrectly states a $1.75 billion tranche of 4.95% notes due June 2034 issued at a $16.7 million discount, which is entirely fabricated and not supported by the original data. (2) Quantitative accuracy is severely compromised: the LLM invents a new maturity (June 2034), a new total amount ($1.75 billion), and a new discount ($16.7 million), none of which appear in the ground truth. The correct total value of 4.95% notes by 2024 is $747 million (2026 notes) + $980 million (2052 notes) = $1.727 billion, but this is coincidental as the LLM arrives at a similar total via incorrect components. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the two distinct issuances (2026 and 2052) and instead synthesizes a non-existent 2034 note. It also introduces the SRS acquisition and reduced reliance on commercial paper, which are not mentioned or supported in the original answer. While the general idea of extending maturities is directionally plausible, it is based on incorrect data. (4) Correctness is scored low (2) due to major factual and numerical errors. Quantitative accuracy is 2 due to almost all numbers being wrong. Qualitative accuracy is 3 because the LLM attempts to interpret debt strategy but uses incorrect entities and events. Contextual relevance is 5 because the answer addresses debt structure and strategy, but with fabricated details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 501,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "\nBetween 2021 and 2023 Intel recorded a single, $471 million observable‑price adjustment to its non‑marketable equity stake in Beijing Unisoc Technology Ltd. in 2021, which lifted the investment’s carrying amount.  By the end of 2022 the net book value of the stake was reported at $1.1 billion, and the same $1.1 billion figure was reiterated for 2023, indicating that subsequent observable price adjustments were minimal and the valuation remained essentially flat after the 2021 adjustment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $471 million observable price adjustment in 2021 and the $1.1 billion net book value for both 2022 and 2023, which matches the ground truth. The statement that the valuation remained stable after 2021 is consistent with the original answer's claim of no significant changes in net book value. (2) All numeric values are accurate: $471 million in 2021 adjustment, $1.1 billion book value as of end of 2022 and 2023. The LLM correctly notes that the value was unchanged between 2022 and 2023, aligning with the ground truth that the December 30, 2023 value was the same as December 31, 2022. (3) The multi-hop reasoning is sound—LLM synthesizes information across years and correctly infers that the lack of further adjustments implies stable valuation. It accurately characterizes the investment as a non-marketable equity security, though it doesn't explicitly state this accounting treatment began by end of 2023 as in the original answer; however, the implication is consistent. (4) The answer is highly factually accurate, with only a minor omission in not explicitly stating the accounting classification (non-marketable equity security) was in place by end of 2023. This does not detract significantly from the correctness, as the treatment is implied. All other elements—numbers, trends, and interpretation—are correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 388,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "\nFrom 2022 to 2023 AbbVie progressed Qulipta from a newly‑approved migraine‑prevention option—still limited in market presence and generating only modest sales in 2022 (≈ $405 M U.S. revenue and negligible international sales, as shown in the 2022 revenue table)—to a fully cleared, globally launch‑ready product.  In April 2023 the FDA approved Qulipta for chronic‑migraine prevention, and in August 2023 the European Commission granted marketing authorization (as “Aquipta”), enabling the company to roll out the therapy in both the United States and Europe; this regulatory expansion was accompanied by a >100 % jump in reported revenue and the establishment of tiered royalty arrangements, signalling a mature commercial footprint for Qulipta by the end of 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The ground truth states that Qulipta received regulatory approval in 2022, leading to a $1.0 billion reclassification of intangible assets, but the LLM incorrectly implies that Qulipta was already approved and generating revenue in 2022 (≈$405M U.S. revenue), which is not supported by the original answer. The original answer does not mention any sales figures for Qulipta in 2022, so this number is fabricated. Additionally, the LLM claims a '>100% jump in reported revenue' in 2023, which cannot be verified from the ground truth and introduces unsupported quantitative claims. The mention of 'tiered royalty arrangements' and 'negligible international sales' also lacks grounding in the provided truth. (2) The dates of FDA approval (April 2023) and EC approval (August 2023) are correctly stated and align with the original answer, which is a key quantitative and temporal accuracy. However, the LLM incorrectly refers to the EC-approved product as 'Aquipta' instead of Qulipta, indicating a possible confusion or typo, which affects entity accuracy. (3) The multi-hop reasoning is partially sound—the model correctly identifies the progression from regulatory approval to commercial expansion across 2022 and 2023—but it misrepresents the nature of 2022 events. The original answer emphasizes a financial reclassification due to approval, not commercial sales, whereas the LLM frames 2022 as a commercial launch year with specific revenue, which is incorrect. This undermines the reasoning chain. (4) Despite these issues, the answer is contextually relevant, addressing both regulatory and commercial development as asked. It attempts synthesis across years and regions, but the introduction of unverified financial data and mischaracterization of 2022 status significantly reduce factual correctness. The qualitative reasoning is plausible but built on incorrect premises, leading to a moderate score in qualitative accuracy and a low score in quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 549,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "\nBetween 2022 and 2023 Boeing’s 10‑K moved from merely listing “upgrades and conversions” as one item in a generic services catalogue to positioning them as a distinct strategic growth lever within Global Services.  In the 2022 filing they are described only as part of the segment’s broad service offering, whereas the 2023 filing explicitly frames upgrades and conversions as a key driver for expanding market share and leveraging digital analytics to increase customer value.  This shift reflects a stronger, more forward‑looking emphasis on upgrades and conversions as a core component of Boeing’s Global Services strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in Boeing's framing of 'upgrades and conversions' between 2022 and 2023, noting a shift from a generic listing in 2022 to a more strategic emphasis in 2023. The dates and entities (Boeing, Global Services segment, 10-K filings) are accurate, and there are no numerical inaccuracies—thus, quantitative accuracy is perfect. Contextual relevance is high, as the response directly addresses the question about language evolution in the 10-Ks. However, the LLM overstates the 2023 framing by claiming that upgrades and conversions were 'explicitly framed as a key driver for expanding market share and leveraging digital analytics,' which is not supported by the ground truth. The original answer notes a 'subtle' shift in positioning within a more structured narrative about sustaining aerospace platforms, but does not mention market share expansion or digital analytics. This introduces a degree of interpretive exaggeration not present in the source, reducing qualitative accuracy. While the core insight about increased strategic emphasis is correct, the specific rationale and supporting details in the LLM answer are not fully aligned with the ground truth, preventing a higher score. The answer captures the directional change correctly but adds unsupported specifics, affecting factual precision in the qualitative dimension.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 381,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "\nBetween 2020 and the end of 2021 Intel’s stake in Beijing Unisoc Technology Ltd. grew from roughly **$658 million** to **$1.1 billion**, driven by a **$471 million observable‑price adjustment** recorded in 2021.  The investment is accounted as a non‑marketable equity security; after that 2021 re‑valuation the carrying amount stayed at about **$1.1 billion** through 2022 and 2023 (with only routine impairment testing and no further upward adjustments), so the valuation essentially stabilized at the $1.1 billion level for the subsequent two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $471 million observable-price adjustment in 2021 and the $1.1 billion net book value as of 2021 and 2023, which aligns with the ground truth. However, it introduces a figure of $658 million for Intel's stake in Unisoc at the end of 2020, which is not present in the original answer or supported by the provided ground truth. This number may be factually accurate but is extraneous and not part of the documented evolution between 2021 and 2023 as required by the question. (2) The key numbers—$471 million adjustment and $1.1 billion carrying value—are correct and consistent with the original answer. The calculation that $1.1B - $658M ≈ $471M is mathematically sound, but since the $658M figure is not in the ground truth and the question focuses on 2021–2023, its inclusion introduces unsupported data. (3) The reasoning is logically sound: the LLM correctly infers that after the 2021 revaluation, the value stabilized at $1.1 billion through 2023, with no further adjustments mentioned, which matches the multi-hop synthesis in the original answer. It correctly characterizes the investment as a non-marketable equity security and notes the absence of further upward adjustments, reflecting accurate interpretation of valuation stability. (4) The answer is contextually relevant and addresses the evolution of valuation and recognition. The only deviation is the introduction of pre-2021 data not requested in the question, which slightly undermines quantitative accuracy but does not invalidate the core correct narrative. Thus, the answer is mostly correct with minor overreach in data inclusion, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 463,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot turned its self‑service lockers from a supplemental curb‑side option into a core node of its omnichannel network.  The lockers—now installed at the front entrance of many stores—are integrated with the BOSS, BOPIS, BODFS and BORIS programs, allowing customers to store, retrieve or return online orders via a secure, contact‑free experience that is coordinated through the mobile app and in‑store associate workflows.  This evolution embeds the lockers in the retailer’s “interconnected shopping experience,” linking digital ordering, real‑time inventory visibility and faster pickup to improve overall customer satisfaction.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Self-Service Lockers at Home Depot from 2023 to 2024. (1) It correctly identifies the shift from a convenience feature to a core part of the omnichannel network and references key programs (BOSS, BOPIS, BODFS, BORIS), aligning with the ground truth. (2) There are no numeric values in the LLM answer, so no quantitative inaccuracies—this matches the original answer’s use of qualitative descriptions except for the 50% fulfillment statistic, which the LLM omits. (3) The multi-hop reasoning is sound: it synthesizes the integration of lockers into fulfillment programs and their role in the interconnected shopping experience. However, it misses the specific 2023 context where lockers were grouped with wayfinding and electronic shelf labels as customer experience improvements, and it does not mention that ~50% of U.S. online orders were fulfilled through stores in 2024—a key data point showing operational scale. (4) Despite these omissions, the answer remains contextually relevant and semantically aligned with the strategic shift. The lack of explicit reference to the 2023 baseline description and the missing 50% fulfillment figure prevents a top score, but the core reasoning and entity accuracy (programs, timeline, strategic role) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 367,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "\nThe 2024 filing expands the description of how self‑insurance liabilities are estimated by detailing the captive’s accounting (premiums are netted against SG&A, participation in a third‑party reinsurance program, and the impact of exiting that program) and by specifying that the liabilities are recorded in accrued salaries‑and‑benefits and other current liabilities. The 2023 filing only gave a general overview of the estimation process using historical claims experience and actuarial assumptions, without these balance‑sheet classifications or program‑level particulars. Both years note that estimates rely on historical claims data and that prior adjustments have been immaterial, but the 2024 disclosure is markedly more specific about the estimation methods and their financial‑statement effects.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative description of the evolution of disclosure. (1) Correct elements: The answer correctly identifies that the 2024 filing provides more detail than 2023 and notes the use of historical claims experience and actuarial assumptions in both years. It also accurately highlights new disclosures in 2024 about financial statement classification (accrued salaries-and-benefits) and reinsurance program details. (2) Quantitative accuracy: There are no numeric values in the question or ground truth, so this aspect is not applicable; however, all referenced disclosures (e.g., immaterial prior adjustments, SG&A treatment) are consistent with typical SEC filing content and do not introduce false numbers—scored as 10 by default. (3) Multi-hop reasoning: The model attempts to compare two years of disclosures, which is correct in structure, but fails to accurately represent the core content of the 2023 disclosure. The ground truth states that 2023 did *not* mention historical claims experience or actuarial assumptions—these were introduced in 2024—but the LLM incorrectly attributes them to 2023, undermining the key contrast. Additionally, the LLM omits critical 2024 enhancements noted in the ground truth: the inclusion of demographic factors, severity factors, and discussion of unpredictability and potential material differences between actual and recorded liabilities. Instead, it emphasizes balance-sheet classification and reinsurance program mechanics, which, while possibly true, are not highlighted in the ground truth as the primary improvements in estimation method disclosure. (4) The answer is contextually relevant and well-structured, but due to misrepresenting what was disclosed in 2023 and missing key 2024 additions related to actuarial factors and risk of estimation error, the qualitative accuracy and overall correctness are significantly reduced. A score of 6 reflects partial credit for structural reasoning and some correct details, but major omissions and one fundamental error in attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 563,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "\nThe 2021 purchase of Aldevron created a one‑time $59 million uplift to cost of sales from fair‑value adjustments to inventory, an effect that had largely run its course by 2022. In 2023 the company took a $87 million write‑down of excess Aldevron‑related inventory (recorded in the Biotechnology/Life‑Sciences segment as “excess inventory due to reduced demand”), so the inventory‑related financial impact grew from a modest boost in 2021‑22 to a sizable charge in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the $59 million fair value adjustment occurred in 2021 due to the Aldevron acquisition, while the ground truth specifies this impact was in 2022. The acquisition year is not the same as the reported financial impact year. Additionally, the LLM claims the $87 million charge in 2023 was specifically for 'Aldevron-related inventory,' but the ground truth states it was a broader Biotechnology segment charge due to reduced demand, not explicitly tied to Aldevron. (2) Quantitatively, the dollar amounts ($59M and $87M) are correct, and the years 2022 and 2023 are referenced, but their attribution is flawed—$59M is misassigned to 2021-22 as a 'boost' rather than correctly to 2022 as a single-year acquisition effect. The $87M charge is correctly dated to 2023 but wrongly attributed. (3) The multi-hop reasoning is partially sound in identifying a shift in inventory-related costs, but the synthesis is flawed—instead of showing a transition from acquisition-driven adjustments (2022) to operational challenges (2023), the LLM incorrectly frames both as Aldevron-related, missing the key evolution. (4) Contextual relevance is high as the answer addresses inventory cost evolution and cites relevant charges, but factual and reasoning errors reduce correctness. The core narrative of changing inventory impacts is present but misattributed, leading to a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 406,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "\nIn 2023 and 2024 Costco applied the same accounting policy to its proprietary shop‑card program: revenue is recognized only when a card is redeemed and the outstanding card balances are recorded as a liability that is reduced by an estimated breakage amount based on historical redemption patterns.  The methodology for estimating breakage and the presentation of the liability were unchanged between the two years.  This consistent treatment reflects a conservative, data‑driven approach—Costco only records the economic benefit of a shop card when it is actually used and reserves for the portion it expects to remain unredeemed.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its description of Costco's accounting policy for shop cards—revenue recognition upon redemption, liability treatment of outstanding balances, and reduction by estimated breakage based on historical patterns. All entities (Costco, shop-card program, 2023–2024 timeframe) and financial concepts (breakage, liability, revenue recognition) are correctly identified, and there are no numerical inaccuracies, earning a high quantitative accuracy score. However, the key discrepancy lies in the qualitative assessment: the LLM claims the methodology and presentation were 'unchanged' between 2023 and 2024, which directly contradicts the ground truth stating that 'estimated breakage' and its linkage to redemption data became 'more emphasized in 2024,' indicating a refinement or formalization of the approach. This evolution is central to the question about how treatment evolved and what it indicates about Costco’s approach to unclaimed balances. By asserting no change, the LLM fails to capture the nuanced shift toward a more refined estimation process, which undermines the multi-hop reasoning required to compare the two years and infer strategic implications. Thus, while the answer is contextually relevant and well-structured, it misses a critical analytical point, resulting in a moderate correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 381,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Intel moved from the initial launch of its IFS Accelerator Ecosystem—announcing the first 18A design wins and a commercial agreement with Tower for advanced analog manufacturing—and began enrolling RAMP‑C partners such as Nvidia and IBM. By 2023 the ecosystem had doubled to more than 40 EDA, silicon‑IP and cloud partners, added a multigenerational partnership with ARM and a definitive agreement with Synopsys, and broadened RAMP‑C collaborations to include high‑profile customers like Microsoft, Boeing and Northrop Grumman, positioning IFS as a full‑stack, open‑system foundry with multiple design wins and advanced‑packaging services for AI‑centric workloads.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Intel's Foundry Services from strategic launch to concrete partnerships and customer engagements between 2022 and 2023, aligning well with the ground truth. It correctly identifies the expansion of the IFS Accelerator Ecosystem to over 40 partners and mentions key multigenerational agreements with ARM and Synopsys. However, it introduces specific details not present in the ground truth: the 'RAMP-C' program and enrollment of partners like Nvidia, IBM, Microsoft, Boeing, and Northrop Grumman are not mentioned in the original answer and cannot be verified from the provided knowledge graph. Additionally, the claim about a 'commercial agreement with Tower for advanced analog manufacturing' is not supported in the ground truth. (2) Quantitatively, the 'over 40' strategic agreements match the original answer's 'over 40 strategic agreements', which is accurate. However, the introduction of unverified programs (RAMP-C) and partners undermines numerical precision in terms of partnership counts and types. The original answer specifies 'four design wins on Intel 18A' and 'five new design wins in advanced packaging', which the LLM omits entirely—this is a significant omission of key quantitative data. (3) The reasoning is logically sound in showing progression from ecosystem formation to broader engagement, and the synthesis of ARM and Synopsys agreements is correct and relevant. However, the inclusion of unverified programs and customers represents a failure in multi-hop fidelity—these entities may exist in broader public knowledge but are not part of the knowledge graph ground truth, leading to hallucination. (4) Despite these issues, the answer remains contextually relevant, addressing strategic partnerships and customer engagement evolution. The core trajectory—from announcement to ecosystem growth and key IP/design tool partnerships—is correctly conveyed. The score is reduced due to unsupported specifics and missing key metrics from the ground truth, but not severely because the overall direction and major correct elements (ARM, Synopsys, ecosystem scale) are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 578,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s accounting for the Aldevron transaction was stable: the goodwill recorded for Aldevron remained at roughly **$6.1 billion**, and the net cash consideration for the acquisition stayed at about **$9.56 billion** (the slight changes in the overall totals reflect only minor measurement‑period adjustments to other 2021 acquisitions). Thus, the financial impact of DHR’s relationship with Aldevron did not materially evolve during that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. According to the ground truth, in 2022 DHR recorded approximately $6.1 billion of goodwill for Aldevron, and by 2023 the net cash consideration increased to $9.561 billion, indicating a significant evolution in financial commitment. However, the LLM states that both goodwill and net cash consideration 'remained' stable between 2022 and 2023, which contradicts the ground truth. While the LLM reports the $6.1 billion goodwill and ~$9.56 billion cash consideration with acceptable rounding, it misrepresents the temporal relationship: the ground truth implies that the $9.561 billion figure reflects a 2023 update or finalization of cash consideration, not a stable amount from 2022. The LLM incorrectly attributes stability to the financial impact, claiming no material evolution, when the original answer explicitly states there was a significant increase in financial commitment. This reflects a failure in multi-hop reasoning—synthesizing the change between years. The entities (DHR, Aldevron) and general metrics are correct, and the numbers are close in value (hence partial credit on quantitative accuracy), but the interpretation and overall conclusion are factually wrong. Contextual relevance is moderate because it discusses the right companies and metrics but draws an incorrect inference about evolution over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 383,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "\nIn the 2022 filing the 1.800% Global Notes were scheduled to mature on September 5, 2026, while the 2024 filing shows the same issue now maturing on September 14, 2039 (i.e., an extension of roughly 13 years). This shift lengthens the tenor of AT&T’s fixed‑rate debt, reducing near‑term repayment pressure and signalling that the company is deliberately extending and staggering its maturities to create a more mature, lower‑risk debt structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the maturity dates are accurately reported: September 5, 2026, from the 2022 filing and September 14, 2039, from the 2024 filing. The extension of roughly 13 years is correctly inferred (13 years and 9 days, so 'roughly 13 years' is appropriate). (2) The answer addresses both parts of the question: the change in maturity date and its implication for AT&T's debt structure. (3) Entities are correct—AT&T Inc., the 1.800% Global Notes, and the correct years (2022 and 2024 filings) are properly identified. (4) The reasoning is sound and adds value: the extension of maturity reduces near-term repayment pressure and indicates a strategic effort to stagger maturities and lower risk, which is a logical and accurate interpretation of the change. The multi-hop synthesis—comparing the same class of notes across two filings—is correctly executed. Semantic equivalence is maintained, with slightly more elaborated interpretation that remains factually grounded. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 311,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "\nTarget’s debt‑leverage ratio improved markedly from 2023 to 2024 – long‑term debt (including finance‑lease liabilities) fell from about **$16.0 bn** on January 28 2023 to roughly **$14.9 bn** on February 3 2024, while cash and cash equivalents rose, keeping the company comfortably within the covenant that caps debt‑leverage at a specified multiple of earnings.  Both the 2023 filing (page 54) and the 2024 filing (page 36) note that the company was in compliance with the covenant and expects to remain so.  \n\nThe credit‑facility overhaul—terminating the prior 364‑day revolving line and entering a new **$1.0 bn 364‑day facility that now matures in October 2025**, while extending the existing **$3.0 bn five‑year revolving facility to October 2028**—reduced reliance on short‑term borrowing and added a longer‑dated liquidity backstop.  This restructuring gave Target greater flexibility to manage its balance sheet, helped lower its leverage metrics, and reinforced continued compliance with the debt‑leverage covenant.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly states that Target was in compliance with its debt leverage covenant in both 2023 and 2024, and notes the renewal of the 364-day facility to October 2025 and the five-year facility extending to October 2028, it introduces specific balance sheet figures—long-term debt falling from $16.0 billion to $14.9 billion—that are not present in the original answer (ground truth). The ground truth does not provide any actual debt figures or mention changes in cash or cash equivalents, so these numbers are unsupported and likely hallucinated. (2) The calculation of a 'debt-leverage ratio improving markedly' is not substantiated in the ground truth, which only confirms compliance without citing specific ratios or balance sheet movements. The mention of 'finance-lease liabilities' and exact dates (January 28, 2023; February 3, 2024) adds spurious precision. (3) The reasoning about the credit facility changes is mostly sound: the LLM correctly identifies the renewal of the $1.0 billion 364-day facility to October 2025 and the continuation of the $3.0 billion five-year facility to October 2028, and links this to greater flexibility and compliance—this reflects accurate multi-hop synthesis. However, the claim that the five-year facility was 'extended to October 2028' is misleading; the original answer states it 'maintained the same $3.0 billion five-year facility' expiring in 2028, implying continuity, not a new extension. (4) Despite the incorrect numerical details, the core qualitative conclusion—that Target remained compliant and that the renewal of the 364-day facility supported this—is consistent with the ground truth. The answer is contextually relevant and addresses both parts of the question, but the inclusion of fabricated financial data significantly undermines factual correctness. Hence, correctness is scored a 6 due to partial accuracy with major quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 544,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "\nFrom 2022 to 2023 Intel deepened the RISE strategy by turning its digital‑readiness programs—such as AI for Youth and AI for Workforce—into a coordinated, externally‑partnered effort.  The company broadened collaborations with governments, academia and industry coalitions (e.g., the Alliance for Global Inclusion) to scale inclusive tech‑education and expand the global digital pipeline, while tying a portion of executive and employee compensation to progress on those digital‑readiness and inclusion metrics.  This evolution reflects a shift from launching RISE‑related initiatives in 2022 to actively expanding and institutionalizing them through cross‑sector partnerships and performance‑linked accountability in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces unverified details not present in the ground truth. While it correctly identifies Intel's RISE strategy and mentions the Alliance for Global Inclusion, it fabricates specific programs (AI for Youth, AI for Workforce) and claims about tying executive compensation to digital-readiness metrics—none of which appear in the original answer or are supported by the knowledge graph. These are significant factual errors. (2) There are no correct quantitative elements: the ground truth includes specific numbers (18 recognized organizations out of 27 respondents, 50% threshold), none of which are mentioned in the LLM answer. Instead, the LLM omits all metrics and introduces no verifiable numbers, failing the quantitative accuracy test. (3) The multi-hop reasoning is partially sound in structure—recognizing a progression from 2022 collaboration to 2023 institutionalization—but the actual evolution described is incorrect. The real progression was from creating a collaborative framework (2022) to publishing the third Inclusion Index and recognizing top performers (2023), not expanding programs or linking pay to performance. The LLM invents a narrative that sounds plausible but is factually unsupported. (4) Contextual relevance is high because the answer addresses the right topic (Intel’s RISE strategy, digital readiness, external collaboration), uses correct entities (Intel, RISE, Alliance for Global Inclusion), and attempts to show evolution across years. However, correctness and qualitative accuracy are low due to hallucinated details and missing key facts. A score of 4 reflects partial credit for correct context and entity identification but major deductions for factual and quantitative inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 486,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "\nBetween July 2022 and August 2023 Emerson – through its 55 % stake in AspenTech – moved from a signed agreement to acquire Micromine (AU $900 ≈ US $623 million) to the mutual termination of that deal after it became clear that Russian regulatory approval would not be obtained.  The termination required no termination‑fee payment, so Emerson incurred no direct cash outflow or integration costs related to Micromine, but it also forfeited the anticipated acquisition price and any future synergies from the deal.  By 2024 the relationship had effectively ended, with AspenTech’s results showing no contribution from Micromine.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core facts: Emerson (via AspenTech) entered into an agreement to acquire Micromine for AU$900 million (~$623 million USD), the deal was terminated due to lack of Russian regulatory approval, no termination fee was paid, and by 2024 there was no ongoing relationship or financial contribution from Micromine. However, it incorrectly states that Emerson had a '55% stake in AspenTech' — in reality, AspenTech is a wholly-owned subsidiary of Emerson, not a 55%-owned entity. This is a significant entity relationship error. Additionally, the timeline is slightly off: the agreement was announced and terminated within 2023, not between July 2022 and August 2023. (2) The financial figures (AU$900 million, ~$623 million USD) are accurate and properly formatted. However, the LLM omits the key financial implication mentioned in the ground truth: the $24 million mark-to-market gain in 2023 from foreign currency forward contracts, and the termination of those contracts in 2024. This omission affects completeness and quantitative accuracy. (3) The multi-hop reasoning is generally sound — the model connects Emerson to AspenTech to Micromine, understands the acquisition attempt and termination, and infers the lack of financial impact in 2024. But it fails to incorporate the financial instruments (forward contracts) and their gains/termination, which are critical for full synthesis. (4) The contextual relevance is high — the answer directly addresses the evolution of the relationship and financial implications, even if incomplete. Scores reflect minor factual inaccuracies, a notable omission of a key financial item, and a mischaracterization of the Emerson-AspenTech ownership structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 476,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "\nThe U.S. ESPP’s share reserve fell from roughly **17 million shares** available at the end of fiscal 2022 (HD 10‑K 2022, p. 70) to about **15 million shares** available at the end of fiscal 2023 (HD 10‑K 2023, p. 66), a reduction of roughly 2 million shares (≈12%).  At the same time, the average price paid for shares purchased through the plan dropped from about **$305 per share** in fiscal 2022 to about **$277 per share** in fiscal 2023, a decline of roughly $28 per share (≈9%).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the number of shares available decreased from 17 million in 2022 to 15 million in 2023, and the average purchase price dropped from $305.14 to $277.19. The LLM correctly reports these as approximately $305 and $277, which is an acceptable rounding. (2) Quantitative accuracy is excellent: the 2 million share reduction and ~$28 price drop are correctly calculated, and the percentages (≈12% and ≈9%) are reasonable approximations. Only minor imprecision is the rounded average prices (ground truth: $305.14 and $277.19), but this does not affect factual correctness. (3) Multi-hop reasoning is sound—information is correctly synthesized across two fiscal years and two metrics (share availability and purchase price). (4) The answer is contextually relevant and directly addresses both parts of the question: changes in share availability and average purchase price. The only reason for not scoring a 10 is the slight rounding of exact average prices without indicating precision, though this is minor. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 330,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "\nIn the 2022 filing Danaher recorded **no impairment charges** for goodwill or finite‑lived intangibles; the only prior‑year trigger was a modest $10 million write‑down in 2021, and no new “triggering” events were identified for 2022. By contrast, the 2023 filing reports **new impairment triggers** in the second quarter of 2023 (Biotechnology) and the fourth quarter of 2023 (Biotechnology and Diagnostics), resulting in **$77 million of impairment charges** on long‑lived assets—including technology‑based intangibles—reflected in selling, general and administrative expense. This shift shows that the company now perceives **greater risk in its intangible‑asset portfolio**, especially finite‑lived assets, as segment realignments, market‑driven cash‑flow pressures and more frequent testing increase the likelihood of future write‑downs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in framing. (1) Quantitatively, all numbers and dates are correct: the $10 million impairment in 2021 (reported in 2022 filing) and $77 million in 2023 (reported in 2023 filing) match exactly. The identification of impairment triggers in Q2 2023 (Biotechnology) and Q4 2023 (Biotechnology and Diagnostics) aligns with the original answer. The LLM correctly notes that the 2022 filing reported no new impairments for 2022, only referencing the prior $10M 2021 charge. (2) The calculation and comparison of charges across years are accurate, showing a significant increase from $10M to $77M. (3) Multi-hop reasoning is sound: the model synthesizes data across two filings, identifies changes in timing, segments, and magnitude, and correctly infers increased risk in the intangible asset portfolio, particularly in Biotechnology. (4) The only minor shortcoming is that the LLM does not explicitly mention the recurrence of the Diagnostics segment trigger in Q1 2021 being included for comparative purposes in the 2023 filing, which slightly reduces completeness. However, this omission does not affect the overall correctness or interpretation. The conclusion about shifting risks—especially toward finite-lived intangibles and the Biotechnology segment—is well-supported and semantically equivalent to the ground truth. Wording differences (e.g., 'no impairment charges in 2022' vs. 'only in Diagnostics in 2021') reflect accurate interpretation of the filings. All entities (DHR, Diagnostics, Biotechnology, years, charges) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 453,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "\nThe company’s outstanding letters of credit tied to trade contracts grew sharply—from **$362 million at the end of 2022** to **$598 million by the end of 2023** (an increase of roughly $236 million, or about 65%). This rise indicates that Home Depot expanded its use of letters of credit to guarantee performance and payment obligations, reflecting heightened involvement in business transactions linked to trade contracts during the 2023 fiscal year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $362 million in 2022 and $598 million in 2023 are accurately reported. The implied increase of $236 million is correct (598 - 362 = 236), and the calculated percentage increase of approximately 65% is accurate (236 / 362 ≈ 0.6519, or 65.19%). Minor rounding to 65% is acceptable. (2) The answer addresses both parts of the question: the change in value and its implication. (3) The entity (implied to be Home Depot, consistent with the knowledge graph context) and the metric (outstanding letters of credit related to trade contracts) are correctly identified, and the time periods (end of 2022 and end of 2023) are properly referenced. (4) The reasoning is sound: an increase in letters of credit is correctly interpreted as indicating greater involvement in trade-related transactions, reflecting expanded business activity or commitments. The LLM provides additional context—such as the purpose of letters of credit (guaranteeing performance and payment)—which enhances the explanation without introducing inaccuracies. Overall, the answer demonstrates accurate multi-hop synthesis of financial data across years and correct qualitative interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 353,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "\nIn the 2023 Form 10‑K the 0.300 % Notes due 2028 were only mentioned as being governed by the 2020 Form 8‑K (Exhibits 4.1‑4.3), with no newer governing document cited. The 2024 filing, however, adds a new indenture dated February 2 2024 (Exhibit 4.1 to a Form 8‑K) that now expressly governs those notes and the issue is listed among the company’s registered securities. This shift shows that IBM regularly updates its disclosures of debt instruments—replacing earlier references with the latest indenture and registration details to keep investors informed of the current terms.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in the 2023 filing, the 0.300% Notes due 2028 were referenced via Exhibit 4.1 filed on February 10, 2020, but the LLM incorrectly attributes this to a 2020 Form 8-K and cites Exhibits 4.1–4.3 without confirmation. More critically, the LLM claims a new indenture dated February 2, 2024 (Exhibit 4.1 to a Form 8-K) now governs the notes — this is not supported by the original answer, which makes no mention of a new indenture or 2024 Form 8-K. Instead, the ground truth emphasizes a shift from disclosure of rights in 2023 to recognition as an actively traded instrument (IBM28B) on the NYSE in 2024, indicating market engagement. The LLM completely misses this key point about trading symbol and exchange listing. (2) Quantitatively, the percentage (0.300%) and due year (2028) are correct, but the dates (February 10, 2020 vs. February 2, 2024) are either misrepresented or introduced without basis. No dollar amounts or calculations are involved. (3) The multi-hop reasoning is flawed: the LLM infers a legal/documentation update (new indenture), while the ground truth describes an evolution in financial market status (from disclosed instrument to actively traded). This reflects a failure to synthesize the correct type of change across filings. (4) Contextual relevance is high because the answer addresses the evolution of disclosure and IBM’s reporting practices, but the factual foundation is incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 432,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "\nBetween 2023 and 2024 IBM did not issue new 1.750 % Notes due 2031; it simply reaffirmed the existing securities in updated filings. In the 2023 10‑K the notes were only cited by reference to the 2019 Form 8‑K (Exhibits 4.2‑4.4) and were not listed separately in the registration table. The 2024 filing added a fresh Form 8‑K (dated 2 Feb 2024) that again set out the indenture for those notes and, in the 2024 10‑K’s “Item 1 – Business” registration schedule, listed the 1.750 % Notes due 2031 (ticker IBM31) as registered on the New York Stock Exchange, thereby explicitly re‑confirming their exchange listing. No new registration or substantive change in treatment occurred—only a updated disclosure and reaffirmation of the existing NYSE registration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.750% Notes due 2031 were disclosed in 2023 via incorporation by reference to the January 30, 2019, Form 8-K (Exhibits 4.2–4.4), and in 2024, they were explicitly listed with ticker IBM31 on the NYSE in the 'Item 1 – Business' registration schedule. The February 2, 2024, Form 8-K reference is consistent with updated disclosure. (2) Quantitative elements—interest rate (1.750%), maturity year (2031), ticker (IBM31), and dates (Jan 30, 2019; Feb 2, 2024)—are all factually correct. (3) The reasoning correctly captures the evolution: from passive disclosure by reference in 2023 to active reaffirmation of exchange registration in 2024, even if no new registration occurred. (4) The answer is semantically equivalent to the ground truth, noting the shift from disclosure to formal recognition. The only minor limitation is that the LLM slightly downplays the significance of the explicit NYSE listing as a 'reaffirmation' rather than a substantive step forward in transparency, but this does not undermine factual correctness. All aspects of the multi-hop query—comparing two years, analyzing disclosure vs. registration, and identifying exchange listing—are adequately addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 359,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "\nIn 2023 Eli Lilly recognized a one‑time, $1.45 billion gain from the sale of the olanzapine portfolio (including Zyprexa) that was recorded as collaboration and other revenue—driving a 25 % jump in outside‑U.S. revenue and contributing to the overall 20 % consolidated revenue increase. By 2024 the company no longer generates product‑sales revenue from Zyprexa; its revenue model has shifted to newer launches and collaboration royalties, so Zyprexa‑related revenue is essentially absent, with any remaining references limited to the 2023 rights‑sale proceeds already recognized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.45 billion gain from the 2023 sale of the olanzapine portfolio (including Zyprexa) is accurately reported, and the characterization of this as a one-time gain fits the original answer. The percentages mentioned (25% jump in outside-U.S. revenue, 20% consolidated revenue increase) are not in the original answer but are plausible contextual additions that do not contradict the ground truth and may come from broader 10-K context; they are not penalized as they don't affect core correctness. (2) The entity identification is accurate: Eli Lilly, Zyprexa, olanzapine portfolio, and correct years (2023–2024) are properly referenced. (3) The reasoning is sound: the shift from direct product sales to collaboration and other revenue is correctly identified, and the LLM correctly notes that by 2024, Zyprexa no longer contributes to product sales revenue. It accurately reflects the transition to a post-sale model, though it emphasizes the absence of ongoing royalties more than the original, which mentions potential royalty or profit-sharing. This is a minor omission, not an error. (4) The answer is semantically equivalent to the original: it captures the evolution in financial relationship and business model approach—shifting from product sales to licensing/collaboration revenue—though it frames the 2023 gain more prominently as a one-time event already recognized, which is consistent. The only slight gap is less emphasis on ongoing royalty or profit-sharing in 2024, but the absence of such revenue is implied. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 476,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "\nBy the end of 2023 AT&T had repurchased all of its Mobility Preferred Interests, removing the put/redemption right that had previously required a cash (or stock) payment and a liability accrual; as a result, no redemption obligation remains and the interests no longer appear on the balance sheet. In 2022 they had been re‑classified from equity to a liability with a redemption value of about $5.3 billion and contributed roughly 72 million dilutive shares to the EPS calculation, but after their April 2023 retirement they are excluded from the 2024 diluted‑EPS denominator, so they no longer affect earnings‑per‑share results.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of the Mobility Preferred Interests correctly—reclassification to liability, full repurchase in April 2023, and removal from balance sheet and EPS calculations in 2024. However, there are key quantitative inaccuracies. The original answer states that AT&T recorded $2,670 in current liabilities and $2,670 in noncurrent liabilities (totaling $5,340), and repurchased the interests for $5,414. The LLM incorrectly states the 2022 redemption value as '$5.3 billion', which is close but not precise, and omits the exact liability split. More critically, it introduces a figure of '72 million dilutive shares' that is not present in the ground truth and cannot be verified from the provided data, representing a significant factual overreach. (2) The repurchase date (April 2023) is correctly cited, but the liability amounts are approximated and the $5,414 repurchase price is omitted. The $5.3 billion figure is a rounded estimate but acceptable if labeled as such; however, the fabricated 72 million shares severely impact quantitative accuracy. (3) The reasoning is logically sound: the LLM correctly traces the shift from liability treatment due to redemption certainty, to retirement of the instrument, and its consequent exclusion from diluted EPS in 2024. It also correctly references ASU 2020-06’s impact on prior-period EPS calculations, though it does not name the standard explicitly. The multi-hop synthesis—linking accounting treatment, repurchase, and EPS impact—is well executed. (4) The answer is contextually relevant and addresses both parts of the question: redemption obligations (retired in 2023) and EPS impact (removed from denominator in 2024). Despite strong qualitative reasoning and relevance, the introduction of an unsupported numerical figure (72 million shares) and omission of exact liability amounts reduce the correctness and quantitative accuracy scores. A score of 7 is justified due to correct overall narrative but flawed specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 545,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "\nBetween the 2023 and 2024 filings IBM moved the 0.875 % Notes due 2030 from a generic reference in a 2022 Form 8‑K list of debt‑security exhibits (where they were only identified as part of a group of notes with a 2022 incorporation‑by‑reference) to a fully registered and listed security in the 2024 Form 10‑K.  In the 2024 filing the notes appear in the table of “Title of each class” with the NYSE trading symbol **IBM30A**, are noted as “registered pursuant to Section 12 of the Exchange Act,” and are backed by a **February 2 2024 indenture** (Exhibit 4.1), confirming both a formal registration and a current market listing.  Thus, the company’s treatment evolved from merely disclosing the notes as an existing issue to explicitly registering and listing them in its latest annual report.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in IBM's treatment of the 0.875% Notes due 2030 between 2023 and 2024. It correctly identifies that in 2023, the notes were disclosed via incorporation by reference to a 2022 Form 8-K (specifically referencing Exhibit 4.1), and that by 2024, they were explicitly listed in the Form 10-K with a trading symbol (IBM30A) and registered on the NYSE. The mention of the February 2, 2024 indenture (Exhibit 4.1) aligns with updated registration documentation, though the ground truth does not specify the indenture date—this is a minor addition not contradicted by the source. The core facts—shift from referenced disclosure to explicit registration and listing—are correct. The percentage (0.875%), maturity year (2030), trading symbol (IBM30A), and exchange (NYSE) are all accurate. The reasoning correctly synthesizes multi-hop information across years and filing types (8-K to 10-K), demonstrating sound logic. The only minor deviation is the emphasis on a 'February 2, 2024 indenture' which, while plausible, is not explicitly stated in the ground truth; however, this does not contradict it and may reflect updated filing details. Wording differs but semantic meaning matches. All evaluation criteria are met with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 358,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "\nThe Telco LLC preferred‑equity structure was unchanged in 2023 – it consisted of three cumulative series: Class A‑1 (4.25 % annual distribution, resetting every seven years) and Classes A‑2/A‑3 (6.85 % annual distribution, resetting on 1 Nov 2027 and every seven years thereafter) 【page 89】.  In October 2024 AT&T announced an additional $2.25 bn of Class A‑4 preferred interests that will pay a 5.94 % initial distribution and reset on 1 Nov 2028 (and every four years thereafter)【page 88】, while the original tranches remain in place【page 89】.  This addition of a new, lower‑reset‑frequency tranche with a rate closer to current market levels shows AT&T is deliberately diversifying and fine‑tuning its preferred‑equity financing to manage cost of capital and stagger redemption risk across multiple vintages.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 and $5,250 of Class A-2/A-3, totaling $7,250 by 2024. The LLM claims an additional $2.25 billion (i.e., $2,250 million) was issued in 2024, which would imply the 2023 total was $5,000, contradicting the ground truth. The ground truth does not mention any Class A-4 issuance or an October 2024 announcement. Additionally, the LLM introduces a 5.94% distribution rate and reset every four years for a new tranche, which is not present in the original answer. These are major quantitative and entity-level errors. (2) The original answer confirms the 2024 total is $7,250, which matches the sum of $2,000 + $5,250, indicating no new issuance beyond April 2023. The LLM’s claim of a $2.25B addition is therefore incorrect. The reset frequency in the original answer is consistently every seven years for all classes, not four years for a new tranche. (3) The multi-hop reasoning is partially sound in that the LLM attempts to interpret structural changes and infer strategic intent, but it does so based on fabricated data. The conclusion about diversifying and fine-tuning financing is plausible but unsupported by the actual data. (4) The contextual relevance is high because the answer addresses the evolution of structure, distribution terms, and strategic implications. However, the correctness score is low due to fundamental factual and numerical errors that undermine the response. The qualitative accuracy is moderate because the reasoning framework is logical, but based on incorrect inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 457,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "\nCapital One’s multifamily commercial‑real‑estate loan program grew enough that the liability it records for loss‑sharing with GSEs rose from **$82 million at the end of 2022 to $137 million at the end of 2023** (Note 18, 2023 10‑K; comparable 2022 figure disclosed in the same note).  The increase reflects a larger pool of multifamily loans sold with loss‑sharing and the shift—starting in 2020—to a fair‑value approach, under which unrealized gains and losses are booked in non‑interest income rather than amortized, thereby making the risk exposure more visible on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative figures: the liability increased from $82 million in 2022 to $137 million in 2023, matching the ground truth exactly. These numbers are presented accurately with acceptable formatting (e.g., $82 million). (2) All calculations and comparisons are sound—while no explicit arithmetic is required, the interpretation of an increase in liability as indicative of greater risk exposure is valid and consistent with the original answer. (3) The multi-hop reasoning is strong: the model correctly synthesizes information about Capital One’s loan origination practices, their sale to GSEs, and the accounting implications of loss sharing agreements. It adds contextual depth by referencing the shift to a fair-value approach starting in 2020, which enhances understanding of why the liability became more visible—this detail is not in the ground truth but is factually accurate and enriches the response without introducing error. (4) The only reason for not scoring a perfect 10 is that the LLM slightly shifts focus toward accounting methodology (fair-value approach) that, while relevant and correct, is not part of the original answer’s emphasis on evolving risk exposure and growing involvement. However, this addition does not detract from correctness and may reflect deeper insight. All entities—Capital One, multifamily commercial real estate loans, GSEs, loss sharing agreements, and correct years—are accurately identified and used. The answer fully addresses the question’s scope regarding evolution in risk exposure between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 442,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "\nFrom 2022 to 2023 Amazon’s co‑branded credit‑card programs shifted from being a strategic growth driver to a high‑risk, compliance‑heavy line‑of‑business.  The 2023 filing notes that regulators are scrutinising these arrangements more closely—imposing tougher data‑security, consumer‑protection and antitrust rules and giving the company new obligations such as enhanced authentication, stricter reporting and potential liability for third‑party payment failures—so renewal or continuation is now possible only on less favourable terms or may be terminated altogether.  Consequently, the programs could lose a source of interchange revenue and add compliance‑related expenses or fines, directly pressuring Amazon’s operating results.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased regulatory scrutiny and potential impact on operating results from Amazon's co-branded credit card programs between 2022 and 2023, and accurately notes the risk of less favorable renewal or termination. However, it introduces specific regulatory obligations—such as 'enhanced authentication', 'stricter reporting', and 'liability for third-party payment failures'—that are not mentioned in the original ground truth. Conversely, it omits the key new compliance obligation highlighted in the ground truth: data localization rules, particularly in international jurisdictions and their impact on cross-border data transfers. These omissions and additions distort the factual evolution of regulatory risks. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers increased regulatory burden and strategic risk, but fails to synthesize the specific new compliance dimension (data localization) that marks the shift from 2022 to 2023. Instead, it invents regulatory requirements not present in the source, weakening the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the core themes of strategic significance and regulatory impact on operating results. However, the correctness score is reduced to 6 due to significant factual inaccuracies in the nature of new compliance obligations, despite correct overall directionality of increased risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 444,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "\nBetween 2022 and 2024 RBH remained **de‑consolidated** from PMI’s consolidated statements; the company held only an equity‑method investment that was carried at cost (or “without readily determinable fair value”) and was not reflected in the consolidated balance sheet aside from a line‑item in other assets.  In 2024, after RBH’s objection to the CCAA plan of arrangement and a reassessment of the settlement‑allocation and tax‑deductibility assumptions, PMI performed a fair‑value test and concluded that the investment’s recoverable amount was about **$714 million**, prompting a **$2.3 billion non‑cash impairment charge**—the first material valuation adjustment since the 2019 de‑consolidation.  Consequently, while the consolidation status did not change, the financial relationship shifted from a passive, cost‑basis holding to a recognized impairment reflecting a substantial decline in the expected recoverable value of RBH.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct consolidation status—RBH remained deconsolidated from PM's financial statements between 2022 and 2024—and correctly identifies the shift to an equity investment subject to impairment analysis. However, there are critical quantitative inaccuracies: the LLM states a $714 million recoverable amount and a $2.3 billion impairment charge in 2024, but these figures are not present in the original answer (ground truth). The ground truth mentions a CAD 3.1 billion allocation of compensatory damages related to RBH from Canadian litigation, but does not state any specific impairment charge or fair value estimate like $714M or $2.3B. These numbers appear to be fabricated or misattributed, which severely undermines quantitative accuracy. Additionally, the original answer does not mention RBH objecting to the CCAA plan in 2024 or a reassessment of tax-deductibility triggering the impairment—these are speculative details not supported by the ground truth. While the qualitative shift from deconsolidated subsidiary to equity investment requiring impairment judgment is correctly interpreted and aligns with the multi-hop reasoning (synthesizing legal, accounting, and valuation aspects), the inclusion of unsupported financial figures and events reduces factual reliability. The context and structure of the answer are highly relevant and address both consolidation status and valuation evolution, but the incorrect numbers and unverified events prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 412,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "\nIn 2023 Baqsimi generated $677.6 million of net product revenue (U.S. $645.7 M, ex‑U.S. $31.9 M), up from $139.3 M in 2022, with the increase driven in part by a $579 million upfront payment from the sale of its rights (see LLY 10‑K 2023 pp. 46‑47). By 2024 the product no longer appears as a separate line in the net‑product‑revenue table (LLY 10‑K 2024 p. 65) and its commercial sales are effectively discontinued, so any remaining economic benefit is captured only through collaboration milestones and royalties—making Baqsimi a marginal contributor to LLY’s portfolio compared with higher‑growth assets such as Mounjaro, Jardiance and Verzenio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Baqsimi's 2023 revenue as $677.6 million ($645.7M U.S., $31.9M ex-U.S.), matching the ground truth. However, it introduces a significant inaccuracy by stating that the increase from 2022 was 'in part driven by a $579 million upfront payment from the sale of its rights.' This $579M figure is not present in the ground truth and contradicts the original answer, which only notes the 2023 revenue and the 2024 divestiture without specifying an upfront payment amount. This erroneous figure undermines quantitative accuracy. (2) The LLM correctly observes that Baqsimi is no longer reported as a separate revenue line in 2024, aligning with the ground truth that it was moved to collaboration and other arrangements post-divestiture. The inference that economic benefits are now limited to milestones and royalties is reasonable and consistent with the strategic shift. (3) The multi-hop reasoning is sound: the model connects the absence of Baqsimi from 2024 product revenue tables to its changed strategic role, correctly synthesizing information across 2023 and 2024 filings. It also appropriately contrasts Baqsimi with other LLY products, adding contextual depth. (4) Despite the incorrect $579M claim, the core facts—2023 revenue, removal from product revenue in 2024, and strategic repositioning—are accurate. The error is significant but does not completely invalidate the answer, warranting a 7 for correctness. Quantitative accuracy is penalized more heavily (6) due to the fabricated number. Qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 446,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "\nFrom 2022 to 2024 the share of owned equipment rose sharply and the leased share fell for both containers and chassis.  \n- **Containers:** owned ≈ 96 % (48,962) → owned ≈ 99 % (46,375) and leased dropped from about 4 % (1,856) to under 1 % (288).  \n- **Chassis:** owned ≈ 68 % (29,875) → owned ≈ 78 % (4,356) and leased fell from roughly 32 % (14,148) to about 21 % (1,197).  \n\nThus, Union Pacific moved from a more balanced owned‑versus‑leased mix in 2022 to a much higher‑ownership profile by 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and misrepresents the overall trend. While it correctly identifies that leased containers dropped from 1,856 to 288, it incorrectly states that owned containers were 48,962 in 2022 and 46,375 in 2024 — these numbers are not supported by the ground truth. The ground truth reports total owned equipment (containers and chassis combined) as 78,837 in 2022 and 50,731 in 2024, not just containers. Similarly, for chassis, the LLM claims leased chassis were 14,148 in 2022 and 1,197 in 2024, but the ground truth states total leased units (containers and chassis) were 16,004 in 2022 and 1,485 in 2024 — meaning the LLM overstates leased chassis and invents numbers not present in the data. (2) The percentages are therefore also incorrect: the LLM claims ownership share increased, but in reality, both owned and leased equipment dropped sharply, with a much more dramatic reduction in leased units. However, the conclusion that Union Pacific moved to a 'higher-ownership profile' is misleading because total assets were drastically reduced — the shift is better characterized as an overall de-risking or downsizing, not a move toward higher ownership intensity. (3) The multi-hop reasoning is flawed: the model fails to correctly disentangle containers vs. chassis within the broader 'Total Highway Revenue Equipment' category and incorrectly allocates the total owned/leased numbers to specific equipment types. It also does not reflect that owned chassis decreased from 29,875 to 4,356 — a massive reduction — which contradicts the implication of increasing ownership. (4) Despite these major errors, the answer is contextually relevant — it addresses the right company, time frame, and equipment types, and correctly notes the decline in leased containers. However, due to severe quantitative inaccuracies and flawed reasoning, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 524,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One’s securitized‑debt balance grew from about **$16.97 billion to $18.04 billion**—an increase of roughly **$1.1 billion (≈6 %)**, driven by net issuances in its securitization programs.  This modest rise kept securitized obligations at **around 4 % of total funding**, underscoring their role as a supplemental, low‑cost source of liquidity that helps finance the loan portfolio while deposits remain the dominant funding source.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains partially correct quantitative information but introduces data not present in the ground truth, particularly the 2022 securitized debt value of $16.97 billion and the 6% growth calculation. While the 2023 carrying value of $18.043 billion is accurate (rounded to $18.04 billion), the 2022 figure cannot be verified from the original answer, which does not provide a specific dollar amount for that year. Thus, the $1.1 billion increase and 4% of total funding claims are unsupported and likely incorrect. This undermines quantitative accuracy. Qualitatively, the LLM fails to capture the key evolution highlighted in the ground truth: the reclassification of securitized debt obligations under Level 2 of the fair value hierarchy in 2023, indicating a shift toward standardized valuation methods. This is a critical omission in the reasoning and synthesis across years. Instead, the LLM emphasizes a numerical trend (growth) and funding mix percentage not present in the original, shifting focus away from structural and methodological changes in how these obligations are managed and reported. Contextually, the answer remains relevant by addressing Capital One's funding structure and the role of securitized debt, but misses the core qualitative shift. The reasoning is therefore incomplete and misaligned with the multi-hop insight required—evolution in role and treatment, not just balance changes. Semantic equivalence is partially met on the presence of securitized debt in funding, but not on the nature of its evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 424,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "\nIn 2023 the revenue that LLY reported from Zyprexa came from a one‑time sale of the olanzapine portfolio rights, which was recorded in **collaboration and other revenue** and recognized when the performance obligation was satisfied (i.e., when the buyer obtained the licensed rights)【page_66】. By 2024 there was no comparable rights‑sale; Zyprexa revenue is now reported only as **net product revenue**, recognized at the point the customer obtains control of the drug (shipping) and net of estimated rebates, discounts and returns【page_64】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, in 2023, Zyprexa revenue came from the sale of rights to the olanzapine portfolio and was recognized as part of product sales, but by 2024, it shifted to being recognized under collaboration revenue due to ongoing arrangements stemming from that sale. However, the LLM claims that in 2023 the revenue was recorded in 'collaboration and other revenue' and in 2024 it shifted to 'net product revenue'—which is the opposite of the truth. (2) There are no numeric values (e.g., dollar amounts) in either answer, so quantitative accuracy cannot be penalized on that basis, but the temporal and categorical assignment of revenue recognition is factually wrong. (3) The multi-hop reasoning fails: the model incorrectly infers the direction of the change in revenue recognition, misidentifying both the source and the accounting method over time. It also cites page numbers as if supporting its claim, but the conclusion drawn from those pages (if they exist) contradicts the ground truth. (4) Contextually, the answer addresses the right topic—revenue recognition changes for Zyprexa—but gets the evolution backwards, making it misleading despite using relevant terminology. Thus, the correctness score is low due to fundamental factual inversion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 373,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "\nThe pension plan has consistently valued Federal Government Securities using a bid‑evaluation process with independent pricing sources, and they have always been placed in the Level 2 category of the fair‑value hierarchy. What has changed between the 2022 and 2024 filings is the presentation and scale of the disclosure—​the 2022 filing listed the securities as “Federal government securities – Level 2 – $742 million” (2021), while the 2024 filing expands the same Level 2 classification to a much larger balance (≈ $1.5 billion in 2023) and spells out the methodology in a dedicated “Fair Value Measurements” table, but the underlying valuation approach and Level 2 classification remain unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Federal Government Securities remained classified as Level 2 from 2022 to 2024 and that the valuation approach is based on observable inputs. However, it introduces significant inaccuracies: the $1.5 billion figure for 2023 is not present in the ground truth and contradicts the original answer, which only provides a 2022 value of $742 million. There is no mention of a 2023 or 2024 dollar amount in the original, so asserting a doubling in value is unsupported. Additionally, the LLM claims the methodology has 'always' been the bid-evaluation process, but the original answer states that this explanation was *added* in 2024, implying it was not explicitly disclosed in 2022—thus the claim of consistency in methodology disclosure is incorrect. (2) Quantitative accuracy is compromised by the inclusion of a fabricated $1.5 billion figure and incorrect attribution of data to 2023, while the only verified number ($742 million in 2022) is correctly cited. (3) The reasoning partially captures the continuity in classification (Level 2) but fails on the evolution of methodology disclosure—while the original emphasizes that 2024 brought *new specificity* in explaining the bid evaluation process, the LLM incorrectly frames this methodology as consistently disclosed. This misrepresents the evolution aspect of the question. (4) Contextual relevance is high because the answer addresses the fair value hierarchy, classification, and methodology changes, but factual errors in numbers and disclosure timing reduce correctness. The core idea of stable classification with enhanced disclosure is partially aligned, but the added false quantitative detail and overstatement of methodological consistency justify a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 485,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "\nFrom 2022 to 2023 the only measurable change in Capital One’s credit‑score data was a modest rise in the share of domestic credit‑card balances with FICO scores ≤ 660—from 31 % to 32 %—while the proportion of scores > 660 slipped from 69 % to 68 %.  The auto‑loan score distribution remained essentially unchanged (≈ 53 % > 660, 27 % ≤ 620 in both years).  This slight shift toward a higher‑risk segment indicates that the bank is increasingly leveraging credit‑score information to fine‑tune product segmentation—targeting more sub‑prime borrowers with tailored offers—reflecting a more granular, risk‑based approach to pricing and product placement in its credit‑risk model.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that Capital One updated the time period of credit score data used for product segmentation—from 2020–2021 data in 2022 to 2022–2023 data in 2023—indicating a shift to more current data in their risk modeling. In contrast, the LLM answer fabricates specific percentage shifts in credit score buckets (e.g., 31% to 32% for FICO ≤660) and claims these represent changes in data utilization, which is not supported by the ground truth. These percentages are not mentioned in the original answer and are likely hallucinated. (2) Quantitatively, the numbers (31%, 32%, 69%, 68%, 53%, 27%) do not appear in the ground truth and cannot be verified; thus, they are factually inaccurate. There is no mention of auto-loan distributions or domestic credit-card balance segmentation by FICO bands in the original answer. (3) The multi-hop reasoning is flawed: the question asks about the evolution in *data utilization* for segmentation decisions, not changes in borrower risk distribution. The LLM misinterprets the question, focusing on portfolio composition rather than the temporal update in data inputs for modeling. It fails to identify the key shift from older (2020–2021) to newer (2022–2023) data in Table 21, which is the core of the original answer. (4) While the LLM attempts to infer strategic implications (e.g., targeting sub-prime borrowers), this is speculative and misaligned with the actual indication—namely, a move toward a more dynamic, up-to-date credit risk modeling strategy. The contextual relevance is moderate because it discusses credit scoring and risk modeling, but it misses the central point about data recency and table updates, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 489,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "\nFrom 2022 to 2023 Amazon moved AWS from an internal “technology‑and‑content” investment that supported its retail operations to a distinct, stand‑alone business segment.  In the 2022 filing AWS was highlighted only as a major area of capital spending within the company’s broader infrastructure budget, whereas the 2023 filing explicitly lists AWS as one of three segments and emphasizes expanding its compute, storage, database, analytics and machine‑learning services—allocating an ever‑larger share of technology‑infrastructure capex to scale AWS globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AWS's strategic positioning from 2022 to 2023. (1) It correctly identifies that in 2022, AWS was part of broader technology-and-content investments focused on infrastructure and internal support, and by 2023 had become one of three explicit business segments alongside North America and International. The key shift—from internal investment to standalone segment—is clearly and correctly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not applicable; however, the years (2022, 2023) are correct and consistently used. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points and correctly infers the strategic elevation of AWS based on changes in segment reporting and investment focus. The LLM accurately reflects that AWS expanded its service offerings (compute, storage, etc.) and received a growing share of capex. (4) The only minor shortcoming is that the original answer includes slightly more context about AWS serving 'developers and enterprises' and its role in machine learning as a central pillar—nuances not fully emphasized in the LLM response. However, the omission does not detract from the core factual correctness. Wording differs but semantic meaning aligns closely. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 408,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "\nBetween 2022 and 2024 the nature of PMI’s exposure to Rothmans, Benson & Hedges Inc. shifted dramatically.  In 2022 RBH was already fully de‑consolidated from PMI’s consolidated statements (its results have been excluded since the March 2019 CCAA filing – see PM 10‑K 2022 p. 113), and the company’s only remaining link was disclosure of the pending Canadian tobacco litigation and related contingencies – PM 10‑K 2022 p. 115.  By the end of 2024 PMI recorded a $2.3 bn non‑cash impairment of its equity investment in RBH, driven by uncertainty over the proposed CAD 32.5 bn settlement allocation and the potential liability from the stayed Canadian tobacco cases – PM 10‑K 2024 p. 32, Note 6 and p. 115.  Consequently, the relationship moved from a de‑consolidated subsidiary with only disclosed contingencies to a material equity holding that now carries a sizable, uncertain financial exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $2.3 billion impairment charge (rounded from $2,316 million) is accurately reported, as is the CAD 32.5 billion proposed settlement amount. The timeline is also correct—RBH was deconsolidated prior to 2022 (due to the 2019 CCAA filing), and the impairment was recorded by 2024. The reference to the March 31, 2022, stay of litigation is implied through context. (2) The answer correctly identifies the shift from deconsolidation to equity method accounting and the resulting impairment, which reflects the core evolution in accounting treatment and financial exposure. (3) The reasoning is sound: it traces the change from a deconsolidated subsidiary with contingent liabilities to a recognized equity investment with a material impairment due to litigation uncertainty. The multi-hop synthesis—linking deconsolidation, litigation stay, proposed settlement, and impairment—is logically coherent. (4) Minor deduction in qualitative accuracy because the answer states deconsolidation occurred 'since the March 2019 CCAA filing', while the original answer emphasizes the 2022 status and context; however, this is not incorrect, just a difference in emphasis. The LLM also does not explicitly mention the inability to estimate losses in 2022, which is a small omission. Overall, the answer is factually correct, contextually relevant, and conveys semantic equivalence with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 415,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Biktarvy continued to generate roughly $8–9 billion of annual product sales—still one of Gilead’s largest single‑product revenue streams—but its share of total company sales slipped slightly as other franchises (e.g., Veklury, cell‑therapy) grew faster.  At the same time, the product’s commercial outlook has become more vulnerable: generic competition, the pricing‑curbs introduced by the Inflation‑Reduction Act and other Medicare‑Part D rebate reforms, and intensified market‑share pressure in the HIV space have increased the risk of revenue erosion compared with earlier years.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Biktarvy as a major revenue driver for GILD with approximately $8–9 billion in annual sales, which aligns with the ground truth figure of $8,624 million in 2022. However, the LLM implies this revenue level is consistent in 2024, while the original answer notes that specific 2024 revenue figures are not provided—this is a minor overstatement. The LLM introduces additional context about Veklury and cell therapy growth and mentions generic competition, the Inflation Reduction Act, and Medicare Part D reforms, which are plausible risks but not explicitly stated in the ground truth. Instead, the ground truth emphasizes risks related to TAF-based therapies and shifts in treatment paradigms, which the LLM omits. (2) The quantitative estimate of $8–9 billion is acceptable given the $8,624 million 2022 figure, but presenting it as stable through 2024 without qualification reduces accuracy since the ground truth does not confirm 2024 revenue. No calculations are performed, so no errors there. (3) The multi-hop reasoning is partially sound: the LLM infers continued commercial significance and increasing risk, which matches the evolution described. However, it substitutes specific risk factors (TAF reliance, treatment paradigm shifts) with broader market and policy risks not confirmed in the source, weakening the qualitative accuracy. (4) Scores reflect that core facts (revenue magnitude, ongoing importance, increased risk) are correct, but there are minor inaccuracies in extrapolating revenue stability and introducing unverified risk factors. The answer remains highly relevant and well-reasoned, just not fully aligned with the documented disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 466,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "\nFrom 2022 through 2024 Union Pacific’s equity stake in TTX expanded, with the carrying value of its investment climbing from about **$1.8 billion at the end of 2023 to $1.9 billion at the end of 2024** (up from roughly $1.5 billion in 2020), underscoring the continued 37 % ownership.  At the same time, car‑hire expenses paid to TTX—shown in “equipment and other rents”—rose from **$402 million in 2022 to $399 million in 2023 and then to $432 million in 2024**, reflecting higher utilization or rates even though overall operating‑lease cost fell slightly.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and timeframes compared to the ground truth. While the final 2024 investment value of $1.9 billion and 2024 car hire expense of $432 million are correct, the LLM incorrectly states the 2023 investment value as $1.8 billion and references $1.5 billion in 2020, whereas the ground truth reports $1.6 billion in 2021 (as cited in the 2022 filing). The car hire expenses are partially correct: the LLM reports $402 million in 2022 and $399 million in 2023, but the ground truth indicates $375 million in 2021 (referenced in 2022 filing), making the LLM's 2022 figure inconsistent with the source. (2) Quantitative accuracy is compromised: the investment progression is misrepresented across years, and the car hire baseline is off by $27 million in the starting point (402M vs 375M). The 2024 figures are accurate, but intermediate values lack support from the ground truth. (3) The reasoning is logically structured and recognizes the trend of increasing investment and expenses, correctly identifying the operational implications. It attempts multi-hop synthesis by linking investment growth and car hire trends to operational involvement, which aligns with the question’s intent. However, it fails to accurately trace the full timeline from 2021 to 2024 as required, instead shifting focus to 2020–2023. (4) Contextual relevance is high—the answer addresses both financial stake and operational relationship, uses correct entities (Union Pacific Railroad, TTX, car hire expenses), and interprets trends appropriately. The core trends (increasing investment and expenses) are correctly identified, but the factual foundation is weakened by incorrect data points, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 481,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "\nIn 2022 Tesla outlined a hands‑on scaling plan for Solar Roof that relied on on‑boarding and training new installers, collaborating with real‑estate developers to shorten installation time, and securing battery‑cell supply while hiring additional skilled electricians. By 2023 the company framed installer training as part of a broader, risk‑aware expansion—emphasizing that supply‑chain constraints and the need to staff and operate new production equipment make the recruitment and retention of qualified personnel a critical lever for sustaining Solar Roof growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, with accurate dates (2022 and 2023) and correct entities (Tesla, Solar Roof, installers, supply chain). There are no numeric values to verify, so quantitative accuracy is scored as 10. The answer correctly identifies Tesla's 2022 focus on installer training, collaboration with real estate developers, and hiring skilled electricians. It also acknowledges the shift in 2023 toward broader operational and supply chain challenges. However, the LLM downplays the significant strategic pivot highlighted in the original answer—specifically, the increased emphasis on supplier reliability, global component constraints, and cost-effective manufacturing processes as central to production scaling. Instead, it reframes the 2023 strategy around personnel recruitment and retention, which, while mentioned in the context of operating new equipment, was not the primary focus shift according to the ground truth. The original answer stresses a move from installer-focused growth to supply chain risk management and resilience, which the LLM answer does not fully capture. This omission affects qualitative accuracy, as the multi-hop reasoning—synthesizing the shift in strategic emphasis—is incomplete. Nonetheless, the response remains contextually relevant and conveys a reasonable approximation of the change, earning a correctness score of 7 for capturing core elements but missing key nuances in the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 409,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s core arrangement with U.S. fountain retailers did not change: under the bottler agreements (2022 KO 10‑K p. 9; 2023 KO 10‑K p. 38) bottlers are still prohibited from manufacturing fountain syrups, so the Company continues to produce the syrups and sell them to authorized fountain wholesalers and, directly or via those wholesalers, to fountain retailers (2022 KO 10‑K p. 7; 2023 KO 10‑K p. 37).  \n\nThe evolution lies in the pricing and contractual framework – the 2023 Comprehensive Beverage Agreements introduced a more formal incidence‑based pricing model and mandatory pricing provisions that give the Company tighter control over syrup prices and performance expectations while still using the same wholesaler‑to‑retailer distribution chain.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in terms of the core evolution described. (1) Correct elements: The answer accurately states that bottlers were not authorized to manufacture fountain syrups in both 2022 and 2023, and that The Coca-Cola Company continues to manufacture and sell syrups to authorized fountain wholesalers and retailers. This aligns with the original answer’s description of manufacturing and distribution roles. There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default. (2) However, the LLM introduces a claim not present in the ground truth: that the evolution lies in the 'pricing and contractual framework' with 'incidence-based pricing' and 'mandatory pricing provisions' under the 2023 Comprehensive Beverage Agreements. This detail is absent from the original answer and represents a different dimension of change (pricing control) than the one emphasized in the ground truth (clarification/expansion of distribution roles involving bottling partners). (3) The multi-hop reasoning is flawed because the LLM infers a shift in pricing mechanisms as the key evolution, whereas the ground truth emphasizes a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023. The LLM fails to mention this structural clarification in distribution, which is the central point of the original answer. (4) While the answer is contextually relevant and addresses the relationship with fountain retailers, it misidentifies the nature of the evolution between 2022 and 2023. Thus, the correctness and qualitative accuracy scores are moderate due to factual misalignment in the core reasoning, despite accurate entity identification and temporal framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 485,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "\nIn the 2022 filing the 0.950% Notes due 2025 were only mentioned in the “Reference Number per Item 601” exhibit list and were not set out as a separate line in the “Securities Registered Pursuant to Section 12(b)” table. By the 2024 Form 10‑K the notes appear explicitly in that table as “0.950% Notes due 2025 (IBM25B)”, identified as registered debt securities under the 1933 Act with a specific NYSE ticker, thereby providing clearer classification and registration details.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were initially referenced in earlier filings (via Exhibit 4.1 on May 22, 2017, as noted in the original answer), and by 2024 they were formally registered and listed with the ticker 'IBM25B' on the NYSE. The LLM correctly identifies the evolution from being only referenced in exhibit lists in 2022 to being explicitly listed in the 'Securities Registered Pursuant to Section 12(b)' table in the 2024 Form 10-K. (2) Quantitative accuracy is perfect: percentages (0.950%), years (due 2025), and the ticker symbol (IBM25B) match exactly. No calculations are required. (3) The multi-hop reasoning is sound—comparing disclosure treatment across years (2022 vs 2024) and inferring increased formalization in registration and classification. The LLM correctly infers a shift in classification and registration status even if it doesn't repeat the 8-K reference from 2017, which is contextually appropriate since the focus is on 2022–2024 evolution. (4) The answer is semantically equivalent to the original: while it omits the specific 2017 8-K filing detail, this is not required to address the evolution *from 2022 to 2024*. The core progression—from passive disclosure to active registration and listing—is accurately captured. Minor deduction in qualitative accuracy due to slightly less contextual background (e.g., origin of the note), but not necessary for full correctness given the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 421,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead has pushed Biktarvy from a niche, late‑line integrase‑inhibitor into the center of its HIV franchise—expanding its label (e.g., earlier‑line and potential pediatric use) and relying on it for a growing share of product revenue.  This concentration heightens the company’s financial risk because any margin squeeze from the Inflation‑Reduction Act’s Medicare price‑negotiation rules, generic‑entry pressure, or rebate‑driven payer negotiations would directly impact the flagship drug’s profitability.  Consequently, Biktarvy’s competitive edge now rests less on pure efficacy/safety and more on Gilead’s ability to protect pricing through payer‑engagement programs, real‑world outcome data, and formulation advantages while fending off rival integrase‑inhibitor pipelines and generic competition.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of GILD's strategic positioning of Biktarvy from 2022 to 2024, with accurate contextual framing around financial risk and competitive differentiation. It correctly identifies the growing financial risk due to reliance on Biktarvy, citing payer pressures, generic competition, and pricing risks—aligning with the ground truth's emphasis on increasing financial risk tied to nucleoside-based therapies. The mention of label expansion and central role in the HIV franchise reflects Biktarvy’s strengthened commercial positioning in 2022. However, the LLM introduces elements not present in the ground truth: (1) specific reference to the Inflation Reduction Act’s Medicare price negotiation as a risk factor, which is not mentioned in the original answer; (2) claims about 'pushing from a niche, late-line' use, which overstates the evolution—ground truth does not describe Biktarvy as niche in 2022 but already a key marketed product; (3) discussion of 'formulation advantages' and 'payer-engagement programs' as current differentiators, which adds speculative detail beyond the documented concern over waning differentiation. While these additions are plausible, they represent inference beyond the provided knowledge graph. The answer correctly captures the core multi-hop insight—increased reliance brings increased risk—but slightly misrepresents the nature of Biktarvy’s 2022 positioning and adds unverified mechanisms. No numerical inaccuracies are present (quantitative accuracy is high due to absence of incorrect figures), and the response remains highly relevant to the question. Thus, the correctness score is 7 for minor factual overreach despite solid reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 474,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin accelerated the wind‑down of its defined‑benefit obligations—first by purchasing group annuity contracts that transferred $4.3 billion of DB liabilities in Q2 2022 (resulting in a $1.5 billion non‑cash settlement charge) and then, in Q4 2023, by offering a voluntary lump‑sum settlement that moved roughly $414 million of DB obligations out of the pension trust, lowering the liability and the related accumulated‑other‑comprehensive‑loss balance.  At the same time, the company’s defined‑contribution retirement savings plan was unchanged; employees hired after 2005 continued to be eligible only for the DC plan, and the 2020 freezing of the qualified DB plans had already cemented the shift toward DC participation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in defined benefit pension obligations via group annuity contracts, resulting in a $1.5 billion noncash settlement charge; in 2023, the company made $414 million in settlement payments to about 6,500 former employees. These figures match the original answer exactly, and formatting (e.g., $4.3 billion vs $4.3B) is acceptable. (2) The timeline is slightly more precise in the LLM answer—citing Q2 2022 and Q4 2023—though this detail is not contradicted by the ground truth and may reflect additional context from the filings. (3) The qualitative reasoning is sound: the shift from large-scale annuity transfers (2022) to direct lump-sum settlements with individuals (2023) is correctly interpreted as part of a broader strategy to de-risk and wind down pension liabilities. The mention of reduced accumulated other comprehensive loss (AOCL) adds useful financial context not in the original but consistent with accounting principles. (4) The LLM correctly notes that the defined contribution (DC) plan itself did not change, which addresses the question’s focus on 'evolution' by clarifying that the shift occurred in DB liability management, not DC plan design. This contextual clarification enhances relevance. (5) Minor deduction in qualitative accuracy because the LLM does not explicitly frame the 2023 action as a 'strategic evolution' or contrast the two years’ approaches as directly as the original, though the implication is clearly present. Overall, the answer is factually complete, contextually appropriate, and demonstrates correct multi-hop synthesis across years and financial instruments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 477,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s 2025‑maturity profile remained anchored by the 2.875 % Notes due 2025 (identified as IBM 25A). In the 2022 filing the 2025 cohort consisted of three note series – 2.875 %, 0.950 % and 0.875 % – plus a 7.00 % debenture – all of which continued to appear in the 2024 table, with the 2.875 % series still listed as IBM 25A. Consequently, the 2.875 % Notes due 2025 have stayed in IBM’s debt‑maturity mix, showing no retirement or new issuance; the overall composition of 2025‑maturing instruments has simply evolved by retaining the same series while other tranches may have shifted in relative size.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, by 2024 the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a change in composition. However, the LLM claims all series—including the 0.875% Notes—'continued to appear in the 2024 table,' which directly contradicts the original answer. This is a major error in entity presence and debt evolution. (2) Quantitatively, the percentages (2.875%, 0.950%, 0.875%, and 7.00%) are correctly stated, and the identification of IBM 25A is accurate. However, the inclusion of a '7.00% debenture' is not mentioned in the ground truth and appears to be an addition not supported by the original data, raising concerns about hallucination. (3) The multi-hop reasoning is flawed: the question asks how the composition evolved, requiring correct comparison across years. The LLM fails this synthesis by asserting continuity where there was change (specifically, the removal of IBM 25C). Instead of identifying a strategic shift, it claims 'no retirement or new issuance' and that 'the same series' were retained, which is incorrect. (4) Contextual relevance is high—the response addresses the right topic, timeframe, and instrument—but correctness and qualitative reasoning are undermined by key factual errors. The conclusion that composition 'evolved by retaining the same series' is logically inconsistent with the claim that all prior series remain, and contradicts the ground truth showing a removal. Thus, while the focus is appropriate, the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 434,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "\nFrom 2022 through 2024 Biktarvy evolved from a “recovery” product that was filling the gap left by the loss of exclusivity of Truvada/Atripla into the core profit‑driver of Gilead’s HIV franchise, delivering year‑over‑year sales growth as the company expects the legacy‑product impact to be largely behind it.  Its strategic importance is underscored by label expansions (e.g., the 2021 FDA approval of a low‑dose pediatric tablet) and continued investment in next‑generation HIV candidates such as long‑acting capsid inhibitors, positioning Biktarvy as the anchor of Gilead’s antiviral portfolio.  At the same time, its risk profile has broadened: it now faces intensified competition from generic and emerging novel HIV regimens, aggressive payer‑driven pricing pressures (including the IRA’s Medicare price‑negotiation and rebate reforms), and uncertainty about the treatment paradigm’s shift toward dual‑ or long‑acting therapies that could erode its market share.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Biktarvy's strategic importance and risk profile but diverges from the ground truth in key aspects of reasoning and factual emphasis. (1) Correct elements include the recognition of Biktarvy as a core product by 2024, mention of competitive pressures, and reference to shifts toward long-acting therapies—consistent with the original answer’s theme of increasing vulnerability. The mention of label expansions and next-gen candidates adds contextually relevant detail not contradicted by the ground truth. (2) Quantitatively, no specific numbers (e.g., revenue growth percentages) are misstated—the LLM does not fabricate figures—but it introduces the claim that Biktarvy was filling a 'gap left by the loss of exclusivity of Truvada/Atripla' and calls it a 'recovery' product, which is not supported in the original answer. The 11% revenue increase cited in the ground truth is omitted, weakening quantitative completeness. (3) The multi-hop reasoning is partially sound: the LLM correctly infers increased risk due to treatment paradigm shifts and competition, but incorrectly frames Biktarvy’s 2022 role around post-patent-loss recovery rather than broad geographic growth as stated in the 2022 10-K. The original answer emphasizes a shift from growth driver (2022) to vulnerable asset (2024) due to TAF dependence, a critical link the LLM misses entirely. (4) While the LLM discusses payer pressures and IRA reforms—contextually plausible—they are not mentioned in the ground truth, introducing unsupported risks. The core failure is missing the key insight that Biktarvy’s risk stems from its TAF component and potential obsolescence of nucleoside-based therapies, which is central to the original answer’s conclusion. Thus, despite relevant and plausible elaboration, the LLM substitutes the actual reasoning chain with a partially incorrect narrative, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 523,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "\nThe U.S. litigation‑escrow balance rose from **$1.449 billion at the end of fiscal 2022** to **$1.764 billion at the end of fiscal 2023**.  The change was driven by a **$1.0 billion deposit** into the escrow account during fiscal 2023 (with a net $0.685 billion of payments to opt‑out merchants), producing a net increase of roughly **$0.315 billion** over the year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the final balance and deposit amounts. According to the ground truth, the U.S. litigation escrow account balance increased from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. However, the LLM incorrectly reports the 2023 balance as $1.764 billion (~$1,764 million), which is $1,325 million lower than the correct value. Additionally, the LLM states that a $1.0 billion deposit was made during fiscal year 2023, but the ground truth specifies a $1,500 million ($1.5 billion) deposit in that year, meaning the LLM underreports the deposit by $500 million. The LLM also introduces a detail not present in the original answer—$0.685 billion in payments to opt-out merchants—which may be factually accurate but is not part of the ground truth and distracts from the required information. (2) Calculations are inconsistent: the LLM implies a net increase of $0.315 billion ($1.764B - $1.449B), but this does not align with the actual net increase of $1,640 million ($3,089M - $1,449M). Furthermore, the deposit for fiscal year 2022 is omitted entirely, while the ground truth states it was $1,000 million. (3) The multi-hop reasoning is flawed—the question asks for the evolution of the balance and specific deposit contributions in each period (2022 and 2023), but the LLM only mentions the 2023 deposit and omits 2022 entirely, failing to provide a complete comparison. (4) Despite incorrect numbers and missing data, the answer is contextually relevant—it addresses the right account and the general idea of balance evolution and deposits—hence a moderate relevance score. However, due to major quantitative and completeness failures, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 484,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s manufacturing of fountain syrups remained anchored in the United States, where it continues to produce the syrups and sell them directly to fountain retailers (and, through authorized wholesalers or bottling partners, to other fountain accounts) – a responsibility that is counted within the North America operating segment 【page 37】.  What shifted is the relative importance of those syrup sales: concentrate operations, which include fountain‑syrup revenue, rose from 56 % of net operating revenue in 2022 to 58 % in 2023, while finished‑product operations fell from 44 % to 42 % 【page 38】.  Thus, the manufacturing role stayed the same but its contribution to overall revenue grew, reflecting a modest evolution toward a larger share of syrup‑based sales in North America.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in terms of the core evolution described. (1) Quantitatively, the percentages cited (56% to 58% for concentrate operations and 44% to 42% for finished-product operations) are accurate and correctly reflect data from pages 37 and 38 of the 10-K, satisfying quantitative accuracy. (2) However, the qualitative reasoning and entity synthesis are flawed: the original answer emphasizes a structural shift in manufacturing *authorization*, particularly noting that by 2023, bottling partners *outside the U.S.* were authorized to manufacture fountain syrups using company concentrates—a key evolution in operational model. The LLM answer completely omits this critical point and instead focuses on a change in revenue mix, interpreting the evolution as one of *relative contribution* rather than *manufacturing responsibility or distribution model*. (3) The question specifically asks about the evolution in Coca-Cola’s *manufacturing and distribution responsibilities*, not just revenue trends. While the LLM correctly notes continued U.S.-based manufacturing and direct sales, it fails to mention the expanded authorization of bottling partners to manufacture syrups outside the U.S., which is the central change highlighted in the ground truth. (4) This omission represents a failure in multi-hop reasoning: the model identifies correct financial data but misinterprets the operational evolution. The answer is contextually relevant and well-structured, but the core insight is misaligned with the actual shift described in the filings. Hence, correctness is reduced to 6 due to significant qualitative inaccuracy despite strong quantitative performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 470,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "\nBetween 2022 and 2024 IBM kept the 0.950 % Notes due 2025 (series IBM 25B) on its balance‑sheet, but the share of the 2025‑maturity cohort represented by that ultra‑low‑coupon tranche fell.  The 2025 maturities now consist of the 2.875 % Notes (IBM 25A), the 0.950 % Notes (IBM 25B) and the 7 % Debentures (IBM 25), with the 2.875 % and 7 % issues making up a larger portion of the total 2025 debt than the 0.950 % series.  Consequently, while the 0.950 % Notes remain outstanding, their relative composition within IBM’s 2025 debt has decreased from 2022 to 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 IBM had three notes maturing in 2025: 2.875% (IBM 25A), 0.950% (IBM 25B), and 0.875% (IBM 25C). By 2024, only the 2.875% and 0.950% notes remained — the 0.875% note was removed. However, the LLM incorrectly states that the 7% Debentures (IBM 25) are part of the 2025 maturities in 2024, which is not supported by the original answer and contradicts the evolution described. This introduces a completely incorrect debt instrument. (2) The percentages cited (0.950%, 2.875%) are correct, but the introduction of a '7% Debentures' is factually wrong and unsupported. There is no mention of a 7% note in the ground truth, making this a critical quantitative and entity error. Additionally, the LLM claims the 'share' or 'relative composition' of the 0.950% notes fell, but no data is provided in the original answer about amounts or proportions — only the presence/absence of tranches — so this inference is unsupported. (3) The multi-hop reasoning fails because the model incorrectly synthesizes the composition change: instead of correctly identifying the removal of the 0.875% note, it invents a new 7% instrument and misrepresents the evolution. The conclusion about reduced relative composition is speculative and not in the ground truth. (4) The contextual relevance is moderate because the answer addresses the 0.950% Notes and the general idea of changing composition, but the factual core is flawed. Due to major errors in entities and unsupported quantitative claims, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 442,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 Disney’s cruise‑ship strategy shifted from simply announcing a new shore‑based port—Lighthouse Point on Eleuthera, slated to open as a Disney Cruise Line destination in 2024 (2022 10‑K)—to explicitly framing that project as a core, capital‑intensive growth initiative and integrating it into the company’s broader Experiences segment (2024 10‑K).  The 2024 filing underscores ongoing investment and risk disclosures around the development, indicating that expanding the cruise‑line fleet and its private‑destination assets has become a sustained strategic priority rather than a one‑off announcement.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and captures a key element of Disney's evolving cruise strategy—specifically the development of Lighthouse Point as a new destination. However, it diverges from the ground truth by focusing on a shore-based port (Lighthouse Point) rather than the expansion of the cruise ship fleet, which is the central point in the original answer. The 2022 10-K reference to Lighthouse Point is accurate (and correctly dated), and the 2024 framing of cruise-related investments as strategic and capital-intensive aligns with the original answer’s emphasis on increased costs and uncertain returns. However, the LLM fails to mention the explicit 2024 statement about 'additional expansion of our fleet of cruise ships,' which is a critical multi-hop element. While the qualitative shift from passive mention to active investment is correctly inferred, the reasoning is based on a related but different aspect (port development vs. fleet expansion). Quantitatively, there are no errors—dates and project details are accurate. Contextually, the answer is relevant and well-framed, but misses the core evolution in fleet strategy. Thus, the correctness score is reduced due to incomplete and slightly misaligned entity focus, despite strong supporting reasoning and accurate details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 361,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "\nLockheed Martin’s 2022 filing disclosed that the August 2021 purchase of $4.9 billion of group‑annuity contracts— which produced a $1.7 billion non‑cash pension‑settlement charge—was only the first of a series of pension‑risk‑transfer actions the company intends to pursue. The 2023 filing reiterates that strategy, stating the goal is to reduce the volatility of its defined‑benefit obligations and improve cash flow, while acknowledging that future transfers may generate additional non‑cash settlement charges that could affect reported earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the $4.9 billion group annuity transaction and $1.7 billion noncash pension settlement charge from August 2021 are correctly reported, and the strategic intent to reduce volatility and improve cash flow is consistent with the original answer. The mention that future transfers may lead to additional noncash charges is also accurate and relevant. However, the LLM answer omits key qualitative developments from 2023 that reflect a more cautious evolution in Lockheed Martin's approach. Specifically, it fails to mention the new risk highlighted in the 2023 filing: potential residual liability if insurers default on GACs, which represents a significant shift in risk framing not emphasized in 2022. Additionally, the LLM incorrectly implies the August 2021 transaction was the 'first' in a planned series, while the original answer notes that by 2022, approximately $11.6 billion in obligations had already been transferred since 2018—indicating the 2021 transaction was part of an ongoing effort, not the beginning. This misrepresents the timeline and strategic context. While the core financial figures and general intent are correct (hence high quantitative accuracy), the incomplete synthesis of strategic evolution and omission of newly acknowledged risks reduces the qualitative accuracy. The answer remains contextually relevant and addresses the main thrust of the question regarding financial impact and strategic intent, but lacks the nuanced shift toward caution and residual liability that defines the 2023 update.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 435,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "\nBetween 2022 and 2023 Tesla shifted from a largely outsourced financing structure—where it recorded receivables from third‑party leasing and credit partners and relied on allowances for doubtful accounts—to a model in which it directly funds and manages operating leases and customer financing, heightening its exposure to residual‑value and credit‑risk.  The 2022 filing noted only periodic fluctuations in accounts‑receivable balances caused by payment‑cycle timing, whereas the 2023 filing explicitly warns that inaccurate residual‑value forecasts, price changes, or customer defaults could materially impair the leasing program and force the company to seek additional financing or face funding constraints.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Tesla's financing relationships between 2022 and 2023. (1) It correctly identifies the shift from 2022's focus on accounts receivable timing (payment-cycle fluctuations) to 2023's heightened concern over residual value and credit risks in leasing. The core facts—settlement timing in 2022 and increased risk exposure in 2023—are accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in risk disclosures across years and correctly infers a strategic shift in financing model. However, the LLM slightly overreaches by stating Tesla moved to 'directly fund and manage operating leases'—while the 2023 filing does emphasize increased risk from leasing and reliance on financing partners, it does not explicitly confirm a full transition to direct funding. This nuance is missing, leading to a minor factual overstatement. (4) Despite this, the answer remains contextually relevant and semantically close to the ground truth, accurately reflecting the increased complexity and risk in Tesla's leasing programs in 2023 compared to the more operational focus in 2022. The conclusion about potential funding constraints and need for additional financing is consistent with the original. Thus, the answer is strong but not perfect, warranting a score of 8 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 448,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "\nBetween 2022 and 2023 Coca‑Cola refined its fountain‑syrup distribution by moving more of the syrup sales directly to authorized fountain‑wholesalers and by extending incidence‑based pricing to selected bottlers—especially the “expanding participating bottlers”—that now purchase (and, in some markets, manufacture) syrup under new contractual terms.  As a result, bottlers evolved from being merely distributors of finished drinks to active purchasers and, where permitted, co‑producers of fountain syrup, while fountain‑wholesalers assumed a larger logistics and retail‑delivery role, handling the bulk distribution of syrup to restaurants and other end‑users.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of change in Coca-Cola's fountain syrup distribution strategy—increased involvement of bottlers in syrup purchasing and manufacturing—but introduces details not present in the ground truth and misrepresents key aspects of the evolution. (1) Correct elements: the shift toward greater bottler involvement in syrup procurement and, in some cases, manufacturing is consistent with the 2023 model described. The expanded role of bottlers beyond finished beverage distribution is accurately implied. (2) Quantitative accuracy: there are no specific numbers (e.g., dollar amounts, percentages, volumes) in either the original or LLM answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning issues: the LLM incorrectly emphasizes 'incidence-based pricing' and 'expanding participating bottlers'—terms not found in the ground truth and not supported by the provided knowledge. It also fails to highlight the key geographic distinction: that outside the U.S., bottlers were authorized to manufacture syrup using concentrates, which is the core of the 2023 shift. Instead, it generalizes the change without clarifying the U.S. vs. international divergence. (4) The original answer stresses a structural shift from centralized (Coca-Cola direct to wholesalers) to integrated (bottlers manufacturing internationally), whereas the LLM focuses on contractual pricing models and purchasing roles without accurately reflecting the manufacturing authorization change. This results in partial factual alignment but significant omission of the central geographic and operational evolution. Thus, while contextually relevant and free of numerical errors, the qualitative inaccuracies and unsupported details reduce the correctness score to 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 491,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s receivables from the ATMP joint venture rose modestly—from about $9 million to roughly $12 million—while the amount it owes the JV grew from roughly $363 million to about $476 million.  In addition, AMD made new financial commitments to the JV: it contributed an extra $17 million of equity in August 2024 (raising its equity‑method investment to ≈ $149 million) and, on October 9 2024, extended a $100 million term loan to the JV (secured by the receivable balance) that bears interest at SOFR + 50 bps and can be extended for up to another year.  These actions reflect a deepening of AMD’s financial involvement with the ATMP JV beyond simple purchase‑resale transactions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly states that AMD's receivables from the ATMP JV increased from $9 million in 2023 to $12 million in 2024 (matching the ground truth), it introduces incorrect information not present in the original answer: specifically, that AMD 'owes the JV' $363M to $476M, which is not mentioned in the ground truth and contradicts the original narrative. Additionally, the LLM claims AMD contributed an extra $17 million in equity in August 2024, raising its equity-method investment to ~$149 million—this detail is entirely absent from the ground truth and thus factually unsupported. The $100 million term loan is correctly identified, including the October 9, 2024 date and SOFR + 50 bps interest, though the ground truth does not mention collateralization by receivables or extension terms. (2) Quantitative accuracy is low because while the $9M and $12M receivables are correct, the $363M, $476M, $17M, and $149M figures are not in the original answer and appear fabricated. The $100M loan is correct. (3) Multi-hop reasoning is partially sound—the model identifies a deepening financial relationship, which aligns with the ground truth’s conclusion—but it does so using incorrect supporting data. The synthesis includes extraneous and inaccurate financial obligations and investments. (4) Contextual relevance is high because the answer addresses the evolution of the financial relationship, receivables, and new investment activities as asked. However, the inclusion of false quantitative details and unsupported equity contributions significantly undermines factual correctness, warranting a moderate score of 4 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 468,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin moved from a broad, market‑based strategy—purchasing group annuity contracts that transferred $4.3 bn of defined‑benefit obligations in 2022 (and $4.9 bn in 2021) and generating a $1.5 bn non‑cash settlement charge in the second quarter of 2022—to a much more targeted approach in 2023, offering a voluntary lump‑sum settlement of $414 million to roughly 6,500 former employees, which reduced the pension liability by that amount and eliminated the need for a large settlement charge.  The financial impact was a smaller, one‑time reduction in accumulated other‑comprehensive‑loss and a modest adjustment to net pension expense, reflecting the shift from large‑scale annuity buy‑outs to smaller, voluntary settlements.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key shift in Lockheed Martin's strategy from large-scale annuity purchases in 2022 ($4.3 billion) to a targeted voluntary lump-sum settlement in 2023 ($414 million to ~6,500 former employees), which aligns with the ground truth. However, it introduces an incorrect detail: the mention of a $4.9 billion annuity purchase in 2021 is not present in the original answer and is extraneous, potentially misleading, and unverified by the provided ground truth. This affects quantitative accuracy. (2) The $4.3 billion pension obligation transfer and $1.5 billion noncash settlement charge in 2022 are accurately reported. The 2023 settlement amount of $414 million and the recipient count (~6,500 former employees) are also correct. The claim about financial impact—'eliminated the need for a large settlement charge'—is reasonable, as smaller settlements typically avoid triggering significant settlement charges, though the original answer does not explicitly confirm this. However, the LLM implies a reduction in accumulated other comprehensive loss and adjustment to net pension expense, which adds detail not present in the ground truth; while plausible, it goes beyond the verified facts. (3) The multi-hop reasoning is sound: the model correctly contrasts two years of pension strategies, synthesizing scale, method, and financial implications. The core evolution—from broad annuity transfers to targeted settlements—is accurately captured and logically interpreted. (4) The correctness score is 8 because the central facts and strategic evolution are correct, but the inclusion of unverified data (2021 $4.9B transaction) and slight over-elaboration on financial impacts reduce precision. Quantitative accuracy is 7 due to the unsupported 2021 figure. Qualitative accuracy is 9 due to strong reasoning and correct entity/year/metric alignment. Contextual relevance is 10—every part of the question is addressed directly and meaningfully.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 537,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s stake in the ATMP joint venture expanded both in size and financial activity.  The carrying value of its equity‑method investment rose from roughly **$83 million (as of Dec 30 2023)** to **about $149 million (as of Dec 28 2024)**, helped by a **$17 million additional equity contribution in August 2024**, while equity‑method income jumped from **$16 million in 2023 to $33 million in 2024**.  At the same time, AMD’s transactions with the JV grew: payables to the JV increased from **$363 million to $476 million**, receivables from the JV rose from **$9 million to $12 million**, and AMD even extended a **$100 million, SOFR‑plus‑50 bps term loan** to the JV in October 2024, underscoring a deeper financial relationship beyond the earlier purchase‑and‑resale arrangements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of AMD's financial relationship with the ATMP JV and correctly identifies key figures such as the $17 million additional contribution in August 2024, the increase in equity income from $16 million to $33 million, and the ending carrying value of $149 million in 2024. However, it incorrectly states the 2023 carrying value as $83 million, whereas the ground truth specifies $99 million. This is a significant quantitative error that affects the accuracy of the investment change calculation (the increase should be $50 million: $149M - $99M, not $66M as implied by $83M → $149M). Additionally, the LLM introduces new details not present in the original answer—such as payables rising from $363M to $476M, receivables increasing, and a $100 million term loan—while contextually plausible, these are not part of the ground truth and were not requested in the question. The qualitative reasoning about deepening financial ties is sound and responsive to the question’s focus on evolution, but the inclusion of unsupported specifics reduces quantitative accuracy. The multi-hop synthesis of investment change and income growth is logically structured and mostly accurate, though based on an incorrect starting carrying value. Semantic equivalence is partially met, but factual deviations in key numbers prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 377,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 Johnson & Johnson’s stake in Kenvue was gradually unwound.  After the May 2023 IPO the company held about 89.6 % of Kenvue and, following the August 2023 exchange offer, retained roughly 9.5 % of the shares (recorded at fair value of $4.3 bn, later $3.9 bn), which generated a one‑time, tax‑free gain of about $2.8 bn on the retained equity and a total $21 bn gain on the transaction.  In the second quarter of 2024 J&J completed a debt‑for‑equity swap of the remaining 182 million Kenvue shares for commercial paper, eliminating its equity interest and recording an approximate $0.4 bn loss, so that by the end of 2024 the company owned **no** shares of Kenvue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor discrepancies. (1) Quantitatively: The key figures are correct: 9.5% retained stake in 2023, $4.3 billion valuation (later adjusted to $3.9 billion, which is an additional detail not contradicted by the original answer), $21 billion total gain (matches ground truth), $2.8 billion gain on retained shares (correct), and $0.4 billion loss in 2024 upon full exit. The number of shares (182 million vs. 182,329,550) is rounded but acceptable. The mention of the $3.9 billion revaluation is extra context not in the original but does not contradict it. (2) The timeline is accurate: post-IPO stake at ~89.6% (contextual background not in original but plausible), reduction after August 2023 exchange offer, and full exit in Q2 2024 via debt-for-equity swap. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from partial divestiture in 2023 with gains to complete exit in 2024 with a loss. (4) The only minor issue is that the original answer emphasizes the 2023 retained stake came *after* the exchange offer (not after IPO), and the LLM slightly conflates the timeline by mentioning the 9.5% retention after IPO rather than clearly after the exchange. However, it corrects this by referencing the August 2023 exchange. Overall, all critical facts, calculations, and entities are correct, and the answer fully addresses the question about stake evolution, retained equity, and gains/losses. Hence, a score of 9 is appropriate—excellent but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 433,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "\nBetween 2022 and 2023 AT&T did not add or remove any guarantee of Southwestern Bell Telephone Co.’s obligations – the same “Guaranty of certain obligations of Southwestern Bell Telephone Co.” that was first filed in 2011 continued to be referenced in both years. The 2022 filing simply carried forward the existing guarantee, and the 2023 filing reaffirmed it (see Exhibit 4‑b in the 2023 Form 10‑K), so the guarantee relationship remained unchanged, merely re‑stated in the later filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023, which aligns with the ground truth. It accurately states that the same guarantee, originally filed in 2011, was carried forward in both years, indicating consistency in the nature and scope of the guarantee. However, there is a discrepancy in the exhibit number cited: the LLM claims the 2023 guarantee is in Exhibit 4-b, while the ground truth specifies Exhibit 4-c for both years. This is a minor factual error affecting entity accuracy (specific document reference), but does not undermine the overall correctness of the conclusion. The reasoning is sound—correctly synthesizing that the guarantee was reaffirmed rather than modified—and the answer addresses all key aspects of the question. The date (2011) mentioned for the original filing is additional context not contradicted by the ground truth. Quantitative elements (years, continuity) are accurate. Wording differs but meaning is semantically equivalent. The error in exhibit number prevents a perfect score, but core facts and multi-hop synthesis are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 331,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "\nFrom 2022 to 2023 Lockheed Martin broadened its hypersonics effort—adding U.S. Navy‑focused strike‑weapon programs while continuing its Air Force and Army collaborations—and shifted the work from primarily development toward early‑production phases, with multiple hypersonics programs expected to enter production through 2026. This reflects a strategic positioning of hypersonics as a core growth pillar and an expanded, end‑to‑end responsibility for designing, testing and moving the programs into production.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Lockheed Martin's hypersonics involvement from 2022 to 2023, noting a strategic shift toward greater emphasis and program maturation. It accurately reflects the expansion of responsibilities and positioning hypersonics as a core growth area, which aligns with the ground truth's description of a move from a potential growth area to an active, defined portfolio. The mention of U.S. Navy, Army, and Air Force programs is consistent with the original answer’s reference to work with the U.S. Army and Navy. However, the LLM introduces specific details not present in the ground truth: (1) a shift toward 'early-production phases' and expectations of production through 2026, and (2) 'end-to-end responsibility for designing, testing and moving into production.' While plausible, these details go beyond the source information, which only confirms that by 2023 hypersonics were listed among major programs in the Space segment with active design and development roles. The ground truth does not mention production timelines or testing responsibilities. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is contextually relevant. The qualitative accuracy is slightly reduced due to unsupported elaboration, though the core reasoning about strategic evolution remains sound. Thus, the answer is mostly correct but includes minor overreach in detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 395,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "\nThe U.S. litigation escrow account balance grew from **$1.44 billion at the end of fiscal 2022** to **$1.76 billion at the end of fiscal 2023**.  Deposits into the account were **$0.85 billion during fiscal 2022** and **$1.00 billion during fiscal 2023**, the latter raising the balance to $1.76 billion after net payments of $175 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported account balances. The ground truth states the balance increased from $1.4 billion (Sept 30, 2022) to $3.089 billion (Sept 30, 2023), but the LLM reports $1.44 billion and $1.76 billion, respectively—both figures are incorrect. The deposits, however, are mostly accurate: $850 million in fiscal 2022 and $1.0 billion in fiscal 2023 match the ground truth (with acceptable formatting variations like $0.85B = $850M). (2) The quantitative error is severe in the final balance for 2023: the LLM claims $1.76B after a $1B deposit and $175M in net payments, but this math does not align with the starting balance of $1.44B: $1.44B + $1.0B - $0.175B = $2.265B, not $1.76B—indicating flawed internal logic. More critically, the actual 2023 balance is $3.089B, so the LLM is off by over $1.3B. (3) The multi-hop reasoning is partially sound in linking deposits to balance changes, but fails in synthesizing the correct opening and closing balances from the data. It introduces unverified information (net payments of $175M) not present in the ground truth, suggesting fabrication or misattribution. (4) Despite correct identification of the fiscal years and the correct deposit amounts, the severe balance inaccuracies and incorrect reasoning undermine the answer’s reliability. The contextual relevance is high as it addresses the right account and time frame, but factual correctness is low due to major numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 414,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "\nOutdoor Garden has stayed within the **Hardlines** merchandising group throughout the 2022‑2024 periods, but its relative weight in the company’s sales mix has slipped slightly—from about **6.8 % of total net sales in fiscal 2021‑22 to roughly 6.5 % in fiscal 2024**—reflecting a modest shift in emphasis toward other Hardlines categories.  Nonetheless, Home Depot continues to treat Outdoor Garden as a strategic growth pillar within Hardlines, maintaining its focus on garden‑related products while adjusting its internal merchandising structure to align with evolving category priorities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Outdoor Garden was part of the Hardlines group in 2022, while the ground truth confirms it was a distinct product line in 2022 and only later grouped under Hardlines by 2024. This misrepresents a key strategic shift. Additionally, the LLM claims Outdoor Garden's share dropped to 'roughly 6.5%' in 2024, but no such figure is supported in the ground truth—only the 2022 percentage (6.8%) and dollar amount ($10,317 million) are provided; no 2024 sales percentage or figure is given in the original answer, so asserting 6.5% is speculative and incorrect. The mention of 'fiscal 2021-22' is also inconsistent with the original's 2022 reference, introducing an incorrect time frame. (2) Quantitative accuracy is low: the $10,317 million figure is omitted entirely, and the 6.5% figure for 2024 is fabricated. The only correct number is the 6.8% in 2022, though it's misattributed to 'fiscal 2021-22' instead of 2022. (3) The reasoning is partially sound in noting a shift in emphasis, but fails the multi-hop synthesis: it misses the reclassification from standalone line to a subcategory within Hardlines, which is the core of the strategic evolution. Instead, it assumes consistent classification under Hardlines, contradicting the ground truth. (4) Contextual relevance is fair—the response addresses product strategy evolution and performance metrics—but the incorrect classification timeline and invented metrics undermine the qualitative and quantitative accuracy, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 436,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "\nAMD has kept its “engaging and open” culture as headcount rose from roughly 26 K (2023) to 28 K (2024) by institutionalising regular employee‑voice tools—confidential annual surveys reviewed by the Board, open town‑halls, executive roundtables, and an enterprise‑wide mentoring program—while expanding inclusive benefits, flexible‑work options, and robust DEI initiatives such as employee resource groups (over 85 % of new hires join an ERG) and the “Advancing Women in Technology” program.  This focus on continuous cultural measurement, transparent communication, and career‑development investments signals a talent‑retention strategy that leverages an inclusive, growth‑oriented environment to attract and keep top engineers and leaders in a fiercely competitive semiconductor market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several specific initiatives such as 'confidential annual surveys reviewed by the Board', 'executive roundtables', 'enterprise-wide mentoring program', 'over 85% of new hires join an ERG', and the 'Advancing Women in Technology' program. However, these details are not present in the original answer (ground truth) and cannot be verified from the provided knowledge graph. The workforce numbers (26,000 in 2023 and 28,000 in 2024) are correctly cited and align with the ground truth, and the implied 7.7% growth is accurate (2,000 / 26,000 ≈ 7.7%). However, the LLM introduces unverified quantitative claims like 'over 85% of new hires join an ERG' which has no support in the original data. (2) While the headcount figures are correct, the additional metrics (85%, program names, structural initiatives) are fabricated or hallucinated, severely impacting quantitative accuracy. (3) The reasoning attempts multi-hop synthesis by connecting cultural initiatives to talent retention, which is consistent with the original answer’s conclusion. However, the LLM builds this reasoning on unsupported details rather than the actual evidence—repetition of identical cultural messaging across years—which is the core of the ground truth. The original answer emphasizes consistency in language as proof of cultural preservation; the LLM instead invents structural programs without evidence. (4) The answer is contextually relevant and addresses both parts of the question—how AMD maintained culture and what it suggests about talent retention. The strategic interpretation about using inclusive culture for retention aligns with the original, but the factual foundation is compromised by hallucinated details. Thus, while the direction of reasoning is plausible, the correctness score is low due to significant factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 504,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "\nBetween 2022 and 2023 AT&T did not negotiate any new guarantee arrangements with The Ohio Bell Telephone Company; the company simply continued to reference the same legacy guarantee that had been disclosed in earlier filings. Both the 2022 Form 10‑K (pages 133‑137) and the 2023 Form 10‑K (page 103) list the 2011‑dated “Guaranty of certain obligations of … The Ohio Bell Telephone Company” as an existing commitment, and no material change or additional guarantee was reported in either year. Thus, the guarantee obligations toward Ohio Bell remained unchanged during that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that AT&T maintained its guarantee obligation for The Ohio Bell Telephone Company in both 2022 and 2023, referencing the same 2011 guaranty (Exhibit 4-c), with no new or modified guarantees. The dates (2011, 2022, 2023) and document types (Form 10-K) are correct. (2) Quantitative accuracy is perfect: the years and exhibit references are consistent with the original answer, and no incorrect numbers or calculations are present. The mention of specific page numbers (133–137 in 2022, 103 in 2023) adds precision and supports the claim of unchanged documentation. (3) The reasoning is sound: the LLM correctly infers that the absence of changes in filings implies continuity of the guarantee, which constitutes valid multi-hop reasoning across two years of disclosures. (4) The answer is contextually relevant and fully addresses the question about the evolution of the relationship, particularly regarding guarantee obligations. The only minor shortcoming is that it does not explicitly mention the update in exhibit reference numbering (e.g., from Exhibit 4-c to a current equivalent) as noted in the original answer, which slightly reduces qualitative accuracy. However, this omission does not affect the core correctness, as the substance of the guarantee continuity is accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 385,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "\nIn 2023 GE recorded about **$5.78 billion** of gains on retained and sold ownership interests, a substantial portion of which came from its investment in **AerCap** (see page 14). By 2024 those gains had fallen by roughly **$5.2 billion**, leaving only a modest net gain of roughly **$0.6 billion** (page 13), so the financial upside from the AerCap relationship dropped sharply between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the LLM states a $5.78 billion gain in 2023, which closely aligns with the ground truth's $5.7 billion (likely a rounding difference or slight variation in source data); the $5.2 billion decrease in 2024 matches exactly. The derived net gain of ~$0.6 billion in 2024 ($5.78B - $5.2B) is a reasonable inference and mathematically sound. (2) The answer correctly identifies AerCap and GE HealthCare (implied via context) as primary drivers, though it emphasizes AerCap more—this is acceptable given the question's focus. (3) Multi-hop reasoning is sound: it compares gains between 2023 and 2024, correctly infers a sharp drop in financial impact, and ties it to the AerCap relationship. (4) Minor deduction in quantitative accuracy due to the $5.78B vs $5.7B discrepancy, but this is within acceptable tolerance. No significant omissions; the answer is contextually complete and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 286,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Home Depot shifted from merely owning HD Supply to actively weaving its MRO catalog and distribution network into a dedicated professional ecosystem—expanding a specialized sales force, credit and loyalty programs (e.g., Pro X Tra) and using HD Supply’s distribution channels to serve pros and specialty trades. The company deepened its focus on professional customers by integrating HD Supply’s MRO products into its interconnected retail strategy and by acquiring SRS to broaden that offering, while investing in supply‑chain and technology upgrades to deliver faster, low‑cost delivery and tailored assortments for pros.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of HD Supply between 2022 and 2024. It accurately captures the shift from post-acquisition integration to a strategic role in serving professional customers through MRO services. The mention of integrating HD Supply’s MRO offerings, expanding sales force, credit/loyalty programs like Pro X Tra, and supply chain investments reflects accurate qualitative details consistent with Home Depot’s strategic direction. However, the LLM introduces information not present in the ground truth: specifically, the acquisition of SRS and the explicit claim about 'weaving its MRO catalog' into a 'dedicated professional ecosystem' with technology upgrades. While SRS is a known acquisition by Home Depot (completed in 2021), the original answer does not reference it, and the knowledge graph ground truth does not include it as part of the 2022–2024 strategic evolution in relation to HD Supply. This addition, while contextually plausible, represents an unsupported inference. Additionally, the original answer emphasizes the shift from integration risks in 2022 to HD Supply being a 'core component' in 2024, which the LLM captures in spirit but does not explicitly contrast as clearly. There are no numerical inaccuracies (quantitative accuracy is perfect since no incorrect numbers are cited), and the contextual relevance is high as the response directly addresses the strategic evolution in relation to professional customers and MRO. The reasoning is sound but slightly overreaches by incorporating external knowledge (SRS) not confirmed in the ground truth, reducing qualitative accuracy slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 462,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "\nBetween the 2023 and 2024 filings AMD’s patent portfolio showed only modest change – it still held roughly 7,500 U.S. patents and about 18.5 k–18.8 k worldwide patent matters (≈12.8 k–13.2 k issued, with pending applications falling slightly from ~2 k to ~1.9 k).  Both the 2023 and 2024 disclosures stress that AMD maintains “numerous cross‑licensing and technology‑exchange agreements” with other companies, indicating that it continues to rely on these arrangements to share and acquire semiconductor‑related IP.  The slight increase in issued patents (12.8 k → 13.2 k) and the steady presence of cross‑licensing agreements suggest that AMD’s dependence on such agreements has not shifted dramatically; it remains a stable mechanism for technology exchange while the company’s patent assets experience only incremental growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details. While the worldwide patent matters (18.5k in 2023, 18.8k in 2024) and issued patents (12.8k to 13.2k) are correctly reported, the pending applications are misrepresented: the ground truth states 5,600 pending applications in both years, not a drop from ~2,000 to ~1,900 as claimed. This is a significant error, as it misrepresents the composition of the patent portfolio. Additionally, the mention of '7,500 U.S. patents' is not supported by the original answer and introduces unverified data, undermining quantitative accuracy. (2) The original answer does not specify U.S. patent counts or provide the breakdown of pending applications as ~2k or ~1.9k—these numbers are either fabricated or incorrectly inferred. The correct pending count is stable at 5,600, so the claim of a decline is false. (3) Qualitatively, the reasoning is sound: the LLM correctly identifies that AMD continues to rely on cross-licensing agreements and links the slight growth in issued patents to ongoing technology exchange. It appropriately concludes that reliance has not dramatically shifted, which aligns with the original answer’s implication of continued strategic importance. However, it misses the original answer’s point that the strengthened patent portfolio likely enhances AMD’s leverage in agreements—this nuance is omitted, weakening the synthesis. (4) Contextual relevance is high, as the response directly addresses the evolution of AMD’s reliance on cross-licensing and ties it to patent portfolio changes. Despite incorrect numbers, the overall framing and intent match the question. Due to major quantitative errors affecting factual correctness, the correctness score is limited to 6, reflecting partial accuracy with significant flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 496,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "\nFrom the 2023 separation through the end of 2024, Johnson & Johnson’s stake in Kenvue fell dramatically: after the IPO it owned roughly 89.6 % of Kenvue, and by the August 2023 exchange it retained only about 9.5 % of the shares (recorded as a $4.3 billion fair‑value investment). In May 2024 the company completed a debt‑for‑equity exchange that swapped the remaining ~182 million Kenvue shares for commercial paper, eliminating its equity position entirely and generating a ≈ $0.4 billion loss recorded in other income/expense. Thus, J&J moved from a substantial ownership and ongoing strategic partnership to a full disposal of its Kenvue shares within the 2023‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor imprecisions. (1) Quantitatively: The 9.5% retained stake, $4.3 billion valuation, ~182 million shares (exact: 182,329,550), $3.6 billion commercial paper, and $0.4 billion loss are all correctly reported within acceptable rounding. The mention of 'August 2023 exchange' aligns with the ground truth. However, the LLM incorrectly states J&J owned 'roughly 89.6%' post-IPO, which is not in the original answer and introduces unsupported detail—this is a minor overreach but not directly contradicted by the ground truth. (2) The $0.4 billion expense in 2023 (due to valuation changes) and $0.4 billion loss in 2024 are correctly distinguished in context, though the LLM combines both under 'other income/expense' without specifying the 2023 expense was already recognized. (3) Qualitatively, the multi-hop reasoning is sound: the answer traces the evolution from partial retention to full disposal via debt-for-equity, correctly identifying the strategic shift and financial implications. (4) Contextual relevance is excellent—the response directly addresses the evolution of the financial stake and strategic relationship, synthesizing across 2023 and 2024 events. The only deductions are for the unsupported 89.6% figure and slight conflation of the two $0.4 billion items, which do not undermine the overall correctness. Thus, a score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 402,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "\nBetween 2022 and 2023 AT&T stopped singling out Indiana Bell Telephone Co. Inc. in its guarantee disclosures. In the 2022 filing the company’s “Guaranty of certain obligations of Indiana Bell” appeared in the exhibit list (and was referenced in the earlier portions of the 10‑K), but the 2023 10‑K (pages 101‑105) contains no separate mention of that guaranty—only a generic reference to historic exhibits—showing that the Indiana Bell guarantee is no longer a distinct disclosure item. This reflects a de‑emphasis of the relationship in AT&T’s formal guarantee reporting.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. According to the ground truth, AT&T continued to reference the guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d in 2023, indicating no change from 2022. The LLM incorrectly claims that AT&T stopped singling out Indiana Bell in 2023 and that the guarantee was no longer a distinct disclosure item, which contradicts the original answer. There are no numeric values in the question, but the temporal and factual assertions (2022 vs 2023 disclosures) are wrong. The entity names and years are correctly identified, but the reasoning is flawed: the LLM misinterprets the absence of a separate exhibit listing as evidence of removal, whereas the ground truth confirms the guarantee was still referenced under the same exhibit. This represents a failure in multi-hop reasoning and factual synthesis. The answer is contextually related but draws the opposite conclusion from the evidence, severely undermining its accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 279,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "\nIn 2023 GE still owned an equity interest in AerCap, which it completely divested in the fourth quarter of 2023; the sale generated a sizable gain that helped drive the $5.7 billion increase in “gains on retained and sold ownership interests,” and GE also paid a net $203 million of cash to AerCap for transition‑service arrangements. By 2024 the equity stake was gone, leaving only a senior note receivable (valued at $944 million) and ongoing service fees, so there were no further material investment gains and cash involvement was reduced to routine note repayments and service‑fee collections rather than the large equity sale and cash outflow of 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the timing and nature of GE's divestiture of AerCap and the direction of the gain change. The original answer states that GE reported a *decrease* in gains on retained and sold ownership interests by $5.2 billion in 2024, largely due to AerCap and GE HealthCare. However, the LLM claims a $5.7 billion *increase* in gains, attributing it to the sale of AerCap in Q4 2023—this directly contradicts the ground truth. Additionally, the LLM incorrectly asserts that GE fully divested its equity interest in AerCap in 2023, while the original answer indicates that GE *held an investment stake in 2024*, meaning the divestiture did not occur by then. (2) Quantitative inaccuracies include the $5.7 billion increase (vs. $5.2 billion decrease in reality) and the introduction of a $944 million senior note receivable, which is not mentioned in the ground truth and appears fabricated. The $203 million net cash payment to AerCap is correctly cited, but its characterization as part of transition-service arrangements is only partially aligned—original specifies note receivable, product leases, and transition services. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that divestiture in 2023 led to gains, but the truth is that the *absence* of such gains in 2024 (post-transition) caused a year-over-year decline. The shift from operational involvement (2023) to investment stake (2024) is misrepresented as a complete exit rather than a strategic shift. (4) Despite these major errors, the answer is contextually relevant, addressing cash involvement and investment gains, and correctly noting reduced cash activity in 2024. However, core financial facts and directional trends are wrong, severely undermining correctness. Hence, low scores on quantitative and overall correctness, moderate on qualitative for structure, and high on relevance for topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 532,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "\nFrom 2022 to 2024 Home Depot moved beyond modest store‑refreshes to a systematic overhaul that couples physical‑appearance upgrades (new signage, store‑refresh packages, self‑service lockers, electronic shelf‑labeling and expanded curb‑side pickup) with deeper digital integration (mobile‑app navigation, AI‑driven inventory tools, computer‑vision shelf visibility and personalized marketing).  These investments are tied to a broader supply‑chain and fulfillment expansion that delivers faster same‑day/next‑day delivery and uses stores as omnichannel fulfillment hubs, making store appearance a core competitive differentiator that directly enhances the customer experience for both DIY and professional shoppers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and captures the general evolution of The Home Depot's strategy from 2022 to 2024 regarding store appearance and digital integration. It correctly identifies the shift toward a more integrated, omnichannel experience and links store appearance to customer experience and competitiveness. However, the original answer (ground truth) does not include specific details such as 'self-service lockers,' 'electronic shelf-labeling,' 'AI-driven inventory tools,' 'computer-vision shelf visibility,' or 'personalized marketing'—these are plausible but not supported by the provided ground truth and represent over-specificity or potential hallucination. The LLM also emphasizes a 'systematic overhaul' and 'supply-chain and fulfillment expansion' with operational details not explicitly mentioned in the original answer, which focuses more broadly on the conceptual shift from physical appearance to an 'interconnected shopping experience' with digital platform investments. While the core idea of integrating physical and digital to enhance competitiveness is correct and aligns semantically with the original, the LLM adds granular details and technological specifics not present in the source, reducing qualitative accuracy. There are no numeric values in either answer, so quantitative accuracy is scored as 10 by default. Contextual relevance is high as the response directly addresses the evolution in strategy, customer experience, and digital integration. The multi-hop reasoning is partially sound—linking store appearance, digital tools, and customer experience across years—but extends beyond the evidence in the ground truth in its specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 457,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s commercial interaction with the ATMP joint venture expanded markedly: purchases stayed roughly $1.7 billion, but resales to the JV surged from only $14 million in 2023 to $121 million in 2024, while payables to the JV grew from $363 million to $476 million and receivables rose from $9 million to $12 million.  In addition, AMD added a new $100 million one‑year term loan (SOFR + 50 bps) to the JV in October 2024 and contributed $17 million of extra equity in August 2024, which helped lift equity‑method income from $16 million in 2023 to $33 million in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies not present in the ground truth. While it correctly identifies the increase in resales from $14 million in 2023 to $121 million in 2024 and the $100 million term loan in October 2024, it introduces multiple unsupported figures: 'purchases stayed roughly $1.7 billion', 'payables grew from $363 million to $476 million', 'receivables rose from $9 million to $12 million', 'contributed $17 million of extra equity in August 2024', and 'equity-method income from $16 million to $33 million'. None of these are mentioned in the original answer or supported by the knowledge graph ground truth. (2) Quantitative accuracy is low because while two key numbers (resales: $14M → $121M and $100M loan) are correct, the rest of the numerical claims are fabricated or hallucinated. The $1.7B purchases, payables, receivables, equity contribution, and equity-method income figures have no basis in the provided truth. (3) The reasoning partially captures the deepening financial relationship but overreaches by adding unverified financial arrangements and metrics. The multi-hop synthesis is flawed because it invents data points across multiple financial dimensions (equity, payables, receivables, income) without evidence. (4) Contextual relevance is high because the answer addresses the evolution of the financial relationship and focuses on resales and new arrangements as asked. However, correctness score is low due to significant hallucination of financial data beyond what the ground truth supports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 429,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "\nBetween 2023 and 2024 J&J strengthened its privacy‑compliance framework in direct response to emerging global privacy statutes.  The 2024 filing notes that the company has expanded mandatory data‑privacy training, formalized third‑party risk assessments and integrated privacy controls into its AI‑ and cybersecurity‑investment programs, all to meet new data‑localisation requirements and tighter cross‑border‑data‑flow rules that regulators are imposing worldwide.  This evolution reflects a more proactive, governance‑driven approach to satisfy heightened enforcement and to mitigate the legal and reputational risks associated with the evolving privacy‑law landscape.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but introduces specific details not present in the original ground truth, affecting qualitative accuracy. (1) Correct elements: The core evolution—J&J strengthening its privacy compliance between 2023 and 2024 in response to global privacy laws and cross-border data flow regulations—is consistent with the original answer. The emphasis on global regulatory changes, data localization, and cross-border data flows aligns well. (2) Quantitative accuracy: There are no explicit numbers (e.g., dollar amounts, percentages, headcounts), so no numeric inaccuracies exist; thus, quantitative accuracy is high. (3) Multi-hop reasoning: The model correctly infers an evolution from 2023 to 2024 and synthesizes the increasing global regulatory pressure, which is valid. However, the original answer does not mention 'mandatory data-privacy training,' 'formalized third-party risk assessments,' or 'integration into AI- and cybersecurity-investment programs'—these are plausible elaborations but not supported by the source. The original notes a broader focus on 'evolving technology and data-driven initiatives' and 'multiple vendors and third parties,' which the LLM reinterprets with more specificity than warranted. (4) The shift from 'other territories' in 2023 to 'globally' in 2024 is correctly implied in the LLM’s 'worldwide' framing. However, the original does not describe the approach as 'governance-driven' or explicitly link it to 'reputational risks,' which are interpretive additions. While semantically aligned in direction, the LLM over-specifies implementation actions not confirmed in the ground truth, warranting a score of 7 for correctness and qualitative accuracy. Contextual relevance remains high as all content directly addresses the question’s focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 494,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the company’s estimate of borrower‑litigation losses for Bank BPH fell from **$2.67 billion to $2.46 billion**.  Accordingly, the valuation allowance recorded against the bank’s financing receivables – of which about **$1.71 billion was tied to the litigation in 2023 and $1.52 billion in 2024** – was reduced from roughly **$1.96 billion to $1.59 billion**.  Because of this decline, GE did not need any additional capital contributions in 2024 (unlike the $1.8 billion non‑cash loan‑forgiveness it provided in mid‑2023).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and misrepresents key financial figures. While the total estimated litigation losses are approximately correct ($2.67B in 2023 vs. $2.669B actual; $2.46B in 2024 vs. $2.461B actual), the valuation allowances are incorrectly stated. The LLM claims the valuation allowance was reduced from $1.96B to $1.59B, but the ground truth reports $1.712B in 2023 and $1.517B in 2024 — the LLM conflates valuation allowances with a higher, incorrect total. Additionally, the LLM introduces a claim about a $1.8B non-cash loan forgiveness in mid-2023 and absence of capital contributions in 2024, which is not supported by the original answer and represents unverified, extraneous information. (2) Calculation verification: The sum of $1.712B (valuation) + $957M (other liabilities) = $2.669B (correct for 2023); $1.517B + $944M = $2.461B (correct for 2024). The LLM does not reflect this breakdown accurately and invents a total allowance figure ($1.96B) not present in the truth. (3) Multi-hop reasoning is partially sound — the model recognizes a decline in litigation exposure and links it to valuation allowances — but fails to correctly synthesize the components of the loss and mischaracterizes GE’s actions (e.g., capital contributions, loan forgiveness) not mentioned in the ground truth. (4) The contextual relevance is high as the answer addresses the evolution of GE’s exposure and litigation losses. However, due to significant quantitative errors and introduction of unsupported claims, the correctness and quantitative accuracy scores are reduced. The qualitative accuracy is moderate because core trends (decline in losses and allowances) are captured, but reasoning is flawed by incorrect data aggregation and extraneous details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 491,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "\nIn 2022 the Indoor Garden line was grouped only under the **Hardlines** merchandising department (it generated about $10.1 billion of Hardlines sales). By fiscal 2024 the company still reports Indoor Garden within Hardlines but now lists it as a **stand‑alone merchandising department**, giving it its own net‑sales line and emphasizing its growth; Indoor Garden sales rose modestly to **$10.5 billion in 2024**, indicating that HD is positioning the category as a distinct, higher‑visibility driver within its Primary segment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect and contradicts the ground truth. In 2022, the Indoor Garden product line generated $15,546 million (i.e., $15.546 billion), not $10.1 billion as claimed. The LLM incorrectly states it was already under Hardlines in 2022, while the ground truth shows it was a standalone category then. By 2024, the LLM falsely claims Indoor Garden became a 'stand-alone merchandising department,' when in fact it was integrated into Hardlines—exactly the opposite of what occurred. The reported 2024 sales figure of $10.5 billion is also incorrect and unsupported by the original data. (2) Quantitative accuracy fails on all counts: both sales figures ($10.1B vs $15.546B in 2022; $10.5B in 2024) are wrong, and no correct percentage (10.3%) is mentioned. (3) The multi-hop reasoning is fundamentally flawed: instead of recognizing the shift from standalone to integrated (into Hardlines), the model asserts the reverse—elevating Indoor Garden to standalone status in 2024, which is the opposite of the truth. (4) Contextual relevance is low but not zero because the answer discusses the right product line (Indoor Garden), company (HD), and general theme (categorization change), so some topical alignment exists. However, factual and directional inaccuracies render the response highly misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 374,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "\nFrom 2022 to 2024 the company moved beyond simple cost‑containment and productivity programs to a more layered sourcing approach that now couples those initiatives with selective commodity‑hedging (notably in Hill’s Pet Nutrition) and explicit price‑adjustment actions, while still relying on productivity and sustainability‑focused sourcing to blunt raw‑material price swings. The 2024 disclosures also emphasize managing heightened climate‑related supply‑chain risks through a broader set of sourcing tactics, ongoing efficiency programs and limited hedging, indicating an evolution toward a more diversified risk‑management toolkit for commodity‑price volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of the evolution of Colgate-Palmolive's sourcing strategies from 2022 to 2024. It accurately captures the shift toward a more diversified and proactive approach to managing commodity price volatility, including cost containment, productivity initiatives, and selective hedging. The mention of climate-related supply chain risks in 2024 matches the original answer's emphasis on geopolitical and climatic disruptions. However, the LLM introduces 'Hill’s Pet Nutrition' as a specific unit where commodity hedging is applied, which is not mentioned in the ground truth and cannot be verified from the provided information—this is a minor over-specificity that slightly undermines qualitative accuracy. Additionally, while the original answer explicitly references derivative instruments and local currency borrowings in 2022, the LLM omits these details, instead generalizing to 'selective commodity-hedging' and 'price-adjustment actions.' Despite this, the core evolution in strategy—increased focus on raw material volatility, defensive tactics, and broader risk management—is correctly conveyed. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer remains highly relevant to the question. The reasoning is sound and reflects appropriate multi-hop synthesis across years and strategic shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 389,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "\nTREMFYA’s worldwide sales rose sharply from **$3.15 billion in 2023 to $3.67 billion in 2024** – an increase of roughly **16–17 %**.  This growth was attributed to **continued market expansion in psoriasis and psoriatic arthritis, stronger physician and patient adoption, favorable patient‑mix, and share‑gain momentum** (the company specifically cites “market growth and share gains” as the drivers of TREMFYA’s performance).  Additional contributions came from the rollout of new indications (e.g., ulcerative colitis, Crohn’s disease) and the subcutaneous formulation, which helped sustain its upward trajectory despite modest declines in other immunology products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports TREMFYA's sales of $3.15 billion in 2023 and $3.67 billion in 2024, which aligns with the ground truth values of $3,147 million and $3,670 million (rounded appropriately). The stated growth of roughly 16–17% matches the exact 16.6% increase in the original answer. The calculation is accurate: (3,670 - 3,147) / 3,147 ≈ 16.6%. (2) Quantitative accuracy is perfect—values are correctly converted from millions to billions, and percentage change is properly estimated. (3) The qualitative reasoning is strong: the LLM identifies market expansion in psoriasis and psoriatic arthritis, favorable patient mix, and share gains as growth drivers, which are consistent with the original answer. It adds additional context not in the ground truth—new indications (ulcerative colitis, Crohn’s) and subcutaneous formulation—which, while plausible, are not mentioned in the original knowledge base and thus represent minor over-enrichment. However, this does not contradict the truth and may reflect broader public information. The core multi-hop synthesis—linking sales growth to operational performance and market dynamics across 2023–2024—is sound. (4) The answer is highly relevant, fully addressing both parts of the question: sales performance evolution and contributing factors. The only minor deviation is the inclusion of extra details beyond the ground truth, but the key facts, numbers, and reasoning are correct and well-synthesized. Hence, a correctness score of 9 is warranted—excellent but not perfectly aligned in every qualitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 437,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "\nThe 2023 filing re‑classified A+E’s audience metrics from the main “Linear Networks” subscriber tables into a separate “Equity Investments” table and began citing the figures from internal management reports rather than Nielsen estimates.  Disney’s ownership stake in A+E stayed at 50 % (jointly held with Hearst), but the way the partnership is now presented means the subscriber numbers are disclosed only as part of the equity‑method investment disclosures and the financial return is shown solely as “Equity in the income (loss) of investees.”",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions affecting completeness. (1) Quantitatively, all key facts are accurate: the 50% ownership stake (jointly held with Hearst), the shift in reporting structure in 2023, and the use of internal management reports instead of Nielsen estimates are consistent with the original answer. The years (2022 vs 2023) are correctly referenced. (2) However, the LLM omits the specific subscriber numbers—69 million in 2022 and 58 million in 2023—which are central to the question about how the structural change affected subscriber reporting. While it correctly notes the change in disclosure location (from 'Linear Networks' to 'Equity Investments'), the absence of actual figures reduces completeness. (3) The reasoning is sound: it correctly identifies the shift from a partnership to an equity-method investment and explains the financial reporting impact—showing returns under 'Equity in the income (loss) of investees'. This reflects proper multi-hop synthesis between ownership structure, accounting treatment, and disclosure practices. (4) Contextually, the answer is highly relevant, directly addressing how the relationship change affected both subscriber number reporting and financial stake presentation. The omission of exact subscriber counts prevents a top score, but the core conceptual and factual framework is accurate. Hence, high scores across the board with a slight deduction in correctness and qualitative accuracy for missing key data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 423,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "\nBetween 2022 and 2023 the AerCap investment moved from an **$865 million unrealized loss** (reported in 2022 under “Investment in and note with AerCap realized and unrealized gain (loss)”) to a **$129 million realized gain** in 2023, reflecting the partial sale of the equity stake and the write‑up of the remaining position. By the end of 2023 GE had sold all of its AerCap common shares, leaving only a senior note; therefore in 2024 there were **no further realized or unrealized gains or losses from AerCap**—the note is carried at cost (with any changes shown only as interest income), so the company’s financial impact from AerCap essentially ceased after 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the LLM incorrectly states that GE reported a $129 million *realized* gain in 2023, while the ground truth specifies it was an *unrealized* gain of $129 million. This mischaracterization of the gain type is a critical error. Additionally, the LLM introduces a figure from 2022 ($865 million unrealized loss) that is not relevant to the question, which specifically asks about 2023–2024. (2) The most severe error is the claim that 'in 2024 there were no further realized or unrealized gains or losses from AerCap' because GE sold all shares and only held a senior note carried at cost. This directly contradicts the ground truth, which states that in 2024, GE recognized a $5.2 billion *decrease in gains* compared to 2023, with AerCap being a primary contributor—indicating a material negative financial impact, not zero impact. (3) The reasoning is flawed: the LLM assumes no valuation changes on the note means no financial impact, but the ground truth shows AerCap still had a significant negative effect on GE’s financials in 2024 through reduced gains. (4) While the LLM correctly identifies AerCap as a key entity and focuses on the right time frame (2023–2024), it fails the multi-hop synthesis by not connecting the decline in gains in 2024 to AerCap’s contribution. The contextual relevance is moderate because it addresses the evolution of the relationship, but the core financial conclusion is factually wrong. Thus, the answer is mostly incorrect despite some contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 436,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard refined its multi‑layered security model by adding explicit, proactive monitoring and performance‑standard requirements that target risks arising from third‑party service providers, and by embedding those controls into new ecosystem platforms such as VCN, Mastercard Send and Track BPS that are delivered through partnerships with fintechs, central banks and other external partners.  This evolution shows that the company is moving from a generic cyber‑risk posture to a strategic, ecosystem‑wide approach that treats third‑party integration as a core security concern, demonstrating a pre‑emptive response to emerging cyber threats.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Mastercard's security approach from 2022 to 2024. It correctly identifies that Mastercard enhanced its multi-layered security framework to explicitly address third-party service provider risks by 2024, which was not explicitly mentioned in 2022. The answer accurately reflects the strategic shift toward an ecosystem-wide security posture. However, the LLM introduces specific platform names (VCN, Mastercard Send, Track BPS) and specifies that performance-standard requirements and proactive monitoring were added, which are not present in the original ground truth. While these details are plausible and contextually consistent, they go beyond the documented evidence in the knowledge graph, making the response slightly over-specified. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. The reasoning is sound and multi-hop synthesis is appropriate—comparing two time points and inferring strategic intent from changes in risk management focus. The answer is fully contextually relevant, directly addressing all parts of the question. The minor over-specification prevents a perfect score, but the core facts, timeline, and strategic interpretation are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 367,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "\nTarget has continued to meet its debt‑leverage covenant in both years.  In 2022 it swapped its $2.5 bn revolving line that was set to expire in 2023 for a new $3 bn five‑year unsecured facility (now maturing in 2028) and added a $1 bn 364‑day facility, and the company repeatedly states it is “in compliance with these covenants” and expects to remain so.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that in 2022, Target swapped a '$2.5 bn revolving line' set to expire in 2023 — this is not supported by the ground truth, which mentions a $3.0 billion facility expiring in October 2026 (not 2023) and no prior $2.5 billion facility. The LLM also misrepresents the timing of the credit facility changes, implying the $3.0 billion facility was replaced in 2022, while the ground truth states the extension to 2028 occurred in 2023. The $1.0 billion 364-day facility is correctly identified, but the LLM incorrectly implies it was added in 2022, when it was obtained in 2023. (2) Quantitative accuracy is partially correct: the $3.0 billion and $1.0 billion amounts are accurate, but the expiration dates (2026 vs. 2028, and 2024 for the 364-day facility) are misrepresented in context. The claim about a 2023 expiration for the old facility is false. (3) The multi-hop reasoning is partially sound — the model correctly infers ongoing compliance and links covenant adherence to facility changes — but the synthesis is flawed due to incorrect temporal attribution of events. It conflates 2022 and 2023 developments. (4) Despite these errors, the core message — that Target remained in compliance with its debt leverage covenant despite changes to its credit facilities — is correct, and the answer addresses the evolution of compliance and facility changes, maintaining contextual relevance. However, significant factual and chronological inaccuracies reduce correctness and quantitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 437,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "\nThe 2023 filing warned only of generic “social and ethical” concerns that AI could damage the brand, whereas the 2024 filing spells out concrete, regulator‑driven risks: emerging AI‑specific rules (e.g., the EU AI Act, DSA), heightened liability for inaccurate, biased or copyrighted generative‑AI outputs, and the need for extensive testing, governance and compliance investments to mitigate those technical and legal exposures. In short, the risk has shifted from a broad reputational warning to a detailed, compliance‑heavy exposure tied to accuracy, bias, toxicity, privacy and copyright of generative‑AI products such as Agentforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Salesforce's AI-related risks from 2023 to 2024 with strong semantic equivalence to the ground truth. It correctly identifies that in 2023, risks were more generic, focusing on reputational concerns related to 'social and ethical' issues, while in 2024, the risks became more concrete and compliance-driven, including regulatory frameworks like the EU AI Act and DSA, liability for biased, inaccurate, or copyrighted AI outputs, and increased costs for governance, testing, and compliance. These align with the original answer’s key points about expanded risk profiles, legal liabilities, and AI-specific costs. The only minor shortcoming is that the LLM answer does not explicitly mention Salesforce’s prior risk related to third-party integrations and customer warranty expectations in 2023, which was a specific element of the original answer. However, it correctly characterizes the shift in risk nature. All entities (Agentforce, EU AI Act, DSA) and years (2023, 2024) are accurate. There are no numerical inaccuracies (no calculations required), and the reasoning correctly synthesizes a multi-hop comparison across years and risk domains. The answer is fully contextually relevant and conveys the core transformation in risk profile effectively.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 365,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Lowe’s moved beyond the baseline two‑day delivery that was already in place for most parcel‑eligible items.  The company expanded its gig‑partner network to offer same‑day delivery on select products and, for the first time, can deliver major appliances next‑day to almost every U.S. ZIP code.  In addition, it finalized a market‑based delivery model that adds extra distribution capacity for big‑and‑bulky items, giving customers faster, broader‑coverage shipping options.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key improvements in Lowe's delivery capabilities between fiscal years 2023 and 2024. It correctly identifies that two-day delivery was the baseline in 2023 and that enhancements were made in 2024, including next-day delivery for major appliances in nearly every U.S. ZIP code—this aligns with the ground truth. However, the LLM introduces 'same-day delivery on select products' via a gig-partner network and a 'market-based delivery model for big-and-bulky items,' which are not mentioned in the original answer. While these details may reflect real initiatives, they are not supported by the provided ground truth and represent additional claims not present in the source. The core facts—improved speed (two days or less) and expanded next-day appliance delivery—are accurately conveyed. The reasoning is sound and contextually relevant, with only minor overreach in specificity beyond the original answer. Quantitative and temporal references (fiscal years, delivery timeframes) are accurate, though no explicit numbers (e.g., percentages, ZIP code counts) are provided in either version. Thus, the answer is factually consistent on major points but includes unverified supplementary details, warranting a score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 353,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "\nThe February 2021 sale of Dermstore produced a one‑time $335 million pretax gain that lifted 2021 operating income, but Dermstore represented less than 1 % of Target’s consolidated revenue, so its contribution to total sales was essentially negligible and did not recur. Consequently, in 2022—when operating income was $3.85 billion (without any Dermstore gain)—and again in 2023—when operating income rose to $5.71 billion—Target’s revenue and operating performance reflect the post‑sale period, with the sale’s financial impact now confined to that single, non‑recurring gain.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $335 million pretax gain from the February 2021 sale of Dermstore LLC and notes its non-recurring nature, which aligns with the ground truth. It accurately states that Dermstore represented less than 1% of Target's consolidated revenues, supporting the minimal impact claim. However, the LLM introduces specific operating income figures for 2022 ($3.85 billion) and 2023 ($5.71 billion) that are not present in the original answer and are potentially misleading—these numbers may reflect actual operating income but were not part of the ground truth and could imply a level of detail not supported by the source. The original answer emphasizes that Dermstore had no significant post-sale financial impact in either year, which the LLM captures in spirit but slightly misrepresents by focusing on Target’s total operating income without clarifying that Dermstore’s standalone contribution remained negligible. (2) The date of sale (February 2021) and the $335 million pretax gain are correctly reported. The format ($335 million) matches. However, the inclusion of Target’s total operating income for 2022 and 2023 introduces quantitative data not verified in the ground truth, reducing quantitative accuracy slightly. (3) The reasoning is mostly sound: the LLM correctly infers that because the gain was non-recurring and Dermstore was a negligible contributor, there was no ongoing financial impact in 2022 or 2023. However, it fails to explicitly state that Dermstore continued to represent less than 1% of consolidated revenues, operating income, and net assets in both 2022 and 2023—a key point in the original answer. This omission reduces qualitative accuracy. (4) The answer is contextually relevant and addresses the evolution of financial impact over time, correctly concluding no meaningful change occurred post-sale. The core message aligns with the ground truth, but lacks full completeness on the multi-hop verification that Dermstore remained below the 1% threshold in both years. Hence, correctness is reduced to 7 due to partial omission of key qualifying details and introduction of unverified aggregate figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 583,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Salesforce shifted Data Cloud from a supplemental data‑integration layer to the central “hyperscale, trusted data engine” that powers the entire Customer 360 platform and fuels AI‑driven outcomes across Sales, Service, Marketing and Commerce. The 2024 filing positions Data Cloud as the foundation for Agentforce and industry‑specific clouds, using it to differentiate Salesforce in a crowded cloud‑AI market while also exposing the company to new competitive pressures around pricing, data‑privacy and AI‑model governance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Data Cloud's strategic positioning between 2023 and 2024. It accurately reflects the shift from a data-integration layer to a central 'hyperscale, trusted data engine' (matching the 2023 description in the ground truth) and correctly identifies its expanded role in powering Customer 360, AI-driven outcomes, and new offerings like Agentforce and industry-specific clouds—consistent with the 2024 emphasis on broader platform integration. The mention of increased competitive pressures in the cloud-AI space aligns with the 2024 filing’s note on market uncertainty and rising competition. However, the LLM omits a key qualitative shift highlighted in the ground truth: Salesforce’s explicit acknowledgment of limited experience in pricing consumption-based models, which signals strategic risk in monetization. While the LLM mentions competitive pressures around pricing, it does not clearly convey this specific internal challenge related to business model execution. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and all entities (Data Cloud, Salesforce, Agentforce, Customer 360) and timeframes (2023 to 2024) are correctly referenced. The reasoning is sound and synthesizes multi-hop concepts—linking product evolution, competitive landscape, and strategic risk—though slightly less precise on the monetization aspect. Contextual relevance is excellent, directly addressing the question’s focus on strategic positioning within Salesforce’s offerings and competitive dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 433,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Lowe’s moved from **designating forward interest‑rate swaps as cash‑flow hedges**—a $1.3 bn notional that was settled when the 2023 Notes were issued and produced a $247 m cash receipt (with the effective portion recorded in OCI and later re‑classified to earnings as the hedged interest expense accrued)—to **using the same type of swaps as fair‑value hedges** of its existing fixed‑rate debt.  In 2024 the Company held $850 m of fixed‑to‑floating swaps and elected the shortcut method, which assumes perfect effectiveness; consequently the fair‑value changes of those swaps offset the carrying amount of the hedged debt and **have no net impact on earnings**.  Thus, the hedge designation shifted from cash‑flow (where gains/losses flow through OCI and eventually earnings) to fair‑value (where the offset eliminates earnings volatility), and the financial impact changed from a recognized $247 m gain (and related OCI reclassifications) in 2023 to essentially zero earnings effect from the remaining fair‑value swaps in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the shift in hedge designation from cash flow hedges in 2023 to fair value hedges in 2024, and accurately describes the accounting implications: cash flow hedges impacting OCI with subsequent reclassification to earnings versus fair value hedges using the shortcut method resulting in no net earnings impact. This reflects sound multi-hop reasoning and correct qualitative understanding of the accounting evolution.\n\nHowever, there are key quantitative inaccuracies. The original answer states the 2023 forward interest rate swap had a notional amount of $2.0 billion, but the LLM reports $1.3 billion—this is a significant discrepancy. Additionally, while the $247 million cash receipt upon settlement is correctly reported, the LLM incorrectly implies this was a 'gain' recognized in earnings, whereas the ground truth specifies it was recorded in OCI first and then reclassified, which affects the timing and presentation but not the ultimate earnings impact. The 2024 notional amount is stated as $850 million in the LLM answer, but the original answer does not specify any notional amount for 2024 swaps, so this figure is unsupported and likely incorrect.\n\nEntity accuracy and contextual relevance are strong: LOW is correctly identified, years (2023–2024) are accurate, and the question’s focus on hedge designation and financial impact is fully addressed. The explanation of the shortcut method and its effect on earnings is semantically equivalent and correct.\n\nOverall, the core reasoning and directional conclusion are correct, but the incorrect notional amounts and unsupported specifics reduce quantitative accuracy, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 464,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "\nBetween 2022 and 2023 Target shifted from merely showcasing a broad list of owned‑brand names (which represented about one‑third of sales) to treating the owned‑brand portfolio as a strategic growth engine.  The 2023 strategy explicitly calls for **strengthening and curating** that portfolio—adding exclusive, higher‑margin brands and deepening signature partnerships—to differentiate Target’s assortment, boost traffic and market‑share gains, and support its broader objectives of relevance, sustainability and technology‑enabled shopping.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Target's strategy from 2022 to 2023. It correctly identifies the shift from merely listing owned brands (with a correct qualitative note that they represented about one-third of sales, aligning with Target's public disclosures though not explicitly in the ground truth) to strategically strengthening and curating the portfolio in 2023. The strategic objectives—differentiating assortment, driving traffic, market share, and supporting broader goals—are consistent with the ground truth's emphasis on 'delighting with newness, style, and value' and driving growth. The mention of exclusive, higher-margin brands and signature partnerships adds contextual detail that aligns with Target’s known strategy (e.g., collaborations like Threshold, Good & Gather) and enhances the answer without introducing inaccuracies. The only minor gap is that the ground truth emphasizes the 'core element of overall strategy' framing more explicitly, which the LLM implies but doesn’t quote directly. There are no calculation errors, and all entities (Target, owned brands, 2022–2023 timeframe) are correct. The reasoning is sound, showing a clear multi-hop synthesis between descriptive presence in 2022 and strategic lever in 2023. Quantitative accuracy is high: while 'one-third of sales' is not in the original answer, it is a well-known figure from Target’s reporting and does not contradict the ground truth, which states 'over 40 brands' contributing significantly—thus acceptable as contextual enrichment. Overall, the answer is semantically equivalent and slightly enriched, with excellent contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 454,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "\nFrom 2022 to 2023 GM moved beyond isolated software‑enabled services such as OnStar and Super Cruise to roll out a full‑stack, over‑the‑air software platform that will be standard on most of its vehicles.  The 2023 filing notes that this platform will deliver new subscription‑based features—security, climate and comfort controls, personal themes, and an EV‑ownership experience—while integrating with the company’s expanding EV‑charging ecosystem and supporting future services like GM Defense.  This evolution signals a strategic, heavy investment in scalable digital solutions that can generate recurring revenue and underpin GM’s EV and autonomous‑vehicle growth agenda.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of GM's software-enabled services from 2022 to 2023. It accurately captures the shift from general descriptions in 2022 (e.g., OnStar, Super Cruise as isolated services) to a more strategic, platform-based approach in 2023 with over-the-air (OTA) updates and scalable digital solutions. The mention of subscription-based features like security, climate control, personal themes, and EV ownership experience is consistent with the 2023 filing’s emphasis on enhanced digital services. The integration with the EV-charging ecosystem and forward-looking applications (e.g., GM Defense) reflects accurate extrapolation of GM’s strategic direction.\n\nQuantitatively, there are no specific numbers, dates, or financial figures in either the original or LLM answer beyond '2022' and '2023', which are correctly used. The reference to 'select 2024 models' in the ground truth (e.g., Cadillac LYRIQ, Chevrolet Silverado EV) is not explicitly mentioned in the LLM answer, which is a minor omission affecting completeness. However, the LLM correctly infers that the platform is being rolled out across future vehicles.\n\nQualitatively, the reasoning is sound and reflects multi-hop synthesis: connecting the evolution of software services to broader strategic goals like recurring revenue, EV growth, and autonomous vehicles. The LLM adds value by identifying 'recurring revenue' as a motivation, which is implied but not stated in the original, and this is a reasonable interpretation. However, it slightly overreaches by stating the platform 'will be standard on most of its vehicles'—a claim not directly supported in the ground truth, which only confirms deployment on select 2024 models. This affects precision but not core correctness.\n\nContextually, the answer is highly relevant, addressing all parts of the question: evolution in service offerings, platform deployment, and implications for investment in scalable digital solutions. The conclusion about 'strategic, heavy investment' is well-supported.\n\nOverall, the answer is factually accurate and contextually strong, with only minor omissions and one slight overstatement, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 603,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Optimized Application Experiences/Observability category’s revenue rose 14%—from $581 million to $661 million, an $80 million increase—with ThousandEyes cited as a key driver of that growth. This reflects a noticeable uptick in ThousandEyes’ contribution to the segment’s total sales over the two‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. It states that the Observability category grew from $581 million to $661 million (an $80 million increase), implying a base of $581M in 2022. However, the ground truth does not provide absolute revenue figures—only the year-over-year increases ($75M in 2022 and $80M in 2023). The $581M and $661M figures are fabricated or misattributed and are not supported by the original answer. While the $80 million increase and 14% growth for 2023 align with the ground truth, the 11% growth in 2022 is omitted, and the LLM incorrectly applies the 14% growth to the entire two-year period rather than specifying it as the 2023 figure. (2) The calculation of $80M increase is correct per the ground truth for 2023, but the LLM retroactively infers absolute revenue values not present in the original data, which is a critical error. The 14% growth is correctly attributed to 2023, but the absence of 2022’s 11% growth and $75M increase undermines completeness and accuracy. (3) The reasoning partially captures the upward trend in ThousandEyes’ contribution, correctly identifying it as a key growth driver in 2023. However, it fails to mention Intersight and monitoring/analytics offerings as co-drivers, and it does not explicitly compare 2022 and 2023 growth increments as required by the question. The multi-hop synthesis is weak—while it infers increased contribution, it does so using incorrect base figures. (4) Despite the numerical inaccuracies, the answer is contextually relevant and addresses the evolution of ThousandEyes’ contribution with the right directionality (increasing). The qualitative assessment is lowered due to unsupported data inference, but relevance remains high as the core theme—growing contribution—is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 486,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "\nIn the 2023 Form 10‑K, Amendment No. 4 to the Executive Severance Plan is listed as a distinct exhibit (Exhibit 10.34), but the 2024 filing no longer presents it as a separate exhibit—it is only referenced within the general description of the restated plan. This shift shows Lockheed Martin is consolidating older amendments into the core plan document and de‑emphasizing them as stand‑alone exhibits, indicating a more streamlined disclosure strategy that focuses on the most recent, restated version rather than individual prior amendments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies that Amendment No. 4 was a standalone exhibit (Exhibit 10.34) in the 2023 10-K and is no longer a separate exhibit in the 2024 10-K. This matches the original answer. (2) The dates and exhibit numbers are not contradicted—the reference to the September 2022 10-Q is omitted in the LLM answer but not misstated, so this is a minor omission rather than an error. (3) The reasoning about a shift toward consolidation and a streamlined disclosure strategy is sound and logically inferred from the change in exhibit treatment. The LLM correctly synthesizes the evolution in disclosure approach across two filings. (4) The only shortcoming is that the LLM does not mention that Amendment No. 4 is now grouped with Amendments 2, 3, 5 in a sequence in the 2024 filing, which adds context about integration into a broader historical sequence. This detail is present in the ground truth and contributes to the 'integrated' narrative. While the LLM captures the essence of consolidation, it misses this specific multi-hop detail, slightly weakening the qualitative accuracy. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score but not perfect due to the omitted detail about the grouping of amendments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 373,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "\nFrom 2023 to 2024 JPMorgan’s Standardized CET1 capital ratio edged up from roughly **15.0 % to 15.7 %**, driven by higher CET1 capital and only modest growth in risk‑weighted assets.  Its Tier 1 leverage ratio remained essentially unchanged at **about 7.2 %** (well above the 4 % minimum), and the supplementary leverage ratio stayed at **6.1 %**, comfortably exceeding the 5 % regulatory floor.  Thus, the firm strengthened its CET1 position while maintaining ample leverage buffers throughout the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific figures not present in the ground truth, particularly the 2024 Standardized CET1 capital ratio of 15.7%, which is not mentioned or implied in the original answer. The ground truth only provides the 2023 CET1 ratio (15.0%) and the 2024 Tier 1 leverage ratio (7.2%), but does not state the 2024 CET1 ratio or any trend in it. The LLM incorrectly implies a year-over-year increase in CET1 from 15.0% to 15.7%, which cannot be verified from the ground truth and thus constitutes a factual overreach. (2) The Tier 1 leverage ratio of 7.2% in 2024 matches the ground truth and is correctly noted as above the 4.0% requirement. However, the LLM adds a new metric—supplementary leverage ratio of 6.1% exceeding a 5% floor—which is not mentioned in the original answer and introduces unverified data. (3) The reasoning is partially sound: the conclusion that JPMorgan maintained compliance is consistent with the ground truth, and the synthesis of capital strength relative to requirements is reasonable. However, the multi-hop reasoning fails because it fabricates data points (2024 CET1 ratio, supplementary leverage ratio) rather than strictly relying on the provided information. (4) The contextual relevance is high because the answer addresses the evolution of capital ratios and compliance, but the quantitative accuracy is low due to unsupported numbers. The qualitative accuracy is moderate because the logic and entity identification (JPMorgan, correct metrics, correct years) are accurate, but the answer goes beyond the evidence. Correctness score is 6 due to correct core compliance conclusion and one verified number (7.2%), but penalized for significant invented data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 469,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "\nBetween 2022 and 2023 GM Financial moved from being a largely “behind‑the‑scenes” financing unit to a clearly‑identified, stand‑alone reportable segment in the consolidated statements.  In the 2023 filing (Note 23 Segment Reporting, page 98) the segment shows $13.4 bn of revenue and $5.0 bn of EBT‑adjusted earnings, and its interest income ($146 m), interest expense ($‑950 m), allowance for loan losses and related financing‑activity cash flows are disclosed separately in the consolidated income‑statement and cash‑flow statement (pages 61‑65).  Compared with the 2022 presentation, the segment’s share of total assets, cash‑flow from financing activities and earnings before income taxes has grown, and its results are now presented net of eliminations within consolidated net income and EBT, reflecting a tighter integration of GM Financial’s operations into GM’s overall financial reporting.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right topic and showing an attempt at multi-hop reasoning. (1) The claim that GM Financial became a 'stand-alone reportable segment' in 2023 is incorrect — GM Financial was already a reportable segment in 2022 (referred to as 'GM Financial' or 'FinCo'), so the characterization of a shift from 'behind-the-scenes' to a reportable segment is false. (2) The quantitative details such as $13.4 billion revenue and $5.0 billion EBT-adjusted earnings for GM Financial in 2023 are not supported by the ground truth and appear fabricated; the original answer does not include any specific financial figures, suggesting such precision was not present in the source documents. Similarly, the cited interest income ($146M), interest expense ($950M), and page references (e.g., Note 23, page 98) are overly specific but unverifiable from the ground truth and likely incorrect. (3) The qualitative evolution described in the original answer focuses on the increased disclosure clarity around tax adjustments due to consolidation — specifically, the impact on deferred tax positions and income tax provisions — which the LLM answer completely misses. Instead, it emphasizes structural integration and growth in financial metrics, which is not aligned with the documented change. (4) While the LLM answer correctly infers tighter integration into financial reporting, it misrepresents the nature and evidence of that evolution. The reasoning is plausible but not grounded in the actual disclosures. Thus, while contextually relevant and attempting synthesis, the answer fails on factual and quantitative accuracy, which are critical in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 474,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "\nCostco continues to account for step‑rent and other periodic rent increases that are tied to price indices or sales volume as **variable lease payments**—they are recognized only when the underlying event occurs and are not included in the lease‑asset/liability measurement. Both the 2022 and 2024 filings disclose that such escalations are allocated on a **straight‑line basis over the lease term (including any renewal options that are reasonably certain to be exercised)**, with no material change in policy; the 2024 disclosure merely refines the wording and adds a note about the absence of residual‑value guarantees, but the recognition and measurement treatment remains the same.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about accounting treatment. The ground truth states that in 2022, step-rent provisions based on price indices or sales volume were accounted for on a straight-line basis, but by 2024 there was a shift to treating them as variable lease payments, no longer straight-lined. However, the LLM claims that both in 2022 and 2024, such increases are accounted for on a straight-line basis and that there was no material change in policy—directly contradicting the ground truth. This misrepresents the evolution of the accounting treatment, which is the central point of the question. The LLM incorrectly asserts that variable lease payments are recognized only when the underlying event occurs and are excluded from lease asset/liability measurement, but then contradicts itself by saying they are still straight-lined—this is conceptually inconsistent under ASC 842. The contextual relevance is moderate because it addresses lease accounting and the relevant factors (price indices, sales volume), but the reasoning is flawed and entity references (implied company) are not explicitly confirmed. There are no numeric values to verify, so quantitative accuracy is based on conceptual correctness of financial treatment, which is inaccurate. The multi-hop synthesis fails because the model does not correctly identify a change over time, instead asserting consistency where there was a policy shift. Overall, the answer conveys the opposite of the ground truth despite using plausible accounting terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 424,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "\nThe company’s disclosures show a modest reduction in the expected cash outflows.  In the 2023 outlook the qualified pension plan’s 2025 payment was projected at **$1.86 billion**, but the 2024 outlook lowers that to **$1.80 billion**.  Likewise, the long‑term aggregate of **$10.0 billion** projected for the 2029‑2033 period in 2023 is revised to about **$9.99 billion** for the 2030‑2034 window in the 2024 filing, indicating a slight decline in the overall future funding obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in key numbers and misrepresents the trend. According to the ground truth, the 2025 projected payment remained unchanged at $1,860 million from 2023 to 2024. However, the LLM incorrectly states that the 2025 projection decreased from $1.86 billion to $1.80 billion, which is factually wrong. The long-term projection is partially correct: the LLM correctly notes a decrease from $10.0 billion to $9.99 billion, though it mischaracterizes the original period (2029–2033 vs. 2030–2034 in the new filing), which is a minor shift but still a detail mismatch. (2) Quantitative accuracy is low: the $1.80 billion figure for 2025 is incorrect—ground truth shows no change at $1,860 million. The long-term amounts are close ($10,020M vs $10.0B and $9,990M vs $9.99B), so those are acceptable within rounding, but the 2025 drop is a critical error. (3) The multi-hop reasoning is partially sound—comparing projections across years and identifying a slight decline in long-term obligations is valid—but the conclusion is undermined by incorrect data for 2025. The model fails to recognize that the 2025 obligation did not decrease. (4) Contextual relevance is high as the answer addresses both time horizons and discusses the evolution of obligations. However, due to the major error in the 2025 projection, the correctness score is low despite some accurate elements in the long-term trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 395,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "\nIn the 2023 filing JPMorgan merely flagged that “funding costs could be negatively affected by actions taken to satisfy liquidity‑coverage and net‑stable‑funding‑ratio requirements and to address obligations under its resolution plan,” linking those obligations to the need to pre‑position liquidity in its non‑U.S. subsidiaries. By the 2024 filing the language was expanded: the bank now explicitly ties any credit‑rating downgrade or stress‑buffer increase to higher funding spreads, stresses the importance of maintaining additional liquidity buffers in its subsidiaries to meet resolution‑plan requirements, and notes that upcoming regulatory changes (e.g., Basel III revisions and the GSIB surcharge) could further raise the cost of complying with those resolution‑plan‑related liquidity standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in JPMorgan Chase's disclosures between 2023 and 2024 with strong fidelity to the original answer. (1) It correctly identifies that in 2023, the firm highlighted resolution plan obligations affecting funding costs and liquidity due to LCR and NSFR requirements and non-U.S. liquidity pre-positioning—matching the ground truth. In 2024, it accurately notes an expansion in disclosures to include dynamic regulatory changes (e.g., Basel III, GSIB surcharge), credit-rating downgrades, and stress-buffer increases impacting funding spreads and liquidity—consistent with the shift toward regulatory and macroeconomic uncertainty in the original. (2) There are no numeric values, dates, or financial figures in dispute; all references to years (2023, 2024) and regulatory frameworks (Basel III, GSIB) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure tone and content across two years, connects resolution plans to liquidity and funding costs, and integrates external regulatory developments. The only minor shortcoming is that the LLM does not explicitly mention 'systemic events' or 'economic effects of systemic events' as a driver of regulatory change, which is a specific element in the original 2024 disclosure expansion. However, referencing 'upcoming regulatory changes' in the context of Basel III and GSIB surcharges implies this broader context. (4) The answer is fully relevant, directly addressing the evolution in liquidity risk management strategies and funding cost considerations. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a slight omission in contextual nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 475,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "\nBetween 2022 and 2023 Optum Rx’s accounts‑receivable rose from **$7.1 bn to $8.6 bn**, signalling larger amounts due from its pharmacy‑network payers, and the company recorded **no material bad‑debt expense**. Revenue is still recognized on a **gross basis when prescriptions are dispensed**, but the business now carries a **$11.8 bn backlog of future performance‑obligation revenue**—about half of which is expected to be recognized in the next three years—reflecting a shift toward longer‑term contracts and more revenue to be earned over time. (Pages 46 & 47)",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly reports the increase in accounts receivable from $7.1 billion in 2022 to $8.6 billion in 2023, which matches the ground truth and addresses a key part of the question. It also correctly states that revenue is recognized on a gross basis at the point of prescription dispensing, aligning with the original answer’s description of the gross revenue model. However, the LLM introduces new information not present in the ground truth: a '$11.8 bn backlog of future performance-obligation revenue' and 'no material bad-debt expense'. These details are not mentioned in the original answer and cannot be verified against the provided ground truth, suggesting potential hallucination or misattribution. 2) Quantitatively, the $7.1 billion and $8.6 billion figures are accurate and correctly attributed to the respective years. The format variation (bn vs billion) is acceptable. However, the $11.8 billion figure lacks corroboration and may be incorrect in this context. 3) The reasoning is partially sound in linking rising receivables to ongoing operations under the gross revenue model, but the introduction of a 'backlog of future performance obligations' implies a structural shift in revenue recognition that is not supported in the original answer. The ground truth states the model 'remained aligned' with the prior year, contradicting the implication of a significant shift toward long-term contracts. This misrepresents the evolution of the financial structure. 4) The answer is contextually relevant and addresses revenue recognition and accounts receivable, but adds unsupported details that distort the factual picture. While core financials are correct, the qualitative inaccuracy in describing a strategic shift lowers overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 478,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "\nUPS’s quantitative exposure to interest‑rate risk through floating‑to‑fixed swaps remained modest, with a $4 million cumulative fair‑value hedge adjustment on long‑term debt and a $5 million reclassification of AOCI gains to interest expense in 2024 (down from $10 million in 2023). At the same time, the company’s strategy evolved to rely more on cash‑flow swaps and forward‑starting interest‑rate agreements to lock in fixed rates on future debt issuances, reflecting a more targeted approach to managing rising borrowing costs while keeping the overall hedge footprint limited.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that UPS had a $28 million notional amount for Floating to Fixed Interest Rate Swaps in 2022, but the LLM does not mention this figure at all. Instead, it introduces unrelated figures such as a $4 million fair-value hedge adjustment and $5 million reclassification of AOCI gains in 2024—metrics not present in the original answer and not equivalent to notional exposure. These numbers are factually incorrect in the context of the question. (2) The LLM claims data for 2023 and 2024 related to AOCI reclassifications and fair-value adjustments, but the original answer provides no such information, nor does it reference these specific financial line items. There is no support for the $10 million in 2023 or the comparative decline. The core quantitative metric—$28 million notional in 2022—is entirely missing, and the 2024 strategy shift is not tied to any updated notional amount, making the quantitative evolution impossible to assess. (3) The multi-hop reasoning is flawed. The question asks for evolution in both quantitative exposure and strategic approach between 2022 and 2024. While the LLM correctly identifies a strategic shift toward more active interest rate management (e.g., using cash-flow swaps and forward-starting agreements), this is only partially aligned with the original answer’s claim of a broader strategy to manage the fixed/floating mix. However, the LLM invents specific instruments and financial impacts not present in the ground truth, undermining the qualitative accuracy. (4) Contextual relevance is moderate—the response addresses interest rate risk and hedging strategy, which is relevant—but due to fabricated numbers and misrepresentation of UPS’s disclosures, the overall correctness is very low. The answer fails on core factual content and thus scores poorly on quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 523,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "\nBetween 2022 and 2023 GM deepened its partnership with LG Energy Solution by expanding the equally‑owned Ultium Cells LLC battery‑cell joint venture—adding production sites in Ohio, Tennessee and Michigan to feed its growing EV lineup.  At the same time the Chevrolet Bolt battery recall was broadened to cover additional model years, and GM recorded a $2.6 billion accrual for recall costs, of which $1.6 billion was reimbursed by LG and a $0.6 billion balance remained on the books as of 31 Dec 2023, showing both the growth of the JV and the shifting financial exposure tied to the LG‑related recall.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $2.6 billion recall accrual and $1.6 billion reimbursed (treated as receivable) from LG are accurately reported. The mention of a $0.6 billion balance remaining on the books is logically derived ($2.6B - $1.6B = $1.0B? Wait—this is a discrepancy: $2.6B - $1.6B = $1.0B, not $0.6B). This is a critical error in calculation or reporting. However, the original answer does not specify the remaining balance, so while the $0.6B figure is incorrect, it may stem from misinterpretation of filings. This reduces quantitative accuracy slightly, but since the core figures ($2.6B and $1.6B) are correct, the score remains high. (2) Completeness: the answer addresses both joint venture expansion (Ultium Cells LLC, with locations) and recall-related costs, satisfying both parts of the multi-hop question. (3) Entity accuracy is strong: GM, LG Energy Solution, Ultium Cells LLC, Chevrolet Bolt EV recall—all correctly identified with correct time frame (2022–2023). (4) Reasoning is sound: the dual narrative of strategic growth and financial liability is well synthesized, capturing the evolution from collaboration to cost-sharing due to defects. The incorrect remaining balance ($0.6B vs correct $1.0B) is a notable but isolated error. (5) Semantic equivalence is high—LLM conveys the shift in financial relationship effectively, even adding geographic detail (Ohio, Tennessee, Michigan) that enriches context without distorting facts. Final scores reflect minor quantitative misstep but overall excellent performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 445,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "\nThousandEyes revenue grew and was a key driver of the 14 % rise in the Observability product category, adding roughly $80 million in fiscal 2023 versus fiscal 2022. This increase reflects a higher contribution from ThousandEyes within the broader Observability suite.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that ThousandEyes contributed to a 14% rise in the Observability category in fiscal 2023 with $80 million in growth, but the ground truth shows that the Observability category grew by 27% ($176 million) in fiscal 2023, with $80 million being the increase in fiscal 2022, not 2023. The $80 million figure is thus misattributed to the wrong fiscal year and incorrectly presented as new growth in 2023. (2) Quantitative accuracy is severely compromised: the percentage (14% vs actual 27%), dollar amount ($80M attributed to 2023 vs actual $176M), and timing are all incorrect. The model conflates fiscal 2022 data with 2023. (3) The reasoning is flawed—while the model correctly identifies ThousandEyes as a key contributor, it fails to perform the necessary multi-hop synthesis: recognizing that fiscal 2022 had $80M growth (partly from ThousandEyes), and fiscal 2023 had $176M growth (with Splunk as a new contributor and ThousandEyes driving organic growth). It also omits the critical detail that excluding Splunk, growth was 15%, underscoring ThousandEyes' role. (4) Contextual relevance is moderate because the answer addresses the evolution of ThousandEyes' contribution within Observability, but due to incorrect figures and timeline confusion, the core message is misleading. The model appears to reverse the years for the $80M figure and invents a 14% growth rate not present in the original data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 410,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 UPS left the $276 million 7.620% debentures unchanged: they remain callable at any time with a redemption price equal to the greater of principal plus accrued interest or the present‑value of the remaining scheduled payments discounted at the Treasury rate plus 5 bps, and interest continues to be paid semi‑annually at the fixed 7.620% rate (April and October). No sinking‑fund requirement or interest‑rate adjustment has been introduced, and the debentures are still carried at roughly $280 million on the balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the principal amount ($276 million), carrying value (~$280 million), interest rate (7.620%), semi-annual payment schedule (April and October), and redemption terms involving the greater of principal plus accrued interest or present value of remaining payments discounted at Treasury rate plus 5 bps. These quantitative details match the ground truth. (2) All numbers and percentages are accurate: $276M principal, $280M carrying value, 7.620% rate, 5 bps spread, correct months for interest payments. No calculation errors. (3) However, the reasoning about the evolution of the relationship is flawed. The ground truth states that in 2022, only basic details (principal, maturity date, carrying value) were provided, while in 2024, UPS clarified the detailed redemption terms and interest structure. The LLM incorrectly frames this as 'unchanged' in terms of redemption terms, when in fact the *disclosure* evolved — the terms may have been in place earlier but were only explicitly detailed in 2024. This misrepresents the nature of the evolution, which is in disclosure transparency, not static terms. (4) The answer is highly factually accurate and contextually relevant, but the qualitative reasoning fails to capture the multi-hop nuance: the change is in reporting detail over time, not the absence of change in terms. Hence, correctness and qualitative accuracy are reduced, while quantitative accuracy remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 406,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the Fixed‑Maturity‑Securities‑AFS portfolio that backs MetLife’s pension and post‑retirement plans slipped modestly in total size—from roughly **$6.80 bn to $6.71 bn**.  The shift in composition was slight but notable: **U.S. government‑bond holdings rose from about $1.51 bn to $1.58 bn** (an increase of roughly 4–5 %), while **corporate‑security holdings edged up from about $3.00 bn to $3.08 bn** (a rise of roughly 2–3 %).  Consequently, the share of the portfolio devoted to both U.S. Treasuries and corporate bonds grew modestly, even as the overall fair‑value of the AFS holdings declined a little.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and time periods. The ground truth states that the total fair value of Fixed Maturity Securities AFS increased from $2,164 million (as of December 31, 2021, reported in 2022) to $6,714 million (in 2023). However, the LLM incorrectly claims the portfolio decreased from $6.80 billion in 2022 to $6.71 billion in 2023, which misrepresents both the direction and magnitude of change. The LLM also uses incorrect base-year data: the $2,164 million value is from the end of 2021 (reported in 2022), not the end of 2022. This is a critical error in temporal reasoning. (2) The LLM’s numbers for U.S. government bonds and corporate securities are partially correct for 2023: it reports $1.58 billion (vs. $1.575 million in truth) and $3.08 billion (vs. $3,083 million), which are close but slightly overstated. However, the 2022 figures it invents ($1.51 billion and $3.00 billion) are not supported by the ground truth, which does not provide a 2022 breakdown—only a 2021 baseline. Thus, the comparison is fabricated. (3) The multi-hop reasoning is flawed: the model assumes a year-on-year comparison between 2022 and 2023 is possible with full data, but the original answer only provides a 2021 baseline and 2023 figures, with no intermediate 2022 composition. The LLM incorrectly infers 2022 values and mislabels the timeline. (4) While the LLM captures the general trend of growth in both U.S. government and corporate securities, it reverses the overall trend (claiming a decline in total value when it actually surged), misstates the starting point, and invents data for 2022. The qualitative reasoning about composition shifts is plausible but based on incorrect inputs. Contextually, the answer addresses the right entities (MET, AFS securities, U.S. government bonds, corporate securities) and the right time frame, so relevance is high. However, due to major quantitative and reasoning errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 542,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "\nFrom 2022 through 2023 GM’s cash commitment to the Ultium Cells LLC joint venture grew materially – the 2022 10‑K shows a $0.5 billion outflow in 2021 and the 2023 MD&A references additional capital infusions (including the $0.5 billion “Investment in Ultium Cells LLC” line and the broader $5.2 billion credit facility that GM extended to support Cruise, which underpins Ultium’s expansion).  At the same time, the partnership faced heightened regulatory scrutiny: in February 2023 GM self‑disclosed potential TSCA violations tied to imports into Ultium, and in November 2023 the EPA settled the matter with a consent agreement that imposes roughly $5.1 million in civil penalties that are jointly borne by GM and Ultium Cells LLC.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in GM's relationship with Ultium Cells LLC—shifting from financial investment to operational entanglement with regulatory consequences—and correctly identifies the $5.1 million civil penalty and TSCA self-disclosure in February 2023. However, there are key quantitative inaccuracies: the $0.5 billion investment is misattributed to 2021 in the LLM answer (based on '2022 10-K shows a $0.5 billion outflow in 2021'), while the ground truth states it was reported in 2022 as part of that year’s investing activities. This creates confusion about timing. Additionally, the LLM introduces a $5.2 billion credit facility extended to Cruise as part of Ultium’s funding, which is not mentioned in the ground truth and appears to conflate separate financial activities (Cruise funding vs. Ultium investment), introducing factual noise. (2) The $5.1 million penalty amount and February/November 2023 dates are accurate and correctly cited. However, the claim of 'additional capital infusions' beyond the $0.5 billion lacks support in the ground truth, which only confirms the $0.5 billion investment in 2022. (3) The multi-hop reasoning is partially sound—linking financial involvement to regulatory outcomes is appropriate and reflects synthesis across time and domains (investment → operational role → regulatory liability). But the inclusion of unrelated financial figures (Cruise credit facility) undermines the accuracy of the financial narrative. (4) The contextual relevance is high, as the answer directly addresses both financial and regulatory dimensions of the relationship. Qualitative accuracy is strong in structure and logic, but quantitative accuracy is reduced due to incorrect year attribution and unsupported financial figures. Correctness score is 7 because the central facts (TSCA disclosure, $5.1M penalty, shift in relationship nature) are correct, but financial details contain significant errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 531,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "\nBetween 2022 and 2024 the company continued to purchase natural‑gas and fuel under variable‑price, index‑linked contracts, but it consistently applied the “normal purchases and normal sales” exception, meaning these contracts are not marked‑to‑market and are accounted for at cost. No material shift in the nature or volume of such variable‑priced contracts is disclosed; the practice remains the same across the three fiscal years.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of the nature of the contracts and accounting treatment, correctly stating that variable-priced, index-linked contracts were used and that the 'normal purchases and normal sales' exception was applied, avoiding mark-to-market accounting. There are no numeric inaccuracies, so quantitative accuracy is high. However, the LLM incorrectly asserts that there was 'no material shift' and that 'the practice remains the same across the three fiscal years,' which directly contradicts the ground truth indicating a more formalized or strategic evolution by 2024, including explicit recognition of derivative characteristics. This reflects a failure in qualitative accuracy and reasoning: the model missed the nuanced evolution in how these contracts were managed or accounted for, particularly the increased alignment with derivative frameworks. While the answer is contextually relevant and addresses the use of variable-priced contracts, it fails to capture the key multi-hop insight—the progression toward more structured accounting treatment by 2024. Thus, while not factually wrong on surface details, it misrepresents the evolution, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 341,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Cisco kept the same set of expenses excluded from its segment‑performance metrics for the APJC region.  The company continues to omit research‑and‑development, sales‑and‑marketing, general‑and‑administrative costs, amortization and impairment of acquisition‑related intangible assets, share‑based compensation, significant litigation settlements and other contingencies, restructuring and asset‑impairment charges, and certain other items from gross‑margin calculations when evaluating the APJC segment.  No new expense categories were introduced or removed; the exclusion policy remained unchanged across the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that Cisco maintained a consistent approach to expense exclusions for the APJC segment between fiscal 2022 and 2023, with no changes in policy—this matches the original answer's conclusion of 'no change in how APJC's performance was internally measured.' (2) All expense categories excluded are accurately listed: research and development, sales and marketing, general and administrative, amortization and impairment of acquisition-related intangibles, share-based compensation, litigation settlements, restructuring and asset-impairment charges. The LLM includes 'other contingencies' and 'certain other items,' which are slightly broader than the original but do not contradict it—these may reflect standard phrasing in Cisco’s disclosures and are not factually incorrect. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the same exclusions applied across both years, leading to the conclusion of consistency. (4) There are no numerical or date inaccuracies (fiscal 2022 and 2023 are correctly referenced), and the answer fully addresses the question about evolution (or lack thereof) in reporting approach. The minor difference in phrasing (e.g., 'other contingencies') prevents a perfect 10, but the semantic meaning and factual content are substantially equivalent. Thus, correctness is scored 9 for high accuracy with negligible wording variance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 411,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 UnitedHealth moved from a largely underwriting‑and‑contract‑focused cost‑containment model to a more data‑driven, senior‑specific strategy that directly targets the rise in outpatient procedures.  The 2023 disclosures note that “increased care patterns, primarily related to outpatient procedures for seniors” are driving higher medical costs, and the company says it is “mitigating those increases by engaging physicians and consumers with information and helping them make clinically‑sound choices” — a clear shift toward proactive care‑management and value‑based payment designs that adjust pricing and benefit structures to curb senior outpatient spending. (See UNH 2022 p. 17; 2023 p. 27‑28; 2023 p. 26 on Medicare‑Advantage rate pressure.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in UNH's strategy from 2022 to 2023: in 2022, the focus was on underwriting and contracts amid concerns about deferred care and rising demand, while in 2023, the company shifted to targeted, data-driven interventions addressing rising outpatient costs for seniors. The mention of engaging physicians and consumers with information to support clinical decisions matches the original answer's emphasis on data-driven insights. (2) There are no numerical figures (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable in that sense—but all references to years (2022, 2023) and document locations (e.g., page numbers) are correctly cited, supporting factual grounding. (3) The multi-hop reasoning is sound: the model synthesizes UNH’s changing approach across two years, identifies the specific issue (outpatient costs for seniors), and correctly infers a strategic shift from reactive/contract-based to proactive, value-based care management. The reference to Medicare Advantage rate pressure adds contextual depth consistent with the 2023 filing. (4) The only minor shortcoming is the characterization of the 2022 approach as 'underwriting-and-contract-focused,' which, while reasonable, is slightly more specific than the original answer’s broader description of 'accurate cost prediction and risk-based arrangements.' This is a nuanced difference in emphasis but does not constitute a factual error. Overall, the answer is factually correct, contextually rich, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 465,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2024 UPS expanded the scope of its time‑definite services—adding same‑day, next‑day, two‑day and three‑day air options and growing its day‑definite ground offering to move more than 17 million U.S. packages daily—while tightening network integration through RFID‑enabled “Smart Package” facilities, a single global air‑and‑ground network, and the insourcing of SurePost final‑mile delivery (effective Jan 2025) to gain greater control over last‑mile service.  At the same time the company reshaped its network (Fit‑to‑Serve, Efficiency Reimagined) to focus on higher‑yielding volumes and to better leverage its 188,000 entry points and 52,000 global Access Point locations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in UPS's time-definite delivery services between 2022 and 2024, including network integration and service expansion. Key correct elements include the insourcing of SurePost final-mile delivery for greater control, the integrated global air-and-ground network, and expanded service scope. However, the LLM incorrectly states that the SurePost insourcing is effective January 2025, while the ground truth specifies it occurred in 2024—this is a significant factual error in timing. Additionally, the LLM introduces specific quantitative claims not present in the original answer, such as 'more than 17 million U.S. packages daily' and references to 'RFID-enabled Smart Package facilities', 'Fit-to-Serve', and 'Efficiency Reimagined' initiatives, which are not mentioned in the ground truth and cannot be verified from it. (2) Quantitative accuracy is compromised due to the unsupported 17 million package figure and the incorrect 2025 date for SurePost insourcing. The ground truth does not provide package volume numbers or RFID facility details, so these appear to be hallucinations. (3) The multi-hop reasoning is generally sound—linking network integration with service expansion and control over final delivery—but the inclusion of unverified operational initiatives and incorrect timing reduces reliability. The model correctly identifies the strategic shift in network control and service breadth. (4) Despite the addition of unverified details and a date error, the LLM conveys a largely accurate and relevant picture of UPS's evolving service scope and integration strategy, hence a correctness score of 7. The answer is contextually strong and semantically aligned in direction, though not fully factually aligned in specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 487,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 2.50 % Notes maturing in April 2026 were explicitly listed as part of the Thirteenth Supplemental Indenture (Exhibit 4.14) dated April 20 2016, confirming that the series remained outstanding. By the 2023 filing the same indenture is still referenced, but the latest supplemental indentures (the 20th Supplemental Indenture of March 2022 and the 22nd Supplemental Indenture of March 2023) no longer mention the 2.50 % notes, showing that the company now treats the issue as a legacy tranche and does not include it in any newer debt‑package amendments.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth. (1) Quantitatively, while the interest rate (2.50%) and maturity (April 2026) are correct, and the Thirteenth Supplemental Indenture date (April 20, 2016) is accurately cited, the LLM incorrectly references the 20th and 22nd Supplemental Indentures from March 2022 and March 2023 as no longer mentioning the notes. The ground truth does not support this claim, nor does it indicate any newer supplemental indentures being used to exclude the notes. (2) In terms of completeness, the LLM fails to capture the core evolution described in the original answer: a shift in disclosure treatment from historical/planning context in 2022 to active recognition as issued debt in 2023. Instead, it asserts the opposite — that the notes were 'no longer mentioned' in newer filings, implying diminished recognition, when the truth is they gained explicit recognition. (3) Entity accuracy is mostly correct (Lowe's, indenture, note terms), but the references to later supplemental indentures (20th and 22nd) appear fabricated or misattributed, as the ground truth does not mention them in this context. (4) Reasoning is flawed: the LLM concludes the notes are treated as a 'legacy tranche' excluded from new amendments, which contradicts the ground truth indicating increased, not decreased, recognition. The multi-hop synthesis is therefore incorrect — it misinterprets the direction of change in disclosure treatment. (5) While the answer is contextually relevant to Lowe's debt disclosures and attempts to analyze evolution, the factual and logical errors severely undermine its correctness. The semantic meaning is not equivalent to the original answer; in fact, it conveys the opposite narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 483,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "\nFrom 2022 to 2024 the way sovereign‑debt concerns affect Costco’s supply chain has become more pronounced and direct. In 2022 the filings noted that macro‑economic stresses—including sovereign‑debt crises, tariffs and commodity‑price volatility—could raise merchandise costs and force pricing adjustments, but the impact was largely indirect. By 2024 the same disclosures show that expanding international operations (now generating roughly one‑third of sales abroad) and heightened exposure to foreign‑currency swings mean that sovereign‑debt‑related financing pressures and trade restrictions now have a clearer effect on sourcing costs, prompting Costco to tighten supplier contracts and pass on—or absorb—higher inventory expenses to protect margins.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in Costco's exposure to sovereign debt crises from 2022 to 2024, correctly identifying an increasing direct impact on sourcing and cost structure. It accurately reflects that in 2022 the risk was framed as part of broader macroeconomic factors (indirect impact), while in 2024 the language intensified to reflect clearer, more direct consequences. However, the LLM introduces specific details not present in the original answer: (1) the claim that 'one-third of sales' are now generated abroad is a quantitative addition with no support in the ground truth; (2) mentions of 'tightening supplier contracts' and 'passing on or absorbing higher expenses' are plausible inferences but not stated in the original. The ground truth emphasizes a shift in disclosure language—from potential adverse effects to explicit negative impacts—and links 2024 concerns to broader supply chain risks like geopolitical instability and supplier compliance, which the LLM underrepresents. While the reasoning is logically sound and contextually relevant, and the qualitative shift is correctly interpreted, the addition of unsupported specifics reduces factual precision. Quantitative accuracy is high because the only number mentioned (one-third) is a minor inference and not directly contradicted by the source, but it is unverified. The answer synthesizes across years appropriately but adds operational details beyond the source. Thus, the correctness score is 7 for accurate core message with minor factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 422,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "\nBetween the end of 2021 and the end of 2023 the shares reserved for future grants under the 2020 Stock Incentive Plan fell from **≈ 64 million** to **≈ 53 million** (a reduction of about 11 million shares).  This decline shows that UnitedHealth has already used a sizable portion of its authorized equity pool for prior awards, but it still retains a meaningful—though diminished—reserve of roughly 53 million shares that can be tapped for new share‑based compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of shares available for future grants in 2021 (64 million) and 2023 (53 million), matching the ground truth exactly. The approximate notation (≈) is acceptable given typical reporting variations in financial disclosures. The calculated reduction of 11 million shares (64M - 53M) is accurate. (2) All numeric values and the implied calculation (difference between years) are correct. No errors in numbers, dates, or units. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years (2021 to 2023) and links the decrease in available shares to UnitedHealth Group's capacity for future share-based awards. The interpretation—that prior awards have consumed part of the equity pool while a meaningful reserve remains—is logically consistent with the trend and adds appropriate context without overreaching. (4) The answer fully addresses both parts of the question: the change in shares (quantitative) and what it indicates about future capacity (qualitative). The wording differs slightly from the original answer but maintains semantic equivalence. One point deducted from qualitative accuracy because the original answer emphasizes the 'reduction in capacity' more directly, while the LLM slightly softens the implication by noting 'meaningful reserve'; however, this does not make the answer incorrect—just slightly less precise in tone. All other aspects are factually and contextually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 411,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "\nBetween 2022 and 2024 the collective‑bargaining agreement for the IAM National Pension Fund / National Pension Plan was extended—its expiration moved from 31 July 2024 (2022 filing) to 31 July 2029 (2024 filing).  UPS’s annual contributions remained material, hovering around $50 million per year (≈ $48‑$53 million in 2022‑2024) and consistently exceeding 5 % of the plan’s total contributions.  In 2024 the company also formalized a withdrawal from the related District 9 IAM pension trust, recording a $19 million liability, which shows the relationship is still strategically important even as its terms evolve.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the extension of the expiration date from July 31, 2024, to July 31, 2029, which matches the ground truth and addresses the evolution of the contractual relationship. It also correctly states that UPS contributed more than 5% of total plan contributions, aligning with the significance criterion in both periods. However, the LLM introduces specific dollar figures ($48–53 million annually, $50 million) and a $19 million liability related to a withdrawal from the District 9 IAM pension trust—details not present in the original answer and unsupported by the provided ground truth. These additions, while possibly accurate in a broader context, are not part of the verified knowledge graph and introduce unverified quantitative claims. (2) The expiration dates are correct and properly attributed to the 2022 and 2024 filings. The 5% contribution threshold is accurately maintained. However, the dollar amounts and the District 9 withdrawal with a $19 million liability are extraneous and not corroborated by the original answer, reducing quantitative accuracy. (3) The multi-hop reasoning is sound in synthesizing changes over time in expiration dates and contribution significance. The model correctly infers sustained importance based on continued >5% contributions. However, the introduction of a separate pension trust (District 9) and associated liability reflects either a conflation of related but distinct plans or an overreach in inference not supported by the ground truth, weakening qualitative accuracy slightly. (4) The answer is highly relevant and captures the core evolution: extended expiration and sustained contribution significance. The extra details, while potentially contextually related, detract from factual precision. Correctness score is 7 due to accurate core facts but unverified numerical additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 507,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Company’s 2020 revolving credit facility was amended and restated as the 2023 Credit Agreement, extending its maturity from **March 2025 to September 2028** while keeping the borrowing capacity at **$2 billion**; the related third‑amended and restated agreement (entered in December 2021) was also extended to **September 2028**, leaving the **combined $4 billion of available credit** essentially unchanged.  (Pages 60 – 2022 filing show the $2 billion, March 2025 maturity; pages 59 – 2023 filing show the amendment extending the term to September 2028 and confirming the $4 billion total availability.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 2020 Credit Agreement's original maturity date (March 2025) and $2.0 billion availability in fiscal 2022, the amendment in September 2023 extending maturity to September 2028 while maintaining $2.0 billion availability, and the combined $4.0 billion total availability remaining unchanged. (2) Quantitative accuracy is perfect: dates and dollar amounts match exactly, with acceptable formatting variations (e.g., $2 billion = $2.0 billion). (3) The multi-hop reasoning is sound—correctly linking the evolution of the 2020 agreement into the 2023 agreement and noting the parallel extension of the Third Amended and Restated Credit Agreement to maintain total availability. (4) The only minor shortcoming is slight ambiguity in referring to the 'related third-amended and restated agreement (entered in December 2021)' without explicitly naming it as a separate facility or clarifying that it was also part of the overall credit structure; however, the conclusion about combined $4 billion availability being unchanged is correct and aligns with the original answer. Wording differs slightly but semantic equivalence is maintained. No irrelevant or incorrect information is introduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 364,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "\nMDLZ’s net‑investment‑hedge derivative program expanded materially: the notional amount of the contracts was about **$6.9 billion at the end of 2022**, rose to **$7.5 billion at year‑end 2023**, and reached **$8.6 billion as of 31 December 2024** (see MDLZ_10k_2022.pdf p. 111; MDLZ_10k_2024.pdf p. 96). This roughly 25 % increase over the two‑year span reflects a deliberate scaling‑up of cross‑currency swaps and forwards to hedge a larger share of the company’s non‑U.S. investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the notional amount as of December 31, 2021 (reported in 2022) was $3,915 million and $4,551 million as of December 31, 2020 — data that the LLM omits entirely. Instead, the LLM claims a notional amount of $6.9 billion at the end of 2022, which does not align with the ground truth values provided for 2020 and 2021. The ground truth does not report a value for December 31, 2022, but does state that by 2023 it was $7,456 million (~$7.5B), which the LLM correctly reports as $7.5 billion at year-end 2023. The 2024 figure of $8.647 billion is correctly rounded to $8.6 billion by the LLM, so that value is acceptable. However, the LLM fabricates a 2022 figure ($6.9B) that is not present in the original answer or supported by the disclosed trend. (2) Calculations: The LLM claims a 'roughly 25% increase over the two-year span' from $6.9B to $8.6B — this math is approximately correct (about 24.6%), but it's based on an incorrect starting point. The actual increase from 2023 ($7,456M) to 2024 ($8,647M) is about 16%, and the original answer emphasizes growth from 2023 to 2024, not 2022 to 2024. Thus, the percentage comparison is misleading. (3) Multi-hop reasoning: The LLM correctly identifies the upward trend and the purpose of the hedges (hedging non-U.S. investments), showing good qualitative synthesis. It references appropriate document sources (10-Ks for 2022 and 2024), though the data cited doesn't fully match the ground truth. However, it fails to accurately represent the earlier data points and misrepresents the timeline. (4) Justification: The correctness score is 6 due to partial accuracy — the 2023 and 2024 figures are close enough to be acceptable, and the overall trend interpretation is sound, but the invented 2022 number and incorrect comparative analysis reduce confidence. Quantitative accuracy is low (5) due to the fabricated $6.9B figure. Qualitative accuracy is higher (7) because the reasoning and intent are logical. Contextual relevance is high (9) as the response directly addresses the evolution of MDLZ's hedging strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 582,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft 365 shifted from a broad AI‑platform foundation (Azure AI and the early Copilot stack) to a tightly integrated generative‑AI layer that can understand and act on business data across Outlook, Teams, Word, Excel and other apps.  In 2024 the company added role‑specific Copilot assistants (Copilot for Sales, Service and Finance), the Copilot Studio customization environment, a consumer‑focused Copilot Pro subscription, and expanded ambient‑intelligence capabilities from Nuance—all of which embed AI‑driven automation, insights and security (e.g., Copilot for Security) directly into productivity and collaboration workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Microsoft 365's AI integration from 2022 to 2024: starting with foundational AI tools and progressing to an AI-first platform centered on Copilot. The key 2024 capabilities—Copilot for Sales, Service, and Finance—are accurately mentioned, matching the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable; however, the years (2022, 2024) are correct and consistently used—no errors. (3) The multi-hop reasoning is sound: the model synthesizes the progression over time and correctly links the introduction of role-specific Copilots and broader AI enhancements to productivity and collaboration. It adds slightly more detail (e.g., Copilot Studio, Copilot Pro, Nuance, Copilot for Security), which are contextually plausible extensions of Microsoft’s 2024 AI strategy and do not contradict the ground truth—these can be seen as complementary details rather than inaccuracies. (4) Semantic equivalence is strong: the core message—that Microsoft 365 became an AI-first platform with Copilot at the center and introduced role-specific AI assistants in 2024—is preserved. The only minor gap is that the original emphasizes the integration with Microsoft Graph and business data more explicitly, which the LLM mentions implicitly via 'understand and act on business data' but could have named directly. This small omission prevents a perfect 10. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 445,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "\nBetween 2022 and 2024 3M moved from an ad‑hoc, self‑reported acknowledgement that its NPDES permit for the Decatur, AL plant omitted several PFAS compounds—prompting temporary process idling and the start of treatment‑control upgrades—to a formal, regulator‑approved interim Consent Order (July 2020, still the governing framework in 2024) that obligates the company to continuously characterize PFAS discharges, conduct periodic analytical studies and reporting, and implement capital‑improvement and remediation actions as part of a defined, ongoing compliance program. In other words, the approach evolved from a one‑time disclosure and pause in operations to a binding, multi‑year regulatory agreement that mandates sustained PFAS discharge monitoring, characterization and corrective measures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) It incorrectly states that a 'regulator-approved interim Consent Order' from July 2020 was the governing framework in 2024, but the original answer makes no mention of such an order or its approval status, nor does it reference any binding regulatory agreement. This is a major fabrication. (2) The claim that 3M's 2022 actions led to 'temporary process idling' is not supported by the original answer, which only mentions submitting an application to ADEM to add PFAS to the permit. (3) The LLM suggests regulatory approval and a formal, ongoing compliance program was in place by 2024, but the ground truth explicitly states that ADEM had 'not yet acted on the permit modification request,' contradicting the notion of regulator-approved or formalized progress. (4) The evolution described in the LLM answer—framing the shift as moving to a binding regulatory agreement—is fundamentally incorrect; the actual evolution was from disclosure and application submission to installing and optimizing treatment controls while awaiting regulatory action. (5) Quantitatively, the reference to a 'July 2020' Consent Order is factually wrong and not in the original timeline (2022–2024). (6) While the LLM captures the general theme of progression from identification to action, the specific entities, regulatory status, and timeline are misrepresented, undermining both qualitative and quantitative accuracy. The answer is contextually relevant to the question’s intent but fails on core factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 441,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "\nBetween 2022 and 2023 Lowe’s did not issue any new 4.550 % notes; the only reference to that coupon appears in the **Fifteenth Supplemental Indenture of April 5, 2019**, which created the 4.550 % Notes due April 5, 2049.  The **Twentieth Supplemental Indenture (March 24, 2022)** and the **Twenty‑Second Supplemental Indenture (March 30, 2023)** added other tranches—e.g., 4.450 % notes in 2022 and 4.800 %, 5.150 %, 5.750 % and 5.850 % notes in 2023—but they did not reference or expand the 4.550 % series.  Thus, the 4.550 % notes remained part of the indenture from 2019 and were not altered or supplemented in the 2022‑2023 filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes were established in the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. The answer correctly states that no new issuance or modification occurred in 2022 or 2023. (2) Quantitative accuracy is perfect: dates (April 5, 2019; April 5, 2049), percentages (4.550%), and references to supplemental indentures (Twentieth on March 24, 2022; Twenty-Second on March 30, 2023) match expected data. The additional note tranches issued in those years (e.g., 4.450% in 2022; 4.800%, 5.150%, etc. in 2023) are correctly cited as unrelated to the 4.550% series. (3) Reasoning is sound and demonstrates multi-hop synthesis: the model correctly infers that because the 4.550% Notes were not mentioned in the 2022 or 2023 supplemental indentures, they remained unchanged, which is consistent with the ground truth. (4) The only minor shortcoming is that the original answer emphasizes the continuity of reference to the 4.550% Notes in 2023 filings, while the LLM focuses more on absence of change—slightly less explicit on ongoing relevance, but still semantically equivalent. Overall, the answer is highly accurate, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 362,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 MDLZ’s stake in Keurig Dr Pepper fell from roughly 13 % to below the 5 % threshold that triggers significant influence, forcing a move from equity‑method accounting to fair‑value measurement of marketable securities.  In 2022 the company sold 6.8 million KDP shares for $185 million and recorded a $71 million pre‑tax gain, and in 2023 the re‑classification to marketable securities allowed it to recognize a $593 million pre‑tax gain on the remaining shares (including the $493 million gain from prior equity‑method transactions).  By the end of 2024 MDLZ had fully exited its KDP investment, concluding the relationship.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key financial figures and timing. While it correctly states that MDLZ recognized a $71 million pre-tax gain in 2022 from the sale of KDP shares, it incorrectly attributes the $493 million pre-tax gain (from the original answer) to 2023 and inflates the total gain to $593 million, claiming $493 million was part of that larger amount. The original answer specifies a $493 million pre-tax gain in 2024 due to a change in accounting, not in 2023, and does not mention a $593 million figure. Additionally, the LLM claims MDLZ fully exited its KDP investment by end of 2024, which is not stated in the ground truth. (2) Quantitative accuracy is compromised: the $593 million gain is unsupported, the timing of the $493 million gain is off by a year, and the percentage ownership drop from 13% to below 5% is plausible but not confirmed in the original answer. The 2022 sale of 6.8 million shares for $185 million is not in the ground truth and cannot be verified. (3) The multi-hop reasoning is partially sound—recognizing a shift in accounting treatment due to reduced ownership is consistent with equity method logic—but the synthesis is flawed due to incorrect timing and magnitude of gains. The conclusion about full exit is an overreach. (4) Despite these errors, the answer captures the essence of a changing financial relationship and correctly identifies the shift in accounting impact, earning moderate scores for qualitative accuracy and high relevance. However, major quantitative errors reduce the correctness score to 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 442,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the Xbox Game Pass library expanded dramatically—from a curated catalog of roughly 100 first‑ and third‑party titles in 2022 to “over 400 first‑ and third‑party console and PC titles” by 2024.  Microsoft has repositioned the service as the central pillar of its gaming strategy, emphasizing subscription growth, cloud‑gaming accessibility across consoles, PC and mobile, and deeper integration with advertising and first‑party content to broaden the user base and increase engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the expansion of Xbox Game Pass from approximately 100 titles in 2022 to over 400 by 2024, matching the ground truth in both scale and direction of growth. The strategic repositioning as a 'central pillar' (LLM) aligns semantically with 'cornerstone' (ground truth), accurately reflecting increased strategic emphasis. 2) Quantitatively, the numbers '100' and 'over 400' are factually correct and consistent with the original answer. The phrasing 'over 400 first- and third-party console and PC titles' adds specificity (platforms) not contradicted by the ground truth. 3) The reasoning correctly synthesizes multi-hop information: it infers increased strategic importance from the library expansion and broader integration (cloud, advertising, first-party content), which is implied in the ground truth's mention of 'subscriptions and community growth'. The only minor gap is that the LLM slightly expands on strategic elements (e.g., advertising integration) not explicitly mentioned in the ground truth, but these are reasonable inferences consistent with Microsoft's known strategy. 4) The answer is fully contextually relevant, directly addressing both the scale (number of titles) and strategic positioning over time. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth, warranting a high score with only a slight deduction in qualitative accuracy due to minor extrapolation beyond the provided details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 412,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings, 3M continued to incorporate the identical “Formof Deferred Stock Unit Award Agreement for deferred stock units granted on or after January 1, 2019 to non‑employee directors under the 2016 Long‑Term Incentive Plan” by reference to the 2018 filing. No new or amended DSU agreement, exhibit, or revised disclosure was introduced in either the 2022 or 2024 filings, so the structure and wording of the award have remained unchanged from 2022 through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that the structure and wording of the Deferred Stock Unit (DSU) Award Agreement for non-employee directors under the 3M 2016 Long-Term Incentive Plan remained unchanged from 2022 to 2024, and accurately notes the continued use of the form applicable to grants on or after January 1, 2019. It correctly states that no new or amended agreement was introduced in the 2022 or 2024 10-K filings. However, the LLM incorrectly claims incorporation by reference to the 2018 filing, which is not supported by the ground truth. The original answer clarifies that the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, indicating ongoing maintenance of the plan with amendments as of May 8, 2023—this nuance is missing in the LLM response. This omission affects the completeness and reasoning accuracy, particularly in the multi-hop aspect of tracking how disclosures evolved through successive filings. While the core fact about structural consistency is correct, the LLM fails to capture the updated referencing path (2023 10-K vs. 2018), which is important for understanding disclosure mechanics. Quantitative accuracy is high—dates like January 1, 2019, and the absence of changes are correctly cited. Contextual relevance is perfect, as the response directly addresses the evolution of the agreement. Qualitative accuracy is reduced due to incomplete synthesis across years and filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 398,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "\nBetween 2023 and 2024 the First‑Mortgage book grew from about $26.1 bn to $27.3 bn (≈ 4‑5 % increase) while HELOCs slipped from $0.473 bn to $0.421 bn (≈ 11 % decline).  Origination‑cost exposure rose from $100 million to $112 million, and the share of the combined First‑Mortgage + HELOC portfolio concentrated in California fell only modestly from roughly 43 % to 42 %.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts from the ground truth: origination costs increased from $100 million in 2023 to $112 million in 2024, and California concentration decreased from 43% to 42%. These numbers match the original answer exactly, with acceptable formatting (e.g., $100 million vs $100 million). (2) The LLM adds extra detail not in the original answer—specific portfolio sizes for First Mortgages ($26.1B to $27.3B) and HELOCs ($0.473B to $0.421B)—which are factually consistent with external data but not mentioned in the ground truth. While this does not contradict the original answer, it introduces information beyond the scope of the provided truth, slightly affecting qualitative accuracy. However, since these figures are accurate and contextually relevant, they do not reduce correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in origination costs and geographic concentration across years and links them to portfolio evolution. The conclusion about modest decline in California exposure aligns with the 1-percentage-point drop. (4) All entities (Charles Schwab Bank’s First Mortgages and HELOCs portfolio, origination costs, California concentration) are correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with slightly enhanced detail. Thus, correctness is high—only a perfect 10 is withheld due to the addition of unverified (though plausible) portfolio size figures not in the original truth, which could introduce risk if those numbers were incorrect. However, since they are accurate and support the reasoning, a 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 456,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "\nIn fiscal 2023 Nike’s research‑and‑development text highlighted Dri‑FIT as a flagship performance fabric, underscoring its importance for moisture‑wicking apparel and product differentiation. By fiscal 2024 the same paragraph merely lists Dri‑FIT among a broader set of Nike technologies (Air, Zoom, Flyknit, etc.), reflecting a shift from a singular Dri‑FIT emphasis to a more integrated, portfolio‑wide innovation focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim. The original answer (ground truth) states that the exact same language was used in both Nike's fiscal 2023 and 2024 10-K filings, indicating no change in the description or strategic emphasis on Dri-FIT. The LLM incorrectly asserts a shift in emphasis—from highlighting Dri-FIT as a 'flagship performance fabric' in 2023 to merely listing it among other technologies in 2024. This misrepresents the actual filings, which used identical wording in both years, showing no such evolution. There are no numeric values in the question or answers, so quantitative accuracy is not applicable beyond correct use of fiscal years (which the LLM got right). The reasoning is flawed because it invents a narrative of strategic shift unsupported by the source text. While the entities (Nike, Dri-FIT, fiscal years) are correct, the synthesis across years is invalid. The answer is contextually relevant to the question but fundamentally wrong in its conclusion, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 296,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "\nFrom 2022 through 2024 Mondelez has treated backup and disaster‑recovery as a core pillar of its cyber‑risk program, repeatedly noting that it “continues to invest and augment” those capabilities.  In the 2022 filing (page 45) the company said it was dedicating focused resources to network security, backup and disaster‑recovery, and workforce training, and the 2024 filing (page 21) reiterates that it is “enhancing the monitoring and detection of threats… and adjusting information‑security controls” while still emphasizing continued investment in backup and disaster‑recovery to guard against the growing frequency and sophistication of ransomware and state‑sponsored cyber attacks.  Thus, the company’s backup‑and‑recovery investment has evolved from a baseline, reactive measure in 2022 to a more robust, continuously‑upgraded component of a broader, proactive cybersecurity strategy by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Mondelez's increased focus on backup and disaster recovery from 2022 to 2024 in response to cybersecurity threats is properly conveyed. The 2022 context—dedicating focused resources to backup, disaster recovery, and network security—is accurately represented, as is the 2024 expansion involving enhanced monitoring, detection, and investment in cybersecurity infrastructure. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, correctly inferring an evolution from reactive to proactive investment. The mention of ransomware and state-sponsored attacks aligns with the original’s reference to state-sponsored actors and AI-driven threats. (4) The only minor gap is that the LLM does not explicitly mention 'artificial intelligence' as an emerging threat vector noted in the original answer, which slightly reduces qualitative accuracy. However, referencing 'growing sophistication of ransomware' captures part of that context. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 378,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "\nBetween fiscal years 2022 and 2024 Microsoft shifted from merely working toward a $500 million target for spending with Black‑ and African‑American‑owned suppliers—reaching roughly 90 % of that goal in FY 2022—and by FY 2024 it had fully met the commitment, actually spending the full $500 million while doubling the number of Black‑owned suppliers in its pipeline.  In addition, the company announced a new $150 million investment in minority depository institutions to further increase capital available to Black‑owned small businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: the $500 million spending goal, 90% progress in FY 2022, full achievement by FY 2024, and the additional $150 million investment in Minority Depository Institutions are all accurately reported. Format variations (e.g., $500 million vs $500M) are acceptable and do not affect accuracy. (2) The answer correctly identifies Microsoft as the entity and accurately references fiscal years 2022 and 2024, aligning with the original timeline. (3) The multi-hop reasoning is sound: it synthesizes Microsoft’s progress toward its supplier diversity goal over time and correctly adds the expansion into financial support for Black-owned small businesses. (4) The only minor shortcoming is that the LLM slightly condenses the detail about 'doubling the number of Black and African American-owned suppliers'—the original specifies that the pipeline reached 90% of the goal to spend $500M *and* double the number of suppliers, while the LLM implies both were fully achieved by FY 2024 without explicitly confirming the doubling occurred. However, this does not constitute a factual error, just a slight omission in specificity. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 372,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "\nFrom the 2022 filing Abbott reported ≈ 10.6 million common shares reserved for future issuance under the Non‑U.S. Employee Stock Purchase Plan, while the 2023 filing shows that number had fallen to ≈ 8.6 million shares (as of Dec 31 2023).  The decline indicates that Abbott is exhausting the ESPP reserve and is therefore deploying a larger share of its authorized capital toward employee‑stock purchases—signaling a more aggressive use of equity‑based incentives to motivate global staff.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the approximate number of shares available in 2022 and 2023: ~10.6 million (actual: 10,638,639) and ~8.6 million (actual: 8,565,087), which is quantitatively accurate with acceptable rounding. The dates are also correct—December 31, 2021, for the 2022 filing and December 31, 2023, for the 2023 filing. However, the LLM mischaracterizes the trend: while the numbers are correct, it interprets the decline as a sign of 'more aggressive use of equity-based incentives,' which contradicts the ground truth interpretation of a 'reduction' suggesting 'tightening or adjustment' in strategy. 2) The numerical values are accurate within reasonable rounding (10.6M ≈ 10,638,639; 8.6M ≈ 8,565,087), so quantitative accuracy is high. 3) The multi-hop reasoning fails at the synthesis stage: although the model pulls correct figures from different years and identifies the decrease, it draws the opposite conclusion about Abbott's strategic intent. This reflects flawed qualitative reasoning. The decrease in available shares could result from increased usage (supporting LLM's view), but without evidence of increased participation or authorization of new shares, the correct inference per the ground truth is a potential tightening—not expansion—of the program. 4) Contextually, the answer addresses both parts of the question (evolution of shares and strategic implication), so relevance is high. However, the incorrect interpretation of the strategic signal significantly undermines the overall correctness, warranting a mid-range score of 5/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 430,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "\nNike moved from simply listing Air cushioning as one of many innovative technologies in 2023 to establishing a dedicated Air Manufacturing Innovation subsidiary in 2024 that directly supplies Air‑Sole and related components from its own facilities in Oregon, Vietnam and Missouri. This vertical‑integration reflects a strategic shift toward centralising Air‑technology development, expanding the Air platform across multiple product lines (e.g., Air Max, ZoomX, React) and tying its evolution to performance and sustainability goals.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in factual content and misrepresents the evolution of Nike Air technology between fiscal years 2023 and 2024. The original answer, based on the knowledge graph, indicates a shift in narrative tone and strategic positioning of Nike Air—from being highlighted as an innovative technology in 2023 to being grouped with mature technologies like Zoom, Free, and React in 2024, signaling its transition to a foundational, integrated component. However, the LLM introduces factually unsupported claims, such as the creation of a dedicated 'Air Manufacturing Innovation' subsidiary in 2024 and vertical integration with facilities in Oregon, Vietnam, and Missouri. These entities and operational changes do not appear in the ground truth and are not corroborated by the provided data. There are no quantitative figures (e.g., dollar amounts, percentages, production volumes) in either answer, so the quantitative accuracy is neutral—no numbers to verify or falsify. The reasoning is flawed because the LLM fabricates organizational and manufacturing developments rather than analyzing the shift in strategic emphasis evident in the language used across the two fiscal years. While the LLM attempts to address the strategic evolution of Nike Air, it does so with invented details rather than textual analysis from the filings, failing the multi-hop synthesis requirement. Contextually, the answer is relevant to the topic of product development strategy, but the fabricated specifics undermine its validity. Thus, the correctness score is low due to major factual inaccuracies, despite addressing the general theme.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 446,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott kept Osmolite® as a core offering within its Nutritional Products enteral‑feeding portfolio—listing it alongside Jevity®, Glucerna®, Oxepa®, Freego™ and other disease‑specific formulas in both years’ disclosures.  The 2023 filing emphasizes ingredient innovation and a broader product‑line strategy, positioning Osmolite as a flagship, nutritionally complete solution for adult enteral nutrition while maintaining its place among Abbott’s other enteral brands.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces unsupported claims not present in the ground truth, affecting factual accuracy. (1) Correct elements: Osmolite is accurately positioned within Abbott's enteral feeding portfolio in both 2022 and 2023, and it is correctly listed alongside other products like Jevity®, Glucerna®, Oxepa®, and Freego™. The mention of Osmolite as a nutritionally complete adult formula aligns with its known use. (2) Quantitative accuracy is high—no numerical data is misstated, and the years (2022, 2023) are correct. (3) However, the LLM incorrectly implies strategic evolution by stating that the 2023 filing 'emphasizes ingredient innovation' and positions Osmolite as a 'flagship' solution, which is not supported by the original answer. The ground truth explicitly states there was no significant repositioning, introduction, or discontinuation—indicating stable, not evolving, positioning. This misrepresents the multi-hop synthesis: the model inferred strategic emphasis not present in the data. (4) Contextual relevance is strong as the answer addresses Abbott, Osmolite, enteral feeding, and product line strategy. However, the qualitative inaccuracy in reasoning and unsupported strategic claims reduce the correctness score. The answer suggests evolution where the truth indicates stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 369,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "\nBetween 2022 and 2024, 3M’s PFAS remediation in Minnesota and Alabama shifted from relying on the long‑standing 2007 Minnesota Settlement Agreement and 2009 Alabama TSCA consent order to facing newer, state‑driven enforcement actions—including MPCA violation notices, updated health‑based water limits, a draft NPDES permit with stricter PFAS limits, and a series of EPA information requests and a July 2024 RCRA consent order for the Decatur site.  At the same time the company increased its PFAS‑related accrual by $0.7 billion and paid $3.1 billion in 2024, reflecting a move from prior planning to active, closely supervised cleanup and compliance oversight.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness. (1) It incorrectly references a '2009 Alabama TSCA consent order'—the ground truth states a July 2020 Interim Consent Order with ADEM, not TSCA-based or from 2009. (2) It mentions an 'RCRA consent order in July 2024 for the Decatur site'—this is not supported by the original answer, which notes ongoing investigations but no such order. (3) The claim that 3M 'paid $3.1 billion in 2024' and increased its accrual by '$0.7 billion' is not present in the ground truth and introduces financial data not in the source, making it factually unsupported. (4) The original answer emphasizes evolving draft permits from MPCA in 2024 (August and December), updated HBVs from MDH in January 2024, and proposed HRLs in October 2024—all of which are omitted in the LLM response. (5) While the LLM correctly identifies increased regulatory scrutiny and references the 2007 Minnesota Settlement Agreement, it mischaracterizes the nature and timeline of enforcement actions. (6) The answer captures the general trend of escalating regulatory pressure and transition from planning to active remediation, which maintains some contextual relevance and qualitative reasoning. However, the incorrect legal frameworks, fabricated financial figures, and missing key regulatory developments (e.g., draft NPDES permit revisions, HBVs, HRLs) result in major multi-hop reasoning failures. The quantitative inaccuracies are severe due to unsupported dollar amounts and dates. Despite this, the answer remains focused on the question’s core topic—evolving PFAS obligations—earning moderate marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 458,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "\nBetween 2022 and 2024 Coca‑Cola HBC AG remained classified as an equity‑method investment for The Coca‑Cola Company, with the ownership stake essentially unchanged at roughly 19 % (approximately 19 % as of Dec 31 2022 and 19 % as of Dec 31 2024). No reclassification or material shift in the nature of the relationship occurred, indicating a stable financial tie over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that The Coca-Cola Company's ownership stake in Coca-Cola HBC AG was approximately 19% in both 2022 and 2024. The ground truth indicates that while Coca-Cola HBC AG was an equity method investee in 2022, the specific ownership percentage was not disclosed. In contrast, the 2024 filing explicitly stated a 22% ownership stake as of December 31, 2024. The LLM incorrectly asserts a precise and consistent 19% stake across both years, which contradicts the disclosed information. (2) The quantitative inaccuracies are significant: the 19% figure is unsupported for either year—especially for 2024, where the correct value is 22%. This represents a direct factual error in percentage and misrepresents the evolution of the stake. (3) The multi-hop reasoning is flawed. The question asks about the evolution of the financial relationship, particularly regarding classification and stake percentage. The LLM correctly notes that the investment remained under the equity method, which aligns with the ground truth. However, it fails to recognize that the key development was the formal disclosure of a specific percentage (22%) in 2024, whereas none was provided in 2022. Instead, it fabricates a consistent 19% stake, missing the core insight about increased transparency and quantification in reporting. (4) The contextual relevance is moderate because the answer addresses the right companies and time frame and correctly identifies the accounting method. However, due to the critical error in ownership percentages and the failure to capture the evolution in disclosure, the qualitative and quantitative accuracy scores are low. The correctness score is 2 due to major factual errors undermining the answer’s reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 484,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Oracle has shifted hybrid deployment from a peripheral option to a core growth pillar, investing ≈ $7 billion + each year in R&D to build hybrid‑ready capabilities such as Oracle Cloud@Customer, OCI and SaaS extensions that let customers run workloads across on‑premise, cloud and hybrid environments.  This spending underpins the rising share of cloud‑services and license‑support revenue—up to 71 % of total sales in FY 2022 and expected to keep climbing—and reflects a tight integration of cloud, license, hardware and services in Oracle’s product roadmap.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Oracle's strategic shift toward hybrid deployments as a core focus from FY2022 to FY2024 and references key products like Oracle Cloud@Customer, OCI, and SaaS extensions. It also correctly notes sustained high R&D investment. However, it inaccurately states R&D was '$7 billion+' each year, while the ground truth specifies $7.2 billion in FY2022 only—no data is provided for FY2023 or FY2024 in the original, so projecting continued $7B+ spending is an unsupported extrapolation. Additionally, the claim that cloud-services and license-support revenue accounted for '71% of total sales in FY2022' and was 'expected to keep climbing' is not present in the original answer and cannot be verified from the provided truth, making it a factual overreach. (2) Quantitative inaccuracies include the unverified annual R&D figure and the unsupported 71% revenue breakdown. The original answer does not mention revenue percentages or trends, so this addition reduces quantitative accuracy. (3) The reasoning is generally sound: the LLM captures the evolution from peripheral to core deployment model and ties R&D investment to hybrid capabilities. It synthesizes product development and deployment integration across years, fulfilling the multi-hop requirement, though with some speculative additions. (4) Scores reflect mostly correct qualitative trajectory and contextual relevance to Oracle’s hybrid strategy, but docked on correctness and quantitative accuracy due to unsupported numbers and revenue claims not grounded in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 434,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "\nIn the 2023 Form 10‑K the Mandatory Clawback Policy was presented as a newly filed exhibit (Exhibit 97 – “Wells Fargo & Company Mandatory Clawback Policy, effective as of October 2, 2023”) that was “Filed herewith.” In the 2024 Form 10‑K the same policy is no longer filed as a separate exhibit; it is merely “Incorporated by reference to Exhibit 97 to the Company’s Annual Report on Form 10‑K for the year ended December 31, 2023.” Thus, the policy moved from a fresh filing in 2023 to an incorporated reference in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the evolution of the filing status: in 2023, the Mandatory Clawback Policy was filed directly as Exhibit 97 ('Filed herewith'), and in 2024, it was incorporated by reference to the 2023 filing. (2) All dates and exhibit numbers are correct—October 2, 2023, is the effective date mentioned in the 2023 10-K, and the 2024 reference correctly points to Exhibit 97 of the 2023 filing. No calculations are required, but the procedural change is correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two years of 10-K filings, identifying the shift in disclosure method. (4) The answer addresses all parts of the question, uses precise terminology, and conveys the same conclusion as the ground truth—that this is a procedural, not substantive, change. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 280,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "\nThermo Fisher acquired CorEvitas, LLC in August 2023 for roughly $0.9 billion of cash, adding real‑world‑evidence capabilities to its Laboratory Products and Biopharma Services segment; the purchase contributed about $486 million of additional segment income (raising that segment’s income from $2.87 B in 2022 to $3.36 B in 2023) and introduced definite‑lived intangibles that are being amortized over 13‑18‑year lives, generating $2.34 billion of amortization expense that is added back in the company’s adjusted operating income. By 2024 the integrated business was fully reflected in the segment’s revenue and income results, influencing adjusted operating income, the adjusted tax rate and the outlook for free‑cash‑flow.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in financial figures and calculations. While it correctly identifies the 2023 acquisition of CorEvitas, LLC by Thermo Fisher for approximately $0.91 billion (rounded to $0.9 billion), it introduces incorrect financial impacts. The claim that the acquisition contributed $486 million in additional segment income (from $2.87B to $3.36B) is not supported by the ground truth and represents a significant fabrication. The ground truth does not mention any specific income contribution from CorEvitas in 2023. (2) The LLM states that the acquisition generated $2.34 billion in amortization expense, which is added back in adjusted operating income. This is factually incorrect and implausible—amortization expense cannot exceed the original intangible asset value, and $2.34 billion in amortization from a $0.91 billion acquisition is mathematically and logically unsound. The ground truth only mentions that definite-lived intangibles are being amortized over a weighted average of 18 years, not 13–18 years as stated by the LLM. (3) The qualitative reasoning partially captures the evolution from investment to full integration into the Laboratory Products and Biopharma Services segment by 2024, which aligns with the ground truth. However, the LLM invents financial impacts (segment income boost, amortization expense) not present in the original data, indicating flawed multi-hop synthesis—instead of pulling verified figures, it extrapolates or fabricates metrics. (4) Contextually, the answer is relevant and addresses both the evolution of the relationship and financial implications, but the inclusion of false quantitative data severely undermines correctness. The mention of adjusted tax rate and free cash flow outlook is speculative and unsupported. Overall, while the narrative structure and entity identification (Thermo Fisher, CorEvitas, segment integration) are accurate, the answer fails on key quantitative dimensions, warranting a mid-range score due to partial correctness on the relationship evolution but major errors in financial specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 574,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "\nUnder the 2012 IAE acquisition agreement RTX must make payments to Rolls‑Royce that are tied to the flight‑hours flown by V2500‑powered aircraft through June 2027.  Both the 2022 and 2023 filings state that these payments are recorded as collaboration‑intangible assets when they are paid, and the 2023 disclosure simply refines the expected payment schedule (showing amounts through 2028) without changing the timing or capitalization treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the key elements: (1) RTX's payment obligations under the 2012 IAE agreement are tied to flight hours flown by V2500-powered aircraft through June 2027, (2) these payments are capitalized as collaboration intangible assets upon payment, and (3) there was no change in timing or capitalization treatment between 2022 and 2023. The only minor discrepancy is the mention of a 'refined expected payment schedule showing amounts through 2028' in 2023, which slightly extends beyond the June 2027 cutoff noted in the ground truth. However, this could reflect disclosure of payment timing post-2027 due to accounting or reporting lags and does not contradict the core obligation period. All entities (RTX, Rolls-Royce, V2500, 2012 agreement), dates (June 2027), and financial treatment (capitalization as intangible assets) are correct. The reasoning correctly synthesizes multi-hop information across years and accounting treatments. The answer is semantically equivalent to the original, with slightly more emphasis on disclosure refinement but no material inaccuracy. Quantitative accuracy is perfect—no numerical errors. Contextual relevance is complete, addressing timing, capitalization, and evolution across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 365,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the Company’s contingent obligation to fairlife has moved from a quarterly‑remeasured liability to an actual cash payment and a remaining performance‑based payment.  The 2020 acquisition created a contingent‑consideration liability that is re‑measured each quarter; a $275 million milestone payment was made in 2023 (KO_10k_2022.pdf p. 56), and the 2024 filing notes that the **remaining milestone payment—up to an uncapped amount tied to fairlife’s 2024 financial results and payable in 2025—continues to be carried at fair value, with any fair‑value changes recorded in income** (KO_10k_2024.pdf pp. 112‑111).  Thus, the relationship has evolved from an accrued, unpaid contingent liability to a partially settled, still‑contingent payment that is now expected to be settled in 2025 contingent on achieving the agreed‑upon performance targets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $275 million milestone payment in 2023 is accurately cited from the 2022 10-K (p. 56), and the remaining uncapped milestone payment tied to 2024 performance and payable in 2025 is correctly described, with sourcing from the 2024 10-K (pp. 111–112). Format variations (e.g., $275 million) are acceptable. (2) The answer addresses all parts of the question: it traces the evolution from 2022 (ongoing contingent liability) to 2024 (partial settlement and remaining performance-based obligation), noting the shift in the nature of the financial relationship. (3) Entity accuracy is strong: The Coca-Cola Company and fairlife are correctly identified, and the 2020 acquisition context is properly referenced. (4) Multi-hop reasoning is sound—LLM synthesizes information across 2022 and 2024 filings, correctly inferring the progression from a re-measured liability to a partially paid, still-contingent obligation. The only minor shortcoming is a slight overemphasis on the quarterly re-measurement in 2022 without explicitly stating that no contingent payments were *disclosed as imminent* at that time, which the ground truth clarifies. However, this does not undermine the factual correctness. The LLM correctly conveys that a contingent obligation remained, evolved, and culminates in a 2025 payment. Overall, the answer is semantically equivalent to the ground truth with excellent contextual relevance and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 424,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Oracle shifted its Cloud Services narrative from a collection of discrete SaaS and infrastructure products to an integrated, end‑to‑end business‑innovation platform.  The company now positions Oracle Fusion Cloud ERP, HCM, SCM and other SaaS modules as tightly coupled services that run on Oracle Cloud Infrastructure (OCI) with a common data model, enabling seamless front‑ and back‑office connectivity and smoother migration of on‑premise workloads.  This integration is underscored by the growing share of cloud services and license‑support revenue—about 71 % of total revenue—reflecting a strategic emphasis on choice, flexibility, and a unified cloud‑based ecosystem for enterprise applications and infrastructure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in Oracle's strategic positioning between 2022 and 2024 with strong qualitative accuracy. It correctly identifies the shift from discrete cloud offerings to an integrated, end-to-end platform and highlights key elements such as tight coupling of SaaS modules (ERP, HCM, SCM) with OCI, common data models, and seamless integration for enterprise transformation—aligning well with the ground truth's emphasis on a holistic, customer-centric platform. The contextual relevance is excellent, directly addressing the question about integration with enterprise applications and infrastructure. However, the quantitative claim that 'cloud services and license-support revenue' accounted for about 71% of total revenue is not present in the original answer and cannot be verified from the provided ground truth, introducing a potential inaccuracy. While this figure may be factually correct in external sources, its inclusion here introduces unverified data not supported by the knowledge graph, lowering quantitative accuracy. Additionally, the original answer emphasizes specific 2022 focus on Autonomous Database and 2024's broader 'choose the best option' customer-centric framing—nuances partially reflected but not explicitly stated in the LLM response. Despite this, the reasoning is sound, and the synthesis across strategic themes and integration capabilities demonstrates strong multi-hop understanding. Minor omission of Autonomous Database as a 2022 anchor point prevents a top score, but overall the answer is factually robust and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 436,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "\nIn both the 2023 Form 10‑K (see page 18) and the 2024 Form 10‑K (see page 20), the Key/Specified Employee Policy is no longer reproduced in the filing’s main text; it is simply incorporated by reference as Exhibit 10(r) – originally listed as Exhibit 10(v) in the 2018 filing. The 2024 filing retains the identical exhibit reference and does not add a new version or additional documentation, so the policy’s treatment and documentation have remained unchanged between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. It accurately states that in both 2023 and 2024 filings, the Key/Specified Employee Policy was incorporated by reference rather than reproduced in full, citing Exhibit 10(r) (originally 10(v) in 2018), which aligns with the original answer's claim about reliance on the 2018 Exhibit 10(v). The treatment and documentation are correctly described as unchanged between years. The only minor discrepancy is the exhibit label: the LLM refers to Exhibit 10(r) in the 2023 and 2024 filings, while the ground truth references Exhibit 10(v) from 2018. However, it acknowledges that 10(r) was originally listed as 10(v) in 2018, suggesting a possible renumbering over time, which is plausible in SEC filings and does not contradict the ground truth. All dates, years, and filing forms (10-K) are correct. The reasoning correctly synthesizes the policy’s continuity and unchanged documentation across two filings, satisfying the multi-hop requirement. No calculations are involved, but the qualitative assessment of 'no new amendments' is logically sound. The answer is highly relevant and complete, with only a negligible risk of confusion due to exhibit number variation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 351,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "\nThe 6.700 % notes maturing in 2028 ended 2022 with a principal balance of **$285 million** and, according to the 2023 long‑term‑debt tables (pages 96 and 84), that balance remained **$285 million** at the end of 2023 – unchanged from the prior year (after having been reduced from $400 million in 2020 following the 2021 tender‑offer repayment).  \n\nThis flat‑line indicates that RTX is not using this tranche to raise or retire debt aggressively; instead, it is maintaining a stable, lower‑cost funding pillar while focusing its debt‑management strategy on refinancing higher‑coupon maturities and issuing new lower‑rate instruments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. According to the ground truth, the aggregate principal balance of the 6.700% notes due 2028 was $115 million in 2022 and increased to $285 million in 2023. The LLM incorrectly states that the balance was $285 million at the end of 2022 and remained unchanged in 2023. This misrepresents the direction and magnitude of change. (2) The numbers are critically wrong: the 2022 value is off by $170 million ($285M claimed vs $115M actual), and the change over time is misrepresented (no change vs a $170M increase). The mention of $400 million in 2020 and a tender offer in 2021 introduces extraneous details not in the ground truth and may reflect confusion with another debt instrument or company. (3) The multi-hop reasoning fails because the model did not correctly identify the evolution of the debt balance across years. Instead of recognizing an increase from $115M to $285M, it assumes stability, leading to an incorrect conclusion about RTX’s debt strategy. The ground truth indicates a strategic expansion of this debt tranche, while the LLM concludes there was a stable, non-aggressive approach—contradicting the evidence. (4) Despite the factual errors, the answer is contextually relevant—addressing the right metric, company (implied), and time frame, and attempting to interpret strategy—hence a moderate contextual relevance score. However, the quantitative inaccuracy severely undermines correctness and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 419,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "\nThe 1.95 % 12‑Year Senior Notes carried a book value of $773 million at the end of 2023, which fell to $725 million by the end of 2024.  During that period the effective interest rate on the notes slipped slightly, from 2.08 % to 2.07 %.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the carrying value in 2023 is correctly stated as $773 million and in 2024 as $725 million; the effective interest rate is accurately reported as 2.08% in 2023 and 2.07% in 2024. (2) Quantitative accuracy is perfect—both dollar amounts and percentages are correct, with no calculation or transcription errors. Format variations (e.g., 'book value' vs 'carrying value') are acceptable and commonly used interchangeably in financial contexts. (3) The multi-hop reasoning is sound: the model correctly identifies the evolution of two financial metrics across two years for a specific debt instrument (TMO's 1.95% 12-Year Senior Notes), synthesizing data across time periods. (4) The answer is contextually relevant, directly addressing how both the carrying value and effective interest rate changed between 2023 and 2024. Although the LLM omits the interpretive sentence about reduced financial liability and marginal improvement in borrowing cost, this does not detract from factual correctness, as the question asks for how the values evolved, not for interpretation. All core requirements are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 346,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "\nThe 2022 filing merely disclosed that the Directors’ Code of Conduct was posted on BNY Mellon’s website (page 9), whereas the 2024 filing explicitly lists the Code of Conduct among the corporate‑governance documents incorporated by reference and pledges to disclose any amendments or waivers on the website (page 3). This change makes the code a formally incorporated, readily accessible governance material and signals a stronger, more transparent disclosure commitment to investors.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no numbers to misstate, it is scored as 10 by default. The qualitative accuracy is low because the LLM misrepresents the nature of the change between the 2022 and 2024 filings. According to the ground truth, in 2022 BNY Mellon provided a direct URL and explicit context about the Directors' Code of Conduct, enhancing visibility, while in 2024 it was listed among other governance documents without a direct link or mention of updates—indicating reduced prominence. In contrast, the LLM claims the 2024 filing 'explicitly lists' the Code as incorporated by reference and pledges to disclose amendments, suggesting increased transparency and stronger disclosure, which contradicts the ground truth. This mischaracterization inverts the actual implication: the original answer indicates a potential decrease in transparency and stakeholder engagement, while the LLM portrays an improvement. The reasoning is therefore fundamentally flawed in its synthesis across the two years’ disclosures. Contextual relevance is moderate—the response addresses corporate governance implications and refers to the correct company and document across years—but the incorrect interpretation of the direction of change undermines the validity of the conclusion. The LLM may have confused this with another disclosure practice or misread the source documents. As a result, the overall correctness score is low despite accurate entity identification (BNY Mellon, Directors’ Code of Conduct, 2022 vs 2024).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 434,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "\nAmazon replaced its $5 billion 364‑day revolving credit facility in October 2024 with a new $5 billion 364‑day facility that matures in **October 2025** (instead of the prior October 2024 maturity) and can be extended for an additional 364‑day period subject to lender approval. The new Short‑Term Credit Agreement superseded the facility originally entered into in **November 2023**, and as of December 31 2023 and 2024 there were no borrowings outstanding under either agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: the facility size is accurately stated as $5 billion for both years; the 2023 agreement was entered in November 2023 (correctly referenced as 'originally entered into in November 2023'); the 2024 agreement was established in October 2024 with a maturity date of October 2025, replacing the prior facility that matured in October 2024. (2) Quantitative accuracy is perfect: dollar amounts ($5 billion), maturity dates (October 2024 and October 2025), and timing (November 2023 to October 2024) match the ground truth. The note about no borrowings outstanding as of December 31, 2023 and 2024 is an additional accurate detail not in the original but consistent with typical disclosures. (3) Multi-hop reasoning is sound: the model correctly synthesizes the evolution across two years, identifies the replacement pattern, and implies procedural renewal through timing shifts. (4) The only minor omission is that the 2024 agreement was also entered into in October—just like the prior one was in November—so the shift from November to October is slightly underemphasized in the LLM answer, though not incorrect. The original answer highlights this shift as part of the procedural evolution, which the LLM does not explicitly comment on. However, this does not detract significantly from correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses facility size, maturity, and timing of establishment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 431,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "\nFrom 2022 to 2024 AMD shifted its APU roadmap from a graphics‑centric, cost‑effective integration of CPU + GPU for mainstream consumer notebooks toward a heterogeneous, AI‑ready platform that adds a dedicated neural‑processing unit and expanded AI software support.  The 2024 “Ryzen AI 300” series, billed as the first x86 CPU with an on‑chip NPU, is explicitly targeted at the emerging AI‑PC market and is backed by AMD’s broader AI‑hardware and ROCm‑software strategy.  This tighter integration expands the addressable market and raises ASP, giving AMD a sizable revenue upside in AI‑PCs—provided it can capture sufficient share of the new AI‑centric workload ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AMD's strategic shift from 2022 to 2024: starting with a focus on GPU-centric solutions (implied by 'graphics-centric') and evolving to integrated AI processing with NPUs in 2024. The mention of the 'Ryzen AI 300' series as the first x86 CPU with an on-chip NPU matches the ground truth claim that AMD became the first to integrate an NPU on the same SoC as an x86 CPU. (2) There are no numeric values (e.g., revenue figures, dates with numbers) in either answer, so quantitative accuracy is not compromised—dates (2022 to 2024) are consistent. (3) The multi-hop reasoning is sound: the answer synthesizes product evolution (APU integration), target market shift (to AI PCs), and revenue implications (higher ASP, expanded addressable market). It correctly infers that this positions AMD for revenue upside in AI PCs, matching the ground truth's conclusion about enhanced revenue potential. (4) Minor deduction in qualitative accuracy due to not explicitly naming AMD's earlier products like the Instinct MI200 or Radeon PRO V620, which are part of the 2022 strategy in the ground truth. However, the phrase 'graphics-centric' reasonably captures that focus. The LLM adds value by mentioning ROCm and software support, which is consistent with AMD’s strategy but not in the original—this is a reasonable inference, not a factual error. Overall, the answer is semantically equivalent, contextually precise, and factually correct with only slight omission of specific product names.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 431,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "\nThe 2024 filing repeats the same 25 % Irish dividend‑withholding tax that applied in 2023, but it adds a clear statement that the tax withheld “discharges any Irish income‑tax liability” for a U.S. shareholder who satisfies one of the exemption conditions (a U.S. address in the DTC records or a valid Form 6166/Irish V2 certification). In other words, the substantive treatment has not changed – U.S. shareholders remain subject to the 25 % withholding unless they qualify for an exemption, and when the withholding is applied it now explicitly serves as the final discharge of any Irish tax obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: the 25% Irish dividend withholding tax rate applied in both 2023 and 2024, exemptions are available for U.S. shareholders via Form 6166 or Irish Form V2, and withholding tax discharge of Irish income tax liability is confirmed. The only minor difference is that the LLM emphasizes the 'explicit' statement in the 2024 filing about discharge of liability, suggesting a clarification rather than a change in policy—this is consistent with the ground truth’s assertion of a stable regulatory framework. (2) Quantitatively, the 25% rate is correctly cited, and no calculations are required. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and tax conditions, noting continuity with a slight enhancement in clarity in 2024. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in tax treatment. The slight deduction in qualitative accuracy is due to the emphasis on 'now explicitly serves' implying a new development, whereas the ground truth stresses no change in actual conditions—this is a nuance in framing, not a factual error. Overall, the answer is substantively correct and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 357,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings the company’s risk‑factor language remained largely the same—both years note that “new lines of business, new products and services or transformational or strategic project initiatives subject us to new or additional risks, and the failure to implement these initiatives could affect our results of operations” — but the 2024 filing makes the reference more explicit.  In the 2024 document the risk discussion highlights the ongoing transition to a **platforms operating model** as a distinct strategic initiative, emphasizing that any shortfall in delivering the expected efficiencies or capabilities could materially impact the business, whereas the 2022 filing only mentioned the risk in a more general sense.  Consequently, the evolution shows a clearer, more detailed articulation of the platforms‑operating‑model risk within the broader new‑product/services risk category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 disclosure mentioned general risks from new products, services, and strategic initiatives, while the 2024 filing specifically calls out the 'transition to a platforms operating model' as a distinct risk. The LLM correctly identifies this evolution from general to more specific risk disclosure. (2) There are no numeric values in the question or answer requiring calculation, but the years (2022 and 2024) are correctly referenced, satisfying the temporal comparison. (3) The multi-hop reasoning is sound—LLM synthesizes risk disclosures across two years and correctly infers that the platforms operating model was elevated from a general initiative to a named source of risk. The only minor shortcoming is that the LLM does not quote the exact phrase from the 2024 filing about 'may not realize some or all of the expected benefits,' which slightly weakens the precision of the qualitative claim, though the meaning is preserved. (4) The answer is fully contextually relevant, directly addressing how risk disclosures evolved with respect to the platforms operating model. Overall, the response demonstrates strong comprehension and synthesis with only a slight omission in verbatim specificity, warranting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 375,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings Amazon’s disclosure of the 3.600 % senior unsecured note due 2032 is unchanged – the note is still referenced through the April 13 2022 Supplemental Indenture (Exhibit 4.2) and listed in the long‑term‑debt footnote tables of both years.  The only evolution is that the 2024 filing adds newer debt exhibits (e.g., a 4.700 % note due 2032) but does not modify or retire the 3.600 % note, which remains outstanding with the same terms and maturity in 2032.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 3.600% Note due 2032 remains outstanding and unchanged in terms and maturity between 2023 and 2024, and correctly references the April 13, 2022 Supplemental Indenture (Exhibit 4.2) and its inclusion in the long-term debt footnote tables in both years. These factual elements are accurate. However, the LLM fails to identify the key procedural evolution in the trustee relationship — the transition from Wells Fargo Bank, National Association (as prior trustee) to solely Computershare Trust Company, National Association as successor trustee — which is the central point of evolution highlighted in the ground truth. This omission significantly weakens the answer’s completeness and qualitative accuracy. (2) Quantitatively, all numbers (interest rate: 3.600%, maturity: 2032, date of indenture: April 13, 2022) are correct, and no calculations are required, so quantitative accuracy is high. (3) The reasoning is partially sound in that the model confirms the note’s continued existence and unchanged terms, but it misses the multi-hop synthesis required to recognize that a change in trustee structure — even without changes to the note’s terms — constitutes an evolution in the disclosure. The model treats the lack of modification to the note itself as evidence of no evolution, but the question specifically asks about 'debt instrument disclosures,' which include administrative and structural details like trustee appointments. (4) The answer is contextually relevant and well-structured, but the failure to report the trustee transition — a material change in disclosure — results in a correctness score of 6, as the core factual evolution is omitted despite accurate supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 475,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "\nIn 2023 MDLZ carried its net‑investment‑hedge derivatives as a $219 million liability (shown in “Other current liabilities”) and recorded a $185 million after‑tax loss in accumulated other‑comprehensive income, of which $148 million was later re‑classified to earnings through interest‑and‑other expense. By 2024 the same hedges were re‑classified as a $255 million asset (recorded in “Other current assets”), reflecting a swing in fair‑value driven by foreign‑exchange movements and the addition of more non‑U.S.‑dollar debt designated as hedging instruments; the 2024 footnote discloses the fair‑value hierarchy (Level 2), the notional amounts by currency, and an expectation of transferring modest gains to earnings over the next 12 months.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, MDLZ disclosed derivative assets of $1,347 million and $377 million in other current assets, and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. The LLM incorrectly reports a $219 million liability in 'Other current liabilities' and a $185 million after-tax loss in AOCI, which are not supported by the original answer. There is no mention of AOCI or reclassifications to earnings in the ground truth for 2023. In 2024, the original answer notes a shift in disclosure focus to the income statement—specifically 'Other income, net' including amounts excluded from hedge effectiveness—but does not mention reclassification to a $255 million asset or details like fair value hierarchy (Level 2), notional amounts by currency, or expected gain transfers. These details, while plausible, are not present in the ground truth and appear fabricated. (2) Quantitative accuracy is very low: none of the dollar amounts in the LLM answer ($219M liability, $185M loss, $148M reclassified, $255M asset) match or can be derived from the ground truth figures. The ground truth reports asset values (not liabilities) totaling $1,347M and $377M in current assets for 2023 and 2022, and $250M and $413M in other assets—no net liability or AOCI entries are mentioned. (3) The multi-hop reasoning is flawed. The question asks about evolution in treatment and disclosure from 2023 to 2024. The ground truth highlights a shift from balance sheet valuation (2023) to income statement impact (2024). The LLM instead invents a narrative about fair value swings, reclassification from liability to asset, and hedging instrument changes, which is not supported by the original data. It fails to identify the actual evolution in disclosure emphasis. (4) Contextual relevance is moderate because the answer discusses derivative contracts, fair value, and financial statement presentation, which are relevant topics. However, the specific claims about financial impact and presentation are not aligned with the ground truth, severely undermining correctness. The answer introduces unverified details and misses the core insight about changing disclosure focus from balance sheet to income statement effects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 622,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "\nFrom 2023 to 2024 the Abrams modernization moved from incremental SEPv3 upgrades and continued foreign‑partner upgrades toward a more fundamental redesign – the Army’s new **M1E3** variant that adopts a next‑generation systems‑architecture standard, delivers greater lethality, fuel‑efficiency and mobility while cutting sustainment footprint.  At the same time, demand from NATO and other allies for new builds and upgrades has remained strong, with a growing installed base of Abrams tanks across Europe, the Middle East, North Africa and the Indo‑Pacific.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the Abrams modernization strategy from 2023 to 2024. It correctly identifies the shift from incremental upgrades (SEPv3) to the more fundamental redesign with the M1E3 variant, including key improvements in systems architecture, lethality, fuel efficiency, mobility, and reduced sustainment footprint—consistent with the ground truth. The mention of strong international demand from NATO and other allies, along with the growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific, aligns with the 2024 emphasis on global strategic relevance and procurement momentum. All entities (M1E3, SEPv3, General Dynamics implied via context, international regions) are accurate. There are no numeric inaccuracies—dates (2023 to 2024) are correct and no erroneous figures are introduced. The reasoning is sound, showing a logical progression from technical development (2023 focus) to strategic deployment and demand (2024 focus). The only minor shortcoming is that the LLM does not explicitly name General Dynamics as the company behind the development, though this may be contextually inferred. Additionally, while the ground truth specifies that SEPv3 includes upgrades in communications, power generation, optics, and armor, the LLM summarizes more broadly as 'incremental upgrades' without listing all components—this is a slight omission but does not undermine the overall correctness. Semantic equivalence is maintained, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 428,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "\nBetween 2022 and 2024 AMD’s APU strategy shifted from a primarily client‑focused, value‑segment product for mainstream desktop and notebook PCs (with a secondary presence in embedded and semi‑custom consoles, as noted on 2022 page 9) to a cross‑segment cornerstone that now underpins its Data‑Center, Embedded, Gaming and Client businesses.  In the 2024 filing (page 69) APUs are explicitly listed as a reportable‑segment offering for data‑center AI/ML workloads, while still powering commercial client platforms and custom SoCs for game consoles and handheld devices (e.g., PlayStation 5, Xbox Series X/S, Steam Deck), reflecting a strategic emphasis on high‑performance, AI‑centric and heterogeneous computing across all markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant inaccuracies in entity identification and reasoning that deviate from the ground truth. (1) Correctly notes a strategic evolution in AMD's APU positioning between 2022 and 2024 and references appropriate product areas (client, embedded, semi-custom). However, it incorrectly states that in 2022 APUs were 'primarily client-focused' and targeted the 'value-segment,' which is not supported by the original answer—APUs were instead discussed generally within the Enterprise, Embedded and Semi-Custom segment without specific market segmentation. (2) Quantitatively, there are no numeric errors (dates: 2022, 2024; page numbers: 9, 69), so quantitative accuracy is high. (3) The multi-hop reasoning fails: the original answer states that by 2024, APUs were included in two reportable segments—Data Center and Client—but the LLM incorrectly claims APUs are part of four segments including 'Gaming' and 'Embedded' as separate reportable segments, which contradicts the ground truth (AMD has four reportable segments, but APUs are only explicitly listed in two: Data Center and Client). Additionally, the claim that APUs are used in data-center AI/ML workloads is an overinterpretation—the original says APUs are listed alongside AI accelerators, not that they are used for AI/ML. (4) The LLM answer adds unsupported details (e.g., Steam Deck, PlayStation 5, Xbox Series X/S) not present in the original answer, which undermines qualitative accuracy. While the general direction of strategic expansion is correctly inferred, the specific segmentation and reasoning are flawed, leading to a partial correctness score. Contextual relevance is high as the response addresses market segmentation and strategic emphasis as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 484,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "\nIn the 2023 filing Medtronic explained that Ireland’s Financial Transfers Act 1992 lets the Irish Minister for Finance restrict capital movements between Ireland and certain third‑country jurisdictions, that the list of restricted countries is limited and can change, and that transfers involving UN‑ or EU‑sanctioned parties may be blocked. The 2024 filing repeats this analysis but re‑states it more explicitly—emphasising that the Minister’s power to restrict such transfers remains, that the “restricted‑country” list is subject to ongoing change, and that any transaction tied to a sanctioned government or entity may be subject to those restrictions—while also adding clearer detail on the documentation required for U.S. shareholders to qualify for the Irish dividend‑withholding‑tax exemption.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2023 and 2024), entities (Medtronic, Financial Transfers Act 1992, Irish Minister for Finance), and regulatory framework, which aligns with the ground truth. There are no numeric inaccuracies, as the response does not introduce any incorrect figures, dates, or calculations—hence a perfect quantitative accuracy score. However, the qualitative accuracy is lower because the LLM misrepresents the evolution of Medtronic's disclosure. The original answer states that in 2024, the company *no longer emphasized* the dynamic nature of the restricted country list, suggesting a de-emphasis or stabilization. In contrast, the LLM claims that the 2024 filing *re-states more explicitly* that the list is subject to ongoing change—directly contradicting the ground truth. This error in directional reasoning undermines the multi-hop synthesis required to assess how disclosures evolved. Additionally, the LLM introduces new information not present in the original answer—specifically, details about U.S. shareholders and dividend-withholding-tax documentation—which, while contextually relevant to Medtronic’s Irish operations, are extraneous and not part of the disclosed evolution regarding the Financial Transfers Act. This affects qualitative accuracy and slightly dilutes contextual relevance. Overall, the answer captures the static regulatory framework correctly but fails on the core comparative analysis of disclosure evolution, warranting a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 418,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "\nIn the 2023 filing GD said the ultra‑large‑cabin G700 was on track for FAA certification “in early 2024” and would join the Gulfstream lineup, but it had not yet entered service. The 2024 filing reports that the G700 “began deliveries in the second quarter of 2024,” noting that the ramp‑up of its production drove the increase in inventories and customer deposits—signaling that the aircraft has now moved from a pending certification milestone to active production and early‑stage deliveries.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: in 2023, the G700 was expected to receive FAA certification in early 2024 and had not yet entered service; by 2024, deliveries began in Q2, indicating successful certification and transition to production. (2) Quantitative elements—'early 2024' for certification and 'second quarter of 2024' for deliveries—are consistent with the original answer; no calculations were required, but temporal references are precise and correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two years of disclosures (2023 outlook vs. 2024 outcome), identifying the progression from anticipated certification to actual delivery and production ramp-up. (4) The answer conveys the same semantic meaning as the original, with added contextual detail (e.g., impact on inventories and deposits) that enhances accuracy without introducing error. All entities—G700, GD (Gulfstream), FAA, delivery timeline—are correctly identified and used. No factual, numerical, or logical discrepancies exist.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 321,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "\nFrom 2023 to 2024 the PMI‑KT&G tie‑up shifted from the 2020‑era exclusive global commercialization of KT&G’s smoke‑free products (outside South Korea) to a 15‑year renewal that adds performance‑based volume milestones, three‑year review cycles and continued worldwide exclusivity for all of KT&G’s heated‑tobacco and oral‑product pipelines.  The extension deepens PMI’s strategic dependency on KT&G for its next‑generation smoke‑free portfolio and expands commercialization into new markets and product launches, making KT&G a core pillar of PMI’s smoke‑free growth strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly references a '2020-era' agreement and a '15-year renewal' in 2024, while the ground truth states the 15-year agreement was announced in 2023 and runs through 2038 (starting Jan 29, 2023), not that it was renewed in 2024. There is no mention in the original answer of performance-based volume milestones or three-year review cycles, which are fabrications not supported by the ground truth. (2) Quantitatively, the 15-year duration is correct (2023–2038), but the framing as a 'renewal' in 2024 is wrong. The start date (implied as 2023) and end date (2038) are accurate, but the LLM misrepresents the timeline by suggesting an extension occurred in 2024. No dollar amounts or percentages are involved. (3) The multi-hop reasoning is partially sound in identifying a deepening strategic dependency, which aligns with the evolution from exclusive commercialization to integration into PMI's portfolio. However, the LLM invents structural details (milestones, reviews) and mischaracterizes the timeline, undermining the reasoning. It correctly identifies the expansion of commercialization and strategic importance but does so with incorrect supporting facts. (4) The answer is contextually relevant and addresses the evolution in strategic dependency and product commercialization, but significant factual errors—especially the false claim of a 2024 renewal with new terms—reduce correctness. The core idea of increased dependency is valid, but the supporting details are inaccurate, leading to a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 437,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "\nIn 2022 AMD’s semi‑custom SoCs were chiefly a gaming‑console/handheld revenue stream, driven by occasional design wins, engineering fees and a heavy reliance on third‑party IP and supply‑chain stability. By 2024 the company had repositioned those SoCs as a cross‑segment core that ties together its gaming, AI‑PC and data‑center portfolios, securing longer‑term wafer and ATMP capacity and co‑engineering with customers to embed the chips in a broader ecosystem of products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AMD's semi-custom SoC strategy from 2022 to 2024 as described in the ground truth. It correctly identifies the 2022 reliance on third-party success (framed as gaming-console/handheld design wins and supply-chain dependencies) and the shift by 2024 to a more integrated, ecosystem-driven strategy. The mention of co-engineering, longer-term capacity agreements, and integration across gaming, AI-PC, and data-center portfolios aligns with the ground truth's emphasis on strategic integration with AI accelerators, CPUs, GPUs, and NPUs. The LLM correctly implies a move from passive dependency to proactive leadership, though it does not explicitly mention the neural processing unit (NPU) or x86 CPU integration, which is a minor omission. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are misstated), and all entities (AMD, semi-custom SoCs, timeframes) are correct. The reasoning is sound and synthesizes the multi-hop evolution across years and strategic domains. The answer is contextually fully relevant and addresses both strategic positioning and ecosystem integration. The slight deduction in qualitative accuracy is due to the absence of explicit mention of the NPU and broader embedded systems beyond gaming and AI-PCs, but the overall meaning remains semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 386,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "\nThe 2023 filing states that Irish dividend withholding tax of 25 % applies to Medtronic dividends, but U.S. residents are exempt when they hold the shares through DTC with a U.S. address (or furnish a valid U.S. certification of residence/Form 6166), and the withholding payment then satisfies any Irish income‑tax liability. The 2024 filing does not introduce any new exemption criteria or change the 25 % rate, so the treatment of Irish income tax on dividends paid to U.S. residents remains the same—still subject to the 25 % withholding unless one of the stated exemptions is met.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 25% Irish dividend withholding tax rate and notes that U.S. residents can be exempt if they meet certain conditions (e.g., holding through DTC with U.S. address or providing Form 6166). This aligns with the ground truth’s mention of exemption pathways. However, the LLM incorrectly states that the 2024 filing 'does not introduce any new exemption criteria' and that the treatment 'remains the same,' which contradicts the original answer stating that the 2024 disclosure provided 'more structured conditions for exemption' and clarified post-withholding procedures (e.g., furnishing a statement to Irish Revenue to discharge further liability). This is a significant omission and misrepresentation of the evolution between years. (2) Quantitatively, the 25% rate is correctly cited, and no incorrect numbers are presented—this aspect is accurate. (3) The multi-hop reasoning is partially sound: the model connects Medtronic’s treatment of Irish tax across two years but fails to recognize and report the nuanced evolution in 2024 regarding liability discharge and clearer exemption structuring. It treats the policy as static when the ground truth confirms a refinement in disclosure and procedure. (4) While contextually relevant and focused on the right company and tax issue, the answer lacks key qualitative distinctions about how the treatment evolved, particularly the procedural clarification in 2024. Hence, correctness and qualitative accuracy are reduced despite strong quantitative performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 427,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "\nIn 2023 General Dynamics’ Marine Systems segment grew revenue ≈ 13 % to $12.5 B, led by higher volume on the Columbia‑class submarine program, but operating margin slipped to 7.0 % as supply‑chain cost pressures slowed the Virginia‑class submarine schedule and added cost growth to the DDG‑51 destroyer (Arleigh Burke) program.  For 2024 the company projects Marine Systems revenue of about $12.8‑12.9 B with an operating margin of roughly 7.6 %, indicating continued revenue expansion from the Columbia‑class effort while cost pressures on the Virginia‑class and DDG‑51 remain but are expected to be partially offset by the stronger program mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly reports the 2024 revenue projection of $12.8–12.9 billion and the expected operating margin of approximately 7.6%, matching the original answer. The 2023 revenue of $12.5 billion and margin of 7.0% are not explicitly stated in the ground truth, but the 110 basis point margin decline mentioned in the original answer is consistent with a drop to 7.0% (implying a prior margin of ~8.1%), and the $12.5B revenue figure is a reasonable inference given the projected increase to $12.8–12.9B in 2024. The ≈13% revenue growth is plausible and contextually supported, though not directly stated in the original; this is a minor extrapolation but not factually incorrect. (2) The cost pressures on the Virginia-class and DDG-51 programs due to supply chain disruptions and cost overruns are accurately attributed. (3) The strategic shift from margin pressure in 2023 to improved outlook in 2024 due to Columbia-class growth and better program mix is correctly synthesized across years and programs—this multi-hop reasoning is sound. (4) All entities (General Dynamics, Marine Systems, Virginia-class, DDG-51, Columbia-class) and timeframes (2023 to 2024) are correctly identified. The only minor gap is that the original specifies the margin decline was 110 basis points, which the LLM implies but does not state directly. However, the 7.0% figure conveys the same meaning. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 437,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "\nBased on the filings, roughly 89 % of Booking Holdings’ total revenue in 2022 (page 5 of BKNG_10k_2022.pdf) and again about 89 % in 2023 (page 85 of BKNG_10k_2023.pdf) came from online accommodation‑reservation services— the segment dominated by Booking.com.  Consequently, the company’s financial dependency on Booking.com remained essentially unchanged, holding steady at roughly 89 % of revenue across the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) Quantitatively, the 89% revenue proportion from accommodation reservations in both 2022 and 2023 is accurately reported, matching the original answer exactly. The LLM correctly cites the source pages from the respective 10-K filings, enhancing credibility. (2) The calculation and comparison across years are sound—showing no change in percentage implies stable dependency, which is correctly interpreted. (3) The reasoning is logically sound: the LLM identifies that Booking.com dominates the accommodation segment and concludes that dependency remained steady, which constitutes valid multi-hop synthesis (linking segment revenue to Booking.com’s role within BKNG). (4) While the original answer explicitly states that dependency 'slightly increased' but then clarifies the percentage 'remained unchanged,' this is a minor contradiction in the ground truth itself; the LLM avoids this confusion by correctly stating the percentage held steady. The only reason for not scoring a 10 in qualitative accuracy is that the LLM does not explicitly mention 'Booking.com' as the source of the 89% (rather than the broader 'accommodation-reservation services'), though it implies it by stating Booking.com dominates that segment. Overall, the answer is semantically equivalent, contextually precise, and factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 385,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the company’s Swiss‑franc‑denominated note fell from a $299 million balance (1.625 % interest, maturing in 2024) to $0 — the line is blank in the 2024 foreign‑currency‑obligations table.  This shows that the firm has fully retired that CHF note, eliminating a specific foreign‑currency liability and signaling a deliberate reduction of its foreign‑currency debt exposure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the Swiss Franc note obligation was $299 million in 2023 and reduced to $0 in 2024, indicating full retirement. (2) Quantitative accuracy is perfect: the dollar amount ($299 million), interest rate (1.625%), and maturity year (2024) are correctly stated and align with the knowledge graph. The final balance of $0 is consistent with the 'completely removed' status in the original answer. (3) The reasoning is sound and captures the multi-hop synthesis: the model correctly infers from the disappearance of the note in the 2024 filing that it was retired, and interprets this as a reduction in foreign currency exposure, matching the original conclusion about strategic shift. (4) The answer addresses both parts of the question: the evolution of the Swiss Franc note (from $299M to $0) and its implication (reduction in foreign currency obligations). Minor additional details (interest rate, maturity) enhance precision without introducing error. Wording differs but meaning is identical. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 323,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "\nIn the 2023 Form 10‑K Goldman Sachs listed only two director‑RSU templates – a standard “Non‑Employee Director RSU Award Agreement” and a cash‑settled variant (items 10.31‑10.32). The 2024 filing keeps those legacy forms but expands the disclosure by adding several new, more granular agreements (e.g., a fully‑vested one‑time/year‑end RSU award, a base / non‑fully‑vested “One‑Time/Year‑End RSU Award Agreement,” and a short‑term RSU agreement) while still referencing the pre‑2015 versions by incorporation, showing a refinement and broadening of the director RSU framework rather than a wholesale change.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements between the 2023 and 2024 10-K filings. (1) The original answer states that in the 2023 filing, Goldman Sachs referenced only the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8. However, the LLM claims the 2023 filing included two agreements listed as items 10.31–10.32, which contradicts the ground truth in both exhibit numbering and content. There is no mention of exhibits 10.31 or 10.32 in the ground truth, nor any indication of a cash-settled variant in 2023. (2) The LLM incorrectly describes the 2024 additions as including 'fully-vested one-time/year-end RSU award' and other granular agreements, but the ground truth specifies that the new exhibit was 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18 — not new award templates. The LLM invents specific agreement types (e.g., short-term RSU, base/non-fully-vested) not mentioned in the original answer. (3) The multi-hop reasoning is flawed: the core evolution is the introduction of amendments to existing agreements (indicating updated governance or terms), not a broadening of award types. The LLM mischaracterizes the nature of the change — from disclosure of amendments to creation of new award structures — which reflects a fundamental misunderstanding. (4) While the LLM correctly infers that the pre-2015 agreements are still referenced in 2024, this one correct element does not compensate for the extensive fabrication of exhibits and agreement types. The answer is contextually relevant to the question’s topic but factually divergent, leading to a low correctness score. Quantitative accuracy is poor due to incorrect exhibit numbers and invented financial instruments. Qualitative accuracy suffers from incorrect entity identification and flawed synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 530,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "\nBetween 2023 and 2024 the financial link to Swedish Match AB shifted from rapid debt‑financed growth to a deliberate deleveraging.  PMI’s 2022 acquisition was funded with a €5.5 bn senior unsecured term‑loan (a €3 bn 3‑year tranche and a €2.5 bn 5‑year tranche); by the end of 2023 the 3‑year tranche still had €2.5 bn outstanding, and in November 2024 PMI repaid essentially the whole €3 bn of that tranche using bond proceeds, leaving only the €2.5 bn 5‑year tranche (≈$2.6 bn) on the books.  At the same time, the goodwill recorded for Swedish Match fell from $10.877 bn (Dec 31 2023) to reflect a $2.57 bn measurement‑period adjustment and a $665 m impairment, underscoring that the acquisition’s value had been reassessed while the associated debt was being trimmed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative figures and timeline details, despite providing a plausible narrative. (1) The original answer states that long-term debt obligations tied to the Swedish Match AB acquisition were $6,121 million in 2023 and decreased to $2,610 million in 2024. The LLM does not mention these exact figures and instead introduces a €5.5 billion term loan from 2022, which is not reflected in the ground truth. The reported €2.5 billion outstanding on the 3-year tranche at end-2023 does not align with the $6.121 billion total obligation in 2023 per the original answer. (2) The LLM claims PMI repaid the €3 billion tranche in November 2024, but the ground truth reflects a year-end 2024 figure of $2.61 billion in long-term debt—suggesting no such full repayment occurred by then. The conversion of €2.5 billion to $2.6 billion is approximately correct, but the narrative around repayment timing and structure is unsupported. (3) The mention of goodwill adjustments ($10.877 billion, $2.57 billion measurement-period adjustment, $665 million impairment) is detailed but not part of the original question’s focus on debt obligations; this adds extraneous detail while missing the core data. (4) Multi-hop reasoning is attempted—linking acquisition financing to debt reduction—but based on incorrect or unverified financial instruments and timelines. The correct trend (debt reduction from ~$6.1B to ~$2.6B) is conceptually aligned, but the explanation relies on fabricated financing structures. Thus, while contextually relevant and showing an attempt at synthesis, the answer fails on quantitative accuracy, which is critical in financial evaluations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 463,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "\nFrom 2023 to early 2024 BMS moved from a largely exploratory KRAS‑inhibition program to a market‑ready, acquisition‑driven strategy.  The January 2024 purchase of Mirati (for $4.8 bn) gave BMS an FDA‑approved KRAS‑G12C inhibitor—Krazati—plus a pipeline of next‑generation KRAS‑targeting assets (e.g., the PRMT5 inhibitor MRTX1719) and the ability to test Krazati in combination with PD‑1 blockade for first‑line NSCLC.  Consequently, BMS’s KRAS‑inhibition effort shifted from early‑stage discovery to a fully integrated, clinically advanced portfolio that now includes a marketed second‑line NSCLC therapy and multiple late‑stage combination trials aimed at expanding KRAS‑targeted treatment across solid tumours.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in BMY's (Bristol Myers Squibb's) strategic positioning around KRAS inhibition from 2023 to 2024. (1) Quantitatively, all key facts are correct: the $4.8 billion acquisition of Mirati in January 2024 is accurately stated, and the FDA approval of Krazati as a KRAS G12C inhibitor is correctly noted. The mention of combination trials with PD-1 inhibitors for first-line NSCLC aligns with the ground truth. (2) The LLM correctly identifies the shift from no KRAS assets in 2023 to a fully integrated, clinically advanced portfolio in 2024 via acquisition—this reflects sound multi-hop reasoning across time, corporate action, and clinical development. (3) The only minor omission is that the ground truth specifies an additional 2024 FDA approval for Krazati in advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, which the LLM answer does not mention. This is a relevant expansion of the therapeutic footprint and slightly reduces completeness. (4) Despite this omission, the answer conveys the essential strategic shift, uses correct entities (Mirati, Krazati, PD-1, NSCLC), accurate timing (January 2024 acquisition), and proper context of moving from exploratory to market-ready. Wording differs but semantic meaning is equivalent. The inclusion of MRTX1719 (a next-gen asset) adds value and is factually consistent with Mirati’s pipeline, even if not in the original answer. Overall, the answer is factually strong, well-reasoned, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 421,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "\nBetween 2023 and 2024 the disclosure shifted from a simple historical footnote to the Restricted Partner Compensation Plan (first referenced as an exhibit from 2006) to a explicit linkage with the firm’s newer governance regime.  The 2024 filing incorporates the **Amended and Restated Clawback Policy (effective Dec 1 2023)** and places the restricted‑partner plan within the updated 2021 Stock‑Incentive/Permitted Compensation framework, signaling that the plan is now presented as part of a broader, risk‑aware compensation governance structure that includes the newer clawback and performance‑based rules.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of evolution in Goldman Sachs' compensation disclosures but contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the LLM incorrectly states that the Clawback Policy was introduced as 'Amended and Restated Clawback Policy (effective Dec 1 2023)' and labeled as such in the 2024 filing—however, the ground truth only confirms the introduction of a Clawback Policy as Exhibit 10.1 in 2024, with no mention of the specific effective date or 'Amended and Restated' designation. This is a material factual overstatement. (2) The LLM claims the Restricted Partner Compensation Plan was 'placed within the updated 2021 Stock-Incentive/Permitted Compensation framework'—this linkage is not supported by the ground truth, which makes no mention of the 2021 framework or integration with it. (3) The ground truth emphasizes the exhibit numbering shift (from 10.3 in 2023 to 10.4 in 2024) and the reordering of exhibits to reflect new priorities, particularly the prominence of the Clawback Policy as Exhibit 10.1. The LLM omits this structural detail, which is central to the original answer’s reasoning about disclosure positioning. (4) While the LLM correctly infers a strategic repositioning toward risk-aware governance, this qualitative insight is partially speculative and not fully grounded in the specific exhibit-level evidence provided in the ground truth. The answer is contextually relevant and addresses the question’s intent, but key factual and structural details are either incorrect or invented, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 443,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "\nFrom 2022 to 2023 PMI re‑classified heat‑not‑burn from a broad “reduced‑risk product” into its own sub‑segment of **smoke‑free products**, reporting it separately in the product‑category financial tables (see 2023 pages 39‑40).  The 2023 disclosures also added licensed KT&G heated‑tobacco units to the portfolio and incorporated HTU shipment volumes into regional segment results, showing a tighter integration of heat‑not‑burn into the company’s go‑to‑market and reporting structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the reclassification of heat-not-burn products from 'reduced-risk products' in 2022 to a distinct sub-segment under 'smoke-free products' in 2023, which matches the original answer's description of evolving categorization. (2) The inclusion of licensed KT&G heated tobacco units in 2023 is accurately reported, reflecting expanded product integration beyond internally developed offerings. (3) The LLM adds specific detail about financial reporting integration—mentioning pages 39–40 of the 2023 report and the inclusion of HTU shipment volumes in regional results—which is consistent with deeper business integration and goes slightly beyond the original answer but remains factually plausible and contextually supported. (4) There are no numeric inaccuracies; while no specific numbers (e.g., shipment volumes or revenue) are mentioned, the qualitative claims about reporting structure and categorization are correct. (5) The multi-hop reasoning is sound: it synthesizes changes in product categorization and business integration across years, correctly attributing shifts in strategy and reporting. The only minor shortcoming is that the original answer also notes the inclusion of e-vapor, oral nicotine, wellness, and healthcare in the broader smoke-free category—context that the LLM omits—but this does not detract significantly from the core focus on heat-not-burn evolution. Overall, the answer is semantically equivalent, factually correct, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 431,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "\nBetween 2023 and 2024 BMS moved the business‑risk and disclosure group from a newly created remedial measure under the 2004 SEC Consent Order to a fully institutionalized governance function.  The 2024 filing notes that the group now operates as part of a formal review‑and‑certification process for all SEC reports, continuously monitors the company‑wide policy that limits sales to direct customers (including inventory‑based compliance checks), and escalates any compliance questions to senior management and the board—evolving the group from an ad‑hoc oversight unit into a standing, integrated component of BMS’s risk‑management and disclosure framework.  (Pages 61, 63‑64, 2023 10‑K; 63‑64, 2024 10‑K).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a critical factual error in the date of the SEC Consent Order, incorrectly stating it as 2004 instead of the implied 2023 (based on the original answer's context of group formation in 2023 to comply with the order). This undermines the quantitative and qualitative accuracy. While the LLM correctly identifies the evolution of the business risk and disclosure group into a formal, integrated governance function by 2024—including its role in review/certification of SEC filings, escalation of compliance issues, and ongoing monitoring—this is offset by the erroneous historical framing. The original answer does not mention a 2004 Consent Order or any remedial action dating back that far; rather, it states the group was established in 2023 specifically to comply with the Consent Order, implying the order was recent. The LLM’s claim that the group evolved from a '2004' order introduces a false premise, suggesting a long-standing remedial measure, which contradicts the ground truth that the group was newly created in 2023. Despite this, the description of the group’s 2024 functions aligns semantically with the original answer (formal process, escalation, integration), supporting moderate qualitative accuracy and high contextual relevance. However, the incorrect date constitutes a significant factual deviation that affects the correctness of the multi-hop reasoning, especially regarding the timeline of governance evolution. No other numbers or calculations are present, but the misuse of '2004' instead of '2023' is a severe error in temporal and regulatory context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 436,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "\nBetween 2023 and 2024 UNP’s pension plan completed its de‑risking shift, moving from a higher‑equity mix to a target of roughly 25 % equity and 75 % debt (the “20‑30 % equity / 70‑80 % debt” ranges remain the same in 2024). The plan now ties its long‑term expected return of 5.25 % to this more debt‑heavy allocation, maintaining the same target ranges while signaling that the expected‑return assumption is anchored to the stabilized asset‑allocation mix achieved by the end of 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative details not present in the ground truth, such as a 'target of roughly 25% equity and 75% debt' and a long-term expected return of '5.25%', which are not mentioned in the original answer. The ground truth does not provide any specific target asset allocation percentages for 2024 or expected return figures, only discussing the qualitative shift in disclosure language. Therefore, these numbers are unsupported and likely incorrect. (2) The original answer emphasizes a change in disclosure language—specifically, that in 2023, UNP cited asset allocation, historical returns, and market conditions as bases for expected return (with a 6% actual return disclosed), whereas in 2024, it only stated that expected return 'depends on' asset allocation, omitting other factors and not disclosing an actual return. The LLM answer completely misses this key shift in disclosure policy and instead fabricates a narrative about 'de-risking' and specific allocation targets. (3) The multi-hop reasoning is flawed: the question asks about the evolution in how UNP links expected return to asset allocation in its disclosures, not about changes in actual allocation strategy. The LLM incorrectly shifts focus to portfolio composition changes and expected return assumptions without addressing the core issue—transparency and explanatory factors in the pension disclosure language. (4) While the answer is contextually relevant to UNP’s pension plan and asset allocation, it fails on factual accuracy and reasoning, inventing specifics not in the source and missing the actual evolution in disclosure approach. Hence, low scores on correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 471,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon shifted the way it presents its Directors’ Code of Conduct from a stand‑alone ethics paragraph that merely linked to a PDF (Item 10 of the 2022 filing) to a clearly integrated governance element. In the 2023 Form 10‑K the Code is listed alongside the Corporate Governance Guidelines, By‑laws and committee charters under “Available Information,” and the filing explicitly notes that any amendments or waivers will be posted on the company’s website. This change makes the Directors’ Code more readily accessible and embeds it within the corporate‑governance disclosure rather than treating it as an ancillary ethics statement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in BNY Mellon's disclosure approach between 2022 and 2023: in 2022, the Directors' Code of Conduct was referenced in Item 10 as posted on the website, while in 2023 it was integrated into a centralized list of governance documents. The key factual elements—website accessibility, integration with other governance materials (e.g., Corporate Governance Guidelines, committee charters), and the commitment to post amendments/waivers—are all correct. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a problematic way; the years 2022 and 2023 are correctly used. (3) The multi-hop reasoning is sound: the model synthesizes changes in presentation and placement across two years, correctly inferring increased integration and accessibility. The mention of 'Available Information' in the 2023 10-K matches the structure of SEC filings. (4) The only minor shortcoming is that the LLM characterizes the 2022 disclosure as a 'stand-alone ethics paragraph' and 'ancillary ethics statement,' which slightly overemphasizes its marginal status compared to the original answer’s neutral tone about it being part of broader governance disclosures. However, this does not distort the factual progression. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 402,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, Oracle broadened the deployment flexibility of Oracle Database — it is now offered as the self‑driving Autonomous Database on OCI with consumption‑based pricing and can be run on‑premise or in a hybrid mode through new options such as Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud, and the partner‑focused Alloy and Roving Edge services — while deepening its integration with engineered systems like the Exadata Database Machine, which is available across all three deployment models.  This evolution shows that Oracle is positioning the database as a portable, automated engine that can be moved gradually into the Oracle Cloud without forcing a full lift‑and‑shift, underscoring a hybrid‑and‑multi‑cloud strategy that preserves existing on‑prem investments while accelerating cloud migration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies Oracle's 2023 emphasis on deployment flexibility, citing specific offerings like Exadata Cloud@Customer and Roving Edge Infrastructure (referred to as 'Roving Edge services'), and notes the expansion to include OCI Dedicated Region, Sovereign Cloud, and Alloy—consistent with Oracle's hybrid and multicloud strategy. The answer accurately reflects the 2024 shift toward deeper integration with engineered systems, specifically naming the Exadata Database Machine and its availability across on-premise, cloud, and hybrid models. The conclusion about Oracle’s strategic direction—supporting gradual cloud migration while preserving on-prem investments—is logically sound and semantically equivalent to the ground truth’s interpretation of a maturation toward holistic, performance-optimized solutions. All entities (Oracle, OCI, Exadata, etc.), deployment models, and timeframes (2023–2024) are correct. There are no numerical inaccuracies (no specific numbers to verify, but all qualitative metrics are consistent). The only minor shortcoming is that the LLM answer does not explicitly mention the 'tight integration of database, storage, OS, and networking' as a defining feature of engineered systems, which slightly reduces completeness in describing the engineered systems' architecture. However, the core reasoning and multi-hop synthesis across deployment evolution and strategic intent are robust and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 415,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "\nThe formal review and certification of BMY’s annual and quarterly SEC reports, mandated by the 2004 Consent, was deepened between 2023 and 2024.  In 2023 the company had a company‑wide sales‑policy and a governance process for escalating compliance questions, but by 2024 it added a dedicated business‑risk and disclosure group, retained an outside consultant to continuously re‑engineer its reporting controls, and required more rigorous documentation of budgeting and sales‑incentive disclosures—thereby strengthening monitoring and oversight of the certification process.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) The answer incorrectly references 'BMY' and a '2004 Consent', which are not mentioned in the original answer and are factually unsupported—ground truth states the formal process was established in 2023 as part of a Consent agreement, with no mention of 2004 or BMY. (2) Quantitative accuracy is low: the years 2023 and 2024 are correctly referenced, but the specific developments in those years are fabricated. The original answer notes governance procedures and compliance monitoring in 2023, and integration into sales policies in 2024; the LLM instead invents a 'dedicated business-risk and disclosure group', 'outside consultant', and 'rigorous documentation' requirements, which are not in the ground truth. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution from initial implementation (2023) to integration and sustained enforcement (2024), instead inventing new entities and initiatives. (4) Contextual relevance is moderate because the answer addresses formal review processes and governance, but the specifics are irrelevant due to incorrect entities and fabricated details. Overall, the answer misrepresents the source information and contains no accurate synthesis of the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 383,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "\nFrom 2022 to 2023 Philip Morris International treated heat‑not‑burn (HNB) as a mature, revenue‑generating pillar of its reduced‑risk portfolio rather than an experimental side‑project.  The company reported a 14.7 % increase in heated‑tobacco‑unit shipments and $3.5 bn of HNB revenue in 2023, and it now groups HNB under the “smoke‑free products excluding Wellness and Healthcare” line (alongside licensed KT&G brands), positioning it as a distinct growth segment within its broader smoke‑free offering.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific quantitative claims—14.7% increase in heated-tobacco-unit shipments and $3.5 billion in HNB revenue in 2023—that are not present in the original ground truth answer and cannot be verified from the provided knowledge graph. These figures may be accurate in reality, but since they are absent from the original answer (which is based on actual SEC filing data), they introduce unverified information, reducing factual correctness. (2) The original answer emphasizes a shift in categorization—from Reduced-Risk Products (RRPs) in 2022 to inclusion within the broader 'smoke-free product segment' in 2023, alongside e-vapor and oral nicotine products—and notes the addition of licensed KT&G products. The LLM captures the inclusion of KT&G and the repositioning under smoke-free products, which is correct and relevant. However, it omits mention of e-vapor and oral nicotine products as co-segmented categories, slightly reducing completeness. (3) The reasoning about strategic evolution—from experimental to mature commercial focus—is a reasonable interpretation and aligns with the original answer’s implication of a shift toward commercialization and integration. The multi-hop synthesis across years and product categorizations is partially sound, but the unsupported revenue and shipment figures undermine quantitative reliability. (4) Contextually, the answer is highly relevant, addressing both market positioning and product categorization. While the core qualitative shift is conveyed, the inclusion of unverified metrics significantly affects correctness. Thus, the correctness score is 6 due to partial factual accuracy with notable unsupported claims; quantitative accuracy is low (4) due to unverified numbers; qualitative accuracy is moderate (7) for correct reasoning but incomplete detail; and contextual relevance is high (9) as the response stays focused on the question’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 524,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Oracle broadened the ways customers can run its flagship database, making Oracle Database available not only as a perpetual on‑premise license but also as a native service on Oracle Cloud Infrastructure (OCI) and through hybrid‑cloud options such as Exadata Cloud@Customer and OCI Dedicated Region.  The company further reinforced this flexibility with the launch of **Oracle Autonomous Database**, which automates provisioning, scaling, patching and security and is tightly integrated with other Oracle Cloud services—including Java Cloud, Oracle APEX, MySQL HeatWave and the broader Oracle Middleware stack—so that databases can be deployed, managed and scaled as part of a unified, cloud‑first architecture.  This evolution reflects Oracle’s strategy of delivering the database with far greater deployment choice and deeper, end‑to‑end integration across its cloud, engineered‑system and middleware offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of Oracle's strategic evolution of Oracle Database from 2023 to 2024. It accurately captures the emphasis on deployment flexibility (on-premise, OCI, hybrid via Cloud@Customer and Dedicated Region) and deeper integration with Oracle technologies. The mention of Oracle Autonomous Database and its integration with Java Cloud, APEX, MySQL HeatWave, and Oracle Middleware is factually accurate and adds relevant detail not explicitly in the original answer, but consistent with Oracle’s strategy. However, the original answer highlights a key shift in 2024 toward Oracle Database as a foundational component of engineered systems like Exadata Database Machine—integrating hardware, storage, and OS—which the LLM answer only partially reflects by mentioning Exadata Cloud@Customer without emphasizing the engineered systems integration as a strategic evolution. While Cloud@Customer is an engineered system, the LLM response frames the evolution more around cloud deployment and automation than the structural integration into engineered systems as a core strategic pivot. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and all entities (Oracle, OCI, Exadata, Autonomous Database, APEX, etc.) and timeframes (2023–2024) are correct. The reasoning is sound and contextually relevant, but the qualitative accuracy is slightly reduced because the answer emphasizes cloud-first integration and automation more than the foundational role in engineered systems, which is the central point in the ground truth. Thus, the answer is factually rich and relevant but slightly misses the emphasis on engineered systems as the core of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 475,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "\nBetween 2023 and 2024 BMS moved Krazati from a partner‑licensed asset (held by Mirati) to a fully owned product after acquiring Mirati in January 2024, thereby gaining worldwide commercial rights and a related oncology pipeline. The deal required a $4.1 bn net cash outlay, created a $1 bn contingent value right contingent on FDA acceptance of the PRMT5‑inhibitor NDA, and resulted in the capitalization of $640 m of definite‑lived product‑rights and $3.5 bn of indefinite‑lived IPRD—financial commitments that reflect the deepening strategic integration of Krazati into BMS’s portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly captures the evolution of BMY's (BMS's) relationship with Krazati—from a partnered asset via Mirati in 2023 to full ownership in 2024 through the Mirati acquisition. It accurately notes the strategic deepening via the acquisition and the integration of Krazati into BMS’s portfolio. However, there is a discrepancy in the acquisition cost: the ground truth states $4.8 billion, while the LLM reports a $4.1 billion net cash outlay. Though this may reflect net vs. gross consideration, the primary reported deal value in public filings was $4.8 billion, so the LLM's figure is misleading without clarification. The $1.0 billion contingent value right (CVR) tied to PRMT5 inhibitor development is correctly reported, though the LLM adds specificity—'FDA acceptance of the NDA'—not in the original, which may be an inference but is plausible. The $640 million definite-lived intangible and $3.5 billion indefinite-lived IPRD are plausible accounting entries but not mentioned in the ground truth, so they add detail beyond the original answer, which is acceptable if accurate, but cannot be verified here. (2) Quantitative accuracy is partially compromised: $4.1B vs $4.8B is a significant difference (700M gap), even if due to net vs. gross. The $1B CVR matches. Other figures ($640M, $3.5B) are not in the ground truth and thus cannot confirm correctness. (3) Multi-hop reasoning is strong: the model connects Mirati’s ownership of Krazati, BMS’s acquisition, and the resulting financial commitments, showing understanding of strategic evolution and financial signaling. (4) Scores reflect high qualitative and contextual accuracy, but quantitative inaccuracies—especially the deal value—prevent a 9–10 correctness score. The core facts (acquisition, CVR, strategic shift) are correct, but key financials are not fully aligned with ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 508,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings the 6.244% Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV appear in the same “Securities Registered Pursuant to Section 12(b)” table, are still listed under the ticker BK/P, and continue to be “fully and unconditionally guaranteed by The Bank of New York Mellon Corporation.” No redemption, conversion, amendment or other change in their terms is disclosed in the comparative excerpts, indicating that their legal status and outstanding nature remained unchanged from 2022 through 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the securities are 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV, listed under ticker BK/P, registered under Section 12(b), and fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. (2) There are no numeric or date inaccuracies—percentages, ticker symbol, and years (2022–2023) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of SEC filings (2022 and 2023), identifies the continuity in listing, registration, and guarantee status, and infers no change in treatment or status due to absence of disclosed amendments, redemptions, or conversions. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in the securities’ status. Minor wording differences (e.g., 'appear in the same table' vs. 'remained registered') do not affect factual accuracy. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 312,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "\nBetween 2022 and 2023 the total short‑term credit capacity that PMI has available grew from roughly **$1.9 billion to about $2.7 billion**, while the amount actually borrowed under those facilities slipped only slightly from **$295 million to $283 million**.  The combination of a larger credit line and a modest decline in borrowings signals that PMI’s near‑term liquidity position is stronger and that it is relying less on short‑term financing to meet working‑capital needs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: capacity increased from $1.9 billion to $2.7 billion, utilization decreased from $295 million to $283 million—both figures match the original answer exactly, with acceptable formatting (e.g., 'about' and 'roughly' do not affect precision). (2) The answer is complete, addressing both the change in capacity and utilization, and drawing the correct implication about PMI's near-term liquidity posture. (3) Entities—PMI, short-term credit arrangements, 2022 to 2023 timeframe, and financial metrics—are correctly identified and used. (4) The reasoning is sound: the synthesis of increased capacity and decreased utilization logically supports the conclusion of a stronger liquidity position and reduced reliance on short-term financing, which aligns with the original answer's interpretation. The semantic meaning is equivalent, with only minor rewording for fluency. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 295,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Oracle has moved the Autonomous Database from a stand‑alone, self‑driving database to a core engine of its next‑generation cloud platform.  The 2024 filing stresses that the database is now tightly integrated with a broader set of OCI services—including Java Cloud, Oracle APEX low‑code, Analytics Cloud, MySQL HeatWave and AI/ML offerings—via open interfaces that let developers build cloud‑native applications, while its automation has been expanded to cover automatic scaling, patching, security‑threat detection and remediation, and consumption‑based pricing.  This evolution positions the Autonomous Database as an end‑to‑end, fully automated database service that spans OCI compute, storage, networking and emerging AI capabilities, and can be deployed flexibly across shared OCI, dedicated regions, Exadata Cloud@Customer and sovereign‑cloud environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the evolution of Oracle's Autonomous Database positioning from 2023 to 2024, capturing the shift from a self-managed automated database to a more integrated, cloud-native platform. The answer accurately highlights deeper integration with Oracle Cloud services such as Java Cloud, Oracle APEX low-code, Analytics Cloud, MySQL HeatWave, and AI/ML offerings—consistent with the 2024 emphasis on open interfaces and broader service integration. It also correctly emphasizes expanded automation capabilities including automatic patching, scaling, security threat detection and remediation, and consumption-based pricing, which aligns with the ground truth's focus on machine learning-powered automation for diagnostics, fault prediction, and threat detection. The mention of deployment flexibility across shared OCI, dedicated regions, Exadata Cloud@Customer, and sovereign-cloud environments adds contextual detail not explicitly in the original but is factually consistent and enhances completeness. The only minor gap is that the original answer specifically notes the 2023 focus on hybrid/on-premise deployment and reduction in IT effort, which the LLM summarizes as 'stand-alone, self-driving' but could have been slightly more precise. However, this does not detract significantly from the overall correctness. There are no numerical inaccuracies (quantitative accuracy is perfect), reasoning is sound across multi-hop elements (synthesizing changes over time and integration with other services), and the response is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 448,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 GM trimmed its direct financial stake in Ultium Cells Holdings LLC: the committed capital contribution that had been $1.4 billion in 2022 fell to $0.8 billion by Dec 31 2023, and in 2024 the company recorded only about $0.5 billion of new equity investment (a $0.7 billion cash outflow in the cash‑flow schedule), whereas it had invested $0.8 billion in 2022.  This reduction lowered GM’s maximum loss exposure tied to the joint venture and signaled a strategic pull‑back, positioning Ultium Cells as a more passive partnership rather than a core capital‑intensive investment.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative details and qualitative interpretation. (1) Quantitatively, the LLM states that GM's committed contribution was $1.4 billion in 2022 and dropped to $0.8 billion by end of 2023, but the ground truth only references 2023 and 2024, with a $0.8 billion commitment in 2023 and a $0.7 billion realized investment in 2024. The mention of 2022 figures is extraneous and unsupported by the ground truth. Additionally, the LLM claims a $0.5 billion equity investment and $0.7 billion cash outflow in 2024, which contradicts the ground truth that reports a $0.7 billion direct investment—no distinction is made between equity investment and cash outflow in the original, and the amounts do not align. (2) The LLM incorrectly frames the evolution as a reduction and 'strategic pull-back', while the ground truth describes a shift from contingent commitment to direct investment, indicating increased strategic engagement, not disengagement. This is a fundamental reversal of the correct interpretation. (3) The multi-hop reasoning fails: the model does not correctly synthesize the change from a VIE with contingent commitment (2023) to a direct investment (2024), instead inventing a narrative of capital reduction based on incorrect prior-year data. (4) While the answer addresses the topic of capital involvement and strategic positioning, the factual inaccuracies and flawed reasoning severely undermine correctness. Contextual relevance is moderate because it discusses the right entity and timeframe, but with incorrect data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 434,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "\nBetween the sixth‑anniversary release on June 21 2022 and the eighth‑anniversary release on June 21 2024, the Litigation Management Deed’s “anniversary releases” saw the as‑converted value released decline from **$3.5 billion** to **$2.7 billion**, and the number of series A preferred shares issued fell from **176,655** to **99,264** (with cash payments of $3 million and $5 million, respectively, to cover fractional shares). This reduction reflects a smaller release of protection under the Europe retrospective responsibility plan in the later year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key quantitative facts: in 2022, $3.5 billion of as-converted value and 176,655 series A preferred shares were issued; in 2024, $2.7 billion and 99,264 shares. These match the ground truth exactly. The dates (June 21, 2022 and June 21, 2024) are accurate and consistent with the sixth and eighth anniversaries. (2) All numbers are correct, including the minor cash payments for fractional shares ($3 million and $5 million), which were not in the original answer but are factually accurate and add detail without contradicting the ground truth. No calculation errors. (3) The reasoning is sound: the LLM correctly infers a decline in both value and shares issued, linking it to a reduced financial burden, though it uses slightly different phrasing (‘smaller release of protection under the Europe retrospective responsibility plan’) compared to the original’s ‘reduction in financial burden... over time’. This is semantically equivalent and contextually appropriate. (4) The answer is fully relevant, addressing both parts of the question—evolution in as-converted value and shares issued—across the two years. The only minor deduction is for slight rephrasing of the concluding interpretation, but it remains logically consistent. Thus, quantitative accuracy is perfect; qualitative and overall correctness are excellent with negligible deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 390,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the Aearo entities moved from a voluntary Chapter 11 restructuring (July 2022–June 2023) to full re‑consolidation after the bankruptcy dismissal in June 2023, while 3M executed the $6 bn CAE Settlement (initial $10 m administrative payment, $147 m for bellwether releases, $250 m in Dec 2023 and $253 m in Jan 2024). The settlement triggered a $4.2 bn pre‑tax charge in 2023 that was recorded as a corporate special item and reduced the Safety & Industrial segment’s operating income; by 2024 the charge is largely settled, the special‑item cost has fallen, and the Aearo businesses are now reported as part of the re‑combined Safety & Industrial results, with segment margins adjusted for the residual PFAS‑exit costs and the Solventum spin‑off.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, which undermines its correctness. (1) Quantitative Accuracy: The $6 billion CAE Settlement amount is incorrect — the original answer does not specify a total settlement value, and no such figure is supported in the ground truth. The breakdown of payments ($10M, $147M, $250M, $253M) is not present in the original answer and appears fabricated. The $4.2 billion pre-tax charge is also not mentioned in the ground truth and contradicts the statement that the reconsolidation had an 'immaterial income statement impact.' These errors severely compromise numerical accuracy. (2) Completeness: While the answer addresses litigation (CAE Settlement) and business adjustments, it misrepresents the financial impact and omits the key point about the Aearo Entities being referenced in 2024 within the Transportation and Electronics segment due to prior divestiture/acquisition effects — instead incorrectly placing them in Safety & Industrial. (3) Entity Accuracy: The mention of 'PFAS-exit costs' and 'Solventum spin-off' introduces entities and events not referenced in the original answer, adding unsupported context. The Safety & Industrial segment reference is incorrect; the ground truth ties Aearo’s 2024 treatment to Transportation and Electronics. (4) Reasoning: The multi-hop synthesis is flawed — the model incorrectly links Aearo’s reconsolidation to segment-level income impacts and margin adjustments not present in the original, and invents a financial timeline unsupported by the data. (5) Semantic Equivalence: Despite some correct elements (e.g., reconsolidation after bankruptcy dismissal in 2023), the overall narrative diverges factually. The original emphasizes a shift from litigation (2023) to strategic financial reporting (2024); the LLM overemphasizes financial charges and segment impacts not in the source. Thus, while contextually relevant and attempting the right analytical arc, the answer fails on core factual and quantitative grounds.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 550,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the **Class C common stock kept its limited‑voting profile** (no voting rights except for a few defined matters) and remained convertible only through the indirect mechanisms that affect the broader capital structure (e.g., conversion‑rate adjustments tied to litigation releases and the exchange of Class B‑1 shares for Class C).  However, the **earnings‑per‑share performance of Class C improved markedly**, rising from **$28.00 (basic) / $28.00 (diluted) in 2022** to **$33.13 / $33.17 in 2023** and then to **$38.92 / $38.97 in 2024**, outpacing the growth of Class A’s EPS over the same periods.  This EPS acceleration reflects the allocation of a growing share of net income to Class C in the company’s as‑converted earnings‑per‑share calculations, while the total as‑converted share count remained relatively stable due to modest conversion‑rate adjustments and share‑repurchase activity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2024, Class C Common Stock had $33.17 basic EPS and $33.13 diluted EPS, while the LLM claims $38.92 basic and $38.97 diluted EPS for 2024—this is a major deviation. Additionally, the LLM reports Class C EPS in 2022 as $28.00, but the original answer does not provide 2022 EPS figures, so this number is unsupported. The LLM also introduces 2023 EPS data ($33.13 / $33.17), which is not in the ground truth and incorrectly swaps the basic and diluted values compared to 2024 in the original. (2) The calculation of EPS trends is therefore invalid due to incorrect input numbers. The claim that Class C EPS 'outpaced' Class A is plausible given the ground truth (Class A EPS was $8.29 in 2024), but the magnitude and trajectory are misrepresented. (3) The qualitative reasoning about governance stability (limited voting rights unchanged) aligns with the original answer’s note that the governance role appeared unchanged. The LLM correctly identifies that Class C’s financial performance diverged positively from Class A, which is consistent with the ground truth. However, it fabricates intermediate-year data and misstates final 2024 figures, undermining the multi-hop synthesis. (4) The contextual relevance is high because the response addresses both structural treatment and EPS performance across years, directly responding to the question’s focus. However, due to severe quantitative errors and unsupported data points, the correctness score is low despite some accurate conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 449,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved ADAS/AD from an internal R&D focus to a commercialized revenue stream within its automotive segment—its financial tables now list a dedicated “Automotive (2)” line that explicitly includes ADAS/AD and show that automotive revenue grew from $1.5 billion in 2022 to $2.9 billion in 2024.  The company also began reporting ADAS/AD‑related sales‑based royalties and included ADAS/AD in its performance‑obligation disclosures, signaling that development and commercialization activities have shifted to market‑driven licensing and product sales.  This evolution reflects Qualcomm’s expanded R&D investment and strategic positioning of ADAS/AD as a distinct growth driver alongside handsets and IoT.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Qualcomm's ADAS/AD involvement from R&D in 2022 to commercialization by 2024, aligning with the ground truth's core narrative. It accurately identifies the shift from development to revenue generation within the automotive segment. However, the LLM introduces specific quantitative claims not present in the original answer: namely, automotive revenue growing from $1.5 billion in 2022 to $2.9 billion in 2024, and the existence of a 'Automotive (2)' line in financial tables. These figures and categorizations are not supported by the ground truth, which confirms the inclusion of ADAS/AD in automotive revenue but does not provide exact revenue numbers or mention a sub-line item labeled 'Automotive (2)'. (2) The quantitative accuracy is reduced because the revenue figures and line-item detail are fabricated or over-specified. While the direction of growth (increasing automotive revenue) is plausible and consistent with commercialization, the exact numbers cannot be verified from the ground truth and thus constitute inaccuracies. (3) The multi-hop reasoning is sound: the model correctly infers that inclusion in revenue streams, performance obligations, and royalty reporting indicates commercialization, and contrasts this with earlier-stage R&D and investment activities. This synthesis across strategic, financial, and reporting dimensions demonstrates strong qualitative reasoning. (4) Contextual relevance is perfect—the answer directly addresses the evolution in strategic activities and revenue categorization as asked. The core qualitative progression is correct, but the addition of unsupported numbers lowers quantitative and overall correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 473,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "\nBetween 2022 and 2024 Visa has tightened the mechanics of its U.S. Retrospective Responsibility Plan by (1) significantly expanding the U.S. litigation escrow account (deposits rose to $1.5 billion in 2024 and the balance reached $3.1 billion) and by amending the loss‑sharing and omnibus agreements to expressly include post‑2015 opt‑out MDL‑1720 cases, thereby allocating any settlement or judgment on a ≈ 66.7 % Visa / 33.3 % Mastercard split; and (2) reinforcing the conversion‑feature of its class B‑stock and the makewhole reimbursement obligations, which dilute the B‑stock conversion rate whenever escrow funds are added, shifting any shortfall onto participating members.  This evolution shows Visa is moving from a primarily internal reserve‑based approach to a contractual, member‑shared liability model that externalizes litigation risk and makes the company’s exposure contingent on the financial strength of its network participants.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth does not mention specific dollar amounts such as '$1.5 billion' in deposits or '$3.1 billion' in escrow balance, nor does it specify a 66.7%/33.3% liability split between Visa and Mastercard. These figures and the reference to Mastercard are entirely absent from the original answer and represent serious fabrications. There is also no mention of MDL-1720 opt-out cases or amendments to loss-sharing agreements including those cases. (2) The quantitative inaccuracies are severe: the numbers provided (e.g., $1.5B deposits, $3.1B balance, 66.7%/33.3% split) are not present in the ground truth and cannot be verified. The original answer only states that the 2022 plan used an escrow account and that by 2024, additional mechanisms were introduced—without specifying amounts or percentages. (3) While the LLM correctly identifies the evolution toward a more structured, multi-mechanism approach and mentions real components like the Class B stock conversion feature, makewhole agreements, indemnification, and omnibus agreements, it distorts the reasoning by introducing incorrect intercompany dynamics (e.g., Mastercard liability sharing) and misrepresenting the risk-sharing mechanism as a shift onto members via stock dilution, which is not supported in the original. The multi-hop synthesis is partially sound in identifying the expansion of mechanisms but fails in accurately representing their function and interrelation. (4) The contextual relevance is high because the answer addresses the evolution of the plan and Visa’s risk management strategy. However, the correctness score is low due to major factual and quantitative errors that undermine the reliability of the response. The qualitative accuracy is moderate because some structural elements are correctly noted, but the reasoning is compromised by unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 529,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "\nBetween 2023 and 2024 Merck’s “alliance revenue” from Lynparza rose from **$1.199 bn to $1.311 bn** – a **9 % increase** (11 % when stripped of foreign‑exchange effects) – underscoring stronger demand, especially in international markets.  The product’s strategic relevance was reinforced by new regulatory milestones: in **January 2025** China’s NMPA approved Lynparza as an adjuvant therapy for BRCA‑mutated, HER2‑negative early‑breast cancer (based on the OlympiA trial), expanding its label beyond oncology indications, and the intangible asset tied to Lynparza remained a **$1.5 bn** component of Merck’s product‑rights portfolio with no impairment noted.  These developments signal that Lynparza’s revenue trajectory is accelerating and that its pipeline expansion and global label growth are positioning the drug as a continued strategic priority for Merck.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct and aligns well with the ground truth. It accurately reports a 9% increase in alliance revenue for Lynparza from $1.199 billion in 2023 to $1.311 billion in 2024, which matches the 9% growth mentioned in the original answer. The additional detail of 11% growth excluding foreign exchange effects is plausible and adds context without contradicting the ground truth. The $1.5 billion intangible asset value is correctly carried over from 2023 and stated as unchanged in 2024, consistent with the absence of impairment or write-down. The January 2025 China NMPA approval for adjuvant early breast cancer treatment is accurately reported, reinforcing strategic importance. (2) Quantitative verification: $1.199B to $1.311B is indeed a ~9.3% increase, which rounds to 9%—this is accurate. The $1.5B intangible asset figure is consistent. Dates (January 2025) and percentages are correct. (3) Multi-hop reasoning is sound: the model synthesizes financial data (revenue, asset value), performance indicators (revenue growth, international demand), and strategic developments (regulatory approval) across time periods and entities (Merck, AstraZeneca collaboration implied, China NMPA). The conclusion that Lynparza remains a strategic priority is logically supported. (4) Minor deduction in correctness and quantitative accuracy due to introducing specific revenue figures ($1.199B, $1.311B) not present in the original answer—while consistent with a 9% growth and plausible, they are more precise than the source truth provides. However, since they do not contradict and support the same conclusion, this is a minor issue. Otherwise, all key facts, entities, and reasoning are accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 474,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "\nBetween 2022 and 2024 Skoal’s standing in Altria’s oral‑tobacco segment eroded: its retail share fell from roughly 9 % to 7.6 % and shipment volume slipped about 10 % (from ≈163 million to ≈147 million units), while its closest rival Copenhagen also lost ground (share down from 23.5 % to 19.1 %). The overall oral‑tobacco category’s share dropped from 42.5 % to 37.5 % as price hikes on Skoal and Copenhagen were partially offset by growth in the on! nicotine‑pouch brand, which captured 8.3 % of the category in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key figures are correct: Skoal's retail share decline from 9.3% in 2022 to 7.6% in 2024 is accurately reported as 'roughly 9%' to 7.6%—a minor rounding of 9.3% is acceptable. Copenhagen's drop from 23.5% to 19.1% and the overall segment decline from 42.5% (2023) to 37.5% (2024) are correctly cited. The on! brand's rise to 8.3% in 2024 is also accurate. The LLM adds shipment volume data (163M to 147M units, ~10% drop), which is not in the original answer but does not contradict it and may reflect additional context from filings; since it's plausible and consistent, it doesn't reduce accuracy. (2) Completeness: The answer addresses Skoal's declining market position, compares it to Copenhagen and on!, and contextualizes it within Altria's broader oral tobacco trends—fulfilling the multi-hop requirement. (3) Entity accuracy is strong: correct brand names (Skoal, Copenhagen, on!), correct parent (Altria), and correct time frame (2022–2024). (4) Reasoning is sound: the synthesis of market share trends, competitive dynamics, and the impact of price hikes and product substitution (growth in on!) shows logical, multi-hop understanding. The only minor shortcoming is the omission of on!'s 2023 share (6.8%), which would have strengthened the comparison, but its 2024 value is correctly noted. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 408,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "\nIn fiscal 2022 Dynamics 365 contributed roughly **$4.7 billion** of revenue, and in fiscal 2023 that grew to about **$5.4 billion**—an increase of roughly **$0.75 billion (≈16 %)**.  While the absolute amount rose, its share of total Microsoft Cloud revenue remained around **5 %** (since Cloud revenue was $91.4 B in 2022 and $111.6 B in 2023).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific revenue figures for Dynamics 365 in FY2022 ($4.7B) and FY2023 ($5.4B), as well as a calculated growth of ~16%, none of which are present or verifiable in the original answer (ground truth). The ground truth does not provide absolute revenue for Dynamics 365—only that it grew 39% in FY2022 and is a component of Microsoft Cloud revenue ($91.2B in FY2022, $111.6B in FY2023). Thus, the LLM fabricates precise dollar amounts and growth rates not supported by the source. (2) The calculation of a $0.75B increase and 16% growth is mathematically plausible (5.4 - 4.7 = 0.7B), but since the inputs are incorrect, the output is factually wrong. The Microsoft Cloud revenue figures cited in the LLM answer ($91.4B vs $91.2B) are slightly off from the ground truth ($91.2B in FY2022), though this minor discrepancy is less critical. (3) The multi-hop reasoning is partially sound—the LLM attempts to assess evolution by comparing two fiscal years and contextualizing Dynamics 365 within Microsoft Cloud. However, it falsely assumes Dynamics 365’s share can be calculated as ~5% based on invented revenue numbers, which undermines the qualitative accuracy. (4) While the answer is relevant and structured appropriately, the invention of unsupported quantitative data severely compromises factual correctness. The original answer explicitly states that exact FY2023 growth for Dynamics 365 is not provided, making the LLM’s precise figures misleading. Hence, low scores for quantitative and overall correctness, moderate for qualitative reasoning, and high for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 441,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "\nBetween 2023 and 2024 Merck broadened the scale of its foreign‑exchange hedging within the Balance Sheet Risk Management program.  The notional amount of designated forward contracts rose from roughly $12.8 bn (2023) to about $12.5 bn (2024) and the company added additional forward and collar contracts to hedge a larger share of its forecasted sales (extending the hedge horizon to up to two years).  It also deepened its net‑investment hedging by using more forward contracts and euro‑denominated debt as economic hedges, with the resulting fair‑value changes recorded in OCI rather than earnings, reflecting a more extensive and layered hedging approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding quantitative figures and instruments used. The original answer states that in 2023, Merck used forward contracts without specifying a notional amount, and did not designate them as hedges. However, the LLM claims notional amounts of $12.8B (2023) and $12.5B (2024), which are not present in the ground truth and thus factually incorrect. Additionally, the LLM incorrectly states that forward contracts were 'designated' in 2023 and 2024, while the original specifies they were *not designated* as hedges in 2023 and implies a shift in 2024 toward more structured hedging—possibly with designation—but does not confirm designation of forwards. (2) The LLM introduces 'net-investment hedging' using euro-denominated debt and recording in OCI, which is not mentioned in the original answer and represents a complete addition unsupported by the source. This undermines quantitative and qualitative accuracy. (3) While the LLM correctly identifies an expansion in hedging scope and mentions collar options (aligned with the original), it misses the key point that Merck introduced *purchased local currency put options* and *collar options* in 2024—instead vaguely referencing 'additional forward and collar contracts'. It also fabricates a 'hedge horizon of up to two years' and specific cost-benefit layering logic not stated in the LLM response. (4) The contextual relevance is moderate because the answer addresses the evolution of hedging strategy and instruments, showing awareness of forward contracts, collars, and increased hedging of forecasted sales. However, the inclusion of fabricated numbers, incorrect hedge designation status, and invented mechanisms (OCI treatment, debt as hedge) severely reduce factual correctness. The reasoning is partially sound in identifying broad trends but fails on precise multi-hop synthesis from the original disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 528,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal significantly expanded its merchant‑financing footprint, purchasing roughly $1.7‑1.8 billion of merchant receivables each year and deepening its PPWC/PPBL loan programs that are originated, serviced and funded directly by the company.  At the same time, the credit‑loss allowance for those merchant loans fell sharply—from about $160 million at the end of 2023 to $113 million at the end of 2024—reflecting improved credit quality and lower charge‑off rates, so the company required markedly smaller provisions despite the larger receivable balances.  This evolution shows a shift from a primarily defensive allowance strategy in 2022 toward a more aggressive, capital‑intensive investment in merchant financing that is now being managed with a reduced risk reserve.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of PayPal expanding its merchant financing activities between 2022 and 2024 and correctly identifies the shift from risk disclosure to active investment, particularly through PPWC and PPBL. However, several key quantitative inaccuracies undermine the factual correctness. The ground truth states that PayPal purchased approximately $1.8 billion in merchant receivables in 2024, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. The LLM incorrectly implies that PayPal purchased $1.7–1.8 billion *each year*, which is not supported by the original answer—only 2024’s purchase is specified. Additionally, the LLM introduces new figures—credit loss allowances of $160 million at end-2023 and $113 million at end-2024—that are not present in the ground truth. The original answer references a principal and interest coverage ratio of 9% as of December 31, 2021 (down from 23% in 2020), which the LLM omits entirely and replaces with unrelated allowance figures. (2) The quantitative inaccuracies are significant: the $160M and $113M allowance numbers are fabricated or misattributed, and the annual purchase amount is overgeneralized to multiple years without evidence. While $1.8 billion in 2024 aligns with the truth, claiming similar amounts for prior years is unsupported. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift from risk provisioning to direct investment and links it to product expansion (PPWC/PPBL). However, it fails to incorporate the correct metric for early years (coverage ratio) and invents a narrative around declining allowances that isn’t in the source. (4) Despite these issues, the answer remains contextually relevant and captures the qualitative evolution accurately. The core idea—a strategic shift toward active merchant financing—is correct, but the use of incorrect numerical support reduces overall correctness. Hence, a score of 6 reflects partial accuracy with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 555,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "\nThe goodwill assigned to Altria’s smokeable‑products segment is essentially unchanged – it remained about **$99 million** in the 2022 filing (MO 10‑K 2022, p. 66) and stayed at that level through 2024.  At the same time, the segment’s operating income stayed the company’s primary earnings driver, climbing to **$10.8 billion in 2024** (up from $10.67 billion in 2023) and still comprising roughly **95 % of total operating income** (MO 10‑K 2024, p. 31).  Thus, while goodwill exposure is modest and stable, the financial significance of smokeable products to Altria’s profitability has remained dominant and slightly strengthened from 2022 to 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $99 million goodwill allocation for smokeable products in 2022, matching the ground truth. However, it incorrectly states that this goodwill amount 'remained at that level through 2024,' while the original answer explicitly notes that no updated goodwill figure is disclosed for 2024. This is a significant factual overstatement, as the absence of disclosure means stability cannot be confirmed. The operating income figures are mostly accurate: $10.8 billion in 2024 (rounded from $10,821 million) and $10.67 billion in 2023 (from $10,670 million) are acceptable approximations. However, the claim that smokeable products comprise 'roughly 95% of total operating income' is not present in the ground truth and cannot be verified from the provided data, introducing unsupported information. (2) Quantitative accuracy is partially compromised due to the unsupported assertion about goodwill in 2024 and the addition of the 95% figure, which is not in the original. The rounding of operating income is acceptable. (3) The multi-hop reasoning is generally sound—linking goodwill and operating income trends across years—but fails on the critical point of assuming unchanged goodwill in 2024 without evidence. The synthesis of operational significance increasing slightly due to income growth is consistent with the ground truth. (4) Contextual relevance is high, as the answer directly addresses the evolution of financial significance through both goodwill and operating income. The qualitative reasoning is strong except for the unsupported extrapolation. Correctness score is 7 due to core factual accuracy on income and 2022 goodwill, but docked for asserting undisclosed continuity in goodwill and adding unverified percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 482,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "\nIn fiscal 2022 the commercial segment of LinkedIn contributed roughly $13.8 billion to Microsoft Cloud revenue, and in fiscal 2023 that contribution rose to about $15.0 billion—an increase of roughly $1.2 billion (≈9%). Its share of the total Microsoft Cloud figure slipped slightly, from about 15 % in FY 2022 to roughly 13 % in FY 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and factual content. The ground truth states that Microsoft Cloud revenue (which includes LinkedIn's commercial portion) was $91.2 billion in FY2022 and $111.6 billion in FY2023. However, the LLM claims that LinkedIn's commercial segment contributed $13.8B in FY2022 and $15.0B in FY2023 — specific figures that are not supported by the original answer and appear to be fabricated. There is no mention in the ground truth of LinkedIn's standalone contribution to Microsoft Cloud revenue, nor any percentage breakdown (e.g., 15% or 13%) of LinkedIn’s share. The original answer does not provide enough information to calculate LinkedIn’s isolated revenue contribution or its percentage of the total Microsoft Cloud. Therefore, the LLM has introduced precise numbers and ratios that are not present or inferable from the ground truth. While the LLM attempts multi-hop reasoning by analyzing proportionality and growth trends, this is based on false premises. The contextual relevance is moderate because it addresses the evolution of LinkedIn's commercial contribution within Microsoft Cloud, but the factual foundation is incorrect. The 9% growth and declining share narrative, while logically structured, are unsupported. Thus, the correctness score is very low due to complete lack of alignment with verified data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 382,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "\nBetween 2023 and 2024 Lynparza’s commercial reach broadened markedly: after receiving its first U.S. approval (May 2023) for BRCA‑mutated mCRPC and a subsequent Japan approval (August 2023), the drug generated **$1.311 bn of alliance revenue in 2024**, a **9 % year‑over‑year increase** (≈11 % excluding foreign‑exchange effects), driven by “higher demand in most international markets.”  The expansion continued into 2025 with a **China NMPA approval for an adjuvant breast‑cancer indication**, underscoring the product’s growing geographic footprint and the sustained revenue growth from its multi‑region approvals.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Correctly identifies the 2023 U.S. and Japan approvals for BRCA-mutated mCRPC based on the PROpel trial, with approximate dates (May and August 2023), consistent with FDA and MHLW approvals. (2) Correctly states the 9% year-over-year revenue growth in 2024, matching the original answer; the additional detail of $1.311 billion in alliance revenue is plausible and contextually consistent, though not present in the ground truth—this is a minor addition, not a contradiction. The note about 11% growth excluding FX effects is extra but reasonable. (3) Correctly anticipates the January 2025 China NMPA approval for adjuvant breast cancer treatment (germline BRCA-mutated, HER2-negative high-risk early breast cancer) based on OlympiA, accurately framing it as a geographic and therapeutic expansion. (4) The multi-hop reasoning—linking approvals to revenue growth and geographic expansion—is sound and well-synthesized across time and regions. The only minor gap is that the original answer does not specify the $1.311 billion figure, so while the percentage growth is correct, the absolute revenue number is an addition not in the source. However, this does not contradict and may reflect supplementary data. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 379,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "\nBetween 2023 and 2024 the projected future‑income‑tax benefit that RTX records for the Powder Metal Matter declined sharply—from **$644 million in 2023 to $455 million in 2024** (see 2023 10‑K page 98 and 2024 10‑K page 98).  The drop reflects a reduction in the underlying tax‑loss and credit carryforwards after the company adjusted its valuation allowances (the allowance balance fell from $1.465 bn to $1.439 bn), indicating that the tax attributes generated by the Powder Metal Matter are now expected to produce fewer realizable tax savings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial shift in RTX's treatment of the Powder Metal Matter from 2023 to 2024, accurately stating the decrease in future income tax benefits from $644 million to $455 million, which matches the ground truth. The calculation of the decline (a $189 million drop) is implied and numerically correct, though not explicitly stated as a difference or percentage. (2) All numeric values—$644 million in 2023 and $455 million in 2024—are factually accurate and match the ground truth. The additional detail about valuation allowances decreasing from $1.465 billion to $1.439 billion is consistent with the type of reasoning found in 10-K disclosures and supports the conclusion, even if not part of the original answer. This enhances qualitative accuracy without introducing error. (3) The multi-hop reasoning is sound: the model correctly infers a shift in financial treatment from a prior year context (implied sales reduction in 2023) to explicit recognition as a future tax benefit in both years, with a declining trend. While the original answer notes a shift from 'reduction in sales' to 'future tax benefit', the LLM focuses on the tax benefit trajectory and omits the 2023 sales impact detail, which is a minor omission but does not invalidate the core correctness. (4) The answer is contextually highly relevant, directly addressing the evolution in financial treatment and its impact on future income tax benefits. The explanation of valuation allowances adds depth and plausible reasoning for the decline, demonstrating strong qualitative understanding. The only reason for not scoring a 10 is the omission of the initial 2023 characterization as a sales reduction, which was part of the multi-hop evolution described in the ground truth. However, since the question emphasizes 'impact on future income tax benefits', the focus on tax benefit figures remains justified. Overall, the answer is factually precise, well-reasoned, and highly aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 547,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "\nFrom February 2022 through September 2022 PayPal and Paidy expanded the facility from an initial ¥60 billion unsecured revolving line to a ¥90 billion (≈ $574 million) commitment, with interest at the Tokyo Interbank Offered Rate plus a 0.40 %–0.60 % margin and a maturity in February 2027. By the end of 2023 the company had drawn ¥50 billion of that amount, and as of December 31 2024 the full ¥90 billion was outstanding—leaving essentially no remaining borrowing capacity—so the line that once provided up to ¥90 billion now sits fully utilized and will expire in February 2027.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 2024 borrowing capacity as ¥90.0 billion (≈$574 million), the interest rate based on Tokyo Interbank Offered Rate plus 0.40%–0.60%, and the February 2027 maturity date. However, it incorrectly states that the facility was already unsecured in February 2022, while the ground truth indicates that the 2022 facility was secured and only restructured to unsecured by 2024. The LLM also fabricates an initial ¥60 billion unsecured line in 2022, which contradicts the ground truth stating a $198 million secured facility in 2022 with $98 million outstanding as of December 31, 2021. Additionally, the LLM claims the full ¥90 billion was outstanding as of December 31, 2024, but the ground truth does not mention drawdown amounts or remaining capacity. (2) Quantitative accuracy is partially correct: the ¥90 billion and $574 million figures align (allowing for exchange rate variation), and the interest rate margin is accurate. However, the initial $198 million facility in 2022 is misrepresented as ¥60 billion, which is factually incorrect and not equivalent. The timeline of expansion (February–September 2022) is not supported by the ground truth, which does not specify timing of the modification. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution from a secured to unsecured facility and misrepresents the 2022 terms. It introduces PayPal as a party expanding the facility, which is not mentioned in the ground truth. The answer also adds details about drawdowns (¥50 billion by end of 2023, full drawdown by 2024) that are not present in the original answer, introducing unsupported specifics. (4) The contextual relevance is high as it directly addresses the evolution of borrowing capacity and terms, but the correctness score is limited by significant factual inaccuracies and invented details. The qualitative accuracy is moderate due to correct identification of 2024 terms but failure in accurately representing 2022 conditions and the transition between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 569,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "\nBetween 2022 and 2024 Altria moved from an aggressive “note‑issuance and refinancing” stance—evidenced by the $5.5 bn of senior unsecured notes it issued in 2020 and the $5 bn of notes it repaid in 2021—to a strategy that emphasizes repayment of maturing debt and only modest new issuances.  By the end of 2024 the company’s total long‑term debt had fallen to $24.9 bn (down from $28 bn in 2021), and the proportion of senior unsecured notes within its overall capital structure was markedly lower, indicating a reduced reliance on such notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Altria continued to rely on long-term senior unsecured notes as a key capital source in 2024, with a decrease in cash from $4.5B (2022) to $3.1B (2024), suggesting potentially increased reliance on external financing like notes. In contrast, the LLM claims Altria reduced its reliance on senior unsecured notes, citing a decline in total long-term debt to $24.9B in 2024 from $28B in 2021, which is not supported by the provided ground truth (no such figures are mentioned for total debt). (2) Quantitatively, the LLM introduces numbers not present in the original answer: $5.5B issued in 2020, $5B repaid in 2021, total debt of $24.9B in 2024 and $28B in 2021—none of which appear in the ground truth. The only numbers in the original are $4.5B and $3.1B in cash and cash equivalents for 2022 and 2024, respectively. These are completely omitted in the LLM response. (3) The reasoning is flawed: the LLM infers reduced reliance on notes due to debt repayment and lower total debt, but the original answer suggests stable use of notes and a possible increase in reliance due to lower cash reserves. The multi-hop synthesis fails—no connection is made between declining cash and continued use of notes as a capital source. (4) Contextual relevance is moderate because the answer discusses Altria’s debt instruments and capital strategy, but it misrepresents the evolution and direction of reliance. The core conclusion (decreased reliance) is unsupported and factually incorrect per the ground truth, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 446,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "\nIn 2023 RTX recorded a $5.4 bn net‑sales charge and a $2.9 bn operating‑profit charge for the Powder Metal Matter, which depressed pretax earnings but produced roughly a 4 % benefit to the 2023 effective tax rate by lowering taxable income. By 2024 the deferred‑tax schedule shows the Powder Metal Matter’s tax benefit falling from $644 m (2023) to $455 m (2024), indicating that the tax relief from that item is being exhausted and future income‑tax benefits will be smaller, with the company now relying on other credits and audit settlements for its tax rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the Powder Metal Matter contributed $644 million to RTX's future income tax benefits in 2023 and $455 million in 2024, matching the ground truth exactly. These figures are critical and accurately reported with correct dollar amounts and years. (2) Quantitative accuracy is perfect: the values $644M (2023) and $455M (2024) are correctly cited, and the direction of change (decrease) is accurately described. While the LLM introduces additional context—such as the $5.4B net-sales charge and $2.9B operating-profit charge, which are not in the ground truth—these do not contradict the original answer and may reflect broader but accurate filing details. The 4% benefit to the effective tax rate is plausible but not verifiable from the ground truth; however, it does not detract from correctness since the core question focuses on future income tax benefits. (3) The multi-hop reasoning is sound: the model correctly identifies the decline in deferred tax benefits from 2023 to 2024 and infers that this indicates the exhaustion of tax relief, leading to smaller future benefits—this aligns with and expands upon the ground truth’s conclusion about diminishing impact. (4) The answer is semantically equivalent and even richer in context, though slightly beyond the scope. The core facts are correct, complete, and properly synthesized across years and financial impacts. The minor addition of extra charges does not introduce error but enhances context, warranting a high score. Thus, correctness is 9 due to the inclusion of unverified but plausible details, but not 10 because the original answer did not require or confirm those specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 462,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal expanded the Paidy Credit Agreement from a modest $198 million secured revolving line (with only about $98 million drawn and roughly $100 million of capacity left as of Dec 2021) to a much larger unsecured ¥90 billion facility (≈$574 million) that was fully drawn during 2024, leaving essentially no borrowing capacity remaining at year‑end 2024. This shows a dramatic increase in both the available credit size and the amount actually utilized.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key numbers are correct: $198 million borrowing capacity in 2022, $98 million drawn as of December 31, 2021 (implying ~$100 million available), and by 2024, ¥90.0 billion (≈$574 million) facility fully drawn. The conversion from yen to dollars is consistent with the original. (2) The answer correctly notes that the 2024 facility was unsecured and fully utilized, leaving no capacity—this aligns with the ground truth. (3) Multi-hop reasoning is sound: it synthesizes data across years (2021, 2022, 2024), entities (PayPal, Paidy), and financial terms (revolving credit, drawdown status), correctly inferring increased reliance. (4) Wording differs slightly (e.g., 'modest' vs 'approximately'), but all factual claims match. No omissions or inaccuracies. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 261,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the stake held by outside parties in Accenture Canada Holdings Inc. remained minimal – the consolidated financial statements show non‑controlling ownership of less than 1 % as of 31 August 2024, essentially unchanged from the prior year.  The exchangeable shares of Accenture Canada Holdings Inc. continue to be convertible on a one‑for‑one basis into Accenture plc Class A ordinary shares, and during fiscal 2024 the company purchased only 47,752 such exchangeable shares (cost $15,254), so there was no material evolution in the ownership structure or equity relationship.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that noncontrolling ownership in Accenture Canada Holdings Inc. was less than 1% as of August 31, 2024, which aligns with the ground truth. It also accurately notes the one-for-one exchangeability of Accenture Canada Holdings Inc. shares into Accenture plc Class A ordinary shares. However, it incorrectly concludes there was 'no material evolution' in the ownership structure, directly contradicting the ground truth that the equity relationship became more formalized in 2024 with the introduction of structured provisions around Class X shares and exchangeable share mechanics. (2) The quantitative data — less than 1%, August 31, 2024 date, and the 47,752 exchangeable shares purchased for $15,254 — are factually accurate and match disclosures in the filings. These numbers are correctly reported, though the ground truth does not mention the share purchase, so this is supplemental but plausible data. (3) The multi-hop reasoning fails: while the LLM retrieves correct individual facts, it synthesizes them into an incorrect conclusion. The evolution from a simple noncontrolling interest disclosure in 2023 to a more structured equity framework in 2024 involving Class X shares and exchangeability safeguards is a key qualitative shift that the LLM overlooks entirely. This represents a failure in reasoning across time periods and legal structures. (4) The answer is contextually relevant and includes accurate terminology and entities (Accenture plc, Accenture Canada Holdings Inc., exchangeable shares, noncontrolling interests), but misses the core analytical point of structural evolution, leading to a moderate correctness score despite numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 466,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "\nMerck’s balance‑sheet‑risk program still relies on forward‑exchange contracts to offset monetary‑asset and liability exposure, but the scope of currencies and the way the contracts are used have broadened from 2022 to 2024.  In 2022 the forwards were applied mainly to developed‑country currencies (euro, yen, pound, Canadian dollar, Swiss franc) and, for developing‑country exposures such as the renminbi, only when a cost‑benefit analysis of exposure size, volatility and hedging cost deemed it economical; by 2024 the same screening is used, but the company also adds the renminbi (and other emerging‑market currencies) more routinely and employs forwards both for ordinary balance‑sheet risk and for net‑investment hedging via euro‑denominated debt, while still marking most of these contracts to market in “other (income) expense” rather than as formal hedge accounting items.  The underlying cost‑benefit logic—balancing expected earnings‑volatility reduction against hedging expense—remains the same, but the 2024 framework expands the currency basket and integrates forwards more tightly with the company’s net‑investment hedging strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the evolution of Merck's approach between 2022 and 2024, despite using plausible financial terminology and structure. (1) The ORIGINAL ANSWER states that in 2022, Merck used forward contracts for both developed and developing country currencies (specifically mentioning the Chinese renminbi) based on a cost-benefit analysis. By 2024, the detailed discussion of cost-benefit analysis and specific mention of the renminbi was *omitted*, suggesting a simplification or shift in emphasis. However, the LLM answer incorrectly claims that by 2024, Merck *expanded* its use of forwards to include the renminbi and other emerging-market currencies 'more routinely' and integrated them into net-investment hedging via euro-denominated debt—details not present in the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or original answer, so quantitative accuracy is not applicable beyond correct reference to years (2022, 2024), which the LLM gets right. (3) The multi-hop reasoning is flawed: the LLM infers an expansion and integration of hedging strategies in 2024, while the ground truth suggests a *reduction* in disclosed detail and possible simplification, not broadening. This reverses the direction of change. (4) The LLM introduces specific mechanisms—'net-investment hedging via euro-denominated debt' and 'marking to market in other (income) expense'—that are not in the original answer and cannot be verified from the provided truth. These additions reflect plausible-sounding but unsupported elaboration. While the LLM correctly identifies the use of cost-benefit analysis in 2022, it incorrectly asserts that this framework continued unchanged in 2024, whereas the original answer highlights its omission, implying a shift. Overall, the answer is contextually relevant and uses appropriate financial concepts, but the core claim about the evolution of Merck’s strategy is factually inverted and includes unsupported details, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 559,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "\nThe 2024 filing shows the deferred‑tax asset tied to the Powder Metal Matter falling from **$644 million in 2023 to $455 million in 2024** (a $189 million reduction).  This decline signals that the tax benefit RTX had been counting on from the matter is being used up or impaired, meaning future income‑tax benefits linked to it will be **smaller than previously projected**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the deferred tax asset decreased from $644 million in 2023 to $455 million in 2024, a $189 million reduction, which matches the original answer. (2) The LLM correctly identifies the shift in disclosure treatment—from an operational loss impacting revenue in 2023 to a deferred tax asset in 2024—and accurately interprets the declining value as indicating reduced future income tax benefits. (3) The reasoning is sound: the reduction in the deferred tax asset implies that the anticipated tax benefit is being utilized or impaired, leading to smaller future benefits. This captures the core implication of the change in disclosure. (4) While the original answer adds context about the $5.3 billion net sales charge in 2023 affecting Pratt & Whitney, the LLM omits this detail but still correctly focuses on the key point regarding future income tax benefits. The omission slightly reduces completeness but does not affect the correctness of the conclusion about financial impact on future tax benefits. Therefore, the answer is factually correct, contextually relevant, and logically sound, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 344,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal deepened its merchant‑finance program by formalizing a longer‑term, risk‑sharing partnership with its bank and investment‑firm collaborators—most notably extending a multi‑year agreement (amended in December 2024) that expands the commitment period to 2026 and raises the maximum balance of loans that can be sold, while retaining full servicing rights.  At the same time the scale of its merchant‑receivable activity grew sharply: the company purchased roughly **$1.8 billion of merchant receivables in 2024** (up from $1.7 billion in 2023) and grew the outstanding portfolio from about **$1.2 billion to $1.5 billion**, with the partner‑institution’s participation interest also increasing to $53 million, underscoring a more substantial and mature collaboration.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's merchant receivables involvement between 2022 and 2024. Quantitatively, all key figures are accurate: $1.8 billion in receivables purchased in 2024 (up from $1.7 billion in 2023), outstanding balance increase from $1.2 billion to $1.5 billion as of December 31, 2023 and 2024 respectively, and participation interest rising to $53 million in 2024 from $44 million in 2023 — all matching the ground truth. The answer correctly identifies the growing scale and deepening collaboration with partner institutions. However, the LLM introduces a detail not present in the original: the 'multi-year agreement amended in December 2024 extending to 2026' and increased loan sale capacity. While plausible, this specific contractual update is not supported by the ground truth and represents an addition not verifiable from the provided data, slightly undermining qualitative accuracy. The core multi-hop synthesis — connecting changes in financial volumes, partner participation, and program evolution — is sound and relevant. The answer addresses both the relationship with partner institutions and the scale of offerings, satisfying completeness. Wording differences are acceptable under semantic equivalence, but the unverified contractual detail prevents a top score. Contextual relevance is excellent, directly addressing the question's focus on evolution, partnerships, and scale.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 400,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "\nMerck’s alliance revenue from Lynparza rose from **$1.12 billion in 2022 to $1.31 billion in 2024** – an approximate **17 % increase** over the two‑year period (about 7 % growth in 2023 and 9 % growth in 2024).  The uptick was driven primarily by **higher demand for Lynparza in most international markets**, as noted in the 2024 financial discussion, and by the continued expansion of its approved indications, which bolstered sales abroad despite pricing pressures in some regions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Merck's alliance revenue from Lynparza was $989 million in 2022, not $1.12 billion as stated by the LLM. The 2024 revenue is reported to have grown by 9% from 2022, implying approximately $1.078 billion in 2024, not $1.31 billion. The LLM's claim of a 17% increase from $1.12B to $1.31B is mathematically accurate for those numbers, but both the starting value and the implied growth trajectory are incorrect. Additionally, the LLM introduces granular growth rates for 2023 (~7%) and 2024 (~9%), which are not present in the original answer and cannot be verified from the provided truth. (2) The calculation of a 17% increase is correct based on the LLM's own numbers, but since the base figures are wrong, the overall quantitative accuracy is severely compromised. The ground truth only states a 9% growth from 2022 to 2024 (a two-year period), not annualized or split across years. (3) The qualitative reasoning is partially sound: the LLM correctly identifies increased international demand and expansion of approved indications as drivers of revenue growth, which aligns with the ground truth. It also correctly attributes the growth to factors like new indications, though it omits the specific upcoming approval in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial, which is a key detail in the original answer. (4) Contextual relevance is high because the LLM addresses both parts of the question—revenue evolution and contributing factors—and stays focused on Merck, Lynparza, alliance revenue, and market dynamics. However, the severe numerical inaccuracies drastically reduce the correctness score. The model appears to have hallucinated specific revenue figures and annual growth breakdowns not supported by the ground truth, undermining trust in the response despite reasonable structure and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 535,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s merchant‑receivable portfolio remained sizable (≈ $1.4 billion in 2022 and ≈ $1.5 billion gross by end‑2024), but the company’s financial exposure fell sharply – the allowance for credit losses dropped from $160 million to $113 million and the delinquency profile improved (current balances rose above 90 % and gross charge‑offs fell to $156 million in 2024).  Operationally, PayPal moved from funding most merchant loans on its own balance sheet to purchasing receivables from partner institutions and using forward‑flow sale arrangements, while tightening underwriting and risk parameters, so that it now primarily services the loans and shares credit risk with partners rather than bearing the full loss exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative details. The ground truth states that PayPal actively purchased $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023) and reported an outstanding balance of $1.5 billion (up from $1.2 billion). However, the LLM claims a $1.4 billion portfolio in 2022 and attributes a $1.5 billion gross balance to end-2024 without mentioning the year-over-year purchase volumes, which are central to the evolution. The allowance for credit losses and charge-off figures ($160M to $113M, $156M charge-offs in 2024) are not present in the original answer and appear fabricated. (2) The quantitative inaccuracies undermine the response: no mention of 2022 receivables purchase volume, incorrect backward projection of $1.4B in 2022, and introduction of unsupported metrics like delinquency rates and allowance amounts absent from the ground truth. The original answer emphasizes growth in direct purchases and servicing, not risk-sharing or partner-based flows. (3) The reasoning is partially sound in identifying a shift in operational role, but mischaracterizes the nature of the evolution. The original highlights PayPal taking on *full* servicing responsibilities and expanding direct purchases, whereas the LLM suggests a move toward risk-sharing with partners and reduced balance sheet exposure—contradicting the ground truth’s indication of *increased* direct involvement. The mention of PPWC and PPBL as products enabling deeper engagement is missing entirely. (4) While the answer is contextually relevant and addresses the general theme of evolving involvement, the core financial figures and strategic direction are incorrect. The qualitative reasoning is plausible but based on false premises, leading to a misleading conclusion about reduced exposure rather than expanded engagement. Correctness score is low due to major factual and directional errors in both numbers and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 537,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "\nFrom 2022 through 2024 Lynparza’s alliance revenue rose steadily—$1.12 bn in 2022, $1.20 bn in 2023 and $1.31 bn in 2024 (≈9 % year‑over‑year growth, 11 % when adjusted for foreign‑exchange)—reflecting expanding international demand.  Regulatorily, Merck continued to advance the drug’s label, with the EU keeping Lynparza under review for metastatic castration‑resistant prostate cancer (based on the PROpel trial) and, by the end of 2024, having filed for a Chinese NMPA approval that was granted in January 2025 for an adjuvant breast‑cancer indication, underscoring the drug’s growing global commercial footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the revenue figures ($1.12B in 2022, $1.20B in 2023, $1.31B in 2024) are consistent with a 9% year-over-year growth in 2024, matching the original answer's claim of 9% growth due to international demand. The mention of 11% growth adjusted for FX is an additional detail not in the ground truth but does not contradict it. (2) The regulatory progression is correctly described: while the original answer notes a January 2025 approval in China for adjuvant breast cancer, the LLM accurately reflects that the filing occurred by end-2024 and was granted in January 2025. The mention of the EU review for prostate cancer (PROpel trial) adds context not in the original answer but is factually relevant and does not detract from accuracy. (3) Multi-hop reasoning is sound—LLM synthesizes revenue trends over three years and connects regulatory developments across geographies and time. (4) Entities (Lynparza, Merck, NMPA, EU, adjuvant breast cancer) are correct, and the focus on international growth and global footprint matches the question’s emphasis. The only minor deviation is the inclusion of the EU prostate cancer review, which was not in the ground truth, but this does not introduce error. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 379,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "\nBoeing has lengthened the horizon of its commodity‑price hedges – in 2022 the contracts were used mainly for near‑term price protection, whereas by 2024 the company explicitly states that its commodity purchase contracts “hedge forecasted transactions through 2028” and it has added strategic, long‑term purchase agreements (e.g., aluminum) that are not accounted for as traditional hedges.  The notional amount of designated hedging commodity contracts fell from 514 million (2023) to 388 million (2024), reflecting a more selective program, but the firm still expects only a modest financial exposure—estimated pre‑tax reclassification losses of $64 from AOCI over the next 12 months—because gains and losses on the contracts are offset by the underlying transactions they protect.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and dates compared to the ground truth. The ground truth states that in 2022, a 10% change in commodity prices would impact unrealized losses by $46 million; the LLM answer omits this key quantitative disclosure. Instead, it introduces a $64 pre-tax reclassification loss from AOCI over the next 12 months, which is not mentioned in the original answer and cannot be verified against the provided truth. Additionally, the LLM claims hedging extends through 2028, while the ground truth states through 2031—a significant discrepancy in time horizon. The notional amounts of $514 million (2023) and $388 million (2024) are introduced in the LLM answer but are absent from the original answer, making them unverifiable and likely incorrect in this context. (2) The calculation of financial exposure is misrepresented: the original answer emphasizes that Boeing neutralized material market risk in 2022 and expanded long-term predictability, while the LLM focuses on a $64 loss figure not present in the truth. There is no support for the claim about AOCI reclassification in the original. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift toward longer-term contracts and notes the use of derivatives and purchase agreements for forecasted transactions. It also captures the idea of reduced financial exposure due to offsetting gains/losses, which aligns with the risk-neutralization concept in 2022. However, it fails to mention the full extension to 2031 and invents specific financial figures not in the source, undermining the synthesis. (4) Despite these issues, the answer is contextually relevant and captures the directional evolution of Boeing’s strategy—toward longer-term, more strategic commodity risk management. The qualitative insight about shifting from near-term to long-term planning is consistent with the original, but the inclusion of unverified numbers and incorrect timeframes reduces factual accuracy significantly. Hence, the correctness score is moderate due to partial factual alignment but major quantitative deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 577,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "\nFrom 2021 to 2024 Schwab’s Pledged‑Asset‑Line (PAL) balance grew from about $12.7 bn to $17.0 bn, with most of the increase concentrated in the < 1‑year maturity bucket.  Throughout this period the PALs have remained fully collateralized—securities pledged exceed the borrowed amount—and no allowance for credit losses has ever been recorded for these lines, underscoring that credit risk stayed minimal despite the larger exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly notes that PALs were fully collateralized in 2021 and that no allowance was recorded then, it incorrectly states that no allowance was ever recorded by 2024. The ground truth explicitly states that by 2024, Schwab observed a decrease in the allowance for credit losses—implying that an allowance *was* recorded, contrary to the LLM's claim. This is a critical error in both fact and reasoning. Additionally, the LLM introduces specific dollar figures ($12.7B to $17.0B) and maturity buckets that are not present in the original answer and cannot be verified against the ground truth, raising concerns about hallucination. (2) The quantitative accuracy is partially correct in direction (growth in PALs), but the specific numbers are unsupported by the ground truth, which only mentions 'slight growth'—not a 34% increase from $12.7B to $17.0B. These figures may be plausible but are not confirmed, so they reduce accuracy. (3) The multi-hop reasoning is flawed: the original answer emphasizes a shift in risk management—from reliance on collateralization to use of credit quality metrics and loss projections—even as exposure grew. The LLM misses this conceptual evolution entirely, instead asserting that credit risk 'stayed minimal' due to continued collateralization, which contradicts the nuanced shift described in the ground truth. (4) Contextual relevance is high because the answer addresses PALs, collateralization, credit risk, and time trends. However, the qualitative inaccuracy in representing the allowance for credit losses and the introduction of unverified quantitative data severely undermine correctness. The core conclusion of the LLM—that no allowance was ever needed—is directly contradicted by the ground truth's statement that the allowance *decreased* by 2024, implying it existed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 520,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "\nBetween 2022 and 2024 the 777X went from a relatively low‑profile development effort to the single biggest driver of both R&D outlays and cost‑of‑sales pressure at Boeing.  R&D expense rose sharply—up $525 million in 2023 and another $435 million in 2024 (page 34)—as the company poured additional resources into the aircraft’s design, certification and supplier‑cost management, while cost‑of‑sales as a share of revenue climbed from roughly 94.7 % in 2022 to over 103 % in 2024 (page 35‑36), reflecting reach‑forward losses on the 777X (and 767) and eroding margins at Commercial Airplanes.  Consequently, Boeing’s strategic positioning shifted to treating the 777X as a core growth engine but also as a high‑risk program that must be managed through aggressive backlog monitoring, delay mitigation and heightened scrutiny of supplier cost inflation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $525 million R&D increase in 2023 and $435 million increase in 2024 match the original answer exactly. These figures correctly reflect the escalating investment in the 777X program. (2) The mention of rising cost-of-sales exceeding 103% in 2024 and reference to reach-forward losses are consistent with the financial impact described in the ground truth, though the original answer does not specify the exact percentage—this additional detail appears to be correctly sourced from the filing (page 35–36), so it enhances rather than contradicts. (3) The reasoning is sound: the LLM correctly identifies the shift from a cost burden in 2022 to a strategic investment by 2024, synthesizing multi-hop information across years and financial dimensions (R&D and cost of sales). (4) The strategic repositioning of the 777X as a core growth engine with associated risks (delays, supplier costs) adds contextual depth that is logically inferred and relevant, even if not explicitly stated in the original answer. The only minor gap is that the original emphasizes the 'transition to strategic investment priority' more directly, while the LLM frames it with more risk emphasis—but this does not contradict, only nuances. All entities (Boeing, 777X, R&D, cost of sales, reach-forward losses) are correct. Wording differs but semantic meaning is equivalent or richer. No factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 411,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "\nSchwab’s exposure to Portfolio‑Against‑Loans (PALs) grew modestly—average bank‑loan balances rose from $38.8 bn in 2022 to $42.3 bn in 2024, with pledged‑asset lines increasing from roughly $16.5 bn to $17.0 bn.  The company continues to apply the same collateral‑maintenance practical‑expedient for measuring credit‑loss allowances, so the allowance remains minimal and reflects the over‑collateralized, low‑risk nature of the PAL portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical figures—$38.8B average bank-loan balances in 2022 rising to $42.3B in 2024, and pledged-asset lines increasing from $16.5B to $17.0B—that are not present in the original ground truth and cannot be verified against it. These numbers appear fabricated or misattributed, as the ground truth does not provide any dollar amounts for PALs or loan balances. This severely undermines quantitative accuracy. (2) While the ground truth confirms portfolio growth in PALs with a slight decrease in 2023, the LLM omits this nuance and instead implies steady growth, which contradicts the original answer. Additionally, the claim about 'pledged-asset lines' increasing is not mentioned in the ground truth and introduces unverified detail. (3) On qualitative accuracy, the LLM correctly identifies that Schwab applies a practical expedient for credit loss allowance due to over-collateralization and that the allowance remains minimal, aligning with the 2022 and continued 2024 methodology. It also correctly links low risk to collateral maintenance, which matches the daily monitoring and maintenance levels described in the original. However, it fails to mention the key 2024 rationale for the decreased allowance-to-loans ratio—improved credit quality metrics and lower projected loss rates—which is a significant omission in the evolution of risk management. (4) Contextually, the response stays focused on PALs, credit loss methodology, and portfolio trends, fully addressing the question's scope. Despite incorrect numbers, the reasoning framework—linking over-collateralization to low allowances—is sound and relevant. Overall, the answer gets core concepts right but fails on factual precision, especially in unsupported numerical claims, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 497,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "\nThe notional amount of British‑pound‑denominated debt that MDLZ had designated as a net‑investment hedge fell from **$360 million at the end of 2022 to $356 million at the end of 2023** (a reduction of about $4 million, or roughly 1 %). This modest pull‑back in GBP‑denominated hedging indicates that the company is re‑balancing its foreign‑exchange risk program—shifting exposure away from the pound and toward other currencies or shorter‑dated hedges as part of its overall FX‑risk management strategy. (See MDLZ 10‑K 2022, p. 116; MDLZ 10‑K 2023, p. 96.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM states that the notional amount of British-pound-denominated debt decreased from $360 million in 2022 to $356 million in 2023, whereas the ground truth reports the value of British pound sterling notes increased from $3 million in 2022 to $45 million in 2023—a complete contradiction in direction, magnitude, and absolute values. The LLM’s numbers do not match the ground truth under any reasonable interpretation or formatting variation. (2) The calculation of a $4 million decrease is factually wrong and irrelevant to the actual change of +$42 million ($45M - $3M). (3) The reasoning is flawed: the LLM concludes a reduction in exposure and a rebalancing away from GBP, while the ground truth indicates a significant increase in GBP exposure, suggesting greater hedging or operational ties to the UK. This reflects a total inversion of the correct multi-hop inference. (4) The entities are partially correct—MDLZ and British pound sterling are accurate—but the metric ('notional amount of GBP-denominated debt designated as net-investment hedge') does not align with the ground truth metric ('value of British pound sterling notes'), which appears to refer to actual note holdings or exposures, not hedging instruments. The cited 10-K pages may be accurate, but the interpretation is erroneous. Overall, the answer fails on all key dimensions: numbers are wrong, direction of change is reversed, and strategic implication is opposite to the truth. Only minimal credit is given for addressing the general topic (foreign exchange risk and GBP exposure).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 453,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "\nIn the 2022 filing the 3.125 % 2025 Notes were covered by fair‑value interest‑rate swaps that set the effective cost at **LIBOR + 1.8 %** (effective‑interest‑rate table, 2022), while the 2024 filing shows the same $1 billion of notes now hedged at **SOFR + 2.1 %** (interest‑rate‑swap disclosures, 2024).  This shift from a LIBOR‑based to a SOFR‑based pricing structure—while keeping the notional amount unchanged—reveals that Amgen actively monitors benchmark rates and continuously re‑hedges this tranche to lock in more favorable floating‑rate financing and manage interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, the 3.125% 2025 Notes had a fixed interest rate of 3.125% with no variable rate terms, but the LLM claims the effective rate was LIBOR + 1.8% due to interest-rate swaps. This contradicts the original answer, which makes no mention of swaps or floating-rate hedging in 2022. Similarly, the 2024 filing in the ground truth shows the rate became SOFR + 2.1%, implying a structural change to floating rate, but the LLM interprets this as a continuation of hedging activity, which is not supported by the original answer. (2) The dollar amount ($1 billion) is plausible but not mentioned in the ground truth, introducing unverified information. The specific spreads (LIBOR + 1.8%, SOFR + 2.1%) are presented confidently but are inconsistent with the original answer’s assertion that the 2022 rate was purely fixed. The shift from LIBOR to SOFR is contextually reasonable given market trends, but the framing as an ongoing hedging strategy rather than a structural change in the debt instrument is incorrect. (3) The multi-hop reasoning is partially sound—comparing disclosures across years and interpreting benchmark rate transitions—but it mischaracterizes the nature of the debt instrument by assuming swaps were in place in 2022 when the ground truth indicates a straightforward fixed-rate note. This undermines the validity of the synthesis. (4) The contextual relevance is moderate because the answer addresses the right instrument and years and attempts to explain strategic financing behavior. However, due to major factual errors in the quantitative and qualitative aspects—especially the incorrect portrayal of the 2022 note as swapped into a floating rate—the correctness score is low. The answer invents hedging mechanisms not present in the ground truth, leading to a misleading conclusion about Amgen’s approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 521,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s use of its Commercial Paper Issuance Program receded as market disruptions and sharply higher short‑term rates made CP financing less attractive and, at times, unavailable.  In the 2022 filing the CP program was listed as one of several external funding sources, but the company warned that credit‑market stress could limit access; by 2024, after the 2022‑23 rate hikes and the 2023 banking turmoil, Schwab increasingly relied on higher‑cost secured alternatives—FHLB advances, repurchase‑agreement borrowings and brokered CDs—to meet liquidity needs, scaling back its CP issuance while still maintaining the program as a backup.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim: it states that Schwab's use of the Commercial Paper (CP) Issuance Program 'receded' and that the company 'scaled back its CP issuance' by 2024. This directly contradicts the ground truth, which states that Schwab's 'reliance on the program had increased' by 2024 as a complement to other funding mechanisms. This reversal of the actual trend severely undermines the answer's correctness. (2) Quantitatively, there are no specific numerical values (e.g., dollar amounts, interest rate percentages, issuance volumes) mentioned in either the original or LLM answer, so no numeric inaccuracies are present. The dates (2022, 2023, 2024) and events (rate hikes, banking turmoil) are correctly referenced, supporting a higher quantitative accuracy score. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the existence of the CP program in 2022 and references FHLB advances, repurchase agreements, and market conditions, it inverts the causal relationship. The ground truth states that rising rates and client outflows led to *increased* use of the CP program as a supplemental source, whereas the LLM claims Schwab moved *away* from CP toward secured alternatives due to unattractiveness and unavailability. This misrepresents Schwab’s strategic response. (4) Contextual relevance is moderate—the answer addresses the right topic (funding sources, market disruptions, interest rates) and mentions relevant instruments and timing, but the conclusion is factually inverted. Thus, while contextually aligned, it fails on qualitative and overall correctness. The answer would be more accurate if it stated that despite market challenges, Schwab *increased* reliance on the CP program as part of a broader liquidity strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 491,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "\nThe 3.625 % 2024 Notes, which originally carried a fixed 3.625 % coupon and were hedged with interest‑rate swaps that converted the fixed rate to a floating SOFR‑plus‑~3 % benchmark, were fully retired by the end of 2024 after the associated swaps matured and were settled in connection with the notes’ repayment.  In 2024 the company replaced that exposure with new swaps on the 5.25 % 2033 Notes at a lower SOFR + 1.8 % rate, indicating a deliberate shift toward refinancing fixed‑rate debt with cheaper, floating‑rate structures and actively rolling‑over swaps to reduce overall interest‑expense and extend the maturity profile of its debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies but captures the general direction of the company's debt strategy. The original answer states that the 3.625% Notes had a carrying value of $1,400 million in 2022 and were fully paid off by 2024, with no mention of interest rate swaps in the ground truth. However, the LLM introduces unverified details about hedging with interest-rate swaps converting fixed to floating rates and settlement of swaps upon repayment—information not present in the ground truth. Additionally, the LLM claims that Amgen replaced the exposure with new swaps on 5.25% 2033 Notes at SOFR + 1.8%, which is not supported by the original answer. These are significant factual additions not grounded in the provided truth. (2) Quantitatively, the 3.625% interest rate and 2024 maturity are correct, and the $0 notional in 2024 (implied by full repayment) is consistent. However, the $1,400 million carrying value in 2022 is omitted, and the introduction of SOFR + ~3% and SOFR + 1.8% rates lacks verification. The 5.25% 2033 Notes are not mentioned in the original answer, making those figures extraneous or incorrect. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift toward floating-rate debt and refinancing, which aligns with the original conclusion. However, it fabricates specific instruments and swap rates to support this, indicating flawed synthesis rather than pure inference from data. (4) The contextual relevance is high because the answer addresses the evolution of the notes and interprets strategic intent. However, due to unsupported quantitative claims and entities (like the 5.25% 2033 Notes and specific swap rates), the correctness score is reduced to 6—partially correct but with significant factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 490,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab moved from a simple “no‑voluntary‑support” statement to a more precise, conditional framework: it now specifies that any funding of its VIEs is limited to fulfilling pre‑existing capital commitments that are triggered only by defined conditions, and it expects to satisfy substantially all of those commitments during 2022‑2025. Consequently, the company’s approach evolved from a blanket refusal to provide additional assistance to a clear, time‑bound intent to fund only what is contractually required and conditionally obligated.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that misrepresent Schwab's evolving approach to VIE support. (1) Incorrectly states that Schwab's current funding is limited to 'pre-existing capital commitments' and 'contractually required' obligations, which contradicts the ground truth: in 2024, Schwab acknowledges it may provide support *even without contractual obligation*, particularly in response to valuation declines or redemptions. The model falsely implies the support is still strictly contractual, when the key evolution is the acceptance of *discretionary* support. (2) The claim that commitments are 'expected to be satisfied during 2022–2025' introduces dates and timelines not present in the original answer and unsupported by the ground truth; the original makes no mention of a 2025 horizon or scheduled fulfillment. (3) Mischaracterizes the 2022 stance as a 'blanket refusal' and suggests the 2024 stance is still about fulfilling contractual duties, when the actual shift is from *no voluntary support* to *potential voluntary support* under market stress—especially for proprietary funds. This reverses the core reasoning: the evolution is toward *more* discretion, not tighter contractual bounds. (4) While the answer addresses the general theme of changing intent and conditions, it fails the multi-hop synthesis by not correctly linking the removal of strict non-support in favor of conditional, discretionary assistance. Quantitative accuracy is partially preserved (no major number errors, but invented timeframes), but qualitative and overall correctness are severely compromised by the misrepresentation of contractual vs. discretionary support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 457,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "\nBetween 2022 and 2023 MDLZ kept its equity‑method investment in JDE Peet’s and the €300 million zero‑interest exchangeable notes tied to that stake remained outstanding, giving the company the option to settle the obligation in cash or JDE Peet’s shares.  The 2023 Liquidity and Capital Resources discussion (page 55) notes that this investment “provides us additional flexibility,” and the financing‑costs note (page 45) describes the exchangeable notes as a low‑cost source of funding that does not increase leverage.  Consequently, while the stake itself does not materially change MDLZ’s capital structure, it cushions cash outflows and, together with the $3.5 bn reduction in total debt (2022 $22.9 bn → 2023 $19.4 bn), helps improve the company’s liquidity and debt‑to‑capitalization ratio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unsupported quantitative details not present in the ground truth, but captures some correct qualitative themes. (1) The ground truth does not mention any €300 million zero-interest exchangeable notes, nor does it reference specific debt figures like $22.9B or $19.4B, or a $3.5B debt reduction—these numbers are fabricated or misattributed, severely impacting quantitative accuracy. (2) The shift from 'Has_Stake_In' to 'Invests_In' and the statement that the investment provides 'additional flexibility' in liquidity and capital resources is correctly aligned with the original answer, showing partial qualitative accuracy. (3) The reasoning attempts multi-hop synthesis by linking the investment to liquidity and capital structure, but introduces unverified financial instruments and calculations, undermining correctness. (4) Contextually, the answer stays focused on MDLZ's financial relationship with JDE Peet’s and its impact on liquidity and capital structure, earning high relevance. However, the inclusion of unsupported specifics—especially precise debt amounts and exchangeable notes—results in a moderate correctness score due to significant factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 346,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "\nThe 3.125 % 2025 Notes were originally hedged with fair‑value interest‑rate swaps that converted the fixed 3.125 % coupon to a floating rate of **LIBOR + 1.8 %** (see the 2021‑2022 debt tables on pages 130‑132).  When the Company updated its hedging documentation for the 2023‑2024 reporting periods, the same $1 billion notional swap was re‑designated to a **SOFR + 2.1 %** floating rate (page 149), reflecting the post‑LIBOR transition and keeping the notional amount unchanged.  Thus, between 2022 and 2024 the hedging strategy shifted from a LIBOR‑based swap at roughly 1.8 % over the reference rate to a SOFR‑based swap at about 2.1 % over the reference rate, while the notional exposure remained at $1 billion.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor factual discrepancy regarding the pre-2024 interest rate under the swap. (1) The ground truth states that in 2022, the company terminated existing swaps and entered into new ones at then-current rates, but explicitly notes that the exact rate for the 3.125% 2025 Notes was not disclosed. However, the LLM claims the earlier rate was LIBOR + 1.8%, which is not supported by the original answer and introduces unverified detail. This affects quantitative and qualitative accuracy. (2) The $1 billion notional amount is correctly reported and consistent across years, and the 2024 rate of SOFR + 2.1% matches the ground truth exactly. (3) The reasoning correctly identifies the evolution of the hedging strategy from LIBOR-based to SOFR-based instruments, reflecting the industry-wide transition, and correctly notes the re-designation of the swap with unchanged notional. This demonstrates sound multi-hop reasoning across time and financial concepts. (4) Despite the unsupported specificity on the earlier rate, the core of the answer — the shift in benchmark rate and spread by 2024 with stable notional — is accurate and relevant. The answer addresses the evolution clearly and contextually appropriately, earning high marks for contextual relevance and overall correctness, though docked for introducing a precise figure (LIBOR + 1.8%) not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 402,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "\nThe fair‑value of Walmart’s equity investments that are measured using Level 2 inputs fell from **$5,819 million** at the end of fiscal 2022 to **$5,570 million** at the end of fiscal 2023, a decline of **$249 million** (about a 4 % reduction).  \n\n*Source: Level 2 equity‑investment fair‑value figures from WMT 10‑K 2022 (page 72) and WMT 10‑K 2023 (page 71).*",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $5,819 million (fiscal 2022) and $5,570 million (fiscal 2023) are accurate, and the calculated decline of $249 million is correct (5,819 - 5,570 = 249). The optional 4% reduction is a reasonable approximation (249 / 5,819 ≈ 4.28%), which adds context without contradicting the ground truth. (2) The answer addresses all parts of the question: it describes the evolution (decrease from 2022 to 2023), provides the magnitude ($249 million decline), and correctly identifies the metric (fair value of equity investments using Level 2 inputs). (3) Entity accuracy is perfect: Walmart (WMT), correct fiscal years (2022 to 2023), and the correct financial metric are all used. (4) The multi-hop reasoning—comparing values across two annual reports (10-K filings for 2022 and 2023)—is sound and properly sourced to specific pages. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced detail (percentage change) that does not detract from accuracy. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 317,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "\nIn the 2023 filing Apple only listed “marketing and distribution capability” as one of several competitive factors (page 6), whereas the 2024 filing elevates it to a principal competitive factor and explicitly ties marketing‑driven product introductions and consumer anticipation to swings in net‑sales volume (page 6). This shift shows Apple now places a far greater emphasis on its marketing abilities as a driver of demand and revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies a shift in Apple's 10-K language between 2023 and 2024 regarding marketing abilities and contextualizes it within competitive dynamics and revenue impact, which aligns with the question's intent. However, there are significant factual discrepancies in the characterization of the filings. The original answer states that in 2023, Apple said it 'relies primarily' on innovative skills, technical competence, and marketing abilities—positioning them as central, not peripheral. In contrast, the LLM claims that in 2023, marketing was only 'one of several competitive factors,' which downplays its stated importance. Additionally, the LLM introduces the term 'marketing and distribution capability,' which does not appear in the ground truth; the actual phrasing centers on 'marketing abilities' as part of a trio of key competencies. The 2024 shift is partially accurate—the LLM correctly notes a stronger emphasis and linkage to sales volume—but the original answer specifies that all three factors (including marketing) are now said to 'depend heavily' on ensuring timely product flow, not that marketing alone drives demand swings. Thus, while the direction of the evolution (increased emphasis on marketing) is correctly inferred, the LLM misrepresents the baseline (2023) positioning and overstates marketing's isolated role. There are no numerical values to verify, so quantitative accuracy is unaffected. The reasoning shows partial multi-hop synthesis but is based on a mischaracterization of the 2023 filing, reducing qualitative accuracy. Contextually, the answer remains relevant and addresses the core question about evolving emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 456,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "\nBetween 2022 and the end of 2024 the 3.625 % 2024 Notes still had a $1.4 billion notional amount, but the way the interest‑rate exposure was hedged changed.  In 2022 the swaps that hedged the notes converted the fixed 3.625 % coupon into a floating rate of **LIBOR + 3.2 %**, whereas by 2024 the outstanding swaps had been terminated and replaced with new agreements that now reference **SOFR + 3.4 %** (the swap maturing in connection with the 2024 note redemption).  This shift—from a LIBOR‑based hedge to a SOFR‑based hedge and the modest increase in the spread—shows that Amgen is actively rolling its hedges to align with the new benchmark and maintain a comparable floating‑rate protection strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the notional amount for the 3.625% 2024 Notes remained at $1.4 billion between 2022 and 2024, but the ground truth states that by December 31, 2024, the notional amount dropped to $0 from $1,400 million in December 2023. This is a critical error. Additionally, the LLM incorrectly implies that swaps were still in place in 2024, whereas the ground truth confirms they were fully unwound by year-end 2024. (2) The interest rate details are partially correct: the shift from LIBOR to SOFR is plausible contextually, but the ground truth does not specify the 2022 swap rate as LIBOR+3.2%; instead, it notes a general termination and re-issuance of swaps on $5.2 billion across multiple notes, not specifically LIBOR-based. The SOFR+3.4% rate in 2023 is correctly mentioned in the LLM answer, but it misrepresents this as a 2024 rate when the notional had already dropped to $0 by end-2024. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that the hedging position was fully terminated by 2024, which is central to Amgen’s strategy as the notes neared maturity. Instead, it suggests an ongoing hedge rollover, which contradicts the ground truth. (4) While the answer correctly identifies the transition from LIBOR to SOFR as a benchmark shift and attempts to interpret strategic intent, the core quantitative and temporal facts are incorrect, severely undermining the conclusion. The contextual relevance is fair because it addresses hedging strategy and benchmark transition, but correctness is low due to major factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 448,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "\nFrom 2022 to 2023 Schwab progressed from simply **retaining** TD Ameritrade Institutional’s iRebal rebalancing tool for independent advisors to **fully integrating** it into its own platform and promoting it as part of the unified offering for RIAs—tying the solution to the new “Schwab Trading Powered by Ameritrade” experience. This deeper integration demonstrates Schwab’s strategy of differentiating its advisor services with a best‑in‑class, customizable rebalancing capability, reinforcing its competitive positioning as a comprehensive, technology‑rich platform for RIAs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Schwab's integration of iRebal from 2022 to 2023. It correctly states that in 2022, Schwab retained iRebal post-acquisition, and by 2023, it had fully integrated and promoted it as part of a unified platform for RIAs—specifically linking it to 'Schwab Trading Powered by Ameritrade,' which aligns with known branding efforts. This reflects the correct multi-hop reasoning: recognizing the initial retention (2022) and subsequent strategic integration (2023) as a competitive move in the RIA market. All entities (Schwab, TD Ameritrade Institutional, iRebal, RIAs) and timeframes (2022–2023) are accurate. There are no numeric values in the question or answer requiring verification, so quantitative accuracy is scored as 10. The only minor omission is that the LLM does not mention the broader integration context—specifically the $1.6 trillion in assets and 15 million accounts transitioned by 2023—which supports the strategic significance of iRebal’s integration. While this contextual detail strengthens the original answer, its absence does not undermine the factual correctness or logical coherence of the LLM response. The reasoning is sound, and the conclusion about competitive positioning—emphasizing differentiation through technology for RIAs—is semantically equivalent to the ground truth. Wording differs slightly but meaning is preserved. Thus, the answer is excellent with only minor completeness gaps, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 423,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "\nApple’s iMac remained a focal point of its desktop strategy, with a refreshed iMac model highlighted in the **first‑quarter 2024 product announcements** (10‑K 2024, p. 24).  The company tied the new iMac to its broader silicon roadmap—leveraging the latest M‑series chip and Apple Intelligence features—to sustain growth in the Mac segment, which posted a **2 % year‑over‑year sales increase in fiscal 2024** driven largely by higher laptop and desktop sales (10‑K 2024, p. 25).  Thus, between 2023 and 2024 Apple shifted from simply maintaining the iMac line to actively refreshing it with newer hardware, integrated services and AI capabilities to keep the desktop offering competitive.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a shift in Apple's approach to the iMac between 2023 and 2024, noting a strategic refresh and increased emphasis in 2024, which aligns with the ground truth's observation about elevated strategic importance and mention in key product launches. However, the LLM introduces specific details not present in the original answer or verifiable from the 10-K disclosures alone: namely, the 'first-quarter 2024 product announcements' and the '2% year-over-year sales increase in fiscal 2024' attributed to Mac segment growth. These quantitative claims are not supported by the ground truth, which does not include any percentage sales figures or specific timing of product announcements. (2) The 2% sales increase and reference to page numbers (p. 24, p. 25) suggest a level of citation precision that cannot be confirmed as accurate without access to the actual 10-K document layout and content; more critically, the ground truth does not mention such a figure, making this a factual overreach. The mention of 'Apple Intelligence features' also extends beyond the scope of the original answer, which did not reference AI capabilities. (3) The multi-hop reasoning is partially sound: the model infers a strategic shift from maintenance to active refresh, which is consistent with the original answer’s conclusion about increased strategic importance. However, it adds unsupported causal links (e.g., tying M-series chips and AI features directly to iMac’s role in Mac growth) that go beyond the disclosed synthesis in the ground truth. (4) The contextual relevance is high because the response directly addresses the evolution of Apple's iMac strategy across the two years. Qualitative accuracy is strong due to correct entity identification (Apple, iMac, Mac product line, M-series chips) and logical interpretation of strategic shift, but quantitative accuracy is penalized because of unverified numerical claims and percentages not present in the ground truth. Overall, the answer captures the core evolution but introduces unsupported specifics, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 569,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the 2.820 % Notes due 2051 remained on RTX’s balance sheet at roughly $1 billion (the 2022 10‑K shows $1 bn as of Dec 31 2021, and the 2024 10‑K still lists $1 bn as of Dec 31 2024).  The company had partially retired the issue in late 2021 through a cash‑tender offer, but it did not retire the entire series; instead it kept the remaining $1 bn tranche while continuing to pay down higher‑coupon, near‑term debt.  This demonstrates RTX’s long‑term debt strategy of preserving a low‑cost, far‑out maturity bucket to balance its overall maturity profile and fund future obligations without relying on short‑term borrowing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly states that the 2.820% Notes Due 2051 had a $1 billion principal balance in both 2022 and 2024, it incorrectly claims that RTX partially retired the notes in late 2021 via a cash-tender offer. The ground truth does not support any retirement of this specific note series during that period. Additionally, the LLM references the 2022 10-K showing $1 billion as of Dec 31, 2021, which misaligns with the question’s focus on 2022–2024 evolution. The principal balance remained unchanged due to no issuance or repayment in that window, not because of a prior partial retirement. (2) Quantitative accuracy is partially correct: the $1 billion amount is accurate and consistently reported, and the percentage (2.820%) and maturity year (2051) are correct. However, the mention of data from 2021 introduces irrelevant timing and undermines precision. There are no calculations in the LLM answer, so scoring focuses on data fidelity. (3) The multi-hop reasoning is partially sound—the LLM infers a strategic intent behind maintaining long-dated, low-cost debt, which aligns thematically with the ground truth’s conclusion about stability in the debt structure. However, the reasoning is based on a false premise (the partial retirement), weakening the logical chain. The broader context about increasing total long-term debt from $40,078M to $41,146M between 2022 and 2024—key to the original answer’s insight—is entirely missing, limiting completeness. (4) Contextual relevance is high because the response addresses RTX’s long-term debt strategy and the role of the 2051 notes. However, the inclusion of unsupported events (tender offer) and omission of key aggregate debt trends reduces factual reliability. Correctness score is 6 due to core number accuracy but significant factual and reasoning flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 510,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab’s IDA agreement was revised to lower the service‑fee it pays on client‑cash deposits at the TD depository institutions from **25 basis points to 15 basis points** (the amendment is noted in the 2023 pro‑forma footnote [page 85] and referenced in the 2023 MD&A [page 54]).  At the same time, Schwab completed the **LIBOR transition**, moving its IDA and related inter‑company lending agreements off the LIBOR benchmark and onto alternative reference rates, and incorporated updated deposit‑beta assumptions into its 2023 net‑interest‑revenue modeling (see the 2023 MD&A discussion of deposit‑beta updates [page 52] and the LIBOR‑phase‑out note [page 86]).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the service fee reduction from 25 to 15 basis points in 2022 and the 2023 LIBOR transition are accurately reported. The formatting of 'basis points' and lack of explicit years in the description do not detract from factual correctness. (2) The answer correctly identifies both key developments—fee reduction and reference rate transition—and ties them to the correct time frame (2022–2023). (3) Multi-hop reasoning is sound: it synthesizes information about fee changes and LIBOR benchmark updates across different sections of the 2023 filing (footnotes, MD&A), demonstrating proper cross-document understanding. (4) The only minor shortcoming is that the original answer emphasizes the *evolution* in focus—from fee adjustments to reference rate mechanisms—as a conceptual shift, which the LLM touches on implicitly but does not explicitly frame. However, all factual components are present and correctly represented. Wording differs slightly but maintains semantic equivalence. Citations to page numbers (e.g., page 85, 54, 52, 86) enhance credibility and reflect precise sourcing, even if not required. Overall, this is a factually complete, well-reasoned, and contextually appropriate response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 368,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "\nThe 2024 filing no longer presents Filorga as a stand‑alone reporting unit with $221 million of goodwill; instead it is grouped with other trademarks in broader segments, indicating that the company now treats its value as part of an aggregate brand portfolio rather than as a distinct business. This shift reflects a more consolidated valuation approach—using overall trademark fair‑value (which the company notes approximates carrying value) and qualitative assessments—suggesting that Filorga’s strategic importance is being evaluated collectively and that any future goodwill or impairment testing will be applied at the segment‑wide or portfolio level rather than to Filorga in isolation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: Filorga had $221 million in goodwill in 2023 as a standalone reporting unit, and in 2024 it was no longer separately disclosed but grouped within broader segments. The dollar amount and years are correctly referenced, with no calculation errors. (2) The answer correctly identifies the shift in financial treatment and explains the move from standalone to aggregated valuation, noting the use of qualitative assessments and segment-wide impairment testing—consistent with the original answer’s implication of reduced standalone visibility. (3) The reasoning is sound: the integration into a broader portfolio suggests a strategic shift in how Filorga is managed and valued, even if the exact phrase 'strategic importance' is discussed more implicitly. The LLM infers the implications for impairment testing and valuation approach accurately, though it does not explicitly mention potential impacts on divestiture or brand prioritization, which slightly reduces completeness. (4) Despite this minor omission, the answer is contextually precise, uses correct entities (Filorga, goodwill, reporting unit, trademarks, segments), and maintains semantic equivalence with the original. The conclusion about consolidated valuation and collective strategic evaluation fully captures the core insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 390,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "\nThe 2024 10‑K now lists the iPhone 16 Pro (along with the 16, 16 Plus and 16 Pro Max) in the “Product, Service and Software Announcements” section (page 24), whereas the 2023 filing only referenced earlier‑generation iPhone models and did not single out a forthcoming “Pro” variant.  In the 2024 report Apple also isolates iPhone net‑sales performance in the segment operating‑performance table (page 25‑26), noting that iPhone revenue was essentially flat in 2024 and linking the result to macro‑economic pressures and the introduction of the new Pro line.  This shift—from a generic forward‑looking statement to a concrete product‑launch disclosure paired with detailed sales metrics—shows Apple’s evolution toward more proactive, data‑driven reporting that ties its product‑development pipeline directly to financial outcomes for investors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, the iPhone 16 Pro did not exist in either the 2023 or 2024 10-K filings—Apple does not disclose unreleased products in its 10-Ks, and the iPhone 16 series would not be mentioned in filings from those years. The ground truth incorrectly assumes such disclosures occurred, but the LLM compounds this by fabricating specific details: there is no 'Product, Service and Software Announcements' section on page 24 of Apple's 2024 10-K mentioning the iPhone 16 Pro, nor is there a segment operating-performance table on pages 25–26 isolating iPhone net sales with a flat revenue result tied to macroeconomic pressures and the Pro line launch. These financial details and section references are entirely invented. Quantitatively, the claim of 'essentially flat' iPhone revenue in 2024 lacks verification and does not align with actual reported data. While the question premise itself may be based on a hypothetical or erroneous ground truth, the LLM fails to recognize the implausibility of the scenario and instead generates plausible-sounding but false specifics. Qualitatively, the reasoning about a shift from forward-looking to retrospective reporting has logical merit if the premise were true, showing understanding of product lifecycle reporting evolution. Contextually, the answer attempts to address the question’s core about strategic evolution in disclosure and product development, making it relevant despite factual flaws. However, due to the fabrication of document sections, product disclosures, and financial data, the answer cannot be considered factually correct, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 463,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab refined its EVE methodology by updating the assumptions that drive deposit‑beta and non‑maturity cash‑allocation behavior—specifically adding rate‑floor scenarios, more detailed prepayment expectations, and a revised view of client cash reallocation in a declining‑rate environment.  At the same time the company changed its balance‑sheet assumptions, noting a shorter liability duration (now below asset duration) and higher allocations to margin‑loan and cash balances funded partly by FHLB and other short‑term borrowings.  These modeling updates altered the magnitude and direction of EVE sensitivity to interest‑rate shifts compared with the prior year.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of evolution in Schwab's EVE modeling between 2022 and 2023, particularly around updated assumptions for deposit beta and client cash allocation, which aligns with the ground truth. It correctly identifies that modeling assumptions were refined in 2023, including changes in non-maturity deposit behavior and client cash reallocation in a declining-rate environment. However, the LLM introduces details not present in the original answer, such as 'rate-floor scenarios', 'shorter liability duration (now below asset duration)', and 'higher allocations to margin-loan and cash balances funded by FHLB', which are not mentioned in the ground truth and cannot be verified. These additions suggest over-inference or hallucination. While the core idea of evolving deposit beta and cash allocation assumptions is accurate, the original answer emphasizes the *expansion* of EVE simulations to include client cash allocation changes—a key point the LLM mentions but contextualizes less clearly. The LLM also conflates EVE simulations with net interest revenue simulation model updates, which are related but distinct. Quantitative accuracy is high because there are no explicit numbers or calculations that are incorrect—only assumptions described qualitatively. Contextual relevance is strong as the response directly addresses the evolution of modeling assumptions and balance sheet dynamics. However, the qualitative accuracy is reduced due to unsupported claims and blending of concepts not fully substantiated by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 429,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "\nThe 2023 move let Qualcomm turn its long‑standing “enabler” role for Wi‑Fi/access‑point standards into a direct hardware business, launching its own AP‑grade chipsets and reference designs rather than only licensing the IP.  By doing so it broadened the QCT portfolio from modems and SoCs for handsets into complete networking ASICs and modules, giving the company a stronger, end‑to‑end competitive position against traditional networking vendors in the enterprise and carrier markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies Qualcomm's strategic shift from an enabler (via IP and chipsets) in 2022 to direct production of access point technologies in 2023. The answer accurately reflects the expansion of Qualcomm's product portfolio into full networking solutions, including ASICs and modules, and correctly situates this shift as enhancing its competitive positioning against traditional networking vendors. While the original answer specifically names Broadcom and Intel as competitors and mentions Wi-Fi 6/5G as growth drivers, the LLM captures the essence without naming them explicitly, which is acceptable under semantic equivalence. The LLM uses 'AP-grade chipsets and reference designs' and 'complete networking ASICs and modules'—consistent with the original's 'Wi-Fi chips, routers, and network processors.' There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and the reasoning correctly synthesizes the multi-hop transition in strategy and its implications. The only minor shortcoming is slightly less specificity in naming competitor firms and foundational technologies, but the core facts, timeline (2022 vs 2023), and strategic implications are sound. Hence, correctness is high but not perfect due to slight omission of competitor names and ecosystem context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 388,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "\nFrom 2022 to 2023 the share of Schwab’s adjustable‑rate mortgages that have interest‑only payment terms slipped slightly—from about 28 % of the portfolio to roughly 27 %—and the portion of those interest‑only balances that are not scheduled to reset for three or more years fell from roughly 89 % to about 86 %.  In other words, both the proportion of interest‑only loans and the length of their reset protection declined modestly over the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the percentages for 2022 (28% of adjustable-rate mortgages being interest-only, with 89% not scheduled to reset for three or more years) and 2023 (27% and 86%, respectively) are correctly reported. Minor wording variations like 'slipped slightly' and 'fell from' appropriately reflect the small decreases. (2) Quantitative accuracy is perfect—no calculation errors, and the values match exactly with acceptable phrasing like 'about 28%' for 28%. (3) The multi-hop reasoning is sound: the answer synthesizes data across two years and two metrics (percentage of interest-only loans and reset timing), correctly identifying the trend in Schwab's HELOC product structure. (4) Contextual relevance is high—the response directly addresses the evolution of the interest-only payment structure as requested, with precise and relevant details. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 283,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2023 Qualcomm kept XR in the IoT/consumer category of its QCT revenue—page 12 of the 2022 filing lists “XR” among the consumer applications tracked under IoT, and page 71 of the 2023 filing shows IoT revenue (which includes XR) falling from $7.35 billion in 2022 to $5.94 billion in 2023.  At the same time, the company’s strategic‑investment arm (Qualcomm Ventures) continued to target early‑stage XR startups, as noted on page 71 of the 2023 filing where “XR” is listed alongside 5G, AI, automotive and other focus areas for Qualcomm Ventures.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but misses the core evolution described in the ground truth, leading to a partially correct assessment. (1) Quantitatively, the revenue figures are accurate: IoT revenue declined from $7.35 billion in 2022 to $5.94 billion in 2023, as reported in the respective filings (page 12 of 2022 and page 71 of 2023), and XR is correctly noted as part of the IoT/consumer segment. These numbers match the source data, justifying a high quantitative accuracy score. (2) However, the qualitative reasoning is flawed: the ground truth emphasizes a strategic shift from *investment-only* involvement in XR (via Qualcomm Ventures) in 2022 to *direct product revenue generation* in 2023, indicating commercialization. The LLM answer correctly notes that Qualcomm Ventures continued investing in XR startups in 2023 but fails to highlight the key evolution — that by 2023, XR had moved from being only an investment focus to a direct product revenue stream. Instead, it only states that XR remains within the broader IoT category, which downplays the significance of the shift. (3) The multi-hop synthesis is incomplete: while the model connects XR to IoT revenue and references Ventures, it does not contrast 2022 (investment phase with no explicit revenue disclosure) with 2023 (revenue-generating phase), which is central to the question. (4) Contextually, the answer is relevant and cites correct document locations, but it lacks the interpretive layer needed to explain the strategic evolution. Thus, while factually grounded in parts, it fails to convey the main conclusion of the original answer — the transition from investment to monetization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 457,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "\nThe 3.030 % Notes Due 2052 were issued in November 2021 with an aggregate principal of **$1.1 billion**.  Neither the 2022 nor the 2023‑2024 filings record any repayment or additional issuance of that series, and the long‑term‑debt tables for 2022‑2024 still list **$1.1 billion** outstanding.  This flat‑line trajectory shows that RTX is keeping a sizable, long‑dated fixed‑rate tranche on its balance sheet as a stable component of its overall debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the aggregate principal balance of the 3.030% Notes Due 2052 as $1.1 billion (equivalent to $1,100 million) in both 2022 and 2024, matching the ground truth. It accurately notes no repayments or additional issuances occurred, and the amount remained stable across filings. The only minor discrepancy is the use of '2023-2024 filings' instead of explicitly stating 2024, but this does not affect factual accuracy. 2) Quantitatively, all numbers are correct: $1.1 billion = $1,100 million, and the interest rate (3.030%) and issuance date (November 2021) align with known facts. No calculations were required, but the consistency in reported value is properly observed. 3) The reasoning is sound: the model correctly infers that the unchanged balance indicates strategic stability in RTX's long-term debt structure, which matches the ground truth's conclusion about 'strategic consistency.' It synthesizes information across years and correctly interprets the absence of changes. 4) The answer is semantically equivalent to the original, conveying the same core message—stable principal balance indicating deliberate capital structure management—while using slightly different phrasing ('flat-line trajectory,' 'sizable, long-dated fixed-rate tranche'). The answer fully addresses both parts of the question: evolution (stable) and implication (strategic consistency).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 387,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "\nBetween 2023 and 2024 AXP shifted from a broad “commercial‑payments” emphasis to a concrete evolution of its corporate‑card portfolio—explicitly “evolving our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions, and designing innovative financing, banking and payment products for business customers.”  This focus shows that AXP is treating corporate‑card and commercial‑payment offerings as a distinct growth pillar, leveraging its high‑spending member base and partner ecosystem to deepen relationships with enterprises and expand revenue from business‑to‑business spending.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AXP's strategic focus in both 2023 and 2024, citing the evolution of card value propositions and differentiation of corporate card and expense management solutions, as well as the move toward innovative financing, banking, and payment solutions. However, it misrepresents the direction of the shift: the original answer states that AXP shifted from product differentiation in 2023 to a more integrated, solution-oriented approach in 2024, whereas the LLM implies a shift from 'broad commercial payments emphasis' to a more concrete corporate card focus, which reverses the actual progression. The core facts about product evolution and integration are present, but the framing of the shift is inaccurate. (2) There are no numerical values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes AXP's commercial payments strategy across years and references key strategic language from both periods. However, the logical inference about the strategic shift is flawed—the evolution is from focused product differentiation to broader integrated solutions, not the other way around. This affects qualitative accuracy. (4) Contextual relevance is high: the answer addresses both parts of the question (evolution between 2023–2024 and implications for commercial strategy) and uses appropriate terminology. Despite the reversed narrative, it captures relevant themes like growth pillars, enterprise relationships, and B2B revenue expansion. Correctness is penalized for the mischaracterization of the strategic shift, but core content remains factually grounded.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 474,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "\nPCA SKIN remains positioned as a skin‑health brand inside Colgate‑Palmolive’s Oral, Personal and Home Care segment, and its products continue to be sold through the same multi‑channel network used for other personal‑care offerings—namely traditional retailers, wholesalers, distributors and, especially, skin‑health professionals (with growing direct‑to‑consumer sales). The 2024 filing shows no structural shift in these distribution channels; PCA SKIN still leverages professional‑grade outlets and e‑commerce to reach consumers.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant inaccuracy in reasoning and misses a key evolution in distribution channels. (1) Correct elements: PCA SKIN remains within Colgate-Palmolive’s Oral, Personal and Home Care segment, and it continues to be distributed through traditional retailers, wholesalers, distributors, and e-commerce channels—consistent with the 2023 description. The mention of skin health professionals is relevant. (2) Quantitative accuracy: There are no numerical values in the question or answer, so this aspect is not applicable; no errors in dates (2023–2024 correctly referenced). (3) Multi-hop reasoning failure: The original answer highlights a specific evolution—'by 2024, the filing expanded distribution to include sales to skin health professionals in some geographies,' indicating a strategic refinement. The LLM answer incorrectly states there was 'no structural shift' and that the channels remained the same, which contradicts the ground truth showing an expansion. Furthermore, the LLM introduces 'growing direct-to-consumer sales' not mentioned or supported in the original answer, adding unsupported detail. (4) The answer is contextually relevant and well-structured but fails to accurately reflect the change in strategic positioning, which is the core of the question. Thus, while entities and general context are correct, the qualitative reasoning is flawed, leading to a correctness score of 6—partially correct but with significant omissions and an incorrect conclusion about channel stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 425,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "\nBetween 2022 and 2023 the Opdivo strategy moved from a broad IO‑expansion focus to a more‑targeted push into earlier disease settings and new tumor types, underscored by FDA/EU approvals of Opdivo for adjuvant melanoma (both monotherapy and in combination) and for neoadjuvant NSCLC chemotherapy (EU and Japan), plus continued development of subcutaneous formulations and new IO combos such as Opdualag.  These added indications and combination regimens are positioned to offset the company‑wide revenue dip by sustaining Opdivo sales growth—particularly in high‑value earlier‑line markets—while the broader portfolio faces pricing pressure and generic erosion.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of Opdivo from 2022 to 2023, noting a shift toward earlier lines of therapy and new tumor types, which aligns with the ground truth. It accurately references adjuvant melanoma and neoadjuvant NSCLC approvals, as well as development of subcutaneous formulations and new combinations like Opdualag. However, it omits key details from the original answer, such as the full list of approved indications in 2022 (e.g., bladder, blood, CRC, HCC, MPM, stomach cancers) and the specific markets (FDA/EU) for Opdivo + Yervoy combinations in NSCLC, melanoma, RCC, etc. The mention of 'IO-expansion' and 'IO combos' is accurate but less specific than the ground truth’s clear identification of Yervoy as a key combination partner. (2) There are no numeric values, dates, or calculations in either answer to verify, so quantitative accuracy is not compromised—no errors in this regard. (3) The multi-hop reasoning is partially sound: the model infers strategic intent from indication expansions and formulation improvements, correctly linking them to revenue sustainability. However, it fails to fully synthesize the breadth of 2022 approvals and their commercial impact (e.g., U.S. revenue growth in NSCLC, kidney, gastric/esophageal cancers via combinations), which is a key part of the original answer’s logic. (4) The answer is contextually relevant and captures the core trajectory—expansion into earlier lines, new formulations, combo therapies—but lacks completeness in entity coverage and specificity of indications and combinations. Thus, while the reasoning and implications are directionally correct, the omission of key factual elements from the ground truth limits the correctness score to 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 481,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "\nAmerican Express’s holdings of foreign government bonds and obligations showed virtually no change in fair‑value between the two years – the cost basis fell slightly from $770 million in 2023 to $765 million in 2024, and the reported fair value moved in the same direction (≈$770 million to $765 million).  The maturity profile remained heavily front‑loaded: as of 2024, about $764 million (nearly 100 %) of these securities were due within one year, with only $1 million maturing between one and five years and none beyond five years, underscoring a continued emphasis on short‑term exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, American Express held $549 million in foreign government bonds in 2023, not ~$770 million as stated. The LLM incorrectly reports a 'cost basis' of $770 million in 2023 and fair value '≈$770 million', which contradicts the ground truth fair value of $549 million. The 2024 fair value of $765 million is correct, but the characterization of 'virtually no change' is false given the actual increase from $549M to $765M (a 39% rise). The maturity distribution for 2024 is correctly reported ($764M within one year, $1M between 1-5 years). However, the 2023 maturity profile is completely misrepresented — ground truth states all $549M matured in 12+ months, but LLM fails to mention this or implies continuity in short-term focus, which is incorrect. (2) Quantitative errors include: wrong 2023 fair value ($549M vs claimed ~$770M), incorrect implication of stable holdings, and introduction of unmentioned 'cost basis' figures not in the original answer. The only correct numbers are the 2024 total ($765M) and its maturity split. (3) Multi-hop reasoning fails: the model does not correctly synthesize the evolution from long-term maturities in 2023 to predominantly short-term in 2024. Instead, it suggests a consistent short-term strategy, which contradicts the ground truth shift. (4) Scores reflect major factual errors in key financial figures and misrepresentation of trends, though the answer is contextually relevant by addressing fair value and maturity and focusing on the correct entity and time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 442,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the pool of cash that cannot be moved freely to the United States shrank – from roughly **$4.3 billion** of restricted cash as of January 31 2022 to about **$3.3 billion** of restricted cash as of January 31 2025.  The remaining restricted cash can only be repatriated through dividends or intercompany financing that must be **approved by the non‑controlling interest shareholders (e.g., Flipkart’s minority owners) and is subject to local legal or regulatory limitations**.  Consequently, while the absolute amount of non‑freely‑transferable cash has declined, the conditions governing any transfer have remained tied to shareholder approval and local restrictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the key figures—$4.3 billion in 2022 and $3.3 billion in 2024 (reported as of January 31, 2025, which corresponds to fiscal 2024)—are correct. The dates are appropriately mapped to Walmart's fiscal year ends. (2) The explanation of transfer conditions correctly identifies that repatriation requires approval from noncontrolling interest shareholders and is subject to local legal or regulatory constraints. It appropriately references Flipkart’s minority owners as an example, which is consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time in both the amount and the governance conditions of restricted cash. (4) The only minor shortcoming is that the original answer notes a shift in language from specifically naming Flipkart to a broader reference to noncontrolling interests, suggesting an evolution in framing. The LLM answer mentions Flipkart as an example but does not explicitly highlight this shift in framing or scope. However, it does correctly generalize the condition to non-controlling interest shareholders, capturing the essence of the evolution. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for not fully articulating the nuance in the change of language and scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 402,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "\nBased on the disclosed weighted‑average asset allocations, the U.S. Retiree Health Care Plan held roughly 80 % of its assets in fixed‑income securities and cash equivalents and about 20 % in equity securities in both the 2023 and 2024 filings. The plan’s target ranges (75‑85 % fixed income, 15‑25 % equity) were unchanged, and the actual 2023 (80 % / 20 %) and 2024 (80 % / 20 %) percentages show essentially no evolution in the composition between the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the asset allocation percentages for fixed income and equity securities remained unchanged between 2023 and 2024 at approximately 80% and 20%, respectively, which aligns with the ground truth (79.5% and 20.5%). The slight discrepancy in percentages (80/20 vs 79.5/20.5) is minor and likely due to rounding, but the ground truth specifies exact dollar amounts ($210M fixed income, $54M equity), which the LLM omits. These figures are critical for full quantitative accuracy. (2) The LLM does not mention the actual dollar values of the assets or the total plan assets ($264M), which are key components of the original answer and necessary for complete factual precision. While percentages are close and directionally correct, the absence of exact figures reduces quantitative accuracy. (3) The reasoning is sound: the LLM correctly infers no evolution in composition based on consistent allocations and unchanged target ranges, demonstrating proper multi-hop synthesis across the two filings. (4) The answer is contextually relevant and captures the core conclusion—no meaningful change in allocation—while using semantically equivalent phrasing. However, the lack of exact dollar amounts and slight rounding of percentages prevents a top score. Thus, correctness is high but not perfect due to missing granular financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 384,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "\nBetween 2022 and 2024 Honeywell has moved its non‑employee director compensation onto the 2016 Stock Plan for Non‑Employee Directors (the successor to the 2006 plan) and has updated the governing award documents twice since 2021.  The 2023 amendment (Exhibit 10.54* to the 2024 10‑K) revises the “Form of Stock‑Option Agreement” (Exhibit 10.52*) and the “Form of Restricted‑Stock‑Unit Agreement” (Exhibit 10.53*), adding performance‑based vesting triggers, cash‑settlement alternatives and revised change‑in‑control provisions.  This evolution shows a deliberate shift toward more performance‑linked, flexible director pay that can be adjusted without launching a new plan, reflecting a broader move to align non‑employee director compensation with long‑term shareholder interests.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in several critical ways. (1) The question specifically asks about the evolution of the *2006* Stock Plan for Non-Employee Directors between 2022 and 2024, but the LLM incorrectly claims that Honeywell moved to the *2016* plan, which is not supported by the original answer or the implied timeline. The ground truth indicates that the 2006 plan was still referenced in 2024 via exhibit numbers, not replaced. (2) The LLM introduces a '2023 amendment' (Exhibit 10.54*) and updated forms (Exhibits 10.52*, 10.53*) that are not mentioned in the original answer; these exhibits and the associated details (performance-based vesting, cash-settlement, change-in-control provisions) are fabrications not present in the ground truth. (3) The original answer notes the *disappearance* of the 'Form of Restricted Unit Agreement' from the exhibit list between 2022 and 2024, suggesting a shift toward stock options. The LLM instead claims both option and restricted unit agreements were updated, which contradicts the ground truth. (4) The reasoning is therefore flawed: the LLM infers a move toward performance-linked, flexible pay, while the ground truth suggests a narrowing of award types (dropping restricted units), possibly indicating a simplification or strategic preference for options, not increased complexity. (5) The answer is contextually relevant in topic (director compensation evolution) but factually inaccurate in entities, dates, exhibits, and conclusions. No correct numbers or exhibit references from the ground truth are accurately reflected. The entire multi-hop synthesis is based on non-existent data, resulting in a fundamentally incorrect response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 471,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Walmart’s ownership in Flipkart was cut from roughly 83 % to about 75 % after the subsidiary’s $3.2 billion equity raise in FY 2022, generating a cash inflow that reduced the carrying value of the investment and diluted Walmart’s voting control.  At the same time, Flipkart is under intensified Indian regulatory scrutiny—including a Competition Commission of India antitrust investigation that could bring monetary penalties or conduct remedies, and a foreign‑direct‑investment show‑cause notice that may lead to further fines or restrictions on its ownership structure—creating material uncertainty about the long‑term financial return and legal exposure of Walmart’s stake.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative facts: Walmart's ownership stake decreased from 83% to 75% due to a $3.2 billion equity raise by Flipkart in FY 2022. These numbers match the ground truth exactly, and the timing (FY 2022) aligns with the original answer’s reference to 2022. (2) All numeric values—percentages, dollar amounts—are accurate and properly contextualized. There are no calculation errors or date inaccuracies. (3) The reasoning is largely sound: the LLM correctly infers that the equity raise led to dilution and reduced carrying value, which reflects accurate financial understanding. It also correctly notes ongoing regulatory scrutiny in India, including FDI-related show-cause notices and antitrust investigations. However, it slightly misattributes the timing and origin of the regulatory actions: the original answer specifies that the show-cause notice was issued in July 2021 (before the reporting period) and relates to violations from 2009–2015—before Walmart’s acquisition. The LLM does not clarify that these issues predate Walmart’s ownership, which weakens the nuance around Walmart’s exposure to legacy risks. Additionally, the mention of the 'Competition Commission of India antitrust investigation' is not present in the ground truth and may conflate separate regulatory matters. (4) Despite this minor overgeneralization of regulatory risks, the core multi-hop synthesis—linking financial dilution in 2022 to continued exposure to pre-acquisition regulatory risks by 2024—is well-executed and semantically aligned with the original. The answer captures the evolution from financial participation to risk management. Thus, the correctness score is 9 due to high factual accuracy with a minor qualitative omission regarding the pre-acquisition nature of the regulatory issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 500,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "\nBetween the end of 2022 (cash ≈ $9.6 bn) and the end of 2024 (cash ≈ $10.6 bn), Honeywell’s total cash rose after a dip in 2023, with the net increase driven by $10.4 bn of long‑term debt issuance and $2.3 bn of commercial‑paper proceeds used to fund acquisitions and shareholder returns.  The company continued to keep a large share of its liquidity abroad—about $8 bn of cash, cash equivalents and short‑term investments were held in non‑U.S. subsidiaries as of 31 Dec 2024—while U.S.‑based cash grew to roughly $3 bn, reflecting a strategic emphasis on deploying domestic cash for dividend increases, share‑repurchase programs and U.S.‑based M&A while still maintaining ample offshore cash for global investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that HON had $11.5 billion in cash as of December 31, 2021 (reported in 2022), and $11.0 billion as of December 31, 2024. However, the LLM incorrectly reports ~$9.6 billion at the end of 2022 and ~$10.6 billion at the end of 2024, which misrepresents both the starting and ending cash balances. Additionally, the LLM introduces a $3 billion U.S. cash figure for 2024 (implying $8 billion non-U.S. out of $11 billion total), but this calculation is inconsistent with its own stated total of $10.6 billion. While the $8 billion non-U.S. subsidiary cash figure aligns with the original answer, the total cash amount does not, leading to a mismatch. (2) The LLM introduces extraneous details not present in the ground truth, such as $10.4 billion in long-term debt issuance and $2.3 billion in commercial paper proceeds, which are unsupported by the provided answer and distract from the core question about cash composition and geographic distribution. These additions suggest incorrect data sourcing or synthesis. (3) The multi-hop reasoning is partially sound in identifying the shift toward more non-U.S. cash holdings and noting strategic deployment of U.S. cash, which reflects an understanding of geographic distribution trends. However, the failure to accurately report the total cash figures across years undermines the validity of the comparison. The strategic emphasis on safety and diversification—explicitly mentioned in the ground truth—is omitted and replaced with unverified claims about dividend increases and share repurchases. (4) Despite incorrect numbers and unsupported details, the answer addresses the geographic shift in cash (non-U.S. vs. U.S.) and attempts to explain strategic emphasis, maintaining moderate contextual relevance. The qualitative reasoning shows some correct direction but lacks fidelity to the source data. Thus, the correctness score is low due to major quantitative errors, though not zero because of partial alignment on the non-U.S. cash figure and geographic trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 572,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "\nFrom 2023 to 2024 the Company expanded the Membership Rewards liability model to include explicit sensitivity metrics—projecting that a 25‑basis‑point increase in the ultimate redemption rate would add roughly $197 million to the liability and a 1‑basis‑point rise in the weighted‑average cost‑per‑point would add about $220 million—while emphasizing that the estimate now relies on statistical‑actuarial inputs and periodic reassessment of partner contracts and redemption‑pattern shifts.  At the same time, the accounting for deferred fees was refined, with a more granular breakdown of deferred Membership Rewards fees, direct acquisition‑cost offsets and cancellation reserves, yielding a clearer presentation of the related liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $197 million impact from a 25 basis point increase in Ultimate Redemption Rate (URR) and the $220 million impact from a 1 basis point increase in weighted average cost (WAC) per point are correctly reported, matching the original answer exactly. These figures are critical quantitative elements and are reproduced accurately. (2) The answer correctly identifies the evolution from 2023 to 2024: while 2023 focused on deferred fees, 2024 introduced a more sophisticated, model-driven approach using actuarial inputs like URR and WAC. The mention of 'statistical-actuarial inputs', 'periodic reassessment of partner contracts', and 'redemption-pattern shifts' adds contextual depth consistent with a more comprehensive liability modeling framework. (3) The multi-hop reasoning is sound—synthesizing changes in accounting treatment (deferred fees) with enhancements in liability estimation methodology across two years. (4) Minor deduction in qualitative accuracy due to slightly stronger emphasis on 'direct acquisition-cost offsets' and 'cancellation reserves', which, while plausible, are not explicitly mentioned in the ground truth. However, these do not contradict the original and may be inferred details. Overall, the answer captures the core evolution accurately, with full quantitative fidelity and excellent contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 398,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Adobe has moved Frame.io from a newly‑acquired, stand‑alone video‑collaboration tool into the core of its Creative Cloud and Digital Experience stacks.  The platform is now tightly integrated with Creative Cloud apps (e.g., Premiere Pro, Photoshop, Express), the Adobe Experience Platform, and AI‑driven services such as Firefly, positioning Frame.io as the collaboration hub that links video workflows, document‑cloud services and generative‑AI capabilities across Adobe’s end‑to‑end creative ecosystem while contributing to the growth of Digital‑Media ARR.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Frame.io's strategic positioning within Adobe's ecosystem between 2022 and 2024. (1) It correctly identifies the shift from a newly acquired standalone platform to a core component of Adobe's creative ecosystem. While the original answer specifies the $1.18 billion acquisition cost and the Digital Media segment, the LLM omits the dollar amount and does not explicitly name the reportable segment, which is a minor factual omission. (2) There are no numeric inaccuracies—no incorrect figures or miscalculations, so quantitative accuracy is perfect. (3) The reasoning is sound: the LLM correctly infers deeper integration with Creative Cloud apps (Premiere Pro, Photoshop), mentions integration with Experience Platform and AI tools like Firefly, and positions Frame.io as a collaboration hub. However, it incorrectly implies integration with 'document-cloud services' and the 'Adobe Experience Platform'—details not supported in the ground truth. The original answer highlights integration with Workfront and inclusion in Adobe GenStudio, which the LLM omits. Instead, it adds Firefly and Experience Platform, which may be plausible but are not in the verified data. (4) Despite these minor inaccuracies and substitutions, the answer remains contextually relevant and conveys a semantically similar trajectory of integration and strategic elevation. The omission of GenStudio and misattribution of integrations prevent a top score, but the overall qualitative and contextual fidelity is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 427,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "\nBetween the 2022 and 2023 reporting periods the fair‑value amount attributed to “equity‑like” private‑alternative funds that is measured using significant unobservable inputs (Level 3) grew sharply—from $5.5 million in 2022 to $25.1 million in 2023, an increase of roughly $19.6 million (about a 350 % rise). This shows that a much larger share of the equity‑like fund holdings was valued through Level 3 inputs in 2023, indicating greater reliance on internal, unobservable valuation techniques over the two‑year span.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer correctly identifies the increase in fair value of equity-like funds measured using Level 3 inputs from $5.5 million in 2022 to a value in 2023, and notes the significant growth. However, it reports the 2023 value as $25.1 million instead of the correct $25.4 million from the ground truth, making the dollar increase $19.6 million (vs. correct $19.9 million) and the percentage increase approximately 350% (vs. actual ~362%). These quantitative inaccuracies, while minor, affect precision. (2) The correct calculation is: ($25.4M - $5.5M) / $5.5M ≈ 3.618 or 362% increase. The LLM reports ~350%, which is close but not exact, likely due to using $25.1M. All other numbers (2022 value, direction and magnitude of change) are accurate. (3) The reasoning is sound: the model correctly synthesizes the evolution across years, identifies the use of Level 3 inputs, and draws a logical conclusion about increased reliance on unobservable inputs. The multi-hop aspect (comparing two years of fair value data for a specific investment type and valuation level) is handled well. (4) Despite the small numerical discrepancy, the overall interpretation and qualitative message align with the ground truth. The answer is contextually complete and relevant, addressing the evolution in composition via fair value changes in Level 3 inputs for equity-like private alternative investments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 384,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe moved Frame.io from a freshly‑acquired video‑collaboration tool into a core, AI‑enhanced hub that is tightly woven into the Creative Cloud suite and the broader Digital Media portfolio.  The 2022 filings note its integration into Digital Media and its connection to Premiere Pro, Photoshop and other Creative Cloud apps, while the 2024 disclosures emphasize expanded integrations—such as Camera‑to‑Cloud, Firefly‑powered generative features, and availability in Adobe GenStudio—positioning Frame.io as the primary collaborative layer that accelerates end‑to‑end content creation and drives subscription growth within Adobe’s Digital Media business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Frame.io was acquired in October 2021 and integrated into Adobe's Digital Media segment, with deeper integration by 2024. The LLM correctly identifies its role as a collaborative hub and notes integration with Premiere Pro, Photoshop, and other Creative Cloud apps—consistent with the original answer. It also adds value by specifying Camera-to-Cloud, Firefly-powered features, and inclusion in Adobe GenStudio, which are plausible extensions of the 2024 integration and consistent with Adobe’s AI-driven strategy. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the timeframes (2022 and 2024) are used correctly and contextually. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution of Frame.io from initial integration to deeper ecosystem embedding, correctly positioning it as a core collaboration layer across Adobe’s creative tools. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., AI enhancements, Firefly, Camera-to-Cloud), but no factual inaccuracies. One minor point preventing a perfect 10 is that the original answer explicitly mentions After Effects, Lightroom, and Workfront integrations, which the LLM omits—though mentioning 'Creative Cloud apps' broadly covers them. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 404,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "\nBetween 2022 and 2024 CVS shifted from a set of discrete medication‑management programs (e.g., Pharmacy Advisor, disease‑management and weight‑management services, and basic digital adherence tools) to a unified, AI‑driven clinical platform—its proprietary **Canopy** system—that weaves pharmacy, claims and clinical data together.  The newer platform adds predictive‑analytics and machine‑learning‑based rules engines, real‑time adherence alerts, and integrated scheduling/virtual‑care tools (e.g., MinuteClinic appointment engines, SMS reminders, and digital results portals) that let clinicians intervene earlier, personalize therapy and drive lower‑cost drug choices.  This evolution also expands value‑based contracts (Oak Street Health, Signify Health, Cordavis biosimilars) that tie reimbursement to adherence and cost‑efficiency outcomes, making medication‑management a core component of CVS’s broader cost‑containment and quality‑improvement strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of CVS's evolution in medication management—toward greater integration, digital enablement, and value-based care—which aligns with the question's focus. However, it introduces significant factual inaccuracies. The proprietary **Canopy** system, described as central to the 2024 strategy, is not mentioned in the ground truth and cannot be verified as a real CVS platform from the provided data. Similarly, the claim that CVS used AI-driven predictive analytics, machine learning rules engines, SMS reminders, and integrated virtual care tools like MinuteClinic scheduling as part of a unified platform lacks support in the original answer. While CVS did expand digital tools (e.g., NovoLogix for preauthorization), the specific technologies cited (Canopy, AI/ML engines, SMS alerts) are unverified and appear fabricated or conflated. The mention of 'Pharmacy Advisor' and 'disease-management and weight-management services' in 2022 is partially correct, but the original answer emphasizes formulary management, opioid prescribing limits, and mail/specialty pharmacy—not these branded programs. The LLM correctly identifies Oak Street Health and value-based care expansion but incorrectly includes Signify Health and Cordavis biosimilars, which are not referenced in the ground truth. The 2024 launch of the CVS Weight Management program integrating GLP-1 optimization and lifestyle coaching is omitted entirely. There are no explicit numerical errors (dates like 2022–2024 are correct), so quantitative accuracy is moderate. Qualitative accuracy is low due to incorrect entity identification and unsupported technological claims. Contextual relevance is high because the response addresses the core theme of digital and clinical evolution in medication management. Overall, the answer reflects a plausible narrative but is factually divergent from the ground truth, failing on key multi-hop synthesis points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 524,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Adobe moved Frame.io from a newly‑acquired platform that was first integrated only into Premiere Pro and After Effects for native review and approval (page 7) to a broadly‑embedded collaboration layer across the Creative Cloud suite. By 2024 the company had added real‑time upload, frame‑accurate commenting, Camera‑to‑Cloud ingest and tight integration with Adobe Express, Firefly Services and GenStudio, making Frame.io’s workflows a native collaborative layer for video, design and document projects (pages 6, 12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the timeline from 2022 to 2024 and the evolution of Frame.io from a video-specific tool to a broader collaboration layer within Creative Cloud. Key integration points—Premiere Pro, After Effects, Photoshop, and Lightroom—are implied through 'broadly-embedded collaboration layer' and explicitly mentioned integrations. The mention of Camera-to-Cloud ingest matches the ground truth. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the answer synthesizes information about acquisition timing, integration progression, and feature enhancements across years and products. One minor omission is Workfront, which is named in the original answer as a 2024 integration point but not mentioned in the LLM response. Additionally, the LLM mentions integration with Adobe Express, Firefly Services, and GenStudio—details not present in the ground truth—which may be accurate but are unverified and slightly extend beyond the provided facts. (4) Despite this, the core facts, timeline, and strategic shift are correctly conveyed with strong semantic equivalence. The answer is fully contextually relevant, directly addressing both the evolution of integration and specific collaboration enhancements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 390,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "\nIn 2024 the Firm shifted a larger share of its loan‑valuation work from Level 3 (unobservable) inputs to Level 2 by treating recently executed transaction prices, market price quotations and CDS‑spread adjustments as the primary observable inputs (see Notes 2‑3 in the 2023 10‑K and the “Loans and Lending Commitments” discussion on pages 99‑100).  This refinement reduced the reliance on proprietary discounted‑cash‑flow models and made the fair‑value estimate more directly anchored to observable market trades, which is reflected in the narrower gap between contractual principal and reported fair value (‑$11.1 bn in 2023 versus ‑$10.2 bn in 2024).  Consequently, recently executed transactions now play a more central and transparent role in the Firm’s fair‑value determination for loans and other assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unverified details not present in the ground truth, significantly affecting correctness. (1) The claim that the firm shifted valuation from Level 3 to Level 2 inputs using recently executed transactions as primary observable inputs is not supported by the original answer, which states only that transaction data became more targeted to held-for-sale loans and other investments—not a broad methodological shift in fair value hierarchy treatment. (2) References to 'Notes 2-3 in the 2023 10-K' and specific pages (99-100) are fabricated or unverifiable from the ground truth, which does not mention these sources. (3) The quantitative figures of -$11.1 bn in 2023 and -$10.2 bn in 2024 (representing gap between contractual principal and fair value) are not present in the original answer and cannot be confirmed; thus, the calculation and comparison are unsupported. (4) The original answer emphasizes a refinement in the *application* of transaction data (more focused on held-for-sale loans and extended to other investments), while the LLM overstates this as a systemic shift toward greater reliance on transaction prices, misrepresenting the evolution. (5) While the LLM correctly identifies that recently executed transactions play an important role in fair value determination and that their use evolved, it fails to accurately describe the nature of that evolution—specifically, the narrower categorization and extension to other assets using DCF and multiples. The reasoning is partially sound but based on incorrect premises. Contextual relevance is high as the answer addresses fair value determination and the role of transaction data over time, but factual and quantitative inaccuracies reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 484,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe moved Substance 3D Stager from a stand‑alone, separately‑priced app in the Substance 3D suite to a core, tightly‑integrated hub of the **Adobe Substance 3D ecosystem**.  In the 2022 filing the company noted that Substance 3D apps were sold apart from Creative Cloud, but by the 2024 filing it describes Stager together with Painter, Sampler, Designer and Modeler as part of a unified desktop‑and‑VR workflow that “builds and assembles 3D scenes,” links to other Substance 3D tools, and is positioned alongside Firefly‑powered generative services for a seamless, end‑to‑end 3D content‑creation pipeline.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe's positioning of Substance 3D Stager between 2022 and 2024. It accurately captures the shift from a standalone product to an integrated component of a broader 3D ecosystem. The entities (Substance 3D Stager, Painter, Sampler, Designer, Modeler) and years (2022, 2024) are correctly identified, and there are no numerical inaccuracies (no specific financials or dates requiring calculation). The answer adds detail not explicitly in the ground truth—such as Stager being 'stand-alone, separately-priced' in 2022 and integration with VR and Firefly—suggesting possible inference beyond the source data. While plausible, these additions are not confirmed in the original answer and slightly exceed the evidence provided, which only notes trademark listing in 2022 and functional description in 2024. Thus, while the core facts and reasoning are sound (multi-hop synthesis across years and products), the extra details reduce qualitative accuracy slightly. However, the answer remains contextually relevant and semantically aligned with the main evolution described.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 328,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "\nFrom 2022 to 2023 GE moved from a peripheral, “may‑be‑important” reference to grid‑scale batteries in its decarbonisation narrative to a more central, explicitly‑strategic role for the technology within its new energy platform (GE Vernova). In the 2022 filing the company noted that deep‑decarbonisation would “likely depend … on technologies that are not yet deployed … (such as grid‑scale batteries or other storage solutions),” treating storage as an uncertain future opportunity. By the 2023 filing—after the separation of the power and renewable‑energy businesses—GE repeatedly cites grid‑scale batteries (alongside hydrogen, CCS, SMRs, etc.) as a key enabler of its long‑term growth and decarbonisation goals, signalling a higher level of strategic reliance, though still contingent on policy incentives, cost reductions and technology maturation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly captures the evolution in GE's strategic positioning on grid-scale batteries from 2022 to 2023. In 2022, GE viewed grid-scale batteries as part of a set of emerging technologies that might become important, which the LLM accurately characterizes as an 'uncertain future opportunity' and notes the phrasing around decarbonization 'likely depend[ing]' on such technologies. By 2023, the LLM correctly identifies that grid-scale batteries were elevated in strategic importance, now listed among key enablers of growth and decarbonization within GE Vernova, reflecting increased strategic reliance. The mention of continued contingency on policy, cost, and tech maturity adds contextual nuance consistent with the cautious tone in filings. The only minor gap is that the original answer emphasizes a shift from 'speculative investment' to 'dependency'—a slightly stronger framing of strategic integration—though the LLM’s description of 'more central, explicitly-strategic role' is semantically close. No numeric or date inaccuracies; all entities (GE, GE Vernova, grid-scale batteries, decarbonization strategy) are correct. Multi-hop reasoning across years and strategic context is sound. Wording differs but meaning is substantively equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 369,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "\nBetween 2022 and 2024 CVS continued to report that it holds **no broker‑quoted debt securities** for the periods it evaluates—​the 2022 filing notes the company had none for the years ended 2022 and 2021 (the language was carried forward into the 2024 filing, which explicitly states there were “no broker‑quoted debt securities for the years ended December 31, 2024 and 2023”). Consequently, broker‑quoted inputs no longer appear in its fair‑value hierarchy disclosures, and the absence of such securities means they have **no direct effect on the company’s fair‑value measurements, earnings, or other‑comprehensive‑income balances** in either year. The company now relies solely on observable market‑based Level 2 inputs and internally derived Level 3 pricing for private‑placement securities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its core factual claims: CVS disclosed no broker-quoted debt securities for the relevant years in both 2022 and 2024 filings, and this absence means such securities have no impact on fair value measurements. The dates are mostly accurate, though there is a minor misstatement: the 2022 filing would cover years ended 2021 and 2020 (not 2022 and 2021 as stated), since 10-Ks report on prior fiscal years. The LLM incorrectly implies the 2022 filing discusses 2022 and 2021, when in fact the ground truth specifies it refers to 2021 and 2020. This is a factual error in temporal alignment. However, the 2024 filing correctly references years ended 2024 and 2023. The answer correctly identifies the continued absence of broker-quoted securities and their lack of impact on financial reporting. It adds value by noting the use of Level 2 and Level 3 inputs, which is contextually relevant and plausible, though not explicitly in the ground truth. The key qualitative difference in the evolution—reduced emphasis or removal of discussion about review processes or negative impacts in 2024—is not mentioned in the LLM answer, which omits the shift in disclosure tone or depth. This is a meaningful omission in the evolution aspect of the question, which asked about changes in 'presence or impact on financial reporting' and disclosure practices over time. While the LLM captures the quantitative consistency (no such securities), it misses the qualitative evolution in narrative emphasis, which is central to the original answer. Thus, while factually sound on the main point, it lacks completeness in capturing the full evolution of disclosure practices. Quantitative accuracy is high (9/10) due to the date misstatement. Qualitative accuracy is 8 due to correct reasoning but missing nuance. Contextual relevance is perfect—directly on topic and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 510,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "\nBetween 2023 and 2024 the “Equity securities / mutual funds” line in BlackRock’s Equity Securities at FVTNI grew from **$1,585 million to $1,950 million** – an increase of about **$365 million (≈23 %)**.  The broader equity‑method investment balance rose only modestly, from **$2,756 million to $2,783 million** (+$27 million), but its composition shifted: private‑equity holdings fell from **$1,264 million to $1,060 million**, while real‑asset and multi‑asset mutual‑fund holdings increased (from $417 million to $520 million) and the deferred‑cash‑compensation component declined (from $241 million to $173 million).  In short, mutual‑fund exposure expanded substantially, private‑equity exposure contracted, and the overall equity‑method portfolio was essentially flat with a different mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, in 2023, BlackRock reported $1,211 million in equity securities/mutual funds, but the LLM states $1,585 million — a major discrepancy. The 2024 value of $1,950 million is correct. For equity method investments, the ground truth reports $1,895 million in 2023, but the LLM incorrectly states $2,756 million; the 2024 value of $2,783 million is correct. These errors affect all derived calculations and comparisons. (2) The LLM calculates a $365 million increase in equity securities/mutual funds, but with correct numbers this should be $739 million ($1,950M - $1,211M), making the LLM's calculation invalid. The equity method investment change is reported as +$27 million, but correct math would show +$888 million — a massive understatement. The LLM also introduces subcategories (private equity, real assets, deferred compensation) not mentioned in the original answer and unsupported by the provided truth, suggesting fabrication or hallucination. (3) While the LLM attempts multi-hop reasoning by comparing changes across years and discussing composition shifts, it fails to accurately synthesize the correct data points. The conclusion that equity method investments were 'essentially flat' contradicts the ground truth, which shows a large increase, indicating flawed reasoning based on incorrect data. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant — it addresses the right categories and time frame, and interprets the question appropriately. Hence, moderate score for contextual relevance and some qualitative reasoning, but very low quantitative and overall correctness due to critical factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 479,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "\nBoth the 2022 10‑K (pages 55‑59) and the 2024 10‑K (pages 47‑51) describe the same impairment process: the Company tests each available‑for‑sale debt security for credit‑related impairment by comparing its fair value to amortized cost and evaluating cash‑flow expectations and issuer credit ratings. It concludes that the unrealized losses observed through 2024 are driven by interest‑rate movements rather than borrower credit deterioration, so no material allowance for credit losses has been recorded in either year.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution described in the ground truth. (1) What was correct: The LLM accurately states that unrealized losses in both 2022 and 2024 were attributed to interest rate movements rather than credit deterioration, and that no material allowance for credit losses was recorded—this aligns with the original answer. It also correctly identifies the impairment evaluation methodology involving fair value, amortized cost, cash flow expectations, and issuer credit ratings. (2) Quantitative accuracy: There are no numerical figures in this question, but all factual assertions about the absence of material allowances and the cause of unrealized losses are consistent with the ground truth and thus quantitatively accurate. (3) Multi-hop reasoning assessment: The LLM fails in synthesizing the evolution from 2022 to 2024. The ground truth highlights a structural change by 2024—credit-related impairments are now accounted for through a separate allowance account, with explicit recognition in investment income, indicating a more formalized framework. The LLM incorrectly implies continuity by stating 'the same impairment process' and 'no material allowance...in either year,' thereby overlooking the shift toward a more structured accounting approach even if the allowance remains immaterial. This omission represents a failure in multi-hop reasoning across years to detect procedural evolution beyond just outcomes. (4) Justification for scores: Correctness is scored 5 because core facts are right but the critical evolution in accounting treatment is missing. Quantitative accuracy is 10 because there are no numerical errors. Qualitative accuracy is 5 due to flawed reasoning about the change in framework. Contextual relevance is 8 because the response addresses the topic and question directly but lacks depth on the evolution aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 508,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 AMD’s equity interest in the ATMP joint venture rose from roughly **$83 million to $99 million** (page 79), and the equity‑method income it records—recorded as “Equity income in investee”—increased from **$14 million in 2022 to $16 million in 2023** (also page 79).  This growth reflects a larger investment balance and higher gains from the JV’s operations, indicating that AMD’s financial relationship with the ATMP JV deepened over that period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value of AMD's investment in ATMP JV increased from $83 million in 2022 to $99 million in 2023, and equity income rose from $14 million to $16 million—both figures match the original answer exactly. Minor formatting differences (e.g., 'roughly' and bolding) do not affect factual accuracy. (2) The answer is complete, addressing both parts of the question: evolution of investment value (carrying value) and equity income over the two-year period. (3) Entities are correctly identified: AMD, ATMP JV, and the relevant financial metrics ('equity-method income', 'carrying value') are accurately named and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis—comparing values across two years and interpreting the trend as a deepening financial relationship, which aligns with the conclusion in the ground truth. The mention of 'page 79' suggests source fidelity, though not required for correctness. Overall, the answer is factually precise, semantically equivalent, and demonstrates strong reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 332,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth’s tort exposure remained centered on medical‑malpractice and other provider‑related disputes, but the volume and variety of such claims increased—particularly disputes over out‑of‑network payments and the adequacy of risk‑based arrangements with physicians and hospitals. The company continues to be largely self‑insured and records only estimated liabilities, explicitly warning that actual losses could far exceed those estimates and could materially affect its results of operations, financial position and cash flows.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that UnitedHealth Group remains exposed to tort claims related to medical malpractice and provider-related disputes and notes the company's self-insured status with potential for losses to exceed recorded liabilities—this aligns with the 2022 ground truth. However, the LLM introduces claims about 'out-of-network payments' and 'risk-based arrangements' as key evolving issues, which are not mentioned in the original answer and represent a shift in focus not supported by the ground truth. The original answer emphasizes a qualitative evolution in the nature of tort claims: from medical malpractice with new legal theories in 2022 to broader clinical quality, patient safety, and reputational risks in 2024. The LLM fails to capture this shift and omits the 2024 emphasis on reputational harm and systemic risk. While the answer is factually plausible and contextually relevant, it does not accurately reflect the documented evolution between 2022 and 2024. There are no numerical inaccuracies (hence high quantitative score), but the qualitative synthesis across years is incomplete and slightly misdirected, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 333,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "\nBetween 2023 and 2024 Boeing reshaped its revolving‑credit structure by retiring the $0.8 billion 364‑day facility and the amended $3.2 billion five‑year line, while keeping the legacy $3.0 billion three‑year revolving agreement (due August 2025) and adding a new $3.0 billion five‑year revolving facility (maturing August 2028).  The company also retains a $3.0 billion three‑year line and a $3.2 billion five‑year line that remain in place, giving it roughly $10 billion of total undrawn borrowing capacity as of Dec 31 2024.  This evolution reflects a liquidity strategy that emphasizes extending maturities, preserving a sizable undrawn credit buffer, and relying on revolving facilities as back‑up sources of funding rather than long‑term debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM incorrectly states that Boeing retired a $0.8 billion 364-day facility and an amended $3.2 billion five-year line, which is not supported by the ground truth. The original answer states that Boeing had a $3.0 billion three-year revolving credit agreement in 2023 and in 2024 replaced other facilities with a new $4.0 billion five-year agreement—there is no mention of $0.8 billion or $3.2 billion facilities being terminated. The LLM also incorrectly claims Boeing added a new $3.0 billion (not $4.0 billion) five-year facility maturing in August 2028 (not May 2029). Additionally, the LLM invents a total undrawn capacity of $10 billion as of Dec 31, 2024, which is not in the original answer and cannot be verified from the provided data. (2) Completeness: While the answer attempts to address the evolution of credit agreements and liquidity strategy, it misrepresents the actual changes. It fails to correctly identify the new $4.0 billion facility and its May 2029 maturity, a key fact. (3) Entity Accuracy: The company (Boeing) and general concept (revolving credit) are correct, but specific financial instruments and amounts are wrong. (4) Reasoning: The multi-hop synthesis is flawed—the LLM incorrectly infers the retention of multiple credit lines ($3.0 billion three-year, $3.2 billion five-year) that the original answer says were terminated. The conclusion about liquidity strategy (extending maturities, preserving buffers) is directionally similar but based on incorrect premises. (5) Semantic Equivalence: The overall message is not equivalent—the original reflects a strategic upgrade to a larger, longer facility; the LLM describes a more complex restructuring with incorrect figures. The answer is contextually relevant but factually unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 507,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s stock‑based compensation from the 2017 performance‑based options fell slightly – it recorded $56 million of expense for options that vested in 2023, versus $52 million for those that vested in 2024.  At the same time, the cash intrinsic value realized from exercising those options rose sharply, from $44 million of intrinsic value in 2023 to $373 million of intrinsic value in 2024, driven by the higher BlackRock stock price and a larger volume of exercises.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $56 million fair value in 2023, $52 million in 2024 (correct slight decrease), and intrinsic values of $44 million in 2023 and $373 million in 2024 (correct sharp increase). The formatting ($56 million vs $56 million) is acceptable. (2) The answer is complete, addressing both parts of the question: evolution of fair value of vested options and intrinsic value of exercised options across 2023 and 2024. (3) Entities are correct—the 2017 Performance-based Options are properly referenced, and the years 2023 and 2024 are accurately used. (4) The reasoning is sound and adds contextual insight (mentioning higher BlackRock stock price and increased exercise volume) that aligns with the implied financial dynamics, enhancing the explanation without introducing inaccuracies. The multi-hop synthesis—linking vesting expense to fair value and realized benefit to intrinsic value across years—is logically and factually correct. (5) Semantic equivalence is strong: 'fell slightly' and 'rose sharply' appropriately characterize the changes, and the financial metrics are correctly interpreted. All scoring categories warrant top marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 351,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "\nBetween 2022 and 2023 AMD moved from a broad‑brush estimate that applied historical return, rebate and price‑protection experience to all contracts and then adjusted for known events, to a more granular, data‑driven approach.  In 2023 the company specifically incorporated “product‑restocking rights” for both OEMs and distributors and used trended, actual historical return‑rate information that is updated with the latest known circumstances to calculate the adjustment to revenue.  This refinement improves the precision of the return‑rights estimate and reflects the newer contractual terms and market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative description of AMD's methodology evolution. (1) Correct elements: The answer correctly identifies that AMD used trended historical return rate data and updated it with known circumstances/events, which aligns with the 2022 approach. It also acknowledges a shift toward greater granularity in 2023. There are no numeric values to verify, so quantitative accuracy is not compromised. (2) However, the LLM introduces the term 'product-restocking rights'—which is not mentioned in the ground truth—and incorrectly frames the change as incorporating new contractual elements like restocking rights, when the actual shift was a more structured application of variable consideration under ASC 606-10-32-8 through 14. (3) The multi-hop reasoning is flawed: the original answer emphasizes a move toward codified accounting standards (ASC 606) and the use of 'most likely amount' as the estimation method, which the LLM completely omits. Instead, it fabricates a focus on 'restocking rights' and implies a data granularity improvement not present in the source. (4) While the direction of change (more refined estimation) is correctly implied, the specific methodological changes described are factually incorrect. Thus, despite good contextual relevance and no numerical errors, the qualitative inaccuracy reduces the correctness score to 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 392,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "\nFrom the end of 2023 to the end of 2024 the outstanding 2017 Performance‑based options fell sharply—from **1,549,080 shares** to **625,825 shares**, a reduction of roughly **923 k shares**.  The decline is driven almost entirely by **exercises (≈ 905 k shares)** with only a modest amount forfeited (≈ 18 k shares), indicating that holders are increasingly exercising these deep‑in‑the‑money options as the stock price has risen, while forfeiture plays a negligible role.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in shares under option from 1,549,080 at the end of 2023 to 625,825 at the end of 2024, matching the ground truth exactly. It accurately reports exercises as approximately 905,000 shares (exact value is 905,219) and forfeitures as approximately 18,000 shares (exact is 18,036), which are acceptable rounding variations. The calculated reduction of roughly 923k shares (actual difference: 1,549,080 - 625,825 = 923,255) is numerically accurate. (2) All numbers and calculations are correct within reasonable rounding; no factual errors in quantitative data. (3) The reasoning is sound: the model correctly infers that the sharp decline is due primarily to exercises and minimally to forfeitures, aligning with the lifecycle completion trend described in the ground truth. It adds contextual insight about the options being 'deep-in-the-money' and stock price appreciation, which is plausible and enhances the explanation without contradicting the source. (4) The answer fully addresses both parts of the question—quantitative evolution and interpretation of trends—and maintains semantic equivalence with the original answer. The only minor gap is not explicitly stating that this reflects the approach to the final vesting date, though the implication is present. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 overall for slight elaboration beyond the source without detracting from correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 416,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "\nBetween 2022 and 2024 Optum Rx expanded from a traditional pharmacy‑benefit manager into a full‑stack pharmacy‑care platform: its network grew to >65,000 retail sites (and added home‑delivery, specialty/infusion, rare‑disease and gene‑therapy support), it began offering direct‑to‑consumer solutions, and it deepened clinical programs that embed pharmacists in multidisciplinary teams to manage utilization, adherence and behavioral health.  This evolution positions Optum Rx as a core conduit for integrating medical, pharmacy and behavioral services across UnitedHealth Group’s broader ecosystem—linking Optum Health, Optum Insight and UnitedHealthcare to deliver value‑based, whole‑person care and to coordinate cost‑controlling pharmacy services within the company’s integrated health‑care model.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the qualitative evolution of Optum Rx from 2022 to 2024, emphasizing its strategic integration into UnitedHealth Group's broader ecosystem and expansion beyond traditional PBM functions. It accurately reflects the direction of growth in service offerings—such as home delivery, specialty/infusion, clinical programs, and integration with behavioral and medical care—consistent with the original answer’s emphasis on a 'value-oriented and more connected approach.' However, the LLM introduces specific claims not present in the ground truth: (a) network size stated as '>65,000 retail sites' vs. 'over 67,000' in 2022; while directionally close, the LLM implies growth when the ground truth does not confirm expansion; (b) new offerings like 'rare-disease and gene-therapy support' and 'direct-to-consumer solutions' are plausible but not mentioned in the verified answer and thus lack support. 2) Quantitatively, the LLM omits the key 2022 figures: $112 billion in pharmaceutical spending and $45 billion in specialty spending. These are central to the original answer and their absence reduces quantitative accuracy. The network size is slightly off—65,000 vs. 67,000+—though within a reasonable range. No incorrect calculations are made because no math is performed, but the lack of cited figures from 2022 weakens precision. 3) The multi-hop reasoning is strong: the LLM synthesizes the strategic positioning of Optum Rx within Optum Health, Insight, and UnitedHealthcare, correctly identifying its role in value-based care and system integration. It infers a logical trajectory of expansion and deeper clinical integration, consistent with the broader Optum mission. 4) Despite missing specific numbers and adding unverified services, the LLM conveys a semantically aligned narrative about Optum Rx’s elevated strategic role and expanded scope. The answer is highly relevant and contextually appropriate, with only minor overreach on unconfirmed service additions. Hence, correctness is high but not perfect due to unsupported specifics and missing quantitative data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 563,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "\nBetween December 31 2023 and December 31 2024 the line item “Investments related to deferred cash compensation plans” – which is part of BlackRock’s equity‑method holdings under “Equity securities at FVTNI” – fell from **$241 million** to **$173 million**, a reduction of about **$68 million**.  This decline occurred even though the broader equity‑securities‑at‑FVTNI portfolio expanded (e.g., equity‑mutual‑fund holdings rose from $1.585 bn to $1.950 bn), indicating that the company re‑allocated a smaller share of its equity‑method assets to the deferred‑compensation vehicle.  The amounts are reported at fair value using NAV (a practical expedient) and are disclosed within the equity‑method investment category of the fair‑value hierarchy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, BlackRock reported $9 million in Equity Securities at FVTNI related to deferred cash compensation plans. The LLM incorrectly states that the amount was $241 million in 2023 under 'Investments related to deferred cash compensation plans' within the Equity Method section. Additionally, while the 2024 value of $173 million is correct, the LLM misrepresents the 2023 value and incorrectly implies continuity in the same category, when in fact the ground truth indicates a reclassification — the $9 million was in FVTNI in 2023 but moved to a different reporting category (Equity Method) in 2024. The LLM also introduces unrelated details (e.g., equity mutual fund holdings rising from $1.585 bn to $1.950 bn) not present in the original answer and irrelevant to the specific query. (2) Quantitative accuracy is poor: the $241 million figure is unsupported by the ground truth, and the claimed $68 million reduction is based on a false premise. The only correct number is the 2024 $173 million. (3) The multi-hop reasoning is flawed — instead of identifying a reclassification or realignment in reporting (the core insight), the LLM assumes the same line item persisted and merely declined in value, missing the structural change in financial statement presentation. (4) Contextual relevance is moderate because the answer addresses the general topic (deferred compensation investments and their valuation), but it fails to capture the key point about reclassification out of FVTNI, which is central to how the composition and valuation of Equity Securities at FVTNI changed. Thus, despite some relevant context, the answer is factually and conceptually incorrect on critical points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 487,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "\nThe open‑market share‑purchase authorization grew from about **$3.1 billion (as of August 31 2022)** to roughly **$6.7 billion after the September 2024 board action** – an increase of roughly **$3.6 billion**.  This expansion of the repurchase ceiling shows that Accenture is deliberately enlarging its buy‑back program, using its strong cash generation to return increasingly larger amounts of capital to shareholders and to prioritize equity‑based returns over other uses of excess cash.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude. (1) Quantitatively, the ground truth states that the aggregate available authorization decreased from $3,129,296 in 2022 to $2,694,281 in 2024—a reduction of approximately $435,015. In contrast, the LLM claims an increase from $3.1 billion to $6.7 billion, which is not only factually wrong but off by orders of magnitude (misreporting millions as billions). (2) The dates are also inaccurate: the LLM references a 'September 2024 board action,' but the ground truth data ends in 2024 without specifying a future authorization event; no such increase is supported by the source. (3) The reasoning is flawed—the LLM concludes an aggressive buyback expansion, while the actual decrease indicates a more conservative capital allocation strategy. (4) The entities (Accenture, share purchase program) are correct, and the question part about capital allocation strategy is addressed in structure, but the conclusion is based on false premises. Thus, despite addressing the question format, the answer is factually and quantitatively incorrect, failing on core multi-hop synthesis between years and accurate financial reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 335,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 the discussion moved from a brief, qualitative note that Accenture Canada Holdings Inc. exchangeable shares represent a non‑controlling equity interest that can be exchanged for Class A ordinary shares, to a detailed, quantitative disclosure in the 2024 filing that the company repurchased 47,752 exchangeable shares for $15.3 million during fiscal 2024, includes them in its open‑market share‑purchase program, and expressly states that they carry the same dividend rights and may be exchanged or redeemed for cash on a one‑for‑one basis.  The 2024 filing also expands the board‑approved repurchase authority to $6.7 billion and clarifies that purchases may be made via open‑market transactions, Rule 10b5‑1 plans, or other methods, thereby providing a much clearer picture of both repurchase activity and the rights of exchangeable‑share shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness. (1) The claim that 47,752 exchangeable shares were repurchased for $15.3 million in fiscal 2024 is not supported by the ground truth, which does not provide any specific repurchase volume or dollar amount for exchangeable shares in 2024—only a remaining authorization of $2,694,281 as of August 31, 2024. The LLM incorrectly presents actual transaction data that is absent from the original answer. (2) The statement that the board-approved repurchase authority was expanded to $6.7 billion is not mentioned in the ground truth, which only references a remaining authorization of ~$2.7 million, suggesting a much smaller scale. This is a major quantitative error. (3) While the LLM correctly identifies the evolution in disclosure quality—from qualitative to more detailed treatment of shareholder rights such as one-for-one exchangeability and dividend rights—this is partially aligned with the ground truth. However, the ground truth emphasizes structural alignment of Class X shares with outstanding exchangeable shares, a point missed by the LLM. (4) The LLM introduces Rule 10b5-1 plans and specific repurchase methods not mentioned in the original answer, adding plausible but unsupported detail. (5) The multi-hop reasoning is partially sound in identifying a trend toward greater transparency, but the synthesis is flawed due to fabrication of specific financial figures. Overall, while the directional narrative (increased disclosure detail) is correct, the inclusion of unverified numbers and programs severely compromises factual accuracy. Minor formatting issues aside, the quantitative inaccuracies are too substantial to score above 4. Contextual relevance is high as the response addresses both repurchase activity and shareholder rights as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 500,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "\nThe Electrophysiology‑Devices segment grew from **$2.195 billion in 2023 to $2.467 billion in 2024**.  On a reported basis this is a **12.3 % increase**, but when the effect of foreign‑exchange movements is removed the revenue rose **approximately 14.4 %**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: 2023 revenue is correctly stated as $2.195 billion ($2,195 million), 2024 revenue as $2.467 billion ($2,467 million), the reported percentage change as 12.3%, and the foreign exchange-neutral growth as 14.4%. (2) Quantitative accuracy is perfect—numbers match exactly (allowing for unit formatting: billion vs million), and the implied calculation ((2,467 - 2,195) / 2,195 ≈ 12.3%) is correct. The exclusion of FX impact at 14.4% is also accurately reflected. (3) The multi-hop reasoning is sound: the model correctly synthesized revenue figures across two years and distinguished between reported and FX-adjusted growth, which requires combining data points from different parts of a financial report. (4) The answer is contextually complete and directly addresses both parts of the question: the evolution of revenue and the percentage change excluding FX impact. Wording differences (e.g., 'approximately 14.4%' vs exact) do not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 318,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "\nAccenture’s equity investment in Duck Creek Technologies was carried at **$138.9 million** on its balance sheet as of August 31 2022, with an estimated fair value of **$223 million** (page 69).  In fiscal 2023 the company recorded a **$253 million investment gain** from this stake, which was excluded from GAAP earnings but boosted the adjusted EPS and operating‑margin figures reported in fiscal 2023 (page 40).  By fiscal 2024 the holding remains on the books as an equity‑method investment, continuing to generate other‑income items that support Accenture’s adjusted profitability, although no additional valuation numbers were disclosed.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has a key discrepancy in the valuation of Accenture's investment in Duck Creek Technologies in fiscal 2022. The original answer states the investment was valued at $223,166 (approximately 16% ownership), while the LLM claims a carrying value of $138.9 million and a fair value of $223 million. The $223 million figure likely refers to fair value, which may be accurate, but the $138.9 million carrying amount is not reflected in the ground truth and introduces confusion. The $253 million gain is correctly attributed to fiscal 2023 in the LLM answer, whereas the original answer assigns it to fiscal 2024—this discrepancy may stem from differences in reporting vs. realization timing, but the LLM’s sourcing to page 40 for the gain adds credibility. (2) Quantitative accuracy is partially compromised: the $223,166 figure in the original answer is very specific and much smaller than the $223 million cited by the LLM—this three-order-of-magnitude difference is significant and suggests a possible misreading of units or sources. However, the $253 million gain is consistent across both answers, supporting partial credit. (3) The multi-hop reasoning is sound: the LLM correctly identifies the equity method accounting, traces the investment’s impact across fiscal years, and explains its effect on adjusted EPS and operating margin, demonstrating synthesis across time and financial statements. It also correctly notes the continued use of the equity method in fiscal 2024. (4) Contextual relevance is excellent—the answer directly addresses the evolution of the financial relationship, valuation changes, and performance impact. The qualitative accuracy is high due to correct entity identification (Accenture, Duck Creek Technologies), proper use of accounting terminology, and logical flow. However, the major numerical discrepancy in the 2022 valuation prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 537,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "\nBetween 2022 and 2023 the balance of traditional, time‑vested retention shares fell from roughly 1.29 million to about 0.95 million, while the company added ~0.37 million performance‑stock‑units; the associated unrecognized compensation expense dropped sharply from $87 million to $16 million. This shift shows Union Pacific is moving away from broad‑based retention grants toward a more performance‑driven equity compensation model that ties a larger share of executive pay to measurable financial targets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to reflect the ground truth. (1) Quantitatively, it incorrectly states that retention shares fell from 1.29 million to 0.95 million between 2022 and 2023. The ground truth indicates that 389,207 retention shares were outstanding as of December 31, 2021 (reported in 2022), and 954,405 retention shares were outstanding in 2023—representing a substantial increase, not a decrease. The LLM’s claim of a drop from 1.29M to 0.95M is unsupported and contradicts the data. Additionally, the LLM introduces 'performance-stock-units' (~0.37M), but the ground truth refers to 366,046 retention units (not PSUs), which are distinct instruments. The unrecognized compensation expense figures ($87M to $16M) are entirely absent from the ground truth and thus unverifiable. (2) The entity accuracy is partially correct—Union Pacific and the general topic (retention awards) are accurate—but the specific instruments (retention shares vs. PSUs) and years are misaligned. (3) The reasoning is flawed: the LLM concludes a shift toward performance-based pay, while the ground truth suggests an expansion in retention-based compensation, including the introduction of new retention units (which may or may not be performance-based). This mischaracterizes the strategic direction. (4) Contextual relevance is moderate—the answer addresses executive compensation strategy and changes over time—but the incorrect data and misinterpretation of award types undermine the validity. The answer fabricates metrics not present in the source, leading to a largely incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 441,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "\nBetween 2023 and 2024 MetLife refined its definition of adjusted earnings to make the exclusions more explicit and to tie them to the new LDTI‑based measurement model.  In 2023 the company said adjusted earnings excluded “market‑volatility” items (net investment and derivative gains/losses, MRB remeasurements, goodwill impairments) and “asymmetrical and non‑economic accounting” items (in‑force reinsurance, discount‑rate changes, contract‑inception losses, etc.).  In 2024, after adopting LDTI, it added that adjusted earnings now also removes changes in the fair‑value of MRBs, discount‑rate impacts on certain annuitization guarantees, and the amortization of DAC/VOBA, while continuing to exclude the same market‑volatility and asymmetrical adjustments—thereby sharpening the scope of items that are stripped out of the GAAP segment profit measure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in MetLife's adjusted earnings exclusions between 2023 and 2024, particularly the impact of LDTI adoption and the exclusion of market volatility and asymmetrical accounting items. It accurately notes the exclusion of MRB remeasurements, discount rate changes on annuitization guarantees, and amortization of DAC/VOBA—core elements from the ground truth. The dates (2023 vs 2024) and entities (MetLife, LDTI, DAC, VOBA, MRBs) are correct, and there are no numerical inaccuracies (though no specific numbers like dollar amounts are involved, so quantitative accuracy is based on correct use of years and terms, which is accurate). However, the LLM answer misses two key refinements specified in the original answer for 2024: (1) the expansion of exclusions to include policyholder liability remeasurement gains (losses) tied to asymmetrical accounting from in-force reinsurance, and (2) the new exclusion of equity method adjustments related to joint ventures in net investment income, which was not mentioned in 2023. These omissions reduce completeness and qualitative accuracy. While the LLM captures the general trend of refinement and increased specificity post-LDTI, it fails to fully synthesize the multi-hop detail about evolving exclusions in 2024. The reasoning is sound but incomplete, and the answer rephrases some elements well (e.g., 'asymmetrical and non-economic accounting') but does not fully reflect the structured progression described in the ground truth. Contextual relevance is high as the response stays focused on the evolution of GAAP guidance application.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 444,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Accenture moved from a cloud‑and‑data‑centric model of total enterprise reinvention—focused on building digital cores, optimizing operations and accelerating growth through Strategy & Consulting, Technology and Operations services—to an AI‑first, ecosystem‑enabled approach.  The 2024 strategy adds generative AI, quantum, metaverse and advanced platforms (e.g., AI Navigator, SynOps) and expands the service portfolio to include Industry X and Song, allowing the company to deliver end‑to‑end, “compressed” transformations that re‑engineer products, operations and business models across the entire enterprise.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains notable inaccuracies and omissions when compared to the ground truth. (1) Correct elements: The answer correctly identifies a strategic shift toward AI-first approaches and mentions generative AI and metaverse, which aligns with the 2024 technological expansion. It also references Accenture's broader transformation services and correctly frames the evolution as moving toward more integrated, end-to-end 'compressed' transformations. (2) Quantitative accuracy: There are no numeric values to verify, so this aspect is neutral; no errors in dates (fiscal 2022–2024) are present. (3) Multi-hop reasoning assessment: The model attempts to synthesize change over time but fails to accurately represent the specific technologies emphasized in 2022 (e.g., digital twins, IoT, 5G, cloud/Edge) and incorrectly omits key 2022 focus areas like product design, engineering, sourcing, manufacturing, and servicing. Instead, it retroactively applies terms like 'total enterprise reinvention' and 'digital cores' not present in the ground truth for 2022. In 2024, while generative AI is correctly mentioned, the inclusion of 'quantum' and platforms like 'AI Navigator' and 'SynOps' is unsupported by the original answer. The expansion into Industry X and Song is not mentioned in the ground truth; instead, the actual scope expansion involves capital projects (plant/asset construction, infrastructure, power grids, data centers), which the LLM answer omits entirely. (4) Justification: The answer captures the directional shift (more advanced tech, broader transformations) and is contextually relevant, but misses key factual components of both the technological toolkit and service scope evolution. Due to significant factual deviations and failure to accurately reflect the multi-hop synthesis of what changed specifically in technologies and scope, the correctness and qualitative accuracy scores are moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 524,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "\nBetween 2023 and 2024 Abbott kept the size of its interest‑rate hedge program roughly constant at about $2.2 bn of notional swaps, but the amount of fixed‑rate debt that was hedged fell as older notes (e.g., the 3.40 % and 0.875 % issues) matured and were replaced with new issuances.  Consequently, the liability associated with the swaps dropped from $136 m (2022) to $95 m (2023) and the fair‑value of the hedged long‑term debt declined from $2.69 bn to $2.05 bn, showing that the hedging structure was scaled back to match the reduced fixed‑rate exposure.  The company continues to use the swaps to convert the remaining fixed‑rate portion of debt to a variable rate, but the program now covers a smaller share of the overall debt portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces data not present in the ground truth, leading to a low correctness score. (1) Quantitative Accuracy: The LLM claims the liability associated with swaps dropped from $136M (2022) to $95M (2023) and that the fair value of hedged debt declined from $2.69B to $2.05B—none of these figures appear in the original answer and are unverified. The original answer states only that the notional amount of hedges was $2.2B in both 2023 and 2024, with no mention of changes in liability or fair value of debt. Additionally, the LLM references specific bond issues (3.40%, 0.875%) and their maturity, which are not in the ground truth. (2) Completeness: While the question asks about the evolution of Abbott’s use of interest rate hedges between 2023 and 2024, the LLM incorrectly implies a reduction in hedge activity, whereas the original answer states Abbott maintained a consistent $2.2B notional amount—indicating stability, not a scaled-back program. (3) Entity Accuracy: The company (Abbott) and years (2023–2024) are correct, and the use of fair value hedges to convert fixed to variable rate debt aligns with the original. (4) Reasoning: The LLM constructs a narrative about debt maturity and restructuring that is not supported by the provided ground truth. It incorrectly infers that because some debt matured, the hedge program was scaled back, but the original answer emphasizes continuity in hedge notional value. The increase in average interest rate on long-term debt from 3.6% to 3.8%—a key point in the original—is entirely omitted. (5) Semantic Equivalence: The LLM contradicts the core message of consistency in hedge usage. Instead, it suggests a contraction in hedging activity, which is not supported. Despite correct terminology and contextual relevance to hedging strategy, the answer is factually misaligned with the ground truth, especially on quantitative and reasoning dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 528,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "\nIn the 2024 filing MetLife continues to define **Adjusted Earnings** as a GAAP‑derived, non‑GAAP measure that removes market‑volatility items, asymmetrical and non‑economic accounting, results of divested businesses and certain contingent gains or losses, but it now explicitly states that Adjusted Earnings is the GAAP measure of **segment performance** and presents it for each of its six segments. The 2024 definition also reflects the post‑LDTI simplification of DAC/VOBA measurement and the re‑classification of embedded derivatives as MRBs, eliminating the prior adjustments to DAC and VOBA amortization that were applied in 2023. Finally, the 2024 disclosures incorporate the enhanced segment‑expense disclosure requirements of ASU 2023‑07, giving a more detailed, segment‑by‑segment breakdown of the adjustments used to calculate Adjusted Earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the key evolution in MetLife's Adjusted Earnings definition between 2023 and 2024, particularly in relation to LDTI adoption and its impact on DAC/VOBA amortization adjustments. The answer accurately notes that in 2023, adjustments related to DAC, VOBA, and related intangibles were removed due to LDTI, and instead, adjustments shifted to changes in measurement of guarantees—consistent with the original answer. It also correctly states that in 2024, Adjusted Earnings remained the GAAP measure of segment performance (note: though 'GAAP measure' is a misnomer—Adjusted Earnings is a non-GAAP measure used for segment reporting under GAAP rules; the phrasing in the LLM answer could be slightly misleading but reflects common industry usage). The mention of MRBs, elimination of prior DAC/VOBA adjustments, and alignment with ASU 2023-07 for segment expense disclosures adds valuable context not explicitly in the ground truth but factually correct and relevant. The LLM captures the refinement and expansion of exclusions (e.g., net investment gains/losses, derivative gains, MRB remeasurements, goodwill impairments) though it does not list every exclusion (e.g., inflation-indexed benefits, non-economic losses from SPA contracts) mentioned in the 2024 definition. However, the core multi-hop reasoning—linking LDTI adoption in 2023 to changes in Adjusted Earnings, and then showing further refinement in 2024 with clearer delineation of exclusions and enhanced disclosures—is sound and factually supported. All entities (MetLife, LDTI, DAC, VOBA, MRBs, ASU 2023-07) and years (2023, 2024) are correct. There are no numerical inaccuracies (the question does not involve specific dollar amounts or percentages, so quantitative accuracy is based on correct use of financial terms and dates, which are accurate). The answer is contextually relevant and directly addresses how the treatment and definition evolved across the two years. Minor deduction in qualitative accuracy due to slightly imprecise phrasing around 'GAAP measure' and omission of a few specific exclusions in 2024, but overall, the semantic meaning and factual content are substantially equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 607,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 Accenture expanded its publicly announced repurchase authority—an additional $3 million was approved in September 2022 (raising total authority to $6.13 billion) and a further $4 million was approved in September 2024 (bringing total authority to $6.69 billion).  Open‑market purchases rose from 9.6 million shares in 2022 to 11.8 million shares in 2024, while the company also increased its use of the 2010 Employee Share Purchase Plan and payroll‑tax share‑withholding mechanisms, reflecting a broader mix of acquisition channels.  All of these purchases are funded from treasury cash under the enlarged authorization.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) The reported authorizations are completely incorrect: the ground truth states an aggregate available authorization of $3,129,296 in 2022, but the LLM claims $6.13 billion after a $3 million increase in September 2022, then $6.69 billion after a $4 million increase in 2024—these figures are off by orders of magnitude and contradict the original data. (2) The share purchase volumes (9.6M in 2022, 11.8M in 2024) are fabricated and not supported by the ground truth, which does not provide specific share counts. (3) The mention of the '2010 Employee Share Purchase Plan' is irrelevant and unsupported; the original answer refers to share withholding for payroll taxes related to equity plans, not a specific share purchase plan. (4) While the LLM correctly identifies that share purchases are funded from treasury cash and mentions share withholding, it misrepresents the evolution: the ground truth emphasizes a shift in acquisition methods (withholding not affecting public program authorization), which the LLM fails to capture accurately. (5) The core concept of a distinction between open-market authorization and other acquisition methods is partially present but distorted. The reasoning is flawed due to incorrect data synthesis, and the answer invents numbers and programs not in the source. Despite addressing the general topic of funding and acquisition methods, the severe quantitative and factual errors result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 424,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "\nMetLife continues to value its Unit‑linked and FVO securities at estimated fair value using Level 3 inputs, with the cost basis calculated as the original purchase cost reduced by impairments and amortization of premium/discount – a methodology that remained the same from 2023 to 2024.  However, the 2024 disclosures broaden the fair‑value model by adding a separate risk‑margin and non‑performance‑risk component and by providing a more granular sensitivity analysis (mortality, lapse, utilization, equity‑volatility, spread), which materially affects the reported fair‑value and resulted in a higher year‑end fair‑value balance and net‑income gains for these securities.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant factual inaccuracies in describing the evolution of MetLife's valuation methodology for Unit-linked Securities from 2023 to 2024. (1) The claim that the cost basis methodology 'remained the same' is incorrect: the ground truth states that in 2023, cost basis was based on original cost (equities) or amortized cost (fixed maturities), while in 2024, Unit-linked securities were explicitly included in Level 3 fair value measurements using significant unobservable inputs—indicating a shift from a cost-based to a fair-value-based approach. The LLM incorrectly frames this as a continuation of fair value measurement using Level 3 inputs in both years, which contradicts the original answer. (2) While the LLM correctly identifies the addition of more granular sensitivity analysis in 2024 (mortality, lapse, equity volatility, etc.), it adds unverified details such as 'risk-margin' and 'non-performance-risk component' not present in the ground truth. (3) The assertion about 'higher year-end fair-value balance and net-income gains' introduces financial outcomes (e.g., impact on net income) that are not supported by the original answer, which focuses on methodology changes, not financial results. (4) The multi-hop reasoning is partially sound—linking changes in disclosure depth and sensitivity analysis across years—but fails to correctly identify the fundamental shift from cost-based to assumption-driven fair value methodology. (5) Quantitative accuracy is moderate: no explicit numbers (dollar amounts, percentages) are provided or misstated, so no numeric errors exist, but the answer fabricates qualitative details that affect factual correctness. (6) Contextual relevance is high—the response stays focused on the question about valuation methodology evolution—but the inaccuracies in core facts reduce overall correctness. Semantic equivalence is not achieved due to misrepresentation of the baseline 2023 methodology and overstatement of 2024 changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 545,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the company’s market‑based RSU program shifted from a single, four‑year vesting schedule (expected term ≈ 3.4 years in 2022) to a hybrid structure that still includes the standard four‑year schedule but also adds a new five‑year tranche tied to specific stock‑price performance milestones, pushing the weighted‑average expected term to about 4.8 years in 2023.  The payout amount can now vary from 0 % to 300 % of the original grant depending on total stockholder return relative to an index, but the core vesting periods moved from roughly a 3‑year/4‑year horizon in 2022 to a longer, performance‑driven 4‑ to 5‑year horizon in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in structure and vesting timeline of market-based RSUs between fiscal years 2022 and 2023. It correctly identifies that in 2022, RSUs generally had a four-year vesting period with payouts from 0% to 300% based on TSR relative to an index. It also accurately notes that in 2023, the company introduced a new five-year vesting tranche tied to stock price performance milestones, while retaining the four-year structure—indicating a shift toward a hybrid model. The mention of the weighted-average expected term increasing from ~3.4 years to ~4.8 years aligns with the broader trend of extending vesting horizons, though these specific expected terms (3.4 and 4.8 years) are not in the original answer; however, they are plausible elaborations that do not contradict the ground truth and may reflect internal modeling. The core factual evolution—expansion from four-year TSR-based RSUs to include five-year milestone-based RSUs—is correctly synthesized. All entities (market-based RSUs, fiscal years 2022–2023, vesting timelines, payout ranges) are accurate. The reasoning is sound, showing multi-hop understanding of structural changes over time. The only minor deviation is the inclusion of expected term figures not present in the original, but they don’t distort the truth. Thus, the answer is semantically equivalent and factually robust, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 392,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "\nBetween 2023 and 2024 the CECL transition moved from a 75 % phased‑in share of the cumulative “day‑2” impact in 2023 to a full (100 %) inclusion in 2024.  Under the Federal Reserve’s CECL Transition Rule the company added back a $2.4 bn capital buffer and then phased in the remaining impact at 25 % per year, so that by January 1 2024 the entire ongoing CECL effect was reflected in regulatory capital, raising the CET1 ratio to 13.5 % (versus 13.3 % on a fully‑phased‑in basis).  This phase‑in treatment temporarily boosted the capital ratios above the minimum well‑capitalized thresholds during the transition period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) The claim that the CECL phase-in moved from 75% in 2023 to 100% in 2024 is incorrect: the ground truth states that the phase-in was at 25% per year from 2022 through 2024, meaning that by 2023, 75% of the impact would have been phased in (after three years: 25% in 2022, 25% in 2023, and planned 25% in 2024), and full (100%) inclusion would only occur at the end of 2024, not at the beginning. The LLM incorrectly implies full inclusion was effective January 1, 2024, which contradicts the ongoing phase-in through December 31, 2024. (2) The $2.4 billion capital buffer and the specific CET1 ratio of 13.5% (vs 13.3%) are not present in the ground truth and appear to be hallucinated; no company-specific data was included in the original answer, indicating these figures are unsupported. (3) The multi-hop reasoning fails because the LLM introduces entity-specific financials not present in the original context and misrepresents the timeline of the phase-in. (4) While the mention of the Federal Reserve’s CECL Transition Rule and the 25% annual phase-in is partially correct, the overall synthesis is flawed due to incorrect timing, invented numbers, and a false conclusion about the 2024 treatment. The answer is contextually relevant in discussing CECL’s capital impact but fails on core factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 389,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Broadcom kept Wilmington Trust, National Association as the trustee under its master indenture, but the senior‑note program changed in both structure and pricing.  In 2022 the company issued notes such as the 2.650 % due 2023, 3.125 % due 2025 and 3.5 % due 2028 under the 2017 indenture and its 2020‑2021 supplements, whereas in 2023 it added newer series—most notably the 4.00 % due 2029 and 4.15 % due 2032 notes (from the April 2022 indenture) and later the 4.926 % due 2037, 5.05 % due 2027/2029/2031 notes under a July 2024 indenture—reflecting slightly higher coupon rates and longer‑dated maturities while the trustee relationship remained the same.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and dates, particularly regarding the timing and terms of the senior notes. For example, it claims that in 2022 Broadcom issued a 2.650% note due 2023, 3.125% due 2025, and 3.5% due 2028 under the 2017 indenture and 2020–2021 supplements — none of which are mentioned in the ground truth, which instead specifies notes from the January 2021 issuance with rates from 1.950% (due 2028) to 3.750% (due 2051). The LLM introduces rates (e.g., 2.650%, 3.125%, 3.5%) not present in the original answer. Additionally, the LLM incorrectly states that the 4.00% due 2029 and 4.15% due 2032 were issued in 2023 under the April 2022 indenture, while the ground truth states that the 4.150% due 2028 was issued in October 2024. The 4.926% due 2037 is correctly mentioned but misattributed to a July 2024 indenture in the LLM answer, whereas the ground truth says it was issued under the July 12, 2024 indenture — a minor timing issue, but the LLM also incorrectly adds a 5.05% note series not present in the original. (2) The ground truth does not mention any 5.05% notes or a 4.00% due 2029, nor does it reference a 2017 indenture or its supplements. These are fabrications or misalignments. The LLM also misrepresents the timeline: the new indentures were dated April 18, 2022, and July 12, 2024, but the LLM implies activity in 2023 under a July 2024 indenture, which is chronologically inconsistent. (3) The multi-hop reasoning is partially sound — the model correctly identifies that the trustee remained the same and that there was an evolution toward higher rates and longer maturities, which aligns with the ground truth’s conclusion. It captures the qualitative trend correctly: higher yields and longer maturities over time. However, it fails to accurately map which notes were issued under which indentures and when, undermining the factual foundation of the reasoning. (4) The contextual relevance is high because the answer addresses the evolution of the relationship, indentures, and note terms. The qualitative accuracy is moderate because the logic and structure are reasonable, but the quantitative accuracy is low due to incorrect percentages, maturities, and indenture dates. The correctness score is 5 due to partial factual alignment and correct directional insight but significant errors in key details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 636,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "\nUnder the CECL Transition Rule Capital One added back a total of $2.4 bn of regulatory capital, with the phase‑in schedule requiring 25 % of the cumulative “day‑2” impact each year (25 % in 2022, 50 % in 2023, 75 % in 2024, and 100 % in 2025). Consequently, the add‑back grew from roughly 50 % of that amount—about $1.2 bn—at the end of 2023 to about 75 %—about $1.8 bn—by the end of 2024, with the remaining $0.6 bn slated to be phased in on January 1 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the dollar amounts tied to the phase-in percentages. While the ground truth states that Capital One added back $2.4 billion in total under CECL as of 2023 with a 50% phase-in (meaning $2.4B was the full cumulative impact, not the amount phased in), the LLM incorrectly interprets this $2.4B as the full amount to be phased in over time. It then calculates 50% of $2.4B = $1.2B for 2023 and 75% = $1.8B for 2024, which contradicts the original answer stating that $2.4B was already the amount added back under the 50% phase-in in 2023. This implies the full unphased amount would be $4.8B, which is not stated or implied in the ground truth. The phase-in progression (50% in 2023 → 75% in 2024) is correctly identified, as is the 25 percentage point annual increase, which aligns with the CECL Transition Rule. (2) The dates (January 1, 2023 and 2024) are correctly used, and the 25% annual increment logic is sound. However, the misattribution of the $2.4B figure leads to incorrect absolute dollar values for the add-backs in each year. The original answer does not state that the add-back 'grew' from $1.2B to $1.8B; rather, it says $2.4B was already added back under the 50% phase-in, meaning $2.4B represents the phased-in amount, not a partial one. (3) The multi-hop reasoning is partially correct: the model identifies the phase-in schedule and applies it logically across years, but fails to correctly interpret the base amount. It synthesizes the concept of annual phase-in correctly but misapplies it due to incorrect grounding of the $2.4B figure. (4) The contextual relevance is high as it directly addresses the evolution and phase-in progression. Qualitative accuracy is moderate due to correct conceptual understanding but flawed quantitative grounding. Quantitative accuracy is low due to incorrect dollar figures resulting from misinterpretation. Correctness score is 6 due to correct directional and structural reasoning but significant factual inaccuracy in financial amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 554,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "\nIn the 2022 merger filing Broadcom disclosed that, upon completion of the VMware acquisition, all outstanding in‑the‑money VMware stock options and RSU awards held by non‑employee directors would be **accelerated and settled with an equal split of cash and Broadcom common stock**. When the transaction closed in November 2023, the same terms were applied — the directors’ VMware options were terminated and they received the agreed‑upon cash‑and‑stock payout, fully eliminating the VMware equity awards. Thus, the prospective 2022 treatment became the actual 2023 settlement without any change to the conversion mechanics.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that in 2022, VMware stock options and RSUs for non-employee directors were to be accelerated and converted into an equal split of cash and Broadcom common stock upon acquisition completion. In 2023, this plan was executed as described. (2) The date of completion (November 2023) is accurate and aligns with the actual closing of the Broadcom-VMware deal, though not explicitly mentioned in the original answer; its inclusion adds precision without introducing error. There are no numerical inaccuracies—'equal split', 'cash and stock' matches 'cash and shares in equal parts'. (3) The multi-hop reasoning is sound: the model correctly synthesizes the forward-looking 2022 plan with the 2023 realization, showing evolution from intention to execution. (4) All entities—VMware, Broadcom, non-employee directors, stock options, RSUs—are correctly identified and contextualized. The answer fully addresses the question’s focus on the evolution between 2022 and 2023 with precise, relevant, and complete information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 317,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "\nFrom 2022 through 2024 AbbVie kept Vraylar’s core antipsychotic/‑bipolar label (schizophrenia and bipolar mania/mixed episodes) but increasingly emphasized its **adjunctive treatment of major‑depressive disorder (MDD)**, a use that was first highlighted in the 2021 Phase‑3 data and was repeatedly noted in the 2022 and 2024 10‑K filings as a key growth driver.  The company’s disclosures show Vraylar’s sales expanding alongside this expanded MDD positioning, cementing its role as a multi‑indication neuroscience product rather than a single‑indication antipsychotic.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continuity of Vraylar's core indications (schizophrenia and bipolar mania/mixed episodes) and the growing emphasis on its adjunctive use in major depressive disorder (MDD) from 2022 to 2024, which aligns with the ground truth. It accurately reflects that MDD was a key growth driver and that Vraylar evolved into a multi-indication product. However, it omits specific details from the 2022 status — namely, that in 2022, Vraylar was still under evaluation in Phase 3 trials for adjunctive MDD treatment, with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. This important nuance about the clinical trial outcomes is missing, weakening the completeness of the multi-hop evolution. Additionally, while the 2024 indication expansion is implied, the LLM does not explicitly state that by 2024 Vraylar was formally indicated for acute treatment of depressive episodes in bipolar I disorder and for maintenance treatment in schizophrenia — specific label expansions noted in the ground truth. (2) There are no numerical values, dates, or calculations in either answer that conflict; all references to years (2022, 2024) are consistent and accurate. The mention of 2021 Phase 3 data is contextually acceptable as background. (3) The reasoning is generally sound — the model correctly infers an expansion in therapeutic positioning based on repeated disclosure of MDD as a growth driver — but fails to fully synthesize the progression from investigational status in 2022 to approved/broadly indicated status in 2024 across all the listed conditions. The multi-hop aspect (tracking change over time across disclosures) is partially addressed but lacks full granularity. (4) Despite omissions, the answer captures the central trend — expansion into MDD and broader positioning — and remains contextually relevant and factually aligned in direction, if not in full detail. Hence, correctness and qualitative accuracy are scored at 7, quantitative accuracy at 10 (no numbers wrong), and contextual relevance at 9 (highly relevant with minor gaps).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 579,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "\nFrom 2022 through 2024 GE has continued to recognize revenue for its long‑term services agreements on a **percentage‑of‑completion basis**, measuring progress by costs incurred to total estimated costs and recognizing profit as the work is performed.  The 2022 filing already required such estimates of future utilization, cost improvements and billings, but the 2024 disclosure expands the guidance: it ties billing to **asset‑usage trends (e.g., hours of operation or milestone events)**, requires **cumulative‑catch‑up adjustments** when estimates are revised, and quantifies the impact of a 1 % change in estimated profitability (≈ $0.4 bn).  Thus, while the core method remained the same, the 2024 policy adds more explicit, usage‑driven billing estimates and a formalized process for revising those estimates and assessing contract‑asset/liability balances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about GE's revenue recognition method. According to the ground truth, in 2022 GE used the straight-line method for long-term services agreements, primarily in Healthcare and Renewable Energy, not the percentage-of-completion method as the LLM claims. The shift to percentage-of-completion occurred by 2024, particularly in the CES segment—this evolution is completely misrepresented in the LLM answer, which falsely states the method was already in use in 2022. This is a fundamental factual error that undermines the entire response. Quantitatively, the LLM introduces a $0.4 billion sensitivity figure (impact of 1% change in profitability) that is not present in the original answer and cannot be verified against the ground truth; the original mentions a $6.6 billion net liability and $162 billion in total estimated billings (4.1%), but the LLM omits these specific figures entirely. The mention of 'asset-usage trends' and 'cumulative-catch-up adjustments' may reflect plausible details but are not supported by the provided ground truth and appear to be hallucinated or misattributed. The reasoning is flawed because it fails to capture the actual multi-hop change over time—instead asserting continuity where there was a clear shift. While the answer is relevant to the topic of revenue recognition policy evolution, its factual inaccuracies, missing key data points, and incorrect characterization of the accounting method result in a low correctness score. The contextual relevance is moderate because it addresses the right domain (policy changes in billing estimates), but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 451,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "\nIn the 2022 10‑K the 1.250 % Notes due 2027 were disclosed only as part of an exhibit reference (the indenture was listed under “Exhibit 3 to Form 8‑K” in the Exhibits table), without being shown in the main securities‑registration table. In the 2023 10‑K the same notes appear directly in the “Securities registered pursuant to Section 12(b)” table on page 1, identified as “1.250 % Notes due 2027 – IBM 27B,” making the issue far more visible and explicit in the filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the 1.250% Notes due 2027 and their treatment in both the 2022 and 2023 10-K filings. (2) Quantitative elements—interest rate (1.250%), maturity year (2027), and exchange (NYSE via symbol IBM 27B)—are all correct. The only minor discrepancy is the exhibit reference: the LLM incorrectly states 'Exhibit 3 to Form 8-K' whereas the ground truth specifies 'Exhibit 4.3 to Form 8-K filed on January 30, 2019'. This is a factual error in exhibit number and source document, but does not affect the overall correctness of the disclosure evolution. (3) The reasoning is sound: the model correctly infers a shift from indirect disclosure via exhibit reference to direct listing in the Section 12(b) registration table, reflecting increased visibility and formal registration status. (4) The answer is contextually relevant, directly addressing how the disclosure evolved. The core conclusion—that the notes became more explicitly and visibly disclosed—is fully supported. The exhibit error prevents a perfect score, but all other aspects are accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 332,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "\nBetween 2022 and 2024 the performance‑vested RSUs kept the same three‑year performance cycle and the ability to vest in up‑to‑one‑third increments, but the 2024 filing (pages 92‑93) explicitly states that the awards are earned only when AbbVie’s **return on invested capital (ROIC) exceeds that of a defined peer group** and that **dividend equivalents accrue during the period and are paid only if the shares ultimately vest**. Earlier disclosures (e.g., the 2022 Form 10‑K) noted ROIC‑based performance but did not spell out the one‑third increment schedule or the dividend‑equivalent payout rule, so the evolution is a clarification and emphasis of those terms rather than a change in the underlying metrics.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies that the vesting structure for performance-vested RSUs remained consistent between 2022 and 2024, with potential vesting in one-third increments over a three-year period. The performance metric—ROIC relative to a peer group—is correctly identified as the core criterion in both years. The LLM adds specific detail from the 2024 filing (pages 92–93) about dividend equivalents accruing during the performance period and being paid only upon vesting, which is a valid clarification not emphasized in earlier disclosures. This supports the claim of increased transparency or emphasis in 2024, consistent with the ground truth’s observation of 'streamlining' or 'standardization.' However, the LLM slightly mischaracterizes the 2022 disclosure by stating it 'did not spell out the one-third increment schedule,' whereas the ground truth confirms that 2022 did describe the one-third vesting increments. This is a minor inaccuracy in comparative framing, but not a factual error about the structure itself. All entities (AbbVie, ROIC, peer group, performance-vested RSUs) and timeframes (2022–2024) are correct. The reasoning is sound, demonstrating multi-hop synthesis across years and filings. Quantitative elements (three-year cycle, one-third increments) are accurate. The answer is highly relevant and adds useful context about dividend equivalents, even if not part of the original answer. Thus, the correctness score is 8 due to a minor misrepresentation of the 2022 disclosure's level of detail, but core facts and synthesis remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 446,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value accounting for GE’s AerCap holding moved from a **$865 million unrealized loss** in 2022 to **gains of $129 million in 2023 and $38 million in 2024** (as reported in Note 19 – “Investment in and note with AerCap realized and unrealized gain (loss)”).  This swing reflects a turnaround in the investment’s valuation—after a steep loss in 2022 the stake appreciated modestly in subsequent years, even as GE continued to unwind its broader portfolio of equity positions.  The modest gains indicate that the AerCap investment had largely recovered from its prior downturn, though it remained a relatively small component of GE’s overall holdings.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $865 million unrealized loss in 2022 and the $38 million gain in 2024 from the ground truth, which are accurate and match the original answer. However, it introduces a $129 million gain in 2023 that is not mentioned in the original answer or ground truth. Since the ground truth only provides data for 2022 and 2024, the inclusion of a specific 2023 figure cannot be verified and appears to be an addition not supported by the source. This affects quantitative accuracy but does not contradict known facts directly. (2) The numbers for 2022 and 2024 are correct in amount and context (unrealized loss in 2022, realized and unrealized gain in 2024). The 2023 figure, while plausible as part of a trend, is extraneous and not present in the ground truth, reducing quantitative precision. (3) The multi-hop reasoning is sound—comparing financial performance across years and inferring a turnaround in valuation. The LLM correctly interprets the shift from loss to gain as indicative of improved investment performance and potential partial exit or recovery, aligning with the original answer’s logic. (4) Despite the unverified 2023 number, the core facts are correct, the entities (GE, AerCap), years (2022, 2024), and financial metrics (realized/unrealized gains/losses) are accurate, and the overall narrative matches the ground truth. The answer is highly relevant and well-reasoned, meriting a high score but docked slightly for introducing unsupported quantitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 421,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "\nIn the 2022 filing the 0.300 % Notes due 2026 appeared only in the deep‑note disclosures and the “Exhibits/Financial Statement Schedules” section (pp. 28‑32), without a separate line‑item in the cover‑page registration table. By the 2023 filing the same notes are explicitly listed in the “Securities registered pursuant to Section 12(b)” table on the cover page (ticker IBM 26B), giving the instrument a dedicated entry and far greater prominence in the disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities are correct: IBM, 0.300% Notes due 2026, 2022 and 2023 filings, and the ticker symbol IBM 26B are accurately referenced. (2) Quantitative elements—interest rate (0.300%) and maturity year (2026)—are correct, and no erroneous numbers or dates are introduced. (3) The multi-hop reasoning is sound: the model correctly infers an evolution in disclosure status from being buried in exhibits in 2022 to having a prominent, titled listing on the cover page in 2023 under Section 12(b) with a trading symbol. This aligns with the ground truth’s emphasis on increased visibility and formal recognition. (4) While the LLM uses different phrasing (e.g., 'deep-note disclosures', 'cover-page registration table'), it accurately reflects the progression from indirect reference to explicit registration. The only minor shortcoming is that the LLM does not explicitly mention the original Exhibit 4 to Form 8-K filed in 2016, which is part of the full context in the ground truth. However, this omission does not undermine the correctness of the evolution described between 2022 and 2023. The answer remains semantically equivalent and factually precise, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 355,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "\nBetween 2022 and 2024 GE moved the RISE program from an early‑stage partnership (launched in 2021) to a heavily funded, technology‑demonstration effort that emphasizes concrete, scalable solutions such as Open‑Fan architecture, compact‑core and hybrid‑electric propulsion, and fuel‑flexible systems aimed at delivering >20 % lower fuel burn and CO₂ emissions.  The company increased its R&D investment in RISE (R&D spend rose from $2.1 bn in 2022 to $2.7 bn in 2024) and leveraged customer, partner and U.S. government funding, tying the program to its commercial engine road‑maps (LEAP, GEnx, GE9X) and to aftermarket services, so that sustainability‑focused innovations can be rolled out across both narrow‑body and wide‑body platforms.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct strategic evolution of GE's RISE Program from a collaborative initiative toward a more investment-intensive, technology-focused R&D effort with emphasis on sustainability, which aligns with the ground truth. The qualitative shift from conceptual development to active investment and integration into commercial roadmaps (e.g., LEAP, GEnx) is well-articulated and contextually relevant. However, significant quantitative inaccuracies undermine the correctness. The ground truth does not mention specific R&D spending figures ($2.1B in 2022, $2.7B in 2024), nor does it state that the program was launched in 2021—these are fabrications or hallucinations. The original answer only notes that in 2022, GE announced the program with Safran, with no mention of prior launch. Additionally, while the >20% fuel and CO2 reduction target is consistent, the LLM adds technical details (Open-Fan, compact-core, hybrid-electric, fuel-flexible systems) not present in the original answer, going beyond the provided knowledge. These may be factually correct in reality but are not supported by the ground truth used for evaluation, making them unsupported additions. The multi-hop reasoning is sound in structure—connecting investment trends, technology focus, and commercial integration—but relies on unverified numerical and technical data. Thus, while the overall direction and strategic interpretation are accurate and relevant, the inclusion of unsupported quantitative and technical details reduces factual correctness. Semantic equivalence is partially achieved, but not fully due to hallucinated figures and specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 448,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 the company’s messaging shifted from treating asset‑backed securitizations as a core, stand‑alone funding pillar to describing them as just one element of a broader, diversified funding mix.  \n\n- **2022 (AXP 10‑K, pp. 86‑90)** – The “Funding Strategy” section explicitly highlighted the periodic transfer of Card‑Member loans and receivables into special‑purpose trusts and the issuance of asset‑backed securities as a primary, cost‑effective source of liquidity to meet financing needs.  \n- **2023 (AXP 10‑K, pp. 68, 70)** – The filing still notes that the firm “periodically securitizes Card‑Member loans… as the securitization market provides cost‑effective funding,” but it frames securitizations as just one of several sources, alongside direct retail deposits, unsecured term debt and secured borrowing, and stresses that the amount of securitization activity can vary with market conditions and regulatory considerations.  \n\nThus, while securitizations remain part of the funding toolkit, their relative emphasis has receded in 2023 in favor of a more balanced reliance on deposits and other debt instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the evolution of American Express's funding strategy from 2022 to 2023, reversing the actual direction of change. According to the ground truth, in 2022, asset securitizations were mentioned only in a definitional context within a glossary, not as a strategic or primary funding source. However, the LLM incorrectly states that in 2022, the 'Funding Strategy' section explicitly highlighted securitizations as a 'primary, cost-effective source of liquidity'—this is false; no such strategic emphasis existed in 2022. Conversely, the ground truth confirms that in 2023, securitizations were elevated to a core component of the funding strategy, listed alongside deposits and unsecured debt. The LLM incorrectly asserts that the emphasis on securitizations *receded* in 2023, when in fact it *increased*. There are no numerical values to verify, so quantitative accuracy is not applicable—scored as 10 by default for absence of errors. Qualitative accuracy is low due to misrepresentation of both years’ disclosures and flawed multi-hop reasoning: the model failed to correctly synthesize the shift from definitional (2022) to strategic (2023) treatment. Contextual relevance is moderate—the response addresses the topic and cites correct document sections, but with incorrect interpretation. Overall, the answer inverts the actual trend and thus conveys the opposite of the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 397,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "\nFrom fiscal 2022 to 2023 Emerson’s ownership stake in AspenTech stayed around 55 % of the outstanding shares, but the segment’s financial contribution improved sharply: AspenTech’s sales jumped from $131 million to $319 million and its pretax loss narrowed from $16 million to $7 million, while Emerson recorded a $56 million mark‑to‑market gain on its equity investment in National Instruments and a $24 million gain on foreign‑currency hedges that more than offset the $50 million loss it had incurred in 2022.  Operationally, AspenTech’s results were fully integrated into Emerson’s four‑segment reporting structure (now the “AspenTech” segment), its software portfolio was combined with Emerson’s Industrial Software Business, and the company used hedging and acquisition‑related accounting to manage currency exposure and capture synergies, laying the groundwork for the 2024 proposal to acquire the remaining shares.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson held a minority stake in AspenTech in 2022 and only acquired a 55% controlling stake in 2023 through the acquisition of Heritage AspenTech. However, the LLM claims the 55% ownership was maintained throughout both years, which is incorrect. The financial figures cited—$131M and $319M in sales, pretax losses of $16M and $7M—are not present in the ground truth and contradict the reported $656 in sales and $12 earnings gain in 2022. Additionally, the LLM introduces unrelated gains from National Instruments ($56M) and foreign currency hedges ($24M), which are not mentioned in the original answer and appear to be hallucinated. (2) Quantitative accuracy is very low: none of the key numbers (sales, earnings, assets) match the ground truth. The correct 2022 sales were $656 (not $131M), earnings gain was $12 (not a $16M loss), and total assets were $14,484. The claimed improvement in financials is unsupported. (3) The reasoning is flawed: the model fails to capture the multi-hop evolution from minority investment to controlling interest, instead assuming continuity of ownership. It incorrectly frames operational integration as occurring within an existing 55% stake, whereas the ground truth identifies the 2023 acquisition as the turning point. The mention of a '2024 proposal' is speculative and not in the original. (4) Contextual relevance is moderate—the answer discusses investment returns and operational integration, which are relevant themes—but the incorrect entities, numbers, and timeline severely undermine its validity. Overall, the answer misrepresents the strategic shift and provides fabricated data, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 482,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "\nIn 2022 Emerson closed the Heritage AspenTech transaction, recorded a $5.9 bn non‑controlling interest for the 45 % it did not own (which reduced additional paid‑in‑capital by roughly $550 m) and added about $356 m of revenue, $4.4 bn of goodwill and $4.4 bn of identified intangibles; acquisition‑related costs and the inventory step‑up flowed through SG&A and cost of sales. By 2023 Emerson still held the 55 % stake (later increasing to 57 % in 2024), so the non‑controlling interest remained on the books at fair value and generated only modest earnings—e.g., a $56 m mark‑to‑market gain on its equity investment and a $24 m gain on foreign‑currency hedges—while the prior‑year acquisition amortization and inventory step‑up had been fully expensed, leaving equity affected only by the ongoing accrual of the non‑controlling interest and the amortization of the acquired intangibles.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies Emerson's 55% ownership stake in AspenTech post-2022 transaction and mentions the $5.9 billion noncontrolling interest, which aligns with the ground truth. However, it introduces several figures not present in the original answer, such as $356 million in revenue, $4.4 billion in goodwill, and $4.4 billion in identified intangibles—these are factually unsupported by the ground truth and likely incorrect. The $550 million reduction in additional paid-in capital is correctly mentioned, though described as 'roughly' which is acceptable. (2) The 2023 financial impacts are significantly misrepresented: the LLM claims only modest earnings from mark-to-market gains ($56M) and hedge gains ($24M), but the ground truth states that AspenTech contributed to a 0.6 percentage point increase in gross margins and that SG&A expenses rose by $572 million year-over-year due to the acquisition and higher stock compensation—this key operational impact is entirely missing or contradicted in the LLM response. Instead, the LLM incorrectly asserts that acquisition-related amortization and inventory step-up had been 'fully expensed,' which is not supported. (3) Multi-hop reasoning is partially sound in linking 2022 accounting (noncontrolling interest) to 2023 equity impacts, but fails to correctly synthesize the evolution from initial accounting to ongoing operational effects as required by the question. The mention of a future 57% stake in 2024 is irrelevant and distracts from the 2022–2023 focus. (4) The contextual relevance is high because the answer addresses noncontrolling interest, equity impacts, and acquisition-related expenses, but factual inaccuracies and missing core metrics (especially the $572M SG&A increase and gross margin impact) severely undermine correctness. Quantitative accuracy is moderate due to some correct numbers but major unsupported additions. Qualitative reasoning is flawed in drawing incorrect conclusions about expense recognition and operational impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 563,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 6.22 % Debentures due 2027 were mentioned only in the exhibit index – “Exhibit 3 to Form 8‑K (August 1 1997) – the instrument defining the rights of the holders of the 6.22 % Debentures due 2027” – and were not listed among the company’s outstanding securities. By contrast, the 2023 filing places the same issue directly in the “Securities registered pursuant to Section 12(b)” table, identifying it as “6.22 % Debentures due 2027 (IBM 27) – New York Stock Exchange,” thereby giving an explicit, tabular disclosure of the debenture. This evolution reflects a shift from a mere reference in the exhibit list to a full, stand‑alone registration‑statement disclosure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key details are correct: the 2022 filing referenced the 6.22% Debentures due 2027 only in the exhibit index via Exhibit 3 to Form 8-K filed on August 1, 1997, and did not list it among outstanding securities; in 2023, IBM included the debenture in the 'Securities registered pursuant to Section 12(b)' table with its trading symbol 'IBM 27' and exchange (New York Stock Exchange). (2) Quantitative elements—interest rate (6.22%), maturity year (2027), exhibit number (3), form type (8-K), and filing date (August 1, 1997)—are all accurately reported. (3) The multi-hop reasoning is sound: the model correctly contrasts the nature of disclosure across two years, identifying a shift from a passive, historical reference to an active, structured, and market-transparent presentation. (4) The answer fully addresses the evolution in treatment and disclosure, capturing both the structural change in reporting and its implications for transparency. Wording differs slightly but meaning and factual content align perfectly with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 321,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "\nFrom 2023 to 2024 UnitedHealth deepened its reliance on risk‑based and fully‑accountable value‑based contracts—premium revenue from these arrangements now accounts for roughly 80 % of total consolidated revenue (2024 10‑K, p. 16) and the Company explicitly notes that “the profitability of our products depends in large part on our ability to predict and effectively price for and manage medical costs” (2024 10‑K, p. 16).  This shift means the Company must continually refine its actuarial estimates of incurred‑but‑not‑reported medical costs and completion‑factor adjustments, so even small gaps between projected and actual costs can materially affect earnings, while also expanding its service‑delivery duties to include ongoing coordination of provider networks, claim processing and the assumption of both medical and administrative cost risk for enrollees.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increasing exposure of UnitedHealth Group to risk-based arrangements and links it to cost estimation and service delivery responsibilities, aligning with the core theme of the original answer. However, the key quantitative claim that 'premium revenue from these arrangements now accounts for roughly 80% of total consolidated revenue' is not present in the ground truth and cannot be verified from the provided original answer. This introduces a significant factual uncertainty, as no percentage was mentioned in the ground truth for either 2023 or 2024. (2) While the LLM cites a specific figure (80%) and references the 2024 10-K, this data point is absent from the original answer derived from the knowledge graph, making it potentially inaccurate or at least unsupported by the given truth. The original answer emphasizes qualitative shifts—such as increased responsibility for unpaid claims and provider solvency risks—rather than quantifying revenue share. (3) The reasoning is sound in connecting deeper involvement in risk-based contracts to greater cost estimation challenges and expanded service duties, which reflects accurate multi-hop synthesis between financial risk, actuarial estimation, and operational responsibilities. The mention of incurred-but-not-reported (IBNR) costs and completion factors adds technical depth consistent with UnitedHealth’s disclosures. (4) Despite the unsupported percentage, the LLM captures the evolving nature of risk exposure and its implications on cost prediction and service coordination. It misses the specific 2024 escalation in liability for provider failures and data dependency highlighted in the original, but generally conveys a similar trajectory. Hence, the correctness score is 7—core facts and implications are correct, but a major unsourced quantitative claim reduces confidence. Quantitative accuracy is penalized more heavily (6) due to the unverified 80% figure, while qualitative and contextual accuracy remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 548,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "\nBetween 2022 and 2023 Emerson’s stake in AspenTech grew from a modest sales line ($40 M in 2020 → $362 M in 2022) to a ≈55 % equity ownership after it contributed two of its own software businesses, a clear jump in investment magnitude.  In 2023 the partnership deepened further: AspenTech’s earnings turned positive, Emerson began recording intangible amortization tied to the Heritage AspenTech acquisition, and it recognized mark‑to‑market gains (and later hedging activity) on its equity investment, indicating a more strategic, financially‑active relationship.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions. While it correctly identifies the $362 million investment in 2022, it incorrectly frames this as a 'sales line' growing from $40M in 2020, which is not supported by the ground truth and introduces false data. The 55% ownership stake in 2023 is correctly mentioned, but the description of Emerson contributing 'two of its own software businesses' is inaccurate — the ground truth specifies only the Industrial Software Business was contributed, not two. Additionally, the $6.0 billion cash contribution is entirely omitted, a major quantitative error given the scale of the transaction. The mention of AspenTech’s earnings turning positive and Emerson recording mark-to-market gains and hedging activity is not present in the original answer and may be speculative or extraneous. (2) Key numbers like $362M (2022 investment) and 55% ownership are correct, but the omission of the $6.0 billion cash contribution and the incorrect characterization of prior-year figures (e.g., $40M in 2020) significantly reduce quantitative accuracy. The format variation allowance does not apply here because the missing $6B figure is a critical component of the investment magnitude. (3) The reasoning partially captures the evolution from financial to strategic involvement but misrepresents the nature and scale of the transaction. The multi-hop synthesis is weak — it fails to connect Emerson’s cash and business contribution to the creation of 'New AspenTech' and the resulting control shift. The introduction of unverified financial activities (hedging, intangible amortization) distracts from the core strategic shift. (4) Despite inaccuracies, the answer remains contextually relevant by addressing the evolution of the relationship, investment magnitude, and strategic involvement. It attempts to show progression and increased involvement, aligning with the question’s intent, though with flawed support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 531,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 Adobe reframed Target from a standalone “AI‑ and machine‑learning‑driven personalization engine” that tests and optimizes content across channels (as described in the 2022 Experience Cloud overview) into a core, AI‑first capability tightly integrated with the Adobe Experience Platform and enriched with generative‑AI features (e.g., Firefly/GenAI) that enable real‑time, hyper‑personalized journeys across all touchpoints (see the 2023 “Customer Journeys” and “Marketing Planning & Workflow” sections). This evolution signals Adobe’s strategic pivot toward embedding advanced AI and generative‑AI into personalization, making AI‑driven one‑to‑one experiences a central growth driver of its Experience Cloud portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Adobe Target's description in fiscal 2022. The original answer states that in 2022, Adobe Target was part of a broader set of customer journey solutions and characterized as a tool for testing, targeting, and personalizing content — but it was not described as an 'AI- and machine learning-driven personalization engine' in 2022, as the LLM incorrectly claims. That characterization emerged in 2023. The LLM reverses the evolution: it falsely attributes the advanced AI framing to 2022 and then claims Adobe 'reframed' it in 2023, which contradicts the ground truth showing an elevation in 2023. Additionally, the LLM introduces unsupported details such as integration with Firefly/GenAI and 'generative-AI features', which are not mentioned in the original answer and represent speculative enhancements not present in the knowledge graph. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable — no errors here, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution over time, misrepresenting the 2022 state and overstating the 2023 capabilities with unverified AI integrations. The core task — tracing the change in Adobe Target’s role and inferring strategic direction — is undermined by incorrect temporal attribution. (4) Despite these errors, the answer is contextually relevant and addresses the question’s intent, correctly concluding that Adobe is moving toward AI-driven personalization as a strategic priority. However, this conclusion is supported by incorrect premises, reducing qualitative accuracy. The contextual relevance remains high because the response engages directly with the evolution and strategic implications, even if factually flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 508,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "\nAfter closing the Heritage AspenTech acquisition in Q3 2022, Emerson converted every outstanding Heritage AspenTech option and restricted‑stock unit into an equivalent AspenTech award and began reporting those awards as part of its own stock‑based‑compensation expense.  In fiscal 2023 the company recorded $82 million of stock‑based‑compensation expense attributable to AspenTech (up from $32 million in 2022), issued new performance‑share and RSU grants that vest over three‑ to four‑year periods, and continued to manage AspenTech’s revolving credit facility and related debt while the converted awards remained outstanding and subject to the same terms as the originals.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key aspects of Emerson's evolving relationship with AspenTech from 2022 to 2023, including the post-acquisition integration of stock-based compensation plans and ongoing management of debt. However, there are significant quantitative discrepancies. The original answer states that Emerson reported an $8,326 million balance related to AspenTech in 2022 as part of its acquisitions, which reflects the financial stake. The LLM answer omits this critical figure entirely and instead introduces a $82 million stock-based compensation expense in 2023 (vs $32 million in 2022), which is not mentioned in the ground truth. These numbers may be factually correct in context but are absent from the provided ground truth, making them unverifiable and potentially misleading as standalone figures without the larger acquisition cost context. (2) The LLM mentions 'fiscal 2023' and 'Q3 2022' which aligns reasonably with the timeline in the original answer, though the original does not specify quarters. The compensation expense increase from $32M to $82M is precise but not corroborated by the ground truth, which focuses on structural integration rather than expense amounts. (3) The qualitative reasoning is strong: the LLM correctly infers that converting equity awards and managing debt indicates operational integration beyond a passive financial stake. It accurately describes the continuation of AspenTech’s equity plans under Emerson’s umbrella and the issuance of new performance-based grants, which aligns with the original’s point about incentive-driven management. (4) Contextual relevance is high—the response directly addresses both financial stake evolution and integration activities. However, the omission of the $8,326 million acquisition balance, a central indicator of Emerson’s initial financial stake, significantly weakens completeness and quantitative accuracy. While the LLM adds granular detail on compensation expenses, it fails to anchor the response in the primary financial magnitude of the stake, leading to a partially correct but imbalanced picture. Thus, the correctness score is 7: core integration activities are well-described, but key financial facts are missing or substituted with unverified figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 609,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "\nFrom 2022 to 2023 Adobe Experience Platform shifted from being a data‑unification layer that powered AI‑driven insights and audience segmentation to the central engine of Adobe’s end‑to‑end customer‑journey orchestration.  In the 2023 filing the platform is highlighted as the backbone for **Journey Optimizer** and tightly‑integrated AI services such as **Sensei GenAI**, which enable real‑time, cross‑channel campaign personalization and automated decision‑making across Adobe Experience Cloud apps (Marketo Engage, Campaign, Target, etc.).  This evolution reflects a deeper, native integration of AI‑powered analytics and orchestration tools that allow brands to design, execute and measure holistic, multi‑touch journeys within a single, open Experience Platform ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe Experience Platform from 2022 to 2023. It correctly identifies the shift from a data unification and AI-enhanced insights layer (2022) to a central engine for cross-channel orchestration (2023), aligning with the ground truth. The mention of Journey Optimizer as a key app leveraging the platform in 2023 is correct and contextually appropriate. The integration with AI tools like Adobe Sensei is accurately reflected, though the LLM specifies 'Sensei GenAI'—a more specific generative AI component—not explicitly named in the original answer, which refers more broadly to Adobe Sensei-powered services (e.g., automated insights, anomaly detection, Mix Modeler). This is a minor over-specificity but does not constitute a factual error, as Sensei GenAI could be part of the broader Sensei framework. The reference to integration with Marketo Engage, Campaign, and Target is contextually sound and reflects plausible cross-app orchestration, even if not explicitly stated in the ground truth. The original answer highlights Adobe Mix Modeler as a new 2023 feature leveraging the platform for marketing investment optimization, which the LLM omits. This is a minor omission affecting completeness but not the overall correctness of the main evolution narrative. All dates (2022 to 2023) and entity names (Adobe Experience Platform, Adobe Sensei, Journey Optimizer) are accurate. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound, demonstrating multi-hop synthesis between years and functionalities. The answer is semantically equivalent to the original in intent and key facts, with only slight differences in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 476,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "\nUnitedHealth Group deepened its shift toward fully‑accountable, value‑based care—expanding integrated in‑clinic, in‑home and virtual services and using data‑analytics to coordinate high‑quality, affordable care (as described in the 2023 “Delivery System and Payment Modernization” and “fully accountable value‑based plans” sections).  In response to CMS benchmark cuts and risk‑adjustment revisions that tightened Medicare Advantage funding, the company intensified medical‑cost and operating‑cost management, reshaped network composition and benefit designs and raised member premiums, while continuing to invest in coordinated‑care infrastructure to offset the funding pressure (2024 discussion of “intensify medical and operating cost management,” “adjust member benefits and premiums,” and “accelerate the transition from fee‑for‑service to fully accountable models”).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies UnitedHealth Group's 2023 focus on value-based care, integrated delivery models (in-home, virtual, in-clinic), and investment in care coordination technology—consistent with the original answer. In 2024, it accurately reflects the shift due to Medicare Advantage funding pressures, citing CMS benchmark cuts and risk-adjustment changes, and describes appropriate operational responses: network adjustments, benefit redesign, premium increases, and intensified cost management. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model connects UnitedHealth’s strategic direction in 2023 to external policy changes in 2024 and synthesizes the resulting shift from expansion to cost containment. The only minor gap is that the LLM mentions 'raising member premiums'—a detail not explicitly in the ground truth—though this is a reasonable inference from 'adjust member benefits and premiums' in the 2024 filing. This does not constitute a factual error but adds a slight interpretive layer. (4) Contextual relevance is perfect: the answer directly addresses the evolution of care delivery models in response to Medicare Advantage funding pressures across both years. Overall, the answer is factually correct, well-synthesized, and semantically equivalent to the original, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 427,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "\nBetween 2022 and 2023 Thermo Fisher reshuffled its long‑term debt: the older senior unsecured tranches that appeared in the 2022 filing (e.g., the 0.750 % Notes due 2024 and the 2.000 % Notes due 2025) were retired or refinanced, and the newly issued 1.950 % Notes due 2029—first issued in late 2022—remained outstanding and now form a core component of the 2023 debt profile. Consequently, the composition of the company’s debt shifted toward the 2029 maturity, with the 1.950 % Notes representing a larger share of the outstanding senior unsecured portfolio after the earlier notes were removed.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly states that the 1.950% Notes due 2029 were 'newly issued' and 'first issued in late 2022', implying they were not present in 2022. However, the ground truth confirms these notes were already outstanding in 2022 with the trading symbol TMO 29, so they were not new in 2023. (2) The LLM claims older notes like the 0.750% Notes due 2024 and 2.000% Notes due 2025 were retired or refinanced between 2022 and 2023, but the original answer does not mention these instruments or their retirement, making this unsupported and potentially incorrect. (3) The ground truth highlights the introduction of *new* debt instruments in 2023: the 3.200% Notes due 2026 and 3.650% Notes due 2034—information entirely missing from the LLM response. (4) The LLM incorrectly frames the 1.950% Notes due 2029 as a 'new' or 'reshuffled' component, when the original answer emphasizes their *continuity* between years. While the LLM correctly identifies the 1.950% rate and 2029 maturity, its reasoning about the evolution of the debt composition is fundamentally flawed. The answer misrepresents the timeline and nature of the debt instruments, fails to mention key new issuances in 2023, and incorrectly infers retirements. Quantitative accuracy is low due to incorrect dates and maturities implied by context. Qualitative accuracy suffers from incorrect synthesis and unsupported claims. Contextual relevance is moderate as it addresses debt composition and the 2029 notes, but with wrong details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 433,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "\nBetween 2022 and 2023 Thermo Fisher reshaped its senior unsecured debt by retiring several of the shorter‑dated, higher‑coupon series that appeared in the 2022 table (e.g., the 0.750 % Notes due 2024 and the 0.125 % Notes due 2025) and replacing them with a new, lower‑coupon tranche – the 0.500 % Notes due 2028 – together with a suite of newly issued series (1.375 % due 2028, 1.950 % due 2029, 0.875 % due 2031, 2.375 % due 2032, 3.650 % due 2034, 2.875 % due 2037, 1.500 % due 2039 and 1.875 % due 2049).  Consequently, the 2023 debt composition is more heavily weighted toward longer‑dated, lower‑cost notes, with the 0.500 % 2028 issue representing a distinct new category of financing that was not present in the 2022 lineup.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding the 0.500% Notes due 2028. According to the ground truth, these notes were already present in 2022, but the LLM incorrectly states they were 'a distinct new category of financing that was not present in the 2022 lineup,' implying their introduction in 2023. This misrepresents the evolution of the debt composition. Additionally, the LLM invents several note series (e.g., 1.950% due 2029, 0.875% due 2031, 2.375% due 2032, 2.875% due 2037, 1.500% due 2039, 1.875% due 2049) that are not mentioned in the original answer, which only specifies the introduction of the 3.200% Notes due 2026 and 3.650% Notes due 2034 in 2023. While the LLM correctly identifies the 1.375% Notes due 2028 as being present in both years, it adds unsupported details. The strategic interpretation about shifting to longer-dated, lower-cost notes is plausible but not fully supported by the ground truth, which emphasizes diversification with new interest rate structures and maturities. The answer is contextually relevant and attempts multi-hop reasoning, but the quantitative inaccuracies and fabrication of debt instruments severely undermine factual correctness. Minor formatting variations in percentages (e.g., 0.500% vs 0.5%) are acceptable, but the core error lies in the misattribution of the 0.500% Notes' introduction year and the inclusion of non-existent notes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 394,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "\nThe 2023 goodwill‑impairment testing showed an excess of fair value over carrying value of roughly **140 % to 495 %** (or **115 %–435 %** after the company’s 10 % sensitivity test). In the 2024 analysis that excess narrowed to about **70 %–450 %** (or **55 %–395 %** on the same 10 % sensitivity scenario), indicating a clear contraction of the excess margin across both the low‑ and high‑end of the range.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the key percentages for 2023 (140%–495%) and 2024 (70%–450%) are correct and match the original answer exactly. The LLM adds sensitivity test figures (115%–435% in 2023 and 55%–395% in 2024), which are not in the ground truth but are plausible and contextually relevant, likely derived from a 10% adverse assumption as commonly disclosed in 10-Ks. These additions do not contradict the original answer but provide extra detail. (2) The comparison between years correctly identifies a narrowing of the range, especially at the lower end, indicating reduced cushion before impairment—this aligns with the original conclusion. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across two years and interprets the trend appropriately. (4) All entities (DHR, reporting units, goodwill impairment analyses) and years (2023 vs 2024) are accurate. The only reason for not scoring a 10 is that the sensitivity figures, while reasonable, are not present in the ground truth and could be seen as overreach if not explicitly asked for. However, they do not detract from correctness. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 359,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "\nUnder the 2022 Employee Stock Plan, both canceled RSUs and shares withheld to meet tax‑withholding obligations are returned to the share reserve at a 2‑for‑1 ratio (i.e., each canceled RSU or each withheld share adds two shares to the available pool). In 2022 the company recorded roughly 14.7 million canceled RSUs and about 41 million withheld shares, which together contributed roughly 70 million shares to the pool, whereas in 2023 those figures fell to about 8.1 million canceled RSUs and 37 million withheld shares, adding only roughly 33 million shares—so the boost to the pool was more than halved even though the treatment remained the same.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the treatment of canceled RSUs and tax-withheld shares from 2022 to 2023. According to the ground truth, the key change was that in 2023, the '2-for-1' return mechanism (where canceled RSUs or withheld shares replenished the share pool at double the number) was explicitly removed from the plan language. However, the LLM incorrectly states that the 'treatment remained the same' in 2023, which directly contradicts the original answer. This is a critical factual error in both reasoning and entity accuracy. Additionally, the LLM introduces specific quantitative figures (e.g., 14.7 million canceled RSUs in 2022, 41 million withheld shares, 70 million shares added) that are not present in the ground truth and cannot be verified. These numbers appear fabricated or hallucinated, severely undermining quantitative accuracy. While the answer is contextually relevant—focusing on the right topic and attempting to compare 2022 and 2023—it fails on correctness due to the erroneous conclusion that the treatment did not change. The multi-hop reasoning is flawed because it misinterprets the evolution of the plan terms. The ground truth emphasizes a structural change in the plan’s language, while the LLM assumes continuity and attributes differences to volume changes alone. Thus, despite some surface-level plausibility, the answer is factually and logically unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 394,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "\nBetween 2023 and 2024 Danaher’s stake in Aldevron has not changed – it remains a wholly‑owned subsidiary. The 2023 10‑K (pages 73‑74) records the full $6.1 bn goodwill and $3.5 bn of acquired intangibles from the 2021 purchase, and the 2024 filing (pages 6‑7) still lists Aldevron as part of the Life Sciences segment with no new equity investment or divestiture disclosed, confirming that Aldevron is fully integrated into Danaher’s Life Sciences business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Danaher's stake in Aldevron 'has not changed' and that it was a 'wholly-owned subsidiary' throughout, but the ground truth indicates a strategic evolution from a separately accounted financial stake in 2023 (with $9,561 million in net cash consideration) to full integration into the Life Sciences segment in 2024. The LLM incorrectly states the acquisition was in 2021, while the $9.561 billion consideration implies a more recent major transaction. (2) Quantitative accuracy is poor: the LLM cites $6.1 billion in goodwill and $3.5 billion in intangibles, which do not match the $9,561 million net cash consideration in the ground truth. These figures are materially different and not reconcilable without additional context. The use of 'billion' vs 'million' is a critical error. (3) The reasoning is partially sound in noting Aldevron's presence in the Life Sciences segment in both years, but it fails to recognize the multi-hop nuance: the shift from a standalone stake to integration. The model misses the strategic evolution entirely, misinterpreting continued segment inclusion as 'no change'. (4) Contextual relevance is fair—the answer addresses financial stake and segment integration as asked—but due to factual and quantitative errors, the overall correctness is low. The model appears to confuse details from different acquisitions (possibly mixing Aldevron with IDT or others).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 407,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Microsoft deepened AI integration in Microsoft 365 by embedding Copilot (including role‑specific Copilot for Sales, Service and Finance and the Copilot Studio customization tool) directly into the Microsoft 365 suite and by making its usage a measurable part of the commercial‑cloud metrics—Office 365 Commercial revenue growth and Microsoft 365 Consumer subscriber counts now explicitly include Copilot‑related subscriptions. This positioning has turned AI‑enhanced productivity into a clear driver of Microsoft Cloud revenue (up 23 % YoY to $137.4 B) and a key contributor to the double‑digit growth reported in Office Commercial and Microsoft 365 commercial metrics.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased AI integration in Microsoft 365 between 2023 and 2024, particularly through Copilot's embedding into the suite and its role in commercial metrics. It accurately reflects the strategic emphasis on AI as a driver of productivity and cloud revenue. However, it introduces specific quantitative claims not present in the ground truth, such as 'Microsoft Cloud revenue (up 23% YoY to $137.4B)', which are unsupported by the original answer and cannot be verified from the provided context. These figures may be factually accurate in reality but are not part of the knowledge graph's ground truth, making them hallucinated in this evaluation context. (2) The original answer does not include any revenue figures, growth percentages, or dollar amounts. Therefore, the inclusion of '23% YoY' and '$137.4B' fails the quantitative accuracy test. Even though such metrics might exist in public filings, they were not part of the verified knowledge graph output, so their inclusion constitutes a factual overreach. (3) On qualitative reasoning, the LLM correctly synthesizes the evolution of Microsoft 365’s strategy around AI and its incorporation into commercial metrics, including the expansion of what counts in subscriber and revenue tracking (e.g., including Copilot-related subscriptions). It captures the multi-hop element—linking AI integration (Copilot) to product evolution and then to business metrics—though it overreaches by adding unverified financial performance data. The mention of role-specific Copilots and Copilot Studio adds detail beyond the ground truth but is plausible and contextually consistent. (4) The contextual relevance is high because the response directly addresses the evolution of Microsoft 365’s strategic positioning with respect to AI and commercial metrics. The core narrative aligns with the original answer, but the addition of unsupported numbers reduces correctness significantly. A score of 6 reflects that the central strategic shift is well-articulated, but the inclusion of unverified quantitative claims undermines factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 573,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Microsoft deepened Copilot Pro’s integration with the Microsoft 365 ecosystem, moving it from a newly‑introduced consumer subscription that simply offered faster, more powerful AI assistance in Word, Excel, PowerPoint and on the web, to a core productivity layer that is now embedded across the suite, supported by role‑specific extensions (e.g., Copilot for Sales, Service, Finance) and a self‑service Copilot Studio for customization.  At the same time, its web‑based AI assistance was broadened through tighter Bing‑Copilot integration and Edge‑level AI tools, positioning Copilot Pro as the primary personal‑AI assistant for both everyday users and enterprise workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Copilot Pro was introduced in 2023 as a consumer subscription offering faster and more powerful AI assistance in Microsoft 365 apps and on the web, which matches the original answer. The evolution into 2024 is accurately portrayed as deeper integration into Microsoft 365, with an expanded role across enterprise workflows and customization via Copilot Studio. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes the progression from a standalone service to a core productivity layer, correctly inferring broader ecosystem integration and enterprise extensions (e.g., Copilot for Sales, Service, Finance), which, while not explicitly stated in the ground truth, are reasonable and contextually supported elaborations consistent with Microsoft's public AI strategy. (4) The LLM adds value by specifying integration points (Word, Excel, PowerPoint, Bing, Edge) and introducing Copilot Studio and role-specific versions, which enhance completeness without contradicting the original. The only minor deviation is a slightly stronger claim about 'core productivity layer' and specific product extensions not explicitly confirmed in the ground truth, but these are plausible and do not undermine factual correctness. Overall, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 428,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the pool of shares left for future grants under the 2007 Omnibus Incentive Plan fell from **about 50 million shares** (as reported for 2023) to **about 47 million shares** (as reported for 2024).  This roughly 3‑million‑share reduction reflects the issuance of new stock‑based awards (options, RSUs and PSUs) and the separation‑related adjustments, but a substantial reserve remains available for future issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that no specific figure was provided for the remaining shares available under the 2007 Omnibus Incentive Plan in 2023. However, the LLM claims there were 'about 50 million shares' available as of 2023, which is not supported by the ground truth. This is a major quantitative error. The 2024 figure of approximately 47 million shares is correct per the original answer. (2) The calculation of a 3-million-share reduction is based on the fabricated 2023 number and is therefore invalid. The ground truth does not support any specific reduction amount because no 2023 share count was disclosed. (3) The reasoning is flawed in that it assumes comparable disclosures between 2023 and 2024, when the original answer emphasizes a shift in transparency—only 2024 provided a specific number. The LLM incorrectly implies both years had quantified disclosures, failing to capture the evolution in disclosure practices. (4) While the LLM correctly identifies the plan name and that share issuance occurred (via RSUs, PSUs, etc.), and remains focused on the topic, the invention of a precise 2023 figure undermines the core factual basis. The contextual relevance is fair because it addresses the question's intent, but correctness is low due to the unsupported numerical claim. Thus, correctness and quantitative accuracy are heavily penalized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 396,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "\nMicrosoft extended the estimated useful life of its server and network equipment from **four to six years**, a change that took effect at the beginning of fiscal 2023 and remained in place through fiscal 2024. The revision was driven by greater software‑enabled efficiencies in operating that hardware and advances in technology that lengthened the equipment’s functional lifespan. No further alteration to the policy was reported for FY 2024; the six‑year estimate simply continued to be applied.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Microsoft changed the estimated useful life of server and network equipment from four to six years, effective at the beginning of fiscal year 2023, and that the policy remained unchanged in fiscal year 2024—matching the original answer exactly in key facts. (2) All quantitative elements (years: 4 → 6, fiscal years 2023 and 2024) are correct with no calculation errors. (3) The reasoning for the change—software-enabled efficiencies and technological advances—is correctly identified and aligns with the multi-hop synthesis required; the sustained policy in 2024 is also properly noted. (4) The answer addresses both parts of the question: the evolution (change in 2023, stability in 2024) and the influencing factors. Wording differs slightly but conveys identical meaning. No omissions or inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 281,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "\nMDT’s auction‑rate securities held a fair‑value of **$33 million** at the end of fiscal 2022 (April 29, 2022) and remained at **$33 million** at the end of fiscal 2023 (April 28, 2023).  In both years the securities were reported in **“Other Assets”** (non‑current) on the balance sheet and were classified as **Level 3** in the fair‑value hierarchy, indicating that the exposure and its accounting classification were unchanged between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the fair value of auction rate securities as $33 million in both 2022 and 2023, which matches the ground truth. However, it incorrectly states that the securities were classified under 'Other Assets' in both years. According to the original answer, in 2022 they were included in 'Total' within the investment portfolio without a separate classification, and only in 2023 were they explicitly moved to 'Other Assets'. This is a critical factual error in classification evolution. (2) Quantitative accuracy is perfect: the dollar amounts and fiscal years (April 29, 2022 and April 28, 2023) are correctly cited. (3) The multi-hop reasoning is flawed because the model fails to recognize the change in balance sheet classification over time, instead asserting no change. This contradicts the core insight of the ground truth — that there was a shift in reporting. The LLM also introduces unverified details (e.g., 'non-current', 'Level 3') not present in the original answer, which risks hallucination. (4) While the numbers are correct and the response is relevant to the question, the qualitative inaccuracy in describing the classification change severely undermines the correctness. The conclusion that 'exposure and accounting classification were unchanged' is directly contradicted by the ground truth, which emphasizes a shift in classification. Hence, the correctness score is low despite accurate numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 402,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "\nThe company recorded a **$67 million net loss** on its available‑for‑sale debt investments in fiscal 2024, compared with a **$21 million loss** in fiscal 2023 – an increase of roughly **$46 million** in the negative direction. This widening loss reflects weaker investment performance, driven by adverse market conditions such as rising interest rates that depressed the fair value of the debt portfolio, indicating that the company’s short‑term investment returns were negative and underperformed relative to the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net losses for both fiscal years: $21 million in 2023 and $67 million in 2024, matching the ground truth exactly. The increase in loss is calculated as $46 million ($67M - $21M), which is accurate. (2) All numeric values and the calculation of the difference are correct. Format variations (e.g., $67 million) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound—comparing two fiscal years' investment performance and drawing a conclusion about worsening performance is valid. The LLM adds contextual explanation (e.g., rising interest rates) that, while not in the original answer, is plausible and does not contradict the ground truth. However, this added detail is speculative and not verifiable from the provided ground truth, slightly reducing qualitative accuracy. (4) The answer fully addresses both parts of the question: the change in net gains/losses and what it indicates about performance. The conclusion aligns semantically with the original answer’s claim of 'significant worsening.' Thus, the answer is factually correct, complete, and relevant, warranting a high score with only a minor deduction in qualitative accuracy due to unverified explanatory content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 351,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Cisco stopped presenting APJC as a stand‑alone operating unit and began folding its activities into the company‑wide geographic‑segment structure, while directing substantially more cash into the region – e.g., a $25.9 bn acquisition outlay and higher property‑plant‑equipment spend (up from $670 m to $849 m in 2024) that is focused on cloud, software and lease‑based offerings rather than pure hardware roll‑outs.  This re‑allocation of financial resources reflects a shift from a channel‑partner‑driven product‑sale model to a recurring‑revenue model built on software‑as‑a‑service, subscriptions and lease financing, so revenue in APJC is now generated largely through higher‑margin, recurring streams that are recognized over time rather than at the point of hardware shipment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents both the operational and financial aspects of Cisco's approach to the APJC region between 2023 and 2024. (1) Quantitatively, the claimed $25.9 billion acquisition outlay and increases in property, plant, and equipment (PPE) from $670M to $849M are not supported by the ground truth and appear fabricated; the original answer does not mention any specific capital expenditures or acquisitions related to APJC. (2) The claim that Cisco 'stopped presenting APJC as a stand-alone operating unit' contradicts the ground truth, which states that in 2023, APJC *was* one of three geographic segments—implying direct operational presence—and while the 2024 shift involves financial investments, there is no indication that APJC was folded into a broader structure. (3) The qualitative shift described—toward SaaS, subscriptions, and lease financing—is speculative and not mentioned in the original answer; the ground truth focuses on a dual strategy of operational delivery plus new financial investments (marketable/non-marketable equity and equity method investments), not a business model pivot to recurring revenue. (4) The LLM fails the multi-hop reasoning test: it conflates structural changes, capital allocation, and revenue model evolution with data not present in the source, while missing the actual evolution—operational presence in 2023 to added financial investment in 2024. (5) Contextually, the answer addresses the region and revenue model implications, so it remains relevant, but the factual foundation is unsound. Minor credit is given for addressing the question’s general theme of structural and financial evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 462,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "\nBetween 2022 and 2024 Apple has softened the rigid 30 % App Store commission it once enforced, introducing a 15 % “Small Business” rate and permitting alternative payment and distribution options in response to antitrust lawsuits, the U.S. Epic‑Games case and the EU’s Digital Markets Act.  These adjustments—along with new rules for external purchase links in the United States and revised fee structures for iOS/iPadOS apps in the EU—reflect a shift from a single‑rate, closed‑platform model to a more flexible, regulator‑driven approach aimed at preserving the Store’s revenue while addressing legal and market pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Apple's shift in App Store commission policy between 2022 and 2024, noting the 15% Small Business Program rate (introduced earlier but still relevant), and acknowledges regulatory pressures including the EU's Digital Markets Act and the U.S. Epic Games lawsuit. While the ground truth emphasizes Apple's 2022 risk disclosure and 2024 concrete actions, the LLM captures this evolution effectively. (2) Quantitatively, the 30% and 15% commission rates are correct; no specific dollar amounts or erroneous calculations are present. The answer does not specify exact implementation dates (e.g., 2024 changes), but correctly associates the timeline with regulatory responses. (3) The reasoning is sound: it synthesizes Apple’s response across legal and market pressures, identifies key jurisdictions (U.S. and EU), and links changes like alternative payment systems and external links to regulatory compliance. The mention of new developer rules in the EU and U.S. aligns with the ground truth’s reference to new business terms, APIs, and distribution methods. (4) The answer is contextually excellent—directly addressing the evolution of Apple’s approach, the drivers (legal and market), and the impact on commission structure. The only minor shortcoming is that it doesn’t explicitly note Apple’s 2022 forward-looking risk statement about potential revenue impact, which the original answer highlights as a key evolution point. However, the overall semantic meaning and factual content are substantially equivalent. Thus, a high score is warranted, with a small deduction for slight incompleteness in the temporal framing of Apple’s acknowledgment versus action.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 476,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "\nBetween 2022 and 2024 the U.S. Retiree Health Care plan moved its actual holdings toward a higher‑fixed‑income, lower‑equity mix.  Where the plan was invested roughly 65 % in fixed‑income and 35 % in equity in the 2020‑21 period, by the end of 2024 it held about 80 % fixed‑income securities and cash equivalents and only 20 % equity, reflecting a deliberate shift to the upper end of the 65‑80 % fixed‑income target range and a corresponding reduction in equity exposure from the 20‑35 % target band.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in allocation strategy toward more fixed income and less equity by 2024, with accurate 80% fixed income and 20% equity figures. However, it introduces data not present in the ground truth—specifically, a '65% fixed income, 35% equity' mix for a '2020-21 period'—which is not mentioned or supported in the original answer. The ground truth provides actual dollar amounts for 2022 ($248M fixed income and cash equivalents, $137M in equities), which equate to approximately 64.4% fixed income and 35.6% equity, so the 65/35 split is a reasonable approximation. But since the original answer does not reference 2020–2021 or a target range of 65–80%, these details are speculative additions. (2) The quantitative accuracy is partially compromised because the LLM does not reference the actual 2022 dollar values from the ground truth and instead invents an earlier time frame. While the 80/20 split for 2024 matches the original, the lack of mention of 2023 stability (that proportions remained the same between 2023 and 2024) is a minor omission. (3) The multi-hop reasoning is generally sound—the model infers a strategic shift toward conservatism and capital preservation from the increasing fixed income allocation. However, it adds unverified details about target ranges (65–80% and 20–35%) not present in the original, weakening the factual basis. (4) Despite these issues, the core conclusion—a strategic shift to a more conservative allocation by 2024 with 80% in fixed income and 20% in equities—is factually aligned with the ground truth. The answer is contextually relevant and captures the essence of the evolution, but the inclusion of unsupported timeframes and target bands reduces quantitative and qualitative accuracy. Correctness score is 7 due to accurate key percentages in 2024 and correct directional shift, but docked for introducing unverified data and omitting the 2022 dollar figures and 2023 stability note.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 536,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "\nBetween 2022 and 2024 the Embedded Processing segment’s revenue slipped from $3.26 bn to $2.53 bn and its operating profit fell from $1.25 bn to $0.35 bn, reflecting a strategic pull‑back from aggressive growth toward a more mature, cash‑generating role.  Nevertheless, Embedded Processing remains a distinct reportable segment that underpins TI’s four‑point competitive advantage—providing a broad, diversified portfolio that reinforces supply‑chain control, product breadth and market reach—though its share of total revenue and profit has declined, signalling a reduced strategic emphasis relative to the Analog business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that Embedded Processing was not a reportable segment in 2022 but became one in 2024, reflecting a strategic elevation. However, the LLM claims specific revenue and profit figures for Embedded Processing in both 2022 and 2024 ($3.26B to $2.53B revenue, $1.25B to $0.35B operating profit), which contradicts the ground truth—no such segment reporting existed in 2022 because it was not yet a standalone segment. These numbers are entirely fabricated or misattributed. (2) Quantitative accuracy is severely lacking: the dollar amounts, revenue decline, and especially the operating profit drop from $1.25B to $0.35B are not supported by the ground truth and appear incorrect. There is no mention of actual financials in the original answer, so introducing them here is a critical error. (3) The reasoning is flawed: the LLM concludes a 'strategic pull-back' and 'reduced strategic emphasis' based on declining financials, while the ground truth indicates the opposite—a strategic elevation by making Embedded Processing a reportable segment in 2024. This misinterprets the company's intent and direction. The multi-hop synthesis fails: the model does not recognize that the structural change (becoming a reportable segment) signifies increased importance, not decreased. (4) Contextual relevance is moderate because the answer discusses competitive advantages and segment structure, which are relevant topics, but the incorrect data and reversed conclusion undermine the entire response. The mention of TI’s four competitive advantages aligns with the original, but it is applied to false premises. Overall, the answer is mostly incorrect due to fabricated numbers and inverted strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 486,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "\nThermo Fisher issued a €‑denominated 2.00% 10‑Year Senior Note in 2022 (effective interest rate ≈ 2.07%).  The note’s carrying value slipped from $706 million at Dec 31 2023 to $663 million at Dec 31 2024, as the discount was amortized and the security approached its 2025 maturity, while the effective rate stayed close to the 2.00% coupon.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth on multiple critical dimensions. (1) Quantitatively, the LLM states that Thermo Fisher (TMO) issued a €-denominated 2.00% 10-Year Senior Note in 2022 with an effective interest rate of ~2.07%, but the ground truth specifies a $1,200 million USD-denominated note with an effective rate of 2.23%. The LLM also reports a carrying value decline from $706 million to $663 million between 2023 and 2024, which contradicts the ground truth showing no change in principal ($1,200 million) and no amortization toward maturity in 2025—this note matures in 2031, not 2025. (2) The answer is incomplete and misrepresents the evolution between 2022 and 2024: the ground truth confirms stability in both principal and effective interest rate, while the LLM incorrectly implies amortization and a near-term maturity. (3) Entity accuracy issues include referencing a euro-denominated note not mentioned in the truth, assigning a wrong maturity year (2025 vs. 2031), and citing incorrect carrying values. (4) The reasoning is flawed: the LLM appears to describe a different debt instrument altogether—possibly confusing TMO with another company or misreading the note’s term and currency. It fails the multi-hop requirement to compare the same debt instrument across 2022 and 2024 accurately. (5) There is no semantic equivalence: the core facts—currency, amount, maturity, trend, and valuation—are all inconsistent with the ground truth. The only partial match is the 2.00% coupon rate, but even the effective rate is misstated. Overall, the answer reflects a fundamental misunderstanding of the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 451,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "\nREMICADE’s sales have continued to slide – falling 12.8 % from $1.839 bn in 2023 to $1.605 bn in 2024 (the decline began in 2022 as biosimilars entered the market) – and its share of the Immunology portfolio dropped from roughly 9.7 % of total revenue in 2021 to a smaller portion in 2024.  This erosion of market share signals that REMICADE is no longer a primary growth driver for Johnson & Johnson’s Pharmaceutical segment, prompting the company to rely more on newer biologics such as TREMFYA and SIMPONI to sustain immunology‑related earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 12.8% decline in REMICADE sales from $1.839 billion in 2023 to $1.605 billion in 2024, matching the ground truth numerically and semantically. These figures align with the original answer, allowing for format variation (e.g., $1.839 bn = $1,839 million). The percentage decrease is accurate: (1,839 - 1,605) / 1,839 ≈ 0.1272, or 12.72%, which rounds to the reported 12.8%. (2) The LLM adds contextual detail not in the ground truth—mentioning a decline beginning in 2022 due to biosimilars and REMICADE’s share dropping from 9.7% in 2021—but this does not contradict the original answer and is plausibly consistent with the trend. While the 9.7% figure and 2021 reference are not in the ground truth and thus cannot be verified from the provided data, they do not detract from correctness as they are presented as supplementary context. (3) The multi-hop reasoning is sound: the model connects REMICADE’s declining sales to its reduced strategic role in J&J’s Immunology portfolio and correctly infers a shift toward newer biologics like TREMFYA and SIMPONI, which is logically supported by the original answer’s implication of competition or newer alternatives. (4) The answer fully addresses both parts of the question: the evolution of financial performance (quantitative trend) and the implication for J&J’s Pharmaceutical segment (strategic role). The only minor limitation is the introduction of unverified data (2021 revenue share), but core facts, calculations, and synthesis remain accurate and relevant. Hence, high scores across all dimensions with a 9/10 on correctness and qualitative accuracy due to the slight overreach in unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 467,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "\nREMICADE’s revenue has continued to slide – it fell from about **$3.19 billion in 2021** (the last full‑year figure shown in the 2022 10‑K) to **$1.61 billion in 2024**, a **12.8 % drop from 2023** and roughly a **50 % reduction over the three‑year span**.  The decline is attributed to ongoing biosimilar competition (e.g., European biosimilars and U.S. filings) and share loss, especially in Europe, as noted on pages 31‑32 of the 2024 10‑K.  Consequently, REMICADE now represents only a small, shrinking slice of J&J’s Immunology portfolio, which is increasingly driven by newer assets such as STELARA and TREMFYA.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and reasoning but contains key quantitative inaccuracies. The ground truth states REMICADE had $3,190 million in sales in 2022, while the LLM incorrectly cites $3.19 billion in 2021, misaligning the timeline. The 2024 sales figure is close—$1.61 billion vs. the correct $1,605 million—but the 50% reduction claim over three years is approximate and not directly supported by the provided data (which compares 2022 to 2024, not 2021 to 2024). The 12.8% drop from 2023 is correctly cited. However, the original answer does not provide 2023 sales, so the LLM’s use of this number suggests potential hallucination or external sourcing. (2) Calculations: The 12.8% decline from 2023 is accurate per the LLM’s narrative, but without confirmation of 2023 sales in the ground truth, this cannot be fully verified. The 50% drop claim from 2021 to 2024 is not aligned with the original answer, which only provides 2022 and 2024 figures. The correct decline from 2022 ($3,190M) to 2024 ($1,605M) is approximately 49.7%, so the 50% figure is reasonable if referring to that span—but the LLM misattributes the starting year. (3) Multi-hop reasoning is sound: the LLM correctly infers declining market position due to biosimilar competition and shifting portfolio dynamics, citing newer drugs like STELARA and TREMFYA, which aligns with contextual knowledge. It synthesizes the implication of declining sales on portfolio relevance, addressing the second part of the question well. (4) Scores justified as follows: Correctness 7 due to accurate trend and qualitative insight but flawed year alignment and unsupported 2021 figure; Quantitative Accuracy 6 due to incorrect base year and unverified 2023/2021 numbers despite roughly correct magnitudes; Qualitative Accuracy 8 for strong reasoning and correct attribution of causes (biosimilars, market share loss); Contextual Relevance 10 for fully addressing both parts of the question and providing relevant strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 546,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "\nBetween 2021 and 2024 REMICADE’s sales fell sharply—from roughly **$3.2 billion in 2021** to **$1.6 billion in 2024**, a decline of about **50 %**.  The drop is attributed mainly to **biosimilar competition** (infliximab biosimilars launched in the United States and Europe, with additional entrants expected in 2025), **loss of market exclusivity** and related patent expirations, and the resulting **share erosion**, especially in European markets, all of which have continued to pressure demand for the drug.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The original answer states that REMICADE's sales were $16.8 billion in 2021 as part of total Immunology sales, while the LLM claims $3.2 billion in 2021 — a major discrepancy. The 2024 figure is closer ($1.6 billion LLM vs $1,605 million ground truth), but the 2021 number is critically wrong. Additionally, the LLM reports a 50% decline, but the ground truth shows a 12.8% decrease from 2023 to 2024, not over the full 2021–2024 period. The overall trend of decline is correct, and the final 2024 value is approximately accurate. (2) Quantitative accuracy is low: the $3.2B 2021 figure is less than 20% of the correct $16.8B amount. The 50% decline is unsupported by the data provided in the ground truth, which does not specify the full 2021–2024 drop but only the 12.8% year-on-year 2023–2024 decrease. The LLM likely misattributed a segment or product line value as REMICADE-specific. (3) The reasoning about biosimilar competition, loss of market exclusivity, and market share erosion is qualitatively sound and aligns with the causal factors in the original answer. The mention of U.S. and European biosimilar launches is consistent with 'biosimilar competition in the U.S. and other global markets.' However, the answer adds speculative detail (entrants expected in 2025) not in the original. (4) Contextual relevance is high — the answer addresses both parts of the question (sales evolution and contributing factors) and focuses on the right drug and timeframe. Despite incorrect numbers, it captures the directional trend and correct underlying causes. The core failure is in quantitative fidelity, which severely impacts overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 476,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "\nBetween 2022 and 2024, STELARA (ustekinumab) continued to be a major driver of J&J’s immunology franchise, with U.S. sales rising to roughly **$6.7 billion in fiscal 2024** (up from about **$5.9 billion in 2021**). However, the product’s growth slowed and turned negative in 2024 (‑4.6 % YoY) as the **U.S. patent expired in September 2023** and **biosimilar competition intensified**, prompting the company to expect biosimilar launches in 2025 that will further erode sales. In Europe, share loss to biosimilars already contributed to a **1.2 % decline in total immunology sales** and a **4.6 % drop in STELARA sales** versus the prior year. Thus, while STELARA remained a top‑selling immunology drug with about **$10.4 billion in global sales in 2024**, its commercial momentum plateaued and began to decline as exclusivity wanes and biosimilars enter the market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core commercial trend of STELARA correctly—strong revenue in 2024 with a 4.6% decline due to biosimilar competition and patent expiration. However, there are key quantitative inaccuracies. The ground truth states STELARA generated $10,361 million ($10.361 billion) in sales in 2024, while the LLM reports approximately $10.4 billion, which is close but not exact. More significantly, the LLM cites U.S. sales of $6.7 billion in 2024 and references $5.9 billion in 2021, which are not present in the ground truth and introduce unverified data. The 4.6% decline is correctly reported and aligns with the ground truth. The mention of U.S. patent expiration in September 2023 is contextually plausible but not confirmed in the original answer. (2) The calculation of the 4.6% decline matches the ground truth (from $10,858M to $10,361M: (10,858 - 10,361)/10,858 ≈ 4.58%, which rounds to 4.6%), so this is accurate. However, the LLM introduces a 1.2% decline in total immunology sales and a 4.6% drop in STELARA sales in Europe without supporting data in the original answer. (3) The multi-hop reasoning is sound in linking regulatory status in 2022 (filing for pediatric use) to commercial performance in 2024, and the synthesis of declining sales due to biosimilars shows good qualitative understanding. The LLM adds external context (patent expiry, biosimilar launches in 2025) that, while reasonable, goes beyond the provided ground truth. (4) The answer is highly relevant and provides a coherent narrative, but the inclusion of unverified figures (especially U.S.-specific sales and 2021 baseline) reduces quantitative accuracy. The core message—transition from development to mature product with declining sales—is consistent with the ground truth, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 496,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "\nRestasis U.S. net revenue fell from **$382 million in 2023 to $172 million in 2024**, a decline of about **$210 million or roughly 55 %**. The prior year it had already dropped **38.5 %**, falling from **$621 million in 2022 to $382 million in 2023**. (Values are taken from the net‑revenue tables on page 44 of the 2024 Form 10‑K.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $382 million in 2023 and $172 million in 2024 are correctly reported. The 55% decrease from 2023 to 2024 is correctly calculated ((382 - 172) / 382 ≈ 55.0%, with rounding to 'roughly 55%' being acceptable). The 38.5% decrease from 2022 to 2023 is explicitly stated and matches the ground truth, with supporting figures ($621M to $382M) provided. (2) The answer is complete, addressing both parts of the question: the change in total net revenue between 2023 and 2024, and the percentage decrease in each year (implied as the year-over-year change into that year). (3) Entity accuracy is correct: Restasis, U.S. net revenue, and the years 2022–2024 are all properly identified. (4) The multi-hop reasoning is sound—revenue figures across three years are synthesized to compute two year-over-year percentage decreases, which is required for answering the question. (5) Semantic equivalence is maintained: though the LLM adds the source (page 44 of the 2024 10-K), it does not alter or distort the meaning and enhances credibility. All calculations and references align with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 340,
        "total_tokens": 1479
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "\nBetween 2022 and 2023 the Master Lease Agreements moved from being chiefly a tool for securing steady, long‑term revenue and limiting churn in the U.S. portfolio to a strategic pillar of AMT’s international growth plan.  The 2023 disclosures highlight that these MLAs now underpin the company’s diversification into emerging markets, accelerate colocation cycles, and deepen partnerships with large multinational carriers—enabling incremental site‑leasing revenue and reducing non‑contractual churn abroad.  Consequently, MLAs have become essential for sustaining organic revenue growth and strengthening tenant relationships across AMT’s global footprint.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolving strategic role of Master Lease Agreements (MLAs) at AMT between 2022 and 2023, emphasizing their importance in international growth, tenant relationships, reduced churn, and faster deployment. However, it introduces a claim not present in the original answer: that MLAs were 'chiefly a tool for securing steady, long-term revenue and limiting churn in the U.S. portfolio' in 2022. The ground truth makes no U.S.-specific reference or geographic limitation for 2022, instead stating MLAs supported the international portfolio of ~177,000 sites. This mischaracterization affects qualitative accuracy. Additionally, while the LLM correctly notes MLAs support international growth and reduce churn, it omits specific quantitative context from both years: the size of the international portfolio (177,000 sites in 2022, 182,000 in 2023), which is key multi-hop information. These numbers are critical for assessing scale and growth, and their absence reduces completeness. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is largely sound—MLAs are correctly portrayed as increasingly strategic for international expansion and tenant retention. The answer is contextually relevant and well-articulated, but lacks key data points and slightly misrepresents the geographic focus in 2022. Thus, correctness is partially impacted due to omissions and one unsupported claim, warranting a 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 403,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the Google Marketing Platform moved from being a peripheral buying option to a core channel for advertisers purchasing inventory on Google Network properties, and the company’s accounting treatment stayed the same—advertising revenues are recorded on a **gross basis** (the full amount billed to the customer is recognized as revenue and the portion paid to network partners is recorded as cost of revenues), with performance‑ad revenue recognized on user engagement and brand‑ad revenue recognized on impression.  Consequently, the platform’s share of gross advertising revenue grew, but the **recognition and management methodology across the Google Network did not change**.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its qualitative reasoning that undermines the overall correctness. (1) The answer correctly states that advertising revenues are recognized on a gross basis in both years, which aligns with the ground truth for 2023. It also correctly identifies that performance ads are recognized on engagement and brand ads on impressions, adding detail not contradicted by the original. However, it incorrectly asserts that the 'recognition and management methodology across the Google Network did not change' between 2023 and 2024. This directly contradicts the ground truth, which states that in 2024, there was an evolution in the platform's role involving a more nuanced evaluation of principal versus agent status and greater emphasis on control over inventory—key factors supporting gross revenue reporting. This indicates a change in the underlying rationale and explanation for the accounting treatment, even if the gross reporting outcome remained the same. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is flawed: the model fails to recognize that an enhanced explanation and evaluation of control and principal status in 2024 constitutes an evolution in how revenue is managed and justified, even if the recognition method (gross) stayed consistent. The model incorrectly equates unchanged accounting outcome with unchanged role or methodology. (4) While the answer is contextually relevant and uses correct entities (Google Marketing Platform, Google Network properties, correct years), the core claim about no change in methodology contradicts the ground truth's emphasis on evolution in the platform’s role. Thus, the correctness and qualitative accuracy scores are moderate due to this key omission and misinterpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 517,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "\nBetween 2023 and 2024 the liability for Federal Funds Purchased & Securities Loaned rose from roughly **$436 billion to $570 billion** (≈ 31 % growth), and the fair‑value measurement of that liability increased from about **$133 billion to $193 billion** (≈ 45 % growth) (see the “Federal fundspurchasedandsecuritiesloaned or sold under agreements to repurchase” line in the Level 2 fair‑value tables on pages 154‑155).  \n\nThis expansion indicates that Bank of America deliberately increased its short‑term wholesale funding, using market‑based borrowing to supplement its deposit base as interest rates rose and to support continued asset‑side growth. The higher reliance on Federal‑funds and securities‑loaned funding reflects a strategic shift toward short‑term market financing to meet liquidity needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2023 the volume showed a net change of $16,466 million (not a starting value of $436 billion), and in 2024 the fair value was $192,859 million (~$193 billion, which the LLM gets approximately correct). However, the LLM incorrectly states that the 2023 fair value was $133 billion and implies the total liability was $436 billion in 2023 — these figures are not supported by the ground truth and represent a misinterpretation of the data. The 31% and 45% growth rates are based on these incorrect baselines and are therefore invalid.\n\n(2) The only number that aligns with the ground truth is the 2024 fair value (~$193 billion vs. $192,859 million). The $16,466 million net increase in volume in 2023 is completely omitted and replaced with fabricated starting and ending balances. There is no mention of 'net change' in volume as specified in the original answer, and the LLM conflates total liability with volume change.\n\n(3) The reasoning is partially sound — the conclusion that BAC increased reliance on short-term funding is consistent with the ground truth, and the reference to supporting liquidity and asset growth is plausible. However, the multi-hop synthesis is flawed because it uses incorrect numerical foundations to derive its insights. The LLM appears to have misread or misinterpreted the source table, possibly confusing total balances with changes or mixing up categories.\n\n(4) Contextual relevance is high — the answer addresses both parts of the question (changes in volume/fair value and implications for funding strategy) and uses appropriate financial terminology. But due to major factual and numerical errors, especially in the quantitative foundation, the overall correctness score is low. Minor formatting flexibility is allowed, but inventing dollar amounts that do not appear in the source constitutes a serious error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 524,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s wording about the pension and retiree‑medical plan’s exposure to market fluctuations remained the same – it still points to the “Critical Accounting Policies and Estimates” section for a discussion of that exposure – but the level of detail evolved. In the 2022 filing the company gave only a generic statement that the plan’s assets and liabilities are subject to market‑related risks, whereas the 2024 filing adds a concrete quantitative illustration, noting that other pension and retiree‑medical benefits expense rose $272 million in 2024 due to higher settlement charges and a group‑annuity purchase, thereby showing how market‑driven events directly affect the plan’s financial results.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) The key claim that PepsiCo added a quantitative illustration in 2024 about a $272 million increase in pension and retiree benefits expense due to settlement charges and an annuity purchase is not supported by the ground truth and appears fabricated. The original answer makes no mention of this figure or event, nor does it reference any quantitative disclosure. (2) The ground truth states that the evolution in disclosure was a broadening of risk factors from market fluctuations to include inflationary, deflationary, and recessionary conditions—this is entirely missing from the LLM answer. Instead, the LLM incorrectly asserts that the change was the addition of a specific financial impact ($272M), which is not mentioned in the original. (3) The multi-hop reasoning fails: the question asks about how sensitivity disclosures evolved, and the correct answer requires identifying a shift in the *nature* of risk factors described (from market volatility to broader macroeconomic conditions). The LLM instead invents a narrative around a specific expense increase, misrepresenting the evolution. (4) While the LLM correctly notes that both years reference 'Critical Accounting Policies and Estimates,' this minor accuracy does not compensate for the fundamental misrepresentation of the disclosure change. The answer is contextually relevant to the topic but factually divergent, hence a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 409,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "\nBetween 2023 and 2024 Adobe reframed Adobe Scan from a stand‑alone, free mobile scanner into a core, AI‑enhanced component of the Adobe Document Cloud suite.  The 2024 disclosures stress that Scan now works natively alongside Acrobat, Acrobat Sign and the new Acrobat AI Assistant, is offered within subscription plans for individuals, teams and enterprises, and is marketed as part of an end‑to‑end document‑management ecosystem that combines scanning, OCR, e‑signatures and cloud‑based collaboration.  This evolution positions Scan not just as a pocket‑sized scanner but as a integrated step in Adobe’s broader document‑workflow platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Adobe Scan from a standalone free mobile tool in 2023 to a more integrated, AI-enhanced component of Adobe Document Cloud in 2024. The answer captures the key shift in positioning—integration with Acrobat, Acrobat Sign, and the Acrobat AI Assistant—and emphasizes its role in a broader document workflow ecosystem, which matches the original answer's focus on deeper integration with cloud productivity tools and AI features. It also correctly notes the inclusion of Adobe Scan in subscription plans across user tiers, reflecting a strategic shift toward enterprise and team use. While the LLM answer does not explicitly mention 'Content Credentials' or 'Firefly-powered generative AI workflows'—specific AI features highlighted in the ground truth—it broadly captures the AI and integration narrative. This omission prevents a perfect 10 on qualitative accuracy, but the core reasoning, entity identification (Adobe, Adobe Scan, Document Cloud, Acrobat, AI Assistant), and multi-hop synthesis across years and product strategy are sound. There are no numerical values to evaluate, so quantitative accuracy is 10 by default. Contextual relevance is excellent, as the response directly addresses the evolution in positioning within Adobe’s document management ecosystem.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 382,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "\nSince its debut in December 2023, Gemini was embedded as a multimodal foundation across Google’s core services—powering AI‑enhanced Search results, ads tools (Performance Max, Product Studio), Android experiences such as Circle‑to‑Search, Chrome, YouTube, and Google Cloud’s Vertex AI platform. In 2024 Gemini 2.0 was released, offering a larger, more capable model that can simultaneously understand and generate text, code, audio, images and video, supports longer context and faster latency through TPU‑optimized inference, and drives new experimental assistants like Project Astra and Project Mariner, turning Gemini from a single model into a pervasive AI layer that underpins virtually every Google product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Gemini launched in 2023 as a multimodal model, evolved into Gemini 2.0 in 2024, and was integrated across Google's major products. The mention of Project Astra and Project Mariner as experimental assistants in 2024 is consistent with the original answer. (2) Quantitative accuracy is strong: the December 2023 launch date is correct (Gemini was rebranded from Bard in December 2023), and the 2024 release of Gemini 2.0 is accurately noted. No incorrect numbers or dates are present. (3) Multi-hop reasoning is sound: the answer synthesizes the evolution of Gemini’s capabilities and its integration across products, correctly identifying its role as a foundational AI layer. The only minor omission is that the original answer specifies integration into all seven of Google’s two-billion-user products by name (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube), while the LLM mentions most but not all (Gmail and Maps are missing explicitly). However, 'core services' and 'virtually every Google product' imply broad integration, preserving semantic equivalence. (4) The LLM enhances the answer with additional context (e.g., TPU-optimized inference, Vertex AI, Circle-to-Search) that is factually accurate and enriches the response without contradicting the ground truth. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a slight deduction for incomplete enumeration of the seven products.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 430,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "\nBetween 2022 and 2024 Linde’s helium business—grouped in the “Other” category—has seen a modest sales contraction.  In 2024 vs. 2023, sales in this line fell about 2 % (≈ $32 million) as lower volumes dragged down revenue, a trend that continued from the prior year [page 28].  However, operating profit in “Other” rose sharply—up $19 million or 44 % in 2024 vs. 2023—because insurance recoveries and cost‑control measures more than offset the higher helium‑related expenses, turning a volume‑driven decline into a profit‑improvement story [page 28].  Thus, while helium’s contribution to top‑line sales has been pressured, its impact on earnings has improved, reflecting a shift from volume reliance to margin‑focused performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. (1) Quantitatively, the 2% sales decrease in the 'Other' segment is correctly reported and aligns with the ground truth, and the 44% operating profit increase is also accurate. However, the LLM introduces a $32 million sales decline and $19 million profit increase, which are not present in the original answer and cannot be verified against the provided truth. These specific dollar figures are unsupported and likely incorrect. (2) The LLM incorrectly frames the evolution of helium's impact as improving in 2024, stating that 'insurance recoveries and cost-control measures' led to profit improvement. In contrast, the ground truth clarifies that helium-related higher costs *partially offset* an insurance recovery, thereby *limiting* profit growth—not driving improvement. This misrepresents the causal relationship. (3) The original answer emphasizes a negative shift in helium's impact from 2022 (neutral/positive) to 2024 (negative due to volume and cost pressures), but the LLM fails to mention the 2022 context or the deteriorating relationship, instead implying an improvement in earnings performance. This breaks the multi-hop reasoning across years and mischaracterizes the trend. (4) While the LLM correctly identifies the 'Other' segment and links helium to it, it omits the specific negative impact of helium on both sales (via lower global volumes) and operating profit (via higher costs offsetting recovery), which is central to the question. The answer is contextually relevant and well-structured but factually misleading in its interpretation of cause and effect, and introduces unverified numerical estimates. Thus, it is partially correct but contains significant errors in reasoning and unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 501,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "\nThe net carrying amount of acquired franchise rights fell from $626 million at the end of 2023 to $598 million at the end of 2024, a decline of $28 million (about 4.5%).  Over the longer 2022‑to‑2024 horizon the net value dropped by roughly $30 million, indicating a modest downward trend.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. The ground truth states the net value in 2022 was $789 million, but the LLM incorrectly reports a 2023 value of $626 million as a starting point and implies a $30 million drop from 2022 to 2024, which is inconsistent with the actual $191 million decline ($789M to $598M). The only correct figure is the 2024 value of $598 million. (2) Calculations are incorrect: the claimed $28 million decline from 2023 to 2024 may be accurate within the LLM's own data, but the 2023 figure itself is wrong. The actual drop from 2022 to 2024 is $191 million, not 'roughly $30 million'—this is off by more than 85%. The 4.5% decline is based on incorrect inputs. (3) Multi-hop reasoning is partially present—the model attempts to analyze change over time and synthesize values across years—but fails because it uses incorrect source data. It also introduces 2023 data not referenced in the original answer, which may reflect hallucination or misattribution. (4) Contextual relevance is fair because the answer addresses the right metric and time frame, but correctness is severely compromised by inaccurate numbers and miscalculations, warranting a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 347,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "\nChevron’s net natural‑gas output from the Tengizchevroil field (reported as part of its Kazakhstan affiliate) fell slightly from about **114 MMcf/d in 2023 to roughly 113 MMcf/d in 2024** – a modest 1 % decline.  No new, field‑specific delivery commitments were disclosed for 2024; the existing gas‑sale contracts that include Tengizchevroil remain embedded in the company’s broader natural‑gas delivery framework (the U.S. 2024‑2026 obligations and the non‑U.S. 2025‑2027 3.2 trillion‑cubic‑foot schedule for Australia and Israel) and are expected to be satisfied using existing proved reserves and third‑party purchases.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Chevron's total natural gas volumes (including its share from Tengizchevroil) were 596 MMcf/d consumed and 7,148 MMcf/d sold in 2023, increasing to 609 MMcf/d consumed and 7,569 MMcf/d sold in 2024. The LLM instead claims a net output from Tengizchevroil alone of only 114 MMcf/d in 2023 and 113 MMcf/d in 2024, which contradicts the much larger figures in the original answer. There is no mention in the ground truth of a decline; rather, there is a clear increase in both consumption and sales volumes. (2) The numbers provided by the LLM (113–114 MMcf/d) are off by an order of magnitude compared to the Tengizchevroil-inclusive totals in the original answer. Additionally, the LLM introduces unrelated delivery commitments for Australia and Israel and mentions third-party purchases and contracts not referenced in the ground truth, introducing factual inaccuracies. (3) The multi-hop reasoning fails: the LLM does not connect Chevron’s overall natural gas volumes to its Tengizchevroil share as reported in the knowledge graph. Instead, it isolates Tengizchevroil with incorrect figures and draws an erroneous conclusion of declining output, opposite to the growth indicated in the original answer. (4) The contextual relevance is moderate because the answer discusses Chevron and Tengizchevroil in the correct timeframe and touches on delivery commitments, but the core facts, trends, and magnitudes are wrong, leading to a fundamentally misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 436,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 the filing moved from simply noting “amounts paid to Google Network partners primarily for ads displayed on their properties” as part of cost‑of‑revenues to explicitly framing those payments as a distinct cost‑of‑revenues item that is evaluated under a “principal vs. agent” test.  In the 2024 Form 10‑K Google says it may recognize advertising revenue **net of the share paid to network partners** when it acts as an agent, whereas in 2023 the payments were described only as a cost‑of‑revenues expense without that net‑revenue distinction.  This change shows that the role of Network partners has evolved from a behind‑the‑scenes cost to a consciously accounted‑for revenue‑sharing component of Google’s advertising model.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. It accurately identifies the evolution in how payments to Google Network partners are described between 2023 and 2024. The key factual elements—shift in accounting treatment, recognition of payments as part of cost-of-revenues, and the introduction of the 'principal vs. agent' evaluation in 2024—are all correctly reported. The mention of revenue being recognized net of partner shares when Google acts as an agent is a precise and important detail from the 2024 10-K, which reflects a more nuanced revenue-sharing model. This supports the conclusion that the role of partners evolved into a more integrated, revenue-linked component. However, the LLM answer does not explicitly mention the term 'Traffic Acquisition Costs (TAC)'—a key phrase in the original answer that categorizes these payments strategically within Google's advertising cost structure. While the concept is implied through discussion of revenue netting and cost-of-revenues, the absence of TAC as a defined category slightly weakens the completeness of the synthesis. There are no numerical inaccuracies (dates: 2023 vs 2024 are correct), and the reasoning across years is sound. The answer is highly contextually relevant and captures the essence of the change in accounting language reflecting a strategic shift. The qualitative accuracy is slightly reduced due to the missing TAC linkage, but the core reasoning about revenue recognition and cost classification remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 427,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "\nBetween 2023 and 2024 the firm moved from a general reference to “increasing global regulatory focus” on climate change to a concrete warning that state, federal and non‑U.S. jurisdictions are adopting new or heightened climate‑related rules, creating jurisdictional divergence that will amplify legal, compliance and disclosure costs. This fragmentation makes it harder to meet the company’s GHG‑emissions targets and raises the risk that overlapping or conflicting policy requirements will generate additional compliance uncertainty.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately captures the evolution from 2023 to 2024 in Bank of America's assessment of climate-related regulatory requirements, emphasizing the increasing concern over jurisdictional divergence and its impact on compliance, legal, and disclosure risks. The use of terms like 'new or heightened climate-related rules' and 'jurisdictional divergence' matches the original answer. The shift from anticipation in 2023 to more concrete impacts in 2024 is implied through the stronger language in 2024 ('concrete warning'), though the LLM does not explicitly state that the impact has shifted from expected to actual/tangible as clearly as the original answer. A minor shortcoming is the addition of a detail not present in the ground truth: the claim that jurisdictional fragmentation makes it harder to meet GHG-emissions targets. While plausible, this specific point about affecting emissions targets is not mentioned in the original knowledge base answer and represents an extrapolation. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and contextually relevant, with accurate entity identification (Bank of America, climate regulations, jurisdictions). However, the qualitative accuracy is slightly reduced due to the introduction of unverified content about GHG targets. Overall, the answer is factually strong and responsive, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 419,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "\nFrom 2022 through 2024 GM has kept full‑size pickups at the core of its North‑American strategy, but by 2024 the emphasis has deepened: the company is selling more of these trucks, capturing higher prices and higher‑margin variable profit, and rolling out EV versions (e.g., Silverado EV) to sustain growth.  In 2024 wholesale unit volume for GM North America’s full‑size pickups rose 10.1 % (≈317 k units), driving an 11.4 % jump in GMNA net sales to $157.5 bn and an 18.1 % increase in EBIT‑adjusted to $14.5 bn, with the EBIT‑adjusted margin expanding to 9.2 % from 8.7 %—clear quantitative evidence of a stronger performance and market position for the segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the ground truth states that full-size pickup trucks contributed to improved EBIT-adjusted results with a variable profit of approximately 160% on a weighted-average basis in 2024, the LLM introduces specific figures not present in the original—such as a 10.1% increase in wholesale volume (≈317k units), 11.4% jump in GMNA net sales to $157.5B, and 18.1% increase in EBIT-adjusted to $14.5B with margin expansion to 9.2%. These precise numbers are not supported by the ground truth and appear fabricated or hallucinated. (2) There is no verification for the 10.1%, $157.5B, or $14.5B figures in the original answer; the ground truth only confirms increased net wholesale volumes and favorable contribution to EBIT-adjusted, without specific percentages or dollar amounts. The 160% variable profit is a key metric in the original but is entirely missing in the LLM response. (3) The qualitative reasoning is partially sound: the LLM correctly identifies a strategic deepening in focus on full-size pickups from 2022 to 2024 and infers stronger performance and market positioning. It also appropriately notes the introduction of EV versions like the Silverado EV as part of the growth strategy, which aligns with broader industry trends and adds contextual insight. However, it fails to explicitly connect the 2022 risk factor framing to the 2024 strength transition as emphasized in the original, weakening the multi-hop synthesis. (4) Despite strong contextual relevance and logical framing, the hallucination of specific financial metrics severely undermines factual correctness. The answer is plausible-sounding but not factually aligned with the ground truth, warranting a low correctness and quantitative accuracy score. Minor credit is given for correct entity identification (GM, full-size pickups, EBIT-adjusted) and directional accuracy in strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 527,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "\nThe exposure to U.S. Treasury and government‑agency securities in the nuclear decommissioning trusts dropped from roughly $284 million in 2022 to about $190 million in 2024—a decline of roughly one‑third. This pull‑back from low‑yielding government bonds signals a strategic shift toward higher‑return private‑equity and credit assets, indicating a more aggressive investment strategy for the trusts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, in 2022, Alabama Power had $21M and Georgia Power had $293M in U.S. Treasury and government agency securities, totaling $314M—not $284M as stated by the LLM. By 2024, Alabama Power decreased to $20M while Georgia Power increased to $349M, resulting in a total of $369M—not $190M. Thus, the LLM incorrectly reports a decline when there was actually an increase of $55M overall. The claimed drop to $190M is factually wrong and misrepresents the trend. (2) Calculations are flawed: the LLM asserts a drop from $284M to $190M (~one-third decline), but the actual combined allocation rose from $314M to $369M (~17.5% increase). This major miscalculation undermines the entire response. (3) The reasoning is unsound: the LLM concludes a shift toward private equity and a more aggressive strategy, but the original answer indicates a reallocation within subsidiaries—specifically a growing focus on Georgia Power’s portfolio—without any mention of broader asset class shifts or risk appetite changes. There is no evidence in the ground truth supporting a move away from government securities overall or toward private equity. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the evolution of allocations and attempts to interpret investment strategy—hence a moderate score on relevance. However, due to severe inaccuracies in numbers, direction of change, and strategic interpretation, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 435,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "\nFrom 2022 through 2024 PepsiCo moved from a broad‑based, discretionary bottler‑funding program to a more formal, performance‑linked system in which annual incentives are tied to volume, advertising, new‑product support and vending/cooler‑equipment placement.  At the same time the company expanded exclusive territorial rights and concentrated its distribution through a smaller group of independent bottlers that serve key retail accounts (e.g., Walmart), making those bottlers increasingly critical to PepsiCo’s revenue and strategic growth.  Consequently, financial incentives have become tighter‑coupled to bottler performance while the firm’s strategic dependency on those partners has deepened.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in PepsiCo's relationship with independent bottlers from 2022 to 2024. (1) It correctly identifies the shift from a more general incentive structure in 2022 to a formal, performance-linked system by 2024, aligning with the ground truth's description of annual negotiations and targeted allocation of funding to advertising, new product launches, and vending equipment. (2) There are no numeric values in the LLM answer that contradict the ground truth; while it omits the specific 14% Walmart revenue figure, this is a minor omission and does not introduce inaccuracy—formatting and calculations (none required) are sound. (3) The multi-hop reasoning is strong: the model synthesizes changes in financial incentives (from discretionary to structured) and infers increased strategic dependency through concentration of distribution and critical retail partnerships like Walmart. (4) The answer is contextually fully relevant, addressing both financial incentives and strategic dependency as asked. The only reason for not scoring a 10 is the omission of the specific 14% revenue contribution from Walmart, which is a meaningful quantitative detail in the original answer. However, the qualitative and semantic equivalence remains very high, with accurate entity names (PepsiCo, independent bottlers, Walmart), correct time frame (2022–2024), and correct characterization of incentive evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 400,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "\nIn the 2023 10‑K, Adobe Firefly is mentioned only as a newly introduced generative‑AI product in the risk‑factor discussion and appears in the trademark list as a nascent brand. By the 2024 10‑K, Firefly is highlighted both in the trademark filings and in the AI‑related risk disclosures, showing that Adobe has promoted it from an experimental offering to a central, strategically protected component of its product‑innovation roadmap and is now integrating it across its portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in the timeline: it claims that in the 2023 10-K, Adobe Firefly was mentioned in the risk factors as a 'newly introduced generative-AI product' and only 'nascent' in trademarks. However, the ground truth states that in 2023, Firefly was listed in the trademarks (indicating established status), and it was in 2024 that it appeared in the risk factors as a newly released product. The LLM reverses the chronological evolution—placing risk factor disclosure in 2023 when it actually occurred in 2024. This undermines the multi-hop reasoning and leads to an incorrect narrative of Firefly's strategic evolution. While the overall structure and intent of the answer are relevant and contextually appropriate—discussing trademark and risk disclosures to trace strategic importance—the reversal of key facts across years results in significant qualitative inaccuracy. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. Contextual relevance is high because the answer addresses the right documents and strategic interpretation, but the incorrect temporal logic prevents it from accurately reflecting the evolution. Thus, the correctness and qualitative accuracy scores are low due to this core factual inversion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 360,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "\nBetween 2022 and 2023 the importance of contractual rent escalations as a driver of tenant‑billing growth increased.  Churn rose slightly to roughly 3 % in 2023—primarily from T‑Mobile lease cancellations in the U.S. & Canada—yet the company still treats annual escalations (≈3 % in the United States and inflation‑linked abroad) as a core, net‑of‑churn growth engine.  As a result, revenue growth now relies more on the steady escalation of existing lease rents than on the modest churn that was historically present.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but misrepresents the core trend in the role of contractual rent escalations between 2022 and 2023, which is the central focus of the question. Quantitatively, the 3% churn rate and T-Mobile lease cancellations in the U.S. & Canada are accurately cited, and the ≈3% escalation rate in the U.S. aligns with expectations. However, the key qualitative error is the claim that the 'importance' of rent escalations 'increased' in 2023, which contradicts the ground truth: while escalations remained a driver, their effectiveness was undermined by elevated churn, making the growth environment more challenging—not less. The original answer emphasizes that churn introduced a 'countervailing force,' implying that escalations were less sufficient for organic growth in 2023, not more important. The LLM incorrectly frames escalations as a stronger growth engine despite churn, when in reality, the net effect is more nuanced and less positive. This misjudges the multi-hop synthesis: the interaction between rising churn and rent escalations should temper optimism about escalations' role, not reinforce it. While entities (T-Mobile, U.S. & Canada segment) and metrics (churn rate, escalation rates) are correctly identified, the reasoning and conclusion are flawed. The answer is contextually relevant and includes appropriate details, but the incorrect directional assessment of escalations' role reduces factual accuracy. Hence, correctness is partially compromised despite numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 420,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "\nChevron kept the Tengizchevroil joint‑venture in its capital‑allocation plan throughout the transition from 2023 to 2024 – the 2023 Form 10‑K shows that the company spent about $3.5 billion on affiliate‑level projects, with roughly ½ of that amount earmarked for Tengizchevroil’s FGP/WPMP development in Kazakhstan, and the 2024 filing projects a similar $3 billion affiliate‑capex budget in which “nearly half” again goes to that same Kazakh project.  Production data in the 2024 filing list Kazakhstan’s net oil‑equivalent output at about 45 kb/d (essentially unchanged from 2023), confirming that the JV continues to contribute a measurable slice of Chevron’s worldwide production.  Consequently, the partnership’s financial commitment and production involvement have remained steady, with no major shift in either capital spending or output volume between the two years.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that Chevron maintained capital expenditure commitments to Tengizchevroil's FGP/WPMP project in both 2023 and 2024, with 'nearly half' of affiliate capex allocated to it. However, it inaccurately states that Chevron *spent* $3.5 billion in 2023 on affiliate-level projects, while the original answer (ground truth) only mentions an *expected* $3 billion for 2024 — no actual 2023 spend is given. The $3.5B figure and the claim of '½' (50%) allocation are not supported by the ground truth, which says 'nearly half' for 2024, not 2023. (2) The production volume of ~45 kb/d in Kazakhstan is not mentioned in the original answer; this specific number is an addition not present in the ground truth, making it potentially fabricated or misattributed. The original answer only states that Chevron included Tengizchevroil production in its affiliate volumes in 2024, without quantifying it or comparing year-over-year. (3) The reasoning is flawed in that the LLM concludes 'no major shift' in capital or production, while the ground truth emphasizes a *shift from investment (2023 capex focus) to operational phase (2024 production focus)* — a key qualitative evolution that the LLM misses entirely. This reflects a failure in multi-hop synthesis: the model should have inferred a phase transition based on changing emphasis across filings. (4) Despite these issues, the answer is contextually relevant and addresses both capital and production aspects of the relationship. The mention of continued involvement and affiliate capex is directionally correct, warranting partial credit. However, the incorrect numbers, unsupported specifics, and failure to capture the strategic shift significantly reduce factual accuracy and reasoning quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 499,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "\nBetween 2023 and 2024 UPS shifted from a generic statement that it “uses a bond‑matching approach to select specific bonds that would satisfy our projected benefit payments” to a concrete, quantitative methodology that ties the discount rate to a yield‑curve built from long‑term, high‑quality fixed‑income securities and reports the resulting rate (5.88 % for 2024 versus 5.42 % in 2023). The 2024 note also supplies the sensitivity of the projected benefit obligation to each basis‑point change in the discount rate, showing a far more detailed and specific application of the bond‑matching process for both U.S. pension and post‑retirement medical plans.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) The claim that UPS adopted a 'concrete, quantitative methodology' in 2024 with a yield-curve built from fixed-income securities and reported specific discount rates (5.88% for 2024 vs 5.42% in 2023) is unsupported by the original answer, which makes no mention of these percentages or any change in quantitative methodology. The ground truth states there was no material change in the mechanics of the bond matching approach. (2) The assertion that UPS began reporting sensitivity of the projected benefit obligation to basis-point changes in the discount rate in 2024 is not corroborated by the original answer and represents an addition of detail not present in the source. (3) The qualitative shift described in the LLM answer—moving from generic to concrete—is contradicted by the ground truth, which emphasizes continuity in practice and only a subtle shift in language (from active use to 'guides' the selection). The original answer notes a framing change, not an operational or methodological enhancement. (4) While the LLM correctly identifies that the bond matching approach relates to projected benefit cash flows and applies to U.S. pension and postretirement plans, it fundamentally misrepresents the nature and extent of evolution between 2023 and 2024. The multi-hop reasoning fails because it infers new quantitative disclosures and methodological advances that are not present in the ground truth. The contextual relevance is moderate because the topic and general concept (evolution of bond matching) are addressed, but the specifics are factually wrong. Overall, the answer fabricates numerical data and overstates methodological changes, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 489,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Linde’s helium business moved from a growth contributor to a constrained, volume‑declining operation – the “Other” segment (which includes global helium wholesale) saw sales fall $32 million, or about 2 %, in 2024 as helium volumes dropped, while operating profit in that same segment rose $19 million, or 44 %, because lower helium‑related costs and an insurance recovery for LAMT more than offset the revenue dip.  Consequently, the modest sales contraction from helium weighed on overall sales, but the segment’s profit improvement helped lift consolidated operating profit despite the revenue decline.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a $32 million (2%) decrease in sales in the Other segment due to lower helium volumes in 2024, it incorrectly states that operating profit in that segment rose by $19 million (44%) due to lower helium-related costs and an insurance recovery. The ground truth states that helium had a negative impact on operating profit, with costs contributing to downward pressure—only partially offset by the LAMT insurance recovery. Thus, the claim of a $19M operating profit increase is directly contradicted by the original answer, which implies a decline or at best a muted outcome, not a strong improvement. (2) The $32 million sales decline and 2% figure are accurate and correctly attributed to lower global helium and LAMT volumes. However, the $19 million operating profit increase and 44% figure are not supported by the ground truth and appear to be fabricated or misattributed. (3) The multi-hop reasoning is partially sound—linking helium volume declines to sales impact and referencing LAMT and the Other segment shows appropriate synthesis. However, the conclusion that helium contributed to profit growth contradicts the shift from neutral/positive to negative operational impact described in the original answer, failing the core qualitative assessment of helium's evolving role. (4) Scores reflect partial credit for correct sales impact and segment identification, but major deductions for incorrect profit direction and magnitude, which fundamentally misrepresents helium’s financial impact. Contextual relevance is high as the answer addresses the right segments, time frame, and causal factors, despite factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 471,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "\nBank of America’s unfunded capital commitments for renewable‑energy projects fell sharply, dropping from **$6.2 billion at the end of 2023 to $4.6 billion at the end of 2024** (a reduction of roughly $1.6 billion).  At the same time, the tax credits the company recognized from those renewable‑energy equity investments slipped slightly, from **$4.0 billion in 2023 to $3.9 billion in 2024** (a decline of about $0.1 billion).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: unfunded capital contributions decreased from $6.2 billion in 2023 to $4.6 billion in 2024, and recognized tax credits declined from $4.0 billion to $3.9 billion. The implied differences ($1.6 billion and $0.1 billion) are correctly represented. (2) The answer is complete, addressing both parts of the question: the evolution of unfunded capital contributions and the corresponding change in tax credits. (3) Entities are accurate—Bank of America, correct years (2023 and 2024), and correct financial metrics (unfunded capital contributions and recognized tax credits). (4) The reasoning is sound: the LLM correctly infers a sharp drop in commitments and a slight decline in tax benefits, aligning with the ground truth's interpretation of reduced near-term funding with stable tax benefits. (5) Semantic equivalence is maintained—though the LLM uses slightly different phrasing (e.g., 'fell sharply', 'slipped slightly'), the factual content and implications are identical to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 317,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "\nFrom 2022 to 2024 GM trimmed the proportion of fleet sales in its overall volume—fleet sales fell to roughly 11 % of total U.S. vehicle sales in 2021 and continued to decline, and the company repeatedly notes that “certain fleet transactions, particularly sales to daily‑rental car companies, are generally less profitable than retail sales.”  At the same time, the 2024 disclosures highlight a strategic shift: GM is now directing commercial‑fleet business toward its purpose‑built electric‑vehicle line (BrightDrop EV600/EV410) and selling those vehicles through dedicated fleet‑order channels and GM Financial commercial‑financing products, positioning fleet sales as higher‑margin, strategic contracts rather than the low‑margin volume sales it relied on in 2022.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GM viewed fleet sales—especially to daily rental companies—as less profitable than retail in 2022, which aligns with the ground truth. It also captures the strategic shift by 2024 toward more structured fleet sales, particularly through dedicated channels and GM Financial, and highlights a move toward higher-margin commercial fleet contracts. However, the LLM introduces a specific percentage (11% in 2021) that is not mentioned in the original answer and is outside the 2022–2024 timeframe asked. This number, while possibly factual, is not supported by the ground truth and introduces a quantitative claim not present in the source, reducing quantitative accuracy. (2) The mention of 2021 data is a deviation from the requested 2022–2024 scope, and the decline 'continued' is an extrapolation not confirmed in the original. No other numbers (e.g., profit margins, sales volumes) are provided in either answer, so the core financial comparison (lower profitability in 2022 vs. improved margin focus in 2024) is semantically consistent. (3) The multi-hop reasoning is sound: the model synthesizes the evolution of sales channels (direct/dealer in 2022 → dedicated fleet channels and GM Financial in 2024) and links it to profitability strategy. It correctly infers a strategic pivot from volume-driven, low-margin fleet sales to targeted, higher-margin commercial fleet sales, especially via BrightDrop EVs—information implied in the 2024 emphasis on structured channels. (4) Despite the off-timeframe statistic, the LLM captures the core evolution in channel strategy and profitability intent. The addition of BrightDrop and GM Financial provides useful context not in the original but plausibly aligned with GM’s 2024 strategy. Thus, the answer is mostly correct with minor but notable quantitative overreach, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 514,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s ownership in the Sabra joint‑venture did not change – it remained a 50 % equity interest – but the accounting treatment evolved.  In 2022 the company recorded a **$122 million pre‑tax gain** from re‑measuring that 50 % stake at fair value (page 73), which boosted earnings.  In 2023 and 2024 the company instead recognized **small pre‑tax credits of $7 million and $13 million**, respectively, reflecting adjustments to prior estimates of the investment (page 75); these credits were booked mainly in selling, general and administrative expense (and partially cost of sales).  The result was a shift from a one‑time gain to modest periodic earnings adjustments, while the commercial relationship – PepsiCo’s role as the exclusive U.S. distributor of Sabra’s products – remained unchanged (page 7).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) The ORIGINAL ANSWER states that PepsiCo owned Sabra fully in 2022 as part of a joint venture and then divested down to a 50% equity stake by 2024, resulting in a $122M pre-tax gain. In contrast, the LLM claims PepsiCo 'remained' at a 50% equity interest throughout 2022–2024, which directly contradicts the ownership change described in the ground truth. This misrepresents the core evolution of the relationship. (2) While the LLM correctly cites the $122 million pre-tax gain, it incorrectly attributes it to 2022 as a re-measurement gain while already holding 50%, whereas the truth is the gain resulted from the change in ownership structure (i.e., the divestiture itself). Additionally, the LLM introduces $7M and $13M credits in 2023 and 2024 not mentioned in the original answer, adding unsupported details. (3) The multi-hop reasoning fails: the model does not correctly synthesize the timeline or causality—ownership changed, triggering a one-time gain; the LLM instead implies stable ownership with ongoing accounting adjustments. (4) Despite these major errors, the answer is contextually relevant—addressing the right companies, time frame, financial metric (pre-tax gain), and general theme of accounting treatment—hence a moderate relevance score. However, the core factual claim about ownership stability is false, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 401,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "\nBetween the 2023 and 2024 10‑K filings Adobe’s description of Adobe Scan shifted from a stand‑alone, free mobile scanner that simply creates PDFs with basic OCR (2023) to a more centrally positioned component of the Document Cloud/Acrobat ecosystem that is tightly integrated with Acrobat Sign, the new AI‑powered Acrobat AI Assistant, and generative‑AI services such as Firefly (2024).  This evolution reflects Adobe’s effort to embed Scan as a gateway for users to enter the broader cloud‑based workflow—leveraging AI, subscription‑based credits, and enterprise APIs—rather than presenting it merely as a complimentary scanning utility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Adobe Scan from 2023 to 2024, noting its transition from a standalone scanning tool (implied by trademark listing in 2023) to an integrated component of Adobe Document Cloud in 2024. The mention of integration with Acrobat Sign, AI-powered features like Acrobat AI Assistant, and generative AI services such as Firefly adds valuable context not explicitly in the ground truth but consistent with the strategic direction implied by the 2024 positioning. These enhancements reflect a plausible and contextually appropriate elaboration on the deeper integration within Adobe’s ecosystem. There are no factual errors in entities, years, or product names. The reasoning is sound and represents valid multi-hop synthesis: connecting Adobe Scan’s role in 2023 (as a trademarked product) to its expanded functional integration in 2024 within Document Cloud and AI-driven workflows. No numerical data is present, so quantitative accuracy is scored based on absence of incorrect figures (scored 10). The only reason for not giving a perfect 10 in correctness is that the original answer focuses on trademark status in 2023 while the LLM interprets this as a 'stand-alone, free mobile scanner'—a reasonable inference but not directly stated in the ground truth. However, this does not constitute an error, just slight interpretive expansion. Overall, the answer is factually correct, comprehensive, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 417,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "\nFrom 2022 through 2024 the nature of GM’s indemnification duties to Stellantis has remained essentially unchanged: under the 2017 sale agreement GM guarantees that the former Opel/Vauxhall business will indemnify Stellantis for inaccuracies in representations, warranties, emissions‑related claims, product‑liability issues and certain recall costs (including the Takata‑inflator recalls).  The 2022 filing noted that these obligations are subject to time limits, thresholds or caps and that GM could not quantify any reasonably possible loss, while the 2024 filing confirms that GM has already indemnified Stellantis for an immaterial amount on a few recalls and believes any further indemnification is remote, even though ongoing European consumer‑lawsuits and other indirect‑tax or emissions matters still create unresolved exposure that cannot yet be measured.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of GM's financial exposure to Stellantis from 2022 to 2024, though with minor omissions and slight mischaracterization of the shift in nature of obligations. (1) Quantitatively, the answer correctly notes that GM accrued an immaterial amount related to indemnifications as of 2024, aligning with the ground truth. It also accurately references ongoing exposures such as emissions-related claims, Takata recalls, and European regulatory matters. No specific dollar figures are missing or misstated, and the use of 'immaterial' is consistent across both answers. (2) The answer addresses the continuity of indemnification obligations from the 2017 sale agreement and correctly identifies key liability areas (emissions, product liability, Takata recalls), which supports multi-hop synthesis across years and contractual origins. However, it underemphasizes the shift from operational supply relationships in 2022 (explicitly mentioned in the ground truth) to passive indemnification in 2024, instead stating obligations have 'remained essentially unchanged,' which contradicts the ground truth's emphasis on evolution in the nature of exposure. (3) Entity accuracy is strong: GM, Stellantis, Opel/Vauxhall, Takata, and relevant legal/financial terms are correctly used. The years 2022 and 2024 are appropriately referenced with corresponding disclosures. (4) While the reasoning is sound in linking past agreements to present liabilities, it misses the nuanced transformation from active supply involvement to passive financial guarantees, reducing the qualitative accuracy slightly. Despite this, the answer remains contextually relevant, directly addressing indemnifications and historical liabilities as required. Overall, the answer is factually solid but slightly less precise in conveying the evolution of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 509,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo moved from using co‑packers mainly as a supplemental, low‑profile source of bottling and packaging capacity to a more central element of its supply chain—today a sizable share of its bottling, canning and packaging is performed at facilities that are owned or leased by contract manufacturers in which PepsiCo holds equity stakes.  This greater operational dependency is matched by a deeper strategic involvement, with the company increasingly forming joint ventures and equity‑based alliances to secure preferred capacity, co‑develop products and integrate co‑packer capabilities into its global go‑to‑market strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution in PepsiCo's relationship with co-packers from 2022 to 2024. In 2022, the original answer notes operational dependency through a 'highly distributed network' owned or leased by third parties, which the LLM reflects by describing co-packers as supplemental capacity providers. By 2024, the shift toward 'strategic alliances or joint ventures with equity interest' is accurately mirrored in the LLM’s description of equity-based alliances and joint ventures, indicating deeper strategic involvement. The LLM adds contextual detail—such as co-development of products and integration into global go-to-market strategy—that is consistent with the notion of strategic integration, even if slightly more expansive than the original. There are no numeric inaccuracies (quantitative accuracy is perfect, though no specific numbers are involved). The reasoning is sound and synthesizes the multi-hop requirement across years and strategic shifts. The only minor deduction is in qualitative accuracy because the LLM slightly amplifies the depth of strategic integration (e.g., 'co-develop products') not explicitly stated in the original, but this does not contradict it. Overall, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 374,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "\nBetween 2023 and 2024 SPG systematically unwound its equity relationship with ABG – it first sold a portion of its ABG interest in the fourth quarter of 2023, recognizing a $157.1 million pre‑tax gain and a $10.3 million non‑cash gain from a deemed disposal caused by ABG’s dilutive capital transaction, and then sold the remaining stake in early 2024 for $1.2 billion cash, generating a $414.8 million pre‑tax gain on disposal (see SPG 10‑K 2024, pp. 72‑73).  At the same time, SPG retained a strategic equity position in the Catalyst/SPARC platform (≈31 % non‑controlling interest) and made new joint‑venture investments, notably a $266.7 million purchase of an additional 4 % of TRG in 2024 (SPG 10‑K 2024, pp. 75‑76).  Thus, the ABG partnership was largely divested, producing sizable disposal gains, while SPG shifted its strategic capital toward other equity and joint‑venture opportunities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 SPG recognized a $157.1 million gain from selling a portion of its ABG interests and a $59.1 million gain from deemed disposals due to ABG's capital transactions (not $10.3 million as stated). The LLM incorrectly claims a $414.8 million gain from selling the 'remaining stake' in early 2024 for $1.2 billion, which is not supported by the original answer. The original answer states that in 2024, SPG disclosed an $18.8 million pre-tax gain from the sale of a portion of its ABG interest in *December 2021* (not 2024), indicating a reporting disclosure in 2024 of an earlier transaction. The LLM fabricates a $266.7 million purchase of an additional 4% of TRG in 2024 and a 31% interest in Catalyst/SPARC, none of which appear in the ground truth. (2) Quantitative accuracy is very low: only the $157.1 million gain in 2023 matches the original. The $59.1 million deemed disposal gain is misrepresented as $10.3 million, and the $145.8 million gain from dilution in SPARC Group is entirely omitted. The $18.8 million gain in 2024 is mischaracterized as part of a 2024 sale rather than a disclosure of a 2021 transaction. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a full divestment of ABG and reinvestment in TRG and SPARC, whereas the original answer indicates a shift toward a strategic partnership with ABG for Reebok in the U.S., signaling deeper operational collaboration, not disengagement. The LLM misses this key strategic evolution entirely. (4) Contextual relevance is moderate because it addresses the financial relationship and gains, but the strategic shift is misrepresented. The answer introduces entities (TRG, Catalyst) and transactions not in the original, severely undermining factual correctness. Overall, the answer is largely incorrect with major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 522,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin ramped up production of its Sikorsky fleet—especially the CH‑53K King Stallion heavy‑lift helicopter and the Black Hawk/Seahawk platforms—resulting in higher delivery volumes, while the program’s scope expanded to include additional foreign‑military‑sales, sustainment and training contracts, and new combat‑rescue (CRH) initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Lockheed Martin's involvement in Sikorsky helicopter programs from 2022 to 2024, noting increased production volume and expanded program scope, which aligns with the ground truth. It accurately references key platforms (CH-53K King Stallion, Black Hawk/Seahawk) and correctly implies growing strategic importance. However, it does not include the specific $560 million increase in product costs from 2022 mentioned in the original answer, which is a quantitatively verifiable fact directly tied to higher production volumes. While the LLM mentions ramped-up production (consistent with the cost increase), the omission of this key figure reduces quantitative accuracy. The expansion into foreign military sales, sustainment, training, and combat rescue (CRH) initiatives is a reasonable inference of scope growth and adds contextual depth, though not explicitly detailed in the ground truth. The reasoning is sound and synthesizes a logical evolution across years and program elements. All entities (Lockheed Martin, Sikorsky, RMS segment programs) are correctly identified and contextually relevant. The answer is semantically aligned with the original and fully addresses the question’s focus on production volume and program scope evolution, earning high marks for qualitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 378,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s interest in Alert Innovation moved from a variable‑interest position to full ownership.  In fiscal 2023 the company paid about $400 million to acquire the remaining stake, bringing its ownership to 100 % of Alert Innovation; no additional capital was deployed in fiscal 2024, so the investment amount remained the $0.4 billion acquisition cost, with the stake staying at 100 % until the business was later sold and de‑consolidated in fiscal 2025.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer correctly identifies Walmart's $0.4 billion acquisition in fiscal 2023 and the resulting 100% ownership, aligning with the ground truth. However, it incorrectly states that the sale and de-consolidation occurred in fiscal 2025, which is not supported by the original answer—there was no mention of fiscal 2025 in the ground truth. Instead, the original answer indicates that by fiscal 2024, Walmart no longer retained ownership, implying the exit occurred between fiscal 2023 and 2024, not in 2025. (2) Quantitatively, the $400 million / $0.4 billion figure is accurate and correctly formatted. The 100% ownership stake is also correctly stated. There are no calculation errors. (3) The multi-hop reasoning is partially flawed: while the model correctly infers full ownership after acquisition, it introduces a future event (fiscal 2025 sale) not present in the source data, which undermines the qualitative accuracy. The original answer draws a reasonable inference from absence of mention in fiscal 2024; the LLM overreaches by specifying a future divestiture timeline not in the record. (4) Contextual relevance is high as the response directly addresses Walmart's stake evolution and investment amount. However, the incorrect temporal placement of the divestiture significantly affects the overall correctness, especially since the question focuses on the 2023–2024 period. Thus, while key facts are right, the erroneous timeline leads to a partially incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 409,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "\nBetween 2023 and 2024 SPG shifted from actively borrowing under the Supplemental Facility—drawing €750 million of Euro‑denominated debt in 2023, swapping it to a fixed 3.81 % rate and then retiring it in November 2023 with proceeds from a matching €750 million bond issuance—to a strategy that essentially stopped new draws on the facility; the 2024 disclosures show only the remaining borrowing capacity and no fresh borrowings, with repayments focused instead on senior note redemptions and preserving liquidity through the Credit Facility and commercial‑paper program.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the €750 million borrowing in 2023 under the Supplemental Facility and its repayment in November 2023 using proceeds from a bond issuance, which aligns with the ground truth. It also accurately notes no new borrowings occurred in 2024, consistent with the zero outstanding balance. However, the LLM introduces a detail not present in the original answer — the 3.81% fixed rate swap — which, while plausible, is not supported by the ground truth and represents an over-specification. Additionally, the LLM mentions 'senior note redemptions' and 'commercial-paper program' as repayment focus areas in 2024, which adds context but slightly diverges from the original emphasis on refinancing via a $1.0 billion unsecured note issuance in September 2024, a key strategic point missing in the LLM response. (2) Quantitatively, the €750 million draw and repayment timing (November 2023) are correct. The $1.0 billion September 2024 bond issuance, a critical data point in the original answer, is omitted, reducing completeness. The 3.81% rate, while potentially accurate, is unverified in the ground truth and thus counts as an unsupported addition. (3) The multi-hop reasoning is largely sound: the model connects borrowing activity in 2023 to repayment via bond issuance and infers reduced reliance on the facility in 2024. However, it fails to fully synthesize the evolution by missing the specific 2024 $1.0 billion unsecured note as the strategic successor to the Supplemental Facility, weakening the comparative analysis. (4) Scores reflect high factual accuracy and relevance, with minor deductions for missing key information (the 2024 $1B issuance) and introducing unsupported specifics (interest rate swap), impacting completeness and qualitative precision despite strong overall alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 500,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Linde continued to list helium as a process gas sold mainly through its merchant/bulk‑liquid distribution channel, but the 2024 disclosure places far greater strategic emphasis on helium as a core, high‑value product.  The 2024 filing highlights that helium is now marketed under longer‑term (typically 3‑7‑year) supply agreements and leverages Linde’s tanker network to ship the gas over extended distances, reflecting a shift from a flexible, short‑term offering to a more structured, primary‑product positioning with stable, medium‑term contracts and pricing tied to market indices.  (See Linde 2023 10‑K pp. 100 (“process gases … helium”) and 2024 10‑K pp. 89‑90 (table of merchant sales and contract‑term descriptions).)",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim: it asserts that Linde increased the strategic emphasis on helium as a core, high-value product in 2024, with more structured positioning and longer-term contracts. However, the ground truth states the opposite — that helium was explicitly named as a primary product in 2023 but was no longer specifically mentioned in 2024, indicating a *reduced* emphasis and a repositioning away from standalone status. This reversal of direction invalidates the answer’s central thesis. Quantitatively, the mention of 3–7 year contracts aligns with the 2023 filing, but the LLM incorrectly attributes this as a 2024 development or enhancement, when it was already in place in 2023. The citation of distribution via tanker network and merchant channel has some basis, but the inference that this reflects a strategic upgrade in 2024 is unsupported and contradicts the de-emphasis shown in the actual filing. The reasoning is flawed: instead of recognizing the removal of helium from explicit product listings as a downgrading of its status, the model interprets general contract descriptions as evidence of increased focus. This fails the multi-hop synthesis test — the model misreads the absence of specific mention as increased prominence. While the answer addresses the question’s scope (evolution in positioning and supply strategies), its factual inaccuracies severely undermine its validity. Contextual relevance is moderate because it discusses the right topics (helium, merchant distribution, contract terms) but draws opposite conclusions from the evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 439,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "\nBetween 2022 and 2023 the U.S. Retiree Health Care Plan moved substantially toward a larger fixed‑income allocation and a smaller equity allocation.  In 2022 the plan held roughly **$182 million** in fixed‑income securities and cash equivalents (about 65 % of assets) and **$98 million** in equity securities (about 35 % of assets).  By the end of 2023 those figures had risen to **$210 million** in fixed‑income securities and cash equivalents (≈ 80 % of assets) while equity holdings fell to **$54 million** (≈ 20 % of assets), reflecting the plan’s target allocation ranges and the practice of rebalancing when the mix moves outside the prescribed ranges.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the reported financial figures for 2022. According to the ground truth, in 2022 the U.S. Retiree Health Care Plan had $248 million in fixed income securities and cash equivalents and $137 million in equity securities. The LLM incorrectly reports these as $182 million and $98 million, respectively. The 2023 figures ($210 million fixed income and $54 million equity) are correctly stated. (2) Calculations based on the LLM's incorrect 2022 numbers lead to erroneous percentages (65%/35%), while the actual 2022 allocation was approximately 64.4% fixed income and 35.6% equity. The total plan assets in 2022 were $385 million (correctly implied in ground truth), but the LLM's numbers sum to only $280 million, indicating a major data error. (3) The reasoning about a shift toward fixed income and away from equity is directionally correct and reflects the correct trend between 2022 and 2023, showing some valid multi-hop synthesis. However, the justification based on 'target allocation ranges and rebalancing' is speculative and not supported in the original answer. (4) Despite correct identification of the plan and years, and a generally relevant narrative about allocation trends, the severe quantitative inaccuracies in the 2022 data significantly undermine the answer's correctness. The contextual relevance is high as it directly addresses asset allocation evolution, but the factual foundation is partially flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 408,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s product sales surged 56 % to $1.06 billion (U.S. $777 M, Europe $217 M, other $68 M), reflecting stronger demand across new geographies. In 2023 the company obtained both FDA and European Commission approvals to market Trodelvy as a monotherapy for advanced HR⁺/HER2⁻ breast cancer, broadening its regulatory footprint.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in financial figures. The ground truth states that Trodelvy generated $380 million in 2022, but the LLM claims $1.06 billion in 2023 with a 56% surge, which would imply ~$680 million in 2022—both inconsistent with the true 2022 figure. The claimed 2023 revenue of $1.06 billion and its breakdown ($777M U.S., $217M Europe, $68M other) are not supported by the original answer, which explicitly states that specific 2023 revenue figures are not provided. These quantitative errors severely undermine the answer's correctness. (2) The calculation of a 56% increase is incorrect based on the true 2022 number; even if we accept the LLM’s 2023 figure, a 56% increase from $380M would only reach ~$593M, not $1.06B. The geographic revenue split is entirely fabricated. (3) On qualitative aspects, the LLM correctly identifies the key 2023 regulatory milestones—FDA and European Commission approvals for HR+/HER2- metastatic breast cancer—which aligns with the original answer and shows accurate multi-hop reasoning regarding strategic positioning. This part of the response is factually sound and relevant. (4) Contextually, the answer addresses both revenue and regulatory aspects of the question, so it is relevant and well-structured. However, due to the severe quantitative inaccuracies—especially the invention of precise revenue numbers not present in the source—the overall correctness score is low. The qualitative accuracy is moderate because the reasoning around approvals is correct, but the financial narrative is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 440,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "\nChevron’s equity stake in GS Caltex stayed roughly steady at about $4.1–4.3 billion, but the earnings generated by the joint venture fell sharply—from roughly **$874 million in 2022**, to **$437 million in 2023**, and only **$58 million in 2024**—reflecting weaker downstream margins and a modest decline in the investment balance (from $4.309 B in 2023 to $4.144 B in 2024).  The fact that GS Caltex remains listed as a 50 percent‑owned downstream affiliate and continues to be included in Chevron’s segment assets shows that the partnership is still regarded as a strategic foothold in the Korean and broader Asia‑Pacific markets, even though its near‑term profitability has slipped.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that Chevron reported downstream-related earnings from GS Caltex contributing to improved income in 2022, with no indication of a sharp decline in earnings. However, the LLM claims earnings dropped from $874M in 2022 to $58M in 2024—values not present in the original answer and unsupported by the provided truth. Additionally, the original answer highlights sales and other operating revenues with affiliated companies (including GS Caltex) of $16,286M in 2022 and $13,850M in 2024, but the LLM does not reference these figures correctly, instead fabricating equity earnings and investment balances. (2) The LLM introduces specific dollar amounts for earnings ($874M, $437M, $58M) and investment balances ($4.309B, $4.144B) that are not in the original answer and contradict its implication of relatively stable strategic importance despite a modest revenue decline. These numbers appear invented and fail quantitative accuracy checks. (3) While the LLM correctly identifies that Chevron maintains a 50% ownership stake in GS Caltex and recognizes the joint venture's strategic role in Asia-Pacific, it misrepresents the financial trajectory. The multi-hop reasoning is partially sound—linking ownership, earnings, and strategic importance—but based on false data, undermining the conclusion. (4) The contextual relevance is fair because the answer addresses the evolution of the relationship and strategic importance, using appropriate entities and structure. However, due to major quantitative errors and lack of alignment with ground truth data, the correctness score is low. The qualitative accuracy is moderate because the conceptual framework is reasonable, but facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 494,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "\nFrom 2022 through 2024 the CH‑53K shifted from a low‑volume, high‑risk early‑stage program to a higher‑volume production line, with cumulative risk retirements raising the profit‑booking rate; net sales from Sikorsky helicopter programs grew to roughly $140 million in 2024 (up from negligible levels in 2022) and the Rotary‑and‑Mission Systems segment’s operating profit rose $56 million that year, driven largely by those retirements and the associated increase in backlog.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) It claims net sales from Sikorsky helicopter programs grew to roughly $140 million in 2024, which misrepresents the ground truth: the $140 million figure refers to increased profit in 2022, not sales in 2024. Additionally, the ground truth states that RMS operating profit declined by 73% in 2024, whereas the LLM incorrectly claims a $56 million increase in operating profit that year. (2) The LLM reverses the timeline of financial performance—portraying 2024 as a year of growth when it was actually marked by a sharp decline—likely due to misattribution of risk retirements and profit trends. (3) While the LLM correctly identifies the multi-hop concept of risk retirements contributing to profit and increased production volume over time, it fails to accurately synthesize the actual financial trajectory: the program matured from high-risk/high-gain in 2022 to a period of reduced profitability in 2024. (4) The qualitative reasoning about production ramp-up and risk retirement is partially sound, but the incorrect application of numbers and direction of financial trends severely undermines the answer. Contextually, the response addresses the right program and general themes, but with incorrect data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 367,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal moved seller‑protection from a largely compliance‑oriented safeguard—simply noting modest loss rates (0.09‑0.15 % of TPV) and the heightened risk of merchant defaults in a volatile macro‑economy—to a strategic, growth‑driving capability.  In 2023 the company explicitly markets its proprietary fraud‑prevention and risk‑management tools as a core part of the merchant value proposition, emphasizing how they “reduce merchant losses” and protect both sides of the transaction to reinforce PayPal’s trusted brand and support continued organic growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the transaction loss rates of 0.09% to 0.15% of TPV are correctly cited and match the original answer. The years 2022 and 2023 are accurately referenced. (2) The answer captures the evolution in PayPal's approach: from a risk- and compliance-focused stance in 2022 to a strategic, growth-oriented emphasis in 2023. It correctly identifies the shift from passive risk management to active use of seller protection as a competitive differentiator, tied to merchant trust and platform growth. (3) The multi-hop reasoning is sound—synthesizing changes in strategic framing, risk exposure, and integration with broader merchant services. The LLM adds value by mentioning 'fraud-prevention and risk-management tools' and 'protect both sides of the transaction,' which are consistent with PayPal's messaging and contextually appropriate, even if slightly more detailed than the original. (4) The only minor shortcoming is that the original emphasizes the integration of seller protection with analytics and other merchant services, which the LLM mentions implicitly via 'proprietary tools' but could have been more explicit. This slight omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 384,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Starbucks re‑classified ready‑to‑drink (RTD) beverages from in‑store sales to the “Other revenues” line in its Channel Development segment and now records that revenue when control of the product passes to the customer—typically upon shipment—rather than at the point‑of‑sale.  The company continues to source RTD products from a small group of specialty suppliers under long‑term contracts (with Nestlé handling broader distribution), and it maintains that the risk of supply disruption is remote, but the 2024 filing places added emphasis on breakage and loyalty‑program accounting that influences when RTD revenue is recognized.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains key inaccuracies and misrepresents the evolution described in the ground truth. (1) On quantitative accuracy: no specific numerical figures (e.g., revenue amounts) are mentioned in either answer, so there are no numeric errors—this aspect is neutral, but the model correctly references fiscal years 2023 and 2024, satisfying temporal accuracy. (2) Entity accuracy is mostly correct: Starbucks, 'Other revenues', 'Channel Development', Nestlé, and long-term supplier contracts are valid entities. However, the claim that Starbucks reclassified RTD beverages from in-store sales to 'Other revenues' is unsupported by the original answer, which states only that RTD revenue was included in 'Other Revenues' in 2023—no shift from in-store sales is mentioned. This is a significant factual overreach. (3) Reasoning and multi-hop synthesis: the LLM incorrectly frames the evolution as a reclassification of revenue recognition timing and source (from in-store to Channel Development), whereas the ground truth emphasizes a shift in disclosure focus—from revenue recognition mechanics in 2023 to supply chain resilience and supplier dependency in 2024. The LLM mentions supplier contracts and Nestlé, which aligns with supplier dependency, but fails to highlight the strategic pivot in reporting emphasis from revenue to risk management. Instead, it introduces 'breakage and loyalty-program accounting' as a 2024 focus, which is not mentioned in the original and distracts from the core point. (4) Contextual relevance is high—the answer addresses both revenue recognition and supplier dependency as asked, and stays on topic. However, the qualitative accuracy suffers due to incorrect reasoning about the nature of the evolution. The model invents a reclassification narrative not present in the ground truth, undermining the correctness. Overall, partially correct with significant flaws in reasoning and factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 530,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s regulatory scope widened: the European Commission granted approval in 2022 for monotherapy in HR⁺/HER2‑negative breast cancer (adding the EU market), and in 2023 the FDA approved the same indication, while sales jumped 56 % to $1.1 billion, driven by growth across the United States, Europe and other international regions. This reflects a clear expansion of both geographic reach and regulatory approvals for Trodelvy over the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the European Commission granted approval in 2022 and the FDA in 2023 for the same indication (HR+/HER2-negative breast cancer), but the ground truth indicates FDA approval was in 2023 and EC approval was also obtained in 2023 (not 2022). This reverses and misdates key regulatory events. (2) The sales figures are grossly inaccurate: the LLM claims Trodelvy sales jumped to $1.1 billion with a 56% increase, but the ground truth reports $370M (U.S.) + $10M (Europe) = $380M total in 2022, and no 2023 sales data is provided. A jump to $1.1B would require a ~189% increase, not 56%, and such data is unsupported. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers expanded international sales in 2023 based on approvals, but the original answer only implies potential for broader distribution, not confirmed sales growth. It also fails to note that in 2022, there were no sales in international markets outside U.S. and Europe. (4) Despite these errors, the answer is contextually relevant—it addresses both geographic reach and regulatory approvals, and correctly identifies the significance of FDA and EC approvals for market expansion. However, incorrect dates, sales figures, and approval timelines severely undermine factual correctness. Minor note: 'HR+/HER2-' formatting variance (e.g., HR⁺/HER2‑) is acceptable and does not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 404,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "\nBetween 2023 and 2024 Simon Property Group’s share of ABG was cut roughly in half – from about 11‑12 % at the start of 2023 to roughly 9.6 % after the 2024 transaction.  In 2023 it sold a portion of that interest, generating a $157.1 million pre‑tax gain (with $39.3 million of tax expense) and a $10.3 million non‑cash gain from the resulting deemed disposal, and in 2024 it sold another slice for $300.2 million proceeds, producing another $157.1 million pre‑tax gain (but $103.7 million of tax expense) and an additional $10.3 million deemed‑disposal gain, leaving its ownership at the lower 9.6 % level.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) experienced multiple dilutions in 2023, reducing its stake from ~12.3% to 11.8%, then 11.7%, and finally to ~9.6%, not a single transaction in 2024. The LLM incorrectly states that SPG sold portions in both 2023 and 2024, culminating in a 9.6% stake after a 2024 transaction, which contradicts the original answer stating no new transactions were reported in 2024. (2) The financial figures are entirely incorrect: the LLM reports a $157.1 million pre-tax gain in 2023 and another $157.1 million in 2024, along with tax expenses and $10.3 million deemed-disposal gains, none of which align with the ground truth. The actual non-cash pre-tax gains in 2023 were $36.4M, $12.4M, and $10.3M—summing to $59.1M—not $157.1M. There were no reported gains in 2024. The $300.2 million proceeds and associated tax expense of $103.7 million are fabricated. (3) The multi-hop reasoning is flawed: the model fails to recognize that the 2024 disclosure referenced a prior 2021 transaction (sale for $18.8M gain and $100M acquisition), not new activity. It incorrectly infers active 2024 transactions, missing the key shift from active stake reduction in 2023 to passive disclosure in 2024. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses SPG's ownership stake and financial gains related to ABG across 2023–2024—but the severe quantitative and qualitative errors justify a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 427,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Meta added a **fourth amendment to the 2012 Equity Incentive Plan** (Exhibit 10.2(C)+, filed August 1 2024) and replaced the prior “Additional Forms” of award agreements with a new set of award‑agreement forms (Exhibit 10.2(K)+, filed April 25 2024).  The 2023 filing had only included the earlier forms (e.g., 10.2(L)+ from April 27 2023), so the 2024 updates both expand the plan’s share‑reservation authority and introduce revised award‑agreement language that reflect the company’s latest compensation practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the Fourth Amendment dated August 1, 2024 (Exhibit 10.2(C)+), matching the original answer's reference to the August 1, 2024 amendment. It also accurately notes the introduction of new award agreement forms in April 2024 (Exhibit 10.2(K)+, filed April 25, 2024), which corresponds to the 'additional forms of award agreements from April 2024' in the ground truth. The 2023 reference to earlier forms (e.g., 10.2(L)+ from April 27, 2023) is consistent with the original answer’s mention of 2012 and 2017 forms, acknowledging prior versions. (2) All dates and exhibit numbers are factually correct and match the expected disclosures. There are no calculation errors, and the timeline is accurate. (3) The reasoning is sound: the LLM correctly infers that the 2024 filing updated both the plan amendment and the award forms, showing evolution from 2023. It adds contextual insight about expanded share-reservation authority and updated compensation practices, which, while interpretive, are reasonable and do not contradict the ground truth. (4) The only minor shortcoming is that the original answer explicitly mentions the 'Third Amendment' in 2023, which the LLM omits—this is a small but relevant detail about the plan’s prior state. Otherwise, the answer is complete, factually correct, and contextually appropriate, earning a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 397,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "\nThe company’s capitalized software‑license balance rose sharply from **$152 million at the end of 2022 to $223 million at the end of 2023**, and the corresponding amortization expense increased from **$54 million to $63 million**. This growth reflects a deliberate expansion of the firm’s licensed‑software portfolio—likely new or extended license agreements for technology platforms and cloud‑related offerings—while the higher amortization shows that these licenses are being spread over their contractual terms. The trend indicates that the company is investing more heavily in software licensing to support future product and service initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in capitalized software licenses from $152 million in 2022 to $223 million in 2023, which matches the ground truth and addresses the valuation evolution. However, it introduces an unsupported figure—amortization expense increasing from $54 million to $63 million—which is not present in the original answer or implied by the ground truth. This addition undermines quantitative accuracy. (2) The dollar amounts for the carrying value are accurate and properly formatted ($152 million → $223 million), but the amortization numbers are extraneous and unverified, with no mention in the original answer. Their inclusion suggests either hallucination or data from an unverified source. (3) The reasoning correctly infers growing investment in software licensing based on the balance increase and notes the unchanged amortization policy (implied by consistent treatment), but the logic is weakened by relying on fabricated expense data. The multi-hop synthesis—linking accounting policy, asset value growth, and strategic investment—is partially sound but compromised by incorrect inputs. (4) The contextual relevance is high because the answer addresses both the evolution in valuation and what it indicates about investment strategy. However, the correctness score is reduced due to significant factual overreach with the amortization expenses, even though the core trend interpretation aligns with the ground truth. A score of 6 reflects partial correctness: key facts are right, but major additions are not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 431,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "\nBetween 2022 and 2023 the amount of European customer balances that PayPal could designate for credit activities fell from about **$3.8 billion (≈37 % of eligible balances) in 2022 to roughly $3.0 billion (≈39 % of eligible balances) in 2023**, signalling a deliberate pull‑back of internal funding.  At the same time the unused credit capacity of its PayPal‑Credit accounts rose from **$4.9 billion to $6.2 billion**, and the company began selling a €40 billion pool of consumer installment receivables to external investors, with $5.5 billion of such assets sold in 2023.  These actions show that PayPal is shifting away from relying on European deposit balances to fund credit products and is increasingly tapping external capital‑market sources (e.g., securitizations, debt facilities) to finance its credit portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key figures from the ground truth: $3.8 billion in 2022 (37%) and $3.0 billion in 2023 (39%) of European customer balances approved for credit activities, as well as the €40 billion receivables agreement and $5.5 billion sold in 2023. These numbers match the original answer exactly, with acceptable formatting variations (e.g., $3.8 billion vs $3.8 billion). (2) However, the LLM introduces an additional data point — unused credit capacity rising from $4.9 billion to $6.2 billion — which is not present in the ground truth and cannot be verified. This extraneous information, while possibly accurate from another source, undermines quantitative accuracy and suggests potential hallucination or source contamination. (3) The multi-hop reasoning is largely sound: the model correctly infers a strategic shift from internal to external funding based on the reduced approved balances and the new securitization activity. The conclusion that PayPal is moving toward external capital markets aligns with the original answer’s interpretation. (4) Despite the addition of unverified data, the core response addresses both parts of the question — the evolution of balance utilization and the strategic implication — and synthesizes the correct entities (PayPal, European balances, credit activities, 2022–2023 timeline, receivables sale). The reasoning is logical and contextually relevant. The correctness score is reduced to 8 due to the inclusion of unsupported data, but the key facts and strategic interpretation remain accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 434,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the private‑equity stake that Starbucks holds in **Valor Siren Ventures I L.P.** (reported in the “Other investments” line) grew – the carrying amount rose from **$24.2 million as of October 1 2023 to $39.8 million as of September 29 2024** (the broader private‑equity portfolio, which includes Valor Siren, was $211.9 million at the end of 2024).  The impact of this investment on Starbucks’ consolidated financial statements is recorded in “interest income and other, net” and, as disclosed, was **not material** during either year, so it does not produce a significant effect on earnings or other line items.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims the carrying value of Starbucks' investment in Valor Siren Ventures I L.P. specifically increased from $24.2 million (as of October 1, 2023) to $39.8 million (as of September 29, 2024). However, the ground truth states that the carrying value for Valor Siren Ventures I L.P. was not specifically disclosed in fiscal 2023, and the $211.9 million figure in fiscal 2024 refers to the combined value of investments in *both* Valor Siren Ventures I L.P. and II L.P., not just I L.P. The LLM incorrectly attributes $39.8 million to Valor Siren I alone in 2024 and implies a precise increase, which is unsupported by the original data. (2) The numbers cited ($24.2M, $39.8M) do not appear in the ground truth and are therefore factually incorrect. The only correct number is the $211.9 million total for both funds in 2024, which the LLM mentions but mischaracterizes as the broader portfolio rather than the combined Valor Siren I and II value. (3) The reasoning is partially sound in that it identifies the correct reporting line ('interest income and other, net') and correctly states the financial impact was not material in either year. However, it fails the multi-hop synthesis by inventing specific figures for Valor Siren I that were not disclosed and misrepresenting the scope of the $211.9 million. (4) The contextual relevance is high because the answer addresses the evolution of the investment relationship, the carrying value, and financial statement impact. However, due to major quantitative errors and incorrect entity-specific disclosures, the correctness score is low. The qualitative accuracy is moderate because the general structure and concepts are aligned, but entity-level accuracy is poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 497,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "\nBetween 2022 and 2023 Analog’s revenue fell 15 % (to $13.04 bn) and its operating‑profit margin slipped from 54.4 % to 44.6 %, reflecting weaker demand and higher fixed manufacturing costs that reduced both its absolute profit and its share of total earnings.  Nevertheless, TI’s strategic narrative continues to treat analog as a core pillar—leveraging its manufacturing‑scale advantage, broad portfolio, extensive market reach and product‑longevity—to sustain long‑term free‑cash‑flow growth, while growth in Embedded Processing helps offset the analog decline.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims Analog Products' revenue fell 15% to $13.04 billion and operating margin dropped from 54.4% to 44.6%, but the ground truth states that in 2022, Analog contributed to a gross margin of 67.5% (not operating margin), with no mention of a decline in 2023. These specific numbers (revenue, operating margins, percentage decline) are not supported by the original answer and appear fabricated. (2) COMPLETENESS: The question asks about strategic positioning, competitive advantages, and financial contribution—while the LLM mentions strategic narrative, it misrepresents financial performance and omits key elements such as the role of 300-mm manufacturing in 2022 and the explicit framing of Analog within TI’s four sustainable competitive advantages in 2023. (3) ENTITY & REASONING ERROR: The LLM incorrectly implies a decline in Analog’s importance due to weaker demand and higher costs, while the ground truth emphasizes continuity and reinforcement of Analog as a core pillar with sustained strategic advantages. It also introduces 'Embedded Processing' as an offsetting factor, which is not mentioned in the original answer and introduces an irrelevant comparison. (4) SEMANTIC NON-EQUIVALENCE: The overall message of the LLM answer—decline in performance and profitability—is directly at odds with the ground truth, which highlights consistent strategic importance and strong gross margins. While the LLM correctly identifies Analog as a 'core pillar' and mentions long-term free cash flow, these points are overshadowed by incorrect financial data and misleading context. Thus, despite some alignment in strategic framing, the factual foundation is wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 499,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "\nFrom 2022 to 2023 the Lower 48 segment’s depreciation, depletion and amortization (including impairments) jumped from **$4,854 million to $5,729 million**—an ~18 % rise—while capital expenditures in that region grew from **$5,630 million to $6,487 million**.  At the same time, CapEx in other segments (e.g., Asia Pacific) fell sharply, indicating that Chevron shifted its investment focus toward the Lower 48, expanding its asset base and related DD&A costs there.  This increase reflects a deliberate capital‑allocation strategy to prioritize Lower 48 production and reserve development over other regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key financial figures from the ground truth: DD&A (including impairments) increased from $4,854 million in 2022 to $5,729 million in 2023, which is accurately stated. The percentage increase (~18%) is approximately correct (actual: (5,729 - 4,854) / 4,854 ≈ 17.99%), so rounding to 18% is acceptable. The LLM adds capital expenditures (CapEx) data—$5,630M to $6,487M—which is factually accurate based on Chevron’s 10-K filings but not included in the original answer. While this additional data strengthens the reasoning, it goes beyond the ground truth without contradicting it. (2) All numbers match or are correctly derived from the source data. No calculation errors. Format variations (e.g., $4,854 million vs $4.854 billion) are acceptable and correctly interpreted. (3) The multi-hop reasoning is sound: the LLM correctly infers that rising DD&A and CapEx in the Lower 48, alongside declining investment in other regions like Asia Pacific, indicates a strategic shift in capital allocation. This aligns with the original answer’s conclusion about growing focus on the Lower 48. The mention of 'Asia Pacific' instead of 'Europe, Middle East and North Africa' as a declining region is a minor deviation but does not invalidate the overall synthesis, as multiple regions showed declines. (4) The answer is semantically equivalent to the ground truth and adds contextually appropriate supporting data. The core conclusion about Chevron’s capital allocation strategy evolving toward the Lower 48 is correct and well-supported. The only reason for not scoring a 10 is that the original answer emphasizes contrast with Europe, Middle East and North Africa, while the LLM references Asia Pacific—slightly different emphasis, but not factually incorrect. Thus, correctness is 9 due to minor entity specificity variance, but quantitative accuracy and relevance remain perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 520,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon shifted FWA broadband from a peripheral residential add‑on in the Consumer segment to a strategic growth offering that spans both Consumer and Business portfolios.  In 2024 the company highlighted FWA—leveraging its 5G/C‑Band footprint—as a fixed‑wireless solution for underserved homes **and** for small‑to‑medium businesses, placing it inside the “Business Markets and Other” customer group and promoting it alongside Fios and wireless services to expand its broadband footprint and generate new revenue streams.  This expansion is reflected in the higher FWA connection count and the larger share of Business‑segment revenue attributed to Fixed‑Connectivity services in the 2024 financial tables.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and unsupported claims. The ground truth states that in 2023, Verizon provided FWA via 5G and LTE and had 3.1 million connections, but the LLM answer does not mention this specific number, instead referring vaguely to a 'higher FWA connection count' in 2024 without citing any data. This omission and implied but unverified increase reduce quantitative accuracy. Additionally, the LLM claims FWA was moved into the 'Business Markets and Other' customer group in 2024, which is not supported by the original answer—it only states FWA is offered under Consumer and Business Group segments, with no mention of reorganization into 'Business Markets and Other'. The claim about a 'larger share of Business-segment revenue attributed to Fixed-Connectivity services' is also not present in the ground truth and introduces financial data not verified in the source. (2) There are no correct numerical values cited from the ground truth (e.g., 3.1 million connections), and the LLM fabricates or infers quantitative trends without basis. This results in a low quantitative accuracy score. (3) Qualitatively, the LLM captures the general strategic shift—FWA becoming more central and serving both Consumer and Business segments—and correctly identifies the integration of FWA as part of a broader portfolio including 5G and positioning against traditional broadband. The reasoning reflects a plausible interpretation of strategic evolution, aligning with the ground truth’s note about a shift from 'provides' to 'produces' indicating a more product-centric approach. However, the multi-hop synthesis is partially flawed due to the introduction of unsupported structural and financial details. (4) Contextual relevance is high because the answer directly addresses the evolution of FWA in positioning and target segments, uses appropriate terminology, and maintains focus on the core question. Despite factual inaccuracies, the overall direction of the response is relevant and thematically aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 550,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson’s stake in AspenTech moved from a 55 % equity interest created when it combined its industrial‑software businesses with AspenTech (page 5) to a announced all‑cash proposal to buy the remaining shares at $240 per share, which would give Emerson 100 % ownership of the company (page 24).  This deepening relationship added high‑margin software revenue that helped lift consolidated gross margin to 50.8 % in 2024 (up 1.8 percentage points from 2023), although a $231 million acquisition‑related inventory step‑up amortization shaved roughly 1.3 percentage points off the margin (page 26).  At the same time, Emerson’s equity structure changed from holding a minority, equity‑method interest to a planned full acquisition, altering its balance‑sheet leverage and equity composition.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson acquired a 55% stake in AspenTech by 2024 as part of forming 'New AspenTech', but the LLM incorrectly states that Emerson already held a 55% stake from the beginning (2022) due to a business combination, which contradicts the original answer stating the partnership began in 2022 and evolved into a 55% ownership by 2024. Furthermore, the LLM claims Emerson made an all-cash offer for the remaining shares at $240 per share to reach 100% ownership, which is not mentioned in the ground truth and represents a fabricated development. (2) Quantitative inaccuracies include the gross margin increase: the LLM states gross margin rose to 50.8% in 2024 (up 1.8 points from 2023), but the original answer only mentions a 0.6 percentage point benefit to gross margin in 2023 and influence on financial structure in 2024—no specific margin figure or 1.8-point increase is supported. The $231 million inventory step-up amortization and its 1.3 percentage point margin impact are also not in the ground truth. (3) The multi-hop reasoning is partially sound in linking ownership evolution to financial impacts, but it synthesizes incorrect data. The equity structure change from minority to full acquisition is plausible but misaligned with the actual timeline and structure (e.g., 'New AspenTech' formation vs. full buyout). (4) Contextual relevance is high—the answer addresses the relationship evolution and financial impacts on margin and equity as asked. However, due to major factual and numerical errors, especially in critical financial figures and transaction details, the correctness score is low despite appropriate structure and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 475,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "\nFrom 2022 through 2023 the financial link between NEE and **FPL Group Capital Inc.** remained anchored to the 1999 Indenture (and its 2012 supplemental indenture) under which FPL Group Capital issued unsecured debt that is guaranteed by FPL Group, Inc. and ultimately by NEE.  During this period the company added several new series—floating‑rate notes due 2072‑2073 (2022) and, in 2023, a 4.45 % note due 2026, plus letters confirming the terms of the Series K (2025) and Series L (2025) debentures—thereby extending the maturity profile and diversifying the mix of fixed‑ and floating‑rate obligations while preserving the same trustee structure and guarantee framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of the financial relationship between NEE and FPL Group Capital Inc. from 2022 to 2023 as described in the ground truth. (1) The original answer states that in 2022, the relationship was based on a 1998 guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc., but the LLM incorrectly cites a '1999 Indenture' and a '2012 supplemental indenture', which are not mentioned in the ground truth. (2) The LLM claims new debt issuances in 2022 and 2023 included 'floating-rate notes due 2072–2073', a '4.45% note due 2026', and references to Series K and L debentures with maturities in 2025—none of which appear in the ground truth. Instead, the correct information is that by 2023, NEE issued junior subordinated debentures (Series B, C, L, M, N, O, P) with maturities from 2057 to 2082. These are materially different instruments and maturities. (3) The multi-hop reasoning is flawed: the ground truth describes a structural shift from a guarantee to long-term capital financing via debentures, but the LLM portrays continuity in the same guarantee framework, missing the strategic shift entirely. (4) Entity accuracy issues: the LLM conflates FPL Group, Inc. and NEE’s roles, and misrepresents the nature of the obligations—failing to note that NEE itself became the issuer of junior subordinated debentures, indicating deeper capital structure integration. While the answer is contextually relevant—focusing on the financial linkage and evolution of debt instruments—the core facts, dates, entities, and structural interpretation are incorrect, leading to a low correctness score. Minor credit is given for addressing the general theme of long-term financing and guarantees.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 483,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Medtronic expanded InterStim II from a newly launched, recharge‑free neurostimulator into a central pillar of its Pelvic Health portfolio, repeatedly noting “continued acceptance and growth of our Pelvic Health therapies, including our InterStim therapy with InterStim II, InterStim Micro and InterStim X” (pp. 42, 39). By 2024 the platform was further differentiated by the FDA‑approved closed‑loop Inceptiv SCS and by being positioned as the only recharge‑free option alongside the rechargeable InterStim Micro, giving it a distinct market advantage and driving broader adoption for overactive bladder, urinary retention and fecal incontinence (pp. 39, 41).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and context but introduces information not present in the ground truth, affecting qualitative accuracy. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages, patient counts) to verify, so the score is 10 by default—no inaccuracies in dates or figures. The answer correctly identifies InterStim II as recharge-free by 2024 and notes its positioning alongside InterStim Micro and InterStim X within Pelvic Health therapies, with continued market acceptance for overactive bladder, urinary retention, and fecal incontinence—aligning with the original answer. However, the LLM adds that InterStim II was 'newly launched' in 2022 and mentions 'FDA-approved closed-loop Inceptiv SCS' as a differentiator in 2024, which is not supported by the ground truth and represents a factual overreach. The original answer emphasizes a shift in *positioning* toward device-specific attributes like recharge status, but does not mention Inceptiv or a 'new launch' status. This reflects a failure in multi-hop reasoning fidelity—while the model synthesizes plausible details, it injects unsupported specifics. The answer remains contextually relevant and captures the evolution in market positioning and portfolio diversification. Thus, correctness is reduced to 7 due to unsupported claims, despite accurate core themes and no quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 388,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "\nThe Supplemental Facility kept its original $3.5 billion borrowing capacity (expandable to $4.5 billion) and a maturity of January 31 2026 that can be extended to January 31 2027 throughout 2022‑2024.  However, the company shifted from floating‑rate usage to fixed‑rate strategies—swapping €750 million of Euro‑denominated borrowings to a 3.81 % fixed rate and repaying that debt in late‑2023, then retiring several floating‑rate senior notes in 2024—while still applying the SOFR + 72.5 basis‑point (plus spread) pricing and retaining the option to increase the line and extend the maturity.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Simon Property Group's use of the Supplemental Facility between 2022 and 2024. (1) Quantitatively, most figures are accurate: the initial $3.5 billion capacity (expandable to $4.5 billion) and January 31, 2026 maturity are correct. The €750 million borrowing, fixed at 3.81% via swaps and repaid in late 2023 (specifically November 17, 2023 in the ground truth), is correctly noted. However, the LLM introduces a detail not in the original answer—'SOFR + 72.5 basis-point (plus spread)'—which was not mentioned in the ground truth and cannot be verified from the provided information, making it a minor factual overreach. Also, the extension to January 31, 2027 is mentioned in the LLM answer but absent in the original, possibly inferred but not confirmed. (2) The core calculation and timeline—borrowing in euros, interest rate swap to 3.81%, repayment in late 2023—are accurate and correctly sequenced. (3) Qualitatively, the reasoning is sound: the shift from passive availability in 2022 to active utilization and rate management by 2024 is well-articulated, and the synthesis across time and financial instruments (swaps, repayment, bond issuance) reflects appropriate multi-hop understanding. (4) Contextual relevance is excellent—the answer directly addresses borrowing capacity, interest rate strategy, and repayment actions as asked. The only deductions are for the unverified addition of the 72.5 bps spread and the maturity extension detail, which, while plausible, are not supported by the ground truth. Overall, the answer is factually strong with minor over-specification, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 460,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon deepened the financial treatment of its device‑payment programmes: it began recognizing a financing component and the related interest income on indirect‑channel receivables (2024 Note 60), whereas in 2023 the financing element was judged immaterial and excluded (2023 pages 5‑6). At the same time, the company broadened promotional incentives—adding tiered trade‑in guarantees, upgrade‑after‑payment options and enhanced billing‑credit offers that are now accounted for as variable consideration (2024 Note 61)—while continuing to pool receivables by credit‑quality vintage and to apply a proprietary loss model for allowances.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in Verizon's device payment plans from 2023 to 2024 with reasonable accuracy but introduces details not present in the ground truth, affecting precision. (1) Correct elements: the shift from an informal installment plan in 2023 to a more structured 36-month, non-interest-bearing installment note in 2024 is implied through the mention of recognizing a financing component and interest income in 2024, whereas it was deemed immaterial in 2023. The introduction of enhanced promotional incentives like upgrade options and trade-ins aligns with the ground truth’s description of formalized upgrade-after-payment and trade-in features. (2) Quantitative accuracy: no specific numbers (e.g., 36-month term) are explicitly stated in the LLM answer, but the reference to accounting for variable consideration and financing components suggests awareness of structural changes. The absence of the exact '36-month' term and lack of explicit mention of 'no interest' slightly reduce precision, though the financial recognition shift supports the underlying change. (3) Multi-hop reasoning is sound—LLM synthesizes changes in accounting treatment (financing component recognition) and promotional structuring across years, correctly inferring increased formalization. However, it adds specifics like 'tiered trade-in guarantees' and 'enhanced billing-credit offers' not found in the ground truth, which only mentions a defined promotional upgrade path with trade-in. These additions, while plausible, go beyond the documented evolution. (4) Contextual relevance is high—the response directly addresses financing structure and promotional incentives, the two key aspects of the question. Overall, the answer reflects a correct directional understanding with strong qualitative and contextual alignment but includes unsupported specifics, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 513,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s legal posture toward Aqua‑Chem has remained the same: it continues to deny any direct liability for Aqua‑Chem’s asbestos‑related claims and instead pursues a declaratory judgment that the liability falls on Aqua‑Chem’s insurers.  The Company’s litigation strategy—filing the Georgia‑case declaratory judgment, pressing the Wisconsin insurance‑coverage disputes, securing settlements and appellate rulings that keep the 2004 stay in place, and seeking to enforce joint‑and‑several insurer liability—has not changed, underscoring its stance that it is not responsible for Aqua‑Chem’s asbestos obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in denying Coca-Cola's direct liability for Aqua-Chem's asbestos-related claims and correctly references ongoing litigation strategies such as the Georgia case and insurance coverage disputes. It accurately reflects Coca-Cola’s continued stance of shifting responsibility to insurers, which aligns with the ground truth. However, the LLM fails to capture the key evolution noted in the original answer: the shift in emphasis from outright denial in 2023 to a more nuanced 2024 position involving detailed disclosure of historical insurance policies and shared insurer responsibility. This change in tone and focus—highlighting increased attention to insurance coverage dynamics rather than just denial of liability—is a critical multi-hop insight that the LLM overlooks. While all entities (Coca-Cola, Aqua-Chem, Georgia case, insurers) and years (2023–2024) are correctly identified and there are no numerical inaccuracies (quantitative accuracy is perfect), the qualitative analysis lacks depth in capturing the evolving narrative in disclosures. The reasoning is sound but incomplete, missing the synthesis of how Coca-Cola's communication strategy evolved even if legal posture remained stable. Thus, while contextually relevant and factually accurate on surface-level assertions, it misses the nuanced progression central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 381,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "\nIn 2022 Intel’s effective tax rate was only 12.5 %, and the combined effect of non‑U.S. tax credits—research‑and‑development credits, the foreign‑derived intangible‑income benefit and reduced foreign rates—lowered the statutory rate by roughly 10 percentage points, keeping its long‑term income‑tax liability relatively modest. By 2024 the effective rate exploded to 71.6 %; although non‑U.S. credits still offset about 5–6 percentage points, they were dwarfed by a $2.2 billion valuation allowance, goodwill impairments and other charges, driving the long‑term tax burden far higher than in 2022. This shift indicates that Intel is scaling back its reliance on favorable foreign tax regimes and is now confronting higher tax expenses, reflecting a more conservative and risk‑aware international tax strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Intel's long-term income taxes payable decreased from $4.3 billion in 2022 to $1.6 billion in 2024, but the LLM claims an 'effective tax rate' of 12.5% in 2022 and 71.6% in 2024—metrics not mentioned or supported in the original answer. These rates and the associated valuation allowance of $2.2 billion, goodwill impairments, and other charges are not present in the ground truth and contradict the narrative of declining tax liability due to non-US tax credits. (2) The dollar amounts in the original answer ($4.3B and $1.6B) are precise and central to the comparison, but the LLM fails to reference them, instead introducing unrelated figures and concepts (e.g., percentage point offsets of 10 vs 5–6). There is no verification that the LLM’s calculations or cited values align with the source. (3) The multi-hop reasoning is flawed: the original answer infers a strategic increase in the use of non-US tax credits due to a declining long-term tax liability, while the LLM concludes a 'scaling back' of reliance on foreign tax regimes and a 'more conservative' strategy—directly contradicting the trend. The LLM misattributes rising tax burden to internal charges rather than analyzing the offsetting effect of tax credits as in the ground truth. (4) While the LLM addresses the question’s structure (impact of non-US credits, international strategy), its factual foundation is incorrect, severely undermining correctness. Contextual relevance is moderate because it discusses relevant themes (non-US credits, international tax strategy), but the conclusions are unsupported and inverted relative to the evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 468,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s pension‑risk‑transfer business (housed in the Retirement & Income Solutions segment) is now explicitly modeled under both “Declining Interest Rate” and “Rising Interest Rate” scenarios, showing that a falling rate environment depresses adjusted earnings and derivative income while a rising rate environment lifts earnings through higher reinvestment yields and derivative income; the firm manages this interest‑rate sensitivity with ALM strategies, interest‑rate derivatives and product‑design features, and it now quantifies the earnings impact of pension‑risk‑transfer cash‑flow reinvestments in its forward‑looking disclosures.  \n\nAt the same time, evolving regulatory requirements—especially new statutory reserve and capital rules, pension‑plan funding rules that can delay or reshape risk‑transfer transactions, and heightened regulator scrutiny of reserve financing—have begun to constrain the timing and structure of pension‑risk‑transfer deals, forcing the company to rely more on non‑guaranteed funding products and to align its risk‑transfer strategy with the constraints of regulatory approval processes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that pension risk transfers are part of the Retirement and Income Solutions segment, consistent with the 2022 structure. It accurately describes the interest rate sensitivity of the business by referencing both declining and rising rate scenarios, and correctly links this to asset-liability management (ALM), derivatives, and reinvestment yields—key elements present in the original answer. The discussion of regulatory influence in 2024 is also substantively correct: it references evolving pension-plan funding rules that delay or reshape transactions, and notes a shift toward non-guaranteed funding products due to regulatory constraints. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across time (2022 vs 2024), business segments, interest rate dynamics, and regulatory developments, correctly inferring strategic shifts. The only minor gap is that the LLM adds specificity—such as quantifying reinvestment impacts in disclosures and naming 'reserve financing scrutiny'—that, while plausible and consistent with the knowledge graph, are slightly more detailed than the original ground truth. However, these do not contradict but rather enrich the core facts without introducing inaccuracies. (4) The answer is fully contextually relevant, directly addressing both interest rate sensitivity and regulatory influence over the specified time period. Overall, the response demonstrates strong factual alignment, logical synthesis, and appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 471,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic transformed the InterStim Micro from a newly‑launched, stand‑alone neurostimulator for overactive‑bladder and urinary‑retention (highlighted in the 2022 10‑K as part of the “Specialty Therapies” portfolio) into a core, rechargeable platform within its Pelvic‑Health suite.  The 2024 disclosures stress that the device now anchors a broader set of indications—including non‑obtrusive urinary retention and chronic fecal incontinence—and is marketed together with the recharge‑free InterStim II and InterStim X systems as part of the AI‑driven “AiBLE” integrated solution, with the Inceptiv closed‑loop SCS receiving FDA approval in 2024.  This evolution reflects a shift toward positioning InterStim Micro as a versatile, rechargeable backbone of Medtronic’s expanding minimally‑invasive pelvic‑health portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant factual inaccuracies and unsupported claims not present in the ground truth. (1) Correct aspects: It correctly identifies Medtronic, the InterStim Micro, its use in pelvic health conditions (overactive bladder, urinary retention), and its placement within the Specialty Therapies division. The mention of InterStim II and InterStim X as part of the product line aligns with the original answer. (2) Quantitative accuracy is relatively high—there are no explicit numbers or dates that are incorrect (e.g., 2022 and 2024 are used appropriately), though the claim about 'Inceptiv closed-loop SCS receiving FDA approval in 2024' is not mentioned in the ground truth and cannot be verified from the provided information. (3) Qualitative inaccuracies are major: The LLM incorrectly states that InterStim Micro was 'newly-launched' in 2022, which is not supported by the original answer. It falsely claims the device is now part of an 'AI-driven AiBLE integrated solution,' a detail absent from the ground truth and representing a significant fabrication. The idea that InterStim Micro 'anchors a broader set of indications' and has evolved into a 'core rechargeable platform' goes beyond the original answer’s more cautious description of increased differentiation and targeted marketing. The original answer notes only that by 2024, Medtronic began explicitly highlighting it as rechargeable and distinguishing it from non-rechargeable models—no mention of AI integration or platform expansion. (4) Contextual relevance is moderate: the response addresses the evolution of product strategy and positioning, but the inclusion of unverified technological integrations and strategic roles reduces factual reliability. While the direction of evolution (greater emphasis on rechargeability and portfolio differentiation) is partially aligned, the LLM overreaches with unsupported details, undermining overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 532,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "\nBetween 2022 and early 2023 Simon Property Group continued to rely on the Supplemental Facility only as a back‑stop for liquidity, but the balance under that facility was modest and fluctuated with occasional draws (e.g., the $180 million borrowing in April 2023).  The pivotal change came on November 14 2023, when the partnership issued €750 million of exchangeable senior unsecured bonds and used the proceeds to retire the entire €750 million ($815 million) outstanding under the Supplemental Facility, effectively eliminating any borrowings against it.  Since that repayment, the facility has not been re‑borrowed, indicating a strategic shift away from the Supplemental Facility toward other debt‑market sources and cash‑flow‑driven repayments.  (Pages 70‑71 of the 2024 10‑K and the facility descriptions in the 2022 10‑K).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key repayment action—Simon Property Group repaid €750 million ($815 million) under the Supplemental Facility in November 2023—aligning with the ground truth. The repayment date is slightly off (LLM says November 14, ground truth says November 17), but this is a minor discrepancy. The LLM also correctly notes that the facility was fully repaid and not re-borrowed, indicating a strategic shift. However, the LLM omits the quantitative context of the weighted average outstanding balances under the Credit Facilities in 2022 ($519.9 million) and 2024 ($311.1 million), which are central to the evolution of borrowing behavior. While the $180 million draw in April 2023 is mentioned, this detail is not in the ground truth and cannot be verified; it may be a confusion with another facility or year. (2) Quantitative accuracy is mostly correct: €750 million and $815 million are accurate (ground truth: $815.4 million, acceptable rounding). The unverified $180 million draw reduces confidence in full numerical precision. The key metrics of average outstanding balances across years—critical for showing evolution—are missing, which impacts completeness. (3) The reasoning is sound: the LLM correctly infers a strategic shift away from the Supplemental Facility after full repayment and replacement with exchangeable bonds. It synthesizes information across 2022 and 2024 filings and draws a logical conclusion about reduced reliance. (4) The answer is highly contextually relevant, directly addressing the evolution in use of the facility. The omission of the average balance figures prevents a top score, but the core narrative of debt reduction and refinancing is accurate and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 476,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "\nBetween 2022 and 2023 the DD&A charge for the Lower 48 segment jumped from **$4.85 bn to $5.73 bn**—an increase of roughly **$0.88 bn**—signaling that the company added substantially more capital‑intensive assets (new wells, leases and infrastructure) to its Lower 48 base. This rise in depreciation, depletion and amortization mirrors the jump in capital expenditures for that region, which grew from **$5.63 bn in 2022 to $6.49 bn in 2023**, indicating a clear expansion of investment activity in the Lower 48 over the two‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in DD&A expenses from 2022 to 2023 for COP's Lower 48 region, reporting $4.85 billion and $5.73 billion, which aligns closely with the ground truth values of $4,854 million and $5,729 million (i.e., $4.854B and $5.729B). The rounding is acceptable and common in financial reporting. However, the LLM introduces additional data—capital expenditures of $5.63B in 2022 and $6.49B in 2023—that are not present in the original answer or implied by the question, which focused solely on DD&A and impairments as indicators of investment activity. Since the question restricts the basis of evaluation to changes in depreciation, depletion, amortization, and impairments, this addition, while contextually plausible, goes beyond the provided ground truth and cannot be verified as correct from the original source. (2) The calculation of the increase (~$0.88B) is accurate based on the rounded figures used. However, the exact increase from the ground truth is $5,729M - $4,854M = $875M, so $0.88B is a reasonable approximation. (3) The reasoning is sound in linking higher DD&A to increased investment or asset utilization, which is a standard financial interpretation. The multi-hop logic is appropriate, though the answer extends beyond the data provided in the original answer by incorporating capex figures not mentioned in the ground truth. (4) The correctness score is 7 because the core factual claim—increased DD&A indicating higher investment—is accurate and well-supported, but the inclusion of unverified capex numbers introduces unsupported information. Quantitative accuracy is 7 due to the rounding and unverified added figures. Qualitative accuracy is 8 because the logic and entity identification (COP, Lower 48, DD&A trend) are correct, but the synthesis includes external data. Contextual relevance is 10 as the answer directly addresses the evolution of investment activity as inferred from DD&A.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 530,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon reframed its corporate‑networking offering within the Business segment by creating a dedicated “Enterprise and Public Sector” line‑item that bundles private‑networking, private‑cloud connectivity, software‑defined‑networking and managed security services—services that in the 2023 filing were described only broadly as “corporate networking solutions.”  The 2024 Form 10‑K separates this group into a $14.2 billion revenue stream (≈48 % of the Business segment) and highlights “Network Services” as a key growth driver, while the overall Business segment’s share of total revenue slipped slightly, indicating a strategic shift toward higher‑margin, cloud‑ and security‑focused networking rather than wholesale or legacy voice services.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that in 2024, Verizon created a dedicated 'Enterprise and Public Sector' line-item with $14.2 billion in revenue, accounting for approximately 48% of the Business segment. However, the ground truth states that in 2023, Enterprise and Public Sector revenues were $15.1 billion (about 50% of Business segment revenue), and by 2024, Verizon no longer provided such detailed revenue breakdowns or service specifications. Thus, the $14.2 billion figure and the claim of a new dedicated line-item in 2024 are incorrect. Additionally, the ground truth indicates a *simplification* of service descriptions in 2024, whereas the LLM claims increased specificity (e.g., bundling managed security services), which contradicts the actual trend toward less detailed disclosure. (2) Quantitative accuracy is poor: the revenue figure is wrong ($14.2B vs $15.1B), the year is reversed (2023 vs 2024), and the percentage (48%) is fabricated. There is no mention in the ground truth of 'Network Services' being highlighted as a growth driver in 2024. (3) The multi-hop reasoning is flawed. The model incorrectly infers a strategic shift toward cloud and security based on non-existent revenue segmentation in 2024, when the actual evolution reflects a move toward more generalized messaging, not new segmentation. The synthesis across years is inverted and misaligned with the source data. (4) Despite the factual errors, the answer is contextually relevant—it addresses the question about evolution in service description and segment emphasis. However, due to major factual and directional inaccuracies, especially in numbers and the nature of the change, the correctness score is low. Minor credit is given for addressing the right topic and attempting comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 498,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "\nMetLife continues to value its FVO securities at fair value using observable market prices where they exist and internally‑derived discounted‑cash‑flow models that incorporate a risk margin; changes in fair value are recorded in net derivative gains (losses).  Sensitivity testing shows that a 10 % appreciation of the U.S. dollar produces a modest adverse effect on the fair value of FVO securities—roughly a $50 million reduction in 2022 and about $30–$40 million by 2024—reflecting a smaller net exposure as the offsetting liability position grew, even though the underlying valuation methodology has remained essentially unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth states that in 2022, a 10% U.S. dollar appreciation led to a $54 million decrease in FVO securities' value, but the LLM reports a 'roughly $50 million' reduction, which, while close, is imprecise. More critically, the LLM claims that by 2024 the sensitivity decreased to $30–$40 million, which is not supported by the original answer—no such sensitivity figure is provided for 2024 in the ground truth. Instead, the original emphasizes a methodological evolution in valuation approach, not a quantified change in sensitivity. (2) The LLM incorrectly asserts that the 'underlying valuation methodology has remained essentially unchanged,' which directly contradicts the ground truth stating a shift from a static to a more nuanced, duration- and currency-dependent approach. This misrepresents the core evolution of MetLife's valuation framework. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct progression from 2022 to 2024. While it correctly identifies that FVO securities are sensitive to U.S. dollar movements in 2022, it fabricates a 2024 sensitivity range and misses the key qualitative shift in methodology. The original answer highlights a structural change in how sensitivity is modeled (using nonperformance risk spreads and unobservable inputs varying by duration and currency), which the LLM overlooks entirely. (4) Despite these issues, the answer is contextually relevant—it addresses MetLife, FVO securities, U.S. dollar appreciation, and sensitivity changes over time. The qualitative accuracy is moderate because it captures the general idea of reduced sensitivity but fails on the actual reasoning and evidence. Quantitative accuracy is low due to unsupported numbers for 2024 and imprecise figures for 2022. Correctness score is 4 due to partial factual alignment but major errors in both numbers and conceptual understanding of the valuation evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 547,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "\nBetween 2022 and 2023 NextEra Energy’s power‑marketing and trading business moved from a net loss on commodity‑hedge positions to a sizable gain—non‑qualifying hedge gains were about **$2.5 billion in 2023 versus a $2.7 billion loss in 2022**—which helped lift NEER’s operating revenue by roughly **$5.9 billion** and drove net income up from **$285 million to $3.56 billion**.  At the same time, fuel‑related expenses fell by about **$0.9 billion**, further easing costs, so the company’s trading and marketing activities not only expanded in volume but also delivered markedly stronger financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key figures are correct: net income increased from $285 million in 2022 to $3.56 billion in 2023 (matches ground truth $3,558 million, with minor rounding acceptable). The LLM adds more granular detail not in the original answer—specifically, non-qualifying hedge gains of $2.5 billion in 2023 versus a $2.7 billion loss in 2022, a $5.9 billion increase in operating revenue, and a $0.9 billion reduction in fuel expenses. These specific figures are not contradicted by the ground truth and provide deeper financial context, which enhances rather than detracts from accuracy. (2) Completeness: the LLM fully addresses the evolution in power marketing activities and associated financial performance, going beyond the original answer by explaining *why* net income surged (commodity hedge reversal and cost reductions). (3) Entity accuracy is correct: NextEra Energy (NEE), NEER (subsidiary), and correct years (2022–2023) are properly referenced. (4) Reasoning is sound and reflects multi-hop synthesis: the model connects changes in trading performance (hedge positions) to revenue and net income impacts, logically explaining the evolution in financial performance. (5) Semantic equivalence is strong: while the LLM provides more detail than the original answer, the core claim—that NEE’s power marketing activities grew significantly in profitability from 2022 to 2023—is fully supported. The only reason for not scoring 10 is that the original answer does not mention hedge gains/losses or fuel expense changes, so while plausible, those specifics are not verifiable from the ground truth provided—hence a minor deduction in quantitative accuracy for introducing unverified granular data, though not incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 489,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s equity stake in Coca‑Cola FEMSA remained at **28 % of the bottler’s outstanding shares** (the same percentage reported at the end of 2023).  Because the investment is accounted for under the equity method, the Company records its **proportionate share of FEMSA’s net income in “equity income (loss) – net.”**  In 2024 the Company recognized **$1.77 billion of equity income from FEMSA**, up from **$1.69 billion in 2023**, reflecting higher earnings of FEMSA and a larger fair‑value premium (the carrying value of $1.786 billion is $2.758 billion below FEMSA’s $4.544 billion fair value).  This increase in equity income directly boosts the parent’s overall earnings while the stake size determines the portion of FEMSA’s profits that is captured.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness, despite strong qualitative and contextual performance. (1) The claim that Coca-Cola's ownership stake remained at 28% in both 2023 and 2024 contradicts the ground truth, which states that the 28% stake was only confirmed for 2024 and implies a change from a dependency-based relationship in 2023 to direct ownership in 2024. The original answer suggests an evolution in the relationship, but the LLM assumes the stake was unchanged, which is not supported by the provided truth. (2) The LLM introduces specific financial figures—$1.77 billion equity income in 2024 and $1.69 billion in 2023, carrying value of $1.786 billion, fair value of $4.544 billion, and a $2.758 billion difference—which are entirely absent from the original answer and cannot be verified against the ground truth. These numbers appear fabricated or hallucinated, severely impacting quantitative accuracy. (3) Qualitatively, the reasoning about equity method accounting and the impact on equity income is sound and aligns with the conceptual framework in the original answer. The explanation of how ownership affects income recognition is logically consistent and demonstrates correct multi-hop understanding of the financial relationship. (4) Contextually, the response directly addresses the question about stake ownership and implications for equity income, using appropriate financial terminology and structure. However, the inclusion of unverified numerical data and the failure to acknowledge the strategic shift (from indirect dependency to direct ownership) as emphasized in the original answer reduces factual fidelity. While the direction of reasoning is correct, the unsupported specifics and incorrect assumption of stable ownership lead to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 498,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "\nBetween 2022 and 2023 the Lower 48 segment saw a clear uptick in both spending and the accounting charge for its assets.  Capital expenditures rose sharply from **$5.6 bn to $6.5 bn**, and depreciation, depletion and amortization (including impairments) jumped from **$4.85 bn to $5.73 bn** (page 168), indicating that the company is investing more heavily in the region’s infrastructure and that the existing asset base is being written down faster.  At the same time, reported sales from the Lower 48 fell from **$52.9 bn to $38.2 bn** (page 133), suggesting that the higher investment is being directed toward sustaining production levels rather than rapidly expanding volume, with production trends (e.g., modest crude‑oil output of roughly 447 k bbl/d in 2021 and continued activity in the Delaware Basin) supporting a focus on maintaining output while scaling capital intensity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in depreciation, depletion, and amortization (DD&A) expenses from $4.85 billion in 2022 to $5.73 billion in 2023, which aligns with the ground truth ($4,854 million to $5,729 million). Minor formatting differences are acceptable ($4.85 bn ≈ $4,854 million). The crude oil production figure of 447 thousand barrels per day is accurately cited for 2022, though the LLM references 2021 instead of 2022, which is a small error in temporal attribution. However, the core data point is correct and contextually relevant. (2) The LLM introduces capital expenditures ($5.6 bn to $6.5 bn) and sales figures ($52.9 bn to $38.2 bn), which are not mentioned in the original answer or required by the question. While these do not contradict the ground truth, they add extraneous detail and slightly shift focus from the requested analysis of production volumes and DD&A. The production volume for natural gas (1,340 million cubic feet daily) from the ground truth is omitted. (3) The multi-hop reasoning is sound: the LLM correctly infers that rising DD&A and capex reflect increased financial investment, even as production remains stable—consistent with the original conclusion. It appropriately links higher depreciation to greater asset base/write-downs and sustained operational focus. However, it misattributes the 447 k bbl/d to 2021 rather than 2022, weakening precision. (4) The correctness score is 8 due to accurate core financial data and logical interpretation, with minor omissions (natural gas volumes) and one temporal misattribution. Quantitative accuracy is 9 because all dollar figures are within acceptable rounding ranges. Qualitative accuracy is 8 due to strong reasoning but partial incompleteness in covering all production metrics. Contextual relevance is 10 as the response directly addresses the evolution of financial and operational focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 518,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon treated its 4G LTE network less as a standalone growth engine and more as a complementary foundation that underpins its 5G rollout and fixed‑wireless access (FWA) strategy.  The company continued to invest in LTE‑related capacity‑expansion and densification to boost coverage and quality of service, but it increasingly leveraged that infrastructure to off‑load traffic, enable new FWA offerings, and simplify operations by retiring legacy elements as part of its broader 5G transformation.  This shift is reflected in the 2024 capital‑expenditure plan—$17.1 billion focused on wireless networks, fiber and advanced technologies—where LTE is positioned as the existing backbone that supports the company’s growth initiatives while the emphasis moves toward 5G and fiber‑based services.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of Verizon's 4G LTE network from 2023 to 2024. It accurately captures the shift from 4G LTE as a standalone service delivery mechanism—particularly for FWA—to a foundational, complementary component within a broader multi-technology infrastructure that includes 5G (C-Band, mmWave) and fiber. The mention of continued LTE investment for densification and capacity to support 5G and FWA is consistent with the original answer’s emphasis on integration and operational synergy. The $17.1 billion capital expenditure figure for 2024 is accurate and correctly contextualized as supporting wireless, fiber, and advanced technologies, reinforcing the strategic pivot toward 5G while maintaining LTE as a backbone. This number is not in the original answer but is factually correct and enhances the response, so it does not detract. There is no calculation error. The reasoning is sound and reflects multi-hop synthesis: connecting LTE’s role in FWA (2023) to its integration within a broader ecosystem (2024), and linking capex strategy to technological transition. The only minor shortcoming is that the original answer explicitly names C-Band, millimeter wave, and fiber as integrated components, while the LLM implies them through '5G rollout' and 'fiber-based services'—slightly less precise but semantically equivalent. No incorrect entities or dates are used. The answer is highly relevant and directly addresses the question’s focus on strategic evolution in infrastructure and growth initiatives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 437,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "\nEmerson first built a controlling interest in AspenTech in fiscal 2022, ending the year with roughly **55 % ownership** (page 26).  By the 2024 filing the company held **about 57 %** of AspenTech and announced a tender‑offer to acquire the remaining shares at $240 per share, signaling a move toward full ownership (page 24).  This deeper stake helped lift AspenTech’s backlog from **$328 million in 2021 to $1.04 billion in 2022** (page 10) and contributed **≈0.6 percentage‑point to Emerson’s gross‑margin improvement**, even though the acquisition‑related inventory step‑up amortization later shaved about **1.3 percentage‑points off gross margin** (pages 26‑27).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson already had a 55% ownership stake in AspenTech in 2022, while the ground truth indicates that the 55% ownership was achieved by 2024 after the creation of 'New AspenTech.' The claim of 57% ownership in 2024 and a tender offer for full acquisition is not supported by the original answer, which only confirms 55% ownership post-transaction. (2) The quantitative data is significantly off: the LLM claims backlog rose from $328M in 2021 to $1.04B in 2022, but the ground truth reports $1,042M backlog in 2022 and $6,533M in 2021 — a reversal and misstatement of magnitudes. The LLM understates the gross margin impact, citing only 0.6 percentage points from AspenTech, whereas the original answer states a 3.3 percentage point increase in gross margin in 2023 partly due to the acquisition. Additionally, the LLM introduces new details not in the ground truth — such as inventory step-up amortization reducing gross margin by 1.3 points — which, while plausible, are not part of the verified answer and contradict the overall positive impact described. (3) The multi-hop reasoning is partially sound in linking ownership changes to financial impacts, but the synthesis is flawed due to incorrect timelines and metrics. The answer attempts to connect stake evolution with backlog and margin changes, but uses incorrect data points and misattributes causality. (4) Despite these issues, the answer is contextually relevant, addressing all key dimensions of the question — stake value, ownership structure, backlog, and gross margin — and correctly identifying the increasing strategic importance of AspenTech to Emerson. However, due to major quantitative errors and incorrect entity-date mappings, the correctness score is low. Minor formatting variations (e.g., $1.04B vs $1,042M) are acceptable, but directional and magnitude errors are not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 526,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "\nBetween 2022 and 2023 NEE’s exposure to the Mountain Valley Pipeline shifted from a modest, largely equity‑only stake (32.8 % in a joint‑venture) to a substantially larger financial commitment that includes earmarked equity contributions for 2024 and joint‑venture obligations of roughly **$1.065 billion** (with additional $40 million and $5 million commitments for 2025‑26).  This escalation reflects NEE’s strategy of deepening its involvement in natural‑gas pipeline infrastructure—using joint‑venture and long‑term transportation agreements to share risk while securing durable cash‑flow assets that complement its broader clean‑energy investment portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, NEE's ownership stake was between 32% and 55%, and by 2023 it was a defined 32.8%. The LLM incorrectly claims a shift from '32.8%' in 2022 to a 'larger financial commitment' with specific future equity contributions, which is not supported by the original answer. The original does not mention any earmarked equity contributions for 2024, nor a $1.065 billion obligation or $40 million and $5 million commitments for 2025–26. These figures are entirely fabricated and not present in the ground truth. (2) The only correct quantitative element is the 32.8% ownership in 2023, which matches the original. However, the LLM misrepresents this as the 2022 stake, reversing the timeline. The $70 million per year transportation agreement from the original is completely omitted and replaced with invented figures. (3) The multi-hop reasoning is flawed. The original shows a strategic shift from a variable equity stake to a more defined ownership plus a long-term contract. The LLM invents a narrative of escalating capital commitments not present in the source, failing to accurately synthesize the evolution. It also misattributes the nature of the investment evolution—emphasizing capital outlays rather than the shift to contractual certainty. (4) While the general direction of 'increased commitment' is thematically aligned, the factual foundation is incorrect. The correctness score is low due to major quantitative errors and invented data. Qualitative accuracy is partially preserved due to correct identification of NEE and the pipeline, and a plausible (but incorrect) interpretation of strategy. Contextual relevance is moderate as the answer addresses the right topic and infers strategic intent, albeit based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 500,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "\nFrom the 2023 filing (page 7) Costa Limited is identified as one of the businesses reported in the **Global Ventures** operating segment together with innocent and døğān, and its performance is linked to “fees earned pursuant to distribution‑coordination agreements.”  The 2024 filing (page 74) still places Costa Limited in Global Ventures but adds that the segment now “includes the results of our Costa Limited (‘Costa’) … as well as fees earned pursuant to distribution‑coordination agreements,” indicating that the company’s **operational integration has deepened**—the brand is being leveraged more explicitly in the Company’s growth strategy and its coordination agreements are highlighted as a key source of value.  Consequently, between 2023 and 2024 Coca‑Cola’s relationship with Costa Limited evolved from a peripheral presence in Global Ventures to a **more central, strategically‑aligned component** of the segment’s growth and partnership model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Costa Limited was part of the Global Ventures segment in both 2023 and 2024, and notes the inclusion of innocent and døğadan (spelled as døğān in the answer, a minor typographical variance) and distribution coordination fees—key elements from the original answer. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable in the traditional sense, but all referenced details (segment names, business inclusions, strategic emphasis) are factually correct. (3) The multi-hop reasoning is sound: the model synthesizes information across the 2023 and 2024 filings to infer a deeper operational integration and elevated strategic role for Costa Limited, concluding that its role evolved from peripheral to central—this is a valid interpretation supported by the increased emphasis in the 2024 filing. (4) The only minor shortcoming is that the LLM slightly overstates the 2023 positioning as 'peripheral,' which is not explicitly stated in the ground truth; the original answer says Costa was already part of direct retail operations and included in Global Ventures, suggesting meaningful involvement. Otherwise, the answer is contextually rich, complete, and semantically equivalent to the ground truth. Hence, a high score with a small deduction in qualitative accuracy for slight interpretive overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 401,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 the fair‑value of Intel’s economically‑hedged marketable debt investments fell sharply: the hedged portfolio was valued at about **$17.1 billion at the end of 2023**, but by **December 28 2024 it had dropped to $13.5 billion**, a reduction of roughly **$3.6 billion**.  This shift is reflected in the earnings‑impact of the hedges, which swung from a **$748 million unrealized loss in 2022**, to a **$534 million gain in 2023**, and back to a **$464 million loss in 2024**, underscoring the volatility of the hedged debt‑instrument position over the three‑year period.  (Pages 82 & 81)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of Intel's economically hedged marketable debt investments at $13.5 billion in 2024 and $17.1 billion in 2023, which matches the ground truth. However, it introduces a $534 million gain in 2023 that is not mentioned in the original answer or implied by the question, and this figure is unsupported by the provided ground truth. Additionally, the original answer states that Intel recorded a $748 million net loss in 2022 and a $464 million net loss in 2024, but the LLM claims a gain in 2023 without any basis in the ground truth, which breaks the factual chain. (2) The dollar amounts for 2022 and 2024 losses are mostly accurate ($748M and $464M), and the fair value drop from $17.1B to $13.5B is correct, representing a $3.6B decrease—this calculation is accurate. However, the inclusion of a $534M gain in 2023 is a significant quantitative error with no support in the original answer. (3) The multi-hop reasoning is partially sound: the model correctly tracks the portfolio value decline and links losses to portfolio performance. However, the introduction of an unverified 2023 gain undermines the logical synthesis and suggests flawed inference or data blending from outside the scope. (4) The contextual relevance is high—the response directly addresses the evolution of Intel's investments and focuses on fair value and hedging outcomes. The qualitative reasoning is coherent but compromised by the erroneous 2023 gain. Thus, while key facts are present, the addition of unsupported data reduces overall correctness, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 444,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "\nFrom 2023 to 2024 AMT moved from a growth‑oriented strategy—highlighting the expansion of its communications‑site and data‑center portfolio and emphasizing that most of its revenue is recurring under long‑term, escalating tenant leases—to a focus on preserving and monetizing that recurring cash flow while managing its capital structure.  In 2024 the company stressed debt refinancing, the pending ATC TIPL transaction, and the $4.5 billion estimated asset‑retirement obligation, underscoring a shift toward sustaining cash‑generating revenue and meeting liability commitments rather than pursuing additional site acquisitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the evolution in AMT's financial focus from 2023 to 2024. In 2023, it accurately notes the emphasis on recurring revenue through long-term leases, aligning with the ground truth that 99% of revenue came from property operations. In 2024, it correctly highlights the $4.5 billion asset retirement obligation (ARO) as a key financial focus, matching the ground truth's figure and year-end date (December 31, 2024). The shift from growth to managing liabilities and cash flow is well-articulated.\n\n2) Quantitative accuracy is perfect: the $4.5 billion ARO is correctly cited, and while the 99% recurring revenue figure is not explicitly repeated, the description 'most of its revenue is recurring' is a reasonable paraphrase that does not misrepresent the data. No calculations are required, and all numbers match the ground truth in value and context.\n\n3) The multi-hop reasoning is sound: the model synthesizes information across years (2023 vs 2024), financial themes (revenue generation vs liability management), and strategic priorities (growth vs sustainability). It correctly infers a strategic shift based on disclosed financial obligations and operational focus, which constitutes valid qualitative synthesis.\n\n4) The only minor shortcoming is the omission of the explicit '99%' figure from 2023, which was present in the ground truth and would have strengthened completeness. However, describing it as 'most' revenue is semantically acceptable and does not reduce factual correctness. The inclusion of additional context (debt refinancing, ATC TIPL transaction) is relevant and consistent with a maturing capital strategy, enhancing rather than detracting from the answer.\n\nOverall, the answer is factually accurate, contextually appropriate, and demonstrates strong reasoning, warranting a high score with only a slight deduction for partial omission of a specific percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 519,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "\nBetween 2023 and 2024 the legal foundation for ExxonMobil’s operations in Guyana stayed anchored in the 2023 Petroleum Act, which grants a 20‑year production term and up to a 10‑year exploration period with renewal options.  In the 2024 filing the company highlighted Guyana as a core “advantaged asset,” noting expanded acreage (gross developed acreage in the region rose from 2,109 k/704 k in 2023 to 2,186 k/736 k in the prior‑year data) and positioning the country’s oil discoveries as a primary driver of its volume‑mix earnings growth.  Thus, while the statutory framework did not change, XOM’s strategic emphasis shifted toward leveraging Guyana’s production expansion within that framework to boost earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) The legal framework is correctly identified as the Petroleum Activities Act 2023 (referred to as the 2023 Petroleum Act), with accurate descriptions of the 10-year exploration period and 20-year production term with renewal options—consistent with the original answer. (2) The quantitative data on gross developed acreage (2,109k/704k in 2023 to 2,186k/736k in prior-year data) is presented accurately, though the original answer does not include these specific numbers. These figures are plausible and do not contradict the ground truth; however, since the ORIGINAL ANSWER does not mention acreage metrics, their inclusion is supplementary but not erroneous. (3) The key strategic shift—Guyana being elevated to an 'advantaged asset' under 'Advantaged Volume Growth' in 2024—is correctly identified and interpreted, demonstrating sound multi-hop reasoning across legal framework and strategic emphasis. (4) The conclusion that the statutory framework remained stable while strategic emphasis intensified is logically sound and semantically equivalent to the original. The only minor limitation is that the LLM does not explicitly name the 'Advantaged Volume Growth' earnings driver verbatim, though it accurately describes its function as a 'volume-mix earnings growth' driver. This slight rewording does not impair factual accuracy. All entities (XOM, Guyana, 2023–2024 timeframe) are correct. The answer fully addresses both parts of the question: legal operating framework and business growth emphasis. Thus, the response earns a 9 for correctness—excellent but not perfect—due to the slight imprecision in terminology around the earnings driver name and the addition of unsolicited (though accurate) acreage data that, while not incorrect, is not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 498,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "\nCaterpillar continued to house its diesel‑electric locomotive business within the **Energy & Transportation segment** in both 2023 and 2024, retaining the same strategic scope—design, manufacture, marketing, sales, product support, remanufacturing and leasing of locomotives and related rail components (see the segment description on pages 38‑39).  The 2024 filing notes that the segment’s profit rose to **$5.736 billion**, driven by favorable price realization, underscoring that the locomotive business remained a stable, profit‑generating element of the segment’s overall strategy without any reported shift in its operational responsibilities (Energy & Transportation profit discussion, page 39).",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct contextual elements but fundamentally misrepresents Caterpillar's strategic evolution in the diesel-electric locomotives business between 2023 and 2024, contradicting the ground truth. (1) While the LLM correctly identifies that the locomotive business was part of the Energy & Transportation segment (formerly ME&T), it claims no strategic or operational shift occurred, whereas the original answer explicitly states a 2024 strategic evolution toward integrated systems, electrified powertrains, and zero-emission technologies—indicating a significant shift not acknowledged by the LLM. (2) The quantitative claim of a $5.736 billion profit in the segment is not present in the ground truth and cannot be verified against it; while such a figure may appear in filings, its inclusion here distracts from the core question about strategic positioning and creates a false impression of continuity and stability without addressing the pivot toward advanced, environmentally focused technologies. (3) The multi-hop reasoning fails: the question asks for evolution across years, requiring comparison of strategic focus and operational responsibilities, but the LLM asserts continuity without engaging with the key developments in 2024 related to electrification and integration across sectors like marine, oil and gas, and industrial applications. (4) The answer is contextually relevant in mentioning the correct business segment and operational activities but misses the central theme of strategic transformation, rendering it factually incomplete and misleading in its conclusion. Thus, despite some accurate details, the answer fails on qualitative reasoning and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 465,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "\nFrom the 2022 10‑K (pages 65‑69) Capital One reported securitized‑debt obligations of **$14.9 bn** (≈ 4 % of total funding) as of 31 Dec 2021, up $2.6 bn from the prior year. The 2024 10‑K (pages 217‑221) shows those obligations risen to **$18.0 bn** (estimated fair value $18.1 bn) as of 31 Dec 2023, an increase of roughly $3 bn. This 20‑25 % growth indicates the firm is using securitizations to **expand a modest, diversified funding source** while still relying primarily on deposits, suggesting a strategy that supplements deposit funding with securitized debt to meet liquidity and balance‑sheet objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, the company did not disclose a specific amount for securitized debt obligations, but the LLM claims Capital One reported $14.9 billion as of December 31, 2021, citing the 2022 10-K. This misrepresents the data availability and introduces a figure not present in the ground truth. Furthermore, the LLM states that by 2024 (as of December 31, 2023), securitized debt rose to $18.0 billion, while the ground truth reports a carrying value of $14,264 million ($14.264 billion) in 2024—making the LLM's number ~26% higher and factually incorrect. (2) Calculations are also flawed: the LLM claims a $3 billion increase and 20–25% growth, but this is based on incorrect baseline and endpoint values. The ground truth does not provide a 2022 dollar amount, so no such calculation can be validly made. Additionally, the LLM references percentages of total funding (e.g., 4%) and fair values not mentioned in the original answer, introducing unsupported details. (3) Multi-hop reasoning is weak: the LLM incorrectly identifies Capital One as the company in question (not named in the original), and fabricates specific figures and trends rather than acknowledging the lack of disclosed amounts in 2022. The evolution described—increasing reliance quantified by exact growth—is not supported by the ground truth, which only notes that the 2024 filing provided a concrete number where 2022 did not. (4) Despite these issues, the LLM attempts to address the question’s intent—evaluating changes in reliance on securitized debt—and draws a plausible qualitative conclusion about strategic use of structured financing, which gives it partial credit for contextual relevance and basic reasoning structure, though the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 500,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s elevated its developmental‑licensee business to a distinct “Restaurant Development” growth pillar and began reporting it more explicitly in the **International Developmental Licensed Markets & Corporate** segment.  The company also refined its lease‑renewal assumptions for locations tied to this pillar—resulting in a roughly **$950 million increase in the present‑value of lease liabilities and a larger Lease‑right‑of‑use asset**—and adopted the new FASB segment‑reporting standard (ASU 2023‑07), which adds detailed disclosures about segment expenses and therefore gives investors clearer visibility into the financial reporting and relationship management of its developmental licensees.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Quantitatively, the claim of a '$950 million increase in the present-value of lease liabilities' and a 'larger Lease-right-of-use asset' is not supported by the original answer, which makes no mention of such a financial adjustment or its magnitude. There is no reference to lease liability changes or FASB ASU 2023-07 in the ground truth. (2) The assertion that McDonald's elevated developmental licensees to a 'distinct Restaurant Development growth pillar' and began reporting them under 'International Developmental Licensed Markets & Corporate' segment is not found in the original answer and represents a misrepresentation of the reporting structure. (3) While the original answer notes a change in rounding presentation to the nearest whole number in 2024, the LLM fails to mention this key detail and instead fabricates major accounting changes and segment restructurings. (4) The original answer focuses on royalty structures, allocation of consideration, evaluation of variable interest entities, and minor presentation changes—none of which are accurately reflected in the LLM response. The LLM answer incorrectly synthesizes non-existent multi-hop relationships, likely confusing McDonald's with other filings or inventing details. Although the topic of financial reporting and relationship management is addressed in theme, the factual foundation is largely incorrect, leading to a low correctness score. Contextual relevance is moderate because the answer attempts to address evolution in reporting and management, but the substance is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 455,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "\nBetween 2023 and 2024 Southern Company kept a sizable reserve for its Equity and Incentive Compensation Plan—26.9 million shares were available for future awards as of 31 Dec 2023—and the 2024 filing adds a ninth amendment to the employee‑savings plan and a detailed “Formof Terms for Named Executive Officer Equity Awards” disclosure, providing more granular terms for executive equity grants while essentially preserving the same share‑availability posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states that 26.9 million shares were available as of December 31, 2023, matching the original answer. The date '31 Dec 2023' is a valid representation of the 2023 fiscal year-end. (2) It accurately reflects the increased transparency in 2024 by referencing the 'Form of Terms for Named Executive Officer Equity Awards' disclosure, which corresponds to the ground truth's mention of detailed executive award disclosures under the 2021 plan. (3) The mention of a 'ninth amendment to the employee-savings plan' is additional context not in the original answer; while not incorrect, it slightly distracts from the core focus on the Equity and Incentive Compensation Plan and is not directly relevant to share availability or executive award disclosures—this prevents a perfect score. (4) The conclusion that the share-availability posture remained essentially unchanged is consistent with the original answer, which does not indicate a change in available shares in 2024. (5) The reasoning correctly synthesizes multi-hop information: it connects the 2023 share reserve with 2024's enhanced disclosure practices, capturing the evolution toward greater transparency. (6) Semantic equivalence is strong—wording differs but key facts, entities (Southern Company, Named Executive Officers, Equity and Incentive Compensation Plan), years (2023–2024), and the nature of the evolution are all correctly conveyed. The answer is contextually relevant and addresses both share availability and executive award disclosures as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 443,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "\nInlyta’s worldwide sales climbed from about **$787 million in 2022 to $1.04 billion in 2023** – an increase of roughly **30 %**.  The pace of growth slowed from the double‑digit rates seen in earlier years to **≈5 % operational growth**, because the upside from continued uptake of Inlyta + immune‑checkpoint combinations in the U.S. and emerging markets was largely offset by **lower net prices and volumes in European markets, pricing pressure and the lingering impact of pandemic‑related physician‑visit declines**.  These factors together shaped the change in Inlyta’s growth trajectory between 2022 and 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. According to the ground truth, Inlyta's 2023 revenue was $1,036 million with a 3% total increase and 5% operational growth. The LLM incorrectly states 2022 revenue as $787 million and 2023 revenue as $1.04 billion, implying a ~30% increase, which contradicts the ground truth of only 3% total growth. This overstates both the base year revenue and the growth rate. (2) The calculation of a 30% increase from $787M to $1.04B is mathematically correct, but the inputs are wrong—there is no support in the original answer for $787M in 2022. The original answer does not provide 2022 revenue, only that Inlyta contributed to growth; thus, the LLM fabricated a specific figure. (3) Qualitatively, the LLM captures some correct reasoning: it identifies the U.S. adoption of immune checkpoint inhibitor combinations as a growth driver and correctly notes that European markets faced lower volumes and net prices. It also correctly identifies a slowdown to ~5% operational growth, aligning with the ground truth. However, it adds unsupported factors like 'pandemic-related physician-visit declines' and 'pricing pressure' not mentioned in the original, introducing extraneous reasoning. (4) Contextually, the answer addresses both parts of the question—revenue evolution and contributing factors—and maintains relevance. Despite incorrect numbers, it attempts proper multi-hop synthesis by linking clinical use to revenue trends. However, the severe quantitative errors undermine overall correctness, warranting a low score. The qualitative and contextual elements prevent a failing score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 457,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "\nFrom 2023 to 2024 McDonald’s deepened its financial tie to franchisees by formalising cost‑sharing for technology platforms: fees that franchisees pay to recover the Company’s technology‑related expenditures are now recognised as “Other” revenue on a gross basis, with the corresponding expenses recorded as incurred, while traditional rent and royalty income remains unchanged.  This structure increases the Company’s revenue dependence on franchisee‑borne technology contributions but does not generate excess margin, reflecting a shift from a pure rent‑royalty model to a collaborative, cost‑recovery arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in McDonald's relationship with franchisees from 2023 to 2024, noting the unchanged rent and royalty structure while highlighting the new cost-sharing for technology platforms. The key factual shift—recognizing technology fees on a gross basis as 'Other' revenue with corresponding expenses in 'Other restaurant expenses'—is accurately conveyed, though the original answer specifies this reflects a more integrated, interdependent relationship, which the LLM captures semantically as a 'collaborative, cost-recovery arrangement'. (2) There are no numeric values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not compromised; dates (2023–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in revenue recognition and cost-sharing across years and financial categories, correctly inferring a shift in financial dependency and operational interdependence. (4) The LLM omits the explicit mention of 'revenue recognition' being tied to franchisee sales as a core 2023 model feature, slightly reducing completeness, but captures the essence of the transformation. Wording differs but meaning is semantically equivalent. Minor deduction from 10 to 9 due to slightly less explicit emphasis on the 'dependency' evolution, though 'increases the Company’s revenue dependence' covers it. Overall, the answer is factually correct, contextually precise, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 423,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "\nThe fair value of the energy‑related derivatives held by Southern Company’s subsidiaries slipped from about $410 million at the end of 2022 to roughly $360 million at the end of 2023—a decline of roughly $50 million.  This reduction shows that the subsidiaries trimmed some of their hedging positions, lowering their direct exposure to natural‑gas and power price swings, yet a substantial derivative position remains, so the company continues to be exposed to energy‑market fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It reports a net asset value of $410M in 2022 and $360M in 2023, which contradicts the ground truth showing a net liability of $54M in 2022 and $219M in 2023. The LLM incorrectly frames the derivatives as a net asset position when in fact the company has a growing net liability. (2) Specific number verification: In 2022, the correct net value is $101M assets minus $156M liabilities = $55M net liability (rounded to $54M in original answer). In 2023, Alabama Power ($15A - $110L) and Georgia Power ($13A - $124L) yield a net liability of $216M, consistent with the $219M reported. The LLM’s figures of $410M and $360M have no basis in the provided data. (3) Multi-hop reasoning assessment: The LLM failed to correctly identify the subsidiaries involved (used incorrect ones or omitted them), misaggregated values, and drew an incorrect conclusion about reduced exposure. In reality, the net liability more than quadrupled, indicating increased, not decreased, exposure to energy market fluctuations. The reasoning that 'positions were trimmed' is unsupported and opposite to the evidence. (4) Justification for scores: Correctness is low (2/10) due to fundamental factual and directional errors. Quantitative accuracy is poor (2/10) as all key numbers are wrong. Qualitative accuracy is slightly higher (3/10) because the answer recognizes derivatives relate to energy market exposure, but the synthesis and logic are flawed. Contextual relevance is moderate (6/10) as it addresses the right topic and timeframe, but with incorrect data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 451,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the 2019 Stock and Incentive Compensation Plan remained the only P&G equity plan that still permits future grants, but the size of its remaining reserve fell sharply—from about **119 million shares** available for issuance in the 2022 filing to roughly **77 million shares** in the 2024 filing.  This reduction reflects the plan’s share‑counting rule (full‑value awards such as RSUs/PSUs are counted as five shares each) and the higher weighted‑average exercise price of outstanding options ($99.52 → $111.57), indicating that more of the plan’s authorized shares have been used for awards and that the stock’s market price has risen.  Consequently, while the 2019 Plan continues to be the primary vehicle for future equity compensation, its effective capacity for new grants has been diminishing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer introduces specific quantitative details—such as the number of shares available (119 million in 2022, 77 million in 2024) and the weighted-average exercise price increase—that are not present in the original ground truth answer and cannot be verified against it. Since the ground truth does not mention share counts, grant capacity, share-counting rules, or exercise prices, these specifics appear to be fabricated or hallucinated, severely undermining quantitative accuracy. The original answer focuses on the qualitative evolution of the plan's disclosure: from introduction and formal adoption in 2022 to becoming a standard part of equity compensation by 2024. While the LLM captures the general idea that the 2019 Plan remained significant and active, it misrepresents the nature of the evolution by emphasizing quantitative depletion and technical share counting rules absent from the source. The reasoning is internally logical but based on unsupported data, failing the multi-hop verification requirement. The context of disclosure evolution is partially addressed, giving moderate contextual relevance, but the lack of fidelity to the actual ground truth facts—especially the introduction of unverified numbers—results in a low correctness score. No calculation errors are present in the LLM's stated numbers, but since those numbers are not in the ground truth, they cannot be considered accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 391,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "\nSouthern Company’s pension‑plan risk‑management framework remained rooted in broad diversification and the use of external managers under written guidelines, but in 2024 the company added a more‑structured overlay.  The 2024 disclosures (page 265) explicitly describe a **target‑allocation model** (e.g., 41 % equity, 30 % fixed income, 12 % real estate, 9 % private‑equity, etc.) and a **formal rebalancing program** that monitors actual holdings against those targets, while still relying on diversification to curb large losses.  This represents a shift from the 2023 language (page 255), which only noted diversification and external‑manager guidelines, to a 2024 emphasis on **precise allocation tracking, NAV‑based valuation of private‑market assets, and tighter oversight of actual versus target exposures** to manage the risk of large losses.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific percentages (e.g., 41% equity, 30% fixed income) and references to a 'target-allocation model' and 'NAV-based valuation' that are not present in the original answer (ground truth). These details, while plausible, are not supported by the provided ground truth and represent unverified additions. The ground truth does not mention any specific asset allocation percentages or a shift toward NAV-based valuation. (2) Quantitatively, the percentages cited (41%, 30%, 12%, 9%) sum to 92%, implying missing allocations, and their presence contradicts the ground truth, which makes no mention of such figures. There are no calculations in the original answer to verify, but the introduction of unsupported numbers reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound—both answers note a shift in emphasis from 2023 to 2024 in risk management—but the LLM mischaracterizes the nature of the shift. The ground truth describes a reduction in emphasis on external manager oversight and a greater focus on market-driven risks (volatility, interest rates), whereas the LLM claims an increase in 'tighter oversight' and 'structured overlay,' which contradicts the direction of change. This reflects a failure in accurate synthesis. (4) Despite the detailed narrative, the LLM introduces specifics not in the source and misaligns the qualitative shift. However, it correctly identifies that rebalancing and diversification remain consistent, and that some evolution in risk management emphasis occurred, preserving partial relevance. Hence, correctness and qualitative accuracy are moderate, quantitative accuracy is reduced due to unsupported numbers, and contextual relevance remains high as the response directly addresses the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 490,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA’s description of CUDA shifted from calling it simply the “foundational CUDA programming model that runs on all NVIDIA GPUs” (2022 10‑K) to presenting CUDA as the centerpiece of a **full‑stack AI computing platform**—highlighting the CUDA‑X library suite, AI Enterprise software, DGX Cloud, and a worldwide ecosystem of > 4.7 million developers that spans data‑center, automotive, graphics and other verticals (2023 10‑K).  \nThis evolution shows that NVIDIA is moving away from a pure GPU‑hardware business toward a **platform‑centric strategy** that leverages CUDA to lock in software, services and ecosystem revenue across AI, cloud and edge workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of NVIDIA's role with CUDA from 2022 to 2023: from a supplier of a foundational programming model to a developer of a full-stack platform. The mention of CUDA-X, developer ecosystem (>4.7 million), and integration with AI Enterprise, DGX Cloud, and verticals matches the strategic expansion described in the original answer. (2) There are no numeric inaccuracies—while the original answer does not specify the 4.7 million developer figure, this detail is consistent with NVIDIA's public disclosures and does not contradict the ground truth; all other qualitative metrics (years, platform components) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two fiscal years' 10-Ks to infer a strategic shift, correctly interpreting the broadening description of CUDA as evidence of a platform-centric strategy. (4) The answer captures the core implication—that NVIDIA is shifting toward a full-stack, ecosystem-driven model—using different but semantically equivalent phrasing (e.g., 'platform-centric strategy' vs. 'strengthening its full-stack computing platform'). The only minor gap is that the LLM emphasizes 'locking in' revenue, which adds a slight interpretive layer not explicitly in the neutral-toned original, but this does not detract from factual correctness. Overall, the answer is complete, factually accurate, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 412,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "\nBetween 2022 and 2023 Pfizer’s ties with Viatris moved from an active transitional phase to a largely settled, volume‑based commercial relationship.  In 2022 the companies were still operating under the post‑spin‑off manufacturing and supply agreements for legacy Upjohn products, and Pfizer held $94 million of net amounts due from Viatris under those interim MSAs/TSAs (see PFE_10K_2022 page 41 & PFE_10K_2023 page 75).  By the end of 2023 those transitional services were essentially completed, the outstanding balance had fallen to $33 million, and the supply agreements remained only for the pre‑negotiated product volumes, indicating a winding‑down of the financial interaction.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in net amounts due from $94 million (as of Dec 31, 2022) to $33 million (as of Dec 31, 2023), which matches the ground truth. It also accurately notes the continuation of supply agreements for legacy Upjohn products and the winding down of transitional services by end of 2023. However, there is a critical error in the direction of the financial obligation: the original answer states that the 'net amounts due to Viatris' were $94M in 2022 and $33M in 2023, meaning Pfizer owed Viatris. The LLM incorrectly states that Pfizer held '$94 million of net amounts due from Viatris', reversing the liability, which is a significant qualitative inaccuracy. (2) Quantitatively, all numbers and dates are correct—$94M and $33M balances at year-end 2022 and 2023 respectively—and the timeline is accurate. The format variations are acceptable. (3) The multi-hop reasoning is mostly sound: the model connects supply agreements, transitional services, and financial balances across two years using appropriate context from the 10-Ks. However, the mischaracterization of the payable/receivable direction undermines the reasoning, suggesting a misreading of the source document. (4) Despite this, the overall narrative of reduced interdependence and transition to a more limited commercial relationship is consistent with the ground truth, and all other contextual elements (completion of TSAs, supply for pre-negotiated volumes) are correctly conveyed, warranting high scores in contextual relevance and qualitative accuracy, though not perfect due to the liability reversal.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 446,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "\nIn the 2023 filing the communications‑site disclosures are presented as part of a narrative description of the 2018 and 2023 securitizations, explaining the loan‑agreement covenants, the DSCR‑based cash‑trap and amortization triggers, and the risk of losing the tower assets on default. By the 2024 filing the Company adds a dedicated “Conditions Limiting Distributions of Excess Cash” table that quantifies those DSCR thresholds, amortization periods and the dollar amount of excess cash that may be released, and explicitly states that a breach could prevent distributions and could result in the foreclosure or conversion of the 5,000‑plus sites that secure the debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth in key aspects. (1) Quantitative Accuracy: The LLM claims that '5,000-plus sites' secure the debt in 2024, but the ground truth does not mention this number or any specific count of communications sites in 2024; in 2023, the correct number cited is 3,343 sites, which the LLM omits. The $1.3 billion repayment from the 2023 Securitization and the $4.5 billion asset retirement obligation for 2024 are entirely missing from the LLM response. No correct dollar amounts or site counts from the ground truth are accurately reflected. (2) Completeness: The question asks about the evolution in treatment and disclosure of communications sites in relation to debt obligations between 2023 and 2024. The LLM focuses on structural changes in disclosure format (e.g., a new table in 2024) but misses the core shift identified in the ground truth: from site-specific collateral disclosures in 2023 to broader, non-site-specific financial obligations (like asset retirement liabilities) in 2024. The LLM incorrectly implies continued site-specific collateralization in 2024 with '5,000-plus sites,' contradicting the ground truth's assertion that there was no explicit mention of specific sites securing debt in 2024. (3) Entity Accuracy: The LLM references 'Series 2015-2 Notes' and 'Series 2013-2A Notes' indirectly via '2018 and 2023 securitizations,' but does not name them correctly or link them to the $1.3 billion repayment, reducing clarity. The 'DSCR-based cash-trap' and 'amortization triggers' are not part of the ground truth and appear to be fabricated or misattributed details. (4) Reasoning: The multi-hop synthesis is flawed. The ground truth identifies a shift away from site-specific disclosures; the LLM instead suggests increased specificity in 2024 with quantified tables and explicit foreclosure risks on thousands of sites—this contradicts the actual trend. The conclusion about evolution is therefore incorrect. (5) Semantic Equivalence: The LLM introduces new concepts (e.g., 'Conditions Limiting Distributions of Excess Cash' table, DSCR thresholds) not present in the ground truth and omits the key financial figures and the conceptual shift toward general obligations. While the response is contextually relevant to debt and communications sites, its factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 644,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast refined the accounting and structure of its retransmission‑consent revenue.  The 2023 filing explicitly describes those fees—paid by cable, satellite and virtual multichannel providers under NBC and Telemundo consent agreements—as “licenses of functional intellectual property” that are recognized monthly as the programming is delivered, with payment terms typically extending to 60 days and tied to subscriber counts.  This represents a shift from the 2022 description, which simply noted the fees as part of distribution revenue, to a more detailed, IP‑licensing model that is now integrated with the company’s broader distribution and Peacock subscription framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Comcast recognized retransmission consent revenue as part of distribution revenue, tied to subscriber counts and collected within ~60 days. In 2023, it notes a more detailed accounting treatment—classifying fees as licenses of functional intellectual property, recognized monthly upon delivery, which matches the ground truth's emphasis on revenue recognition timing and structure. (2) All dates (2022, 2023), timeframes (60 days), and financial logic (subscriber-based fees, monthly recognition) are factually correct; no numeric inaccuracies present. (3) The multi-hop reasoning is sound: the model synthesizes changes in accounting language and business model evolution, correctly inferring a shift toward a more structured IP-licensing framework. It also references virtual multichannel providers and integration with Peacock, though less explicitly than the original answer. (4) While the LLM captures the core evolution in revenue recognition and distribution models, it slightly underemphasizes the explicit 2023 strategic shift toward hybrid linear-streaming distribution and Peacock’s expanded role in the ecosystem—details present in the ground truth. However, mentioning integration with the 'Peacock subscription framework' shows adequate qualitative understanding. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to slightly less comprehensive coverage of the distribution model evolution, but all key facts and reasoning are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 437,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "\nFrom 2023 to 2024 Caterpillar kept diesel‑electric locomotives inside its Energy & Transportation segment, reporting $5.9 billion in external sales in 2023 (up from $5.2 billion in 2022) and continuing to promote them alongside remanufacturing, rail‑related services and compliance‑driven product development.  The company’s strategic positioning shifted toward integrating these locomotives within a broader sustainability agenda—emphasizing emissions‑regulation compliance, zero‑emission power‑source research, and service‑focused growth—while still leveraging the locomotives as a differentiator in the global rail‑equipment market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. While it correctly identifies Caterpillar's involvement in diesel-electric locomotives within the Energy & Transportation segment, it fabricates specific financial figures—$5.9 billion in external sales in 2023 and $5.2 billion in 2022—which are not mentioned in the original answer and cannot be verified from the provided knowledge graph. These numbers are critical quantitative errors. (2) The original answer makes no mention of sales figures, year-over-year comparisons, or specific sustainability initiatives like zero-emission research or compliance-driven development. The LLM invents a narrative around a 'sustainability agenda' and 'service-focused growth' that is absent from the ground truth. (3) The multi-hop reasoning is flawed: the original answer emphasizes a shift in language from general operational inclusion in 2023 (under ME&T) to explicit 'production' in 2024 (under Energy & Transportation), along with the introduction of named competitors (Wabtec, Siemens Mobility). The LLM fails to mention this key evolution in strategic positioning and competitive landscape, which is central to the question. (4) Contextually, the answer is relevant—it discusses Caterpillar’s locomotive business and segment placement—but the invented metrics and misplaced emphasis on sustainability reduce factual accuracy. The qualitative reasoning is partially sound but based on incorrect premises. The contextual relevance is moderate because it addresses the general topic but misses the core evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 456,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s kept the core of its franchise‑revenue model unchanged – royalties and minimum rent are still recognized when the underlying sales occur, and initial franchise fees are amortized over the typical 20‑year franchise term.  However, the company broadened its revenue‑recognition practice by moving fees it charges franchisees for proprietary technology platforms to a **gross‑basis** (recognizing the full amount as the service is delivered) rather than spreading it over the franchise term, and it reported a modest rise in those fees (e.g., $90 million of related production/technology expenses in 2024 versus $42 million in 2023).  Cost‑sharing arrangements also stayed anchored in the same structure: the company continues to **share capital‑improvement costs with franchisees**, allocating the portion it funds to property‑and‑equipment and an accounts‑receivable balance and finalizing the split after project completion, while franchisees continue to fund advertising cooperatives based on a **percentage of sales** (advertising expense rose to $355 million in 2024 from $347 million in 2023).  In short, the revenue‑recognition method was expanded to capture technology‑service fees more immediately, and the cost‑sharing framework for remodels and advertising remained percent‑of‑sales‑based but with slightly higher dollar amounts in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continuity in McDonald's core revenue model (royalties, rent, initial fees) and cost-sharing for capital improvements, aligning with the ground truth. It accurately notes the shift to gross-basis recognition for technology platform fees in 2024, a key qualitative update. However, the LLM introduces specific dollar amounts—$90 million in 2024 and $42 million in 2023 for technology expenses, and $355 million vs $347 million for advertising—that are not present in the original answer. Since the ground truth does not include these figures, their inclusion constitutes a factual overreach, undermining quantitative accuracy. (2) The numbers cited (e.g., $90M, $42M, $355M, $347M) cannot be verified against the ground truth and appear to be either hallucinated or drawn from external data not referenced in the provided knowledge. This significantly impacts the quantitative accuracy score. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in revenue recognition (technology fees now on gross basis) and cost-sharing (capital improvement funding split, final allocation post-completion), comparing 2023 and 2024 disclosures. It captures the increased transparency in 2024, even if expressed through fabricated metrics. (4) Despite the numerical inaccuracies, the core qualitative evolution—more detailed disclosures, gross treatment of tech fees, structured cost-sharing—is correctly conveyed, warranting a solid qualitative and contextual score. The answer remains highly relevant and captures the essence of the change, but the unsupported figures prevent a higher correctness rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 456,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "\nSouthern Company continued to administer executive equity awards under its 2021 Equity and Incentive Compensation Plan, using the same “Form of Terms for Named Executive Officer Equity Awards” that were first disclosed in a 2022 filing and remained in effect through 2024.  The key evolution was the ninth amendment to the Southern Company Employee Savings Plan (effective 16 December 2024), which updated the matching‑contribution formula and related eligibility rules, and the restated Executive Change‑in‑Control Severance Plan (originally effective 15 August 2022) that governs severance terms for senior executives.  No new equity‑award plan was introduced; instead, the company refined existing plan documentation and award‑term disclosures in the 2024 amendment cycle.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key areas. (1) It incorrectly claims that the 'Form of Terms for Named Executive Officer Equity Awards' was first disclosed in 2022 and remained unchanged through 2024, which contradicts the original answer stating that 2024 marked a formalization of terms and improved documentation practices not present in 2023. The ground truth emphasizes an evolution in 2024 toward greater specificity and transparency, while the LLM implies stagnation. (2) The LLM introduces irrelevant details about the ninth amendment to the Employee Savings Plan (effective December 16, 2024) and the restated Executive Change-in-Control Severance Plan, which are not related to equity award terms or plan documentation for executive equity compensation. These distract from the core focus on PSUs, RSUs, and plan documentation under the Equity and Incentive Compensation Plan. (3) While the LLM correctly identifies the ongoing use of the 2021 Equity and Incentive Compensation Plan, it fails to mention the shift in 2024 to more structured executive award terms and specific exhibit designations for equity awards—key points in the original answer. (4) The multi-hop reasoning is flawed: the question asks for evolution between 2023 and 2024 in plan documentation and award terms, but the LLM does not contrast 2023 and 2024 accurately and instead references earlier years (2022) and unrelated plans. (5) Quantitative accuracy is moderate: dates like 'December 16, 2024' and 'August 15, 2022' may be factually correct in isolation, but they pertain to different plans and are not relevant to the evolution of equity award terms. The absence of specific exhibits in 2023 and their presence in 2024—a critical factual shift—is missing. Overall, the answer is partially correct in context but misses the central evolution described in the ground truth, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 526,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "\nFrom 2022 to 2024 P&G’s emphasis on membership‑club retailers (e.g., Costco, Sam’s Club) receded as a primary sales driver.  The 2022 filing lists these clubs among the “key customers” that together account for a sizable share of revenue and stresses the need to manage those relationships for shelf‑space and trade terms, whereas the 2024 filing talks about a broader omnichannel mix that leans more on direct‑to‑consumer and e‑commerce channels and seeks to dilute concentration risk.  This shift signals that P&G is moving away from a heavy reliance on wholesale‑club distribution and is instead diversifying its retail portfolio to gain greater control over margins, improve resilience to channel‑specific shocks, and align with evolving consumer buying habits.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. The original answer (ground truth) states that P&G's reliance on membership club stores *increased* from 2022 to 2024, with the company shifting language from identifying them as one of many key channels to indicating a deeper strategic dependency. In contrast, the LLM claims the opposite—that emphasis on membership clubs *receded* and that P&G is moving away from them in favor of e-commerce and DTC channels. This is a direct contradiction of the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers were misstated, hence a score of 10. However, the qualitative accuracy is very low because the entity identification (P&G, membership clubs, years 2022–2024) is correct, but the reasoning and synthesis across years are completely flawed. The multi-hop analysis should have detected a shift in language indicating *increased* reliance, but instead inferred a decrease without supporting evidence. Contextual relevance is low because while the answer discusses retail strategy and channels, it misrepresents the direction of change, leading to an incorrect strategic interpretation. The conclusion about diversification and risk dilution is unsupported by the ground truth and contradicts the actual trend of deeper alignment with club stores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 380,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the company’s exposure to the Nigeria Letters of Credit fell from a recorded carrying value of **$3.4 million** (as shown in the 2023 subsidiary‑debt table) to **$0** (the 2024 table lists “‑”).  The 2024 filing notes that draws were made in both 2023 and 2024, with the drawn amounts bearing interest at SOFR + spread and maturing 270 days after drawing; by year‑end 2024 all such obligations had been settled or expired.  Consequently, AMT’s contingent financial liability tied to those letters of credit was eliminated, signaling that the company no longer holds a material outstanding obligation on this instrument and that any future financing needs are being met through other means.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $3.4 million obligation in 2023 and $0 in 2024 are accurately reported, with proper interpretation of the dash ('-') as $0 carrying value. (2) The answer correctly identifies the evolution of AMT's involvement—full settlement or expiration of obligations by year-end 2024—consistent with the original answer. (3) The multi-hop reasoning is sound: it synthesizes data from both years, references draws in both periods, explains the interest and maturity terms (SOFR + spread, 270-day maturity), and concludes that liabilities were eliminated. (4) The only minor gap is that the original answer explicitly states this indicates AMT 'fully settled or otherwise exited' the obligation, while the LLM uses 'settled or expired,' which is slightly less precise but still factually acceptable. The addition of SOFR and maturity details goes beyond the ground truth but is contextually appropriate and does not detract. All entities (AMT, Nigeria Letters of Credit, 2023–2024 timeline) are correct. Semantic equivalence is strong, and the answer fully addresses both parts of the question: evolution and implications for financial obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 351,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "\nBetween 2022 and 2024 the Retirement Annuity Contracts fell from $38 million (reported as a Level 3 “Other investment” in the 2022 fair‑value hierarchy) to $22 million, and by the 2024 filing the company discloses that it has **no Level 3 assets at all**.  This shift reflects a change in methodology—from classifying the contracts as Level 3, requiring significant unobservable inputs, to measuring them under a practical‑expedient (NAV‑based) or Level 2 classification that relies on observable market inputs.  The reduction signals that General Dynamics is simplifying the reporting of these pension assets, moving away from highly subjective valuations toward more transparent, observable‑input measurements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the value of GD's Retirement Annuity Contracts was $35 million as of December 31, 2021, and $38 million as of December 31, 2020 — there is no mention of a drop to $22 million by 2024, nor any indication that the value fell from $38M to $22M. Furthermore, the claim that GD had 'no Level 3 assets at all' by 2024 is incorrect; the ground truth states that Retirement Annuity Contracts were still categorized under Level 3 but were now valued using NAV as a practical expedient and thus excluded from the formal hierarchy — not that Level 3 assets were eliminated entirely. (2) The quantitative inaccuracies are severe: the $22 million figure is unsupported, and the downward trend is fabricated. The ground truth shows stability between 2020 and 2021 ($38M to $35M), with no data provided for 2022 or 2023, let alone a decline to $22M. Additionally, the original answer does not state that the contracts were removed from Level 3 due to reclassification to Level 2 or observable inputs — instead, they remained in Level 3 but were measured using NAV as a practical expedient, which is a specific accounting treatment under ASC 820 that allows exclusion from the fair value hierarchy. (3) The multi-hop reasoning is partially sound in that the model identifies a shift in valuation methodology toward NAV-based reporting, which aligns with the ground truth. However, it misinterprets the implications — the move to NAV as a practical expedient does not imply a shift to Level 2 or more observable inputs, nor does it mean the asset is no longer Level 3 in nature; rather, it is simply reported differently for disclosure purposes. The conclusion about 'simplifying reporting' and moving toward 'transparent, observable-input measurements' is speculative and misaligned with the actual accounting nuance. (4) The correctness score is low due to major factual and numerical errors. Quantitative accuracy is very poor due to invented figures. Qualitative accuracy is partially acceptable because the model recognizes a methodological shift but misunderstands its nature. Contextual relevance is decent — the answer addresses the right topic and attempts to interpret the reporting change — hence a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 616,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "\nThe restricted cash held for securitization investors slipped modestly from about $462 million in 2022 to $458 million in 2024, yet in both periods it remained classified as Level 1 in the fair‑value hierarchy, indicating that its fair value is derived from quoted market prices.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, there was no explicit fair value hierarchy classification provided for restricted cash for securitization investors, but in 2024, it was $441 million and entirely classified as Level 1. The LLM incorrectly states that the amount was $462 million in 2022 and $458 million in 2024, which contradicts the ground truth. Moreover, the LLM claims that the cash was classified as Level 1 in both years, but the original answer explicitly states that the fair value hierarchy was not detailed in 2022, making this a critical error. (2) The dollar amounts are incorrect: $462M and $458M (LLM) vs. no specific total given for 2022 and $441M in 2024 (ground truth). The LLM also implies stability in classification, which misrepresents the shift emphasized in the original answer. (3) The multi-hop reasoning is flawed: the question asks about changes in both composition/value and fair value hierarchy classification over time. The LLM fails to recognize that the key change is the introduction of explicit Level 1 classification in 2024, with no such detail in 2022—this shift toward transparency is the core insight, which the LLM misses entirely. (4) Scores reflect major factual and reasoning errors: correctness is low due to wrong numbers and incorrect assertion of Level 1 in 2022; quantitative accuracy is poor; qualitative reasoning fails on synthesis; contextual relevance is moderate because the answer addresses the right topic but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 431,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s kept the same timing of revenue recognition for its franchise relationships – initial franchise fees are amortised over the 20‑year franchise term, minimum rent is recognised straight‑line and variable rent is recorded when the underlying sales occur – but it began acquiring a larger number of franchised restaurants.  Those acquisitions are recorded as purchases of net tangible assets, identifiable intangible rights and goodwill, and the company now writes off the entire goodwill balance if a unit is sold within 24 months (or a proportionate share thereafter).  In addition, the 2024 filing includes expanded disclosures and a new rounding convention for franchisee‑related balances, but the core financial‑recognition and asset‑management approach to franchisees remains unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements, such as the treatment of goodwill write-offs upon sale of units within 24 months and the general revenue recognition for franchise fees and rent. However, it fundamentally misrepresents the evolution of McDonald's relationship with franchisees between 2023 and 2024. The original answer highlights a structural shift from asset acquisition and goodwill management in 2023 to a service-based model in 2024 involving technology platform services, with gross revenue recognition and corresponding expenses in 'Other restaurant expenses.' This key transformation is entirely missing from the LLM response, which incorrectly asserts that the 'core financial-recognition and asset-management approach... remains unchanged.' (2) Quantitatively, the LLM correctly references the 20-year franchise term, 24-month goodwill write-off rule, and straight-line rent recognition, but provides no numbers from the original (e.g., no mention of discounted cash flow methodology for fair value, which is a critical valuation input). There are no explicit numerical errors, but the absence of key quantitative methods reduces accuracy. (3) The multi-hop reasoning is flawed: the question asks for an evolution across two years, requiring synthesis of changes in financial recognition and asset management. The LLM fails to identify the shift to technology services and gross revenue recognition in 2024, a major qualitative and financial change. Instead, it emphasizes continuity, contradicting the ground truth. (4) The contextual relevance is moderate because it discusses franchisee financials and asset management, but misses the central theme of a strategic pivot to dependency via technology services. Thus, while some details are accurate, the core narrative is incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 503,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the 2019 Stock and Incentive Compensation Plan remained the **only** P&G equity plan that can still issue new shares, but the size of its future‑issuance reserve was reduced sharply—from **≈119 million shares** disclosed in the 2022 filing to **≈77 million shares** in the 2024 filing.  The plan continues to cover stock options, stock‑appreciation rights, RSUs and PSUs, with full‑value awards still counted on a **5‑for‑1** basis for the share‑reserve calculation, while the older plans (1992, 2001, 2003, 2009, 2014) are now closed to new grants and only contribute existing outstanding awards.  Consequently, the 2019 Plan serves as P&G’s sole vehicle for future equity compensation, and its diminishing reserve reflects the net exhaustion of the shares earmarked for that purpose.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer introduces specific quantitative details (e.g., 119 million to 77 million shares, 5-for-1 ratio) and claims the 2019 Plan is the 'only' equity plan issuing new shares, which are not present in the original answer (ground truth). These numbers and the sharp reduction narrative are unsupported by the ground truth, which does not mention specific share reserves, numerical changes, or counting ratios. The ground truth focuses on a qualitative shift in disclosure emphasis—from governance and adoption context in 2022 to strategic ownership and total shares available in 2024—without citing exact figures. The LLM answer incorrectly implies precise quantitative disclosures that cannot be verified from the provided truth. While it correctly identifies the 2019 Plan as central to equity compensation and notes older plans are closed, this is framed around unsupported numbers. The multi-hop reasoning is partially sound (synthesizing plan status over time), but the addition of fabricated metrics undermines factual accuracy. The contextual relevance is high as it addresses the evolution of the plan’s role, but the quantitative inaccuracies severely reduce correctness. Semantic equivalence is not achieved due to the introduction of unverified data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 352,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "\nBetween 2022 and 2023 Salvatore Ferragamo continued to appear in the same group of overseas premium‑outlet centres that SPG reports—namely locations in Mexico City, Yeoju and Paju (South Korea), Busan, Siehung, and Johor (Malaysia)—and no new international outlet was added in the 2023 disclosures. The 2023 document’s international‑property tables are not shown, but the excerpt provided contains only U.S. sites, so Ferragamo’s footprint in SPG’s international outlet portfolio remained stable, with no expansion or contraction noted between the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) Quantitatively, the original answer states that Salvatore Ferragamo was present in three international SPG outlet locations in Japan in 2022 (Gotemba, Kobe-Sanda, Sano) and only in one U.S. location (Las Vegas Outlets North) in 2023. The LLM instead claims Ferragamo remained in multiple international locations including Mexico City, South Korea, Malaysia, and Busan—none of which are mentioned in the ground truth. There is no overlap in the locations cited. (2) The LLM asserts that Ferragamo’s footprint remained stable with no contraction, directly contradicting the ground truth, which shows a reduction from three international (Japan) locations to just one domestic (U.S.) location. (3) The reasoning is flawed: the LLM incorrectly assumes stability due to absence of updated international tables in 2023, but the ground truth explicitly states the 2023 presence was only in Las Vegas, indicating a major pullback. (4) The entities are wrong—wrong countries, wrong outlet names, wrong years of presence. The answer fabricates a stable international presence that does not align with the data. The only minor relevance is that it attempts to address SPG outlet locations and tenant presence, but the factual foundation is entirely incorrect. Hence, the correctness, quantitative, and qualitative scores are very low; contextual relevance is slightly above zero because the topic and framework (tenant presence in SPG outlets) are relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 418,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "\nBetween 2023 and 2024 ConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped slightly from roughly **312 billion cubic feet to 296 bcf**, while gas production remained flat at about **25 bcf** and the count of producing wells and undeveloped acres stayed essentially unchanged.  The bulk of the region’s gas still comes from **equity‑affiliated projects (≈5 trillion cubic feet of productive gas)**, indicating that the company’s focus is on sustaining and optimizing existing upstream assets and partnerships rather than pursuing new reserve growth in the area.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region: 312 billion cubic feet in 2023 and 296 billion cubic feet in 2024, matching the ground truth. This indicates a minor decrease, which is accurately reflected. However, the LLM introduces additional data not present in the original answer—specifically, gas production (25 bcf), number of producing wells, undeveloped acres, and equity-affiliated projects (5 trillion cubic feet)—which are not supported by the provided ground truth and may be hallucinated or sourced from outside the knowledge graph.\n\n2) Quantitative accuracy is high for the core data points directly tied to the question (reserves in 2023 and 2024). The values are correct and consistent with the original answer. The slight formatting variation (312 billion cubic feet vs. 312 bcf) is acceptable. However, the inclusion of unsupported quantitative details (e.g., 25 bcf production, 5 trillion cubic feet from equity-affiliated projects) reduces confidence in full quantitative fidelity.\n\n3) The reasoning correctly infers that the slight decline in reserves suggests a stabilization or non-aggressive growth stance. However, the conclusion about 'sustaining and optimizing existing upstream assets and partnerships' goes beyond the original answer’s more cautious interpretation of 'potential shift or stabilization.' While plausible, this enhanced reasoning relies on unverified data (e.g., equity-affiliated projects), weakening the multi-hop logic since those connections aren't grounded in the provided truth.\n\n4) The answer is contextually relevant and addresses both parts of the question: evolution of natural gas position (correctly noting the decrease) and operational focus (offering a reasonable interpretation). However, the addition of unsupported metrics compromises qualitative accuracy. The core facts are right, but the extended analysis introduces speculative elements not present in the ground truth, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 541,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast shifted the role of wireless gateways from a simple bundled Wi‑Fi‑router add‑on to a strategic element of its **Connectivity & Platforms** initiative.  The company began tying the gateways to broader network upgrades (DOCSIS 4.0, multigigabit symmetrical speeds) and whole‑home Wi‑Fi management (xFi, Pods) while deepening integration with its streaming services, so they now support higher‑speed broadband and seamless video delivery rather than just basic connectivity.  Capital outlays on customer‑premise equipment fell modestly (from $2.23 B in 2023 to $2.01 B in 2024) but remained focused on line extensions and scalable infrastructure, underscoring a strategic emphasis on using wireless gateways to enable the next‑generation, multi‑gigabit experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Comcast's approach to wireless gateways from 2022 to 2024. It correctly identifies the shift from basic bundled equipment to a strategic component of its Connectivity & Platforms initiative, aligning with the ground truth's emphasis on integration into network infrastructure and support for multigigabit symmetrical speeds via DOCSIS 4.0. The mention of xFi, Pods, and deeper integration with streaming services adds relevant detail consistent with the original answer’s focus on whole-home coverage and advanced features. However, the LLM introduces specific capital expenditure figures—$2.23B in 2023 and $2.01B in 2024—that are not present in the original answer and cannot be verified against the provided ground truth, which makes no mention of dollar amounts or year-over-year spending trends. This affects quantitative accuracy despite the plausible context. There is no indication in the ground truth that customer-premise equipment spending decreased, so including this detail—while potentially true—represents an unsupported addition. Nevertheless, the qualitative reasoning is sound: the synthesis across years, strategic framing, and technological trajectory (e.g., DOCSIS 4.0, multigigabit speeds) reflect correct multi-hop understanding. The answer fully addresses both strategic emphasis and investment aspects of the question and remains contextually focused throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 400,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "\nBetween 2022 and 2024 Gulfstream’s large‑cabin, ultra‑long‑range G600 (paired with the G500) saw its cumulative deliveries jump from roughly **150 aircraft by the end of 2021 to more than 300 by the end of 2024**, indicating that about **150 additional G600s were built and handed over during the 2022‑2024 period**.  \n\nThe G600 continues to anchor Gulfstream’s premium large‑cabin lineup, complementing newer models such as the G700 and G800 and now representing a growing share of the company’s aircraft‑manufacturing revenue and market presence.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports cumulative deliveries of the G500 and G600 as 'roughly 150 by the end of 2021' and 'more than 300 by the end of 2024', which aligns with the ground truth stating 'almost 150 by year-end 2021' and 'over 300 by year-end 2024'. The inference that about 150 additional aircraft were delivered during 2022–2024 is logically sound and accurate. (2) Quantitatively, all numbers and timeframes are correct. The use of 'end of 2021' instead of 'year-end 2021' is semantically equivalent. The calculation of ~150 additional deliveries is valid. (3) The qualitative reasoning is mostly sound: the G600's growing market presence is correctly inferred from delivery growth. However, the LLM incorrectly states that the G600 complements the 'G700'—the ground truth mentions the G800 and G400 as newer models, not the G700. Additionally, the original answer notes that the G600 was no longer described as a new product, indicating maturity, but the LLM misses this nuance and instead emphasizes it as a current anchor and revenue contributor, which is plausible but not directly supported in the provided truth. (4) The answer is highly relevant to the question, addressing both cumulative deliveries and the G600’s evolving role. It captures the core multi-hop synthesis (delivery growth over time and product lifecycle progression), though with a minor error in referencing the G700 instead of the G800/G400. Thus, the correctness score is 8 due to mostly accurate facts and reasoning with a small but notable entity/reference error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 429,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s stake in Corebridge fell dramatically—from roughly 52 % (the amount that kept Corebridge consolidated in AIG’s 2023 10‑K) to about 22.7 % by the end of 2024 after a series of secondary offerings, a June 9 2024 de‑consolidation, and subsequent share sales.  As a result of the de‑consolidation AIG recorded a $4.8 billion loss, then began accounting for its remaining interest as an equity‑method investment, recognizing only dividends and the fair‑value changes of its Corebridge shares (and, later, the $282 million gain on the December 2024 sale of 120 million shares to Nippon) in net investment income.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, factually correct evolution of AIG's financial relationship with Corebridge from 2023 to 2024. (1) Quantitatively, it correctly states AIG's initial ownership of approximately 52% in 2023 (aligns with ground truth 52.2%), and notes the reduction to 22.7% by end of 2024, which is consistent with de-consolidation and secondary offerings. The $4.8 billion loss on de-consolidation and the $282 million gain on the December 2024 sale to Nippon are specific, accurate figures not in the ground truth but plausibly derived from external data; however, since the ground truth does not include these, their presence is not penalized as long as they don't contradict—here, they enhance detail without error. The June 9, 2024 de-consolidation date matches exactly. (2) The shift to equity method accounting is correctly identified, as is the recognition of income via dividends and fair value changes (though the ground truth emphasizes pre-tax income based on dividends and stock price changes, while LLM mentions fair value changes and investment income—semantically equivalent in context). (3) Multi-hop reasoning is sound: the answer connects ownership percentage, de-consolidation, accounting change, and income recognition impact, synthesizing events across time and financial reporting implications. (4) Minor deduction in quantitative accuracy due to rounding 52.2% to 52%—acceptable but slight imprecision. No major omissions or errors; the answer exceeds ground truth in specificity. Contextual relevance is perfect—directly addresses equity ownership and income recognition as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 447,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla shifted the Solar Roof from a modest, largely outsourced pilot line to a more vertically integrated production flow centered on Gigafactory New York, but this expansion made the business heavily dependent on specialized battery‑cell supply chains and volatile raw‑material prices.  The rapid scale‑up introduced operational hurdles—tight construction schedules, limited qualified‑labor pools, and component‑shortage risks—that caused production delays and forced design tweaks to improve manufacturability and cost control.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies despite using plausible-sounding details. The claim that Tesla shifted from an 'outsourced pilot line' in 2022 is incorrect — the ground truth states that in 2022, Tesla was already producing Solar Roof at Gigafactory New York as a dedicated facility, not a modest or outsourced operation. The LLM incorrectly introduces 'specialized battery-cell supply chains' as a dependency for Solar Roof, which is not supported by the original answer; the Solar Roof is a roofing and solar tile product, not a battery product, and its manufacturing dependencies relate to design tolerances, quality control, and supply chain coordination, not battery cells. The mention of 'volatile raw-material prices' is not in the original and misrepresents the stated challenges. While the LLM correctly identifies production delays and design tweaks, it misattributes causes and evolution. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised — the LLM does not fabricate numbers, earning a 10. (3) The multi-hop reasoning is flawed: the LLM fails to accurately synthesize the shift from a focused 2022 production setup to increased complexity and risk in 2024. Instead, it invents a narrative of vertical integration from an outsourced model that is not in the source. The original emphasizes operational challenges like design tolerances, output rates, and supply chain coordination — the LLM mentions component shortages and labor pools, which are not in the ground truth. (4) Correctness is scored 4 due to significant factual and conceptual errors, despite some alignment on delays and design changes. Qualitative accuracy is low (4) due to incorrect entities and reasoning. Contextual relevance is moderate (7) because the answer addresses the general theme of production evolution and challenges, but with incorrect specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 525,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "\nFrom 2023 to 2024 Qualcomm moved its on‑device AI effort beyond smartphones, positioning AI as a cross‑industry growth engine for automotive, IoT and other new markets.  The company correspondingly deepened its business focus on AI‑driven products and directed substantially more R&D and strategic investment—through acquisitions, partnerships and targeted spending—toward commercializing on‑device AI in these expanded product areas.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Qualcomm's expansion of on-device AI beyond smartphones into automotive and IoT, and notes increased R&D and strategic investments in 2023–2024, which aligns with the ground truth. However, it misrepresents the nature of Qualcomm's strategic evolution: the original answer emphasizes a shift from direct product commercialization to a more investment-centric, ecosystem-enabling approach focused on long-term development. In contrast, the LLM answer states Qualcomm intensified its focus on 'AI-driven products' and 'commercializing on-device AI,' which contradicts the ground truth that the company moved away from immediate commercialization toward enabling third-party integration. This is a significant qualitative error in reasoning and strategic interpretation. There are no numerical figures in the question or answers, so quantitative accuracy is not applicable but assumed correct by default. Contextual relevance is high as the response addresses the timeframe and domain of Qualcomm’s AI evolution. The failure to accurately capture the shift in business model from product-centric to investment/ecosystem-centric reduces the correctness score despite accurate mention of R&D, acquisitions, and expanded markets.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 351,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "\nBetween 2022 and 2023 the footprint of Dolce & Gabbana shifted from a very limited appearance—confined to the Punta Norte Premium Outlet in Mexico City and a few Japanese centres (Gotemba, Kobe‑Sanda and Rinku)—to a more stable, multi‑property presence that now includes those same Japanese outlets and is reflected in the expanded International Premium‑Outlet tables for 2023.  This continuity (and modest expansion) shows that SPG is deliberately anchoring its premium‑outlet portfolio with globally recognised luxury designers, using D & G as a signal of upscale positioning to attract affluent shoppers and differentiate its premium‑outlet destinations from other retail centres.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims Dolce & Gabbana expanded or maintained its presence in Japan (Gotemba, Kobe-Sanda, Rinku) in 2023, but the original answer states that by 2023, the brand was only present at Las Vegas Outlets North Premium NV in the U.S., indicating a withdrawal from Japan, not continuity. The LLM also incorrectly mentions Punta Norte Premium Outlet in Mexico City, which is not referenced in the ground truth. (2) Quantitatively, the LLM misrepresents the number and location of properties: it falsely asserts continued presence in multiple Japanese outlets in 2023, and introduces a new location (Mexico City) not in the original data. There are no correct numerical comparisons because the core data is wrong. (3) The reasoning is flawed: instead of identifying a strategic contraction and repositioning from Japan to a single U.S. flagship, the LLM infers expansion and stability, leading to an incorrect conclusion about SPG’s strategy. The multi-hop synthesis fails—information across years and locations is misrepresented. (4) While the answer attempts to address brand positioning strategy, the conclusion about 'anchoring with luxury designers' and 'upscale positioning' is based on false premises, reducing contextual relevance despite addressing the general theme.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 372,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "\nBetween 2023 and 2024 ConocoPhillips modestly increased its exploration outlay in the Asia Pacific/Middle East—consolidated exploration expense rose to **$49 million in 2023** (up from $45 million in 2022, p. 156)—and in 2024 the company recorded **significant reserve additions and new discoveries** in the region (e.g., ~118 million barrels of upward revisions and extensions/discoveries in the Middle East through equity affiliates, pp. 144‑146).  This upward trend shows that COP is **prioritising growth of its resource base and future production in the Asia Pacific/Middle East**, using additional drilling, acreage acquisition and equity‑partner discoveries to strengthen its strategic focus there.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that COP spent $49 million in 2023 and $0 in 2024 on exploration in the Asia Pacific/Middle East region, indicating a complete halt. However, the LLM claims exploration increased and that there were significant discoveries and upward reserve revisions in 2024, which contradicts the $0 expenditure. (2) Quantitative inaccuracies include the false claim of 'significant reserve additions' and 'upward revisions of ~118 million barrels' in 2024, which are not supported by the ground truth. The only correct number is the $49 million for 2023, but it incorrectly frames this as an increase. The $45 million in 2022 is mentioned but irrelevant to the question. (3) The multi-hop reasoning is flawed: instead of recognizing the drop from $49M to $0 as a strategic withdrawal, the model infers increased strategic focus based on reserve revisions through equity affiliates—information not in the ground truth and misaligned with the actual investment trend. (4) The answer fails on correctness and quantitative accuracy due to major factual and directional errors. Qualitative accuracy is low because of incorrect entity linking and reasoning. Contextual relevance is moderate because it addresses the region and time frame, but with wrong conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 378,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "\nComcast maintains its 30 % economic stake in Universal Beijing Resort, but the goodwill recorded for the theme‑park segment fell from about **$5.8 billion in 2022** to **$5.0 billion by the end of 2024**, reflecting impairments and a re‑allocation of goodwill across its reporting units.  At the same time, the resort’s outstanding debt slipped modestly from roughly **$3.5 billion at the end of 2023** to **$3.4 billion at the end of 2024** (having been $3.5 billion in 2023 and $3.4 billion in 2024), indicating a slight de‑leveraging over the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Comcast's 30% ownership stake in Universal Beijing Resort and the reduction in debt from $3.5 billion in 2023 to $3.4 billion in 2024, which aligns with the ground truth. However, it introduces a fact not present in the original answer — the goodwill values of $5.8 billion in 2022 and $5.0 billion in 2024 — which were not mentioned in the ground truth and thus cannot be verified as accurate in this context. This is a significant addition that affects quantitative accuracy. (2) While the debt figures for 2023 and 2024 are correct, the LLM implies that debt data was available for 2022 by stating 'slipped modestly from...2023 to 2024' and referencing a '2022–2024 period', but the original answer states no specific debt or stake figures were provided in 2022. This misrepresents the timeline of disclosure. (3) The reasoning partially captures the evolution of debt involvement and correctly synthesizes the 2023–2024 debt trend, but fails to acknowledge that 2022 was a year of no explicit financial disclosure on stake or debt — a key nuance in the multi-hop timeline. (4) The answer is contextually relevant and well-structured, but the inclusion of unverified goodwill figures and incorrect implication of 2022 debt data reduce factual accuracy. Correctness score is 6 due to partial factual alignment with major additions not in ground truth; quantitative accuracy is penalized for unsupported numbers; qualitative reasoning is fair but flawed in timeline handling; relevance is high as it directly addresses the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 437,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2023 Duke Energy’s net‑derivative balance fell sharply – the “Derivatives (net)” table shows an ending balance of **$29 million in 2022 versus $13 million in 2023**, a reduction of roughly 55 %.  At the same time the company purchased far fewer new contracts (purchases dropped from **$74 million to $42 million**) and settled a larger share of existing positions (settlements turned from a modest outflow of **$32 million to $68 million**), while the recognized unrealized gain improved from a **$35 million loss to a $10 million gain**.  This pattern indicates that Duke Energy deliberately unwound and settled a portion of its derivative book, reducing its net‑derivative asset position and shifting toward a more conservative management of derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, correct evolution of Duke Energy's net derivatives balance and settlement activity from 2022 to 2023. It correctly states the net derivatives balance decreased from $29 million in 2022 to $13 million in 2023, matching the ground truth. Settlements are accurately reported as increasing from $32 million to $68 million. The 55% reduction calculation is approximately correct (actual: (29-13)/29 ≈ 55.17%). The answer includes additional accurate details not in the ground truth—such as purchases and unrealized gains—from likely the same source data, which enhances completeness without introducing errors. These extra details (purchases: $74M to $42M; unrealized gain shift from $35M loss to $10M gain) are consistent with a more comprehensive analysis and do not contradict the original answer. The reasoning is sound: the conclusion that Duke Energy unwound positions and adopted a more conservative approach is a logical inference from higher settlements and a declining net balance, which aligns with the ground truth’s indication of a shift in management. All entities (Duke Energy, years 2022–2023, derivative metrics) are correct. The only minor point preventing a perfect 10 is that the ground truth does not mention purchases or unrealized gains, so including them—while likely accurate—goes beyond the verified data; however, this does not reduce correctness. Overall, the answer correctly synthesizes multi-hop data and conveys the same core insight with enhanced depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 421,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 SPG continued to treat its LTIP units as participating, potentially‑dilutive securities that are not material to earnings‑per‑share or‑unit, but the disclosure became more detailed and the valuation methodology was expanded.  The 2022 program disclosed a maximum potential fair‑value of $20.6 million and noted that earned units would vest on Jan 1, 2026, while the 2023 program raised the maximum potential fair‑value to $42.5 million, introduced a Monte Carlo‑based estimate for market‑based awards, added a TSR‑modifier for performance conditions, and scheduled the determination of earned units for 2024‑2026 with vesting on Jan 1, 2027.  Thus, while the dilutive impact remained immaterial, the 2023 filing provided a more granular performance‑ and market‑based fair‑value model and a longer‑term vesting schedule.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution in SPG's disclosure and treatment of LTIP units from 2022 to 2023, correctly noting increased detail in 2023, including the use of a Monte Carlo model and more granular performance conditions. It also correctly identifies that LTIP units are treated as potentially dilutive and participating securities. However, the quantitative details introduced—such as the $20.6 million and $42.5 million maximum fair values, vesting dates (Jan 1, 2026/2027), and the claim about 'determination of earned units for 2024–2026'—are not present in the original ground truth and cannot be verified from the provided knowledge. These specific dollar amounts, dates, and vesting schedules represent fabricated or hallucinated data, which severely undermines factual accuracy. The original answer makes no mention of these figures or timelines, focusing instead on the methodological shift in valuation (Monte Carlo for market-based units) and the confirmation of treatment under the two-class method. While the LLM correctly infers a trend toward more detailed disclosure, it adds unsupported specifics, leading to significant quantitative inaccuracies. The reasoning is logically structured and contextually relevant, showing understanding of the disclosure evolution, but the inclusion of unverified numbers reduces correctness. Semantic equivalence fails on quantitative elements, though the qualitative direction of the answer aligns with the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 406,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "\nBetween 2022 and 2024 Comcast’s exposure to Atairos shifted from a $5 billion total capital pledge (with a $400 million annual call cap and a $45 million yearly management‑fee commitment) to a reduced $4.5 billion overall commitment and a lowered $40 million annual management‑fee obligation.  Capital contributions rose to $145 million in 2023, fell to $73 million in 2024, and the unfunded balance dropped from about $1.5 billion (as of 2021) to roughly $1.4 billion by the end of 2024, leaving Comcast’s stake at $5.1 billion (equity‑method) with no consolidation.  Thus, while the size of the capital commitment was trimmed and the management‑fee amount modestly reduced, Comcast continued to fund Atairos through periodic cash contributions and retains a $1.4 billion remaining unfunded commitment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that deviate from the ground truth. While it correctly identifies the reduction in capital commitment from $5 billion to $4.5 billion and the $40 million annual management fee in 2024, it introduces incorrect figures not present in the original answer: a $400 million annual call cap and a $45 million yearly management-fee commitment in 2022 are not mentioned in the ground truth. The original answer states only a $5 billion aggregate capital commitment in 2022 with no mention of annual caps or specific prior management fees. Additionally, the LLM provides specific capital contributions ($145M in 2023, $73M in 2024) and unfunded balances ($1.5B in 2021, $1.4B in 2024), which are not in the original answer and appear to be fabricated or inferred beyond the provided data. The $5.1 billion equity-method stake is also not mentioned in the ground truth. (2) Quantitative accuracy is low because multiple numbers (e.g., $45M fee, $400M cap, contribution amounts, unfunded balances) are either incorrect or unsupported. The only correct numbers are the $5B (2022), $4.5B (2024), and $40M (2024 management fee). (3) The reasoning partially captures the evolution of Comcast's commitment but adds unsupported details, undermining the multi-hop synthesis. The conclusion about a 'recalibration' is reasonable but not explicitly drawn from correct evidence. (4) The answer is contextually relevant and addresses the question's focus on capital funding and management fees, but the inclusion of unverified figures and calculations significantly reduces factual correctness. Minor wording flexibility is acceptable, but invented data points make the answer misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 472,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "\nFrom the 2023‑2024 tables, ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East fell from **296 billion cubic feet (2023)** to **289 billion cubic feet (2024)** – a decline of roughly 7 bcf (≈2 %). The decrease is modest and is driven mainly by revisions and production that slightly outpaced new extensions and discoveries; undeveloped reserves stayed flat at about 7 bcf.  \n\nThis pattern shows that the company is **maintaining a stable, non‑expansionary presence** in the Asia Pacific/Middle East, with little net growth in gas reserves, and is instead directing its operational resources toward other regions (e.g., the Lower 48 and Canada) where it is pursuing more aggressive development and acquisition activity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, COP's natural gas reserves in the Asia Pacific/Middle East region were 312 billion cubic feet (bcf) in 2023 and decreased to 296 bcf in 2024. However, the LLM incorrectly states reserves as 296 bcf in 2023 and 289 bcf in 2024, reversing the correct values and introducing a new, unsupported figure. This results in an incorrect year-over-year change (7 bcf decrease vs. the correct 16 bcf decrease). (2) The calculation of a 2% decline is based on incorrect inputs and is therefore inaccurate. The correct decrease is 16 bcf, or approximately 5.1% (16/312), not 2%. The claim that undeveloped reserves remained flat at 7 bcf is not supported by the ground truth, which does not provide a breakdown of developed vs. undeveloped reserves. (3) While the LLM attempts multi-hop reasoning by linking reserve changes to operational focus and comparing regions, this inference goes beyond the information in the ground truth. The original answer only suggests a 'potential shift in operational focus or resource allocation' based on the modest reduction; the LLM overreaches by asserting a strategic redirection toward the Lower 48 and Canada, which is not substantiated in the provided data. (4) Despite these issues, the LLM answer is contextually relevant and addresses both parts of the question—reserve evolution and implications for operational focus—with reasonable structure and interpretation. However, due to major quantitative errors and unsupported qualitative inferences, the overall correctness is significantly compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 453,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "\nIn 2022 Comcast’s wireless‑gateway strategy was to procure a standardized set of customer‑premise equipment from a limited group of suppliers and make the devices available to broadband subscribers either as a direct purchase or through interest‑free 24‑month financing, bundling them with its internet service. By contrast, the 2024 plan shifts the investment focus to the underlying network, with capital spending directed toward scalable infrastructure, line‑extensions and DOCSIS 4.0 upgrades that will deliver multigigabit symmetrical speeds rather than expanding gateway procurement. (2022 10‑K pp. 6‑7; 2024 10‑K p. 51)",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Comcast's 2022 procurement strategy involving standardized wireless gateway purchases from limited suppliers and customer financing options, which aligns with the ground truth. It also accurately references the 2024 shift toward network infrastructure investment, citing DOCSIS 4.0 and multigigabit symmetrical speeds. However, the LLM mischaracterizes the 2024 focus as being *away* from gateway procurement, stating capital spending is directed 'rather than expanding gateway procurement.' This contradicts the ground truth, which emphasizes that wireless gateways remain a key component of 2024 capital expenditures and are being actively integrated into network upgrades. The LLM implies a trade-off that isn't present in the original answer, suggesting a divergence instead of an evolution where gateways are now strategically deployed as part of infrastructure. (2) There are no numeric values, dollar amounts, or percentages in either answer, so quantitative accuracy is not compromised—no errors in dates (2022, 2024) or document references (10-K pages). (3) The multi-hop reasoning is partially sound: the model connects procurement in 2022 to investment strategy in 2024, but fails to synthesize the continuity—gateways are not being de-emphasized but rather repositioned as strategic infrastructure elements. The conclusion misrepresents the relationship between gateway deployment and network investment. (4) Correctness is scored 6 due to this significant conceptual error, despite accurate sourcing and contextual framing. Qualitative accuracy is 6 because the reasoning flaw affects the core comparison. Quantitative accuracy is 10 (no numbers, but correct years and references). Contextual relevance is 9—highly relevant with strong document support, but slightly misaligned in interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 504,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla’s treatment of the Solar Roof shifted from a growth‑focused initiative to a more restrained, engineering‑driven priority.  In the 2022 filing the roof was highlighted as a revenue driver for the Energy segment—deployments were rising and the company was working to lower unit costs—but it still suffered from under‑utilized factories and modest gross margins.  By the 2024 filing the product is no longer presented as a central growth pillar; instead Tesla emphasizes broader energy‑storage and battery‑cell programs, and the disclosed challenges center on limited supplies of specialized glass and solar‑cell materials and the complexity of scaling a new, highly engineered manufacturing process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in Tesla's approach to the Solar Roof: from being a growth driver in 2022 to facing production and scaling challenges in 2024. The key points—revenue contribution in 2022, deployment efforts, cost reduction, and under-utilized capacity—are consistent with the original answer. By 2024, the shift in emphasis to manufacturing complexity, supply constraints (specialized glass and solar-cell materials), and scaling difficulties matches the ground truth's mention of 'production ramp delays similar to past launches.' (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable in terms of calculations, but all references to years (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points and correctly infers a strategic shift based on changes in tone and emphasis in Tesla’s disclosures. (4) The LLM adds slightly more detail than the original (e.g., 'under-utilized factories', 'modest gross margins', 'lowering unit costs'), which are plausible and contextually appropriate but not explicitly confirmed in the ground truth. This prevents a perfect 10, as these details, while reasonable, go beyond the provided truth. However, they do not contradict it, and the core factual and conceptual content is correct. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy due to correct use of time periods and absence of numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 447,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "\nFrom 2022 to 2023 the “Net pending transactions and other investments” line in the Duke Energy Master Retirement Trust rose from **$14 million (2022)** to **$54 million (2023)** – an increase of roughly **$40 million (≈ 285 %)**. This jump shows that Duke Energy has markedly expanded its short‑term, highly liquid holdings, likely to fund upcoming capital projects, manage cash‑flow timing and support strategic initiatives such as regulatory‑driven investments or growth opportunities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The original answer states that Duke Energy's investment in Net Pending Transactions and Other Investments *decreased* from $53 million in 2022 to $14 million in 2023. The LLM incorrectly claims an *increase* from $14 million (2022) to $54 million (2023), reversing the years and misstating the amounts. This fundamental error invalidates the entire response. (2) Quantitative accuracy is extremely low: the LLM swaps the values and assigns them to the wrong years. The claimed increase of $40 million (≈285%) is based on incorrect inputs and direction. The correct change is a *decrease* of $39 million (from $53M to $14M, or ~73.6% decrease). (3) The qualitative reasoning fails because it interprets an increase where there was actually a significant decrease. The conclusion that Duke Energy 'expanded its short-term holdings' contradicts the ground truth, which indicates a strategic *reduction* or completion of initiatives. The multi-hop synthesis is flawed—either the model misread the data or confused the years and entities. (4) Scores reflect near-total factual inaccuracy: correctness is 1 due to complete reversal of trend; quantitative accuracy is 1 due to wrong numbers and calculations; qualitative accuracy is 1 due to invalid reasoning based on false premises; contextual relevance is 3 because the answer addresses the right category and company, but with incorrect data and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 412,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "\nThe company kept the same liability‑driven investment targets – ≈20 % equity/80 % fixed‑income for its pension assets and 55 % equity/45 % for post‑retirement assets – but the actual portfolio was tweaked between 2023 and 2024: equity rose modestly (pension equity ↑ from 18 % to 21 %; post‑retirement equity ↑ from 53 % to 57 %) while the Treasury‑related fixed‑income share fell (pension ↓ from 25 % to 16 %; post‑retirement ↓ from 16 % to 13 %).  At the same time, defined‑contribution plan expense increased to **$112 million in 2024** (up from $109 million in 2023), and the 2024 filing added a more detailed fair‑value hierarchy disclosure of plan assets (Level 1/2/NAV breakdowns and a note that Level 3 holdings are immaterial), providing a clearer view of the asset composition than the prior year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the right question and showing relevant reasoning structure. (1) Quantitative Accuracy: The ground truth states that defined contribution plan expenses increased from $109M in 2023 to $112M in 2024 — this part is correctly reported. However, the detailed asset allocation percentages (e.g., pension equity rising from 18% to 21%, Treasury-related fixed income falling from 25% to 16%) are not present in the original answer and are therefore unsupported. The original answer only confirms that the *target* allocation remained at 20%/80% equity/fixed income in both years, with no mention of actual portfolio allocations or post-retirement asset targets (like 55%/45%) or their changes. (2) The LLM introduces a 'fair-value hierarchy disclosure of plan assets (Level 1/2/NAV breakdowns)' and notes about Level 3 holdings being immaterial — this level of detail is not in the ground truth. While the original does state that the 2024 filing added a new disclosure about characterizing the actual composition of plan assets, it does not specify the form of that disclosure. Thus, the LLM over-specifies with potentially incorrect details. (3) Reasoning and Synthesis: The model correctly identifies the multi-hop nature of the question — comparing two years, tracking expense changes, and assessing evolution in disclosure practices. It attempts to synthesize across time and metrics, but the synthesis is based on fabricated or unsupported data points. (4) Contextual Relevance: The answer is well-structured and focused on the right topic — evolution of the liability-driven investment framework, defined contribution expenses, and transparency in asset composition — hence high relevance. However, the inclusion of unverified percentages and disclosures undermines factual correctness. Overall, the answer appears plausible but diverges materially from the ground truth on key quantitative and qualitative points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 533,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "\nBetween FY 2023 and FY 2024 Qualcomm moved from a broad‑based AI research agenda to a concrete, revenue‑driving on‑device AI strategy.  The 2024 10‑K explicitly calls out “on‑device artificial intelligence (AI)” as a core growth pillar and notes that the company will continue to invest heavily in AI‑centric silicon, AI‑software ecosystems and related R&D—particularly for automotive and IoT applications—while also expanding patents and strategic investments in AI‑related technologies.  In short, the company deepened its focus on commercializing on‑device AI, tying future growth to AI‑enabled products in new markets beyond mobile handsets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in Qualcomm's strategic focus on On-Device AI between fiscal 2023 and 2024. It correctly identifies the shift from a broader AI research agenda (aligned with the 2023 emphasis on 5G and integrated circuits enabling expansion into automotive and IoT) to a more concrete, investment-driven strategy in 2024. The mention of investing in AI-centric silicon, software ecosystems, R&D, patents, and strategic transactions aligns with the ground truth's emphasis on active investment and expansion beyond mobile. While the original answer highlights acquisitions or strategic transactions more explicitly, the LLM's reference to 'strategic investments' captures a similar intent. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and all entities—Qualcomm, fiscal years 2023 and 2024, On-Device AI, automotive, IoT—are correctly identified. The reasoning is sound, showing a logical progression from vision to execution. The answer is contextually relevant and fully addresses both parts of the question: evolution of focus and specific investments/direction changes. The only minor shortcoming is slightly less precision in articulating the shift from 'strategic vision' to 'active investment' compared to the original, but the core meaning is preserved. Hence, a score of 9 is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 387,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "\nThe Voting Trust Agreement continues to be filed as **Exhibit 9.1** (and 9.2) in both the 2022 and 2023 Form 10‑K filings, with the identical caption “**Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated March 1 2004**” between Melvin Simon & Associates and the Simon family members. No re‑classification, amendment, or relocation of the exhibit appears in the 2023 filing, signalling that the underlying governance structure remains unchanged and stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in a critical aspect: it claims that the 2023 10-K filing retains the 'Second Amended and Restated' designation in the exhibit caption, while the ground truth explicitly states that this modifier was dropped in the 2023 filing. This misrepresents the core evolution in classification and presentation between the two years. The LLM asserts that the exhibit caption is identical across both years, which contradicts the ground truth. As a result, the conclusion about stability, while directionally aligned with the original answer, is based on incorrect evidence. The mention of Exhibit 9.1/9.2 and the date March 1, 2004, is consistent with the entities involved, so entity accuracy is partially correct. However, the reasoning fails the multi-hop requirement because it does not recognize the change in nomenclature that signals governance continuity (i.e., no new amendments). The answer is contextually relevant—addressing exhibit classification and governance stability—but fundamentally flawed in factual accuracy. Quantitative accuracy is low because the key detail (presence vs. absence of 'Second Amended and Restated') is binary and misrepresented. Qualitative accuracy is poor due to incorrect synthesis and reasoning based on false premise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 358,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "\nCOP’s proved natural‑gas reserves in the Asia Pacific/Middle East fell from about **312 billion cubic feet (BCF) at the end of 2023 to roughly 296 BCF at the end of 2024** – a decline of roughly 5 %.  The drop is driven by **downward price‑related revisions in the region’s equity‑affiliate holdings (≈ 81 BCF of lower‑price revisions, partially offset by ~ 55 BCF of technical gains)** and only modest reserve additions from extensions and discoveries (mainly in the Middle East and Australia).  \n\nBecause the region’s reserve base is now a **small, slightly shrinking share of COP’s total global gas portfolio**, the trend signals that COP is **de‑emphasising the Asia Pacific/Middle East** as a strategic growth area and is instead focusing reserve development on North‑American unconventional plays and other regions with more robust reserve growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region: 312 BCF in 2023 and 296 BCF in 2024, matching the ground truth exactly. The calculated decline of 16 BCF (5.1%) is accurately reflected as 'roughly 5%'—a reasonable rounding. 2) The quantitative accuracy is perfect: all numbers (312, 296, 5%) are correct, and the explanation includes additional granular detail (81 BCF downward price revisions, 55 BCF technical gains) not in the original answer but consistent with plausible SEC filing data. These do not contradict the ground truth and enhance the explanation. 3) The qualitative reasoning is strong: the LLM correctly infers that the decline suggests de-emphasis of the region in favor of other areas like North American unconventional plays. It goes further than the original by citing specific drivers (price revisions, technical gains, modest additions), demonstrating sound multi-hop synthesis. 4) The only minor gap is that the LLM does not mention the 5,870 BCF held by equity affiliates in 2024—a notable omission from the ground truth that adds context about the region’s continued significance despite the decline. However, this does not invalidate the overall conclusion. 5) The answer is contextually fully relevant, directly addressing both parts of the question: evolution of reserves and strategic implications. The reasoning is logically sound and factually grounded. The omission of the equity affiliate figure prevents a perfect 10, but the core facts, calculations, and interpretation are correct and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 435,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "\nBetween 2023 and early 2024 AIG moved from fully consolidating Corebridge—so that Corebridge’s debt and earnings were reflected in AIG’s balance sheet and results—to de‑consolidating the insurer after it fell below the 50 % ownership threshold and lost board control on June 9 2024.  Following the de‑consolidation AIG retained a 22.7 % equity stake and began accounting for the investment under the equity method, recognizing income from dividends and changes in Corebridge’s stock price (e.g., a $601 million equity‑method gain in 2024) and later realized gains on share sales; Corebridge’s own debt (≈ $9.4 bn of senior notes, DDTL facility, etc.) remained on Corebridge’s books and was no longer consolidated into AIG’s debt, leaving AIG’s own debt structure essentially unchanged aside from the $261 million equity‑increase recorded from the secondary offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the essential evolution in AIG's financial relationship with Corebridge between 2023 and 2024. (1) Quantitatively, the LLM correctly identifies the deconsolidation date (June 9, 2024), the shift to equity method accounting, and the 22.7% retained stake. It references a $601 million equity-method gain in 2024, which aligns with plausible income from dividends and stock price changes, though the original answer does not specify this exact figure—this is a minor addition not contradicted by ground truth. The $261 million equity increase from a secondary offering is contextually relevant and consistent with AIG’s disclosures. The ≈$9.4 billion Corebridge debt figure matches the original $9,368 million total debt (sum of $6,452M senior notes + $989M junior subordinated + other debt), so rounding is acceptable. (2) The original answer emphasizes that in 2023, Corebridge debt was consolidated on AIG’s balance sheet; the LLM correctly notes that after deconsolidation, Corebridge’s debt remained on its own books and was no longer part of AIG’s debt structure. (3) The qualitative reasoning is sound: the LLM correctly identifies the trigger for deconsolidation (loss of >50% ownership and board control), the shift to equity method accounting, and the components of equity method income (dividends and stock price changes). It adds useful context—realized gains on share sales and the secondary offering impact—not in the original but consistent with public filings. (4) The only minor gap is that the LLM does not explicitly break down the 2023 debt structure into senior unsecured and junior subordinated amounts as in the original answer, though it references the total debt. This omission slightly reduces completeness but does not affect the core correctness. Overall, the answer demonstrates strong multi-hop reasoning across time, ownership, accounting treatment, and financial reporting, with excellent semantic equivalence to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 537,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "\nBetween 2022 and 2024 NextEra’s Special‑Use funds moved from a largely short‑term, high‑quality fixed‑income tilt—reflecting the need for highly liquid assets to cover storm‑damage reserves and short‑duration nuclear‑decommissioning cash‑flows (see 2022 10‑K pages 56‑57)—to a more balanced portfolio that now carries a noticeably larger equity component (equity holdings of roughly $2.6 bn for NEE and $1.0 bn for FPL at 31 Dec 2024, versus a smaller equity share in 2022).  This modest increase in equity exposure indicates a slight expansion of risk appetite, while the continued heavy weighting in short‑duration debt and regulatory‑linked assets shows the company is still prioritising liquidity to meet its storm‑damage and decommissioning obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, in 2022, NextEra Energy (NEE) had $2,505 million in Special Use Funds, all in fixed income securities. In 2024, the portfolio shifted to include $6,164 million in equity securities, along with various fixed income components totaling over $2,000 million. However, the LLM claims equity holdings of only $2.6 billion for NEE and $1.0 billion for FPL (a subsidiary) at the end of 2024, which is substantially lower than the correct $6,164 million solely for NEE. This misrepresents the scale and nature of the shift. 2) The numbers are not accurate: the LLM underreports NEE's 2024 equity allocation by more than half and incorrectly splits the allocation between NEE and FPL without justification or support from the ground truth, which only reports consolidated NEE figures. There is no mention in the ground truth of FPL-level breakdowns. 3) The reasoning partially captures the strategic shift from fixed income to equities but understates it as a 'modest increase' and 'slight expansion of risk appetite', whereas the ground truth shows a dramatic transformation—from 100% fixed income to a portfolio where equities dominate (over 70% of total Special Use Funds in 2024). The LLM’s conclusion downplays the significance of the change. 4) While the LLM correctly identifies the purpose of Special Use Funds (storm-damage reserves, decommissioning), and notes a shift toward equities, it fails to accurately quantify the change or reflect the full extent of the strategic evolution. The contextual relevance is fair because it addresses the question's intent, but factual correctness is compromised by major numerical errors and incorrect entity-level attribution (FPL vs NEE).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 489,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "\nBetween 2022 and 2024 the risk that site‑infrastructure sharing would curb new lease activity grew from a general caution to a concrete, 5G‑driven threat.  In both years the filings warned that “extensive sharing of site infrastructure, roaming or resale arrangements … including due to increases in advanced network technology such as 5G, as an alternative to leasing our communications sites, without compensation to us, may cause new lease activity to slow if carriers utilize shared equipment rather than deploy new equipment, or may result in the decommissioning of equipment on certain existing sites.”  However, the 2024 discussion tightens this language to “RAN sharing, roaming or resale arrangements … due to increases in advanced network technology such as 5G,” explicitly linking the rise of 5G‑based sharing models to a higher likelihood of reduced lease renewals, lower lease rates and greater churn, thereby amplifying the magnitude of the risk for American Tower.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: the evolution of risk from a general concern in 2022 to a more specific and financially impactful threat in 2024 is accurately described. The mention of RAN sharing, roaming, and resale arrangements in the context of 5G-driven carrier behavior is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable—however, the absence of any incorrect numbers or fabricated data supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 vs 2024), identifies the shift in risk specificity (from general infrastructure sharing to RAN-specific arrangements), and links it to 5G adoption and its impact on lease activity. The LLM also correctly attributes the risk to American Tower (AMT), referred to as 'us' in the filings. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2024 filing emphasizes the 'lack of compensation' to AMT as a key financial concern, though it does mention 'without compensation to us' in the quote and refers to lower lease rates and churn, which implies financial impact. This slight omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is contextually precise, factually correct, and demonstrates strong reasoning across time periods and risk dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 422,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "\nChevron’s equity investment in Angola LNG Limited slipped from **$1.96 billion at the end of 2022 to $1.76 billion at the end of 2023**, a decline of about $200 million.  The stake is still accounted for under the **equity‑method** – Chevron records its share of Angola LNG’s earnings (reported as $513 million for 2023) and adjusts the carrying amount of the investment accordingly, while retaining its **36.4 percent ownership** and the same accounting treatment used in prior years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies not present in the ground truth. The original answer states there was a structural and relational shift in Chevron's investment classification—from 'Depends_On' in 2022 to 'Invests_In' in 2023—indicating a change in the nature of the financial relationship. However, the LLM answer completely omits this key qualitative evolution and instead introduces specific dollar amounts for the carrying value of the investment ($1.96B in 2022, $1.76B in 2023) and Chevron’s share of earnings ($513M in 2023), which are not mentioned or supported by the ground truth. These figures may be plausible but are not part of the verified knowledge graph data, making them incorrect in this evaluation context. (2) The quantitative accuracy is low because the dollar values and earnings figure are fabricated or hallucinated; no such numbers appear in the original answer, and no verification source is provided. The 36.4% ownership percentage is correctly retained, which is a point in favor, but the rest of the financial data lacks grounding. (3) The multi-hop reasoning is flawed: the question asks about evolution in investment structure and equity method accounting, and the correct answer hinges on the reclassification of the relationship type (from 'Depends_On' to 'Invests_In'). The LLM fails to mention this critical shift and instead focuses on unverified financial metrics, missing the core conceptual change. While it correctly notes that equity-method accounting was maintained, it does not address the structural reclassification that defines the evolution. (4) Contextual relevance is high because the answer stays focused on Chevron, Angola LNG Limited, ownership percentage, and equity-method accounting. However, correctness and qualitative accuracy are penalized due to hallucinated numbers and omission of the key relational shift, resulting in a partially correct but misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 530,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "\nFrom 2022 to 2023 the G600 stayed a core element of Gulfstream’s large‑cabin fleet, with cumulative deliveries climbing from almost 150 aircraft (as of year‑end 2021) to more than 250 by the end of 2023—demonstrating uninterrupted production and rising market demand. Its performance specifications—top‑tier cruise speeds (≈Mach 0.90), an ≈8,000‑nautical‑mile range, enhanced fuel efficiency and a larger cabin, plus more than 90 city‑pair speed records—remain unchanged, keeping the G600 at the benchmark level of Gulfstream’s product line while newer models such as the G700 and G800 are positioned to extend range and capability further.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the G600 as a core part of Gulfstream's lineup and notes its production continuity and growing deliveries, aligning with the ground truth's emphasis on maturity by 2023. However, the quantitative claim of 'more than 250 deliveries by end of 2023' is partially accurate but lacks sourcing from the original answer, which confirms this figure. The LLM incorrectly references 'almost 150 aircraft as of year-end 2021'—a number not present in the ground truth and not logically derived (the original does not provide 2021 delivery data). This introduces a factual assumption that undermines quantitative accuracy. (2) Performance metrics like Mach 0.90 cruise speed, ~8,000 nm range, and city-pair records are plausible but not mentioned in the original answer; while they may be true, their inclusion shifts focus to unverified technical details rather than the evolution of the G600’s strategic role, which is the core of the question. (3) The reasoning correctly infers that the G600 transitioned from new to established, and notes its technological influence on newer models like G700/G800—this aligns with the original’s point about the Symmetry Flight Deck being foundational. However, the LLM does not explicitly state the shift in characterization from 'recent addition' in 2022 to 'mature product' in 2023, missing a key qualitative evolution. Instead, it emphasizes unchanged performance, which is relevant but secondary. (4) The answer is contextually strong and well-structured, addressing both production status and performance, but overemphasizes unconfirmed specs and introduces unsupported delivery numbers, reducing quantitative reliability. The core narrative of maturation and platform influence is sound, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 490,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s shifted from a purely royalty‑and‑rent model to a more partnership‑oriented approach. The company now regularly co‑invests with franchisees in restaurant modernizations, digital‑platform upgrades and supply‑chain initiatives—sharing capital costs and strategic goals—while still earning revenue through rent, royalties, initial fees and technology‑recovery charges. This deeper financial collaboration reflects a move toward joint‑value creation rather than a purely transactional franchise relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's relationship with franchisees between 2022 and 2024. It correctly identifies the shift from a transactional model (rent, royalties, fees) to a more collaborative, co-investment-based partnership. The key qualitative elements—co-investment in modernizations, digital upgrades, and shared strategic goals—are consistent with the ground truth. While the original answer emphasizes 'operating system upgrades' and 'catering to consumer preferences,' the LLM answer substitutes with 'digital-platform upgrades' and 'supply-chain initiatives,' which are plausible specifics but not explicitly mentioned in the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound, demonstrating correct multi-hop synthesis across years and strategic models. The answer is fully contextually relevant. The only minor deviation is the addition of 'supply-chain initiatives' and 'technology-recovery charges,' which are not present in the original, slightly reducing qualitative accuracy. Overall, the semantic meaning and factual core are preserved, warranting a 9/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 345,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023 the smokeable‑products segment saw a modest dip in sales: net revenues fell from **$22,476 million in 2022 to $21,756 million in 2023** (about a $720 million or 3.2 % decline).  Operating income also slipped only slightly, moving from **$10,688 million in 2022 to $10,670 million in 2023**, a reduction of roughly $18 million (≈0.2 %).  The segment therefore experienced a small revenue contraction but essentially flat operating profitability over the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: net revenues of $22,476 million in 2022 and $21,756 million in 2023, and operating income of $10,688 million in 2022 and $10,670 million in 2023. The calculated differences ($720 million decline in revenue, $18 million drop in operating income) and percentages (3.2% and ~0.2%) are correct. (2) The answer is complete, addressing both net revenues and operating income across both years as required by the question. (3) Entities are accurate—'smokeable products' is correctly identified as the segment, and years 2022 and 2023 are properly referenced. (4) The reasoning is sound: the LLM correctly synthesizes year-over-year performance, computes changes, and draws the appropriate conclusion of a small revenue decline and nearly flat operating profitability. The semantic meaning fully aligns with the original answer, with added clarity through percentage calculations that do not distort the facts. All aspects meet the highest standard of accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 309,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "\nFrom 2022 through 2024 Opdivo shifted from being mainly a co‑developed immuno‑oncology asset with Ono (with shared development costs and a 50/50 profit split in Japan) to a broader platform that is being expanded through new collaborations and regulatory milestones.  In 2024 the FDA approved the subcutaneous formulation Opdivo Qvantig and granted fresh indications—including neoadjuvant NSCLC, urothelial carcinoma and a first‑line Opdivo + Yervoy regimen for colorectal cancer—while the partnership with Nektar on the NKTR‑214 combo entered Phase III, reinforcing Opdivo’s role as a central growth engine and a versatile backbone for BMY’s oncology pipeline.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Opdivo's strategic role within BMY from 2022 to 2024 and correctly identifies the shift from co-development with Ono to broader use as a backbone in oncology. However, there are significant factual inaccuracies. First, the profit-sharing arrangement with Ono is misrepresented: the ground truth specifies an 80-20 split for single-party compounds and equal sharing for combinations, not a 50/50 split in Japan as stated. Second, the LLM claims FDA approvals in 2024 for neoadjuvant NSCLC, urothelial carcinoma (in combination with cisplatin/gemcitabine), and a first-line Opdivo + Yervoy regimen for colorectal cancer—however, the ground truth only confirms the urothelial carcinoma approval in March 2024. The other indications are either not mentioned or not verified in the provided truth. Additionally, the approval of Opdivo Qvantig (subcutaneous formulation) and the Phase III trial with Nektar’s NKTR-214 are not supported by the original answer and appear to be hallucinated or sourced from external knowledge. While the answer correctly identifies the strategic pivot toward independent expansion and Opdivo’s central role in BMY’s pipeline, it fails on key quantitative and entity-specific details. The reasoning is partially sound in identifying a strategic evolution, but the synthesis includes unverified collaborations and approvals, undermining factual correctness. Contextual relevance is high as the response directly addresses the question’s focus on strategic evolution, collaboration, and new approvals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 429,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "\nBetween 2022 and 2024 AMT shifted from broadly describing variable‑rate benchmarks—citing SOFR + spread on Nigerian letters of credit and “interest rate … above LIBOR/EURIBOR” for its revolving facilities—to explicitly naming the fixed coupons of its latest securitizations (5.490 %/5.735 % for the 2023‑Series A/R notes and 3.652 %/4.459 % for the 2018‑Series A/R notes).  The newer filings retain the same DSCR‑based covenants (Cash‑Trap at 1.30× and Minimum DSCR at 1.15× that trigger reserve accounts and mandatory amortization) but add detailed triggers for amortization of the 2015‑2 notes and prepayment considerations, moving from generic benchmark references to precise rate disclosures and expanded covenant mechanics.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents AMT's disclosures between 2022 and 2024. (1) Quantitatively, the LLM incorrectly states that AMT disclosed fixed coupons for securitizations (e.g., 5.490%/5.735% for 2023-Series A/R notes and 3.652%/4.459% for 2018-Series A/R notes), which are not mentioned in the ground truth and appear fabricated. These specific percentages and series names have no support in the provided ground truth. (2) The claim that AMT shifted to 'explicitly naming fixed coupons' contradicts the ground truth, which emphasizes a shift from LIBOR to SOFR in Nigerian letters of credit—not a move toward fixed-rate disclosures. (3) The LLM introduces DSCR-based covenants (Cash-Trap at 1.30×, Minimum DSCR at 1.15×) and detailed amortization triggers for the 2015-2 notes, none of which are present in the original answer; the ground truth notes that 2024 disclosures focused on consequences of non-compliance without specifying renewal terms or interest rate structures, suggesting simplification, not expansion of covenant mechanics. (4) The reasoning is flawed: the LLM suggests a shift from 'generic benchmark references to precise rate disclosures,' while the ground truth indicates a move away from LIBOR/EURIBOR toward SOFR and a reduction in covenant detail. The LLM inverts the direction of evolution in covenant disclosure. (5) Entity accuracy is partially correct—AMT, SOFR, LIBOR, EURIBOR are correctly identified—but misapplied in context. The years 2022 and 2024 are correctly framed, but the cited financial instruments and terms are not supported. (6) Contextual relevance is moderate: the answer addresses interest rate benchmarks and covenants, but with incorrect details, making it misleading despite topical alignment. Overall, the answer fails on factual correctness and multi-hop synthesis, introducing unsupported specifics and reversing the trend in covenant disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 525,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s shifted from a primarily “land‑lord” model—where it owned or long‑term‑leased real estate and collected rent and royalties from franchisees—to a more collaborative co‑investment approach.  In the 2024 filing the company stresses that it now works hand‑in‑hand with franchisees to fund restaurant upgrades and new openings, often sharing capital and using developmental‑license or affiliate structures that give it equity stakes (especially in markets such as China and Japan).  This evolution reflects a move toward joint‑venture‑style investments that aim to modernize stores, meet consumer‑preference goals and generate higher‑margin revenue rather than relying solely on passive franchisee reinvestment.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual discrepancies. The original answer (ground truth) states that in 2022, McDonald's emphasized systemwide coordination for ESG initiatives without detailing real estate ownership, and by 2024 clarified its conventional franchise model where it typically owns or leases real estate while franchisees invest in equipment and interior elements. This model was described as a co-investment structure enabling high performance. In contrast, the LLM answer incorrectly frames the evolution as a shift from a 'land-lord model' to a 'collaborative co-investment approach' with joint ventures and equity stakes, particularly in China and Japan—information not present in the ground truth. The LLM introduces developmental-license and affiliate structures with equity stakes, which are not mentioned in the original answer. While the general direction of increased strategic structuring is loosely aligned, the specific mechanisms (joint ventures, equity stakes, market-specific strategies) are fabrications or misrepresentations. The reasoning is flawed because it invents a transformation that isn't supported by the source material—there is no evidence in the ground truth of a shift away from the traditional model; rather, the model was clarified over time. The contextual relevance is high because the answer addresses real estate ownership and co-investment between 2022 and 2024, but the factual basis is partially incorrect, leading to a correctness score of 5—partially right on the existence of a co-investment framework, but wrong on the nature and evolution of the strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 486,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "\nIn the 2022 filing the 2015 Stock‑Compensation Plan for Non‑Employee Directors was still presented as a distinct, shareholder‑approved plan, with its latest amendment (effective Oct 26 2022) disclosed in the Annual Report; by the 2023 filing the plan was no longer listed as a separate plan in the equity‑compensation table, its available shares being folded into the broader 2020 Performance Incentive Plan and only a brief exhibit reference remained. This shift shows Altria’s move to consolidate director compensation into a single, streamlined equity‑incentive framework, emphasizing simplicity, transparency and alignment with its overall shareholder‑approved governance structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, the 2015 Stock Compensation Plan was formally amended and restated effective October 26, 2022, and incorporated by reference from the September 30, 2022, Form 10-Q. However, the LLM claims the plan was no longer listed as a separate plan in the 2023 filing and that its shares were folded into the 2020 Performance Incentive Plan — a claim not supported by the ground truth. There is no mention in the original answer of consolidation into the 2020 plan or removal from the equity-compensation table. (2) The date of the amendment (October 26, 2022) is correctly cited by the LLM, which aligns with the ground truth. However, the key quantitative fact — 703,256 shares available in 2022 — is completely omitted in the LLM response, a major deficiency. The LLM introduces the idea of consolidation without numerical support or confirmation from the source. (3) The multi-hop reasoning is flawed. While the LLM attempts to infer governance implications (streamlining, transparency), it does so based on an incorrect premise — that the plan was merged or discontinued — whereas the ground truth indicates it was updated and formally restated, not absorbed. This mischaracterization undermines the reasoning chain. (4) Despite the factual errors, the LLM remains contextually relevant by addressing director compensation governance and attempting to interpret Altria’s strategic intent. The qualitative analysis of governance trends (simplicity, alignment) is reasonable but built on incorrect data, limiting its validity. The answer fails on core correctness due to missing and inaccurate facts, especially regarding plan status and share availability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 478,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "\nFrom 2022 through 2024, carriers have increasingly turned to roaming, RAN‑sharing and resale arrangements—accelerated by 5G roll‑outs and cost pressures—to meet capacity needs without leasing separate tower space.  This shift has slowed new lease additions and even prompted the de‑commissioning of redundant equipment on existing sites, indicating that competitive pressures are constraining AMT’s lease growth and forcing the company to contend with lower‑cost, shared‑infrastructure alternatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in roaming and resale arrangements' impact on AMT's leasing activity from 2022 to 2024. It correctly identifies that infrastructure sharing (roaming, RAN-sharing, resale), driven by 5G and cost pressures, has reduced the need for new leases and even led to decommissioning of existing equipment—directly aligning with the ground truth. The answer conveys the growing competitive pressure from shared infrastructure alternatives, which constrains AMT’s lease growth. All entities (AMT, carriers, 5G, RAN-sharing) and timeframes (2022–2024) are correctly referenced. There are no numerical inaccuracies, as the response does not include specific numbers but accurately describes trends. The only minor shortcoming is that it does not explicitly state that the concern 'evolved' from 2022 (initially focused on slowing new leases) to 2024 (now including decommissioning), which slightly weakens the multi-hop synthesis compared to the original. However, the overall meaning and implications are semantically equivalent. Thus, the answer is factually correct, contextually relevant, and well-reasoned with only a slight nuance missing in the progression of risk over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 345,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s moved from a largely “hands‑off” franchise model—where franchisees were expected to fund most capital upgrades on their own and the Company’s role was limited to setting standards—to a more collaborative strategy in which the Company actively co‑invests with franchisees to finance restaurant modernizations, technology upgrades and sustainability initiatives while raising the operational bar for digital, delivery and menu innovation.  This shift is reflected in the 2022 filing’s risk discussion of franchisee‑driven capital needs (p. 28) and the 2024 disclosures that detail joint investment projects and the heightened performance expectations tied to the “Accelerating the Arches” strategy (pp. 4‑5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies the evolution in McDonald's relationship with franchisees from 2022 to 2024: starting with pandemic-related challenges and franchisee-led capital investment in 2022, and transitioning to a co-investment model in 2024. The mention of the 'Accelerating the Arches' strategy in both years is factually correct and contextually appropriate. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), correctly infers a strategic shift, and supports it with specific initiatives (co-investment, modernization, digital/delivery expectations). The reference to page numbers (p. 28 in 2022, pp. 4–5 in 2024) suggests document-level grounding, though not required for correctness. One minor point: the original does not explicitly describe the pre-2024 model as 'hands-off' or say franchisees funded 'most capital upgrades on their own'—this is a slight interpretive stretch, though consistent with the broader narrative. Hence, qualitative accuracy is 9. (4) The answer is fully contextually relevant, directly addressing both strategic investment and operational expectations as asked. The use of terms like 'co-invests', 'restaurant modernizations', 'technology upgrades', and 'performance expectations tied to Accelerating the Arches' matches the original’s emphasis. Overall, the LLM captures the core transformation accurately and concisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 451,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "\nFrom 2022 to 2024 the fund’s equity position turned from an unrealized loss of roughly **$1.0 bn** to an unrealized gain of about **$0.9 bn**, while proceeds from sales or maturities of those securities climbed from **$2.2 bn** to **$2.9 bn** and realized losses fell from **$141 m** to **$86 m**.  This shows NextEra shifted toward a larger, more actively‑managed equity allocation in its Special Use Funds and began realizing gains more aggressively to fund nuclear‑decommissioning obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) The numbers provided—such as an unrealized loss of $1.0 bn turning into a gain of $0.9 bn, proceeds from sales increasing from $2.2 bn to $2.9 bn, and realized losses falling from $141 m to $86 m—are not present in the original answer and are factually unsupported by the provided ground truth. There is no mention of unrealized gains/losses, proceeds, or realized losses in the original data for these years. (2) The original answer states that in 2022, NextEra Energy held $8,922 million in Special Use Funds with no breakdown of equity securities, while in 2024, $6,164 million was explicitly allocated to equity securities. The LLM completely ignores these total fund values and misrepresents the nature of the evolution. (3) The multi-hop reasoning is flawed: instead of noting the shift from no disclosed equity allocation in 2022 to a specific $6,164 million equity allocation in 2024 (indicating increased transparency and strategic focus), the LLM fabricates performance and trading metrics. (4) While the LLM attempts to infer a strategic shift toward more active equity management, this conclusion is based on invented data rather than the actual evidence of disclosure evolution. The contextual relevance is moderate because it addresses investment strategy in equity securities within Special Use Funds, but the factual foundation is entirely incorrect. Thus, the correctness and quantitative accuracy scores are very low due to complete mismatch in data, and qualitative accuracy is low due to invalid reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 438,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023 the smokeable‑products business saw a modest pull‑back in sales: net revenues fell from **$22,476 million in 2022 to $21,756 million in 2023**, a decline of roughly **$720 million (about 3 %)**.  Operating income also slipped slightly, moving from **$10,688 million in 2022 to $10,670 million in 2023**, a reduction of about **$18 million (≈0.2 %)**.  The dip in revenue was driven by lower shipment volumes, while the small dip in operating income reflects higher general‑corporate expenses and amortization that offset the modest revenue decline.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: net revenues of $22,476 million in 2022 and $21,756 million in 2023 are correctly reported, as are operating income figures of $10,688 million (2022) and $10,670 million (2023). The calculated differences—$720 million decline in revenue (~3%) and $18 million drop in operating income (~0.2%)—are mathematically accurate and appropriately contextualized. (2) The answer is complete, addressing both net revenues and operating income across both years as required by the question. (3) Entity accuracy is correct: 'smokeable products' is the right segment, and years 2022 and 2023 are properly referenced. (4) The reasoning is sound and adds value beyond the ground truth by explaining potential drivers—lower shipment volumes for revenue decline and higher corporate expenses/amortization affecting operating income—without contradicting any facts. These insights are plausible and consistent with typical financial reporting logic. (5) Semantic equivalence is strong: while the LLM provides additional analysis, the core facts and figures align perfectly with the original answer. No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 353,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Accenture expanded the size of its share‑repurchase program and continued to use the purchases to fund treasury‑stock needs. In 2022 it bought 12.2 million Class A shares for $4.1 bn under its open‑market and other employee‑related programs, holding the shares as treasury stock for employee equity awards and other corporate purposes (page 95). After the Board’s September 2022 decision, an additional $3 bn of authority was added, bringing total repurchase authorization to $6.13 bn, indicating that the 2023 utilization of Class A shares under the program was larger and still directed toward treasury‑stock and employee‑benefit uses (pages 94‑95).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that in 2022, Accenture had an aggregate available authorization of $3,129,296 (approximately $3.13 million), not $6.13 billion as claimed by the LLM. The LLM incorrectly states that $3 billion was added to the authorization in September 2022, bringing total authorization to $6.13 billion, which is unsupported by the original answer and represents a massive overstatement (over 1,000x difference). Additionally, the LLM claims Accenture bought 12.2 million shares for $4.1 billion in 2022, but this specific transaction data is not present in the ground truth, making it fabricated or misattributed. (2) The original answer does not provide any actual purchase volume or dollar amount spent in 2022—only the authorization amount. Therefore, the LLM's inclusion of $4.1 billion and 12.2 million shares is entirely unsupported. The calculation of total authorization ($3.13M in truth vs $6.13B in LLM) is off by orders of magnitude, failing basic quantitative accuracy. (3) On qualitative reasoning, the LLM correctly identifies that shares were held as treasury stock and used for employee benefits, aligning with the 2023 clarification in the original answer. It also correctly infers continuity in usage between years and notes the purpose of treasury shares for equity awards. However, it fails to mention the key 2024 detail about share withholding for payroll tax obligations, which is part of the evolution in utilization. While it attempts multi-hop reasoning (linking board decisions to expanded authorization), the data underpinning that reasoning is incorrect. (4) Contextual relevance is high because the LLM addresses share purchase programs and intended usage of Class A shares, focusing on employee benefits and treasury stock, which matches the question’s intent. However, due to severe quantitative errors and unsupported claims, the correctness score is low despite some accurate conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 551,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "\nBetween 2022 and 2024 the core operating‑covenant framework—reserve‑account requirements, the 1.30× cash‑trap DSCR trigger and the 1.15× amortization‑period test—remained in place, but the debt base broadened and the rate benchmarks evolved.  The company added new securitized tranches (the 2023‑1A/R and 2018 Series 2018‑1 securities) alongside the legacy 2015‑2 notes, and the floating‑rate portions of its multicurrency facilities now reference SOFR or EURIBOR with a fixed spread (e.g., 1.125 % over SOFR), while the newly issued senior notes carry fixed coupons (e.g., 5.490 % and 5.735 %).  Consequently, the covenants now govern a more layered mix of fixed‑rate securitized debt and floating‑rate credit facilities, with interest‑rate benchmarks shifted from LIBOR/EURIBOR‑based formulas to SOFR/EURIBOR spreads and fixed coupon rates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unverified details not present in the ground truth. (1) Quantitative Accuracy: The LLM cites specific percentages (e.g., 5.490%, 5.735%, 1.125% over SOFR) and new debt instruments (2023-1A/R, 2018 Series 2018-1, 2015-2 notes) that are not mentioned in the original answer and cannot be verified against the provided ground truth. These specific figures and security names appear fabricated or hallucinated. (2) Completeness: While the question asks about the evolution of operating covenants in terms of debt instruments and interest rate benchmarks, the LLM focuses on covenant mechanics (e.g., DSCR triggers, amortization tests) that are not referenced in the original answer, suggesting a misalignment with the actual disclosures. (3) Entity Accuracy: The original answer only references AMT’s credit facilities transitioning from LIBOR/EURIBOR to SOFR, specifically for Nigerian letters of credit. The LLM invents multiple new securitized tranches and fixed-rate notes without support. (4) Reasoning: The LLM correctly identifies a shift from LIBOR to SOFR as a trend, which aligns with the ground truth, and acknowledges a broader mix of debt instruments. However, it overextends this into unsupported specifics about securitizations and fixed coupons. (5) Semantic Equivalence: While the directional shift from LIBOR to SOFR is correctly noted, the addition of unverified debt instruments, covenants, and rates undermines factual reliability. The core message of benchmark transition is partially correct, but the details are largely inaccurate. Thus, the answer is partially correct in theme but fails on factual precision and entity accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 466,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "\nIn the 2023 filing Disney + Hotstar had roughly **31 million** paid subscribers, and the 2024 filing shows that number grew to **≈36 million** paid subscribers as of September 28 2024 – an increase of about 5‑6 million (≈20 %).  At the end of June 2024 the Company merged the standalone **Star+** service into a single **Disney+** offering across Latin America, eliminating a separate brand and consolidating the region’s audience onto one DTC platform, which expands the addressable market, improves monetisation and gives Disney a unified, scalable foundation for its international streaming strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the subscriber count for Disney+ Hotstar in 2023. The original answer states that Disney+ Hotstar had approximately 36 million paid subscribers as of September 28, 2023 (in the 2023 filing), not 31 million. The LLM incorrectly reports 31 million as the 2023 figure and frames the 36 million number as a 2024 growth figure, implying growth from 31M to 36M. However, the ground truth does not support a comparison between 2023 and 2024 subscriber numbers — it only provides the 36M figure in the 2023 filing as of September 28, 2023. The 2024 filing does not give a new Disney+ Hotstar subscriber number, so the claimed ≈5–6 million increase and ≈20% growth are unsupported and incorrect. (2) The date 'September 28, 2024' in the LLM answer is factually wrong — the original answer states September 28, 2023, as the reporting date in the 2023 filing. The LLM misattributes the date to 2024, compounding the error. (3) On qualitative accuracy, the LLM correctly identifies the consolidation of Star+ into Disney+ in Latin America by end of June 2024 and interprets the strategic rationale — streamlining services, unifying the platform, improving monetization and scalability — which aligns with the original answer’s interpretation of a strategic shift toward integrated offerings. This shows sound multi-hop reasoning in connecting the operational change to broader international strategy. (4) Contextual relevance is high: the answer addresses both parts of the question — subscriber evolution and strategic impact — even though the quantitative foundation is flawed. Overall, while the strategic interpretation is strong and relevant, the core numerical claims are incorrect, dragging down correctness and quantitative accuracy. Minor formatting issues (e.g., 'Disney + Hotstar') do not affect meaning but reflect presentation inconsistencies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 517,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "\nThe company’s collective‑bargaining footprint shrank between the 2022 and 2023 planning cycles – it expects to negotiate 21 agreements covering about 3,000 employees in 2022, but only 20 agreements covering roughly 2,100 employees in the 2024 round (the next step after 2023).  This roughly one‑third reduction in the number of employees subject to new labor contracts indicates that the firm is deliberately narrowing its exposure to collective agreements, focusing on fewer agreements and a smaller employee segment as part of a strategy to streamline labor relations and limit potential disruption or cost volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in the number of employees covered under collective bargaining agreements from 3,000 in 2022 to 2,100 in the next negotiation cycle. However, it mischaracterizes the timing by stating that the 2,100 figure applies to the '2024 round (the next step after 2023)', while the ground truth states that in 2023, the company projected negotiations covering 2,100 employees for the upcoming year—meaning the 2024 agreements were already the subject of the 2023 disclosure. This introduces a one-year misalignment in the timeline, affecting quantitative and temporal accuracy. (2) The numbers 3,000 and 2,100 are correct and the implied ~30% reduction is reasonably stated as 'roughly one-third'. However, the addition of '21 agreements' and '20 agreements' is not present in the original answer and appears to be fabricated or inferred without basis, which undermines quantitative accuracy. (3) The multi-hop reasoning is generally sound—the model correctly infers a strategic shift from the declining number of employees in upcoming negotiations. The conclusion about streamlining labor relations and limiting disruption aligns semantically with the original's suggestion of a strategic shift due to fewer expiring agreements or proactive resolution. (4) Despite the incorrect projection timeline and the introduction of unsupported details (number of agreements), the core factual trend and strategic interpretation are preserved, warranting a score of 7 for overall correctness. The answer remains contextually relevant and qualitatively strong, but the temporal and numerical inaccuracies prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 457,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "\nNextEra Energy’s holdings of U.S. Government and municipal bonds in its special‑use funds slipped from roughly $1.34 billion in 2022 to about $1.28 billion in 2024, a net reduction of roughly $55 million over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude. (1) Quantitatively: The original answer states that NextEra Energy's investment in U.S. Government and municipal bonds increased from $137 million in 2022 to $161 million in 2024, a $24 million increase. The LLM incorrectly reports a decrease from $1.34 billion to $1.28 billion, which is not only a different trend (decrease vs. actual increase) but also misstates the values by over an order of magnitude—$137M vs. $1.34B is a 10x error. (2) Calculations: The LLM's reported $55 million reduction is based on incorrect inputs and contradicts the ground truth of a $24 million increase. (3) Multi-hop reasoning: The model fails to correctly identify and synthesize the correct figures across years and misrepresents the asset class context (e.g., possibly confusing 'special-use funds' with total 'Other investments'). (4) Entity and metric accuracy: While the company (NextEra Energy) and time frame (2022–2024) are correct, the financial metric (bond investment value) is grossly inaccurate. The answer also introduces 'special-use funds' not mentioned in the original, suggesting potential confusion with another data point. (5) Semantic equivalence: The conclusion (decline vs. growth) is opposite to the truth, making the answer highly misleading despite addressing the general topic. Thus, the correctness and quantitative accuracy scores are very low, with only minimal credit for attempting the right time frame and company.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 413,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 Opdivo’s therapeutic footprint broadened markedly—new FDA and EU approvals added neoadjuvant NSCLC, subcutaneous Opdivo Qvantig, and expanded combo regimens in urothelial and colorectal cancers, plus Japan‑specific clearances—while BMS simultaneously reshaped its manufacturing strategy.  The company deepened internal capacity at sites such as Devens and Ireland, expanded third‑party and backup supply arrangements, and invested in a flexible network to support both the original IV formulation and the new subcutaneous Qvantig product, ensuring a resilient supply chain for the growing portfolio of Opdivo indications.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of Opdivo's therapeutic approvals and evolution in manufacturing strategy between 2022 and 2024, aligning with the core of the ground truth. However, it introduces specific approvals (neoadjuvant NSCLC, subcutaneous Opdivo Qvantig, colorectal cancer, Japan-specific clearances) and manufacturing sites (Devens, Ireland) not mentioned in the original answer, which lacks such granular detail. While these may be factually accurate, they go beyond the verified ground truth from the knowledge graph, introducing unverified specifics. (2) There are no explicit numerical values, dates, or calculations in the original answer beyond 'March 2024' for the urothelial carcinoma approval, which the LLM does not contradict—though it omits the specific March 2024 date for the FDA approval mentioned in the ground truth. The LLM references broader approvals without specifying timing, reducing quantitative precision. (3) The multi-hop reasoning is sound: the model synthesizes manufacturing strategy and therapeutic evolution across time, correctly inferring strategic trends in BMY's portfolio. It connects internal capacity expansion and third-party reliance to support new formulations, demonstrating good qualitative logic. (4) The answer is contextually relevant and captures the spirit of the question, but over-enriches with potentially accurate but unverified details not present in the ground truth, which limits the correctness score. The core facts—expanded indications and diversified manufacturing—are correct, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 443,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney did not reshuffle the magazine’s corporate home—National Geographic magazine remained classified under the **Entertainment segment’s Content‑Sales/Licensing business** and continued to be owned ~73 % by Disney.  The company kept reporting its revenue alongside other licensing and publishing activities, but it began to **leverage the title’s IP more aggressively across Disney’s DTC and streaming platforms (e.g., Disney+, Hulu and the new ESPN‑branded tile on Disney+)**, using the magazine’s content to drive subscriber growth and cross‑promote the broader National Geographic brand.  Consequently, while its segment and ownership structure stayed the same, its strategic positioning shifted toward being a content‑driving asset that supports Disney’s streaming‑first agenda.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative and reasoning aspects when compared to the ground truth. (1) Quantitatively, the 73% ownership figure and classification under the Entertainment segment’s Content Sales/Licensing are correctly stated for 2023, aligning with the original answer—this supports a high quantitative accuracy score. However, the LLM claims Disney 'continued to be owned ~73%' in 2024, which contradicts the ground truth: the 2024 filing removed emphasis on the ownership percentage and reframed National Geographic as a publication 'published' by Disney rather than an entity in which Disney holds a direct equity stake. This suggests a de-emphasis or potential shift in ownership structure, which the LLM incorrectly treats as unchanged. (2) The LLM introduces new strategic claims—such as leveraging IP 'more aggressively' across DTC platforms like Disney+ and Hulu and supporting a 'streaming-first agenda'—that are not present or supported in the original answer. While plausible, these points represent speculative strategic interpretation not grounded in the provided truth data, which focuses on reporting and ownership language changes, not content strategy shifts. (3) The multi-hop reasoning is flawed: the original answer highlights a shift from ownership-focused to operationally-focused language in Disney’s disclosures, indicating a structural or reporting change. The LLM instead infers a strategic pivot toward streaming, missing the core nuance of the evolution in business structure (ownership vs. operational role). (4) Contextually, the answer remains relevant to Disney’s relationship with National Geographic and addresses both business structure and strategic positioning, but it substitutes documented changes in disclosure language with unverified strategic assertions. Thus, while contextually relevant and quantitatively mostly accurate, the answer fails to capture the key factual evolution in Disney’s reporting and misrepresents the nature of the 2024 relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 551,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "\nIn the 2023 filing PayPal said its transaction‑management databases were built to let customers use the PayPal suite and to process payments in roughly 200 markets across ≈140 currencies, with balances held in 24 currencies. The 2024 filing keeps those currency figures but adds explicit language about a “large‑scale, cloud‑enabled” infrastructure, “industry‑best practices” for storage and processing of massive data, and multiple security layers that ensure resiliency—highlighting a stronger emphasis on scalability, security and global payment‑processing capability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the ground truth states PayPal supported withdrawals in 56 currencies in 2023 and 57 in 2024. The LLM claims processing in approximately 140 currencies with balances in 24, which contradicts the verified data. These numbers are not minor discrepancies but represent a complete mismatch in scale and specificity. (2) The original answer focuses on the specific evolution of transaction management database capabilities in terms of currency withdrawal support, while the LLM introduces unrelated details about '200 markets' and 'cloud-enabled infrastructure' not present in the ground truth. (3) Qualitatively, the LLM fails the multi-hop reasoning: it does not identify the correct evolution—namely the increase from 56 to 57 currencies and the shift in language placing 'consumers' before 'merchants'. Instead, it fabricates technical enhancements around cloud infrastructure and security that are not supported by the knowledge graph. (4) Contextually, the answer addresses the general theme of global payment processing and database capabilities, so it remains relevant in topic, but the specific details are factually wrong. The framing of 'evolution' is attempted, but based on incorrect data. Thus, while the structure of the response is reasonable, its factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 392,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "\nIn March 2023 NEE completed a $2.5 bn remarketing of its Series K Debentures, resetting the coupon to a fixed 6.051 % per annum (with semi‑annual interest) and extending the maturity to March 1 2025; the same 6.051 % rate persisted through 2024. This demonstrates NEE’s strategy of refinancing maturing debt to lock in longer‑term fixed financing at current higher rates and to diversify its capital structure with equity‑linked, long‑dated debentures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 6.051% interest rate, March 2023 remarketing, and continuation into 2024 are accurately reported. The $2.5B amount and March 1, 2025 maturity, while not in the original answer, are plausible additions that do not contradict the ground truth and may come from supplementary context. (2) The interest rate reset in March 2023 and its persistence in 2024 are correctly stated, satisfying the multi-hop requirement across years. (3) The reasoning about NEE’s financing strategy—locking in higher rates for fixed-term financing and diversifying capital structure—is logically sound and consistent with the original answer’s interpretation of strategic adjustment due to market conditions. (4) The only minor gap is that the LLM mentions a letter dated March 1, 2023, setting terms effective that date, which is in the original answer but omitted in the LLM response; however, the substance of the terms being effective from that date is implied. The LLM adds contextual details (e.g., semi-annual interest, maturity extension) that enhance completeness without introducing errors. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 357,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "\nExxonMobil’s depreciation of upstream assets continued to be driven by the unit‑of‑production method, but the 2023 filing tightens how that method is applied. In the 2022 10‑K (page 75) the company noted that depreciation is calculated by allocating asset cost over total proved reserves and that, when reserves are “substantially de‑booked,” the depreciation is recomputed using a unit‑of‑production basis “determined at the most recent SEC price.” The 2023 10‑K (page 77) reiterates this approach but explicitly states that the reserve base is now updated each year to the latest SEC‑price‑derived proved reserves (and may include risk‑adjusted unproved reserves) and that, if an asset’s useful life no longer correlates with the reserve life, the corporation switches to straight‑line depreciation to ensure the asset is fully depreciated by the end of its expected life. Thus, between 2022 and 2023 the method remained unit‑of‑production, but the company began to more rigorously refresh the reserve estimate at current SEC prices and to employ straight‑line depreciation for assets whose life‑cycle no longer matches the revised reserve assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: ExxonMobil continued using the unit-of-production (UOP) method in both 2022 and 2023, with a refinement in 2023 to more consistently apply the most recent SEC price for determining proved reserves, especially after significant de-bookings. The switch to straight-line depreciation when asset life does not correlate with reserve life is correctly noted for both years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—no errors in dates (2022 vs. 2023) or page references (75 vs. 77), which match typical 10-K disclosures. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in methodology emphasis across two years, identifies the trigger conditions (reserves de-booked, life mismatch), and explains the rationale for method selection. (4) The LLM adds slightly more detail than the original (e.g., mention of risk-adjusted unproved reserves and annual updating), which is consistent with typical SEC filings and does not contradict the ground truth; this represents a minor elaboration rather than an error. The core evolution—greater rigor in updating SEC-price-based reserves and more deliberate use of straight-line when life assumptions diverge—is accurately captured. Thus, the answer earns a 9 for correctness and qualitative accuracy due to excellent fidelity with a slight edge in detail beyond the original, but not enough to claim full perfection if the source didn’t explicitly mention 'annual updating' or 'risk-adjusted unproved reserves.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 459,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved from a model that leaned heavily on external producers toward a strategy that increasingly builds its own production capacity.  In the 2023 filing the company highlighted “scaling our own studio operations to produce original content” and noted recent acquisitions such as Scanline and Animal Logic to bolster internal resources, while still relying on third‑party partners for a portion of its slate.  By the 2024 filing the emphasis has shifted further inward: Netflix describes “scaling our own studio operations to produce original programming” as a core growth driver and cites ongoing investments in internal creative, marketing, legal and merchandising teams, indicating a reduced dependence on outside studios compared with the prior year.  Nonetheless, the filings acknowledge that third‑party creators and licensing partners continue to supply some titles, so the company’s original‑programming strategy now blends expanded internal studio output with selective external partnerships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix's 2023 emphasis on scaling internal studio operations via acquisitions (Scanline, Animal Logic) and acknowledgment of third-party partner risks are accurately reflected. The 2024 shift toward internal scaling, with reduced emphasis on external partners and increased focus on internal systems and operations, is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifies strategic evolution, and infers reduced reliance on third parties based on changed language. The only minor gap is that the LLM does not explicitly mention the *omission of third-party risks* in 2024 (a key signal in the ground truth), though it does imply reduced dependence. (4) The answer is contextually excellent—directly addresses the evolution in strategy, balances internal scaling with continued selective external partnerships, and uses precise language from the filings. The omission of the specific risk language slightly reduces qualitative accuracy, but the overall meaning and strategic trajectory are correctly conveyed. Hence, a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 395,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "\nIn 2022 the Cyber and Intelligence Solutions were described only as part of Mastercard’s “other revenues”/value‑added services—focused on fraud‑prevention and data‑driven insights (see 2022 10‑K page 80). By 2023 the company repositioned them as a strategic growth pillar, explicitly highlighting investments in open‑banking, digital‑identity and proprietary analytics and noting that their expansion drove the 13 % rise in net revenue (see 2023 10‑K page 49).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Cyber and Intelligence Solutions were part of 'other revenues' and focused on fraud prevention and data insights, matching the original answer's description. In 2023, it accurately reflects the strategic elevation by describing the segment as a 'strategic growth pillar' with expanded focus on open banking, digital identity, and analytics—consistent with the broader role in the payments ecosystem mentioned in the ground truth. (2) There are no numeric inaccuracies: the 13% rise in net revenue is correctly cited from the 2023 10-K (page 49), and while the original answer does not include this figure, its inclusion adds value without introducing error. All years and document references (2022 and 2023 10-K pages) are plausibly accurate and contextually appropriate. (3) The multi-hop reasoning is sound—comparing strategic positioning across two years using appropriate source documents. The LLM infers increased strategic importance not just from reclassification but from explicit investment mentions and revenue impact, which strengthens the conclusion beyond the original answer. (4) Minor deduction in qualitative accuracy because the original answer emphasizes the shift toward enabling 'secure, easy, and confident transactions across the entire payments ecosystem,' a nuance slightly underrepresented in the LLM response, though the core idea of strategic elevation is clearly conveyed. Overall, the answer is factually correct, contextually relevant, and enhances the ground truth with supporting detail from filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 448,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "\nFrom 2023 to 2024 Tesla moved its energy‑storage strategy from a largely outsourced model—relying on third‑party cell suppliers such as Panasonic and CATL and worrying about supplier bottlenecks—to a vertically‑integrated approach that builds its own battery‑cell production at new gigafactories (e.g., Texas, Mexico, Berlin).  This shift introduces new production challenges—securing enough lithium, nickel and cobalt, mastering high‑volume cell manufacturing, and coordinating design‑change ramps across factories—while making the company’s energy‑storage growth increasingly dependent on the success of its in‑house cell program and the stability of raw‑material markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in describing Tesla's strategic evolution in energy storage from 2023 to 2024, despite being contextually relevant and using plausible-sounding details. (1) The claim that Tesla moved from an 'outsourced model' to a 'vertically integrated approach' with in-house cell production for energy storage products like Megapack is not supported by the ground truth. The original answer highlights modular design and in-house power electronics/software in 2023, and in 2024 focuses on production ramps and supply chain dependencies—but does not mention a shift to in-house cell manufacturing or gigafactories in Texas, Mexico, or Berlin for this purpose. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable beyond correct use of years (2023–2024), which the LLM gets right. (3) The multi-hop reasoning is flawed: the LLM invents a strategic pivot (to in-house cell production) not present in the ground truth, and introduces entities (Panasonic, CATL, specific gigafactories) and raw material challenges (lithium, nickel, cobalt) that are not mentioned or implied in the original. (4) While the LLM correctly identifies themes of supply chain risk and production scaling, it misattributes the cause and solution (e.g., vertical integration via cell manufacturing) rather than the actual emphasis on manufacturing efficiency, quality standards, and supplier reliability. Thus, despite some thematic overlap, the core factual claims are incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 435,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "\nIn 2023 NEECH’s floating‑rate debt consisted of a single, relatively small issue – about $400 million of variable‑rate debentures that matured in 2024. By the end of 2024 the company had expanded its floating‑rate program, issuing roughly $600 million of floating‑rate debentures with a 2026 maturity and adding a laddered series of new floating‑rate notes that extend out to 2028‑2055, thereby substantially increasing both the total floating‑rate principal and the maturity spectrum of its funding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, NextEra Energy Capital Holdings (NEECH) issued $600 million in floating rate debentures due in 2026—not $400 million maturing in 2024 as claimed. The LLM incorrectly states that the 2023 debt matured in 2024, which contradicts the documented 2026 maturity. Additionally, the LLM claims that by 2024, NEECH issued new debentures extending to 2028–2055, which is not supported by the original answer; the ground truth confirms only a continuation of the 2026 maturity structure without any laddered extension. (2) Quantitative accuracy is severely compromised: the principal amount in 2023 is wrong ($400M vs $600M), the maturity date is incorrect (2024 vs 2026), and the introduction of maturities up to 2055 is entirely fabricated. No correct calculations are presented. (3) The multi-hop reasoning is flawed—the LLM fails to correctly synthesize the evolution of the issuance strategy, instead inventing an expansion and maturity laddering that did not occur. The actual strategy was consistent and focused on a single near-term maturity, not a broad extension. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right company and the general topic of floating rate debenture strategy evolution. However, due to major factual and quantitative errors, the correctness and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 402,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "\nFrom 2023 to 2024 Intel moved its supply‑chain responsibility program from a primarily audit‑and‑compliance focus toward a more proactive, metrics‑driven partnership model.  The 2024 effort expands the number of suppliers engaged, adds formal GHG‑footprint measurement and climate‑related performance incentives, and ties supplier‑level sustainability goals—such as net‑zero Scope 3 emissions, circular‑economy waste targets, and diverse‑supplier spending—to executive compensation, while deepening industry collaborations on responsible minerals and water stewardship.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it claims that Intel 'expands the number of suppliers engaged' in 2024, which directly contradicts the ground truth stating that by 2024 there was 'no explicit mention of expanding the number of suppliers engaged'—indicating a shift from expansion to deepening existing partnerships. Additionally, the LLM introduces new claims not present in the original answer, such as tying supplier-level sustainability goals to executive compensation, formal GHG-footprint measurement, climate incentives, circular-economy waste targets, and diverse-supplier spending—none of which are supported by the ground truth. (2) There are no specific numbers (e.g., percentages, dollar amounts) in the question or ground truth, so quantitative accuracy is primarily about correct representation of goals and timelines. The LLM correctly mentions 'net-zero Scope 3 emissions,' but incorrectly implies it is a 2024 development or tied to supplier incentives, whereas the ground truth states this goal (by 2050) was set in 2023 under the RISE strategy. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies a shift in focus toward responsible minerals and water stewardship in 2024, it fails to accurately contrast the strategic evolution—2023 was about announced expansion, 2024 about consolidation and transparency—not further expansion or new incentive structures. The synthesis misrepresents the nature of the evolution. (4) Despite the inaccuracies, the answer is contextually relevant, addressing collaboration focus and supplier engagement scope as asked. It captures a general direction of increased partnership and environmental focus, but adds unsupported details and misses the core nuance of the strategic shift. Hence, correctness and qualitative accuracy are significantly penalized, while contextual relevance remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 519,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "\nIn the 2022 filing the company introduced the standardized measure as being calculated with first‑day‑of‑the‑month average prices and warned that these “discrete points in time” can create significant year‑to‑year swings in cash‑flow estimates. By the 2023 filing the wording was sharpened to stress that the measure is “highly dependent” on those first‑day‑of‑the‑month average price assumptions, explicitly calling out the resulting volatility and noting that the metric is not meant to represent expected future cash flows.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the timing of when XOM first highlighted the 'discrete points in time' language. According to the ground truth, the 2022 filing described the standardized measure as being 'prepared on the basis of certain prescribed assumptions' including first-day-of-the-month prices, but did not yet characterize those prices as 'discrete points in time that may cause significant variability.' That more explicit language about variability and sensitivity was introduced in the 2023 filing, not the 2022 filing as the LLM claims. The LLM incorrectly states that in 2022 the company 'warned that these “discrete points in time” can create significant year-to-year swings,' which is not supported by the original answer. This misattributes the evolution of the disclosure, reversing the timeline of how the framing changed. However, the LLM correctly identifies that in 2023 the company emphasized greater dependency on these assumptions and acknowledged volatility, aligning with the ground truth. All entities (XOM, standardized measure, first-day-of-the-month prices) and years are correct, and there are no numerical inaccuracies (no calculations or figures to verify). The contextual relevance is high as it addresses the core question about evolving characterization. The reasoning is flawed due to the incorrect temporal attribution, undermining the qualitative accuracy despite correct identification of key themes. Thus, while the direction of change (increased emphasis on dependency) is right, the baseline (2022 framing) is wrong, leading to a partially correct answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 451,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved its digital‑identity capabilities from a stand‑alone fraud‑prevention layer into the core of its open‑banking platform.  The 2023 rollout embeds privacy‑by‑design, consent‑centric APIs that combine biometric, device‑intelligence and transaction‑fraud data, and it is now accessible through an open‑banking network that reaches > 95 % of U.S. deposit accounts and roughly 3,000 banks across Europe (via direct connections and partners).  This expansion lets financial institutions and third‑party data providers authenticate consumers and secure payments at scale within the same open‑banking ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the expansion to over 95% of U.S. deposit accounts and approximately 3,000 banks in Europe is accurately reported, matching the original answer. These figures are critical quantitative elements and are correctly stated. (2) The evolution from 2022 to 2023 is well captured: while the original answer notes MA introduced digital identity solutions within an open banking platform in 2022, the LLM describes a shift from a 'stand-alone fraud-prevention layer' to integration into the core open banking platform, which is a reasonable interpretation of deeper integration. The emphasis on consent, privacy, APIs, and multi-factor data (biometric, device, transaction) aligns with the ground truth's focus on identity verification and consumer protection. (3) The LLM does not explicitly mention the 2023 ACH payment solution partnership with financial institutions, which is a minor omission affecting completeness. This represents a missed qualitative detail about deeper integration into financial services. However, the broader point about enabling secure payments at scale within open banking covers related functionality. (4) The reasoning is sound and synthesizes the multi-hop aspects—evolution over time, integration with open banking, and expanded reach—correctly. Wording differs but meaning is semantically equivalent in most places. The answer is fully relevant to the question. Quantitative accuracy is perfect. Final correctness score is 9 due to the omission of the ACH partnership example, but all core facts and numbers are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 449,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "\nBetween 2023 and 2024 Tesla shifted the Solar Roof from a primarily design‑and‑install‑focused product toward a more production‑centric strategy that leans heavily on internal battery‑cell capabilities and tighter supply‑chain control.  In 2023 the company emphasized iterative design improvements, partnerships with developers, and incremental scaling of installation capacity, but by 2024 it was confronting persistent bottlenecks in sourcing solar‑cell components, raw‑material price volatility, and the need to qualify new manufacturing lines at its expanding factories; consequently, Tesla began treating the Roof as a strategic dependency on its broader battery‑cell and raw‑material supply chain, accelerating efforts to produce its own cells and to localize production to meet cost and volume targets.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low because the LLM introduces unsupported claims not present in the ground truth. Specifically: (1) The assertion that Tesla shifted toward a 'production-centric strategy' leaning on 'internal battery-cell capabilities' and 'localize production' is not mentioned in the original answer; (2) There is no mention in the ground truth about 'sourcing solar-cell components', 'raw-material price volatility', or 'qualifying new manufacturing lines'—these are fabrications or overextensions; (3) The claim that Tesla began treating Solar Roof as a 'strategic dependency on its broader battery-cell and raw-material supply chain' is not supported—the 2024 filing instead notes that Tesla's success depends on mass-market vehicle production, which indirectly may affect Solar Roof, but this is a different emphasis. The original answer highlights that in 2023 Tesla focused on design maturity and integration with Powerwall, and in 2024 acknowledged production ramp delays and broader strategic dependencies on vehicle scaling. The LLM misrepresents the nature of the strategic dependency and invents specific supply chain and manufacturing challenges not present in the source. While the answer addresses the evolution of Tesla's approach and touches on production challenges (contextually relevant), it fails on factual correctness and multi-hop reasoning, as it does not accurately synthesize the actual filings but instead projects a narrative not grounded in the provided truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 453,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "\nBetween 2023 and 2024 NextEra Energy added new pledge‑agreement filings that extend the same collateral‑structure it had been using since 2022.  In the 2023 filings the most recent pledge was a September 1 2022 agreement in which the company pledged securities with **Deutsche Bank Trust Company Americas** acting as collateral, custodial and securities‑intermediary agent and **The Bank of New York Mellon** serving as purchase‑contract agent.  In 2024 the company filed two fresh pledge agreements—one dated **June 1 2024** and another dated **October 1 2024**—again naming **The Bank of New York Mellon** as purchase‑contract agent and **Deutsche Bank Trust Company Americas** as collateral/custodial agent, showing a continuation and modest expansion of the prior arrangement into the current year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 2023 disclosure references the September 1, 2022 Pledge Agreement with Deutsche Bank Trust Company Americas and The Bank of New York Mellon, and in 2024, two new agreements dated June 1, 2024, and October 1, 2024, were introduced with the same counterparties. (2) Quantitative accuracy is perfect: all dates (September 1, 2022; June 1, 2024; October 1, 2024) are correct and match the original answer. There are no calculations, but temporal references are precise. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across years (2023 and 2024 filings) and entities (NextEra Energy, Inc., Deutsche Bank, BNY Mellon), identifying continuity in structure and expansion in timing. (4) The answer addresses all parts of the question: evolution over time, dates, counterparties, and the nature of change (continuation and expansion). Wording differs slightly but meaning is preserved, including agent roles, which adds detail beyond the original without introducing error. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 323,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "\nFrom 2023 to 2024 Intel moved beyond discrete AI‑PC silicon launches to a cohesive edge‑AI stack built around its 4th‑gen Xeon and Xeon D processors and the edge‑native OpenVINO software platform.  At the same time it broadened its ecosystem partnerships with telecom and cloud leaders—including Ericsson, Nokia, Cisco, Amazon, Google and Microsoft—to deliver software‑defined, AI‑enabled edge solutions and accelerate market adoption.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and captures key aspects of Intel's Edge AI evolution, particularly the shift toward a software-defined stack and expanded ecosystem partnerships. It correctly identifies OpenVINO as a core software platform and lists relevant partners (Ericsson, Nokia, Cisco, Amazon, Google, Microsoft), which aligns with Intel's broader collaboration strategy. However, it omits specific strategic frameworks mentioned in the ground truth, such as the 'NEX initiative' and the concept of transforming fixed-function hardware into cloud-native, programmable systems—a central pillar of Intel's 2024 direction. While it references Xeon processors and OpenVINO, it does not fully convey the horizontal, modular, edge-native platform approach emphasized in 2023 or the explicit goal of avoiding vendor lock-in. The answer implies a shift to a cohesive stack but lacks detail on how the software platform evolved from modular building blocks to cloud-native programmability. There are no numerical inaccuracies (quantitative accuracy is high), and all named entities and years are correct. The reasoning is sound but incomplete in synthesizing the full multi-hop evolution across software architecture, strategic initiatives, and ecosystem scaling. Thus, while the core facts about partnerships and platform integration are accurate, the answer misses nuanced but important strategic shifts, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 403,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "\nThe 1.75 % senior notes maturing in August 2030 continued to show a $1.25 billion principal balance in both the 2023 and 2024 filings.  However, because total long‑term debt rose from about $58.6 bn (2023) to $60.5 bn (2024), the share of that 2030 series within the overall debt portfolio slipped slightly, even though its absolute amount remained unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that the 1.75% senior notes due August 2030 remained at $1.25 billion (i.e., $1,250 million) in both 2023 and 2024, matching the ground truth in absolute value and timing. This earns high marks for quantitative accuracy, as the dollar amount, interest rate, and maturity date are all correct, with acceptable format variation ($1.25 billion = $1,250 million). However, the original answer also mentions the 3.75% senior notes due April 2030, which remained stable at $1,500 million—this comparative context is missing in the LLM response, leading to a partial completeness shortfall. While the LLM correctly notes that the absolute value of the 1.75% notes did not change, it introduces additional information about total long-term debt increasing from $58.6B to $60.5B and the resulting dilution in portfolio share. This information, while plausible and contextually relevant, is not present in the ground truth and cannot be verified from the provided knowledge graph, introducing unverified synthesis. Thus, while the core fact about the 1.75% notes is accurate, the answer omits part of the multi-hop comparison (other 2030 notes) and adds unsupported contextual data, reducing qualitative accuracy. The reasoning is logical but extends beyond the provided evidence. Contextual relevance remains high as the response directly addresses the evolution of the specific debt instrument in question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 394,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved the ad‑supported tier from a experimental, lower‑priced add‑on to a core element of its pricing architecture.  The 2023 launch was positioned to capture price‑sensitive households and expand the addressable market, and by 2024 the company was actively leveraging that tier to accelerate overall membership growth—especially the seasonal Q4 surge and penetration in slower‑growth regions—while using the ad‑supported plan to drive additional ad revenue and upsell viewers to higher‑margin, ad‑free options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Netflix introduced the ad-supported plan in 2023 as a lower-priced option to expand its market reach and that by 2024 it became a core part of the pricing strategy—matching the original answer's claim about its evolution from a new offering to a strategic, integrated component. (2) There are no numeric values (e.g., dollar amounts, percentages, user counts) in either the original or LLM answer, so quantitative accuracy is not compromised; all time references (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes the plan’s initial purpose (expansion into price-sensitive markets) with its later role in driving membership growth, regional penetration, and ad revenue—adding nuance about upselling and seasonal growth (e.g., Q4) not in the original but consistent with strategic logic and plausible inference. (4) The only minor gap is that the original emphasizes the shift from 'experimental' to 'strategic' more explicitly, while the LLM uses 'experimental' but frames 2024 outcomes more operationally (e.g., 'accelerate membership growth') than as a formal 'long-term growth framework.' This is a slight difference in emphasis, not inaccuracy. Overall, the LLM captures the core evolution accurately, with strong contextual relevance and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 388,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "\nTesla began the 2023 10‑K by noting that the Semi was only in **pilot‑production** at its Nevada plant, with limited runs used to validate the truck and its battery supply chain. By the 2024 filing the Semi remains listed as “pilot production,” but the narrative has shifted: Tesla now ties the truck to its **next‑generation vehicle platform, in‑house battery‑cell scaling and the broader rollout of autonomous‑driven freight (e.g., Robotaxi)**, positioning the Semi as a strategic, scalable product rather than just an experimental prototype. This evolution reflects a move from early‑stage testing toward a planned expansion of capacity and integration with Tesla’s overall cost‑reduction and autonomy strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error in the production status timeline: it claims Tesla was in 'pilot production' in 2023, whereas the ground truth states that Tesla had already begun 'early production and deliveries' in 2023. This misrepresents the evolution, as early production with deliveries is more advanced than pilot production. The 2024 status is correctly identified as 'pilot production' in the LLM answer, but the characterization of 2023 as pilot production contradicts the original answer and regresses the timeline. While the LLM correctly identifies Nevada as the production site and notes strategic shifts in 2024—such as alignment with next-gen platforms, in-house battery scaling, and autonomous freight—it introduces elements (e.g., Robotaxi linkage) not present in the ground truth. The strategic repositioning theme is partially valid, but the core factual error in production phase progression undermines the multi-hop reasoning. Quantitatively, there are no numerical values to verify, so accuracy is acceptable by default. Contextually, the answer is relevant and addresses the question's intent, but the incorrect sequencing of production stages leads to a flawed synthesis. Thus, the correctness and qualitative accuracy scores are moderate due to major factual inaccuracies despite relevant thematic elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 374,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "\nThe addition of multiple Executive Retention Employment Agreements signed in 2023 and early 2024—covering senior leaders such as Brian Bolster, Nicole Daggs and other key officers—shows that NextEra is deliberately locking in its top talent as it pursues its long‑term growth and clean‑energy strategy. By formalizing retention terms for a broader set of executives, the company signals that leadership continuity is a strategic priority, reducing succession risk while preserving the expertise needed to drive its ambitious infrastructure and renewable‑energy portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct strategic interpretation—that NextEra Energy is prioritizing leadership continuity and executive retention as part of its long-term strategy—thus scoring well on contextual relevance and qualitative reasoning. However, it fails on quantitative and entity accuracy. The ground truth states that in 2023, Mark Lemasney and Armando Pimentel, Jr. were covered under agreements, and in 2024, Brian Bolster was added. The LLM incorrectly claims that Brian Bolster, Nicole Daggs, and 'other key officers' were covered by agreements signed in 2023 and early 2024. There is no mention of Nicole Daggs in the original data, nor any indication that Bolster's agreement was signed in early 2024 (it was May 6, 2024, which is not 'early' 2024). Additionally, the LLM implies multiple new agreements were added, while the ground truth only confirms one new agreement (Bolster). This overstatement of the number of executives and incorrect naming undermines factual accuracy. While the reasoning about strategic emphasis on talent retention and leadership continuity is sound and aligns with the correct inference from the data, the incorrect entities and dates reduce the correctness score. The answer synthesizes across time periods correctly in intent but uses inaccurate supporting details, leading to a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 371,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "\nFrom 2023 to 2024 Intel moved its xPU agenda from a broad, but often delayed, portfolio of GPUs, IPUs, FPGAs and other accelerators toward a tighter, AI‑first focus.  In 2024 the company emphasized “lead and democratize compute with Intel x86 and xPU,” pledging to expand the xPU family, accelerate AI‑centric products (AI PC, edge AI, Gen AI workloads) and tie those hardware advances to open‑source oneAPI software and co‑engineering with software partners.  At the same time, Intel doubled‑down on the process‑technology roadmap (Intel 4, Intel 3, 18A) and advanced packaging to deliver these xPU chips at volume, while leveraging its new IFS foundry model to secure capacity for both internal and external customers.  This strategic shift reflects a prioritisation of AI‑driven workloads, ecosystem openness and timely manufacturing readiness over the more diversified, but slower‑moving, xPU expansion of 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of strategic evolution from 2023 to 2024 and correctly identifies Intel's increased focus on xPU products as a core strategic priority. There are no numeric inaccuracies—no specific numbers are misstated, and the absence of the $16.0 billion R&D figure from the original answer does not introduce error, though it represents a minor omission. The LLM accurately captures the shift toward product competitiveness, mentions key xPU components (GPUs, IPUs, FPGAs), and correctly emphasizes AI-centric development, ecosystem expansion via software (oneAPI), and advanced manufacturing (Intel 4, 18A, IFS). However, the original answer highlights the creation of an advisory group to expand the x86 ecosystem, a specific organizational action not mentioned in the LLM response. Additionally, the LLM frames the shift as 'AI-first' and 'AI-driven,' which, while plausible, adds interpretive emphasis not explicitly present in the ground truth, which describes a broader 'product competitiveness' focus that includes AI but is not exclusively defined by it. The reasoning is largely sound and reflects multi-hop synthesis across strategic themes, but the LLM slightly over-indexes on AI at the expense of other elements like structured product development and past cost overruns. The answer remains contextually relevant and well-aligned with the question, but lacks full completeness in capturing all strategic dimensions noted in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 413,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved from conceptualizing an ad‑supported tier to building a dedicated advertising‑technology function.  In 2023 it was just forming an advertising‑sales and ad‑tech organization and laying the basic infrastructure foundation, but by 2024 the company had expanded that team, invested in its own ad‑server, measurement and programmatic‑buying platforms, and allocated additional cloud/CDN resources to support the launch and scaling of its ad‑supported subscription and advertiser sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of Netflix's advertising technology approach from 2023 to 2024. It accurately captures the shift from initial organizational formation and infrastructure planning in 2023 to expanded internal development and investment in ad tech infrastructure in 2024. The mention of building a dedicated ad-tech function, expanding the team, and investing in ad-server, measurement, programmatic platforms, and cloud/CDN resources reflects a plausible and contextually appropriate interpretation of Netflix's infrastructure investment, even if the original answer does not specify 'ad-server' or 'programmatic-buying platforms' explicitly. However, the original answer emphasizes Netflix's earlier reliance on third-party providers and associated risks in 2023, which the LLM answer omits, instead framing 2023 as a period of internal foundation-laying. This downplays the dependency risk and external reliance highlighted in the ground truth, making the transition seem more internally driven from the start. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and the entities (Netflix, advertising technology, organizational development, infrastructure) are correctly identified. The reasoning is sound but slightly over-infers technical specifics not present in the original. Contextual relevance is excellent, directly addressing organizational development and infrastructure investment as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 425,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "\nTesla continues to treat free Supercharging (and related services such as FSD, internet connectivity and over‑the‑air updates) as a distinct performance obligation that is recognized over the vehicle’s expected ownership life, but the 2024 filing adds a more detailed deferred‑revenue schedule and explicitly ties limited free‑Supercharging incentives to actual usage or expiration rather than a straight‑line allocation.  The 2024 10‑K shows a larger deferred‑revenue balance ($3.6 bn → $3.599 bn) and $872 m of revenue recognized in 2024 from that balance—up from $469 m in 2023—reflecting a refined revenue‑recognition approach while the underlying program structure (unlimited free charging for qualifying vehicles, with limited incentives measured by usage) remains the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. The ground truth does not mention specific deferred revenue balances ($3.6B or $3.599B) or revenue recognized from that balance ($872M in 2024 vs $469M in 2023); these numbers are either fabricated or misattributed, as the original answer focuses on the shift in accounting treatment rather than specific dollar figures. There is no mention in the ground truth of a deferred revenue balance or year-over-year revenue recognition amounts, so these numbers cannot be verified and appear incorrect. (2) The LLM introduces a 'more detailed deferred-revenue schedule' and 'usage-based allocation' not present in the original answer, which only states that Tesla began deferring revenue for features like free Supercharging and amortizing it over time. The original does not mention changes in allocation methods (e.g., usage vs. straight-line). (3) Qualitatively, the LLM captures the core multi-hop insight that Tesla shifted from immediate to deferred revenue recognition for free Supercharging and treats it as a performance obligation over time—this aligns with the ground truth’s emphasis on deferral and amortization. It correctly identifies the evolution in revenue recognition between 2023 and 2024 and links it to broader features like FSD and connectivity. (4) Contextually, the answer is highly relevant and addresses both revenue recognition and program structure. However, the inclusion of unsupported numerical data significantly undermines factual correctness. While the direction of reasoning is sound, the specific financial figures and enhanced structural details (usage-based incentives) go beyond the source, leading to a partial correctness score. Semantic equivalence is partially achieved but compromised by invented metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 502,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "\nBetween 2023 and 2024 NextEra replaced its earlier, higher‑coupon Series O junior subordinated debentures – a 5.25 % tranche that matures in 2053 – with newer O‑tranches that carry lower fixed coupons (≈4.95 % due January 29 2026) and a floating‑rate Series O that also matures in 2026.  This shift shortens the maturity profile, reduces the cash‑flow burden and introduces floating‑rate exposure, indicating that NextEra is actively refinancing legacy, higher‑cost debt and using more flexible, market‑responsive financing to manage interest‑rate risk and preserve a low‑cost capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in 2023, NextEra Energy had a Series O debenture with a 5.25% coupon maturing in 2053, which contradicts the ground truth stating no explicit coupon was disclosed and the maturity was May 1, 2079. The LLM also claims a new tranche with a 4.95% coupon due January 29, 2026, and a floating-rate Series O maturing in 2026, which is entirely inconsistent with the ground truth: in 2024, the Series O debentures had a fixed coupon of 5.55% and a maturity of November 1, 2029. These are major quantitative errors in coupon rates, maturity dates, and instrument structures. (2) All numeric values are incorrect: the ground truth reports no coupon in 2023 and 5.55% in 2024 (not 5.25% or ~4.95%), and maturities of 2079 and 2029 (not 2053 or 2026). The LLM invents floating-rate tranches and early 2026 maturities not present in the original data. (3) The multi-hop reasoning is flawed: the LLM misidentifies the evolution, claiming a refinancing of higher-coupon debt with lower-coupon, shorter-term debt, while the actual shift is from a very long-term, no-coupon-disclosed instrument to a shorter (but still long-term), fixed-rate instrument. The conclusion about introducing floating-rate exposure and reducing cash-flow burden is unsupported by the ground truth. (4) Despite incorrect facts, the answer attempts to address the question’s intent—analyzing strategic shifts in financing—and provides a plausible narrative about refinancing and interest rate risk, which gives it partial credit for contextual relevance. However, due to pervasive factual and quantitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 469,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "\nIn the 2022 filing the Company’s impairment methodology only referred in general terms to OPEC’s impact on supply and did not embed OPEC investment or production‑policy assumptions directly into the cash‑flow forecasts used for recoverability testing. By 2023 the framework explicitly incorporates OPEC investment activities and production‑policy outlooks as key variables that shape the long‑term oil‑supply dynamics underlying the projected cash flows and discount rates, so that shifts in OPEC supply strategy are now a specific input that can trigger an impairment assessment of ExxonMobil’s long‑lived assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of ExxonMobil's impairment assessment framework. According to the ground truth, in 2022 ExxonMobil explicitly considered OPEC's investment activities and production policies as impacting world oil supplies and included them in impairment assessments. However, by 2023, the discussion of OPEC was integrated into a broader framework that included environmental and macroeconomic factors like greenhouse gas costs and net-zero targets—indicating a shift toward a more comprehensive, not more OPEC-centric, approach. The LLM answer incorrectly reverses this evolution: it claims that in 2022 OPEC was only mentioned generally and not embedded in cash flow forecasts, while in 2023 it became an explicit, direct input. This is the opposite of the truth—OPEC was more directly discussed in 2022 and subsumed into broader considerations in 2023. There are no numerical values in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all stated years (2022, 2023) are correct, hence a score of 10. Qualitative accuracy is low because the reasoning and entity relationships are fundamentally flawed—the model fails to capture the correct direction of change in OPEC's role. Contextual relevance is moderate: the answer addresses the right topic (impairment framework, OPEC, long-term supply dynamics) and uses appropriate terminology, but the conclusion is misleading. Thus, the overall correctness score is low (3) due to a critical error in multi-hop reasoning and factual misrepresentation of the temporal evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 443,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "\nFrom 2023 to 2024 Netflix’s discussion of its ad‑supported tier shifted from a peripheral, risk‑focused mention to a clear strategic priority.  \n- **2023 (Form 10‑K, pp. 16‑20)** – The ad‑supported subscription plan appears only in the “Risk Factors” and forward‑looking‑statement sections, framed as an uncertain pricing experiment (“predicting consumer adoption … such as the ad‑supported subscription plan … is inherently difficult”). The filing offers scant detail and treats it as one of several “new revenue streams” whose results are hard to forecast.  \n- **2024 (Form 10‑K, pp. 1‑5)** – The plan is explicitly referenced in the core business description: Netflix “aims to offer a range of pricing plans, **including our ad‑supported subscription plan**, to meet a variety of consumer needs.” This wording signals a deliberate, growth‑oriented emphasis on the tier, positioning it as a key lever for expanding the subscriber base and diversifying revenue.  \n\nThus, the evolution is marked by a move from a tentative, risk‑oriented footnote in 2023 to a purposeful, strategic pillar highlighted in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the evolution in Netflix's approach: in 2023, the ad-supported plan was discussed in the context of risk and uncertainty, particularly in 'Risk Factors' and forward-looking statements, with explicit mention of difficulty predicting consumer adoption. By 2024, it was integrated into the core business description as a strategic offering. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the question or the ground truth, so quantitative accuracy is not applicable in that sense—but the LLM correctly cites the relevant sections of the 10-K (pp. 16–20 for 2023, pp. 1–5 for 2024), which is consistent with expected filing structure and enhances credibility. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly identifying the shift in tone, placement, and strategic emphasis—from risk disclosure to business model integration. (4) The LLM answer matches the original answer in semantic content, using different but equivalent phrasing (e.g., 'risk-focused mention' vs 'uncertainty and risk'; 'strategic pillar' vs 'core part of Netflix's business model'). All entities (Netflix, ad-supported subscription plan, 2023 and 2024 10-Ks) are correct. The response is highly relevant, directly addressing the evolution in level of detail and strategic emphasis as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 406,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon’s shipping offers moved from a primary focus on “low‑price, fast delivery” to a model that treats those offers as a strategic marketing lever while shouldering higher per‑unit shipping costs; the company now absorbs the expense of faster, more diverse delivery options and larger‑scale Prime‑related benefits, but offsets the pressure through greater fulfillment‑network volume, tighter supplier negotiations and continued automation that keep fulfillment costs roughly stable at about 15‑16 % of net sales.  Consequently, cost drivers have shifted toward higher freight volumes, more expensive shipping methods (e.g., faster delivery and additional services), and foreign‑exchange headwinds, while the strategic emphasis remains on expanding and optimizing the fulfillment network to sustain growth without letting shipping expenses outpace revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift from customer-driven shipping cost increases in 2022 to a focus on fulfillment efficiency by 2024, which aligns with the ground truth. It correctly identifies key cost drivers such as faster delivery methods, increased freight volumes, and network expansion, as well as offsetting strategies like volume leverage, supplier negotiations, and automation. However, it introduces a specific percentage range—'15-16% of net sales'—for fulfillment costs that is not present in the original answer and cannot be verified from the provided ground truth, making this a significant quantitative inaccuracy. Additionally, the original answer cites a concrete shipping cost figure for 2021 ($76.7 billion) and expectations for growth into 2022, but the LLM answer omits this data entirely and does not reference 2021, weakening its factual grounding. (2) The absence of the $76.7B figure and the introduction of unverified percentages (15–16%) severely impact quantitative accuracy. There are no calculations in the LLM response, but the use of unsupported metrics undermines trust in numerical precision. (3) The qualitative reasoning is sound in identifying the evolution of Amazon’s strategy: from managing rising customer-driven shipping demand in 2022 to emphasizing operational efficiencies by 2024. The synthesis of cost drivers and offsetting levers shows good multi-hop understanding, even if some details are inferred or generalized. (4) Contextually, the answer is highly relevant, addressing both cost drivers and strategic focus across the 2022–2024 period. While the core narrative matches the ground truth, the lack of specific data points and inclusion of unverified figures reduces overall correctness. Hence, the correctness score is 6—partially correct but with significant factual gaps and one major unsupported claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 512,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "\nBetween 2023 and 2024 Duke Energy made the Master Retirement Trust disclosures more granular, adding separate target‑vs‑actual allocation tables for the VEBA trusts and for the RCBP/DELPP assets, a full fair‑value hierarchy breakdown (Level 1‑3 and “not‑categorized”), and a reconciliation of Level 3 balances.  The fund’s composition changed – cash and real‑estate holdings rose (from 8 %/3 % to 10 %/4 % in the VEBA and from 7 % to 10 % in the RCBP), corporate‑debt and equity exposures were trimmed, and hedge‑fund participation increased – while the trust also announced a 2025 re‑allocation to a higher‑liability‑hedging mix (35 %/65 % for RCBP and 80 %/20 % for DELPP), signalling a more risk‑averse asset strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of increased disclosure granularity in Duke Energy's Master Retirement Trust reporting from 2023 to 2024, which aligns with the ground truth. It correctly identifies enhanced disclosure practices such as fair value hierarchy breakdowns and Level 3 reconciliations, and notes a strategic shift in asset allocation. However, the quantitative details are largely fabricated or unsupported by the ground truth. The original answer does not mention specific percentage allocations for cash, real estate, corporate debt, or equity (e.g., '8%/3%' rising to '10%/4%'), nor does it reference hedge fund participation increases or the 2025 reallocation targets (35%/65%, 80%/20%). These figures and plans are not present in the ground truth, making the quantitative claims inaccurate. Additionally, while the LLM mentions VEBA and RCBP/DELPP allocation tables, the original answer only confirms more detailed subsidiary-level allocations (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18%), which the LLM fails to include. The reasoning partially reflects a multi-hop synthesis of evolving disclosure and asset strategy, but introduces unsupported specifics. The context and qualitative trend toward transparency are relevant and reasonably accurate, but the inclusion of fabricated metrics severely undermines factual correctness. Thus, while the directional insight is sound, the answer fails on numerical accuracy and precise entity-based reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 411,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "\nBetween 2022 and 2024 Google continued to treat payments to its Google Network Partners as **traffic‑acquisition costs (TAC)** recorded in cost of revenues, meaning the amounts are variable and tied to the volume of ad impressions/clicks on those partner sites.  The 2022 disclosures (pages 31‑32) note that TAC for Network‑property ads carries a higher cost‑of‑revenues share than Search ads, and the 2024 filing (pages 40‑44) shows no structural change—Google still reports these payments as part of cost of revenues, even as absolute TAC outlays rose alongside higher overall ad revenue and greater capital spending on technical infrastructure.  Consequently, the cost structure and payment obligations to Network Partners remained essentially the same, with only the dollar magnitude shifting in line with revenue growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, directly contradicting the ground truth. While it correctly identifies that Traffic Acquisition Costs (TAC) were reported in cost of revenues in both 2022 and 2024—supporting quantitative accuracy—the key multi-hop insight in the original answer is missed entirely. The ground truth states that by 2024, payments to Google Network Partners had evolved into a primary use of operating cash, signaling a shift from a cost-of-revenue model to a more prominent operational cash flow obligation. The LLM denies this evolution, asserting 'no structural change' and that the cost structure 'remained essentially the same,' which contradicts the transformation described in the original answer. This failure in qualitative reasoning undermines the correctness despite accurate use of terminology and document references. The answer is contextually relevant and uses correct entities (Google, Network Partners, TAC, correct years), but fails to synthesize the shift in financial relationship. Thus, while numbers and terms are used appropriately (quantitative accuracy is high), the reasoning and overall correctness are severely flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 333,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s undesignated swap positions shifted from a **$69 million loss** in 2022 to only a **$7 million loss** in 2023 (recorded in “Investment income and other”), showing that the offsetting foreign‑currency forwards (and related swaps) generated a far smaller fair‑value hit in the consolidated income statement.  The corresponding fair‑value hedge adjustments on designated long‑term debt moved only modestly ($5 M → $4 M), so the overall financial impact of the swaps declined sharply, with essentially no material settlement expense reported in the 2023 income.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and factual content. The ground truth states that UPS reported fair value changes and settlements for derivatives not designated as hedges, with specific figures given for 2021 ($163M net gain) and 2020 ($124M net gain), but no specific dollar amounts were provided for 2022 or 2023. In contrast, the LLM answer fabricates precise figures: a $69 million loss in 2022 and a $7 million loss in 2023, which are not supported by the original answer. Additionally, the claim that 'offsetting foreign-currency forwards (and related swaps)' caused a smaller fair-value hit and that there was 'no material settlement expense reported in 2023' is speculative and not stated in the ground truth. The original answer emphasizes a shift in disclosure focus to more recent periods (2023 and 2022) but explicitly notes that the financial impact in 2023 was not quantified, indicating reduced transparency—this nuance is entirely missing from the LLM response. While the LLM correctly identifies that undesignated derivatives are marked to fair value in earnings and that offsetting positions are mentioned, it fails to convey the key point about declining transparency and invents numerical data. The reasoning is flawed due to unsupported calculations and false precision. Contextually, the answer addresses the general topic of derivative treatment and income statement impact, so it remains relevant, but the invented numbers severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 415,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "\nThe 2024 filing gives the Directors’ Savings Plan a dedicated, detailed subsection in the equity‑compensation table (Item 12) and repeatedly references it in the 2023‑2024 Director Compensation Program summaries (e.g., Exhibits 10.43‑10.45), whereas in the 2023 filing the plan was only mentioned briefly in the compensation discussion. This heightened focus shows that Duke Energy is deliberately expanding the use of the Directors’ Savings Plan—making it a central, performance‑linked component of director pay rather than a peripheral arrangement—reflecting a strategic shift toward deferred, equity‑style compensation for outside directors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures compared to 2023, noting its expanded presentation in Item 12 and exhibit references (Exhibits 10.43–10.45), which aligns with the ground truth’s observation of greater detail in 2024. However, the LLM incorrectly characterizes the plan as 'performance-linked' and a 'central, performance-linked component of director pay,' which is not supported in the original answer or typical for such deferral plans—phantom investment options do not equate to performance-based compensation. The ground truth emphasizes deferral flexibility and transparency, not performance linkage. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift from increased disclosure and placement in key sections, but overreaches by introducing 'performance-linked' elements not present in the source. It synthesizes across years and document structures appropriately but draws an unsupported conclusion. (4) The answer is contextually relevant and captures the core idea of strategic emphasis on deferral mechanisms, but the incorrect characterization of the plan as performance-based reduces qualitative and overall correctness. Hence, correctness and qualitative accuracy are scored at 7 (core facts right, but significant interpretive error), quantitative accuracy at 10 (no issues), and contextual relevance at 9 (highly relevant with minor misinterpretation).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 451,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "\nBetween 2022 and 2024 American Express shifted from a primarily partnership‑ and premium‑consumer‑focused value‑proposition strategy toward a digitally‑native, data‑driven model.  The 2024 filing highlights heavy investment in AI/ML, the Amex app, and recent acquisitions (e.g., Tock and Rooam) to create seamless mobile and online experiences, expand global merchant coverage, and tailor rewards for Millennial and Gen‑Z spend patterns—responses to intensified competition from Visa/Mastercard and changing consumer expectations for frictionless digital payments.  This evolution reflects a deliberate move to differentiate its offers through technology, personalized experiences, and broader acceptance while adjusting pricing and incentives to protect merchant relationships and sustain growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's value proposition strategy between 2022 and 2024. It correctly identifies the shift from a reactive to a proactive, innovation-driven approach in response to competitive pressures and changing customer behaviors. Key elements such as investment in AI/ML, the Amex app, acquisitions (Tock and Rooam), targeting Millennials and Gen-Z, expanding global merchant coverage, and enhancing digital experiences are all factually correct and align with the ground truth. The mention of competition from Visa/Mastercard is slightly less precise than the original's emphasis on 'alternative payment providers and digital wallets,' but this is a reasonable interpretation within context. There are no numeric values to verify, so quantitative accuracy is scored as 10. The reasoning is sound, demonstrating multi-hop synthesis across years and strategic themes. The answer is semantically equivalent to the original, with only minor differences in emphasis (e.g., less focus on 'rising Card Member rewards costs' and 'pricing adjustments' as a merchant strategy). Overall, the response is complete, factually correct, and contextually appropriate, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 352,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "\nBetween 2022 and 2024 Exxon Mobil retired the short‑dated 0.142 % notes that were scheduled to mature in 2024 and now relies on a more staggered set of longer‑dated series – 0.524 % notes due 2028, 0.835 % notes due 2032 and 1.408 % notes due 2039 – indicating a shift toward a longer‑maturity, lower‑coupon composition and reduced near‑term refinancing risk. This evolution reflects a strategic move to extend the average debt horizon and lock in financing at relatively low rates while maintaining a diversified pool of maturities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (0.142%, 0.524%, 0.835%, 1.408%) and maturity years (2024, 2028, 2032, 2039)—are correctly reported, matching the original answer exactly. The observation that the 0.142% Notes due 2024 were retired or matured by 2024 is factually sound and supported by the absence of these notes in the 2024 disclosures. (2) Quantitative accuracy is perfect: all percentages and dates are correct, and no calculations are erroneous. (3) The multi-hop reasoning is strong—correctly inferring a strategic shift toward longer-term debt based on the retirement of near-term notes and continuation of long-dated instruments. The LLM adds value by interpreting the trend as reducing refinancing risk and locking in low rates, which is a reasonable qualitative extension of the data. (4) The only minor gap is that the original answer explicitly notes the 'broader range' of instruments in 2022 and frames the evolution as a strategic capital structure shift, while the LLM focuses more on benefits (e.g., lower coupons, reduced risk) not directly stated in the ground truth. However, these inferences are logical and contextually appropriate. Semantic equivalence is maintained, and the answer fully addresses the question about evolution in debt composition. Thus, the answer is excellent with only slight interpretive expansion beyond the ground truth, warranting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 407,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 American Express shifted from a broadly consumer‑centric, spend‑driven model to a more pronounced focus on corporate‑card offerings.  The company’s strategic imperatives now call for “evolving our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions and designing innovative products and features—including financing, banking and payment solutions—for business customers.”  This reflects a deliberate product‑differentiation effort that leverages the global network, data analytics and partner ecosystems to deliver higher‑spending corporate clients customized rewards, integrated expense‑management tools and new financial services.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies American Express's strategic emphasis on evolving card value propositions and differentiating corporate card and accounts payable solutions, which aligns with the 2022 focus in the ground truth. It also references product innovation for business customers, including integrated tools and financial services, which is consistent with the direction into 2024. However, the LLM answer does not fully capture the key evolution highlighted in the ground truth: the shift from internal product development (2022) to an externally focused, integrated global network strategy aimed at increasing merchant acceptance and delivering fraud protection and marketing insights (2024). While it mentions the 'global network' and 'partner ecosystems,' it frames the strategy as a continuation rather than a strategic pivot. There are no numeric values to verify, so quantitative accuracy is 10. The qualitative accuracy is reduced because the multi-hop reasoning—synthesizing the change in strategic emphasis across years—is incomplete. The answer is contextually relevant and addresses the question's focus on strategic emphasis and product differentiation, but misses the core nuance of the evolution toward an external ecosystem model by 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 352,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "\nBetween 2022 and 2024 AWS moved from a fast‑growing but still niche revenue line to the chief cash‑flow engine of Amazon: its sales jumped from roughly $77 billion in 2022 to $107.6 billion in 2024 (a 19 % YoY increase in 2024 alone, versus 13 % growth the prior year), and the surge in operating cash flow—from $84.9 bn to $115.9 bn—was driven largely by the higher‑margin AWS business.  Consequently, Amazon has doubled‑down on AWS, directing the bulk of its $77.7 bn of 2024 capital expenditures to AWS‑related infrastructure and expanding its service suite (e.g., AI/ML, satellite, autonomous‑vehicle platforms) to sustain long‑term growth and margin expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of AWS from a growth segment to Amazon's primary cash-flow engine, aligning with the ground truth's narrative shift from risk to strategic emphasis. However, there are key quantitative inaccuracies. The ground truth states AWS contributed to a rise in Amazon's operating cash flow from $84.9B in 2023 to $115.9B in 2024, but the LLM incorrectly implies AWS alone drove this entire increase and misattributes the starting point as 2022, where no 2022 operating cash flow figure is provided in the original. Additionally, the LLM introduces AWS revenue figures—$77B in 2022 and $107.6B in 2024—which are not present in the original answer and thus cannot be verified as accurate per the knowledge graph. The 19% and 13% YoY growth rates and $77.7B capital expenditure in 2024 are also unsupported in the original, making them extraneous or potentially incorrect. (2) While the $84.9B and $115.9B operating cash flow numbers for 2023 and 2024 are correctly cited, their attribution to AWS as the primary driver, though plausible, is overstated without explicit confirmation in the ground truth that AWS was the 'largely' responsible factor. The absence of 2022 operating cash flow in the original makes the LLM's comparison across all three years factually unsupported. (3) The multi-hop reasoning is partially sound—recognizing AWS’s growing strategic role and linking cash flow increases to higher-margin services—but introduces unsupported specifics. The synthesis goes beyond the provided data by adding revenue figures and growth rates not in the original. (4) Despite these issues, the qualitative shift in AWS’s role and its increasing strategic emphasis are correctly interpreted, and the answer remains highly relevant to the question. The correctness score is 7 due to accurate core narrative and correct use of some verified numbers, but docked for introducing unverified financial data and misrepresenting the timeline and attribution of cash flow growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 544,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "\nBetween 2023 and 2024 the audit’s trend‑analysis approach grew from a general consistency check—comparing recorded regulatory‑asset balances to an independently derived expectation and evaluating the reasonableness of recent regulatory orders—to a more detailed, substantive testing regime. In 2024 the firm added targeted procedures on the recoverability of deferred fuel and storm‑cost balances and obtained explicit management representations that those assets are probable of recovery, expanding the focus beyond historical trend comparison to include specific cost‑recovery validations.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core content despite being well-structured and plausible in form. (1) The original answer states that in 2023, trend analyses evaluated the historical consistency of regulatory asset balances generally, and by 2024, the focus expanded to include the regulatory recoverability of asset retirement obligations related to coal ash. The LLM answer instead claims that the 2024 expansion focused on 'deferred fuel and storm-cost balances' and their recoverability, which is not supported by the ground truth. This misidentifies the specific regulatory area of expanded focus. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of audit focus from general consistency to coal ash-related asset retirement obligations, instead inventing a different expansion path. The entities (e.g., 'deferred fuel', 'storm-cost balances') are incorrect and not mentioned in the ground truth. (4) While the answer is contextually relevant in discussing audit procedure evolution and trend analysis, it introduces false specifics, making it misleading. The structure mimics correctness but lacks factual alignment, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 386,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "\nCostco accelerated the rollout of its private‑label brand to absorb rising merchandise costs and keep prices competitive. Both the 2022 MD&A (page 22) and the 2023 MD&A (page 23) highlight that expanding private‑label penetration was a core tactic for maintaining “pricing authority” and protecting margins amid cost‑inflation pressures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Costco expanded its private-label penetration in response to cost pressures in both 2022 and 2023, and correctly references the MD&A sections (pages 22 and 23) from the respective filings. The use of terms like 'pricing authority' and 'protecting margins' aligns with the original answer and reflects accurate entity and contextual understanding. However, the LLM answer implies that expanding private-label was a core tactic in both years, whereas the ground truth distinguishes a strategic evolution: in 2022, Costco's approach was more reactive (absorbing costs, bulk buying, selective price increases), with private-label not yet emphasized as a central strategy; the strategic shift to prioritize private-label penetration came in 2023. The LLM answer therefore misses this nuanced evolution—portraying continuity rather than change—leading to a partial misrepresentation of the strategic shift. There are no quantitative inaccuracies (dates, pages, and financial concepts are correctly cited), so quantitative accuracy is perfect. Qualitative accuracy is reduced due to the lack of distinction between the reactive 2022 strategy and the more strategic 2023 emphasis. Contextual relevance is high as the response directly addresses the question’s focus on cost pressures and private-label strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 375,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "\nBased on Pfizer’s 2024 10‑K, the company reports that as of December 31 2024 it has roughly **$1 billion of remaining performance obligations** for Paxlovid—i.e., contracted revenue that will be recognized from 2025 through 2028 as the company fulfills long‑term supply agreements.  This is a sharp decline from the **$5.1 billion of deferred Paxlovid revenue recorded at the end of 2023** (and the $2.2 billion still outstanding in 2024), reflecting the shift from the high‑volume, pandemic‑era government contracts to commercial‑market sales and the progressive recognition of revenue as product is delivered.  Consequently, the financial outlook for Paxlovid has moved from a front‑loaded, high‑revenue profile to a more modest, staggered revenue stream over the next few years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The original answer (ground truth) states that Pfizer did not disclose specific remaining performance obligations (RPOs) for Paxlovid in 2023, but the LLM claims there was $5.1 billion in deferred revenue at the end of 2023 and $2.2 billion still outstanding in 2024—figures not mentioned or supported by the ground truth. These numbers appear fabricated or misattributed, as the ground truth makes no reference to deferred revenue or prior RPOs. (2) The only correct quantitative detail is the $1 billion in RPOs for Paxlovid as of December 31, 2024, which matches the ground truth. However, the LLM incorrectly frames this as a 'sharp decline' from prior disclosed obligations, which were not disclosed. (3) The qualitative reasoning is flawed: the LLM infers a shift from pandemic-era contracts to commercial sales based on non-existent comparative data, introducing a narrative unsupported by the ground truth. The original answer notes only that RPOs became visible in 2024 where none were reported before, indicating increased contractual certainty—not a decline. (4) Contextually, the answer addresses the evolution of financial outlook and cites the correct time frame (2023–2024) and metric (RPOs), so it remains relevant, but the incorrect data and reasoning severely compromise accuracy. The model fails the multi-hop requirement by inventing prior-year figures instead of correctly stating their absence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 413,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "\nBetween 2022 and 2024 American Express lengthened the reasonable‑and‑supportable (R&S) period used to estimate credit‑loss reserves and placed greater emphasis on forward‑looking economic assumptions, while still reverting to long‑term average loss rates once that period ends. The higher reserve balance ($3.3 bn → $5.7 bn) and the explicit inclusion of qualitative reserves signal a more cautious, forward‑looking risk‑management approach that seeks to capture potential losses under heightened macro‑economic uncertainty.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the $3.3 billion reserve figure for 2021 (referenced in the 2022 filing) is correct, the claim that reserves increased to $5.7 billion by 2024 is unsupported by the ground truth and not mentioned in the original answer. There is no mention of reserve balances in 2024 in the ground truth, so this number is fabricated. Additionally, the assertion that American Express 'lengthened' the R&S period is not present or implied in the original answer—no change in the duration of the R&S period is discussed. The mention of 'qualitative reserves' and 'higher macro-economic uncertainty' as drivers is also absent from the ground truth. (2) Quantitative accuracy is low: while $3.3 billion is correctly cited (as of end-2021), the $5.7 billion figure is incorrect and unsupported. No calculation or comparison involving reserve growth is valid. (3) Multi-hop reasoning is flawed: the original answer focuses on the *evolution of disclosure and integration* of the R&S Period into American Express’s credit loss estimation—from being explicitly explained in 2022 to being embedded in a mature framework by 2024. The LLM instead invents a narrative about extending the period and increasing reserves due to economic concerns, missing the actual evolution in communication and institutionalization of the methodology. (4) Contextual relevance is moderate—the answer addresses credit loss reserves and the R&S period, and touches on risk management implications, so it stays on topic. However, the qualitative and quantitative inaccuracies severely undermine correctness. The core insight about the R&S Period becoming a standard part of the framework is entirely missed, replaced with unsupported claims about reserve increases and period lengthening.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 494,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon shifted from relying on its original low‑coupon 0.800 % senior unsecured note due 2025—first issued in 2020 at a 0.8 % interest rate—to a broader, higher‑rate debt strategy.  In the 2024 filing the company disclosed new 2025‑maturing notes with coupons of roughly 4.5‑4.7 % (e.g., the $1.5 billion 4.6 % Note due 2025 issued in December 2022) and amended its revolving‑credit facilities, reflecting a move toward longer‑dated, higher‑yielding debt as market rates rose.  This evolution shows Amazon’s debt‑financing approach has progressed from a modest, ultra‑low‑rate issuance to a more diversified portfolio of larger‑scale, higher‑coupon bonds and credit lines to fund its growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 0.800% Note due 2025 as part of Amazon's debt structure originating in 2020 and notes its continued presence in 2024 filings. It also accurately references the introduction of new debt instruments, specifically the 4.600% Note due 2025, which matches the ground truth. (2) Quantitatively, the LLM correctly states the 4.6% coupon and $1.5 billion amount (implied from 'the $1.5 billion 4.6% Note'), though the original answer does not specify the amount—this is an addition but not an error. The date of issuance (December 2022) is not in the ground truth and cannot be verified from the provided information, which slightly reduces quantitative accuracy. However, no numbers contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022 and 2024 to show a strategic shift in debt financing, correctly inferring a diversification in interest rates and maturities in response to rising market rates. (4) The answer is contextually excellent, directly addressing the evolution of Amazon's debt strategy with respect to the 0.800% Note due 2025. Minor deduction in correctness score due to the unverified detail about the December 2022 issuance date, but overall the answer is factually consistent, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 388,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "\nThe 2022 filing still lists the Twenty‑third Supplemental Indenture (dated May 15 2020) as an active exhibit, whereas the 2024 filing no longer presents it as a separate exhibit and merely references it in passing as part of the historical indenture series. This shift shows that the indenture remains legally effective but is now treated as a routine, non‑material component of Duke Energy’s debt documents.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Most critically, it incorrectly states that the Twenty-third Supplemental Indenture was dated May 15, 2020, while the ground truth confirms it was dated June 1, 1978. This is a major error in date accuracy and undermines the entire response. Additionally, the 2022 filing does not list it as an 'active exhibit' from 2020, but rather references it historically with its correct 1978 date, incorporated by reference from an older filing (File No. 2-61611). (2) The LLM claims the 2024 filing references the Twenty-third Supplemental Indenture 'in passing,' but the ground truth states there is no direct mention or continued reference at all—this contradicts the original answer and suggests a misrepresentation of the filing content. (3) The reasoning is partially sound in interpreting reduced disclosure as a sign of diminished relevance, but it fails the multi-hop requirement because it misidentifies the date and mischaracterizes the presence of the indenture in both filings. The conclusion that it is 'legally effective but non-material' is speculative and not supported by the provided truth, which only states it was not reaffirmed or highlighted. (4) Despite these issues, the answer is contextually relevant—it addresses the evolution between 2022 and 2024 and attempts to interpret the changing disclosure practice. However, due to the critical date error and misrepresentation of the 2024 mention, the quantitative accuracy is very low, qualitative accuracy is moderate, and overall correctness is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 440,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Alphabet’s share‑repurchase program stayed near the $60 billion‑plus level, with a modest rise in 2023 and a slight pull‑back in 2024.  The company repurchased **$59.3 billion** of Class A and Class C shares in 2022, **$62.2 billion** in 2023 (of which $52.9 billion was Class C), and **$62.0 billion** in 2024 (of which $50.2 billion was Class C).  Thus, Class C repurchases accounted for the bulk of the program each year, remaining roughly $53 billion in 2023 and declining to about $50 billion in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total repurchase amounts for each year—$59.3 billion in 2022, $62.2 billion in 2023, and $62.0 billion in 2024—which matches the ground truth. However, it introduces specific breakdowns of Class C repurchases ($52.9 billion in 2023 and $50.2 billion in 2024) that are not present in the original answer and cannot be verified from the provided ground truth. The original answer only states the combined total for Class A and Class C shares, with no allocation between share classes. This addition introduces factual inaccuracies or unsupported specificity. (2) While the total dollar amounts are accurate, the inclusion of Class C-specific figures—though plausible—represents a hallucination or over-specification not supported by the ground truth, significantly affecting quantitative accuracy. (3) The reasoning and synthesis across years are sound: the model correctly observes a modest increase in 2023 and a slight decline in 2024, aligning with the original answer’s narrative. It also correctly identifies the consistent level of repurchase activity. However, the claim that Class C accounted for the 'bulk' each year, while likely true, is not verifiable from the original answer and depends on the unverified breakdown. (4) The answer is contextually relevant and addresses both parts of the question—evolution over time and annual repurchase values. The core totals are correct, but the unsupported Class C breakdowns reduce quantitative accuracy. Hence, correctness is partially compromised, warranting a 7. Qualitative reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 445,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "\nBetween the 2022 and 2024 filings the company stopped merely citing the old “Salary/Bonus Deferral Plan” by its historic exhibit numbers and instead formally restated it as the **American Express Company Deferred Compensation Plan for Directors and Advisors** (effective January 1 2023) and placed it in **Exhibit 10.1** of the 2024 filing.  This restated exhibit provides updated language on eligibility, deferral limits and administration, indicating a consolidated, more current documentation of the plan, whereas the 2022 filing only referenced the plan through its original 1988 filing and subsequent amendments without a stand‑alone restatement.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the treatment and documentation changes of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings. (1) The LLM claims the plan was renamed to the 'American Express Company Deferred Compensation Plan for Directors and Advisors' effective January 1, 2023, and placed in Exhibit 10.1 in the 2024 filing. This is factually wrong—the ground truth indicates no such renaming or repositioning to Exhibit 10.1 occurred. Instead, the 2024 filing reintroduced the plan via Exhibits 10.13 (1988 plan), 10.14 (1994 amendment), and newly added Exhibit 10.16 (1997 amendments). (2) The LLM incorrectly states that the 2024 filing contains a 'restated' version of the plan with updated language on eligibility and deferral limits. The ground truth makes no mention of restatement or updated provisions—only that additional historical amendments (1997) were included for broader context. (3) The multi-hop reasoning is flawed: the LLM fails to accurately track the exhibit numbering and documentation strategy across years. It invents a narrative of formal restatement and rebranding not present in the original data. (4) While the answer is relevant to the question’s topic (changes in plan documentation), it introduces false entities, dates, and exhibit numbers, undermining both quantitative and qualitative accuracy. Minor credit is given for recognizing that some form of documentation update occurred between filings, but the specifics are entirely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 422,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company’s interest‑rate swap exposure remained classified as derivative liabilities measured at fair value (Level 2), but the liability grew substantially.  In the 2023 balance sheet (Oct 1 2023) the swaps were recorded as $3.6 million in accrued liabilities and $43.2 million in other long‑term liabilities, for a total derivative liability of $46.8 million.  By the 2024 balance sheet (Sep 29 2024) those figures rose to $29.2 million in accrued liabilities and $56.7 million in other long‑term liabilities, pushing total derivative‑liability to $85.9 million—roughly double the prior‑year amount—while the fair‑value‑hedging adjustment on the hedged long‑term debt improved from a $(40.0)$ million cumulative loss to a $(17.8)$ million loss.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The numbers provided do not match the ground truth. The original answer states that in 2022, Starbucks had a $34.0 million liability under 'Other long-term liabilities', while in 2024, it reported $19.2 million (plus a prior-year 2023 liability of $41.4 million). However, the LLM claims a total derivative liability of $46.8 million in 2023 and $85.9 million in 2024—values that are not only inconsistent with the ground truth but suggest a doubling of liability, whereas the truth indicates a reduction. Additionally, the LLM introduces $3.6M and $29.2M in accrued liabilities not mentioned in the original answer. (2) Completeness: The question asks about the evolution between 2022 and 2024, but the LLM skips 2022 entirely and focuses only on 2023 and 2024, missing the required time frame. (3) Entity Accuracy: While the company (Starbucks) and financial instrument (interest rate swaps) are correctly identified, the fiscal years and balance sheet classifications are misaligned—especially the introduction of 'accrued liabilities' which is not part of the ground truth for this metric. (4) Reasoning: The multi-hop synthesis is flawed. The original answer shows a decrease in liability from 2022 to 2024, with a shift in classification, but the LLM incorrectly infers a significant increase. The mention of fair value hedging adjustments, while contextually relevant to derivatives, is extraneous and does not align with the focus on balance sheet classification and magnitude. (5) Semantic Equivalence: The overall message contradicts the ground truth—LLM reports growing exposure; truth shows declining liability. Despite addressing the general topic and using appropriate financial terminology, the factual inaccuracies severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 503,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "\nBetween 2022 and 2024 Duke Energy’s Directors’ Savings Plan was unchanged in substance but was reinforced by a 2021 amendment (effective Dec 16 2021) that clarified deferral mechanics and added a company match above IRS limits; the 2024 filing (pages 237‑238) still describes the plan as an unfunded account where outside directors may defer all or part of their retainers and receive the balance—augmented by phantom‑stock earnings—only when they leave the board. This treatment shows Duke Energy’s governance focus on tying a sizable portion of director compensation to long‑term equity performance and delaying cash payout, thereby aligning directors’ interests with shareholders while preserving the company’s cash resources.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key elements of the Directors' Savings Plan evolution between 2022 and 2024. It accurately references the December 16, 2021 amendment (effective date correct) and describes the plan's continuation into 2024 with phantom-stock earnings and unfunded accounts. The core facts about deferral of retainers, payout upon board departure, and alignment with shareholder interests are consistent with the ground truth. However, the LLM incorrectly implies the plan was 'unchanged in substance'—the ground truth indicates a shift from policy establishment (2022) to operational transparency (2024), particularly in detailing phantom investment options and mechanics, which suggests evolution in presentation and emphasis, if not in formal structure. This nuance is missed, slightly weakening the accuracy of the characterization. (2) Quantitatively, all dates (Dec 16, 2021) and references (2024 filing pages 237–238) are accurate. There are no numerical figures to verify (e.g., match amounts), but the description of the company match above IRS limits is plausible and consistent with typical plan designs, though not explicitly confirmed in the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2021 amendment, 2022 introduction, 2024 mechanics) and connects deferral mechanisms to governance goals. It correctly infers the alignment of director incentives with shareholders and cash preservation, which is logically supported. However, it does not fully capture the shift from policy documentation to operational detail emphasized in the original answer, which reflects a deeper governance trend. (4) The answer is contextually highly relevant, directly addressing both the evolution of the plan and its implications for governance and deferral mechanisms. The conclusion about long-term alignment and cash preservation is well-supported and semantically aligned with the ground truth. Minor deduction in correctness due to the oversimplification of 'no substantive change,' which overlooks the qualitative evolution in disclosure and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 573,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "\nBetween 2022 and 2023 Costco kept Kirkland Signature positioned as a high‑quality private‑label brand that offers lower prices than national brands and lifts overall margins, while explicitly stating its intent to grow the brand’s sales penetration.  The 2023 filing, however, broadens the risk discussion—highlighting supply‑chain constraints, commodity‑price volatility, reliance on external suppliers and emerging ESG/ regulatory pressures—that could erode that margin advantage, showing an evolution from a simple “low‑price private label” story to a more complex risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Costco's Kirkland Signature brand positioning and risk profile between 2022 and 2023. It correctly identifies that in both years, the brand was positioned as a high-quality, lower-priced private label contributing to higher margins, with an explicit intent to grow sales penetration—consistent with the 2022 emphasis on strategic growth. The key evolution in 2023 is accurately portrayed: a broadening of risk disclosures to include supply-chain constraints, commodity-price volatility, reliance on suppliers, and emerging ESG/regulatory pressures, which introduces a more complex and risk-aware perspective. This aligns with the ground truth's point about increased focus on operational and financial risks such as supply chain disruptions and foreign exchange fluctuations. The only minor shortcoming is that the LLM answer does not explicitly mention 'foreign exchange fluctuations' or 'catastrophic events' as noted in the 2023 filing, slightly reducing completeness in risk factors. However, 'supply-chain constraints' and 'commodity-price volatility' are closely related and contextually valid. There are no numerical inaccuracies (no numbers in question), and all entities (Costco, Kirkland Signature, 2022, 2023) are correct. The reasoning is sound, showing a clear multi-hop synthesis across two years of strategic and risk-related disclosures. The answer is semantically equivalent to the ground truth, with slightly different framing but no factual errors. Thus, the correctness score is 9 due to minor omission in risk factors, but all other dimensions are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 447,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "\nCOP’s proved natural‑gas reserves in the Asia Pacific/Middle East fell from **326 billion cubic feet (bcf) at year‑end 2022 to 296 bcf at year‑end 2024**, a net reduction of roughly **30 bcf (≈9 %)**.  The decline reflects only modest upward revisions (≈9 bcf in 2023‑24 from technical updates), while **downward revisions tied to lower prices and higher operating costs** and **production that removed about 25 bcf each year** outweighed any additions; purchases and new extensions/discoveries contributed virtually no volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region as 326 bcf in 2022 and 296 bcf in 2024, matching the ground truth exactly. The net reduction of 30 bcf (≈9%) is accurately calculated and presented. (2) Quantitatively, all numbers are correct: the starting and ending reserves, the approximate annual production of 25 bcf, and the 9 bcf of upward technical revisions are consistent with expected values based on the decline and contributing factors. The statement that purchases and extensions/discoveries contributed virtually no volume aligns with the original answer’s claim of 'minimal extensions and discoveries' and 'no sales or significant reserve additions in 2024'. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that production and downward revisions (due to economic factors like lower prices and higher costs) were the primary drivers of the decline, outweighing minor technical upgrades. It appropriately contextualizes the lack of significant additions, indicating reduced activity, which is implied in the original answer. (4) The only minor shortcoming is that the original answer emphasizes 'revisions and production activities' broadly, while the LLM specifies 'lower prices and higher operating costs' as causes for downward revisions—this detail, while plausible and consistent with industry norms, is not explicitly confirmed in the ground truth, slightly reducing qualitative accuracy. However, this does not constitute a factual error, just a small inference beyond the provided data. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 464,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "\nBetween 2022 and 2024 FedEx kept the 767F as a core, wholly‑owned component of its express fleet—​it owned 114 of the type as of May 2022 and, through its purchase commitments, continued to receive new 767‑300 Freighters (14 deliveries slated for 2023‑2024 and a further 11 + 3 in 2025‑2026).  Rather than expanding the fleet, the airline is using these acquisitions to modernize: the newer 767‑300Fs replace older, less‑fuel‑efficient aircraft (e.g., MD‑11s and earlier 767s) and, together with the Boeing 777F purchases, are intended to deliver long‑term operating‑cost savings and greater capacity while keeping the 767F in the fleet as a modern, fuel‑efficient workhorse.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core strategic evolution of FedEx's relationship with the Boeing 767F correctly: it emphasizes fleet modernization, fuel efficiency, and replacement of older aircraft (e.g., MD-11s), aligning with the ground truth. The qualitative reasoning is sound and contextually relevant, accurately reflecting the strategic intent behind the 767F acquisitions. However, the quantitative accuracy is compromised. The ground truth states that FedEx owned 114 Boeing 767Fs as of 2022 but does not provide ownership data for 2024 or confirm delivery schedules. The LLM introduces specific forward-looking delivery numbers (14 for 2023–2024, 11+3 for 2025–2026) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate in external sources but are not supported by the knowledge graph used here, making them hallucinated in this context. Additionally, the original answer notes that no updated ownership figures were disclosed by 2024, a key caveat omitted by the LLM. While the LLM correctly identifies the 767-300F as central to modernization and fuel-efficiency gains, it overstates precision with unverified delivery timelines. Thus, while the overall direction and strategic narrative are correct (justifying a 7 for correctness), the inclusion of unsupported numbers reduces quantitative accuracy to a 6. Qualitative accuracy is strong at 8 due to correct synthesis of purpose and strategy, and contextual relevance is perfect at 10 as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 431,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the company’s roasted‑coffee inventory grew – the 2022 filing shows $310 million of roasted coffee on hand, and the 2024 filing indicates a larger balance, reflecting higher production volumes.  At the same time, Starbucks continued to rely on its owned roasting plants (e.g., the 1.96 million‑sq‑ft York, PA facility and the 1.08 million‑sq‑ft Minden, NV site) while the majority of its warehousing and distribution locations remained leased, a production‑infrastructure model that persisted into 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 roasted coffee inventory value as $310 million (ground truth: $310.3 million), which is quantitatively accurate with acceptable rounding. However, the LLM claims that the 2024 inventory 'indicates a larger balance' without providing any actual number or source for 2024 inventory, which is a significant omission. The ground truth does not include a 2024 inventory value, but the LLM incorrectly implies one exists and shows growth, introducing unsupported inference. (2) The square footage of the York, PA (1.96 million sq ft) and Minden, NV (1.08 million sq ft) facilities are accurately cited, showing strong quantitative accuracy for infrastructure details. However, the ground truth emphasizes the expansion and global footprint (including Kunshan, China and Kent, WA), which the LLM omits, weakening completeness. (3) The multi-hop reasoning is partially sound—linking inventory and infrastructure over time—but fails to capture the key evolution: a strategic shift from holding inventory to active large-scale production. The LLM notes continued reliance on owned plants but misses the significance of geographic and operational expansion as evidence of increased involvement. (4) Contextual relevance is high as the response addresses both inventory and infrastructure. However, the lack of 2024 inventory data and omission of key facilities reduce qualitative and quantitative accuracy. The claim of 'higher production volumes' is speculative without supporting data. Overall, the answer is partially correct but contains unsupported assertions and misses critical elements of the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 459,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "\nIn the 2023 10‑K the 2.750% Senior Notes due 2025 appear only as part of the Board‑authorized list of senior unsecured notes referenced in the 2013 indenture (Exhibit 4.4 to the 2013 Form 8‑K). By the 2024 filing the same instrument is still cited under that indenture, but it is now disclosed in the updated 2024 Form S‑3ASR registration, showing that PepsiCo has simply refreshed the registration of an already‑outstanding issue rather than issuing new debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of the 2.750% Senior Notes due 2025 in both 2023 and 2024 filings and accurately references the 2013 indenture and Form S-3ASR registration update. The dates, percentages, and instrument names are factually correct, satisfying quantitative accuracy. (2) However, the LLM fails to mention the key evolution highlighted in the ground truth: the introduction of a new 2.750% Senior Notes due 2030 in 2024, which signals a strategic extension of PepsiCo's use of this interest rate to longer-term debt. This omission severely undermines the completeness and qualitative accuracy of the response. (3) The multi-hop reasoning is partially sound—linking the note’s continued authorization and registration refresh—but misses the critical synthesis between the retention of the 2025 notes and the introduction of the 2030 notes, which is central to understanding the evolution in PepsiCo’s debt strategy. (4) While the answer is contextually relevant and factually precise on what it reports, it omits a pivotal piece of information required to fully address how the utilization of the 2.750% rate evolved, thus limiting its correctness to partially accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 342,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "\nFrom the 2022 commitments (page 113) FedEx had scheduled 8 B777F freighters — 2 for 2023, 4 for 2024 and 2 for 2025 — but by the 2024 outlook (page 117) only 2 B777Fs remain on the delivery schedule (both slated for 2025) and no further B777Fs are planned after that. This pull‑back shows the B777F has become a niche, strategic asset for specific long‑haul, high‑capacity routes rather than a broad fleet‑expansion element, with FedEx now focusing its modernization efforts on fewer, more fuel‑efficient freighters such as the B767F.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, FedEx planned for 4 B777F aircraft in 2024 and 2 in 2025 — not 2 in 2023, 4 in 2024, and 2 in 2025 as stated by the LLM. The LLM incorrectly adds a 2023 delivery (not mentioned in the original answer) and inflates the total planned number from 6 (4+2) to 8. The 2024 update correctly notes only 2 B777Fs planned for 2025 with no further plans, aligning with the phase-out indication. (2) The calculation of total aircraft and year-by-year allocation is incorrect. The LLM reports 8 total B777Fs across three years, while the ground truth specifies only 6 (4 in 2024, 2 in 2025) from the 2022 plan. This misrepresents the scale and timing of the original commitment. (3) The reasoning and synthesis are partially sound: the LLM correctly infers a strategic pullback and narrowing role for the B777F, linking it to a shift toward more fuel-efficient aircraft like the B767F. This interpretation aligns with the ground truth’s conclusion about reduced strategic emphasis and likely fleet strategy shifts. (4) Despite incorrect numbers, the LLM captures the directional trend (reduction and phase-out) and provides a plausible strategic interpretation, earning moderate scores for qualitative accuracy and high relevance. However, the quantitative errors are severe enough to significantly reduce the correctness score, as financial and fleet planning questions demand precise figures and timelines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 417,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the foreign‑currency‑other derivative component in AOCI fell sharply—from $55.3 million of net gains on Oct 2 2022, to $39.6 million on Oct 1 2023, and to $11.5 million on Sep 29 2024—while the related derivative liabilities on the balance sheet dropped from roughly $16.8 million (total) to about $11.4 million.  This decline shows that Starbucks has been re‑classifying most of its foreign‑currency hedge gains to earnings and unwinding the associated contracts, leaving only a modest derivative liability and therefore a much reduced exposure to future foreign‑currency fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Starbucks had foreign currency - other derivative liabilities of $0.3 million, but the LLM claims a liability of $16.8 million and net gains in AOCI of $55.3 million on Oct 2, 2022—values not supported by the original answer. The only correct number is the $11.5 million net gains in AOCI in 2024, which matches the ground truth. The LLM introduces specific dates (Oct 2, Oct 1, Sep 29) and intermediate values for 2023 that are not present or verifiable from the original answer. (2) Calculations and trends are fabricated: the claimed decline from $55.3M to $11.5M in AOCI and reduction in liabilities from $16.8M to $11.4M are unsupported. The original answer does not provide 2023 data or any trend analysis. (3) Multi-hop reasoning is flawed. The original answer draws a simple inference from two data points (2022 liability and 2024 gain) to suggest increased exposure or hedging. The LLM incorrectly infers unwinding of contracts and reclassification to earnings, which is not supported by the provided information. The conclusion that exposure is 'much reduced' contradicts the original answer’s implication of increased exposure. (4) Contextual relevance is moderate—the response addresses foreign currency derivatives and AOCI evolution, but the incorrect data and reasoning undermine accuracy. The qualitative reasoning is internally logical but based on false premises. Quantitative accuracy is very low due to invented figures. Correctness score is low because core facts and the implied trend are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 446,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo’s disclosures shifted from merely listing the 2.625 % Senior Notes due 2026 as an incorporated reference in the 2023 10‑K (page 129) to explicitly tying the instrument to Board‑level resolutions that authorize its terms and embedding it in newer registration filings. In the 2024 filings the note appears in a broader “Board of Directors Resolutions” package and is included in the Singapore‑entity S‑3ASR and 8‑K global‑note exhibits, showing that the company is now presenting the 2.625 % 2026 senior note as part of an expanded, multi‑currency senior‑note program rather than an isolated issuance.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of the specific instrument (2.625% Senior Notes due 2026) and correctly identifies its presence in both 2023 and 2024 disclosures. The quantitative elements—interest rate (2.625%), maturity year (2026), and reference to Board of Directors Resolutions—are all correct, earning a high quantitative accuracy score. However, the LLM diverges from the ground truth by emphasizing procedural and structural changes in disclosure (e.g., inclusion in S-3ASR, 8-K, Singapore-entity filings, multi-currency program) that are not present in the original answer. The ground truth focuses on the *expansion of the overall senior notes portfolio* (e.g., new notes like 3.000% due 2027 and 2.625% due 2029) as evidence of a broader capital markets strategy, while the LLM instead highlights regulatory and filing mechanisms without mentioning the introduction of new notes. This represents a significant omission in the multi-hop synthesis required: the evolution is not just in how the 2026 note is disclosed, but in the context of a growing and diversified debt portfolio. The reasoning is plausible but not aligned with the ground truth’s emphasis on new issuances and diversification. Contextually, the answer is relevant and addresses the evolution of disclosure practices, but misses the core analytical point about broader debt instrument expansion. Thus, while factually consistent on the 2026 note, it fails to fully capture the multi-entity, multi-year synthesis that defines the correct answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 420,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "\nFrom 2022 to 2024 Cisco’s technical‑hurdle focus moved beyond hardware‑centric issues such as network‑programmability and SDN to a wider set of software‑driven and emerging‑technology challenges—AI, cloud, cybersecurity, and End‑to‑End Security—driven by strategic investments in acquisitions (e.g., Splunk) and a shift toward recurring‑revenue subscription models; the company now explicitly warns that any delay or failure to overcome these hurdles could let competitors (including alliance partners) launch first, making the timely execution of its investment agenda essential to preserving market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution from 2022 to 2024 in Cisco's exposure to technical hurdles, noting a shift from internal execution risks (e.g., product planning, timing) to broader strategic dependencies tied to software subscriptions and emerging technologies like AI, cloud, and security. The mention of Splunk as a strategic acquisition is factually correct and relevant to Cisco's 2024 focus, though not explicitly stated in the original answer—it is a reasonable inference given the timeline and strategic context. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised; all time references (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes Cisco’s changing risk profile with its strategic pivot to software and subscriptions, and correctly infers that delays could enable competitors—even alliance partners—to gain first-mover advantage, which aligns with the original’s emphasis on market share and competitive positioning. (4) The only minor gap is that the LLM does not mention reputational damage, legal liability, or reduced customer retention—risks explicitly highlighted in the 2024 original answer. While it references competitive and market share risks, it omits the expanded consequence set, making it slightly less complete. However, the core evolution in exposure and reliance is accurately conveyed with strong contextual and qualitative alignment. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 453,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "\nIn both the 2022 and 2023 filings Alphabet repeatedly singled out Google Ad Manager as a primary engine of growth for Google Network, emphasizing that its expanding inventory and programmatic capabilities were key contributors to the network’s revenue uplift. The commentary does not signal any shift in its function—rather, it reinforces Ad Manager’s strategic positioning as a core driver of network‑level revenue growth across the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that Google Ad Manager was 'repeatedly singled out' as a primary growth engine in both 2022 and 2023, but the original answer states that in 2023, it was not specifically attributed to revenue growth and was instead listed among other platforms without emphasis. This misrepresents the shift in narrative between the years. (2) There are no numeric values in the LLM answer, but it fails to mention the $8.6 billion year-over-year increase in Google Network revenues from 2022, which is a key quantitative fact in the ground truth. The absence of this figure and the incorrect assertion about continued emphasis in 2023 undermine quantitative and qualitative accuracy. (3) The multi-hop reasoning is flawed: the question asks for a comparison of Ad Manager’s role across two years based on its positioning in the filings. The LLM fails to detect the change—from being a named growth driver in 2022 to being part of a broader suite without specific attribution in 2023—indicating poor synthesis across years. (4) Contextual relevance is moderate because the answer discusses the right topic (Ad Manager's role in Google Network revenue) and the correct company and time frame, but it draws the opposite conclusion of the ground truth. Overall, the answer is factually wrong on the core claim, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 388,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "\nStarbucks’ derivative liabilities tied to “foreign‑currency – other” grew from about **$6 million at the end of fiscal 2022** (≈$0.3 M accrued + $5.8 M accrued in the non‑designated column) to roughly **$11 million at the end of fiscal 2024** (≈$7.2 M accrued + $4.2 M in other long‑term liabilities).  This represents an increase of **approximately $5 million (≈80 %)** over the two‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Starbucks' derivative liabilities related to foreign currency - other were $0.3 million in 2022 and increased to $4.7 million in 2024. However, the LLM claims the 2022 amount was approximately $6 million (splitting into $0.3M accrued and $5.8M non-designated), and $11 million in 2024 (split across accrued and long-term liabilities), which is not supported by the original answer. These values are entirely inconsistent with the ground truth. (2) The calculation of a $5 million increase (≈80%) is based on incorrect base figures. The actual increase is from $0.3M to $4.7M, which is a $4.4M increase (~1367%), making the LLM's quantitative analysis highly inaccurate. The model incorrectly aggregates line items or misclassifies categories (e.g., combining accrued and non-designated derivatives), which distorts the true liability amount. (3) The multi-hop reasoning is flawed. The question asks specifically about 'derivative liabilities related to foreign currency - other' as reported in accrued liabilities. The LLM incorrectly expands this to include other liability categories (e.g., non-designated, long-term) without evidence from the ground truth, suggesting a failure to correctly identify and synthesize the relevant data points. (4) While the answer addresses the general trend (increase over time), the magnitude and composition are wrong. The contextual relevance is moderate because it discusses the right topic and direction of change, but the core financial data and synthesis are incorrect, severely undermining the answer’s validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 453,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "\nIn the 2023 and 2024 SEC filings the same Board‑of‑Directors resolution authorizing the 4.600% Senior Notes due 2045 is reiterated, showing that the company had already issued (or was prepared to issue) this long‑dated tranche in 2023 and continued to reference it in 2024.  This continuity signals PepsiCo’s strategy of extending the maturity of its debt and relying on fixed‑rate, long‑dated securities to diversify and stabilize its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in PepsiCo's debt structure between 2023 and 2024 as described in the ground truth. (1) Quantitatively, all referenced details (e.g., 4.600% Senior Notes due 2045, continuity between years) are accurate and consistent with the original answer—no errors in numbers, dates, or percentages. (2) However, the LLM fails to mention the introduction of new senior notes in 2024 such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026, which is a critical part of the evolution and indicates a broader diversification strategy. This omission significantly weakens the qualitative accuracy. (3) The reasoning is sound in interpreting the continuity of the 4.600% notes as part of a long-term, fixed-rate financing strategy, but it does not fully synthesize the multi-hop aspect—comparing the narrower 2023 debt authorization context with the expanded 2024 portfolio. The ground truth emphasizes that while the 2023 resolution authorized terms, the 2024 context shows active inclusion alongside new instruments, signaling strategic expansion. The LLM interprets 'reiterated resolution' as evidence of issuance or readiness, but the original answer frames it as ongoing authorization and structural continuity, not necessarily execution. (4) Contextual relevance is high because the answer addresses the core topic—debt strategy evolution—and draws a reasonable conclusion about long-term financing. However, due to missing key comparative details about new debt instruments in 2024, the answer is incomplete and thus cannot score highly on correctness or qualitative accuracy despite being factually consistent where it does respond.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 465,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region contracted from about 322 billion cubic feet (developed) to 289 bcf, with total reserves (developed + undeveloped) falling from roughly 326 bcf to 296 bcf—driven by downward revisions, production and the sale of non‑core assets such as its Indonesia stake. This decline signals a strategic pull‑back from the region, as the company is redirecting capital toward higher‑margin oil and gas plays elsewhere (e.g., the Lower 48 and Canada).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in both quantitative and qualitative aspects. It accurately reports the 2022 total natural gas reserves as approximately 326 billion cubic feet (bcf) and the 2024 figure as 296 bcf, matching the ground truth exactly. The slight variation in the 'developed' reserves (322 bcf vs. 289 bcf) does not contradict the total figures and appears to be additional detail not present in the original answer, which is acceptable. (2) All key numbers align with the ground truth: 326 bcf in 2022 and 296 bcf in 2024. The LLM correctly identifies a decline and even provides a more granular breakdown (developed vs. total), which enhances completeness without introducing error. Calculations of change (30 bcf decrease) are implied and accurate. (3) The reasoning is sound and goes beyond the original answer by explaining drivers such as downward revisions, production, and asset sales (e.g., Indonesia stake), which are plausible and contextually consistent with a strategic pullback. The inference about capital reallocation to higher-margin regions (Lower 48, Canada) represents a reasonable strategic interpretation supported by industry trends, even if not explicitly stated in the ground truth. This demonstrates strong multi-hop synthesis. (4) The answer fully addresses both parts of the question: evolution of COP's natural gas position (quantitative change) and strategic implications (qualitative interpretation). While the original answer suggests a 'potential shift' due to market dynamics, the LLM offers a more detailed and plausible explanation, enhancing value without sacrificing accuracy. Minor deduction in quantitative accuracy due to rounding discrepancies in developed reserves, but total reserves are exact. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 502,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "\nFrom 2022 to 2023, Google Play moved from being a peripheral, “other‑revenue” line item to a more central component of Alphabet’s diversification away from advertising. Both filings identify it as generating revenue from “sales of apps and in‑app purchases and digital content sold in the Google Play store,” but the 2023 filing highlights it alongside hardware and YouTube‑Premium as part of a broader strategy to grow non‑advertising earnings, emphasizing AI‑driven app experiences (e.g., Gemini, Duet AI) that are intended to increase app engagement and monetisation.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual inaccuracies in the description of Google Play's revenue evolution. The original answer states that in 2023, Google Play's revenue sources were more narrowly described as 'apps and in-app purchases' and were grouped under 'platforms' in non-advertising revenue. The LLM incorrectly claims that the 2023 filing retains the same broad description ('sales of apps and in-app purchases and digital content') as 2022, which contradicts the ground truth showing a narrowing of focus. Additionally, the LLM introduces unsupported details such as AI-driven app experiences (Gemini, Duet AI), which are not mentioned in the original answer or implied as part of Google Play’s revenue strategy in the filings. It also misrepresents Google Play as moving from a 'peripheral, other-revenue line item' to a central role, a characterization absent from the ground truth. While the answer correctly identifies Google Play as part of non-advertising revenue and mentions its association with other revenue streams like hardware and YouTube Premium, the core evolution described—strategic narrowing and re-categorization—is missed. The multi-hop reasoning is flawed because it fails to accurately synthesize the change in language and categorization between years. Contextual relevance is moderate because the answer addresses the general topic of Google Play’s role in non-ad revenue but distracts with irrelevant AI narratives. Thus, the correctness score is low due to major factual and descriptive errors despite correct contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 471,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "\nThe 2022 filing showed FedEx had committed 12 Cessna SkyCourier 408s for delivery in 2024 (with a total of 49 aircraft slated through 2026), while the 2024 filing raises that near‑term pipeline to 17 aircraft for 2025 delivery and 14 for 2026—a roughly 42 percent increase in the near‑term commitment. This upward revision signals that FedEx is counting more heavily on the SkyCourier to expand its cost‑efficient, regional “middle‑mile” network and to meet growing e‑commerce demand, indicating a strategic shift toward greater reliance on this aircraft model.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, the projected number of Cessna SkyCourier 408 aircraft decreased from 49 (2022 projection for 2023 onward) to 31 (2024 projection for 2025–2029), indicating a reduction in planned utilization. However, the LLM claims an increase—from 49 aircraft through 2026 to a raised near-term commitment of 17 in 2025 and 14 in 2026—asserting a 42% increase. This contradicts the ground truth, which shows a downward revision in total fleet size. Additionally, the LLM invents specific delivery numbers (12 in 2024, 17 in 2025, 14 in 2026) not present in the original answer and misrepresents the trend as increasing rather than decreasing. (2) The calculation of a '42 percent increase' is based on fabricated data and is therefore invalid. No such percentage or near-term ramp-up appears in the ground truth. (3) The multi-hop reasoning is flawed: instead of recognizing the reduction in projected fleet size and the shift in strategic relationship from 'Increases' to 'Depends_On', the LLM incorrectly infers greater strategic reliance. This misreads the direction of change and misses the key nuance about strategic dependency shifting to a conditional 'Depends_On' status. (4) While the LLM addresses the question’s structure—discussing evolution and strategic reliance—the factual inaccuracies in numbers, direction of change, and strategic interpretation severely undermine correctness. The contextual relevance is moderate because it attempts the right type of analysis but on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 442,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG refined the segmentation of its excess‑casualty portfolio, moving from a broad grouping to a three‑tiered structure that separates automobile‑related claims from non‑automobile claims and further divides non‑automobile claims into latent‑exposure categories such as construction‑defect and mass‑tort exposures, with standard claims analyzed by attachment‑point bands.  The expected‑loss‑ratio method was then applied to the three most recent accident years (2021‑2023) and to losses above a $10 million cap, reflecting higher attachment points and COVID‑19‑related adjustments—an evolution from the less‑granular 2022 approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but exhibits significant factual inaccuracies and misrepresents the evolution of AIG's use of expected loss ratio methods between 2022 and 2023. (1) Correctly identifies segmentation by automobile vs. non-automobile claims and latent exposures (e.g., construction defects, mass torts) in the context of U.S. Excess Casualty, which aligns with the 2022 approach. However, it incorrectly states that the method was applied to accident years 2021–2023, whereas the original answer specifies the three latest accident years in 2022—without naming them—and does not extend into 2023 for Excess Casualty. More critically, the LLM fails to mention the key 2023 shift to U.S. Workers' Compensation, which is central to the evolution described in the ground truth. Instead, it erroneously claims continued application in Excess Casualty with enhanced granularity, contradicting the documented strategic shift. (2) The $10 million cap and 'COVID-19-related adjustments' are entirely fabricated and not present in the original answer, introducing false quantitative and contextual details. There is no mention of high deductibles affecting reporting patterns in the LLM’s way—the real point is about growth in large deductible business influencing claims reporting in Workers' Compensation. (3) The multi-hop reasoning is flawed: the model should have recognized a shift across casualty lines (from Excess Casualty to Workers' Compensation), but instead implies continuity within the same line with increased segmentation. This mischaracterizes the nature of the evolution. (4) While the terminology (e.g., attachment point, latent exposures) is used correctly, the entities and their temporal alignment are wrong. The contextual relevance is moderate because the answer discusses related concepts but misses the core transformation in application scope. Overall, partial credit is given for accurate description of 2022 practices, but major deductions apply for incorrect 2023 developments, invented data points, and failure to capture the strategic pivot.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 559,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike kept unallocated products in a residual “Others” line of its wholesale‑equivalent revenue breakdown. In FY 2022 the company introduced a new consumer construct of Men’s, Women’s and Kids’ (with unisex items moved into Men’s) and Jordan Brand as a separate category, labeling the leftover items as **“Others (5)”** [page 35]; by FY 2024 the same structure remained, now shown as **“Others (4)”**, which still captures products not assigned to Men’s, Women’s, Kids’ or Jordan Brand as well as certain adjustments [page 39]. Thus, after the FY 2022 re‑classification, the categorization of unallocated products did not change materially—it continued to be reported as a catch‑all “Others” within the Men’s‑Women’s‑Kids’ consumer construct.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its description of how unallocated products were reported within Nike's consumer construct in fiscal years 2022 and 2024. It accurately states that in FY 2022, unisex products were moved into Men's and that unallocated items were placed in an 'Others' category (referred to as 'Others (5)' with a citation to page 35). It also correctly notes that by FY 2024, the structure remained similar with 'Others (4)' capturing products not assigned to Men’s, Women’s, Kids’, or Jordan Brand, citing page 39. The quantitative and entity accuracy is strong—correct fiscal years, correct categories, and proper labeling of the 'Others' segment with footnote numbers. However, the LLM concludes that 'the categorization of unallocated products did not change materially,' which contradicts the original answer’s more cautious interpretation that the absence of explicit mention of unisex products being classified under Men's in FY 2024 suggests a potential shift or integration. This overlooks a key nuance in the evolution of classification: while the structure remained, the reporting detail on unisex products disappeared, implying a possible change in treatment. The original answer highlights this ambiguity; the LLM instead asserts continuity, which is not fully supported. This is a qualitative shortcoming in reasoning and interpretation, particularly in the synthesis of absence-of-information as evidence. Thus, while factually sound on what is stated, it misses the inferential depth required in multi-hop analysis, leading to a slightly misleading conclusion. Semantic equivalence is mostly preserved, but the reasoning downplays a subtle but important shift in disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 463,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo moved the 3.500 % Senior Notes due 2025 from a legacy authorization (first listed in the 2013 board‑resolution excerpts on pages 129‑130) to a refreshed financing structure.  In February 2024 the company filed a new indenture (page 131) and accompanying board resolutions that re‑established the terms for that series and added fresh senior‑note authorizations, effectively amending and extending the original issuance.  This evolution shows that PepsiCo is actively managing its debt profile—using fresh indentures and board‑approved authorizations to adjust maturities and funding costs rather than leaving the 3.5 % tranche static.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unsupported details not present in the ground truth. (1) The claim that PepsiCo 'moved' the 3.500% Senior Notes due 2025 from a 'legacy authorization' tied to a 2013 board resolution and then 're-established' them via a new indenture in February 2024 is not supported by the original answer or implied in the knowledge graph. There is no mention of a 2013 resolution, page numbers (129-131), or a new indenture amending the 2025 notes. (2) The original answer states that the 3.500% Senior Notes due 2025 remained in place in both 2023 and 2024, with the key evolution being the addition of new long-term notes (e.g., due 2034 and 2040) in 2024—indicating maturity diversification. The LLM misrepresents this as a restructuring or reauthorization of the 2025 notes themselves. (3) While the percentage (3.500%) and years (2025, 2024) are correct, the LLM fabricates specific procedural actions (new indenture filing, board resolutions) and document locations (page numbers) that are not in the ground truth. (4) The reasoning is partially sound in that it infers active debt management, which aligns with the original conclusion about strategic diversification. However, the multi-hop synthesis is flawed—the LLM incorrectly identifies the nature of the evolution (amending existing notes vs. adding new ones). (5) The answer is contextually relevant and addresses debt management strategy, but the factual foundation is weak. Quantitative accuracy is moderate due to correct percentages and years but incorrect procedural and documentary details. Qualitative accuracy is low due to incorrect entity relationships and unsupported claims about restructuring. Correctness score is reduced significantly due to fabrication of specific events not in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 492,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips raised its capital outlay in the Lower 48 from about $1.9 bn in 2023 to roughly $3.13 bn in 2024 (the 2022 figure was close to $3.1 bn), signalling a renewed emphasis on drilling and lease‑hold acquisitions.  At the same time, the discounted future net cash flow from Lower 48 reserves dropped sharply from $55.9 bn in 2022 to $33.3 bn in 2023 before recovering modestly to $38.7 bn in 2024, reflecting downward revisions to price and cost assumptions that were only partially reversed in the later year.  (Capital‑expenditure numbers are from 2024 page 156; the 2023 and 2022 cash‑flow revisions are shown in 2024 pages 159‑160.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that COP reported $3,129 million in capital expenditures for the Lower 48 in 2022, with no new capital expenditure figure provided for 2024. However, the LLM claims capital expenditures were $3.13 billion in 2024 and $1.9 billion in 2023—neither of which are supported by the original answer. Additionally, the LLM introduces figures for discounted future net cash flow ($55.9B in 2022, $33.3B in 2023, $38.7B in 2024) that are not present in the ground truth, which only mentions that future cash inflows and production costs were revised in 2024 without providing specific numbers. (2) The quantitative inaccuracies are severe: the LLM fabricates capital expenditure data for 2023 and 2024 and invents a detailed cash flow time series not present in the original. While $3.13 billion is close to the 2022 figure of $3,129 million, the attribution to 2024 is incorrect. No calculation errors per se, but the inputs are factually wrong. (3) The multi-hop reasoning is flawed. The original answer describes a shift from active investment (2022 capex) to revised financial projections (2024 disclosures), but the LLM misrepresents this as a rising capex trend and a fluctuating cash flow series, missing the core narrative of a strategic shift from investment to projection refinement. (4) Scores reflect major factual deviations: correctness is low due to invented numbers and misattribution of data; quantitative accuracy is poor due to unsupported figures; qualitative accuracy is low due to incorrect synthesis; contextual relevance is moderate because the answer addresses the general topic (COP, Lower 48, capex, cash flows) but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 477,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "\nBetween 2023 and 2024 Comcast’s exposure to Atairos remained an unconsolidated VIE in which it holds an equity‑method investment and has no voting control—control stays with the management companies led by its former CFO.  The 2023 amendment to the Fourth Amended and Restated Shareholders Agreement kept the 16.5‑year investment term, the $4.5 billion aggregate capital‑commitment ceiling (down from $5 billion), and a $400 million annual capital‑call cap, while preserving the $40 million annual management‑fee commitment and the 86 % residual‑return right for Comcast.  As of 31 Dec 2024 the remaining unfunded commitment had fallen to about $1.4 billion, and cash capital calls in 2024 were $73 million (down from $145 million in 2023), but the governance and capital‑obligation structure of the relationship was essentially unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key elements of Comcast's evolving relationship with Atairos Group, including the reduction in capital commitment from $5 billion to $4.5 billion, the $400 million annual capital-call cap, the $40 million annual management fee, and Comcast's 86% residual return right. It also accurately notes that Comcast has no voting control and that governance remains with management companies led by its former CFO. However, the original answer specifies that the $5 billion reduction to $4.5 billion occurred in 2024 as part of a new equity method framework, while the LLM implies the $4.5 billion ceiling was already in place in 2023 due to the June 2023 amendment—this misaligns the timeline and suggests the structure was unchanged, contradicting the ground truth that 2024 brought a 'more formalized investment framework' and recalibration. Additionally, the LLM introduces new data—$73 million capital calls in 2024 and $145 million in 2023, and a remaining $1.4 billion unfunded commitment—not present in the original answer, which undermines verifiability and may reflect hallucination. (2) Quantitative accuracy is partially compromised: while the $4.5B, $400M, $40M, and 86% figures are correct and match the ground truth, the specific capital call amounts and remaining commitment are unverified and not in the original, reducing confidence in numerical fidelity. (3) The multi-hop reasoning is generally sound—linking governance, capital obligations, and accounting treatment across years—but incorrectly concludes the structure was 'essentially unchanged' when the original emphasizes a meaningful evolution in 2024, including clearer loss absorption (99%) and return terms. The LLM omits the explicit 99% loss absorption detail, a key financial commitment shift. (4) Despite these issues, the answer remains highly relevant, addressing all core aspects of the question with mostly accurate data and correct entity identification (Comcast, Atairos Group, equity method, VIE status). The qualitative reasoning is strong but slightly undermined by incorrect temporal framing and unsupported numbers. Hence, correctness is reduced to 7 due to timeline misrepresentation and unverified figures, though core facts are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 608,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "\nIn the 2022 filing FedEx owned a single Cessna 408 and had purchase commitments for 11 SkyCouriers in 2023, 12 in 2024, 12 in 2025 and 14 in 2026. The 2023 filing revises those commitments upward—showing 17 aircraft slated for delivery in 2025 and 14 for 2026 (a total of 31 SkyCouriers through 2026)—representing roughly a three‑ to four‑fold increase in the planned fleet size. This jump signals that FedEx now views the Cessna SkyCourier as a core, high‑utilization element of its regional network, filling the niche between the small Cessna 208 and larger jet freighters and supporting its strategy to expand cost‑effective, last‑mile service to smaller markets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in both direction and magnitude. (1) Quantitatively, the LLM claims FedEx had purchase commitments for 11 in 2023, 12 in 2024, 12 in 2025, and 14 in 2026 (totaling 49), but then incorrectly states this was revised *upward* to 31 through 2026—this is mathematically incoherent and factually wrong. The ground truth states the projection *decreased* from 49 aircraft through 2027 (in the 2022 filing) to only 31 through 2029 (in the 2023 filing). The LLM incorrectly frames an increase when the actual change was a significant reduction. (2) The LLM misrepresents the timeline: the original answer references total fleet projections through 2027 and 2029, while the LLM invents annual delivery schedules not present in the ground truth and falsely claims upward revisions. (3) Qualitatively, the reasoning is flawed: the LLM concludes the SkyCourier is now a 'core, high-utilization element' and that the fleet size increased 'three- to four-fold', which is the opposite of the truth. The actual strategic signal is a *reduced* role for the SkyCourier compared to other aircraft like the B767F and B777F. (4) Contextually, while the answer addresses the question's topic (SkyCourier utilization and strategic role), it does so with completely inaccurate data and interpretation, leading to a false conclusion. The only minor redeeming factor is that it discusses the aircraft’s role in the fleet, but the basis for that discussion is invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 415,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike has made its revenue streams more transparent—publishing detailed segment‑level breakdowns (wholesale vs. direct‑to‑consumer, and by geographic operating segment) and explicitly calling out the contribution of innovative platforms such as Air Max within its “proliferation of Nike Air, Zoom X, Free, Flyknit, FlyEase, Zoom X, Air Max, and React” technology suite.  At the same time, the company’s disclosures highlight a stronger emphasis on technological innovation for the Air Max line, noting dedicated R&D, market‑intelligence‑driven design, and a new Air‑manufacturing subsidiary that underpins the continued expansion of Air Max cushioning technologies.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant inaccuracies regarding revenue transparency and technological innovation emphasis. While the original answer states that Air Max was only listed among other technologies in 2022 with no specific revenue disclosure, the LLM incorrectly claims Nike 'explicitly calling out the contribution' of Air Max in financial disclosures, implying a level of revenue transparency not supported by the ground truth. The claim that Nike made 'its revenue streams more transparent' with segment-level breakdowns including Air Max's contribution is factually incorrect—Air Max did not have standalone or quantified financial reporting in either year. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is based on correct representation of financial disclosure practices. The LLM fabricates the idea of 'contribution' being disclosed, which constitutes a factual error. (3) The multi-hop reasoning fails: the original answer identifies a shift from passive listing (2022) to strategic emphasis without financial disclosure (2024). The LLM incorrectly infers that increased transparency includes financial metrics for Air Max, when in fact no such data was released. Additionally, the LLM introduces unsupported details like 'dedicated R&D', 'market-intelligence-driven design', and 'new Air-manufacturing subsidiary'—none present in the original answer—representing hallucinated content. (4) Despite these issues, the LLM correctly identifies the growing emphasis on Air Max as an innovation platform and contextualizes it within Nike's broader technology suite, which aligns with the original’s point about strategic positioning. This earns partial credit for contextual relevance and qualitative insight, though factual correctness is compromised by overstatement and fabrication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 502,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "\nFrom 2023 to 2024 the company kept overall capital spending roughly flat (≈ $8.2 billion in 2023 and essentially the same in 2024), but the mix shifted toward the theme‑park side.  In 2023 the $8.2 billion of Connectivity & Platforms capex included early‑stage spending on Epic Universe—primarily land acquisition and initial construction—while in 2024 the firm explicitly noted “increased spending on theme‑park attractions” and that a portion of that year’s capital budget was devoted to “the construction of Epic Universe,” indicating a move from land‑purchase to active attraction‑building as the development priority.  No separate dollar figure for Epic Universe is disclosed; the investment is embedded in the overall capex, which rose slightly in emphasis for theme‑park projects in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and assumptions that prevent a perfect score. (1) Quantitatively, the LLM correctly identifies the $8.2 billion capital expenditure figure for 2023 under Connectivity & Platforms, which matches the original answer. However, it incorrectly states that the 2024 capex was 'essentially the same' at $8.2 billion. The original answer does not provide a total capex figure for 2024, nor does it confirm that the amount was flat year-over-year; thus, this is an unsupported inference. While the lack of a specific Epic Universe dollar amount is correctly noted, the assertion of 'slightly increased emphasis' is interpretive but reasonable given the qualitative shift described. (2) The entity accuracy is strong: Comcast, Epic Universe, Universal theme parks, and the correct years (2023–2024) are all properly referenced. The categorization of spending shifting from land acquisition and initial construction (2023) to active attraction-building (2024) is a reasonable interpretation of the evolution in development priorities, consistent with the original answer’s description of a shift from infrastructure to guest experience. (3) The reasoning is sound for a multi-hop synthesis: the model infers a strategic shift based on changes in disclosed priorities, even without itemized figures. It correctly notes that Epic Universe spending is embedded in broader categories and not broken out separately in 2024. (4) Contextual relevance is excellent—the response directly addresses both investment amounts and thematic park development priorities across the two years. The only deduction is for the unsupported claim about 2024 total capex being flat, which introduces a small factual risk. Overall, the answer captures the core evolution accurately with appropriate caveats, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 515,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "\nIn the 2022 filing FedEx reported 6 ATR‑72 600F aircraft in its owned fleet (page 40). The 2023 10‑K shows that, as part of its purchase commitments, the company was scheduled to receive 11 ATR‑72 600Fs during fiscal 2023, which would have raised the in‑service count to roughly 17 aircraft, and it also projected additional deliveries of 6 in 2024 and 6 in 2025 (pages 115‑116). Consequently, utilization of the ATR‑72 600F grew from six aircraft at the end of 2022 to about 17 by the end of 2023, with a continued expansion of six‑aircraft increments in the following planning years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) It misrepresents the original data: the 2022 filing did not state that FedEx owned 6 ATR 72-600F aircraft; rather, it projected operating 11 in 2023, 6 in 2024, 6 in 2025, and 1 in 2026. The LLM incorrectly cites a 'fleet of 6' from page 40 as owned, but this misinterprets the context—those numbers refer to future projections, not current ownership. (2) The 2023 filing updated these projections to 7 for 2025 and 3 for 2026, but the LLM incorrectly claims continued expansion with '6-aircraft increments', which contradicts the downward revision. (3) The LLM falsely calculates an in-service count of 'roughly 17' by end of 2023, which is unsupported—the projection was 11 for 2023, not cumulative with prior. (4) The core of the question asks about evolution in *projections* between 2022 and 2023 filings for the same future periods; the LLM instead interprets it as actual fleet growth and delivery schedules, failing the multi-hop reasoning. (5) The ground truth emphasizes a *reduction* in planned utilization over time, while the LLM concludes the opposite—expansion. This fundamental reversal of the trend results in a very low correctness score. While the answer is relevant to the topic and cites plausible document pages, the factual and logical errors are severe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 376,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike moved from a relatively simple, aggregate “sales‑related reserve” that was disclosed only as a single balance‑sheet figure (‑$1.0 bn in 2022) to a more granular, estimate‑driven framework that explicitly breaks the variable consideration into (1) the most‑likely amount of revenue, (2) a separate estimate of the cost of inventory for expected returns, and (3) a detailed calculation based on historical return rates, specific outstanding returns and discretionary discounts.  The 2024 disclosure also notes that adjustments to the reserve are recorded in the period when actual returns, discounts or claims differ from the estimate, indicating a shift toward recognizing revenue net of variable consideration in real‑time rather than relying on a static reserve.  This evolution reflects Nike’s adoption of a more refined ASC 606‑compliant revenue‑recognition model that better matches revenue with the expected net amount to be received.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that Nike's product return reserve in fiscal 2022 was $269 million, recorded in Prepaid expenses and other current assets. However, the LLM claims a '$1.0 bn' sales-related reserve in 2022, which is both incorrect in amount and characterization—no such figure appears in the ground truth. Additionally, the LLM invents a breakdown of variable consideration into three components (most-likely amount, cost of inventory, and detailed calculation) that is not supported by the original answer. While the shift toward a 'most likely amount' approach in 2024 is correctly identified, the LLM overstates the granularity and structure of the new methodology. (2) The quantitative inaccuracy is severe: the $1.0 billion figure is more than triple the actual $269 million, and no source supports this number. The original answer does not mention a 'single balance-sheet figure' of -$1.0 bn or any such phrasing. Furthermore, the LLM incorrectly implies that the 2024 methodology includes historical return rates and discretionary discounts, which are not mentioned in the ground truth. (3) The reasoning partially captures the multi-hop evolution—moving from a disclosed dollar amount in 2022 to a more formalized estimation process in 2024—but adds unsupported details about real-time adjustments and a granular framework. The core insight about alignment with ASC 606 and estimating variable consideration is directionally correct but overstated. (4) Despite the incorrect numbers and fabricated details, the answer remains contextually relevant by addressing the evolution in Nike’s return reserve estimation and linking it to revenue recognition changes. Hence, contextual relevance is high, but correctness and quantitative accuracy are low due to major factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 508,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "\nThe 2022 commitment table lists 12 Cessna SkyCourier 408 deliveries for 2025 and 14 for 2026, with no scheduled deliveries beyond 2026. By the 2024 update the 2025 forecast had risen to 17 aircraft (an increase of five) while the 2026 figure remained at 14, and still no deliveries are planned after 2026. This upward revision shows that FedEx is increasingly counting on the SkyCourier 408 to modernize and expand its regional fleet, underscoring a strategic reliance on the model for future growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numbers and timeline. According to the ground truth, in 2022, FedEx (FDX) planned for 12 Cessna SkyCourier 408 aircraft by 2025 and intended to maintain that number through 2026. However, the LLM incorrectly states that the 2022 plan included 14 aircraft in 2026. The 2023 update correctly notes an increase to 17 for 2025 but fails to reflect the reduction to 14 by 2026—instead claiming the 14 figure was already in place in 2022 and remained unchanged. This misrepresents the shift: the ground truth shows an increase followed by a pullback, while the LLM implies only an increase with no decline. (2) The LLM references a '2024 update', which is not part of the question or ground truth (the comparison is between 2022 and 2023 plans); this introduces an incorrect reporting year. Additionally, the claim that 'no deliveries are planned after 2026' is not supported in the original answer and adds unsupported extrapolation. (3) The multi-hop reasoning is partially sound—linking changes in fleet projections to strategic reliance—but draws an incomplete conclusion. The ground truth emphasizes a short-term increase followed by a moderate decline, indicating strategic recalibration. The LLM instead concludes an ongoing strategic expansion, missing the nuance of reduced 2026 plans. (4) Scores reflect partial correctness: numbers are partially accurate (17 for 2025 is correct), but key details are wrong (2022 and 2026 figures), hurting quantitative accuracy. Qualitative reasoning is logical but based on flawed data. Contextual relevance is high as it addresses fleet changes and strategic implications, though with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 469,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "\nFrom 2023 to 2024 Mastercard expanded its real‑time account‑based payments platform from the 13 markets where it was fully operational in 2023 to a global footprint that now supports instant, account‑to‑account transfers across more than 180 markets and roughly 10 billion endpoints worldwide (2023 Doc p.13; 2024 Doc p.70‑74).  At the same time, the company deepened the platform’s security by embedding tokenization, AI‑driven fraud‑scoring and dynamic‑control tools such as InControl™, and by running a 24/7 distributed, peer‑to‑peer network that provides end‑to‑end encryption and real‑time monitoring of every transaction (2023 Doc p.12; 2024 Doc p.73‑74).  This combination of broader operational scale and tighter, multi‑layered security enables Mastercard to move larger volumes of real‑time payments while protecting both senders and receivers.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The original answer states that Mastercard was operating or implementing real-time payments in 13 markets in 2023, with expansion and enhancement in 2024. However, the LLM claims the platform expanded from 13 markets in 2023 to over 180 markets in 2024, which is not supported by the ground truth and represents a major overstatement. The ground truth does not mention '10 billion endpoints' or a 24/7 distributed peer-to-peer network with end-to-end encryption and real-time monitoring—these specific technical details and scale metrics are absent from the original. While the LLM correctly identifies key security features like tokenization and AI-driven fraud scoring (aligned with 'fraud scoring and tokenization in real time' in the original), it adds unverified capabilities such as InControl™ and dynamic-control tools without confirmation in the ground truth. The reasoning partially captures the evolution in scale and security but overreaches in both scope and technical detail. The answer is contextually relevant and addresses both operational scale and security, but the quantitative inaccuracies severely undermine factual correctness. Semantic equivalence fails on key metrics, and the multi-hop synthesis is flawed due to unsupported extrapolations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 376,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Nike trimmed the size of its foreign‑currency cash‑flow hedge program—from roughly **$18–19 billion of notional forwards and options in 2022** to about **$16 billion as of May 31 2024**—while still using forwards and options to lock in exchange rates up to 12‑24 months in advance and to hedge up to 100 % of the identified exposure.  The fair‑value of these derivatives is recorded as assets or liabilities on the balance sheet, and **deferred net gains of $607 million (2022) and $231 million (2024, net of tax) are held in accumulated other comprehensive income and are expected to be re‑classified to net income over the next 12 months**, directly impacting cost of sales and other income when the underlying transactions settle.  Thus, the hedging strategy has moved from a broader, more aggressive hedge book in 2022 to a tighter, more designated cash‑flow approach in 2024, with the same impact on financial liabilities through the AOCI reclassification mechanism.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The notional amounts cited ($18–19 billion in 2022, $16 billion in 2024) are not present in the original answer and contradict the ground truth, which does not mention notional values at all. The deferred net gains of $607 million (2022) and $231 million (2024) are entirely fabricated and do not appear in the original; the ground truth states a net gain of $8 million after tax in 2022 but provides no comparable figure for 2024. (2) Completeness: While the question asks about evolution in use of forwards and options and their impact on financial liabilities and hedging strategy, the LLM introduces details (notional size, AOCI balances, reclassification timing) absent from the source, failing to report the actual liability figures from 2024 ($110 million in accrued liabilities, $5 million in deferred taxes). (3) Entity Accuracy: The companies and financial instruments (forwards, options) are correctly identified, and the years (2022, 2024) are accurate. (4) Reasoning: The LLM attempts multi-hop reasoning by inferring a strategic shift, but it bases this on incorrect data. The conclusion about a 'tighter, more designated cash-flow approach' is unsupported by the ground truth, which only notes increased liabilities and a net gain in 2022. (5) Semantic Equivalence: The overall message diverges significantly—the original highlights changes in reported liabilities and a small net gain, while the LLM emphasizes a reduction in hedge program size and large AOCI balances. Despite relevant context (hedging up to 12–24 months, impact on income), the core financial facts are wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 472,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "\nPuffs continued to be listed under the “Family Care” sub‑category of the Baby, Feminine & Family Care segment in both 2022 and 2023. The only evolution was a restructuring of the segment’s internal categories— the 2023 filing dropped the separate “Baby Care” sub‑category, but Puffs remained classified within “Family Care.”",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Puffs remained in the 'Family Care' sub-category within the Baby, Feminine & Family Care segment in both 2022 and 2023, which aligns with the ground truth. There are no numeric inaccuracies, so quantitative accuracy is high. However, the key evolution described in the original answer—specifically, that 'Tissues' was explicitly listed in 2022 but replaced with a more general, consolidated reporting format in 2023 without sub-category breakdowns—is not accurately reflected. Instead, the LLM claims the 'Baby Care' sub-category was dropped in 2023, which may be true but is not the focus of the question about Puffs' classification evolution. This misrepresents the nature of the change: the shift was in reporting granularity for Family Care (specifically around Tissues), not the elimination of Baby Care. The reasoning is partially sound but fails the multi-hop synthesis by focusing on an adjacent change rather than the specific product category classification detail for Puffs. While contextually relevant and factually consistent in parts, the answer misses the core nuance of how Puffs' categorization context evolved—specifically the simplification of sub-category disclosures within Family Care. Thus, the correctness and qualitative accuracy scores are reduced due to this significant omission and redirection of the key change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 381,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Tampax stayed in the same place in P&G’s portfolio – it is still reported under the **Baby, Feminine & Family Care segment**, specifically within the **Feminine Care sub‑category** alongside the other feminine‑care brands (e.g., Always and Always Discreet).  No re‑classification or addition of new product lines occurred; its categorization and associated product lineup remained consistent across the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Tampax's categorization remained unchanged between 2022 and 2023. According to the ground truth, there was a meaningful repositioning: in 2022, Tampax was under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, but by 2023, it was specifically associated with 'Menstrual Care', reflecting a more focused positioning separate from general 'Family Care'. The LLM incorrectly states there was no reclassification or change in product lines, which contradicts the documented evolution. While the broader segment ('Baby, Feminine & Family Care') is correctly identified and no numerical inaccuracies are present (hence high quantitative accuracy), the failure to recognize and report the shift from 'Feminine Care' to 'Menstrual Care' represents a major qualitative error. This misrepresents the multi-hop insight about strategic repositioning, undermining the answer’s correctness. The response is contextually relevant in discussing Tampax’s portfolio placement but misses the key change the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 308,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "\nOracle’s Engineered Systems moved from a broad‑based hardware push to a more selective, cloud‑oriented focus between fiscal 2022 and fiscal 2023.  Constant‑currency hardware revenue slipped about 3‑5 % and its contribution to total margin fell from roughly 60 % to 59 %, reflecting a deliberate de‑emphasis on non‑strategic hardware products while still using engineered systems to support its cloud infrastructure.  At the same time, the company kept R&D spending on an upward trajectory—up about 5 % in constant currency to $5.6 bn (≈ 17 % of total revenue)— indicating continued investment to modernize its engineered‑system portfolio and align it with its cloud strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in fiscal 2023, hardware represented 6% of total revenues, but the LLM incorrectly claims hardware margin contribution fell from 60% to 59% and that constant-currency hardware revenue declined 3-5%, none of which appear in the original answer. There is no mention in the ground truth of margin percentages or revenue decline. Additionally, the LLM introduces a $5.6B R&D figure (17% of revenue), which is not present in the original; while Oracle did state it would continue R&D investment, no specific dollar amount or percentage was provided in the truth. (2) The quantitative inaccuracies are severe: none of the percentages (3-5% revenue decline, 60% to 59% margin, 5% R&D increase, $5.6B, 17%) are supported by the ground truth. These numbers are either fabricated or misattributed. (3) The reasoning partially captures a strategic shift—highlighting continued R&D and a cloud-aligned focus—which aligns with the 2023 emphasis on investment in new offerings. However, it fails the multi-hop requirement: the original does not compare margin contributions or revenue trends across years, nor does it provide R&D spending figures. The LLM invents a narrative of de-emphasis based on unsupported metrics. (4) Correctness is low due to major factual and numerical errors. Qualitative accuracy is slightly higher because the general direction of strategy (continued R&D, cloud alignment) is plausible, but not explicitly stated in the truth. Contextual relevance is moderate as the answer addresses strategy and investment, but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 451,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s non‑U.S. pension assets in private‑funds grew from $90 million to $115 million, with the portion classified as Level 3 rising from $36 million to $74 million while the Level 2 share fell from $54 million to $41 million; the amount measured at NAV (and thus excluded from the hierarchy) slipped only modestly from $10 million to $8 million. This shift shows a greater allocation to private‑fund investments and a re‑classification of most of that exposure into the lowest level of the fair‑value hierarchy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, Honeywell reported $1,105 million in private fund investments for its U.S. pension plans (Level 3), not non-U.S. plans. The LLM incorrectly claims $90 million in non-U.S. private fund investments in 2022, which is not supported by the ground truth. The ground truth does not provide a 2022 breakdown for non-U.S. plans at all, so the LLM's detailed figures ($36M Level 3, $54M Level 2, $10M NAV) are fabricated. In 2023, the correct figure is $115 million for non-U.S. plans, with $41M Level 2 and $74M Level 3, which the LLM correctly reports. However, the comparison is invalid because the 2022 data is wrong. (2) Quantitative accuracy fails because the 2022 numbers are entirely incorrect: $90M total (vs. no reported non-U.S. total in ground truth), $36M Level 3 (vs. no such data), $54M Level 2 (vs. no such data). The only correct numbers are the 2023 $115M total, $41M Level 2, and $74M Level 3. The LLM also introduces NAV amounts ($10M and $8M), which are not mentioned in the original answer and thus unsupported. (3) The multi-hop reasoning is flawed: the model assumes a 2022 non-U.S. breakdown exists and constructs a narrative of growth and reclassification, while the ground truth shows a shift from U.S. to non-U.S. plans and a large decrease in overall private fund exposure. The LLM misidentifies the direction of change (increase vs. significant decrease) and misattributes the data. (4) Contextual relevance is moderate because the answer discusses the right topic (private fund allocation in non-U.S. pension plans, fair value hierarchy levels) and correctly reports the 2023 figures, but the incorrect 2022 data and resulting erroneous conclusion severely undermine correctness. The qualitative reasoning is based on false premises, leading to an incorrect interpretation of trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 518,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the $1 billion, 3.375 % 2014 USD Notes—originally due in April 2024 and listed as short‑term debt on the 2023 balance sheet—reached maturity.  In 2024 the company let the notes mature and fully repaid the $1 billion principal (using cash on hand and proceeds from its newly issued 2024 USD Notes), thereby removing the 2014 series from the outstanding‑debt schedule.  The repayment is reflected in the 2024 maturity table ($1.338 bn due in 2024) and the firm continues to rely on its commercial‑paper program and revolving credit facility for liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor additional details not present in the original answer. (1) Quantitatively, all key facts are correct: the $1 billion principal amount, 3.375% interest rate (though not in the ground truth, not contradicted), maturity in April 2024, classification as short-term debt in 2023, and full repayment in 2024. The mention of 'using cash on hand and proceeds from its newly issued 2024 USD Notes' is plausible context but not confirmed in the ground truth; however, it does not contradict it. The reference to the $1.338 billion due in 2024 in the maturity table may include other obligations but is not inconsistent with the $1 billion repayment of the 2014 notes. (2) All numbers and dates match or are consistent with the ground truth. Format variations (e.g., $1 billion vs $1 billion) are acceptable. (3) The multi-hop reasoning is sound: the model correctly infers the transition from short-term debt in 2023 to full repayment in 2024, synthesizing status and action across years. (4) The answer is contextually excellent—directly addressing the evolution of the debt and specific 2024 actions. The only reason for not scoring 10 is the inclusion of slightly more detailed funding sources and a broader maturity figure ($1.338 bn) that, while not inaccurate, go beyond the verified ground truth. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 404,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s continued to disclose its standard Officer Indemnification Agreement (Exhibit 10.23) by reference in its annual reports, with the same wording and filing history (originally filed in 2019 and re‑referenced in the 2022 and 2024 10‑Ks). No new or substantially revised indemnification provision was introduced; instead, the company added updated claw‑back policies (Exhibits 97.1‑97.2) and a refreshed severance plan (Exhibit 10.28), indicating a modest expansion of executive‑risk oversight while preserving the core indemnification language for governance continuity.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in identifying the exhibit number as 10.23, while the ground truth confirms it is Exhibit 10.43. This misidentification undermines entity accuracy. Additionally, the claim that claw-back policies (Exhibits 97.1–97.2) and a refreshed severance plan (Exhibit 10.28) were added between 2022 and 2024 is not supported by the ground truth, which makes no mention of such changes—thus introducing unverified information. However, the core point that the indemnification agreement was unchanged and originally filed in 2019 is correct, as is the re-filing in 2022 and 2024. (2) Quantitatively, the years (2019, 2022, 2024) are accurate, and there are no numerical calculations to verify. The error lies in exhibit numbers and unconfirmed additions, not dates or amounts. (3) The multi-hop reasoning is partially sound—the model correctly infers stability in indemnification terms and links it to governance continuity—but it overreaches by suggesting an 'expansion of executive-risk oversight' based on unverified exhibit additions, which are not in the ground truth. This weakens the reasoning chain. (4) Despite the incorrect exhibit number and unsupported claims about new policies, the answer addresses the question’s intent regarding evolution and governance implications, maintaining contextual relevance. However, the factual inaccuracies significantly reduce correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 404,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "\nIn the 2022 filing Always Discreet was described as holding “about 15 % market share” in the adult‑incontinence sub‑category, positioned as a notable but secondary player behind the category leaders. By the 2023 filing that share had slipped to “over 10 %” in the key markets, indicating a modest erosion of its position and a weaker competitive standing within the adult‑incontinence segment, even though the brand remains part of the broader Baby, Feminine & Family Care business that is still a global market‑leader in feminine care overall.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in the 2022 filing, Always Discreet had 'over 10% market share,' but the LLM incorrectly claims it was 'about 15%.' Additionally, the 2023 filing does not provide any updated market share figure—contrary to the LLM's claim that it 'slipped to over 10%,' which falsely implies both a specific number and a decline. No such comparative data exists in the 2023 filing. (2) Quantitative accuracy is low because the percentages cited (15% and 'slipped to over 10%') are not supported by the original documents. There is no evidence of a decline, nor a precise 15% figure in 2022. The model fabricates a trend that isn't present. (3) The multi-hop reasoning is flawed: while the model correctly identifies Always Discreet as part of the Baby, Feminine & Family Care segment in both years, it incorrectly infers a performance decline due to a change in disclosure language. The original answer correctly interprets the absence of a market share figure in 2023 as a shift in communication, not a performance change. The LLM overinterprets and introduces unsupported conclusions. (4) Contextual relevance is moderate because the answer addresses the right brand, category, and time frame, and attempts to analyze positioning changes. However, the core conclusion about market share erosion is incorrect, severely undermining factual reliability. The answer would be more accurate if it noted the presence of a disclosed share in 2022 and its omission in 2023, without assuming a trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 433,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Oracle reframed Engineered Systems from a stand‑alone hardware line‑up into the “hardware foundation” of its cloud strategy—emphasizing that Exadata, SPARC and storage platforms are now sold primarily as pre‑integrated engines that run Oracle Cloud Infrastructure, Autonomous Database and Cloud@Customer, and can be deployed on‑premise, in OCI or as a hybrid cloud.  This shift reinforces the cloud‑transformation narrative by tying hardware sales to cloud consumption (lower‑margin, support‑contract‑driven revenue) and by positioning Engineered Systems as the differentiated, secure substrate that enables customers to move and expand workloads onto Oracle’s cloud services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Oracle's strategic positioning of Engineered Systems between 2022 and 2023. (1) It correctly identifies the shift from standalone hardware to a 'hardware foundation' for Oracle's cloud strategy, aligning with the ground truth's emphasis on tighter integration with cloud services like OCI, Autonomous Database, and Cloud@Customer. The role in hybrid and on-premise deployments is accurately described. (2) Quantitatively, the LLM does not introduce any incorrect numbers or misstate fiscal years. While it omits the specific figure that hardware revenues (including Engineered Systems) represented 6% of total revenue in fiscal 2023 and 2024—mentioned in the ground truth—this is a minor omission rather than an error. No calculations are required, and all referenced fiscal periods (2022–2023) are accurate. (3) The multi-hop reasoning is sound: the model synthesizes the technical integration of Engineered Systems with cloud offerings and infers their strategic role in supporting cloud transformation, including the business model shift toward support-driven, lower-margin revenue. However, it does not explicitly mention the broader hardware business expansion (to include servers, storage, OS) or the accounting treatment as combined performance obligations, which are key elements in the ground truth. It also omits mention of ongoing R&D investments. (4) Despite these omissions, the answer remains contextually rich and highly relevant, effectively conveying the strategic repositioning. The semantic meaning aligns closely with the original answer, just with less detail on financials and organizational accounting. Hence, a high score is warranted, but not perfect due to missing key specifics from the 2023 update.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 485,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "\nThe 2022 10‑K explicitly described the 2020 Stock Plan as “the successor to the 2011 Stock Plan” and noted that 5,530,106 shares remaining under the 2011 plan were available for grant under the new plan. In the 2023 10‑K that language was dropped; the filing simply states that the 2020 Plan was approved and outlines its award types and current share‑reserve figures, without referring to it as the successor to the 2011 plan. Thus the disclosure shifted from an explicit “successor” wording in 2022 to a more current, activity‑focused description in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 10-K included the carry-forward of 5,530,106 shares from the 2011 Stock Plan to the 2020 Stock Plan, and this detail was omitted in the 2023 10-K. The number 5,530,106 is correctly stated, and the years (2022 and 2023) are accurate. (2) Quantitative accuracy is perfect—no calculations were required, but the numeric value is precisely reported with no formatting issues. (3) The reasoning is sound: the LLM correctly identifies the shift in disclosure tone—from explicitly labeling the 2020 Plan as the 'successor' in 2022 to a more current, standalone description in 2023. While the original answer does not use the word 'successor,' the LLM’s inclusion of this term is a reasonable interpretation of the relationship implied by the share carry-forward, and it does not distort the factual evolution. (4) The answer is contextually relevant, directly addressing how the disclosure evolved between the two filings. The only minor deviation from the original answer is the use of 'successor' language not explicitly present in the ground truth, but this is a semantically reasonable inference. Thus, the answer is factually correct and complete, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 381,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s private‑fund exposure in its U.S. pension portfolio grew only modestly – direct private‑investment holdings rose from **$1.284 bn to $1.293 bn** and private‑fund assets measured at NAV increased from **$1.258 bn to $1.265 bn**, moving the “other‑types” allocation from roughly **7.5 % to about 7.6 % of total plan assets**, still within the 10‑20 % target range but edging higher.  \nThis slight uptick indicates that the company is deliberately maintaining – and modestly expanding – its allocation to alternative, long‑horizon investments, reflecting a capital‑deployment priority focused on generating higher, inflation‑linked returns while preserving portfolio diversification and funding stability for future pension obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Honeywell's investment in private funds was $1,244 million in 2022 and $1,265 million in 2023. However, the LLM reports private-fund assets at NAV increasing from $1.258 billion to $1.265 billion and direct private-investment holdings from $1.284 billion to $1.293 billion — none of which match the ground truth figures. The $1.244 billion figure for 2022 is entirely missing or mischaracterized. The reported increase from $1.258B to $1.265B implies a much smaller base and different starting point, leading to incorrect analysis. (2) The calculation of the percentage of total plan assets (7.5% to 7.6%) is not supported by the ground truth, which does not provide total plan asset figures or such percentages. The mention of a '10-20% target range' is extraneous and unverified in the provided truth. (3) While the LLM attempts multi-hop reasoning by interpreting strategic intent behind allocation changes, it does so using incorrect base data. The qualitative insight — that Honeywell is maintaining or modestly expanding exposure to alternatives for diversification and return — aligns semantically with the ground truth’s interpretation, earning partial credit. (4) Contextually, the answer addresses the evolution and strategic implication as asked, but the factual foundation is flawed. The correctness score is low due to major numerical errors, though not completely wrong since the direction of change (slight increase) and strategic interpretation are plausible. Quantitative accuracy is severely penalized due to incorrect inputs and unsupported calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 459,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the Company moved from a situation in which **no Class B‑2 common shares were outstanding** (the 2023 tables show a “‑” for both shares and EPS) to issuing and reporting **49 million Class B‑2 shares** in its 2024 filings.  The shares were created as part of the **Class B‑1 common‑stock exchange offer** completed in May 2024, under which tendered Class B‑1 shares were retired and replaced with newly issued Class B‑2 (and Class C) shares; the newly‑issued Class B‑2 shares are convertible into Class A common stock, participate in dividends on an as‑converted basis, and their conversion rate is adjusted downward when the U.S. litigation escrow account is funded or when covered litigation is resolved.  Consequently, the 2024 disclosures now list Class B‑2 as an outstanding class with a disclosed share count, conversion mechanics, and related equity‑impact disclosures that were absent in the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) Quantitatively, it claims that 49 million Class B-2 shares were issued in 2024 and that no Class B-2 shares were outstanding in 2023, which directly contradicts the ground truth: the original answer states that no Class B-2 shares were outstanding *prior to* the Class B-1 exchange offer (consistent with 2023), but crucially, the 2024 filing did *not* report any outstanding Class B-2 shares or disclose a new issuance—instead, it only referenced the historical lack of outstanding shares. The LLM invents a specific figure of '49 million Class B-2 shares' with no basis in the ground truth. (2) The claim that the Class B-1 exchange offer was 'completed in May 2024' and resulted in newly issued Class B-2 shares is unsupported; the original answer indicates no such update occurred in 2024 and that disclosures were absent. (3) Qualitatively, the LLM misrepresents the evolution: it asserts active issuance and new disclosures in 2024, while the ground truth emphasizes a *lack* of updates and suggests reduced emphasis or potential discontinuation. The LLM incorrectly infers that because Class B-2 was mentioned in relation to the exchange offer, it must have been issued, failing to recognize that the 2024 filing only reiterated prior context without confirming any new outstanding status. (4) Contextually, the answer addresses the right topic (Class B-2 stock evolution) and mentions relevant mechanisms like conversion tied to litigation escrow, but the core narrative is inverted: instead of correctly identifying a reduction in disclosure, it fabricates an expansion. This represents a major failure in multi-hop reasoning and factual grounding, warranting a low correctness score despite some relevant terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 489,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "\nBetween fiscal 2022 (ended January 29 2022) and fiscal 2024 (ended February 1 2025) the liability tied to the Target Circle loyalty program dropped sharply—from roughly **$89 million** of deferred revenue in 2022 to only **$19 million** by the end of 2024.  This reduction shows that the company is now recognizing the promised rewards more quickly (or that fewer rewards remain outstanding), indicating that the Target Circle program has evolved from a largely deferred‑revenue model toward a more immediate‑recognition/redemption structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both timing and values. It incorrectly states that the deferred revenue dropped from $89 million in 2022 to $19 million by the end of 2024, skipping the key intermediate data point of $117 million as of February 3, 2024. This omission misrepresents the trend—deferred revenue actually increased from $89M to $117M before dropping to $19M by February 1, 2025. The LLM conflates fiscal 2024 (ending February 3, 2024) with the end of the 2024 fiscal year (which is February 1, 2025), leading to incorrect temporal alignment. (2) The numbers themselves—$89M and $19M—are correct but applied to wrong time points. The $117M figure for 2024 is entirely omitted, which is a critical error in quantitative accuracy. The claim that liability 'dropped sharply' between 2022 and 2024 is false—the actual change during that period was an increase. (3) The reasoning is partially sound in interpreting the drop to $19M as a shift toward immediate recognition or higher redemptions, but it fails the multi-hop requirement by not acknowledging the intermediate growth in liability. The synthesis across years is incomplete and misleading. (4) Contextual relevance is high because the answer addresses the Target Circle program, deferred revenue, and program evolution. However, due to major factual and temporal errors, the correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 398,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "\nThe 4.375 % Senior Notes were valued at **$980 million** on December 31 2022 and rose to **$996 million** on December 31 2023 – an increase of roughly **$16 million (about 1.6 %)**. This modest uptick suggests that investors viewed Netflix’s credit as slightly less risky or that broader market yields shifted in a way that made the notes more attractive, though the price still traded below par, indicating continued caution.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states the fair value of Netflix's 4.375% Senior Notes *increased* from $980 million to $996 million, but the ground truth states it *decreased* from $980 million to $996 million. This is a direct contradiction — an increase cannot be correct if the value decreased. Despite using the same numbers, the direction of change is reversed, which fundamentally alters the interpretation. (2) The numbers themselves ($980 million and $996 million) and dates (December 31, 2022, and December 31, 2023) are correctly cited, and the $16 million difference is accurate. However, the percentage change is miscalculated: a rise from $980M to $996M is about a 1.63% increase, which the model approximates correctly as 1.6%, but since the actual change was a *decrease*, this calculation is applied to the wrong directional movement. (3) The multi-hop reasoning is partially sound — the model attempts to interpret market implications based on fair value changes — but the conclusion is invalid due to the incorrect direction of change. The original answer notes the value moved *closer to par*, which implies an increase in value if it was below par, but the LLM incorrectly frames an increase as a sign of reduced risk without confirming the par relationship, and contradicts the ground truth by calling it an 'uptick' when it should be a decrease. (4) The contextual relevance is high — the answer addresses both parts of the question (change in fair value and investor perception) and uses appropriate financial reasoning. However, the qualitative accuracy is reduced due to flawed logic stemming from the quantitative error. The correctness score is low because the core fact — direction of change — is wrong, which undermines the entire analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 490,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the number of Visa’s Class C shares rose from 10 million (the weighted‑average shares shown for 2023) to about 16 million (the weighted‑average shares shown for 2024) – an increase of roughly 6 million shares.  This growth was driven primarily by the May 2024 exchange offer in which Visa accepted 241 million Class B‑1 shares and issued ≈ 48 million new Class C shares to those participants (see page 40).  The Class C securities remain classified as a separate series of common stock with no established public trading market, and their equity classification was unchanged; the higher share count is reflected in the 2024 EPS figures (basic $38.97 and diluted $38.92) reported on page 59.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, Visa issued approximately 48 million Class C shares in exchange for 241 million Class B-1 shares. However, the LLM incorrectly states that this exchange occurred in May 2024, reversing the timeline. Furthermore, the ground truth explicitly states that by 2024, only 10 shares of Class C common stock were issued and outstanding — not millions. The LLM’s claim of 10 million shares in 2023 and 16 million in 2024 is entirely incorrect and contradicts the original data. (2) Quantitative accuracy is very low: the numbers (10 million, 16 million, 6 million increase) are fabricated and do not appear in the source. The 48 million Class C shares were issued in 2023, not 2024, and the final balance is 10 shares, not millions. The EPS figures cited ($38.97, $38.92) and page references (40, 59) are unverifiable and likely hallucinated. (3) The reasoning is flawed: the model fails to correctly synthesize the multi-hop information — it misattributes the timing of the exchange, invents share counts, and misses the key point that Class C shares were effectively retired or stabilized at 10 shares by 2024. It incorrectly implies ongoing issuance when the truth indicates conclusion of restructuring. (4) Contextual relevance is moderate because the answer addresses equity structure, share issuance, and classification as asked, but the factual foundation is so compromised that the response is misleading. The classification detail (no public trading market) is plausible but does not redeem the core inaccuracies. Scores reflect major factual and quantitative errors despite attempting the right topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 467,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "\nLowe’s has continued to list Rough Plumbing under its Building‑Products category, but between 2022 and 2024 the company moved it from a stand‑alone product line to a service‑centric offering.  The 2024 disclosures emphasize installation services, protection‑plan coverage, and a remote “central‑selling” team that lets customers complete contracts online—showing a deeper, integrated engagement with Rough Plumbing beyond simply selling the merchandise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Rough Plumbing was initially a product under the 'Building Products' category in 2022 and evolved into a service-oriented offering by 2024, incorporating installation services and protection plans—matching the original answer's core claim. The mention of a 'remote central-selling team' and online contract completion adds contextual detail consistent with a deeper service integration, supporting the qualitative shift. All entities (Lowe's, Rough Plumbing, time frame 2022–2024) and classifications are correct. There are no numeric inaccuracies; while the original answer includes a specific quantitative point (approximately 5% of total sales attributed to installed sales in 2024), the LLM answer omits this percentage. This is a minor omission affecting completeness but does not detract from the overall correctness of the evolution described. The reasoning is sound and reflects proper multi-hop synthesis—connecting changes in business classification and service offerings over time. The answer is semantically equivalent in substance, though slightly less complete due to the missing 5% figure. Hence, a high score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to strong but not fully comprehensive reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 391,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Visa created a new Class B‑2 common‑stock class as part of its B‑1 exchange offer (see page 59 – Class B‑2 EPS appears only in 2024 and 49 million weighted‑average shares are reported; page 61 shows total B‑1 + B‑2 shares outstanding falling from 245 million in 2023 to 125 million in 2024). The exchange retired a large block of B‑1 shares and issued roughly 120 million B‑2 shares (and 48 million C shares), giving the company a distinct second‑class of shares that now figures in its capital‑structure tables. This restructuring reduces the overall B‑class share count, removes transfer restrictions on the retired B‑1 shares, and provides a new class that can be converted to Class A stock, indicating that Visa is reshaping its dual‑class capital structure to better manage litigation‑related escrow and future equity‑based incentives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that 77 million Class B-2 shares were introduced in 2023, but the LLM claims approximately 120 million B-2 shares were issued and references 49 million weighted-average shares in 2024—numbers that do not align with the original answer. There is no mention in the ground truth of C shares or a B-1 exchange offer issuing B-2 shares; instead, the original answer states that no B-2 shares were outstanding prior to the B-1 exchange offer in 2024, implying they may have been eliminated or restructured, not newly created as part of it. (2) The LLM incorrectly asserts that Class B-2 EPS appears only in 2024 and cites page references and share count changes (245M to 125M) that are not corroborated by the ground truth. The calculation of ~120 million B-2 shares issued is unsupported and contradicts the original answer’s indication that B-2 shares were no longer outstanding by 2024. (3) The multi-hop reasoning is flawed: the LLM infers the creation of B-2 shares as part of an exchange offer, while the ground truth suggests a reversal—B-2 shares existed in 2023 but were absent before the 2024 exchange, indicating retirement or replacement. This misrepresents the evolution and strategic implication. (4) Despite these errors, the LLM correctly identifies a capital structure shift involving Class B shares and attempts to interpret the strategic rationale, showing some contextual understanding. Hence, contextual relevance is moderate to high, but correctness and quantitative accuracy are low due to unsupported numbers and reversed timeline logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 462,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "\nThe accrued liability for the Target Circle program was $117 million as of February 3 2024 and fell to $19 million by February 1 2025 – a reduction of roughly 84 %.  This sharp decline indicates that the program’s financial obligations have been markedly trimmed, suggesting that Target has scaled back or restructured the Circle rewards mechanism rather than continuing to expand it.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that no liability was disclosed in 2022 and that deferred revenue reached $117 million by February 3, 2024, indicating growth. The LLM incorrectly claims an accrued liability of $117 million in 2024 and a drop to $19 million in 2025, which is not supported by the original answer and introduces a future date (2025) not mentioned in the question or ground truth. (2) Quantitative inaccuracies are severe: the $19 million figure and 84% decline are entirely fabricated. The original answer reports only a $117 million deferred revenue as of early 2024 with no subsequent reduction. (3) The multi-hop reasoning is flawed—the LLM fails to recognize that the emergence of a $117 million liability where none was previously reported indicates program growth, not contraction. Instead, it invents a narrative of downsizing based on false data. (4) Contextual relevance is low because the answer addresses the general topic (Target Circle financials) but misrepresents the trend and underlying facts. The conclusion about scaling back contradicts the ground truth's indication of expansion. Scores are low due to complete factual inaccuracy, especially in numbers and temporal data, and flawed reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 365,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, NVIDIA’s discussion of environmental risk shifted from a broad reference to climate‑related uncertainties to an explicit warning that new or proposed **pollution‑limit regulations** (such as emissions caps and carbon‑tax rules) could raise operating costs and **restrict the ability of data‑center customers to expand**.  This heightened focus signals that the company now sees pollution‑limit rules as a concrete regulatory hurdle that could affect its operations and the growth of its data‑center customer base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in NVDA's risk disclosure between 2023 and 2024. It correctly identifies the shift from general climate-related cost concerns in 2023 to a more specific warning in 2024 about pollution-limit regulations (e.g., emissions caps, carbon taxes) affecting both NVDA's operations and, critically, its customers' ability to expand data centers. The answer reflects the multi-hop synthesis required: connecting regulatory changes (pollution limits) to operational costs (compliance, energy) and then to downstream demand risk via customer constraints (land, permitting for data centers). All entities (NVDA, data-center customers, pollution-limit regulations) and timeframes (2023 to 2024) are correct. There are no numerical inaccuracies—this is a qualitative risk assessment, so no specific numbers are involved, but the characterization of the risk evolution is factually sound. The only minor shortcoming is that the original answer notes NVDA's 2023 concerns already included impacts on manufacturing and supply chain, which the LLM answer does not explicitly mention, though it does reference operating costs. This omission slightly reduces completeness but does not undermine the central point about growing concern over customer expansion constraints. Overall, the LLM answer is semantically equivalent in intent and meaning, with strong reasoning and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 396,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s Guaranteed Senior Notes grew primarily through a $500 issuance by its Japanese subsidiary in November 2023 (four notes with fixed rates of 1.400 %– 2.120 % and maturities 2033‑2043), which was recorded at **Level 3** fair‑value input (discounted cash‑flow valuation). In July 2024 the subsidiary repaid $77 of those notes, leaving a net carrying balance of **$919** in 2024 versus **$484** in 2023; the overall fair‑value of the long‑term debt (including the Guaranteed Senior Notes) was reported as roughly **$5.4 billion** in 2024 versus **$5.74 billion** in 2023. Thus, the notes were added at Level 3 valuation, partially reduced by a modest repayment, and remained classified as Level 3 measurements in subsequent reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $500 issuance in 2023 by the Japanese subsidiary, the fixed interest rate range (1.400%–2.120%), the Level 3 fair value input, and the $77 repayment in 2024. It also correctly reports the overall fair value of long-term debt decreasing from $5.74 billion (approx. $5,738 million) in 2023 to $5.4 billion (approx. $5,412 million) in 2024. However, it introduces a critical error by stating the net carrying balance of the Guaranteed Senior Notes was $919 in 2024 versus $484 in 2023 — these figures are not supported by the ground truth and appear fabricated or miscalculated. The original answer does not provide carrying balances for the Guaranteed Senior Notes specifically, only the total long-term debt fair value. (2) The dates (November 2023 issuance, July 2024 repayment) are plausible but not specified in the ground truth, so their inclusion adds detail beyond the source and cannot be verified — this introduces potential inaccuracy. The fair value figures ($5.4B and $5.74B) are acceptably close to the true values ($5,412M and $5,738M), so minor rounding is acceptable. However, the carrying balances ($919 vs $484) are quantitatively wrong and not derivable from the given data. (3) The multi-hop reasoning is partially sound: the model connects issuance, repayment, and fair value changes across years and correctly attributes Level 3 inputs. But it incorrectly infers or calculates carrying amounts for the Guaranteed Senior Notes, which undermines quantitative accuracy. (4) The contextual relevance is high — the answer addresses issuance, repayment, fair value inputs, and valuation trends. The qualitative reasoning is logical and well-structured, but the inclusion of unsupported numerical figures significantly reduces factual correctness. Hence, correctness is penalized heavily for false precision, though core facts (issuance, repayment, fair value trend, Level 3) are mostly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 529,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "\nFrom 2022 to 2024 Netflix stepped up its spending on streaming‑service upgrades—technology‑and‑development costs jumped ≈ 24 % and content‑amortization expanded—while simultaneously building a more formal cybersecurity function; the 2022 filing notes the appointment of a Vice President of Security and Privacy Engineering and board‑level risk oversight, and the 2024 filing shows that this role now receives regular external audits, bug‑bounty programs and a dedicated enterprise‑risk assessment.  Personnel‑wise, the company continued to stress the importance of its Co‑CEOs and senior technology/security leaders, while highlighting succession planning and the recruitment of skilled cybersecurity talent, shifting the risk profile from pure capital investment to heightened cyber‑risk and talent‑retention exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces unverified data not present in the ground truth. While the general direction of evolution—from personnel investment to cybersecurity focus—is correctly identified, specific quantitative claims are unsupported. The 24% increase in technology-and-development costs and expanded content amortization are not mentioned in the original answer and cannot be verified against the provided ground truth. The $384 million personnel cost increase from 2022 is omitted entirely, which is a key quantitative anchor in the original answer. (2) The mention of a 'Vice President of Security and Privacy Engineering' appointment in 2022 and 'regular external audits, bug-bounty programs, dedicated enterprise-risk assessment' in 2024 adds detail not present in the ground truth. While plausible, these specifics were not disclosed in the knowledge graph and represent hallucination or over-inference. The original answer emphasizes general cybersecurity program development and risk disclosures, not specific roles or programs. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift from growth-focused investment (personnel) to risk management (cybersecurity). It connects personnel and security themes across years, but fails to accurately ground this in the disclosed financial figure ($384M) and instead substitutes unsupported metrics. The evolution in risk exposure—toward cyber and talent retention—is thematically aligned but not explicitly detailed in the original. (4) Correctness is scored at 5 due to partial factual alignment but significant quantitative and detail-level inaccuracies. Quantitative accuracy is low (3) because key numbers are missing or invented. Qualitative accuracy is moderate (6) as the thematic shift is recognized, but with overreach in specifics. Contextual relevance is high (8) because the answer addresses the core evolution in investment and risk exposure as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 539,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "\nThe 2023 filing introduced the company’s then‑current “2023 Form of Restricted Stock Unit Agreement” (Exhibit 10.24), and the 2024 filing replaced it with an updated “2024 Form of Restricted Stock Unit Agreement” (Exhibit 10.26) that revises vesting schedules, adds performance‑based conditions and other language to better align equity payouts with long‑term shareholder value. This progression shows a deliberate lifecycle‑management approach—periodically refreshing the RSU agreement to tighten the link between executive compensation and performance metrics and to keep the equity component consistent with evolving compensation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key details from the original answer. (1) It incorrectly states that the '2023 Form of Restricted Stock Unit Agreement' was introduced in the 2023 filing and then replaced by a '2024 Form' in the 2024 filing. However, the ground truth indicates that the '2024 Form' was introduced in the 2023 filing ('Filed herewith') and then carried forward as 'Previously filed' in the 2024 filing, with the '2025 Form' being newly filed in 2024. This misalignment in dates and filing status is a critical error. (2) The LLM invents specific changes to the agreement—such as revised vesting schedules and performance-based conditions—that are not mentioned or supported in the original answer. The ground truth focuses on the procedural lifecycle (newly filed vs. previously filed) and the pattern of annual updates, not on substantive changes to terms. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution of document status across filings (a core aspect of the question) and instead fabricates content-level changes. (4) While the general theme of 'proactive lifecycle management' and alignment with compensation strategy is contextually relevant and somewhat aligned with the original conclusion, the factual foundation is incorrect. The answer is semantically dissimilar due to invented details and incorrect timing. Quantitative accuracy is very low due to wrong years and non-existent exhibit changes. Qualitative accuracy suffers from incorrect entity relationships and reasoning. Contextual relevance is moderate because the topic and strategic interpretation are in the right domain, but the specifics are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 465,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "\nThe $750 million 4.90 % senior notes were issued in November 2023 with a maturity of April 15 2029 (they carry a $3.4 million discount).  Their net carrying amount increased modestly from $743 million at the end of fiscal 2023 (January 28 2024) to $744 million at the end of fiscal 2024 (February 2 2025), reflecting the ongoing amortization of the discount and accrued interest.  The notes remain unsecured, semi‑annual‑interest obligations that cannot be redeemed before maturity except under the standard change‑of‑control or optional‑redemption provisions, so their maturity timeline stays fixed at 2029.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly states the initial principal amount ($750 million), issuance date (November 2023), maturity date (April 15, 2029), and discount ($3.4 million), it incorrectly claims the carrying amount increased from $743 million to $744 million by the end of fiscal 2024. The ground truth states the carrying amount was $743 million as of January 28, 2024 (end of fiscal 2023), and does not provide a figure for 2024 beyond confirming the notes remained outstanding. The LLM fabricates a $744 million value for 2024, which is unsupported. Additionally, the ground truth indicates the carrying amount slightly decreased due to amortization, not increased. (2) The dates are mostly correct: issuance in November 2023 and maturity in April 2029 match. However, the LLM misrepresents the direction of the carrying amount change. The fiscal year-end dates (January 28, 2024, and February 2, 2025) are plausible but not confirmed in the ground truth. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the notes as outstanding and recognizes amortization effects—but incorrectly infers an increase in carrying amount, which contradicts the expected accounting treatment (initial discount amortization typically increases carrying amount toward par, but the ground truth says it 'slightly decreased', which may reflect timing or reporting nuance; however, LLM's specific $744M figure is unsupported). (4) The contextual relevance is high—the answer addresses structure, carrying amount, maturity timeline, and interest terms. However, the incorrect quantitative claim about the 2024 carrying amount significantly undermines factual correctness. The qualitative reasoning is reasonable but flawed in conclusion. Thus, correctness is scored at 5 due to major quantitative error despite correct identification of most structural elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 529,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "\nBetween November 2023 and July 2024 the Japanese subsidiary issued roughly $500 of Guaranteed Senior Notes—four fixed‑rate notes maturing between 2033 and 2043 with coupons of 1.400% to 2.120%—and then repaid $77 of those notes in July 2024, leaving the balance of the issuance still outstanding as part of long‑term debt. This issuance marked the first time the subsidiary accessed capital through Guaranteed Senior Notes, and the subsequent partial repayment reduced the outstanding amount but did not eliminate the debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $500 issuance amount and $77 repayment are correct, as are the interest rates (1.400% to 2.120%). The original answer does not specify exact issuance dates or maturities, but the LLM adds plausible details (issuance between November 2023 and July 2024, maturities 2033–2043) that do not contradict the ground truth and may reflect additional context from the filing. The $77 repayment in July 2024 is consistent with the original. (2) The LLM correctly identifies the Japanese subsidiary’s issuance and partial repayment, and correctly frames the issuance as a financing activity (implied by the original’s mention of proceeds in 2024 filing). (3) Multi-hop reasoning is sound: it synthesizes issuance in 2023 and repayment in 2024, and infers that the remaining balance is still outstanding—logical and consistent with long-term debt treatment. (4) The only minor deviation is the claim that this was the 'first time' the subsidiary accessed capital via Guaranteed Senior Notes, which is not stated in the ground truth and thus a slight overinference. However, this does not materially affect correctness. Overall, the answer is factually solid, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 357,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "\nThe company continues to disclose that competitors can introduce after‑market parts and services for its products—a risk that is listed among its core competitive and technological‑innovation concerns in both the 2022 and 2023 Form 10‑K filings.  While the language is essentially the same in the two years, the 2023 filing reiterates that such after‑market offerings could “detract from our sales” and thereby negatively affect revenue and profitability, but it does not indicate that the risk has grown materially; it remains a consistent, though not quantified, threat to the business and its financial statements.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative shift in how DHR framed the risk of competitors developing after-market parts from 2022 to 2023, which is central to the question. While it correctly notes that the risk was mentioned in both years and could 'detract from our sales,' it inaccurately states that 'the language is essentially the same,' which contradicts the ground truth. In reality, the 2023 filing reframed the risk as being 'Impacted By' broader industry pressures (e.g., cost containment, managed care pricing), embedding it within a wider context rather than presenting it as a direct, standalone threat as in 2022. This evolution in framing—indicating a relative de-emphasis or strategic recalibration—is a critical nuance that the LLM fails to capture. There are no numerical inaccuracies (hence high quantitative accuracy), and the entities (DHR, 2022, 2023, Form 10-K) are correct. The answer is contextually relevant and addresses the financial impact (revenue and profitability), but the reasoning is flawed in its assessment of the change over time, failing the multi-hop synthesis required to compare the qualitative evolution of risk disclosure across years. Thus, while factually consistent in parts, it lacks the depth of comparative analysis needed for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 365,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix moved from a single‑price, three‑tier structure to a more granular, region‑specific pricing model that introduced an ad‑supported, lower‑cost tier and raised the rates on its standard and premium plans.  The company also added new service features—such as games, live programming and enhanced recommendation technology—to broaden the value proposition.  These changes were intended to slow the slowdown in paid‑membership growth, lift average revenue per user to offset rising content costs, and keep Netflix competitive against new streaming rivals and piracy.  (See NFLX‑10K 2022 pp. 22, 23, 24; NFLX‑10K 2024 pp. 4‑8.)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in Netflix's membership plans from 2022 to 2024, including the introduction of an ad-supported tier and pricing adjustments, which aligns with the ground truth. It correctly identifies business challenges such as slowing membership growth and competition. However, it introduces elements not present in the original answer: specifically, the mention of 'games, live programming, and enhanced recommendation technology' as new service features is not supported in the ground truth, which only references enforcement of terms of use and the ad-tier introduction. (2) Quantitative accuracy is partially compromised: while the ground truth provides specific figures (19% revenue increase, 11% membership growth, 7% rise in ARPU, 50% drop in net additions), the LLM omits these entirely and instead makes general claims without citing numbers. This is a significant omission, especially since the original answer relies on precise metrics to establish the business context. The LLM does not verify or reflect the calculation logic (e.g., revenue growth driven by membership and ARPU increases), reducing quantitative fidelity. (3) The multi-hop reasoning is generally sound—linking pricing changes to business challenges like competition and member retention—but overreaches by adding unmentioned features and strategies not in the source. The citation of 10-K pages adds apparent credibility but cannot compensate for unsupported content. (4) Despite these issues, the answer remains contextually relevant and semantically close to the original intent, earning high marks for qualitative reasoning and relevance. The correctness score is 7 due to accurate core narrative but missing key data points and addition of unsupported features.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 486,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "\nBoeing continues to record the present‑value of in‑orbit incentive fees as revenue during the construction of a satellite, but the 2023 filing makes clear that such payments are **contingent on the spacecraft meeting performance specifications for up to 15 years after acceptance** – if the satellite under‑performs, the company may be required to refund the incentive and take a material charge.  The 2023 discussion also notes that the **risk exposure has widened** as more development programs (e.g., Commercial Crew, KC‑46A, VC‑25B and satellite contracts) now include in‑orbit incentives, leading to larger potential reach‑forward losses and greater earnings volatility.  Consequently, while the accounting treatment (recognizing revenue in the construction period) has not changed, the **financial risk and the possibility of future charge‑backs have been emphasized as more significant in 2023**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Boeing's approach to in-orbit incentive payments between 2022 and 2023. (1) It correctly identifies the key qualitative shift: while Boeing maintained its accounting practice of recognizing the net present value of in-orbit incentive fees during construction, the 2023 filing emphasized heightened risk exposure due to long-term performance contingencies (up to 15 years post-acceptance). This aligns with the ground truth’s emphasis on increased financial recognition risks. (2) Regarding quantitative accuracy, the LLM answer does not include the specific $1,585 million loss figure mentioned in the original answer. This is a minor omission—while the magnitude of losses is a key data point in the ground truth, the LLM conveys the concept of 'larger potential reach-forward losses' and 'material charge' which reflects the spirit of the quantification. However, the absence of the exact number prevents a perfect score. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 vs 2023), identifies continuity in accounting treatment, and correctly infers an escalation in risk disclosure and financial exposure. Programs like Commercial Crew, KC-46A, and VC-25B are accurately referenced. (4) The answer is contextually fully relevant, directly addressing risk exposure and financial recognition as asked. Wording differs but semantic meaning matches closely. The LLM slightly generalizes 'satellite contracts' beyond the original scope (which focused on fixed-price development programs including non-satellite ones), but this does not materially distort the truth. Overall, this is a strong, factually consistent response with only a minor gap in numerical specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 480,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "\nIn the 2023 filing the Directors’ Code of Conduct was mentioned only in the proxy and was posted on BNY’s website, with a statement that any future amendments or waivers would be disclosed there. The 2024 filing makes the code part of a publicly listed set of governance documents (e.g., corporate‑governance guidelines, bylaws, committee charters) that are posted on the website, thereby improving its visibility and signaling that updates will be published directly on the site.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant mischaracterization of the evolution in disclosure and accessibility. (1) Correct elements: both years are accurately referenced, and it correctly notes that in 2023 the Code was posted online with a commitment to disclose amendments; it also correctly states that in 2024 the Code was included among other governance documents on the website. (2) Quantitative accuracy: there are no numerical values to evaluate, so this aspect is neutral; no errors in dates or financial figures. (3) Multi-hop reasoning: the model fails in its synthesis by claiming that the 2024 change 'improved visibility' and 'streamlined' access, which contradicts the ground truth that describes a shift to a more 'consolidated and implicit reference'—indicating less direct access due to the removal of the specific URL. The original answer emphasizes a move away from detailed disclosure, while the LLM interprets it as an improvement in visibility, which is a qualitative misjudgment. (4) Contextual relevance is high because the response addresses the question’s focus on changes in disclosure and accessibility across the two years, but the conclusion misrepresents the nature of the change. Thus, while factually grounded in some details, the reasoning and interpretation are flawed, leading to a misleading overall assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 379,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "\nBetween 2022 and 2023 Mobileye Drive shifted from a prototype‑stage L4 platform aimed at early robotaxi pilots to a commercially‑ready, fleet‑focused solution.  In 2023 the company announced OTA updates active in 22 cities, secured its first production design wins for the Chauffeur‑level system (e.g., Polestar, FAW and a major Western OEM), and deepened its go‑to‑market model by bundling Drive with Moovit’s mobility‑intelligence platform and supplying it to transportation‑network companies, public‑transit operators and AV‑ready vehicle OEMs.  This evolution reflects a move toward scaling the Drive stack through VaaS (Vehicle‑as‑a‑Service) partnerships and broader OEM collaborations rather than limited pilot deployments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Mobileye Drive™ between 2022 and 2023, with accurate qualitative insights and strong contextual relevance. (1) It correctly identifies the shift from early pilots in 2022 to a commercial, fleet-focused strategy in 2023, including targeting transportation network companies, public transit operators, and AV-ready OEMs. It also accurately notes the bundling with Moovit, which aligns with the ground truth. (2) Quantitatively, the LLM mentions OTA updates active in 22 cities and design wins with Polestar, FAW, and a major Western OEM in 2023. While these specific details (e.g., 22 cities, Polestar, FAW) are plausible and consistent with Mobileye’s trajectory, they are not present in the provided ground truth and cannot be verified as part of the knowledge graph answer. This introduces unverifiable specifics, slightly reducing quantitative accuracy. (3) The reasoning is sound: the model correctly infers a strategic evolution from prototype/pilot phase to commercial scaling via partnerships and VaaS, which reflects accurate multi-hop synthesis of the strategic shift. However, it omits key 2022 collaborations with Udelv and Transdev, and the Geely design win, which are central to the original answer. (4) Despite these omissions, the overall semantic meaning and strategic narrative are equivalent. The answer is highly relevant and well-framed, earning full marks for contextual relevance. Minor completeness gaps and unverified specifics prevent a top score, but core facts and logic are solid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 430,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "\nFrom 2022 through 2024 the Tower Preferred Interests moved from the original two‑series structure—Class A‑1 paying a 5.0 % quarterly distribution and Class A‑2 paying 4.75 % (both with a five‑year reset scheduled for December 2024)—to a revised framework introduced in November 2024.  The amendment split the interests into a Fixed‑Rate Class A (5.90 % distribution, resetting every five years and callable beginning in 2029) and a Floating‑Rate Class A (distribution equal to SOFR + 250 bps, also resetting every five years and callable at any time), while updating redemption and call provisions.  Thus the distribution rates shifted from the static 5.0 %/4.75 % levels in 2022 to a higher, mixed‑rate profile (5.90 % fixed plus a market‑linked floating rate) by 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of the Tower Preferred Interests from 2022 to 2024 with generally accurate structure and rates, but contains key factual inaccuracies in dates and timing that affect quantitative precision. (1) Correct elements: The 2022 structure with Class A-1 at 5.0% and Class A-2 at 4.75% is accurately described, as is the total shift to Fixed Rate (5.90%) and Floating Rate (SOFR + 250 bps) structures. The five-year reset and the concept of annual transition to floating rate are partially reflected. (2) Quantitative errors: The amendment date is incorrectly stated as November 2024 instead of August 2024 (per ground truth). Additionally, the original answer notes the 2019 Tower preferred interests were reclassified in 2024, but the LLM implies a direct evolution from the 2022 series without clarifying that the 2024 change applied to 2019 interests. The LLM also adds details not in the original—such as callability beginning in 2029 and 'callable at any time'—which are unsupported by the ground truth. (3) Reasoning: The multi-hop synthesis between 2022 structure and 2024 amendment is logically sound and captures the shift from dual fixed-rate series to a hybrid fixed/floating framework. However, the failure to specify that the 2024 change reclassified *2019* interests (not directly the 2022 series) weakens the causal chain. (4) Contextual relevance is high—the answer directly addresses structural and rate evolution as asked. Despite incorrect dates and unsupported call provisions, the central financial terms and transformation are conveyed with semantic fidelity, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 450,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "\nFrom 2022 to 2023 the Balanced Index Fund continued to be valued by a **market‑approach (Level 1) using quoted prices of identical instruments**, so the underlying investment methodology did not change.  However, the **unrealized gains/(losses) embedded in its Level 3 holdings flipped from a net loss of about $41 million in 2022 (losses of $16 m corporate, $11 m mortgage‑backed, $14 m municipal and $1 m real‑asset positions) to a modest net gain of roughly $11 million in 2023 (gains of $2 m corporate, $6 m mortgage‑backed and $3 m other fixed‑income)**, reflecting the improved market‑value performance of those Level 3 assets over the year.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies the shift from unrealized losses to gains in corporate and mortgage-backed/asset-backed securities, it introduces additional categories not present in the original answer: $14 million in municipal losses and $1 million in real-asset losses in 2022, and $3 million in 'other fixed-income' gains in 2023. These figures are not supported by the ground truth and result in incorrect net totals: the LLM claims a net loss of $41 million in 2022 and a net gain of $11 million in 2023, whereas the original answer reports only $16M + $11M = $27M in losses in 2022 and $2M + $6M = $8M in gains in 2023. These miscalculations and fabricated categories represent major factual errors. On qualitative accuracy, the LLM incorrectly states that the Balanced Index Fund was valued using Level 1 inputs in both years, while the original answer notes that the 2023 methodology *explicitly referenced* a market approach based on quoted prices (Level 1), implying a change or clarification in disclosure, not consistency. However, the LLM does capture the core idea of a turnaround in performance and addresses both parts of the question—investment approach and unrealized gains/losses—demonstrating reasonable multi-hop synthesis. The contextual relevance is high as it directly responds to the evolution from 2022 to 2023 and interprets the implications correctly. Overall, the answer is partially correct but marred by unsupported numbers and a key misrepresentation of the valuation methodology continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 440,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, the company’s discussion of accounting developments shifted from a peripheral risk‑factor mention (2023 page 5: “changes in accounting standards … could have a material impact…”) to an explicit component of its forward‑looking outlook (2024 page 5 and the forward‑looking‑statements paragraph, which tie accounting‑standard changes to capital‑ratio targets, dividend/share‑repurchase plans and technology‑related investments).  This evolution shows that evolving accounting standards have moved from being a mere compliance concern to a strategic driver that directly shapes BNY Mellon’s capital‑allocation, reporting and strategic‑priority decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in BNY Mellon's forward-looking statements between 2023 and 2024: from a general mention of accounting standards as a potential risk to a more integrated and strategic consideration. The specific references to 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 are accurately reflected in the LLM’s mention of 'dividend/share-repurchase plans' and 'technology-related investments', which are semantically consistent. (2) There are no numeric values, dates, or financial figures in dispute; the years 2023 and 2024 are correctly used, and no calculations are required. Page numbers (e.g., page 5) are cited plausibly and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes changes in language across filings and infers a strategic shift in how accounting developments are treated—from compliance to strategic influence—correctly linking this to capital allocation and business planning. (4) The only minor shortcoming is that the LLM answer does not explicitly quote the expanded 2024 phrasing about 'regulatory, technology, market, economic or accounting developments' as in the original answer, slightly reducing completeness. However, it captures the essence by tying accounting changes to capital ratios and strategic decisions. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 437,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "\nIn 2022 the company highlighted culture‑building, recognition and engagement programs to strengthen the associate experience, but in 2023 the emergence of heightened store‑safety risks—such as rising shrink, organized retail crime and the need for stricter safety protocols—combined with escalating cyber‑threats (data‑breach vulnerabilities, ransomware, supply‑chain attacks) could undermine that progress. These risks create a less secure, more stressful work environment that may erode associate morale, increase turnover, and counteract the positive effects of the earlier engagement‑focused initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2022 focus on engagement initiatives (culture-building, recognition, engagement programs) and the 2023 emergence of store safety risks (organized retail crime, rising shrink) and cybersecurity threats (data breaches, ransomware, supply-chain attacks) are correctly identified. The potential impact on associate morale, turnover, and the erosion of earlier engagement gains is accurately conveyed. (2) There are no numeric values, percentages, or financial figures in either the question or answers that require verification—thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 vs 2023), shifts in focus (from internal engagement to external risks), and their implications on the associate experience. The only minor shortcoming is the absence of the specific statistic from 2022 that 'four out of five associates were emotionally committed,' which adds slight contextual depth in the original answer but does not alter the core conclusion. (4) The LLM answer is semantically equivalent to the original—wording differs but meaning is preserved. The answer is fully relevant to the question, addressing both years, the nature of initiatives/risks, and their comparative impact on associates. Thus, correctness is high, with only a minor omission preventing a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 406,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "\nBetween 2022 and 2023 the learning‑curve moved from a peripheral, “what‑if” factor in the list of variables that could erode margins to a core quantitative driver in the company’s program‑accounting estimates.  In the 2022 filing it was cited only as one of several items that could lead to lower margins or a reach‑forward charge, whereas in the 2023 filing the curve is explicitly used to estimate program accounting quantities, production‑rate adjustments, abnormal production costs and the size of potential losses—making it a direct determinant of profitability forecasts and risk‑management decisions for programs such as the 787 and 777X.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of the 'learning curve' concept between 2022 and 2023 as described in the ground truth. It correctly identifies that in 2022, the learning curve was a risk factor associated with margin erosion and potential reach-forward charges, particularly for programs like the 787. In 2023, it accurately reflects the shift where the learning curve became a core, quantitatively integrated component of program accounting, influencing production rate assumptions, abnormal costs, and profitability forecasts—consistent with the ground truth's emphasis on its integration into cost estimation and risk management. All entities (e.g., 787, 777X) and years (2022, 2023) are correct. There are no numerical inaccuracies, as the response does not introduce specific dollar amounts or percentages that could be incorrect. The reasoning is sound and demonstrates proper multi-hop synthesis across years and program contexts. The only minor shortcoming is that the LLM slightly reframes the narrative using terms like 'peripheral, what-if factor' and 'core quantitative driver,' which, while semantically aligned, are more interpretive than the original's neutral tone. However, this does not affect factual correctness. Overall, the answer is factually complete, contextually relevant, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 373,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "\nThe 2024 filing repeats the same disclosure that was already present in the 2023 filing: it notes that certain officers and directors elect to take part in the dividend‑reinvestment (and other) plans and that they may have shares withheld to cover taxes or exercise‑price payments, with such elections being structured either to satisfy the Rule 10b5‑1 affirmative‑defense safe harbor or to constitute a non‑10b5‑1 trading arrangement.  No new officers or directors are named, and the language is essentially unchanged—only the surrounding context (e.g., an added bullet about a severance‑plan amendment) differs, indicating a consistent treatment of the DRIP across the two filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim, directly contradicting the ground truth. The original answer states that the 2024 filing omitted the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements that was present in the 2023 filing, indicating a simplification. However, the LLM claims the disclosure was 'repeated' and 'essentially unchanged,' which is false. This misrepresents the evolution of the disclosure, which is the central focus of the question. There are no numeric values to assess, so quantitative accuracy is scored as 10 by default (no errors in numbers). Qualitative accuracy is very low because the model fails to identify the key change in disclosure depth and incorrectly asserts consistency. Contextual relevance is moderate because the answer addresses the right topic (officer/director participation in DRIP and trading arrangements) and references correct concepts (Rule 10b5-1, tax withholding), but draws the wrong conclusion about the evolution between years. The model appears to have misread or misremembered the 2024 filing's content, leading to a fundamentally flawed response despite using semantically plausible language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 334,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "\nFrom fiscal 2021 through fiscal 2023 Home Depot more than doubled its spending on an interconnected experience—capital outlays rose from **$2.6 billion** to **$3.2 billion**—and shifted the focus from basic omni‑channel integration to a fully data‑driven, personalized journey.  The company now tailors the experience by delivering location‑based, intent‑matched marketing, offering same‑day/next‑day delivery and curb‑side pickup, equipping associates with hdPhone/Sidekick and computer‑vision tools for real‑time inventory visibility, and enhancing mobile apps and self‑checkout (electronic shelf labels, BOPIS/BOSS options) to provide smoother, more relevant shopping interactions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the capital expenditure amount for fiscal 2023. The ground truth states that $2.6 billion was invested in fiscal 2021, but does not provide the 2023 capital expenditure figure. The LLM incorrectly claims it rose to $3.2 billion, which is unsupported by the original answer and constitutes a major quantitative inaccuracy. There is no mention in the ground truth of doubling spending or specific figures for 2023, so this number is fabricated. (2) Other numerical claims (e.g., same-day delivery, BOPIS/BOSS) are plausible but not mentioned in the original answer and thus cannot be verified; however, they do not contradict it directly. The core error lies in the unsupported $3.2 billion figure and the claim of more than doubling, which misrepresents the evolution of investment levels. (3) Qualitatively, the LLM correctly identifies the strategic shift toward a more personalized, data-driven experience using customer intent and location, aligning with the original answer’s emphasis on enhanced merchandising IT tools. It adds specific examples like hdPhone/Sidekick, computer vision, electronic shelf labels, and mobile app improvements, which are contextually relevant and plausible extensions of the strategy, though not explicitly stated in the ground truth. These additions improve completeness but introduce unverified details. (4) Contextually, the response is highly relevant, addressing both the evolution of investment and changes in personalization. However, the incorrect financial data undermines the correctness score. While the reasoning reflects a logical interpretation of how such a strategy might evolve, the unsupported numbers break factual fidelity. The model fails the multi-hop verification by inventing a key financial metric instead of acknowledging absence of 2023 capex data in the source. Final scores reflect partial correctness: core strategic shift understood (qualitative accuracy 6), but major penalty on quantitative accuracy (4) due to false capex figure, leading to overall correctness of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 564,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "\nBetween 2022 and 2023 the capital that Danaher devoted to Aldevron’s expansion grew sharply – 2021’s $1.3 billion of capex (which was already boosted by the Aldevron acquisition) was followed by an estimated $1.5 billion of planned spending in 2022 to lift manufacturing capacity for COVID‑19‑related and other biopharma products.  By 2023, however, Aldevron‑specific acquisition outlays had essentially stopped; the only acquisition‑related cash charge linked to Aldevron was the $28 million of transaction costs recorded in 2021, with subsequent cash use shifting to integration expenses for later deals (e.g., Abcam) rather than new capital or acquisition spending on Aldevron.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that $1.3 billion in capex occurred in 2021, while the ground truth specifies $1.5 billion anticipated in 2022 related to Aldevron capacity. The LLM also claims that acquisition-related spending on Aldevron stopped by 2023 and only $28 million in transaction costs were recorded in 2021, which directly contradicts the ground truth stating that $9,561 million in net cash consideration was paid to Aldevron in 2023—indicating the acquisition was finalized then, not earlier. This is a major error in both timing and magnitude. (2) Quantitatively, the numbers are largely incorrect: $1.3B in 2021 (vs. $1.5B planned in 2022), omission of the $9.561B 2023 payment, and misattribution of $28M transaction costs as the only outlay. The $9.561B figure is critical and entirely missing from the LLM response. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that the 2023 payment represents the culmination of the acquisition process, not a cessation of spending. Instead, it incorrectly frames 2023 as a year of no Aldevron-related acquisition spending, when in fact the largest single financial outlay occurred then. The evolution from capital investment to full acquisition is completely misrepresented. (4) Contextual relevance is moderate—the response addresses capital investment and acquisition expenditures between DHR and Aldevron over the two years, but with incorrect data and reasoning, undermining the core of the answer. The mention of Abcam integration expenses is irrelevant and distracts from the focus on Aldevron. Overall, the answer is mostly incorrect due to fundamental errors in key financial figures and the timeline of the acquisition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 479,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "\nFrom 2022 through 2024 the Telco LLC preferred interests expanded from the $2 billion of Class A‑1 interests issued in September 2020 to a total of $7.25 billion after the April 2023 issuance of $5.25 billion of new Class A‑2 and A‑3 interests, a level that remained unchanged through 2024.  The securities pay an initial annual cash distribution of 4.25 % for the Class A‑1 interests and 6.85 % for the Class A‑2/A‑3 interests (both subject to declaration) and each series resets every seven years—Class A‑1 on its original schedule and the newer classes with their first reset on 1 Nov 2027.  No changes to the distribution rates or reset timing were made between 2022 and 2024; only the addition of the new classes and their reset schedule were introduced.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in framing. (1) All key facts are correct: the initial $2,000 million (stated as $2 billion) in Class A-1 preferred interests, the April 2023 issuance of $5,250 million ($5.25 billion) in Class A-2 and A-3, and the resulting total of $7,250 million ($7.25 billion) by 2024. Distribution rates are correctly reported as 4.25% for A-1 and 6.85% for A-2/A-3. The reset schedule is accurately described: every seven years, with the new classes resetting first on November 1, 2027. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and dates match the ground truth, with acceptable formatting variations (e.g., $2 billion = $2,000 million). The sum $2,000 + $5,250 = $7,250 is correct and properly reflected. (3) Reasoning is sound: the model correctly synthesizes information across time (2022 to 2024), identifies the structural change (addition of new classes), and notes that no changes were made to existing terms—only new instruments with their own reset schedules were introduced. (4) The only minor shortcoming is that the original answer emphasizes a 'strategic shift toward higher-yielding preferred instruments,' which the LLM omits. While not required for factual correctness, this interpretive point adds context. However, the LLM correctly implies this by contrasting the rates. No factual errors or omissions affect the core answer. Thus, the answer is excellent but not fully exhaustive in qualitative nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 426,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "\nBetween 2022 and 2024 AIG expanded the Expected‑Loss‑Ratio (ELR) technique beyond its original use on U.S. Property and Special‑Risk lines to additional long‑tail, high‑severity lines such as U.S. Excess Casualty, U.S. Workers’ Compensation, program business and UK/Europe Property/Special Risks, and began applying it most heavily to the latest accident year where development data are thin.  The rationale evolved to rely on ELR when loss‑development patterns are inconsistent, emergence is very slow, or the portfolio includes large‑deductible or reinsured exposures with limited historical data, so that reserve estimates are anchored to premium‑based expected loss ratios rather than unreliable development factors.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's use of Expected Loss Ratio (ELR) methods between 2022 and 2024, correctly identifying expansion into newer lines and the rationale for use in data-scarce or high-severity contexts. However, there are significant discrepancies in entity accuracy and completeness compared to the ground truth. The original answer specifies that in 2022, ELR was used primarily for the latest accident year and in aviation exposures (in combination with other methods), but the LLM incorrectly states initial use was in 'U.S. Property and Special-Risk lines'—this is not supported by the ground truth. Additionally, while the 2024 expansion to U.S. Workers’ Compensation aligns with the original answer, the LLM adds several lines (U.S. Excess Casualty, program business, UK/Europe Property/Special Risks) that are not mentioned in the ground truth, introducing unsupported detail. The rationale provided—relying on ELR when development patterns are inconsistent or data are limited—is semantically consistent and accurate. Quantitatively, there are no explicit numbers, dates, or calculations to verify, so the score is based on factual alignment; the years 2022 and 2024 are used appropriately. The reasoning shows partial multi-hop synthesis: it correctly infers broader application over time and appropriate rationale, but fails to accurately represent the starting point (aviation, not property lines) and overextends the scope of expanded lines. Contextually, the response is highly relevant and well-structured, but factual inaccuracies in key entities reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 441,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "\nFrom 2023 to 2024 Target shifted its owned‑brand strategy from a descriptive note that “about one‑third of merchandise sales come from owned and exclusive brands” (2023 filing) to a deliberate growth pillar: the 2024 filing explicitly calls out “strengthening our owned‑brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships” as a core element of its strategy to deliver “newness, style and value” and increase relevance.  This reflects a move toward deeper integration of owned brands across categories, more exclusive design collaborations and digital‑first launches, and using the portfolio to drive traffic and market‑share growth, whereas the 2023 filing merely characterized the portfolio’s size and diversity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution from 2023 to 2024. It accurately captures the shift from a general emphasis on owned brands in 2023 to a more strategic, execution-focused approach in 2024. The mention of 'about one-third of merchandise sales come from owned and exclusive brands' in 2023 is factually consistent with typical Target disclosures, though this specific percentage is not included in the original ground truth answer; however, it does not contradict it and adds contextual detail. The 2024 strategic emphasis on 'strengthening our owned-brands portfolio' as a core pillar matches the ground truth's indication of a more concrete execution phase. The LLM correctly identifies the progression in strategic depth and integration across categories, exclusive collaborations, and traffic-driving goals. However, the ground truth specifically highlights the expansion to 'over 40 distinct brands' as evidence of portfolio development, a concrete detail not mentioned in the LLM response, representing a minor omission in completeness. There are no calculation errors, and all years and entities (Target, 2023, 2024, owned brands) are accurate. The reasoning is sound, demonstrating multi-hop synthesis between two years’ strategic priorities. Wording differs but meaning is semantically equivalent, with slight over-enrichment (e.g., digital-first launches) that is plausible but not confirmed in the ground truth. Thus, the answer earns high marks but not perfect due to missing the specific 'over 40 brands' metric that anchors the 2024 execution phase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 444,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "\nIBM’s decision to keep its existing 0.875 % Notes due 2030 on the 2024 filing while simultaneously issuing fresh 2.900 % Notes due 2030 shows that it is deliberately refinancing part of its long‑term capital structure.  By tapping the market with a higher‑coupon, 30‑year bond, IBM is locking in financing at today’s prevailing rates and extending the maturity profile of its debt, indicating that it views the current environment as one where it can still raise cheap, long‑dated capital despite rising interest rates.  This dual‑track approach reflects a strategy of diversifying funding sources and managing debt‑maturity risk while maintaining confidence in its creditworthiness.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: IBM maintained the 0.875% Notes due 2030 and issued new 2.900% Notes due 2030 in 2024. All percentages (0.875%, 2.900%) and maturity year (2030) are accurate, satisfying quantitative accuracy. (2) The numbers and dates are correct—no calculation errors or misstatements. The interest rate increase is accurately portrayed. (3) However, the reasoning contains a significant misinterpretation: the LLM frames the issuance of the higher-coupon bond as evidence that IBM views current rates as 'cheap,' which contradicts the implication in the ground truth—that higher rates suggest less favorable borrowing conditions. The ground truth emphasizes that the rate jump may reflect deteriorated market conditions or targeting different investor segments, not confidence in cheap capital. Additionally, the LLM incorrectly refers to the new bond as '30-year,' but both notes mature in 2030; without knowing issuance years precisely, assuming a 30-year term is speculative (the original 0.875% note was issued earlier, likely around 2020, making it ~10-year at issuance). (4) Despite this, the answer captures the strategic intent of diversifying funding sources and managing maturity risk, aligning with the ground truth’s point on portfolio diversification and refinancing strategy. Thus, while core facts are correct and contextually relevant, the qualitative reasoning is partially flawed in interpreting market conditions and instrument terms, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 423,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "\nBetween 2022 and 2024 AT&T shifted its long‑term debt mix from a portfolio dominated by short‑ and medium‑term fixed‑rate notes (e.g., the 1.450 % notes due 2022 and the 2.500 % notes due 2023 that appeared in the 2022 filing) toward a larger share of longer‑dated, fixed‑rate issuances.  The 2024 prospectus introduces the 4.000 % Global Notes due June 1 2049 (ticker T 49A) for the first time and adds a suite of new series maturing from 2026 through 2067 (such as 2.9 % due 2026, 4.375 % due 2029, 7.0 % due 2040, 5.35 % due 2066, etc.), expanding the overall maturity profile and reinforcing the company’s longer‑term financing strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key elements of the ground truth. (1) Quantitative Accuracy: The claim that the 4.000% Global Notes due June 1, 2049 were introduced for the first time in 2024 is incorrect — the original answer states these notes were already listed in 2022 under ticker T 49A. Additionally, the LLM invents multiple new notes (e.g., 2.9% due 2026, 4.375% due 2029, 7.0% due 2040, 5.35% due 2066) that are not mentioned in the ground truth; only the 4.300% Global Notes due November 18, 2034 (T 34C) were added by 2024. Dates, percentages, and tickers are largely fabricated. (2) Completeness: The answer fails to correctly identify the evolution of the specific instruments mentioned in the question — it omits the fact that the 2049 notes existed in 2022 and incorrectly frames their appearance in 2024 as a new issuance. It also fails to mention the absence of the 2034 notes in 2022 and their addition in 2024. (3) Entity Accuracy: Wrong tickers and maturities are introduced (e.g., T 34C is not referenced, but new fictitious ones are). The company (AT&T) and general concept of long-term debt are correct, but specific securities are misrepresented. (4) Reasoning: The multi-hop reasoning is flawed — the model incorrectly infers a strategic shift based on fabricated data. It does not accurately compare the 2022 and 2024 debt compositions as required. (5) Semantic Equivalence: The overall message — that AT&T extended its maturity profile — may align loosely, but the factual foundation is unsound. Due to major errors in numbers, dates, and instrument tracking, the answer is mostly incorrect despite addressing the general topic of debt evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 465,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "\nIn 2023 the Heritage AspenTech purchase generated about **$258 million of intangible‑asset amortization** (primarily customer‑relationship and developed‑technology intangibles) and contributed to the company’s **$72 million of total restructuring expenses**, which were largely integration‑related. By 2024 the same intangibles continued to be amortized at roughly the same $258 million level (forming part of the $1.077 billion total amortization, with $560 million coming from the newer NI acquisition), while **restructuring costs more than tripled to $228 million**, reflecting deeper head‑count reductions, facility exits and integration‑related stock‑compensation expenses as Emerson pursued broader cost‑synergy and restructuring initiatives post‑acquisition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. According to the ground truth, intangibles amortization decreased from $258 million in 2023 to $97 million in 2024. However, the LLM incorrectly states that amortization remained at the same $258 million level in 2024, which is a major quantitative inaccuracy. Restructuring costs are correctly reported as $72 million in 2023 and $228 million in 2024, matching the ground truth. (2) The calculation and trend analysis for amortization is therefore incorrect—instead of a reduction in amortization burden (from $258M to $97M), the LLM claims it remained flat, undermining the core financial evolution. The tripling of restructuring costs is correctly noted. (3) The multi-hop reasoning fails because the model does not synthesize the correct change in amortization over time, which is central to the question. It introduces irrelevant details about the NI acquisition and total amortization ($1.077 billion), which are not in the ground truth and distract from the specific focus on Heritage AspenTech. (4) The contextual relevance is moderate because the answer addresses the right topic and time frame, and correctly identifies restructuring cost increases. However, the critical error in amortization values—especially asserting no change when there was a substantial decrease—results in a low correctness score. Minor wording flexibility is allowed, but core financial inaccuracies dominate the evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 414,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 AIG kept expected‑loss‑ratio (ELR) techniques at the core of its workers‑compensation reserving, but it refined how and where they are applied.  In 2022 the ELR was used mainly for the most‑recent accident year on guaranteed‑cost business and for the most‑recent five years on excess‑of‑deductible business, with segmentation by state (CA/NY vs. other states) and by deductible size; by 2024 the company emphasized that ELR weight is now given “significant” weight only to the latest accident year for guaranteed‑cost lines, while excess‑of‑deductible and large‑deductible portfolios receive ELR weight across the latest five years, and it further separates business by deductible magnitude and whether claims are handled by AIG or a third‑party administrator.  The growing proportion of large‑deductible accounts— which slows claim emergence and reporting—has prompted AIG to adjust its ELR assumptions (e.g., incorporating COVID‑19 frequency/severity shifts and claims‑strategy changes) and to treat these subsets more separately in its reserve models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key details are correct: the use of expected loss ratio (ELR) methods in 2022 for guaranteed cost (most recent accident year) and excess-of-deductible (most recent five accident years) is accurately reflected. The continuation and refinement in 2024, including the focus on deductible size and claim handling (AIG vs. third-party administrators), are correctly stated. (2) The increasing proportion of large deductible accounts and their impact on slowing claim emergence is properly noted, as is the need to adjust ELR assumptions due to this trend. (3) The multi-hop reasoning is sound—information is correctly synthesized across years (2022 vs. 2024), business types (guaranteed cost, excess-of-deductible, large deductible), and operational factors (claim handling, reporting patterns). (4) One minor omission prevents a perfect score: the 2024 disclosure about limitations in claim count data due to aggregation and reinsurance exclusions—explicitly mentioned in the ground truth—is not included in the LLM answer. This is a relevant qualitative detail that enhances understanding of data constraints in reserving. However, the core evolution of ELR methodology, segmentation, and impact of large deductible accounts is thoroughly and correctly conveyed. Wording differs but semantic meaning is equivalent. No factual or numerical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 400,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "\nTarget’s cyber‑threat investigation has moved from a loosely referenced “cyber fusion center” in the 2023 filing to a formally governed function in 2024 that is embedded in the company’s enterprise‑risk‑management program and reported regularly to the Audit & Risk Committee and Board.  The 2024 disclosure also stresses tighter integration of the Fusion Center’s threat‑intelligence work, expanded collaboration with external industry groups to share best‑practice intelligence, and a stronger investment in internal talent and third‑party assessments to make threat investigation and response more coordinated and proactive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Target's cybersecurity approach from 2023 to 2024. It correctly identifies the continued operation of the Cyber Fusion Center and its enhanced governance in 2024, including formal reporting to the Audit & Risk Committee and Board—aligning with the ground truth's mention of a 'coordinated escalation model' to management and the Board. The answer also reflects expanded external collaboration, consistent with the original answer’s note on industry engagement and third-party assessments. It accurately conveys the increased structure, integration with enterprise risk management, and investment in internal talent and external testing. The only minor shortcoming is that it does not explicitly mention 'regular training and compliance activities for team members,' a specific detail in the original answer. However, the reference to 'stronger investment in internal talent' is a reasonable proxy. There are no numerical inaccuracies (quantitative accuracy is perfect, though the question is qualitative), and all entities (Target, Cyber Fusion Center, Board reporting) are correct. The reasoning is sound, synthesizing changes across years and domains (internal operations, external collaboration). The answer is fully contextually relevant and semantically equivalent to the ground truth with only slight omission of granularity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 386,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "\nBetween 2023 and 2024 Eli Lilly’s Baqsimi‑related revenue shifted from a one‑time, upfront payment for the product’s rights to ordinary product sales.  In 2023 the company recorded a **$579 million** upfront payment from the sale of Baqsimi rights (shown in the 2023 revenue table on page 47) and also recognized **$677.6 million** of net product revenue from Baqsimi sales (page 48), up from only $139.3 million in 2022.  Thereafter, Baqsimi revenue is accounted for under the company’s standard revenue‑recognition policy—recognizing sales when control transfers, estimating rebates/returns, and without a financing component (pages 62‑65)—and no new distinct contractual arrangement for Baqsimi was disclosed for 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the evolution of Eli Lilly's financial relationship with Baqsimi between 2023 and 2024. (1) QUANTITATIVE INACCURACY: The LLM claims Eli Lilly recorded $579 million as an upfront payment for Baqsimi rights in 2023 AND also recognized $677.6 million in net product revenue from Baqsimi sales. However, the ground truth states that the $579 million was the revenue attributed to the sale of Baqsimi rights — not in addition to product sales. There is no mention in the original answer of $677.6 million in product revenue for Baqsimi in 2023, nor any indication that Baqsimi transitioned to 'ordinary product sales' in 2024. In fact, the original answer indicates Baqsimi was folded into broader collaboration revenue, not sold as a standalone product. (2) COMPLETENESS & REASONING FAILURE: The LLM incorrectly frames the shift as moving from an upfront payment to regular product sales, which contradicts the ground truth — the actual shift was from direct product/rights revenue to being included within collaborative arrangement revenue disclosures, indicating a more complex accounting treatment, not simpler product sales. The LLM fails to identify this key multi-hop insight about revenue recognition model evolution. (3) ENTITY & CONTEXTUAL ISSUES: While Eli Lilly and Baqsimi are correctly identified, the description of contractual arrangements in 2024 is wrong — the original answer notes integration into collaboration revenue (implying ongoing or revised contractual structure), whereas the LLM says no new arrangement was disclosed, missing the significance of the reporting change. (4) SEMANTIC NON-EQUIVALENCE: The overall narrative is factually inverted — the original describes a move toward complexity in revenue recognition; the LLM describes a move toward simplicity. This fundamental contradiction invalidates the core of the response. Minor contextual elements (e.g., reference to revenue recognition policy) are accurate but do not compensate for major errors in financial interpretation and data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 557,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "\nFrom 2023 to 2024 AT&T moved from retiring its legacy Mobility preferred interests—completing a $5.4 bn repurchase in April 2023 that was financed by the April 2023 expansion of Telco LLC’s cumulative preferred securities—to a broader preferred‑equity strategy that amends the 2019 Tower Holdings structure (resetting distribution rates, converting the interests into Fixed‑Rate and Floating‑Rate Classes and extending call rights) and adds a planned $2.25 bn Telco LLC Class A‑4 issuance for 2025 to fund further redemptions.  This evolution reflects a shift toward layered, reset‑rate preferred interests in subsidiaries to manage capital, preserve cash flexibility, and support ongoing dividend and share‑repurchase activities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic shift from repurchasing Mobility Preferred Interests in 2023 to expanding Tower Holdings and Telco LLC preferred interests in 2024, which aligns with the ground truth. However, there are key quantitative inaccuracies. The repurchase amount is stated as $5.4 billion, which matches the ground truth's $5,414 million (approx. $5.4B), so that is acceptable. But the LLM claims the Telco LLC preferred issuance was $5.25B in 2023, while the LLM answer implies a $2.25B Class A-4 issuance planned for 2025 — this is not in the original answer and introduces a forward-looking element not supported by the ground truth. The original answer states total Telco LLC preferred interests reached $7,250M by 2024, including the original $2,000M and 2023 additions ($5,250M), totaling $7,250M — correct. But the LLM misrepresents this as a 'planned' $2.25B issuance for 2025, which is not stated in the original. (2) The restructuring of the 2019 Tower preferred interests into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps is correctly mentioned, though the LLM adds 'extending call rights' which is plausible but not in the original. The 6.85% distribution rate on the 2023 Telco issuance is omitted in the LLM answer. (3) The multi-hop reasoning is sound: the model correctly identifies the shift from repurchasing legacy interests to issuing new preferred structures in subsidiaries. It synthesizes the Mobility repurchase, Telco financing, and Tower restructuring as part of a capital management strategy. However, the introduction of a 'planned 2025 issuance' not in the original answer reflects either incorrect inference or hallucination, undermining quantitative accuracy. (4) The contextual relevance is high — the answer directly addresses the evolution of AT&T’s capital structure strategy. Qualitative accuracy is strong in framing the strategic pivot, but the incorrect characterization of the Telco issuance timeline and omission of key rates reduce precision. Correctness score is 7 due to accurate core narrative but significant quantitative and detail-level errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 577,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "\nFrom 2023 to 2024 Emerson deepened its stake in AspenTech, moving from roughly a 55‑57 % ownership position to announcing a cash proposal that would give it 100 % of the company.  The integration of AspenTech’s software business helped lift Emerson’s consolidated gross margin by 1.8 percentage points to 50.8 % in 2024, although this improvement was partially offset by $231 million of acquisition‑related inventory step‑up amortization that reduced margin by about 1.3 percentage points.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The claim that Emerson had a 55-57% ownership stake in AspenTech in 2023 is false; the ground truth states that Emerson acquired a 55% stake in 2024 as part of a new transaction. There is no mention of a prior ownership stake in 2023. The LLM incorrectly reverses the timeline and implies an increase from 55-57% to 100%, when in fact the 55% stake was newly acquired in 2024. The $6.0 billion cash payment is omitted entirely. (2) The gross margin impact is misrepresented: the ground truth states AspenTech contributed a 3.3 percentage point increase in 2023 (before the acquisition) and a 1.8 percentage point increase in 2024. The LLM incorrectly attributes the 1.8 point increase to 2024 alone and ties it to a consolidated margin of 50.8%, which is not in the original answer. The $231 million inventory step-up amortization is not mentioned in the ground truth and appears fabricated. (3) ENTITY & REASONING ERRORS: The transformation is mischaracterized as moving toward 100% ownership, which is not supported by the original answer. The original states Emerson became a majority shareholder (55%) in 'New AspenTech' in 2024, with no mention of a move to full acquisition. (4) The answer partially addresses the financial impact on gross margin and ownership, so it retains some contextual relevance, but the core facts—timing, ownership evolution, financial figures—are incorrect. Multi-hop reasoning fails because the model conflates years, misattributes financial impacts, and invents details not present in the source. Overall, the answer is mostly incorrect despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 467,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "\nAIG's Japan pension plans have continued to account for roughly two‑thirds of its non‑U.S. pension assets, with their share staying around 66‑67 % of total non‑U.S. plan assets from 2022 through 2024. Over the same period the weighted‑average discount rate applied to these plans increased from about 1.48 % to 1.81 % (an increase of roughly 0.33 percentage points).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that AIG's Japan pension plans accounted for 'roughly two-thirds' (66-67%) of non-U.S. pension assets from 2022 through 2024, which directly contradicts the ground truth stating that Japan accounted for 61% of non-U.S. pension *assets* in 2022 and a declining share of *projected benefit obligations* (54% in 2023, 50% in 2024). The LLM incorrectly conflates assets with obligations and misrepresents the magnitude and trend. The ground truth shows a decline in Japan's share of obligations, not stability at two-thirds. (2) The discount rate numbers are partially correct: the increase from 1.48% in 2023 to 1.81% in 2024 is accurate. However, the LLM implies this change occurred 'from 2022 through 2024' but provides no 2022 rate, while the ground truth does not specify the 2022 discount rate. The calculation of a 0.33 percentage point increase is correct based on the 2023–2024 change. (3) The multi-hop reasoning is flawed: the LLM fails to distinguish between pension assets and projected benefit obligations, a critical distinction in pension accounting. It also misses the downward trend in Japan's contribution to non-U.S. obligations, which is central to the question. The synthesis across years and metrics is inaccurate. (4) Despite these issues, the answer is contextually relevant, addressing both parts of the question—evolution of contribution and change in discount rate—and uses appropriate financial terminology. The qualitative reasoning is plausible but based on incorrect data. Quantitative accuracy is low due to the incorrect percentage figures and misattribution of metrics. Correctness score is 4 due to partial accuracy on the discount rate but major errors in the core trend of Japan's contribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 491,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "\nIn the 2022 10‑K the threat from “competitive stores, websites, products, services, price decreases, or improvements” appears only as a stand‑alone bullet in the list of operational risks, with no explicit linkage to broader market conditions. By the 2023 10‑K the same wording is retained but is embedded in a wider discussion of external factors—such as macro‑economic uncertainty, inflation, consumer‑spending trends and geopolitical developments—so the competitive‑store risk is framed as part of the larger external market environment that can affect Amazon’s growth and pricing pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Amazon's disclosure between the 2022 and 2023 10-K filings. (1) It correctly identifies that in 2022, competitive stores were listed as a standalone bullet among operational risks, with the exact phrase 'competitive stores, websites, products, services, price decreases, or improvements'—matching the original answer. In 2023, it notes the retention of this language but its integration into a broader context of external factors, which aligns with the ground truth. (2) There are no numerical values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable in a traditional sense, but all references to years (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the framing of competitive stores shifted from an isolated operational risk to being contextualized within macroeconomic and geopolitical conditions. The only minor shortcoming is that the LLM does not explicitly quote the 2023 phrasing about 'continued growth of demand' and 'general economic, business, and geopolitical conditions worldwide,' though it accurately paraphrases the broader context (e.g., 'macro-economic uncertainty, inflation, consumer-spending trends and geopolitical developments'). (4) The answer is semantically equivalent to the original, with slightly more concise phrasing and a focus on the framing shift. It fully addresses the question about the evolution in disclosure and the reframing of external market conditions. Thus, the answer is excellent but not perfect—hence a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 452,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "\nTarget’s 2023 filing mentioned port‑security only as a generic supply‑chain risk tied to broader trade tensions (especially with China). In the 2024 filing the issue is called out explicitly within the political‑economic uncertainty section, highlighting transport‑capacity constraints and geopolitical conflicts that could disrupt ports in Asia (including India), which could cause inventory shortages, higher costs and force alternative sourcing—thereby expanding both the geographic scope and the operational impact of port‑security risks.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and multi-hop reasoning, despite being internally consistent and addressing the general theme of port security risks. (1) The geographic focus is misrepresented: the original answer states that in 2023, Target specifically highlighted California ports, whereas the LLM claims the risk was generic and tied to trade tensions with China and Asian ports including India. This is a significant factual error—Target’s 2023 focus was domestic (California), not international or Asia-centric. In 2024, Target broadened to 'major U.S. ports,' not expanded to Asia as the LLM suggests. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is flawed: the LLM incorrectly synthesizes the evolution of risk as a geographic expansion to Asia, when in fact the shift was from specific (California) to general (U.S. ports), remaining domestic. Additionally, the operational impact in 2023 involved past disruptions and alternative arrangements, while 2024 emphasized future risks like cost increases and supply issues—this nuance is partially captured by the LLM (higher costs, inventory shortages) but misattributed to the wrong geography and context (geopolitical conflicts abroad vs. labor disputes and global conflicts affecting U.S. ports). (4) Contextual relevance is moderate because the answer discusses port security, supply chain risks, and operational impacts, which are relevant, but the incorrect geographic and causal framing undermines the response. The LLM appears to have hallucinated a shift toward Asia and alternative sourcing, which is not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 472,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "\nBetween 2023 and 2024 the amortization of the intangibles acquired in the Heritage AspenTech combination grew sharply – $258 million of amortization was recorded in 2023, and the full‑year 2024 amortization of those same intangibles (after removing the $560 million of NI‑related amortization) was about $517 million, pushing total intangible amortization from $482 million in 2023 to $1,077 million in 2024.  At the same time, restructuring expenses linked to the integration of the AspenTech business rose from $1 million in 2023 to $8 million in 2024 (with an additional $12 million recorded in other segments), reflecting the ongoing workforce reductions, facility closures and other integration‑related costs that the company continues to incur.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson reported $258 million in intangibles amortization related to the AspenTech acquisition in 2023, and this specific amortization was no longer reported in 2024, indicating a shift away from AspenTech as a newly acquired entity. However, the LLM claims that amortization for AspenTech intangibles increased to $517 million in 2024, which directly contradicts the ground truth. Additionally, the LLM states that restructuring costs increased from $1 million in 2023 to $8 million in 2024, but the ground truth reports $72 million in 2023 and $228 million in 2024—massive discrepancies in both absolute values and trends. (2) The numbers provided in the LLM answer ($517M amortization in 2024, $1M and $8M restructuring costs) are entirely inconsistent with the ground truth ($258M amortization in 2023, none specifically tied in 2024; $72M to $228M restructuring). The calculation of 'full-year 2024 amortization' and subtraction of '$560 million of NI-related amortization' introduces unverified and unsupported data not present in the original answer. (3) The multi-hop reasoning is flawed: instead of recognizing that AspenTech-related amortization ceased being highlighted in 2024 (suggesting integration completion), the LLM incorrectly infers it increased. It also misattributes restructuring cost increases to AspenTech integration with minimal figures, while the ground truth shows large-scale restructuring increases potentially linked to broader strategic shifts. (4) The contextual relevance is moderate because the answer addresses the right topic—acquisition-related amortization and restructuring costs—but the qualitative and quantitative inaccuracies severely undermine correctness. Due to major factual and numerical errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 509,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "\nBetween 2022 and 2024 AIG kept the practice of applying Expected‑Loss‑Ratio (ELR) techniques mainly to newer accident years, but the 2024 filing expands that weighting to a broader set of lines—including cyber, mergers‑and‑acquisitions, fidelity and professional‑liability—whereas in 2022 the emphasis was confined largely to D&O, E&O, EPLI and professional‑liability. As a result, the share of the reserve model devoted to ELR grows with the recency of the accident year and now carries a larger weight for low‑frequency/high‑severity businesses in the 2022‑2024 years than it did two years earlier.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of AIG expanding the use of Expected Loss Ratio (ELR) methods between 2022 and 2024, particularly for recent accident years and low-frequency/high-severity lines, which aligns with the ground truth. It correctly identifies that ELR was used in D&O, E&O, EPLI, and professional liability in 2022. However, it introduces inaccuracies by claiming expansion into 'cyber, mergers-and-acquisitions, fidelity' in 2024—none of which are mentioned in the original answer. Instead, the ground truth specifies that by 2024, ELR methods were expanded to U.S. Workers' Compensation, a long-tail line, used in combination with loss development and frequency/severity methods. This is a significant factual deviation. While the LLM correctly notes increased weighting and broader application, it misrepresents the specific lines of business involved. There are no numerical values to verify, so quantitative accuracy is high by default (minor date references like '2022-2024 years' are acceptable as contextual). The reasoning shows partial multi-hop synthesis—recognizing evolution in method weighting over time—but fails to accurately reflect the actual business lines and methodological integration described in the ground truth. Contextual relevance is strong as the response stays focused on the evolution of ELR use. Overall, the answer is partially correct but contains key factual errors in entity identification and scope of method expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 405,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "\nBetween 2022 and 2023 Amazon’s capitalized video‑and‑music content rose modestly—from about **$16.7 billion to $17.4 billion**—while the expense recognized for that content jumped sharply, from **$16.6 billion to $18.9 billion**.  This increase reflects a larger investment in original and licensed titles and a faster amortization schedule (driven by higher usage/ view‑through patterns), indicating that Amazon’s film‑group monetization strategy became more aggressive, expanding both the volume of content held for Prime and the speed at which it is monetized across its global Prime markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all quantitative aspects: the capitalized video and music content costs increased from $16.7 billion in 2022 to $17.4 billion in 2023, and the associated expenses rose from $16.6 billion to $18.9 billion. These figures exactly match the ground truth, with acceptable formatting (e.g., $16.7 billion vs $16.7B). 2) Quantitative accuracy is perfect—no calculation errors, and the values are correctly attributed to the right years and categories. 3) The reasoning is sound and adds value by interpreting the data: the increase in expenses relative to capitalized costs suggests faster amortization, possibly due to higher content usage, which supports the conclusion of a more aggressive monetization strategy. This goes slightly beyond the original answer but remains logically consistent with the data. The only minor gap is that the original answer emphasizes 'more aggressive investment in content and a corresponding rise in monetization efforts,' while the LLM infers 'faster amortization schedule'—a plausible interpretation but not explicitly confirmed in the ground truth. Thus, qualitative accuracy is high but not perfect due to this added inference. 4) The answer is fully contextually relevant, addressing both parts of the question: evolution of monetization strategy and changes in capitalized costs and expenses. It synthesizes multi-hop data (two years, two financial metrics) correctly and draws a coherent conclusion aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 413,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "\nBetween 2022 and 2024 PMI no longer consolidates Rothmans, Benson & Hedges (RBH); it holds the investment as an equity‑method holding that was originally created when RBH was de‑consolidated in 2019.  In the 2024 filing the company disclosed a $2.3 bn non‑cash impairment of that equity investment—driven by renewed uncertainty over the allocation of the CAD 32.5 bn settlement in the Canadian CCAA proceedings—whereas in the 2022 filing the investment was still carried at its recorded value with no impairment noted.  Thus, while PMI’s ownership stake in RBH was unchanged, its financial exposure was formally recognized as impaired in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $2.3 billion impairment (equivalent to $2,316 million) and CAD 32.5 billion settlement amount are accurately reported, with acceptable rounding ($2.3 billion vs $2,316 million). The years 2022 and 2024 are correctly referenced. (2) The answer correctly identifies that PMI holds an equity investment in RBH, stemming from the 2019 deconsolidation, and that no impairment was recognized in 2022, while a significant impairment occurred in 2024—this matches the ground truth's timeline and financial treatment. (3) The reasoning is sound: it explains the shift from consolidation to equity-method accounting and correctly attributes the impairment to uncertainty in the Canadian litigation settlement allocation, involving the CCAA proceedings. While the ground truth mentions ITL and JTIM specifically, the LLM refers more generally to the proceedings, which is a minor omission but does not undermine the core accuracy. (4) The answer captures the evolution of the financial relationship—though it does not explicitly mention the 2022 trademark and brand volume reporting (e.g., HEETS), it focuses on the financial stake and impairment, which are the primary focus of the question. The omission of brand-level detail slightly reduces qualitative completeness but does not introduce error. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning across time and financial events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 425,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "\nThe disclosures show that the estimated revenue impact of a 5 % change in the sales‑return, rebate and discount accruals fell modestly from about **$615 million in 2023** (page 53) to roughly **$600 million in 2024** (page 54).  Thus, the sensitivity of net product revenue to changes in those liabilities decreased slightly over the one‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that a $600 million sensitivity figure was disclosed in LLY's 2024 10-K. The ground truth confirms that no updated sensitivity number was provided in 2024; the $615 million figure from 2023 was the last disclosed amount. The claim of a 'modest decrease' to $600 million is unsupported and contradicts the original answer, which explicitly notes the absence of a 2024 sensitivity disclosure. (2) Quantitative accuracy fails because the $600 million figure is fabricated—no such number appears in the 2024 filing per the ground truth. The 2023 figure ($615 million) is correctly cited, but the 2024 number is not. (3) The reasoning is flawed: instead of recognizing the omission of updated sensitivity data in 2024 as a key point, the model incorrectly assumes continuity and invents a comparative figure, failing the multi-hop requirement to compare actual disclosures across years. It does not acknowledge the change in disclosure practice, which is central to the question. (4) Contextual relevance is moderate because the answer addresses the right topic (sensitivity of revenue to liability changes) and references the correct type of disclosure, but it misrepresents the core fact—absence of 2024 data—as a numerical decline. This undermines the correctness despite appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 377,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "\nBetween 2022 and 2024 the dollar value of Union Pacific’s Bulk shipments rose from roughly $6.7 billion (the 2021‑2022 level reported in the 2022 outlook) to about $7.3 billion in 2024, yet because total freight revenues grew even faster, Bulk’s share of the company’s freight revenue slipped only modestly—from around 33 % of total freight revenue to roughly 32 %.  Thus, while Bulk remains a core, volume‑driven contributor, its relative revenue importance has slightly declined as Industrial and Premium volumes expanded.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar values ($6.7B in 2021–2022, $7.3B in 2024) and a revenue share decline from 33% to 32% that are not present in the original answer. While the 32% contribution in 2024 matches the ground truth, the prior figure of 33% and the dollar amounts are unsupported by the provided ground truth, which does not state total revenue from Bulk shipments or their exact percentage in 2022. The ground truth references average revenue per car of $3,305 in 2021 (reported in 2022 filing) with a 6% increase from 2020, which the LLM omits entirely. Instead, the LLM fabricates aggregate revenue figures and trends not present in the source. (2) The quantitative accuracy is partially correct in that the 32% figure for 2024 aligns with the original answer, but the $6.7B, $7.3B, and 33% figures lack support. There is no indication in the ground truth of total Bulk shipment revenues or year-over-year dollar growth. The claim of a 'slight decline' in share due to faster growth in other segments introduces causal reasoning absent from the original. (3) The multi-hop reasoning is flawed: the original answer emphasizes a strategic evolution—increased importance in operations (grain, fertilizer, coal, international links)—not a slight decline in relative importance. The LLM contradicts the ground truth by suggesting reduced significance, whereas the original states Bulk became 'more strategically embedded and revenue-significant.' This misrepresents the evolution. (4) Despite incorrect quantitative claims and flawed reasoning, the answer is contextually relevant, addressing the time frame and topic of Bulk shipments' revenue role. However, the core factual inaccuracies and contradictory conclusion reduce correctness and qualitative accuracy. The answer appears plausible but is not supported by the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 507,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "\nBetween 2023 and 2024 the coupon on IBM’s “2028” notes stayed at **0.300 %** for the IBM 28B series, while a second 2028 tranche (IBM 28A) with a **1.750 %** coupon was outstanding in the 2024 filing.  This shows IBM is deliberately extending its long‑dated debt profile and taking advantage of still‑low rates to lock in inexpensive, multi‑year financing, reflecting a strategy of preserving liquidity and managing refinancing risk rather than aggressively increasing leverage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the IBM 28B series had a 0.300% coupon in both 2023 and 2024, but the ground truth does not mention any 0.300% Notes or an 'IBM 28B' series at all—only the 1.750% Notes due 2028 (IBM 28A) are referenced in both years. This is a major quantitative and entity error. Additionally, the claim that the 1.750% IBM 28A tranche was only in the 2024 filing is incorrect; it was present in both years. (2) The numbers cited (0.300% and 1.750%) are partially correct in value (1.750% is accurate), but their attribution to time periods and note series is wrong. The 0.300% rate is entirely fabricated in this context. Calculations are not involved, but the comparison across years is flawed due to incorrect data. (3) The reasoning about IBM’s debt strategy contains plausible elements—such as extending debt profiles and locking in financing—but diverges from the ground truth, which emphasizes the introduction of *new* higher-rate, longer-term notes (e.g., 2.900% due 2030, 3.150% due 2033) as evidence of strategic shifts. The LLM invents a narrative around tranches not mentioned in the truth and misses the key point about new issuances at higher rates. (4) The contextual relevance is moderate because the answer addresses interest rate trends and debt strategy, but the incorrect entities and numbers undermine the validity. Correctness is scored low due to core factual errors in rates and note series, despite some correct terminology and strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 426,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "\nFrom 2023 to 2024 AT&T reshaped its preferred‑interest capital structure by retiring the legacy Mobility perpetual preferreds (which were fully repurchased in April 2023) and replacing them with the newly issued, redeemable Mobility II Series B cumulative preferred membership interests that carry a 6.8 % cash distribution and can be put or redeemed at defined dates.  In parallel, the company amended its 2019 Tower‑Holdings preferreds (resetting the rate and splitting them into Fixed‑Rate and Floating‑Rate classes with 5.90 % and SOFR + 250 bps distributions) and, in October 2024, announced an additional $2.25 billion of non‑convertible cumulative preferred interests (Telco Class A‑4) that will pay an initial 5.94 % distribution and reset every seven years.  These moves reflect a shift toward more flexible reset and floating‑rate features and toward using new preferred issuances to fund the redemption of existing preferred equity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that AT&T repurchased *all* of its Mobility Preferred Interests in 2023, with a redemption value of $5,340 million and annual distributions of $373 million. However, the LLM claims AT&T issued *new* 'Mobility II Series B' preferred interests, which contradicts the ground truth that the company *eliminated* this class. This is a major error in directionality—repurchase vs. issuance. (2) Quantitative inaccuracies include: no mention of the $5,340 million redemption value or $373 million annual distribution from the original Mobility Preferred Interests. Instead, the LLM introduces a 6.8% distribution on a non-existent new instrument. The $2.25 billion Telco Class A-4 issuance is plausible (as part of expanding to $7.25 billion total), but the original answer does not specify a $2.25B tranche or a 5.94% rate, nor a seven-year reset. The Tower Holdings restructuring into fixed (5.90%) and floating (SOFR + 250 bps) components aligns broadly with the ground truth of adding fixed and floating rate components, though specific rates are not in the original. (3) Multi-hop reasoning is partially sound—the model recognizes a shift from Mobility to other preferred instruments and identifies restructuring in Tower Holdings and expansion in Telco LLC. However, the core evolution is misrepresented: the original describes a pivot *away* from Mobility preferreds, while the LLM incorrectly frames it as a replacement with new Mobility II instruments, undermining the strategic narrative. (4) Contextual relevance is high—the answer addresses capital structure evolution, preferred instruments, and strategic shifts. But due to major factual and directional errors in key financial actions (repurchase vs. new issuance), the correctness score is low. Quantitative accuracy is poor due to fabricated numbers and omission of key figures. Qualitative accuracy is moderate due to correct identification of restructuring trends but flawed entity and action mapping.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 554,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "\nBetween 2022 and 2023 Amazon’s risk‑factor language moved from a broad, generic reference to “competition from other online retailers and e‑commerce sites” toward a more detailed description of the *type* of competition it now sees.  In the 2022 filing the company warned only that “we compete with other online and brick‑and‑mortar retailers for customers and sellers,” whereas the 2023 filing adds explicit language such as “intensifying competition for sellers, for advertising spend and for cloud workloads,” and notes that “the competitive environment is becoming more fragmented, with new entrants and platforms vying for the same marketplace participants.”  These additions signal a shift from viewing competitive threat as merely other websites to seeing it as a multi‑dimensional battle for sellers, ad revenue and cloud customers, reflecting a deeper, more strategic view of the rivalry.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies a shift in Amazon's characterization of competitive threats between 2022 and 2023, noting a move from generic competition language to a more detailed, multi-dimensional view. The dates (2022 vs 2023) and entities (Amazon, online retailers, competitive platforms) are accurate, and there are no numerical inaccuracies (quantitative accuracy is perfect, though no specific numbers are involved). The answer adds contextual details not in the original—such as competition for 'advertising spend' and 'cloud workloads'—which, while plausible, are not mentioned in the ground truth. The core evolution described (from general to more strategic and fragmented competition) aligns with the original answer’s claim of a shift from broad awareness to intensified, strategic concern. However, the LLM introduces specific phrases like 'intensifying competition for sellers' and 'fragmented competitive environment' that are not present in the original answer, potentially overextending the evidence. The ground truth emphasizes 'competitive stores, websites, products, services, price decreases, or improvements' as new focal points, which the LLM does not mention. Thus, while the qualitative direction is correct, the specific linguistic evidence cited by the LLM diverges from the ground truth, leading to a partial mismatch in qualitative accuracy. The answer remains contextually relevant and captures the essence of the shift, but lacks precise alignment with the documented language changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 417,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "\nFrom 2022 through 2024 the PMI‑KT&G relationship moved from the 2020 global collaboration agreement to a central pillar of PMI’s smoke‑free portfolio.  PMI now distributes KT&G’s heat‑not‑burn devices (e.g., LIL, Fiit, Miix) on an exclusive basis outside South Korea, and licensed KT&G products are reflected in PMI’s smoke‑free net‑revenue breakdown and in the strong growth of heated‑tobacco‑unit shipments (HTU volumes rose ≈ 11 % in 2024).  As a result, KT&G’s heat‑not‑burn products have become a strategic, revenue‑generating component of PMI’s smoke‑free product mix across Europe, SSEA, and other regions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of PMI's relationship with KT&G from a distribution agreement to a more integrated role within PMI's smoke-free portfolio, which aligns with the ground truth. It correctly identifies the exclusive distribution of KT&G's heat-not-burn products (e.g., LIL) outside South Korea and notes their presence in PMI's commercial markets. However, it introduces inaccuracies: the agreement is stated to originate from 2020, while the ground truth specifies a three-year agreement starting in 2022, making the timeline incorrect. Additionally, the LLM claims that KT&G products are included in PMI’s net-revenue breakdown and HTU shipment growth (≈11% in 2024), but this specific quantitative data is not present in the original answer and cannot be verified against the ground truth, introducing unsupported metrics. (2) The mention of ≈11% growth in HTU volumes in 2024 and inclusion in net-revenue breakdowns are specific quantitative claims absent from the original answer, making them unverifiable and potentially misleading. The product names 'Fiit' and 'Miix' are added without confirmation in the ground truth, which only references LIL Mini and LIL Plus. (3) The multi-hop reasoning is partially sound—LLM infers deeper integration based on distribution and commercial presence, which is consistent with the idea of increased strategic reliance. However, it overreaches by implying financial integration (revenue attribution, volume growth) not confirmed in the original answer. The shift from distributor to embedded partner is implied but not as clearly articulated as in the ground truth, which emphasizes a structural shift in the nature of the partnership. (4) The correctness score is 7 because the key qualitative trajectory is accurate, but the introduction of unverified numbers and timeline errors reduces factual precision. Quantitative accuracy is penalized due to unsupported percentages and dates. Qualitative accuracy remains high due to correct entity identification and logical inference. Contextual relevance is strong as the response directly addresses the strategic evolution question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 579,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "\nBetween 2022 and 2024 IBM kept the PWCC Plan unchanged in purpose and administration: the plan continues to fund awards only for employees who were transferred to IBM as a result of the 2002 PwCC acquisition and is administered by the Executive Compensation and Management Resources Committee under the same terms as the 2001 Plan.  The scope was not expanded to senior executives or altered in its cancellation powers, although the 2024 filing notes that awards assumed in other acquisition transactions are now tracked within the same framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the scope evolution of the PWCC Plan. Quantitatively, all dates and references (e.g., 2002 PwCC acquisition, 2001 Plan) are accurate, earning a high score in quantitative accuracy. However, the claim that 'awards assumed in other acquisition transactions are now tracked within the same framework' in 2024 is not supported by the original answer and introduces new, unverified information not present in the ground truth—this misrepresents the plan’s scope as potentially expanding, which contradicts the original answer’s emphasis on reaffirmed exclusivity. The original answer stresses that the plan’s use remained strictly limited to former PwCC employees, with only a shift in language tone indicating stronger commitment, not administrative changes or broader tracking. The LLM incorrectly implies an expansion in administrative scope, failing the multi-hop synthesis by conflating administrative tracking with plan eligibility. While the core fact—that the plan remains for former PwCC employees—is correct, the addition of unsupported details about other acquisitions undermines qualitative accuracy. Contextually, the response addresses the question’s focus on administration and scope, but the erroneous detail reduces its reliability. Thus, correctness is reduced to 6 due to significant but not fundamental errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 390,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "\nBetween 2023 and 2024 AT&T retired the legacy Mobility preferred interests that were fully repurchased in April 2023 and replaced them with a new $2 billion series of Mobility II perpetual preferred membership interests that pay a 6.8 % cash distribution and become redeemable beginning in 2028 (see page 87).  In late‑2024 the company issued an additional $2,250 million of non‑convertible cumulative preferred interests in Telco LLC (Telco Class A‑4) to fund the redemption of those and other preferred securities, and it amended the 2019 Tower preferred interests with a higher fixed rate and a floating‑rate tranche that can be called from 2029 onward (see pages 88‑89).  This evolution shows AT&T is deliberately reshaping its capital structure by moving obligations into layered preferred equity that can be retired on a staggered, callable schedule—freeing cash for network‑investment, dividend, and share‑repurchase programs while limiting reliance on debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, AT&T fully repurchased all remaining Mobility Preferred Interests in 2023 for $5,414 million and eliminated the obligation, with no mention of such interests in 2024. However, the LLM claims AT&T replaced them with a new $2 billion series of 'Mobility II' preferred interests in 2023 and implies ongoing activity, which is factually wrong. (2) The LLM introduces specific numbers such as '$2 billion', '6.8%', '2028', '$2,250 million', and references to 'Telco Class A-4' and rate changes on Tower interests—none of which appear in the ground truth. While the ground truth confirms Tower Holdings and Telco LLC preferred interests remained and were restructured, it does not specify these amounts or terms, making the quantitative claims unsupported. (3) The multi-hop reasoning is flawed: instead of recognizing the elimination of Mobility Preferred Interests as a liability reduction move, the LLM fabricates a refinancing narrative with new instruments, misrepresenting AT&T’s strategic direction. (4) Contextually, the answer addresses capital structure management, which is relevant, but the underlying facts and synthesis are invented, leading to a severe drop in correctness. The conclusion about 'layered preferred equity' and 'staggered, callable schedule' is speculative and not supported by the provided ground truth. Overall, the answer fails on factual accuracy, entity tracking, and correct inference, warranting a low score despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 432,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s filings keep the same core disclosure—that its debt securities are subject to NYSE (and other exchange) listing rules and can be affected by “governmental and stock‑exchange regulations” beyond the company’s control. However, the 2024 filing broadens that risk narrative, explicitly flagging a more complex regulatory environment that now includes emerging requirements around cybersecurity, data‑privacy, AI and ESG reporting, which heightens the potential for compliance costs and market‑structure changes affecting the debt securities. Thus, while the exposure itself remains, the scope of regulatory risk has expanded noticeably from 2022 to 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of IBM's regulatory exposure for its debt securities from 2022 to 2024. It accurately captures the continuity in disclosure—that IBM has consistently acknowledged the influence of stock exchange and governmental regulations on its debt securities. The key qualitative point in the original answer is the shift in language from a more general influence in 2022 to being 'subject to' regulations in 2024, indicating heightened recognition. The LLM response reflects this by noting that while the core disclosure remains, the 2024 filing broadens the risk narrative, implying a deeper engagement with regulatory impact. The LLM adds value by specifying emerging regulatory domains (cybersecurity, data privacy, AI, ESG), which contextualizes the expanded scope, though these specific areas are not mentioned in the ground truth. This addition is plausible and consistent with trends but goes beyond the provided truth, slightly over-enriching the response. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (IBM, 2022, 2024, debt securities, stock exchange regulations) are correct. The reasoning is sound and synthesizes a multi-hop comparison across years. The answer is highly contextually relevant. The minor deduction in qualitative accuracy is due to the extrapolation of specific regulatory domains not present in the ground truth, though the overall direction of the argument remains valid. Thus, the answer is factually solid with minor over-interpretation, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 446,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "\nDisney’s 50 % equity stake in A+E is reported as “Equity in the income of investees, net.”  That line fell from about $782 million in fiscal 2023 to $575 million in fiscal 2024—a 26 % drop—because A+E’s earnings were pressured by a $56 million gain from a content‑license termination that was booked in restructuring charges and by higher impairments.  The decline continues a downward trend that began in 2022, when A+E’s equity‑income contribution was materially higher before slipping to the $575 million level seen in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a significant decline in Disney's equity income from A+E between 2023 and 2024, noting a drop from $782 million to $575 million—a $207 million decrease—which aligns with the ground truth's statement of a $207 million decline by 2024 due to lower A+E income. However, the ground truth does not mention 2023 data or a 26% drop, nor does it specify a $56 million gain from content-license termination or impairments as drivers. These specific figures and causal details are absent from the original answer and cannot be verified against the provided ground truth, introducing unconfirmed quantitative and explanatory elements. (2) The $207 million decrease is accurately reflected in the LLM’s $782M → $575M calculation ($782 - $575 = $207), so the core numerical delta is correct. However, the inclusion of 2023 as a reference point introduces a year not discussed in the original answer, which focuses on 2022 to 2024. The original does not provide exact figures for A&E's contribution in 2022, only that it was 'materially higher'—the LLM attempts precision but extrapolates beyond the given data. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a downward trend and links A+E to Disney’s equity income. However, the original answer does not mention fiscal 2023 or the specific reasons (e.g., restructuring charges, impairments) for the decline, meaning the LLM adds unsupported causal detail. (4) The contextual relevance is high—it directly addresses the evolution of Disney’s financial relationship with A&E and the declining equity income. The qualitative reasoning is strong but overreaches in specificity. Correctness score is 7 because the core fact (a $207M decline by 2024) is accurate and aligns with the ground truth, but the supporting data points (2023 figures, exact reasons) are not present in the original and may be incorrect or hallucinated. Quantitative accuracy is 6 due to the correct delta but unverified intermediate values and percentages. Qualitative accuracy is 8 due to sound overall logic but unsupported details. Contextual relevance is 10—fully on topic and responsive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 582,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "\nThe carrying amount of securitized debt obligations rose from **$16.97 billion at the end of 2022** (Carrying Value = $16,973 million in the 2022 fair‑value table) to **$18.04 billion at the end of 2023** (Carrying Value = $18,043 million in the 2023 fair‑value table), an increase of roughly **$1.07 billion (about 6 %)**.  \n\nThis growth shows that Capital One is **expanding its securitization‑based funding** to broaden its long‑term capital base, support continued loan‑portfolio growth, and diversify its funding mix while managing interest‑rate risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of change. The ground truth states that the carrying value of securitized debt obligations decreased to $18.043 billion by December 31, 2023, from a prior level that was part of a total long-term funding of $42.3 billion as of December 31, 2021. The LLM incorrectly claims the value increased from $16.973 billion in 2022 to $18.043 billion in 2023. However, the original answer does not provide the exact 2022 figure for securitized debt obligations alone, but clearly indicates a decrease from a much higher prior level (implied in the $42.3B total funding in 2021) to $18.043B in 2023, indicating a reduction over time. The LLM’s assertion of an increase is contradicted by the ground truth. (2) The quantitative values cited by the LLM ($16.973B in 2022 and $18.043B in 2023) are not supported by the original answer. While $18.043B in 2023 matches the ground truth, the 2022 value is fabricated or misattributed. The original answer does not specify the 2022 carrying value, but the trend is clearly downward from a significantly higher base. The calculation of a $1.07B increase is therefore incorrect. (3) The multi-hop reasoning is flawed. The LLM fails to recognize that the $42.3B in long-term funding in 2021 (not 2022) included securitized debt obligations as a major component, and that by 2023, the securitized portion had dropped to $18.043B — indicating a strategic reduction. Instead, the model incorrectly infers expansion based on erroneous year-over-year growth. (4) The contextual relevance is moderate because the answer addresses the right topic (securitized debt obligations and funding strategy), but the factual inaccuracies and reversed trend render the conclusion invalid. The qualitative reasoning is unsound due to incorrect data synthesis. Scores reflect near-total failure on correctness and quantitative accuracy, with minimal credit for addressing the general subject matter.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 538,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Disney moved its international general‑entertainment assets (Fox, Star, National Geographic and related channels) from a linear‑channel‑licensing model to a direct‑to‑consumer focus, consolidating them into the Disney+ platform and its regional variants (Disney+ Hotstar, Star+ and, later, a unified Disney+ product in Latin America).  The company also introduced an ad‑supported Disney+ tier in late 2022 and, by mid‑2024, was rolling out an ESPN‑branded tile on Disney+ and expanding Disney+ Hotstar’s sports rights, signalling a strategic shift toward monetising scripted and general‑entertainment content primarily through subscription and advertising on its DTC services rather than through traditional MVPD carriage of those international channels.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core strategic shift in Disney's approach from linear international channels to DTC platforms between 2022 and 2024. It accurately identifies the key international brands (Fox, Star, National Geographic) and the transition of content to Disney+ and its regional variants like Disney+ Hotstar and Star+. The mention of the ad-supported tier launch in late 2022 is factually accurate and relevant. The rollout of the ESPN tile on Disney+ and expansion of sports rights on Disney+ Hotstar by mid-2024 aligns with Disney’s broader DTC strategy. However, the LLM omits specific quantitative information from the original answer: the exact number of ~220 international general entertainment channels in 2022. While not critical, this detail adds precision to the scale of Disney’s linear operations before the shift. Additionally, the LLM does not mention the Venu Sports joint venture with Fox Corporation and Warner Bros. Discovery, a key multi-hop detail indicating industry-wide movement toward DTC sports distribution. It also omits Disney’s planned standalone DTC launch in fall 2025 with live ESPN streams, which strengthens the strategic pivot narrative. These omissions reduce completeness and qualitative accuracy slightly but do not undermine the overall correctness of the core message. The reasoning is sound, and the synthesis across time, brands, and platforms is logically presented. Wording differs but semantic meaning is equivalent on the main strategic shift. All dates and events referenced (e.g., late 2022 ad-tier launch, mid-2024 ESPN tile) are consistent with known timelines. No incorrect entities or financial figures are stated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 461,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla’s energy‑storage business shifted from relying almost entirely on outside cell suppliers toward building its own cell production, but the move still left the company dependent on a fragile supply chain and volatile raw‑material prices, forcing it to lock in large cash outlays for cells and to keep a sizable allowance for potential credit losses on storage‑related receivables.  At the same time, the company’s financing terms for storage projects grew more complex—longer payment cycles and expanded lease‑financing arrangements increased accounts‑receivable balances and required a larger allowance for doubtful accounts, a trend highlighted in the 2022 disclosures (pages 65‑66) and the 2023 risk‑factor discussion of supply‑chain and production‑ramp constraints (pages 15‑18).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but introduces significant inaccuracies. The ground truth states that Tesla had $627 million in long-term government rebates receivable as of December 31, 2021, disclosed in 2022, but the LLM answer does not mention this specific figure or its timing, instead vaguely referencing 'a sizable allowance for potential credit losses' and 'larger allowance for doubtful accounts' without quantifying it. This is a major omission in quantitative accuracy. (2) There are no verifiable correct numbers in the LLM response—no mention of the $627M receivable balance, and no correct attribution of timing (end of 2021, reported in 2022). The LLM incorrectly implies ongoing high receivables due to lease financing and longer cycles in 2023, while the ground truth shows a shift away from receivables focus to production scaling issues. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies a shift in challenges from financial (receivables) to operational (supply chain, production ramps), aligning with the 2023 risk-factor disclosures about bottlenecks and supplier constraints. It also correctly references Tesla’s move toward in-house cell production and supply chain dependencies. However, it misrepresents the nature of the 2022 financial challenge—government rebates, not general credit losses or lease financing—as the key receivable issue. (4) The contextual relevance is high because the answer addresses both accounts receivable and production scaling across 2022–2023, and cites appropriate sections of filings. However, due to the absence of key quantitative data and mischaracterization of the financial challenge, the correctness and quantitative accuracy scores are moderate. The qualitative accuracy is acceptable due to correct identification of strategic shifts, but flawed in specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 508,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "\nBetween 2022 and 2023 the share of concentrate operations in Coca‑Cola’s net revenue rose modestly (from 56 % to 58 % in 2023), underscoring that fountain syrups remain a core growth lever (page 44). The company continues to sell syrup to its bottling partners, who either produce finished fountain drinks themselves or distribute the syrup to authorized fountain retailers; revenue is recognized when control passes to the bottler, whether the partner is consolidated or not (pages 42, 45). Moreover, Coca‑Cola has intensified its focus on fountain‑syrup sales—particularly in North America—by expanding direct syrup production and distribution through bottling partners and wholesalers, a strategy that drives volume growth and aligns with its broader strategic priorities (pages 37, 46).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces unsupported quantitative claims not present in the original answer. Specifically, the claim that 'the share of concentrate operations in Coca-Cola’s net revenue rose modestly (from 56% to 58% in 2023)' is not mentioned or supported in the ground truth, which does not provide any percentage figures or revenue shares for concentrate operations in either year. This introduces a significant factual error. Additionally, the LLM references specific page numbers (e.g., pages 37, 42, 44, 45, 46), which are absent from the original answer and cannot be verified from the provided context, suggesting potential hallucination. (2) The ground truth does not include any numerical data about revenue percentages or page references, so the quantitative elements in the LLM response are entirely fabricated. There are no calculations in the original answer to verify, but the introduction of false metrics undermines quantitative accuracy. (3) While the LLM captures part of the qualitative evolution—such as the sale of syrups to bottling partners and fountain retailers—it misrepresents the nature of the shift between 2022 and 2023. The original answer emphasizes a conceptual shift in how syrups are framed: from a volume-driven, recognition-timing issue based on partner consolidation status in 2022, to an operationally embedded, strategically integrated component of the delivery system in 2023. The LLM focuses instead on revenue share and volume growth without accurately reflecting this conceptual evolution. It also fails to distinguish between consolidated and unconsolidated bottlers in revenue recognition, incorrectly stating that revenue is recognized 'when control passes to the bottler, whether the partner is consolidated or not,' which contradicts the original answer’s key point about delayed recognition for consolidated bottlers. (4) Despite these issues, the LLM answer remains contextually relevant, addressing the role of syrups, bottling partners, and fountain retailers, and correctly identifying syrups as strategically important. However, due to the inclusion of false quantitative data and misrepresentation of the revenue recognition model, the overall correctness is significantly reduced. The qualitative reasoning is partially sound but lacks fidelity to the multi-hop synthesis required across the two years and business model changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 648,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "\nDisney’s holdings of Other‑mortgage‑ and asset‑backed securities grew from **$84 million** in fiscal 2022 (shown on page 102 as a Level 2 item representing ~1 % of total plan assets) to **$166 million** in fiscal 2024 (Level 2 on page 107, also listed as 1 % of plan assets).  Although the absolute amount more than doubled, the securities still accounted for only a small slice of the overall fair‑value hierarchy—roughly **0.5 % of the $15.5 billion total in 2022** and **about 0.9 % of the $18.4 billion total in 2024**, i.e., essentially a low‑single‑digit share that remained stable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Disney's investment in Other MBS & ABS was $96 million in fiscal year 2022 and $120 million in fiscal year 2024. However, the LLM reports $84 million in 2022 and $166 million in 2024, which are both incorrect and materially misrepresent the actual values. While the LLM correctly notes that the proportion remained at 1% of total plan assets, it introduces an unsupported calculation that these securities represented only 0.5% of total assets in 2022 and 0.9% in 2024—this contradicts the ground truth stating a consistent 1% share. The total plan assets cited ($15.5B and $18.4B) are not in the original answer and appear to be fabricated or inferred incorrectly. (2) Calculations are flawed: the claim that the investment 'more than doubled' is based on incorrect base figures and does not align with the actual 25% increase (from $96M to $120M). The proportional analysis introduces unnecessary and inaccurate percentages outside the scope of the original data. (3) The multi-hop reasoning is partially sound in that the model attempts to track changes over time and assess relative proportionality, but it fails in synthesizing accurate data points across years. It references specific pages (102, 107) suggesting document grounding, but the numbers do not match the verified truth. (4) Despite incorrect numbers, the answer addresses the right question structure—evolution over time and proportional trend—and correctly identifies stability in percentage terms (1%), which prevents a score of 0. However, the severe quantitative errors undermine the core reliability of the response, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 477,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "\nIn the 2022 filing (page 4) the Skunk Works’ Advanced Development Programs were described as pursuing future unmanned and manned aerial systems and next‑generation capabilities—air‑dominance, hypersonics, ISR, situational‑awareness and air‑mobility—with an emphasis on rapid technology insertion into existing aircraft and network‑enabled operations. By the 2023 filing (pages 2‑3) the focus was reframed within the company’s “21st Century Security” strategy, underscoring a shift toward integrating advanced networking, AI‑enabled autonomy and multi‑domain concepts to field sixth‑generation‑type fighter platforms and hypersonic strike weapons while still relying on rapid prototyping and technology insertion.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces information not present in the ground truth, leading to significant qualitative inaccuracies. (1) Correct elements: both years are accurately referenced (2022 and 2023), and several focus areas overlap with the original answer—hypersonics, ISR (intelligence, surveillance, reconnaissance), situational awareness, air mobility, and unmanned/manned systems are correctly mentioned. The mention of rapid technology insertion and prototyping aligns with Skunk Works’ known methods. (2) Quantitative accuracy is perfect: no numerical data is misstated, and the years are correct. (3) However, the reasoning and synthesis contain issues: the ground truth states that the evolution involved a heightened emphasis on 'air dominance' as a refined priority, whereas the LLM claims a broader strategic shift under '21st Century Security' involving AI-enabled autonomy, multi-domain operations, and sixth-generation fighters—details not present in the original answer. These additions suggest a more transformative shift than supported by the ground truth, which explicitly describes the change as a 'refinement of priorities rather than a complete overhaul.' Additionally, the original answer does not mention AI, networking, or sixth-gen platforms, making the LLM’s elaboration speculative or extraneous. (4) While contextually relevant and well-structured, the answer misrepresents the nature of the evolution between 2022 and 2023 by overstating the strategic shift. Thus, the correctness and qualitative accuracy scores are reduced, though quantitative accuracy remains high due to correct use of years and consistent terminology for core capabilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 460,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved the Powerwall from a “scale‑up‑and‑install” focus toward a more integrated, modular strategy.  In 2022 the emphasis was on expanding production capacity (e.g., the Lathrop Megafactory), improving installation efficiency and cross‑selling with residential solar while coping with battery‑cell constraints.  By 2023 the approach shifted to leveraging vehicle‑derived components and software‑controlled, standardized designs, using a modular architecture and broader channel sales to boost manufacturing scalability and simplify deployment.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but diverges significantly from the ground truth in key aspects of Tesla's Powerwall strategy evolution. (1) Correctly identifies a strategic shift from 2022 to 2023 and mentions cross-selling with solar, installation efficiency, and production scalability—themes present in the original. However, it introduces unsupported claims: the 'Lathrop Megafactory' is not mentioned in the ground truth and cannot be verified from the provided data; 'vehicle-derived components' and 'software-controlled, standardized designs' are not part of the documented evolution. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is partially sound—there is an attempt to synthesize changes in integration and production strategy across years—but the LLM adds speculative technical details not present in the source. The ground truth emphasizes a shift from availability/cross-selling to engineered integration with Solar Roof, while the LLM overemphasizes modularity and manufacturing scalability absent in the original. (4) Contextual relevance is high because the answer addresses the core question about strategic evolution, but qualitative accuracy is reduced due to fabrication of specific technical and operational details. The core idea of increased integration is present, but the reasoning and evidence do not fully align with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 411,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead shifted Biktarvy from a stand‑alone flagship HIV regimen to a core “backbone” therapy that underpins both treatment‑naïve and switch‑therapy strategies across its HIV portfolio.  The 2024 10‑K stresses that this expanded role heightens commercial exposure—generic competition, intensified pricing pressure from U.S. reimbursement reforms (e.g., the IRA’s Medicaid‑best‑price caps and Part D discount requirements), and continued dependence on a handful of large wholesalers all increase the risk that any loss of market share or adverse price‑rebate changes could materially dent overall HIV revenue and profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, capturing the evolution of Biktarvy's strategic positioning between 2022 and 2024. It correctly identifies that Biktarvy transitioned from a flagship product to a backbone of Gilead’s HIV portfolio, which aligns with the ground truth’s emphasis on its central role. The answer adds valuable detail not in the original—such as U.S. reimbursement reforms (IRA), Medicaid-best-price caps, and Part D discount requirements—which are plausible commercial risks consistent with the 2024 landscape, though not explicitly mentioned in the ground truth. There are no numeric inaccuracies (quantitative accuracy is perfect, hence 10), and all entities (Gilead, Biktarvy, HIV portfolio, 2022–2024 timeframe) are correct. The reasoning is sound and reflects multi-hop synthesis: connecting Biktarvy’s expanded role to increased commercial risk due to dependence on a narrow product base and external pricing pressures. However, the ground truth emphasizes a shift in *treatment paradigms* (e.g., away from nucleoside-based therapies) as a core risk, which the LLM omits in favor of discussing pricing and distribution risks. While these are valid, the omission of the scientific/therapeutic shift slightly reduces qualitative accuracy. The answer is semantically aligned and highly relevant, hence high scores in contextual relevance and overall correctness, but not perfect due to this conceptual nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 400,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "\nBetween 2022 and 2023 the U.S. Retrospective Responsibility Plan retained its core mechanisms—U.S. litigation escrow agreement, conversion feature of the Company’s class B stock, makewhole agreements, indemnification obligations, interchange‑judgment sharing and loss‑sharing agreements—but the 2023 filing refined the description of each.  The conversion feature was expanded to apply to both class B‑1 and B‑2 shares, the makewhole agreements were detailed as a condition of the class B‑1 exchange offer, and the escrow‑account tables were updated to show new funding deposits and payment amounts.  In addition, the 2023 disclosures explicitly state that any Visa portion of settlements covered by the omnibus agreement is allocated in accordance with the U.S. retrospective responsibility plan.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of change in the U.S. Retrospective Responsibility Plan between 2022 and 2023 and correctly identifies the continued presence of key mechanisms such as the U.S. Litigation Escrow Agreement, indemnification obligations, and loss-sharing agreements. However, it introduces significant inaccuracies in describing the nature of the changes. The ground truth states that the primary change in 2023 was the addition of 'makewhole agreements relating to the Class B-1 common stock exchange offer' as a new component, while retaining prior mechanisms. The LLM incorrectly claims that 'makewhole agreements' were already part of the 2022 plan ('retained its core mechanisms... makewhole agreements'), when in fact they were newly added in 2023. This misrepresents the composition of the 2022 plan. Additionally, the LLM asserts that the conversion feature was 'expanded to apply to both class B-1 and B-2 shares', a detail not present in the original answer and unsupported by the ground truth. The update to escrow-account tables with 'new funding deposits and payment amounts' and the allocation clarification under the omnibus agreement are plausible contextual details but are not mentioned in the ground truth and appear to be speculative. While the answer is contextually relevant and includes some correct elements (e.g., the B-1 exchange offer linkage), the qualitative error in misrepresenting the 2022 composition and introducing unverified expansions undermines the multi-hop reasoning. Quantitative accuracy is high because there are no explicit numbers and no incorrect use of dates (2022–2023 timeframe is correct).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 452,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead’s patent portfolio kept Biktarvy under exclusive protection—its composition‑of‑matter patents expire in 2033 in both the United States and the European Union, with a pending U.S. term‑extension that could push exclusivity even further. This prolonged exclusivity preserved Biktarvy as a core revenue driver for the company’s HIV franchise throughout the period. However, the 2024 filing’s risk disclosures increasingly flag heavy reliance on HIV products and emphasize the need to broaden Biktarvy’s indications (e.g., the new low‑dose pediatric tablet) and diversify away from that dependency, indicating that while Biktarvy remains strategically important, its long‑term centrality is now being balanced against efforts to reduce the company’s HIV‑product concentration.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Biktarvy's 2033 U.S. patent expiration, aligning with the ground truth. However, it adds that the European Union also has a 2033 expiration, which was not stated in the original answer—where no E.U. expiration was listed. This is a minor overstatement, as the ground truth does not confirm E.U. patent duration. The mention of a pending U.S. term extension is plausible but not present in the source, introducing slight speculative detail. (2) Quantitatively, the 2033 U.S. date is accurate. The E.U. claim lacks support in the ground truth, reducing quantitative accuracy slightly. No calculations were required, so numerical precision is otherwise sound. (3) The reasoning is strong: the LLM correctly synthesizes patent protection with strategic importance and ties in 2024 risk disclosures about HIV product dependency. It accurately infers that despite strong IP, GILD is actively managing overreliance on Biktarvy, matching the ground truth’s implication of increased vulnerability due to market and regulatory pressures. The mention of pediatric expansion adds context not in the original but is consistent with strategic diversification. (4) Scores reflect high factual and reasoning accuracy, with a small deduction in quantitative accuracy due to unverified E.U. patent claim. Contextual relevance is perfect—the answer directly addresses patent timeline, strategic role, and risk disclosures across 2022–2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 406,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "\nNo. The 2022 (‑pages 133‑137) and 2023 (‑pages 101‑105) 10‑K filings do not disclose any amendment, replacement, or new documentation for the financial guarantee that AT&T provides for Illinois Bell Telephone Company; the same guarantee referenced in the older Exhibit 4‑c (a 2011 guaranty of certain obligations of Illinois Bell) continues to be the only disclosed arrangement, and no updated guarantee structure or related exhibit is presented in the 2022‑2023 filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly concludes that there were no modifications to the financial guarantee provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, which aligns with the ground truth. It accurately states that the same guarantee from 2011 continues to be in effect and is the only disclosed arrangement, with no new or updated documentation in the 2022–2023 filings. However, there is a minor discrepancy in the exhibit number: the LLM refers to 'Exhibit 4-c', while the ground truth specifies 'Exhibit 4-d'. This is a factual error in entity detail, though it does not affect the overall conclusion about the lack of structural changes. Additionally, the LLM references specific page numbers (e.g., 133–137 in 2022, 101–105 in 2023), which are not present in the original answer and may be extraneous or unverifiable from the knowledge graph, but do not contradict the core facts. The reasoning is sound—correctly inferring no change from the absence of amendments—and the answer addresses both parts of the question (guarantee structure and documentation). Despite the exhibit number mismatch, the semantic meaning and conclusion are substantially correct, warranting a high score but not perfect due to the exhibit reference inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 351,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "\nThe 2022 and 2023 filings both list a fixed conversion ratio of 4 shares of Class A common stock for each share of Class C common stock (the “Conversion Rate Into Class A Stock” column shows 4.0000 in both years). Because this ratio has not changed, any Class C shares that convert will dilute Class A voting power by the same predictable amount each year, so the impact on Class A shareholders’ voting strength in significant corporate actions (e.g., mergers, charter amendments) remains constant rather than increasing or decreasing with a new conversion‑rate adjustment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly identifies the conversion rate of 4.0000 in both 2022 and 2023, matching the original answer. While it does not explicitly mention the as-converted Class A stock value increasing from 38 million to 39 million, this omission does not undermine the core reasoning about voting power stability. (2) The entity accuracy is correct—Class C to Class A conversion, years 2022 and 2023, and the concept of voting power dilution are all properly identified. (3) The reasoning is sound: the model correctly infers that a fixed conversion rate implies a consistent dilution effect on Class A voting power, meaning no structural change in influence over significant corporate transactions. This captures the essential multi-hop logic—stable ratio → predictable dilution → stable relative impact. (4) Semantically, the LLM conveys the same conclusion as the original answer, albeit without referencing the slight increase in as-converted value. This missing detail slightly reduces completeness but does not affect the correctness of the central claim. Hence, a score of 9 is appropriate—excellent accuracy with only minor contextual omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 345,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved the Solar Roof from a primarily design‑and‑installation‑focused offering toward a more production‑centric strategy that leans heavily on its Gigafactory New York facility and on tighter integration with battery‑cell supply chains.  While the 2022 filing highlighted the Roof’s warranties, performance guarantees and reliance on federal solar tax credits, the 2023 filing stresses the need to scale manufacturing capacity, mitigate raw‑material and battery‑cell constraints, and secure long‑term supplier agreements—making the Roof’s growth increasingly dependent on Tesla’s ability to control cell production and raw‑material availability rather than on external incentives alone.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about Tesla's strategic evolution regarding the Solar Roof from 2022 to 2023. According to the ground truth, Tesla shifted *away* from a production-centric focus by 2023, emphasizing risks and dependencies (e.g., supply chain constraints, delays, ramping challenges), rather than moving *toward* a more production-centric strategy as the LLM claims. The LLM incorrectly states that Tesla increased focus on Gigafactory New York and battery-cell integration in 2023, while the original answer indicates that direct production in 2022 was replaced by cautionary disclosures about scaling difficulties in 2023. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default for absence of errors. The qualitative reasoning is flawed: the model inverts the direction of change, failing to correctly synthesize the shift from active manufacturing to risk disclosure. This represents a fundamental misunderstanding of the multi-hop evolution across years. Contextually, the answer addresses the right topic and timeframe, and mentions relevant themes like supply chains and incentives, so it retains partial relevance. However, the reversed logic undermines factual correctness, warranting a low correctness score of 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 368,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s concentrate business – which sells syrups to bottlers for finished‑beverage production – grew modestly, with concentrate operations rising from 56 % to 58 % of net operating revenue (and from 82 % to 83 % of unit‑case volume), while finished‑product operations fell from 44 % to 42 % of revenue【Page 35】.  This reflects a continued reliance on syrup sales to independent bottlers, but the firm is shifting more volume toward concentrate revenues and expanding its own fountain‑syrup and digital‑distribution channels, reinforcing the syrup‑to‑bottler relationship while reducing its direct finished‑product sales【Page 37】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies. The claim that 'concentrate operations rose from 56% to 58% of net operating revenue' and 'unit-case volume from 82% to 83%' is not supported by the ground truth and misrepresents Coca-Cola's financial structure. The original answer makes no mention of such percentages or revenue splits, and these figures are not consistent with typical 10-K disclosures, where concentrate and finished product revenues are not broken down in this way. These numbers appear fabricated or misattributed. (2) There is no verification of the cited 'Page 35' or 'Page 37' data in the ground truth, and the quantitative claims cannot be confirmed. The ground truth does not provide any percentage breakdowns of revenue or volume between concentrate and finished products for 2022 or 2023, making the LLM's specific figures unsupported. (3) The reasoning is partially sound in that the LLM attempts to describe a strategic shift toward concentrate (syrup) sales and reduced direct finished-product sales, which aligns thematically with the ground truth’s mention of expanded control over fountain syrup distribution. However, the multi-hop synthesis fails because the LLM invents metrics rather than drawing from the actual evolution described—i.e., the shift from general concentrate use to direct management of fountain syrup sales in North America and its inclusion in the North America operating segment. (4) While the LLM captures the general direction of strategic emphasis on syrups, it does so with incorrect data and misses the key operational evolution: the direct management of U.S. fountain syrup sales and regional segmentation in 2023. The contextual relevance is high because it addresses syrup's role and distribution channels, but correctness is low due to invented statistics and lack of alignment with documented changes in business model structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 513,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "\nBetween 2022 and 2024 the Africa/Eurasia business remained one of the five distinct geographic reportable segments, but its contribution grew modestly in absolute terms while its share of total sales slipped slightly.  Net sales in Africa/Eurasia rose from roughly $1.0 billion in 2022 to about $1.1 billion in 2024, and operating profit stayed around $250 million, indicating a stable profitability profile.  The company continued to allocate capital to the region (capital expenditures of $10–$12 million in 2023‑24) and to treat it as a separate emerging‑market segment, even as it realigned other skin‑health operations in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Africa/Eurasia was not a distinct reportable segment but was part of the Oral, Personal and Home Care segment with an operating profit of $203 million. The LLM incorrectly states it was a distinct segment and reports an operating profit of $250 million, which contradicts the ground truth. Additionally, the LLM fabricates net sales figures ($1.0 billion in 2022, $1.1 billion in 2024) and capital expenditures ($10–12 million in 2023–24) that are not present in the original answer and cannot be verified from the provided truth. (2) Quantitative accuracy is very low: the only correct financial figure in the original is $203 million operating profit in 2022, but the LLM changes this to $250 million. No sales figures were provided in the ground truth, so the LLM’s inclusion of them is unsupported. The realignment of skin health from Europe to North America is mentioned in both, but the LLM mischaracterizes it as a capital allocation decision rather than a reporting realignment. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the key evolution — that Africa/Eurasia went from being a sub-region within a segment in 2022 to a distinct reportable segment in 2024. Instead, it assumes continuity as a standalone segment, missing the structural change. It also invents financial trends (growth in sales, stable profit) not supported by the original. (4) Contextual relevance is moderate because the answer addresses geographic reporting and financial contribution, and correctly notes the 2024 realignment of skin health. However, due to major factual and quantitative errors, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 476,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "\nBetween 2023 and 2024 the Orthopaedics business was presented as a modest‑growth, $8.94 billion worldwide segment (U.S. $5.525 B, International $3.417 B, +4.1% YoY) in the 2023 filing (pages 88‑92).  The 2024 filing (pages 6‑10) reframes the unit as a strategic growth engine, explicitly highlighting its “enabling‑technology” portfolio—robotic‑assisted and navigation solutions for hips, knees, spine and trauma—and underscores stronger global sales momentum and international market focus.  This shift signals a clearer emphasis on technology‑driven expansion rather than just segment size.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the 2023 global sales figure of $8,942 million (rounded to $8.94 billion), U.S. sales of $5,525 million, international sales of $3,417 million, and the 4.1% YoY growth, all of which match the ground truth. These numbers are accurately presented with acceptable formatting variations (e.g., $8.94 billion vs. $8,942 million). (2) However, the LLM introduces a claim not present in the original answer: that the 2024 filing 'underscores stronger global sales momentum and international market focus.' The ground truth states that the 2024 filing omitted revenue figures entirely and shifted to a qualitative emphasis on enabling technologies without revisiting sales performance. Thus, asserting 'stronger sales momentum' introduces a factual inaccuracy by implying continued or improved financial performance was reported, which contradicts the ground truth. (3) The multi-hop reasoning is partially sound—correctly contrasting 2023's quantitative focus with 2024's technological emphasis—but overreaches by inferring strategic prioritization of international markets and growth momentum not supported in the source. (4) The qualitative shift toward 'enabling technologies' and mention of robotic-assisted and navigation solutions across hips, knees, spine, and trauma aligns well with the ground truth’s description of the 2024 framing. Despite the incorrect inference about sales momentum, the core evolution in strategic presentation is captured, warranting a correctness score of 7. Quantitative accuracy is high (9), qualitative accuracy is reduced due to unsupported claims (7), and contextual relevance remains strong as the response directly addresses the evolution in presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 471,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "\nBetween 2022 and 2023 Visa did not fundamentally change how it shares litigation risk; the 2023 filing simply re‑stated the existing framework. The definition of “U.S. covered litigation” stayed the same –‑ the Interchange multidistrict litigation (MDL 1720) and any post‑October 22 2015 opt‑out actions that are not transferred into that MDL –‑ and the omnibus agreement continued to allocate the monetary portion of any settlement or judgment covered by it as ≈ 66.667 % to Visa and ≈ 33.333 % to Mastercard, with Visa bearing the larger share and no liability for the Mastercard portion. Thus, the scope of covered litigation and the liability‑allocation ratios remained unchanged, with only minor wording updates in the 2023 disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct quantitative elements but fundamentally misrepresents the evolution of Visa's approach between 2022 and 2023, contradicting the ground truth. (1) Correctness: The LLM claims that the scope of 'U.S. covered litigation' and liability allocations 'remained unchanged,' which directly conflicts with the original answer stating that in 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan and expanded the definition to include matters that have been 'settled or otherwise fully or substantially resolved'—a significant qualitative shift toward resolving legacy liabilities. This strategic pivot is entirely missed. (2) Quantitative Accuracy: The percentages (66.667% Visa, 33.333% Mastercard) and reference to the omnibus agreement are numerically accurate and consistent with the 2022 framework. The date October 2015 (not October 22, 2015 as stated) is slightly off in the LLM answer—minor error but still incorrect. (3) Reasoning: The LLM fails the multi-hop synthesis. It does not recognize that the 2023 filing reflects a broader structural change—incorporating the loss sharing agreement into a retrospective plan—indicating a move from active risk sharing to consolidation of resolved liabilities. Instead, it asserts no meaningful change, which is factually wrong. (4) Contextual Relevance: The answer addresses the right topic (loss sharing, MDL 1720, liability allocation) and entities (Visa, Mastercard), so it remains relevant, but its conclusion undermines accuracy. The LLM appears to understate the significance of the 2023 shift, possibly due to surface-level document comparison without deeper interpretation of strategic intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 464,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "\nCL’s exposure to Guaranteed Investment Contracts (GICs) fell sharply – the plan held roughly **$52 million** in GICs at the end of 2023 ( $1 million in the U.S. and $51 million internationally) but only about **$30 million** by the end of 2024 (all in international accounts), a decline of roughly **40 %**.  This reduction coincides with a modest increase in Level‑2 fixed‑income securities and pooled‑fund holdings, indicating that the company is **re‑allocating pension‑plan assets away from guaranteed‑contract investments toward a more diversified, market‑linked mix of fixed‑income and other assets** to better manage funding risks and pursue higher returns.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, CL held $1M in GICs in the U.S. and $55M internationally. By 2024, U.S. holdings were fully phased out (0), and international dropped to $34M. The LLM incorrectly reports $51M internationally in 2023 (not 2022) and $30M in 2024—all figures not aligned with the source. The claimed 40% decline is unsupported: from $56M (1+55) in 2022 to $34M in 2024 is a ~39% drop, but the LLM uses incorrect intermediate values. (2) The LLM introduces 2023 data not present in the original answer, which only provides 2022 and 2024. This is a factual overreach. The $30M international-only figure in 2024 is close to the true $34M but still inaccurate. (3) The reasoning about strategic reallocation is semantically aligned—shifting away from GICs toward diversified fixed-income and pooled funds matches the ground truth’s indication of strategic reallocation. This shows sound qualitative synthesis and correct interpretation of intent. (4) While the core trend (reduction in GICs, especially in U.S.) is correctly identified, the use of incorrect years, misstated amounts, and fabricated percentages undermines factual reliability. The answer is contextually relevant and addresses both parts of the question (evolution and strategic implication), but quantitative errors reduce correctness. Hence, correctness_score is 5: partially correct with major data inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 407,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "\nBetween 2022 and 2024 the Mastercard Developer Platform shifted from a generic API catalogue to a purpose‑built integration hub that explicitly targets digital‑asset and emerging‑technology adoption. In 2022 it was introduced simply as a single‑access point for developers to discover and call Mastercard’s payment APIs, but by 2024 the platform was highlighted as the conduit for plugging in blockchain‑based tokens, tokenization, AI‑driven fraud and authentication tools, Click‑to‑Pay, and cross‑border disbursement APIs, offering sandbox environments, pre‑built connectors and compliance‑ready modules that let fintechs, crypto exchanges and enterprise partners embed Mastercard’s security, data and payment rails directly into their solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of the Mastercard Developer Platform from 2022 to 2024, noting its initial role as a single access point for APIs and its expanded strategic positioning by 2024 to support digital assets and emerging technologies. The mention of blockchain-based tokens, tokenization, and integration with next-gen financial infrastructure (e.g., programmable payments) corresponds to the ground truth's reference to the Mastercard Multi-Token Network™ and support for blockchain transactions. While the LLM does not explicitly name the 'Mastercard Multi-Token Network™', it accurately captures its functionality by describing the platform as enabling integration with blockchain-based tokens and programmable payment systems. The inclusion of AI-driven fraud tools, Click-to-Pay, and cross-border disbursement APIs adds contextual detail consistent with Mastercard’s broader innovation trajectory, even if not explicitly detailed in the ground truth. All dates (2022, 2024) are correct, and there are no numerical inaccuracies. The reasoning is sound, demonstrating multi-hop synthesis across time periods and technological developments. The answer is semantically equivalent to the original, with slightly more expansive terminology but no factual deviation. Minor deduction in qualitative accuracy due to the absence of the specific 'Multi-Token Network™' branding, which is a notable named component in the 2024 evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 416,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the pension funds held virtually **no U.S. common‑stock exposure**—the 2023 and 2024 disclosures list $0 million of U.S. common stocks, a pattern that also appeared in the 2021 data.  At the same time the allocation to fixed‑income and other asset classes grew (e.g., fixed‑income securities rose to about 62 % of U.S. plan assets in 2024), while the target equity weight in the plan’s strategic allocation remains around 20‑21 %.  This shift indicates that the company is deliberately reducing its U.S. equity tilt and re‑balancing toward a more conservative, liability‑driven mix of fixed‑income and other investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains significant factual inaccuracies. It correctly states that there was no investment in U.S. common stocks in the U.S. pension plan in 2024 (and implies the same for 2022), aligning with the ground truth. However, it completely omits the key fact that the international pension plan held a $2 million investment in U.S. common stocks in both 2022 and 2024—this is a critical omission that undermines completeness and correctness. (2) Quantitatively, the LLM correctly reports $0 million in U.S. common stocks for the U.S. plan, but introduces unverified data: it references 2023 and 2021 disclosures not mentioned in the original answer, and cites specific percentages (e.g., 62% fixed-income, 20-21% target equity) that are not present in the ground truth and cannot be verified. These additions reduce quantitative accuracy. (3) The reasoning is flawed in its multi-hop synthesis: while it infers a strategic shift toward conservative assets, it does so without acknowledging the persistent $2M international allocation, leading to an incomplete and potentially misleading conclusion about the company’s overall strategy. The original answer emphasizes a deliberate avoidance in the U.S. plan but minimal presence internationally—nuance missing in the LLM response. (4) Contextual relevance is moderate: the answer addresses the evolution and strategic implications, but misrepresents the full picture by ignoring the international plan’s holdings. Scores reflect partial factual alignment but major omissions and unsupported additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 438,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Disney moved from the initial rollout of its newest vessels (e.g., the Disney Wish entered service in 2022) to a more explicit multi‑year fleet‑expansion strategy, announcing in fiscal 2024 plans to add additional ships and to increase capital spending on the Experiences segment that includes the cruise line.  Management highlighted that these investments carry operational risk—potential cost overruns, lower‑than‑expected demand, and the possibility of asset write‑downs (as illustrated by the impairment of the Star Wars: Galactic Starcruiser project)—so the company must carefully manage financing, supply‑chain and market‑acceptance uncertainties while pursuing its cruise‑ship growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its portrayal of Disney's strategic evolution between 2022 and 2023. The original answer states that Disney shifted from a growth-oriented capital investment focus in 2022 to emphasizing operational risk and external disruptions (e.g., hurricanes) in 2023. In contrast, the LLM claims Disney moved toward a 'multi-year fleet-expansion strategy' with increased capital spending, citing plans announced in 'fiscal 2024'—which is outside the 2022–2023 timeframe in question. This misrepresents the strategic shift as continued expansion rather than a pivot to risk mitigation. (2) Quantitatively, the LLM references the Disney Wish entering service in 2022, which is factually accurate, but introduces a forward-looking announcement (fiscal 2024 plans) not present in the ground truth and irrelevant to the 2022–2023 evolution. There are no numerical values (e.g., dollar amounts, percentages) in either answer, so scoring focuses on temporal accuracy—dates like 'fiscal 2024' are incorrect for the scope of the question. (3) The multi-hop reasoning is flawed: the original answer requires synthesizing a shift in narrative tone—from investment to risk—across two years. The LLM instead infers continued strategic expansion and generalizes operational risks (e.g., cost overruns, demand risk, Star Wars: Galactic Starcruiser write-down) that are not tied to cruise ships as operational exposures in 2023. The mention of the Starcruiser impairment, while a real event, is unrelated to cruise ships and distracts from the core point about hurricanes and external disruptions affecting cruise operations. (4) The contextual relevance is moderate because the answer discusses cruise ships, capital investment, and operational risks—but it gets the direction of the strategic shift wrong. Instead of reflecting a recalibration from growth to risk management, it portrays ongoing growth with risk awareness. This fundamental misalignment with the ground truth severely limits factual correctness, warranting a low correctness score despite some relevant terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 566,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "\nMastercard’s short‑duration FX derivatives have expanded from a modest, non‑designated tool that merely offset the few‑day foreign‑exchange risk inherent in daily settlement (as described in the 2022 10‑K “non‑designated derivatives” note) to a core component of a formal cash‑flow‑hedging program.  In the 2024 filing the company explicitly designates these contracts, records the effective portion in accumulated other‑comprehensive income and re‑classifies it to earnings, and the notional amounts have grown (e.g., $3.9 bn of cash‑flow‑hedged FX contracts in 2024 versus the modest amounts reported for 2021), allowing Mastercard to hedge a broader set of forecasted cash‑flows while still using the same short‑term contracts to manage the limited settlement‑exposure that lasts only a few days.  This evolution reflects a shift from ad‑hoc risk mitigation to a structured, accounting‑transparent hedging strategy that still caps the settlement horizon at a few days but now covers a much larger portion of the company’s FX risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Mastercard's use of short-duration foreign exchange derivative contracts between 2022 and 2024. (1) The original answer states that Mastercard continued using these contracts with the same objective—reducing volatility in gains and losses from currency fluctuations during daily settlement—with no indication of a shift from 'ad-hoc' to a 'structured, accounting-transparent hedging strategy.' The claim that short-duration contracts became part of a formal cash-flow-hedging program by 2024 is not supported by the ground truth. (2) The LLM introduces specific quantitative claims such as '$3.9 bn of cash-flow-hedged FX contracts in 2024' and comparisons to 'modest amounts reported for 2021,' which are not present in the original answer and cannot be verified against the provided ground truth. There is no mention of notional amounts, accumulated other comprehensive income (AOCI), or reclassification to earnings in the original, making these details fabricated. (3) The multi-hop reasoning is flawed: while the original notes a dynamic adjustment in hedging strategies related to euro-denominated debt (de-designation/re-designation in 2023–2024), it does not link this to short-duration settlement contracts. The LLM incorrectly conflates broader debt hedging changes with operational settlement derivatives. (4) Contextually, the answer addresses the question’s focus on evolution and risk management, but the core narrative of transformation in the use of short-duration contracts is unsupported. The continuity emphasized in the original answer is replaced with a false progression. Thus, despite relevant terminology and plausible structure, the answer is largely incorrect on key facts, numbers, and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 489,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "\nFrom 2023 to 2024 Salesforce narrowed the scope of its strategic investment portfolio, shifting from a broad set of enterprise‑cloud startups toward a more focused set of AI‑enabled ISVs, system‑integrators and vertical‑specific cloud providers that can fuel its Agentforce and Data Cloud initiatives.  At the same time, it deepened ecosystem integration by expanding the AppExchange, investing in partner go‑to‑market programs, and embedding partner technologies (MuleSoft, Tableau, Slack) into its AI‑driven platform, using reinvested proceeds from prior exits to grow this targeted, ecosystem‑centric portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numeric data, dates, or calculations, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual deviations from the ground truth. The original answer states that Salesforce shifted from investing in a broad portfolio of enterprise cloud companies in 2023 to deeper ecosystem integration and strategic dependency in 2024, particularly through the AppExchange and third-party developer enablement. The LLM answer introduces specific initiatives (Agentforce, Data Cloud), technologies (MuleSoft, Tableau, Slack), and funding mechanisms ('reinvested proceeds from prior exits') that are not mentioned or supported in the ground truth. It also claims a narrowing of investment focus toward 'AI-enabled ISVs' and 'vertical-specific cloud providers,' which is a more specific and technologically driven shift than described in the original. While the general direction of increased ecosystem integration and platform dependency aligns with the truth, the LLM adds unsupported details and over-specifies the strategic pivot, suggesting a level of technological and financial engineering not present in the source. The answer is contextually relevant and addresses the evolution in investment focus and ecosystem integration, but the reasoning is not fully sound due to hallucinated elements. Thus, while the high-level theme is correct, the factual basis for the multi-hop synthesis is compromised, warranting a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 431,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "\nThe company’s method for accruing vendor‑funding income was unchanged between FY 2023 and FY 2024 – it continues to base accrual rates on the specific terms of each vendor agreement and to update those rates throughout the year as actual purchase volumes are tracked.  Both years stress that the accruals are “sensitive to projected purchase volumes,” especially for programs that provide stepped‑up funding once graduated volume thresholds are met, and any deviation between forecasted and actual volumes is used to adjust the accrual rate accordingly.  Thus, while the underlying calculation remained the same, the 2024 discussion reiterates the same sensitivity to volume changes and the practice of confirming accrued amounts with vendors to ensure they reflect real‑time purchase performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its qualitative interpretation, which undermines the core of the question. (1) Correct elements: The answer correctly states that the company’s methodology for accruing vendor-funding income remained consistent between FY 2023 and FY 2024 and that accruals are based on vendor agreement terms and updated with actual purchase volumes. It also correctly identifies that projected purchase volumes impact accruals, particularly for programs with volume thresholds. (2) Quantitative accuracy: There are no numeric values in the question or answer, so this aspect is not applicable; no errors in dates or fiscal years. (3) Multi-hop reasoning assessment: The model fails in synthesizing a key distinction between the two fiscal years. The ground truth emphasizes that while the methodology was unchanged, FY 2023 explicitly highlighted sensitivity to 'graduated purchase volumes,' whereas FY 2024 omitted this specific language, suggesting a potential shift in emphasis or simplification. The LLM incorrectly asserts that both years 'stress' sensitivity to volume changes and that the 2024 discussion 'reiterates the same sensitivity,' which contradicts the ground truth that this explicit reference was dropped in 2024. (4) This misrepresentation of the evolution in disclosure language — interpreting continued sensitivity as equivalent to unchanged emphasis — leads to an incorrect conclusion about the evolution of the company's approach. While the underlying method may be stable, the change in disclosure suggests a qualitative shift in how the company communicates or applies the sensitivity, which the LLM overlooks. Hence, despite correct context and structure, the answer misses a critical nuance required by the question, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 497,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "\nFrom 2022 through 2024 the Lilly‑Boehringer Ingelheim alliance has moved from a primarily commercial partnership on Jardiance to a more legally intertwined relationship: both companies now face a growing slate of joint and separate lawsuits—including Lilly’s 340B pricing litigation, BI’s patent‑infringement suits, and product‑liability actions on Jardiance—while also sharing an indemnity agreement that obligates BI to defend and cover Lilly for those claims.  At the same time, the 2024 Inflation‑Reduction Act price‑setting decision designated Jardiance for a 66 % discount, heightening regulatory and financial exposure for the product and reinforcing the two firms’ mutual dependence on its success.  Thus, the strategic tie‑up has deepened in legal involvement and reliance on Jardiance, with both parties navigating intensified litigation and government‑mandated pricing pressures together.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures key elements of the strategic evolution between LLY and Boehringer Ingelheim (BI), particularly around increased collaborative dependency due to the Inflation Reduction Act (IRA) 66% discount on Jardiance in 2024, which aligns with the ground truth. The quantitative accuracy is strong: the 66% discount and 2024 IRA pricing decision are correctly stated. However, significant inaccuracies undermine the qualitative correctness. The claim that LLY and BI became 'legally intertwined' with 'joint and separate lawsuits' and that BI has an indemnity obligation to defend and cover LLY for litigation is not supported by the original answer or known public facts in the knowledge graph. The ground truth explicitly states that in 2022, LLY was *not* a party to BI's Hatch-Waxman litigation, underscoring legal separation, not entanglement. The LLM incorrectly reverses this trajectory by suggesting increased legal integration, when the truth reflects deeper *commercial and regulatory* dependency, not legal co-litigation or indemnity arrangements. This misrepresents the nature of the relationship evolution. While the answer correctly identifies heightened mutual dependence due to IRA pricing, it fabricates legal collaboration and shared litigation exposure, which constitutes a major factual error in multi-hop reasoning. The model synthesizes an incorrect narrative of legal convergence, whereas the truth shows commercial interdependence growing despite ongoing legal separation. Thus, while contextually relevant and partially accurate in numbers, the answer fails on core factual and inferential accuracy regarding legal involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 452,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "\nFrom 2022 to 2023 Disney shifted its cruise‑ship spending from a single, land‑based project – the development of a dedicated Disney Cruise Line destination at Eleuthera (Lighthouse Point) slated for 2024 (2022 10‑K, p. 22) – to a broader capital program that earmarks funds for new ship builds, refurbishments and related infrastructure as part of the overall Parks & Experiences budget (2023 10‑K, p. 12).  This evolution ties the cruise‑line investments directly to the company’s larger theme‑park and resort expansion strategy, using the ships to extend the Disney vacation experience across both sea and land.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution in Disney's capital investment strategy toward cruise ships from 2022 to 2023 and correctly identifies the broader Parks & Experiences context, but introduces specific details not present in the original ground truth, affecting factual accuracy. (1) The claim about a 'dedicated Disney Cruise Line destination at Eleuthera (Lighthouse Point) slated for 2024' and its citation to the 2022 10-K, page 22, is factually plausible but not mentioned in the ground truth, making this an unsupported addition. The original answer does not reference any specific project or timeline like Lighthouse Point or 2024, nor does it mention refurbishments or infrastructure tied to ships—only that cruise ships were newly listed as a capital investment focus in 2023. (2) There are no explicit numbers (dollar amounts, percentages, ship counts) in either the original or LLM answer, so quantitative accuracy is not heavily penalized, but the introduction of a specific project (Eleuthera) with a timeline (2024) implies precision that isn't in the source. (3) The multi-hop reasoning is partially sound—comparing 2022 and 2023 10-Ks to show a shift in emphasis—but the LLM overreaches by inferring a strategic pivot from 'land-based project' to 'broader capital program' based on a single destination project, which the ground truth does not support. The original answer emphasizes a shift from no specific mention of cruise ships in capital spend in 2022 to explicit inclusion in 2023, which the LLM captures in spirit but distorts with added detail. (4) Contextual relevance is high because the answer addresses the core question about strategic evolution within Parks & Experiences. However, the added specifics reduce qualitative and overall correctness. A score of 6 reflects partial accuracy with significant embellishment that affects factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 509,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard Foundry moved from a primarily experimental, short‑term prototyping hub into a full‑scale innovation platform that actively co‑creates with fintechs, central banks and crypto‑focused partners.  It now leverages acquisitions such as Recorded Future and subscription‑management tools, deploys AI‑driven fraud and decision‑intelligence solutions, and launches market‑ready products—including Alias‑Based Remittances, expanded tokenization and “Digital First” card programs—while still offering its Launchpad workshops and early‑stage fintech scouting.  This evolution reflects a shift from scouting emerging technologies to delivering integrated, AI‑enabled, cross‑border payment solutions that span blockchain, cybersecurity and fintech ecosystems.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general direction of Mastercard Foundry's evolution from an experimental unit to a more integrated innovation platform, which aligns with the ground truth. However, it introduces significant factual inaccuracies that undermine its correctness. (1) The claim that Mastercard Foundry evolved into a 'full-scale innovation platform' that 'co-creates with central banks and crypto-focused partners' and leverages acquisitions like Recorded Future is unsupported by the original answer and not present in the ground truth. Recorded Future is not mentioned in the knowledge base, and there is no indication of central bank collaboration. (2) The mention of 'AI-driven fraud and decision-intelligence solutions', 'Alias-Based Remittances', 'Digital First card programs', and 'subscription-management tools' are specific product claims absent from the original answer and cannot be verified. (3) While the ground truth highlights Foundry’s 2024 focus on blockchain-based business models and the Mastercard Multi-Token Network™, the LLM overreaches by generalizing to AI, cybersecurity, and cross-border solutions not explicitly tied to Foundry. (4) The core evolution—shifting from thought leadership and early-stage access in 2022 to active experimentation and enabling new technologies like programmable payments in 2024—is partially reflected, but the LLM adds speculative details and misattributes capabilities. Quantitative accuracy is scored higher because there are no explicit numbers, dates, or calculations to verify or refute—dates (2022–2024) are correct. Qualitative accuracy is low due to incorrect entity attributions and unsupported technological engagements. Contextual relevance is moderate because the response addresses the question’s theme but with fabricated details. Overall, the answer is partially correct in direction but fails on factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 509,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "\nBetween 2022 and 2024 the Boehringer Ingelheim partnership shifted from a pure R&D‑focus to one increasingly shaped by U.S. price‑setting rules; as noted in the 2024 filing (p. 46), HHS selected Jardiance—co‑developed with Boehringer Ingelheim—as one of the first ten drugs to be subject to a 66 % government‑set discount beginning in 2026, and the IRA’s mandatory rebate and discount provisions (p. 45) have accelerated revenue erosion and intensified pricing pressure on the collaboration’s assets.  At the same time, the alliance continues to pursue regulatory pathways such as Breakthrough and Fast‑Track designations for newer candidates (e.g., tirzepatide), but the new pricing environment has forced tighter cost management and a greater emphasis on expanding capacity to offset the margin impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift from regulatory facilitation to pricing pressures, noting the 66% government-set discount on Jardiance under the Inflation Reduction Act (IRA), with implementation in 2026, which aligns with the ground truth. However, it incorrectly references tirzepatide as part of the Lilly-Boehringer Ingelheim collaboration, which is factually inaccurate—tirzepatide (Mounjaro/Zepbound) is a fully owned Eli Lilly asset, not co-developed with Boehringer Ingelheim. This misattribution undermines the qualitative accuracy. (2) Quantitatively, the 66% discount, 2026 effective date, and reference to HHS selection are all accurate and match the ground truth. The mention of 'p. 45' and 'p. 46' suggests correct sourcing from a 10-K or similar filing, though exact page numbers are not part of the ground truth verification. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the evolution from early regulatory designations (Breakthrough Therapy, Fast Track) to later pricing pressures under the IRA. However, the erroneous inclusion of tirzepatide as a joint asset breaks the chain of accurate entity linkage, indicating a failure in entity disambiguation across collaborations. (4) The answer is contextually relevant and captures the core financial and strategic evolution, but the incorrect attribution of tirzepatide reduces the correctness score. The qualitative accuracy is docked due to this significant entity error, though the overall narrative arc remains valid. Hence, a score of 7 is justified—core facts and numbers are correct, but with a notable factual flaw in entity mapping.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 456,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "\nFrom 2023 to 2024 the CH‑53K King Stallion shifted from being cited merely as a flagship rotary‑lift platform in Lockheed Martin’s Rotary and Mission Systems (RMS) portfolio to a core growth pillar of the company’s 21st‑Century Security strategy.  In 2024 the firm emphasized scaling CH‑53K production and integrating the type into broader all‑domain lift and sustainment concepts, while leveraging heightened geopolitical demand—exemplified by the 2023‑24 Israeli order and ongoing U.S. government interest—to secure longer‑term contracts and expand export opportunities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of the CH-53K's strategic positioning within Lockheed Martin's RMS segment, noting a shift toward broader all-domain integration and growth emphasis, which aligns with the ground truth. However, it introduces specific claims not supported by the original answer: (1) the mention of the '21st-Century Security strategy' is absent in the ground truth and cannot be verified from the provided context; (2) the reference to a '2023-24 Israeli order' is factually unsupported in the original answer, which makes no mention of international orders or specific contracts; (3) while the ground truth notes a shift toward digital technologies like AI/ML and autonomy, the LLM overstates integration into 'all-domain lift and sustainment concepts' with a focus on production scaling, which is not explicitly stated. The qualitative shift from a near-to-mid-term growth element to a more integrated, technology-forward portfolio is partially reflected, but the LLM emphasizes export opportunities and production scaling not present in the original. There are no numerical figures in either answer, so quantitative accuracy is scored as 10 by default. Contextual relevance is high as the response stays on-topic and addresses strategic evolution. However, the added details, while plausible, represent speculative elaboration rather than accurate synthesis, reducing qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 395,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "\nThe 2022 10‑K (page 5) lists a seven‑product co‑commercial diabetes suite with Boehringer Ingelheim—including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR and Basaglar—whereas the 2024 10‑K (pages 6‑10) no longer references most of those partners‑branded agents and instead spotlights only a few higher‑value diabetes assets. This contraction signals that Lilly is shifting its strategic focus toward higher‑margin, cardiovascular‑outcome‑driven diabetes medicines and scaling back the breadth of its Boehringer Ingelheim collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies the 2022 portfolio as including seven products (naming all: Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar) and notes the 2024 portfolio is reduced, focusing only on key assets—consistent with the ground truth stating only Jardiance, Glyxambi, Synjardy, and Trijardy XR remain. (2) Quantitative accuracy is perfect: the years (2022 and 2024), document types (10-K), and product counts (seven down to four) are correct. Page references (2022: p.5; 2024: pp.6–10) are plausible and contextually appropriate. (3) The reasoning is sound: the narrowing of the portfolio is correctly interpreted as a strategic shift toward higher-value, cardiovascular-benefit diabetes drugs like Jardiance and its combinations, which is a valid inference supported by market trends and Lilly’s broader strategy. The LLM infers a focus on higher-margin, outcome-driven medicines, which is a reasonable interpretation of the strategic refocusing described in the ground truth. (4) The only minor gap is that the LLM does not explicitly name the dropped products (Trajenta, Jentadueto, Basaglar) as being removed, though it implies this by stating they are no longer referenced. It also doesn’t mention potential drivers like generic competition or patent life, which the ground truth includes. However, the core insight—strategic refocusing on higher-performing assets—is clearly conveyed. Semantic equivalence is strong, and the answer is highly relevant to the question about shifting strategic priorities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 441,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the JASSM program helped drive a sharp rise in Missiles & Fire Control backlog—backlog grew from $32.2 billion in 2023 to $38.8 billion in 2024, with higher orders on JASSM (alongside PAC‑3 and GMLRS) cited as the primary cause.  Production activity accelerated, lifting MFC net sales by $1.4 billion (13 %) in 2024, but the program’s profitability came under pressure: operating profit fell from $1.54 billion in 2023 to just $0.41 billion in 2024, reflecting large profit‑booking adjustments and a $1.4 billion loss on a classified contract.  Thus, while JASSM remained strategically important for backlog growth and sales volume, its financial contribution weakened in 2024 due to margin‑eroding losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM claims specific figures not present in the ground truth: a backlog increase from $32.2B to $38.8B, a $1.4B sales increase (13%), and operating profit falling from $1.54B to $0.41B due to a $1.4B loss on a classified contract. None of these numbers appear in the original answer, and the ground truth does not mention any decline in profitability or losses on classified contracts. The only number in the LLM answer that aligns partially is the $1.2B increase in tactical and strike missile programs (LLM says $1.4B), but even this is misrepresented as being solely due to JASSM when it's part of a broader category. (2) Completeness: While the LLM correctly identifies increased production activity and JASSM’s role in backlog growth alongside PAC-3 and GMLRS, it introduces new, unsupported claims about financial deterioration that contradict the neutral-to-positive evolution described in the ground truth. (3) Entity Accuracy: The entities (JASSM, MFC, PAC-3, GMLRS) are correctly identified, and the time frame (2023–2024) is accurate. (4) Reasoning: The multi-hop synthesis is flawed—while the model attempts to link JASSM to backlog and production changes, it fabricates financial performance details and misrepresents the program’s contribution. The conclusion that 'financial contribution weakened' is unsupported and contradicts the ground truth, which emphasizes rising strategic importance. (5) Semantic Equivalence: The overall message diverges significantly—the ground truth describes growing strategic importance and production ramp-up without mentioning financial setbacks, while the LLM portrays a program with declining profitability. Despite relevant context and correct entities, the answer is factually incorrect on key metrics and conclusions, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 517,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "\nBetween 2023 and 2024 JPM moved from a largely rating‑driven, portfolio‑level assessment of Business Banking Loans to a more granular, borrower‑specific risk‑monitoring framework that emphasizes early‑warning metrics such as delinquency age, refreshed FICO scores, combined LTV and geographic concentration (see pages 242, 250‑252).  This shift enables the Firm to spot early signs of borrower distress—e.g., rising 30‑149‑day delinquencies or deteriorating credit scores—so that loss‑mitigation actions can be taken sooner.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of JPM's credit risk focus from 2023 to 2024. It accurately captures the shift from a broader, rating-driven approach to a more granular, early-warning-focused framework emphasizing delinquency and credit score monitoring. The mention of '30-149-day delinquencies' aligns with the ground truth's emphasis on loans more than 30 days past due as early indicators of distress. There are no numeric inaccuracies—dates (2023 to 2024), timeframes (30+ days delinquent), and metrics (FICO, LTV, delinquency age) are correctly referenced or reasonably inferred. The answer adds detail not in the original (e.g., refreshed FICO scores, geographic concentration, LTV, page references), which enhances granularity but slightly diverges from the original's emphasis on integration into the 'Consumer, excluding credit card' risk framework. While these additions may reflect accurate data from the cited pages, they are not part of the ground truth's defined scope, introducing minor over-specificity. The core multi-hop reasoning—synthesizing a shift in risk focus over time and its implications for early distress detection—is sound and correctly structured. The answer fully addresses both parts of the question: the evolution in focus and its implications. Semantic equivalence is high, though the original answer more clearly links the shift to alignment with broader consumer loan risk frameworks. The LLM answer is contextually excellent, directly relevant, and factually consistent on key points, warranting a high score with minor deduction for added details not present in the verified truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 458,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "\nTarget’s SPP II long‑term incentive plan was first disclosed in the 2022 10‑K as the “Target Corporation SPP II (2016 Plan Statement) (as amended and restated effective April 3 2016)”. The 2023 10‑K reproduces the identical exhibit reference and does not list any subsequent amendment, indicating that the plan’s terms were unchanged between the two filings. This continuity reflects Target’s compensation philosophy of relying on a stable, pre‑approved equity‑based incentive structure rather than frequent revisions, underscoring a disciplined, performance‑driven executive‑pay framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim. According to the ground truth, the SPP II plan evolved from the 2016 Plan Statement (effective April 3, 2016) in the 2022 filing to the 2022 Plan Statement (effective May 1, 2022) in the 2023 filing, indicating a material update to the plan. However, the LLM incorrectly states that the 'identical exhibit reference' was reproduced and that 'terms were unchanged,' which directly contradicts the ground truth. This error undermines both quantitative and qualitative accuracy. The dates (April 3, 2016, and May 1, 2022) are critical data points, and the LLM fails to acknowledge the latter, missing the key change. The reasoning is flawed because it draws a conclusion about stability and disciplined framework based on a false premise of no change. While the answer addresses the question's structure and attempts to interpret implications for executive compensation, the synthesis across filings is incorrect. The contextual relevance is moderate because it discusses the right topic (SPP II, executive compensation framework) but bases its analysis on inaccurate information. Overall, the answer fails on the primary metric of correctness due to a fundamental misrepresentation of the plan's evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 351,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "\nFrom 2022 through 2024 the only contractual milestone exposure tied to the Incyte/Olumiant partnership remained the **up‑to‑$100 million of regulatory‑milestone payments and up‑to‑$100 million of sales‑based milestone payments** that Incyte could earn under the collaboration agreement (the same caps that were disclosed as of Dec 31 2021).  The company had already capitalized $260 million of regulatory milestones in 2021 and $210 million of earlier milestones, and it continues to record royalties on Olumiant sales (up to 20 % plus a low‑teens royalty on COVID‑19 sales) as cost of sales; no additional milestone amounts were recognized in 2022‑2024, so the future payments remain contingent on achieving later regulatory approvals or sales thresholds.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It claims that as of 2024, Incyte still had up to $100 million in regulatory and $100 million in sales-based milestones available — directly contradicting the original answer, which states that by 2024 there is no mention of remaining regulatory milestones, implying they were either paid out or dropped. The LLM incorrectly asserts continuity in milestone structure from 2022 to 2024, while the ground truth indicates a shift in the compensation structure over time. (2) Quantitatively, the $100M regulatory and $100M sales milestones are correctly cited for 2022, aligning with the original answer. However, the mention of $260M capitalized in 2021 and $210M of earlier milestones is not present in the ground truth and appears to be fabricated or misattributed, introducing false data. These numbers cannot be verified against the provided truth and undermine quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to recognize the evolution of the obligation over time — a key part of the question. Instead of identifying a shift from dual milestone types (regulatory + sales) to primarily sales-based royalties, it asserts the structure remained unchanged. This misrepresents the contractual evolution. The mention of ongoing royalties (up to 20% and low teens for COVID-19) is accurate and matches the original answer, showing partial correct synthesis. (4) Contextual relevance is high because the answer addresses the right companies (Incyte, Olumiant), time frame (2022–2024), and types of payments (milestones, royalties). However, due to major factual and reasoning errors — especially the failure to reflect the disappearance of regulatory milestones by 2024 — the overall correctness score is low. The answer conveys the opposite of the true evolution: it suggests continuity where there was change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 523,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Cisco’s APJC segment revenue grew only modestly—from about **$8.03 bn** (page 105) to roughly **$8.06 bn**, and its gross margin rose from **$5.24 bn** to **$5.28 bn** (page 105).  The goodwill allocated to APJC increased slightly from **$5.36 bn** to **$5.38 bn** (page 76), while the net balance of purchased finite‑life intangible assets in the region stayed flat at roughly **$1.65 bn** (page 77), and long‑lived assets in the International (which includes APJC) were essentially unchanged around **$1 bn** (page 106).  Consequently, Cisco’s financial exposure in APJC remained stable during the 2022‑2023 period, with only minor increases in revenue, gross margin and goodwill before the larger post‑FY2023 investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Cisco did not disclose specific financial figures for the APJC region in fiscal 2022, and only in fiscal 2023 were asset balances reported ($5,382 million). However, the LLM answer fabricates detailed revenue, gross margin, goodwill, and intangible asset figures for both years, including exact numbers like $8.03B revenue and $5.36B goodwill in 2022, which are not supported by the provided data. (2) Quantitative accuracy is very low: none of the numbers in the LLM response (e.g., $8.03B revenue, $5.24B gross margin) appear in the ground truth, and the only actual figure in the truth—$5,382M in APJC assets in 2023—is not mentioned. The LLM incorrectly cites 'page 105' and 'page 76' as sources, but no such data was in the input. (3) The reasoning is flawed: the question asks about evolution of financial exposure based on segment reporting and asset balances, but the LLM invents a narrative of stability based on non-existent multi-year disclosures. The ground truth emphasizes that 2022 lacked segment-level asset data, making any year-over-year comparison impossible—this nuance is entirely missed. (4) Contextual relevance is moderate because the answer addresses Cisco and the APJC region over the correct fiscal years, but it fails the core requirement: accurately reflecting disclosure limitations and asset reporting evolution. The LLM assumes granular data was available in 2022 when it was not, leading to a fundamentally incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 427,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the Lilly‑Boehringer Ingelheim collaboration on Jardiance shifted from a routine co‑development and marketing partnership to one increasingly shaped by U.S. price‑setting under the Inflation Reduction Act.  In August 2023 HHS designated Jardiance as one of the first ten drugs subject to mandatory government‑set pricing, and in August 2024 it announced a 66 % discount off the 2023 list price, forcing the partners to anticipate substantial revenue erosion and to adjust their pricing, reimbursement, and capacity‑expansion strategies to mitigate the regulatory impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Jardiance was selected in August 2023 as one of the first ten drugs under the Inflation Reduction Act (IRA), and a 66% discount was applied in August 2024 compared to the 2023 U.S. list price. These dates and percentages match the original answer exactly. (2) Quantitative accuracy is perfect—66% discount, August 2023 and August 2024 timing are all correctly reported. (3) The multi-hop reasoning is sound: the answer connects the regulatory change (IRA price-setting) to its impact on the LLY-Boehringer Ingelheim collaboration, including strategic shifts in pricing, reimbursement, and capacity planning. (4) The only minor omission is that the 2022 growth context (30% U.S., 28% ex-U.S.) from the original answer is not mentioned, which slightly reduces completeness but does not affect the core accuracy of the evolution in response to regulation. The answer focuses on the regulatory impact phase (2023–2024), which is the central thrust of the question. Wording differs but semantic meaning and factual content are equivalent. Thus, high scores across all dimensions with a 9 in correctness due to partial omission of 2022 performance context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 350,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "\nBetween 2022 and 2023 GM’s risk discussion shifted from a generic warning that product‑safety recalls—particularly those involving global platforms—could harm its finances and reputation, to a concrete focus on the Chevrolet Bolt EV recall and the broader EV/AV strategy, emphasizing that safety controversies now directly jeopardize its positioning in electric and autonomous vehicles. This evolution reflects a heightened awareness that recalls tied to its EV/AV platforms could have outsized financial and brand‑reputation consequences.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in spirit but contains a key factual inaccuracy in the timeline and emphasis. The original answer states that in 2022, GM already specifically cited the Chevrolet Bolt EV recall (not a generic warning) as an example of financial and logistical risks from global platform recalls. The LLM incorrectly characterizes the 2022 discussion as 'generic,' when in fact it was already focused on the Bolt EV. This misrepresents the evolution: the shift was not from generic to specific, but from a cost/logistics focus (2022) to an expanded emphasis on reputational risk tied to EV/AV leadership (2023). The LLM correctly identifies the strategic shift in 2023 and the relevance to EV/AV positioning, and there are no numerical or date errors (quantitative accuracy is perfect). The reasoning is sound in recognizing a strategic evolution, but the flawed characterization of 2022 weakens the multi-hop synthesis. Contextually, the answer is highly relevant and captures the broader narrative arc, just with an incorrect starting point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 301,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "\nBetween 2022 and 2024 the Guaranteed Senior Notes issued by Costco’s Japanese subsidiary expanded from an existing balance of roughly $590 million (reported in 2022) to a new issuance of about $500 million in November 2023, and after a $77 million repayment in July 2024 the outstanding amount rose to $919 million by year‑end 2024. This evolution shows that Costco is deliberately using its Japan entity to tap long‑dated, low‑coupon capital markets—issuing notes maturing as far out as 2033‑2043—to build a stable, diversified source of financing that supports its long‑term capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, only general terms were used to describe the Guaranteed Senior Notes, with no specific dollar amount provided—however, the LLM claims a balance of $590 million in 2022, which is not supported by the ground truth. The $500 million issuance in November 2023 is correctly identified in amount and timing, and the $77 million repayment in July 2024 is also accurate. However, the LLM incorrectly calculates the outstanding amount as $919 million by year-end 2024, implying the $500 million was added to a pre-existing $590 million and then reduced by $77 million. This is flawed because the ground truth does not confirm a $590 million starting balance, nor does it indicate that the $500 million was in addition to prior notes—only that new notes totaling $500 million were issued. (2) The maturities (2033–2043) and fixed interest rates (1.400%–2.120%) are correctly reflected in substance, though the LLM omits the specific rate range. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic use of long-term financing through extended maturities and low coupons, aligning with the ground truth’s conclusion about long-term strategy. However, it fabricates a quantitative baseline (the $590 million) not present in the original data, undermining the validity of the synthesis. (4) The contextual relevance is high because the answer addresses both the evolution of the notes and the implications for Costco’s financing strategy. However, due to major quantitative errors and unsupported assumptions, the correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 464,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the carrying amount of Cisco’s available‑for‑sale debt securities rose from **$11.9 billion** (as reported on July 30 2022) to **$15.6 billion** (as reported on July 29 2023), an increase of roughly **$3.6 billion (≈30 %)**.  This growth shows that Cisco deliberately expanded its portfolio of high‑quality, investment‑grade debt instruments—using excess cash to earn modest yields while preserving a low‑risk, liquid investment position that supports future strategic opportunities such as acquisitions or share‑holder returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude. The ground truth states that Cisco's available-for-sale debt investments decreased from $15,592 million in 2022 to $9,865 million in 2023 — a drop of $5,727 million. The LLM incorrectly claims an increase from $11.9 billion to $15.6 billion, which is not only wrong but opposite to the actual trend. Additionally, the LLM cites a 30% increase, which is unsupported by the data. (2) The numbers are significantly off: $11.9B vs. correct $15,592M (~$15.6B) in 2022; $15.6B vs. correct $9,865M (~$9.9B) in 2023. The LLM appears to have confused the years or misread the financial statements. The calculation of a $3.6B increase is therefore erroneous. (3) The multi-hop reasoning fails completely: the model should have compared the two years' values, computed the difference, and inferred a strategic reduction. Instead, it concludes an expansion, which contradicts the evidence. (4) The contextual relevance is low but not zero — it discusses investment strategy and uses relevant financial terminology, so partial credit is given for attempting to address the question’s intent, but factual inaccuracies dominate the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 343,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "\nFrom 2023 to 2024, JPMorgan Chase’s exposure to system‑damage risk has risen as its dependence on third‑party service providers has deepened and the frequency and sophistication of attacks against those vendors have increased, heightening the chance of data breaches and ransomware incidents. As a result, the firm now confronts greater uncertainty in fully recovering and restoring compromised data—often facing extended outages, higher remediation costs, and amplified regulatory and reputational penalties.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of JPMorgan Chase's system damage risks from 2023 to 2024 with a focus on third-party vendor attacks and data recovery challenges, aligning well with the original answer in tone and direction. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The LLM captures the increased risk due to third-party dependencies, ransomware, and data recovery difficulties, which reflects the core of the ground truth. However, it omits specific details present in the original answer, such as the shift from zero-day vulnerabilities and DDoS attacks in 2023 to 2024's emphasis on ransomware targeting vendors, losses exceeding cyber insurance coverage, and the new concern about systems processing fraudulent transactions. These omissions reduce completeness and qualitative accuracy. While the reasoning is sound and contextually appropriate, the answer does not fully synthesize all multi-hop elements (e.g., specific threat evolution and financial implications like insurance shortfalls), leading to a moderate deduction in qualitative accuracy. Contextual relevance remains high as the response directly addresses the question's focus on risk evolution, third-party threats, and recovery challenges.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 360,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "\nBy the end of 2024 Costco had poured capital into expanding its physical footprint and private‑label production capacity to fuel the “increase the penetration of our private‑label items” strategy outlined in the 2022 filing.  The company opened 29 new warehouses in 2024 (adding roughly 130 million sq ft of floor space) and, as noted in the 2024 property disclosure, operates additional processing, packaging and manufacturing facilities that produce Kirkland‑Signature merchandise.  These investments—combined with upgrades to its supply‑chain and e‑commerce platforms—were designed to broaden the availability and sales of private‑label products across its U.S., Canadian and other international operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core operational investments Costco made by 2024 to support its private-label growth strategy—specifically, the operation of processing, packaging, and manufacturing facilities for Kirkland Signature products, which aligns with the ground truth. It also accurately references the 2022 filing's strategic goal of increasing private-label penetration. However, the LLM introduces specific quantitative claims not present in the original answer or implied by the context: namely, that Costco opened 29 new warehouses in 2024 and added approximately 130 million sq ft of floor space. These figures are not mentioned in the ground truth and cannot be verified from the provided information, making them potentially inaccurate and lowering the quantitative accuracy. Additionally, while the mention of supply-chain and e-commerce upgrades may be plausible, they are not cited in the original answer as direct operational investments tied to private-label growth, representing a minor overextension. The qualitative reasoning is otherwise sound—correctly linking the 2022 strategy to 2024 operational outcomes and demonstrating multi-hop understanding (from strategy to execution across years). The answer is contextually relevant and captures the essence of internal production scaling, even if it adds unsupported specifics. Semantic equivalence is mostly preserved but undermined by the inclusion of unverified metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 399,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "\nBetween 2022 and 2023 UnitedHealth’s Medicaid‑managed‑care bidding continued to rely on assumptions about enrollment growth, utilization and medical‑cost trends, but the 2023 filing highlighted that bid accuracy is now tightly linked to potential policy changes, competitive‑bid pressure and CMS risk‑adjustment audits that can produce retrospective payment adjustments or contract loss. Consequently, the company explicitly warned that any material mis‑estimation of those assumptions could materially and adversely affect its results of operations, financial position and cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in UnitedHealth Group's approach to Medicaid managed care contract bidding between 2022 and 2023. It correctly identifies that while assumptions about enrollment, utilization, and medical costs remained central, the 2023 filing placed greater emphasis on bid accuracy being vulnerable to external factors such as policy changes, competitive pressures, and CMS audits—aligning with the ground truth's focus on increased attention to bid assumptions. The answer adds specific detail about CMS risk-adjustment audits and retrospective payment adjustments, which are contextually plausible and consistent with the type of risks described, though not explicitly mentioned in the original answer. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced (9) because the original answer emphasizes a shift from 'renewal risk to retain members' in 2022 to 'assumptions in bidding' in 2023, a contrast that the LLM answer implies but does not explicitly state. However, the LLM still conveys the essential evolution in risk focus. Contextual relevance is perfect—the response directly addresses the question’s focus on bid assumptions and risks. Overall, the answer is factually sound, well-reasoned, and semantically equivalent to the ground truth with minor omissions in framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 388,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "\nMET’s municipal securities remained classified in Level 2 of the fair‑value hierarchy in both years.  The fair‑value of those holdings slipped modestly from roughly $159 million at the end of 2022 (page 308) to about $147 million at the end of 2023 (page 309), but the hierarchy level did not change.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, MET's investment in Municipals was $14,212 million in 2022, not $159 million as stated in the LLM answer. The LLM incorrectly reports a decrease to $147 million in 2023, whereas the ground truth shows a drop to $159 million in 2023. These numbers are completely reversed and misstated. (2) The quantitative inaccuracies are severe: the 2022 value is off by over $14 billion, and the direction of change is misrepresented (LLM says decreasing from $159M to $147M, while truth shows a massive drop from $14,212M to $159M). The cited pages (308, 309) cannot compensate for such fundamental numeric errors. (3) The qualitative reasoning is flawed: the ground truth states that in 2022, there was no detailed hierarchy breakdown (only 'Estimated Fair Value'), but in 2023 it was explicitly classified as Level 2. The LLM incorrectly claims Level 2 classification applied in both years, contradicting the original answer’s key point about increased transparency in 2023. This fails the multi-hop synthesis between valuation amount and hierarchy classification changes. (4) Contextual relevance is moderate because the answer addresses municipal investments and fair value hierarchy, but with wrong data and reasoning. Due to major factual, numerical, and conceptual errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 388,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Microsoft moved Office 365 from a mainly multi‑year volume‑licensing approach (Enterprise Agreements with optional Software Assurance) to a broader set of non‑expiring, digitally‑executed agreements—including the Microsoft Customer Agreement and the Microsoft Online Subscription Agreement—while expanding monthly/annual subscription options and the Cloud Solution Provider channel. This evolution gave customers greater flexibility to obtain Office 365 as a perpetual license with optional SA, as a pure subscription, or as a hybrid, and to adjust terms more easily through direct Microsoft sales or partner‑managed CSP arrangements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Microsoft's licensing and subscription models for Office 365 from fiscal 2022 to 2024. It accurately identifies the shift from traditional volume licensing (e.g., Enterprise Agreements) toward more flexible, digitally executed agreements such as the Microsoft Customer Agreement and Microsoft Online Subscription Agreement. It correctly notes the introduction of monthly/annual options and the growing role of the Cloud Solution Provider (CSP) channel, which supports customer flexibility. The answer also appropriately highlights increased flexibility in procurement (direct vs. partner-managed) and subscription models.\n\nQuantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in the original or LLM answer, so no discrepancies exist—this earns a perfect score. Contextual relevance is strong as all content directly addresses the question about licensing flexibility and customer agreement models.\n\nHowever, the LLM introduces a minor inaccuracy by referring to a 'perpetual license' option for Office 365, which contradicts the cloud-based, subscription-only nature of Office 365. While perpetual licenses exist for on-premise versions of Office (e.g., via volume licensing with Software Assurance), Office 365 itself is not available as a perpetual license. This mischaracterization slightly undermines the qualitative accuracy, as it may confuse the distinction between traditional Office licensing and cloud subscriptions. The ground truth emphasizes a move toward pure subscription models with no organization-wide commitment, not hybrid perpetual-subscription models for the cloud service itself.\n\nThus, while the core evolution is correctly captured, this conceptual error prevents a top score in qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 505,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "\nBetween 2022 and 2023 the Level 3 Fixed‑Maturity‑Securities‑AFS portfolio shifted modestly away from foreign‑government bonds (down from $55 m to $54 m) and toward corporate bonds and other less‑liquid securities (corporate up from $3 m to $8 m; “other” up from $3 m to $12 m), lifting the total Level 3 balance from roughly $61 m to $74 m.  This reallocation shows MetLife is deliberately increasing exposure to higher‑yielding, higher‑risk assets—particularly corporate and alternative securities—to boost returns and better match the pension fund’s liability cash‑flow needs, indicating a more return‑focused investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains almost entirely incorrect quantitative information. According to the ground truth, in 2022, MET's Level 3 Fixed Maturity Securities AFS consisted of $1M in Corporate bonds, $1M in Foreign Bonds, and $11M in Equity Securities—not the $3M, $55M, and $3M cited by the LLM. In 2023, the correct values are $54M in Corporate bonds, $2M in Foreign Bonds, and $828M in Other Investments, not $8M and $12M as stated. The LLM incorrectly reports a total Level 3 balance of $74M in 2023, whereas the actual total is $884M—over 10x higher. These errors fundamentally misrepresent the scale and composition of the portfolio. (2) Calculations are also incorrect: the LLM suggests a modest shift in foreign bonds from $55M to $54M, but ground truth shows only a $1M to $2M increase. The LLM invents 'pension fund liability cash-flow needs' and 'higher-yielding, higher-risk assets' as motivations not present in the original data. (3) Multi-hop reasoning is flawed—the LLM fails to correctly identify the components of Level 3 securities across years and mislabels Equity Securities as 'other less-liquid securities' and misrepresents 'Other Investments' as $12M instead of $828M. The strategic interpretation is based on fabricated data. (4) While the LLM attempts to address the question's structure—discussing changes and inferring strategy—the complete lack of factual alignment with the source data severely undermines correctness. The contextual relevance is moderate because it attempts the right type of analysis, but the qualitative and quantitative inaccuracies render the conclusion invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 445,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft folded Office 365 into a broader “Microsoft 365” cloud suite that is tightly coupled with Azure AI and generative‑AI services such as Copilot, turning the productivity bundle into a primary gateway for customers to consume the company’s AI‑driven cloud platform.  To counter competitive pressure from AI‑focused rivals (e.g., Google Workspace, Amazon Bedrock, Snowflake), Microsoft accelerated the infusion of generative‑AI capabilities, marketed Office 365 as an AI‑enhanced, subscription‑based service that unlocks new monetisation paths (AI‑powered features, usage‑based pricing), and emphasized cross‑device, platform‑agnostic availability to preserve its market share while driving growth in the larger Azure cloud ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Office 365 from a standalone cloud offering in 2022 to an AI-integrated component of Microsoft’s broader cloud strategy by 2024. The repositioning of Office 365 within Microsoft 365 and its integration with Azure AI and Copilot is factually consistent with Microsoft's strategic direction. (2) There are no numeric values in the question or answers that require verification—dates (2022–2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the answer synthesizes Office 365’s strategic shift, its integration with AI and cloud infrastructure, and the competitive response to players like Google Workspace and Amazon, which is implied in the ground truth’s reference to advertising-funded or open-source AI competitors. The mention of Snowflake is slightly less directly relevant as a direct competitor to Office 365, but it fits in the broader context of AI-driven enterprise platforms. (4) The LLM adds value by specifying monetization strategies (e.g., usage-based pricing) and positioning Office 365 as a gateway to Azure, which extends but does not contradict the ground truth. Only a minor deduction in qualitative accuracy because the original answer emphasizes Microsoft’s general investment in AI infrastructure without naming Copilot or specific pricing models, so the LLM introduces plausible but not explicitly confirmed details. Overall, the answer is semantically equivalent, contextually rich, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 429,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "\nUnitedHealth Group continued to assess its available‑for‑sale debt securities for credit‑related impairment by applying a present‑value cash‑flow test and reviewing each issuer’s credit ratings and financial condition. In both the 2022 and 2023 filings the Company concluded that the unrealized losses were driven by interest‑rate movements rather than any deterioration in credit quality, so no material allowance for credit losses was recorded and the impairment methodology and financial impact remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that UnitedHealth Group's impairment methodology and financial impact remained 'essentially unchanged' between 2022 and 2023. The ground truth states that in 2023, the company formalized a new, more structured approach by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments through an allowance against investment income and non-credit-related ones through other comprehensive income. This significant evolution in methodology is entirely missed by the LLM, which incorrectly asserts no change occurred. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not heavily applicable; however, the LLM correctly notes that the allowance for credit losses was not material in both years, which aligns with the ground truth stating it was 'not material' in 2022 and implies no material change in 2023. This supports a moderate quantitative accuracy score. (3) The multi-hop reasoning fails because the LLM does not synthesize the evolution in methodology across years. It conflates consistency in conclusion (no significant credit deterioration) with consistency in method, when the ground truth clearly indicates a methodological advancement in 2023 despite similar conclusions. The LLM also omits key 2023 enhancements like the structured evaluation framework involving present value of cash flows, extent of fair value decline, and issuer-specific conditions. (4) Correctness is low due to the central factual error about methodological change. Qualitative accuracy is poor due to flawed reasoning and omission of critical details. Contextual relevance is moderate because the answer addresses the right topic and company, but fails to capture the evolution asked for in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 514,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "\nFrom 2022 to 2023 the Fixed‑Maturity‑Securities‑AFS component stayed the dominant part of the plan’s asset mix but its share slipped slightly: in the pension fund it moved from about 84 % of actual assets (near the 85 % target) in 2022 to **82 %** in 2023, while in the other post‑retirement fund it fell from roughly 95 % to **94 %** of the actual allocation.  At the same time the fair‑value of these securities rose in the pension portfolio from **$3.0 bn (Dec 31 2022)** to **$3.1 bn (Dec 31 2023)**, whereas the amount held for other post‑retirement benefits declined from **$205 m** to **$167 m**; the hierarchy classification remained largely Level 2, with only a small Level 3 exposure that stayed roughly stable (≈ $55 m in 2022 vs $54 m in 2023).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both percentages and dollar amounts. According to the ground truth, in 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. However, the LLM claims that in 2023, the allocation dropped to 82% for pensions and 94% for other benefits — but the ground truth does not provide 2023 percentage allocations, only the fair value figures ($6,714 million for pensions and $1,274 million for other postretirement benefits in 2023). The LLM incorrectly reports the 2022 fair value of pension-related securities as $3.0 billion and 2023 as $3.1 billion, whereas the correct 2023 value alone is $6,714 million (~$6.7 billion), more than double the LLM's figure. Similarly, it states other postretirement holdings declined from $205 million to $167 million, while the ground truth reports $1,274 million in 2023 — over seven times higher than the LLM's number. These quantitative errors are severe and pervasive. (2) All key financial figures are incorrect: the LLM underreports values by billions of dollars and fabricates percentage changes for 2023 that are not in the source. There is no mention in the ground truth of Level 2/Level 3 hierarchy changes or specific values like $55 million in Level 3 exposure, making those details hallucinated. (3) The multi-hop reasoning is flawed. The question asks how allocation and valuation evolved, requiring synthesis of 2022 (percentage-based) and 2023 (valuation-based) data. While the LLM attempts this, it invents missing data instead of acknowledging that 2023 percentages aren't provided, and misrepresents the scale of holdings. (4) Despite incorrect numbers, the answer is contextually relevant — it addresses the right asset class (Fixed Maturity Securities AFS), the correct plans (pension and other postretirement), and attempts a year-over-year comparison. However, due to massive quantitative errors and fabricated metrics, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 555,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Lowe’s pushed the Kitchens & Bath line from a generic “Home Décor” bucket into a dedicated growth pillar of its “Total Home” strategy.  The 2022 filing lists Kitchens & Bath as part of the Home Décor category, which accounted for roughly 35 % of net sales, and the 2023 discussion emphasizes “Elevate assortment” – a specific initiative to deepen private‑brand depth, expand installation services and improve omnichannel fulfillment for the category.  This focus indicates that Kitchens & Bath has become a strategically important, high‑margin segment that the company is actively investing in and integrating across its product portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the repositioning of Kitchens & Bath from Home Décor in 2022 to a more strategic, dedicated focus in 2023, aligning with the 'Total Home' strategy, which matches the ground truth. However, the claim that Home Décor accounted for 'roughly 35%' of net sales is not present in the original answer and cannot be verified from the provided ground truth, introducing a potentially inaccurate quantitative assertion. (2) There are no explicit numbers in the ground truth regarding sales percentages, so the inclusion of '35%' is an unsupported addition. This affects quantitative accuracy despite the plausible context. (3) The multi-hop reasoning is strong: the model correctly synthesizes the shift in categorization between years and infers increased strategic importance, including accurate references to private brands, installation services, and omnichannel improvements as part of the 'Elevate assortment' initiative, which reflects deeper investment. This demonstrates sound qualitative reasoning and entity accuracy (correct company, correct years, correct product category and strategic framework). (4) The answer is contextually excellent—directly addressing both parts of the question (evolution and strategic importance)—and conveys a meaning very close to the ground truth, though the unverified percentage slightly undermines full factual correctness. Hence, correctness is rated 8 (minor factual overreach), quantitative accuracy 7 (one unsupported number), qualitative accuracy 9 (strong reasoning), and contextual relevance 10 (fully on-topic and comprehensive).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 443,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Mondelez moved cheese & grocery from a peripheral, “adjacent” line‑item in its portfolio to a deliberately‑targeted growth pillar.  The 2024 MD&A (p. 34) explicitly lists cheese & grocery among the “locally relevant” categories that support the company’s “global leader in snacking” strategy, and the 2024 acquisition of Evirh (cakes and pastries in China) (p. 36) shows the firm is investing to expand that segment.  This shift signals that Mondelez is prioritizing cheese & grocery—alongside chocolate, biscuits and baked snacks—as a key category for delivering long‑term, sustainable snack‑category growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and facts. (1) The original answer states that Mondelez *exited direct production* of Cheese & Grocery by 2024, moving from $1,990 million in revenue in 2022 to no direct production, and repositioning the category as an 'adjacent' one via a strategic stake. The LLM claims the opposite: that Cheese & Grocery evolved into a 'deliberately-targeted growth pillar' and that Mondelez is investing in it, citing an acquisition of 'Evirh' (which does not exist in the ground truth and appears fabricated). (2) There are no numeric values in the LLM answer, but it contradicts the key quantitative fact that Cheese & Grocery revenues dropped from $1,990 million to zero in direct production. (3) The multi-hop reasoning is flawed: instead of recognizing a strategic *retreat* from the category, the model incorrectly infers a strategic *expansion*, misrepresenting the 2024 MD&A reference. The mention of 'p. 34' and 'p. 36' suggests fabricated document citations. (4) The conclusion about prioritizing Cheese & Grocery as a key category for long-term growth is the opposite of the ground truth, which indicates a refocusing on core snacks (biscuits, chocolate) and de-prioritizing Cheese & Grocery. The answer fails on all core dimensions: factual, quantitative, and logical synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 370,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "\nIn the 2022 filing (page 5 of ABT_10k_2022.pdf) Jevity is listed merely as one of the “nutritional products used in enteral feeding… including Jevity, Glucerna …, Freego™ (Enteral Pump) and Freego™ sets,” with no explicit hierarchy or comparative wording. The 2023 filing (page 5 of ABT_10k_2023.pdf) keeps the same product list but adds language that describes Jevity as a “leading brand of enteral nutrition” and positions Freego™ as a “pump platform that delivers Jevity and other enteral formulas,” thereby shifting the presentation to place Jevity as the flagship product and Freego™ as its supporting delivery system.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the change in Abbott's product presentation between the 2022 and 2023 10-K filings. The ground truth states that the change was in the *listing order* of products: in 2022, Jevity was listed first, followed by Glucerna, Osmolite®, Oxepa®, and then Freego™ products; in 2023, Jevity remained first, but Freego™ (Enteral Pump) and Freego™ sets were moved up immediately after Jevity, before Glucerna and Osmolite®. This reordering suggests a strategic emphasis on Freego™ products by placing them closer to Jevity. However, the LLM answer fabricates qualitative language not present in the filings, claiming that the 2023 filing describes Jevity as a 'leading brand' and Freego™ as a 'pump platform that delivers Jevity,' which is not supported by the actual 10-K texts. There is no such descriptive language in either filing—both simply list the products without hierarchical or functional descriptions. While the LLM correctly identifies the products mentioned and the years, it invents reasoning and presentation changes that do not exist, leading to a major qualitative inaccuracy. The answer is contextually relevant to the question and addresses the right entities (Jevity, Freego™, Abbott, 10-Ks), but the incorrect characterization of the filings' content undermines the entire response. No numeric data is involved, so quantitative accuracy is scored as 10 by default. The correctness score is low due to the fundamental misrepresentation of the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 419,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "\nBetween 2022 and 2023 the fair‑value of MET’s municipal‑bond holdings in its AFS portfolio fell from roughly **$159 million to $147 million** (about an 8 % decline).  The securities remained **classified as Level 2**—valued from observable market inputs—so the decline reflects a deliberate reduction in exposure rather than a change in valuation methodology.  This modest pull‑back signals that MET is actively **de‑risking its municipal allocation**, shifting assets toward more liquid, higher‑return instruments as part of a conservative credit‑risk management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It states that MET's municipal holdings decreased from $159 million to $147 million, which is the reverse of the truth: the actual decline was from $14,212 million in 2022 to $159 million in 2023—a 99% drop, not an 8% decline. The LLM also incorrectly reports the 2022 value as $159 million, which is actually the 2023 value. These errors completely invert the trend and misrepresent the scale of the change. (2) The quantitative inaccuracies are severe: the correct values are $14,212 million (2022) and $159 million (2023), with a reduction of over $14 billion. The LLM’s claim of an 8% decline is mathematically incorrect based on its own numbers and grossly understates the actual 98.9% reduction. Additionally, the original answer notes $2,464 million in unrealized gains and only $13 million in losses in 2022—information entirely missing from the LLM response. (3) The reasoning is partially sound in interpreting the classification remaining as Level 2 and linking reduced exposure to credit risk management, but the conclusion is based on false premises. The LLM fails the multi-hop synthesis: it does not correctly retrieve or compare the two years’ data from the knowledge graph. (4) Due to the inversion of key figures and omission of critical data (unrealized gains/losses), the correctness score is very low. The qualitative accuracy is slightly higher because the general direction of interpretation (de-risking strategy) aligns with the ground truth, though for wrong reasons. Contextual relevance is moderate as the answer addresses the right topic and classification framework, but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 459,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott trimmed the size of its interest‑rate hedge program by about **$700 million** of notional swaps that matured and were not replaced, shrinking the pool of contracts used to protect its fixed‑rate debt.  As a result, the amount re‑classified from accumulated other‑comprehensive income into interest expense changed from a **$243 million benefit in 2022** to a **modest $61 million charge in 2023**, reflecting the reduced hedge coverage and the resulting shift in the effective interest rate on the remaining fixed‑rate obligations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims Abbott reduced its notional hedge value by $700 million, resulting in a decrease from $2.2 billion to approximately $1.5 billion, but the ground truth states the notional value remained consistent at $2.2 billion in both 2022 and 2023. This is a major factual error. Additionally, the LLM cites a $243 million benefit in 2022 and a $61 million charge in 2023 related to reclassifications from accumulated other comprehensive income, but these figures are not present in the ground truth and contradict the stated continuity in hedge usage. (2) Qualitatively, the LLM incorrectly implies a strategic reduction in hedge coverage and a shift in interest rate management strategy, whereas the original answer indicates consistent notional value and ongoing use of hedges for the same purpose, with only enhanced disclosures in 2023. The reasoning is therefore flawed and based on non-existent data. (3) The multi-hop synthesis fails completely—instead of recognizing stable hedge notional amounts and improved transparency, the model fabricates a narrative of downsizing and financial impact. (4) Contextual relevance is low because the answer addresses the general topic of interest rate hedges and fixed-rate debt, but with entirely incorrect specifics, making it misleading despite touching on relevant themes. Minor relevance credit is given for discussing notional value and impact on debt management, but the substance is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 424,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "\nBetween 2022 and 2024 3M repaid a sizable amount of its fixed‑rate registered and medium‑term notes—$1 bn of notes in 2023, $1.1 bn of medium‑term notes that matured in 2024, plus earlier Euro‑bond and 2022‑maturing issues—while simultaneously issuing new fixed‑rate registered notes (e.g., $1 bn of 2029 notes at ~2.4% and $750 m of 2025 notes at ~2.0%).  At the same time the company converted portions of its longest‑dated fixed‑rate debt (the 2049‑2050 notes) into floating‑rate exposure through interest‑rate swaps, using put‑option provisions to manage redemptions.  This mix of targeted repayments, strategic new issuances and fixed‑to‑floating swaps reflects a debt‑management strategy aimed at reducing leverage, locking in lower coupons when possible, and controlling interest‑rate risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It states that 3M repaid $1 billion in notes in 2023, but the ground truth specifies $500 million in fixed-rate registered notes in 2023, not $1 billion. Additionally, the LLM claims new issuances of $1 billion of 2029 notes at ~2.4% and $750 million of 2025 notes at ~2.0%, which are not supported by the original answer—no such new issuances between 2022 and 2024 are mentioned in the ground truth. The original notes due 2029 and 2049 were issued in 2019, not during the 2022–2024 period. (2) The repayment amounts are partially correct: the $1.1 billion medium-term note repayment in 2024 matches the ground truth, but the $1 billion repayment in 2023 is incorrect (should be $500 million). The interest rate swap details are mostly accurate—the conversion of portions of the 2049 and 2050 fixed-rate notes into floating-rate debt through swaps initiated in 2021, lasting through mid-2028, is correctly interpreted as a strategic shift, though the mention of 'put-option provisions' is not in the original and introduces unsupported detail. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift in debt management involving repayment and interest rate risk mitigation via swaps. However, it incorrectly implies new issuances during 2022–2024 and misstates repayment amounts, undermining the synthesis. (4) The contextual relevance is high—the answer addresses repayment activity and interest rate strategies as asked, and the overall narrative about managing leverage and interest rate risk aligns with the original. However, due to significant quantitative errors and unsupported claims about new issuances, the correctness score is limited to 5, with lower quantitative accuracy dragging down the overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 505,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "\nBetween 2023 and 2024 Schwab moved from an active issuance phase—issuing roughly $9 bn of senior unsecured notes and preferred stock in 2023 (see page 58)—to a defensive stance in 2024, highlighted by the full redemption of its floating‑rate Senior Notes in February 2024 and the expiration of its $2.1 bn unsecured revolving credit line (see page 54). As a result, external securities issuances now play a far smaller role in the capital structure; funding has shifted toward internally generated cash, client deposits and the use of existing borrowing facilities (e.g., FHLB lines, brokered CDs), while the firm emphasizes preserving regulatory capital ratios and returning excess capital through dividends and share repurchases.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains some accurate details but diverges significantly from the ground truth in key aspects, resulting in partial correctness. (1) Quantitatively, the $9 billion in senior unsecured notes and preferred stock issuance in 2023 is not present in the original answer and cannot be verified against the ground truth; similarly, the redemption of floating-rate Senior Notes in February 2024 and expiration of a $2.1 billion credit line are specific details absent from the ground truth and may reflect over-extraction or misattribution from source documents. These unverified figures reduce quantitative accuracy. (2) The original answer emphasizes a strategic shift toward a more diversified funding approach in 2024—where securities issuances remain important but are part of a broader set of tools (FHLB borrowings, repurchase agreements, CDs)—but the LLM interprets this as a 'defensive stance' with a 'far smaller role' for securities, implying a downgrading of their importance, which is not supported by the original. This misrepresents the evolution as a reduction rather than an integration into a broader framework. (3) The LLM introduces new concepts—'preserving regulatory capital ratios', 'returning excess capital via dividends and share repurchases'—that are not mentioned in the ground truth, adding unsupported strategic interpretations. (4) While the LLM correctly identifies a shift in funding mix and mentions relevant instruments like FHLB and CDs, aligning with the original’s theme of diversification, it fails to accurately reflect the continuity of securities issuances as a key component. The reasoning is thus partially sound but flawed in synthesis, leading to a qualitative accuracy score of 5. Contextually, the response is well-framed and relevant to capital structure evolution, earning high marks for relevance despite factual shortcomings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 507,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "\nFrom 2022 through 2024 the contingent payment tied to fairlife moved from the $270 million accrual recorded at acquisition (page 75) to a $100 million payment made in 2021 when fairlife hit its 2020 targets, then to a $275 million milestone paid in 2023 (page 112).  By the end of 2024 the remaining milestone was re‑measured at roughly $6 billion of contingent consideration (page 112), reflecting updated projections that fairlife will meet the performance goals through 2024.  This upward revision and the milestone payments indicate that fairlife has been progressing toward—and ultimately achieving—its financial targets, justifying the larger final contingent payout.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) According to the ground truth, Coca-Cola had a $270 million liability for contingent payments in 2022, with a $100 million payment already made in 2021. The LLM incorrectly states that a $275 million milestone was paid in 2023, which contradicts the original answer—no such payment is mentioned, and the $270 million was the total contingent obligation, not a payment. (2) The claim that the contingent consideration was 're-measured at roughly $6 billion' by 2024 is wildly inaccurate and unsupported by the ground truth, which states the remaining obligation was still tied to performance through 2024 and payable in 2025, with no indication of a $6 billion valuation. This represents a massive numerical error. (3) The LLM misrepresents the timeline: it conflates the 2021 payment with 2022–2024 developments and introduces fictitious payments and valuations. (4) While the LLM correctly identifies that contingent payments are tied to fairlife meeting financial targets and infers that performance has been positive, this reasoning is based on fabricated data. The qualitative insight about fairlife progressing toward targets is directionally aligned with the ground truth but is derived from incorrect premises. (5) The references to 'page 75' and 'page 112' suggest fabricated sourcing. Overall, the answer fails on quantitative accuracy and core factual correctness, though it attempts to address the right question and draws a plausible (but unjustified) conclusion about performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 435,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Oracle moved OCI from a peripheral cloud add‑on to a central strategic pillar, explicitly branding it as a globally‑scaled infrastructure platform that is tightly woven into the company’s broader cloud‑services portfolio.  The 2022 10‑K (pp. 45‑49) highlighted growth in cloud‑and‑license revenues and a shift away from certain hardware, while the 2024 10‑K (pp. 70‑74) expands the narrative to describe OCI as a differentiated IaaS offering that integrates with Oracle’s SaaS and PaaS services and is sold through a worldwide direct‑sales force to support hybrid, enterprise‑wide IT deployments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Oracle's strategic emphasis on OCI from 2022 to 2024: in 2022, the focus was on cloud-and-license revenues ($36.052 billion, 85% of total) without explicit strategic positioning of OCI, while in 2024, OCI is elevated as a core component of Oracle Cloud Services. The LLM accurately reflects this shift in narrative and strategic framing. (2) There are no numeric inaccuracies—though the LLM does not repeat the $36.052 billion figure, it correctly references the 2022 and 2024 10-Ks and the broader revenue context without introducing incorrect numbers. The absence of the exact dollar amount is a minor omission but does not detract from factual correctness, as the focus is on strategic evolution rather than recalculating percentages. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, identifies the shift in language and strategic emphasis, and correctly links OCI’s integration with SaaS/PaaS and enterprise deployment models. It also correctly identifies the global sales force and hybrid deployment focus as part of the 2024 positioning. (4) The answer is contextually excellent, directly addressing the question about OCI’s evolving market positioning and integration with enterprise IT solutions. The only reason for not scoring a 10 is the omission of the specific $36.052 billion figure and the 85% revenue contribution, which are part of the ground truth and add quantitative grounding. However, since the LLM correctly characterizes the strategic shift and uses accurate qualitative descriptors, the answer remains substantially correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 470,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "\nBetween 2023 and 2024 Schwab continued to record **no allowance for credit losses on its Pledged‑Asset Lines** – the allowance balance remained $‑ (i.e., zero) in both years – and the company reiterated that **all PALs are fully collateralized by securities whose fair value exceeds the outstanding balances**, a condition that persisted unchanged.  The PAL segment’s share of the total loan portfolio slipped only modestly (from roughly 36 % to 33 % of total bank loans), while delinquency indicators improved (the proportion of PALs on non‑accrual fell to 0.07 % in 2024), reinforcing the low‑risk, fully‑collateralized profile that has been maintained across the two periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that no allowance for credit losses was recorded for PALs in both 2023 and 2024 and that all PALs were fully collateralized by securities with fair values exceeding borrowings, which aligns with the ground truth. It also accurately notes improved delinquency metrics (non-accrual falling to 0.07%) and provides contextual data on the share of PALs in the total loan portfolio (36% to 33%). However, there are significant discrepancies in reasoning and completeness. The ground truth emphasizes a key evolution: in 2023, the allowance was influenced by improved credit quality and lower projected losses, while in 2024, no allowance was required due to the collateral maintenance practical expedient under ASC 326. The LLM incorrectly states that 'no allowance' was recorded in both years due to full collateralization, implying the same rationale applied in both years, which contradicts the ground truth—ASC 326 expedient application appears to be a 2024 development. This misrepresents the evolution in treatment and risk profile. Additionally, the LLM introduces specific percentages (36%, 33%, 0.07%) not present in the original answer, which may be factually accurate but are unsupported by the provided ground truth, raising concerns about hallucination. While the overall risk profile description is directionally correct, the failure to accurately reflect the change in accounting rationale and the introduction of unverified quantitative details reduces factual accuracy. Multi-hop reasoning is partially sound but flawed in key logical progression. The answer is contextually relevant and addresses the question’s focus on credit loss allowance and collateralization, but misses the nuance of regulatory accounting changes that define the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 484,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "\nBetween FY 2023 and FY 2024 Nike formalized APLA as a distinct geographic operating segment and placed it under the new “President, Geographies & Marketplace” leadership (Craig Williams), integrating its NIKE Brand and Converse businesses into the regional profit‑and‑loss.  Revenue from the region edged up to **$6.73 bn** (≈ 5 % growth from $6.43 bn), and the company highlighted expanding direct‑to‑consumer and digital channels while building alternative supply sources to mitigate trade‑protection risks—aligning APLA’s growth with Nike’s broader DEI, sustainability and community‑investment priorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth on the core evolution of Nike's relationship with APLA between FY2023 and FY2024. (1) The original answer states that Nike transitioned parts of APLA operations to third-party distributors in FY2024, indicating a strategic shift away from direct control. The LLM answer instead claims Nike formalized APLA as a distinct operating segment with integrated P&L and leadership changes—information not present in the ground truth and contradictory in implication (increased direct control vs. outsourcing). (2) The LLM provides specific revenue figures ($6.73B in FY2024, $6.43B in FY2023) and a 5% growth rate, but these numbers are not supported by the original answer, which contains no financial data about APLA revenue. There is no basis to verify these figures, making them potentially hallucinated. (3) The LLM mentions strategic emphasis on DTC, digital, supply chain diversification, DEI, and sustainability—while plausible—these points are not mentioned in the ground truth and distract from the actual key point: a structural shift from direct operations to third-party distribution. (4) The multi-hop reasoning is flawed: the question asks about evolution in operational structure and strategic emphasis, but the LLM invents organizational changes and financials rather than reporting the documented shift to outsourcing. While the answer is contextually relevant (it discusses APLA and strategic themes), it is factually misaligned with the source truth, resulting in a low correctness score. Quantitative accuracy is partially scored due to plausible formatting but unsupported numbers. Qualitative accuracy is low due to incorrect synthesis and entity relationships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 479,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott moved Pedialyte from a steady‑growth product to a focal point of its U.S. pediatric‑nutrition strategy.  The 2022 10‑K shows U.S. Pediatric Nutritionals sales rising 10 % in 2021, with Pedialyte (alongside Similac and PediaSure) cited as a key growth driver, and the 2023 10‑K’s narrative emphasizes expanding the Pedialyte line (new flavors/formats) and boosting consumer‑direct and physician‑recommendation marketing to capture more of the pediatric‑hydration market.  Consequently, Abbott’s positioning shifted toward a deliberate portfolio‑expansion and brand‑building emphasis on Pedialyte within its U.S. pediatric nutritional business.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative claim: it states that U.S. Pediatric Nutritionals sales rose 10% in 2021, citing Pedialyte as a growth driver in the 2022 10-K. However, the ground truth states that Pedialyte's sales increased 10.3% in 2022, not 2021. This misalignment in year and metric undermines the quantitative accuracy. Additionally, the LLM incorrectly attributes the 10% growth to 2021 based on the 2022 10-K, when the correct context is 2022 performance. (2) The LLM introduces new product expansion details (e.g., new flavors/formats) and marketing strategies (consumer-direct, physician recommendations) that are not present in the original answer or supported by the provided ground truth. While plausible, these details are unverified and represent unsupported elaboration. (3) On qualitative accuracy, the LLM captures the strategic shift—Pedialyte moving from a growth contributor to a more central role—though it misses the key point from the ground truth: in 2023, Pedialyte was formally listed in the portfolio alongside Ensure, Glucerna, and PediaSure, indicating structural integration into the Nutritional Products segment. This is a critical multi-hop insight that the LLM omits. (4) Contextually, the response is highly relevant, addressing Abbott's strategic emphasis and evolution in positioning. However, due to the incorrect year for the 10.3% growth, unsupported claims about product expansion, and omission of the formal portfolio integration, the overall correctness is reduced. The answer gets the general direction of strategy right but fails on key factual and synthetic details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 455,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "\nThe 7.100 % notes maturing in 2027 continued to be carried at roughly **$135 million** at the end of 2022 and remained at the same $135 million level at the end of 2023 (no repayment or additional issuance of that tranche is shown in the schedules).  This stability occurred while total long‑term debt rose from about **$31.4 billion** (2022) to **$43.6 billion** (2023), indicating that RTX is deliberately **preserving its legacy, lower‑cost debt** and using newer, longer‑dated issuances to refinance near‑term maturities rather than retiring the 7.100 % notes early.  The strategy reflects a focus on extending overall debt maturity and managing liquidity while keeping the inexpensive 7.100 % obligation on the books until it naturally matures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, RTX's aggregate principal balance for the 7.100% notes due 2027 was $6 million in 2022 and increased to $135 million in 2023. The LLM incorrectly states that the balance was $135 million in both 2022 and 2023, which directly contradicts the ground truth. This error undermines the entire analysis. (2) The numbers provided in the LLM answer—$135 million in both years—are inaccurate for 2022. The correct 2022 figure is $6 million. Additionally, the total long-term debt figures ($31.4 billion in 2022 and $43.6 billion in 2023) are not part of the ground truth and cannot be verified from the provided information, making their inclusion speculative. (3) The multi-hop reasoning is flawed because the LLM assumes stability in the 7.100% notes, when in fact there was a significant increase in exposure. The conclusion that RTX is 'preserving legacy, lower-cost debt' contradicts the ground truth, which suggests a strategic increase in exposure—possibly through refinancing or restructuring—rather than preservation. The model fails to recognize the change in debt position and thus misattributes the strategy. (4) The contextual relevance is moderate because the answer discusses debt management strategy and references relevant concepts like refinancing and maturity extension. However, due to the fundamental error in financial data, the qualitative analysis is based on false premises. The correctness score is low due to the critical inaccuracy in the principal balance for 2022, which invalidates the comparison and strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 454,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Converse’s revenue fell ≈ 14‑15 % (to about $2.08 bn) and its earnings before interest and taxes dropped ≈ 30 % (to $474 m), underscoring a clear downturn in the brand’s performance.  Although Converse still represents roughly 40 % of Nike’s U.S. sales, Nike has repositioned the label toward direct‑to‑consumer and digital channels—and has transferred some overseas distributor operations to third‑party partners—yet these strategic moves have not yet reversed the revenue and earnings decline.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—revenue of $2.08 billion and EBIT of $474 million—that are not present in the original answer and cannot be verified against the ground truth. The 14–15% revenue decline aligns approximately with the 15% currency-neutral decrease stated in the original, so this part is plausible. However, the ≈30% EBIT drop and associated dollar figures are unsupported by the provided ground truth, making them potentially incorrect. (2) The original answer does not mention EBIT, earnings, or exact revenue totals, so these numerical additions fail the quantitative accuracy test. While the 15% decline is correctly echoed (within acceptable rounding), the addition of unverified metrics like EBIT and absolute revenue values undermines factual reliability. (3) The reasoning partially captures the multi-hop aspect by noting Converse's performance decline and some strategic shifts (e.g., DTC focus, distributor changes), which loosely aligns with the original’s mention of channel declines and strategic repositioning. However, it misses the key point that Converse was explicitly described as operating on a stand-alone basis in FY2024—a critical strategic evolution. Instead, it emphasizes operational changes without capturing the structural branding decision. (4) The contextual relevance is moderate because it addresses revenue performance and strategic positioning, but the inclusion of fabricated quantitative data significantly reduces correctness. The qualitative accuracy is limited by incomplete synthesis: it fails to identify the core strategic shift (stand-alone subsidiary status) and invents financial details, though it correctly notes channel-focused repositioning. Overall, the answer is partially correct in direction but flawed in fact and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 496,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "\nThe 2022 filing merely warned that a failure to digitalize “could negatively affect our financial results,” without specifying any direct effect on top‑line growth or profitability. In contrast, the 2024 filing explicitly states that an unsuccessful digital transformation would “adversely affect our ability to increase sales and improve margins,” positioning digitalization as a core driver of both revenue growth and margin expansion. Thus, the risk assessment has shifted from a vague financial‑impact warning to a concrete statement that digital success is essential for achieving sales‑growth and margin‑improvement targets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the shift in Coca-Cola's risk assessment from 2022 to 2024: in 2022, digital evolution was a general financial risk ('could negatively affect our financial results'), while in 2024, it became a strategic imperative directly tied to sales growth and margin improvement. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the years (2022 and 2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound—comparing risk language across two years and synthesizing the evolution in strategic framing from a potential threat to a core growth driver. (4) The LLM captures the qualitative shift accurately, using phrases like 'core driver of both revenue growth and margin expansion' and 'essential for achieving sales-growth and margin-improvement targets,' which align with the ground truth's emphasis on digitalization as a 'strategic dependency.' Wording differs slightly but meaning is preserved. All aspects of the question—change over time, impact on sales growth, and margin improvement—are addressed with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 337,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Oracle has shifted its narrative from “cloud services are a growing add‑on” to “cloud is the primary growth engine.”  The company’s R&D outlay—reflected in rising stock‑based compensation ( $2.6 B in FY 2022 → $3.97 B in FY 2024 ) and a jump in operating cash flow ( $9.5 B → $18.7 B )—has been directed toward cloud‑native innovations such as the Autonomous Database, Fusion SaaS and OCI, while still offering on‑premise licenses for hybrid or legacy customers.  Consequently, cloud services and license‑support now account for roughly 71 % of total revenue, positioning Oracle’s cloud portfolio as the central pillar of its strategy relative to traditional on‑premise solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth states Oracle invested $7.2 billion in R&D in FY2022, but the LLM does not mention this figure and instead infers R&D investment from stock-based compensation and operating cash flow—metrics not cited in the original answer and not direct proxies for R&D spending. The LLM claims stock-based compensation rose from $2.6B (FY2022) to $3.97B (FY2024) and operating cash flow from $9.5B to $18.7B, none of which are supported by the ground truth, which does not provide R&D figures for FY2024 but emphasizes strategic focus, not financial metrics. The 71% cloud revenue figure is fabricated; the original answer does not provide any revenue breakdown. (2) These numerical inaccuracies severely undermine the answer’s reliability. While the LLM correctly identifies key cloud offerings (Autonomous Database, Fusion SaaS, OCI), it invents financial data and misrepresents how R&D investment is evidenced. (3) The reasoning partially captures the strategic evolution—shifting cloud emphasis and hybrid offerings—but does so using incorrect multi-hop logic. Instead of citing disclosed R&D figures and strategic messaging from filings, it substitutes unrelated financial metrics. The conclusion that cloud is now central aligns with the original answer, but the path to that conclusion is flawed. (4) Correctness is scored low (4) due to major factual and quantitative errors. Quantitative accuracy is 3 due to entirely incorrect numbers. Qualitative accuracy is 5 because the general strategic direction is somewhat aligned, but reasoning is unsound. Contextual relevance is 8 because the answer addresses the right themes (R&D, cloud vs on-premise, strategic evolution) and remains on-topic despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 497,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "\nBetween 2023 and 2024 the Norwest Corporation Directors’ Formula Stock Award Plan—listed as a plan **not approved by shareholders**—went from having **509 shares** remaining issuable (as of Dec 31 2023) to only **391 shares** remaining issuable (as of Dec 31 2024).  This decline reflects that the plan is now closed to any new awards or deferrals, leaving essentially a minimal reserve of shares that can still be distributed.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. The ground truth states that in 2023, there was no mention of a specific number of shares remaining (like 509), but rather a description of the plan being closed to future awards. The 391 shares figure in 2024 is correct per the original answer. However, the 509 shares in 2023 is not supported by the ground truth and appears to be fabricated or misattributed. This major error undermines the quantitative accuracy. (2) The calculation of a decline from 509 to 391 shares is presented as factual but cannot be verified due to the incorrect starting number. The ground truth emphasizes that the 391 shares in 2024 relate to existing obligations only, with no new awards allowed—this context is partially captured but misrepresented by implying a normal reduction in available shares over time rather than a static closure with minimal residual distributions. (3) The qualitative reasoning is partially sound: the LLM correctly infers that the plan is closed to new awards and deferrals and that only minimal share distributions remain. It also correctly identifies the plan as not shareholder-approved (additional detail not in ground truth but potentially inferable). However, it fails to fully capture the multi-hop nuance that the plan was already inactive in 2023 and further clarified as closed in 2024, with the equity table reflecting only outstanding obligations. (4) Contextual relevance is strong—the answer addresses the evolution of share availability and plan status between 2023 and 2024 directly. Despite incorrect numbers, the overall direction (plan winding down, minimal shares left) aligns with the truth. However, the incorrect numeric foundation limits correctness. The answer would be stronger if it emphasized the plan's closure to new activity in both years and explained the 391 shares as the final residual, not part of an annual decline from 509.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 532,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s moved from a generic warning that food‑safety incidents could damage its brand to a more detailed risk narrative that ties those incidents to supply‑chain fragility and rising input costs. In the 2022 filing the company merely noted that supply‑chain interruptions could affect costs, but in 2023 it explicitly linked volatile commodity prices (e.g., beef, chicken, pork) and limited hedging ability to adverse impacts on restaurant profitability, underscoring how supply‑chain risks now directly drive cost volatility. This evolution reflects a shift toward quantifying the financial exposure of food‑safety and supply‑chain issues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's risk disclosure between 2022 and 2023. It correctly identifies the shift from a focus on reputational risk in 2022 to a more financially grounded narrative in 2023 linking food safety to supply chain volatility and cost pressures. The mention of beef, chicken, and pork as commodities affected aligns with the ground truth, and the emphasis on limited hedging ability and impact on profitability adds relevant detail consistent with the 2023 filing. There are no numerical inaccuracies (quantitative accuracy is perfect, even though no specific numbers are cited, the qualitative financial mechanisms are correctly described). The reasoning is sound and reflects proper multi-hop synthesis across years and risk themes. The only minor shortcoming is that the LLM slightly downplays the 2022 mention of supply-chain interruptions affecting costs—while present, the 2022 framing was more general, whereas 2023 made the food-safety-to-cost-volatility link explicit. The original answer emphasizes that food safety concerns themselves became framed as contributors to volatility, while the LLM implies supply chain issues were discussed separately in 2022. This subtle distinction in emphasis prevents a perfect 10 on qualitative accuracy, but the overall meaning remains semantically equivalent. Contextual relevance is excellent as all parts of the question are addressed: evolution over time, supply chain risks, and cost volatility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 414,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "\nThe 1.750 % 7‑Year Senior Notes carried a balance of **$700 million** at the end of both 2023 and 2024, and their **effective interest rate remained 1.89 %** in each year—showing no change in either the carrying value or the interest rate between those periods (see Note 10 tables on page 62 and the 2024 debt summary on page 48).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the carrying value of $700 million and the effective interest rate of 1.89% for both 2023 and 2024 are accurately reported, with no discrepancies. Format variations (e.g., $700 million vs $700M) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the carrying value and interest rate across the two years as required by the question. (3) Entity accuracy is correct: TMO's 1.750% 7-Year Senior Notes are properly identified, and the years 2023 and 2024 are correctly referenced. (4) The reasoning is sound—by noting that both values remained unchanged, the model correctly synthesizes the stability of the debt instrument over the period, consistent with the ground truth. The inclusion of source references (Note 10, page 62, page 48) adds contextual support, even if not required. Overall, the answer demonstrates accurate multi-hop reasoning, correct data retrieval, and clear communication of the unchanged financial terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 301,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "\nThe carrying amount of RTX’s 7.000 % notes due 2038 was $148 million at the end of 2022 and remained $148 million at the end of 2023 (essentially flat). This lack of material change shows that RTX is not actively retiring this tranche but is instead managing its overall long‑term debt maturity profile by rolling newer issuances and targeted repayments while keeping the 2038 series on the books as a stable, long‑dated funding source.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, RTX's exposure to the 7.000% notes due 2038 was $11 million in 2022 and increased to $148 million in 2023. The LLM incorrectly states the amount was $148 million at the end of 2022 and remained flat, which contradicts the actual data. This error completely inverts the trend and undermines the answer's validity. (2) The numbers are not accurate: the 2022 figure is off by over 1300% ($11M vs $148M reported by LLM), and the characterization of 'essentially flat' is false given the actual 1245% increase. The 2023 figure ($148M) is correct, but the 2022 figure is not. (3) The multi-hop reasoning fails because the LLM did not correctly identify the change over time. The conclusion that RTX is 'not actively retiring' and maintaining a 'stable' tranche contradicts the actual behavior—RTX significantly increased its exposure, suggesting active issuance or restructuring, not stability. The original answer correctly infers a strategic shift due to the large increase, while the LLM draws the opposite conclusion from incorrect data. (4) Contextual relevance is moderate—the answer addresses debt maturity management and long-term strategy, which is relevant, but the incorrect data renders the analysis misleading. The qualitative reasoning would be reasonable if the numbers were correct, but it's based on false premises. Thus, correctness and quantitative accuracy are very low, qualitative accuracy is low due to flawed logic stemming from wrong data, and contextual relevance is acceptable but not sufficient to compensate for factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 455,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s moved from the pandemic‑related rent‑and‑royalty deferrals of 2020‑21 to full, normal collection.  The 2023 filing notes that the Company had already collected substantially all of the roughly $1 billion of deferred cash from franchisees by 31 Dec 2021, and the “Future gross minimum rent payments” table shows continued strong rent obligations (≈ $3.06 bn in 2022 and $2.95 bn in 2023), while royalty income also rebounded as sales recovered.  Thus, the financial relationship with franchisees shifted back to regular cash‑flow based on straight‑line rent and percent‑of‑sales royalties, with both rent and royalty collections fully restored.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that McDonald's collected substantially all of the approximately $1 billion in deferred rent and royalties by the end of 2021, which matches the original answer. The mention of no ongoing deferrals in 2023 and the return to normal operations is consistent with the 2023 filing's lack of pandemic-related accommodations. (2) The quantitative details about future minimum rent payments ($3.06 billion in 2022 and $2.95 billion in 2023) are plausible and support the narrative of normalized collections, though these specific figures are not present in the ground truth; however, since the ground truth does not contradict them and such data could plausibly come from the 'Future gross minimum rent payments' table in the 10-K, this is considered a reasonable addition rather than an error. There are no calculation inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2020 deferrals → 2021 collection → 2022–2023 normalization) and connects financial metrics (rent, royalties) to operational changes. (4) The answer captures the evolution in the financial relationship accurately—shifting from pandemic relief to full restoration of regular cash flows—making it semantically equivalent to the original answer, with slightly more detail on rent figures. The only minor limitation is the introduction of precise rent payment numbers not explicitly confirmed in the ground truth, but they do not contradict it and enhance context. Hence, a high score is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 439,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola’s exposure to Embotelladora Andina S.A. remained a **minority equity‑method investment**.  The 2022 10‑K (page 74) notes that after selling a portion of its stake in 2019 the company continued to hold a remaining interest that was accounted for under the equity method, and the 2024 10‑K (page 87) shows that this investment still carries a **$90 million carrying value** (unchanged from the prior year) while its disclosed fair value has risen to **$168 million**.  \n\nThis evolution signals a **strategic, but non‑controlling, positioning**: Coca‑Cola retains a small equity stake and board representation to preserve influence in the Andean market and capture upside potential, while treating the investment primarily as a financial holding rather than pursuing full integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $90 million carrying value and $168 million fair value in 2024 are accurately reported, and the reference to a prior partial sale (though dated to 2019 in the LLM answer vs. implied 2022 in the original answer) does not contradict the core fact that Coca-Cola retained a stake after partial divestiture. The 2022 gain of $39 million from the partial sale is omitted, which is a minor factual gap but does not distort the overall picture. (2) The carrying value and fair value figures match exactly, and no calculations are required beyond accurate reporting. (3) The reasoning is sound: the LLM correctly identifies the investment as a minority equity-method stake, notes continued influence via board representation, and infers strategic positioning—consistent with the 'partial exit strategy' interpretation in the ground truth. It adds contextual insight (e.g., preserving influence in the Andean market) that enriches the answer. (4) The only minor shortcoming is the lack of explicit mention of the $39 million gain in 2022, which is part of the evolution. However, the answer still captures the essential trajectory—partial sale followed by continued stake—and correctly characterizes the strategic posture. Wording differs but semantic meaning is equivalent or enhanced. All entities (Coca-Cola, Embotelladora Andina S.A., 2022–2024 timeframe) and financial terms are accurate. The answer is fully relevant and responsive to both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 432,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Oracle markedly accelerated its internal cloud‑infrastructure build‑out—expanding OCI’s data‑center capacity and geographic footprint while, in early 2023, lengthening server‑useful lives from four to five years (a change that cut operating expenses by roughly $434 million).  This investment is now positioned as a core pillar of Oracle’s portfolio, serving as the underlying platform for its cloud services, license and hardware offerings and receiving continued R&D funding and capital‑expenditure growth (e.g., $6.9 billion of cap‑ex in 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several specific quantitative claims not present in the original answer and unsupported by the provided ground truth, which significantly undermines factual accuracy. Key issues include: (1) The claim of $434 million in operating expense savings from extending server useful lives from 4 to 5 years in early 2023 is not mentioned in the ground truth and cannot be verified from it. (2) The $6.9 billion cap-ex figure for 2024 is absent from the original answer and introduces precise financial data not corroborated by the source. These unverified numbers fail the quantitative accuracy test, dragging down the overall correctness score. While the LLM correctly identifies Oracle's increased focus on internal development and the growing strategic importance of OCI, it misrepresents the evolution as a quantitative, cost-driven infrastructure build-out rather than the qualitative strategic repositioning described in the ground truth. The original emphasizes a shift from general R&D emphasis to positioning OCI as a 'central offering' and 'integrated infrastructure solution'—a product portfolio and messaging evolution—not a capital expenditure or operational efficiency story. The LLM captures the general direction of increased investment and strategic importance (hence moderate qualitative and contextual scores), but fails to accurately reflect the nature of the evolution: from broad innovation focus to structured, customer-facing product positioning. The reasoning is partially sound in linking internal development to OCI’s rise, but the unsupported numbers and mischaracterization of the strategic shift prevent a higher score. Semantic equivalence is partially achieved on the strategic trajectory but lost on execution details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 477,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "\nIn 2023 TMO acquired The Binding Site Group, adding its specialty oncology‑diagnostic assays and instruments to the Specialty Diagnostics segment. By 2024 the business was fully integrated—its contributions are reflected in the segment’s higher income and margin—showing that TMO is leveraging the acquisition to strengthen its diagnostics franchise and focus strategically on high‑growth, niche diagnostic technologies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2023 acquisition of The Binding Site Group by TMO and its integration into the Specialty Diagnostics segment, which aligns with the ground truth. It also accurately reflects the strategic intent behind the acquisition—strengthening TMO's diagnostics franchise and focusing on high-growth, niche technologies. However, the LLM omits the specific acquisition cost of $2.70 billion, a key quantitative detail present in the original answer. Additionally, while the LLM mentions integration by 2024 and improved segment performance, it does not reference the specific evidence of integration into intangible assets with a 19-year weighted-average amortization period for customer relationships, which is a concrete indicator of post-acquisition integration in the financial statements. (2) No incorrect numbers are stated; the absence of the $2.70 billion figure is a factual omission rather than an error. All other dates and financial implications are qualitatively consistent. (3) The reasoning is logically sound and reflects multi-hop understanding—linking acquisition to integration and then to strategic focus—but misses the deeper financial evidence (amortization period) that supports integration, weakening the qualitative accuracy. (4) The answer remains contextually relevant and captures the strategic implication well, hence high scores in contextual relevance and qualitative accuracy despite missing key details. Quantitative accuracy is scored highly because no numbers are wrong—only incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 428,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "\nBetween 2022 and 2024 the filing shifted the disclosure of the Directors’ Code of Conduct from a relative, minimally described link (“bnymellon/documents/pdf/in relations/directors‑code‑ofconduct.pdf”) to a fully qualified, stable URL on the corporate site (“https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf”).  The 2024 filing also explicitly states that any amendments or waivers to the Directors’ Code of Conduct will be posted on the website, underscoring a clearer, more accessible public disclosure while maintaining the same scope—applying to all directors of BNY Mellon.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct scope of application—applying to all directors—consistent between 2022 and 2024, which aligns with the ground truth. However, there are significant inaccuracies in the URL details. The LLM incorrectly claims that in 2022 the link was only a 'relative, minimally described' path, when in fact the original answer confirms a full URL was used: https://www.bnymellon.com/... This misrepresents the 2022 disclosure as less accessible than it was. Additionally, the LLM states that the 2024 filing includes a new commitment to post amendments or waivers, but this detail is not present in the ground truth and cannot be verified, introducing unsupported information. The domain change from 'bnymellon.com' to 'bnym.com' (as per ground truth) is not mentioned at all, which is a key rebranding signal. While the answer correctly identifies continuity in policy scope and improved disclosure intent, it misses the actual URL change involving the rebranding to 'BNY' (i.e., 'bnym.com'), undermining quantitative and qualitative accuracy. The reasoning is partially sound but based on incorrect or invented details. Contextual relevance is high as it addresses website accessibility and scope as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 343,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s tightened the way it reports franchisee‑generated income—rent is now recorded straight‑line, royalties are recognized at the point of sale and initial fees are amortized over the 20‑year franchise term—and it introduced a separate “Other revenues” line that captures franchisee‑paid recoveries for technology platforms and brand‑licensing fees (a disclosure that was only partial in the 2022 filing).  This reflects a strategic shift toward treating those technology‑and‑brand collaborations with franchisees as distinct, recurring revenue streams rather than merely cost‑recovery items, giving a clearer, more granular picture of the Company’s partnership with its franchisees.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces specific financial reporting details not present in the ground truth. (1) The Original Answer states that in 2022, transactions with franchisees were not material to consolidated financials, and in 2023, McDonald's emphasized franchisees as key stakeholders with a clearer breakdown of restaurant ownership. The LLM response, however, claims changes in revenue recognition (e.g., straight-line rent, point-of-sale royalties, amortization of fees over 20 years) and a new 'Other revenues' line for technology and brand-licensing fees—none of which are supported by the ground truth. (2) There are no numbers in the Original Answer to verify, but the LLM fabricates specific accounting policies (e.g., 20-year amortization, straight-line rent) and new disclosure categories without basis, failing quantitative accuracy. (3) The multi-hop reasoning is flawed: instead of identifying the shift from 'non-material transactions' to 'strategic stakeholder emphasis,' the model invents a detailed narrative about revenue recognition changes and new reporting lines. (4) While the LLM attempts to address the evolution in McDonald's relationship with franchisees, it does so with factually incorrect details, undermining correctness. The contextual relevance is moderate because it discusses financial reporting and strategic emphasis, but the substance is fabricated, leading to a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 396,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "\nThe Clif Bar contingent consideration was carried at fair value (Level 3) in other liabilities and, as of December 31 2023, was reported at $548 million — the amount disclosed in the 2023 fair‑value table (page 99) and derived from a Monte Carlo simulation (page 99).  The 2023 purchase‑price allocation adjustments for Clif Bar were the last remeasurements disclosed (page 87), and the 2024 filing shows no subsequent fair‑value update or new purchase‑price allocation adjustments, so the liability remained unchanged through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate in terms of quantitative details: it correctly identifies the $548 million fair value of the contingent consideration liability as of December 31, 2023, attributes it to a Monte Carlo simulation, and notes its classification in other liabilities at fair value (Level 3), all of which align with the ground truth. The mention of page references (e.g., page 99 for the fair-value table and simulation, page 87 for purchase price allocation adjustments) adds precision and supports the claim that the 2023 disclosures were the last remeasurements. The core reasoning — that no new fair value updates or adjustments were disclosed in 2024 — is consistent with the original answer’s conclusion that the 2024 filing lacks updated figures or valuation methods. However, the LLM slightly mischaracterizes the implication: while it states the liability 'remained unchanged through 2024,' the ground truth more cautiously suggests the contingent consideration may have been finalized or reclassified as part of purchase price allocation, without asserting that the amount stayed the same. This overconfidence in asserting no change (rather than acknowledging absence of disclosure) introduces a minor qualitative inaccuracy. The answer is contextually relevant and addresses both the fair value measurement in 2023 and the lack of 2024 updates, fulfilling the multi-hop requirement across years and disclosures. Thus, while factually strong and numerically precise, the reasoning slightly oversimplifies the uncertainty present in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 430,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "\nBetween 2022 and 2024 AMD’s public messaging shifted from simply listing Vulkan as a supported API for its Radeon GPUs (e.g., “support current‑generation APIs like DirectX 12 Ultimate and **Vulkan**”) to embedding Vulkan within a broader, software‑centric strategy that couples the API with RDNA 3 graphics, the Adrenalin driver suite, FidelityFX tools and the ROCm open‑software stack—even extending Vulkan‑based compute into data‑center and AI workloads.  This evolution reveals AMD’s competitiveness play: rather than relying on a single API, it leverages open, cross‑platform standards as a differentiator, investing in driver and ecosystem development to attract developers, OEMs and cloud partners while reducing reliance on proprietary ecosystems such as Nvidia’s CUDA or Microsoft‑only DirectX.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AMD's continued support for Vulkan between 2022 and 2024 and ties it to the evolution from RDNA 2 to RDNA 3 architecture (implied in 2024 with Radeon RX 7000 Series), which matches the original answer. While the original explicitly names RDNA 2 in 2022 and RDNA 3 in 2024, the LLM correctly infers the architectural progression and contextualizes Vulkan support within broader software and ecosystem development. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information about API support, GPU architecture, software tools (Adrenalin, FidelityFX, ROCm), and strategic positioning against competitors like Nvidia and Microsoft. It goes beyond the original answer by elaborating on AMD’s ecosystem strategy, which is a valid and insightful extension of the ground truth. (4) The LLM answer captures the core factual content—continued Vulkan support, architectural advancement, competitiveness—and enhances it with accurate contextual details about software differentiation and open standards. The only minor shortcoming is that it does not explicitly name RDNA 2 in 2022, though the implication is clear. Overall, the answer is semantically equivalent and adds valuable depth without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 402,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "\nThe 2023 operating‑profit decline of about **$1.9 billion** (from $5.5 bn in 2022 to $3.6 bn in 2023) was driven primarily by a **$2.9 billion charge related to the Powder Metal Matter** recorded at Pratt & Whitney, which more than offset modest profit gains elsewhere. This integration‑related charge, together with a smaller drop in the FAS/CAS operating adjustment, pulled operating‑profit margins down from 8.2 % in 2022 to 5.2 % in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.9 billion decrease in operating profit from 2022 to 2023 and attributes it primarily to the $2.9 billion Powder Metal Matter charge, which aligns with the ground truth. The specific figures—$5.5 billion in 2022 and $3.6 billion in 2023—are consistent with a $1.9 billion decline. The 8.2% to 5.2% margin drop adds contextual detail not in the original answer but does not contradict it. (2) All numeric values are accurate: the $2.9 billion charge, $1.9 billion operating profit decrease, and implied margins are factually correct and internally consistent. The LLM provides additional precision (exact profit figures and margins) that are plausible and do not conflict with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes the impact of the Powder Metal Matter charge on operating profit trends between 2022 and 2023, contrasting the prior year’s favorable trend (implied by the ground truth’s mention of declining integration charges) with the 2023 deterioration. It correctly identifies the charge as integration-related and locates it at Pratt & Whitney, which is contextually accurate. The only minor gap is that it does not explicitly mention the 2022 decline in Acquisition Accounting Adjustments as a positive factor, though this is implied by the contrast in trends. (4) The answer is semantically equivalent and highly relevant, adding useful detail without introducing errors. The slight deduction in qualitative accuracy is due to the omission of the explicit 2022 integration cost trend, but the overall reasoning and synthesis remain strong. Quantitative accuracy is perfect, and contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 470,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "\nBetween 2023 and 2024 the only accounting activity that directly reflects MDLZ’s ongoing relationship with Clif Bar is the settlement of acquisition‑related items from the 2022 purchase.  In 2023 MDLZ recorded $0.14 million of integration costs and a $0.09 million net increase in contingent‑consideration adjustments tied to Clif Bar (up from $0.05 million in 2022), while in 2024 those charges dropped to essentially zero, showing that the integration and contingent‑consideration phases were completed and no further acquisition‑related financial impacts have been recognized.  The Clif Bar brand continues to be carried as an indefinite‑life intangible asset with no specific impairment reported in 2024, indicating a stable post‑acquisition relationship.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that MDLZ acquired Clif Bar effective August 1, 2022, with related financial impacts discussed in the 2023 10-K, and purchase price allocation adjustments noted in the 2024 10-K. However, the LLM claims MDLZ recorded $0.14 million in integration costs and $0.09 million in contingent consideration adjustments in 2023, dropping to zero in 2024—these specific dollar amounts are not present in the ground truth and appear fabricated. There is no mention in the original answer of exact figures like $0.14M or $0.09M, nor a comparison to $0.05M in 2022. (2) The calculation of changes in contingent consideration and integration costs is unsupported by the provided ground truth, making the quantitative claims invalid. The ground truth does mention integration costs and contingent consideration adjustments generally in the 2023 filing and purchase price allocation adjustments in 2024, but without specific numbers. (3) The reasoning partially captures the multi-hop evolution—acquisition in 2022, discussion in 2023, and post-acquisition adjustments in 2024—but incorrectly frames the 2024 developments as 'essentially zero' charges, while the original answer emphasizes ongoing financial recalibration via purchase price allocation adjustments, which implies active accounting activity, not cessation. The LLM incorrectly concludes that 'no further acquisition-related financial impacts have been recognized' in 2024, contradicting the ground truth's indication of active adjustments. (4) While the LLM correctly identifies the companies (MDLZ, Clif Bar), the timeline (post-2022 acquisition discussed in 2023 and 2024 filings), and the general concept of integration and contingent consideration, the inclusion of false specifics severely undermines correctness. The mention of Clif Bar as an indefinite-life intangible asset with no impairment is plausible but not confirmed in the ground truth, making it an unsupported addition. Thus, while contextually relevant and showing some correct conceptual understanding, the answer fails on factual accuracy due to invented numbers and incorrect conclusions about the cessation of financial activity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 611,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "\nFrom 2023 into 2024 Gulfstream moved from merely offering sustainable‑aviation‑fuel (SAF) as an option to actually flying a trans‑Atlantic route on 100 % SAF (November 2023) and embedding that focus into its newest powerplants.  The company’s latest clean‑sheet jets—most notably the ultra‑long‑range, ultra‑large‑cabin **G700** (certified early 2024) and the **G800/G400** family—are equipped with next‑generation, low‑specific‑fuel‑consumption engines and aerodynamic upgrades (new wing, advanced Symmetry Flight Deck) that deliver markedly higher fuel efficiency and lower emissions than the G500/G600 they replace.  These aircraft exemplify Gulfstream’s shift toward energy‑efficient propulsion as a core element of its product development strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution from 2023 to 2024 in Gulfstream's approach to energy-efficient engines and correctly identifies the G700 as a key aircraft reflecting this shift, which aligns with the ground truth. However, there are notable inaccuracies affecting quantitative and qualitative precision. First, the claim that Gulfstream flew a trans-Atlantic route on 100% SAF in November 2023 is not supported by the original answer, which only states Gulfstream emphasized SAF use and R&D in 2023 without mentioning specific flights—this is an unverified addition. Second, the LLM introduces the G800/G400 family as being equipped with next-generation engines, but the original answer only highlights the G700 as featuring 'all-new engines' in 2024; no mention is made of the G800 or G400 in this context, making this a factual overreach. Additionally, the original answer stresses that no new aircraft model with energy-efficient engines was introduced in 2023, while the LLM implies continuity by suggesting these engines replaced the G500/G600, which is not explicitly confirmed in the ground truth. The certification of the G700 in early 2024 is plausible but not specified in the original, which only notes its introduction in 2024. Despite these issues, the central reasoning—that Gulfstream moved from strategic emphasis in 2023 to operational realization in 2024 with the G700—is sound and contextually relevant. The answer synthesizes the multi-hop idea of progression over time and links it to product development, even if it adds unsupported details. Wording differences are acceptable under semantic equivalence, but the inclusion of unverified aircraft models and specific flight events reduces factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 470,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "\nFrom 2022 to 2024 AMD’s semi‑custom SoC revenue shifted from being described mainly as “non‑recurring engineering fees that depend on a customer’s decision to adopt the chip and the success of that customer’s product” (2022) to a more contract‑driven, production‑based model in which revenue is recognized over the manufacturing run of non‑cancellable purchase orders using a cost‑plus‑margin approach (2024).  This evolution is underpinned by longer‑term wafer‑supply agreements that guarantee capacity and pricing through 2025, allowing AMD to lock in volume customers (e.g., gaming consoles and AI‑accelerator platforms) and treat semi‑custom SoCs as a strategic growth pillar rather than a purely opportunistic revenue stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in AMD's semi-custom SoC revenue model from 2022 to 2024: in 2022, revenue was tied to non-recurring engineering (NRE) fees and dependent on customer adoption and product success; by 2024, it shifted to a production-based model with revenue recognized over manufacturing runs via firm purchase orders and cost-plus-margin accounting. This matches the original answer’s characterization of a move from dependency to active production and strategic integration. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2024, and mention of agreements through 2025) are consistent and plausible within context. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in revenue recognition, strategic dependencies, and long-term supply agreements to infer a deeper strategic shift, correctly identifying the move from opportunistic to strategic positioning. It adds specific detail (e.g., cost-plus-margin, non-cancellable POs, wafer supply agreements) that enriches the ground truth without contradicting it. (4) The only reason for not scoring a 10 is that the LLM does not explicitly mention the broader product portfolio integration (e.g., alignment with AI accelerators, GPUs, APUs, DPUs) emphasized in the original answer, which is a minor omission in completeness. However, the reference to AI-accelerator platforms and strategic growth pillar implies this context. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 451,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "\nThe company’s preferred‑share authorizations were unchanged between FY 2023 and FY 2024 – it continues to be authorized to issue up to 127.5 million $0.20‑par Preferred Shares and 500 thousand $1.00‑par A Preferred Shares, but at the end of both years none of these shares were issued or outstanding.  This stability shows that Medtronic is not using preferred equity as a financing tool; instead, its capital strategy relies on a strong equity base, cash‑generating operations, and opportunistic ordinary‑share repurchases (with a newly‑approved $5 billion increment in 2024) to return capital to shareholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports that the preferred share authorization remained unchanged between FY 2023 and FY 2024, with 127.5 million $0.20-par Preferred Shares and 500 thousand $1.00-par A Preferred Shares authorized in both years, and none issued or outstanding. These quantitative details match the ground truth exactly, earning full marks for quantitative accuracy. (2) The answer addresses the structural evolution (no change) and infers implications for capital strategy, which aligns with the original answer. However, it introduces additional information not present in the ground truth—specifically, that the company is named Medtronic and details about ordinary-share repurchases with a $5 billion increment in 2024. While this may be factually correct in context, it goes beyond the provided knowledge graph data and assumes entity identification (Medtronic) not specified in the question or original answer. (3) The multi-hop reasoning is sound in linking unchanged authorization and lack of issuance to a capital strategy that does not rely on preferred equity. The conclusion about relying on cash-generating operations and share repurchases is a reasonable inference but adds external context not supported in the ground truth. (4) The correctness score is 8 because core facts and numbers are accurate and the main inference about capital strategy is valid, but the answer includes unverified entity-specific details and strategic context not present in the original answer, slightly reducing qualitative accuracy. Contextual relevance remains high as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 445,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "\nBetween 2022 and 2024 the discussion of reputational risk shifted from being a secondary consequence of operational or technical failures (e.g., errors in processing, cyber‑security incidents, regulatory or litigation actions) to a distinct, stand‑alone risk that is tied to external perceptions and broader ESG‑related concerns. In the 2022 filing reputational harm is mentioned only as a possible outcome of specific internal incidents, whereas the 2024 filing explicitly lists “adverse events, publicity, government scrutiny or other reputational harm” as a risk in its own right and links it to newer concerns such as climate change, sustainability expectations, pandemics and geopolitical events. This evolution reflects a move toward viewing reputational risk as a direct, stakeholder‑driven exposure that can be triggered by a wider range of public and environmental factors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the evolution in BK's risk disclosures between 2022 and 2024 regarding reputational risk and adverse publicity. In 2022, reputational harm was framed as a consequence of operational or regulatory incidents, which matches the original answer's mention of links to government scrutiny and other reputational harm. By 2024, the LLM correctly notes the expansion to include broader ESG-related concerns such as climate change, sustainability, pandemics, and geopolitical events—this aligns with the ground truth's emphasis on sustainability concerns like climate change and diversity. The LLM also appropriately highlights the connection to new operational models (referencing 'platforms operating model transition' in the original) by contextualizing reputational risk within changing business models and stakeholder expectations. All entities (BK, years 2022 and 2024, reputational risk, adverse publicity) are correct. There are no numerical inaccuracies (quantitative accuracy is not central here, but no numbers are misstated). The reasoning is sound and reflects proper multi-hop synthesis across time periods and thematic developments in risk framing. The only minor shortcoming is that the LLM does not explicitly name the 'platforms operating model transition'—instead alluding to it through broader operational and stakeholder shifts—so a slight deduction in qualitative accuracy is warranted. However, the semantic meaning and overall evolution are accurately conveyed, making the response factually correct and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 446,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "\nAmazon continued to treat its stake in Anthropic as an **available‑for‑sale convertible note (Level 3)**, recording fair‑value changes in accumulated other‑comprehensive income rather than in earnings.  The 2023 $1.25 bn note was initially valued with discounted‑cash‑flow assumptions, and by 2024 the exposure was expanded to a potential additional $2.75 bn note; the fair‑value model then incorporated more market‑based comparables and reflected heightened uncertainty from global economic conditions, making the valuation more sensitive to Anthropic’s performance and to the lack of a public market price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.25 billion initial investment in 2023 and the potential additional $2.75 billion investment by Q1 2024 are accurately reported. The classification as an available-for-sale Level 3 asset is correctly stated. (2) The answer correctly notes the shift in valuation methodology from discounted cash flow in 2023 to increased use of market-based comparables in 2024, reflecting greater emphasis on valuation challenges due to lack of public market data and global economic uncertainty—this matches the ground truth's point about heightened valuation risk. (3) The multi-hop reasoning is sound: the answer synthesizes information about investment classification, valuation approach evolution, and external factors affecting fair value. (4) Minor omission: the LLM does not explicitly mention that the 2024 disclosure framed the investment as part of a broader portfolio of convertible debt in private companies, which slightly reduces completeness. However, the core evolution in approach—especially the increased focus on valuation complexity—is well captured. Wording differs but semantic meaning is equivalent. No factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 349,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s IP‑risk disclosure shifted from a broad warning that “failure to obtain or adequately protect our intellectual‑property rights (including trade‑secrets and know‑how) could harm the business” to a more pointed emphasis on emerging technology threats.  In the 2024 filing the language explicitly cites “developments in artificial‑intelligence technologies” and the need to guard against third‑party infringement claims, reflecting a heightened concern that new digital and AI‑driven capabilities could erode or be used to undermine MDLZ’s proprietary know‑how.  Consequently, the risk profile has expanded from generic IP loss to a technology‑focused, enforcement‑and‑infringement risk that is more acute in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its characterization of the evolution of MDLZ's intellectual property risks between 2023 and 2024. According to the ground truth, in 2023 MDLZ specifically mentioned artificial intelligence as a concern in relation to intellectual property protection, while in 2024 this AI-specific language was dropped in favor of broader regulatory and compliance risks. The LLM answer reverses this trend: it claims that AI was not mentioned in 2023 and only emerged in 2024, stating that the 2024 filing 'explicitly cites developments in artificial-intelligence technologies'—this is factually wrong. In reality, it was the 2023 filing that referenced AI, not 2024. Additionally, the LLM incorrectly asserts that the 2024 risk disclosure reflects a 'heightened concern' and 'more pointed emphasis on emerging technology threats,' when the actual shift was a move away from AI-specific language toward general legal and reputational risks. There are no numerical values in the question or answers, so quantitative accuracy is not applicable—however, the absence of numbers does not excuse the factual inversion. The reasoning is flawed because it synthesizes the opposite of what the data shows, failing the multi-hop requirement to accurately compare disclosures across years. While the answer is framed in a relevant context (IP protection risks), its core claims are factually inverted, making it highly misleading. Thus, the correctness and qualitative accuracy scores are low, despite the technically sound structure and relevant topic focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 431,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "\nIn the 2023 Form 10‑K the company disclosed the current Non‑Employee Director RSU agreements (10.31‑10.34) and noted that they were first adopted in the 2020, 2017 and 2015 annual reports, with the most recent incorporated exhibit dating from 2020. The 2024 Form 10‑K retains the same agreement numbers but adds newer performance‑based RSU award forms and references a December 1 2023 clawback policy and the amended 2021 Stock‑Incentive Plan, showing that while the substantive agreement structure has not changed, the governing plan and compliance obligations have been updated to reflect more recent filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in multiple critical areas. (1) The exhibit numbers cited (10.31–10.34) do not match the ground truth (Exhibit 10.17 in 2023 and 10.18 in 2024, referencing Exhibit 10.69 from the 2008 Annual Report). These exhibit numbers are factually wrong. (2) The dates and historical references are inaccurate: the LLM claims agreements were adopted in 2020, 2017, and 2015, and references a December 1, 2023 clawback policy and the 2021 Stock-Incentive Plan, none of which appear in the ground truth. The ground truth emphasizes a continuity from a November 28, 2008 amendment, not recent updates. (3) The core evolution described in the ground truth—shifting documentation emphasis to formalize or consolidate prior amendments via deeper historical referencing—is entirely missed. Instead, the LLM fabricates new details about performance-based RSUs and updated compliance obligations not present in the original. (4) Multi-hop reasoning fails: the model does not correctly identify the evolution in exhibit referencing between years or the continuity under similar exhibit numbers with a shift in underlying sources. The answer is semantically unrelated to the ground truth despite addressing a similar topic. Minor contextual relevance is granted for discussing director equity awards and SEC filings, but factual and quantitative accuracy is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 393,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "\nBetween 2022 and 2023 Booking Holdings deepened its **merchant‑based model**, taking on greater contractual risk and operational responsibility for travel‑service transactions.  In 2022 the company noted that it was “increasingly processing transactions on a merchant basis” and that this would generate “merchant revenues” but also added personnel, payment‑processing, charge‑back and other expenses; by 2023 the 10‑K shows that cash received from travelers is recorded in **Deferred merchant bookings**—a liability that reflects amounts estimated to be paid to travel providers as well as the firm’s future commission revenue—and that **incentive programs are accounted for as a reduction of revenue** at the time they are granted.  Consequently, revenue recognition shifted to a net‑basis (commission/margin) while the company now bears the bulk of refunds, payment‑processing and fraud‑related costs, marking a clear evolution in both revenue‑recognition treatment and contractual duties toward travel service providers.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth, despite using plausible financial terminology and referencing real accounting concepts. (1) The claim that BKNG deepened its 'merchant-based model' and took on greater contractual risk, including bearing 'the bulk of refunds, payment-processing and fraud-related costs,' contradicts the original answer, which states BKNG emphasized its role as an intermediary without responsibility for service delivery. The ground truth highlights a clarification in accounting treatment—not an operational shift toward greater liability. (2) The mention of 'Deferred merchant bookings' and incentive programs being accounted for as a reduction of revenue is not supported by the original answer, which does not reference these specific liabilities or accounting treatments. (3) While the LLM correctly identifies that revenue is recognized on a net basis due to BKNG's role as an agent, it misattributes this to increased contractual responsibility, whereas the original answer frames it as a more detailed disclosure of existing practice, not a change in business model. (4) The original answer emphasizes a shift in disclosure and accounting clarity—not a substantive evolution in contractual duties. The LLM incorrectly infers a material change in business model and risk exposure. Quantitative accuracy is scored higher because there are no explicit numbers to verify, and the accounting terms used (e.g., net basis, deferred revenue) are technically valid, even if misapplied. Contextual relevance is moderate because the answer addresses revenue recognition and contractual responsibilities, but the reasoning is flawed. The multi-hop synthesis fails because it draws incorrect conclusions from the implied accounting disclosures. Overall, the answer is partially correct on the revenue recognition method but fundamentally wrong on the nature and direction of the evolution in BKNG's relationship with providers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 538,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings Goldman Sachs consolidated the executive‑life‑insurance disclosures from two separate exhibits (10.11 – Metropolitan Life and 10.12 – Pacific Life in 2023) into a single exhibit (10.12) in 2024, and the wording now references the policies as being incorporated by reference to the same 2006 quarterly‑report filings.  The 2024 filing also places the updated “Amended and Restated Executive Life Insurance Policy” within the revised claw‑back/compensation‑policy section, reflecting a streamlined, unified structure for those disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly claims that Goldman Sachs consolidated two exhibits into a single exhibit (10.12) in the 2024 filing, whereas the ground truth states that both exhibits were retained and renumbered to 10.12 and 10.13 respectively—no consolidation occurred. (2) The claim that the policies are now 'incorporated by reference to the same 2006 quarterly-report filings' is not supported by the original answer and introduces unverified information. (3) The assertion that the 'Amended and Restated Executive Life Insurance Policy' was placed in a 'revised claw-back/compensation-policy section' reflects a complete mischaracterization; the original answer makes no mention of policy amendments or relocations within the filing, only a renumbering of exhibits. (4) The original answer emphasizes a structural reorganization in exhibit numbering, not consolidation or substantive policy changes, which the LLM misrepresents. While the LLM correctly identifies the companies (Metropolitan Life and Pacific Life) and the general topic (executive life insurance disclosures), its core claims about consolidation, incorporation by reference, and policy relocation are factually wrong. The reasoning is therefore flawed, failing to accurately synthesize the exhibit changes across the two years. The answer is contextually relevant to the question about disclosure structure but conveys a misleading narrative. Quantitative accuracy is low due to incorrect exhibit numbers and implied changes in count (from two to one). Qualitative accuracy suffers from incorrect entity relationships and invented details. Contextual relevance is moderate because it addresses the right topic and filings, but with major errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 484,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "\nBetween 2022 and 2024 Broadcom repeatedly highlighted that its FBAR‑filter technology is a core strategic differentiator, and it deliberately manufactures these filters in its own U.S. and Singapore facilities rather than outsourcing them.  By keeping the proprietary FBAR process internal, the company protects its IP, accelerates time‑to‑market for high‑speed wireless modules, and reinforces its competitive edge against fabless and integrated‑device‑manufacturer rivals, a positioning that has become even more critical as the company expands its patent portfolio and customer collaborations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic importance and manufacturing approach for FBAR filters between 2022 and 2024. It accurately conveys that Broadcom maintains internal fabrication of FBAR filters to protect IP and accelerate time-to-market, which is consistent across both years. The emphasis on strategic differentiation and competitive positioning is correctly captured. However, the LLM answer omits a key element from the original answer: the explicit expansion of the competitive landscape by 2024 to include specific competitors such as Qorvo, Qualcomm, and Skyworks. While it generically references 'fabless and integrated-device-manufacturer rivals,' it fails to name these specific companies, which were highlighted in the ground truth as evidence of increased competitive pressure. This omission slightly weakens the completeness and qualitative accuracy of the multi-hop synthesis, particularly in showing how the competitive context evolved. There are no numerical values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. The answer remains contextually relevant and semantically close to the original, with strong reasoning and correct entity identification (Broadcom, FBAR filters, internal fabrication), warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 377,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "\nBetween 2023 and 2024 Krazati moved from a late‑stage investigational KRAS‑inhibitor (being tested in 1L NSCLC and 2L + mutated CRC) to a commercially approved, core growth asset after BMS acquired Mirati (January 2024) and secured FDA/EMA approval for second‑line NSCLC and for KRAS‑mutated colorectal cancer; the company now markets Krazati as a pillar of its oncology portfolio and is advancing it into first‑line NSCLC (KRYSTAL‑17) and combination strategies.  The transaction valued the asset at roughly **$640 million of definite‑lived marketed‑product rights plus $3.5 billion of indefinite‑lived IPRD** within a **$4.8 billion purchase price (net $4.1 billion)**, implying a high market‑based valuation of its future first‑line sales and associated contingent value rights ($≈$1 billion) and goodwill ($≈$150 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Correctly identifies Krazati's evolution from investigational to approved status, with FDA/EMA approvals in second-line NSCLC and KRAS-mutated colorectal cancer, and the shift toward first-line NSCLC development via KRYSTAL-17 and combination with PD-1 inhibitors. (2) Quantitatively, the $4.8 billion acquisition price is correct; the breakdown into $640 million definite-lived assets, $3.5 billion indefinite-lived IPRD, and implied ~$1 billion contingent value rights and ~$150 million goodwill is consistent with typical SEC filing disclosures and reasonable allocation logic, though the original answer does not specify these internal valuation components—these are plausible inferences but not explicitly confirmed in the ground truth. Thus, while financially sound and likely accurate, these sub-components are not verifiable from the provided ground truth, slightly reducing quantitative certainty. (3) Multi-hop reasoning is strong: connects BMY’s acquisition of Mirati (January 2024) to securing full rights, links approvals to expanded clinical strategy, and infers strategic elevation of Krazati within the oncology portfolio. (4) All entities (BMY/BMS, Krazati, Mirati, KRYSTAL trials) and timelines (2023 vs 2024) are correct. The answer exceeds the original in financial detail, which is informative but not fully corroborated—hence a 9 instead of 10 on correctness. Semantic equivalence is maintained, and the response fully addresses both clinical development focus and financial valuation as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 435,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "\nBetween 2022 and 2023 the volume of BKNG’s “deferred merchant bookings” rose sharply, reflecting larger cash‑payments from travelers that the company holds until it can settle with travel service providers and recognize its commission or margin.  At the same time, BKNG continues to fund various incentive programs—referral bonuses, rebates, credits, discounts and loyalty points—that are recorded as a direct reduction of revenue when granted, so its financial statements show both the cash liability to providers and the revenue‑impact of those incentives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the evolution in BKNG's relationship with travel service providers between 2022 and 2023, particularly regarding financial obligations and incentives. It correctly identifies the increase in 'deferred merchant bookings' as a key indicator of growing financial liability to providers, which aligns with the ground truth. It also accurately describes incentive programs (referral bonuses, rebates, loyalty points) and their accounting treatment as a reduction of revenue. However, the LLM omits the explicit contrast in the nature of the relationship shift—from competitive in 2022 to more dependent in 2023—which is a key qualitative point in the original answer. While the financial mechanics are well-explained, the strategic shift in relationship dynamics is underemphasized. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (BKNG, deferred merchant bookings, incentive types) are correctly identified. The reasoning is sound and contextually relevant, but the answer falls slightly short in fully synthesizing the multi-hop insight about strategic dependency versus competition. Hence, a score of 8 is justified for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 350,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "\nFrom 2022 through 2024 Broadcom kept custom touch‑controller design inside its Wireless semiconductor portfolio, continuing to supply ASICs that digitize touch‑screen signals for mobile handsets and tablets.  The 10‑K filings show the same product description and emphasis on “custom touch controllers” as a core part of its mixed‑signal/custom‑silicon offerings, indicating that the component’s role in the product lifecycle remained stable rather than undergoing a substantive shift.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually inconsistent with the ground truth in terms of the evolution of Broadcom's role, which is the core of the question. While there are no explicit numbers to verify, the qualitative assessment of Broadcom's role from 2022 to 2024 diverges significantly from the original answer. The ground truth states that Broadcom evolved from a supplier of Custom Touch Controllers in 2022 to an active producer involved in design and creation by 2024, indicating a strategic shift. However, the LLM claims the role 'remained stable' with 'no substantive shift,' directly contradicting the documented evolution. This misrepresents the multi-hop synthesis across years and reflects a failure in reasoning about the progression in Broadcom's involvement. Entity accuracy (Broadcom, Custom Touch Controllers, years 2022–2024) and contextual relevance are strong—the answer addresses the right topic and timeframe. Wording and focus are appropriate, but the conclusion is factually incorrect. Thus, while the answer is well-structured and contextually relevant, it fails on core qualitative accuracy, warranting a low correctness score despite perfect quantitative accuracy (no incorrect numbers).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 337,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "\nUnion Pacific’s freight‑car strategy shifted from a larger share of owned/finance‑leased assets toward a more lease‑focused, capital‑light model between 2023 and 2024.  The company’s finance‑lease portfolio fell from $310 million to $244 million, while operating‑lease assets remained flat around $1.6–1.7 billion, and the weighted‑average lease term rose to 5.8 years, indicating a greater reliance on operating leases with fixed‑price purchase options that are not material to the business.  Consequently, the 2025 capital plan emphasizes targeted purchases to replace aging cars and support growth, but the overall acquisition approach is now centered on leasing and incremental fleet renewal rather than large‑scale direct acquisitions.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in direction and key facts. The ground truth states that Union Pacific shifted *from leasing* in 2023 to *acquiring freight cars* in 2024, including lease buyouts increasing from $57M to $143M. In contrast, the LLM claims the company moved toward a 'more lease-focused, capital-light model', which is the opposite of the truth. This core misrepresentation invalidates the answer. (2) Quantitatively, the LLM introduces numbers not in the original answer—finance lease portfolio dropping from $310M to $244M, operating leases at $1.6–1.7B—none of which appear in the ground truth and contradict the narrative of increased ownership. The lease buyout figures ($57M in 2023, $143M in 2024) are completely omitted. The weighted-average lease term of 5.8 years and 2025 capital plan details are unsupported by the provided truth. (3) The multi-hop reasoning is flawed: instead of recognizing that higher lease buyouts indicate a shift toward ownership, the model incorrectly interprets leasing metrics as evidence of a leasing strategy, failing to synthesize the significance of buyouts as a signal of asset acquisition. (4) Scores reflect major factual and directional errors: low correctness and qualitative accuracy due to incorrect trend and reasoning; moderate contextual relevance because the topic (freight car acquisition strategy) is addressed, albeit inaccurately; poor quantitative accuracy due to fabricated or misapplied figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 412,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "\nThe FY 2022‑FY 2023 shift in APLA was essentially a re‑mix of sales rather than a revenue decline: APLA revenue grew 13 % to $6.73 bn, but the share of sales through third‑party distributors rose (wholesale in APLA climbed from $3.53 bn to $3.93 bn) while direct‑to‑consumer growth was modest, squeezing gross margin and prompting higher sales‑related reserves and inventory adjustments. This distributor transition eliminated the earlier non‑recurring foreign‑currency translation charge that had been recorded in FY 2020, so the period’s financial impact is limited to the operational effect of the structural change—steady revenue growth offset by lower profitability and increased reserve balances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and introduces unsupported quantitative data not present in the ground truth. The original answer does not mention any specific revenue figures (e.g., $6.73B), growth percentages (13%), or breakdowns of wholesale ($3.53B to $3.93B) in APLA for FY2022 or FY2023. These numbers are fabricated or hallucinated, as the ground truth focuses on structural and accounting impacts rather than detailed P&L metrics. There is also no mention in the original answer of gross margin pressure, sales-related reserves, inventory adjustments, or profitability impacts—these are speculative additions. (2) The quantitative inaccuracies are severe: the LLM invents precise dollar amounts and percentages with no basis in the provided ground truth. Even if such data existed elsewhere, the knowledge graph ground truth—which is authoritative here—does not include them, making their inclusion incorrect in this evaluation context. Additionally, the reference to a 'non-recurring foreign-currency translation charge... recorded in FY2020' is factually wrong; the original answer states the charge was anticipated in FY2022 due to the upcoming transition, not that it occurred in FY2020. (3) The multi-hop reasoning is partially sound in that the LLM identifies the shift from direct operations to third-party distributors as a structural change. It correctly infers that this transition affects financial reporting and operational model, and it references the strategic nature of the change. However, it fails to mention the key point about non-cash cumulative foreign currency translation losses being released in anticipation of the transition in FY2022, and the shift to reporting via a strategic stake in FY2023. It also omits the reference to Note 18 on divestitures, which is a critical audit trail element in the original. (4) The correctness score is low (3) due to major factual and numerical errors, despite some contextual alignment with the theme of structural change. Quantitative accuracy is very poor (2) because all numbers are unsupported. Qualitative accuracy is moderate (4) as some conceptual elements (transition to distributors, reduced direct ops) are directionally correct. Contextual relevance is acceptable (6) because the answer addresses the general topic and timeframe, but with significant factual drift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 635,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "\nFrom 2022 through 2024 Broadcom continued to **fabricate its proprietary InP‑based vertical‑cavity surface‑emitting lasers (and side‑emitting lasers) inside its own U.S. and Singapore III‑V wafer facilities**, while outsourcing commodity CMOS and other low‑margin processes to external foundries.  This internal‑fab strategy was repeatedly highlighted as a way to **protect IP, accelerate time‑to‑market, and preserve a differentiated, high‑performance portfolio** that competes directly with specialist suppliers such as Lumentum and other integrated device manufacturers.  Consequently, Broadcom’s InP‑laser capability remained a core element of its competitive positioning in fiber‑optic and data‑center markets, even as the company broadened its overall product and software breadth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that Broadcom used internal fabrication for InP-based lasers (including VCSELs and side-emitting lasers) in both 2022 and 2024, specifying proprietary processes and internal III-V wafer facilities in the U.S. and Singapore—consistent with the original answer’s emphasis on internal fabrication. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes Broadcom’s continued internal fabrication strategy with its competitive positioning, correctly identifying Lumentum as a competitor and implying the strategic importance of InP lasers in differentiation—this matches the ground truth’s point about increased emphasis on competitive landscape. The mention of Coherent Corp. in the original answer is missing in the LLM response, which is a minor omission but does not undermine the core accuracy. (4) The LLM enhances the answer with additional context (e.g., outsourcing commodity CMOS, reasons for internal fab like IP protection and time-to-market), which is plausible and consistent with Broadcom’s known strategy, though not explicitly in the ground truth. These additions do not introduce errors and improve clarity. Overall, the answer captures the evolution accurately: continuity in internal fabrication and growing emphasis on competitive differentiation via InP lasers. Only a perfect match would include Coherent Corp. as a named competitor, but the omission does not detract significantly from the correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 458,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "\nBetween fiscal‑year 2022 and 2023 the 10‑K filings show that Swoosh, LLC continued to own roughly **77 % of the Class A Common Stock**, and that this stake would convert into about **16 % of the Class B Common Stock** – a proportion that was unchanged in the 2023 filing. Because Class A shares elect three‑quarters of Nike’s board and carry voting rights that are not diluted by conversion, the Knight family (via Swoosh) retains decisive control over governance even though public shareholders hold the remaining Class B equity. Consequently, shareholder influence remains heavily weighted toward the Swoosh/LLC owners rather than the broader Class B investor base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Swoosh, LLC owned approximately 77% of NIKE's Class A Common Stock in both 2022 and 2023, and that this would translate to about 16% ownership of Class B Common Stock upon conversion—matching the ground truth exactly. All quantitative figures are accurate and consistent with the original answer. (2) The numbers—77% and 16%—are reported correctly for both years, and no calculations are required beyond these stated percentages, which are used appropriately. Format variations (e.g., '77 %' with space) do not affect accuracy. (3) The LLM correctly synthesizes the implication of ownership structure across years, noting the sustained control by Swoosh, LLC. It enhances the reasoning by correctly explaining that Class A shares elect three-quarters of the board and carry superior voting rights, which supports the conclusion about concentrated shareholder influence. While the original answer emphasizes Travis Knight’s role, the LLM refers to the 'Knight family (via Swoosh)', which is semantically equivalent and contextually valid. (4) The answer is fully relevant, addressing both the evolution (no change) and implications (continued control) as required. The only minor shortcoming is slightly less specificity on Travis Knight’s managerial role compared to the original, but the core influence point is preserved. Thus, the answer is factually complete and logically sound, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 404,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "\nFrom 2022 to 2023 PMI shifted its reduced‑risk portfolio from a stand‑alone offering to a fully integrated component of its core business. The 2022 acquisition of Swedish Match added the ZYN oral‑nicotine pouch brand, which was combined with PMI’s IQOS heated‑tobacco products, and by the end of 2023 these combined RRPs were available in 84 markets; reduced‑risk product net revenue grew to **$9.1 bn** (up from $6.8 bn in 2020) as shown in the segment‑revenue table [page 97]. Starting in Q1 2024 the company will report Swedish Match results together with the four geographical segments, reflecting the completion of portfolio integration and broader market availability [pages 29, 30, 97].",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the strategic shift toward integration and expanded market availability, which aligns with the ground truth. However, it introduces inaccuracies and omits key details. The ground truth states that in 2023, Reduced-Risk Products (RRPs) were reclassified under a broader category called Smoke-Free Products (SFPs), which now included wellness and healthcare offerings. The LLM answer does not mention this reclassification into SFPs or the inclusion of wellness/healthcare, instead focusing on integration via the Swedish Match acquisition and reporting changes starting in Q1 2024. While the acquisition is contextually relevant, it shifts focus from the core rebranding and category expansion described in the original answer. (2) Quantitatively, the LLM claims RRP net revenue was $9.1 billion in 2023, but the ground truth does not provide a 2023 revenue figure—only that revenues were separately reported in 2022. The $6.8 billion figure cited is from 2020, not 2022, making the comparison misleading and unsupported by the ground truth. The 84 markets figure for 2023 is correct and matches the original answer. However, the claim about reporting integration starting in Q1 2024 is forward-looking and not directly responsive to the 2022–2023 evolution asked in the question. (3) The multi-hop reasoning is partially sound—linking Swedish Match acquisition to portfolio integration is logical, but the answer fails to synthesize the key conceptual shift from RRPs to SFPs as a strategic repositioning. It emphasizes structural reporting changes rather than the branding and categorization evolution emphasized in the ground truth. (4) Correctness is scored 6 due to partial factual alignment but significant omissions and one major quantitative inaccuracy. Quantitative accuracy is 5 due to incorrect revenue attribution and unsupported comparison. Qualitative accuracy is 7 because the reasoning is coherent and contextually grounded but misses the central reclassification point. Contextual relevance is 9 as the answer addresses the general theme of integration and market expansion, even if not precisely as documented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 580,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "\nFrom 2022 through 2024 Caterpillar moved its reciprocating‑engine business away from the low‑margin, oil‑field well‑servicing market and toward higher‑value applications such as gas‑compression, power‑generation (especially data‑center engines), industrial and marine/rail uses.  This shift is reflected in the sales‑by‑application table (2024 $6.98 bn Oil & Gas vs. 2024 $7.76 bn Power Generation) and the narrative that “decreased sales in reciprocating engines used in well‑servicing applications were offset by increased sales in reciprocating engines used in gas‑compression applications and increased sales for turbines and turbine‑related services” (page 37).  As a result, the share of total ME&T revenue coming from oil‑and‑gas fell while power‑generation and transportation grew, and the higher‑margin power‑generation and services portfolio lifted the segment’s gross‑margin potential, even though overall volume in the traditional well‑servicing market declined.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and does not align with the ground truth. (1) The core factual claims about Caterpillar's strategic evolution are wrong: the original answer states that from 2022 to 2024, Caterpillar evolved by adding remanufacturing of reciprocating engines and services for other companies, shifting from a seller to a full lifecycle service provider. The LLM instead claims Caterpillar shifted away from oil-field well-servicing to higher-value applications like power generation and data centers—a narrative not supported in the ground truth. (2) Quantitative inaccuracies: the LLM cites specific dollar figures ($6.98 bn Oil & Gas, $7.76 bn Power Generation) and references a 'sales-by-application table' and page 37, none of which appear in or are verifiable from the ground truth. These numbers are fabricated or hallucinated. There is no mention of ME&T revenue shares or volume declines in the original. (3) Multi-hop reasoning failure: the LLM invents a market shift and financial breakdown without grounding in the provided truth. It fails to identify the actual strategic evolution—remanufacturing expansion—and its implications on gross margin via lower material costs and service-based revenue. (4) While the LLM attempts to address revenue composition and margin impact, it does so using incorrect premises, making the reasoning unsound. The contextual relevance is moderate because it discusses related themes (revenue mix, margin potential), but the specifics are factually detached from the ground truth. Minor score given only for attempting to discuss margin and revenue shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 440,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon kept the same public commitment—to post any amendment or waiver of the Directors’ Code of Conduct on its website—but the 2023 filing made the disclosure promise more explicit.  The 2023 filing states that the revised code will be posted on the corporate‑governance page of the company’s website and referenced in the proxy statement, ensuring that stakeholders can locate the updated policy quickly and that the information will also be included in the next periodic filing.  No new disclosure channel was introduced; the evolution was a stronger, more precise wording of the existing website‑posting and proxy‑filing practice.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces a claim not supported by the ground truth. The original answer states that BNY Mellon's approach 'remained consistent' between 2022 and 2023 with 'no change in the specific mechanism or transparency commitment,' indicating stability in both practice and wording. However, the LLM answer asserts that the 2023 filing 'made the disclosure promise more explicit' and included 'stronger, more precise wording,' which contradicts the ground truth's assertion of no change in the described commitment. There are no numerical inaccuracies (quantitative accuracy is high), and the entities (BNY Mellon, Directors' Code of Conduct, website posting, proxy statement) are correctly identified. The contextual relevance is strong as it directly addresses the question about mechanisms and transparency. However, the qualitative accuracy is reduced because the model infers an evolution in wording and explicitness not present in the ground truth, reflecting a failure in multi-hop reasoning or misinterpretation of the source data. This overstatement of change undermines the correctness despite accurate core facts about the website posting and proxy reference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 336,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Nike moved from a hybrid wholesale‑plus‑direct model in APLA to a fully distributor‑driven structure.  In FY 22 the company was still selling to wholesale accounts in the region, but by FY 23 it had entered agreements to sell its legal entities in Argentina, Uruguay and Chile and was transitioning those markets—and ultimately the broader APLA footprint—to third‑party distributors, thereby cutting the number of wholesale partners and reducing selling, general & administrative costs [FY22 p. 31; FY23 p. 87‑88].  This shift reflects a broader operational streamlining (including workforce reductions and a focus on NIKE Direct and digital channels) that trades short‑term revenue growth for longer‑term profitability and lower exposure to foreign‑exchange volatility in the region [FY22 p. 31; FY23 p. 88].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Nike's shift from direct and wholesale operations in APLA in FY22 to transitioning toward third-party distributors in FY23. The mention of Argentina, Uruguay, and Chile adds specific detail consistent with known market exits and is supported by the cited pages (FY23 p.87-88). (2) There are no numeric values (percentages, dollar amounts, dates) in the original or LLM answer beyond fiscal years, which are correctly stated as FY22 and FY23—no quantitative inaccuracies. (3) The multi-hop reasoning is sound: the LLM synthesizes operational changes (shift to distributors), strategic rationale (cost reduction, FX volatility), and broader context (workforce reductions, focus on NIKE Direct/digital), all of which reflect accurate interpretation of Nike’s strategic pivot. The only minor deviation is the claim of moving to a 'fully distributor-driven structure,' which slightly overstates the case—the original answer says 'transitioning certain businesses,' implying a partial, not complete, shift. This nuance is lost, but the overall direction and intent are correct. (4) The answer is contextually excellent, directly addressing both operational structure and market participation changes. Citations from official reports enhance credibility. Thus, the answer earns a 9/10 for correctness—very close to perfect, with only slight overgeneralization preventing a 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 404,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "\nBetween 2022 and 2024, favorable price realization moved from a primary growth engine — adding roughly $1 billion to sales and pushing the consolidated operating‑profit margin up from 13.5 % (2021) to over 20 % (2024) — to a modest offset that helped preserve profitability even as total sales slipped 3 % in 2024.  However, the net benefit was eroding because price realization turned unfavorable in the Construction and Resource Industries, signaling a diminishing contribution to profitability compared with the earlier strong impact.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that favorable price realization contributed $9.223 billion to sales in 2022, but the LLM claims only 'roughly $1 billion,' which is off by over 800%. Additionally, the LLM states that price realization turned unfavorable in Construction and Resource Industries, which is not mentioned or supported in the original answer. The claim that consolidated operating-profit margin rose from 13.5% in 2021 to over 20% in 2024 is unsupported by the provided ground truth, which only gives absolute profit figures ($10.335B in 2023 to $10.792B in 2024), not margins. The 3% sales decline in 2024 is not mentioned in the original answer. (2) Quantitative accuracy is very low: the $9.223B figure is critical and completely misrepresented; the $2.251B volume decline is ignored; the profit increase from $10.335B to $10.792B is not mentioned. Instead, the LLM introduces margin data not present in the original. (3) The multi-hop reasoning is flawed: while the LLM attempts to show evolution from growth driver to offset, it misrepresents the magnitude and direction of impact. It fails to correctly synthesize the role of price realization in offsetting volume declines in 2024 as described in the ground truth. (4) Contextual relevance is moderate because the answer addresses the evolution of price realization’s impact on sales and profitability, but the incorrect numbers and introduced concepts (e.g., unfavorable shift in segments, margin expansion) undermine the validity. The conclusion about eroding benefit contradicts the ground truth, which shows price realization successfully supporting profitability despite volume declines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 470,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "\nBetween 2023 and 2024 GM shifted from a primarily strategic focus on scaling EV production and cutting battery costs—using ICE profits to fund the transition—to a concrete supply‑chain agenda that builds a resilient, North‑American‑centric EV manufacturing network. The 2024 filing emphasizes investments in strategic sourcing, multi‑year raw‑material supply agreements and holding higher inventory of critical battery materials, reflecting a move to secure the supply chain as a core pillar of its EV capacity growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in GM's EV manufacturing strategy from 2023 to 2024: shifting from broad strategic scaling and cost reduction (funded by ICE profits) to a more concrete, resilient, North American-focused supply chain approach in 2024. The mention of strategic sourcing, multi-year supply agreements, and holding higher inventory of critical battery materials is consistent with the original answer’s emphasis on securing supply through raw material investments and structured agreements. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes changes in strategic focus and supply chain development across two years, correctly attributing evolving priorities to the respective years. The only minor omission is that the 2023 context in the LLM answer does not explicitly mention the risks of high fixed costs and facility inflexibility noted in the original answer, which slightly reduces completeness. However, the core evolution in strategy is accurately conveyed. (4) The answer is fully contextually relevant, directly addressing both strategic focus and supply chain development as required by the question. Wording differs but semantic meaning matches closely. Minor deduction from 10 to 9 due to slight incompleteness in 2023 risk disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 404,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "\nPfizer’s remaining performance obligations for Paxlovid have collapsed sharply—​from the billions of dollars of advance‑payment and deferred‑revenue contracts tied to government stock‑purchase agreements in 2022, to only about **$1 billion of contracted revenue** that is now expected to be recognized from 2025 through 2028 (as disclosed in the 2024 10‑K).  This reflects the transition from the early, largely government‑driven EUA sales and large‑scale stockpiling to commercial‑market deliveries, with most of the large‑scale government contracts having been fulfilled and the associated revenue reversals already recorded.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct $1 billion figure for remaining performance obligations related to Paxlovid as disclosed in the 2024 10-K, which aligns with the ground truth. However, it incorrectly implies that there were 'billions of dollars' in obligations in 2022, which contradicts the ground truth stating that Pfizer did not disclose specific remaining performance obligations for Paxlovid in 2022. The answer fabricates a quantitative baseline for 2022 that is not supported by the original data, introducing a significant factual inaccuracy. While the directional trend (decline in obligations) is plausible, the characterization of 2022 as having 'billions' in obligations is unsupported and misleading. The mention of revenue recognition from 2025 through 2028 adds detail not present in the ground truth, but does not directly contradict it; however, this lacks corroboration and shifts focus toward revenue timing rather than the evolution of disclosed obligations. The reasoning is partially sound in noting a transition from government to commercial markets, but this contextual interpretation, while reasonable, is not part of the ground truth and distracts from the core factual comparison. Entity accuracy (Pfizer, Paxlovid, 10-K, 2024) is correct, and the $1 billion figure is accurately cited. However, the incorrect retroactive quantification of 2022 obligations undermines quantitative and qualitative accuracy. The answer is contextually relevant and addresses the evolution question, but with flawed premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 420,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Caterpillar moved from a broad, qualitative oversight of supplier financial health to a more structured, contract‑driven risk‑mitigation framework.  The 2023 filing explicitly calls out “supplier financial viability” as a monitored risk and details the use of supplier agreements that include intellectual‑property protections, production‑level and continuity clauses, and the right to adjust or terminate orders if a supplier’s financial condition deteriorates.  In contrast, the 2022 disclosures referenced supplier risk only in general terms, without the same level of contractual safeguards or explicit monitoring language.  Consequently, the 2023 approach adds concrete contractual levers and a clearer monitoring process to mitigate supply‑base disruptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and representation of the evolution between 2022 and 2023. (1) Correct elements: Both years involve monitoring supplier financial viability, and the 2023 filing does place more explicit emphasis on 'supplier financial viability' as a disclosed risk. The general direction of increased focus is accurate. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this aspect is not applicable; no errors present. (3) Multi-hop reasoning assessment: The LLM incorrectly claims that Caterpillar moved from 'general terms' in 2022 to 'concrete contractual levers' in 2023, including clauses for order adjustment or termination based on financial deterioration. However, the ground truth states that in 2022, Caterpillar already used 'a variety of agreements' to protect IP and mitigate risks, including monitoring financial viability. The 2023 update emphasizes financial viability more prominently and strengthens strategic sourcing models, but there is no evidence in the ground truth of new contractual clauses like 'right to adjust or terminate orders' being introduced. This is an overstatement not supported by the original answer. (4) The LLM answer misrepresents the nature and extent of change—portraying a shift from qualitative to structured, contract-driven frameworks—whereas the ground truth indicates continuity in monitoring practices with only a heightened emphasis and reordering of risk disclosures. Thus, while contextually relevant and directionally plausible, the answer introduces unsupported specifics about contractual evolution, reducing its factual accuracy. Correctness score is 6 due to partial accuracy with significant factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 481,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "\nBetween 2022 and 2024 Visa transformed its Risk and Identity Solutions from a peripheral, generic offering into a central, AI‑driven pillar of its value‑added services portfolio.  The company introduced the Visa Protect suite—including Deep Authorization, Protect for A2A Payments and Risk Manager with scheme‑agnostic Advanced Authorization— and embedded these real‑time fraud‑prevention tools across both Visa‑owned and non‑Visa transactions, linking them to its broader “network‑of‑networks” strategy and to other services such as Open Banking, Visa Direct, Visa+ and advisory consulting.  This evolution reflects a strategic positioning of risk and identity as an integrated, network‑agnostic capability that enhances every payment flow and supports Visa’s expanded suite of value‑added offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Visa's Risk and Identity Solutions between 2022 and 2024. It accurately captures the strategic shift from a less-defined offering in 2022 to a more integrated, structured role within value-added services by 2024. The mention of network-agnostic services (e.g., for non-Visa transactions) and integration with services like Visa Direct and Open Banking reflects the broader strategic positioning described in the original answer. However, the LLM introduces specific product names (e.g., Visa Protect, Deep Authorization, Risk Manager with Advanced Authorization) and terms like 'AI-driven' and 'network-of-networks' that, while plausible, are not present in the ground truth and may over-specify details not confirmed in the source. The three-pillar framework from the original answer (Visa transactions, non-Visa transactions, services beyond payments) is not explicitly mentioned, though the concepts are partially reflected. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and the reasoning demonstrates sound multi-hop synthesis of strategic evolution. The answer is highly relevant to the question and conveys the core progression in strategic positioning and integration. The slight deduction in qualitative accuracy is due to the addition of unverified product-specific details and absence of the explicit three-pillar structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 410,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s exposure to shelf‑space limitations remained a material risk, but the nature of that risk shifted. In the 2022 filing the risk was framed mainly around “limitations on access to shelf space, delisting of our products and changes in retail‑customer policies,” while the 2023 filing adds that the **rapid growth of e‑commerce and the emergence of alternative retail channels (e.g., subscription services, direct‑to‑consumer brands) are reshaping the retail landscape and creating new pricing pressures and retailer‑relationship challenges**. Consequently, while the traditional vulnerability to constrained shelf availability persists, the company now also contends with a broader set of retail‑policy changes and the competitive impact of alternative channels that can further erode shelf‑space opportunities and margin‑pressuring pricing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2022 risk was potential and focused on shelf space limitations and delisting due to retail customer policies; by 2023, this evolved into an active challenge amid broader retail dynamics, including e-commerce growth and alternative channels like subscription and DTC models. The LLM correctly identifies the shift from a forward-looking risk to an experienced impact. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, correctly identifying the evolution in risk characterization and linking it to changes in retail structure and company response (e.g., investment in digital/analytics implied by adaptation to new channels). The only minor omission is that the LLM does not explicitly mention the company’s planned investment in digital and analytics capabilities, which is part of the original answer and indicates a strategic response. This reduces completeness slightly but does not undermine the core accuracy. (4) The answer is contextually fully relevant, directly addressing the evolution of shelf space risk in relation to retail policy changes and alternative channel expansion. Wording differs but semantic meaning matches the ground truth. Thus, a high score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 429,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Oracle moved from simply offering a menu of hybrid‑deployment options (on‑premise, cloud and hybrid models such as Exadata Cloud@Customer, Dedicated Region and multicloud connectivity) to actively steering customers toward those models.  In FY 2024 it introduced programs that let customers pivot existing license‑and‑support contracts to Oracle Cloud, broadened OCI‑based hybrid and multicloud services, and saw cloud‑services revenue rise to 37 % of total sales (up from 32 % in FY 2023).  Consequently, the strategic emphasis shifted from “providing choice and flexibility” to “driving migration and expansion of workloads onto Oracle Cloud within hybrid environments.”",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution in Oracle's strategic emphasis from offering hybrid deployment choices to promoting migration toward Oracle Cloud within hybrid environments, which aligns semantically with the ground truth. It correctly identifies key offerings like Exadata Cloud@Customer and Dedicated Region and notes broader hybrid and multicloud service expansion in FY2024, reflecting a shift toward deeper integration. However, significant quantitative inaccuracies undermine the correctness: the claim that cloud services revenue rose to 37% of total sales in FY2024 (from 32% in FY2023) is not supported by the original answer or any cited data in the knowledge graph—this specific percentage breakdown is absent in the ground truth and cannot be verified, making it a fabricated metric. There is also no mention in the original answer of programs allowing customers to pivot license-and-support contracts to Oracle Cloud, which introduces unverified product initiatives. While the qualitative shift in strategy—from 'choice and flexibility' to 'driving migration'—is a reasonable interpretation and adds analytical value, it goes beyond the stated evolution in the ground truth, which emphasizes 'deeper integration and support' rather than active steering. The reasoning is logically sound but overreaches by introducing unsupported specifics. Entity accuracy (Oracle, Exadata Cloud@Customer, Dedicated Region, FY2023–FY2024) and contextual relevance are strong. Due to the inclusion of unverified numerical data and unconfirmed programs, the quantitative accuracy is low, pulling down the overall correctness despite otherwise plausible reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 454,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "\nPfizer’s Paxlovid‑related deferred revenue fell dramatically — from about **$5.1 billion of advance payments recorded at the end of 2022** to roughly **$2.2 billion of deferred revenue at the end of 2024** as those advance payments were recognized and the U.S. government inventory was returned.  The company now expects only **≈ $1 billion of future revenue** from the remaining firm delivery obligations for Paxlovid, to be recognized proportionally from 2025 through 2028, indicating a shift from the large, government‑procured purchase commitments of 2022‑23 to a modest, commercially‑driven supply schedule.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The ground truth states that remaining performance obligations for Paxlovid were approximately $1 billion as of December 31, 2024, to be recognized from 2025 through 2028. However, the LLM claims $5.1 billion in advance payments at the end of 2022 and $2.2 billion in deferred revenue at the end of 2024, which are not supported by the original answer. These figures are quantitatively incorrect and contradict the provided truth. (2) The calculation of a decline from $5.1B to $2.2B is fabricated and not present in the original; the ground truth does not mention deferred revenue or advance payments at all, nor does it reference U.S. government inventory returns. The only correct number is the ≈$1 billion in future revenue, which aligns with the original answer’s $1 billion remaining performance obligations. (3) The reasoning is partially sound in that it identifies a shift from pandemic-era high-volume sales to a longer-term commercial model, which matches the original’s theme of reduced but ongoing commitment. However, the multi-hop synthesis is flawed because it introduces data (deferred revenue, government returns) not present in the source, leading to incorrect conclusions about the evolution of financial commitment. (4) While the LLM captures the general direction of reduced financial commitment and multi-year revenue recognition, the severe quantitative inaccuracies undermine factual correctness. The contextual relevance is high because it addresses the timeframe, the product (Paxlovid), and the shift in revenue model, but the core financial data is incorrect, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 473,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "\nCaterpillar’s dealer relationship is still governed by the same standard sales‑and‑service agreements that grant territorial rights, require dealers to promote and support products, keep detailed financial records and can be terminated by either party with 90 days’ written notice (see 2022 10‑K pages 10‑12).  In the 2023 filing the company stresses a more collaborative strategy—expanding financing and insurance support through Cat Financial, investing in dealer‑development programs, and using the dealer network as a growth engine in emerging markets—signaling a shift from a purely contractual arrangement to a partnership‑focused emphasis (see 2023 10‑K pages 9, 11).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of Caterpillar's dealer relationships between 2022 and 2023. (1) Correctly identifies that dealer agreements include territorial rights, promotion requirements, and financial record-keeping, and notes the 90-day termination clause (present in both years), which aligns with general contractual terms. These details are factually consistent with typical SEC disclosures and are reasonably accurate in substance. (2) Quantitative accuracy is high: no specific numbers (dollar amounts, percentages) are cited, but references to page numbers and document sections (e.g., 2022 10-K pp. 10–12, 2023 10-K pp. 9, 11) are plausible and format variations are not an issue. (3) However, the core reasoning is flawed: the LLM claims a shift *from* a contractual arrangement *to* a partnership-focused model in 2023, which directly contradicts the ground truth. The original answer states the opposite — that Caterpillar moved *from a general partnership model* in 2022 *to a more structured, formalized contractual framework* in 2023. This reversal of direction in strategic emphasis is a major qualitative error. (4) The LLM also introduces new elements not in the ground truth — such as expanded financing through Cat Financial, dealer-development programs, and emerging market growth — which, while plausible, are not supported by the provided knowledge graph and appear to be speculative. These additions suggest synthesis beyond the available evidence. Thus, while the answer is contextually relevant and includes accurate fragments, it fails on the key multi-hop comparison: the nature and direction of change in dealer relationships. The conclusion is therefore incorrect, warranting a low correctness score despite some factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 492,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "\nFrom 2022 to 2023 the company sharply trimmed the weight of Africa/Eurasia in its restructuring program—charges attributed to that region fell from roughly 11 % of total 2022 restructuring outlays to only about 5 % of the 2023 total—while capital spending in the region remained modest (historical CapEx of $33 million in 2021 and $13 million in 2020, with no indication of a sizable increase in 2022‑23). This shift signals a strategic re‑allocation of resources away from Africa/Eurasia toward other markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that Africa/Eurasia accounted for approximately 11% of 2022 restructuring charges and dropped to 5% in 2023. The ground truth states that about 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative relate to Africa/Eurasia—there is no mention of 2023 restructuring charges or a drop to 5%. Additionally, the LLM misrepresents historical capital expenditures: it claims $33 million was spent in 2021 and $13 million in 2020, but the original answer states $33 million in 2022, $13 million in 2021, and $8 million in 2020. The LLM reverses the years and omits 2022 CapEx entirely. (2) The quantitative inaccuracies are severe: all three CapEx figures are assigned to wrong years, and the restructuring percentages (11%, 5%) are fabricated with no support in the ground truth. There is no data about 2023 restructuring charge distribution by region in the original answer. (3) The multi-hop reasoning is flawed. The original answer draws a contrast between continued capital investment in 2022 and a shift toward restructuring in 2023 under the 2022 initiative. The LLM incorrectly infers a decline in regional focus based on non-existent 2023 restructuring data and misattributed CapEx, leading to an erroneous conclusion about resource reallocation away from the region. It fails to recognize that the 2023 shift is part of the 2022 initiative and misinterprets the nature of the strategic evolution. (4) Due to major factual errors in numbers, years, and reasoning, the correctness score is low at 3. The answer touches on the idea of shifting focus but does so with incorrect data and logic. Quantitative accuracy is 2 due to pervasive number errors. Qualitative accuracy is 3 because the conceptual framework (shifting focus) is partially aligned but based on false premises. Contextual relevance is 5 because the answer addresses the region and the general theme of strategic shift, but with significant distortions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 550,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "\nFrom 2022 to 2024 Qualcomm moved its 5G strategy from a broad, risk‑laden R&D and standard‑essential‑patent focus toward a more commercial‑driven rollout of integrated 5G modem‑RF and RFFE solutions (e.g., the Snapdragon 5G modem‑RF platform) and expanded 5G into new verticals such as automotive and IoT.  The investment emphasis shifted to higher‑margin, volume‑driven sales of 5G‑enabled chipsets and related components, while still sustaining its 5G patent‑licensing business, resulting in clearer revenue streams from 5G products despite ongoing supply‑chain constraints.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution from 2022 to 2024. It accurately captures Qualcomm's shift from R&D and investment in 5G technologies toward commercialization, including expansion into automotive and IoT verticals, and highlights continued emphasis on patent licensing and high-margin chipset sales. The mention of Snapdragon 5G modem-RF platforms and RFFE solutions reflects accurate product-level detail consistent with Qualcomm's commercialization efforts. There are no numeric values in the original or LLM answer, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM does not explicitly mention the transition to generating the majority of QTL revenues from OFDMA-based products or the specific risks (regulatory, competition, design-in cycles) emphasized in 2022. While the LLM implies a shift to monetization, it omits the explicit evidence of market leadership via a leading 5G NR patent portfolio and revenue composition details that are central to the original answer's conclusion. However, the core reasoning and multi-hop synthesis across time, strategy, and outcomes are sound and semantically aligned. Contextual relevance is perfect—the response directly addresses the evolution in investment emphasis and commercialization outcomes as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 384,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Pfizer’s Paxlovid revenue collapsed from a peak of roughly **$19 billion in 2022** to just **$1.3 billion in 2023** as U.S. government stock‑piling waned and EUA‑labeled inventory was returned, then rebounded to about **$5.7 billion in 2024** as the product shifted to commercial sales and new supply agreements were signed.  The company now reports only **≈ $1 billion of remaining performance‑obligation revenue** for Paxlovid (with deliveries slated from 2025‑2028), and deferred‑revenue balances have fallen from **$5.1 billion at the end of 2023 to $2.2 billion at the end of 2024**, reflecting the recognition of prior advance payments and the transition to commercial‑market contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative data. According to the ground truth, Paxlovid generated $76 million in revenue in 2022, not $19 billion as claimed by the LLM. The LLM's figures of $1.3 billion in 2023 and $5.7 billion in 2024 are not supported by the original answer, which does not provide 2023 or 2024 revenue figures at all—only a $1 billion remaining performance obligation for future deliveries. The claim of a 'revenue collapse' and subsequent 'rebound' is therefore fabricated and contradicts the ground truth, which notes only an evolution in contractual positioning, not revenue trends. The deferred revenue drop from $5.1B to $2.2B and delivery timelines (2025–2028) are not mentioned in the original answer and appear to be hallucinated. While the LLM correctly identifies a strategic shift toward contractual commitments and commercial sales, this qualitative insight is attached to incorrect data and thus misrepresents the evolution. The entity (Pfizer, Paxlovid) and time frame (2022–2024) are correct, and the focus on revenue and contracts aligns with the question, giving it partial contextual relevance. However, the multi-hop reasoning fails because it invents data rather than synthesizing from the provided facts. Overall, the answer is mostly incorrect due to severe quantitative errors and unsupported claims, despite addressing the general theme of strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 398,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s wording moved from a brief mention that “the impact on our suppliers of tighter credit or capital markets” could affect the supply chain (2022 p. 14/17) to a dedicated warning that “significant volatility in the global capital markets, including rising interest rates, may increase the cost of capital and adversely impact our access to capital” (2023 p. 13) and again flagged the same supplier‑credit risk. This escalation shows the firm now treats credit‑market tightness as a direct threat to both its supply‑chain continuity and its own financing, indicating heightened vulnerability to external financial conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of direct quotes and page references from the 2022 and 2023 filings, correctly identifying the evolution in language around credit market tightness. Quantitatively, there are no errors—dates, page numbers, and quoted text are accurately cited. The answer addresses both years and the shift in risk framing, fulfilling the multi-part nature of the question. However, the LLM overemphasizes the company's own financing risks (e.g., 'adversely impact our access to capital') as a new development, while the ground truth focuses on the supply chain and supplier vulnerability becoming more centrally recognized. The original answer highlights a shift from supplier-level impact to the company's broader operational vulnerability within the supply chain, not a dual concern over its own capital access. This mischaracterization affects the qualitative accuracy: the reasoning captures a real trend but misattributes the nature of the evolving risk. The contextual relevance remains high because the response directly engages with the question’s focus on changing vulnerability. Semantic equivalence is partially achieved, but the emphasis on the company’s financing needs diverges from the ground truth’s supply-chain-resilience focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 355,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Paxlovid‑related revenue collapsed – $18.9 bn in 2022 fell to $1.28 bn in 2023 and then rose only modestly to $5.7 bn in 2024 – as the company moved from large U.S. government EUA contracts to commercial‑market sales.  This transition triggered a $3.5 bn non‑cash revenue reversal in Q4 2023 and a $771 m favorable adjustment in Q1 2024 for returned courses, while deferred‑revenue balances for Paxlovid dropped from $5.1 bn (2023) to $2.2 bn (2024), underscoring a sharp reduction in the company’s financial commitment and contractual obligations tied to the product.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual inaccuracies and misrepresents the evolution of Pfizer's financial commitment and contractual obligations for Paxlovid from 2022 to 2024. (1) Quantitatively, the LLM correctly cites the $771 million favorable adjustment in Q1 2024 related to returned Paxlovid courses, aligning with the ground truth. However, it introduces figures not present in the original answer—such as $18.9B revenue in 2022, $1.28B in 2023, $5.7B in 2024, a $3.5B non-cash reversal in Q4 2023, and deferred revenue dropping from $5.1B to $2.2B—none of which appear in the ground truth and cannot be verified against the provided knowledge. These numbers may be factually incorrect or taken out of context. (2) The ground truth emphasizes that as of December 31, 2024, Pfizer had approximately $1 billion in remaining performance obligations for Paxlovid, with deliveries expected from 2025–2028, indicating ongoing long-term contractual commitments. The LLM answer contradicts this by claiming a 'sharp reduction in financial commitment,' which is not supported by the disclosed $1B obligation. (3) The qualitative reasoning is flawed: while the LLM correctly notes the transition from EUA-driven government purchases to commercial sales, it infers declining commitment, whereas the ground truth shows sustained contractual obligations beyond 2024. The mention of renegotiation risk is absent in the LLM response. (4) Contextually, the answer addresses the question’s scope and uses appropriate financial terminology, hence a decent relevance score. However, the core conclusion—that financial commitment has sharply declined—is factually incorrect based on the disclosed $1B future obligation. Thus, despite some accurate details (e.g., the $771M adjustment), the overall synthesis is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 497,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "\nFrom 2023 to 2024 the Company’s recorded exposure to Aearo‑related respirator‑mask/asbestos liabilities fell modestly in the balance sheet – the accrual (excluding Aearo’s own $62 million balance in 2023) dropped from about **$574 million at year‑end 2023 to $523 million at year‑end 2024** – but this decline reflects **$87 million of legal‑defense and settlement payments made in 2024** and a **$36 million increase in the 2024 accrual** for pending and anticipated claims.  Consequently, while the net accrued liability is slightly lower, the **underlying risk remains large**: Aearo’s share of future claims is still capped only by the 1995 indemnity agreement, and the Company acknowledges it cannot estimate how much the liability could exceed the accrued amount because of possible future claim surges, changes in allocation among co‑defendants, or other developments that could push exposure well beyond the current reserve.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) Quantitative Accuracy: The LLM states that the accrual dropped from $574 million in 2023 to $523 million in 2024, implying a net decrease of $51 million. However, the ground truth states that in 2024, Aearo had *specific accruals of $51 million* for asbestos, silica, and coal mine dust claims — not a total liability of $523 million. The LLM incorrectly frames the $574 million as MMM’s total liability *excluding* Aearo in 2023, but then misrepresents the 2024 figure as $523 million, which does not appear in the ground truth. The claimed $87 million in payments and $36 million increase in accrual are entirely fabricated with no support in the original answer. (2) Completeness & Entity Accuracy: The LLM fails to mention the key development in 2024 — the contractual liability limitation between Aearo and Cabot, where Cabot assumed responsibility for pre-1997 exposures in exchange for a $100,000 quarterly fee. This is a central element of the risk evolution and is completely omitted. The LLM also incorrectly suggests that the 1995 indemnity agreement still governs exposure without mentioning the new cost-sharing and limitation framework. (3) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers trends from non-existent data and mischaracterizes the nature of liability evolution — from bankruptcy stay in 2023 to structured, limited liability in 2024 — instead portraying it as a modest reduction with ongoing uncertainty. (4) Semantic Equivalence: The overall message contradicts the ground truth: rather than showing a shift to a more defined and limited liability structure, the LLM suggests persistent, unbounded risk with minimal change. While the mention of MMM and Aearo and the general topic of asbestos/respirator liability is contextually relevant, the core facts, numbers, and reasoning are incorrect. Hence, the correctness score is low despite some topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 540,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "\nSkoal’s retail‑share fell from **9.3 % in 2023 to 7.6 % in 2024**, a drop of about **1.7 percentage points**.  By contrast, its shipment volume slipped from **163.1 million units in 2020 to 147 million units in 2021**, a reduction of roughly **16 million units (≈10 %)**.  Thus, both share and volume declined, but the relative fall in share was larger than the decline in unit shipments.  (Retail‑share data: page 48; shipment‑volume data: page 46.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in Skoal's retail share from 9.3% in 2023 to 7.6% in 2024, which matches the ground truth. However, the shipment volume data is incorrect: the LLM reports 163.1 million units in 2020 and 147 million in 2021, whereas the ground truth states 208.5 million packs/cans in 2020 and 197.4 million in 2021. This is a significant factual error. (2) The calculation of the retail share drop (1.7 percentage points) is accurate. However, the shipment volume decline is misrepresented: the LLM calculates a drop of ~16 million units (≈10%), but using the correct figures from the ground truth, the drop is 11.1 million units (about 5.3%). Thus, both the raw numbers and the derived percentage are wrong. (3) The multi-hop reasoning is structurally sound—the model attempts to compare retail share trend (2023–2024) with shipment volume trend (2020–2021) and draws a comparative conclusion. However, due to incorrect shipment data, the conclusion that 'the relative fall in share was larger than the decline in unit shipments' is based on false premises. In reality, both declines are more closely aligned (1.7 pp in share vs ~5.3% in volume), though still not directly comparable metrics. (4) The contextual relevance is high—the answer addresses both parts of the question and attempts proper synthesis. However, the quantitative inaccuracies severely undermine the correctness. The qualitative reasoning is partially valid but built on incorrect data. Hence, correctness score is 4 (partially correct but major errors), quantitative accuracy is 3 (major data errors), qualitative accuracy is 5 (logical structure but flawed inputs), and contextual relevance is 8 (fully on-topic and structured appropriately).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 478,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm broadened its engineering focus from a modem‑centric architecture to a fully integrated multimedia‑and‑AI‑centric SoC strategy.  The company added dedicated GPU/NPU engines, camera‑vision pipelines and on‑device generative‑AI processing to its Snapdragon platforms, enabling a single chip to handle high‑resolution imaging, video encoding, XR and AI workloads in addition to connectivity.  This tighter integration of multimedia functions—supported by expanded patent licensing and strategic investments such as Qualcomm Ventures—has been reflected in product families that combine modem, RF, AI and multimedia capabilities for smartphones, laptops, automotive and IoT devices.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Qualcomm's multimedia technology strategy from 2022 to 2024. It accurately captures the shift toward tighter integration of multimedia and AI capabilities into Snapdragon SoCs, highlighting on-device generative AI, enhanced imaging, video, and XR workloads—consistent with the 2024 emphasis on AI-enhanced, platform-oriented development. The mention of integration across smartphones, automotive, and IoT reflects the diversification noted in the original answer. However, the LLM slightly overstates the shift as a move 'from a modem-centric architecture,' which is not explicitly supported in the ground truth; the original answer describes multimedia and modem/RF as co-existing focus areas rather than a pivot away from modems. Additionally, while the LLM correctly identifies the inclusion of AI and multimedia integration, it omits the specific point about enabling developers to design and deploy applications across industries—a key element of the 2024 strategy related to platform orientation and ecosystem enablement. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and all entities (Qualcomm, Snapdragon, AI, multimedia technologies, device categories) are correctly identified with appropriate timeframes (2022–2024). The reasoning is sound and reflects multi-hop synthesis across engineering focus and product integration, though slightly less precise in characterizing the nature of the strategic evolution. Contextual relevance is excellent, directly addressing the question’s focus on engineering priorities and product integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 457,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "\nBetween the end of 2022 and 2023 the $0.7 bn equity investment that 3M held in the Aearo Entities was eliminated when the entities were re‑consolidated after the bankruptcy dismissal, and the related $0.6 bn net inter‑company receivable/payable that had appeared on the balance sheet was also removed. Consequently, by the 2024 reporting period there is no separate equity investment or inter‑company balance for the Aearo Entities – any remaining financial interaction is limited to settlement‑related cash outflows (e.g., the $6 bn CAE Settlement funding) recorded as expenses rather than as an equity or inter‑company asset/liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant factual errors. It correctly identifies the $0.7 billion equity investment and $0.6 billion intercompany balance, aligning with the ground truth. However, it incorrectly states that these balances were eliminated 'between the end of 2022 and 2023' due to re-consolidation after 'bankruptcy dismissal'—a detail absent from the original answer and unsupported by the provided context. The original answer specifies the reconsolidation occurred in 2023 and resulted in the removal of these balances as of December 31, 2023, which the LLM misrepresents temporally and causally. (2) Quantitatively, the $0.7 billion and $0.6 billion figures are accurate and correctly attributed, but the mention of a '$6 bn CAE Settlement funding' is not present in the original answer and appears to be an external, potentially erroneous addition. This introduces a major factual discrepancy. (3) The reasoning is flawed: the original answer states that by 2024, 3M 'has a stake in' the Aearo Entities, indicating a retained equity interest. In contrast, the LLM claims there is 'no separate equity investment' in 2024, which directly contradicts the ground truth. This failure to capture the shift from full consolidation to a retained equity interest reflects a breakdown in multi-hop reasoning and understanding of the financial relationship evolution. (4) Contextual relevance is high—the answer addresses equity investment and intercompany balances as asked—but due to key factual and directional errors in the narrative, especially regarding the nature of 3M's 2024 relationship with Aearo, the overall correctness is significantly compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 470,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Visa’s Risk and Identity Solutions shifted from a set of discrete fraud‑prevention tools (e.g., Visa Advanced Authorization, Visa Secure, Identity Score, CardinalCommerce) to a unified, AI‑driven “Visa Protect” suite that adds real‑time, scheme‑agnostic risk scoring, dedicated protection for account‑to‑account (A2A) payments, and tighter integration with tokenization and open‑banking capabilities.  This evolution embeds the function as a core pillar of Visa’s broader value‑added services portfolio—complementing Issuing, Acceptance and Consulting offerings—and reinforces its strategic role in enabling new money‑movement flows, B2B payments and the company’s “network‑of‑networks” growth agenda.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Visa's Risk and Identity Solutions from fraud prevention tools to a more integrated strategic role within value-added services, which aligns with the original answer’s core narrative. It correctly identifies key products like Visa Advanced Authorization and Visa Secure (though adds 'Identity Score' and 'CardinalCommerce' not mentioned in the ground truth). The mention of a shift toward AI-driven capabilities and integration with tokenization and open banking is contextually plausible but not explicitly supported in the original answer. However, the LLM introduces the term 'Visa Protect suite,' which does not appear in the ground truth, and claims a 'unified' suite with 'scheme-agnostic risk scoring' and 'dedicated protection for A2A payments'—specific enhancements not present in the provided truth. The original answer emphasizes structural changes: Risk and Identity Solutions becoming one of five core categories in a broader portfolio of over 200 services by September 30, 2024, which the LLM omits. While the LLM correctly infers strategic elevation, it fabricates specific product branding and technical capabilities. Quantitatively, no incorrect numbers are introduced (no explicit figures to verify), so quantitative accuracy is high by default. Contextual relevance is strong—the answer addresses the strategic positioning and evolution as asked. However, qualitative accuracy suffers due to unsupported details and lack of citation of the actual structural reorganization and scale (200+ products). The reasoning is partially sound but overreaches in specificity without evidence from the source. Thus, the answer is partially correct but contains significant embellishments that reduce factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 479,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "\nRTX continued to present acquisition‑accounting adjustments in a separate table that lists the total adjustment and its component amortizations, and the amount subtracted from operating profit grew only modestly—from **$1.998 billion in 2023** to **$2.058 billion in 2024** (an increase of roughly $60 million).  The segment‑level breakdown moved from $(854 m), $(287 m) and $(857 m) for Collins, Pratt & Whitney and Raytheon in 2023 to $(833 m), $(312 m) and $(913 m) respectively in 2024, showing that the impact on operating profit was largely consistent but slightly larger in 2024.  Management notes that these adjustments are not part of its segment‑performance evaluation, and the 2024 figures remain “relatively consistent” with the prior year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims RTX disclosed a $2.058 billion negative impact on operating profit in 2024, with detailed segment breakdowns. However, the ground truth states that RTX did *not* provide any updated quantitative figures for 2024 — meaning the $2.058B number and all segment-level 2024 figures (e.g., $833M, $312M, $913M) are fabricated and factually wrong. The only correct number is the 2023 impact of $1,998 million (correctly stated as $1.998 billion). (2) Qualitatively, the LLM fails to recognize the key shift in disclosure policy: in 2024, RTX moved from quantitative to *qualitative* disclosure, providing only policy context without current-year numbers. Instead, the LLM asserts that RTX 'continued' to present adjustments in a table with updated figures, which contradicts the ground truth. (3) The multi-hop reasoning is flawed — the question asks about the *evolution* of disclosure and quantification, requiring synthesis of changes in both content and approach over time. The LLM incorrectly concludes consistency and provides false precision. (4) Contextual relevance is low because the answer invents data rather than describing the actual shift from numerical to conceptual disclosure. Minor credit is given only for correctly recalling the 2023 figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 380,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Office 365 Commercial line‑of‑business grew from roughly **$44.9 billion** (the “Office products and cloud services” figure reported for 2022) to **$54.9 billion** in 2023 – an increase of about **22 %**.  At the same time Microsoft’s overall Cloud revenue rose from **$91.4 billion** to **$111.6 billion**, meaning the portion of Cloud revenue coming from Office 365 Commercial expanded markedly.  This acceleration shows that Office 365 Commercial is becoming an increasingly dominant driver of Microsoft’s cloud growth trajectory within the broader cloud ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the claimed Office 365 Commercial revenue figures of $44.9B in FY2022 and $54.9B in FY2023. The original answer (ground truth) does not provide specific revenue figures for Office 365 Commercial alone, only noting its role as a growth driver within the Productivity and Business Processes segment and its inclusion in the broader Microsoft Cloud revenue. There is no public disclosure from Microsoft that isolates Office 365 Commercial revenue at this level of precision, making these numbers fabricated or incorrectly inferred. (2) While the Microsoft Cloud revenue figures are correct—$91.4B in FY2022 and $111.6B in FY2023—the calculation of a 22% growth rate for Office 365 Commercial is unsupported due to the lack of source data. The LLM incorrectly implies that 'Office products and cloud services' equals Office 365 Commercial revenue, which is a misrepresentation; that category includes consumer and other non-commercial offerings. (3) The reasoning is partially sound in noting increased prominence within the cloud ecosystem and improved transparency, but it fails the multi-hop synthesis by inventing granular revenue data not present in the source. The conclusion about Office 365 Commercial becoming a 'dominant driver' due to expanding share is speculative and not supported by the ground truth, which only confirms continued growth within a consolidated cloud segment. (4) Scores reflect major quantitative errors (3/10), moderate qualitative accuracy due to correct contextual framing of growth and cloud integration (5/10), high contextual relevance as it addresses the evolution and trajectory (8/10), and an overall correctness score of 4 due to the critical error of introducing false revenue figures despite correct broader trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 499,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "\nMerck’s alliance revenue from Lynparza rose from **$1.199 billion in 2023 to $1.311 billion in 2024**—an approximate **9 % increase** (about **11 % when adjusted for foreign‑exchange**). The growth was driven primarily by **higher demand for Lynparza in most international markets**, reflecting continued uptake across its approved cancer indications and favorable pricing, which more than offset any modest currency headwinds. (The text notes that the 2024 increase “largely due to higher demand in most international markets.”)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a 9% growth in Lynparza alliance revenue from 2023 to 2024, aligning with the ground truth. It adds specific dollar figures ($1.199 billion in 2023 and $1.311 billion in 2024), which are consistent with a 9% increase (1.199 * 1.09 ≈ 1.307, close to 1.311; minor discrepancy likely due to rounding or FX adjustment). The mention of an 11% growth adjusted for foreign exchange is additional context not contradicted by the original answer and plausibly derived from the source. (2) Quantitative accuracy is high: the percentage increase matches exactly, and the dollar amounts are precise and internally consistent. The calculation from 2023 to 2024 is approximately correct (9% of $1.199B is ~$108M; $1.199B + $108M = $1.307B vs reported $1.311B — difference of $4M, likely due to FX adjustments as noted). (3) The reasoning is sound: the LLM correctly attributes the revenue growth to higher international demand, which is the key factor in the ground truth. It appropriately contextualizes the growth within approved indications and pricing dynamics, which are reasonable inferences consistent with pharmaceutical revenue drivers. (4) The answer is fully relevant, addressing both the evolution of revenue and the contributing factors. The only reason for not scoring a 10 is the slight numerical discrepancy in the calculated growth and the addition of FX-adjusted percentage not present in the original, which, while plausible, is an augmentation beyond the ground truth. However, this does not constitute an error, so the score remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 438,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "\nIn the 2023 and 2024 Form 10‑K filings the Procter & Gamble 2014 Stock and Incentive Compensation Plan is still listed in Item 12’s equity‑compensation table, but the 2024 filing explicitly notes that the plan is now closed to new grants—its remaining authorized shares are effectively zero and all future issuances must come from the 2019 Plan. The underlying regulatory requirement (Item 12 of Form 10‑K) has not changed, yet the 2024 disclosure adds clarification on the share‑counting methodology and references the 2024 Proxy Statement for the plan’s current status.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides accurate regulatory context and correctly identifies the 2014 Plan's inclusion in Item 12 of the Form 10-K for both 2023 and 2024, which aligns with the reporting requirement. It adds specific details not in the original answer—such as the plan being closed to new grants and having effectively zero authorized shares in 2024—which are plausible and contextually consistent, but cannot be verified against the ground truth provided, as the original answer does not mention share counts or closure status. This introduces potentially accurate but unconfirmed information, which affects factual reliability. The LLM correctly notes the continued regulatory requirement under Item 12 and references to the 2024 Proxy Statement, showing sound entity and context understanding. However, the original answer emphasizes an evolution in disclosure focus—from regulatory context in 2023 to ownership structure and transparency in 2024—while the LLM focuses on administrative closure and share exhaustion. This represents a different interpretation of 'evolution': the LLM emphasizes operational status, while the ground truth emphasizes reporting intent and integration into equity frameworks. Thus, while the LLM answer is internally logical and contextually relevant, it does not fully align with the ground truth’s qualitative characterization of the plan’s evolving role. Quantitatively, no explicit numbers are in the original answer, but the LLM’s claim about 'remaining authorized shares are effectively zero' lacks corroboration and introduces a specific detail absent from the verified truth, reducing confidence in completeness and accuracy. Multi-hop reasoning is partially sound—tying the plan to reporting requirements across years—but misses the synthesis of shifting disclosure purpose emphasized in the original. Overall, the answer is factually plausible and relevant but diverges on the core qualitative evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 530,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings the company’s disclosure shows the 1992 Stock Plan has become a closed, legacy vehicle: it still appears in the equity‑compensation table and its outstanding options are counted in column (a), but the filings make clear that no additional shares may be granted under that plan.  In contrast, the 2019 Stock and Incentive Compensation Plan is now the sole plan that permits future grants, with a remaining availability of about 77 million shares (out of a total authorized 187 million).  Consequently, the 1992 Plan’s role has shifted from being an active source of new equity awards to a historical pool of existing awards, while the company’s future equity‑compensation supply is drawn exclusively from the 2019 Plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of the 1992 Stock Plan from an active, referenced plan in 2023 to a legacy, closed plan in 2024, now only tracking outstanding options. This matches the ground truth's assertion of a shift from standalone adoption to passive inclusion in a consolidated table. (2) No specific numeric values (e.g., share counts) are mentioned in the original answer, so the LLM’s inclusion of '77 million shares' and '187 million' from the 2019 Plan does not contradict the ground truth and appears contextually accurate based on typical 10-K disclosures—these numbers are plausible and enhance completeness without introducing error. (3) The multi-hop reasoning is sound: the LLM infers from the 2024 filing that the 1992 Plan is no longer active for new grants and that the 2019 Plan is now primary, which is a logical synthesis across years and plans. (4) The answer goes slightly beyond the original by naming the 2019 Plan and providing share figures, but this additional detail is consistent with typical equity compensation disclosures and improves clarity without misrepresenting facts. The only reason for not scoring a 10 is that the original answer emphasizes the 'incorporated by reference' nature in 2023 and the tabular consolidation in 2024, which the LLM describes conceptually but doesn't quote directly—however, the semantic meaning is equivalent. All entities (1992 Stock Plan, equity compensation structure, implication of closure) are correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 431,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company’s messaging shifted from simply noting that large‑scale transformations were a growth opportunity to emphasizing that clients are now **prioritizing multi‑year, high‑value deals** and are **cutting back on shorter‑duration, smaller contracts**—a change driven by volatile economic conditions.  As a result, the **revenue from these transformations is recognized over a longer horizon**, meaning the conversion timeline has lengthened as the business now depends more on sustained, large‑scale engagements rather than quick‑turn consulting work.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in client spending patterns: reduction in smaller, shorter-duration contracts in both 2023 and 2024, with continued prioritization of large-scale, multi-year transformations. The emphasis on longer revenue conversion timelines due to extended contract durations is accurately reflected. (2) There are no quantitative figures in the original answer, and the LLM does not introduce any incorrect numbers, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—synthesizing information across 2023 and 2024 filings to show a strategic shift in emphasis from identifying large-scale transformations as an opportunity to observing an active client-driven prioritization. The LLM slightly strengthens the language by saying the 'messaging shifted' and that clients are 'now prioritizing,' which is a reasonable interpretation but not explicitly stated as a change in tone between years in the original. This minor interpretive leap prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing client spending patterns and revenue conversion timelines as asked. Overall, the LLM conveys the same core information with excellent fidelity, minor wording differences notwithstanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 376,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "\nAccenture’s Class A ordinary‑share issuance for employee compensation fell from about **8.88 million shares in fiscal 2023 to roughly 7.87 million shares in fiscal 2024** (a decline of ~1.0 million shares, or ≈11 %).  The smaller issuance generated **$2.28 billion of additional paid‑in capital** in 2024 versus **$2.15 billion in 2023**, and resulted in a **smaller reduction of treasury stock** ($131 million vs $1.34 billion), which together produced only a modest rise in total shareholders’ equity ($28.29 billion in 2024 versus $25.69 billion in 2023) and a slightly lower dilution of existing shareholders.  (Pages 72 & 82 of the 2024 and 2023 Consolidated Shareholders’ Equity statements.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both direction and magnitude of share activity. (1) Quantitatively, the LLM claims Accenture issued ~7.87 million shares in 2024, but the ground truth states Accenture issued only 7,970 shares (not million) for employee programs in 2024—this is off by a factor of over 1,000. Similarly, the LLM reports 8.88 million shares issued in 2023, but the ground truth indicates Accenture did not issue shares for compensation in 2023; instead, it acquired shares via withholding for tax obligations. The dollar amounts cited ($2.28B and $2.15B in paid-in capital) and treasury stock reductions ($131M vs $1.34B) are unsupported by the ground truth and appear fabricated. The reported total shareholders’ equity ($28.29B in 2024 vs $25.69B in 2023) is irrelevant as the ground truth does not mention total equity figures. (2) The calculation of an 11% decline in issuance is based on false inputs and is therefore invalid. (3) Qualitatively, the reasoning is flawed: the LLM incorrectly frames the trend as a decrease in issuance, while the ground truth describes a shift from share acquisition (2023) to a net issuance (2024), despite the small number of shares issued. The impact on equity structure is misrepresented—the ground truth notes an increase in Class A shares from 15,656,591 to 15,664,561 (an increase of 7,970 shares), which aligns with the issuance, but the LLM fails to mention this and instead invents large-scale equity movements. (4) Contextually, the answer addresses the general topic of employee share compensation and equity impact, so it remains relevant, but the factual inaccuracies severely undermine correctness. The citation of 'pages 72 & 82' cannot be verified but likely misrepresents the data. Overall, the LLM fails the multi-hop synthesis: it does not correctly identify the nature of share activity (acquisition vs issuance), misreads quantities, and invents financial impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 530,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the notional amount of Canadian‑denominated debt that MDLZ uses in its net‑investment‑hedge program rose from **$443 million to $453 million** (≈ 2 % growth).  This modest uptick occurs as the company’s overall foreign‑currency hedge base expanded slightly (total net‑investment‑hedge derivatives grew from $7.3 bn to $7.5 bn) and the composition shifted – Canadian exposure increased while Swiss‑franc and other currency notional fell – indicating a small but deliberate scaling of its Canadian‑currency hedging relative to the broader foreign‑currency‑debt management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth on key factual and quantitative levels. (1) Quantitatively, the LLM reports Canadian-denominated debt increasing from $443 million to $453 million in 2022–2023, which directly contradicts the ground truth stating that Canadian notes were only $3 million in 2022 and increased by $8 million (to $11 million) in 2023. The LLM's figures are off by orders of magnitude. (2) The ground truth emphasizes a reversal of a multi-year downward trend (from $17M in 2019 to $3M in 2021), but the LLM does not mention this historical context or trend reversal, instead framing the change as a modest increase within a much larger base. (3) The LLM introduces the concept of a 'net-investment-hedge program' and total hedge derivatives ($7.3B to $7.5B), which are not mentioned or supported in the original answer, suggesting fabrication or misattribution. (4) While the LLM correctly notes a shift in currency composition and mentions Swiss franc volatility (partially aligning with the ground truth), it misrepresents the scale and nature of MDLZ’s Canadian exposure. (5) The reasoning is internally logical but based on incorrect data, failing the multi-hop synthesis requirement—instead of connecting declining balances over years and the 2023 reversal, it invents a large notional base not present in the source. (6) The answer is contextually relevant in discussing foreign currency debt management but fundamentally inaccurate in magnitude, trend description, and supporting details. Minor alignment exists in noting a shift in foreign currency exposure, but core facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 448,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "\nFrom 2023 to 2024 Accenture moved from a largely exploratory stance toward growth‑stage firms to a deliberately strategic partnership model.  The company deepened its engagement by formalizing Accenture Ventures as the primary vehicle for investing in and co‑creating solutions with high‑potential startups, expanding the use of Innovation Centers, Labs and the broader ecosystem to integrate those firms into client‑focused transformation programs.  This shift was accompanied by a measurable rise in venture‑investment activity and partnership deals in fiscal 2024, signaling a more structured, long‑term investment pipeline that ties growth‑stage technology providers directly to Accenture’s service‑delivery and innovation agenda.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements regarding Accenture's increased strategic engagement with growth-stage companies and the role of Accenture Ventures, but it misrepresents the nature of the evolution between 2023 and 2024. The ground truth states that in 2023, Accenture primarily 'partnered with' growth-stage firms, and in 2024 shifted to directly 'investing in' them—a move from partnership to investment. However, the LLM incorrectly frames the 2023 approach as 'exploratory' and claims a shift to a 'strategic partnership model' in 2024, which inverts the actual progression. The LLM also introduces unsupported details such as a 'measurable rise in venture-investment activity and partnership deals' and 'co-creating solutions' without grounding in the provided truth. (2) There are no numeric values in the LLM answer, so quantitative accuracy is not violated—no incorrect numbers or miscalculations are present, hence a score of 10. (3) The multi-hop reasoning is partially sound in recognizing a strategic evolution involving Accenture Ventures and innovation infrastructure, but it fails to accurately synthesize the key shift from partnership to direct investment, which is the core of the ground truth. The LLM invents a narrative of increasing formality and structure without evidence in the source. (4) Contextual relevance is high because the answer addresses Accenture’s evolving engagement with startups and ties it to innovation strategy, but the factual misrepresentation of the nature of the shift significantly undermines correctness. Thus, the overall correctness score is 5—partially correct but with significant factual inaccuracies in the central claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 466,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "\nFrom 2022 through 2024 Merck’s share of Lynparza sales (reported as “Alliance revenue – Lynparza”) grew from **$1.12 bn in 2022 to $1.199 bn in 2023 and $1.311 bn in 2024**, a roughly **9 % year‑over‑year increase and an 18 % rise over the two‑year span**.  The collaboration’s intangible asset balance tied to Lynparza—primarily capitalized milestone payments—remained at about **$1.1 bn** and is being **amortized over its estimated useful life through 2028**, with the amortization expense continuing to flow through cost of sales.  This steady amortization schedule and the uninterrupted growth in alliance revenue reflect a stable strategic partnership that has deepened rather than shifted dramatically between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the amortization of the $1.1 billion intangible asset through 2028, consistent with the original answer. It also accurately captures the 9% year-over-year revenue growth in 2024 (from $1.199B in 2023 to $1.311B in 2024), aligning with the '9% increase due to higher demand' in the ground truth. The LLM provides even more granular data—exact revenue figures for 2022, 2023, and 2024—which are not contradicted by the original answer and support the stated growth trend. (2) All numbers are quantitatively accurate: $1.1B asset balance, amortization through 2028, and the 9% growth rate (calculated as (1.311 - 1.199)/1.199 ≈ 9.3%) are correct. The LLM’s additional detail (e.g., 18% total growth over two years) is a valid inference and does not conflict with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes financial data across years, correctly links amortization to cost of sales, and interprets stable amortization alongside revenue growth as evidence of a deepening strategic partnership. The only minor shortcoming is that the LLM does not mention the early 2025 China approval, which is part of the strategic evolution in the original answer. However, since the question focuses on 2022–2024 and the approval occurs in early 2025, this omission is contextually justifiable. (4) The answer is highly relevant, factually precise, and semantically aligned with the ground truth. The slight deduction in qualitative accuracy is due to the absence of forward-looking strategic context (China approval), but the core reasoning and data synthesis remain excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 449,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Broadcom moved ValueOps from a peripheral “domain” listed under its Distributed‑Software portfolio (2023 pages 8‑10) to a stand‑alone, prominently featured offering in the Private‑Cloud and Distributed‑Software sections, with a detailed description of its value‑stream management capabilities that align business, development and operations to boost transparency, efficiency and time‑to‑value (2024 pages 8‑9). This shift signals that Broadcom is positioning ValueOps as a core growth engine and the primary vehicle for delivering end‑to‑end visibility and business outcomes across its Distributed‑Software portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AVGO's (Broadcom's) strategic emphasis on ValueOps between 2023 and 2024. It correctly identifies that in 2023, ValueOps was a less prominent offering within the Distributed Software portfolio, and by 2024 it became a central, stand-alone domain alongside DevOps and AIOps. The answer accurately reflects the shift in strategic positioning, noting the enhanced focus on end-to-end visibility, alignment of business and IT, and improved time-to-value—consistent with the ground truth's emphasis on 'end-to-end visibility across all stages of the digital lifecycle' and alignment with business outcomes. The mention of 'Private-Cloud and Distributed-Software sections' and specific page references (2023 and 2024 pages 8–9) adds contextual precision, though the original answer does not specify page numbers, so this is a minor addition rather than an error. The only slight shortfall is that the original answer emphasizes ValueOps becoming one of the three organizing 'domains' structuring the entire portfolio, while the LLM frames it as a 'stand-alone, prominently featured offering'—a nuance in framing but not a factual error. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the reasoning correctly synthesizes multi-hop information across years and strategic contexts. The answer is fully relevant and addresses both parts of the question: the change in strategic emphasis and its implications for the Distributed Software portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 427,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 FedEx moved Network 2.0 from a high‑level strategic concept into an active integration program – the 2023 filing introduced the DRIVE transformation and Network 2.0 as a multi‑year effort to consolidate FedEx Ground and Services, redesign the international air network (the “Tricolor” initiative), and achieve permanent cost‑structure reductions and greater network efficiency. By the 2024 filing the company had completed the new “one FedEx” legal structure and was actively merging the networks, but it explicitly warned that the integration could generate higher‑than‑expected costs, deliver less‑than‑projected savings, and encounter labor, regulatory, customer‑retention and other execution risks, making the timing and magnitude of the anticipated cost savings uncertain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of FedEx's strategic approach to Network 2.0 between 2023 and 2024 with strong factual and semantic alignment to the ground truth. (1) It correctly identifies the shift from strategic planning in 2023—highlighting the DRIVE transformation, network consolidation (FedEx Ground and Services), international air redesign (Tricolor), and expected cost savings—to the 2024 focus on active integration and associated risks. The mention of the 'one FedEx' legal structure aligns with the broader integration context. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised; all time references (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes the shift in tone and content between the two years’ filings—strategic intent in 2023 vs. execution risks in 2024—including risks like labor issues, customer retention, regulatory challenges, and uncertainty in cost savings. These match the original answer’s emphasis on integration complexities and financial uncertainties. (4) The LLM omits a few specific risks mentioned in the original—such as tax impacts, litigation, and asset impairment charges—but captures the core risks (labor, customer agreements, cost overruns) and the overall shift in focus. The addition of 'Tricolor' and 'one FedEx' provides contextual detail not in the original but consistent with public knowledge and plausible within the scope. Overall, the answer is factually correct, well-reasoned, and fully relevant, warranting a 9 for correctness and qualitative accuracy due to minor omissions in risk enumeration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 468,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the earnings impact from equity‑method investment contracts shifted from essentially $0 million in 2022 to a $7 million gain in 2023 (up from $2 million in 2021 and a near‑zero result the prior year).  This jump reflects a larger fair‑value exposure and more active use of the bifurcated embedded‑derivative structure tied to its JDE Peet’s investment, signalling that MDLZ is increasingly relying on these contracts to manage and monetize its equity‑method stake.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, MDLZ reported a net *liability* of $3 million, not a near-zero or $0 million result as claimed by the LLM. The LLM incorrectly states that the 2022 impact was $0 million, which contradicts the original answer. While the 2023 gain of $7 million is correct, the characterization of the 2022 figure is wrong, leading to an inaccurate portrayal of the shift. Additionally, the LLM introduces data not present in the ground truth—namely, a $2 million gain in 2021—which was not part of the original context and is therefore unsupported. (2) Quantitative accuracy is low because the core comparison (from -$3M to +$7M) is misrepresented as a shift from $0M to $7M. This misstates both the magnitude and direction of change. The calculation of a $10M swing (implied in truth) becomes a $7M increase in the LLM’s version, distorting the financial evolution. (3) The reasoning is partially sound in that it infers increased engagement or strategic use of investment contracts from the increase in gains, which aligns with the original answer’s interpretation. However, the multi-hop synthesis is flawed because it fails to recognize the liability-to-gain reversal (a key qualitative shift) and instead frames it as growth from near-zero, undermining the conclusion. The mention of JDE Peet’s and bifurcated embedded-derivative structures, while potentially accurate, goes beyond the provided ground truth and introduces unverified detail. (4) Contextual relevance is high because the answer addresses the evolution of financial impact and attempts to interpret MDLZ’s engagement strategy. However, due to incorrect base figures and unsupported additions, the overall correctness score is limited to 4—partially correct but with major factual errors affecting interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 507,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "\nThe estimated cost to complete for the July 2024 VMware Cloud Foundation releases fell from roughly $45 million in fiscal 2023 to $38 million in fiscal 2024, while the percentage of completion rose from about 55 % to 67 %. This reduction in remaining cost and higher completion rate indicate that the releases are progressing ahead of schedule and are on track for delivery within fiscal 2024, exceeding prior expectations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the estimated cost to complete remained unchanged at $38 million from fiscal year 2023 to 2024. However, the LLM claims it decreased from $45 million to $38 million, which is incorrect. Additionally, the LLM introduces a 'percentage of completion' rising from 55% to 67%, a detail not present in the original answer and unsupported by the ground truth. These fabricated numbers severely undermine factual correctness. (2) Quantitative accuracy is low: the $45M figure and the two percentages (55%, 67%) are entirely incorrect and not mentioned in the ground truth. While the $38M figure in fiscal 2024 is correct, the comparison is invalid due to the incorrect prior-year value. No calculations are performed in the original, so no calculation verification is needed, but the LLM invents metrics that distort the conclusion. (3) The reasoning is flawed due to incorrect data. The conclusion that development is 'ahead of schedule' and 'exceeding prior expectations' contradicts the ground truth, which interprets stable costs as 'proceeding largely as planned'—not exceeding expectations. The multi-hop synthesis fails because the model misrepresents the evolution of costs rather than correctly identifying no change. (4) Contextual relevance is moderate: the LLM addresses the right topic (cost to complete for VMware Cloud Foundation July 2024 releases) and attempts to interpret development progress, but the incorrect data leads to a misleading analysis. The focus on progress relative to expectations is relevant, but the conclusion is factually unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 455,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "\nBetween 2023 and 2024 the Ship & Go kiosk was broadened both in reach and capability: the kiosk network stayed around 1,300 sites but its functionality was deepened—customers can now create a label via mobile/QR code, drop packages into a secure bin, and, importantly, use the same locations for **label‑less, in‑store returns** through FedEx Consolidated Returns.  This expansion ties the kiosk to a larger digital‑design‑to‑print and returns platform, positioning FedEx Office as an omnichannel hub that links e‑commerce fulfillment with reverse‑logistics.  The move signals that FedEx is leveraging its retail footprint to offer a seamless, technology‑driven shipping‑and‑returns experience, reinforcing its strategy of integrating physical stores into the end‑to‑end e‑commerce logistics chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the statement that the kiosk network remained at approximately 1,300 locations is correct and matches the original answer. No other numerical data (dates, percentages, dollar amounts) is present, so no calculation errors exist. (2) The LLM correctly identifies the core functionality in both years: mobile/QR code label generation and secure drop-off. It accurately captures the 2024 enhancement—label-less, in-store returns via FedEx Consolidated Returns—which is explicitly mentioned in the ground truth as part of FedEx Returns Technology. (3) The reasoning is sound: the LLM synthesizes the evolution from a shipping-only tool to a broader returns node, correctly inferring that this reflects a strategic shift toward integrating physical locations into end-to-end e-commerce logistics. The term 'omnichannel hub' and 'reverse-logistics' are interpretive but semantically consistent with the original conclusion about FedEx's strategic positioning. (4) Minor point: the original answer notes that the *description* evolved more than the actual network size or core tech, emphasizing a shift in strategic *emphasis*. The LLM frames it as a 'broadening in capability', which slightly overstates functional changes rather than messaging emphasis, but the practical implications are correctly interpreted. Thus, while not perfectly aligned in nuance, the LLM conveys substantively equivalent and factually correct information. All parts of the question are addressed: evolution between 2023–2024, e-commerce logistics, and returns management. Therefore, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 481,
        "total_tokens": 1918
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 6.0,
    "average_quantitative_accuracy": 6.61,
    "average_qualitative_accuracy": 6.34,
    "average_contextual_relevance": 8.39,
    "score_distribution": {
      "excellent": 293,
      "good": 171,
      "fair": 299,
      "poor": 237
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 10349.58,
    "timestamp": "2026-02-02T18:32:55.327939"
  }
}